Citrus Sinensis ID: 011991

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470---
Protein Sequence
MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK
Secondary Structure (PSIPRED)
cHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccHHHHHHHHHcccccccccccccHHHHHHHHccHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccEEEEcccEEcEEEEEEEccEEEEEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEEcccEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccEEEEccccEEEEcccccEEccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHcccccEEcccccEEcccccccccccccEEEEccccccccccccccccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHcccccccccccccccccccccccccccHHHEEEEEcccccccEEEEEEEcccEEEEEEcccccccccHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEccccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHHHEEEccccEEEEEcccHHHHEEcccccccHccccccccccEEEccHHHHHccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccHcccccHHHHHHHHHHHHHccccccccccccccccc
Coil and Loop (DISEMBL)
MENLTAQLKRGisrqfstgsLRRSLTRQmsrqssfdprrnnmrfsfgrqssldpirrspvqdeltvpenLDSTMQLLFMACRGDVKGVEDLlnegsdvnsidldgrtaLHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKArgakvpktkrtpmtvanprevpeyelnpleLQVRKadgitkgsYQVAKWNGTKVWVKILdkeshkdperiNAFTHELTIVEkarhpnvvQFVGAVTQNIPMMIVLEYHAKGDLASYLqkkgrlspSKVLRFALDLARGmnylheckpdpiihcdlkpknilldnggqlkisgfgllrlqyispekakivfpvshidpanlyvapeiykneefdrsvdaySFGLILYEMIegvqpfhpkppeeVVKLMccegkrpplkikarsyppdlKELIeecwdpkpvirpnFNEIIARLDRIVcncskqgwwkdtfklpwk
Flexible Loop (DISEMBL)
menltaqlkrgisrqfstgslrrsltrqmsrqssfdprrnnmrfsfgrqssldpirrspvqDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKkanidardrwgstaaadakyygnVEVYNILkargakvpktkrtpmtvanprevpeyelnpLELQVRKADGitkgsyqvakwngtKVWVKILDkeshkdperINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEgkrpplkikarsypPDLKELieecwdpkpvIRPNFNEIIARLDRIVCNCskqgwwkdtfklpwk
Low Complexity Region (SEG)
MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK
Disordered region (IsUnstruct)
***********************************************************************STMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA********************YELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKL***
Disordered Region (DISOPRED)
************************************************************************TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNI************************PEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI**********VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKD*FKLPWK
Disordered Region (DISEMBL)
********KRGISRQFSTGS***************DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK
Disordered Region (DISPRO)
*****************TGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	473	2.2.26 [Sep-21-2011]
Q05609	821	Serine/threonine-protein	no	no	0.515	0.297	0.379	3e-36
Q54Y55	506	Dual specificity protein	yes	no	0.585	0.547	0.333	1e-35
P18160	2410	Dual specificity protein	no	no	0.551	0.108	0.343	3e-35
Q54U31	744	Dual specificity protein	no	no	0.566	0.360	0.331	1e-32
Q2MHE4	390	Serine/threonine-protein	no	no	0.498	0.605	0.341	2e-32
Q54R58	918	Probable tyrosine-protein	no	no	0.558	0.287	0.334	1e-31
Q54N73	691	Seven transmembrane domai	no	no	0.610	0.418	0.314	4e-31
Q9FPR3	933	Serine/threonine-protein	no	no	0.526	0.266	0.349	1e-30
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.558	0.162	0.333	2e-30
Q54TA1	749	Probable serine/threonine	no	no	0.553	0.349	0.311	4e-30

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  153 bits (387), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 98/258 (37%), Positives = 143/258 (55%), Gaps = 14/258 (5%)

Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G+   A+W+G+ V VKIL  E     ER+N F  E+ I+++ RHPN+V F+GAVTQ   +
Sbjct: 563 GTVHRAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 621

Query: 261 MIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            IV EY ++G L   L K G   +L   + L  A D+A+GMNYLH   P PI+H DLK  
Sbjct: 622 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 680

Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+L+D    +K+  FGL RL      KA              ++APE+ ++E  +   D 
Sbjct: 681 NLLVDKKYTVKVCDFGLSRL------KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 734

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           YSFG+IL+E+    QP+    P +VV  +  + KR  L+I  R+  P +  +IE CW  +
Sbjct: 735 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--LEIP-RNLNPQVAAIIEGCWTNE 791

Query: 438 PVIRPNFNEIIARLDRIV 455
           P  RP+F  I+  L  ++
Sbjct: 792 PWKRPSFATIMDLLRPLI 809

Acts as a negative regulator in the ethylene response pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1

 Score =  150 bits (380), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 102/306 (33%), Positives = 168/306 (54%), Gaps = 29/306 (9%)

Query: 184 ELNPLELQVRKADGI-TKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           E+ P E+   +  G  + G     +     V VK+L K++  D   ++AF  E+ ++ K 
Sbjct: 18  EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNF-DAATLSAFRKEVHLMSKI 76

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HPN+  F+GA T     +IV E   KG+L + L  +K +L     +R A D A G+N+L
Sbjct: 77  YHPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDAALGINWL 136

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV 361
           HE  P   +H D+K  N+L+D   ++KI  FGL  L+    +K K++   S      LY+
Sbjct: 137 HESNP-VFVHRDIKSSNLLVDENMRVKICDFGLSALK----QKHKMLKDQSSAKGTPLYM 191

Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEGKRPPLKIKAR 420
           APE+   +EF+ S D YSFG++L+E++   +PF H +  E+  + +C + +RPP+     
Sbjct: 192 APEVMMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPI----- 246

Query: 421 SYPPD----LKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS-----KQGWWKDTF--- 468
             P D    L+ LIE+CWD +P+ RP+F EII+ LD ++ + +      + +WK +F   
Sbjct: 247 --PNDCLDSLRRLIEKCWDKEPISRPSFKEIISALDHVIIDAAISDLNGRDFWKKSFLTE 304

Query: 469 -KLPWK 473
            ++PW+
Sbjct: 305 QEVPWE 310

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3

 Score =  150 bits (378), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/294 (34%), Positives = 150/294 (51%), Gaps = 33/294 (11%)

Query: 182  EYELNPLELQVRKADGITKGSYQVAK---WNGTKVWVKILDKESHKDPERINAFTHELTI 238
            EYE++  EL+  +   I KG +   K   W  T V +KI+ ++  K    +  F +E+ I
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164

Query: 239  VEKARHPNVVQFVGAVTQNIP--MMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALD 293
            + K RHPNVVQF+GA T        IV E+   G L  +L     L   +P   L+ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224

Query: 294  LARGMNYLHECKPDPIIHCDLKPKNILLDNGG-------------QLKISGFGLLRLQYI 340
            +A+GMNYLH   P PI+H DL  +NILLD+               + KIS FGL RL+  
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM- 2282

Query: 341  SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE 400
              + +++   V  I     Y+APE++K +      D YS+G++L+E++   +P     P 
Sbjct: 2283 -EQASQMTQSVGCIP----YMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPM 2337

Query: 401  EVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            ++  L   E  RPP+ +   S     KE++ +CWD  P  RP F +II  L  +
Sbjct: 2338 KMAHLAAYESYRPPIPLTTSS---KWKEILTQCWDSNPDSRPTFKQIIVHLKEM 2388

Essential for spore differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1

 Score =  141 bits (356), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 97/293 (33%), Positives = 152/293 (51%), Gaps = 25/293 (8%)

Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           ++ + D + +GS+      K  G +V VKI  K+     E + +F HE+ I+ K  HPNV
Sbjct: 276 EIDRTDFLGQGSFGSVYKGKCRGQEVAVKIPRKQKLSLYE-LTSFRHEVKIMSKIFHPNV 334

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHEC 304
           V F+GA TQ+  M IV E   + DL   L     K   S  + ++ A D A GMN+LH  
Sbjct: 335 VLFLGACTQSGKMQIVTEL-CQTDLEKLLHNDRTKKEFSLFRRMQMAKDAALGMNWLHGI 393

Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE 364
               I+H DLK  N+L+D   ++K++ FG  ++      K    F         L++APE
Sbjct: 394 TR--IVHNDLKTANLLVDINLRVKVTDFGFSQI------KEGEEFQDKAAKGTPLWMAPE 445

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEGKRPPLKIKARSYP 423
           +     ++   D YSFG+IL+E++    P+ H K  +     +C E +RPP+        
Sbjct: 446 VMMGNPYNEKADVYSFGIILWEILTKEAPYSHHKDYDIFFNAICNEKERPPIPADTL--- 502

Query: 424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS-----KQGWWKDTFKLP 471
           P L+ LI+ CWD  P  RP+F+EI+ RL+ I+ +C+      + +WK+ F +P
Sbjct: 503 PSLRHLIQTCWDHNPQNRPSFSEILFRLNEILIDCAIDFDDGRKYWKEHFLVP 555

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  140 bits (354), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/255 (34%), Positives = 136/255 (53%), Gaps = 19/255 (7%)

Query: 213 VWVKILDKESHKDPERI---NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           V VK++   +HK+  R      F  E+ ++ +  HPN+VQF+ A  +     I+ EY ++
Sbjct: 110 VAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 169

Query: 270 GDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
           G+L  YL KK    LS   VLR ALD++RGM YLH      +IH DLK  N+LL++  ++
Sbjct: 170 GNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHS---QGVIHRDLKSNNLLLNDEMRV 226

Query: 328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           K++ FG   L+    E    +           ++APE+ K + + R VD YSFG++L+E+
Sbjct: 227 KVADFGTSCLETQCREAKGNMGTYR-------WMAPEMIKEKPYTRKVDVYSFGIVLWEL 279

Query: 388 IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
              + PF    P +    +  + +RPPL    +   P L  LI+ CW   P  RP+F+ I
Sbjct: 280 TTALLPFQGMTPVQAAFAVAEKNERPPLPASCQ---PALAHLIKRCWSENPSKRPDFSNI 336

Query: 448 IARLDRIVCNCSKQG 462
           +A L++    C K+G
Sbjct: 337 VAVLEKYD-ECVKEG 350

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1

 Score =  138 bits (347), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/284 (33%), Positives = 144/284 (50%), Gaps = 20/284 (7%)

Query: 180 VPEYELNPLELQVRK--ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           + ++E+   EL V K    G     Y+ A+W G  V +K +     +D      F  E++
Sbjct: 167 LKKHEIPSRELTVEKEIGQGFFGKVYK-ARWRGKSVALKKITLIKFRDLTETEIFDKEVS 225

Query: 238 IVEKARHPNVVQFVGAVTQNIPM---MIVLEYHAKGDLASYLQKKG--RLSPSKVLRFAL 292
           I+ K  HP  V F+GA + + P     I++EY   G L   L +K    L PS  L  A 
Sbjct: 226 IMSKLCHPTCVMFIGACSLDGPSNDRSIIMEYMEGGSLRRLLDEKSSYHLPPSLQLSIAR 285

Query: 293 DLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQL-KISGFGLLRLQYISPEKAKIVFP 350
           D+A GMNYLH   K  PI+H DL   NILL++   + KI+ FGL +   + P   ++   
Sbjct: 286 DIAEGMNYLHTNFKEGPIVHRDLTSSNILLNSSYTVAKINDFGLSK--EMKPGPTEMTAA 343

Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
           +  +     ++APE +K E +   VD YSF +IL+E++    P++   P  +  L   E 
Sbjct: 344 MGSL----AWMAPECFKAENYTEKVDVYSFAIILWEIVTCRDPYNGMEPLRLAFLASVED 399

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            R PL      +PP   ELI +CW+  P +RP+F EI+  L++I
Sbjct: 400 YRLPL----NGFPPYWVELISKCWNITPSLRPSFKEILQILNQI 439

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q54N73|7TMK1_DICDI Seven transmembrane domain-containing tyrosine-protein kinase 1 OS=Dictyostelium discoideum GN=7tmk1 PE=3 SV=1

 Score =  136 bits (342), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 101/321 (31%), Positives = 155/321 (48%), Gaps = 32/321 (9%)

Query: 155 NILKARGAKVPKTK----------RTPMTVANPREVPEYELNPLEL---QVRKADGITKG 201
           N+L+ARG  +P             R  ++ +        +L+   +   + +    I +G
Sbjct: 313 NLLRARGEFLPLLTNFQEYTSLFGRESISTSGEGATTALQLSAFYIRFNEFKFGQVIGEG 372

Query: 202 SY---QVAKWNGTKVWVKILDKESHKDPE---RINAFTHELTIVEKARHPNVVQFVGAVT 255
            +   + A W G  V VKIL + S ++ +     N F  E+ I+   RHPNV+QF+G  +
Sbjct: 373 YFGEVRKAVWKGAVVAVKILHRNSFRNTDGNKEENVFLKEVAILSILRHPNVLQFLGVCS 432

Query: 256 QNIPMMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           +     IV EY   G L   L  +  L   +P      A+ +ARGM YLH+ KP+PI+H 
Sbjct: 433 ETNLNGIVTEYMGGGSLDRLLTDRYFLIKQNPILAWNMAISIARGMFYLHDWKPNPILHR 492

Query: 313 DLKPKNILLDNGGQL-KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
           DL  KNILLD    + K++ FGL + Q       ++   V H+     Y APE++  E +
Sbjct: 493 DLSTKNILLDESLTIAKVADFGLSKEQ-----GFEMTSTVGHL----CYQAPEVFIGELY 543

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
               D YSFGL+++ +I G QP     P ++  L   E  RPP+         +L +LIE
Sbjct: 544 TPKADVYSFGLLVWCIITGEQPNQNLQPLKMAHLAAYENYRPPMPQPMDPMWENLGKLIE 603

Query: 432 ECWDPKPVIRPNFNEIIARLD 452
            CW   P  RP+F+ I+  L+
Sbjct: 604 MCWKKSPEERPSFSFILDFLE 624

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  135 bits (339), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 146/269 (54%), Gaps = 20/269 (7%)

Query: 195 ADGITKGSYQV---AKWNGTKVWVK-ILDKESHKDPERINAFTHELTIVEKARHPNVVQF 250
           A+ I  GSY     A W+GT+V VK  LD++       +  F  E+ I+ + RHPNVV F
Sbjct: 672 AERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSG--AALAEFRSEVRIMRRLRHPNVVFF 729

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
           +GAVT+   + IV E+  +G L   L + K  +   + ++ ALD+A GMN LH   P  I
Sbjct: 730 LGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPT-I 788

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           +H DLK  N+L+DN   +K+  FGL RL++ +   +K             ++APE+ +NE
Sbjct: 789 VHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPE------WMAPEVLRNE 842

Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
             +   D YSFG+IL+E+     P+    P +VV  +  + +R  L+I  +   P +  +
Sbjct: 843 PSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRR--LEI-PKELDPVVGRI 899

Query: 430 IEECWDPKPVIRPNF---NEIIARLDRIV 455
           I ECW   P +RP+F    E++  L+R+V
Sbjct: 900 ILECWQTDPNLRPSFAQLTEVLKPLNRLV 928

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  134 bits (336), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/282 (33%), Positives = 156/282 (55%), Gaps = 18/282 (6%)

Query: 182  EYELNPLELQVRKADGITKGSYQVAK--WNGTKVWVKILD-KESHKDPERINAFTHELTI 238
            ++E++  EL++ +  G T G  +V K  W GT+V VK++  K   KD ER  +F  E+ I
Sbjct: 778  DWEIDFSELEIGETLG-TGGYGEVYKSIWKGTEVAVKLISSKHVSKDMER--SFFEEVKI 834

Query: 239  VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLAR 296
            +   RHPNVV F+ A T++  M IV+E+ + G L   L  +    +  +  ++ A   ++
Sbjct: 835  MTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQASK 894

Query: 297  GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
            GM++LH      I+H DLK  N+LLD+   +K+S FGL +++    +K      +  I  
Sbjct: 895  GMHFLHSSG---IVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIH- 950

Query: 357  ANLYVAPEIYKNE-EFDRSV-DAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
               ++APEI  +  E D  + D YSFG+IL+E++   QP+    P  +   +  +G RPP
Sbjct: 951  ---WIAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPP 1007

Query: 415  LKIKA-RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
            +  +A  ++  +  +LI++CW    +IRP F EI+ RL  I+
Sbjct: 1008 ISDEAVTAHSIEYIDLIKQCWHSDTIIRPTFLEIMTRLSNIL 1049

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  132 bits (333), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 139/279 (49%), Gaps = 17/279 (6%)

Query: 183 YELNPLEL-QVRKADGITKGSYQ---VAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           +E+ P+++ ++   + I +GS        W G  V +K     +  D + +N    E TI
Sbjct: 481 FEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELAQEATI 540

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARG 297
           + + RHPN+ QF+G       ++IV+EY   G L   L      L   ++   ALD+A+G
Sbjct: 541 MSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKG 600

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
           MNYLH C P  +IH DLK  N+L+D   ++KIS FGL        +K   + PV      
Sbjct: 601 MNYLHCCDPI-VIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVG----T 655

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP--PL 415
             + APE+ +N+ +    D +SF ++L+E++    P+   P  ++V  +     RP  P 
Sbjct: 656 PCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPP 715

Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           ++ A         LI ECW   P  RP+F EI+ RL+ +
Sbjct: 716 QVSA-----PFTRLITECWSEDPQQRPSFQEIVKRLEAM 749

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	473
356512588	474	PREDICTED: serine/threonine-protein kina	0.997	0.995	0.816	0.0
449438147	473	PREDICTED: serine/threonine-protein kina	0.997	0.997	0.816	0.0
18700701	477	ankyrin-kinase [Medicago truncatula]	1.0	0.991	0.809	0.0
225434181	472	PREDICTED: dual specificity protein kina	0.993	0.995	0.814	0.0
449520086	473	PREDICTED: serine/threonine-protein kina	0.997	0.997	0.816	0.0
356525359	475	PREDICTED: serine/threonine-protein kina	1.0	0.995	0.808	0.0
255577895	482	ankyrin-kinase, putative [Ricinus commun	0.995	0.977	0.810	0.0
147802196	495	hypothetical protein VITISV_010336 [Viti	0.991	0.947	0.794	0.0
18700703	475	putative ankyrin-kinase [Medicago sativa	0.995	0.991	0.802	0.0
297828101	479	hypothetical protein ARALYDRAFT_903788 [	1.0	0.987	0.782	0.0

>gi|356512588|ref|XP_003525000.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  830 bits (2143), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/474 (81%), Positives = 433/474 (91%), Gaps = 2/474 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           ME++ AQLKRGISRQFS+GSLRR+L+RQ +RQ+S DPRRNN RFSFGRQSSLDPIRRSP 
Sbjct: 1   MESIAAQLKRGISRQFSSGSLRRNLSRQFTRQASLDPRRNNQRFSFGRQSSLDPIRRSPC 60

Query: 61  QD--ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV 118
               ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG DVNSIDLDGRTALH+AACEGHV
Sbjct: 61  SGNAELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGIDVNSIDLDGRTALHVAACEGHV 120

Query: 119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPR 178
           EV +LLLS+KAN+DARDRWGSTAAADAKYYGN E+Y +LKARGAKVPKT++TPMTVANPR
Sbjct: 121 EVARLLLSRKANLDARDRWGSTAAADAKYYGNTEIYYMLKARGAKVPKTRKTPMTVANPR 180

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           EVPEYELNP+ELQVRK+DGI+KG+YQVAKWNGTKV VKILDK+S+ DP+ INAF HELT+
Sbjct: 181 EVPEYELNPVELQVRKSDGISKGTYQVAKWNGTKVAVKILDKDSYSDPDTINAFKHELTL 240

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +E+ RHPNVVQFVGAVTQNIPMMIV EYH+KGDLASYLQKKGRLSPSKVLRFALD+ARGM
Sbjct: 241 LERVRHPNVVQFVGAVTQNIPMMIVREYHSKGDLASYLQKKGRLSPSKVLRFALDIARGM 300

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
           NYLHECKPDP+IHCDLKPKNILLDNGGQLKI+GFG +R   ISP++AK+V P  +ID ++
Sbjct: 301 NYLHECKPDPVIHCDLKPKNILLDNGGQLKIAGFGTVRFSLISPDEAKLVQPEPNIDLSS 360

Query: 359 LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK 418
           LYVAPEIYK+E FDRSVDAYSFGLI+YEMIEG  PFHPK  EE V+LMC EGKRP  KIK
Sbjct: 361 LYVAPEIYKDEVFDRSVDAYSFGLIIYEMIEGTHPFHPKSSEEAVRLMCLEGKRPAFKIK 420

Query: 419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPW 472
            + YPP+LKELIEECWDP PV+RP F+++IARLD+IV NCSKQGWWKDTFKLPW
Sbjct: 421 TKHYPPELKELIEECWDPTPVVRPTFSQVIARLDKIVANCSKQGWWKDTFKLPW 474

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449438147|ref|XP_004136851.1| PREDICTED: serine/threonine-protein kinase TNNI3K-like [Cucumis sativus]

 Score =  828 bits (2139), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/474 (81%), Positives = 437/474 (92%), Gaps = 2/474 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           M+N+TAQLKRGISRQFSTGSLRR+L+RQ +RQSS DPRRNN+RFSFGRQSSLDPIRR P 
Sbjct: 1   MDNITAQLKRGISRQFSTGSLRRTLSRQFTRQSSLDPRRNNLRFSFGRQSSLDPIRRCPD 60

Query: 61  QD-ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE 119
           +D EL++P+NLDSTMQLLFMACRGDV+GVEDLLN+G+DVNSIDLDGRTALHIAACEGH  
Sbjct: 61  EDNELSIPDNLDSTMQLLFMACRGDVRGVEDLLNDGTDVNSIDLDGRTALHIAACEGHAA 120

Query: 120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPRE 179
           VVKLLLS+KANIDARDRWGSTAAADAKYYGN E+YNILKARGAKVPK ++TPMTVANPRE
Sbjct: 121 VVKLLLSRKANIDARDRWGSTAAADAKYYGNTEIYNILKARGAKVPKFRKTPMTVANPRE 180

Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           VPEYELNPLELQ+R++DGI+KG+YQVAKWNGTKV VKILDK+ + +P+ INAF HELT++
Sbjct: 181 VPEYELNPLELQIRRSDGISKGAYQVAKWNGTKVSVKILDKDCYCNPDSINAFKHELTLL 240

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
           EK RHPNVVQFVGAVTQN+PMMIV EYH KGDL  YLQKKGRLSPSK LRFALD+ARGMN
Sbjct: 241 EKVRHPNVVQFVGAVTQNLPMMIVSEYHPKGDLGCYLQKKGRLSPSKALRFALDVARGMN 300

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           YLHECKPDPIIHCDLKPKNILLDNGGQLK++GFGL+RL  +S +KAK+  PV  ID +NL
Sbjct: 301 YLHECKPDPIIHCDLKPKNILLDNGGQLKVAGFGLIRLSKMSQDKAKLAHPVV-IDYSNL 359

Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           Y+APEIY NE FDRSVD++SFGLILYEM+EG+QPFHPKPPEEV + +C EGKRPP KIK+
Sbjct: 360 YLAPEIYNNEIFDRSVDSFSFGLILYEMVEGIQPFHPKPPEEVTRAICAEGKRPPFKIKS 419

Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
           +SYPPDLKELIEECWDP+PV+RP F+EII RLD+IV NCSKQGWWKDTFKLPWK
Sbjct: 420 KSYPPDLKELIEECWDPEPVMRPTFSEIIVRLDKIVANCSKQGWWKDTFKLPWK 473

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18700701|gb|AAL78674.1|AF458699_1 ankyrin-kinase [Medicago truncatula]

 Score =  828 bits (2138), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/477 (80%), Positives = 433/477 (90%), Gaps = 4/477 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           MEN+ AQLKRGISRQFS+GSLR++L+RQ +RQ+S DPRRNN+RFSFGRQSSLDPIRRSP 
Sbjct: 1   MENIAAQLKRGISRQFSSGSLRKTLSRQFTRQASLDPRRNNLRFSFGRQSSLDPIRRSPG 60

Query: 61  QDE----LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG 116
            DE    LTVPENLDSTMQLLFMACRGDVKGVEDLLNEG DVNSIDLDGRTALHIAACEG
Sbjct: 61  DDEDQAELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGIDVNSIDLDGRTALHIAACEG 120

Query: 117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
           HV+V KLLLS+KAN+DARDRWGSTAAADAKYYGN EVY +LKARGAKVPKT++TPMTVAN
Sbjct: 121 HVDVAKLLLSRKANLDARDRWGSTAAADAKYYGNTEVYYMLKARGAKVPKTRKTPMTVAN 180

Query: 177 PREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHEL 236
           PREVPEYELNPLELQVRK+DGI+ G+YQVAKWNGTKV VKILDK+S+ DP+ IN F HEL
Sbjct: 181 PREVPEYELNPLELQVRKSDGISTGTYQVAKWNGTKVAVKILDKDSYSDPDTINIFKHEL 240

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR 296
           T++EK RHPNVVQFVGAVTQNIPMMIV EYHAKGDL  Y+QKKGRLSPSKVLRF+LD+AR
Sbjct: 241 TLLEKVRHPNVVQFVGAVTQNIPMMIVREYHAKGDLTGYIQKKGRLSPSKVLRFSLDIAR 300

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYLHECKPDPIIHCDLKPKNILLDNGGQLK++GFG +R   I+P+KA +  P ++IDP
Sbjct: 301 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKVAGFGTVRFSLITPDKALLEQPEANIDP 360

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
           ++LYVAPEIY+ + FDRSVDAYSFGLI+YEMIEG+ PFHPKP EE +KLMC EGKRP  K
Sbjct: 361 SSLYVAPEIYRGDVFDRSVDAYSFGLIVYEMIEGIPPFHPKPAEEALKLMCLEGKRPQFK 420

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
           IK +SYPPDLKELIEECWDP+P +RP F+++IARLD+IV NCSKQGWWKD FKLPWK
Sbjct: 421 IKTKSYPPDLKELIEECWDPEPEVRPTFSQVIARLDKIVANCSKQGWWKDAFKLPWK 477

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225434181|ref|XP_002279175.1| PREDICTED: dual specificity protein kinase shkC-like [Vitis vinifera]

 Score =  827 bits (2136), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/470 (81%), Positives = 432/470 (91%)

Query: 4   LTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDE 63
           + AQLKRGISRQFSTGSL R+L+RQ SRQSS DPRR N+RFS GRQSSLDPIRRSPV +E
Sbjct: 3   IAAQLKRGISRQFSTGSLLRTLSRQFSRQSSLDPRRTNLRFSLGRQSSLDPIRRSPVNEE 62

Query: 64  LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL 123
           L+VPENLDSTMQ+LFMACRGDVKGVEDLLNEG+DVNSIDLDGRTALHIAACEG +EVVKL
Sbjct: 63  LSVPENLDSTMQMLFMACRGDVKGVEDLLNEGTDVNSIDLDGRTALHIAACEGQIEVVKL 122

Query: 124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEY 183
           LLS+KANIDARDRWGSTAAADAKYYGNVE+YNILKARGAK PK ++TPM VANPREVPEY
Sbjct: 123 LLSRKANIDARDRWGSTAAADAKYYGNVEIYNILKARGAKTPKIRKTPMAVANPREVPEY 182

Query: 184 ELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           ELNPLELQVRK+DGITKGSYQVAKWNGTKV VKILDK+S+ DP+ INAF +ELT++EK R
Sbjct: 183 ELNPLELQVRKSDGITKGSYQVAKWNGTKVSVKILDKDSYSDPDSINAFKYELTLLEKVR 242

Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE 303
           HPNVVQFVGAVTQNIPMMIV EYH KGDL SYLQKKGRLS SK LR+ALD+ARGMNYLHE
Sbjct: 243 HPNVVQFVGAVTQNIPMMIVSEYHPKGDLGSYLQKKGRLSLSKALRYALDIARGMNYLHE 302

Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
           CKPDP+IHCDLKPKNILLD+GGQLK++GFGLLRL  +SP+K K+    SHID +N+Y+AP
Sbjct: 303 CKPDPVIHCDLKPKNILLDSGGQLKVAGFGLLRLSKMSPDKVKLAQSGSHIDASNVYMAP 362

Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP 423
           E+Y++E FDRSVD++SFGLILYEMIEGVQPFHPKPPEE +K++C EGKRPP K K+RSYP
Sbjct: 363 EVYRDELFDRSVDSFSFGLILYEMIEGVQPFHPKPPEEAIKMICLEGKRPPFKSKSRSYP 422

Query: 424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
           PDLKELIEECW+P+PV+RP F+E+I RLD+IV +CS+Q WWKDTFKLPWK
Sbjct: 423 PDLKELIEECWNPEPVVRPIFSEVIVRLDKIVGHCSRQAWWKDTFKLPWK 472

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449520086|ref|XP_004167065.1| PREDICTED: serine/threonine-protein kinase TNNI3K-like [Cucumis sativus]

 Score =  827 bits (2135), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/474 (81%), Positives = 437/474 (92%), Gaps = 2/474 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           M+N+TAQLKRGISRQFSTGSLRR+L+RQ +RQSS DPRRNN+RFSFGRQSSLDPIRR P 
Sbjct: 1   MDNITAQLKRGISRQFSTGSLRRTLSRQFTRQSSPDPRRNNLRFSFGRQSSLDPIRRCPD 60

Query: 61  QD-ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE 119
           +D EL++P+NLDSTMQLLFMACRGDV+GVEDLLN+G+DVNSIDLDGRTALHIAACEGH  
Sbjct: 61  EDNELSIPDNLDSTMQLLFMACRGDVRGVEDLLNDGTDVNSIDLDGRTALHIAACEGHAA 120

Query: 120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPRE 179
           VVKLLLS+KANIDARDRWGSTAAADAKYYGN E+YNILKARGAKVPK ++TPMTVANPRE
Sbjct: 121 VVKLLLSRKANIDARDRWGSTAAADAKYYGNTEIYNILKARGAKVPKFRKTPMTVANPRE 180

Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           VPEYELNPLELQ+R++DGI+KG+YQVAKWNGTKV VKILDK+ + +P+ INAF HELT++
Sbjct: 181 VPEYELNPLELQIRRSDGISKGAYQVAKWNGTKVSVKILDKDCYCNPDSINAFKHELTLL 240

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
           EK RHPNVVQFVGAVTQN+PMMIV EYH KGDL  YLQKKGRLSPSK LRFALD+ARGMN
Sbjct: 241 EKVRHPNVVQFVGAVTQNLPMMIVSEYHPKGDLGCYLQKKGRLSPSKALRFALDVARGMN 300

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           YLHECKPDPIIHCDLKPKNILLDNGGQLK++GFGL+RL  +S +KAK+  PV  ID +NL
Sbjct: 301 YLHECKPDPIIHCDLKPKNILLDNGGQLKVAGFGLIRLSKMSQDKAKLAHPVV-IDYSNL 359

Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           Y+APEIY NE FDRSVD++SFGLILYEM+EG+QPFHPKPPEEV + +C EGKRPP KIK+
Sbjct: 360 YLAPEIYNNEIFDRSVDSFSFGLILYEMVEGIQPFHPKPPEEVTRAICAEGKRPPFKIKS 419

Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
           +SYPPDLKELIEECWDP+PV+RP F+EII RLD+IV NCSKQGWWKDTFKLPWK
Sbjct: 420 KSYPPDLKELIEECWDPEPVMRPTFSEIIVRLDKIVANCSKQGWWKDTFKLPWK 473

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356525359|ref|XP_003531292.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  823 bits (2125), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 384/475 (80%), Positives = 432/475 (90%), Gaps = 2/475 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
           ME++ AQLKRGISRQFS+GSLRR+L+RQ +RQ+S DPRRNN RFS GRQSSLDPIRRSP 
Sbjct: 1   MESIAAQLKRGISRQFSSGSLRRNLSRQFTRQASLDPRRNNQRFSIGRQSSLDPIRRSPG 60

Query: 60  -VQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV 118
            VQ ELTVPENLDSTMQLLFMACRGD KGV+DLLNEG DVNSIDLDGRTALH+AACEGHV
Sbjct: 61  PVQPELTVPENLDSTMQLLFMACRGDAKGVDDLLNEGIDVNSIDLDGRTALHVAACEGHV 120

Query: 119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPR 178
           EV +LLL++KAN+DARDRWGSTAAADAKYYGN E+Y +LKARGAKVPKT++TPMTVANPR
Sbjct: 121 EVARLLLTRKANLDARDRWGSTAAADAKYYGNTEIYYMLKARGAKVPKTRKTPMTVANPR 180

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           EVPEYELNPLELQVRK+DGI+KG+YQVAKWNGTKV VKILDK+S+ DP+ INAF HELT+
Sbjct: 181 EVPEYELNPLELQVRKSDGISKGTYQVAKWNGTKVAVKILDKDSYSDPDTINAFKHELTL 240

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +E+ RHPNVVQFVGAVTQNIPMMIV EYH+KGDLASYLQKKGRLSPSKVLRF  D+ARGM
Sbjct: 241 LERVRHPNVVQFVGAVTQNIPMMIVREYHSKGDLASYLQKKGRLSPSKVLRFCHDIARGM 300

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
           NYLHECKPDP+IHCDLKPKNILLD+GGQLKI+GFG +R   ISP++A++V P  +ID ++
Sbjct: 301 NYLHECKPDPVIHCDLKPKNILLDSGGQLKIAGFGTVRFSLISPDEAQLVQPEPNIDLSS 360

Query: 359 LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK 418
           LYVAPEIYK+E FDRSVDAYSFGLILYEMIEG QPFHPK  EE V+LMC EGKRP  KIK
Sbjct: 361 LYVAPEIYKDEVFDRSVDAYSFGLILYEMIEGTQPFHPKSSEEAVRLMCLEGKRPAFKIK 420

Query: 419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
            + YPP+LKELIEECWDP PV+RP F+++I RLD+IV NCSKQGWWKDTFKLPWK
Sbjct: 421 TKHYPPELKELIEECWDPTPVVRPTFSQVIVRLDKIVANCSKQGWWKDTFKLPWK 475

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255577895|ref|XP_002529820.1| ankyrin-kinase, putative [Ricinus communis] gi|223530697|gb|EEF32569.1| ankyrin-kinase, putative [Ricinus communis]

 Score =  817 bits (2110), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 385/475 (81%), Positives = 430/475 (90%), Gaps = 4/475 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           ME +T QLKRGISRQFSTGSLRR+ +RQ SRQ+S DPRR+N+RFSFGRQSSLDPIRRSP 
Sbjct: 1   MEGITTQLKRGISRQFSTGSLRRTFSRQFSRQTSLDPRRHNLRFSFGRQSSLDPIRRSPG 60

Query: 61  ---QDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
              +++  VPENLDSTMQLLFMACRGDVKGVEDLLNEG DVNSIDLDGRTALHIAACEGH
Sbjct: 61  HHDEEQFAVPENLDSTMQLLFMACRGDVKGVEDLLNEGIDVNSIDLDGRTALHIAACEGH 120

Query: 118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANP 177
           VEVV+LLL++KANIDARDRWGSTA ADAKYYGNVEVYNILKARGAK PKT++TPMTVANP
Sbjct: 121 VEVVRLLLTRKANIDARDRWGSTACADAKYYGNVEVYNILKARGAKAPKTRKTPMTVANP 180

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           REVPEYELNPLELQVRK+DGI+KG+YQ+AKWNGTKV VKILDK+S+ DPE INAF HELT
Sbjct: 181 REVPEYELNPLELQVRKSDGISKGTYQLAKWNGTKVTVKILDKDSYSDPESINAFKHELT 240

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
           ++EK RHPNVVQFVGAVTQNIPMMIV EYH KGDL SYLQKKGRLSPSKVLRF+LD+ARG
Sbjct: 241 LLEKVRHPNVVQFVGAVTQNIPMMIVSEYHPKGDLGSYLQKKGRLSPSKVLRFSLDIARG 300

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
           MNYLHECKPDPIIHCDLKPKN+LLD+GGQLK++GFGL+RL  ISP+KAKI  P + IDP+
Sbjct: 301 MNYLHECKPDPIIHCDLKPKNVLLDSGGQLKVAGFGLIRLSKISPDKAKIA-PGTLIDPS 359

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
           N+Y APE++K + FDRSVD YSFG+ILYEMIEGV PFHPK  EE VKLMC E KRPP K 
Sbjct: 360 NIYAAPEVFKEDIFDRSVDTYSFGVILYEMIEGVLPFHPKSNEEAVKLMCLEKKRPPFKS 419

Query: 418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPW 472
           K+RSYPPDLKEL++ECW P+P+ RP F+EII RLD+IV +CSKQGWWKDTFKLPW
Sbjct: 420 KSRSYPPDLKELVDECWHPEPLARPTFSEIIVRLDKIVSHCSKQGWWKDTFKLPW 474

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147802196|emb|CAN63815.1| hypothetical protein VITISV_010336 [Vitis vinifera]

 Score =  816 bits (2108), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/481 (79%), Positives = 431/481 (89%), Gaps = 12/481 (2%)

Query: 4   LTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDE 63
           + AQLKRGISRQFSTGSL R+L+RQ SRQSS DPRR N+RFS GRQSSLDPIRRSPV +E
Sbjct: 3   IAAQLKRGISRQFSTGSLLRTLSRQFSRQSSLDPRRTNLRFSLGRQSSLDPIRRSPVNEE 62

Query: 64  LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL 123
           L+VPENLDSTMQ+LFMACRGDVKGVEDLLNEG+DVNSIDLDGRTALHIAACEG +EVVKL
Sbjct: 63  LSVPENLDSTMQMLFMACRGDVKGVEDLLNEGTDVNSIDLDGRTALHIAACEGQIEVVKL 122

Query: 124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEY 183
           LLS+KANIDARDRWGSTAAADAKYYGNVE+YNILKARGAK PK ++TPM VANPREVPEY
Sbjct: 123 LLSRKANIDARDRWGSTAAADAKYYGNVEIYNILKARGAKTPKIRKTPMAVANPREVPEY 182

Query: 184 ELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           ELNPLELQVRK+DGITKGSYQVAKWNGTKV VKILDK+S+ DP+ INAF +ELT++EK R
Sbjct: 183 ELNPLELQVRKSDGITKGSYQVAKWNGTKVSVKILDKDSYSDPDSINAFKYELTLLEKVR 242

Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR------- 296
           HPNVVQFVGAVTQNIPMMIV EYH KGDL SYLQKKGRLS SK LR+ALD+AR       
Sbjct: 243 HPNVVQFVGAVTQNIPMMIVSEYHPKGDLGSYLQKKGRLSLSKALRYALDIARHVYMQNN 302

Query: 297 -----GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
                GMNYLHECKPDP+IHCDLKPKNILLD+GGQLK++GFGLLRL  +SP+K K+    
Sbjct: 303 IVKCLGMNYLHECKPDPVIHCDLKPKNILLDSGGQLKVAGFGLLRLSKMSPDKVKLAQSG 362

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
           SHID +N+Y+APE+Y++E FDRSVD++SFGLILYEMIEGVQPFHPKPPEE +K++C EGK
Sbjct: 363 SHIDASNVYMAPEVYRDELFDRSVDSFSFGLILYEMIEGVQPFHPKPPEEAIKMICLEGK 422

Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLP 471
           RPP K K+RSYPPDLKELIEECW+P+PV+RP F+E+I RLD+IV +CS+Q WWKDTFKLP
Sbjct: 423 RPPFKSKSRSYPPDLKELIEECWNPEPVVRPIFSEVIVRLDKIVGHCSRQAWWKDTFKLP 482

Query: 472 W 472
           W
Sbjct: 483 W 483

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18700703|gb|AAL78675.1|AF458700_1 putative ankyrin-kinase [Medicago sativa]

 Score =  811 bits (2095), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/477 (80%), Positives = 428/477 (89%), Gaps = 6/477 (1%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           MEN+ AQLKRGISRQFS+GSLR++L+ Q    +  DPRRNN+RFSFGRQSSLDPIRRSP 
Sbjct: 1   MENIAAQLKRGISRQFSSGSLRKTLSCQFG--TRLDPRRNNLRFSFGRQSSLDPIRRSPG 58

Query: 61  QD----ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG 116
            D    ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG DVNSIDLDGRTALHIAACEG
Sbjct: 59  DDQDQVELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGIDVNSIDLDGRTALHIAACEG 118

Query: 117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
           HV+V KLLLS+KAN+DARDRWGSTAAADAKYYGN EVY +LKARGAKVPKT++TPMTVAN
Sbjct: 119 HVDVAKLLLSRKANLDARDRWGSTAAADAKYYGNTEVYYMLKARGAKVPKTRKTPMTVAN 178

Query: 177 PREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHEL 236
           PREVPEYELNPLELQVRK DGI+ G+YQVAKWNGTKV VKILDK+S+ DP+ IN F HEL
Sbjct: 179 PREVPEYELNPLELQVRKNDGISTGTYQVAKWNGTKVAVKILDKDSYSDPDTINIFKHEL 238

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR 296
           T++EK RHPNVVQFVGAVTQNIPMMIV EYHAKGDL  Y+QKKGRLSPSKVLRF+LD+AR
Sbjct: 239 TLLEKVRHPNVVQFVGAVTQNIPMMIVREYHAKGDLTGYIQKKGRLSPSKVLRFSLDIAR 298

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYLHECKPDPIIHCDLKPKNILLDNGGQLK++GFG +R   I+P+KA +  P ++IDP
Sbjct: 299 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKVAGFGTVRFSLITPDKALLEQPEANIDP 358

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
           ++LYVAPEIY+ + FDRSVDAYSFGLI+YEMIEG+ PFHPKP EE +KLMC EGKRP  K
Sbjct: 359 SSLYVAPEIYRGDVFDRSVDAYSFGLIVYEMIEGIPPFHPKPAEEALKLMCLEGKRPQFK 418

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
           IK +SYPPDLKELIEECWDP+P +RP F+++IARLD+IV NCSKQGWWKDTFKLPWK
Sbjct: 419 IKTKSYPPDLKELIEECWDPEPEVRPTFSQVIARLDKIVANCSKQGWWKDTFKLPWK 475

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297828101|ref|XP_002881933.1| hypothetical protein ARALYDRAFT_903788 [Arabidopsis lyrata subsp. lyrata] gi|297327772|gb|EFH58192.1| hypothetical protein ARALYDRAFT_903788 [Arabidopsis lyrata subsp. lyrata]

 Score =  799 bits (2063), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/479 (78%), Positives = 429/479 (89%), Gaps = 6/479 (1%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
           MEN+TAQLKRGISRQFSTGS+RR+L+RQ +RQSS DPRR NMRFSFGRQSSLDPIRRSP 
Sbjct: 1   MENITAQLKRGISRQFSTGSIRRTLSRQFTRQSSLDPRRTNMRFSFGRQSSLDPIRRSPD 60

Query: 60  ---VQDE--LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC 114
                DE  ++VPENLDSTMQLLFMA +GDV+G+E+LL+EG DVNSIDLDGRTALHIAAC
Sbjct: 61  SVRSDDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLDEGIDVNSIDLDGRTALHIAAC 120

Query: 115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV 174
           EGH+ VVK LLS++ANIDARDRWGSTAAADAKYYGN++VYN+LKARGAKVPKT++TPMTV
Sbjct: 121 EGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDVYNLLKARGAKVPKTRKTPMTV 180

Query: 175 ANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
           +NPREVPEYELNPLE+QVRKADGI+KG+YQVAKWNGT+V VKILDK+S+ DPERINAF H
Sbjct: 181 SNPREVPEYELNPLEIQVRKADGISKGAYQVAKWNGTRVSVKILDKDSYSDPERINAFRH 240

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           ELT++EK RHPNV+QFVGAVTQNIPMMIV+EY+ KGDL+ YLQKKGRLSPSK LRFALD+
Sbjct: 241 ELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDI 300

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           ARGMNYLHECKPDPIIHCDLKPKNILLD GGQLKISGFG++RL  IS +KAK+    +HI
Sbjct: 301 ARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFGMIRLSKISQDKAKVANHKAHI 360

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
           D +N Y+APE+YK+E FDR VDA+SFG+ILYE+ EGV  FHP+PPEEV K+MC EGKRP 
Sbjct: 361 DLSNYYIAPEVYKDEIFDRRVDAHSFGVILYEITEGVPVFHPRPPEEVAKMMCLEGKRPV 420

Query: 415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
            K K+RSYPPD+KELIE+CW  +  IRP F+EII RLD+IV NCSKQGWWKDTFK PWK
Sbjct: 421 FKTKSRSYPPDIKELIEKCWHQEAAIRPTFSEIIIRLDKIVANCSKQGWWKDTFKFPWK 479

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	473
TAIR|locus:2044034	479	AT2G43850 [Arabidopsis thalian	1.0	0.987	0.778	1.5e-207
TAIR|locus:2045258	476	AT2G31800 [Arabidopsis thalian	1.0	0.993	0.771	2.6e-205
TAIR|locus:2080517	477	AT3G59830 [Arabidopsis thalian	1.0	0.991	0.752	1.7e-201
TAIR|locus:2098999	471	AT3G58760 [Arabidopsis thalian	0.883	0.887	0.474	2.3e-101
TAIR|locus:2117129	459	AT4G18950 [Arabidopsis thalian	0.873	0.899	0.468	8.2e-99
TAIR|locus:2014849	438	VIK "VH1-interacting kinase" [	0.845	0.913	0.385	5.1e-67
DICTYBASE|DDB_G0278409	506	shkC "SHK subfamily protein ki	0.594	0.555	0.331	3.9e-37
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.566	0.470	0.333	1e-36
TAIR|locus:2194055	992	AT1G18160 [Arabidopsis thalian	0.553	0.264	0.355	2e-36
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.687	0.619	0.303	1.1e-35

TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)]

 Score = 2007 (711.6 bits), Expect = 1.5e-207, P = 1.5e-207
 Identities = 373/479 (77%), Positives = 429/479 (89%)

Query:     1 MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
             MEN+TAQLKRGISRQFSTGS+RR+L+RQ +RQSS DPRR NMRFSFGRQSSLDPIRRSP 
Sbjct:     1 MENITAQLKRGISRQFSTGSIRRTLSRQFTRQSSLDPRRTNMRFSFGRQSSLDPIRRSPD 60

Query:    60 ---VQDE--LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC 114
                  DE  ++VPENLDSTMQLLFMA +GDV+G+E+LL+EG DVNSIDLDGRTALHIAAC
Sbjct:    61 SSKSDDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLDEGIDVNSIDLDGRTALHIAAC 120

Query:   115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV 174
             EGH+ VVK LLS++ANIDARDRWGSTAAADAKYYGN++VYN+LKARGAKVPKT++TPMTV
Sbjct:   121 EGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDVYNLLKARGAKVPKTRKTPMTV 180

Query:   175 ANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
             +NPREVPEYELNPLE+QVRK+DGI+KG+YQVAKWNGT+V VKILDK+S+ DPERINAF H
Sbjct:   181 SNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRVSVKILDKDSYSDPERINAFRH 240

Query:   235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
             ELT++EK RHPNV+QFVGAVTQNIPMMIV+EY+ KGDL+ YLQKKGRLSPSK LRFALD+
Sbjct:   241 ELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDI 300

Query:   295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             ARGMNYLHECKPDPIIHCDLKPKNILLD GGQLKISGFG++RL  IS +KAK+    +HI
Sbjct:   301 ARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFGMIRLSKISQDKAKVANHKAHI 360

Query:   355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
             D +N Y+APE+YK+E FD  VDA+SFG+ILYE+ EGV  FHP+PPEEV ++MC EGKRP 
Sbjct:   361 DLSNYYIAPEVYKDEIFDLRVDAHSFGVILYEITEGVPVFHPRPPEEVARMMCLEGKRPV 420

Query:   415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
              K K+RSYPPD+KELIE+CW P+  IRP F+EII RLD+IV NCSKQGWWKDTFK PWK
Sbjct:   421 FKTKSRSYPPDIKELIEKCWHPEAGIRPTFSEIIIRLDKIVANCSKQGWWKDTFKFPWK 479

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)]

 Score = 1986 (704.2 bits), Expect = 2.6e-205, P = 2.6e-205
 Identities = 367/476 (77%), Positives = 423/476 (88%)

Query:     1 MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
             M N+  QLKRGISRQFSTGSLRR+L+RQ +RQ+S DPRRNNMRFSFGRQSSLDPIRRSP 
Sbjct:     1 MANVVGQLKRGISRQFSTGSLRRTLSRQFTRQASHDPRRNNMRFSFGRQSSLDPIRRSPD 60

Query:    61 QD---ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
                  +L VP+NLD+TMQLLF+ACRGDV+GV+DLL+EG DVNSIDLDGRTALHIAACEGH
Sbjct:    61 GSNGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGIDVNSIDLDGRTALHIAACEGH 120

Query:   118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANP 177
             V+VVKLLL++KANIDARDRWGSTAAADAKYYGN++V+NILKARGAKVPKTKRTPM VANP
Sbjct:   121 VDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNILKARGAKVPKTKRTPMVVANP 180

Query:   178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
             REVPEYELNP ELQVRKADGI+KG YQVAKWNGTKV VKILDK+ +KD + INAF HELT
Sbjct:   181 REVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKILDKDLYKDSDTINAFKHELT 240

Query:   238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
             + EK RHPNVVQFVGAVTQN+PMMIV EYH KGDL SYLQKKGRLSP+KVLRFALD+ARG
Sbjct:   241 LFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQKKGRLSPAKVLRFALDIARG 300

Query:   298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
             MNYLHECKP+P+IHCDLKPKNI+LD+GG LK++GFGL+    +S +K+KI+   +HIDP+
Sbjct:   301 MNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISFAKLSSDKSKILNHGAHIDPS 360

Query:   358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
             N  +APE+YK+E FDRSVD+YSFG++LYEMIEGVQPFHPKPPEE VKLMC EG+RP  K 
Sbjct:   361 NYCMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPKPPEEAVKLMCLEGRRPSFKA 420

Query:   418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
             K++S P +++ELIEECWD +  +RP F+EII RLD+I  +CSKQGWWKDTFK PWK
Sbjct:   421 KSKSCPQEMRELIEECWDTETFVRPTFSEIIVRLDKIFVHCSKQGWWKDTFKFPWK 476

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)]

 Score = 1950 (691.5 bits), Expect = 1.7e-201, P = 1.7e-201
 Identities = 359/477 (75%), Positives = 419/477 (87%)

Query:     1 MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
             M+N+ AQLKRGISRQFSTGS+RR+L+RQ +RQ+S DPRRNNMRFSFGRQSSLDPIRRSP 
Sbjct:     1 MDNIAAQLKRGISRQFSTGSMRRTLSRQFTRQNSLDPRRNNMRFSFGRQSSLDPIRRSPE 60

Query:    60 ---VQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG 116
                 +  ++VPENLDSTMQLLFMA +GDV GVE+LLNEG DVNSIDLDGRTALHIA+CEG
Sbjct:    61 SLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGIDVNSIDLDGRTALHIASCEG 120

Query:   117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
             H +VVK+LLS++ANIDARDRWGSTAA DAKYYGNVEVYN+LKARGAK PKT++TPMTV N
Sbjct:   121 HYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLLKARGAKAPKTRKTPMTVGN 180

Query:   177 PREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHEL 236
             P+EVPEYELNPLELQVRK DGI+KG+YQVAKWNGT+V VKI DK+S+ DPER+NAFT+EL
Sbjct:   181 PKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKIFDKDSYSDPERVNAFTNEL 240

Query:   237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR 296
             T++ KARHPN+VQFVGAVTQN+PMMIV+E + KGDL+ YLQKKGRLSPSK LRFALD+AR
Sbjct:   241 TLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQKKGRLSPSKALRFALDIAR 300

Query:   297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             GMNYLHECKPDPIIHC+L PKNILLD GGQLKISGFGL++L  I  + AK+V   + ID 
Sbjct:   301 GMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKLSKIGEDSAKVVNHEAQIDK 360

Query:   357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             +N Y+APEIYK+E FD+  D +SFG+ILYE+ EGV  FHPKPPEEV + +C EGKRP ++
Sbjct:   361 SNYYIAPEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPKPPEEVAESICIEGKRPTIR 420

Query:   417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
              K++SYPP+LKELIEECW P+  +RP F+EII RLD+IV NCSKQGWWKDTFK PWK
Sbjct:   421 TKSKSYPPELKELIEECWHPEISVRPIFSEIIIRLDKIVTNCSKQGWWKDTFKFPWK 477

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)]

 Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
 Identities = 206/434 (47%), Positives = 282/434 (64%)

Query:    43 RFSFGRQSSLDPIRRSPVQDELTVPEN--L---------DSTMQLLFMACRGDVKGVEDL 91
             RF  GRQSSL P  R+P+ D LT  E+  L         D T++L+++A  GD+ G+  +
Sbjct:    10 RFKLGRQSSLAPESRTPI-DTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDIDGINKM 68

Query:    92 LNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNV 151
             L+ G++V+  D+D RTALH+AAC+G  +VV+LLLS+ A +D +DRWGST  ADA YY N 
Sbjct:    69 LDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADAVYYKNH 128

Query:   152 EVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT 211
             +V  +L+  GAK P     PM V   +EVPEYE++P EL    +  I+KG++  A W G 
Sbjct:   129 DVIKLLEKHGAK-PTI--APMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASWRGI 185

Query:   212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
              V VK   +E   D +++NAF  EL +++K RHPNVVQF+GAVTQ+ PMMIV EY  KGD
Sbjct:   186 DVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 245

Query:   272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             L  YL +KG L P+  ++FAL++ARGMNYLHE KP+ IIHCDL+P NIL D+ G LK++ 
Sbjct:   246 LRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLKVAD 305

Query:   332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
             FG+ +L  +     K    V+ +D +  Y+APE+Y+NEE+D  VD +SF LIL EMIEG 
Sbjct:   306 FGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEMIEGC 365

Query:   392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
             +PFH     EV K    E +RPP     +SYP  L+ELI++CWD +   RP F  II+ L
Sbjct:   366 EPFHEIEDREVPKAYI-EDERPPFNAPTKSYPFGLQELIQDCWDKEASKRPTFRVIISTL 424

Query:   452 DRIVCNCSKQGWWK 465
             + I    +++  WK
Sbjct:   425 ELISDRIARKRSWK 438

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)]

 Score = 981 (350.4 bits), Expect = 8.2e-99, P = 8.2e-99
 Identities = 201/429 (46%), Positives = 279/429 (65%)

Query:    43 RFSFGRQSSLDP--IRRSPVQDELTV---PENLDSTMQLLFMACRGDVKGVEDLLNEGSD 97
             RF+ GRQSS+ P  I    V  E  V    E +D  ++L+++A  GD++G+++L++ G D
Sbjct:     9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68

Query:    98 VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
              N  D+D RTALH+AAC+G  +VV+LLL +KA +D +DRWGST  ADA +Y N++V  IL
Sbjct:    69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128

Query:   158 KARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKI 217
             +  GAK P     PM V   REVPEYE+NP EL   ++  ITKG+Y +A W G +V VK 
Sbjct:   129 EIHGAKHPMA---PMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKK 185

Query:   218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
             LD E   D +++  F  EL ++++ RHPN+VQF+GAVTQ+ PMMIV EY  +GDL   L+
Sbjct:   186 LDDEVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLK 245

Query:   278 KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             +KG+L P+  +R+ALD+ARGM+YLHE K DPIIH DL+P NIL D+ G LK++ FG+ +L
Sbjct:   246 RKGQLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGVSKL 305

Query:   338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
               +  +K     P +  D +  Y+APE++ +EE+D   D +SF LI+ EMIEG  PF  K
Sbjct:   306 VTVKEDK-----PFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPFAEK 360

Query:   398 PPEEVVKLMCCEGKRPPL-KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC 456
                E  +     GK  PL K  +++YP  LK LIEECW  KP  RP F EII RL+ I+ 
Sbjct:   361 EDSEASEAYA--GKHRPLFKAPSKNYPHGLKTLIEECWHEKPAKRPTFREIIKRLESILH 418

Query:   457 NCSKQGWWK 465
             +   +  W+
Sbjct:   419 HMGHKRQWR 427

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 681 (244.8 bits), Expect = 5.1e-67, P = 5.1e-67
 Identities = 162/420 (38%), Positives = 241/420 (57%)

Query:    47 GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD-VNSIDLDG 105
             G Q++      SP  D+      +  T  +L+ A + D   V  LL E    V++ D D 
Sbjct:    12 GEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDPTLVHARDYDK 71

Query:   106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP 165
             RT LH+A+  G ++VVK LL   A+++A+DRW +T  ADA+     ++  +LK+ G    
Sbjct:    72 RTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMIELLKSHGGLSY 131

Query:   166 KTKRT---PMTVANPREVP---EYELNPLELQVRKADGITKGSY-QVAK--WNGTKVWVK 216
                 +   P  V  P  +P   ++E+ P EL    A  I KGS+ ++ K  W GT V VK
Sbjct:   132 GQNGSHFEPKPVPPP--IPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAYWRGTPVAVK 189

Query:   217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
              +      D   I  F HE+ ++ K RHPN+VQF+GAVT+  P+M++ EY   GDL  YL
Sbjct:   190 RILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHQYL 249

Query:   277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKISGFGL 334
             ++KG L+P+  + FALD+ARGM YLH  +P+ IIH DLKP+N+LL N     LK+  FGL
Sbjct:   250 KEKGGLTPTTAVNFALDIARGMTYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 308

Query:   335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
              +L  I  + +  V+ ++    +  Y+APE++K+  +D+ VD +SF +ILYEM+EG  PF
Sbjct:   309 SKL--IKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEMLEGEPPF 366

Query:   395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                 P E  K +  +G RP  + K  +  PDL+ELI +CWD     RP+F +I+ RL++I
Sbjct:   367 ANHEPYEAAKHVS-DGHRPTFRSKGCT--PDLRELIVKCWDADMNQRPSFLDILKRLEKI 423

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009734 "auxin mediated signaling pathway" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0005829 "cytosol" evidence=RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

DICTYBASE|DDB_G0278409 shkC "SHK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 399 (145.5 bits), Expect = 3.9e-37, P = 3.9e-37
 Identities = 100/302 (33%), Positives = 165/302 (54%)

Query:   184 ELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
             E+ P E+   +  G    G     +     V VK+L K++  D   ++AF  E+ ++ K 
Sbjct:    18 EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNF-DAATLSAFRKEVHLMSKI 76

Query:   243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
              HPN+  F+GA T     +IV E   KG+L + L  +K +L     +R A D A G+N+L
Sbjct:    77 YHPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDAALGINWL 136

Query:   302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV 361
             HE  P   +H D+K  N+L+D   ++KI  FGL  L+    +K K++   S      LY+
Sbjct:   137 HESNP-VFVHRDIKSSNLLVDENMRVKICDFGLSALK----QKHKMLKDQSSAKGTPLYM 191

Query:   362 APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEGKRPPLKIKAR 420
             APE+   +EF+ S D YSFG++L+E++   +PF H +  E+  + +C + +RPP+     
Sbjct:   192 APEVMMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDCL 251

Query:   421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS-----KQGWWKDTF----KLP 471
                  L+ LIE+CWD +P+ RP+F EII+ LD ++ + +      + +WK +F    ++P
Sbjct:   252 D---SLRRLIEKCWDKEPISRPSFKEIISALDHVIIDAAISDLNGRDFWKKSFLTEQEVP 308

Query:   472 WK 473
             W+
Sbjct:   309 WE 310

GO:0051219 "phosphoprotein binding" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
 Identities = 97/291 (33%), Positives = 163/291 (56%)

Query:   171 PMTVANPRE-VPEYELNPLELQVRKADGITKGSYQVAKWNGT----KVWVKILDKESHKD 225
             P  V  P +   E+E++  +L++ K   +  GSY    + GT    +V +KIL K    +
Sbjct:   272 PACVEIPTDGTDEWEIDMKQLKIEKK--VACGSYGEL-FRGTYCSQEVAIKIL-KPERVN 327

Query:   226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP 284
              E +  F+ E+ I+ K RH NVVQF+GA T++  + IV E+  +G +  +L K KG    
Sbjct:   328 AEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKI 387

Query:   285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
               +L+ ALD+++GMNYLH+   + IIH DLK  N+L+D    +K++ FG+ R+Q    E 
Sbjct:   388 QSLLKVALDVSKGMNYLHQ---NNIIHRDLKTANLLMDEHEVVKVADFGVARVQ---TES 441

Query:   345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
               +            ++APE+ +++ +D   D +S+ ++L+E++ G  P+    P +   
Sbjct:   442 GVMTAETG----TYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAV 497

Query:   405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
              +  +G RP  KI   ++P  L EL+E+CW   P +RPNF EII  L++++
Sbjct:   498 GVVQKGLRP--KIPKETHPK-LTELLEKCWQQDPALRPNFAEIIEMLNQLI 545

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)]

 Score = 382 (139.5 bits), Expect = 2.0e-36, Sum P(2) = 2.0e-36
 Identities = 100/281 (35%), Positives = 156/281 (55%)

Query:   179 EVPEYELNPLELQVRKADGITKGSY-QVAK--WNGTKVWVK-ILDKESHKDPERINAFTH 234
             +V E E+   E+ V +  G+  GSY +V +  W+GT V VK  +D++     E +  F  
Sbjct:   704 DVAECEILWEEITVAERIGL--GSYGEVYRGDWHGTAVAVKKFIDQDI--TGEALEEFRS 759

Query:   235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
             E+ ++ + RHPN+V F+GAVT+   + IV E+  +G L   + +   +L   K LR ALD
Sbjct:   760 EVRMMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALD 819

Query:   294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
              ARGMNYLH C P  I+H DLK  N+L+D    +K+  FGL R++  +   +K     S 
Sbjct:   820 AARGMNYLHSCNP-VIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSK-----ST 873

Query:   354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
                A  ++APE+ +NE  D   D YS+G+IL+E+    QP+    P +VV  +  + +R 
Sbjct:   874 AGTAE-WMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRR- 931

Query:   414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
              L I      P + ++I +CW   P +RP+F EI+  L ++
Sbjct:   932 -LDIP-EFVDPGIADIIRKCWQTDPRLRPSFGEIMDSLKQL 970

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 356 (130.4 bits), Expect = 1.1e-35, Sum P(2) = 1.1e-35
 Identities = 108/356 (30%), Positives = 177/356 (49%)

Query:   121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR---G-AKV-PKTKRTPMTVA 175
             +K  LS K + D R     + +   +  G + +   +K++   G +K+   T R    V 
Sbjct:   136 MKPKLSHKNSFDKRSFNLRSPSGPIRDLGTLRIQERVKSKKDTGWSKLFDNTGRRVSAVE 195

Query:   176 NPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINA---- 231
                E    +++ L   ++ A G+    Y   K+    V VK++      D   + A    
Sbjct:   196 ASEEF-RVDMSKLFFGLKFAHGLYSRLYH-GKYEDKAVAVKLITVPDDDDNGCLGARLEK 253

Query:   232 -FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL-EYHAKGDLASYLQK-KGRLSP-SKV 287
              FT E+T++ +  HPNV++FVGA  ++ P+  VL +Y  +G L S+L K + R  P  K+
Sbjct:   254 QFTKEVTLLSRLTHPNVIKFVGAY-KDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKL 312

Query:   288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI 347
             + FA+D+ARGM Y+H  +   IIH DLKP+N+L+D    LKI+ FG+        E   +
Sbjct:   313 IEFAIDIARGMEYIHSRR---IIHRDLKPENVLIDEEFHLKIADFGIA----CEEEYCDM 365

Query:   348 VFPVSHIDPANL-YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
             +      DP    ++APE+ K +   R  D YSFGL+L+EM+ G  P+    P +    +
Sbjct:   366 LAD----DPGTYRWMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAV 421

Query:   407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQG 462
               +  RP +       P  +K LIE+CW   P  RP F +I+  L++   +  ++G
Sbjct:   422 VHKNIRPAIP---GDCPVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFAISLEREG 474

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	473
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-53
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-39
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-37
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-35
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-35
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-33
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-33
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-32
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-32
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-31
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-31
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-30
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-28
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-27
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-26
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-26
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-26
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-26
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-25
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-25
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-24
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	2e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-24
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-23
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-22
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-22
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-22
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-22
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-22
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-21
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-21
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-21
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-20
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-20
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	4e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	1e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-19
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	1e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-18
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-18
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-18
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-18
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-17
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-16
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-16
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-15
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-14
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-13
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
pfam00023	33	pfam00023, Ank, Ankyrin repeat	1e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-11
PTZ00322	664	PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct	6e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	1e-10
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	2e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
pfam13857	56	pfam13857, Ank_5, Ankyrin repeats (many copies)	2e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-09
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	3e-09
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-09
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	8e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
smart00248	30	smart00248, ANK, ankyrin repeats	3e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-08
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	7e-08
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-07
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	6e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-07
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
pfam13606	30	pfam13606, Ank_3, Ankyrin repeat	3e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-06
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	4e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-06
TIGR00870	743	TIGR00870, trp, transient-receptor-potential calci	4e-06
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	4e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-05
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	7e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	2e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	3e-04
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	5e-04
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	5e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	5e-04
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	7e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	0.002
PHA02743	166	PHA02743, PHA02743, Viral ankyrin protein; Provisi	0.002
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  182 bits (463), Expect = 3e-54
 Identities = 89/259 (34%), Positives = 128/259 (49%), Gaps = 20/259 (7%)

Query: 198 ITKGSYQV---AKWNGT--KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           +  GS+     AK  GT   V VKIL K S K  +   A   E+ I+ +  HPN+V+ + 
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLID 65

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           A      + +V+EY   GDL  YL + G LS  +  + AL + RG+ YLH      IIH 
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHR 122

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK-NEEF 371
           DLKP+NILLD  G +KI+ FGL +    S                  Y+APE+      +
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPW------YMAPEVLLGGNGY 176

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI---KARSYPPDLKE 428
              VD +S G+ILYE++ G  PF  +   + ++L+      PPL+    K  S   + K+
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI-RRILGPPLEFDEPKWSSGSEEAKD 235

Query: 429 LIEECWDPKPVIRPNFNEI 447
           LI++C +  P  RP   EI
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  180 bits (460), Expect = 8e-54
 Identities = 90/256 (35%), Positives = 131/256 (51%), Gaps = 26/256 (10%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
                    +V VK L +++    ++I  F  E  I+ K  HPNVV+ +G  T+  P+ I
Sbjct: 21  KGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYI 78

Query: 263 VLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           V+EY   GDL SYL+K + +LS S +L FAL +ARGM YL        IH DL  +N L+
Sbjct: 79  VMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLV 135

Query: 322 DNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
                +KIS FGL R      Y      K+  P+        ++APE  K  +F    D 
Sbjct: 136 GENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIR-------WMAPESLKEGKFTSKSDV 186

Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYPPDLKELIEECWD 435
           +SFG++L+E+   G QP+     EEV+  L    G R P   +  + PP+L +L+ +CW 
Sbjct: 187 WSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK--NGYRLP---QPPNCPPELYDLMLQCWA 241

Query: 436 PKPVIRPNFNEIIARL 451
             P  RP F+E++  L
Sbjct: 242 EDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  180 bits (459), Expect = 1e-53
 Identities = 93/277 (33%), Positives = 134/277 (48%), Gaps = 39/277 (14%)

Query: 191 QVRKA--DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
           +V K    G    + +VA        VK L KE   + ER   F  E  +++K  HPNVV
Sbjct: 10  EVYKGKLKGKDGKTTEVA--------VKTL-KEDASEEERK-DFLKEARVMKKLGHPNVV 59

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQK---------KGRLSPSKVLRFALDLARGMN 299
           + +G  T+  P+ +VLEY   GDL  YL+K         K  LS   +L FA+ +A+GM 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDP 356
           YL   K    +H DL  +N L+     +KIS FGL R  Y       K     P+     
Sbjct: 120 YLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              ++APE  K+  F    D +SFG++L+E+   G  P+     EEV++ +  +G R P 
Sbjct: 173 ---WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLP- 227

Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
             K    P +L EL+  CW   P  RP F+E++ RL+
Sbjct: 228 --KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (455), Expect = 5e-53
 Identities = 89/250 (35%), Positives = 131/250 (52%), Gaps = 25/250 (10%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
             TKV VK L KE   + ER   F  E +I++K  HPN+V+ +G  TQ  P+ IV EY  
Sbjct: 27  TETKVAVKTL-KEGASEEERE-EFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMP 84

Query: 269 KGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            GDL  +L+K G  L+   +L+ AL +A+GM YL        +H DL  +N L+     +
Sbjct: 85  GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN---FVHRDLAARNCLVTENLVV 141

Query: 328 KISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
           KIS FGL R       Y      K   P+        ++APE  K+ +F    D +SFG+
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGK--LPIK-------WMAPESLKDGKFTSKSDVWSFGV 192

Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           +L+E+   G QP+     EEV++L+  +G R P   +  + P +L EL+ +CW   P  R
Sbjct: 193 LLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLP---RPENCPDELYELMLQCWAYDPEDR 248

Query: 442 PNFNEIIARL 451
           P F+E++  L
Sbjct: 249 PTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  177 bits (452), Expect = 1e-52
 Identities = 87/251 (34%), Positives = 128/251 (50%), Gaps = 27/251 (10%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
              +V VK L +++    ++I  F  E  I+ K  HPN+V+ +G  T+  P+MIV+EY  
Sbjct: 27  KEVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMP 84

Query: 269 KGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            GDL  YL+K     LS S +L FAL +ARGM YL        IH DL  +N L+     
Sbjct: 85  GGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLV 141

Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
           +KIS FGL R      Y   +  K+  P+        ++APE  K  +F    D +SFG+
Sbjct: 142 VKISDFGLSRDLYDDDYYKVKGGKL--PIR-------WMAPESLKEGKFTSKSDVWSFGV 192

Query: 383 ILYEMIE-GVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           +L+E+   G +P+      EV+  L   +G R P        PP+L +L+ +CW   P  
Sbjct: 193 LLWEIFTLGEEPYPGMSNAEVLEYLK--KGYRLPKPPNC---PPELYKLMLQCWAEDPED 247

Query: 441 RPNFNEIIARL 451
           RP F+E++  L
Sbjct: 248 RPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (445), Expect = 1e-51
 Identities = 78/257 (30%), Positives = 124/257 (48%), Gaps = 18/257 (7%)

Query: 198 ITKGSY-QV--AKWNGTKVWV--KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + +GS+ +V  A+   T   V  K++ K+  K  +       E+ I++K +HPN+V+   
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKK--KIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
                  + +V+EY   GDL   L+K+GRLS  +   +   +   + YLH      I+H 
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHR 121

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLKP+NILLD  G +K++ FGL R Q    EK    F  +   P   Y+APE+   + + 
Sbjct: 122 DLKPENILLDEDGHVKLADFGLAR-QLDPGEKLT-TFVGT---PE--YMAPEVLLGKGYG 174

Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
           ++VD +S G+ILYE++ G  PF        +     + K PP         P+ K+LI +
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK-PPFPPPEWDISPEAKDLIRK 233

Query: 433 CWDPKPVIRPNFNEIIA 449
                P  R    E + 
Sbjct: 234 LLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  159 bits (405), Expect = 2e-46
 Identities = 75/263 (28%), Positives = 114/263 (43%), Gaps = 57/263 (21%)

Query: 198 ITKGSY-QV--AKWNGTKVWV--KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + +G +  V  A+   T   V  KI+ KE       +     E+ I++K  HPN+V+  G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L   L++  G+LS  ++LR  L +  G+ YLH      IIH
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115

Query: 312 CDLKPKNILLDNG-GQLKISGFGL-LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
            DLKP+NILLD+  G++K++ FGL   L         IV           Y+APE+   +
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-------AYMAPEVLLGK 168

Query: 370 -EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE 428
             +    D +S G+ILYE+                                    P+LK+
Sbjct: 169 GYYSEKSDIWSLGVILYEL------------------------------------PELKD 192

Query: 429 LIEECWDPKPVIRPNFNEIIARL 451
           LI +     P  RP+  EI+  L
Sbjct: 193 LIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (361), Expect = 2e-39
 Identities = 65/248 (26%), Positives = 113/248 (45%), Gaps = 28/248 (11%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM--IVLEY 266
            G  + VK ++  S    E + A   E+ I+   +HPN+V++ G+          I LEY
Sbjct: 24  TGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            + G L+S L+K G+L    + ++   +  G+ YLH      I+H D+K  NIL+D+ G 
Sbjct: 83  VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGV 139

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPAN------LYVAPEIYKNEEFDRSVDAYSF 380
           +K++ FG           AK +  +   +          ++APE+ + EE+ R+ D +S 
Sbjct: 140 VKLADFGC----------AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSL 189

Query: 381 GLILYEMIEGVQPF--HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKP 438
           G  + EM  G  P+     P   + K+    G+ P +         + K+ + +C    P
Sbjct: 190 GCTVIEMATGKPPWSELGNPMAALYKIG-SSGEPPEIPEHL---SEEAKDFLRKCLRRDP 245

Query: 439 VIRPNFNE 446
             RP  +E
Sbjct: 246 KKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  136 bits (345), Expect = 3e-37
 Identities = 88/285 (30%), Positives = 141/285 (49%), Gaps = 42/285 (14%)

Query: 183 YELNPLELQVRKADGITKGSY---QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           + +N  EL++     I KG +    +  + G KV VK L  +S        AF  E +++
Sbjct: 1   WAINSKELKLG--ATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVM 54

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARG 297
              RHPN+VQ +G V Q  P+ IV EY AKG L  YL+ +GR  ++ ++ L FALD+  G
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
           M YL E      +H DL  +N+L+      K+S FGL +      +  K   PV      
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK--LPVK----- 164

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV-------KLMCCE 409
             + APE  + ++F    D +SFG++L+E+   G  P+   P ++VV       ++   E
Sbjct: 165 --WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPE 222

Query: 410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           G            PP++ +++++CW+  P  RP F ++  +L  I
Sbjct: 223 G-----------CPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  132 bits (334), Expect = 2e-35
 Identities = 71/268 (26%), Positives = 132/268 (49%), Gaps = 35/268 (13%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+        K +G    +K +D  +  + ER +A  +E+ I++K  HPN++++  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL-NEVKILKKLNHPNIIKYYE 66

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPDP 308
           +  +   + IV+EY   GDL+  ++K+ +        ++L + + L   + YLH  K   
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--- 123

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN------LYVA 362
           I+H D+KP+NI L + G +K+  FG+          +K++   S +D A        Y++
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGI----------SKVL--SSTVDLAKTVVGTPYYLS 171

Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY 422
           PE+ +N+ ++   D +S G +LYE+     PF  +   E+  L   +G+ PP+      Y
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-LKILKGQYPPIP---SQY 227

Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIAR 450
             +L+ L+       P  RP+  +I+  
Sbjct: 228 SSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  131 bits (331), Expect = 5e-35
 Identities = 85/274 (31%), Positives = 134/274 (48%), Gaps = 38/274 (13%)

Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G+ KG         T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V
Sbjct: 27  AKGVVKGE------PETRVAIKTVN-ENASMRERIE-FLNEASVMKEFNCHHVVRLLGVV 78

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKK--------GRLSPS--KVLRFALDLARGMNYLHEC 304
           +   P ++V+E  AKGDL SYL+ +        G   P+  K ++ A ++A GM YL   
Sbjct: 79  STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK 138

Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI---VFPVSHIDPANLYV 361
           K    +H DL  +N ++     +KI  FG+ R  Y +    K    + PV        ++
Sbjct: 139 K---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WM 188

Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
           APE  K+  F    D +SFG++L+EM     QP+     EEV+K +  +G    L     
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-IDGGHLDLPEN-- 245

Query: 421 SYPPD-LKELIEECWDPKPVIRPNFNEIIARLDR 453
              PD L EL+  CW   P +RP F EI++ L  
Sbjct: 246 --CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  126 bits (320), Expect = 1e-33
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 14/216 (6%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K+L K+     + +     E  I+ +  HP +V+   A      + +VLEY   G+L S+
Sbjct: 24  KVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSH 83

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           L K+GR S  +   +A ++   + YLH      II+ DLKP+NILLD  G +K++ FGL 
Sbjct: 84  LSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLA 140

Query: 336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
           +   +S E ++        +    Y+APE+   + + ++VD +S G++LYEM+ G  PF+
Sbjct: 141 K--ELSSEGSRTNTFCGTPE----YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194

Query: 396 PKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
            +  +E+ + +     + PL+       P+ ++LI 
Sbjct: 195 AEDRKEIYEKI----LKDPLRFP-EFLSPEARDLIS 225

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  125 bits (316), Expect = 5e-33
 Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 17/259 (6%)

Query: 198 ITKGSY-QV--AKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I+KG+Y +V  AK   T     +K++ K       +++    E  I+ +A+ P VV+   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           +      + +V+EY   GDLAS L+  G L       +  ++   + YLH      IIH 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHR 117

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID----PANLYVAPEIYKN 368
           DLKP NIL+D+ G LK++ FGL ++  +  +                P   Y+APE+   
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD--YIAPEVILG 175

Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE 428
           +   ++VD +S G ILYE + G+ PFH + PEE+ + +   GK    +    S   +  +
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPEDVEVS--DEAID 232

Query: 429 LIEECWDPKPVIRPNFNEI 447
           LI +   P P  R     I
Sbjct: 233 LISKLLVPDPEKRLGAKSI 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  124 bits (312), Expect = 2e-32
 Identities = 80/259 (30%), Positives = 128/259 (49%), Gaps = 25/259 (9%)

Query: 200 KGS----YQVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           KGS    Y+V + +  + + +K +D  S    ER +A  +E+ I+    HPN++ +  A 
Sbjct: 10  KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAF 68

Query: 255 TQNIPMMIVLEYHAKGDLASYL---QKKGRLSPSK-VLRFALDLARGMNYLHECKPDPII 310
                + IV+EY   GDL+  +   +KK +L P + + R  + L RG+  LHE K   I+
Sbjct: 69  LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---IL 125

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           H DLK  NILL     +KI   G+ ++   +  K +I  P         Y+APE++K   
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP--------HYMAPEVWKGRP 177

Query: 371 FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           +    D +S G +LYEM     PF  +  ++ ++     GK PP+      Y  DL+  I
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LRYKVQRGKYPPI---PPIYSQDLQNFI 233

Query: 431 EECWDPKPVIRPNFNEIIA 449
                 KP +RPN ++I+A
Sbjct: 234 RSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  123 bits (309), Expect = 4e-32
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 38/281 (13%)

Query: 185 LNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKA 242
           +NP EL   K  G  + G   + KW    KV +K +++ +  + +    F  E  ++ K 
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMMKL 56

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G  TQ  P+ IV E+   G L +YL Q++G+LS   +L    D+  GM YL
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
                +  IH DL  +N L+ + G +K+S FG+ R     +Y S   AK  FPV      
Sbjct: 117 ER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK--FPVK----- 166

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             +  PE++   ++    D +SFG++++E+  EG  PF  K   EVV+ M   G      
Sbjct: 167 --WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE-MISRGF----- 218

Query: 417 IKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLD 452
              R Y P L      E++  CW  KP  RP F E++  + 
Sbjct: 219 ---RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (309), Expect = 7e-32
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 38/268 (14%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG---AVTQNIPMMIVLEY 266
           G +V VK L+     + +  + F  E+ I+    H N+V++ G            +++EY
Sbjct: 33  GEQVAVKSLNHSG--EEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR-LIMEY 89

Query: 267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G L  YLQ+ + +++  ++L F+  + +GM+YL   +    IH DL  +NIL+++  
Sbjct: 90  LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESED 146

Query: 326 QLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYS 379
            +KIS FGL ++       Y   E  +         P   Y APE  +  +F  + D +S
Sbjct: 147 LVKISDFGLAKVLPEDKDYYYVKEPGES--------PIFWY-APECLRTSKFSSASDVWS 197

Query: 380 FGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP-------LKIKARSYPPD-----LK 427
           FG+ LYE+     P    PP E ++++     +         LK   R   P      + 
Sbjct: 198 FGVTLYELFTYGDPSQ-SPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY 256

Query: 428 ELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +L++ CW+ +P  RP+F ++I  +DR+ 
Sbjct: 257 DLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  121 bits (304), Expect = 1e-31
 Identities = 82/258 (31%), Positives = 140/258 (54%), Gaps = 29/258 (11%)

Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G+    ++ G KV VK +     K      AF  E  ++ K  H N+V+ +G +  N  +
Sbjct: 20  GAVLQGEYTGQKVAVKNI-----KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL 73

Query: 261 MIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
            IV+E  +KG+L ++L+ +GR  +S  ++L+F+LD+A GM YL   K   ++H DL  +N
Sbjct: 74  YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARN 130

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
           IL+   G  K+S FGL R+  +  + +K+  PV        + APE  K+++F    D +
Sbjct: 131 ILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVK-------WTAPEALKHKKFSSKSDVW 181

Query: 379 SFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWD 435
           S+G++L+E+   G  P+ PK   + VK    +G R  PP        P D+  L+  CW+
Sbjct: 182 SYGVLLWEVFSYGRAPY-PKMSLKEVKECVEKGYRMEPP-----EGCPADVYVLMTSCWE 235

Query: 436 PKPVIRPNFNEIIARLDR 453
            +P  RP+F+++  +L++
Sbjct: 236 TEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 2e-31
 Identities = 74/251 (29%), Positives = 130/251 (51%), Gaps = 25/251 (9%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V +K L K    D +R++ F  E +I+ +  HPN+++  G VT++ P+MI+ EY   G 
Sbjct: 34  DVAIKTL-KAGSSDKQRLD-FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGS 91

Query: 272 LASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L  +L++  G+ +  +++     +A GM YL E      +H DL  +NIL+++    K+S
Sbjct: 92  LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVS 148

Query: 331 GFGLLR-LQYISPE----KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
            FGL R L+           KI  P+        + APE     +F  + D +SFG++++
Sbjct: 149 DFGLSRRLEDSEATYTTKGGKI--PI-------RWTAPEAIAYRKFTSASDVWSFGIVMW 199

Query: 386 E-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF 444
           E M  G +P+     ++V+K +  +G R P        P  L +L+ +CW      RP F
Sbjct: 200 EVMSYGERPYWDMSNQDVIKAV-EDGYRLP---PPMDCPSALYQLMLDCWQKDRNERPTF 255

Query: 445 NEIIARLDRIV 455
           ++I++ LD+++
Sbjct: 256 SQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 8e-31
 Identities = 86/255 (33%), Positives = 125/255 (49%), Gaps = 28/255 (10%)

Query: 206 AKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             WNG TKV VK L K     PE   AF  E  I++K RH  +VQ     ++  P+ IV 
Sbjct: 25  GTWNGTTKVAVKTL-KPGTMSPE---AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80

Query: 265 EYHAKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           EY +KG L  +L+  +G+ L   +++  A  +A GM YL        IH DL  +NIL+ 
Sbjct: 81  EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVG 137

Query: 323 NGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
                KI+ FGL RL    +Y + E AK  FP+        + APE      F    D +
Sbjct: 138 ENLVCKIADFGLARLIEDDEYTAREGAK--FPIK-------WTAPEAANYGRFTIKSDVW 188

Query: 379 SFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           SFG++L E++  G  P+      EV++     G R P   +  + P +L +L+ +CWD  
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLE-QVERGYRMP---RPPNCPEELYDLMLQCWDKD 244

Query: 438 PVIRPNFNEIIARLD 452
           P  RP F  + + L+
Sbjct: 245 PEERPTFEYLQSFLE 259

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 83/275 (30%), Positives = 134/275 (48%), Gaps = 28/275 (10%)

Query: 185 LNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   K  G  + G   + KW G   V +K++ + +  + +    F  E  ++ K 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMMKL 56

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HPN+VQ  G  T+  P+ IV EY A G L +YL+ +KG+L    +L    D+   M YL
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
                +  IH DL  +N L+     +K+S FGL R     QY S +  K  FPV      
Sbjct: 117 ES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK--FPVK----- 166

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             +  PE++    F    D +SFG++++E+  EG  P+      EVV+ +   G R    
Sbjct: 167 --WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLY-- 221

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            + +  P ++  ++  CW  KP  RP F +++++L
Sbjct: 222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 7e-30
 Identities = 74/261 (28%), Positives = 120/261 (45%), Gaps = 24/261 (9%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           KG Y +      +V VK L +E     ++   F  E +++ +  HP +V+ +G V +  P
Sbjct: 13  KGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCIVRLIG-VCKGEP 69

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           +M+V+E    G L  YL+K+  +  S +   A  +A GM YL        +H DL  +N+
Sbjct: 70  LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNV 126

Query: 320 LLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           LL N  Q KIS FG+ R       Y     A   +P+        + APE     +F   
Sbjct: 127 LLVNRHQAKISDFGMSRALGAGSDYYRATTAG-RWPLK-------WYAPECINYGKFSSK 178

Query: 375 VDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
            D +S+G+ L+E    G +P+      EV+  M   G+R P   +    P ++  ++  C
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA-MLESGERLP---RPEECPQEIYSIMLSC 234

Query: 434 WDPKPVIRPNFNEIIARLDRI 454
           W  +P  RP F+E+ +   R 
Sbjct: 235 WKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  115 bits (289), Expect = 2e-29
 Identities = 81/284 (28%), Positives = 140/284 (49%), Gaps = 40/284 (14%)

Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 55

Query: 242 ARHPNVVQFVGA-VTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G  V +   + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV       
Sbjct: 116 EYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVK------ 164

Query: 359 LYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV-------KLMCCEG 410
            + APE  + ++F    D +SFG++L+E+   G  P+   P ++VV       K+   +G
Sbjct: 165 -WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 223

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                       PP + +++++CW      RP+F ++  +L+ I
Sbjct: 224 -----------CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 3e-29
 Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 25/235 (10%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP 284
           P+    F  E  I+++  HPN+V+ +G   Q  P+ IV+E    G L ++L+K K RL+ 
Sbjct: 33  PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV 92

Query: 285 SKVLRFALDLARGMNYLHE--CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ---- 338
            K+L+ +LD A GM YL    C     IH DL  +N L+     LKIS FG+ R +    
Sbjct: 93  KKLLQMSLDAAAGMEYLESKNC-----IHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147

Query: 339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPK 397
           Y   +  K + P+        + APE      +    D +S+G++L+E    G  P+ P 
Sbjct: 148 YTVSDGLKQI-PIK-------WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY-PG 198

Query: 398 PPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
              +  +     G R P     +  P ++  L+ +CW   P  RP+F+EI   L 
Sbjct: 199 MSNQQTRERIESGYRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  113 bits (285), Expect = 7e-29
 Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 36/279 (12%)

Query: 185 LNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++P EL + +  G      +  G +        KV +K + + +  + +    F  E  +
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAMSEED----FIEEAQV 52

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARG 297
           + K  HP +VQ  G  T+  P+ +V E+   G L+ YL+ ++G+ S   +L   LD+  G
Sbjct: 53  MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEG 112

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSH 353
           M YL       +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV  
Sbjct: 113 MAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK--FPVK- 166

Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKR 412
                 + +PE++   ++    D +SFG++++E+  EG  P+  +   EVV+ +   G R
Sbjct: 167 ------WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFR 219

Query: 413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
                K R     + EL++ CW  +P  RP+F+ ++ +L
Sbjct: 220 ---LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  112 bits (283), Expect = 2e-28
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 20/223 (8%)

Query: 235 ELTIVEKARHPNVVQFVG--AVTQNIPMMIVLEYHAKGDLASYLQK----KGRLSPSKVL 288
           E+ I+ + +HPN+V++        N  + IV+EY   GDLA  +QK    +  +    + 
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 289 RFALDLARGMNYLHECKPDP--IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           R    L   +   H        ++H DLKP NI LD    +K+  FGL ++       AK
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 347 IVFPVSHI-DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
                +++  P   Y++PE   +  +D   D +S G ++YE+     PF  +   ++   
Sbjct: 169 -----TYVGTP--YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS- 220

Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
              EGK     I  R Y  +L E+I+   +  P  RP+  E++
Sbjct: 221 KIKEGKFRR--IPYR-YSSELNEVIKSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (286), Expect = 5e-28
 Identities = 69/286 (24%), Positives = 114/286 (39%), Gaps = 25/286 (8%)

Query: 198 ITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-NVVQFVGAV 254
           + +GS+       +   V +K+L K+     + +  F  E+ I+    HP N+V+     
Sbjct: 8   LGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67

Query: 255 TQNIPMMIVLEYHAKGDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                + +V+EY   G L   L+K   KG LS S+ L     +   + YLH      IIH
Sbjct: 68  QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIH 124

Query: 312 CDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK--- 367
            D+KP+NILLD +G  +K+  FGL +L       + I    S       Y+APE+     
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184

Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
                 S D +S G+ LYE++ G+ PF  +                 LKI      P L 
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT--------LKIILELPTPSLA 236

Query: 428 ELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPWK 473
             +        +I    ++++ +L  +  +   +            
Sbjct: 237 SPLS--PSNPELISKAASDLLKKL--LAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (282), Expect = 5e-28
 Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 50/268 (18%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V +K L KE+ +   +   F  E  ++   +HPN+V  +G  T+  P  ++ EY A G
Sbjct: 36  TSVAIKTL-KENAEPKVQ-QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHG 93

Query: 271 DLASYL----------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           DL  +L                  K  L  S  L  A+ +A GM YL        +H DL
Sbjct: 94  DLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDL 150

Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +N L+  G  +KIS FGL R  Y +     ++K + PV        ++ PE     +F
Sbjct: 151 AARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR-------WMPPEAILYGKF 203

Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-------P 423
               D +SFG++L+E+   G+QP++    +EV+++           I++R         P
Sbjct: 204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-----------IRSRQLLPCPEDCP 252

Query: 424 PDLKELIEECWDPKPVIRPNFNEIIARL 451
             +  L+ ECW+  P  RP F +I  RL
Sbjct: 253 ARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  111 bits (279), Expect = 8e-28
 Identities = 75/259 (28%), Positives = 125/259 (48%), Gaps = 21/259 (8%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G Y   +     V VK     +   P     F  E  I+ +  HP++V+ +G +T+N P
Sbjct: 24  QGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80

Query: 260 MMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           + IV+E    G+L SYLQ  K  L  + ++ ++  L+  + YL   +    +H D+  +N
Sbjct: 81  VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARN 137

Query: 319 ILLDNGGQLKISGFGLLR-LQYISPEKA-KIVFPVSHIDPANLYVAPEIYKNEEFDRSVD 376
           +L+ +   +K+  FGL R L+  S  KA K   P+        ++APE      F  + D
Sbjct: 138 VLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-------WMAPESINFRRFTSASD 190

Query: 377 AYSFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWD 435
            + FG+ ++E ++ GV+PF      +V+      G+R P+       PP L  L+ +CW 
Sbjct: 191 VWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNC---PPTLYSLMTKCWA 246

Query: 436 PKPVIRPNFNEIIARLDRI 454
             P  RP F E+ A+L  I
Sbjct: 247 YDPSKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (277), Expect = 1e-27
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 15/224 (6%)

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           DP+ I     E+ ++E  +HPN+V++ G       + I +EY + G L   L + GR+  
Sbjct: 39  DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILD 97

Query: 285 SKVLR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
             V+R + L L  G+ YLH      I+H D+KP NI LD+ G +K+  FG      +   
Sbjct: 98  EHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV--KLKNN 152

Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFD---RSVDAYSFGLILYEMIEGVQPFHPKPPE 400
              +   V  +     Y+APE+    +     R+ D +S G ++ EM  G +P+     E
Sbjct: 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212

Query: 401 EVVKLMCCEGKRPPL--KIKARSYPPDLKELIEECWDPKPVIRP 442
             +      G +PP+   ++     P+ K+ ++ C +  P  RP
Sbjct: 213 FQIMFHVGAGHKPPIPDSLQLS---PEGKDFLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (276), Expect = 2e-27
 Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 27/248 (10%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK L  +  K  + ++ F  E  I+    H N+++  G V  + P+M+V E    G L
Sbjct: 26  VAVKCLKSD--KLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSL 82

Query: 273 ASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
              L+K   G    S +  +A+ +A GM YL   +    IH DL  +NILL +  ++KI 
Sbjct: 83  LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIG 139

Query: 331 GFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL 384
            FGL+R        Y+  E  K+ F          + APE  +   F  + D + FG+ L
Sbjct: 140 DFGLMRALPQNEDHYVMEEHLKVPFA---------WCAPESLRTRTFSHASDVWMFGVTL 190

Query: 385 YEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           +EM   G +P+      +++K +  EG+R     +  + P D+  ++ +CW   P  RP 
Sbjct: 191 WEMFTYGEEPWAGLSGSQILKKIDKEGERLE---RPEACPQDIYNVMLQCWAHNPADRPT 247

Query: 444 FNEIIARL 451
           F  +   L
Sbjct: 248 FAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 25/259 (9%)

Query: 192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
               + I KG +        K  G +V +K++  ES +  E+I     E+ I++K +HPN
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHPN 58

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECK 305
           +V++ G+  +   + IV+E+ + G L   L+     L+ S++     +L +G+ YLH   
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI-DPANLYVAPE 364
              IIH D+K  NILL + G++K+  FGL      S + +      + +  P   ++APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGL------SAQLSDTKARNTMVGTPY--WMAPE 167

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS-YP 423
           +   + +D   D +S G+   E+ EG  P+   PP   +K +       P  ++    + 
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIATNGPPGLRNPEKWS 224

Query: 424 PDLKELIEECWDPKPVIRP 442
            + K+ +++C    P  RP
Sbjct: 225 DEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 4e-27
 Identities = 78/253 (30%), Positives = 114/253 (45%), Gaps = 28/253 (11%)

Query: 208 WNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           WN  T V VK L K    DP+    F  E  I++K RHP ++Q     T   P+ IV E 
Sbjct: 27  WNNTTPVAVKTL-KPGTMDPK---DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82

Query: 267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
              G L  YLQ      L   +++  A  +A GM YL        IH DL  +N+L+   
Sbjct: 83  MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGEN 139

Query: 325 GQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSF 380
              K++ FGL R+     Y + E AK  FP+        + APE      F    D +SF
Sbjct: 140 NICKVADFGLARVIKEDIYEAREGAK--FPIK-------WTAPEAALYNRFSIKSDVWSF 190

Query: 381 GLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPV 439
           G++L E++  G  P+      EV++    +G R P        P +L +++ +CW   P 
Sbjct: 191 GILLTEIVTYGRMPYPGMTNAEVLQ-QVDQGYRMP---CPPGCPKELYDIMLDCWKEDPD 246

Query: 440 IRPNFNEIIARLD 452
            RP F  +  +L+
Sbjct: 247 DRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  108 bits (271), Expect = 8e-27
 Identities = 73/256 (28%), Positives = 115/256 (44%), Gaps = 26/256 (10%)

Query: 206 AKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             W    +V +KIL  +   D  +   F  E+  +++ RH +++      +   P+ I+ 
Sbjct: 25  GLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81

Query: 265 EYHAKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           E   KG L ++L+  +G+ L  + ++  A  +A GM YL E      IH DL  +NIL+ 
Sbjct: 82  ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVG 138

Query: 323 NGGQLKISGFGLLRL---QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYS 379
                K++ FGL RL           KI  P         + APE   +  F    D +S
Sbjct: 139 EDLVCKVADFGLARLIKEDVYLSSDKKI--PYK-------WTAPEAASHGTFSTKSDVWS 189

Query: 380 FGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKP 438
           FG++LYEM   G  P+      EV   +   G R P   K    P ++ +++ ECW  +P
Sbjct: 190 FGILLYEMFTYGQVPYPGMNNHEVYDQI-TAGYRMPCPAKC---PQEIYKIMLECWAAEP 245

Query: 439 VIRPNFNEIIARLDRI 454
             RP+F  +   LD I
Sbjct: 246 EDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  108 bits (270), Expect = 2e-26
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 58/282 (20%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +      +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 31  TTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 88

Query: 271 DLASYLQKKGRLSPSKV------------------------LRFALDLARGMNYLHECKP 306
            L S+L++  ++ PS +                        + FA  ++RGM YL E K 
Sbjct: 89  SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK- 147

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYV 361
             ++H DL  +N+L+  G ++KIS FGL R       Y+   K +I  PV        ++
Sbjct: 148 --LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI--PVK-------WM 196

Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
           A E   +  +    D +SFG++L+E++  G  P+    PE +  L         LK   R
Sbjct: 197 AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL---------LKTGYR 247

Query: 421 SYPPD-----LKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
              P+     +  L+  CW  +P  RP F +I   L++++  
Sbjct: 248 MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  107 bits (270), Expect = 2e-26
 Identities = 72/227 (31%), Positives = 116/227 (51%), Gaps = 37/227 (16%)

Query: 215 VKILDKES---HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +KIL K      K  E +     E  I++  RHP +V   G+   +  + +V+EY   G+
Sbjct: 31  LKILSKAKIVKLKQVEHVLN---EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE 87

Query: 272 LASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L S+L+K GR  P  V RF A  +   + YLH      I++ DLKP+N+LLD+ G +KI+
Sbjct: 88  LFSHLRKSGRF-PEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKIT 143

Query: 331 GFGLLRLQYISPEKAKIVFPVSHIDPANL-----YVAPEIYKNEEFDRSVDAYSFGLILY 385
            FG           AK V   ++     L     Y+APEI  ++ + ++VD ++ G+++Y
Sbjct: 144 DFGF----------AKRVKGRTY----TLCGTPEYLAPEIILSKGYGKAVDWWALGILIY 189

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK-ARSYPPDLKELIE 431
           EM+ G  PF    P ++ + +  EG     K++    + PD K+LI 
Sbjct: 190 EMLAGYPPFFDDNPIQIYEKI-LEG-----KVRFPSFFSPDAKDLIR 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  107 bits (269), Expect = 3e-26
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 59/295 (20%)

Query: 191 QVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
           QV KA+ +      +   N T  V VK+L K+   + +  +  +    +    +H N++ 
Sbjct: 27  QVVKAEAVG-----LDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIIN 80

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALD 293
            +G  TQ  P+ +V+EY A G+L  +L+ +                  L+   ++ FA  
Sbjct: 81  LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ 140

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           +ARGM +L   K    IH DL  +N+L+     +KI+ FGL R              + H
Sbjct: 141 VARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR-------------DIHH 184

Query: 354 ID----------PANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEV 402
           ID          P   ++APE   +  +    D +SFG++L+E    G  P+   P EE+
Sbjct: 185 IDYYRKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243

Query: 403 VKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
            KL+  EG R   P      +   +L  L+ +CW   P  RP F +++  LDR++
Sbjct: 244 FKLL-KEGYRMEKPQ-----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  105 bits (264), Expect = 7e-26
 Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 38/278 (13%)

Query: 185 LNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ K 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMKL 56

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYL 301
            H  +VQ  G  T+  P+ IV EY + G L +YL++ G R  PS++L    D+  GM YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
            E K    IH DL  +N L+D+ G +K+S FGL R     +Y S   +K  FPV      
Sbjct: 117 -ESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK--FPVR----- 166

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             +  PE+    +F    D ++FG++++E+   G  P+      E V     +G      
Sbjct: 167 --WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-EKVSQGL----- 218

Query: 417 IKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIA 449
              R Y P L       ++  CW  K   RP F ++++
Sbjct: 219 ---RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (266), Expect = 7e-26
 Identities = 76/262 (29%), Positives = 127/262 (48%), Gaps = 28/262 (10%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYH 267
           G  V VK   K  H   E +  F  E+ I++  +H N+V++  V        + +V+EY 
Sbjct: 33  GEVVAVK---KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89

Query: 268 AKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             G L  YLQK + RL   K+L +A  + +GM YL   +    +H DL  +NIL+++  +
Sbjct: 90  PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENR 146

Query: 327 LKISGFGLLRLQYISPEKAKIVFP-VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           +KI  FGL ++     E  K+  P  S I     + APE     +F  + D +SFG++LY
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPI----FWYAPESLTESKFSVASDVWSFGVVLY 202

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPP--------LKIKAR-----SYPPDLKELIEE 432
           E+          PP E +++M  + +           LK   R       P ++  +++E
Sbjct: 203 ELFTYSDK-SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKE 261

Query: 433 CWDPKPVIRPNFNEIIARLDRI 454
           CW+  P  RP+F+E+  +++ I
Sbjct: 262 CWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  105 bits (264), Expect = 7e-26
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 26/251 (10%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K L K  + + +R + F  E +I+ +  HPN++   G VT++ P+MIV EY   G L
Sbjct: 35  VAIKTL-KAGYTEKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 92

Query: 273 ASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
            ++L+K  G+ +  +++     +A GM YL +      +H DL  +NIL+++    K+S 
Sbjct: 93  DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSD 149

Query: 332 FGLLRLQYISPEKA------KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           FGL R+    PE A      KI  P+        + APE     +F  + D +S+G++++
Sbjct: 150 FGLSRVLEDDPEAAYTTRGGKI--PIR-------WTAPEAIAYRKFTSASDVWSYGIVMW 200

Query: 386 EMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF 444
           E++  G +P+     ++V+K +  EG R P  +     P  L +L+ +CW      RP F
Sbjct: 201 EVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDC---PAALHQLMLDCWQKDRNERPKF 256

Query: 445 NEIIARLDRIV 455
            +I++ LD+++
Sbjct: 257 EQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  105 bits (263), Expect = 8e-26
 Identities = 74/250 (29%), Positives = 120/250 (48%), Gaps = 25/250 (10%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N TKV VK L   +      + AF  E  +++  +H  +V+    VT+  P+ I+ EY A
Sbjct: 29  NSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84

Query: 269 KGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           KG L  +L   + G++   K++ F+  +A GM Y+        IH DL+  N+L+     
Sbjct: 85  KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLM 141

Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            KI+ FGL R+    +Y + E AK  FP+        + APE      F    D +SFG+
Sbjct: 142 CKIADFGLARVIEDNEYTAREGAK--FPIK-------WTAPEAINFGSFTIKSDVWSFGI 192

Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           +LYE++   +  +P      V      G R P   +  + P +L ++++ CW  K   RP
Sbjct: 193 LLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP---RMENCPDELYDIMKTCWKEKAEERP 249

Query: 443 NFNEIIARLD 452
            F+ + + LD
Sbjct: 250 TFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  105 bits (265), Expect = 9e-26
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 34/237 (14%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--------LS 283
           F  E  I+ K  H N+V+ +G   + +P  I+LE  A GDL S+L ++ R        L+
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLT 114

Query: 284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A+G  YL E      IH D+  +N LL   G     KI+ FG+ R  Y 
Sbjct: 115 MKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171

Query: 341 SP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    +  + + P+        ++ PE + +  F    D +SFG++L+E+   G  P+  
Sbjct: 172 ASYYRKGGRAMLPIK-------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224

Query: 397 KPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
           +  +EV+      G R  PP       Y      ++ +CW   P  RPNF  I+ R+
Sbjct: 225 RTNQEVM-EFVTGGGRLDPPKGCPGPVY-----RIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  104 bits (262), Expect = 2e-25
 Identities = 70/252 (27%), Positives = 123/252 (48%), Gaps = 25/252 (9%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK L  +  KD    + F  EL +  K  H NVV+ +G   +  P  ++LEY   G
Sbjct: 36  TLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLG 93

Query: 271 DLASYLQ---------KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           DL  +L+         K   LS  + +     +A GM++L   +    +H DL  +N L+
Sbjct: 94  DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLV 150

Query: 322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFG 381
            +  ++K+S   L +  Y + E  K+    + + P   ++APE  + ++F    D +SFG
Sbjct: 151 SSQREVKVSLLSLSKDVY-NSEYYKL---RNALIPLR-WLAPEAVQEDDFSTKSDVWSFG 205

Query: 382 LILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPV 439
           ++++E+  +G  PF+    EEV+  +    +   L++      P  L +L+  CW   P 
Sbjct: 206 VLMWEVFTQGELPFYGLSDEEVLNRL----QAGKLELPVPEGCPSRLYKLMTRCWAVNPK 261

Query: 440 IRPNFNEIIARL 451
            RP+F+E+++ L
Sbjct: 262 DRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  103 bits (259), Expect = 4e-25
 Identities = 74/272 (27%), Positives = 132/272 (48%), Gaps = 36/272 (13%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G  ++       V +K L K  + + +R   F  E +I+ +  HPN++   G VT++
Sbjct: 20  VCRGRLKLPGKREIFVAIKTL-KSGYTEKQR-RDFLSEASIMGQFDHPNIIHLEGVVTKS 77

Query: 258 IPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P+MI+ E+   G L S+L Q  G+ +  +++     +A GM YL E      +H DL  
Sbjct: 78  RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAA 134

Query: 317 KNILLDNGGQLKISGFGLLRL--------QYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           +NIL+++    K+S FGL R          Y S    KI  P+        + APE    
Sbjct: 135 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI--PIR-------WTAPEAIAY 185

Query: 369 EEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-- 425
            +F  + D +S+G++++E M  G +P+     ++V+  +  + + PP        P D  
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP--------PMDCP 237

Query: 426 --LKELIEECWDPKPVIRPNFNEIIARLDRIV 455
             L +L+ +CW      RP F +I++ LD+++
Sbjct: 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  104 bits (261), Expect = 4e-25
 Identities = 82/272 (30%), Positives = 134/272 (49%), Gaps = 37/272 (13%)

Query: 211 TKVWVKILDKE-SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  + + KD   + +    + ++ K  H N++  +GA TQ+ P+ +++EY +K
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASK 108

Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YL+ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRD 165

Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 218

Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 274

Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRI+   S Q
Sbjct: 275 MRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  103 bits (258), Expect = 7e-25
 Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 35/258 (13%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           V I   +   +P++   F  E +++ +  HPN+V  +G VTQ  P+ ++ EY  +GDL  
Sbjct: 37  VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE 96

Query: 275 YL-----------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           +L                   K  L     L  A+ +A GM YL        +H DL  +
Sbjct: 97  FLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAAR 153

Query: 318 NILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           NIL+     +KIS  GL R  Y +     + K + P+        ++ PE     +F   
Sbjct: 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR-------WMPPEAIMYGKFSSD 206

Query: 375 VDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
            D +SFG++L+E+   G+QP++    +EV++++    ++  L   +   PP +  L+ EC
Sbjct: 207 SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV----RKRQLLPCSEDCPPRMYSLMTEC 262

Query: 434 WDPKPVIRPNFNEIIARL 451
           W   P  RP F +I  RL
Sbjct: 263 WQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  102 bits (256), Expect = 9e-25
 Identities = 75/252 (29%), Positives = 119/252 (47%), Gaps = 31/252 (12%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           V K     V VK L KE   D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ 
Sbjct: 26  VWKKYSLTVAVKTL-KE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81

Query: 265 EYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           E+   G+L  YL++  R  ++   +L  A  ++  M YL +      IH DL  +N L+ 
Sbjct: 82  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 138

Query: 323 NGGQLKISGFGLLRLQ----YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
               +K++ FGL RL     Y +   AK  FP+        + APE     +F    D +
Sbjct: 139 ENHLVKVADFGLSRLMTGDTYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVW 189

Query: 379 SFGLILYEMIE-GVQPFHPKPPEEVVKLM--CCEGKRPPLKIKARSYPPDLKELIEECWD 435
           +FG++L+E+   G+ P+      +V +L+      +RP         PP + EL+  CW 
Sbjct: 190 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPE------GCPPKVYELMRACWQ 243

Query: 436 PKPVIRPNFNEI 447
             P  RP+F EI
Sbjct: 244 WNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  101 bits (254), Expect = 1e-24
 Identities = 75/222 (33%), Positives = 113/222 (50%), Gaps = 22/222 (9%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRF 290
           F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  S+L +KK  L   ++++F
Sbjct: 39  FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF 98

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           ALD A GM YL E K    IH DL  +N L+     LKIS FG+ R +    Y S    +
Sbjct: 99  ALDAAAGMAYL-ESK--NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155

Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
           I  P+        + APE      +    D +S+G++L+E    GV P+ P    +  + 
Sbjct: 156 I--PIK-------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY-PGMTNQQARE 205

Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
              +G R     K    P D+ ++++ CWD KP  RP F+E+
Sbjct: 206 QVEKGYRMSCPQKC---PDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  101 bits (254), Expect = 2e-24
 Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 28/265 (10%)

Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNI 258
           G+   +        VK L++ +  D E +  F  E  I++   HPNV+  +G    ++  
Sbjct: 14  GTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71

Query: 259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVL-RFALDLARGMNYLHECKPDPIIHCDLKPK 317
           P+ +VL Y   GDL ++++ +      K L  F L +A+GM YL   K    +H DL  +
Sbjct: 72  PL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAAR 127

Query: 318 NILLDNGGQLKISGFGLLR----LQYISP-EKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           N +LD    +K++ FGL R     +Y S         PV        ++A E  + ++F 
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK-------WMALESLQTQKFT 180

Query: 373 RSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELI 430
              D +SFG++L+E M  G  P+      ++   +  +G+R         Y PD L E++
Sbjct: 181 TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLL----QPEYCPDPLYEVM 235

Query: 431 EECWDPKPVIRPNFNEIIARLDRIV 455
             CW PKP +RP F+E+++R+++I 
Sbjct: 236 LSCWHPKPEMRPTFSELVSRIEQIF 260

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 97.8 bits (244), Expect = 2e-24
 Identities = 47/104 (45%), Positives = 66/104 (63%), Gaps = 4/104 (3%)

Query: 76  LLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
            L +A   G ++ V+ LL  G+DVN+ D DGRT LH+AA  GH+E+VKLLL K A+++AR
Sbjct: 10  PLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNAR 69

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           D+ G+T    A   GN++V  +L   GA V    K  RTP+ +A
Sbjct: 70  DKDGNTPLHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLA 113

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (253), Expect = 2e-24
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 14/260 (5%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G  ++       V +K L K  + + +R   F  E +I+ +  H N+++  G VT+ 
Sbjct: 21  VFRGILKMPGRKEVAVAIKTL-KPGYTEKQR-QDFLSEASIMGQFSHHNIIRLEGVVTKF 78

Query: 258 IPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P MI+ EY   G L  YL+   G  S  +++     +A GM YL +      +H DL  
Sbjct: 79  KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAA 135

Query: 317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVD 376
           +NIL+++  + K+S FGL R+    PE     +  S       + APE     +F  + D
Sbjct: 136 RNILVNSNLECKVSDFGLSRVLEDDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASD 192

Query: 377 AYSFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWD 435
            +SFG++++E M  G +P+      EV+K +  +G R P  +     P  + +L+ +CW 
Sbjct: 193 VWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDC---PSAVYQLMLQCWQ 248

Query: 436 PKPVIRPNFNEIIARLDRIV 455
                RP F +I+  LD+++
Sbjct: 249 QDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  101 bits (253), Expect = 3e-24
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 29/210 (13%)

Query: 198 ITKGSYQVAKWNGTKVWV------------KILDKESHKDPERINAFTHELTIVEKARHP 245
           I KG++        KV +            K ++K+   +   +    +E  I+++  HP
Sbjct: 8   IGKGAF-------GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
            +V    +      M +V++    GDL  +L +K + S  +V  +  ++   + YLH   
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI 365
              IIH D+KP NILLD  G + I+ F +            +    S       Y+APE+
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKV----TPDTLTTSTSGTPG---YMAPEV 170

Query: 366 YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
              + +  +VD +S G+  YE + G +P+ 
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (253), Expect = 3e-24
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 24/226 (10%)

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           D E       EL  +     P VV+  GA  +   + IVLEY   G LA  L+K G++  
Sbjct: 39  DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE 98

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
             +   A  + +G++YLH  +   IIH D+KP N+L+++ G++KI+ FG+          
Sbjct: 99  PVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGI---------- 146

Query: 345 AKIVFPVSHIDPANLYV------APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP 398
           +K++   + +D  N +V      +PE  + E +  + D +S GL L E   G  PF P  
Sbjct: 147 SKVL--ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204

Query: 399 PEEVVKLMC--CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
                +LM   C+G  P L   A  + P+ ++ I  C    P  RP
Sbjct: 205 QPSFFELMQAICDGPPPSL--PAEEFSPEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  100 bits (251), Expect = 5e-24
 Identities = 73/245 (29%), Positives = 125/245 (51%), Gaps = 16/245 (6%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +  L +    D +R   F  E   + +  H N+V+  G +T+   MMIV EY + G L
Sbjct: 36  VAIHTL-RAGCSDKQRR-GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93

Query: 273 ASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
            S+L+K +G+L   +++     LA GM YL E      +H  L    +L+++    KISG
Sbjct: 94  DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISG 150

Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEG 390
           F   RLQ    +K++ ++         L+ APE  +   F  + D +SFG++++E M  G
Sbjct: 151 FR--RLQ---EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG 205

Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
            +P+     ++V+K +  +G R P     R+ P  L +L+ +CW  +   RP F++I + 
Sbjct: 206 ERPYWDMSGQDVIKAV-EDGFRLP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHSI 261

Query: 451 LDRIV 455
           L ++V
Sbjct: 262 LSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =   99 bits (249), Expect = 8e-24
 Identities = 69/242 (28%), Positives = 121/242 (50%), Gaps = 20/242 (8%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V +K +  E     ER  A  +E  +++   HPN++++     ++  +MIV+EY   G 
Sbjct: 27  LVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85

Query: 272 LASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LK 328
           LA Y+QK+    L    +L F + +   ++++H      I+H DLK +NILLD     +K
Sbjct: 86  LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVK 142

Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           I  FG+ ++   S  KA  V           Y++PE+ + + +++  D ++ G +LYE+ 
Sbjct: 143 IGDFGISKI-LSSKSKAYTVVGTPC------YISPELCEGKPYNQKSDIWALGCVLYELA 195

Query: 389 EGVQPFHPKP-PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
              + F     P  V+K+M   G   P+   +  Y PDL++LI    +  P  RP  ++I
Sbjct: 196 SLKRAFEAANLPALVLKIM--SGTFAPI---SDRYSPDLRQLILSMLNLDPSKRPQLSQI 250

Query: 448 IA 449
           +A
Sbjct: 251 MA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 74/267 (27%), Positives = 107/267 (40%), Gaps = 54/267 (20%)

Query: 198 ITKGSY-QV----AKWNGTKVWVKILDKESHKDPERINAFTHELTI-VEK------ARHP 245
           I +GS+  V     K    +  +KILDK       ++        + +EK        HP
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR------QLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHEC 304
            +++          +  VLEY   G+L  Y++K G L   K  RF A ++   + YLH  
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFYAAEILLALEYLHSK 121

Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFG----LLRLQYISPEKAKIVFPVSHIDPA--- 357
               IIH DLKP+NILLD    +KI+ FG    L         K       S I+     
Sbjct: 122 G---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 358 -------NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
                    YV+PE+   +   +S D ++ G I+Y+M+ G  PF         +      
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ------ 232

Query: 411 KRPPLKIKARSY------PPDLKELIE 431
                KI    Y      PPD K+LIE
Sbjct: 233 -----KILKLEYSFPPNFPPDAKDLIE 254

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 78/243 (32%), Positives = 119/243 (48%), Gaps = 28/243 (11%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
             TKV +K L K+    PE   AF  E  ++++ +HP +V+    VTQ  P+ I+ EY  
Sbjct: 29  GHTKVAIKSL-KQGSMSPE---AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYME 83

Query: 269 KGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            G L  +L+     +L+ +K++  A  +A GM ++        IH DL+  NIL+     
Sbjct: 84  NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLC 140

Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            KI+ FGL RL    +Y + E AK  FP+        + APE      F    D +SFG+
Sbjct: 141 CKIADFGLARLIEDNEYTAREGAK--FPIK-------WTAPEAINYGTFTIKSDVWSFGI 191

Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           +L E++  G  P+      EV++ +   G R P   +  + P +L EL+  CW  KP  R
Sbjct: 192 LLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMP---RPDNCPEELYELMRLCWKEKPEER 247

Query: 442 PNF 444
           P F
Sbjct: 248 PTF 250

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 86/252 (34%), Positives = 123/252 (48%), Gaps = 29/252 (11%)

Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  WNG TKV VK L K     PE   +F  E  I++K RH  +VQ    V++  P
Sbjct: 20  GEVWMGTWNGNTKVAVKTL-KPGTMSPE---SFLEEAQIMKKLRHDKLVQLYAVVSEE-P 74

Query: 260 MMIVLEYHAKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + IV EY +KG L  +L+  +GR L    ++  A  +A GM Y+        IH DL+  
Sbjct: 75  IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSA 131

Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +G   KI+ FGL RL    +Y + + AK  FP+        + APE      F  
Sbjct: 132 NILVGDGLVCKIADFGLARLIEDNEYTARQGAK--FPIK-------WTAPEAALYGRFTI 182

Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++ +G  P+      EV++     G R P     +  P  L EL+ +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLE-QVERGYRMPC---PQDCPISLHELMLQ 238

Query: 433 CWDPKPVIRPNF 444
           CW   P  RP F
Sbjct: 239 CWKKDPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 33/255 (12%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK+L +    D  R   F  E+ I+ +   PN+ + +G  T + P+ +++EY   GDL
Sbjct: 49  VAVKVL-RPDASDNAR-EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 273 ASYLQK-----------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
             +LQK              LS S +L  A  +A GM YL        +H DL  +N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLV 163

Query: 322 DNGGQLKISGFGLLRLQYISPEKAKI----VFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
                +KI+ FG+ R  Y S +  ++      P+        ++A E     +F    D 
Sbjct: 164 GKNYTIKIADFGMSRNLYSS-DYYRVQGRAPLPIR-------WMAWESVLLGKFTTKSDV 215

Query: 378 YSFGLILYE--MIEGVQPFHPKPPEEVVK---LMCCEGKRPPLKIKARSYPPDLKELIEE 432
           ++FG+ L+E   +   QP+     ++V++       +  R     +  + P D+ EL+ E
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275

Query: 433 CWDPKPVIRPNFNEI 447
           CW      RP F EI
Sbjct: 276 CWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.9 bits (244), Expect = 6e-23
 Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 44/262 (16%)

Query: 213 VWVKIL----DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           V VK L      ++ KD ER      E  ++   +H N+V+F G  T+  P ++V EY  
Sbjct: 38  VAVKTLKETASNDARKDFER------EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME 91

Query: 269 KGDLASYL--------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
            GDL  +L                 G L+ S++L+ A+ +A GM YL        +H DL
Sbjct: 92  HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDL 148

Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKI----VFPVSHIDPANLYVAPEIYKNEE 370
             +N L+     +KI  FG+ R  Y + +  ++    + P+        ++ PE     +
Sbjct: 149 ATRNCLVGYDLVVKIGDFGMSRDVY-TTDYYRVGGHTMLPIR-------WMPPESIMYRK 200

Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           F    D +SFG++L+E+   G QP++    EEV++ +     +  L  + R+ P ++ ++
Sbjct: 201 FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI----TQGRLLQRPRTCPSEVYDI 256

Query: 430 IEECWDPKPVIRPNFNEIIARL 451
           +  CW   P  R N  +I  RL
Sbjct: 257 MLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.9 bits (245), Expect = 7e-23
 Identities = 55/167 (32%), Positives = 88/167 (52%), Gaps = 20/167 (11%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E++++++ +HPN+V+ +  +     + +V EY    DL  YL K+   LSP+ +      
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA---KIVFP 350
           L RG+ Y H  +   I+H DLKP+NIL++  G LK++ FGL R  +  P +    ++V  
Sbjct: 107 LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRTYTHEVV-- 160

Query: 351 VSHIDPANL-YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   L Y APEI   ++ +  +VD +S G I  EMI G   F 
Sbjct: 161 -------TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 15/228 (6%)

Query: 215 VKILDKESHKDPERINAFTHELTIVE-KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K+L K       ++     E  I+  +   P V +   +      + +V+EY   GD A
Sbjct: 26  IKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCA 85

Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           S ++  G L      ++  ++  G+  LH+     IIH D+KP+N+L+D  G LK++ FG
Sbjct: 86  SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           L R    +    K V           Y+APE       D+  D +S G +++E + G  P
Sbjct: 143 LSRNGLENK---KFVGTPD-------YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Query: 394 FHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           FH + P+ V   +       P +       P+  +LI       P  R
Sbjct: 193 FHAETPDAVFDNILSRRINWP-EEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 78/257 (30%), Positives = 132/257 (51%), Gaps = 34/257 (13%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 37  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94

Query: 271 DLASYLQ--------KKGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 95  DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151

Query: 321 LDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R  Y +    +  K + PV        ++APE  K+  F  S D 
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 204

Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEG--KRPPLKIKARSYPPDLKELIEECW 434
           +SFG++L+E+     QP+     E+V+K +   G   +P       + P  + +L+  CW
Sbjct: 205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP------DNCPERVTDLMRMCW 258

Query: 435 DPKPVIRPNFNEIIARL 451
              P +RP F EI+  L
Sbjct: 259 QFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 77/248 (31%), Positives = 124/248 (50%), Gaps = 30/248 (12%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H   ER  A   EL I+     H N+V  +GA T   P++++ EY   G
Sbjct: 67  KVAVKMLKPTAHSS-ER-EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124

Query: 271 DLASYLQKKGR--LSPSKVLRFALDLARGMNYL--HECKPDPIIHCDLKPKNILLDNGGQ 326
           DL ++L++K    L+   +L F+  +A+GM +L    C     IH DL  +N+LL +G  
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC-----IHRDLAARNVLLTHGKI 179

Query: 327 LKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFG 381
           +KI  FGL R       Y+    A++  PV        ++APE   N  +    D +S+G
Sbjct: 180 VKICDFGLARDIMNDSNYVVKGNARL--PVK-------WMAPESIFNCVYTFESDVWSYG 230

Query: 382 LILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           ++L+E+   G  P+   P +     +  EG R      A   P ++ ++++ CWD  P+ 
Sbjct: 231 ILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA---PAEIYDIMKTCWDADPLK 287

Query: 441 RPNFNEII 448
           RP F +I+
Sbjct: 288 RPTFKQIV 295

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 69/236 (29%), Positives = 119/236 (50%), Gaps = 19/236 (8%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L K   K+ E   A   E+ ++ K +HPN+V F  +  +N  + IV+EY   GDL   + 
Sbjct: 35  LTKMPVKEKE---ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRIN 91

Query: 278 K-KGRL-SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL-KISGFGL 334
           + +G L S  ++L + + ++ G+ ++H+ K   I+H D+K +NI L   G + K+  FG+
Sbjct: 92  RQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            R    S E A       +      Y++PEI +N  ++   D +S G +LYE+     PF
Sbjct: 149 ARQLNDSMELAYTCVGTPY------YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202

Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
                 ++V L  C+G   P+   + ++  DL+ LI + +   P  RP+   I+ R
Sbjct: 203 EGNNLHQLV-LKICQGYFAPI---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 21/228 (9%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSP 284
           P+    F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +G RL  
Sbjct: 34  PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV 93

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YI 340
            ++++   + A GM YL E K    IH DL  +N L+     LKIS FG+ R +    Y 
Sbjct: 94  KELIQMVENAAAGMEYL-ESK--HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150

Query: 341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPP 399
           S    K + PV        + APE      +    D +SFG++L+E    G  P+     
Sbjct: 151 STGGMKQI-PVK-------WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202

Query: 400 EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++  + +    + P         P  +  L+E CW+  P  RP+F+ +
Sbjct: 203 QQTREAIEQGVRLPC----PELCPDAVYRLMERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VE+        HP +            +  V+EY   GDL  ++Q  GR   ++  
Sbjct: 40  ECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARAR 99

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++  G+ +LH+     II+ DLK  N+LLD  G +KI+ FG+ +       KA   
Sbjct: 100 FYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--- 153

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC 408
              S       Y+APEI K ++++ SVD +SFG++LYEM+ G  PFH +  +E+   +  
Sbjct: 154 ---STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210

Query: 409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           +    P  I   +     K+ + + ++  P  R
Sbjct: 211 DRPHFPRWISKEA-----KDCLSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 15/206 (7%)

Query: 198 ITKGSYQ---VAKWNGTKVW--VKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFV 251
           I KGS+    +AK      +  VK+L K++  K  E+ +       +++  +HP +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      +  VL+Y   G+L  +LQ++      +   +A ++A  + YLH      II+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIY 119

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DLKP+NILLD+ G + ++ FGL + + I   K    F  +   P   Y+APE+ + + +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGT---PE--YLAPEVLRKQPY 173

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPK 397
           DR+VD +  G +LYEM+ G+ PF+ +
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 64/227 (28%), Positives = 115/227 (50%), Gaps = 13/227 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+ I++  +HPN+V +  +      + +V+EY   G L   + Q   R++  ++     +
Sbjct: 65  EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           + +G+ YLH      +IH D+K  NILL   G +K++ FG      ++ EK+K    V  
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ--LTKEKSKRNSVVG- 178

Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
             P   ++APE+ K +++   VD +S G++  EM EG  P+  +PP   + L+  +G  P
Sbjct: 179 -TPY--WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-P 234

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK 460
           PLK     + P+ K+ + +C    P  RP+  E++ +   +   C K
Sbjct: 235 PLK-NPEKWSPEFKDFLNKCLVKDPEKRPSAEELL-QHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 15/244 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +  G  + VK +  E   +         EL I+ K   P +V F GA   N  + I +EY
Sbjct: 23  RPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80

Query: 267 HAKGDLASYLQKKGRLSPSKVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G L   L++     P ++L + A+ + +G+ YLHE     IIH D+KP NIL+++ G
Sbjct: 81  MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRG 138

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           Q+K+  FG+      S  K  +          + Y+APE  +  ++    D +S GL L 
Sbjct: 139 QIKLCDFGVSGQLVNSLAKTFV--------GTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190

Query: 386 EMIEGVQPFHP--KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           E+  G  P+ P   PP+ + +L+      PP ++ +  + PD ++ +  C    P  RP+
Sbjct: 191 ELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS 250

Query: 444 FNEI 447
           + E+
Sbjct: 251 YKEL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 95.9 bits (238), Expect = 4e-22
 Identities = 79/270 (29%), Positives = 137/270 (50%), Gaps = 32/270 (11%)

Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +GI KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 24  EGIAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 79

Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +     +P    K+++ A ++A GM YL+  K
Sbjct: 80  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK 139

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 140 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 189

Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG----LLDKPDN 245

Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 246 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 67/237 (28%), Positives = 111/237 (46%), Gaps = 17/237 (7%)

Query: 220 KESHKDPERINAFTHELTIV-EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-- 276
           K+  +  + I     E+TI+ E+ RHPN+V++     +N  + IV++      L  +   
Sbjct: 43  KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102

Query: 277 --QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             +KK R +  ++    + +   + YLH  K   I+H DL P NI+L    ++ I+ FGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + +   PE +K+   V  I    LY  PEI KNE +    D ++FG ILY+M     PF
Sbjct: 161 AKQK--QPE-SKLTSVVGTI----LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
           +      +   +  E    PL      Y  D+ ++I  C  P    RP+  ++ A +
Sbjct: 214 YSTNMLSLATKI-VEAVYEPLPEGM--YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 96.6 bits (240), Expect = 4e-22
 Identities = 82/288 (28%), Positives = 138/288 (47%), Gaps = 43/288 (14%)

Query: 191 QVRKADGITKGSYQVAKWNGTKVWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVV 248
           QV  A+ I     +  K     V VK+L D  + KD   ++    E+ +++   +H N++
Sbjct: 27  QVVMAEAIGIDKDKPNK--PVTVAVKMLKDDATDKD---LSDLVSEMEMMKMIGKHKNII 81

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFAL 292
             +GA TQ+ P+ +++EY +KG+L  YL+ +                 +L+   ++  A 
Sbjct: 82  NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY 141

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIV 348
            +ARGM YL   K    IH DL  +N+L+     +KI+ FGL R    + Y   +     
Sbjct: 142 QVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK-KTTNGR 197

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMC 407
            PV        ++APE   +  +    D +SFG++L+E+   G  P+   P EE+ KL+ 
Sbjct: 198 LPVK-------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL- 249

Query: 408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
            EG R     K  +   +L  ++ ECW   P  RP F +++  LDR++
Sbjct: 250 KEGHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 65/218 (29%), Positives = 114/218 (52%), Gaps = 15/218 (6%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSK-VLRFAL 292
           E  ++ K +HPN+V F  +   +  + IV+EY   GDL   +  ++G+L P   +L++ +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS 352
            +  G+ ++HE +   ++H D+K KNI L   G++K+  FG  RL   SP      +  +
Sbjct: 108 QMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSP----GAYACT 159

Query: 353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR 412
           ++     YV PEI++N  ++   D +S G ILYE+     PF     + ++ L  C+G  
Sbjct: 160 YVGTP-YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-LKVCQGSY 217

Query: 413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
            PL      Y  +L+ LI++ +   P  RP+   I++R
Sbjct: 218 KPLPSH---YSYELRSLIKQMFKRNPRSRPSATTILSR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFV 251
           I KGS+        K +G+   VK+L K++  K  E+ +       +++  +HP +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      +  VL+Y   G+L  +LQ++      +   +A ++A  + YLH      II+
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIY 119

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DLKP+NILLD+ G + ++ FGL + + + PE+    F  +   P   Y+APE+ + E +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGT---PE--YLAPEVLRKEPY 173

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPK 397
           DR+VD +  G +LYEM+ G+ PF+ +
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 17/224 (7%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVW--VKILDKESHKDPERINAFTHEL 236
           +   ++L+  E+      G + G  ++AK  GT  +  +K L K      +++     E 
Sbjct: 11  DTSSWKLSDFEMGETLGTG-SFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEK 69

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLA 295
           +I+ +  HP +V  + +      +  +LE+   G+L ++L+K GR  P+ V +F   +L 
Sbjct: 70  SILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF-PNDVAKFYHAELV 128

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
               YLH      II+ DLKP+N+LLDN G +K++ FG  +     P++   +       
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK---VPDRTFTLCGTPE-- 180

Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP 399
               Y+APE+ +++   ++VD ++ G++LYE I G  PF    P
Sbjct: 181 ----YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220

Length = 329

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 27/268 (10%)

Query: 193 RKADGITKGSY-QV----AKWNGTKVWVK--ILDKESHKDPERINAFTHELTIVEKARHP 245
           RK + +  GS+  V       +G    VK   L  +     E +     E+ ++ K +HP
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
           N+VQ++G   +   + I LE    G LA  L+K G      +  +   +  G+ YLH+  
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP---ANLYVA 362
               +H D+K  NIL+D  G +K++ FG+          AK V   S       +  ++A
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGM----------AKQVVEFSFAKSFKGSPYWMA 169

Query: 363 PE-IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE I +   +  + D +S G  + EM  G  P+        V  +    + PP+      
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI---PDH 226

Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIA 449
              + K+ I +C    P +RP   E++ 
Sbjct: 227 LSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 70/246 (28%), Positives = 114/246 (46%), Gaps = 48/246 (19%)

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------GRLSPSKVLRF-- 290
           +H N++  +G  TQ  P+ +++EY AKG+L  +L+ +              P + L F  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 291 ----ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
               A  +ARGM YL   +    IH DL  +N+L+     +KI+ FGL R          
Sbjct: 136 LVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR---------- 182

Query: 347 IVFPVSHID----------PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFH 395
               V  ID          P   ++APE   +  +    D +SFG++++E+   G  P+ 
Sbjct: 183 ---GVHDIDYYKKTSNGRLPVK-WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238

Query: 396 PKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
             P EE+ KL+  EG R     K  +   +L  L+ ECW   P  RP F +++  LD+++
Sbjct: 239 GIPVEELFKLL-REGHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294

Query: 456 CNCSKQ 461
              S++
Sbjct: 295 AAVSEE 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 90/282 (31%), Positives = 133/282 (47%), Gaps = 33/282 (11%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELT 237
           E+P      L L V+   G   G   +  WNGT KV +K L K     PE   AF  E  
Sbjct: 2   EIPR---ESLRLDVKLGQGCF-GEVWMGTWNGTTKVAIKTL-KPGTMMPE---AFLQEAQ 53

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGR-LSPSKVLRFALDLA 295
           I++K RH  +V     V++  P+ IV E+  KG L  +L++  G+ L   +++  A  +A
Sbjct: 54  IMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            GM Y+        IH DL+  NIL+ +    KI+ FGL RL    +Y + + AK  FP+
Sbjct: 113 DGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK--FPI 167

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEG 410
                   + APE      F    D +SFG++L E++ +G  P+      EV++     G
Sbjct: 168 K-------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-QVERG 219

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
            R P     +  P  L EL++ CW   P  RP F  I + L+
Sbjct: 220 YRMPC---PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 41/266 (15%)

Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 50  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106

Query: 271 DLASYLQKKGRLS----------PSKVLRF------ALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +              P + + F         +ARGM YL   K    IH DL
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDL 163

Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 215

Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 271

Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 272 MRDCWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.0 bits (228), Expect = 5e-21
 Identities = 86/282 (30%), Positives = 131/282 (46%), Gaps = 33/282 (11%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELT 237
           E+P      L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  
Sbjct: 2   EIPR---ESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQ 53

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLA 295
           +++K RH  +VQ    V++  P+ IV EY +KG L  +L  +    L   +++  A  +A
Sbjct: 54  VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+
Sbjct: 113 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPI 167

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEG 410
                   + APE      F    D +SFG++L E+  +G  P+      EV+      G
Sbjct: 168 K-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERG 219

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
            R P   +    P  L +L+ +CW  +P  RP F  + A L+
Sbjct: 220 YRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 23/254 (9%)

Query: 198 ITKGSY-----QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+      V K +     +K +D       ER      E  ++ K     ++++  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER-EEAIDEARVLAKLDSSYIIRYYE 66

Query: 253 AVTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
           +      + IV+EY   GDL   L  Q+   L   +V RF + +  G+ +LH  K   I+
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---IL 123

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           H D+K  N+ LD    +KI   G+ +L   +   A  +    +      Y++PE+ +++ 
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY------YLSPELCEDKP 177

Query: 371 FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYPPDLKEL 429
           ++   D ++ G++LYE   G  PF       ++ K++   G  PP+      Y   L +L
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII--RGVFPPVSQM---YSQQLAQL 232

Query: 430 IEECWDPKPVIRPN 443
           I++C       RP+
Sbjct: 233 IDQCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 67/253 (26%), Positives = 106/253 (41%), Gaps = 38/253 (15%)

Query: 215 VKILDKESHKDPER----INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V++    + +   R    + A   E+  ++   H N+VQ++G  T    + I LEY   G
Sbjct: 34  VELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGG 93

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
            + S L+  GR     V  F   +  G+ YLH      I+H DLK  N+L+D  G  KIS
Sbjct: 94  SIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKIS 150

Query: 331 GFGLLRLQYISPEKAKIV--FPVSHIDPANLYVAPEIYKNEEFDRS--VDAYSFGLILYE 386
            FG      IS +   I        +  +  ++APE+  +     S  VD +S G ++ E
Sbjct: 151 DFG------ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE 204

Query: 387 MIEGVQPFHPKPPEEVVKLMC---CEGKRPPLKIKARSYPPDLKELI--------EECWD 435
           M  G +P+     EE +  M     +   PP+       PPD+   +          C+ 
Sbjct: 205 MFAGRRPW---SDEEAIAAMFKLGNKRSAPPI-------PPDVSMNLSPVALDFLNACFT 254

Query: 436 PKPVIRPNFNEII 448
             P  RP   E++
Sbjct: 255 INPDNRPTARELL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 7e-21
 Identities = 56/176 (31%), Positives = 92/176 (52%), Gaps = 5/176 (2%)

Query: 221 ESHKDPER--INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
            S KD +R  ++A   E+ ++++ +H N+VQ++G+      + I LEY   G +A+ L  
Sbjct: 40  ASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN 99

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
            G    + V  F   + +G+NYLH      IIH D+K  NIL+DN G +KIS FG+ +  
Sbjct: 100 YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL 156

Query: 339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
             +    K       +  +  ++APE+ K   + R  D +S G ++ EM+ G  PF
Sbjct: 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 8e-21
 Identities = 62/237 (26%), Positives = 115/237 (48%), Gaps = 18/237 (7%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G  V +K +  E     E + +   E+ +++  +HPN+V+++G++  +  + I+LEY  
Sbjct: 24  TGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   ++K G    S V  +   + +G+ YLHE     +IH D+K  NIL    G +K
Sbjct: 83  NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVK 139

Query: 329 ISGFGL-LRLQYISPEKAKIVFPVSHIDPANLY-VAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++ FG+  +L  +S + A +V           Y +APE+ +      + D +S G  + E
Sbjct: 140 LADFGVATKLNDVSKDDASVV--------GTPYWMAPEVIEMSGASTASDIWSLGCTVIE 191

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           ++ G  P++   P   +  +  +   PPL        P+LK+ + +C+   P +RP 
Sbjct: 192 LLTGNPPYYDLNPMAALFRI-VQDDHPPL---PEGISPELKDFLMQCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 66/268 (24%), Positives = 124/268 (46%), Gaps = 37/268 (13%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG + V        +G  V +K +      D +       E+ ++++  HPNV++++ 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 253 AVTQNIPMMIVLEYHAKGDLA---SYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDP 308
           +  +N  + IVLE    GDL+    + +K+ RL P + + ++ + L   + ++H  +   
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK----AKIVFPVSHIDPANLYVAPE 364
           I+H D+KP N+ +   G +K+   GL R  + S +     + +  P         Y++PE
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTP--------YYMSPE 176

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-CCE----GKRPPLKIKA 419
                 ++   D +S G +LYEM     PF+     + + L   C+       PPL   A
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEKCDYPPL--PA 230

Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEI 447
             Y  +L++L+  C +P P  RP+ + +
Sbjct: 231 DHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 29/252 (11%)

Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +A +N  TKV VK +   S      + AF  E  +++  +H  +V+    VT+  P
Sbjct: 20  GEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTKE-P 74

Query: 260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ E+ AKG L  +L+     +    K++ F+  +A GM ++ +      IH DL+  
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAA 131

Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+      KI+ FGL R+    +Y + E AK  FP+        + APE      F  
Sbjct: 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAK--FPIK-------WTAPEAINFGSFTI 182

Query: 374 SVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +   G R P   +  + P +L  ++  
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMP---RPENCPEELYNIMMR 238

Query: 433 CWDPKPVIRPNF 444
           CW  +P  RP F
Sbjct: 239 CWKNRPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 31/219 (14%)

Query: 198 ITKGSYQ---VAKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEK------ARHPN 246
           + KGS+    +A+  GT     VK+L K+     + +     E T+ EK       +HP 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV-----ECTMTEKRVLALAGKHPF 57

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + Q          +  V+EY   GDL  ++Q+ GR    +   +A ++  G+ +LHE   
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG- 116

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF---PVSHIDPANLYVAP 363
             II+ DLK  N+LLD+ G +KI+ FG+ + + I        F   P         Y+AP
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPD--------YIAP 165

Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
           EI   + +  +VD ++ G++LYEM+ G  PF     +E+
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 59/218 (27%), Positives = 110/218 (50%), Gaps = 15/218 (6%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPS-KVLRFAL 292
           E+ ++   +HPN+VQ+  +  +N  + IV++Y   GDL   +  ++G L P  ++L + +
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS 352
            +   + ++H+ K   I+H D+K +NI L   G +K+  FG+ R+   + E A+      
Sbjct: 109 QICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP 165

Query: 353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR 412
           +      Y++PEI +N  ++   D ++ G +LYEM      F     + +V L    G  
Sbjct: 166 Y------YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV-LKIIRGSY 218

Query: 413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           PP+      Y  DL+ L+ + +   P  RP+ N I+ +
Sbjct: 219 PPVSSH---YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 54/224 (24%), Positives = 110/224 (49%), Gaps = 24/224 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ ++ +  HP++++ +GA  ++    + +E+ A G ++  L K G    + ++ +   L
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LKISGFGLL-----RLQYISPEKAKIV 348
            RG++YLHE   + IIH D+K  N+L+D+ GQ L+I+ FG       +       + +++
Sbjct: 113 LRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVK 404
             ++       ++APE+ + E++ RS D +S G ++ EM     P+    H      + K
Sbjct: 170 GTIA-------FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222

Query: 405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           +       P +        P L+++   C + +P  RP   E++
Sbjct: 223 IASATTA-PSI---PEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 85.5 bits (212), Expect = 4e-20
 Identities = 36/82 (43%), Positives = 55/82 (67%), Gaps = 1/82 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A + G ++ V+ LL +G+DVN+ D DG T LH+AA  G+++VVKLLL   A+++ARD
Sbjct: 44  LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
           + G T    A   G++EV  +L
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 73/256 (28%), Positives = 122/256 (47%), Gaps = 42/256 (16%)

Query: 220 KESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           K+ H+D      F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K
Sbjct: 48  KDDHRD------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 101

Query: 279 K----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
                              LS  ++L FA D+ARGM+YL + +    IH DL  +NIL+ 
Sbjct: 102 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVG 158

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
                KI+ FGL R Q +  +K     PV        ++A E      +  + D +S+G+
Sbjct: 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGV 211

Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPV 439
           +L+E++  G  P+      E+ + +  +G R   PL      Y     +L+ +CW  KP 
Sbjct: 212 LLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVY-----DLMRQCWREKPY 265

Query: 440 IRPNFNEIIARLDRIV 455
            RP+F +I+  L+R++
Sbjct: 266 ERPSFAQILVSLNRML 281

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 74/253 (29%), Positives = 121/253 (47%), Gaps = 34/253 (13%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +V VK L K +  D E+   F  E  ++    HPN+V+ +G    N P  I++E    GD
Sbjct: 28  RVAVKTLRKGA-TDQEKKE-FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGD 85

Query: 272 LASYLQKKGR-------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           L SYL+           L+  ++L   LD+A+G  YL +      IH DL  +N L+   
Sbjct: 86  LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEK 142

Query: 325 GQ-----LKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVD 376
           G      +KI  FGL R  Y S    ++ + + PV        ++APE   + +F    D
Sbjct: 143 GYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-------WMAPESLLDGKFTTQSD 195

Query: 377 AYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK-RPPLKIKARSYPPDLKELIEECW 434
            +SFG++++E++  G QP+     +EV++ +   G+ + P      + P  + +L+  CW
Sbjct: 196 VWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP-----ENCPDKIYQLMTNCW 250

Query: 435 DPKPVIRPNFNEI 447
              P  RP F+ I
Sbjct: 251 AQDPSERPTFDRI 263

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 58/277 (20%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L +E+  D +    F  E  ++ +  HPN+V+ +G      PM ++ EY A G
Sbjct: 36  TMVAVKMLKEEASADMQ--ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYG 93

Query: 271 DLASYL----------------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           DL  +L                           LS ++ L  A  +A GM YL E K   
Sbjct: 94  DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--- 150

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI----VFPVSHIDPANLYVAPE 364
            +H DL  +N L+     +KI+ FGL R  Y S +  K       P+  + P +++    
Sbjct: 151 FVHRDLATRNCLVGENMVVKIADFGLSRNIY-SADYYKASENDAIPIRWMPPESIFYN-- 207

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVK-------LMCCEGKRPPLK 416
                 +    D +++G++L+E+   G+QP++    EEV+        L C +       
Sbjct: 208 -----RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDN------ 256

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR 453
                 P +L  L+  CW   P  RP+F  I   L R
Sbjct: 257 -----CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.0 bits (220), Expect = 7e-20
 Identities = 73/268 (27%), Positives = 131/268 (48%), Gaps = 22/268 (8%)

Query: 186 NPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIVE 240
           +P EL   K + I KGS+ +V K   N T+  V +KI+D E  +D   I     E+T++ 
Sbjct: 1   DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLS 57

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNY 300
           +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     ++ +G++Y
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDY 116

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY 360
           LH  K    IH D+K  N+LL   G++K++ FG      ++ +        +       +
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFG------VAGQLTDTQIKRNTFVGTPFW 167

Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
           +APE+ K   +D   D +S G+   E+ +G  P     P +V+ L+    K  P  ++  
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI---PKNNPPTLEG- 223

Query: 421 SYPPDLKELIEECWDPKPVIRPNFNEII 448
           +Y   LKE +E C + +P  RP   E++
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 42/261 (16%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+        K     V +K++D E  +D   I     E+  + + R P + ++ G
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSPYITKYYG 66

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           +  +   + I++EY   G     L K G+L  + +     ++  G+ YLHE   +  IH 
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE---EGKIHR 122

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS-----HIDPANLYV------ 361
           D+K  NILL   G +K++ FG                 VS      +   N +V      
Sbjct: 123 DIKAANILLSEEGDVKLADFG-----------------VSGQLTSTMSKRNTFVGTPFWM 165

Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           APE+ K   +D   D +S G+   E+ +G  P     P  V+ L+    K  P  ++   
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---PKNNPPSLEGNK 222

Query: 422 YPPDLKELIEECWDPKPVIRP 442
           +    K+ +  C +  P  RP
Sbjct: 223 FSKPFKDFVSLCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.8 bits (220), Expect = 9e-20
 Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 28/258 (10%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYH 267
           G  V VK L +E     +  + +  E+ I++   H N+V++ G  ++     + +++EY 
Sbjct: 33  GEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
             G L  YL K  +L+ +++L FA  +  GM YLH       IH DL  +N+LLDN   +
Sbjct: 91  PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146

Query: 328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           KI  FGL +     PE  +        D    + A E  K  +F  + D +SFG+ LYE+
Sbjct: 147 KIGDFGLAKA---VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203

Query: 388 IEGVQPFHPKPPE------------EVVKL--MCCEGKRPPLKIKARSYPPDLKELIEEC 433
           +         P +             VV+L  +   G R P     ++ P ++  L++ C
Sbjct: 204 LTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP---CPKNCPQEVYILMKNC 260

Query: 434 WDPKPVIRPNFNEIIARL 451
           W+ +   RP F  +I  L
Sbjct: 261 WETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 71/258 (27%), Positives = 123/258 (47%), Gaps = 34/258 (13%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K+L + + ++  R   F  EL ++ K   HPN++  +GA      + I +EY   G+L 
Sbjct: 34  IKMLKEFASENDHR--DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLL 91

Query: 274 SYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            +L+K                   L+  ++L+FA D+A GM YL E +    IH DL  +
Sbjct: 92  DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAAR 148

Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+L+      KI+ FGL R + +  +K     PV        ++A E      +    D 
Sbjct: 149 NVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR-------WMAIESLNYSVYTTKSDV 201

Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E++  G  P+      E+ + +  +G R     K R+   ++ EL+ +CW  
Sbjct: 202 WSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRME---KPRNCDDEVYELMRQCWRD 257

Query: 437 KPVIRPNFNEIIARLDRI 454
           +P  RP F +I  +L R+
Sbjct: 258 RPYERPPFAQISVQLSRM 275

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 82.7 bits (205), Expect = 1e-19
 Identities = 38/89 (42%), Positives = 58/89 (65%), Gaps = 2/89 (2%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A  G+++ V+ LL +G+DVN  D D  TALH+AA  G++E+VKLLL   A+++A+D
Sbjct: 1   LHLAAKNGNLELVKLLLEKGADVNLGDTD--TALHLAARNGNLEIVKLLLEHGADVNAKD 58

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           + G+TA   A   GN+E+  +L   GA +
Sbjct: 59  KDGNTALHLAARNGNLEIVKLLLEHGADI 87

Length = 91

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 32/226 (14%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI--VLEYHAKGDLAS----YLQKKGRLSPSKVL 288
           EL I +  + P +V++ GA        I   +EY   G L S      ++ GR+    + 
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE----K 344
           + A  + +G++YLH  K   IIH D+KP NILL   GQ+K+  FG      +S E     
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFG------VSGELVNSL 159

Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV-- 402
           A      S       Y+APE  + + +  + D +S GL L E+ +   PF P+    +  
Sbjct: 160 AGTFTGTSF------YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213

Query: 403 VKLMCCEGKRPPLKIK-----ARSYPPDLKELIEECWDPKPVIRPN 443
           ++L+      P  ++K        +  + K+ I++C +  P  RP 
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 28/217 (12%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        +P +            +  V+E+   GDL  ++Q KGR    +  
Sbjct: 40  ECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRAT 99

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++  G+ +LH      II+ DLK  N++LD  G +KI+ FG+ +       +A   
Sbjct: 100 FYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC 408
                      Y+APEI +  ++  SVD +SFG++LYEM+ G  PFH    +E+ +    
Sbjct: 157 CGTPD------YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE---- 206

Query: 409 EGKRPPLKIKARSYP----PDLKELIEECWDPKPVIR 441
                 +++    YP     + K+++E+ ++  P  R
Sbjct: 207 -----SIRVDTPHYPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 72/259 (27%), Positives = 126/259 (48%), Gaps = 34/259 (13%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K + + + KD  R   F  EL ++ K   HPN++  +GA      + + +EY   G+L 
Sbjct: 27  IKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 84

Query: 274 SYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            +L+K                   LS  ++L FA D+ARGM+YL + +    IH DL  +
Sbjct: 85  DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR 141

Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           NIL+      KI+ FGL R Q +  +K     PV        ++A E      +  + D 
Sbjct: 142 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDV 194

Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +S+G++L+E++  G  P+      E+ + +  +G R     K  +   ++ +L+ +CW  
Sbjct: 195 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLE---KPLNCDDEVYDLMRQCWRE 250

Query: 437 KPVIRPNFNEIIARLDRIV 455
           KP  RP+F +I+  L+R++
Sbjct: 251 KPYERPSFAQILVSLNRML 269

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 62/253 (24%), Positives = 120/253 (47%), Gaps = 36/253 (14%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K+L +E+   P+       E  ++    HP+VV+ +G +  +  + ++ +    G L
Sbjct: 39  VAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCL 95

Query: 273 ASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             Y+   K  +    +L + + +A+GM+YL E +   ++H DL  +N+L+     +KI+ 
Sbjct: 96  LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITD 152

Query: 332 FGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           FGL +L      +Y + E  K+  P+        ++A E   +  +    D +S+G+ ++
Sbjct: 153 FGLAKLLDVDEKEYHA-EGGKV--PIK-------WMALESILHRIYTHKSDVWSYGVTVW 202

Query: 386 E-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP----DLKELIEECWDPKPVI 440
           E M  G +P+   P  E+  L+  +G+R P        PP    D+  ++ +CW      
Sbjct: 203 ELMTFGAKPYEGIPAVEIPDLL-EKGERLP-------QPPICTIDVYMVLVKCWMIDAES 254

Query: 441 RPNFNEIIARLDR 453
           RP F E+I    +
Sbjct: 255 RPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 69/264 (26%), Positives = 129/264 (48%), Gaps = 30/264 (11%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYH 267
           G +V VK L  ES      I     E+ I+    H N+V++ G  T++    + +++E+ 
Sbjct: 33  GEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 268 AKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             G L  YL + K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  Q
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVS-HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           +KI  FGL +    + E  K  + V   +D    + APE     +F  + D +SFG+ LY
Sbjct: 148 VKIGDFGLTK----AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 386 EM--------------IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
           E+              ++ + P H +     +  +  EGKR P   +  + P ++ +L+ 
Sbjct: 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP---RPPNCPEEVYQLMR 260

Query: 432 ECWDPKPVIRPNFNEIIARLDRIV 455
           +CW+ +P  R  F  +I   + I+
Sbjct: 261 KCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 62/263 (23%), Positives = 122/263 (46%), Gaps = 30/263 (11%)

Query: 191 QVRKADGITKGSYQV---AKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARH- 244
             ++ + I +G+Y      K   T   V +KI++ ++  D   ++    E+ ++ + R  
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQS 59

Query: 245 --PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP---SKVLRFALDLARGMN 299
             PN+ ++ G+  +   + I++EY   G + + L K G ++    S ++R   ++   + 
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIR---EVLVALK 115

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           Y+H+     +IH D+K  NIL+ N G +K+  FG+  L   +  K        +      
Sbjct: 116 YIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY------ 166

Query: 360 YVAPE-IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK 418
           ++APE I + + +D   D +S G+ +YEM  G  P+        + L+    K  P +++
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---PKSKPPRLE 223

Query: 419 ARSYPPDLKELIEECWDPKPVIR 441
              Y   L+E +  C D +P  R
Sbjct: 224 DNGYSKLLREFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 17/210 (8%)

Query: 198 ITKGSY-QV--AKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + +G Y QV  AK   T   V +K + K        +     E  I+   +   +V+ + 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           A   +  + + +EY   GD  + L   G LS      +  ++   ++ LHE      IH 
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHR 125

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLKP+N L+D  G +K++ FGL            IV   + +  +  Y+APE+ + + +D
Sbjct: 126 DLKPENFLIDASGHIKLTDFGL---------SKGIVTYANSVVGSPDYMAPEVLRGKGYD 176

Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
            +VD +S G +LYE + G  PF    P E 
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 48/168 (28%), Positives = 90/168 (53%), Gaps = 12/168 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E  ++++  HP +++          + +++EY   G+L SYL+  GR S S  L +A ++
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
              + YLH  +   I++ DLKP+NILLD  G +K++ FG  +         K+      +
Sbjct: 111 VCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK---------KLRDRTWTL 158

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
                Y+APE+ +++  +++VD ++ G+++YEM+ G  PF    P  +
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 80.4 bits (199), Expect = 1e-18
 Identities = 33/68 (48%), Positives = 47/68 (69%), Gaps = 1/68 (1%)

Query: 69  NLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           NL  T   L +A R G+++ V+ LL  G+DVN+ D DG TALH+AA  G++E+VKLLL  
Sbjct: 24  NLGDTDTALHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEH 83

Query: 128 KANIDARD 135
            A+I+ +D
Sbjct: 84  GADINLKD 91

Length = 91

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 15/174 (8%)

Query: 235 ELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        HP +            +  V+EY   GDL  ++Q   +    +  
Sbjct: 40  ECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT 99

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++  G+ +LH      I++ DLK  NILLD  G +KI+ FG+ +   +   K    
Sbjct: 100 FYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
                      Y+APEI   ++++ SVD +SFG++LYEM+ G  PFH    EE+
Sbjct: 157 CGTPD------YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 21/260 (8%)

Query: 194 KADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
           K + I KGS+ +V K   N TK  V +KI+D E  +D   I     E+T++ +   P + 
Sbjct: 8   KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYIT 65

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           ++ G+  +   + I++EY   G  A  L K G L  + +     ++ +G++YLH  +   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSERK-- 122

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
            IH D+K  N+LL   G +K++ FG+   Q    +  +  F  +       ++APE+ K 
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGT-----PFWMAPEVIKQ 175

Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE 428
             +D   D +S G+   E+ +G  P     P  V+ L+    K  P  ++ +   P  KE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI---PKNSPPTLEGQYSKP-FKE 231

Query: 429 LIEECWDPKPVIRPNFNEII 448
            +E C +  P  RP   E++
Sbjct: 232 FVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+  ++  +HP VV+ +         ++V+EY    DL+  L+ + R L  ++V  +   
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM 107

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L +G+ Y+H      I+H DLKP N+L+   G LKI+ FGL RL   S E+ +     SH
Sbjct: 108 LLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLF--SEEEPR---LYSH 159

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y APE+ Y   ++D  VD ++ G I  E++ G  P  P
Sbjct: 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS-PLFP 202

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 26/252 (10%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N  KV +K +D E  K    ++    E+  + +  HPNVV++  +      + +V+ Y +
Sbjct: 25  NNEKVAIKRIDLE--KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82

Query: 269 KG---DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
            G   D+      +G L  + +     ++ +G+ YLH    +  IH D+K  NILL   G
Sbjct: 83  GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDG 139

Query: 326 QLKISGFGL---LRLQYISPEKAKIVF---PVSHIDPANLYVAPEIYKNEE-FDRSVDAY 378
            +KI+ FG+   L        K +  F   P         ++APE+ +    +D   D +
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPC--------WMAPEVMEQVHGYDFKADIW 191

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA--RSYPPDLKELIEECWDP 436
           SFG+   E+  G  P+   PP +V+ ++  +   P L+  A  + Y    +++I  C   
Sbjct: 192 SFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLETGADYKKYSKSFRKMISLCLQK 250

Query: 437 KPVIRPNFNEII 448
            P  RP   E++
Sbjct: 251 DPSKRPTAEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)

Query: 198 ITKGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFV 251
           I +GSY     V      +++ +K++ KE   D E I+    E  + E A  HP +V   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
                   +  V+E+ + GDL  ++Q++ +L P +  RF + +++  +N+LHE     II
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKL-PEEHARFYSAEISLALNFLHE---RGII 118

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           + DLK  N+LLD  G +K++ +G+ + + I P      F        N Y+APEI + E+
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTF----CGTPN-YIAPEILRGED 172

Query: 371 FDRSVDAYSFGLILYEMIEGVQPF 394
           +  SVD ++ G++++EM+ G  PF
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 55/181 (30%), Positives = 98/181 (54%), Gaps = 10/181 (5%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 25  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 84

Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 85  FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           + + + + P      F  +   P   Y+APEI + E++  SVD ++ G++++EM+ G  P
Sbjct: 142 MCK-EGLRPGDTTSTFCGT---PN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Query: 394 F 394
           F
Sbjct: 196 F 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 23/283 (8%)

Query: 186 NPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIVE 240
           +P EL   K + I KGS+ +V K   N T+  V +KI+D E  +D   I     E+T++ 
Sbjct: 1   DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLS 57

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNY 300
           +   P V ++ G+  +   + I++EY   G  A  L + G     ++     ++ +G++Y
Sbjct: 58  QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKEILKGLDY 116

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY 360
           LH  K    IH D+K  N+LL   G +K++ FG+   Q    +  +  F  +       +
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGT-----PFW 167

Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
           +APE+ +   +D   D +S G+   E+ +G  P     P  V+ L+    K  P  +   
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---PKNNPPTLTG- 223

Query: 421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGW 463
            +    KE I+ C +  P  RP   E++ +   IV N  K  +
Sbjct: 224 EFSKPFKEFIDACLNKDPSFRPTAKELL-KHKFIVKNAKKTSY 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 70/259 (27%), Positives = 130/259 (50%), Gaps = 22/259 (8%)

Query: 198 ITKGSY-QVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + KGSY +V+    + +G +  +K L+  +    ER  A   E  ++ + +HPN+V +  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRE 66

Query: 253 AVT-QNIPMMIVLEYHAKGDLASYL-QKKGRLSP-SKVLRFALDLARGMNYLHECKPDPI 309
           +   ++  + IV+ +   GDL   L ++KG+L P ++V+ + + +A  + YLHE     I
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           +H DLK +N+ L     +K+   G+ R+     + A  +    +      Y++PE++ N+
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY------YMSPELFSNK 177

Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
            ++   D ++ G  +YEM      F+ K    +V  +  EGK PP+    + Y P+L EL
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPM---PKDYSPELGEL 233

Query: 430 IEECWDPKPVIRPNFNEII 448
           I      +P  RP+   I+
Sbjct: 234 IATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 56/242 (23%), Positives = 108/242 (44%), Gaps = 19/242 (7%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           VW K ++     + ER +A  +E+ I+   +HPN++ +      +  ++I +EY   G L
Sbjct: 29  VW-KEVNLTRLSEKERRDAL-NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL 86

Query: 273 ASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
              +  QK        VL +   +   ++Y+H+     I+H D+K  NI L   G +K+ 
Sbjct: 87  YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLG 143

Query: 331 GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
            FG+ ++       A+ V           Y++PE+ +  +++   D ++ G +LYE++  
Sbjct: 144 DFGISKILGSEYSMAETVVGTP------YYMSPELCQGVKYNFKSDIWALGCVLYELLTL 197

Query: 391 VQPFHP-KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
            + F    P   VVK++       P+      Y  +L  L+       P  RP  +E++ 
Sbjct: 198 KRTFDATNPLNLVVKIVQGN--YTPVV---SVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Query: 450 RL 451
           + 
Sbjct: 253 QP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 10/197 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   
Sbjct: 24  GQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           GDL + L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K+
Sbjct: 83  GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKL 139

Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
           + FGL + + I  EK    F    ++    Y+APE+       +S D +SFG++++EM+ 
Sbjct: 140 TDFGLSK-ESIDHEKKAYSF-CGTVE----YMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193

Query: 390 GVQPFHPKPPEEVVKLM 406
           G  PF  K  +E + ++
Sbjct: 194 GSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 27/172 (15%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP--MMIVLEY--HAKGDLASYL-QKKGRLSPSKVLR 289
           E+ +++K RHPN+V+    VT      + +V EY  H   DL   L   + + + S++  
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKC 104

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           +   L  G+ YLH      I+H D+K  NIL++N G LK++ FGL R    +   +    
Sbjct: 105 YMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSA--- 156

Query: 350 PVSHIDPANL-----YVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFH 395
                D  N      Y  PE+      +   VD +S G IL E+  G   F 
Sbjct: 157 -----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 55/174 (31%), Positives = 91/174 (52%), Gaps = 15/174 (8%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ G+      +
Sbjct: 45  ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAV 104

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++A G+ +LH      II+ DLK  N++LD  G +KI+ FG+ + + I   K    
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT 160

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
           F  +   P   Y+APEI   + + +SVD ++FG++LYEM+ G  PF  +  +E+
Sbjct: 161 FCGT---PD--YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 55/189 (29%), Positives = 99/189 (52%), Gaps = 10/189 (5%)

Query: 215 VKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VK+L K++  K  E  +  +    +++  +HP +V    +      +  VL+Y   G+L 
Sbjct: 25  VKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF 84

Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            +LQ++      +   +A ++A  + YLH      I++ DLKP+NILLD+ G + ++ FG
Sbjct: 85  YHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 141

Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           L + + I        F  +   P   Y+APE+   + +DR+VD +  G +LYEM+ G+ P
Sbjct: 142 LCK-ENIEHNGTTSTFCGT---PE--YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Query: 394 FHPKPPEEV 402
           F+ +   E+
Sbjct: 196 FYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 14/224 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KIL KE     + +     E  +++  RHP +     +      +  V+EY
Sbjct: 17  KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY 76

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   I++ DLK +N++LD  G 
Sbjct: 77  VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGH 133

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +         K             Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 134 IKITDFGLCKEGITDAATMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYE 187

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E++ +L+  E  + P     R+   D K L+
Sbjct: 188 MMCGRLPFYNQDHEKLFELILMEDIKFP-----RTLSADAKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 14/182 (7%)

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           D +S +  + +NA   E+ +++  +H  +VQ+ G +  +  + I +EY   G +   L+ 
Sbjct: 38  DPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA 97

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL-RL 337
            G L+ +   ++   +  G+ YLH    + I+H D+K  NIL D+ G +K+  FG   RL
Sbjct: 98  YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Query: 338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
           Q I    +      S       +++PE+   E + R  D +S G  + EM+        K
Sbjct: 155 QTIC---SSGTGMKSVTGTPY-WMSPEVISGEGYGRKADVWSVGCTVVEMLT------EK 204

Query: 398 PP 399
           PP
Sbjct: 205 PP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 72/260 (27%), Positives = 130/260 (50%), Gaps = 24/260 (9%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQ 249
           I KGS+        K +G    VK+L K+   + K+ + I A  + L  ++  +HP +V 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL--LKNVKHPFLVG 60

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
              +      +  VL++   G+L  +LQ++      +   +A ++A  + YLH      I
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---I 117

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           ++ DLKP+NILLD+ G + ++ FGL + + I+       F  +   P   Y+APE+ + +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGT---PE--YLAPEVIRKQ 171

Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE--GKRPPLKIKARSYPPDLK 427
            +D +VD +  G +LYEM+ G+ PF+ +   E+   +  +    RP   + A S    L+
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI---LE 228

Query: 428 ELIEECWDPKPVIRPNFNEI 447
           EL+E+    +   + +F EI
Sbjct: 229 ELLEKDRQRRLGAKEDFLEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 40/239 (16%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F  E  ++   +H ++V+F G      P+++V EY   GDL  +L               
Sbjct: 54  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113

Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            Q KG L  S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ 
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170

Query: 336 RLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GV 391
           R  Y +         + P+        ++ PE     +F    D +SFG+IL+E+   G 
Sbjct: 171 RDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223

Query: 392 QPFHPKPPEEVVKLMCCEGK---RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           QP+      EV++ +  +G+   RP      R  P ++ +++  CW  +P  R N  EI
Sbjct: 224 QPWFQLSNTEVIECI-TQGRVLERP------RVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 15/203 (7%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFV 251
           I +GSY        K N     +K++ KE   D E I+    E  + E+A  +P +V   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V+EY   GDL  ++Q++ +L       +A ++   +N+LHE     II+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DLK  N+LLD  G +K++ +G+ + + + P      F        N Y+APEI + EE+
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTF----CGTPN-YIAPEILRGEEY 173

Query: 372 DRSVDAYSFGLILYEMIEGVQPF 394
             SVD ++ G++++EM+ G  PF
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 17  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 76

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 77  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 133

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 134 IKITDFGLCK-EGISDGATMKTFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 187

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 188 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 44/261 (16%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK+L  +  K     N F  E+ I+ + ++PN+++ +G    + P+ ++ EY   GDL
Sbjct: 47  VAVKMLRADVTKTAR--NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 273 ASYLQKKG------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
             +L ++              +S + +L  A+ +A GM YL        +H DL  +N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161

Query: 321 LDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + N   +KI+ FG+ R  Y       + + V P+        ++A E     +F  + D 
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR-------WMAWESILLGKFTTASDV 214

Query: 378 YSFGLILYEMIE--GVQPFHPKPPEEVV----KLMCCEGKR-----PPLKIKARSYPPDL 426
           ++FG+ L+EM      QP+     E+V+    +    +G++      PL       P  +
Sbjct: 215 WAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPL------CPSPV 268

Query: 427 KELIEECWDPKPVIRPNFNEI 447
            +L+  CW      RP FN+I
Sbjct: 269 FKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 83.9 bits (207), Expect = 9e-18
 Identities = 61/235 (25%), Positives = 114/235 (48%), Gaps = 13/235 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 17  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 76

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 77  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 134

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +      E  K    +        Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 135 IKITDFGLCK------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 188

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           M+ G  PF+ +  E++ +L+  E  R P     R+  P+ K L+       P  R
Sbjct: 189 MMCGRLPFYNQDHEKLFELILMEEIRFP-----RTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 38/242 (15%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F HE  +  + +HPN+V  +G VT+  P+ ++  Y +  DL  +L               
Sbjct: 55  FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114

Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
              K  L P+  +     +A GM +L       ++H DL  +N+L+ +   +KIS  GL 
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLF 171

Query: 336 RLQYISPEKAKI----VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R  Y + +  K+    + P+        +++PE     +F    D +S+G++L+E+   G
Sbjct: 172 REVY-AADYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 223

Query: 391 VQPFHPKPPEEVVKLMCCEGKRP-PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
           +QP+     ++V++++      P P    A  Y      L+ ECW+  P  RP F +I +
Sbjct: 224 LQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVY-----TLMLECWNEFPSRRPRFKDIHS 278

Query: 450 RL 451
           RL
Sbjct: 279 RL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 54/209 (25%), Positives = 104/209 (49%), Gaps = 11/209 (5%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL KE     + +     E  +++  RHP +     +   +  +  V+EY   G+L  
Sbjct: 25  MKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFF 84

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +L ++   S  +   +  ++   + YLH C    +++ DLK +N++LD  G +KI+ FGL
Sbjct: 85  HLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL 141

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            +         K             Y+APE+ ++ ++ R+VD +  G+++YEM+ G  PF
Sbjct: 142 CKEGISDGATMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Query: 395 HPKPPEEVVKLMCCEGKRPPLKI--KARS 421
           + +  E++ +L+  E  R P  +  +A+S
Sbjct: 196 YNQDHEKLFELILMEEIRFPRTLSPEAKS 224

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG---DLASYLQKKGRLSPSKVLRFA 291
           E++I+++   P +V++ G+  +N  + IV+EY   G   D+     K   L+  ++    
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAIL 105

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF-- 349
               +G+ YLH  K    IH D+K  NILL+  GQ K++ FG+      +  K   V   
Sbjct: 106 YQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162

Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
           P         ++APE+ +   ++   D +S G+   EM EG  P+    P   + ++   
Sbjct: 163 P--------FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--- 211

Query: 410 GKRPPLKIKARS-YPPDLKELIEECWDPKPVIRP 442
             +PP  +     + P+  + +++C    P  RP
Sbjct: 212 PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 18/224 (8%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           EL I+ + R P +V F GA      + + +E+   G L    +K G +    + + A+ +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             G+ YL+      I+H D+KP NIL+++ GQ+K+  FG      +S E    +      
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFG------VSGELINSI--ADTF 162

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP--------PEEVVKLM 406
              + Y++PE  +  ++    D +S G+ + E+  G  PF            P  ++ L+
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222

Query: 407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
               + PP ++ +  +P DL++ ++ C    P  RP   ++ A 
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 66/264 (25%), Positives = 118/264 (44%), Gaps = 35/264 (13%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA-----VTQNIPM-MI 262
           +  KV VK+L  +     + I  F  E   +++  HPNV++ +G          +P+ M+
Sbjct: 26  SFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84

Query: 263 VLEYHAKGDLASYL------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +L +   GDL ++L      ++   L    ++RF +D+A GM YL        IH DL  
Sbjct: 85  ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAA 141

Query: 317 KNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           +N +L+    + ++ FGL +  Y      +      PV        ++A E   +  +  
Sbjct: 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK-------WLALESLADNVYTT 194

Query: 374 SVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEG--KRPPLKIKARSYPPDLKELI 430
             D ++FG+ ++E M  G  P+      E+   +      K+PP          D+ EL+
Sbjct: 195 HSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP------DCLEDVYELM 248

Query: 431 EECWDPKPVIRPNFNEIIARLDRI 454
            +CW P+P  RP+F  +  +L+ I
Sbjct: 249 CQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 42/164 (25%)

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRF-------ALDLARGMNYLHECKPDPIIHCDL 314
           +V+EY   GDL + L +K    P +  RF       ALD    + +         IH D+
Sbjct: 78  LVMEYMPGGDLMNLLIRKDVF-PEETARFYIAELVLALDSVHKLGF---------IHRDI 127

Query: 315 KPKNILLDNGGQLKISGFGL------------------------LRLQYISPEKAKIVFP 350
           KP NIL+D  G +K++ FGL                          L      K + V  
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            S +   + Y+APE+ +   +    D +S G+ILYEM+ G  PF
Sbjct: 188 NSTVGTPD-YIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 18/220 (8%)

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL----ASYLQKKGRLSPSKVL 288
             E  ++ K  HP +V+F  +  +     I+ EY    DL             LS ++V 
Sbjct: 50  NQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC 109

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            + + L  G++Y+H+ +   I+H DLK KNI L N   LKI  FG+ RL   S + A   
Sbjct: 110 EWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTF 165

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC 408
               +      Y++PE  K++ +D   D +S G ILYEM      F  +    VV L   
Sbjct: 166 TGTPY------YMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV-LRIV 218

Query: 409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           EG  P L     +Y   L  +++   +  P +RP+  EI+
Sbjct: 219 EGPTPSL---PETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 14/182 (7%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K LDK+  K  +      +E  I+EK     +V    A      + +V+     GDL  +
Sbjct: 24  KKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYH 83

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G      ++ + +A  +  G+ +LH+ +   I++ DLKP+N+LLD+ G ++IS  G
Sbjct: 84  IYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLG 140

Query: 334 L-LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQ 392
           L + L+     K +             Y+APE+ + E +D SVD ++ G  LYEMI G  
Sbjct: 141 LAVELKGGKKIKGRA--------GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192

Query: 393 PF 394
           PF
Sbjct: 193 PF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 190 LQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
            QVRK  G   G     K    KV  K     + KD     A   E  I+E  +HP +V 
Sbjct: 13  FQVRKVTGADTG-----KIFAMKVLKKATIVRNQKDTAHTKA---ERNILEAVKHPFIVD 64

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
            + A      + ++LEY + G+L  +L+++G         +  +++  + +LH+     I
Sbjct: 65  LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGI 121

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-YVAPEIYKN 368
           I+ DLKP+NILLD  G +K++ FGL +              V+H     + Y+APEI   
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-------VTHTFCGTIEYMAPEILMR 174

Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPF 394
               ++VD +S G ++Y+M+ G  PF
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 32/264 (12%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG Y++ K   T V VKIL  +++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 11  VKKGMYKMKKSEKT-VAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIG-ICEA 67

Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  +LQK   ++   +      ++ GM YL E      +H DL  +
Sbjct: 68  ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAAR 124

Query: 318 NILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
           N+LL      KIS FGL +        Y +    K  +PV        + APE     +F
Sbjct: 125 NVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK--WPVK-------WYAPECMNYYKF 175

Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR---PPLKIKARSYPPDLK 427
               D +SFG++++E    G +P+      EV + M   G+R   P         PP++ 
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQ------RCPPEMY 228

Query: 428 ELIEECWDPKPVIRPNFNEIIARL 451
           +L++ CW      RP F  +  RL
Sbjct: 229 DLMKLCWTYGVDERPGFAVVELRL 252

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 59/164 (35%), Positives = 84/164 (51%), Gaps = 26/164 (15%)

Query: 235 ELTIVEKARHPNVVQF----VGAVTQNIPMMIVLEY--HAKGDLASYL-QKKGRLSPSKV 287
           E+ I+ K +HPN+V      VG+    I M  V+EY  H   DL S +   K     S+V
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYM--VMEYVEH---DLKSLMETMKQPFLQSEV 108

Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA-- 345
               L L  G+ +LH+     I+H DLK  N+LL+N G LKI  FGL R +Y SP K   
Sbjct: 109 KCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYT 164

Query: 346 KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMI 388
           ++V  V+       Y APE+     E+  ++D +S G I  E++
Sbjct: 165 QLV--VTL-----WYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 37/243 (15%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L               
Sbjct: 54  FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113

Query: 277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G+L+  ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Query: 337 LQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQ 392
             Y +       + + P+        ++ PE     +F    D +SFG++L+E+   G Q
Sbjct: 171 DIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Query: 393 PFHPKPPEEVVKLMCC--EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           P++     E ++ +    E +RP      R+ PP++  +++ CW  +P  R    +I +R
Sbjct: 224 PWYQLSNTEAIECITQGRELERP------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSR 277

Query: 451 LDR 453
           L  
Sbjct: 278 LQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 24/159 (15%)

Query: 239 VEKARHPNVVQF--VGAVTQN---IPMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFA 291
           +E   HPN+V+   V    +    + + +V E H   DLA+YL K  K  L P  +    
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLM 113

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             L RG+++LH  +   I+H DLKP+NIL+ + GQ+KI+ FGL          A+I    
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL----------ARIYSFE 160

Query: 352 SHIDP--ANL-YVAPEIYKNEEFDRSVDAYSFGLILYEM 387
             +      L Y APE+     +   VD +S G I  E+
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 30/221 (13%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS---YLQKKGRLSPSK-VLRF 290
           E+ ++++  HPNV++++ +  ++  + IVLE    GDL+    Y +K+ RL P + V ++
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            + L   + ++H  +   ++H D+KP N+ +   G +K+   GL R        A  +  
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
             +      Y++PE      ++   D +S G +LYEM     PF+    +++     C+ 
Sbjct: 169 TPY------YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLFSLCQ- 218

Query: 411 KRPPLKIKARSYPP--------DLKELIEECWDPKPVIRPN 443
                KI+   YPP         L+EL+  C  P P  RP+
Sbjct: 219 -----KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPD 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 9e-17
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++  HPN+++ +        + +V E+    DL   ++ + R L  S +  +   
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF-MDTDLYKLIKDRQRGLPESLIKSYLYQ 106

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L +G+ + H      I+H DLKP+N+L++  G LK++ FGL R             P +H
Sbjct: 107 LLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR------PYTH 157

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y APE+   ++ +   VD +S G I  E++   +P  P
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFP 200

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 20/197 (10%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV------TQNIP--M 260
            G  V +K +   + KD   I A   E+ I++K +HPNVV  +         ++     +
Sbjct: 32  TGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90

Query: 261 MIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
            +V  Y    DL+  L+    +L+ S++  + L L  G+NYLHE     I+H D+K  NI
Sbjct: 91  YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANI 146

Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-----YVAPEIYKNE-EFDR 373
           L+DN G LKI+ FGL R     P   K           NL     Y  PE+   E  +  
Sbjct: 147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT 206

Query: 374 SVDAYSFGLILYEMIEG 390
           +VD +  G +  EM   
Sbjct: 207 AVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 76/260 (29%), Positives = 118/260 (45%), Gaps = 33/260 (12%)

Query: 198 ITKGSY-QVAKW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I  G+Y  V K      G  V +K++  E   D E I     E++++++ RHPN+V + G
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67

Query: 253 AVTQNIPMMIVLEYHAKGDLAS-YLQKKGRLSPSK---VLRFALDLARGMNYLHECKPDP 308
           +  +   + IV+EY   G L   Y   +G LS  +   V R  L   +G+ YLHE     
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG--- 121

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRL--QYISPEKAKIVFPVSHIDPANLYVAPEIY 366
            IH D+K  NILL   G +K++ FG+       I+  K+ I  P         ++APE+ 
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP--------YWMAPEVA 173

Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP-LKIKARSY 422
             E    +D   D ++ G+   E+ E   P     P   + L+      PP LK K + +
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK-W 232

Query: 423 PPDLKELIEECWDPKPVIRP 442
            P   + I++C    P  RP
Sbjct: 233 SPVFHDFIKKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 22/259 (8%)

Query: 206 AKWNGTKVWVKILDKESHKDPER-INAFTHELTIVEKARHPNVVQFVG---AVTQNIP-M 260
             +N  +V ++   K+ HK  +  I+   +E+  + +    N+++  G    +  ++P +
Sbjct: 39  GIFNNKEVIIRTF-KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL 97

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            ++LEY  +G L   L K+  LS    L  A+D  +G+  L++    P  + +L   + L
Sbjct: 98  SLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFL 155

Query: 321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAY 378
           +    +LKI   GL ++    P K  + F V        Y + ++  +   E+    D Y
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFK-NVNFMV--------YFSYKMLNDIFSEYTIKDDIY 206

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKP 438
           S G++L+E+  G  PF     +E+  L+  +     L +     P ++K ++E C     
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDC---PLEIKCIVEACTSHDS 263

Query: 439 VIRPNFNEIIARLDRIVCN 457
           + RPN  EI+  L      
Sbjct: 264 IKRPNIKEILYNLSLYKFY 282

Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 56/165 (33%), Positives = 83/165 (50%), Gaps = 20/165 (12%)

Query: 235 ELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL 292
           E  I+E+  HP +V+        + I M+  +EY   G+L + L+ +G        RF +
Sbjct: 43  EKEILEECNHPFIVKLYRTFKDKKYIYML--MEYCLGGELWTILRDRGLFDEYTA-RFYI 99

Query: 293 D---LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
               LA    YLH      II+ DLKP+N+LLD+ G +K+  FG  +    S +K     
Sbjct: 100 ACVVLA--FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC 153

Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
                     YVAPEI  N+ +D SVD +S G++LYE++ G  PF
Sbjct: 154 GTPE------YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 65/272 (23%), Positives = 122/272 (44%), Gaps = 38/272 (13%)

Query: 198 ITKGSYQVAKWNGTK-VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           I  G     K    + V+VK +  + H    ++     E  ++    H N++  +    +
Sbjct: 22  IFYGILIDEKPGKEEEVFVKTV--KDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79

Query: 257 NI-PMMIVLEYHAKGDLASYLQKKGRLSPSKVLR---------FALDLARGMNYLHECKP 306
           +  P  ++  Y   G+L  +LQ+  RL  +   +          A+ +A GM+YLH+   
Sbjct: 80  DGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG- 137

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI---DPANL---Y 360
             +IH D+  +N ++D   Q+KI+   L R           +FP+ +    D  N    +
Sbjct: 138 --VIHKDIAARNCVIDEELQVKITDNALSR----------DLFPMDYHCLGDNENRPVKW 185

Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           +A E   N+E+  + D +SFG++L+E++  G  P+    P E+      +G R    I  
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGYRLAQPI-- 242

Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            + P +L  ++  CW   P  RP+F++++  L
Sbjct: 243 -NCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 70/230 (30%), Positives = 109/230 (47%), Gaps = 23/230 (10%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L+K+  K  +  +   +E  I+EK     VV    A      + +VL     GDL  +
Sbjct: 31  KKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 90

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G       + + +A ++  G+  LH+   + I++ DLKP+NILLD+ G ++IS  G
Sbjct: 91  IYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLG 147

Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           L       PE   I   V  +     Y+APE+ KNE +  S D ++ G +LYEMI G  P
Sbjct: 148 L---AVHVPEGQTIKGRVGTVG----YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Query: 394 FHPKPP----EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE--CWDPK 437
           F  +      EEV +L+    K    +   + + PD + L +   C DPK
Sbjct: 201 FQQRKKKIKREEVERLV----KEVQEEYSEK-FSPDARSLCKMLLCKDPK 245

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 67/307 (21%)

Query: 174 VANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFT 233
           V NP+++P  +       VRK   +              V VKIL  +++K+    N F 
Sbjct: 26  VVNPQDLPTLQF---PFNVRKGRPLL-------------VAVKILRPDANKNAR--NDFL 67

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGR------ 281
            E+ I+ + + PN+++ +G      P+ ++ EY   GDL  +L       K+        
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 282 -------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                  +S S +L  AL +A GM YL        +H DL  +N L+     +KI+ FG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGM 184

Query: 335 LRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-- 389
            R  Y       + + V P+        ++A E     +F  + D ++FG+ L+E++   
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIR-------WMAWECILMGKFTTASDVWAFGVTLWEILMLC 237

Query: 390 GVQPFHPKPPEEVV----KLMCCEGK-----RPPLKIKARSYPPDLKELIEECWDPKPVI 440
             QP+     E+V+    +    +G+     RPP        P  L EL+ +CW      
Sbjct: 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPP------PCPQGLYELMLQCWSRDCRE 291

Query: 441 RPNFNEI 447
           RP+F++I
Sbjct: 292 RPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.0 bits (194), Expect = 3e-16
 Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 39/237 (16%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------- 280
           F  E  ++   +H ++V+F G   +  P+++V EY   GDL  +L+  G           
Sbjct: 54  FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113

Query: 281 --RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
              L+ S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ R  
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 170

Query: 339 YISPEKAKI----VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQP 393
           Y S +  ++    + P+        ++ PE     +F    D +S G++L+E+   G QP
Sbjct: 171 Y-STDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Query: 394 FHPKPPEEVVKLMCCEGK---RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++     EV++ +  +G+   RP      R+ P ++ +L+  CW  +P +R N  EI
Sbjct: 223 WYQLSNNEVIECI-TQGRVLQRP------RTCPKEVYDLMLGCWQREPHMRLNIKEI 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 15/176 (8%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL   +Q+ GR      +
Sbjct: 45  ECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAV 104

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++A G+ +LH      II+ DLK  N++LD+ G +KI+ FG+ +         K  
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
                      Y+APEI   + + +SVD ++FG++LYEM+ G  PF  +  +E+ +
Sbjct: 162 CGTPD------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 49/176 (27%), Positives = 90/176 (51%), Gaps = 15/176 (8%)

Query: 235 ELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ G+    + +
Sbjct: 45  ECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 104

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A +++ G+ +LH      II+ DLK  N++LD+ G +KI+ FG+ +   +     +  
Sbjct: 105 FYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF 161

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
                      Y+APEI   + + +SVD +++G++LYEM+ G  PF  +  +E+ +
Sbjct: 162 CGTPD------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 14/222 (6%)

Query: 198 ITKGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+    QV K +  +++ +K + K        +     E T++ +   P +V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           +      + +VL +   G+L  +LQ++GR   S+   +  +L   +  LH+     +I+ 
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYR 117

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLKP+NILLD  G + +  FGL +L     +K               Y+APE+     + 
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE------YLAPELLLGHGYT 171

Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
           ++VD ++ G++LYEM+ G+ PF+ +   E+ + +  E  R P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 75/245 (30%), Positives = 116/245 (47%), Gaps = 41/245 (16%)

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAF 232
           R V E+E         K + I +G+Y +        +G  V +K +  ++ +D   I++ 
Sbjct: 4   RSVTEFE---------KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL 54

Query: 233 THELTIVEKARHPNVVQF----VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKV 287
             E+T++   RHPN+V+     VG    +I   +V+EY  + DLAS L       S S+V
Sbjct: 55  -REITLLLNLRHPNIVELKEVVVGKHLDSI--FLVMEY-CEQDLASLLDNMPTPFSESQV 110

Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI 347
               L L RG+ YLHE   + IIH DLK  N+LL + G LKI+ FGL R           
Sbjct: 111 KCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART---------Y 158

Query: 348 VFPVSHIDPANL---YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EV 402
             P   + P  +   Y APE+      +  ++D ++ G IL E++   +P  P   E E 
Sbjct: 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQ 217

Query: 403 VKLMC 407
           + L+ 
Sbjct: 218 LDLII 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 12/163 (7%)

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G       + + +A
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
            ++  G+  LH    + I++ DLKP+NILLD+ G ++IS  GL       PE   I   V
Sbjct: 109 AEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGL---AVEIPEGETIRGRV 162

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
             +     Y+APE+ KNE +  S D +  G ++YEMIEG  PF
Sbjct: 163 GTVG----YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 36/192 (18%)

Query: 221 ESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG 280
           ES    +RI             RHP +V           +  V+EY A GDL  ++    
Sbjct: 44  ESLMCEKRI------FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD- 96

Query: 281 RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI 340
             S  + + +A  +  G+ YLHE K   I++ DLK  N+LLD  G +KI+ FGL +    
Sbjct: 97  VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153

Query: 341 ----------SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
                     +PE                ++APE+     + R+VD +  G+++YEM+ G
Sbjct: 154 FGDRTSTFCGTPE----------------FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Query: 391 VQPFHPKPPEEV 402
             PF     EEV
Sbjct: 198 ESPFPGDDEEEV 209

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 66/252 (26%), Positives = 113/252 (44%), Gaps = 26/252 (10%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
            +V VK L   +   P+    F  E+    +  HPNV+Q +G   ++IP ++VLE+   G
Sbjct: 23  ARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80

Query: 271 DLASYLQK-----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
           DL +YL+              + R A ++A G+ +LH+      IH DL  +N  L    
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADL 137

Query: 326 QLKISGFGLLRLQYISPE-----KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSF 380
            +KI  +GL   QY  PE     K     P+  + P  + +  +    ++  +  + +S 
Sbjct: 138 SVKIGDYGLALEQY--PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195

Query: 381 GLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK----RPPLKIKARSYPPDLKELIEECWD 435
           G+ ++E+     QP+     E+V+K +  E      +P L +K   Y     E+++ CW 
Sbjct: 196 GVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK---YSDRWYEVMQFCW- 251

Query: 436 PKPVIRPNFNEI 447
             P  RP   E+
Sbjct: 252 LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 78.4 bits (193), Expect = 6e-16
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 200 KGSY---QVAKWNGT-KVW-VKILDKESHKDPERINAFTHELTIVEK------ARHPNVV 248
           KGS+    +A+  GT +V+ +K+L K+     + +     + T+ EK      A+HP + 
Sbjct: 5   KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDV-----DCTMTEKRILALAAKHPFLT 59

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
                      +  V+EY   GDL   +Q+  +    +   +A ++   + +LH      
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HG 116

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           +I+ DLK  NILLD  G  K++ FG+ + + I        F  +   P   Y+APEI + 
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGT---PD--YIAPEILQE 170

Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPF 394
            E+  SVD ++ G+++YEM+ G  PF
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 12/181 (6%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K LDK+  K          E  I+EK   P +V    A      + +V+     GDL  +
Sbjct: 24  KKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYH 83

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G   L   +V+ ++  +  G+ +LH      I++ D+KP+N+LLD+ G  ++S  G
Sbjct: 84  IYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLG 140

Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           L     +  +  K    ++     N Y+APEI K E +   VD ++ G  +YEM+ G  P
Sbjct: 141 LA----VELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Query: 394 F 394
           F
Sbjct: 194 F 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 22/180 (12%)

Query: 220 KESHKDPERINAFT--HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           KE H D E     T   E++++++ +H N+V+    +     +M+V EY    DL  Y+ 
Sbjct: 31  KEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY-MDKDLKKYMD 89

Query: 278 ---KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
               +G L P+ V  F   L +G+ + HE +   ++H DLKP+N+L++  G+LK++ FGL
Sbjct: 90  THGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGL 146

Query: 335 LRLQYISPEKAKIVFPVSHI--DPANL-YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEG 390
            R             PV+    +   L Y AP++   +  +  S+D +S G I+ EMI G
Sbjct: 147 AR---------AFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 52/240 (21%)

Query: 235 ELTIVEKARHPNVVQ----FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  RH N++     F+  +     +  V E     DL   L  +  L    +  F
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLED---IYFVTELLGT-DLHRLLTSR-PLEKQFIQYF 113

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP NIL++    LKI  FGL R+Q   P+    V  
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ--DPQMTGYV-- 166

Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHP------------- 396
                    Y APEI    +++D  VD +S G I  EM+EG +P  P             
Sbjct: 167 -----STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQFSIITD 220

Query: 397 ---KPPEEVVKLMCCEG-----------KRPPLKIKARSYPPDLKELIEE--CWDPKPVI 440
               PP++V+  +C E            +  P   K ++  P   +L+E+   +DP+  I
Sbjct: 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 17/189 (8%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K++ K      E ++ F  E  I+  +  P + Q   A      + +V+EY   GDL S
Sbjct: 31  MKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS 90

Query: 275 YLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            L +        + +F L +L   ++ +H+      +H D+KP+N+L+D  G +K++ FG
Sbjct: 91  LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFG 147

Query: 334 -LLRLQYISPEKAKIVFPVSHIDPANLYVAPEI------YKNEEFDRSVDAYSFGLILYE 386
              RL        K+V     +   + Y+APE+           +    D +S G+I YE
Sbjct: 148 SAARL-----TANKMVNSKLPVGTPD-YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201

Query: 387 MIEGVQPFH 395
           MI G  PFH
Sbjct: 202 MIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 12/184 (6%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L+K+  K  +  +   +E  I+EK     VV    A      + +VL     GDL  +
Sbjct: 31  KRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFH 90

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G       + L +A ++  G+  LH    +  ++ DLKP+NILLD+ G ++IS  G
Sbjct: 91  IYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLG 147

Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           L       PE   I   V  +     Y+APE+  N+ +  S D +  G ++YEMIEG  P
Sbjct: 148 L---AVKIPEGESIRGRVGTVG----YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Query: 394 FHPK 397
           F  +
Sbjct: 201 FRGR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 30/221 (13%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS---YLQKKGRLSPSK-VLRF 290
           E+ ++++  HPNV+++  +  ++  + IVLE    GDL+    + +K+ RL P K V ++
Sbjct: 52  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            + L   + ++H  +   ++H D+KP N+ +   G +K+   GL R        A  +  
Sbjct: 112 FVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
             +      Y++PE      ++   D +S G +LYEM     PF+    +++     C+ 
Sbjct: 169 TPY------YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLYSLCK- 218

Query: 411 KRPPLKIKARSYPP--------DLKELIEECWDPKPVIRPN 443
                KI+   YPP        +L++L+  C +P P  RP+
Sbjct: 219 -----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 10/201 (4%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYHAKGDLASY 275
            D ES +  + ++A   E+ +++  +H  +VQ+ G +       + I +EY   G +   
Sbjct: 37  FDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ 96

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL- 334
           L+  G L+ S   ++   +  GM+YLH    + I+H D+K  NIL D+ G +K+  FG  
Sbjct: 97  LKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            RLQ I      I      +     +++PE+   E + R  D +S G  + EM+    P+
Sbjct: 154 KRLQTICMSGTGI----RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209

Query: 395 HPKPPEEVVKLMCCEGKRPPL 415
                   +  +  +   P L
Sbjct: 210 AEYEAMAAIFKIATQPTNPQL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS 285
           P   N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+ P 
Sbjct: 40  PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-PE 98

Query: 286 KVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
            +L + ++ + RG+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I    
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMA 155

Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
              V   S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  
Sbjct: 156 NSFVGTRS-------YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208

Query: 405 LMCCE---GKRPPLKIKARSYPPD 425
           +       G+          +PPD
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPD 232

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 52/225 (23%), Positives = 106/225 (47%), Gaps = 17/225 (7%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V VK +D    +  +R     +E+ I+   +HPN+V+   +      + +V+E+   
Sbjct: 44  GRQVAVKKMDL---RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G L   +    R++  ++    L + + +++LH      +IH D+K  +ILL + G++K+
Sbjct: 101 GALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKL 156

Query: 330 SGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           S FG   ++    P +  +V           ++APE+     +   VD +S G+++ EM+
Sbjct: 157 SDFGFCAQVSKEVPRRKSLV-------GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
           +G  P+  +PP + +K +      PP         P L+  ++  
Sbjct: 210 DGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDRM 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 30/238 (12%)

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS- 283
           D  + N    EL I+ KA  P +V F GA      + + +EY   G L            
Sbjct: 39  DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG 98

Query: 284 -PSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
            P  VLR     + +G+ +L E     IIH D+KP N+L++  GQ+K+  FG+      S
Sbjct: 99  IPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156

Query: 342 PEKAKIVFPVSHIDPANLYVAPEIYKNE------EFDRSVDAYSFGLILYEMIEGVQPFH 395
             K  I            Y+APE  K+        +    D +S GL + EM  G  P+ 
Sbjct: 157 LAKTNI--------GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY- 207

Query: 396 PKPPEEVVKLMC-----CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
             PPE    +        +G  P L      Y  D ++ + +C +  P  RP + +++
Sbjct: 208 --PPETYANIFAQLSAIVDGDPPTL---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 30/224 (13%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR--FAL 292
           E  I+  A +P VV    +      + +V+EY   GD A+ L+  G L P  + R  FA 
Sbjct: 51  ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGAL-PVDMARMYFA- 108

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---------E 343
           +    + YLH      I+H DLKP N+L+ + G +K++ FGL ++  +S          E
Sbjct: 109 ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV- 402
           K    F    +     Y+APE+   + + + VD ++ G+ILYE + G  PF    PEE+ 
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 225

Query: 403 -----VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
                  +   EG            P D ++LI       P+ R
Sbjct: 226 GQVISDDIEWPEGDEAL--------PADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 31/214 (14%)

Query: 194 KADGITKGSYQV-----AKWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPN 246
           K + + +GSY       +K NG  V +K++  +     E    FT   E ++++  +H N
Sbjct: 9   KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE----EEGTPFTAIREASLLKGLKHAN 64

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECK 305
           +V     +     + +V EY    DL  Y+ K  G L P  V  F   L RG++Y+H+  
Sbjct: 65  IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-- 121

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI---DPANLYVA 362
              I+H DLKP+N+L+ + G+LK++ FGL R + +           SH    +   L+  
Sbjct: 122 -RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP----------SHTYSNEVVTLWYR 170

Query: 363 PE--IYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
           P   +  + E+   +D +  G I  EMI+GV  F
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 10/178 (5%)

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           KES  D +       E+ ++ + RH N+V    A  +   + +V EY  +  L       
Sbjct: 35  KESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP 94

Query: 280 GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
           G L P  V  +   L + + Y H      IIH D+KP+NIL+   G LK+  FG  R   
Sbjct: 95  GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALR 151

Query: 340 ISPEKAKIVFPVSHIDPANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
             P      +  +       Y APE+   +  + + VD ++ G I+ E+++G +P  P
Sbjct: 152 ARPASPLTDYVATR-----WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFP 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALD 293
           E+ ++++ +HPN++  +        + +V E+  + DL   ++ K   L+P+ +  + L 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEF-METDLEKVIKDKSIVLTPADIKSYMLM 110

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
             RG+ YLH      I+H DLKP N+L+ + G LK++ FGL R  + SP +      ++H
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNR-----KMTH 161

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y APE+ +    +   VD +S G I  E++  V PF P
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLP 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 64/279 (22%), Positives = 125/279 (44%), Gaps = 14/279 (5%)

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E EL  L+L      G       + + +  K+ V I   +     +     T  + 
Sbjct: 2   RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLAR 296
            +    H  +V+ +G +     + +V +    G L  ++ Q +  L P ++L + + +A+
Sbjct: 62  AMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GM YL E +   ++H +L  +NILL +   ++I+ FG+  L Y  P+  K  +  S    
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY--PDDKKYFY--SEHKT 173

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              ++A E      +    D +S+G+ ++EM+  G +P+    P EV  L+  +G+R   
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA- 231

Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             + +    D+  ++ +CW     +RP F E+     R+
Sbjct: 232 --QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 28/205 (13%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+LDK+      ++     E  I+    HP +     +      + +V++Y   G+L  
Sbjct: 31  LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFR 90

Query: 275 YLQK-KGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
            LQ+  G+    +V RF A ++   + YLH      I++ DLKP+NILL   G + +S F
Sbjct: 91  LLQRQPGKCLSEEVARFYAAEVLLALEYLH-LLG--IVYRDLKPENILLHESGHIMLSDF 147

Query: 333 GL----------LRLQYISPEKAKIVFPVSH---IDPANL----------YVAPEIYKNE 369
            L          +        +   V  +      +  +           Y+APE+   +
Sbjct: 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD 207

Query: 370 EFDRSVDAYSFGLILYEMIEGVQPF 394
               +VD ++ G++LYEM+ G  PF
Sbjct: 208 GHGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 20/224 (8%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 36  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 92

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+  ++          +NYLHE K   IIH DLK  NIL    G +K++ FG 
Sbjct: 93  MLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFG- 148

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIY-----KNEEFDRSVDAYSFGLILYEMIE 389
                +S +  + +           ++APE+      K+  +D   D +S G+ L EM +
Sbjct: 149 -----VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203

Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
              P H   P  V  L+      PP   +   +  + K+ +++C
Sbjct: 204 IEPPHHELNPMRV--LLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY    DL  YL   G L S   V  F   
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEY-LDSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L RG++Y H+ K   I+H DLKP+N+L++  G+LK++ FGL R + + P K       S+
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKT-----YSN 162

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y  P++   + E+   +D +  G ILYEM  G +P  P
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 69/259 (26%), Positives = 112/259 (43%), Gaps = 31/259 (11%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-----TQNIPM-MIVLE 265
           KV VK +  + H   E I  F  E   ++   HPNV++ +G        Q IP  M++L 
Sbjct: 29  KVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILP 87

Query: 266 YHAKGDLASYL------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           +   GDL S+L          +L    +L+F +D+A GM YL        IH DL  +N 
Sbjct: 88  FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNC 144

Query: 320 LLDNGGQLKISGFGLLRLQYISP--EKAKIV-FPVSHIDPANLYVAPEIYKNEEFDRSVD 376
           +L     + ++ FGL +  Y      + +I   PV        ++A E   +  +    D
Sbjct: 145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-------WIAIESLADRVYTSKSD 197

Query: 377 AYSFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWD 435
            ++FG+ ++E    G  P+      E+   +   G R  LK +      +L +L+  CW 
Sbjct: 198 VWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNR--LK-QPEDCLDELYDLMYSCWR 253

Query: 436 PKPVIRPNFNEIIARLDRI 454
             P  RP F ++   L+ I
Sbjct: 254 ADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)

Query: 200 KGSYQ-----VAKWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPNVVQFVG 252
           +GSY      +++ NG  V +K++        E    FT   E ++++  +H N+V    
Sbjct: 15  EGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 253 AVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +     +  V EY    DLA Y+ Q  G L P  V  F   L RG+ Y+H      I+H
Sbjct: 71  IIHTKETLTFVFEY-MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILH 126

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPE--KAKIVFPVSHIDPANLYVAPE--IYK 367
            DLKP+N+L+   G+LK++ FGL R + I  +   +++V          L+  P   +  
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV---------TLWYRPPDVLLG 177

Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHP---KPPEEVVKL 405
             ++  ++D +  G I  EM++G QP  P      E++ K+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 18/167 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V EY    DL  Y     G + P  V  F   
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQ 107

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV-- 351
           L +G+ + H      ++H DLKP+N+L++  G+LK++ FGL R   I         PV  
Sbjct: 108 LLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGI---------PVRC 155

Query: 352 -SHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
            S       Y  P++ +  + +  S+D +S G I  E+    +P  P
Sbjct: 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 17/231 (7%)

Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-L 282
           +  E +  F  E+ I+ + +HPN+V    A      + I++E+   G L S + +  R L
Sbjct: 41  ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGL 100

Query: 283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
           +  ++      +   +N+LH  K   +IH DLK  NILL   G +K++ FG+      + 
Sbjct: 101 TEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157

Query: 343 EKAKIVFPVSHIDPANLYVAPEI-----YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
           +K        +      ++APE+     +K+  +D   D +S G+ L E+ +   P H  
Sbjct: 158 QKRDTFIGTPY------WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Query: 398 PPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            P  V  L+      PP   +   +     + ++ C    P  RP   E++
Sbjct: 212 NPMRV--LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 10/189 (5%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VK+L K+     + +     E  I+  AR HP + Q          +  V+E+   GDL 
Sbjct: 25  VKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM 84

Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++QK  R   ++   +A ++   + +LH+     II+ DLK  N+LLD+ G  K++ FG
Sbjct: 85  FHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           + + + I   K    F  +   P   Y+APEI +   +  SVD ++ G++LYEM+ G  P
Sbjct: 142 MCK-EGIFNGKTTSTFCGT---PD--YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Query: 394 FHPKPPEEV 402
           F  +  +++
Sbjct: 196 FEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS 285
           P   N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+ P 
Sbjct: 44  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-PE 102

Query: 286 KVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
           ++L + ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I    
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMA 159

Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
              V   S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  
Sbjct: 160 NSFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Query: 405 LMCCEGKRPP--LKIKARSYPP 424
           +  C  +  P   +   R  PP
Sbjct: 213 MFGCPVEGDPAESETSPRPRPP 234

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 34/265 (12%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG Y++ K     V +K+L  E+ K     +    E  I+ +  +P +V+ +G V + 
Sbjct: 11  VKKGVYKMRK-KQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVRMIG-VCEA 66

Query: 258 IPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
             +M+V+E  + G L  +L  KK  ++ S V+     ++ GM YL        +H DL  
Sbjct: 67  EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAA 123

Query: 317 KNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           +N+LL N    KIS FGL +        Y +    K  +P+        + APE     +
Sbjct: 124 RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK--WPLK-------WYAPECINFRK 174

Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR---PPLKIKARSYPPDL 426
           F    D +S+G+ ++E    G +P+      EV+  +  +GKR   P         PP++
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLDCPA------ECPPEM 227

Query: 427 KELIEECWDPKPVIRPNFNEIIARL 451
             L+++CW  K   RPNF ++  R+
Sbjct: 228 YALMKDCWIYKWEDRPNFAKVEERM 252

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 53/224 (23%), Positives = 110/224 (49%), Gaps = 15/224 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V +K ++ +     E I    +E+ ++++ ++PN+V F+ +      + +V+EY A 
Sbjct: 44  GQEVAIKQINLQKQPKKELI---INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G L   + +   +  +++     +  + + +LH    + +IH D+K  N+LL   G +K+
Sbjct: 101 GSLTDVVTETC-MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKL 156

Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
           + FG      I+PE++K     S +     ++APE+   + +   VD +S G++  EM+E
Sbjct: 157 TDFGFC--AQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210

Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
           G  P+  + P   + L+   G  P L+       P  ++ +  C
Sbjct: 211 GEPPYLNENPLRALYLIATNGT-PELQ-NPEKLSPIFRDFLNRC 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 34/212 (16%)

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
           V  VTQ +P   +L+Y          + K R+    +L + + +A+GM+YL E +   ++
Sbjct: 83  VQLVTQLMPYGCLLDY--------VRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LV 131

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYK 367
           H DL  +N+L+ +   +KI+ FGL RL  I   +        H D   +   ++A E   
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETE-------YHADGGKVPIKWMALESIL 184

Query: 368 NEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP-- 424
           +  F    D +S+G+ ++E++  G +P+   P  E+  L+  +G+R P        PP  
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLP-------QPPIC 236

Query: 425 --DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             D+  ++ +CW      RP F E++    R+
Sbjct: 237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K     +    +    
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 116

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+         +V  +
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 173

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
                   Y APE+     +   VD +S G I  EM
Sbjct: 174 -------WYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 67/261 (25%), Positives = 117/261 (44%), Gaps = 40/261 (15%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
              +V VK L        +    F  E       +H N++Q +G  T+  P ++V+E+  
Sbjct: 21  TPAQVVVKEL--RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78

Query: 269 KGDLASYLQ--KKGRL---SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
            GDL  YL+  +K  L    P+ + R A ++A G+ +LH+   +  IH DL  +N LL  
Sbjct: 79  LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTA 135

Query: 324 GGQLKISGFGLLRLQY-----ISPEKAKIVFPVSHIDP-------ANLYVAPEIYKNEEF 371
              +KI  +GL   +Y     ++P++  +  P+  I P        NL V  +       
Sbjct: 136 DLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDEVHGNLLVVDQ------- 186

Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK----RPPLKIKARSYPPDL 426
            +  + +S G+ ++E+ E G QP+     E+V+     E +    +P LK+         
Sbjct: 187 TKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDR---W 243

Query: 427 KELIEECWDPKPVIRPNFNEI 447
            E+++ CW   P  RP+  E+
Sbjct: 244 YEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 43/149 (28%), Positives = 83/149 (55%), Gaps = 10/149 (6%)

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           + +V +Y + G+L  +LQK+GR S  +   +  +L   + +LH+     I++ DLKP+NI
Sbjct: 71  LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENI 127

Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAY 378
           LLD  G + +  FGL +   ++  K    F  +       Y+APE+  +E+ + + VD +
Sbjct: 128 LLDATGHIALCDFGLSKAN-LTDNKTTNTFCGT-----TEYLAPEVLLDEKGYTKHVDFW 181

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKLMC 407
           S G++++EM  G  PF+ +  +++ + + 
Sbjct: 182 SLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.7 bits (175), Expect = 7e-14
 Identities = 57/242 (23%), Positives = 117/242 (48%), Gaps = 19/242 (7%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPER 228
           R+ ++V +P++    +    E   + A G    +  VA   G +V ++ ++ +     E 
Sbjct: 10  RSIVSVGDPKK----KYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKEL 63

Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           I    +E+ ++ + ++PN+V ++ +      + +V+EY A G L   + +   +   ++ 
Sbjct: 64  I---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIA 119

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
               +  + + +LH    + +IH D+K  NILL   G +K++ FG      I+PE++K  
Sbjct: 120 AVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSK-- 172

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC 408
              S +     ++APE+   + +   VD +S G++  EMIEG  P+  + P   + L+  
Sbjct: 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

Query: 409 EG 410
            G
Sbjct: 231 NG 232

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 53/226 (23%), Positives = 107/226 (47%), Gaps = 15/226 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V +K ++ +     E I    +E+ ++ + +HPN+V ++ +      + +V+EY A 
Sbjct: 44  GQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G L   + +   +   ++     +  + + +LH    + +IH D+K  NILL   G +K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKL 156

Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
           + FG      I+PE++K    V        ++APE+   + +   VD +S G++  EM+E
Sbjct: 157 TDFGFC--AQITPEQSKRSTMVG----TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210

Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWD 435
           G  P+  + P   + L+   G  P L+          ++ +  C +
Sbjct: 211 GEPPYLNENPLRALYLIATNGT-PELQ-NPEKLSAIFRDFLNRCLE 254

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 72.4 bits (177), Expect = 8e-14
 Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 34/220 (15%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL K    + E++     E  I+ +A    VV+   +    + + +++E+   GD+ +
Sbjct: 31  MKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMT 90

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L KK  L+  +   +  +    ++ +H+      IH D+KP N+LLD+ G +K+S FGL
Sbjct: 91  LLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147

Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------------------------------YVAPE 364
                    + +    ++H  P++                               Y+APE
Sbjct: 148 CT-GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
           ++    +++  D +S G+I+YEM+ G  PF  + P+E  K
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 27/224 (12%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +V VK +D    +  +R     +E+ I+    H NVV    +      + +V+E+
Sbjct: 44  KHTGKQVAVKKMDL---RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   +    R++  ++    L + R ++YLH      +IH D+K  +ILL + G+
Sbjct: 101 LEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGR 156

Query: 327 LKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           +K+S FG   ++    P++  +V           ++APE+     +   VD +S G+++ 
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLV-------GTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           EMI+G  P+  +PP + ++           +I+  + PP +K+ 
Sbjct: 210 EMIDGEPPYFNEPPLQAMR-----------RIR-DNLPPRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.3 bits (174), Expect = 9e-14
 Identities = 56/242 (23%), Positives = 118/242 (48%), Gaps = 19/242 (7%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPER 228
           R+ ++V +P++    +    E   + A G    +  +A   G +V +K ++ +     E 
Sbjct: 9   RSIVSVGDPKK----KYTRFEKIGQGASGTVYTAIDIA--TGQEVAIKQMNLQQQPKKEL 62

Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           I    +E+ ++ + ++PN+V ++ +      + +V+EY A G L   + +   +   ++ 
Sbjct: 63  I---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIA 118

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
               +  + +++LH    + +IH D+K  NILL   G +K++ FG      I+PE++K  
Sbjct: 119 AVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSK-- 171

Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC 408
              S +     ++APE+   + +   VD +S G++  EM+EG  P+  + P   + L+  
Sbjct: 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229

Query: 409 EG 410
            G
Sbjct: 230 NG 231

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY  K DL  YL   G   +   V  F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L RG+NY H  K   ++H DLKP+N+L++  G+LK++ FGL R + I P K       S+
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKT-----YSN 163

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y  P+I   + ++   +D +  G I YEM  G +P  P
Sbjct: 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 12/163 (7%)

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G       + + +A
Sbjct: 49  NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
            +L  G+  L     + I++ DLKP+NILLD+ G ++IS  GL       PE   +   V
Sbjct: 109 AELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGL---AVQIPEGETVRGRV 162

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
             +     Y+APE+  NE++  S D +  G ++YEMI+G  PF
Sbjct: 163 GTVG----YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 22/243 (9%)

Query: 215 VKILDKE-SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           V+I  KE   +D   +     E+ +    +H N+VQ++G+ ++N    I +E    G L+
Sbjct: 34  VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93

Query: 274 SYLQKK-GRLSP--SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKI 329
           + L+ K G L      ++ +   +  G+ YLH+ +   I+H D+K  N+L++   G +KI
Sbjct: 94  ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKI 150

Query: 330 SGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYE 386
           S FG   RL  I+P        +        Y+APE+       +    D +S G  + E
Sbjct: 151 SDFGTSKRLAGINPCTETFTGTLQ-------YMAPEVIDKGPRGYGAPADIWSLGCTIVE 203

Query: 387 MIEGVQPFHP-KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFN 445
           M  G  PF     P+  +  +      P +     S   + K  I  C++P P  R + +
Sbjct: 204 MATGKPPFIELGEPQAAMFKVGMFKIHPEI---PESLSAEAKNFILRCFEPDPDKRASAH 260

Query: 446 EII 448
           +++
Sbjct: 261 DLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 12/162 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E ++++  +H N+V     +     + +V EY    DL  Y+   G  LS   V  F   
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L RG+ Y H+ +   ++H DLKP+N+L+   G+LK++ FGL R + + P K       S+
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKT-----YSN 162

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
                 Y  P++   + E+  S+D +  G I YEM  G   F
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 25/181 (13%)

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y  P+   K     P+        ++APE   +  +    D +SFG++L+E+   G  P+
Sbjct: 230 YKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282

Query: 395 HPKPPEEVVKLMCC---EGKRPPLKIKARSY-PPDLKELIEECWDPKPVIRPNFNEIIAR 450
              P  ++ +  C    EG R    ++A  Y  P++ + + +CW  +P  RP F+E++  
Sbjct: 283 ---PGVKIDEEFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Query: 451 L 451
           L
Sbjct: 336 L 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 39/261 (14%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIP------MM 261
            G  V +KI+D       +       E  I+ K + HPN+  F GA  +  P      + 
Sbjct: 30  TGQLVAIKIMDI----IEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85

Query: 262 IVLEYHAKG---DLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPK 317
           +V+E    G   DL   L+KKG+    + + + L +  RG+ YLHE K   +IH D+K +
Sbjct: 86  LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQ 142

Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE-IYKNEEFDRSVD 376
           NILL    ++K+  FG+   Q  S    +  F  +   P   ++APE I  +E+ D S D
Sbjct: 143 NILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGT---PY--WMAPEVIACDEQPDASYD 196

Query: 377 A----YSFGLILYEMIEGVQPF---HPKPPEEVVKLMCCEGKRPPLKIK-ARSYPPDLKE 428
           A    +S G+   E+ +G  P    HP      ++ +    + PP  +K   ++     +
Sbjct: 197 ARSDVWSLGITAIELADGKPPLCDMHP------MRALFKIPRNPPPTLKSPENWSKKFND 250

Query: 429 LIEECWDPKPVIRPNFNEIIA 449
            I EC       RP   E++ 
Sbjct: 251 FISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 43/256 (16%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
             V +K+L    H+D     AF    +++ +  H ++V+  G V      ++V EY   G
Sbjct: 31  VSVVLKVLGS-DHRDSL---AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFG 85

Query: 271 DLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-----DNG 324
            L  +L + K  +S    L  A  LA  ++YL + K   ++H ++  KNIL+     + G
Sbjct: 86  PLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEG 142

Query: 325 GQL--KIS----GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVD 376
                K+S       +L  +            V  I     ++APE  +N +     + D
Sbjct: 143 YVPFIKLSDPGIPITVLSREE----------RVERIP----WIAPECIRNGQASLTIAAD 188

Query: 377 AYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWD 435
            +SFG  L E+   G +P       E  +    + + P           +L  LI +CW 
Sbjct: 189 KWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDC------AELANLINQCWT 242

Query: 436 PKPVIRPNFNEIIARL 451
             P  RP+F  I+  L
Sbjct: 243 YDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 10/180 (5%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
            D ES +  + +NA   E+ +++   H  +VQ+ G +       + I +E+   G +   
Sbjct: 37  FDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ 96

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL- 334
           L+  G L+ +   ++   +  G++YLH    + I+H D+K  NIL D+ G +K+  FG  
Sbjct: 97  LKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            RLQ I      +      +     +++PE+   E + R  D +S G  + EM+    P+
Sbjct: 154 KRLQTICLSGTGM----KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 72/281 (25%), Positives = 130/281 (46%), Gaps = 54/281 (19%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA--------VTQNIPMMIVL 264
           V +KIL++ +   P+    F  E  I+    HP++V+ +G         VTQ +P   +L
Sbjct: 39  VAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLL 96

Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           +Y          + K  +    +L + + +A+GM YL E +   ++H DL  +N+L+ + 
Sbjct: 97  DY--------VHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSP 145

Query: 325 GQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYS 379
             +KI+ FGL RL     +  + +  K+  P+        ++A E     +F    D +S
Sbjct: 146 NHVKITDFGLARLLEGDEKEYNADGGKM--PIK-------WMALECIHYRKFTHQSDVWS 196

Query: 380 FGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP----DLKELIEECW 434
           +G+ ++E++  G +P+   P  E+  L+  +G+R P        PP    D+  ++ +CW
Sbjct: 197 YGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLP-------QPPICTIDVYMVMVKCW 248

Query: 435 DPKPVIRPNFNEIIARLDRIVCNCSK----QGWWKDTFKLP 471
                 RP F E+ A   R+  +  +    QG   D  KLP
Sbjct: 249 MIDADSRPKFKELAAEFSRMARDPQRYLVIQG--DDRMKLP 287

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 57/243 (23%), Positives = 110/243 (45%), Gaps = 17/243 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+
Sbjct: 42  KSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G+
Sbjct: 99  LEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGR 154

Query: 327 LKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           +K+S FG   ++    P +  +V           ++APE+     +   VD +S G+++ 
Sbjct: 155 VKLSDFGFCAQVSKEVPRRKSLV-------GTPYWMAPELISRLPYGPEVDIWSLGIMVI 207

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFN 445
           EM++G  P+  +PP + +K++      PP         P LK  ++      P  R    
Sbjct: 208 EMVDGEPPYFNEPPLKAMKMI--RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAA 265

Query: 446 EII 448
           E++
Sbjct: 266 ELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 63/244 (25%), Positives = 107/244 (43%), Gaps = 38/244 (15%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLS-- 283
           F  E   +++  HPNV++ +G   Q +        +++L +   GDL S+L    RL   
Sbjct: 47  FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDC 105

Query: 284 ----PSKVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
               P+++L +F  D+A GM YL        IH DL  +N +L+    + ++ FGL +  
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Query: 339 YISP--EKAKIV-FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
           Y      + +I   PV        ++A E   +  +    D +SFG+ ++E+    Q  +
Sbjct: 163 YNGDYYRQGRIAKMPVK-------WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215

Query: 396 PKPPEEVVKLMCCEGKRPPLKIKARSYPPD----LKELIEECWDPKPVIRPNFNEIIARL 451
           P      +     +G R  LK      PPD    L  L+  CW   P  RP+F  +   L
Sbjct: 216 PGVENSEIYDYLRQGNR--LK-----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Query: 452 DRIV 455
           ++ +
Sbjct: 269 EKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 66.3 bits (162), Expect = 3e-13
 Identities = 36/83 (43%), Positives = 50/83 (60%), Gaps = 9/83 (10%)

Query: 99  NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYN 155
           N+ D DGRT LH+AA  GH+EVVKLLL   A+++A+D  G T    AA     G++E+  
Sbjct: 1   NARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAA---KNGHLEIVK 57

Query: 156 ILKARGAKVP---KTKRTPMTVA 175
           +L  +GA V    K   TP+ +A
Sbjct: 58  LLLEKGADVNARDKDGNTPLHLA 80

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 27/205 (13%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMIVLEYHAKGDLASY 275
            D +S +  + +NA   E+ +++  RH  +VQ+ G +   +   + I +EY   G +   
Sbjct: 37  FDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ 96

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           L+  G L+ +   R+   + +G++YLH    + I+H D+K  NIL D+ G +K+  FG  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153

Query: 336 -RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE----- 389
            R+Q I      I      +     +++PE+   E + R  D +S    + EM+      
Sbjct: 154 KRIQTICMSGTGI----KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209

Query: 390 ------------GVQPFHPKPPEEV 402
                         QP  P  P+ V
Sbjct: 210 AEYEAMAAIFKIATQPTKPMLPDGV 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)

Query: 282 LSPSKVLRFALDLARGMNYL--HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--- 336
           L    +L F+  +A+GM++L    C     IH DL  +NILL +G   KI  FGL R   
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIR 265

Query: 337 --LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQP 393
               Y+    A++  PV        ++APE   N  +    D +S+G++L+E+   G  P
Sbjct: 266 NDSNYVVKGNARL--PVK-------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Query: 394 FHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR 453
           +   P +     M  EG R    +     P ++ ++++ CWD  P+ RP F +I+  +++
Sbjct: 317 YPGMPVDSKFYKMIKEGYR---MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 59/244 (24%), Positives = 115/244 (47%), Gaps = 19/244 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G +V VK++D       +R     +E+ I+   +H NVV+   +      + +++E+
Sbjct: 43  KHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   + +  RL+  ++      + + + YLH      +IH D+K  +ILL   G+
Sbjct: 100 LQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGR 155

Query: 327 LKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           +K+S FG   ++    P++  +V           ++APE+     +   VD +S G+++ 
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLV-------GTPYWMAPEVISRTPYGTEVDIWSLGIMVI 208

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK-ARSYPPDLKELIEECWDPKPVIRPNF 444
           EM++G  P+    P + +K +      PP K+K A    P L++ +E     +P  R   
Sbjct: 209 EMVDGEPPYFSDSPVQAMKRL---RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATA 265

Query: 445 NEII 448
            E++
Sbjct: 266 QELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL K    + E++     E  I+ +A    VV+   +      + +++E+   GD+ +
Sbjct: 31  MKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMT 90

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L KK  LS      +  +    ++ +H+      IH D+KP N+LLD  G +K+S FGL
Sbjct: 91  LLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147

Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------------------------------YVAPE 364
                    + +    ++H  P++                               Y+APE
Sbjct: 148 CT-GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
           ++    +++  D +S G+I+YEM+ G  PF  + P+E  +
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 17/226 (7%)

Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-ASYLQKKGRL 282
           K  E +  +  E+ I+    HP +V+ +GA   +  + I++E+   G + A  L+    L
Sbjct: 48  KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL 107

Query: 283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
           +  ++      +   + YLH  K   IIH DLK  N+LL   G +K++ FG      +S 
Sbjct: 108 TEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFG------VSA 158

Query: 343 EKAKIVFPVSHIDPANLYVAPEI-----YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
           +  K +           ++APE+      K+  +D   D +S G+ L EM +   P H  
Sbjct: 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Query: 398 PPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
            P  V  L+      PP   +   +  + ++ ++   D  P  RP+
Sbjct: 219 NPMRV--LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 60/261 (22%), Positives = 115/261 (44%), Gaps = 42/261 (16%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA--------VTQNIPMM 261
             K+ V I +      P+       E  ++    +P+V + +G         +TQ +P  
Sbjct: 34  KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFG 93

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
            +L+Y          + K  +    +L + + +A+GMNYL E +   ++H DL  +N+L+
Sbjct: 94  CLLDY--------VREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLV 142

Query: 322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAY 378
                +KI+ FGL +L   + EK        H +   +   ++A E   +  +    D +
Sbjct: 143 KTPQHVKITDFGLAKL-LGADEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVW 195

Query: 379 SFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP----DLKELIEEC 433
           S+G+ ++E M  G +P+   P  E+  ++  +G+R P        PP    D+  ++ +C
Sbjct: 196 SYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLP-------QPPICTIDVYMIMVKC 247

Query: 434 WDPKPVIRPNFNEIIARLDRI 454
           W      RP F E+I    ++
Sbjct: 248 WMIDADSRPKFRELIIEFSKM 268

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 46/172 (26%), Positives = 92/172 (53%), Gaps = 16/172 (9%)

Query: 231 AFTHELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           A T E T  E+       R P +V    A   +  + ++L+Y   G+L ++L ++   + 
Sbjct: 45  AKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE 104

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
           S+V  +  ++   +++LH+     II+ D+K +NILLD+ G + ++ FGL +  +++ E+
Sbjct: 105 SEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE-FLAEEE 160

Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPF 394
            +       I+    Y+APE+ +      D++VD +S G++ +E++ G  PF
Sbjct: 161 ERAYSFCGTIE----YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 39/113 (34%), Positives = 59/113 (52%), Gaps = 9/113 (7%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
               +   +   +  G+ +LH+ +   II+ DLKP+N+LLDN G ++IS  GL       
Sbjct: 94  FPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150

Query: 342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
             K K         P   ++APE+ + EE+D SVD ++ G+ LYEMI    PF
Sbjct: 151 QSKTKGYAGT----PG--FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 14/188 (7%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K  +K      ++++    E  I+    HP  V   G+      + +VLE+   G+ 
Sbjct: 59  VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118

Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
            ++L++  R        +A  +     YL       I++ DLKP+N+LLD  G +K++ F
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF 175

Query: 333 GLLRLQYISPEKAKIVFPVSH-IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
           G           AK+V   ++ +     Y+APEI  N    ++ D ++ G+ +YE++ G 
Sbjct: 176 GF----------AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225

Query: 392 QPFHPKPP 399
            PF+   P
Sbjct: 226 PPFYANEP 233

Length = 340

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 44/163 (26%), Positives = 89/163 (54%), Gaps = 11/163 (6%)

Query: 235 ELTIVEKARH-PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           E  ++E  R  P +V    A   +  + ++L+Y   G+L ++L ++ R    +V  ++ +
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           +   + +LH+     II+ D+K +NILLD+ G + ++ FGL + ++   E  +       
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGT 169

Query: 354 IDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPF 394
           I+    Y+AP+I +  +   D++VD +S G+++YE++ G  PF
Sbjct: 170 IE----YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 46/244 (18%)

Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-ASYLQKKGR 281
           H+D  R      E+ I+    HPNVV+       N  + ++LE+   G L  +++  +  
Sbjct: 111 HEDTVR-RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169

Query: 282 LSPSKVLRFALDLAR----GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           L+         D+AR    G+ YLH      I+H D+KP N+L+++   +KI+ FG+ R+
Sbjct: 170 LA---------DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Query: 338 QYISPEKAKIVFPVSHIDPAN------LYVAPEIYKNEEFDRSVDAY-----SFGLILYE 386
                           +DP N       Y++PE    +    + D Y     S G+ + E
Sbjct: 218 L------------AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Query: 387 MIEGVQPFHPKPPEEVVKLMC--CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF 444
              G  PF      +   LMC  C  + P     A     + +  I  C   +P  R + 
Sbjct: 266 FYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS---REFRHFISCCLQREPAKRWSA 322

Query: 445 NEII 448
            +++
Sbjct: 323 MQLL 326

Length = 353

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 25/221 (11%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL-RFALD 293
           EL I+ K   P ++ F GA      + I  E+   G L  Y     R  P  VL R A+ 
Sbjct: 49  ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVA 103

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           + +G+ YL   K   I+H D+KP N+L++  GQ+K+  FG+      S  K  +      
Sbjct: 104 VVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV------ 154

Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM------C 407
               N Y+APE    E++    D +S G+   E+  G  P+ P+  +    LM      C
Sbjct: 155 --GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQLLQC 211

Query: 408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
              + PP+ +    +       I +C   +P  RP    ++
Sbjct: 212 IVDEDPPV-LPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 40/174 (22%), Positives = 79/174 (45%), Gaps = 21/174 (12%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ +++  +H N+VQ++G    +  + I +E+   G ++S L + G L      ++   +
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             G+ YLH    + ++H D+K  N++L   G +K+  FG  R         ++ +   H 
Sbjct: 112 LDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCAR---------RLAWVGLHG 159

Query: 355 DPANL---------YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP 399
             +N+         ++APE+     + R  D +S G  ++EM  G  P      
Sbjct: 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+++++  +H N+V     V  +  + +V EY  K DL  Y+   G  +S   V  F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           + RG+ Y H  K   ++H DLKP+N+L++  G+LK++ FGL R + + P K       S+
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKT-----YSN 163

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y  P++   + E+   +D +  G I +EM  G +P  P
Sbjct: 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 28/196 (14%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI----VLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL I+   +H N++     +            V++   + DL   +     L+   +  F
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              L RG+ Y+H      +IH DLKP N+L++   +L+I  FG+ R    SP + K  F 
Sbjct: 113 LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFM 168

Query: 351 VSHIDPANL-YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK----------- 397
             ++  A   Y APE+     E+  ++D +S G I  EM+   Q F  K           
Sbjct: 169 TEYV--ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226

Query: 398 ----PPEEVVKLMCCE 409
               P EEV+  +  +
Sbjct: 227 VLGSPSEEVLNRIGSD 242

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 50/216 (23%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM-----MIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           E+ ++   RH N++  +  +    P       IV E   + DL   ++    L+   +  
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQY 107

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           F   + RG+ YLH      +IH DLKP NIL+++   LKI  FGL R      ++   + 
Sbjct: 108 FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 350 PVSHIDPANLYV------APEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHP------ 396
                     YV      APE+  +   + +++D +S G I  E++   +P  P      
Sbjct: 165 E---------YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLFPGRDYID 214

Query: 397 ----------KPPEEVVKLMCCEGKRPPLKIKARSY 422
                      P EE +K +  E        KAR+Y
Sbjct: 215 QLNLIVEVLGTPSEEDLKFITSE--------KARNY 242

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 15/166 (9%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           EL I+ + +H N++  V    +   + +V++  A  DL   + +K RL+ S+V    L +
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQI 128

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             G+N LH+      +H DL P NI +++ G  KI+ FGL R +Y  P  +  +     +
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR-RYGYPPYSDTLSKDETM 184

Query: 355 DPANL---------YVAPE-IYKNEEFDRSVDAYSFGLILYEMIEG 390
                         Y APE +   E++  +VD +S G I  E++ G
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 59/228 (25%), Positives = 92/228 (40%), Gaps = 48/228 (21%)

Query: 215 VKILDKESHKDPERINAFTH---ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +K L K    D    N   H   E  I+ +A +  VV+   +      +  V++Y   GD
Sbjct: 31  MKTLRK---ADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87

Query: 272 LASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           + S L + G +    + RF + +L   +  +H+      IH D+KP NIL+D  G +K++
Sbjct: 88  MMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT 143

Query: 331 GFGL---LRLQYIS--------PEKAKIVFP--VSHIDPANL------------------ 359
            FGL    R  + S          +  +      S ID   L                  
Sbjct: 144 DFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS 203

Query: 360 ------YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
                 Y+APE+     + +  D +S G+ILYEM+ G  PF    P E
Sbjct: 204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE 251

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 29/181 (16%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALD 293
           E  +++   HP+V++    +       +VL  H   DL +YL K+   L   + L     
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-HYSSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           +  G+ YLH  +   IIH D+K +NI +++  Q+ I   G  +            FPV  
Sbjct: 166 ILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ------------FPV-- 208

Query: 354 IDPANLYVA-------PEIYKNEEFDRSVDAYSFGLILYEMI---EGVQPFHPKPPEEVV 403
           + PA L +A       PE+   ++++   D +S G++L+EM+     +    P  PEE V
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268

Query: 404 K 404
           K
Sbjct: 269 K 269

Length = 357

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 14/203 (6%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS 285
           P   N    EL ++ +   P +V F GA   +  + I +E+   G L   L++  R+   
Sbjct: 44  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE 103

Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
            + + ++ + RG+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I     
Sbjct: 104 ILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMAN 160

Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
             V   S       Y++PE  +   +    D +S GL L E+  G  P  P   +E+  +
Sbjct: 161 SFVGTRS-------YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213

Query: 406 ----MCCEGKRPPLKIKARSYPP 424
               +    +  P  I  R  PP
Sbjct: 214 FGRPVVDGEEGEPHSISPRPRPP 236

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 64/259 (24%), Positives = 119/259 (45%), Gaps = 33/259 (12%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK+L ++++K+    N F  E+ I+ + + PN+++ +     + P+ ++ EY   GDL
Sbjct: 49  VAVKMLREDANKNAR--NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 273 ASYLQK-----------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
             +L +              +S S ++  A  +A GM YL        +H DL  +N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLV 163

Query: 322 DNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
                +KI+ FG+ R  Y       + + V P+  +   ++ +        +F  + D +
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-------KFTTASDVW 216

Query: 379 SFGLILYEMIEGV--QPFHPKPPEEVV----KLMCCEGKRPPLKIKARSYPPDLKELIEE 432
           +FG+ L+E++     QP+     E+V+    +    +G++  L   A   P  L +L+  
Sbjct: 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALC-PDSLYKLMLS 275

Query: 433 CWDPKPVIRPNFNEIIARL 451
           CW      RP+F EI A L
Sbjct: 276 CWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQF 250
           VRK  G   G     K       V+      H   ER         ++E  R  P +V  
Sbjct: 19  VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTER--------NVLEHVRQSPFLVTL 70

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             A      + ++L+Y + G++ ++L ++   S  +V  ++ ++   + +LH+     I+
Sbjct: 71  HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IV 127

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           + D+K +NILLD+ G + ++ FGL + +++S EK +       I+    Y+APEI + + 
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTYSFCGTIE----YMAPEIIRGKG 182

Query: 371 -FDRSVDAYSFGLILYEMIEGVQPF 394
              ++VD +S G++++E++ G  PF
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 35/125 (28%), Positives = 60/125 (48%), Gaps = 7/125 (5%)

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           DL   ++    L+ +    F   +  G+ Y+H      ++H DLKP N+L++   +LKI 
Sbjct: 91  DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147

Query: 331 GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIE 389
            FGL R    S    +    ++       Y APEI    + + +++D +S G IL E++ 
Sbjct: 148 DFGLAR--GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL- 204

Query: 390 GVQPF 394
           G +P 
Sbjct: 205 GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 27/241 (11%)

Query: 189 ELQVRKADGITKGSYQ---VAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARH 244
             ++ K   +  G +    V K   T K++V+ + K  + +   I    H+L       +
Sbjct: 15  NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLM----KDN 68

Query: 245 PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC 304
           PN ++   +VT     +++++Y   GDL   L+K+G+LS ++V +    L   +N LH+ 
Sbjct: 69  PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH 128

Query: 305 KPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
               IIH D+K +N+L D    ++ +  +GL           KI+   S  D    Y +P
Sbjct: 129 N---IIHNDIKLENVLYDRAKDRIYLCDYGL----------CKIIGTPSCYDGTLDYFSP 175

Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE--VVKLMCCEGKRPPLKIKARS 421
           E  K   +D S D ++ G++ YE++ G  PF     EE  +  L+  + K+ P  IK  S
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP-FIKNVS 234

Query: 422 Y 422
            
Sbjct: 235 K 235

Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 20/200 (10%)

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S  ++  +A ++ 
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
            G+ ++H      +++ DLKP NILLD  G ++IS  GL         K K   P + + 
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKK---PHASVG 157

Query: 356 PANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPFH---PKPPEEVVKLMCCEGK 411
             + Y+APE+  K   +D S D +S G +L++++ G  PF     K   E+ ++      
Sbjct: 158 -THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV 216

Query: 412 RPPLKIKARSYPPDLKELIE 431
             P      S+ P+LK L+E
Sbjct: 217 ELP-----DSFSPELKSLLE 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 73/271 (26%), Positives = 112/271 (41%), Gaps = 35/271 (12%)

Query: 198 ITKGSYQ-----VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I KG+Y      + K NG+K  VKILD   H   E I A   E  I++  + HPNVV+F 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEA---EYNILKALSDHPNVVKFY 81

Query: 252 GA-----VTQNIPMMIVLEYHAKG---DLASYLQKKGRLSPSKVLRFALDLA-RGMNYLH 302
           G      V     + +VLE    G   DL     K+G      ++ + L  A  G+ +LH
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVA 362
             K    IH D+K  NILL   G +K+  FG      +S +        +       ++A
Sbjct: 142 VNK---TIHRDVKGNNILLTTEGGVKLVDFG------VSAQLTSTRLRRNTSVGTPFWMA 192

Query: 363 PEIYKNEE-----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
           PE+   E+     +D   D +S G+   E+ +G  P     P     L       PP   
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFKIPRNPPPTLH 250

Query: 418 KARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           +   +  +  + I +C       RP  ++++
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 24/167 (14%)

Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFA 291
           +E   HPN+V+ +         +   + +V E H   DL +YL K     L    +    
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETIKDLM 114

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
               RG+++LH    + I+H DLKP+NIL+ +GGQ+K++ FGL R+         +V  +
Sbjct: 115 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTL 171

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP 398
                   Y APE+     +   VD +S G I  EM      F  KP
Sbjct: 172 -------WYRAPEVLLQSTYATPVDMWSVGCIFAEM------FRRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 25/174 (14%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149

Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
           +V+  ALD    M ++H          D+KP N+LLD  G LK++ FG      +   K 
Sbjct: 150 EVV-LALDAIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFGTC----MKMNKE 195

Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFD----RSVDAYSFGLILYEMIEGVQPFH 395
            +V   + +   + Y++PE+ K++  D    R  D +S G+ LYEM+ G  PF+
Sbjct: 196 GMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 27/165 (16%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E  I+    HP+++Q  G  T N    ++L  + K DL  YL  K  ++   +L     +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSV 191

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
            R + YLHE   + IIH D+K +NI +++ G + +  FG               FPV   
Sbjct: 192 LRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG------------AACFPVD-- 234

Query: 355 DPANLYV---------APEIYKNEEFDRSVDAYSFGLILYEMIEG 390
             AN Y          APE+   + +  +VD +S G++L+EM   
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat

 Score = 58.7 bits (143), Expect = 1e-11
 Identities = 20/33 (60%), Positives = 26/33 (78%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           DG T LH+AA  GH+EVVKLLL   A+++ARD+
Sbjct: 1   DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 19/160 (11%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS--PSKVLRFAL 292
           E++++++  HPN+V+ +  V     + +V E+    DL  Y+         P  +  +  
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV- 351
            L +G+ Y H  +   ++H DLKP+N+L+D  G LK++ FGL R   +         PV 
Sbjct: 107 QLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGV---------PVR 154

Query: 352 --SHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMI 388
             +H      Y APEI   + ++   VD +S G I  EM+
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 50/223 (22%), Positives = 95/223 (42%), Gaps = 40/223 (17%)

Query: 245 PNVVQFVGAVTQNIPMMIVLEYHAKG--DLASYLQKKGRLSPSKVL-RFALDLARGMNYL 301
           P  V F GA+ +   + I +E            +  KG   P  +L + A+ + + + YL
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------QYISPEKAKI 347
           H      +IH D+KP N+L++  GQ+K+  FG+                  Y++PE+   
Sbjct: 120 HS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER--- 174

Query: 348 VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLM 406
                 I+P            + +D   D +S G+ + E+  G  P+   K P + +K +
Sbjct: 175 ------INPEL--------NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220

Query: 407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
               + P  ++ A  + P+ ++ + +C       RPN+ E++ 
Sbjct: 221 V---EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 55/229 (24%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K L K    + E++     E  I+ +A +P VV+   +      + +++EY   GD+ +
Sbjct: 31  MKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMT 90

Query: 275 YLQKKGRLSPSKVLRF-------ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            L KK   +  +  RF       A+D    + Y         IH D+KP N+LLD  G +
Sbjct: 91  LLMKKDTFT-EEETRFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHI 140

Query: 328 KISGFGLLR-LQ-YISPEKAKIVFPVSHIDPANL-------------------------- 359
           K+S FGL   L+     E  +I+    H  P+N                           
Sbjct: 141 KLSDFGLCTGLKKSHRTEFYRILS---HALPSNFLDFISKPMSSKRKAETWKRNRRALAY 197

Query: 360 -------YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
                  Y+APE++    +++  D +S G+I+YEM+ G  PF    P+E
Sbjct: 198 STVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 56/248 (22%), Positives = 113/248 (45%), Gaps = 30/248 (12%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA-VTQNIPMM-----IVLEYH 267
           +K++D    ++ E       E+ +++K + H N+  + GA + +N P M     +V+E+ 
Sbjct: 36  IKVMDVTGDEEEE----IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91

Query: 268 AKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
             G +   ++  K   L    +     ++ RG+++LH+ K   +IH D+K +N+LL    
Sbjct: 92  GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 148

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-----FDRSVDAYSF 380
           ++K+  FG      +S +  + V   +       ++APE+   +E     +D   D +S 
Sbjct: 149 EVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202

Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           G+   EM EG  P     P   + L+    + P  ++K++ +    +  IE C       
Sbjct: 203 GITAIEMAEGAPPLCDMHPMRALFLI---PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQ 259

Query: 441 RPNFNEII 448
           RP   +++
Sbjct: 260 RPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 15/169 (8%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF- 290
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +       P K  +F 
Sbjct: 90  FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY 147

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
             ++   ++ +H      +IH D+KP N+LLD  G LK++ FG      +  ++  +V  
Sbjct: 148 TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC----MKMDETGMVRC 200

Query: 351 VSHIDPANLYVAPEIYKNEEFD----RSVDAYSFGLILYEMIEGVQPFH 395
            + +   + Y++PE+ K++  D    R  D +S G+ L+EM+ G  PF+
Sbjct: 201 DTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 23/206 (11%)

Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 3   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 59

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++       +    +  +   L +G+ + H 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P     V   +H      Y AP
Sbjct: 119 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-----VRTYTHEVVTLWYRAP 169

Query: 364 EIYKNEEF-DRSVDAYSFGLILYEMI 388
           EI    ++   +VD +S G I  EM+
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 33/178 (18%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF- 290
           F  E  I+  A    +VQ   A   +  + +V+EY   GDL + +       P K  RF 
Sbjct: 90  FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFY 147

Query: 291 ------ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
                 ALD    M +         IH D+KP N+LLD  G LK++ FG      +  + 
Sbjct: 148 TAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC----MKMDA 194

Query: 345 AKIVFPVSHIDPA---NLYVAPEIYKNE----EFDRSVDAYSFGLILYEMIEGVQPFH 395
             +V      D A     Y++PE+ K++     + R  D +S G+ LYEM+ G  PF+
Sbjct: 195 NGMV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 25/278 (8%)

Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVAKWN-GTKVWVKILDKESHKDPERINAFTH 234
           NP+E         EL  R   G     Y+    N G    +K++  E  +D         
Sbjct: 6   NPQE-------DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQ 55

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ +++  +H N+V + G+  +   + I +E+   G L       G LS S++   + + 
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
            +G+ YLH       +H D+K  NILL + G +K++ FG      +S +    +      
Sbjct: 116 LQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFG------VSAQITATIAKRKSF 166

Query: 355 DPANLYVAPEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
                ++APE+   E    +++  D ++ G+   E+ E   P     P   + LM     
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226

Query: 412 RPP-LKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           +PP LK K + +       ++      P  RP   +++
Sbjct: 227 QPPKLKDKMK-WSNSFHHFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 25/179 (13%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI--VLEYHAKGDLAS----YLQKKGRLSPSKVL 288
           E+ ++ + +H NVV  V    ++    +  + +Y A+ DL      + Q K    P  ++
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 289 RFAL-DLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQYISPE 343
           +  L  +  G++YLH    + ++H DLKP NIL+       G +KI   GL RL + +P 
Sbjct: 111 KSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPL 166

Query: 344 KAKIVFPVSHIDPANL---YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP 398
           K     P++ +DP  +   Y APE+      + +++D ++ G I  E++     F  + 
Sbjct: 167 K-----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 17/177 (9%)

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +ARGM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI 223

Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y  P+   K     P+        ++APE   ++ +    D +SFG++L+E+   G  P+
Sbjct: 224 YKDPDYVRKGDARLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
              P  ++ +  C   K            P++  ++ +CW   P  RP F+E++  L
Sbjct: 277 ---PGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 39/107 (36%), Positives = 53/107 (49%), Gaps = 4/107 (3%)

Query: 53  DPIRRSPVQDEL--TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH 110
            P      ++ +   V   L  T++L  +A  GD  G   LL  G+D N  D DGRT LH
Sbjct: 63  TPDHNLTTEEVIDPVVAHML--TVELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLH 120

Query: 111 IAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
           IA   GHV+VV++LL   A+    D+ G T    A+  G  EV  +L
Sbjct: 121 IACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVVQLL 167

Length = 664

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 68/281 (24%), Positives = 118/281 (41%), Gaps = 25/281 (8%)

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWN-GTKVWVKILDKESHKDPERINAFTHEL 236
           R  P+++    EL  R   G     Y+    + G    VKI+  E   D   I     E+
Sbjct: 4   RRNPQHDY---ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEI 57

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR 296
            +V++ +H N+V + G+      + I +EY   G L       G LS  ++     +  +
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--LQYISPEKAKIVFPVSHI 354
           G+ YLH       +H D+K  NILL + G +K++ FG+       I+  K+ I  P    
Sbjct: 118 GLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTP---- 170

Query: 355 DPANLYVAPEIY---KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
                ++APE+    KN  +++  D ++ G+   E+ E   P     P   + LM     
Sbjct: 171 ----YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF 226

Query: 412 RPPLKIKARS-YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
           +PP K+K ++ +       ++      P  RP    ++  L
Sbjct: 227 QPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 36/157 (22%)

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLL-RL-------------QYISPEKAKIVFPVSHI 354
           +IH D+KP NILLD  G +K+  FG+  RL              Y++PE+         I
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPER---------I 186

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVV-KLMCCEGKR 412
           DP +         N ++D   D +S G+ L E+  G  P+     E EV+ K++  E   
Sbjct: 187 DPPD--------PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238

Query: 413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
            P       + PD    ++ C       RP + E++ 
Sbjct: 239 LPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 19/164 (11%)

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE---KAK 346
           ++  +ARGM +L   K    IH DL  +NILL     +KI  FGL R  Y  P+   K  
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235

Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              P+        ++APE   ++ +    D +SFG++L+E+   G  P+    P   +  
Sbjct: 236 ARLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQINE 284

Query: 406 MCCEGKRPPLKIKARSYP-PDLKELIEECWDPKPVIRPNFNEII 448
             C+  +   +++A     P++  ++  CW   P  RP F+ ++
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 57/248 (22%), Positives = 113/248 (45%), Gaps = 30/248 (12%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIP------MMIVLEYH 267
           +K++D    ++ E       E+ +++K + H N+  + GA  +  P      + +V+E+ 
Sbjct: 46  IKVMDVTEDEEEE----IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC 101

Query: 268 AKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
             G +   ++  KG  L    +     ++ RG+ +LH  K   +IH D+K +N+LL    
Sbjct: 102 GAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENA 158

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-----FDRSVDAYSF 380
           ++K+  FG      +S +  + V   +       ++APE+   +E     +D   D +S 
Sbjct: 159 EVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212

Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           G+   EM EG  P     P   + L+    + PP K+K++ +     + IE C     + 
Sbjct: 213 GITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLS 269

Query: 441 RPNFNEII 448
           RP+  +++
Sbjct: 270 RPSTEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.4 bits (149), Expect = 9e-11
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 13/155 (8%)

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           LTI+     PN+V     +     + +VL++   G L S++ K   +    V R+A ++ 
Sbjct: 37  LTIIPHCV-PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMV 95

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
             ++ LH    + I+  DL P NILLD+ G ++++ F     ++   E +     V    
Sbjct: 96  VALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFS----RWSEVEDSCDGEAVE--- 145

Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
             N+Y APE+    E   + D +S G IL+E++ G
Sbjct: 146 --NMYCAPEVGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 12/160 (7%)

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S +++  +A ++ 
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
            G+ ++H      +++ DLKP NILLD  G ++IS  GL         K K   P + + 
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKK---PHASVG 157

Query: 356 PANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPF 394
             + Y+APE+  K   +D S D +S G +L++++ G  PF
Sbjct: 158 -THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 45/188 (23%), Positives = 74/188 (39%), Gaps = 12/188 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV-GAVTQNIPMMIVLEYHA 268
           G +V +K+L  ++ ++  +   F  E  +  +  HPN+V  +         +  V EY  
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGG 325
              L   L   G L   +  R  L +   +   H      I+H DLKP+NI++       
Sbjct: 63  GRTLREVLAADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHI---DPANLYVAPEIYKNEEFDRSVDAYSFGL 382
             K+  FG+  L     +        +      P   Y APE  + E    + D Y++GL
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPT--YCAPEQLRGEPVTPNSDLYAWGL 177

Query: 383 ILYEMIEG 390
           I  E + G
Sbjct: 178 IFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 2/92 (2%)

Query: 68  ENLDSTM--QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           E+ D  M   LL +A  G+   +E+LL    D +  D  GRT LHIAA +G+ + V +LL
Sbjct: 519 EHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLL 578

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
               N+  RD  G+TA  +A    + +++ IL
Sbjct: 579 KHACNVHIRDANGNTALWNAISAKHHKIFRIL 610

Length = 823

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 58.2 bits (141), Expect = 2e-10
 Identities = 29/50 (58%), Positives = 37/50 (74%), Gaps = 1/50 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           L +A R G++  V+ LL  G+DVN+ D DGRT LH+AA  GH+EVVKLLL
Sbjct: 77  LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 35/225 (15%)

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL---QKKGRLSPSKVL-RFALDLARGM 298
           +HPN++Q +G   + IP ++V EY   GDL SYL   Q   R S   +L R A ++A G+
Sbjct: 53  QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL----LRLQYISPEKAKIVFPVSHI 354
            ++H+      +H DL  +N  L +   +K+  +G+     +  YI  E      P+   
Sbjct: 113 THMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED-DKCVPLR-- 166

Query: 355 DPANLYVAPEIYKN-------EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLM 406
                ++APE+           E  +  + ++ G+ L+E+ E   QP+      EV+  +
Sbjct: 167 -----WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221

Query: 407 CCEGK----RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
             + +    +P L++    Y     E+++ CW   P  R    E+
Sbjct: 222 IKDQQVKLFKPQLEL---PYSERWYEVLQFCWLS-PEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 17/195 (8%)

Query: 209 NGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N  KV+ +KIL+K           F  E  ++    +  +     A      + +V++Y+
Sbjct: 24  NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83

Query: 268 AKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             GDL + L K     P  + RF L ++   ++ +H+      +H D+KP NIL+D  G 
Sbjct: 84  VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 140

Query: 327 LKISGFG-LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-----FDRSVDAYSF 380
           ++++ FG  L+L     E   +   V+   P   Y++PEI +  E     +    D +S 
Sbjct: 141 IRLADFGSCLKLM----EDGTVQSSVAVGTPD--YISPEILQAMEDGKGKYGPECDWWSL 194

Query: 381 GLILYEMIEGVQPFH 395
           G+ +YEM+ G  PF+
Sbjct: 195 GVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 11/195 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           GT V V+I D E+  + E + A  +E+ +    RHPN++      T    + ++  + A 
Sbjct: 25  GTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 270 GDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           G   S L+    +G +S + +        RG+NYLH+   +  IH ++K  +IL+   G 
Sbjct: 84  GSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGL 139

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-YVAPEIYKNEEFDRSV--DAYSFGLI 383
           + +SG   L     + +KAK+V+       + L +++PE+ + + +  +V  D YS G+ 
Sbjct: 140 VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGIT 199

Query: 384 LYEMIEGVQPFHPKP 398
             E+  G  PF    
Sbjct: 200 ACELATGRVPFQDML 214

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 35/200 (17%)

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYL--HECKPDPIIHCDLKPKNILLDNGGQ 326
           +    + + +   LS   ++ F+  +A GM +L    C     +H DL  +N+L+  G  
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC-----VHRDLAARNVLICEGKL 277

Query: 327 LKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFG 381
           +KI  FGL R       YIS  K     P+        ++APE   N  +    D +SFG
Sbjct: 278 VKICDFGLARDIMRDSNYIS--KGSTFLPLK-------WMAPESIFNNLYTTLSDVWSFG 328

Query: 382 LILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP-----DLKELIEECWD 435
           ++L+E+   G  P+   P  E             +K   R   P     ++ E++++CW+
Sbjct: 329 ILLWEIFTLGGTPYPELPMNEQF--------YNAIKRGYRMAKPAHASDEIYEIMQKCWE 380

Query: 436 PKPVIRPNFNEIIARLDRIV 455
            K  IRP+F++++  +  ++
Sbjct: 381 EKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 22/195 (11%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM-- 260
             + +  G KV +K L +    +     A+  EL +++  +H NV+  +   T ++ +  
Sbjct: 33  SALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLDVFTPDLSLDR 91

Query: 261 ----MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
                +V+ +    DL   L K  +LS  ++      + +G+ Y+H      IIH DLKP
Sbjct: 92  FHDFYLVMPFMGT-DLGK-LMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKP 146

Query: 317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSV 375
            N+ ++   +LKI  FGL R Q  S     +V           Y APE+  N   + ++V
Sbjct: 147 GNLAVNEDCELKILDFGLAR-QTDSEMTGYVV--------TRWYRAPEVILNWMHYTQTV 197

Query: 376 DAYSFGLILYEMIEG 390
           D +S G I+ EM+ G
Sbjct: 198 DIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 37/201 (18%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM----- 261
           K     V +K +  E+ K+   I A   E+ I++  +H NVV  +  + +          
Sbjct: 34  KKTKQIVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLI-EICRTKATPYNRYK 91

Query: 262 ----IVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
               +V E+    DLA  L  K  + + S++ +    L  G+ Y+H  K   I+H D+K 
Sbjct: 92  GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKA 147

Query: 317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV---------APEIYK 367
            NIL+   G LK++ FGL R            F +S     N Y           PE+  
Sbjct: 148 ANILITKDGILKLADFGLAR-----------AFSLSKNSKPNRYTNRVVTLWYRPPELLL 196

Query: 368 NE-EFDRSVDAYSFGLILYEM 387
            E ++   +D +  G I+ EM
Sbjct: 197 GERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 20/168 (11%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ---KKGRLSPSKVLRFA 291
           E++++++ +HPN+V     + Q   + ++ E+ +  DL  YL    K   +    V  + 
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL 107

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             + +G+ + H  +   ++H DLKP+N+L+DN G +K++ FGL R   I         PV
Sbjct: 108 YQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI---------PV 155

Query: 352 ---SHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
              +H      Y APE+   +  +   VD +S G I  EM      FH
Sbjct: 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.5 bits (146), Expect = 5e-10
 Identities = 56/248 (22%), Positives = 103/248 (41%), Gaps = 31/248 (12%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K +     +  E+      E+  +++ +HPN +++ G   +     +V+EY   G  
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSA 111

Query: 273 ASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   GQ+K++ 
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLAD 168

Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI---YKNEEFDRSVDAYSFGLILYEMI 388
           FG           A I  P +       ++APE+       ++D  VD +S G+   E+ 
Sbjct: 169 FG----------SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218

Query: 389 EGVQPFHPKPPEEVVKLMC-----CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           E       KPP   +  M       + + P L  ++  +    +  ++ C    P  RP 
Sbjct: 219 E------RKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFRNFVDSCLQKIPQDRPT 270

Query: 444 FNEIIARL 451
             E++  +
Sbjct: 271 SEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 17/203 (8%)

Query: 206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
            K   T V VK ++ +S    E +     E+    + +HPN++ +V +   +  + +V  
Sbjct: 21  HKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79

Query: 266 YHAKG---DLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILL 321
             A G   DL      +G   P   + F L D+   ++Y+H       IH  +K  +ILL
Sbjct: 80  LMAYGSCEDLLKTHFPEGL--PELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILL 134

Query: 322 DNGGQLKISGFGLLRLQYISPEKAKIV--FPVSHIDPANLY-VAPEI-YKN-EEFDRSVD 376
              G++ +SG           ++ ++V  FP S +   NL  ++PE+  +N + ++   D
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NLPWLSPEVLQQNLQGYNEKSD 192

Query: 377 AYSFGLILYEMIEGVQPFHPKPP 399
            YS G+   E+  G  PF   P 
Sbjct: 193 IYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 27/209 (12%)

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K+S ++ E       EL ++   +  N+V+   A  +   + +V EY  K  L    +  
Sbjct: 35  KDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP 94

Query: 280 GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             + P KV  +   L + +++ H+   + I+H D+KP+N+L+ +   LK+  FG  R   
Sbjct: 95  NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFAR--- 148

Query: 340 ISPEKAKIVFPVSHIDPANL--YVAPEIYKNEE------FDRSVDAYSFGLILYEMIEGV 391
                      +S    AN   YVA   Y++ E      + ++VD +S G IL E+ +G 
Sbjct: 149 ----------NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG- 197

Query: 392 QPFHPKPPE--EVVKLMCCEGKRPPLKIK 418
           QP  P   E  ++  +    G  P  ++K
Sbjct: 198 QPLFPGESEIDQLFTIQKVLGPLPAEQMK 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 17/245 (6%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V +K+LDK SH++     +F    +++ +  H ++V   G        ++V EY   G
Sbjct: 28  TEVLLKVLDK-SHRNYSE--SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFG 84

Query: 271 DLASYLQKKGRLSP-SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
            L +YL+K   L   S  L  A  LA  +++L +     + H ++  KN+LL      K 
Sbjct: 85  SLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKT 141

Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMI 388
                ++L    P  +  V P   +     +V PE  +N +    + D +SFG  L+E+ 
Sbjct: 142 GNPPFIKLS--DPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF 199

Query: 389 EGV-QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  +P      ++  KL   E +    ++ A  +  +L  LI +C D +P  RP+F  I
Sbjct: 200 SGGDKPLSALDSQK--KLQFYEDR---HQLPAPKWT-ELANLINQCMDYEPDFRPSFRAI 253

Query: 448 IARLD 452
           I  L+
Sbjct: 254 IRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 18/190 (9%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-C 97

Query: 269 KGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G  +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   G +
Sbjct: 98  LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLV 154

Query: 328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI---YKNEEFDRSVDAYSFGLIL 384
           K+  FG           A I+ P +       ++APE+       ++D  VD +S G+  
Sbjct: 155 KLGDFG----------SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204

Query: 385 YEMIEGVQPF 394
            E+ E   P 
Sbjct: 205 IELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 9/120 (7%)

Query: 281 RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI 340
            LS   V  F   + RG+ YLH      I+H D+KP N+L+++   LKI  FGL R++  
Sbjct: 99  PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE-- 153

Query: 341 SPEKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP 399
            P+++K    ++       Y APEI   +  +  +VD +S G I  E++     F  + P
Sbjct: 154 EPDESKH---MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 51/165 (30%), Positives = 75/165 (45%), Gaps = 21/165 (12%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----------IVLEYHAKGDLASYLQKK-GRLS 283
           E+ I+ +  H N+V     VT     +          +V EY    DL   L+      S
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY-MDHDLMGLLESGLVHFS 114

Query: 284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
              +  F   L  G+NY H+      +H D+K  NILL+N GQ+K++ FGL RL Y S E
Sbjct: 115 EDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARL-YNSEE 170

Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEM 387
                 P ++      Y  PE+   EE +  ++D +S G IL E+
Sbjct: 171 SR----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 35/203 (17%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKARHPNVVQFVGAVT-QNI 258
            G KV +K           +I+ F H         E+ I+ + +H N++  +  +   + 
Sbjct: 29  TGVKVAIK-----------KISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77

Query: 259 PMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                  IV E   + DL   + K   LS   +  F   + RG+ Y+H      ++H DL
Sbjct: 78  ESFNDVYIVQEL-METDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDL 132

Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDR 373
           KP N+LL+    LKI  FGL R+    PE     F   ++     Y APEI  N + + +
Sbjct: 133 KPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTK 189

Query: 374 SVDAYSFGLILYEMIEGVQPFHP 396
           ++D +S G IL EM+   +P  P
Sbjct: 190 AIDIWSVGCILAEMLSN-RPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 72/249 (28%), Positives = 107/249 (42%), Gaps = 37/249 (14%)

Query: 198 ITKGSYQVA-----KWNGTKVWVK-ILDKESH-KDPERINAFTHELTIVEKARHPNVVQF 250
           I KGSY V         G KV +K I D   H  D  RI     E+ ++   RHP++V+ 
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRI---LREIKLLRLLRHPDIVEI 64

Query: 251 VGAVTQNIP-----MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
              +          + +V E   + DL   ++    L+P     F   L R + Y+H   
Sbjct: 65  KHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN 123

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI 365
              + H DLKPKNIL +   +LKI  FGL R+ +     A  +F   ++     Y APE+
Sbjct: 124 ---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA--IFWTDYV-ATRWYRAPEL 177

Query: 366 YKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK---LMC-CEGKRPPLKI-- 417
             +   ++  ++D +S G I  E++ G   F   P + VV    L+    G   P  I  
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF---PGKNVVHQLDLITDLLGTPSPETISR 234

Query: 418 ----KARSY 422
               KAR Y
Sbjct: 235 VRNEKARRY 243

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 46/146 (31%), Positives = 66/146 (45%), Gaps = 18/146 (12%)

Query: 262 IVLEYHAKGDLASYLQKKGR-----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +V EY    DL  ++   GR     L    +  F   L +G+ + H+     ++H DLKP
Sbjct: 83  LVFEY-LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKP 138

Query: 317 KNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI-YKNEEFDRS 374
           +N+L+D   G LKI+  GL R   I P K+      +H      Y APE+   +  +   
Sbjct: 139 QNLLVDKQKGLLKIADLGLGRAFSI-PVKS-----YTHEIVTLWYRAPEVLLGSTHYSTP 192

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPE 400
           VD +S G I  EM    QP  P   E
Sbjct: 193 VDIWSVGCIFAEMSRK-QPLFPGDSE 217

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies)

 Score = 52.7 bits (127), Expect = 2e-09
 Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 1/52 (1%)

Query: 91  LLNEGS-DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           LL  G  D+N+ D +G T LH+AA  G +E+V+ LL    +++ RD  G TA
Sbjct: 1   LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTA 52

Length = 56

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.4 bits (143), Expect = 3e-09
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 38/216 (17%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDLASYLQKK----GRLSPSKVL 288
           E+ ++ + +H N+V+++       N  + I++E+   GDL+  +QK     G++    ++
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 289 RFALDLARGMNYLHECKPDP----IIHCDLKPKNILLDNG----GQL------------- 327
                L   + Y H  K  P    ++H DLKP+NI L  G    G++             
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE--IYKNEEFDRSVDAYSFGLILY 385
           KI  FGL +   I       V           Y +PE  +++ + +D   D ++ G I+Y
Sbjct: 182 KIGDFGLSKNIGIESMAHSCV-------GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           E+  G  PFH        +L+    + P L IK +S
Sbjct: 235 ELCSGKTPFHKA--NNFSQLISELKRGPDLPIKGKS 268

Length = 1021

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 16/150 (10%)

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIH 311
           A      + +V++Y+  GDL + L K     P  + RF L ++   ++ +H+      +H
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVH 125

Query: 312 CDLKPKNILLDNGGQLKISGFG-LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
            D+KP N+LLD  G ++++ FG  LRL         +   V+   P   Y++PEI +  E
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLL----ADGTVQSNVAVGTPD--YISPEILQAME 179

Query: 371 -----FDRSVDAYSFGLILYEMIEGVQPFH 395
                +    D +S G+ +YEM+ G  PF+
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 56.8 bits (136), Expect = 3e-09
 Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 3/77 (3%)

Query: 88  VEDLLNEGS---DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD 144
            + LL  G+     N  D DG T LH AA  G  ++V+LLL   A+ ++R+ +G TA   
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186

Query: 145 AKYYGNVEVYNILKARG 161
           A   G +E+  +L  +G
Sbjct: 187 AAKNGRIELVKLLLDKG 203

Length = 235

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 52.2 bits (126), Expect = 3e-09
 Identities = 26/54 (48%), Positives = 34/54 (62%), Gaps = 1/54 (1%)

Query: 73  TMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
               L  A   G ++ V+ LL +G D+N  D DG TALHIAA  G++EV+KLLL
Sbjct: 1   GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54

Length = 54

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 14/142 (9%)

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKN 318
           + +V++Y+  GDL + L K     P  + RF + ++   ++ +H+      +H D+KP N
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDN 132

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-----FDR 373
           +LLD  G ++++ FG   L+       +    V   D    Y++PEI +  E     +  
Sbjct: 133 VLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPD----YISPEILQAMEDGMGKYGP 187

Query: 374 SVDAYSFGLILYEMIEGVQPFH 395
             D +S G+ +YEM+ G  PF+
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 67/229 (29%), Positives = 100/229 (43%), Gaps = 32/229 (13%)

Query: 235 ELTIVEKARH-PNVVQFVGAVTQN----IPM--M-IVLEYHAKGDLASYLQKKGRLSPSK 286
           +L +V ++   P +V+F GA+ +     I M  M I L+   K     Y   K  +    
Sbjct: 52  DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYK---YVYEVLKSVIPEEI 108

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           + + A+   + +NYL E     IIH D+KP NILLD  G +K+  FG      IS    +
Sbjct: 109 LGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFG------IS---GQ 157

Query: 347 IVFPVSHIDPANL--YVAPEIYKNEEFD----RSVDAYSFGLILYEMIEGVQPFHPKPPE 400
           +V  ++    A    Y+APE       D    RS D +S G+ LYE+  G  P+ PK   
Sbjct: 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRS-DVWSLGITLYEVATGKFPY-PKWNS 215

Query: 401 EVVKL-MCCEGKRPPLK-IKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
              +L    +G  P L   + R + P     I  C       RP + E+
Sbjct: 216 VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 51.1 bits (123), Expect = 8e-09
 Identities = 27/56 (48%), Positives = 34/56 (60%), Gaps = 6/56 (10%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNIL 157
           GRTALH AA  G +E+VK LL K  +I+  D  G+TA   AA     GN+EV  +L
Sbjct: 1   GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAA---ENGNLEVLKLL 53

Length = 54

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 56/245 (22%), Positives = 100/245 (40%), Gaps = 31/245 (12%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK +     +  E+      E+  +++ +HPN +++ G   +     +V+EY   G  
Sbjct: 49  VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSA 107

Query: 273 ASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   GQ+K++ 
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLAD 164

Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI---YKNEEFDRSVDAYSFGLILYEMI 388
           FG           A    P +       ++APE+       ++D  VD +S G+   E+ 
Sbjct: 165 FG----------SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214

Query: 389 EGVQPFHPKPPEEVVKLMC-----CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           E       KPP   +  M       +   P L  ++  +    +  ++ C    P  RP 
Sbjct: 215 E------RKPPLFNMNAMSALYHIAQNDSPTL--QSNEWTDSFRGFVDYCLQKIPQERPA 266

Query: 444 FNEII 448
             E++
Sbjct: 267 SAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.2 bits (138), Expect = 9e-09
 Identities = 49/191 (25%), Positives = 93/191 (48%), Gaps = 14/191 (7%)

Query: 256 QNIPMM-IVLEYHAKGDLASYLQKKGRLS-PSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           +N+ M+ +VL+Y   GDL   ++ + + +   +     L   + +  +H      +IH D
Sbjct: 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168

Query: 314 LKPKNILLDNGGQLKISGFGLLRL--QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
           +K  NILL + G +K+  FG  ++    +S +  +      +      YVAPEI++ + +
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY------YVAPEIWRRKPY 222

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
            +  D +S G++LYE++   +PF  +  EEV+      G+  PL     S  P+++E++ 
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENMEEVMH-KTLAGRYDPL---PPSISPEMQEIVT 278

Query: 432 ECWDPKPVIRP 442
                 P  RP
Sbjct: 279 ALLSSDPKRRP 289

Length = 496

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 13/217 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS---PSKVLRFA 291
           EL  +    H  +V+       +  +++++EY + GDL    Q K RL    P +     
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK--QIKQRLKEHLPFQEYEVG 172

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
           L   + +  L E     ++H DLK  NI L   G +K+  FG  + QY       +    
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVA--- 228

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
           S       Y+APE+++ + + +  D +S G+ILYE++   +PF      E+++     GK
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ-QVLYGK 287

Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
             P      S    +K L++      P +RP   +++
Sbjct: 288 YDPFPCPVSS---GMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 27/195 (13%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--------------VGAVTQN 257
           +V VK   K    DP+ +     E+ I+ +  H N+V+               VG++T+ 
Sbjct: 32  RVAVK---KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88

Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             + IV EY  + DLA+ L++ G LS      F   L RG+ Y+H      ++H DLKP 
Sbjct: 89  NSVYIVQEY-METDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143

Query: 318 NILLDNGG-QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI-YKNEEFDRSV 375
           N+ ++     LKI  FGL R+  + P  +   + +S       Y +P +      + +++
Sbjct: 144 NVFINTEDLVLKIGDFGLARI--VDPHYSHKGY-LSEGLVTKWYRSPRLLLSPNNYTKAI 200

Query: 376 DAYSFGLILYEMIEG 390
           D ++ G I  EM+ G
Sbjct: 201 DMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 31/183 (16%)

Query: 282 LSPSKVLRFALDLARGMNYL--HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--- 336
           L    +LRF+  +A+GM++L    C     IH D+  +N+LL +G   KI  FGL R   
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC-----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263

Query: 337 --LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQP 393
               Y+    A++  PV        ++APE   +  +    D +S+G++L+E+   G  P
Sbjct: 264 NDSNYVVKGNARL--PVK-------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Query: 394 FHPKPPEEVVKLMCCEG---KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           +           M   G    RP         PP++  +++ CW+ +P  RP F++I   
Sbjct: 315 YPGILVNSKFYKMVKRGYQMSRPDFA------PPEIYSIMKMCWNLEPTERPTFSQISQL 368

Query: 451 LDR 453
           + R
Sbjct: 369 IQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 46/209 (22%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-D 293
           E  I+ +A +  VV+   +      +  V++Y   GD+ S L + G + P  + RF + +
Sbjct: 51  ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAE 109

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL---LRLQYIS--------P 342
           L   +  +H+      IH D+KP NIL+D  G +K++ FGL    R  + S         
Sbjct: 110 LTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Query: 343 EKAKIVFPVSHIDPANL------------------------------YVAPEIYKNEEFD 372
            +  + F     DPAN                               Y+APE+     + 
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226

Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
           +  D +S G+ILYEM+ G  PF  + P E
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLE 255

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 41/209 (19%)

Query: 201 GSY-QVAK----WNGTKVWVKILDK--ESHKDPERINAFTHELTIVEKARHPNVVQFVGA 253
           G+Y QV        G KV +K L +  +S    +R      EL +++   H NV+  +  
Sbjct: 26  GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMDHENVIGLLDV 82

Query: 254 VTQNIPMM----IVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
            T    +     + L  H  G DL + + K  +LS   +      + RG+ Y+H      
Sbjct: 83  FTPASSLEDFQDVYLVTHLMGADLNNIV-KCQKLSDDHIQFLVYQILRGLKYIHSAG--- 138

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVA 362
           IIH DLKP NI ++   +LKI  FGL R        Y++                  Y A
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA---------------TRWYRA 183

Query: 363 PEIYKNE-EFDRSVDAYSFGLILYEMIEG 390
           PEI  N   ++++VD +S G I+ E++ G
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 24/179 (13%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----- 336
           L+   +L F   +ARGM +L        +H DL  +N+LL  G  +KI  FGL R     
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFH 395
             Y+S  K     PV        ++APE   +  +    D +S+G++L+E+   G  P+ 
Sbjct: 291 SNYVS--KGSTFLPVK-------WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY- 340

Query: 396 PKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF---NEIIARL 451
             P   V      + K      K      ++ +++ +CW+ +P  RP+F   ++I+  L
Sbjct: 341 --PGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|197603 smart00248, ANK, ankyrin repeats

 Score = 49.1 bits (118), Expect = 3e-08
 Identities = 20/30 (66%), Positives = 25/30 (83%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           DGRT LH+AA  G++EVVKLLL K A+I+A
Sbjct: 1   DGRTPLHLAAENGNLEVVKLLLDKGADINA 30

Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 23/200 (11%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ----FVGAVTQN--I 258
           + K  G KV +K L +    +     A+  ELT+++  +H NV+     F  AV+ +   
Sbjct: 35  IDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93

Query: 259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
              +V+ Y  + DL   +     LS  KV      +  G+ Y+H      IIH DLKP N
Sbjct: 94  DFYLVMPY-MQTDLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGN 147

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDA 377
           + ++   +LKI  FGL R  +   E    V           Y APE+  N   ++++VD 
Sbjct: 148 LAVNEDCELKILDFGLAR--HADAEMTGYVV-------TRWYRAPEVILNWMHYNQTVDI 198

Query: 378 YSFGLILYEMIEGVQPFHPK 397
           +S G I+ EM+ G   F  K
Sbjct: 199 WSVGCIMAEMLTGKTLFKGK 218

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 17/161 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 66  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 126 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 178

Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEG 390
                    Y APEI  N   ++++VD +S G I+ E++ G
Sbjct: 179 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 54.1 bits (131), Expect = 4e-08
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 26/154 (16%)

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-ASYLQKKGRLSPSKVLRFAL-DLARGMNY 300
            HPN+V+      +N  +  V EY  +G+L      +KG+     V+R  +  + +G+ +
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEY-MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY 360
           +H+       H DLKP+N+L+     +KI+ FGL R              +    P   Y
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR-------------EIRSRPPYTDY 158

Query: 361 V------APEIY-KNEEFDRSVDAYSFGLILYEM 387
           V      APEI  ++  +   VD ++ G I+ E+
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 63/261 (24%), Positives = 111/261 (42%), Gaps = 53/261 (20%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K L K+   +  ++     E  I+ +A +  VV+   +      +  V++Y   GD+ S
Sbjct: 31  MKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS 90

Query: 275 YLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            L +   + P  + RF + +L   +  +H+      IH D+KP NIL+D  G +K++ FG
Sbjct: 91  LLIRME-VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 334 LLRLQYISPEKAKIVFPVSHI-----DPANL----------------------------- 359
           L    +     +K     SHI     +P++L                             
Sbjct: 147 LCT-GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA 205

Query: 360 --------YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEG 410
                   Y+APE+   + + +  D +S G+IL+EM+ G  PF  P P E  +K++  E 
Sbjct: 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN 265

Query: 411 K-RPPLKIKARSYPPDLKELI 430
               P ++K     P+  +LI
Sbjct: 266 TLHIPPQVK---LSPEAVDLI 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 38/202 (18%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY-- 266
               V +K +     +  E+      E+  +++ RHPN +++ G   +     +V+EY  
Sbjct: 39  TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            +  D+    +K   L   ++        +G+ YLH  +    IH D+K  NILL   G 
Sbjct: 99  GSASDILEVHKKP--LQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGT 153

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV------APEI---YKNEEFDRSVDA 377
           +K++ FG           A +V       PAN +V      APE+       ++D  VD 
Sbjct: 154 VKLADFG----------SASLV------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 378 YSFGLILYEMIEGVQPFHPKPP 399
           +S G+   E+ E       KPP
Sbjct: 198 WSLGITCIELAE------RKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 30/135 (22%), Positives = 52/135 (38%), Gaps = 22/135 (16%)

Query: 69  NLDSTMQLLFMACRG--DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE-VVKLLL 125
               T   L++          V  LL  G+DVN+ +  G T LH+         V+KLL+
Sbjct: 45  EYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLI 104

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVE----VYNILKARGAKVPKTKRTPMTVANPREVP 181
              A+++A+D+ G T      Y         V  +L  +G             A+   + 
Sbjct: 105 KAGADVNAKDKVGRTPL--HVYLSGFNINPKVIRLLLRKG-------------ADVNALD 149

Query: 182 EYELNPLELQVRKAD 196
            Y + PL + ++  +
Sbjct: 150 LYGMTPLAVLLKSRN 164

Length = 471

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 23/58 (39%), Positives = 37/58 (63%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           L   A R D+  +++LL +G +V+S D  G TAL +A  E HV++V+LL+   A++D 
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDK 683

Length = 823

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 15/170 (8%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS--PSKVLRFAL 292
           E++++++ +H N+V+    V     + +V EY    DL  ++      +  P  +  +  
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-LDLDLKKHMDSSPDFAKNPRLIKTYLY 109

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPV 351
            + RG+ Y H  +   ++H DLKP+N+L+D     LK++ FGL R   I       V   
Sbjct: 110 QILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP------VRTF 160

Query: 352 SHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE 400
           +H      Y APEI   +  +   VD +S G I  EM+   +P  P   E
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ-KPLFPGDSE 209

Length = 294

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 48/182 (26%), Positives = 89/182 (48%), Gaps = 13/182 (7%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L+ E  K  ++I A   E+ ++++ RH N+V  +    +   + +V E+     L   
Sbjct: 33  KFLESEDDKMVKKI-AM-REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL 90

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            +    L  S+V ++   + RG+ + H      IIH D+KP+NIL+   G +K+  FG  
Sbjct: 91  EKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFA 147

Query: 336 RLQYISPEKAKIVFPVSHIDPANLYVAPE-IYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
           R    +P +    +  +       Y APE +  + ++ R+VD ++ G ++ EM+ G +P 
Sbjct: 148 RT-LAAPGEVYTDYVATR-----WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG-EPL 200

Query: 395 HP 396
            P
Sbjct: 201 FP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 52/215 (24%), Positives = 82/215 (38%), Gaps = 58/215 (26%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E  ++ ++  P VV    +      + +++E+   GDL + L K    S   V RF    
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS-EDVTRF---- 105

Query: 295 ARGMNYLHEC--KPDPI-----IHCDLKPKNILLDNGGQLKISGFGLL--------RLQY 339
                Y+ EC    + +     IH D+KP NIL+D GG +K+S FGL            Y
Sbjct: 106 -----YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160

Query: 340 ISPEKAKIVFPVSH------IDPANL---------------------------YVAPEIY 366
               + K             +D  NL                           Y+APEI+
Sbjct: 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220

Query: 367 KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
             + + +  D +S G I++E + G  PF  +   E
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 73/256 (28%), Positives = 109/256 (42%), Gaps = 35/256 (13%)

Query: 198 ITKGSY----QVA-KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I KG+Y    +V  K +G+   VKILD  S  D E I A   E  I++    HPNVV+F 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEA---EYNILQSLPNHPNVVKFY 85

Query: 252 GAVTQNI-----PMMIVLEYHAKG---DLASYLQKKGRLSPSKVLRFALDLAR-GMNYLH 302
           G   +        + +VLE    G   +L   L   G+     ++ + L  A  G+ +LH
Sbjct: 86  GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVA 362
               + IIH D+K  NILL   G +K+  FG +  Q  S    ++    S   P   ++A
Sbjct: 146 N---NRIIHRDVKGNNILLTTEGGVKLVDFG-VSAQLTS---TRLRRNTSVGTP--FWMA 196

Query: 363 PEIYKNEE-----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
           PE+   E+     +D   D +S G+   E+ +G  P     P  V  L       PP  +
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKIPRNPPPTLL 254

Query: 418 KARSYPPDLKELIEEC 433
               +       I +C
Sbjct: 255 HPEKWCRSFNHFISQC 270

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 3/76 (3%)

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           +V+EY   GD+ S L   G       +++  ++A  ++YLH      IIH DLKP N+L+
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLI 137

Query: 322 DNGGQLKISGFGLLRL 337
            N G +K++ FGL ++
Sbjct: 138 SNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 11/108 (10%)

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           F   L RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R         K  F
Sbjct: 113 FLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-----TTSEKGDF 164

Query: 350 PVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHP 396
              ++     Y APE+  N  E+  ++D +S G I  E++ G +P  P
Sbjct: 165 MTEYV-VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 19/162 (11%)

Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     +N   + ++      DL + + K  +LS   V  
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-KCQKLSDEHVQF 122

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R      E    V 
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYV- 176

Query: 350 PVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEG 390
                     Y APEI  N   ++++VD +S G I+ E+++G
Sbjct: 177 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 44/224 (19%)

Query: 191 QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV-- 248
           + ++ DG  +  Y + +  GT + +               +   E+ ++ + +HPNV+  
Sbjct: 19  KAKRKDGKDEKEYALKQIEGTGISM---------------SACREIALLRELKHPNVIAL 63

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDL--------ASYLQKKGRLSPSKVLRFAL-DLARGMN 299
           Q V     +  + ++ +Y A+ DL        AS   KK    P  +++  L  +  G++
Sbjct: 64  QKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 300 YLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
           YLH    + ++H DLKP NIL+       G++KI+  G  RL + SP K     P++ +D
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLK-----PLADLD 173

Query: 356 PANL---YVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFH 395
           P  +   Y APE+      + +++D ++ G I  E++     FH
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 18/107 (16%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA--CEGHVEVVKLLLSKKANI 131
           +             VE LL+ G++VN  + DG   LH+     +  ++++KLL+ K  +I
Sbjct: 110 LLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDI 169

Query: 132 DARDR----------------WGSTAAADAKYYGNVEVYNILKARGA 162
           +A++R                +G T    A Y  N E    L   GA
Sbjct: 170 NAKNRVNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGA 216

Length = 422

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 27/179 (15%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY-HAKGDL--------ASYLQKKGRLSPS 285
           E+ ++ + +HPNV+        +    + L + +A+ DL        AS   KK    P 
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107

Query: 286 KVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQYI 340
            +++  L  +  G++YLH    + ++H DLKP NIL+       G++KI+  G  RL + 
Sbjct: 108 GMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FN 163

Query: 341 SPEKAKIVFPVSHIDPANL---YVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFH 395
           SP K     P++ +DP  +   Y APE+      + +++D ++ G I  E++     FH
Sbjct: 164 SPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 16/177 (9%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
            KV VK +     K P R      E+ I++   H  ++  + A  +    + ++    K 
Sbjct: 120 KKVIVKAVTG--GKTPGR------EIDILKTISHRAIINLIHAY-RWKSTVCMVMPKYKC 170

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           DL +Y+ + G L   + +     L   + YLH      IIH D+K +NI LD      + 
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLG 227

Query: 331 GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
            FG        P+  +       ++      +PE+   + +    D +S GL+L+EM
Sbjct: 228 DFGAACKLDAHPDTPQCYGWSGTLETN----SPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 50.3 bits (121), Expect = 9e-07
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 21/106 (19%)

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L + + Y+H      +IH DLKP NILL++  ++K++ FGL R   +S  +     PV  
Sbjct: 116 LLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPENPV-- 168

Query: 354 IDPANL--YVA------PEI-YKNEEFDRSVDAYSFGLILYEMIEG 390
                L  YVA      PEI   +  + + VD +S G IL EM+ G
Sbjct: 169 -----LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 49.1 bits (116), Expect = 1e-06
 Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 8/102 (7%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA-----CEGHVEVVKL 123
           +LD  + L   A +GD K V+ LL  G+DVN+ D DG T LH+AA      EG++EV KL
Sbjct: 70  DLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKL 129

Query: 124 LLSKKA---NIDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
           LL   A     + RD  G+T    A   G+ ++  +L   GA
Sbjct: 130 LLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGA 171

Length = 235

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 34/94 (36%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   F ++    
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 179

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
              Y APE+     +  +VD +S G I+ EMI G
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 28/72 (38%), Positives = 42/72 (58%), Gaps = 3/72 (4%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N  +V VK+L   +H D ER  A   EL I+    +H N+V  +GA T   P++++ EY 
Sbjct: 67  NVLRVAVKMLKASAHTD-ER-EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYC 124

Query: 268 AKGDLASYLQKK 279
             GDL ++L+KK
Sbjct: 125 CYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 33/122 (27%), Positives = 56/122 (45%), Gaps = 9/122 (7%)

Query: 51  SLDPIRRSPVQDELTVPENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTAL 109
            +  I+   ++D+L         +  L++A    ++  V+ LL+ G+D+NS   +  T L
Sbjct: 14  KVKNIKYIIMEDDLNDYSYKKPVL-PLYLAKEARNIDVVKILLDNGADINSSTKNNSTPL 72

Query: 110 HIAACEGHV-----EVVKLLLSKKANIDARDRWGST--AAADAKYYGNVEVYNILKARGA 162
           H  +   +      E+VKLLL   AN++A D  G T    A +K   +  +   L   GA
Sbjct: 73  HYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGA 132

Query: 163 KV 164
            V
Sbjct: 133 NV 134

Length = 422

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 10/94 (10%)

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   F ++    
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TACTNFMMTPYVV 184

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
              Y APE+     +  +VD +S G I+ E+++G
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat

 Score = 43.4 bits (103), Expect = 3e-06
 Identities = 17/30 (56%), Positives = 23/30 (76%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           DG T LH+AA  G++E+VKLLL   A+I+A
Sbjct: 1   DGNTPLHLAARNGNLELVKLLLEHGADINA 30

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 20/156 (12%)

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNY 300
           K +HPN+V+ +G         ++ EY    +L+  L+    LS  +  + A+ +A+ + +
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRF 795

Query: 301 LH-ECKPDPIIHCDLKPKNILLDNGGQ--LKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
           LH  C P  ++  +L P+ I++D   +  L++S  GLL       +    +        +
Sbjct: 796 LHCRCSPA-VVVGNLSPEKIIIDGKDEPHLRLSLPGLLCT-----DTKCFI--------S 841

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           + YVAPE  + ++     D Y FGLIL E++ G  P
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 26/83 (31%), Positives = 38/83 (45%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V  LL+ G  +N  D+ G T LH A    + E VK LL   AN +  +++G T    A  
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234

Query: 148 YGNVEVYNILKARGAKVPKTKRT 170
             N E++ +L   G  +     T
Sbjct: 235 NNNKEIFKLLLNNGPSIKTIIET 257

Length = 422

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 33/182 (18%)

Query: 222 SHKD-PERI-------NAFTHELTIVEKARHPNV-----VQFVGAVTQNIPMMIVLEYHA 268
           SH D P+R+        +  HE  ++ +  HP V     V+ VG +T     +++ +Y +
Sbjct: 189 SHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKYRS 244

Query: 269 KGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
             DL +YL  + R L  ++V   A  L   ++Y+H    + IIH D+K +N+L++    +
Sbjct: 245 --DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDI 299

Query: 328 KISGFG---LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL 384
            +  FG     R  + +P    I   V      N   APE+   + +  SVD +S GL++
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVD----TN---APEVLAGDPYTPSVDIWSAGLVI 352

Query: 385 YE 386
           +E
Sbjct: 353 FE 354

Length = 461

>gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 27/113 (23%)

Query: 49  QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD-------------VKGVEDLLN-- 93
            +  D + RS +       ENL+ T  LL ++CRG              V  VE +L   
Sbjct: 45  INCPDRLGRSALFVAAIENENLELTELLLNLSCRGAVGDTLLHAISLEYVDAVEAILLHL 104

Query: 94  ----EGSD----VNSIDLD----GRTALHIAACEGHVEVVKLLLSKKANIDAR 134
                 S      N         G TALH+AA   + E+VKLLL + A++ AR
Sbjct: 105 LAAFRKSGPLELANDQYTSEFTPGITALHLAAHRQNYEIVKLLLERGASVPAR 157

The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 36/123 (29%), Positives = 59/123 (47%), Gaps = 5/123 (4%)

Query: 82  RGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           +GD++ ++ L   G+DVN  D +G   +HIA      +++KLLL K A  + +D  G + 
Sbjct: 134 KGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESP 193

Query: 142 AADAKYYGNVEVYNILKARGAKVP-KTKR--TPMTVA--NPREVPEYELNPLELQVRKAD 196
             +A  YG+     +L   G  +  K K   TP+  A  + R   E  +N   +  +  D
Sbjct: 194 LHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIHNRSAIELLINNASINDQDID 253

Query: 197 GIT 199
           G T
Sbjct: 254 GST 256

Length = 434

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 10/94 (10%)

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   F ++    
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 187

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
              Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 42/192 (21%), Positives = 81/192 (42%), Gaps = 33/192 (17%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP--MMIVLEY 266
            G    +K + K+  K  E++N       +   + HPN+++ +  +       + +V E 
Sbjct: 23  TGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81

Query: 267 HAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
               D+  Y   KGR   L   +V  +   L + ++++H      I H D+KP+NIL+ +
Sbjct: 82  M---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD 135

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-------FDRSVD 376
              LK++ FG  R  Y  P             P   Y++   Y+  E       +   +D
Sbjct: 136 -DILKLADFGSCRGIYSKP-------------PYTEYISTRWYRAPECLLTDGYYGPKMD 181

Query: 377 AYSFGLILYEMI 388
            ++ G + +E++
Sbjct: 182 IWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 17/205 (8%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I +GSY V      +  G  V +K    ES  DP        E+ ++++ +HPN+V  + 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
              +   + +V EY     L    +    +    + +      + +N+ H+      IH 
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHR 124

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE-IYKNEEF 371
           D+KP+NIL+   GQ+K+  FG  R+  ++         V+       Y APE +  + ++
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVA----TRWYRAPELLVGDTQY 178

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHP 396
              VD ++ G +  E++ G QP  P
Sbjct: 179 GPPVDVWAIGCVFAELLTG-QPLWP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 16/146 (10%)

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGL-LRLQYISPEKAKIVFPVSHIDPANL-------- 359
           ++H DLKP NILL   G++ I  +G  +  +    +   I     +I  +++        
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193

Query: 360 ---YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
              Y+APE         S D Y+ G+ILY+M+    P+  K      K+   +    P++
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR---KISYRDVILSPIE 250

Query: 417 IKA-RSYPPDLKELIEECWDPKPVIR 441
           +   R  PP L ++  +     P  R
Sbjct: 251 VAPYREIPPFLSQIAMKALAVDPAER 276

Length = 932

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 23/162 (14%)

Query: 235 ELTIVEKARHPNVVQFVGAVT--------QNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           EL +++   H N++  +   T        Q++ +++ L      +L   +Q +  L   +
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL---MDANLCQVIQME--LDHER 120

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           +      +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A 
Sbjct: 121 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAG 170

Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
             F ++       Y APE+     +  +VD +S G I+ EM+
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 28/193 (14%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVV--------QFVGAVTQNIPMMIVLEYH 267
           K+  K+  +DP+  N    EL I++   H N++        +      +NI + +V+E+ 
Sbjct: 93  KVAIKKVLQDPQYKN---RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149

Query: 268 AKGDLASYLQKKGRLSPSK----VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD- 322
            +  +  Y++   R + +     V  ++  L R + Y+H      I H DLKP+N+L+D 
Sbjct: 150 PQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDP 205

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY-KNEEFDRSVDAYSFG 381
           N   LK+  FG  +   ++ +++     VS+I  +  Y APE+      +   +D +S G
Sbjct: 206 NTHTLKLCDFGSAK-NLLAGQRS-----VSYI-CSRFYRAPELMLGATNYTTHIDLWSLG 258

Query: 382 LILYEMIEGVQPF 394
            I+ EMI G   F
Sbjct: 259 CIIAEMILGYPIF 271

Length = 440

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 21/81 (25%), Positives = 39/81 (48%)

Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN 150
           L+  G+D +  + D  + LH+A   G ++ ++LL+  KA +D  D  G T    A   G+
Sbjct: 121 LIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGD 180

Query: 151 VEVYNILKARGAKVPKTKRTP 171
           + +  +L   GA +    +  
Sbjct: 181 IAICKMLLDSGANIDYFGKNG 201

Length = 413

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 62/250 (24%), Positives = 107/250 (42%), Gaps = 32/250 (12%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +V +K+LD  SH+D     AF    +++ +  H ++    G   +    ++V E+   G 
Sbjct: 46  RVVLKVLDP-SHRDIAL--AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGP 102

Query: 272 LASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---- 326
           L   L+K KGR+  +  +  A  LA  ++YL +     ++H ++  KNILL   G     
Sbjct: 103 LDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGT 159

Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGL 382
              +K+S  G+     +S E+     P         ++APE          + D +SFG 
Sbjct: 160 SPFIKLSDPGV-SFTALSREERVERIP---------WIAPECVPGGNSLSTAADKWSFGT 209

Query: 383 ILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
            L E+  +G  P   + P E  +    + + P           +L  LI +C   +P  R
Sbjct: 210 TLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSC------KELATLISQCLTYEPTQR 263

Query: 442 PNFNEIIARL 451
           P+F  I+  L
Sbjct: 264 PSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 2/100 (2%)

Query: 66  VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
              +  +T  L +     D +  E LL+ G++VN  D    + LH A    +  +V +LL
Sbjct: 163 KDRHKGNT-ALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILL 221

Query: 126 SKKANIDARDRWGSTAAADA-KYYGNVEVYNILKARGAKV 164
              A+ DARD+ G+T    +  Y  + ++  +L   G  V
Sbjct: 222 ENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDV 261

Length = 477

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 12/93 (12%)

Query: 55  IRRSPVQDELTVPE------------NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID 102
           I+    QDEL + E            ++     + + A RG+ K V  LL+ G+DVN I 
Sbjct: 149 IKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVNIIA 208

Query: 103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LD  + L  A    +++ +K ++  ++NI+  D
Sbjct: 209 LDDLSVLECAVDSKNIDTIKAIIDNRSNINKND 241

Length = 682

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 42.3 bits (100), Expect = 5e-04
 Identities = 19/56 (33%), Positives = 32/56 (57%), Gaps = 6/56 (10%)

Query: 84  DVKGVEDLLNEGSDVNSIDLDGRTALHI----AACEGHVEVVKLLLSKKANIDARD 135
           + K +  LL +G+DVN++DL G T L +          VE+++LL+   A++ A D
Sbjct: 131 NPKVIRLLLRKGADVNALDLYGMTPLAVLLKSRNAN--VELLRLLIDAGADVYAVD 184

Length = 471

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 1/95 (1%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK 128
           N D    L      GD+KG+E L++  + ++  D  G T L IA  +G + + K+LL   
Sbjct: 132 NTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSG 191

Query: 129 ANIDARDRWGSTAAADAKYYGN-VEVYNILKARGA 162
           ANID   + G  AA       N +++  +   RGA
Sbjct: 192 ANIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGA 226

Length = 413

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 2/99 (2%)

Query: 68  ENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTALHIAAC-EGHVEVVKLLL 125
           +N+     L  MA  G D + +  L+  G+DVN+ D    T LH A+  + + ++V  LL
Sbjct: 303 KNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLL 362

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
              AN++ARD    T    A    NV + N L   GA +
Sbjct: 363 ELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADI 401

Length = 682

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 1/52 (1%)

Query: 82  RGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAACEGHVEVVKLLLSKKANID 132
            GDVK VE+LL+ G   + +   DG T LH+A     ++++KLL+++ A+ D
Sbjct: 78  EGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPD 129

Length = 413

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 27/68 (39%), Positives = 39/68 (57%), Gaps = 3/68 (4%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L K + +  E+  A   EL I+     H N+V  +GA T++ P+ I+ EY   G
Sbjct: 69  KVAVKML-KPTARSSEK-QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYG 126

Query: 271 DLASYLQK 278
           DL +YL K
Sbjct: 127 DLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 26/68 (38%), Positives = 37/68 (54%), Gaps = 3/68 (4%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L K + +  E+  A   EL I+     H N+V  +GA T+  P+ I+ EY   G
Sbjct: 69  KVAVKML-KSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYG 126

Query: 271 DLASYLQK 278
           DL  YL +
Sbjct: 127 DLVDYLHR 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 39.8 bits (92), Expect = 0.002
 Identities = 26/55 (47%), Positives = 31/55 (56%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A   GD   VE LL  G+D NS +  G TAL  AA  G +E+VKLLL K  +
Sbjct: 151 LHWAALNGDADIVELLLEAGADPNSRNSYGVTALDPAAKNGRIELVKLLLDKGLH 205

Length = 235

>gnl|CDD|222925 PHA02743, PHA02743, Viral ankyrin protein; Provisional

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 6/94 (6%)

Query: 75  QLLFMACRGDVKG----VEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSK-K 128
           Q   M    D       +E L+N G+D+N+ +L  G T LHIAA   + E+ + L  +  
Sbjct: 59  QCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLG 118

Query: 129 ANIDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
            N+ A +    TA   A    +  +  IL+A GA
Sbjct: 119 VNLGAINYQHETAYHIAYKMRDRRMMEILRANGA 152

Length = 166

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.5 bits (90), Expect = 0.002
 Identities = 33/167 (19%), Positives = 55/167 (32%), Gaps = 33/167 (19%)

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            L     +  LH            K  NILL   G LK+ G                  P
Sbjct: 23  CLQCLGALRELHRQA---------KSGNILLTWDGLLKLDGS------------VAFKTP 61

Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP-----EEVVKL 405
                P   ++APE+ + + +    D YS G+ LYE ++   P++ +       E ++  
Sbjct: 62  EQSR-PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120

Query: 406 MC---CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
           M       +     + A       ++ +  C    P  R   N  +A
Sbjct: 121 MPADDPRDRSNLEGVSAA---RSFEDFMRLCASRLPQRREAANHYLA 164

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 39.0 bits (90), Expect = 0.003
 Identities = 31/122 (25%), Positives = 49/122 (40%), Gaps = 5/122 (4%)

Query: 47  GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR 106
                L  +      D     +   +    L +     +  +   L     + + DLDGR
Sbjct: 15  FLDLLLVALLLLLSLDLSNPSDKKLNLYLELALLPAASLSELLLKLIVDRHLAARDLDGR 74

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA-----AADAKYYGNVEVYNILKARG 161
             LH AA +G  ++VKLLL+  A+++A+D  G T             GN+EV  +L   G
Sbjct: 75  LPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAG 134

Query: 162 AK 163
           A 
Sbjct: 135 AD 136

Length = 235

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	473
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.93
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PHA02743	166	Viral ankyrin protein; Provisional	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
KOG0508	615	consensus Ankyrin repeat protein [General function	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
PHA02791	284	ankyrin-like protein; Provisional	99.84
PHA02791	284	ankyrin-like protein; Provisional	99.84
PHA02875	413	ankyrin repeat protein; Provisional	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.83
PHA02859	209	ankyrin repeat protein; Provisional	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PHA02859	209	ankyrin repeat protein; Provisional	99.82
PHA02741	169	hypothetical protein; Provisional	99.81
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.8
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.8
KOG0508	615	consensus Ankyrin repeat protein [General function	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
PHA02878	477	ankyrin repeat protein; Provisional	99.79
PHA02875	413	ankyrin repeat protein; Provisional	99.79
PHA02736	154	Viral ankyrin protein; Provisional	99.79
PHA02878	477	ankyrin repeat protein; Provisional	99.79
PHA02795	437	ankyrin-like protein; Provisional	99.78
PHA02884	300	ankyrin repeat protein; Provisional	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
PHA02874	434	ankyrin repeat protein; Provisional	99.78
PHA02874	434	ankyrin repeat protein; Provisional	99.78
PRK10345	210	hypothetical protein; Provisional	99.78
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.77
PHA03095	471	ankyrin-like protein; Provisional	99.76
KOG0505	527	consensus Myosin phosphatase, regulatory subunit [	99.76
PHA03100	480	ankyrin repeat protein; Provisional	99.76
PHA02741	169	hypothetical protein; Provisional	99.76
PHA02946	446	ankyin-like protein; Provisional	99.75
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.75
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
PHA02884	300	ankyrin repeat protein; Provisional	99.74
KOG0515	752	consensus p53-interacting protein 53BP/ASPP, conta	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.74
PHA02798	489	ankyrin-like protein; Provisional	99.74
PHA03100	480	ankyrin repeat protein; Provisional	99.73
KOG0510	929	consensus Ankyrin repeat protein [General function	99.73
KOG0510	929	consensus Ankyrin repeat protein [General function	99.72
PHA03095	471	ankyrin-like protein; Provisional	99.72
PHA02946	446	ankyin-like protein; Provisional	99.72
PHA02876	682	ankyrin repeat protein; Provisional	99.72
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.71
PHA02798	489	ankyrin-like protein; Provisional	99.71
KOG0514	452	consensus Ankyrin repeat protein [General function	99.71
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.71
PHA02743	166	Viral ankyrin protein; Provisional	99.71
PHA02917	661	ankyrin-like protein; Provisional	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
PHA02989	494	ankyrin repeat protein; Provisional	99.7
PHA02795	437	ankyrin-like protein; Provisional	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
PHA02989	494	ankyrin repeat protein; Provisional	99.69
KOG0514	452	consensus Ankyrin repeat protein [General function	99.69
smart00090	237	RIO RIO-like kinase.	99.68
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.68
PHA02917	661	ankyrin-like protein; Provisional	99.68
PHA02876	682	ankyrin repeat protein; Provisional	99.67
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.67
PHA02730	672	ankyrin-like protein; Provisional	99.67
PHA02736	154	Viral ankyrin protein; Provisional	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
PF13857	56	Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A	99.63
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.63
PHA02730	672	ankyrin-like protein; Provisional	99.62
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.61
PHA02792	631	ankyrin-like protein; Provisional	99.61
KOG1710	396	consensus MYND Zn-finger and ankyrin repeat protei	99.6
cd00204	126	ANK ankyrin repeats; ankyrin repeats mediate prote	99.6
KOG0507	854	consensus CASK-interacting adaptor protein (caskin	99.6
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.59
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.59

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-55  Score=389.82  Aligned_cols=398  Identities=27%  Similarity=0.448  Sum_probs=328.5

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      +.+|..|+.||.-.|+..|++..-+.|. |.+|.+|||+||..|+..+|+.||.+|+.||..+....||||+||..||.+
T Consensus         2 edif~wcregna~qvrlwld~tehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrd   81 (448)
T KOG0195|consen    2 EDIFGWCREGNAFQVRLWLDDTEHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRD   81 (448)
T ss_pred             chhhhhhhcCCeEEEEEEecCcccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHH
Confidence            4678999999999999999988777777 889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCCCC-----------------CC
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANP-----------------RE  179 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a~~-----------------~~  179 (473)
                      ||+.|++..+|+|+.|..|+|||||||..|...+++-|+..|+.++..++   +|+..+.+                 +.
T Consensus        82 ivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nr  161 (448)
T KOG0195|consen   82 IVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNR  161 (448)
T ss_pred             HHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCc
Confidence            99999999999999999999999999999999999999999998866554   44433322                 11


Q ss_pred             CCc----c----------c------cChhHHHh-hccCceeeeEEEEEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHH
Q 011991          180 VPE----Y----------E------LNPLELQV-RKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI  238 (473)
Q Consensus       180 ~~~----~----------~------i~~~~~~~-~~~~~ig~G~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~  238 (473)
                      +|.    +          .      ++-..+++ .....--+|..+.++|.|..+++|+++.... +......|..|+..
T Consensus       162 ipfkdt~wkgtktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~  240 (448)
T KOG0195|consen  162 IPFKDTTWKGTKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPA  240 (448)
T ss_pred             ccccccccccccccccccccccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcc
Confidence            110    0          0      00001111 0111123455556789999999999986554 45566889999999


Q ss_pred             HHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeC-CCC
Q 011991          239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHC-DLK  315 (473)
Q Consensus       239 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~-Dlk  315 (473)
                      ++.+.||||+.++++|..+..+.+|..||+.|||+.++.....  .+..++.+++.+++.|++|||+..+  +|-| -|.
T Consensus       241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~ln  318 (448)
T KOG0195|consen  241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLN  318 (448)
T ss_pred             eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcc
Confidence            9999999999999999999999999999999999999987543  6788999999999999999999984  5555 699


Q ss_pred             CCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCC---CchhHHHHHHHHHHHHhCCC
Q 011991          316 PKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD---RSVDAYSFGLILYEMIEGVQ  392 (473)
Q Consensus       316 p~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~~l~ell~g~~  392 (473)
                      +..|+|+++-+.+|+ .+-+++.          .......-.|.||+||.++..+-+   .++|+|||++++||+-|.+.
T Consensus       319 s~hvmidedltaris-mad~kfs----------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trev  387 (448)
T KOG0195|consen  319 SKHVMIDEDLTARIS-MADTKFS----------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV  387 (448)
T ss_pred             cceEEecchhhhhee-cccceee----------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence            999999998877764 1111111          111122235679999999877544   68999999999999999999


Q ss_pred             CCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          393 PFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       393 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ||.+.++.+...++..++.++.+   |+++++.+..|+.-||+.||.+||.+.+++..|++++
T Consensus       388 pfadlspmecgmkialeglrv~i---ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  388 PFADLSPMECGMKIALEGLRVHI---PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCchhhhhhhhhccccccC---CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            99999999999999999988776   7789999999999999999999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-51  Score=388.02  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=216.7

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHH----HHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPE----RINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      ...|.+.+.+|+|+|+.|     +.+|+.||||++++.......    ......+|+++|++|+|||||+++++|..+++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            446888899999999976     568999999999875443311    23445799999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC---CcEEEEeecccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLR  336 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~---~~vkl~DfG~a~  336 (473)
                      .|+||||++||+|.+.+-.++.+.+...+.+++|++.|+.|||++|   |+||||||+|||++.+   ..+||+|||+|+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence            9999999999999999999999999999999999999999999999   9999999999999876   789999999998


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCC---CCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhCCC
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF---DRSVDAYSFGLILYEMIEGVQPFHPKPPEE-VVKLMCCEGKR  412 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~  412 (473)
                      +.+..       ....+.+|||.|.|||++.+.++   ..++||||+||++|-+++|.+||++..... ..++| ..+..
T Consensus       328 ~~g~~-------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI-~~G~y  399 (475)
T KOG0615|consen  328 VSGEG-------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI-LKGRY  399 (475)
T ss_pred             ccccc-------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH-hcCcc
Confidence            86532       12356789999999999987643   358899999999999999999999887776 56666 45555


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..+..+..++++..+||.+||..||++|||+.|+|+|
T Consensus       400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            55556678899999999999999999999999999885

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-50  Score=374.40  Aligned_cols=243  Identities=27%  Similarity=0.476  Sum_probs=212.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc-eEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~  264 (473)
                      +.+..+.||.|..|+|     +.+++.+|+|.+..+  .++...+++.+|+++++..+||+||.++|+|..++. .+|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            4555667887777655     578999999999544  357788999999999999999999999999999995 99999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||++|||.+++...+++++.....++.++++||.|||+ ++   ||||||||+||||++.|.|||||||.|+....+  
T Consensus       158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999999998999999999999999999999996 77   999999999999999999999999999866443  


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhhCCCCCCccc
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK-----PPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~  418 (473)
                            ...+..||..|||||.+.+..|+.++||||||++++|+.+|+.||...     ...+.+..|.. ...|..   
T Consensus       233 ------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~l---  302 (364)
T KOG0581|consen  233 ------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRL---  302 (364)
T ss_pred             ------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCC---
Confidence                  235677999999999999999999999999999999999999999875     45566666633 333332   


Q ss_pred             CCC-CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARS-YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |.+ +|++++.||..||++||.+|||+.|+++|
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            454 99999999999999999999999999886

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-49  Score=384.68  Aligned_cols=267  Identities=41%  Similarity=0.729  Sum_probs=231.5

Q ss_pred             CCccccChhHHHhhccCceeeeEEEEE---EecCcE-EEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe
Q 011991          180 VPEYELNPLELQVRKADGITKGSYQVA---KWNGTK-VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT  255 (473)
Q Consensus       180 ~~~~~i~~~~~~~~~~~~ig~G~~~~~---~~~~~~-vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  255 (473)
                      .+.+.++...+...  ..+|.|+||.+   .|.|.. ||||++......... .+.|.+|+.+|.+++|||||+|+|++.
T Consensus        33 ~~~~~i~~~~l~~~--~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~  109 (362)
T KOG0192|consen   33 LPEEEIDPDELPIE--EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT  109 (362)
T ss_pred             ccceecChHHhhhh--hhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34555555544333  34888888754   789998 999999876655444 789999999999999999999999999


Q ss_pred             eCC-ceEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEe
Q 011991          256 QNI-PMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISG  331 (473)
Q Consensus       256 ~~~-~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~D  331 (473)
                      .+. .+++||||+++|+|.+++..  ...++...++.++.||+.||.|||++++  ||||||||+|||++.++ ++||+|
T Consensus       110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECC
Confidence            887 79999999999999999987  5679999999999999999999999985  99999999999999997 999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK--NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~  409 (473)
                      ||+++......      ...+...||+.|||||++.  ...|+.++||||||+++|||+||+.||.+....++...+...
T Consensus       188 FGlsr~~~~~~------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~  261 (362)
T KOG0192|consen  188 FGLSREKVISK------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG  261 (362)
T ss_pred             Cccceeecccc------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence            99998765432      1223357999999999999  669999999999999999999999999999998888888778


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      +.+|.+   +..+++.+..+|.+||+.||..||++.+++..|+.+......
T Consensus       262 ~~Rp~~---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  262 GLRPPI---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CCCCCC---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            887776   445899999999999999999999999999999999986653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-50  Score=394.07  Aligned_cols=258  Identities=27%  Similarity=0.455  Sum_probs=232.9

Q ss_pred             CCCccccChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEee
Q 011991          179 EVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA  253 (473)
Q Consensus       179 ~~~~~~i~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  253 (473)
                      ++|+...++....|..++.+|+|+|..+     ..+|+.||+|++.+.........+...+|+++.+.|+|||||+|+++
T Consensus         7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~   86 (592)
T KOG0575|consen    7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF   86 (592)
T ss_pred             CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence            4455555555578999999999999743     36899999999998877778888999999999999999999999999


Q ss_pred             EeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       254 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      |++...+|||+|+|+.++|..+++..+.+++.+++.+++||+.||.|||+++   |||||||..|++++++.+|||+|||
T Consensus        87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence            9999999999999999999999999899999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      +|......+.+.      .+.+|||.|.|||++...+.+..+||||+||+||-||.|++||...+-.+.+..|....+..
T Consensus       164 LAt~le~~~Erk------~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~  237 (592)
T KOG0575|consen  164 LATQLEYDGERK------KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM  237 (592)
T ss_pred             eeeeecCccccc------ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc
Confidence            998776443332      34679999999999999999999999999999999999999999999999999996655433


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                           |..++.++++||.++|+.||.+|||+++|+.+
T Consensus       238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 55789999999999999999999999999983

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=364.60  Aligned_cols=246  Identities=30%  Similarity=0.548  Sum_probs=212.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.....||.|+|++|     +.++..||||.+.+... ..+.++.+..|+++++.++|||||.+++++..++.+|||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            5666778999999876     56789999999987654 46777889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC------CcEEEEeeccccccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG------GQLKISGFGLLRLQY  339 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~------~~vkl~DfG~a~~~~  339 (473)
                      ||+||+|.+|+...+.+++.+++.++.||+.||++||+++   ||||||||+|||++..      -.+||+|||+|+...
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9999999999999999999999999999999999999999   9999999999999864      458999999999876


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ....       ..+.+|+|.|||||++....|+.|+|+||+|+++|++++|+.||...+..+.+..+.......+  ..+
T Consensus       167 ~~~~-------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~--~~~  237 (429)
T KOG0595|consen  167 PGSM-------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP--VLP  237 (429)
T ss_pred             chhH-------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC--chh
Confidence            4321       2456799999999999999999999999999999999999999999999999887744443322  234


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ...+..+.+++-..+..+|..|-++.+-..
T Consensus       238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  238 AELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             hhccCchhhhhhHHHhcCccccCchHHhhh
Confidence            456666778888888888888877766543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-49  Score=353.08  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=214.5

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEe-eEeeCCc-eEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-AVTQNIP-MMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~~~~-~~l  262 (473)
                      .+|.+.+.||.|+||.+     .++|..+|.|.+.-+. -+....+....|+.+|++|+|||||++++ .|..+.. ++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            47889999999999854     5799999999998543 46777889999999999999999999998 4555444 999


Q ss_pred             EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          263 VLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPD-PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      |||||++|+|.++++.    ++.+++..+|+++.|++.||..+|+.-++ .|+||||||.||+++.+|.|||+|||++++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999965    34599999999999999999999994432 499999999999999999999999999998


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      +....      .-..+..|||.||+||.+...+|+.+|||||+||++|||+.-.+||.+.+-.+.-.+|.+. ..|+.  
T Consensus       178 l~s~~------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~--  248 (375)
T KOG0591|consen  178 LSSKT------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPL--  248 (375)
T ss_pred             hcchh------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCC--
Confidence            75431      1234678999999999999999999999999999999999999999999888888888554 33333  


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ....||.++..||..|+..||+.||+...++..+
T Consensus       249 p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  249 PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            1267899999999999999999999965444433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-48  Score=359.98  Aligned_cols=247  Identities=27%  Similarity=0.438  Sum_probs=219.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||+|+||.|     +.+++.+|+|++++.........+....|..++..++||.||+++..|++...+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            36788899999999865     4678999999999887777777889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+.||.|...|++.+.+++..+..++.+|+.||.|||++|   ||||||||+|||++.+|+++|+|||+++....... 
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~-  180 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD-  180 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence            99999999999999999999999999999999999999999   99999999999999999999999999985433322 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ...+.+||+.|||||++.+.+|+..+|.||||+++|||++|.+||...+...+.+.|......    ..+..++.
T Consensus       181 -----~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~----~~p~~ls~  251 (357)
T KOG0598|consen  181 -----ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP----LPPGYLSE  251 (357)
T ss_pred             -----ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC----CCCccCCH
Confidence                 234578999999999999999999999999999999999999999999999999988554411    22445899


Q ss_pred             HHHHHHHHccCCCCCCCC----CHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRP----NFNEIIA  449 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RP----s~~ell~  449 (473)
                      +.++++++++.+||++|.    ++.+|.+
T Consensus       252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  252 EARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             HHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            999999999999999996    4555443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-47  Score=367.07  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=227.4

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .+|..++.+|.|+|+.|     +.+++.||||++.+........+.....|-++|.+| .||+|++|+..|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            47888899999999865     568899999999988777777778889999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +||+++|+|.++|++.|.|++..++.++.||+.||+|||++|   ||||||||+|||++.+++++|.|||.|+.+.....
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            999999999999999999999999999999999999999999   99999999999999999999999999988754422


Q ss_pred             c-----cc--ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          344 K-----AK--IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       344 ~-----~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                      .     ..  .......+.||..|.+||++.....++.+|||+|||++|+|+.|.+||.+.+..-++.+|....+..   
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f---  306 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF---  306 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC---
Confidence            2     11  1222366889999999999999999999999999999999999999999999999999886554432   


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                        +.++++.+.+||++.|..||.+|+++++|.+|-
T Consensus       307 --p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  307 --PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             --CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence              567899999999999999999999999998764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=364.06  Aligned_cols=262  Identities=34%  Similarity=0.558  Sum_probs=225.1

Q ss_pred             CCccccChhHHHhhccCceeeeEEEEE---EecCc-EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe
Q 011991          180 VPEYELNPLELQVRKADGITKGSYQVA---KWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT  255 (473)
Q Consensus       180 ~~~~~i~~~~~~~~~~~~ig~G~~~~~---~~~~~-~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  255 (473)
                      ...+++++..++  ..+.||+|-||.|   .|++. .||+|.++.....    .+.|.+|+++|++|+|++||++++++.
T Consensus       198 ~d~wei~r~~l~--l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  198 RDPWEIPREELK--LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             cCCeeecHHHHH--HHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            445667766554  4457999999865   68887 9999999865433    256889999999999999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          256 QNIPMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      .++.+|||||||+.|+|.++|+.  ++.+...+.+.++.||++||+||++++   +|||||-+.||||+++..+||+|||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccc
Confidence            98899999999999999999987  456899999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +|+...+..-..     .....-+..|.|||.+....++.+|||||||++||||+| |+.||.+.+..+++..+ ..|.+
T Consensus       349 LAr~~~d~~Y~~-----~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyR  422 (468)
T KOG0197|consen  349 LARLIGDDEYTA-----SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYR  422 (468)
T ss_pred             cccccCCCceee-----cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCc
Confidence            999543332111     112223456999999999999999999999999999998 99999999999999988 56666


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      .+.   |..+|+.+.++|..||..+|++||||+.+...|+++.....
T Consensus       423 lp~---P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  423 LPR---PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             CCC---CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence            554   77899999999999999999999999999999999887543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-46  Score=340.46  Aligned_cols=249  Identities=21%  Similarity=0.388  Sum_probs=208.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|+...++|.|+||+|     +.+|+.||||++... ..++...+-.++|++++++|+|||+|.++++|.....++||+|
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4777789999999987     568999999999743 3567777888999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+. ++.+-+... ..++...+.++++|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|+....... 
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            9988 555555553 45999999999999999999999999   99999999999999999999999999998754222 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC----------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP----------  413 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  413 (473)
                           ..+.+..|+.|+|||.+.+ .+|+..+|||++||++.||++|.+.|++.+.-+.+..|.......          
T Consensus       157 -----~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  157 -----NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             -----hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence                 2345668899999999887 699999999999999999999999999988766655543222110          


Q ss_pred             ----------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 ----------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                      +.+...+.++..+.+|++.|+..||++|++.++++.|
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                            0011123455779999999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-46  Score=351.58  Aligned_cols=256  Identities=27%  Similarity=0.465  Sum_probs=210.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC--ceEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~l  262 (473)
                      ..+..++.+|+|+||.|     ..+|...|||.+.....   ...+.+.+|+.+|++++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            45778889999999866     23478999999976522   22677899999999999999999999854433  6999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeecccccccc
Q 011991          263 VLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRLQYI  340 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~~~~~  340 (473)
                      .|||+++|+|.+++...+ .+++..++.+++||++||+|||++|   ||||||||+|||++. ++.+||+|||++.....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999876 7999999999999999999999999   999999999999999 69999999999875542


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhhCCCCCCccc
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      .   ...........||+.|||||++..+ ...+++||||+||++.||+||..||.. .........+......|   ..
T Consensus       171 ~---~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P---~i  244 (313)
T KOG0198|consen  171 K---GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP---EI  244 (313)
T ss_pred             c---cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC---CC
Confidence            1   1111223456799999999999863 334599999999999999999999988 44444445554444344   34


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      |..+|+++++|+++|+..||.+||||+++|.|--.....
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            677999999999999999999999999999987554433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=346.35  Aligned_cols=254  Identities=23%  Similarity=0.419  Sum_probs=215.2

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ...|+....||.|.-+.+     ...++.||||++..+.....  ...+.+|+..|+.++||||++++..|..+..+|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            446777788998855433     56789999999998876543  78899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          264 LEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |.||.+||+.++++..  ..+++..+..|++++++||.|||.+|   .||||||+.||||+.+|.|||+|||.+....++
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999873  44999999999999999999999999   999999999999999999999999998877665


Q ss_pred             cccccccccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc---
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK---  416 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  416 (473)
                      +....  .......||+.|||||++..  .+|+.|+||||||++..||.+|..||....+.+++....+ +.+|.+.   
T Consensus       180 G~R~~--~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-n~pp~~~t~~  256 (516)
T KOG0582|consen  180 GDRQV--TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-NDPPTLLTSG  256 (516)
T ss_pred             Cceee--EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCCCCccccc
Confidence            53332  22267789999999999644  4899999999999999999999999999998887765433 3333111   


Q ss_pred             ---ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 ---IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                         .....++..++++|..|+..||++|||+++++++
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence               1223467889999999999999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-45  Score=330.10  Aligned_cols=234  Identities=27%  Similarity=0.498  Sum_probs=215.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...+.+|.|+||.|     +.+|..+|+|++.+...-.....+...+|..+++.+.||+++++.+.|.+.+.+|+|||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            5677788999999965     56789999999998877778888999999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++||.|..++++.+++++..++.++.||+.||+|||+++   |++|||||+|||+|.+|.+||.|||+|+....     
T Consensus       125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----  196 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----  196 (355)
T ss_pred             ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-----
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999976532     


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ...+.+|||.|+|||++...+|+.++|.||||+++|||+.|.+||.+.++..++.+|.......     |+.++++
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f-----P~~fs~~  267 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF-----PSYFSSD  267 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC-----CcccCHH
Confidence                2456789999999999999999999999999999999999999999999999999996655433     5578999


Q ss_pred             HHHHHHHccCCCCCCC
Q 011991          426 LKELIEECWDPKPVIR  441 (473)
Q Consensus       426 l~~li~~cl~~dP~~R  441 (473)
                      +++|+++.|+.|-.+|
T Consensus       268 ~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  268 AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHHHHhhhhHhh
Confidence            9999999999999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=351.34  Aligned_cols=251  Identities=21%  Similarity=0.303  Sum_probs=214.5

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCC-ce
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI-PM  260 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~-~~  260 (473)
                      ...+|.+.+++|.|+||.|     ..+|+.||||.++.+.....+.  .=++|++.+++++ ||||+++.+++.+++ .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            3457999999999999866     5678999999999876654332  2368999999998 999999999998877 89


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      |+|||||+. +|+++++.++ .++++.++.|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+||.+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999999976 9999998764 4999999999999999999999999   9999999999999988899999999998765


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-  417 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  417 (473)
                      ..       .+.+.+..|+.|+|||++. ..-|+.+.|||++||+++|+++-++.|++.+..+.+.+|..-...|.... 
T Consensus       162 Sk-------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  162 SK-------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             cC-------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            43       3467788999999999875 55789999999999999999999999999998877777755444442221 


Q ss_pred             ------------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          418 ------------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       418 ------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                                              ..++.++++.++|.+|+++||.+||+|+|.+++-
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence                                    1234678999999999999999999999999863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-45  Score=355.62  Aligned_cols=245  Identities=24%  Similarity=0.460  Sum_probs=213.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|....+||.|.-|.+     ..+++.||||.+.......   .+-+.+|+.+|+..+|+|||++++.|...+.+|.|||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            5666677887766533     4678899999998765433   3568999999999999999999999998899999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|.+++... .+++.++..+++++++||+|||.+|   |||||||.+|||++.+|.+||+|||++..+.....  
T Consensus       351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            99999999999765 5999999999999999999999999   99999999999999999999999999876543321  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......|||+|||||++....|++++||||||++++||+.|++||-..++-..+..|...+. |.+. .+..+|+.
T Consensus       425 ----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~lk-~~~klS~~  498 (550)
T KOG0578|consen  425 ----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PKLK-NPEKLSPE  498 (550)
T ss_pred             ----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CCcC-CccccCHH
Confidence                34566799999999999999999999999999999999999999999888888888865553 3332 36678999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++|+.+||..||.+||++.|||+|
T Consensus       499 ~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHHHHhhcchhcCCCHHHHhcC
Confidence            9999999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.2e-44  Score=318.92  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=211.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...+.+|.|+|+++     ..+|+.||||.++.....+. .-....+|++.++.++||||+.++++|...+.+.||+|
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5777889999999876     46899999999987654432 23567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+. +|...++... .++...+..++.++++||+|||+++   |+||||||.|+||+++|.+||+|||+|+.++.....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9986 9999997753 4899999999999999999999999   999999999999999999999999999988655332


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI------  417 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  417 (473)
                      .      .....|+.|+|||.+.|. .|+..+||||.||++.||+.|.+.|++.+.-+.+..|......|....      
T Consensus       158 ~------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  158 Q------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             c------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            2      222568889999988664 799999999999999999999999999988887777765555443321      


Q ss_pred             -----------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 -----------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 -----------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                       .....++++.+|+.+|+..||.+|+++.|++++
T Consensus       232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                             122346788999999999999999999999884

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-44  Score=337.85  Aligned_cols=247  Identities=28%  Similarity=0.499  Sum_probs=224.5

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ..-.|.+.+.+|+|+||.++     ..|+.||||.+.++...+....-.+.+|+++|..|+||||++++.+|+..+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            34578888999999999763     6789999999999998888899999999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||.++|.|++|+...+.+++.+++.|++||++|+.|+|.++   ++|||||.+|||+|.++++||+|||++..+.+..
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            9999999999999999999999999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      .       ..+++|+|.|.+||++.+.+|. +.+|.||||+++|-|..|.+||.+.+..-+..+|....++.+      .
T Consensus       208 f-------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP------~  274 (668)
T KOG0611|consen  208 F-------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP------E  274 (668)
T ss_pred             H-------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC------C
Confidence            2       3467799999999999999885 899999999999999999999999999999988866555433      2


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .|.++.-||++||..||+.|.|+++|..|
T Consensus       275 ~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  275 TPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            35689999999999999999999999775

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-44  Score=356.00  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=217.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |+.++-+|.|+-|.+     ..+|+..|||++.+...........+.+|+-+|+.+.||||+++++.++++.++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            456677898888755     578999999999876433444557789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      ++||-|.+++-.+|.+++.++.++++||+.|+.|+|..+   |+||||||+|+|++..+++||+|||+|.......    
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk----  166 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK----  166 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc----
Confidence            999999999999999999999999999999999999999   9999999999999999999999999997543221    


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                         -..+.+|+|-|.|||++.+.+|+ .++||||+|+++|.|++|+.||.+.+...++.++..+...     .|..+|++
T Consensus       167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~-----MPs~Is~e  238 (786)
T KOG0588|consen  167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE-----MPSNISSE  238 (786)
T ss_pred             ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc-----CCCcCCHH
Confidence               12345799999999999999996 8999999999999999999999999999999888544432     35789999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      +++|+++|+..||.+|.|.+||++|-
T Consensus       239 aQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  239 AQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHHHHHHHhccCccccccHHHHhhCc
Confidence            99999999999999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=349.63  Aligned_cols=247  Identities=28%  Similarity=0.480  Sum_probs=212.5

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC-C-HHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCce
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK-D-PERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~-~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  260 (473)
                      ...|.+++.+|.|+|+.+     ..++..||+|++..+... . ....+.+.+|+.+++.++ ||||+++++++.....+
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            346888899999999866     356899999988764222 1 134466778999999998 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC-CcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~-~~vkl~DfG~a~~~~  339 (473)
                      |+||||+.||+|.+++...+++.+..+..+++|++.|++|||++|   |+||||||+|||++.+ +++||+|||++....
T Consensus        96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            999999999999999999889999999999999999999999999   9999999999999999 999999999998653


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-FD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      .      .........||+.|+|||++.+.. |+ .++||||+|+++|.|++|..||.+.+.......+.......    
T Consensus       173 ~------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~----  242 (370)
T KOG0583|consen  173 G------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI----  242 (370)
T ss_pred             C------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC----
Confidence            1      112245567999999999999987 86 89999999999999999999999988888887764333222    


Q ss_pred             cCCCC-CHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          418 KARSY-PPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       418 ~~~~~-~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                       |..+ ++++..|+++|+..||.+|+++.+++.
T Consensus       243 -p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  243 -PSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             3445 999999999999999999999999994

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.7e-44  Score=345.42  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=217.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...+.||+|+||.|     +.+|+.+|+|++++...-....++..+.|-.+|...++|+||+++.+|++..++|||||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            5777889999999966     56899999999998877777788999999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC----
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS----  341 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~----  341 (473)
                      |++||++-.+|.+.+.|++..++.++.+++.|++.||..|   +|||||||+|+|||..|++||+|||++.-....    
T Consensus       222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            9999999999999999999999999999999999999999   999999999999999999999999998422110    


Q ss_pred             ------------------cccc---cc----------------cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHH
Q 011991          342 ------------------PEKA---KI----------------VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL  384 (473)
Q Consensus       342 ------------------~~~~---~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l  384 (473)
                                        ....   ..                ....-...|||-|+|||++.+.+|+..+|.|||||+|
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM  378 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence                              0000   00                0011134799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 011991          385 YEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN---FNEIIA  449 (473)
Q Consensus       385 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~  449 (473)
                      ||||.|.+||.+.++.+....|.........+. ...+++++.+||.+|+. ||.+|..   ++||-+
T Consensus       379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            999999999999999999998876664433322 23467999999999999 9999965   666654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=353.23  Aligned_cols=238  Identities=30%  Similarity=0.507  Sum_probs=205.2

Q ss_pred             CceeeeEEEE---EEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          196 DGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       196 ~~ig~G~~~~---~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      ..+|+|+-|.   +...++.||||.++.-          -..+++-|++|+||||+.|.|+|....-+|||||||..|-|
T Consensus       130 eWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            3577776654   4788999999998632          23578999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccccc
Q 011991          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS  352 (473)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~  352 (473)
                      +.+|+.+..++......|..+|+.||.|||.+.   |||||||.-||||+.+..|||+|||-++...+..       +.-
T Consensus       200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------TkM  269 (904)
T KOG4721|consen  200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------TKM  269 (904)
T ss_pred             HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-------hhh
Confidence            999999989999999999999999999999999   9999999999999999999999999998664431       122


Q ss_pred             CCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHH
Q 011991          353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE  432 (473)
Q Consensus       353 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~  432 (473)
                      .++||..|||||++...+.+.|+||||||||+|||+||+.||.+.....++.-+   +........|..+|+.++-||++
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV---GsNsL~LpvPstcP~GfklL~Kq  346 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV---GSNSLHLPVPSTCPDGFKLLLKQ  346 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec---cCCcccccCcccCchHHHHHHHH
Confidence            467999999999999999999999999999999999999999987766555433   22222233477899999999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          433 CWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       433 cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      ||+.+|..||||.+|+.||+-.-.
T Consensus       347 cw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  347 CWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             HHhcCCCCCccHHHHHHHHhhcCH
Confidence            999999999999999999964433

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-42  Score=335.86  Aligned_cols=252  Identities=21%  Similarity=0.335  Sum_probs=212.2

Q ss_pred             HHhhccCceeeeEEE---EEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee----CCceEE
Q 011991          190 LQVRKADGITKGSYQ---VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~---~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~l  262 (473)
                      ++......++.|+++   .+..+|+.||||.+...........+.+.+|+.++++++||||+++++++.+    ....++
T Consensus        20 i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l   99 (283)
T PHA02988         20 IDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL   99 (283)
T ss_pred             cCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence            333333567777665   3478999999999986654455556888999999999999999999999876    346899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++|+|.+++...+.+++.....++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||+++.....
T Consensus       100 v~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        100 ILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             EEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            999999999999998888899999999999999999999985 6   889999999999999999999999998754322


Q ss_pred             cccccccccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      .         ....+++.|+|||++.+  ..++.++|||||||++|||++|..||...+..+....+......+..   +
T Consensus       177 ~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~  244 (283)
T PHA02988        177 P---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL---P  244 (283)
T ss_pred             c---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---C
Confidence            1         12346788999999976  68899999999999999999999999998888777776544444332   3


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      ..+++.+.+|+.+||+.||++|||++|+++.|+.++.
T Consensus       245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            4678999999999999999999999999999998765

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-43  Score=338.18  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=213.5

Q ss_pred             ChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--C
Q 011991          186 NPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--I  258 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  258 (473)
                      ......|+...+||+|+|+.|     ..+|+.||+|.+..+... +.......+|+.+|++|+||||+++.+.....  +
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            334557888899999999855     467899999999876532 34456778999999999999999999998876  6


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      .+|+|+|||++ +|.-++...+ .|++.++..++.||+.||+|||++|   |+|||||.+|||||++|.+||+|||+|++
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence            89999999988 9999987743 5999999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                      +......     ..+...-|..|+|||++.+. .|+.++|+||.||||.||+.|++.|++.+..+.+..|......|...
T Consensus       268 y~~~~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~  342 (560)
T KOG0600|consen  268 YTPSGSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED  342 (560)
T ss_pred             ccCCCCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence            7654322     24555678889999998775 89999999999999999999999999999888777765444433221


Q ss_pred             c------------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          417 I------------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       417 ~------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .                        ....+++...+|+..+|+.||.+|.|+.++|.
T Consensus       343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1                        01245788999999999999999999999887

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=317.75  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=219.2

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ++.+|.+...||+|.|+++     ..+|+.+|+|+++.+.... ...+.+.+|+.+-+.|+||||+++.+.+...+..|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            3457788889999999855     6789999999998765543 356889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC---CcEEEEeeccccccc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRLQY  339 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~---~~vkl~DfG~a~~~~  339 (473)
                      |+|+|.|++|..-+-.+-..++..+..+++||+.+|.|+|.++   |||||+||.|+++-+.   .-+||+|||++...+
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999999877766556889999999999999999999999   9999999999999643   359999999998765


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ..       .......|||.|||||++...+|+..+|||+.|+++|-|+.|.+||.+.+...++++|.......+ ...+
T Consensus       165 ~g-------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~-~~~w  236 (355)
T KOG0033|consen  165 DG-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP-SPEW  236 (355)
T ss_pred             Cc-------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC-Cccc
Confidence            22       224567899999999999999999999999999999999999999999999999999966554433 3357


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++++++++||++||..||.+|.|+.|.|+|
T Consensus       237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  237 DTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            7899999999999999999999999999864

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=328.69  Aligned_cols=250  Identities=26%  Similarity=0.346  Sum_probs=206.9

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-----CCceE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-----NIPMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~~  261 (473)
                      |...+.+|.|+||++     ..+|+.||||.+.... ...-..++..+|+++++.++|+||+.+++.+..     -..+|
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            334567999999966     5678999999997433 455667889999999999999999999999865     34599


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +|+|+|+ .+|.++++.+..+++..+..++.|++.||+|+|+-+   |+||||||.|++++.++.+||||||+|+.....
T Consensus       103 iV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  103 LVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             EehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence            9999995 499999999888999999999999999999999999   999999999999999999999999999976543


Q ss_pred             cccccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-------
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-------  413 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------  413 (473)
                          ......+.+..|..|+|||++. ...|+.+.||||.||++.||++|++.|++.+.-..+..|......|       
T Consensus       179 ----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  179 ----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence                1222346777899999999875 4589999999999999999999999999866544443332222222       


Q ss_pred             -----------------CC--cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 -----------------PL--KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 -----------------~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                       ..  ....++.++.+.+|+.+||..||.+|+|++|.|.|
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                             11  11235678999999999999999999999999886

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-43  Score=340.44  Aligned_cols=246  Identities=25%  Similarity=0.445  Sum_probs=219.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc-eEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~  264 (473)
                      .|...+.+|.|+||.+     +.+++.+|+|.+.......+. .+...+|+.+++++.|||||.+.+.|..++. ++|||
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5778889999999854     567889999999987665443 4578999999999999999999999999888 99999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      +||+||+|.+.+...+  .++++.+..|+.|++.|+.|||++.   |+|||||+.||+++.++.|+|.|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997653  4899999999999999999999988   9999999999999999999999999998875543


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .      ......|||.|++||++.+.+|+.++|||||||++|||++-+.+|...+......+|......|    .+..+
T Consensus       161 ~------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P----lp~~y  230 (426)
T KOG0589|consen  161 S------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP----LPSMY  230 (426)
T ss_pred             h------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC----CCccc
Confidence            1      1245679999999999999999999999999999999999999999999999999886555332    47789


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+++.+|+.|+..+|..||++.++|.+
T Consensus       231 s~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  231 SSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            9999999999999999999999999987

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.5e-42  Score=338.90  Aligned_cols=256  Identities=27%  Similarity=0.493  Sum_probs=206.3

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeC-
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN-  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~-  257 (473)
                      .+|++.+.||.|+||.+.          .+++.||||++....  .......+.+|+.+++.+ +||||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            367788899999998662          234679999997432  334456789999999999 899999999988754 


Q ss_pred             CceEEEEeccCCCCHHHHHHHc----------------------------------------------------------
Q 011991          258 IPMMIVLEYHAKGDLASYLQKK----------------------------------------------------------  279 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------  279 (473)
                      ..+++||||+++|+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4689999999999999998652                                                          


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCC
Q 011991          280 ----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID  355 (473)
Q Consensus       280 ----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~  355 (473)
                          ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++........    .......
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~  237 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGSAR  237 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch----hcccCCC
Confidence                13677888999999999999999999   999999999999999999999999999754322111    1112234


Q ss_pred             CCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHcc
Q 011991          356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECW  434 (473)
Q Consensus       356 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl  434 (473)
                      +++.|+|||++.+..++.++|||||||++|||++ |..||.+....+........+..+.   .+..+++.+.+++.+||
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl  314 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACW  314 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHc
Confidence            5678999999998899999999999999999997 9999987665444333333333322   25577899999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHh
Q 011991          435 DPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       435 ~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +.||.+|||+.|+++.|++++..
T Consensus       315 ~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         315 QGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             cCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-42  Score=354.94  Aligned_cols=253  Identities=28%  Similarity=0.505  Sum_probs=218.3

Q ss_pred             HhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +......+|.|.||.+.          .....||||.++.+.  +....++|.+|++++..++|||||+|+|.|..++++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            34455679999998662          334679999998653  456789999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC----------C----CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc
Q 011991          261 MIVLEYHAKGDLASYLQKKG----------R----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~----------~----l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      |+|+|||..|+|.+||..++          .    ++..+.+.|+.|||.||.||-++.   +|||||-..|+||.+.-.
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999997531          2    778899999999999999999998   999999999999999999


Q ss_pred             EEEEeeccccccccCccccccccccc-CCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011991          327 LKISGFGLLRLQYISPEKAKIVFPVS-HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVK  404 (473)
Q Consensus       327 vkl~DfG~a~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  404 (473)
                      |||+|||+++..+.++-     +... ...-..+|||||.+..++|+.+||||||||++||+++ |+.||.+.+++++++
T Consensus       642 VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             EEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence            99999999987765421     1111 2224567999999999999999999999999999997 999999999999999


Q ss_pred             HHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       405 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .+.....    ...|.++|.++.+||..||+.+|++||+|+||...|+.....
T Consensus       717 ~i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 CIRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            8854433    234789999999999999999999999999999999987654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7e-43  Score=339.57  Aligned_cols=244  Identities=28%  Similarity=0.537  Sum_probs=216.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     +.+.+.||+|.+.+... ..+..+.+.+|+++++.++||||+.+++.|+...++|+|+|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4666778999999865     56778999999987653 45667889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+.| +|..++...+.++++.+..++.|++.||.|||+.+   |+|||+||.|||++..+.+|+||||+|+.++..    
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~----  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN----  153 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC----
Confidence            9976 99999999999999999999999999999999999   999999999999999999999999999876542    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                        ....+...|||.|||||+..+.+|+..+|+||+||++||++.|.+||-..+-.+....|......+     |...+..
T Consensus       154 --t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~-----p~~~S~~  226 (808)
T KOG0597|consen  154 --TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP-----PSTASSS  226 (808)
T ss_pred             --ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-----cccccHH
Confidence              123456779999999999999999999999999999999999999998888777777775443332     3467899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+|+...+.+||.+|.+-.+++.|
T Consensus       227 f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  227 FVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHHHHHHHhhcChhhcccHHHHhcC
Confidence            9999999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-43  Score=342.04  Aligned_cols=267  Identities=27%  Similarity=0.509  Sum_probs=221.2

Q ss_pred             CccccChhHHHhhccCceeeeEEEEEEec--CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC
Q 011991          181 PEYELNPLELQVRKADGITKGSYQVAKWN--GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI  258 (473)
Q Consensus       181 ~~~~i~~~~~~~~~~~~ig~G~~~~~~~~--~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  258 (473)
                      .+|++...  ++.++..||+|+||.|...  -..||||+++..... ++..+.|++|+.++++-+|.||+-|.|++..+.
T Consensus       385 ~~WeIp~~--ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPE--EVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHH--HhhccceeccccccceeecccccceEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            34554443  5677889999999976322  247999999987754 568899999999999999999999999998877


Q ss_pred             ceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      . .||+.+|+|.+|+.+++.. ..|...+.+.|++||++||.|||.++   |||||||..||++.++++|||+|||++..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence            6 9999999999999999764 34888999999999999999999999   99999999999999999999999999865


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      ...-....    ......|...|||||++..   .+|++.+||||||+|+|||++|..||...+.+.++..+..+-..+.
T Consensus       538 k~~w~g~~----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd  613 (678)
T KOG0193|consen  538 KTRWSGEQ----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD  613 (678)
T ss_pred             eeeecccc----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence            43321111    1223346778999999863   4899999999999999999999999997777777766544333455


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ......++++++++|+..||..++++||.+.+|+..|+.+...+
T Consensus       614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            54556677889999999999999999999999999999988853

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-42  Score=333.76  Aligned_cols=243  Identities=22%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.||+|++...........+.+.+|+++++.++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            4667788999999855     23588999999975443334455778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998754321    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .   .+..+++.
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~---~~~~~~~~  224 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL--E---FPRHLDLY  224 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--C---CCccCCHH
Confidence                 1224588999999999998999999999999999999999999999888777777644322  1   24456889


Q ss_pred             HHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      +.+||++||..||.+||+     ++++++|
T Consensus       225 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         225 AKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            999999999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=339.91  Aligned_cols=272  Identities=30%  Similarity=0.511  Sum_probs=231.8

Q ss_pred             CCCCCCccccChhHHHhhccCceeeeEEEEE-----Eec-C---cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCe
Q 011991          176 NPREVPEYELNPLELQVRKADGITKGSYQVA-----KWN-G---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPN  246 (473)
Q Consensus       176 ~~~~~~~~~i~~~~~~~~~~~~ig~G~~~~~-----~~~-~---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpn  246 (473)
                      +|.....|++...++.+.  +++|.|.||.|     +.. +   ..||||....+.....+...+|++|+++|++++|||
T Consensus       145 ~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~N  222 (474)
T KOG0194|consen  145 RPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPN  222 (474)
T ss_pred             ccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCC
Confidence            444555677777766555  89999999865     222 2   238999998755566888999999999999999999


Q ss_pred             eeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC
Q 011991          247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (473)
Q Consensus       247 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~  325 (473)
                      ||+|+|+.....++++|||+|.||+|.++|++.+ .++..+...++.+.+.||+|||+++   +|||||-..|+|++.++
T Consensus       223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCC
Confidence            9999999999999999999999999999999986 4999999999999999999999999   99999999999999999


Q ss_pred             cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011991          326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVK  404 (473)
Q Consensus       326 ~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  404 (473)
                      .+||+|||+++....-..      ......-+..|+|||.+....|+.++|||||||++||+++ |..||.+....++..
T Consensus       300 ~vKISDFGLs~~~~~~~~------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~  373 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVM------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA  373 (474)
T ss_pred             eEEeCccccccCCcceee------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH
Confidence            999999999875431100      0111123456999999999999999999999999999998 889999999999999


Q ss_pred             HHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       405 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      .+...+.+.+.   +...|+.+..++.+||..||+.||++.++.+.|+.+.....+.
T Consensus       374 kI~~~~~r~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  374 KIVKNGYRMPI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             HHHhcCccCCC---CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence            99777776665   4467889999999999999999999999999999999876653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.3e-42  Score=337.33  Aligned_cols=240  Identities=25%  Similarity=0.451  Sum_probs=205.3

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (473)
                      .||+|+||.+     ..+|+.||+|++.............+.+|+.+++.++||||+++++++..++..|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5788888755     35788999999986544344556778899999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccc
Q 011991          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV  351 (473)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~  351 (473)
                      |.+++...+.+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++......      ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~------~~~  152 (323)
T cd05571          82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG------ATM  152 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC------Ccc
Confidence            9999988888999999999999999999999999   9999999999999999999999999986432211      112


Q ss_pred             cCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHH
Q 011991          352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE  431 (473)
Q Consensus       352 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~  431 (473)
                      ....||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......+....  ..   .+..+++++.+||+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~---~p~~~~~~~~~li~  227 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IR---FPRTLSPEAKSLLA  227 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CC---CCCCCCHHHHHHHH
Confidence            33458999999999999999999999999999999999999999888777766654322  11   24568899999999


Q ss_pred             HccCCCCCCCC-----CHHHHHHH
Q 011991          432 ECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       432 ~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +||..||++||     ++.++++|
T Consensus       228 ~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         228 GLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHccCCHHHcCCCCCCCHHHHHcC
Confidence            99999999999     79999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=329.49  Aligned_cols=255  Identities=27%  Similarity=0.397  Sum_probs=207.8

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCC-----------HHHHHHHHHHHHHHHhcCCCeeeeEEee
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKD-----------PERINAFTHELTIVEKARHPNVVQFVGA  253 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpnIv~l~~~  253 (473)
                      .+|.+...||+|.||.|+     .+++.||||++.+.....           ....+...+|+.+|+++.|||||+|+++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            378899999999999774     468899999997643221           1124688999999999999999999999


Q ss_pred             Eee--CCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          254 VTQ--NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       254 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                      ..+  .+.+|||+|||+.|.+...=.....+++.++++++++++.||+|||.+|   ||||||||+|+|++.+|+|||+|
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence            865  4579999999998877643222222899999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCC---C-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE---E-FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC  407 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~-~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~  407 (473)
                      ||.+.....+.... .........|||.|+|||.+.++   . .+.+.||||+|+++|.|+.|+.||.+....+.+.+|.
T Consensus       254 FGVs~~~~~~~~~~-~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEG-SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             cceeeecccCCccc-cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            99998664332111 11223346799999999998763   2 3478999999999999999999999999999999986


Q ss_pred             hhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ......+.   .+.+.+.+++||.+||.+||++|.+..+|..|.
T Consensus       333 n~pL~fP~---~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  333 NDPLEFPE---NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             cCcccCCC---cccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            65543322   234678999999999999999999999987764

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-42  Score=323.43  Aligned_cols=244  Identities=25%  Similarity=0.393  Sum_probs=201.1

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----  258 (473)
                      .+.|...+.+|.|+||.|     ..+++.||||.+-.+..-       -.+|+++|+.++|||||+++-+|....     
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            345777789999999966     356799999998754321       246999999999999999999886422     


Q ss_pred             ceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC-CcEEEEeec
Q 011991          259 PMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFG  333 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~-~~vkl~DfG  333 (473)
                      ...+|||||+. +|+++++.    +.+++...++-+++||++||+|||+.|   |+||||||.|+|||.+ |.+||||||
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence            46899999986 99999985    456999999999999999999999999   9999999999999976 889999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      .|+.....+.+.       ++..|+.|+|||.+.+. .|+.+.||||.|||+.||+.|.+.|++.+....+..|......
T Consensus       172 SAK~L~~~epni-------SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  172 SAKVLVKGEPNI-------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             cceeeccCCCce-------eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            998876554432       34467889999988764 8999999999999999999999999998877666655544433


Q ss_pred             CCCc------------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPLK------------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~~------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |..+                        ......++++.+|+.+++..+|.+|.++.|++.|
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            3221                        1233568999999999999999999999999875

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.8e-42  Score=337.40  Aligned_cols=243  Identities=23%  Similarity=0.399  Sum_probs=209.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.||+|++...........+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            5777889999999855     34678999999976443334456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+.+|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----  171 (329)
T PTZ00263         99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----  171 (329)
T ss_pred             CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence            9999999999998888999999999999999999999999   999999999999999999999999998754221    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....  ..   .+..+++.
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~---~p~~~~~~  241 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LK---FPNWFDGR  241 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cC---CCCCCCHH
Confidence                 122458899999999999999999999999999999999999999888877777664322  11   24457889


Q ss_pred             HHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      +.+||++||+.||.+||+     +++++.|
T Consensus       242 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        242 ARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            999999999999999997     6888876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=312.25  Aligned_cols=253  Identities=28%  Similarity=0.338  Sum_probs=210.4

Q ss_pred             ChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CC
Q 011991          186 NPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NI  258 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~  258 (473)
                      ......|.+...|+.|+||+|     +.+++.||+|+++.+.....-. -..++|+.++.+.+|||||.+-.+...  -+
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-ItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-ITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-chhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            334457888899999999977     4678899999998755332222 235789999999999999999998764  45


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      .+|+|||||++ +|..++..-+ ++...+++-++.|++.|++|||.++   |+||||||+|+|+++.|.+||+|||+|+.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence            69999999987 9999998754 7999999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                      ++...      .+.+...-|..|+|||.+.+. .|+.++||||+||++.|++++++.|++.+..+.+.+|......|.-.
T Consensus       227 ygsp~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  227 YGSPL------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             hcCCc------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            76552      234556678889999998765 68999999999999999999999999999888887776655444321


Q ss_pred             c------c-------------------CC--CCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          417 I------K-------------------AR--SYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       417 ~------~-------------------~~--~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .      .                   ..  .+++.-.+|+..++..||.+|.|++|.|+
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            1      0                   01  14477889999999999999999999988

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=333.95  Aligned_cols=245  Identities=25%  Similarity=0.477  Sum_probs=212.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|+....||.|+||.+     ..+++.||+|++..+..  ...++.+..|+.++..++++||.++++++..+..++++||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4556678999999866     45788999999987653  4566889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||.||++.+.++..+.+.+..+.-++++++.||.|||+++   .+|||||+.|||+..+|.+||+|||.+-......   
T Consensus        92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---  165 (467)
T ss_pred             HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh---
Confidence            9999999999988877799999999999999999999999   9999999999999999999999999986554331   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                         .....+.|||.|||||++.+..|+.++||||||++.+||.+|.+||....+..+...|. ...+|.   ....+++.
T Consensus       166 ---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~---L~~~~S~~  238 (467)
T KOG0201|consen  166 ---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPR---LDGDFSPP  238 (467)
T ss_pred             ---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCc---cccccCHH
Confidence               12246789999999999999999999999999999999999999999988865554442 222222   23478999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++||..||.+||+.||||.++|+|
T Consensus       239 ~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  239 FKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhh
Confidence            9999999999999999999999886

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=335.89  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=210.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.||+|++.............+..|+++++.++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            4667788999999855     23578999999986543334456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....     
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----  153 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999865422     


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC---CCCcccCCCC
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR---PPLKIKARSY  422 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~  422 (473)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......   +........+
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  229 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL  229 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcccccc
Confidence                123445889999999999989999999999999999999999999988887776665432221   1111111256


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++++.+|+.+||..+|.+||++++++++
T Consensus       230 s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         230 SDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            8999999999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-41  Score=331.45  Aligned_cols=240  Identities=25%  Similarity=0.438  Sum_probs=205.0

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (473)
                      .||+|+||.+     ..+|..||+|++.............+.+|+.+++.++||||++++++|..++..|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            5788988855     34688999999986543344556778899999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccc
Q 011991          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV  351 (473)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~  351 (473)
                      |..++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......      ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~------~~~  152 (323)
T cd05595          82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------ATM  152 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC------Ccc
Confidence            9999988888999999999999999999999999   9999999999999999999999999986432211      112


Q ss_pred             cCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHH
Q 011991          352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE  431 (473)
Q Consensus       352 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~  431 (473)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......     .+..+++++.++|.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~-----~p~~~~~~~~~li~  227 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-----FPRTLSPEAKSLLA  227 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCCHHHHHHHH
Confidence            2345889999999999999999999999999999999999999988877776666433221     24568899999999


Q ss_pred             HccCCCCCCCC-----CHHHHHHH
Q 011991          432 ECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       432 ~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +||..||++||     ++.++++|
T Consensus       228 ~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         228 GLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHccCCHHHhCCCCCCCHHHHHcC
Confidence            99999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.2e-41  Score=325.91  Aligned_cols=248  Identities=25%  Similarity=0.314  Sum_probs=201.6

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |+..+.||+|+||.+     ..+|+.||+|.+.............+.+|+.+++.++|++|+++++++..++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            456678999999865     356899999999765433334445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            9999999888653  35899999999999999999999999   9999999999999999999999999987542211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........ ...+..+++
T Consensus       157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~  230 (285)
T cd05631         157 -----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-EEYSEKFSE  230 (285)
T ss_pred             -----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-ccCCccCCH
Confidence                 11234588999999999999999999999999999999999999987654332222211111111 123456889


Q ss_pred             HHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      ++.+|+++||+.||.+||+     ++++++|
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            9999999999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-42  Score=340.45  Aligned_cols=240  Identities=27%  Similarity=0.397  Sum_probs=213.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .+|+..+.+|+|+||.|     +.+++.+|||++++...-..+.++..+.|..++.... ||.+++++++|++..++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            47888899999999976     5678899999999988877888899999999999885 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+.||++..+ ...+.+++..+..++..|+.||.|||++|   ||+||||.+|||+|.+|.+||+|||+++.....+ 
T Consensus       448 mey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-  522 (694)
T KOG0694|consen  448 MEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-  522 (694)
T ss_pred             EEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC-
Confidence            999999995443 34467999999999999999999999999   9999999999999999999999999997543221 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           ...+++.|||.|+|||++.+..|+.++|.|||||+||||+.|..||++.+.+++++.|......     -|..+|
T Consensus       523 -----~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~-----yP~~ls  592 (694)
T KOG0694|consen  523 -----DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR-----YPRFLS  592 (694)
T ss_pred             -----CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-----CCCccc
Confidence                 2346788999999999999999999999999999999999999999999999999998654322     255789


Q ss_pred             HHHHHHHHHccCCCCCCCCCH
Q 011991          424 PDLKELIEECWDPKPVIRPNF  444 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~  444 (473)
                      .+..++++++|.+||.+|..+
T Consensus       593 ~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  593 KEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHHHHhccCcccccCC
Confidence            999999999999999999776

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.7e-42  Score=306.58  Aligned_cols=249  Identities=27%  Similarity=0.436  Sum_probs=212.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCc
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESH-----KDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~-----~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  259 (473)
                      .|.-.+.+|.|+.+++     +.+|+.+|+|++.....     ......+.-..|+.+++++ .||+|+++.++++.+..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            4555667888877643     67899999999864221     1233456778899999999 69999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      +++|+|.|+.|.|.+++...-.+++...+.+++|++.|++|||.++   |+||||||+|||++++.++||+|||+|+...
T Consensus        98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999999998878999999999999999999999999   9999999999999999999999999998664


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN------EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      ..+       .....+|||+|+|||.+..      .+|+..+|+|++|++||.|+.|.+||......-++..| ..|...
T Consensus       175 ~Ge-------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I-meGkyq  246 (411)
T KOG0599|consen  175 PGE-------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI-MEGKYQ  246 (411)
T ss_pred             Cch-------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH-Hhcccc
Confidence            432       2355779999999998854      37889999999999999999999999766555555555 556555


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .....+.+++...++||++||+.||.+|.|++|.|.|
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            5556688899999999999999999999999999876

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.1e-41  Score=331.68  Aligned_cols=240  Identities=26%  Similarity=0.429  Sum_probs=205.1

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (473)
                      .||+|+|+.+     ..+|+.||+|++.............+.+|+.+++.++||||+++++++..++..|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5788888755     34688999999986544445556788999999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccc
Q 011991          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV  351 (473)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~  351 (473)
                      |.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......      ...
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~------~~~  152 (328)
T cd05593          82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA------ATM  152 (328)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc------ccc
Confidence            9999988888999999999999999999999999   9999999999999999999999999986432211      112


Q ss_pred             cCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHH
Q 011991          352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE  431 (473)
Q Consensus       352 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~  431 (473)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ..   .+..+++++.+||+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~---~p~~~~~~~~~li~  227 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IK---FPRTLSADAKSLLS  227 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--cc---CCCCCCHHHHHHHH
Confidence            33468999999999999899999999999999999999999998887776666553222  11   24568899999999


Q ss_pred             HccCCCCCCCC-----CHHHHHHH
Q 011991          432 ECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       432 ~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +||..||++||     ++.++++|
T Consensus       228 ~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         228 GLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHcCCCHHHcCCCCCCCHHHHhcC
Confidence            99999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=329.27  Aligned_cols=239  Identities=25%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             eeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       198 ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      ||+|+|+.+     ..+++.||+|++.............+..|+.+++.++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            577777754     235789999999754433445567788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccccc
Q 011991          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS  352 (473)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~  352 (473)
                      .+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||+++.......      ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------~~~  151 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------KTN  151 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------ccc
Confidence            999988888999999999999999999999999   99999999999999999999999999875322111      123


Q ss_pred             CCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHH
Q 011991          353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE  432 (473)
Q Consensus       353 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~  432 (473)
                      ...||+.|+|||++.+..++.++||||+||++|+|++|..||...+..+....+.....     ..+..+++.+.+++.+
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~  226 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-----RFPDGFDRDAKDLLIG  226 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----CCCCcCCHHHHHHHHH
Confidence            34689999999999999999999999999999999999999998888777766643221     1245688999999999


Q ss_pred             ccCCCCCCCCC---HHHHHHH
Q 011991          433 CWDPKPVIRPN---FNEIIAR  450 (473)
Q Consensus       433 cl~~dP~~RPs---~~ell~~  450 (473)
                      ||..||.+||+   +.+++.|
T Consensus       227 ~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         227 LLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HcCCCHHHcCCCCCHHHHHcC
Confidence            99999999975   5676654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.3e-41  Score=332.78  Aligned_cols=244  Identities=20%  Similarity=0.341  Sum_probs=209.1

Q ss_pred             HHhhccCceeeeEEEEE---Ee--c-CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA---KW--N-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~--~-~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .+|.+.+.||.|+|+.+   ..  . +..||+|.+...........+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            36788889999999855   21  2 258999999754433445567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+.+|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            999999999999998888999999999999999999999999   999999999999999999999999998754221  


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                             .....||+.|+|||++.+..++.++|||||||++|+|++|..||...++......+......     .+..++
T Consensus       185 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~~  252 (340)
T PTZ00426        185 -------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-----FPKFLD  252 (340)
T ss_pred             -------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCC
Confidence                   12345889999999999888999999999999999999999999988877777666433211     245678


Q ss_pred             HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +.+.++|++||+.||.+|+     +++++++|
T Consensus       253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            8999999999999999995     89998876

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-41  Score=316.08  Aligned_cols=254  Identities=26%  Similarity=0.358  Sum_probs=213.4

Q ss_pred             HhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+++.+.+|.|..|.|   .  .++..+|+|++.++.........+...|.+||+.++||.++.++..|+.+...|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            5677778898877654   3  3458999999998887778888999999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC--
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS--  341 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~--  341 (473)
                      ||+||+|..++++.  +.+++..++.++.+++.||+|||-.|   ||+|||||+||||.++|+|.|+||.++......  
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999998764  56999999999999999999999999   999999999999999999999999997532110  


Q ss_pred             ------------------------------ccc------------------ccccccccCCCCCCcccCCCCcCCCCCCC
Q 011991          342 ------------------------------PEK------------------AKIVFPVSHIDPANLYVAPEIYKNEEFDR  373 (473)
Q Consensus       342 ------------------------------~~~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  373 (473)
                                                    ..+                  .........+.||-.|.|||++.+.+.+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          000                  00001223567888999999999999999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 011991          374 SVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN----FNEIIA  449 (473)
Q Consensus       374 ~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ell~  449 (473)
                      ++|.|+||+++|||+.|..||.+.+..+.+..|.....  .++. ...++..+++||++.|.+||++|..    +.||-+
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l--~Fp~-~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL--KFPE-EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC--cCCC-CCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            99999999999999999999999999998888754332  2222 2256789999999999999999988    787755


Q ss_pred             H
Q 011991          450 R  450 (473)
Q Consensus       450 ~  450 (473)
                      |
T Consensus       392 H  392 (459)
T KOG0610|consen  392 H  392 (459)
T ss_pred             C
Confidence            4

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-40  Score=332.59  Aligned_cols=254  Identities=27%  Similarity=0.475  Sum_probs=207.0

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      .+|.+.+.+|.|+||.+.          .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            467788999999998652          123579999997543  234567789999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHc-----------------------------------------------------------
Q 011991          259 PMMIVLEYHAKGDLASYLQKK-----------------------------------------------------------  279 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------------  279 (473)
                      ..++||||+++|+|.+++...                                                           
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999998542                                                           


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          280 -----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       280 -----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                                 ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++........    
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----  268 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----  268 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce----
Confidence                       13677889999999999999999999   999999999999999999999999998754322110    


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||...............+..+.   .+..+++++.
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  345 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS---RPDFAPPEIY  345 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc---CCCCCCHHHH
Confidence            11122234567999999988899999999999999999997 9999987665554444434433322   2445689999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          428 ELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       428 ~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      +++.+||+.||.+|||+.++++.|++++
T Consensus       346 ~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         346 SIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.4e-40  Score=332.05  Aligned_cols=252  Identities=27%  Similarity=0.490  Sum_probs=205.1

Q ss_pred             HhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCc
Q 011991          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  259 (473)
                      +|++.+.||+|+||.+.          .++..||||++....  .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            57778999999998662          235589999997543  233456789999999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcC-----------------------------------------------------------
Q 011991          260 MMIVLEYHAKGDLASYLQKKG-----------------------------------------------------------  280 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  280 (473)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986421                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          281 ----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       281 ----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                                      .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                            3678889999999999999999999   999999999999999999999999998755332110


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                          .......++..|+|||++.+..++.++|||||||++|+|++ |..||...............+..+.   .+...+
T Consensus       271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  343 (375)
T cd05104         271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML---SPECAP  343 (375)
T ss_pred             ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC---CCCCCC
Confidence                01112234567999999999999999999999999999997 8999987765544444434443332   234567


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .++.+|+.+||+.||++|||+.||++.|++.
T Consensus       344 ~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         344 SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            8999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-41  Score=335.98  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=209.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+|+.||||++.............+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            4667788999999865     24688999999976433334555778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++..........
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999986542211000


Q ss_pred             cc--------------------------------cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 011991          346 KI--------------------------------VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP  393 (473)
Q Consensus       346 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~p  393 (473)
                      ..                                ........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence            00                                0001123589999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 011991          394 FHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN---FNEIIAR  450 (473)
Q Consensus       394 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~  450 (473)
                      |...+..+....+.........+ ....+++++.+||++|+. +|.+|++   +++++.|
T Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         239 FCSDNPQETYRKIINWKETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCHHHHHHHHHcCCCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99988877776664433222221 123578999999999996 9999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-40  Score=335.23  Aligned_cols=255  Identities=21%  Similarity=0.297  Sum_probs=207.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.||+|+||.+     ..+++.||+|++.............+.+|+++++.++||||+++++++.+++.+|+||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            567788999999866     346789999999865544455667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +++|+|.+++...+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...........
T Consensus        83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          83 IPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            999999999988888999999999999999999999999   99999999999999999999999999753311100000


Q ss_pred             -----------------------------------------ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHH
Q 011991          347 -----------------------------------------IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY  385 (473)
Q Consensus       347 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~  385 (473)
                                                               .........||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                     000012346899999999999889999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHcc--CCCCCCCCCHHHHHHH
Q 011991          386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECW--DPKPVIRPNFNEIIAR  450 (473)
Q Consensus       386 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~RPs~~ell~~  450 (473)
                      ||++|..||...+..+....+.........+ ....+++++.+||.+|+  ..+|..||++++++.|
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999999999887766665554322222221 13357899999999954  5566669999999886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-40  Score=332.82  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=207.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|+..+.||+|+||.+     ..+++.||+|++.............+..|+.+++.++||||+++++.+.+...+|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            3667788999999865     34688999999976443334455778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++||+|.+++...+.+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++.........
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999987542211000


Q ss_pred             -----------------------------cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 011991          346 -----------------------------KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP  396 (473)
Q Consensus       346 -----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~  396 (473)
                                                   ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                         000001234689999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCC---CCCCHHHHHHH
Q 011991          397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPV---IRPNFNEIIAR  450 (473)
Q Consensus       397 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~---~RPs~~ell~~  450 (473)
                      .+..+....+.........+. ...+++++.++|.+++. +|.   .||+++||++|
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            888887777754332222211 22468899999998765 444   46899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.8e-40  Score=324.55  Aligned_cols=250  Identities=24%  Similarity=0.428  Sum_probs=205.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.+|.|+|+.+     ..++..+|+|++..+.  .....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            35777888999999865     2367889999997542  3455678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.++|+|||++......   
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            99999999999988878999999999999999999999863  2999999999999999999999999998654321   


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC--------------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG--------------  410 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~--------------  410 (473)
                           ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+....              
T Consensus       158 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             -----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence                 1123458889999999999899999999999999999999999998766554432221000              


Q ss_pred             -----------------------------CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          411 -----------------------------KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       411 -----------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                                                   ...........+++++.+||.+||..||++|||++++++|-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                         00000111224688999999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.2e-40  Score=314.78  Aligned_cols=251  Identities=27%  Similarity=0.485  Sum_probs=209.3

Q ss_pred             HHhhccCceeeeEEEEE---E-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          190 LQVRKADGITKGSYQVA---K-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+|++.+.||+|+||.+   .     ..+..||+|.+....  .......+.+|+.+++.++||||+++++++..++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            45778889999999866   1     235689999997543  3444578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+++|+|.+++... +.+++..++.++.|++.||+|||+++   ++||||||+||+++.++.++++|||.+.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999774 56899999999999999999999999   99999999999999999999999998754321


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ..     ........++..|+|||.+.+..++.++|||||||++|++++ |..||...+..+....+. .+..++   .+
T Consensus       160 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~  230 (266)
T cd05064         160 EA-----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLP---AP  230 (266)
T ss_pred             cc-----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCC---CC
Confidence            11     011112234567999999998999999999999999999875 999999888877776663 332222   25


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      ..++..+.+++.+||+.+|.+||++++|++.|.++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            67889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-41  Score=336.46  Aligned_cols=255  Identities=22%  Similarity=0.315  Sum_probs=207.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.||||++.............+.+|+++++.++||||+++++++.++...|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            3667788999999865     34788999999975433334556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..++.++.|++.||+|||++|   |+||||||+|||++.++.+||+|||+++.........
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999986332110000


Q ss_pred             ----------cc-------------------------------cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHH
Q 011991          346 ----------KI-------------------------------VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL  384 (473)
Q Consensus       346 ----------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l  384 (473)
                                ..                               ........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                      00                               0000124589999999999998999999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 011991          385 YEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR---PNFNEIIAR  450 (473)
Q Consensus       385 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~  450 (473)
                      |+|++|..||...+..+....+.........+ ....+++++.+||++|+. +|.+|   +++.+++.|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            99999999999888777766664433222221 123578999999999997 77776   599999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=321.25  Aligned_cols=243  Identities=23%  Similarity=0.438  Sum_probs=212.9

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      -|...+-+|+|-|.++     ..+|+.||||++.+.... .-....+..|+..|+.++|||||++|++...+..+|||+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4666778999999876     579999999999876553 3344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE-cCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili-~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +-++|+|++||.++ ..+.+..+.+++.||+.|+.|+|...   +|||||||+||.+ .+-|-|||.|||++..+...  
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--  172 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence            99999999999875 45999999999999999999999999   9999999999987 46789999999998654322  


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                           ......+|+..|.|||++.+..|+ +++||||||+++|-|.+|..||+..+..+.+-.|....+..     |..+
T Consensus       173 -----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv-----Pshv  242 (864)
T KOG4717|consen  173 -----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV-----PSHV  242 (864)
T ss_pred             -----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC-----chhh
Confidence                 224456788999999999999998 79999999999999999999999999988888776666543     5678


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      +.++++||..||.+||++|.+.+||..
T Consensus       243 S~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  243 SKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            999999999999999999999999865

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-41  Score=334.67  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=211.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+|+.||+|++.............+..|++++..++||||+++++++.+++..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            4667788999999865     23589999999986543333456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc--
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE--  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~--  343 (473)
                      |+++++|.+++...+.+++..++.++.|++.||+|||++|   |+||||||+|||++.++.+||+|||++........  
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999876543320  


Q ss_pred             ---------------------cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011991          344 ---------------------KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV  402 (473)
Q Consensus       344 ---------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~  402 (473)
                                           ............||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                 00001122345689999999999999999999999999999999999999998887777


Q ss_pred             HHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 011991          403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN-FNEIIAR  450 (473)
Q Consensus       403 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~  450 (473)
                      ...+.........+. ...+++++.+||.+|+. ||.+||+ +++++++
T Consensus       239 ~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 YNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            766644222222211 22378999999999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.5e-41  Score=329.94  Aligned_cols=240  Identities=25%  Similarity=0.445  Sum_probs=204.3

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (473)
                      .+|+|+||.+     ..+|+.||+|++.............+..|+++++.++||||+++++++..++..|+||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            5788988855     24788999999986544444556778899999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      |.+++...+.+++..+..++.||+.||.|||+ ++   |+||||||+|||++.++.+||+|||+++.......      .
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~------~  152 (325)
T cd05594          82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA------T  152 (325)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc------c
Confidence            99999888889999999999999999999997 68   99999999999999999999999999864322111      1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......     .+..+++++.+|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~~~~~~~li  227 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-----FPRTLSPEAKSLL  227 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCCHHHHHHH
Confidence            22345899999999999989999999999999999999999999988877766665332211     2456889999999


Q ss_pred             HHccCCCCCCCC-----CHHHHHHH
Q 011991          431 EECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       431 ~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      ++||..||++|+     ++.++++|
T Consensus       228 ~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         228 SGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=324.84  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=220.6

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceE
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  261 (473)
                      ....|.+...+|.|.|+.+     ..+|+.+|+|++.+.........+.+.+|+.+|+.+. |||||.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3456888899999999866     4569999999998877665556678999999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC----CcEEEEeeccccc
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG----GQLKISGFGLLRL  337 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~----~~vkl~DfG~a~~  337 (473)
                      +|||+|.||.|.+.+... .+++..+..++.|++.++.|||+.|   |+||||||+|+|+...    +.+|++|||+|..
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999876 4999999999999999999999999   9999999999999643    4799999999987


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      ....       .......||+.|+|||++...+|+..+||||+|+++|.|++|..||.+.+.......+..... .....
T Consensus       189 ~~~~-------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-~f~~~  260 (382)
T KOG0032|consen  189 IKPG-------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-DFTSE  260 (382)
T ss_pred             ccCC-------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-CCCCC
Confidence            6441       223456799999999999999999999999999999999999999999998888887744433 33334


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+..++..+.+||++|+..||..|+++.++|+|
T Consensus       261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            577889999999999999999999999999995

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-39  Score=318.08  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=203.2

Q ss_pred             HHhhccCceeeeEEEEEEe---------------------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeee
Q 011991          190 LQVRKADGITKGSYQVAKW---------------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV  248 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~---------------------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  248 (473)
                      ..|.+.+.||.|+||.+..                     ++..||+|.+....  .......+.+|+.++.+++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence            3577788899999986521                     23479999997543  345567899999999999999999


Q ss_pred             eEEeeEeeCCceEEEEeccCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 011991          249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-------------------RLSPSKVLRFALDLARGMNYLHECKPDPI  309 (473)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  309 (473)
                      ++++++...+..++||||+++|+|.+++....                   .+++..++.++.|++.||.|||+.+   |
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence            99999999999999999999999999986532                   2577889999999999999999999   9


Q ss_pred             EeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh
Q 011991          310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE  389 (473)
Q Consensus       310 iH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~  389 (473)
                      +||||||+|||++.++.+||+|||+++........    .......++..|+|||++.+..++.++|||||||++|+|++
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCcee----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence            99999999999999999999999998754332110    11122345678999999988889999999999999999986


Q ss_pred             --CCCCCCCCChHHHHHHHHhh---CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          390 --GVQPFHPKPPEEVVKLMCCE---GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       390 --g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                        +..||...+..+....+...   .........+..+++.+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence              66788877766655443221   1111111234567899999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-40  Score=325.71  Aligned_cols=240  Identities=25%  Similarity=0.400  Sum_probs=201.6

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||+|+||.+     ..+++.||+|++...........+.+..|..++..+ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5788888755     246789999999764333334556778898998877 6999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......      ..
T Consensus        82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~------~~  152 (320)
T cd05590          82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG------KT  152 (320)
T ss_pred             hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC------Cc
Confidence            99999988888999999999999999999999999   9999999999999999999999999986432111      11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .   .+..+++++.+++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--~---~~~~~~~~~~~li  227 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--V---YPTWLSQDAVDIL  227 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--C---CCCCCCHHHHHHH
Confidence            2334689999999999998999999999999999999999999999888887777643221  1   2446789999999


Q ss_pred             HHccCCCCCCCCCH------HHHHHH
Q 011991          431 EECWDPKPVIRPNF------NEIIAR  450 (473)
Q Consensus       431 ~~cl~~dP~~RPs~------~ell~~  450 (473)
                      ++||+.||.+||++      ++++.|
T Consensus       228 ~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         228 KAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             HHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            99999999999998      555553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.9e-40  Score=319.36  Aligned_cols=251  Identities=20%  Similarity=0.293  Sum_probs=200.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+     ..+++.+|+|++..... .....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4667788999988754     24678999999976432 23345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++++++..+....+.+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......... 
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  156 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-  156 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence            9998777666555567999999999999999999999999   999999999999999999999999998765322111 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC------------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP------------  413 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------  413 (473)
                          ......|++.|+|||++.+..++.++||||+||++|+|++|+.||...+..+....+.......            
T Consensus       157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         157 ----NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             ----cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence                1223457889999999998889999999999999999999999998876554433332111000            


Q ss_pred             --------CCc-------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 --------PLK-------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 --------~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                              ...       .....+|+++.+|+++||..||++|||++++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                    000       0012367889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.5e-41  Score=336.17  Aligned_cols=255  Identities=22%  Similarity=0.289  Sum_probs=207.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||.|+|+.+     ..+++.||+|++.............+.+|+++++.++||||+++++.+..++.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            4677889999999865     34688999999975433333445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc-
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK-  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~-  344 (473)
                      |+++|+|.+++...+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...... 
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999997432100000 


Q ss_pred             ------------------------------------ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHH
Q 011991          345 ------------------------------------AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI  388 (473)
Q Consensus       345 ------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell  388 (473)
                                                          ...........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                00000112346899999999999999999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 011991          389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP---NFNEIIAR  450 (473)
Q Consensus       389 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ell~~  450 (473)
                      +|..||......+....+.........+ ....+++.+.++|.+|+ .+|.+|+   ++.++++|
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAETQLKVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999888776666553332222211 12357899999999976 5999999   89999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-40  Score=323.43  Aligned_cols=241  Identities=24%  Similarity=0.402  Sum_probs=202.5

Q ss_pred             CceeeeEEEEEE--------ecCcEEEEEEEcCCCC-CCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          196 DGITKGSYQVAK--------WNGTKVWVKILDKESH-KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       196 ~~ig~G~~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +.||+|+||.+.        ..++.||+|++..... ........+..|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            468999998552        3578999999975322 1223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  155 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---  155 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC---
Confidence            999999999988888999999999999999999999999   99999999999999999999999999864322111   


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHH
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL  426 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  426 (473)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....  ..   .+..+++.+
T Consensus       156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~---~~~~~~~~~  227 (323)
T cd05584         156 ---VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LN---LPPYLTPEA  227 (323)
T ss_pred             ---cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC---CCCCCCHHH
Confidence               1123458999999999999889999999999999999999999999888777666653322  11   245678999


Q ss_pred             HHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          427 KELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       427 ~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      .+||.+||..||++||     ++++++.+
T Consensus       228 ~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             HHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            9999999999999999     88988775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-40  Score=331.72  Aligned_cols=244  Identities=25%  Similarity=0.369  Sum_probs=203.2

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-C-----CeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-H-----PNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~~~~  258 (473)
                      .+|.+.+.||+|+||-|     ..+++.||||+++..    .....+...|+.+|..|+ |     -|+|+++++|...+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            37889999999999854     357899999999854    455677788999999996 4     38999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC--cEEEEeecc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKISGFGL  334 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~--~vkl~DfG~  334 (473)
                      ++|||+|.++. +|+++++.+  ..++...++.|+.||+.||.+||+.+   |||+||||+|||+.+.+  .|||+|||+
T Consensus       262 HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  262 HLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             ceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence            99999999965 999999886  34899999999999999999999999   99999999999997654  699999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      |++....         ...+..++.|+|||++.+.+|+.+.||||||||++||++|.+.|++.+..+.+..|......|+
T Consensus       338 Sc~~~q~---------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  338 SCFESQR---------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             ccccCCc---------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence            9876433         2255678889999999999999999999999999999999999999888777666543322221


Q ss_pred             Ccc-----------------------------------------------cCC-----------CCCHHHHHHHHHccCC
Q 011991          415 LKI-----------------------------------------------KAR-----------SYPPDLKELIEECWDP  436 (473)
Q Consensus       415 ~~~-----------------------------------------------~~~-----------~~~~~l~~li~~cl~~  436 (473)
                      ...                                               .|.           .-...+.+|+++||..
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence            100                                               010           1124589999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 011991          437 KPVIRPNFNEIIAR  450 (473)
Q Consensus       437 dP~~RPs~~ell~~  450 (473)
                      ||.+|+|+.|.++|
T Consensus       489 dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  489 DPAERITPAQALNH  502 (586)
T ss_pred             CchhcCCHHHHhcC
Confidence            99999999999886

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.7e-40  Score=325.20  Aligned_cols=245  Identities=24%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEe
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      |.+.+.||+|+||.+     ..+++.||+|++...........+.+..|..++..+ .||+|+++++++...+.+++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            566778999999865     235679999999865433444556678888888887 48999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......   
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~---  155 (323)
T cd05616          82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---  155 (323)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC---
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999986432211   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....  .   .+..++++
T Consensus       156 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~---~p~~~s~~  227 (323)
T cd05616         156 ---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--A---YPKSMSKE  227 (323)
T ss_pred             ---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--C---CCCcCCHH
Confidence               112345689999999999999999999999999999999999999999888887777644322  1   24568899


Q ss_pred             HHHHHHHccCCCCCCCCCH-----HHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNF-----NEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~-----~ell~~  450 (473)
                      +.+++.+||+.||.+|+++     .+++++
T Consensus       228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         228 AVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            9999999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-40  Score=332.80  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.||+|+||.+     ..+++.||+|++.............+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            567788999999865     346789999999764433445567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc-
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA-  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~-  345 (473)
                      +++|+|.+++...+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.......... 
T Consensus        83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          83 IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            999999999988878999999999999999999999999   9999999999999999999999999975321100000 


Q ss_pred             ----------------------------------------cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHH
Q 011991          346 ----------------------------------------KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY  385 (473)
Q Consensus       346 ----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~  385 (473)
                                                              ..........||+.|+|||++.+..++.++||||+||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~  239 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  239 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence                                                    0000012346899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 011991          386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN---FNEIIAR  450 (473)
Q Consensus       386 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~  450 (473)
                      +|++|..||...++.+....+.........+ ....+++++.++|.+|+ .+|.+|++   +.+++.|
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            9999999999888777666654333222221 23457899999999976 59999987   8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.9e-40  Score=317.56  Aligned_cols=248  Identities=26%  Similarity=0.400  Sum_probs=199.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+     ..++..||+|.+......  .....+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            4777789999999865     346889999999754321  223467889999999999999999999999889999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++ +|.+++...+ .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            9975 9999987654 4789999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc-------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK-------  416 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------  416 (473)
                           ......+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+......+...       
T Consensus       159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence                 1223457888999998865 568999999999999999999999999887766655543322211110       


Q ss_pred             ------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 ------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                        .....+++++.+|+++||+.||.+|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                              0012457889999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-40  Score=325.14  Aligned_cols=251  Identities=26%  Similarity=0.401  Sum_probs=197.8

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----CceE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~  261 (473)
                      |.+.+.+|.|+|+.+     ..+|..||||.+..... .......+.+|+++++.++||||+++++++...     ...|
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            667788999999754     34689999999874322 233345788999999999999999999987543     2479


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+. ++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9999995 699999988888999999999999999999999999   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC-------
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR-------  412 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~-------  412 (473)
                      ....   .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+......       
T Consensus       157 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         157 TPTA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             cCcc---ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            1111   11234568999999999865  57899999999999999999999999876644332222111100       


Q ss_pred             -------------------CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 -------------------PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 -------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         .........+++.+.+++.+||+.||++||+++|++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                               01111123567889999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.8e-40  Score=322.39  Aligned_cols=239  Identities=28%  Similarity=0.469  Sum_probs=199.0

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||+|+||.+     ..+++.||+|++...........+.+..|..++..+ +||||+++++++..+...++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5889998865     245788999999764333334445566777777655 7999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++......      ..
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~------~~  152 (316)
T cd05592          82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE------GK  152 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC------Cc
Confidence            99999988888999999999999999999999999   9999999999999999999999999986532221      11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...  .+.   .+..+++++.+++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~---~~~~~~~~~~~ll  227 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPH---FPRWISKEAKDCL  227 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---CCCCCCHHHHHHH
Confidence            23446899999999999989999999999999999999999999998887777766332  222   2456789999999


Q ss_pred             HHccCCCCCCCCCHH-HHHH
Q 011991          431 EECWDPKPVIRPNFN-EIIA  449 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~-ell~  449 (473)
                      .+||+.||++||++. ++++
T Consensus       228 ~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         228 SKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             HHHccCCHHHcCCChHHHHc
Confidence            999999999999875 5554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-39  Score=312.60  Aligned_cols=250  Identities=30%  Similarity=0.539  Sum_probs=207.9

Q ss_pred             HhhccCceeeeEEEEEE---e-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +|++.+.+|.|+|+.+.   .       ....||+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            56677889999887542   1       22579999987543  345567899999999999999999999999998899


Q ss_pred             EEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC
Q 011991          261 MIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~  324 (473)
                      +++|||+++++|.+++...                ..+++..++.++.|++.||.|||+++   ++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            9999999999999999764                34788899999999999999999999   9999999999999999


Q ss_pred             CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV  403 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  403 (473)
                      +.++|+|||+++........    .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CcEEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999998754332110    11122345678999999988889999999999999999997 99999988887777


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      ..+.. +..+.   .+..+|+++.+|+.+||+.||.+||++.||+++|+.
T Consensus       237 ~~i~~-~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRS-RQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHc-CCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            66643 32222   356789999999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.9e-40  Score=322.50  Aligned_cols=245  Identities=24%  Similarity=0.384  Sum_probs=205.1

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCC-eeeeEEeeEeeCCceEEEEe
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-NVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e  265 (473)
                      |.+.+.||.|+||.+     ..+++.||+|++...........+.+..|..++..+.|+ +|+++++++...+.+|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            567788999999865     235678999999865433344567788999999999765 68889999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........  
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  156 (324)
T cd05587          82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--  156 (324)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999864321111  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+....  +.   .+..++++
T Consensus       157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~---~~~~~~~~  227 (324)
T cd05587         157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VS---YPKSLSKE  227 (324)
T ss_pred             ----ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC---CCCCCCHH
Confidence                1223458899999999999999999999999999999999999999888887777764322  11   24567899


Q ss_pred             HHHHHHHccCCCCCCCCCH-----HHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNF-----NEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~-----~ell~~  450 (473)
                      +.+++++||..||.+|++.     +++++|
T Consensus       228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         228 AVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            9999999999999999986     666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.3e-40  Score=323.55  Aligned_cols=240  Identities=23%  Similarity=0.373  Sum_probs=202.8

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||.|+||.+     ..+++.||+|++...........+.+..|.++++.+ +||||+++++++..++..|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5788888754     235789999999765433444556778899999876 7999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|..++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......      .
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~------~  152 (321)
T cd05591          82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV------T  152 (321)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc------c
Confidence            99999988888999999999999999999999999   99999999999999999999999999864322111      1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......     .+..+++++.+++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~~~~~~~ll  227 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-----YPVWLSKEAVSIL  227 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCCHHHHHHH
Confidence            22345889999999999989999999999999999999999999998888877776433211     2345789999999


Q ss_pred             HHccCCCCCCCC-------CHHHHHHH
Q 011991          431 EECWDPKPVIRP-------NFNEIIAR  450 (473)
Q Consensus       431 ~~cl~~dP~~RP-------s~~ell~~  450 (473)
                      .+||..||++||       +++++++|
T Consensus       228 ~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         228 KAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            999999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.3e-40  Score=306.17  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=206.4

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCe-eeeEEeeEeeCC-----
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN-VVQFVGAVTQNI-----  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~-----  258 (473)
                      ..|....++|.|+|++|     +.+|+.||+|.+..+... +-.-....+|+.+++.|+|+| |+.+++++....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            35667778999999865     568899999999865432 112245689999999999999 999999998876     


Q ss_pred             -ceEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          259 -PMMIVLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                       .+++|+||++. +|.+++....    .++...++.+++||+.||+|||+++   |+||||||+||||++.|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             79999999976 9999998754    4788899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +|+......      ...++..+|..|+|||++.+. .|+...||||+||+++||++++..|++.+..+.+..|......
T Consensus       166 lAra~~ip~------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  166 LARAFSIPM------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             hHHHhcCCc------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            998654321      123455678889999998876 8999999999999999999999999999988777777655544


Q ss_pred             CCCcc-----------------c-C-------CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPLKI-----------------K-A-------RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~~~-----------------~-~-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |....                 . +       +..+++..+++.+|++.+|.+|.|++.++.|
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            42210                 0 1       1123578999999999999999999999987

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.3e-40  Score=321.12  Aligned_cols=239  Identities=28%  Similarity=0.441  Sum_probs=198.6

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||+|+|+.+     ..+|+.||+|++...........+.+..|..++..+ +||||+++++++..++..|+||||+.+|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            5788888755     346789999999764322223345667788888765 8999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..+..++.|++.||+|||++|   |+||||||+|||++.++.++|+|||+++......      ..
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~  152 (316)
T cd05620          82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD------NR  152 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC------Cc
Confidence            99999988888999999999999999999999999   9999999999999999999999999986422111      11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|..||...+..+....+....  +.   .+..+++++.++|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~li  227 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PH---YPRWITKESKDIL  227 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC---CCCCCCHHHHHHH
Confidence            234568999999999999999999999999999999999999999888877776663322  21   2445789999999


Q ss_pred             HHccCCCCCCCCCHH-HHHH
Q 011991          431 EECWDPKPVIRPNFN-EIIA  449 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~-ell~  449 (473)
                      .+||..||++||++. ++++
T Consensus       228 ~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         228 EKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             HHHccCCHHHcCCChHHHHc
Confidence            999999999999984 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.7e-40  Score=322.15  Aligned_cols=244  Identities=26%  Similarity=0.398  Sum_probs=201.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHH---HhcCCCeeeeEEeeEeeCCceEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIV---EKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      |++.+.||.|+|+.+     ..+++.||||++...........+.+..|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            455678999999855     246889999999865433334456677776665   456799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+++++|..++.. +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-  155 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence            999999999988864 46999999999999999999999999   9999999999999999999999999986432211 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+......     .+..++
T Consensus       156 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-----~p~~~~  225 (324)
T cd05589         156 -----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-----YPRFLS  225 (324)
T ss_pred             -----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCCCCC
Confidence                 1123456889999999999999999999999999999999999999988887777766443221     245678


Q ss_pred             HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +.+.++|.+||+.||.+||     ++.+++++
T Consensus       226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            9999999999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.2e-40  Score=322.60  Aligned_cols=240  Identities=27%  Similarity=0.440  Sum_probs=197.1

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||+|+|+.+     ..+++.||+|++.............+..|..+++.+ +||||+++++++.....+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5788888755     246789999999875544455567788999999998 6999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......      ..
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~------~~  152 (329)
T cd05588          82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG------DT  152 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC------Cc
Confidence            99999988888999999999999999999999999   9999999999999999999999999986421111      11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHhhCCCCCCcccCCC
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP--------PEE-VVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--------~~~-~~~~i~~~~~~~~~~~~~~~  421 (473)
                      .....||+.|+|||++.+..++.++|+|||||++|+|++|..||....        ... ....+ ... ...   .+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~-~~~---~p~~  227 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEK-QIR---IPRS  227 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-HcC-CCC---CCCC
Confidence            234568999999999999999999999999999999999999996321        111 22222 221 111   2456


Q ss_pred             CCHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPN------FNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs------~~ell~~  450 (473)
                      +++.+.+++++||+.||.+||+      ++++++|
T Consensus       228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            7899999999999999999998      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.6e-39  Score=317.77  Aligned_cols=248  Identities=25%  Similarity=0.459  Sum_probs=201.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.+|.|+|+.+     ..++..+|+|++....  .......+.+|+++++.++||||++++++|..++..++||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            46788889999999865     2367889999987542  3445577999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+.+++|.+++...+.+++..+..++.|++.||.|||+. +   |+|+||||+|||++.++.+||+|||++....... 
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999998888899999999999999999999985 5   9999999999999999999999999986542211 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC-------------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG-------------  410 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~-------------  410 (473)
                             .....++..|+|||++.+..++.++|||||||++|+|++|..||...........+....             
T Consensus       159 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         159 -------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             -------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence                   122457889999999998889999999999999999999999998665443322110000             


Q ss_pred             ----------------------------CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 ----------------------------KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ----------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                                  ..+........+++++.+|+.+||+.||++|||++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                        0000001112357889999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.9e-40  Score=327.63  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=207.8

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+|+.+     ..+++.||+|++.............+..|+.+++.++||||+++++++..+...|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            46788889999999865     2468899999997543333344566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++|+|.+++... .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........ 
T Consensus       123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-  197 (370)
T cd05596         123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-  197 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence            999999999998764 5889999999999999999999999   99999999999999999999999999875432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE----EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                          .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+.......+.........+ ...
T Consensus       198 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~  272 (370)
T cd05596         198 ----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP-DDI  272 (370)
T ss_pred             ----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC-CcC
Confidence                112345689999999998653    47899999999999999999999999988877777765433222221 123


Q ss_pred             CCCHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVI--RPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~--RPs~~ell~~  450 (473)
                      .+|.++.+||++||..+|.+  ||+++++++|
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            57899999999999999988  9999999886

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.9e-40  Score=320.84  Aligned_cols=240  Identities=26%  Similarity=0.436  Sum_probs=202.1

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||.|+|+.+     ..+++.||+|++.............+..|..+++.+ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5788888755     235789999999865433344556778899999888 6999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.......      .
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~  152 (318)
T cd05570          82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV------T  152 (318)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC------c
Confidence            99999988888999999999999999999999999   99999999999999999999999999864221111      1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....  .   .+..+++.+.+||
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~---~~~~~~~~~~~li  227 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--R---YPRWLSKEAKSIL  227 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--C---CCCcCCHHHHHHH
Confidence            1234578899999999999999999999999999999999999998887777666643221  1   2456789999999


Q ss_pred             HHccCCCCCCCCCH-----HHHHHH
Q 011991          431 EECWDPKPVIRPNF-----NEIIAR  450 (473)
Q Consensus       431 ~~cl~~dP~~RPs~-----~ell~~  450 (473)
                      ++||..||.+||++     .+++++
T Consensus       228 ~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         228 KSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             HHHccCCHHHcCCCCCCCHHHHhcC
Confidence            99999999999999     887764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-40  Score=316.35  Aligned_cols=248  Identities=25%  Similarity=0.328  Sum_probs=201.7

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |++.+.||.|+||.+     ..+++.||+|++.............+.+|+.+++.++||||+++++++..+...++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            566778999999865     246789999999764433333445678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +.+|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            9999999888653  35899999999999999999999999   9999999999999999999999999987543211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......|++.|+|||++.+..++.++||||+||++|++++|..||.+.........+...... .....+..+++
T Consensus       157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  230 (285)
T cd05605         157 -----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE-DQEEYSEKFSE  230 (285)
T ss_pred             -----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh-cccccCcccCH
Confidence                 112235788999999999888999999999999999999999999876654333222111111 11112456889


Q ss_pred             HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      .+.+|+.+||+.||.+||     ++++++++
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            999999999999999999     88898775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-39  Score=333.15  Aligned_cols=247  Identities=20%  Similarity=0.340  Sum_probs=205.9

Q ss_pred             HHhhccCceeeeEEEEE-----Eec-CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~-~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ..|.+.+.+|.|+++.+     ..+ +..||+|.+...   .......+..|+.+++.++||||+++++++..++..|+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            34778888999988754     223 577889877543   344556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          264 LEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999999988754    345889999999999999999999999   9999999999999999999999999997653


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ....    ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..... ++   .+
T Consensus       221 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~---~~  292 (478)
T PTZ00267        221 DSVS----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-DP---FP  292 (478)
T ss_pred             Cccc----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC---CC
Confidence            3211    1112345689999999999999999999999999999999999999998888777776643322 22   24


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+++++.++|.+||..||++||++++++.+
T Consensus       293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            5678999999999999999999999999754

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-39  Score=313.56  Aligned_cols=243  Identities=24%  Similarity=0.343  Sum_probs=195.0

Q ss_pred             eeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       198 ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      ||.|+|+.+     ..+++.+|+|.+...........+.+..|+.+++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            467777644     346889999999765443344456788899999999999999999999999999999999999999


Q ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          273 ASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       273 ~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      .+++..    ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++........     
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-----  152 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-----  152 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence            988743    345899999999999999999999999   99999999999999999999999999865433211     


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHH
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE  428 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~  428 (473)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........ ...+..+++.+.+
T Consensus       153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  230 (280)
T cd05608         153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-VTYPDKFSPASKS  230 (280)
T ss_pred             -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-CCCcccCCHHHHH
Confidence             12234688899999999999999999999999999999999999986543222111111111111 1224568899999


Q ss_pred             HHHHccCCCCCCCC-----CHHHHHHH
Q 011991          429 LIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       429 li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      ++.+||+.||++||     +++++++|
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            99999999999999     77888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.1e-39  Score=305.07  Aligned_cols=246  Identities=26%  Similarity=0.475  Sum_probs=203.5

Q ss_pred             ceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          197 GITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       197 ~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      .+|+|+|+.+.       .++..+|+|++.... ......+.+..|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            47888886442       357899999987543 345566789999999999999999999998754 567999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF  349 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~  349 (473)
                      ++|.+++...+.+++..+..++.|++.||+|||+++   |+||||||.||+++.++.+||+|||+++..........   
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~---  153 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK---  153 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee---
Confidence            999999988778999999999999999999999999   99999999999999999999999999876543321111   


Q ss_pred             cccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHH
Q 011991          350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE  428 (473)
Q Consensus       350 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~  428 (473)
                      ......++..|+|||.+....++.++|||||||++|||++ |..||......+....+.. +..++   .+..+++++.+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~---~~~~~~~~l~~  229 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERME---CPQRCPPEMYD  229 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCC---CCCCCCHHHHH
Confidence            1112234567999999988889999999999999999997 9999998887777766643 33332   24568899999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          429 LIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       429 li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      +|.+||+.||++||++++|.+.|++.
T Consensus       230 li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         230 LMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHHhccCchhCcCHHHHHHHHhcc
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-41  Score=293.92  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=216.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+++.+|.|-||.+     +.++-.||+|++.++.........++.+|+++-..|+||||++++++|.+....||++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            5678889999999854     56778999999987655555556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |...|+|...|.  ..+++++...+.++.|++.||.|+|.++   ||||||||+|+|++..+.+||+|||-+-....   
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---  176 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS---  176 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC---
Confidence            999999999998  5567999999999999999999999999   99999999999999999999999999854321   


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           ......+||.-|.+||...+..++..+|+|++|++.||++.|.+||...+..+.+..|.......     |..++
T Consensus       177 -----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~-----p~~is  246 (281)
T KOG0580|consen  177 -----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF-----PSTIS  246 (281)
T ss_pred             -----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC-----CcccC
Confidence                 12345679999999999999999999999999999999999999999999888988885544332     46789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+++++|.+|+..+|.+|.+..|++.|
T Consensus       247 ~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  247 GGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             hhHHHHHHHHhccCccccccHHHHhhh
Confidence            999999999999999999999999875

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-39  Score=319.10  Aligned_cols=239  Identities=26%  Similarity=0.427  Sum_probs=198.5

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||.|+||.+     ..+++.||+|++.............+..|..++... +||||+++++++.+++.+++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5788888755     245789999999764322223345667788888765 8999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......      .
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~  152 (316)
T cd05619          82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA------K  152 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC------c
Confidence            99999988778999999999999999999999999   99999999999999999999999999864322111      1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|..||...+..+....+....  +.   .+..++.++.+++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~---~~~~~~~~~~~li  227 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PC---YPRWLTREAKDIL  227 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC---CCccCCHHHHHHH
Confidence            223458899999999999899999999999999999999999999888877776663322  11   2345789999999


Q ss_pred             HHccCCCCCCCCCHH-HHHH
Q 011991          431 EECWDPKPVIRPNFN-EIIA  449 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~-ell~  449 (473)
                      .+||+.||++||++. +++.
T Consensus       228 ~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         228 VKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHhccCHhhcCCChHHHHc
Confidence            999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.2e-40  Score=325.72  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=207.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+|+.||+|++.............+..|+.+++.++||||+++++++......++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            4667788999999865     34788999999986544344556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999876 67999999999999999999999999   999999999999999999999999998765332111


Q ss_pred             ccccccccCCCCCCcccCCCCcC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK------NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                           ......||+.|+|||++.      ...++.++|||||||++|+|++|..||...+.......+.........+ .
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~  232 (330)
T cd05601         159 -----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP-E  232 (330)
T ss_pred             -----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC-C
Confidence                 112345889999999986      4567899999999999999999999999888777766664432222211 1


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+++.+.+|+.+|+. +|.+||++++++.|
T Consensus       233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            23578999999999998 99999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.3e-40  Score=321.44  Aligned_cols=235  Identities=26%  Similarity=0.409  Sum_probs=195.3

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHH-HHHhcCCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||.|+|+.+     ..+|+.||+|++.............+..|.. +++.++||||+++++.+..++..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            5788888754     3468999999997543333333445556655 467789999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++......      ..
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~  152 (323)
T cd05575          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS------KT  152 (323)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC------Cc
Confidence            99999988888999999999999999999999999   9999999999999999999999999986432211      11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .   .+..+++.+.++|
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~---~~~~~~~~~~~li  227 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--R---LKPNISVSARHLL  227 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--C---CCCCCCHHHHHHH
Confidence            2334588999999999999999999999999999999999999998888777776643221  1   2345789999999


Q ss_pred             HHccCCCCCCCCCHH
Q 011991          431 EECWDPKPVIRPNFN  445 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~  445 (473)
                      ++||+.||.+||++.
T Consensus       228 ~~~l~~~p~~R~~~~  242 (323)
T cd05575         228 EGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHhhcCHHhCCCCC
Confidence            999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.5e-39  Score=323.58  Aligned_cols=255  Identities=26%  Similarity=0.425  Sum_probs=206.1

Q ss_pred             HHhhccCceeeeEEEEEEe----------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~----------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  258 (473)
                      ..|.+.+.||.|+||.+..          .+..||||++....  .....+.+.+|+++++.+. ||||+++++++....
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3677888999999986621          12469999997543  3444578999999999996 999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHc-----------------------------------------------------------
Q 011991          259 PMMIVLEYHAKGDLASYLQKK-----------------------------------------------------------  279 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------------  279 (473)
                      ..|+|||||++|+|.+++...                                                           
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            999999999999999988642                                                           


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc
Q 011991          280 -------------------------------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD  322 (473)
Q Consensus       280 -------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~  322 (473)
                                                           ..+++..+..++.|++.||+|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                 13677888999999999999999999   99999999999999


Q ss_pred             CCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 011991          323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEE  401 (473)
Q Consensus       323 ~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~  401 (473)
                      .++.+||+|||+++........    .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNY----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             CCCEEEEEeCCcceeccccccc----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999998754322111    11122345678999999998899999999999999999997 999998765544


Q ss_pred             HHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       402 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      ........+..+.   .+..++..+.+++.+||+.||++||++.+|.+.|+++++
T Consensus       348 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 TFYNKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            4333333333322   245678999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8e-40  Score=323.16  Aligned_cols=246  Identities=22%  Similarity=0.372  Sum_probs=200.0

Q ss_pred             hhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCC-CCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceE
Q 011991          192 VRKADGITKGSYQVAK--------WNGTKVWVKILDKESH-KDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  261 (473)
                      |.+.+.||+|+||.+.        .+++.||+|++..... ......+.+..|+.+++.+ .||||+++++++..++.++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            5677889999998652        2678999999975322 2233456788999999999 4899999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999988888999999999999999999999999   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhhCCCCCCc
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKP----PEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~  416 (473)
                      ...     ......||+.|+|||++.+. .++.++|||||||++|+|++|..||....    .......+..  ..+.  
T Consensus       159 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~--  229 (332)
T cd05614         159 EKE-----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPP--  229 (332)
T ss_pred             CCC-----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCC--
Confidence            111     11234689999999998765 47899999999999999999999996432    2223333321  1122  


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                       .+..+++.+.+++.+||+.||++||     +++++++|
T Consensus       230 -~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         230 -FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence             2456789999999999999999999     78888875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-39  Score=310.47  Aligned_cols=242  Identities=25%  Similarity=0.368  Sum_probs=191.3

Q ss_pred             eeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       198 ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      ||+|+|+.+     ..+|+.+|+|.+.............+..|+++++.++||||+++++++..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            477777644     346899999999754333323334566799999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          273 ASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       273 ~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      .+++...+  .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......       .
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------~  150 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------T  150 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------e
Confidence            98886543  4888999999999999999999999   9999999999999999999999999986543221       1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....+++.|+|||++.+..++.++||||+||++|+|++|..||...........+...............+++++.+|+
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC  230 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHH
Confidence            12345788999999998888999999999999999999999999765332111111111111111222346889999999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 011991          431 EECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~ell~  449 (473)
                      ++||+.||.+||+++|+++
T Consensus       231 ~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         231 RLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHhccCHhhCCCCccchh
Confidence            9999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=320.18  Aligned_cols=264  Identities=33%  Similarity=0.498  Sum_probs=204.1

Q ss_pred             cChhHHHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-c
Q 011991          185 LNPLELQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-P  259 (473)
Q Consensus       185 i~~~~~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~  259 (473)
                      +...+..|.....||.|+||.+    ..+|..||||.+.......   ..+|.+|++++.+++|||+|+|+|||.+.+ .
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence            3334457777788999988755    3455899999887654321   345999999999999999999999999988 4


Q ss_pred             eEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      .+||+|||++|+|.+.|....  .++|..+.+|+.++|+||+|||+..+++||||||||.|||+|.+...||+|||+|+.
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            999999999999999997754  789999999999999999999998877899999999999999999999999999965


Q ss_pred             cccCcccccccccccCC-CCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHH---HHHhhC
Q 011991          338 QYISPEKAKIVFPVSHI-DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVVK---LMCCEG  410 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~---~~~~~~---~i~~~~  410 (473)
                      ....  ...    .... .||.+|++||.+..+..+.++||||||+++.|+++|+.+.....   ......   .....+
T Consensus       227 ~~~~--~~~----~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  227 GPEG--DTS----VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             CCcc--ccc----eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            4321  011    1111 68999999999998899999999999999999999998876432   111111   111111


Q ss_pred             CCC-CCccc-C-CCCC--HH---HHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          411 KRP-PLKIK-A-RSYP--PD---LKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       411 ~~~-~~~~~-~-~~~~--~~---l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ... -.... . ..++  ..   +..+..+|++.+|.+||++.|+++.|+.+...
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            100 01111 1 2334  23   55677899999999999999999999666543

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.2e-40  Score=327.09  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=207.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|+..+.||+|+||.+     ..+++.||+|++.............+..|+.++..++||||+++++.+..++.+|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            3566788999999865     24688999999975443344556788899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++||+|.+++.+.+.+++..++.++.|++.||.|||++|   |+||||||+|||++.++.++|+|||++..........
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999986442210000


Q ss_pred             -----------------------------cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 011991          346 -----------------------------KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP  396 (473)
Q Consensus       346 -----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~  396 (473)
                                                   ..........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                         000011234689999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 011991          397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN---FNEIIAR  450 (473)
Q Consensus       397 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~  450 (473)
                      .++.+....+.........+. ...+++++.+||.+|+ .||.+|++   ++++++|
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            888877776644332222211 1246889999999977 49999985   6777665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.2e-38  Score=308.27  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=211.0

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+.+.+|.|+|+.+.          .++..+|+|.+...   .......+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            467778889999987552          12456899988643   24456789999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc
Q 011991          260 MMIVLEYHAKGDLASYLQKKG-------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      .++||||+++++|.+++...+             .+++..++.++.|++.||+|||+++   ++||||||+||+++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999999997543             3899999999999999999999999   999999999999999999


Q ss_pred             EEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011991          327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL  405 (473)
Q Consensus       327 vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  405 (473)
                      ++|+|||+++.......    ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........
T Consensus       159 ~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~  234 (288)
T cd05093         159 VKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  234 (288)
T ss_pred             EEeccCCccccccCCce----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999875432211    111122335677999999998899999999999999999998 9999988887777776


Q ss_pred             HHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       406 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +.... .+.   .+..+++.+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       235 i~~~~-~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGR-VLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCC-cCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            64332 222   2446789999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-38  Score=315.37  Aligned_cols=255  Identities=28%  Similarity=0.512  Sum_probs=206.4

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee-C
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ-N  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~  257 (473)
                      .+|++.+.||.|+||.+.          .+++.||+|++....  .....+.+..|+.+++++ +||||+++++++.. +
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            368888999999998662          124689999987432  234456788999999999 79999999998764 4


Q ss_pred             CceEEEEeccCCCCHHHHHHHc----------------------------------------------------------
Q 011991          258 IPMMIVLEYHAKGDLASYLQKK----------------------------------------------------------  279 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------  279 (473)
                      ..++++|||+++++|.+++...                                                          
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5689999999999999998642                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCC
Q 011991          280 ---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP  356 (473)
Q Consensus       280 ---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~g  356 (473)
                         ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||+++.........    ......+
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~----~~~~~~~  237 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGDARL  237 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----hccCCCC
Confidence               24788999999999999999999999   9999999999999999999999999997653221111    1122345


Q ss_pred             CCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccC
Q 011991          357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWD  435 (473)
Q Consensus       357 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~  435 (473)
                      +..|+|||++.+..++.++|||||||++|+|++ |..||.+....+........+..+.   .+..+++++.+++.+||+
T Consensus       238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~cl~  314 (337)
T cd05054         238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR---APEYATPEIYSIMLDCWH  314 (337)
T ss_pred             CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC---CCccCCHHHHHHHHHHcc
Confidence            667999999999999999999999999999997 9999987655444444333333322   245678999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHHHH
Q 011991          436 PKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       436 ~dP~~RPs~~ell~~L~~~~~  456 (473)
                      .+|++||++.|++++|++++.
T Consensus       315 ~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         315 NNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-38  Score=304.61  Aligned_cols=248  Identities=27%  Similarity=0.500  Sum_probs=206.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...+.+|.|+|+.+     ...++.+|+|.+..+    ......+.+|+++++.++||||+++++++..+...++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            4666678899888754     345889999998643    2234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++++|.+++...  ..+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999764  34889999999999999999999999   99999999999999999999999999876533211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .     .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.. ...+.   .+..+
T Consensus       160 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~  230 (263)
T cd05052         160 T-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRME---RPEGC  230 (263)
T ss_pred             e-----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCC---CCCCC
Confidence            1     1111223557999999998899999999999999999998 9999998877766665532 22222   25678


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      |+.+.+++.+||..||++||++.++++.|+.+
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            89999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=323.31  Aligned_cols=245  Identities=22%  Similarity=0.417  Sum_probs=214.8

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      +..|.....||.|+||.|     ..+.+.||||.+.-......+..+.++.|+..++++.|||++.+.|||..+.+.|||
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            345777788999999866     456789999999877777788889999999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||-| |-.+++.-. +++.+..+..|+.+.++||+|||+++   .||||||..|||+++.|.|||+|||.|....   
T Consensus       105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            999965 999988764 46899999999999999999999999   9999999999999999999999999986542   


Q ss_pred             ccccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                             +...+.|||+|||||++.   .+.|+-++||||||++..||...++|+.+.+....+.-|.. ...|.+.  .
T Consensus       178 -------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-NesPtLq--s  247 (948)
T KOG0577|consen  178 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQ--S  247 (948)
T ss_pred             -------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-cCCCCCC--C
Confidence                   334578999999999985   45899999999999999999999999999998888877743 4444442  4


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+|..+++|+..||.+-|.+|||.+++++|
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            5678899999999999999999999999886

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-38  Score=304.62  Aligned_cols=252  Identities=22%  Similarity=0.417  Sum_probs=207.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+     ..+++.||||.+......+......+.+|+++++.++||||+++++++...+..++|||
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            4667788999988754     34789999999876544556667789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999998853    234889999999999999999999999   999999999999999999999999998765332


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhhCCCCCCcccC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP--EEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ..      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....  ......+ .....++.  ..
T Consensus       160 ~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~  230 (267)
T cd08228         160 TT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL--PT  230 (267)
T ss_pred             hH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCC--Ch
Confidence            11      11234577889999999888899999999999999999999999965432  3333333 22222221  23


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      ..++..+.+++.+||..+|++||+++++++.++.+
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            45778999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-39  Score=324.83  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=206.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||.|+|+.+     ..+++.+|+|++.............+..|+.+++.++||||+++++++..+...|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788889999999865     2467899999997543333344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++|+|.+++... .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.......  
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~--  196 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG--  196 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCC--
Confidence            999999999999765 5899999999999999999999999   9999999999999999999999999987543221  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE----EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                         ........||+.|+|||++.+.    .++.++||||+||++|+|++|..||...+.......+.........+ ...
T Consensus       197 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~  272 (370)
T cd05621         197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP-EDV  272 (370)
T ss_pred             ---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC-Ccc
Confidence               1112345689999999998654    37889999999999999999999999888877777765433322221 123


Q ss_pred             CCCHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVI--RPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~--RPs~~ell~~  450 (473)
                      .+++.+.+++.+|+..+|..  ||+++|+++|
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            56889999999999855543  8899999886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-39  Score=314.43  Aligned_cols=248  Identities=26%  Similarity=0.429  Sum_probs=194.1

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+|+.+     ..+++.||+|++......  .....+.+|+.+++.++||||+++++++..+...++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            35778889999999855     236889999999754321  22245778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+. ++|.+++... +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            9996 5888887664 56899999999999999999999999   9999999999999999999999999986432211 


Q ss_pred             cccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCCc-----
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPLK-----  416 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~-----  416 (473)
                           .......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.... .....+......+...     
T Consensus       158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         158 -----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             -----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence                 11223457889999998865 46889999999999999999999999875432 2222222111111000     


Q ss_pred             ----------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          417 ----------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       417 ----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                                            .....+++++.+|+++||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                                  001124567899999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.2e-39  Score=330.89  Aligned_cols=250  Identities=20%  Similarity=0.333  Sum_probs=209.2

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----  258 (473)
                      ..+|.+.+.||.|+||.+     ..+|+.||||++..... .......+.+|+.++..++|+||+++++.+...+     
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            347888999999999865     34689999999976543 3455678899999999999999999988775432     


Q ss_pred             ---ceEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          259 ---PMMIVLEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       259 ---~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                         .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence               368999999999999998653    35899999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      ||+++........    .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus       187 FGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~  262 (496)
T PTZ00283        187 FGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY  262 (496)
T ss_pred             cccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            9999765432111    112345689999999999999999999999999999999999999998888777766643322


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .    ..+..+++++.+++.+||+.||.+||++.+++.+
T Consensus       263 ~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 D----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            2    2356789999999999999999999999999875

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.1e-39  Score=318.43  Aligned_cols=240  Identities=27%  Similarity=0.440  Sum_probs=196.5

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||+|+|+.+     ..+++.+|+|++.............+..|+.++..+ +||||+++++++..++..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            5889988855     346789999999876544555667788899998877 7999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|..++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.......      .
T Consensus        82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~------~  152 (329)
T cd05618          82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD------T  152 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC------c
Confidence            99999988888999999999999999999999999   99999999999999999999999999864322111      1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------Ch-HHHHHHHHhhCCCCCCcccCCC
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK--------PP-EEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~--------~~-~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...        .. ......+ ... ...   .|..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~-~~~---~p~~  227 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEK-QIR---IPRS  227 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcC-CCC---CCCC
Confidence            23356899999999999999999999999999999999999999521        11 1122222 221 111   2556


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNF------NEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~------~ell~~  450 (473)
                      ++..+.+++++||+.||++||++      .++++|
T Consensus       228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            78999999999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=303.33  Aligned_cols=251  Identities=20%  Similarity=0.394  Sum_probs=206.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC--CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .|.+.+.+|.|+++.+     ..+++.+|+|.+......  .......+.+|+++++.++||||+++++++..+...++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            3566778999988744     346889999998754322  223456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.......
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            999999999999988888999999999999999999999999   99999999999999999999999999865432111


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                      .   ........++..|+|||.+.+..++.++||||+|+++|++++|+.||...........+......+   ..+..++
T Consensus       160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  233 (263)
T cd06625         160 S---GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP---QLPSHVS  233 (263)
T ss_pred             c---cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC---CCCccCC
Confidence            1   011123446778999999999889999999999999999999999998776665555443333222   2355688


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+.+++++||..+|.+||++.+++++
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         234 PDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            999999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-38  Score=306.18  Aligned_cols=249  Identities=28%  Similarity=0.492  Sum_probs=206.4

Q ss_pred             HhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +|.+.+.+|.|+|+.+.          .++..||+|.+....  ..+..+.+.+|+++++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            56777889999997552          224789999987543  234557899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc
Q 011991          261 MIVLEYHAKGDLASYLQKKG--------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      ++||||+++++|.+++...+              .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999997642              3788899999999999999999999   999999999999999999


Q ss_pred             EEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011991          327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL  405 (473)
Q Consensus       327 vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  405 (473)
                      ++|+|||+++........    .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus       161 ~kl~d~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             EEECCcccceecccCcce----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999998754322110    01122235677999999999999999999999999999998 9999988887777766


Q ss_pred             HHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       406 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +.. +..+.   .+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       237 ~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ITQ-GRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHc-CCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            642 22221   24567899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-38  Score=306.23  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=204.6

Q ss_pred             HHHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC
Q 011991          189 ELQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  258 (473)
                      ..+|+....+|.|+|+.+.          ..+..||+|.+....  .......+.+|+.+++.++||||+++++++..+.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3467888899999997552          234679999986432  2344567889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK  328 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vk  328 (473)
                      ..++||||+++++|.+++....          .++...+..++.|++.||.|||+.+   ++|+||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            9999999999999999997532          2567788999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011991          329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMC  407 (473)
Q Consensus       329 l~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~  407 (473)
                      |+|||+++.........    ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+.
T Consensus       160 l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         160 IGDFGMTRDIYETDYYR----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             ECCCCCccccCCcceee----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999987543321111    1112234677999999998889999999999999999998 789999888777666553


Q ss_pred             hhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      ... .+.   .+...++.+.+++.+||+.||++|||+.|++++|+
T Consensus       236 ~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 EGG-LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCC-cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            322 222   24567889999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.1e-40  Score=321.16  Aligned_cols=236  Identities=25%  Similarity=0.380  Sum_probs=198.9

Q ss_pred             CceeeeEEEEEE--------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          196 DGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       196 ~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      +.||.|+|+.+.        .+|+.+|+|++...... ......+..|++++++++||||+++++++..++..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            458888887552        36789999999754322 223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccc
Q 011991          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI  347 (473)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  347 (473)
                      ++|+|.+++.....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.......    
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----  153 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK----  153 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC----
Confidence            99999999988878999999999999999999999999   99999999999999999999999999875432211    


Q ss_pred             cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          348 VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       348 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                        ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.....     ..+..+++.+.
T Consensus       154 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-----~~p~~~~~~~~  226 (318)
T cd05582         154 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-----GMPQFLSPEAQ  226 (318)
T ss_pred             --ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCHHHH
Confidence              12234588999999999988899999999999999999999999998887777766643221     12456789999


Q ss_pred             HHHHHccCCCCCCCCCHHH
Q 011991          428 ELIEECWDPKPVIRPNFNE  446 (473)
Q Consensus       428 ~li~~cl~~dP~~RPs~~e  446 (473)
                      +++++||+.||.+||++.+
T Consensus       227 ~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         227 SLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHHHHhhcCHhHcCCCCC
Confidence            9999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=318.88  Aligned_cols=252  Identities=20%  Similarity=0.314  Sum_probs=205.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+|+.+     ..+++.||+|++...........+.+..|+.+++.++||||+++++++..++.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            4677889999999855     34688999999975333334455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++|+|.+++.. ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-  157 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-
Confidence            9999999999976 456999999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-----EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                          .......||+.|+|||++..     ..++.++||||+||++|+|++|..||...+..+....+.............
T Consensus       158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  233 (331)
T cd05597         158 ----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV  233 (331)
T ss_pred             ----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence                01122358899999999863     357889999999999999999999999888777776665444333333334


Q ss_pred             CCCCHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPV--IRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~--~RPs~~ell~~  450 (473)
                      ..+++.+.++|++|+..+++  .||+++++++|
T Consensus       234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            45789999999998865443  37899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.8e-39  Score=317.00  Aligned_cols=239  Identities=23%  Similarity=0.383  Sum_probs=201.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEe
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      |+..+.||.|+||.+     ..+|+.||+|++...........+.+..|..+++.+. |++|+++++++...+.+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            455678999999865     2468899999997643333445567888999998886 5778889999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--  156 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--  156 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc--
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999864322111  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+......     .+..++++
T Consensus       157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-----~p~~~~~~  227 (323)
T cd05615         157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-----YPKSLSKE  227 (323)
T ss_pred             ----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCccCCHH
Confidence                122345889999999999889999999999999999999999999998887777776443221     24567899


Q ss_pred             HHHHHHHccCCCCCCCCCH
Q 011991          426 LKELIEECWDPKPVIRPNF  444 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~  444 (473)
                      +.+++.+||+.||.+|++.
T Consensus       228 ~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         228 AVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHHHHHcccCHhhCCCC
Confidence            9999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-39  Score=307.36  Aligned_cols=245  Identities=38%  Similarity=0.682  Sum_probs=198.8

Q ss_pred             ccCceeeeEEEEE---Eec------CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          194 KADGITKGSYQVA---KWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       194 ~~~~ig~G~~~~~---~~~------~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +.+.||.|.||.+   .+.      +..|+||.+...  ......+.+.+|++.+++++||||++++|++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            3467999999854   334      678999999542  34556789999999999999999999999999888899999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+++|+|.+++...  ..+++..++.++.|++.||.|||+++   ++|++|+++||+++.++.+||+|||++.......
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            999999999999886  56999999999999999999999999   9999999999999999999999999987652221


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ..    ...........|+|||.+.+..++.++||||||+++||+++ |..||...+..+....+ ..+..+..   +..
T Consensus       158 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~---~~~  229 (259)
T PF07714_consen  158 KY----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPI---PDN  229 (259)
T ss_dssp             SE----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTS---BTT
T ss_pred             cc----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccee---ccc
Confidence            11    11112234556999999988889999999999999999999 78999999888877777 44444332   557


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ++..+.++|.+||+.||++|||+.++++.|
T Consensus       230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  230 CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            899999999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-39  Score=319.10  Aligned_cols=237  Identities=25%  Similarity=0.388  Sum_probs=195.1

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHH-HHHhcCCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||.|+|+.+     ..+++.||+|++.............+..|.. +++.++||||+++++++..++..|+||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5788888755     3467889999997543222223334445544 567789999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.......      .
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~------~  152 (325)
T cd05602          82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG------T  152 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC------C
Confidence            99999988888999999999999999999999999   99999999999999999999999999864322111      1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .   .+..+++.+.+++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~---~~~~~~~~~~~li  227 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--Q---LKPNITNSARHLL  227 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--C---CCCCCCHHHHHHH
Confidence            2345689999999999999999999999999999999999999998888777776643221  1   2346789999999


Q ss_pred             HHccCCCCCCCCCHHHH
Q 011991          431 EECWDPKPVIRPNFNEI  447 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~el  447 (473)
                      .+||+.||.+||++.+.
T Consensus       228 ~~~l~~~p~~R~~~~~~  244 (325)
T cd05602         228 EGLLQKDRTKRLGAKDD  244 (325)
T ss_pred             HHHcccCHHHCCCCCCC
Confidence            99999999999998743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.5e-39  Score=306.46  Aligned_cols=251  Identities=22%  Similarity=0.378  Sum_probs=203.5

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ..+|.+.+.+|.|+|+.+     ..+++.||+|++....   ......+.+|+.+++.++||||+++++.+..++..++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            346888899999999755     2467899999997543   22335678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999999999988778999999999999999999999999   99999999999999999999999999875432111


Q ss_pred             cccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                            ......+++.|+|||.+.   ...++.++|+||+||++|+|++|..||....+......+......++......
T Consensus       162 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06646         162 ------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT  235 (267)
T ss_pred             ------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccc
Confidence                  112345778899999874   34578899999999999999999999976655444333322222222222234


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      .++..+.+++++||+.||++||+++++++++
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            5788999999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-38  Score=300.89  Aligned_cols=245  Identities=29%  Similarity=0.524  Sum_probs=202.3

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.+|.|+|+.+    ..++..+|+|.+......    ...+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            4666778999998744    234568999998644322    25688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++|+|.+++... +.+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||.++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            9999999999753 46899999999999999999999999   999999999999999999999999998754322111 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.. +..+.   .+...+.
T Consensus       157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~---~~~~~~~  228 (256)
T cd05114         157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLY---RPKLASM  228 (256)
T ss_pred             ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCC---CCCCCCH
Confidence                1112234557999999988889999999999999999999 9999998887777776643 22222   2445678


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      .+.+++.+||+.||++||+++++++.|
T Consensus       229 ~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         229 TVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-38  Score=302.69  Aligned_cols=254  Identities=19%  Similarity=0.371  Sum_probs=206.7

Q ss_pred             hhccCceeeeEEEEE----EecCcEEEEEEEcCCCCC---CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          192 VRKADGITKGSYQVA----KWNGTKVWVKILDKESHK---DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      |.+.+.+|.|+|+.+    ..+++.+|+|.+......   .......+.+|+++++.++|+||+++++++......++||
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            667788999998754    347889999998754322   2334467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++.+.+.+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++.........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999988778999999999999999999999999   999999999999999999999999998754322111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                      ...........++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+....  ...+..+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  236 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR--GLMPRLPDSFSA  236 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--CCCCCCCCCCCH
Confidence            111112233457888999999998889999999999999999999999998766554443332221  112223567889


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.++|++||..+|.+||++.+++.+
T Consensus       237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         237 AAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            99999999999999999999999863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.3e-39  Score=309.99  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=195.8

Q ss_pred             HhhccCceeeeEEEEEE------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc---CCCeeeeEEeeEe-----e
Q 011991          191 QVRKADGITKGSYQVAK------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVT-----Q  256 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~  256 (473)
                      +|++.+.||.|+|+.+.      ..+..||+|.+....... .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46777889999998552      236789999987543222 2223456777777766   6999999999885     2


Q ss_pred             CCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                      ...+++||||++ ++|.+++...  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 5999998763  34899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      ++.....       .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus       157 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~  229 (290)
T cd07862         157 ARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  229 (290)
T ss_pred             eEeccCC-------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            8754322       112334578899999999888999999999999999999999999998887766665543222111


Q ss_pred             Cc----------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LK----------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..                      .....+++.+.+++.+||+.||++|||+.|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00                      0113467889999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.9e-39  Score=321.94  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=206.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.+|.|+|+.+     ..+++.+|+|++.............+.+|+.+++.++||||+++++++..+...++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            47888899999999855     3467899999997543333344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++|+|.+++... .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-  197 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-  197 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-
Confidence            999999999998765 5899999999999999999999999   99999999999999999999999999875432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE----EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                          .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+.......+.........+ ...
T Consensus       198 ----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~  272 (371)
T cd05622         198 ----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDN  272 (371)
T ss_pred             ----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC-CcC
Confidence                112345689999999998654    37899999999999999999999999988877777765433322221 234


Q ss_pred             CCCHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVI--RPNFNEIIARL  451 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L  451 (473)
                      .+++.+.++|.+|+..++.+  ||+++++++|.
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            68999999999999844432  78999998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-39  Score=322.97  Aligned_cols=241  Identities=24%  Similarity=0.351  Sum_probs=192.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+.+.||.|+||.+     ..+++.||+|....         ..+.+|+++++.++||||++++++|..+...++|||
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            5888889999999865     35688999997532         246789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ++. ++|..++.....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  
T Consensus       164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~--  237 (391)
T PHA03212        164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA--  237 (391)
T ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc--
Confidence            995 699999988778999999999999999999999999   99999999999999999999999999865322111  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHh-hCCCC----
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP-------PEEVVKLMCC-EGKRP----  413 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-------~~~~~~~i~~-~~~~~----  413 (473)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|..||....       .......+.. .+..+    
T Consensus       238 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        238 ---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence               11234568999999999999999999999999999999999998875321       1111111111 11000    


Q ss_pred             ----------------------CCc---ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          414 ----------------------PLK---IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       414 ----------------------~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                                            ...   .....++.++.+||.+||+.||.+|||++|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                                  000   001134678999999999999999999999997

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-38  Score=302.23  Aligned_cols=252  Identities=26%  Similarity=0.429  Sum_probs=205.2

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCH------HHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDP------ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      |.++..+|.|+|+.+     ..+++.+|+|.+........      ...+.+.+|+.+++.++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            456678898888744     24678999999875443322      2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            999999999999999988888999999999999999999999999   99999999999999999999999999876542


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ...............++..|+|||.+.+..++.++|+||+||++|+|++|..||...+.......+.. ...+.   .+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~  234 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPE---IPS  234 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCc---CCc
Confidence            11111111112234577889999999988899999999999999999999999987766554444322 22222   245


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .++..+.++|++||+.||.+||++.+++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         235 NISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            678999999999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=291.82  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----  258 (473)
                      +.+|++.+.+|.|+|..+     ..+++.+|+|++.-.   ..+..+..++|++..++++||||++++++...+.     
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            457899999999999754     357899999999743   3566788999999999999999999998865333     


Q ss_pred             ceEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                      ..||+++|+..|||.+.+...    ..+++.+++.|+.++++||++||+..+ +++||||||.|||+++++.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccC
Confidence            499999999999999998652    359999999999999999999999985 699999999999999999999999999


Q ss_pred             ccccccCcc---cccccccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Q 011991          335 LRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE--VVKLM  406 (473)
Q Consensus       335 a~~~~~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~--~~~~i  406 (473)
                      ++.....-.   .......+..-..|..|+|||.+.-   .-.+.++|||||||++|.|+.|..||...-...  +...+
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            875432211   1112223334456778999999854   356789999999999999999999995322111  11111


Q ss_pred             HhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ..... ..+  ....+|+.+.++|++|++.||.+||++.+++.+++.++
T Consensus       256 ~n~q~-s~P--~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  256 QNAQI-SIP--NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ecccc-ccC--CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11111 111  12348999999999999999999999999999998764

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-38  Score=317.87  Aligned_cols=243  Identities=22%  Similarity=0.382  Sum_probs=193.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|...+.||.|+|+.+     ..+++.||||++....  .......+.+|+++++.++|+||+++++++..++.+++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            45677788999999855     2358899999996543  3445578899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+.    ...++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            99999998653    23567888899999999999999999   99999999999999999999999999876532211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hhCCCCCCcc
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-----EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC--CEGKRPPLKI  417 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~  417 (473)
                           ......||..|+|||.+..     ...+.++|||||||++|+|++|+.||......+....+.  .....+   .
T Consensus       224 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~  295 (353)
T PLN00034        224 -----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP---E  295 (353)
T ss_pred             -----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC---C
Confidence                 1223468899999998743     234568999999999999999999997433222211111  111111   2


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+..+++++.+||.+||..||++||++.|+++|
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            245678999999999999999999999999985

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.8e-38  Score=307.73  Aligned_cols=259  Identities=30%  Similarity=0.536  Sum_probs=211.7

Q ss_pred             HHhhccCceeeeEEEEEEe------------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee
Q 011991          190 LQVRKADGITKGSYQVAKW------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ  256 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~------------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  256 (473)
                      .+|.+.+.||+|+|+.+..            ++..+|+|.+..+.  .......+..|+++++.+ +||||+++++++..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            4688999999999986521            22469999997542  234456788999999999 79999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEE
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL  320 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nil  320 (473)
                      ++..++||||+++|+|.+++...+                .+++..++.++.|++.||+|||+++   ++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence            999999999999999999997642                3788899999999999999999999   999999999999


Q ss_pred             EcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 011991          321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPP  399 (473)
Q Consensus       321 i~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~  399 (473)
                      ++.++.++|+|||+++.........    ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhh----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999999999999987543211100    0111223467999999988889999999999999999998 8999988777


Q ss_pred             HHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          400 EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       400 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      .+....+. ....+.   .+..++.++.+|+.+||..+|++||++.++++.|++++...+-+
T Consensus       249 ~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~~  306 (307)
T cd05098         249 EELFKLLK-EGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ  306 (307)
T ss_pred             HHHHHHHH-cCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhcC
Confidence            66666553 332222   24567899999999999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.7e-38  Score=305.36  Aligned_cols=253  Identities=26%  Similarity=0.456  Sum_probs=208.4

Q ss_pred             HhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +|.+...+|.|+|+.+.          .++..+++|.+...   .....+.+.+|+++++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            45666788988887442          23456889988643   244456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC
Q 011991          261 MIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~  324 (473)
                      ++||||+++++|.+++..++                .+++..++.++.|++.||+|||+++   ++||||||+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence            99999999999999997542                3788999999999999999999999   9999999999999999


Q ss_pred             CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV  403 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  403 (473)
                      +.++|+|||+++........    .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+..
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             CcEEECCCCcccccCCCcee----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999998754332111    11223345778999999998899999999999999999998 99999888877766


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+. .+..+.   .+..+|..+.+++.+||+.||.+||++.++++.|+++...
T Consensus       236 ~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 ECIT-QGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHh-CCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            6553 232222   2445788999999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=331.12  Aligned_cols=257  Identities=28%  Similarity=0.532  Sum_probs=224.7

Q ss_pred             HhhccCceeeeEEEEE-----E---ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVA-----K---WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~---~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ...+.+.||.|.||.+     +   .....||||.++...  ......+|+.|+.||-+++||||++|.|+........|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            5667788999999865     2   234589999998654  46777899999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |+|||++|+|+.||+.+ +.++..+...+++.|+.||+||.+++   +|||||...||||+.+-.+|++|||++++..++
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999999875 66999999999999999999999999   999999999999999999999999999987665


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      .+..   +....-.-..+|.|||.+..++++.+|||||+|++|||.++ |+.||.+.++++++..| ..+++.+.   |-
T Consensus       785 ~~~~---ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPp---Pm  857 (996)
T KOG0196|consen  785 PEAA---YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPP---PM  857 (996)
T ss_pred             CCcc---ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCC---CC
Confidence            4221   11222223467999999999999999999999999999996 99999999999999998 55665554   56


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ++|..|.+|+..||++|=..||.|.+|+.+|++++.+..
T Consensus       858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            789999999999999999999999999999999998643

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.4e-39  Score=315.49  Aligned_cols=241  Identities=27%  Similarity=0.407  Sum_probs=197.3

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||+|+|+.+     ..+++.||+|++...........+.+..|+.++.++ .||||+++++++.....+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5888988755     346789999999876544555667889999999888 5999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|.+++...+.+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......      ..
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------~~  152 (327)
T cd05617          82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG------DT  152 (327)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC------Cc
Confidence            99999988778999999999999999999999999   9999999999999999999999999986422111      11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK------PPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...      ...+......... ...   .+..++.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~---~p~~~~~  228 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIR---IPRFLSV  228 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCC---CCCCCCH
Confidence            23356899999999999999999999999999999999999999632      1222222222222 111   2556789


Q ss_pred             HHHHHHHHccCCCCCCCCCH------HHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNF------NEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~------~ell~~  450 (473)
                      .+.+++.+||+.||++||++      +++++|
T Consensus       229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            99999999999999999984      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.1e-38  Score=299.49  Aligned_cols=245  Identities=26%  Similarity=0.449  Sum_probs=199.8

Q ss_pred             eeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          198 ITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       198 ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      ||.|+|+.+.       ..+..||+|++....  .....+.+.+|+.++++++||||+++++++.. ...++||||++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            6888887542       234579999987542  34455789999999999999999999998864 5689999999999


Q ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc
Q 011991          271 DLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF  349 (473)
Q Consensus       271 sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~  349 (473)
                      +|.+++.. .+.+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..........   .
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~  153 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---K  153 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce---e
Confidence            99999975 456899999999999999999999999   9999999999999999999999999987543321111   1


Q ss_pred             cccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHH
Q 011991          350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE  428 (473)
Q Consensus       350 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~  428 (473)
                      ......++..|+|||.+....++.++|||||||++|++++ |..||......+....+ ..+..+.   .+..+++++.+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~  229 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLD---CPAECPPEMYA  229 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCC---CCCCCCHHHHH
Confidence            1112223567999999988889999999999999999996 99999988877776655 3333332   24567899999


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          429 LIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       429 li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ++.+||+.||++||++.+|.+.|+.++
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-38  Score=300.62  Aligned_cols=251  Identities=28%  Similarity=0.508  Sum_probs=208.6

Q ss_pred             HhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|.....+|.|+|+.+.   +     +...||+|.+....  .......+.+|+.+++.++||||+++++.+...+..++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            56778889999998552   2     24579999986543  34455778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++++|.+++... +.+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999764 46899999999999999999999999   999999999999999999999999999866422


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      .....    .....++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+.. ....+   .+.
T Consensus       160 ~~~~~----~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~  231 (266)
T cd05033         160 EATYT----TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLP---PPM  231 (266)
T ss_pred             cccee----ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCC---CCC
Confidence            11111    112234567999999998899999999999999999997 9999988877777666633 22222   244


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .+++.+.+++.+||+.+|++||++++++++|+++
T Consensus       232 ~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         232 DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            6789999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-38  Score=301.63  Aligned_cols=248  Identities=28%  Similarity=0.505  Sum_probs=206.6

Q ss_pred             HHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|++.+.+|.|+|+.+    ..++..||+|.+....    ...+.+.+|+.+++.++||||+++++++......+++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            46778889999998755    3456789999986532    234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++++|.+++...  ..++...++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999653  45888999999999999999999999   99999999999999999999999999976533211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .     ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ....+   ....+
T Consensus       159 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~  229 (261)
T cd05072         159 T-----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMP---RMENC  229 (261)
T ss_pred             e-----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCC
Confidence            1     1112234567999999988889999999999999999998 9999988877777666633 22222   23467


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      +.++.+++.+||..+|++||+++++++.|++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            8999999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.4e-38  Score=303.51  Aligned_cols=250  Identities=29%  Similarity=0.519  Sum_probs=205.2

Q ss_pred             HhhccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          191 QVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+++.+.+|+|+|+.+.         ..+..+++|.+....  .......+.+|+.+++.++||||+++++++..+...|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            46677789999997552         245789999997532  3455578899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC
Q 011991          262 IVLEYHAKGDLASYLQKK-----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~  324 (473)
                      +||||+++++|.+++...                 ..+++..+..++.|++.||.|||+++   ++||||||+||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            999999999999998532                 13778889999999999999999999   9999999999999999


Q ss_pred             CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV  403 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  403 (473)
                      +.+||+|||+++.........    ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.......
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYR----VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CcEEeccccccccccCCccee----cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999987653321111    1122334667999999988889999999999999999998 99999887776666


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      ..+.. ...++   .+..+++.+.+++.+||+.||.+||++.+|+++|+.
T Consensus       237 ~~~~~-~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVRK-RQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHc-CCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            65533 22222   355788999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4e-38  Score=306.88  Aligned_cols=253  Identities=27%  Similarity=0.496  Sum_probs=207.6

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      ..|...+.+|.|+|+.+.          ..+..+|+|.+....  .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            467888899999998552          134579999987543  244557899999999999 7999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ..++||||+.+|+|.+++....  .+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997643  3899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      ........    .......++..|+|||.+.+..++.++||||+||++|+|++ |..||......+........+..+. 
T Consensus       190 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-  264 (302)
T cd05055         190 DIMNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA-  264 (302)
T ss_pred             cccCCCce----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC-
Confidence            54322110    01112335677999999988889999999999999999998 9999988776655544434333222 


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                        .+...++.+.+++.+||+.+|++||++.++++.|+++
T Consensus       265 --~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         265 --QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              2445688999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=332.46  Aligned_cols=258  Identities=25%  Similarity=0.433  Sum_probs=205.7

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeE-e---eC-
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAV-T---QN-  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~-~---~~-  257 (473)
                      ..++++.+.|-+|+|+.|     ...|..||+|++...   +....+.+.+|+++|++|+ |+|||.++|.. .   .+ 
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            446788889999999755     223489999999754   6788899999999999996 99999999932 2   11 


Q ss_pred             --CceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          258 --IPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       258 --~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                        -.+.|.||||.||+|-++|..+  .+|++.++++|+.|+++|+++||...+ +|||||||-+||||+.++..||||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCccc
Confidence              2478999999999999999753  459999999999999999999999984 69999999999999999999999999


Q ss_pred             cccccccCccccc---ccccccCCCCCCcccCCCCc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 011991          334 LLRLQYISPEKAK---IVFPVSHIDPANLYVAPEIY---KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC  407 (473)
Q Consensus       334 ~a~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~  407 (473)
                      .+.-.........   ....--...-|+.|+|||.+   .+.+.+.|+|||+|||++|.||...+||.....-.+    .
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----l  267 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----L  267 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE----E
Confidence            9864332211110   00011122358889999976   577899999999999999999999999976543222    2


Q ss_pred             hhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ...+..+.   .+.|+..+.+||+.||+.||.+||++-+++..+-++...
T Consensus       268 ng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  268 NGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             eccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            22322222   357899999999999999999999999999999888764

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9e-39  Score=320.61  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=200.9

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----ceE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----PMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~  261 (473)
                      |...+.||.|+||.+     ..+|+.||+|.+.... ........+.+|+++++.++||||+++++++....     ..|
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            556778999999865     2468999999986532 23345577899999999999999999999998766     789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+. ++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9999996 589999887778999999999999999999999999   999999999999999999999999999754322


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC--------
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR--------  412 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  412 (473)
                      ..     .......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.++......+......        
T Consensus       157 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         157 ES-----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cc-----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            11     112234578889999998774 5789999999999999999999999887766555444321111        


Q ss_pred             ---------------CCCc----ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 ---------------PPLK----IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ---------------~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                     ++..    ......++++.+||.+||+.||.+|||+.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                           1100    1123457889999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.5e-39  Score=316.33  Aligned_cols=235  Identities=26%  Similarity=0.386  Sum_probs=194.3

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHH-HHHhcCCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||.|+|+.+     ..+++.||+|++.............+..|.. +++.++||||+++++++...+..|+||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5788888755     2467899999997543323333455556654 578889999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|...+...+.+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++......      ..
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~  152 (321)
T cd05603          82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE------ET  152 (321)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC------Cc
Confidence            99999988778999999999999999999999999   9999999999999999999999999986432211      11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....  ..   .+...+..+.+++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~---~~~~~~~~~~~li  227 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQ---LPGGKTVAACDLL  227 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CC---CCCCCCHHHHHHH
Confidence            233458899999999998899999999999999999999999999888777766664321  11   2456788999999


Q ss_pred             HHccCCCCCCCCCHH
Q 011991          431 EECWDPKPVIRPNFN  445 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~  445 (473)
                      .+||+.||.+||++.
T Consensus       228 ~~~l~~~p~~R~~~~  242 (321)
T cd05603         228 VGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHccCCHhhcCCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5e-38  Score=297.72  Aligned_cols=243  Identities=28%  Similarity=0.484  Sum_probs=198.7

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (473)
                      .+|.|+|+.+     ..+++.+|+|.+....  .......+.+|+++++.++||||+++++++......++||||+.+++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4777877644     3478899999886432  34555789999999999999999999999999999999999999999


Q ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          272 LASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       272 L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      |.+++... ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++........    ...
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~  152 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY----AST  152 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc----ccc
Confidence            99999764 35899999999999999999999999   99999999999999999999999999864322110    000


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL  429 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~l  429 (473)
                      ......+..|+|||.+.+..++.++|||||||++|++++ |..||...........+.. ...+.   .+..++..+.+|
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~l  228 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLP---CPELCPDAVYRL  228 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCC---CcccCCHHHHHH
Confidence            111123456999999988889999999999999999997 9999987777665555432 22222   245678999999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHH
Q 011991          430 IEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       430 i~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +.+||+.||++|||+.++++.|+
T Consensus       229 i~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         229 MERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=339.24  Aligned_cols=258  Identities=31%  Similarity=0.498  Sum_probs=217.6

Q ss_pred             HHhhccCceeeeEEEEEE------ecC----cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK------WNG----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~------~~~----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      ........||+|.||.+.      ..|    ..||||.+...  .+......|++|..+|+.++|||||+++|++.+...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            345666789999998652      122    35888888653  467778999999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          260 MMIVLEYHAKGDLASYLQKK-------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                      .+|++|||+||+|..||++.       ..++..+.+.++.||++|+.||++++   +|||||.+.|+|++....|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999875       23889999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |+|+..+..+--.    ......-...|||||.+..+.++.++|||||||++||+++ |..||++.++.++..-+...+ 
T Consensus       847 GlArDiy~~~yyr----~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-  921 (1025)
T KOG1095|consen  847 GLARDIYDKDYYR----KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-  921 (1025)
T ss_pred             chhHhhhhchhee----ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence            9999554331110    0111122346999999999999999999999999999998 999999999999988665555 


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      +.+   .|..+|..+.++|.+||+.+|++||++..|++.+..+.....+
T Consensus       922 RL~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  922 RLD---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             ccC---CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            333   3778999999999999999999999999999999998885543

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-38  Score=297.99  Aligned_cols=246  Identities=27%  Similarity=0.479  Sum_probs=202.0

Q ss_pred             ceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          197 GITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       197 ~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      .||.|+|+.+.   +     .+..+|+|.+..+...  ...+.+..|+.+++.++||||+++++++.. ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            57888887552   1     2368999999765432  445678999999999999999999998764 46799999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      +++|.+++...+.+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.........   
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~---  152 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY---  152 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc---
Confidence            9999999988878999999999999999999999999   9999999999999999999999999987654322111   


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                      .......++..|+|||.+.+..++.++|||||||++|++++ |..||...+..+....+.. ....   ..+..+++.+.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~l~  228 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERL---PRPEECPQEIY  228 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcC---CCCCCCCHHHH
Confidence            01111123456999999988899999999999999999997 9999988877766666533 3222   23556789999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          428 ELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       428 ~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      +++.+||..+|++||++.++++.|+.+.
T Consensus       229 ~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         229 SIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            9999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.7e-39  Score=317.02  Aligned_cols=252  Identities=20%  Similarity=0.317  Sum_probs=206.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.+     ..+++.+|+|++.............+..|+.++..++||+|+++++++..+...++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            4667788999999855     23567899999965332233344568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++|+|.+++.+ .+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........ 
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-  157 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-  157 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc-
Confidence            9999999999977 456899999999999999999999999   99999999999999999999999999864422111 


Q ss_pred             ccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                          .......||+.|+|||++.     ...++.++|||||||++|+|++|..||...+..+....+.........+...
T Consensus       158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  233 (332)
T cd05623         158 ----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV  233 (332)
T ss_pred             ----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence                1112345899999999886     3467899999999999999999999999988888777775544433333334


Q ss_pred             CCCCHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVI--RPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~  450 (473)
                      ..+++++.+|+++|+..++..  |++++++++|
T Consensus       234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            567999999999999765544  6899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-38  Score=299.59  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=205.2

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|++.+.+|.|+|+.+    ..+++.||+|.+.....    ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            5777788999988754    23567899999875432    235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +.+++|.+++....  .+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||+++........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999997653  5899999999999999999999999   999999999999999999999999999765422111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                      .     ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+... ...+   .+..++
T Consensus       160 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~---~~~~~~  230 (261)
T cd05068         160 A-----REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMP---CPPGCP  230 (261)
T ss_pred             c-----cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCCcCC
Confidence            0     111122346999999998899999999999999999998 99999988877776665332 2221   244678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      +.+.+++.+||+.+|.+||++.++++.|++
T Consensus       231 ~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         231 KELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            999999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.8e-38  Score=303.82  Aligned_cols=253  Identities=27%  Similarity=0.543  Sum_probs=206.6

Q ss_pred             hhccCceeeeEEEEEEe----------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          192 VRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~~----------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      |++...+|.|+|+.+..          ....+++|.+....  .......+.+|+.+++.++||||+++++.+..++..+
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            55677899999875421          22568888886543  2344578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 011991          262 IVLEYHAKGDLASYLQKK------------------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK  317 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~  317 (473)
                      ++|||+.+++|.+++...                        ..+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence            999999999999998642                        23778899999999999999999999   999999999


Q ss_pred             CEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 011991          318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP  396 (473)
Q Consensus       318 Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~  396 (473)
                      ||++++++.++|+|||+++........    .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccch----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999998754322110    01112234567999999988889999999999999999998 9999988


Q ss_pred             CChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       397 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+.+....+. ......   .+..++.++.+++.+||+.||++||++.++++.|++++..
T Consensus       233 ~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         233 IAPERLFNLLK-TGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             CCHHHHHHHHh-CCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            88777666553 222222   2556889999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3e-38  Score=301.92  Aligned_cols=249  Identities=20%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.+|.|+|+.+     ..+++.||+|.+....   ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            36777788999988754     2368899999987542   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999999999988888999999999999999999999999   9999999999999999999999999986543221  


Q ss_pred             ccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                          .......|+..|+|||.+.   ...++.++|+|||||++|+|++|..||....+.............++.......
T Consensus       161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06645         161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK  236 (267)
T ss_pred             ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence                1122345788999999874   446889999999999999999999999766554444333222222222111235


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++..+.+++.+||..+|++||++++++++
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            77899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.3e-38  Score=308.65  Aligned_cols=255  Identities=22%  Similarity=0.465  Sum_probs=207.7

Q ss_pred             HHhhccCceeeeEEEEEE---e--cCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          190 LQVRKADGITKGSYQVAK---W--NGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~--~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      .+|+..+.+|+|+|+.+.   +  ++.    .||+|.+...  ......+++..|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            357888899999998652   1  333    4899998643  2345567889999999999999999999998764 56


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++|+||+++|+|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            8999999999999999875 35889999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ......    ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+ ..+..++.   
T Consensus       161 ~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~---  232 (316)
T cd05108         161 ADEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQ---  232 (316)
T ss_pred             CCCcce----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCC---
Confidence            322111    1112224567999999999999999999999999999997 99999887766654433 33333322   


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      +..++.++.+++.+||..||.+||++.+++..|.++....
T Consensus       233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            4457889999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.3e-38  Score=304.30  Aligned_cols=250  Identities=25%  Similarity=0.470  Sum_probs=206.0

Q ss_pred             HhhccCceeeeEEEEEE---e-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +|++.+.+|.|+|+.+.   .       .+..||+|.+....  .....+.+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            46777788999887542   1       24789999997543  344557789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC
Q 011991          261 MIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~  324 (473)
                      ++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+++   |+||||||+||+++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            9999999999999998532                24788889999999999999999999   9999999999999999


Q ss_pred             CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV  403 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  403 (473)
                      +.+||+|||+++........    .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+..
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         161 LNVKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CceEecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999998754332111    11122335678999999988889999999999999999998 88999988887777


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      ..+..... .   ..+..++..+.+++.+||+.+|.+||++++|+..|+.
T Consensus       237 ~~i~~~~~-~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQV-L---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCCc-C---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            76643322 2   2356789999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.6e-39  Score=316.74  Aligned_cols=235  Identities=25%  Similarity=0.397  Sum_probs=195.6

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHH-HHHhcCCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      .||.|+|+.+     ..+|+.+|+|++.............+..|.. +++.++||||+++++++..++..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            5788888755     3468899999997643333344455666665 467789999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      +|..++...+.+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.......      .
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~------~  152 (325)
T cd05604          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD------T  152 (325)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC------C
Confidence            99999988888999999999999999999999999   99999999999999999999999999864321111      1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .   .+...+..+.+++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~ll  227 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--V---LRPGASLTAWSIL  227 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--c---CCCCCCHHHHHHH
Confidence            2334588999999999999999999999999999999999999998887777766643221  1   1345788999999


Q ss_pred             HHccCCCCCCCCCHH
Q 011991          431 EECWDPKPVIRPNFN  445 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~  445 (473)
                      ++|+..||.+||++.
T Consensus       228 ~~ll~~~p~~R~~~~  242 (325)
T cd05604         228 EELLEKDRQRRLGAK  242 (325)
T ss_pred             HHHhccCHHhcCCCC
Confidence            999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-38  Score=305.02  Aligned_cols=254  Identities=27%  Similarity=0.422  Sum_probs=206.3

Q ss_pred             HHhhccCceeeeEEEEEEe---------------------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeee
Q 011991          190 LQVRKADGITKGSYQVAKW---------------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV  248 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~---------------------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  248 (473)
                      .+|++.+.+|.|+||.+..                     .+..||+|.+....  .....+.+.+|+++++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3577788999999985521                     23568999987543  235567899999999999999999


Q ss_pred             eEEeeEeeCCceEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 011991          249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK  317 (473)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~  317 (473)
                      ++++++..++..+++|||+.+++|.+++....           .+++..++.++.|++.||.|||+++   ++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99999999999999999999999999997765           6899999999999999999999999   999999999


Q ss_pred             CEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q 011991          318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE--GVQPFH  395 (473)
Q Consensus       318 Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~--g~~pf~  395 (473)
                      ||+++.++.++|+|||+++........    .......+++.|+|||.+.+..++.++|||||||++|+|++  +..||.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            999999999999999998754332111    11123345678999999988889999999999999999998  778888


Q ss_pred             CCChHHHHHHHHhhC---CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          396 PKPPEEVVKLMCCEG---KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       396 ~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      ..+..+....+....   ........+..+|+++.+++.+||+.||.+|||+.||++.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            777666655543221   111111224467889999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.7e-38  Score=299.63  Aligned_cols=246  Identities=27%  Similarity=0.509  Sum_probs=202.6

Q ss_pred             HhhccCceeeeEEEEE---Ee-cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~-~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.+|+|+|+.+   .+ .+..+|+|.+......    ...+.+|+.+++.++||||+++++++..+...++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            5677788999988754   33 3346999998754322    35688999999999999999999999998899999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +.+++|.+++... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.++........ 
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            9999999999764 46899999999999999999999999   999999999999999999999999998755332111 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+.. +..+.   .+...++
T Consensus       157 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  228 (256)
T cd05113         157 ----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLY---RPHLASE  228 (256)
T ss_pred             ----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCC---CCCCCCH
Confidence                1112234567999999988889999999999999999998 9999988877766666633 32222   2345688


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+.+++.+||+.||.+||++.+|++.|+
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            9999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.4e-38  Score=304.85  Aligned_cols=256  Identities=27%  Similarity=0.528  Sum_probs=210.7

Q ss_pred             HHHhhccCceeeeEEEEEE------------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEe
Q 011991          189 ELQVRKADGITKGSYQVAK------------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVT  255 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~------------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  255 (473)
                      ..+|.+...+|.|+|+.+.            .++..+|+|.+....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4567788999999998552            123479999986442  234557889999999999 7999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCE
Q 011991          256 QNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI  319 (473)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Ni  319 (473)
                      .....++||||+.+++|.+++...                ..++...+..++.|++.||.|||++|   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            999999999999999999999763                23677889999999999999999999   99999999999


Q ss_pred             EEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011991          320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKP  398 (473)
Q Consensus       320 li~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~  398 (473)
                      +++.++.+||+|||+++.........    ......+++.|+|||++.+..++.++||||||+++|++++ |..||...+
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccc----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999987653321111    1122235667999999988889999999999999999998 889998888


Q ss_pred             hHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          399 PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       399 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+....+. ......   .+..++..+.+|+.+||..+|++|||+.|+++.|++++.-
T Consensus       245 ~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         245 VEELFKLLK-EGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHHHHHH-cCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            877777663 232222   2456789999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-38  Score=297.26  Aligned_cols=243  Identities=33%  Similarity=0.612  Sum_probs=206.3

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      +|.+.+.+|.|+|+.+   ...|+.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            5667788999988754   56789999999975432    4577899999999999999999999999888999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          268 AKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       268 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ++++|.+++....  .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||.++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999998765  6899999999999999999999999   99999999999999999999999999876522111  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                             ....+..|+|||.+....++.++||||||+++|++++ |..||...+.......+.. ...+.   .+..+++
T Consensus       158 -------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  226 (256)
T cd05039         158 -------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRME---APEGCPP  226 (256)
T ss_pred             -------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCC---CccCCCH
Confidence                   1223456999999988889999999999999999997 9999988877776665532 22222   2456789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      .+.+++.+||..+|++||+++++++.|+.
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.7e-39  Score=316.38  Aligned_cols=252  Identities=20%  Similarity=0.309  Sum_probs=206.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.+     ..+++.||+|++.............+..|..++..++|+||+++++++..++..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            4677889999999854     34678999999975332333445668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |++||+|.+++.. .+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........ 
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  157 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-  157 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence            9999999999987 467899999999999999999999999   99999999999999999999999999875432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-----EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                          .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||...+..+....+.........+...
T Consensus       158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  233 (331)
T cd05624         158 ----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI  233 (331)
T ss_pred             ----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence                11123458999999998865     467889999999999999999999999888877777765544433333334


Q ss_pred             CCCCHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVI--RPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~  450 (473)
                      ..+++.+.+++.+|+..++++  |++++++++|
T Consensus       234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            567899999999999876554  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=318.55  Aligned_cols=240  Identities=23%  Similarity=0.388  Sum_probs=195.8

Q ss_pred             eeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc---CCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       198 ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      ||.|+|+.+     ..+++.||+|++.............+..|..++...   .||||+++++.+..+...|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            577888755     346889999999754333333445566677777665   699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF  349 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~  349 (473)
                      |+|.+++...+.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.++|+|||+++.......      
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~------  151 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK------  151 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC------
Confidence            999999988888999999999999999999999999   99999999999999999999999999865322211      


Q ss_pred             cccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHH
Q 011991          350 PVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE  428 (473)
Q Consensus       350 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~  428 (473)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.......    ....+++++.+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~~  227 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF----PKNVLSDEGRQ  227 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC----CCccCCHHHHH
Confidence            12234589999999998754 58999999999999999999999999888877776664332211    12357899999


Q ss_pred             HHHHccCCCCCCCC----CHHHHHHH
Q 011991          429 LIEECWDPKPVIRP----NFNEIIAR  450 (473)
Q Consensus       429 li~~cl~~dP~~RP----s~~ell~~  450 (473)
                      |+++||..||++||    ++.++++|
T Consensus       228 li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         228 FVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             HHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            99999999999998    56776653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.1e-38  Score=315.01  Aligned_cols=253  Identities=27%  Similarity=0.467  Sum_probs=206.1

Q ss_pred             HhhccCceeeeEEEEEE---e-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCc
Q 011991          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  259 (473)
                      ++.+.+.||.|+||.+.   +       .+..||+|++....  .....+.+.+|++++.++. ||||+++++++...+.
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            56677899999998652   2       23589999997543  2334457899999999997 9999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcC-----------------------------------------------------------
Q 011991          260 MMIVLEYHAKGDLASYLQKKG-----------------------------------------------------------  280 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  280 (473)
                      .++||||+++|+|.+++...+                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999996531                                                           


Q ss_pred             ---------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE
Q 011991          281 ---------------------------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (473)
Q Consensus       281 ---------------------------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili  321 (473)
                                                             .+++..++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                   2566778899999999999999998   9999999999999


Q ss_pred             cCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 011991          322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPE  400 (473)
Q Consensus       322 ~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~  400 (473)
                      +.++.+||+|||+++........    .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999998754322110    11122345778999999988889999999999999999998 89999876665


Q ss_pred             HHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          401 EVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       401 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      +........+.++.   .+..++.++.+|+.+||..+|.+||++++|++.|+.++
T Consensus       349 ~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            55444434443333   24567899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-37  Score=305.08  Aligned_cols=258  Identities=28%  Similarity=0.517  Sum_probs=211.3

Q ss_pred             HHhhccCceeeeEEEEEEe------------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee
Q 011991          190 LQVRKADGITKGSYQVAKW------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ  256 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~------------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  256 (473)
                      .+|.+.+.+|+|+|+.+..            ....+|+|.+....  .......+..|+.+++.+ +||||+++++++..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            4677889999999985521            24579999987543  344567789999999999 69999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEE
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL  320 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nil  320 (473)
                      ++..+++|||+++|+|.+++...                +.+++..+..++.|++.||.|||++|   ++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            89999999999999999999753                24788899999999999999999999   999999999999


Q ss_pred             EcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 011991          321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPP  399 (473)
Q Consensus       321 i~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~  399 (473)
                      ++.++.+||+|||+++.........    ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYK----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EcCCCcEEEcccccccccccccccc----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999997553221110    0111223456999999988889999999999999999998 8999988887


Q ss_pred             HHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          400 EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       400 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      .+....+.. +..+.   .+..++.++.+++.+||+.||++||++.++++.|+++......
T Consensus       243 ~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         243 EELFKLLRE-GHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             HHHHHHHHc-CCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence            777766633 22222   2456788999999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-38  Score=315.74  Aligned_cols=247  Identities=21%  Similarity=0.317  Sum_probs=196.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  258 (473)
                      .+|.+.+.||+|+||.+     ..+|..||+|++.... ........+.+|+.+++.++||||+++++++....      
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            47888899999999865     3468899999997543 23444567889999999999999999999986543      


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            47999999975 77777643  4889999999999999999999999   999999999999999999999999998653


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC----
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP----  414 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  414 (473)
                      ....       ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+.    
T Consensus       174 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         174 CTNF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccCc-------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            2211       12334578899999999999999999999999999999999999987765433322211111100    


Q ss_pred             ----------------C-----------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 ----------------L-----------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ----------------~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                      .                 .......++.+.+||.+||+.||++|||+.|++.|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                            0                 00011245789999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-38  Score=299.20  Aligned_cols=250  Identities=24%  Similarity=0.445  Sum_probs=203.5

Q ss_pred             hccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc-----
Q 011991          193 RKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-----  259 (473)
Q Consensus       193 ~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----  259 (473)
                      .+.+.+|.|+||.+.   .     .+..||+|.+..+.. .......+.+|+++++.++||||+++++++.....     
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456788999998552   1     236799999975433 34456789999999999999999999998765443     


Q ss_pred             -eEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          260 -MMIVLEYHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       260 -~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                       .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             79999999999999998542      24889999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |+++........    .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.. +.
T Consensus       158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~  232 (273)
T cd05035         158 GLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-GN  232 (273)
T ss_pred             cceeeccccccc----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC
Confidence            998765332111    01111224567999999988889999999999999999998 9999988887777666533 22


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .+.   .+..+++.+.+++.+||+.||++||++.|+++.|+++
T Consensus       233 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 RLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222   3557889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.9e-38  Score=304.64  Aligned_cols=253  Identities=28%  Similarity=0.540  Sum_probs=207.5

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      .+|...+.+|.|+|+.+.          .....+|+|.+....  .......+.+|+++++++ +||||+++++++..++
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            356777889999997542          123679999987543  234456789999999999 7999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD  322 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~  322 (473)
                      ..+++|||+.+|+|.+++...                +.+++..++.++.|++.||+|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999999642                35889999999999999999999999   99999999999999


Q ss_pred             CCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 011991          323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEE  401 (473)
Q Consensus       323 ~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~  401 (473)
                      .++.+||+|||+++........    .......++..|+|||.+.+..++.++|||||||++|++++ |..||......+
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYY----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             CCCeEEeCccccccccccccce----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            9999999999998765332110    01112234567999999988899999999999999999997 999999888777


Q ss_pred             HHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       402 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ....+. .+..+.   .+..++..+.+|+.+||..||++|||+.|+++.|+++.
T Consensus       243 ~~~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 LFKLLK-EGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHH-cCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            766653 232222   24467889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.1e-38  Score=300.19  Aligned_cols=253  Identities=23%  Similarity=0.449  Sum_probs=207.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.+|||.+.............+.+|+.+++.++||||+++++++..++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            4666778898888754     35789999999876544455566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |+++++|.+++..    ...+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999864    345899999999999999999999999   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhCCCCCCcccC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE--EVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  419 (473)
                      ..      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....  .....+ .....++  ..+
T Consensus       160 ~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~  230 (267)
T cd08229         160 TT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPP--LPS  230 (267)
T ss_pred             Cc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh-hcCCCCC--CCc
Confidence            11      112335788899999998888999999999999999999999999754432  222222 1222121  123


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ..+++.+.+++.+||..||++|||+.+|++.++++.
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            457889999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-38  Score=297.58  Aligned_cols=245  Identities=27%  Similarity=0.528  Sum_probs=201.3

Q ss_pred             HhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      ++++.+.+|.|+|+.+.    ..+..+|+|++......    ...+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            46677889999987552    24568999998654322    24578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++++|.+++... +.+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            9999999999764 46899999999999999999999999   999999999999999999999999998754322110 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+. ....+.   .+..+++
T Consensus       157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~  228 (256)
T cd05059         157 ----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLY---RPKLAPT  228 (256)
T ss_pred             ----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCC---CCCCCCH
Confidence                0111123456999999998899999999999999999998 899998877777666553 232222   2456789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      .+.+++.+||..+|++|||+.++++.|
T Consensus       229 ~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         229 EVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6e-38  Score=303.06  Aligned_cols=248  Identities=24%  Similarity=0.317  Sum_probs=202.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |+..+.||.|+||.+     ..+++.+|+|.+.............+.+|+++++.++|+||+.+.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            455667999999855     236889999999765544444456678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999888653  35999999999999999999999999   9999999999999999999999999986532211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......|+..|+|||.+.+..++.++|+||+||++|+|++|..||...........+........ ...+..+++
T Consensus       157 -----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  230 (285)
T cd05632         157 -----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-EVYSAKFSE  230 (285)
T ss_pred             -----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-cccCccCCH
Confidence                 11234578899999999888999999999999999999999999987766544333322221111 122456788


Q ss_pred             HHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      .+.+|+.+||+.||++||+     +.+++.+
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            9999999999999999999     7788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-37  Score=299.25  Aligned_cols=253  Identities=23%  Similarity=0.492  Sum_probs=205.6

Q ss_pred             HhhccCceeeeEEEEE---Ee--cCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          191 QVRKADGITKGSYQVA---KW--NGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~--~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      +|++.+.||.|+|+.+   .+  +++    .+++|.+...  .......++..|+.+++.++||||+++++++.. ...+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            5677788999999855   22  344    4777887532  223445678888899999999999999998764 4578


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +++||+++|+|.+++... +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999999764 56899999999999999999999999   99999999999999999999999999976543


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ....    .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.........+ ..+..+..   +
T Consensus       162 ~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~---~  233 (279)
T cd05111         162 DDKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQ---P  233 (279)
T ss_pred             CCcc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC---C
Confidence            2111    11223446678999999988889999999999999999998 99999988776665555 33333332   3


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..++.++.+++.+||..||.+|||+.|+++.|+.+...
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         234 QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            45678899999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-38  Score=324.01  Aligned_cols=242  Identities=24%  Similarity=0.342  Sum_probs=192.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--------
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--------  257 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------  257 (473)
                      .|.+.+.||.|+||.+     ..+++.||||.+....       ....+|+.+++.++||||+++++++...        
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            5888899999999865     2467899999986432       1235799999999999999999886432        


Q ss_pred             CceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEee
Q 011991          258 IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGF  332 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~Df  332 (473)
                      ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            247799999975 88777653    456899999999999999999999999   99999999999999665 6999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |+++.......       .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus       216 Gla~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        216 GSAKNLLAGQR-------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             ccchhccCCCC-------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99975532211       1234578899999988654 789999999999999999999999998877665555433221


Q ss_pred             CCCC------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 RPPL------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ~~~~------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+..                        ...+...|+++.+||.+||..||.+|||+.|+++|
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            1110                        01133467899999999999999999999999876

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-37  Score=299.87  Aligned_cols=255  Identities=23%  Similarity=0.479  Sum_probs=208.1

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      .+|...+.||.|+|+.+.     .+++    .||+|++....  .......+.+|+.+++.+.||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            356777889999998552     2444    48999987543  34556788999999999999999999999875 457


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++++||+++|+|.+++... +.+++..++.++.|++.||+|||+++   |+||||||+||++++++.+||+|||+++...
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            8999999999999999764 56899999999999999999999999   9999999999999999999999999987654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ......    ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+ ..+..++.   
T Consensus       161 ~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~---  232 (279)
T cd05109         161 IDETEY----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLPQ---  232 (279)
T ss_pred             ccccee----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC---
Confidence            321110    1112234567999999988899999999999999999998 99999887776666555 33333322   


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      +..+++++.+++.+||..||++||++.++++.|+++....
T Consensus       233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         233 PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            4567899999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.8e-38  Score=299.07  Aligned_cols=250  Identities=23%  Similarity=0.415  Sum_probs=201.0

Q ss_pred             hccCceeeeEEEEEE---e--cCc--EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------Cc
Q 011991          193 RKADGITKGSYQVAK---W--NGT--KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (473)
Q Consensus       193 ~~~~~ig~G~~~~~~---~--~~~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~  259 (473)
                      .+++.+|+|+|+.+.   .  .+.  .+|+|.+.... ......+.+..|+++++.++||||+++++.+...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            356789999998652   1  222  68999987543 2345568899999999999999999999976432      24


Q ss_pred             eEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          260 MMIVLEYHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      .+++|||+.+|+|.+++...      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            78999999999999987431      23789999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +++........    .......+++.|++||.+.+..++.++|||||||++|+|++ |..||......+....+.. +..
T Consensus       158 ~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~  232 (272)
T cd05075         158 LSKKIYNGDYY----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-GNR  232 (272)
T ss_pred             cccccCcccce----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCC
Confidence            98765332110    01122235667999999999899999999999999999998 8999988877777666533 322


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      +.   .+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       233 ~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 LK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22   2446788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.3e-38  Score=306.16  Aligned_cols=251  Identities=28%  Similarity=0.508  Sum_probs=202.9

Q ss_pred             HhhccCceeeeEEEEE---E--ecCc--EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVA---K--WNGT--KVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~--~~~~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|.+.+.+|.|+||.+   .  .++.  .+++|.+...  ........+.+|++++.++ +||||+++++++..++..++
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            5667788999999855   2  2444  3577766532  2344557888999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc
Q 011991          263 VLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      ||||+++++|.+++...+                .+++..++.++.|++.||+|||+++   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999997542                4788999999999999999999999   999999999999999999


Q ss_pred             EEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011991          327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL  405 (473)
Q Consensus       327 vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  405 (473)
                      +||+|||++........       .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus       163 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  235 (303)
T cd05088         163 AKIADFGLSRGQEVYVK-------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  235 (303)
T ss_pred             EEeCccccCcccchhhh-------cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            99999999853211100       111123556999999988889999999999999999998 9999988777766655


Q ss_pred             HHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       406 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +.. ...+.   .+..+++.+.+|+.+||+.+|++||++++++..|+++...
T Consensus       236 ~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         236 LPQ-GYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             Hhc-CCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            422 21111   2445788999999999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=300.84  Aligned_cols=251  Identities=27%  Similarity=0.500  Sum_probs=198.4

Q ss_pred             hccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceE
Q 011991          193 RKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMM  261 (473)
Q Consensus       193 ~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~  261 (473)
                      ...+.+|.|+|+.+.         .++..||+|.+....  .......+.+|+++++.++||||+++++++..  ....+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            677889999998651         256789999997542  23345678899999999999999999998765  34589


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+++++|.+++... .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||+++.....
T Consensus        85 lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999999999999999765 5999999999999999999999999   999999999999999999999999998765432


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--H------------HHHHH
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE--V------------VKLMC  407 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~--~------------~~~i~  407 (473)
                      .....   ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......  .            .....
T Consensus       161 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         161 HEYYR---VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             chhhc---cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            11110   0111234566999999988889999999999999999999999986533210  0            00011


Q ss_pred             hhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      .....+   ..+..++..+.+++.+||+.||++|||+++++..|+++.
T Consensus       238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111   124567899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.9e-38  Score=298.72  Aligned_cols=249  Identities=27%  Similarity=0.466  Sum_probs=209.1

Q ss_pred             HHHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          189 ELQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..+|...+.+|.|+|+.+    ...+..+++|.+....   ......+..|+.+++.++||||+++++++......++||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            346788889999998754    2347899999987543   334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||.+.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999999763  35899999999999999999999999   9999999999999999999999999987553221


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      .      ......++..|+|||.+....++.++||||||+++|+|++ |..||...+..+....+.. ...++   .+..
T Consensus       159 ~------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~  228 (261)
T cd05148         159 Y------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMP---CPAK  228 (261)
T ss_pred             c------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCC---CCCC
Confidence            1      1112335667999999988889999999999999999998 8999998887777776643 32222   2457


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      +++.+.+++.+||+.||++|||++++++.|+.
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            78999999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.1e-38  Score=297.06  Aligned_cols=245  Identities=24%  Similarity=0.438  Sum_probs=204.5

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|.|+|+.+     ..+++.|++|.+...... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            445567888877643     346899999998765433 45567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++++|.+++...  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999774  46899999999999999999999999   99999999999999999999999999875533211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......+++.|+|||++.+..++.++|+|||||++++|++|..||...+.......+.. +..+..   +..++.
T Consensus       157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~---~~~~~~  227 (256)
T cd08529         157 -----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPV---SQMYSQ  227 (256)
T ss_pred             -----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCC---ccccCH
Confidence                 11223477889999999998899999999999999999999999988887666665533 322222   336789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.+++.+||+.+|++||++.+++++
T Consensus       228 ~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         228 QLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHhhC
Confidence            99999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-38  Score=296.98  Aligned_cols=243  Identities=35%  Similarity=0.585  Sum_probs=204.7

Q ss_pred             ceeeeEEEEE---Eec-----CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          197 GITKGSYQVA---KWN-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       197 ~ig~G~~~~~---~~~-----~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      .+|.|+|+.+   ...     +..+++|.+......  ...+.+.+|+++++.++|+||+++++++......++||||++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            5788887644   222     789999999765432  256789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          269 KGDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       269 ~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      +++|.+++...         ..+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999875         67999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ....    ........++..|+|||.+....++.++||||+||++|+|++ |..||......+....+.. +...   ..
T Consensus       157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~---~~  228 (262)
T cd00192         157 DDDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRL---PK  228 (262)
T ss_pred             cccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC---CC
Confidence            3321    111223446778999999988889999999999999999998 6999999888777776643 2222   23


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +..+|+++.+++.+||..||++|||+.+++++|+
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            5567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-38  Score=305.60  Aligned_cols=245  Identities=27%  Similarity=0.373  Sum_probs=199.5

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |+..+.||.|+||.+     ..+++.||+|.+.............+..|+.+++.++|++|+++++.+..++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            455677999999855     346789999999765444444456678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            9999999998653  34899999999999999999999999   9999999999999999999999999986542211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhCCCCCCcccCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE---EVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~  421 (473)
                           ......|+..|+|||++.+..++.++||||+||++|+|++|..||......   +....+.... .   ...+..
T Consensus       157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~---~~~~~~  227 (285)
T cd05630         157 -----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-Q---EEYSEK  227 (285)
T ss_pred             -----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-h---hhcCcc
Confidence                 112345888999999999889999999999999999999999999865432   1222211111 1   112456


Q ss_pred             CCHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      +++++.+|+++||+.||.+|||     ++|+++|
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            7899999999999999999999     8898874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=302.25  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=203.2

Q ss_pred             HHhhccCceeeeEEEEEEe-----------------c--CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeE
Q 011991          190 LQVRKADGITKGSYQVAKW-----------------N--GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF  250 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~-----------------~--~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  250 (473)
                      .+|++.+.||+|+|+.+..                 +  ...||+|.+....  .....+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            3677888999999986631                 1  2358999997542  34556789999999999999999999


Q ss_pred             EeeEeeCCceEEEEeccCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCC
Q 011991          251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKG------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN  318 (473)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~N  318 (473)
                      ++++......++||||+.+++|.+++....            .+++..+..++.|++.||.|||+++   ++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence            999999999999999999999999986532            3678889999999999999999999   9999999999


Q ss_pred             EEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 011991          319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE--GVQPFHP  396 (473)
Q Consensus       319 ili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~--g~~pf~~  396 (473)
                      |+++.++.+||+|||++.........    .......++..|+|||.+.+..++.++|||||||++|+|++  +..||..
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcce----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999998754332110    11122334667999999988889999999999999999988  6788888


Q ss_pred             CChHHHHHHHHh---hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          397 KPPEEVVKLMCC---EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       397 ~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+..+....+..   ..........+..+|+.+.+|+.+||+.||++|||+++|++.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            776665544321   11111111234457899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8e-38  Score=297.14  Aligned_cols=243  Identities=29%  Similarity=0.570  Sum_probs=202.0

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe-eCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-QNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~  266 (473)
                      +|.+.+.+|.|+|+.+   ...|..+|+|.+....     ..+.+.+|+.+++.++|||++++++++. .+...++||||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            5677788999888644   5678999999986432     2357889999999999999999999764 45678999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++++|.+++...+  .+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999997653  3789999999999999999999999   9999999999999999999999999986432211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                             .....+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. +..+.   .+..++
T Consensus       157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~  225 (256)
T cd05082         157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMD---APDGCP  225 (256)
T ss_pred             -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCC
Confidence                   11223456999999988889999999999999999997 9999988777776665532 22222   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      +.+.+++.+||+.+|++|||+.++++.|+++
T Consensus       226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-37  Score=302.57  Aligned_cols=254  Identities=28%  Similarity=0.483  Sum_probs=206.1

Q ss_pred             HhhccCceeeeEEEEEE-----ecCc--EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGT--KVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|.+.+.||.|+||.+.     .++.  .+++|.++..  ......+.+.+|++++.++ +||||+++++++...+..++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            46677789999998552     2332  4788887632  2344457789999999999 79999999999999899999


Q ss_pred             EEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc
Q 011991          263 VLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      +|||+++++|.+++....                .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            999999999999997532                4788899999999999999999999   999999999999999999


Q ss_pred             EEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011991          327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL  405 (473)
Q Consensus       327 vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  405 (473)
                      +||+|||++.......       .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus       158 ~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~  230 (297)
T cd05089         158 SKIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK  230 (297)
T ss_pred             EEECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999985321110       0011122446999999988889999999999999999997 9999998888777666


Q ss_pred             HHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       406 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      +.. +..+.   .+..+++.+.+|+.+||..+|.+||+++++++.|+.+....++
T Consensus       231 ~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         231 LPQ-GYRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             Hhc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            532 22222   2456889999999999999999999999999999999886544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.4e-38  Score=306.30  Aligned_cols=247  Identities=25%  Similarity=0.449  Sum_probs=200.9

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.+|.|+|+.+     ..++..+|+|.+..+.  .......+.+|+++++.++||||+++++++..++..++|||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            3667788999999855     2367889999987542  34556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999999888889999999999999999999998 46   9999999999999999999999999986542211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-----------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-----------  413 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  413 (473)
                            .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.......           
T Consensus       155 ------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         155 ------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence                  123457888999999988889999999999999999999999997655443332221110000           


Q ss_pred             ----------------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 ----------------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                            ........+++++.+|+.+||..||++||++++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                  0001112367889999999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.1e-38  Score=334.02  Aligned_cols=262  Identities=22%  Similarity=0.280  Sum_probs=207.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|+|+||.+     ..+|+.||+|++..+........+++.+|+++++.++||||+++++++..++..++|||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            4677889999999865     23588999999986554455566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          266 YHAKGDLASYLQKK-----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                      |++|++|.+++...           ..++...++.++.|++.||+|||+++   |+||||||+||+++.++.++|+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999998642           22456678899999999999999999   99999999999999999999999999


Q ss_pred             ccccccCcccc------------cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011991          335 LRLQYISPEKA------------KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV  402 (473)
Q Consensus       335 a~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~  402 (473)
                      ++.........            ..........||+.|+|||.+.+..++.++|||||||++|+|++|..||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            97652111000            000111234689999999999999999999999999999999999999987655443


Q ss_pred             HHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHh
Q 011991          403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP-NFNEIIARLDRIVCN  457 (473)
Q Consensus       403 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~~  457 (473)
                      ....  ....+........+|+.+.+++.+||+.||++|| +++++++.|+.....
T Consensus       240 ~~~~--~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        240 SYRD--VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhh--hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            3221  1111111112346789999999999999999995 567777878777653

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-37  Score=299.54  Aligned_cols=250  Identities=28%  Similarity=0.490  Sum_probs=202.2

Q ss_pred             HHhhccCceeeeEEEEE---Ee-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      ..|.+.+.+|.|+|+.+   ..       .+..||+|.+....  .......+..|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35677778899888644   22       45678999886432  23444678999999999999999999999998889


Q ss_pred             eEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC---cEEE
Q 011991          260 MMIVLEYHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKI  329 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~---~vkl  329 (473)
                      .++||||+++++|.+++...+       .+++..++.++.||+.||+|||+++   ++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999997653       4889999999999999999999999   99999999999998654   5999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........    ........+..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..
T Consensus       161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~  236 (277)
T cd05036         161 ADFGMARDIYRASYY----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG  236 (277)
T ss_pred             ccCccccccCCccce----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999998765322110    01111223456999999998889999999999999999996 9999998887776665533


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      . ..+.   .+..++..+.+++.+||+.+|++|||+.+++++|+
T Consensus       237 ~-~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 G-GRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             C-CcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            2 2222   24567899999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-37  Score=299.53  Aligned_cols=248  Identities=26%  Similarity=0.482  Sum_probs=204.0

Q ss_pred             HhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ++...+.+|.|+|+.+.          .++..+|+|.+...   .......+.+|+++++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            56667789999997552          13568899987643   345567899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC
Q 011991          261 MIVLEYHAKGDLASYLQKKG---------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~  325 (473)
                      +++|||+++++|.+++...+               .+++..++.++.|++.||+|||+.+   ++||||||+||++++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence            99999999999999997643               3788999999999999999999999   99999999999999999


Q ss_pred             cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011991          326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVK  404 (473)
Q Consensus       326 ~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  404 (473)
                      .++|+|||+++........    .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus       160 ~~kL~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYY----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             CEEECCCCceeEcCCCcee----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            9999999998754322110    11122234677999999998899999999999999999998 999998877766665


Q ss_pred             HHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       405 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+.. +..+.   .+..+++.+.+|+.+||+.||.+||++++|++.|+
T Consensus       236 ~~~~-~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 CITQ-GRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHc-CccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            5532 22221   24568899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-37  Score=307.87  Aligned_cols=255  Identities=27%  Similarity=0.497  Sum_probs=204.0

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee-C
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ-N  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~  257 (473)
                      .+|++.+.||.|+||.+.          .+++.||||++....  .......+.+|+.++..+ .||||+++++++.. +
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            368889999999998662          346789999997543  234456788999999999 68999999998765 4


Q ss_pred             CceEEEEeccCCCCHHHHHHHc----------------------------------------------------------
Q 011991          258 IPMMIVLEYHAKGDLASYLQKK----------------------------------------------------------  279 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------  279 (473)
                      ...+++|||+++|+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            5689999999999999998642                                                          


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          280 ---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       280 ---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                               ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.........    ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~  237 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VR  237 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch----hh
Confidence                     12577788899999999999999999   999999999999999999999999998764322111    11


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL  429 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~l  429 (473)
                      .....++..|+|||.+.+..++.++||||||+++|++++ |..||...............+..+..   +..+++++.++
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  314 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQT  314 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHH
Confidence            122335567999999988889999999999999999996 99999876544333333333333222   34567899999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          430 IEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       430 i~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      +.+||+.||++||++.||+++|+.++.
T Consensus       315 ~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         315 MLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-38  Score=297.50  Aligned_cols=248  Identities=25%  Similarity=0.441  Sum_probs=204.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+     ..+++.+++|.+....   ....+.+.+|+++++.++||||+++++++......|++||
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            4667778898888744     2357889999997543   2345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++++|.+++... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            99999999999776 67999999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE---EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                           ......++..|+|||.+.+.   .++.++|+|||||++|+|++|..||...+.......+......+........
T Consensus       157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd06613         157 -----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK  231 (262)
T ss_pred             -----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence                 11234577789999999776   7899999999999999999999999887766655554333222222222345


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.++.+++++||..+|.+||++++++.+
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         232 WSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             hhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            67889999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.6e-37  Score=299.03  Aligned_cols=253  Identities=27%  Similarity=0.453  Sum_probs=205.4

Q ss_pred             HHhhccCceeeeEEEEEEe----------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~----------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+.+.+|+|+|+.+..          .+..||+|.+....  .......+.+|+.+++.++||||+++++++..+..
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678889999999986531          24589999986442  23344568899999999999999999999999899


Q ss_pred             eEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 011991          260 MMIVLEYHAKGDLASYLQKKG----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI  329 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl  329 (473)
                      .++||||+++|+|.+++...+          .++...+..++.|++.||.|||+++   |+||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532          2456788999999999999999999   999999999999999999999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........    .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus       161 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             CcCCccccccccccc----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999998754332111    11112234567999999988889999999999999999998 7899998887776665533


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      .. .+.   .+...++.+.+++.+||+.||++|||+.++++.|++..
T Consensus       237 ~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         237 GG-YLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CC-CCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            22 222   24456889999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.3e-38  Score=296.74  Aligned_cols=244  Identities=26%  Similarity=0.465  Sum_probs=204.5

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+.+|.|+|+.+     ..++..+|+|.+....  .....+.+..|+.+++.++||||+++++++..++.+++||||
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            566778999998744     3468899999986543  234557888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++++|.+++...  ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||.++....... 
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            9999999998653  34889999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. +...+   .+..++.
T Consensus       156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  226 (255)
T cd08219         156 -----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-GSYKP---LPSHYSY  226 (255)
T ss_pred             -----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-CCCCC---CCcccCH
Confidence                 11234578889999999988899999999999999999999999998877666665533 22222   2456788


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.++|.+||+.||++||++.+++..
T Consensus       227 ~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         227 ELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-37  Score=296.94  Aligned_cols=252  Identities=28%  Similarity=0.533  Sum_probs=206.9

Q ss_pred             HhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|++.+.+|.|.|+.+.   .     .+..+|+|.+....  .......+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56777889999987541   1     23379999986543  24456788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999765 45899999999999999999999999   999999999999999999999999998765432


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ....   .......++..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+.. +..++   .+.
T Consensus       160 ~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~  232 (267)
T cd05066         160 PEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLP---APM  232 (267)
T ss_pred             ccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCC---CCC
Confidence            1111   11112223457999999998889999999999999999886 9999988877766666533 22222   234


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .+++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            6789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=298.77  Aligned_cols=250  Identities=29%  Similarity=0.498  Sum_probs=206.0

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+...+|.|+|+.+.          ..+..||+|.+....  .......+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            367778899999997552          123689999986443  23445678899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 011991          260 MMIVLEYHAKGDLASYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI  329 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl  329 (473)
                      .++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            99999999999999999653          23678889999999999999999999   999999999999999999999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........    .......++..|+|||.+.+..++.++|||||||++|++++ |..||...+..+....+. 
T Consensus       161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-  235 (277)
T cd05032         161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-  235 (277)
T ss_pred             CCcccchhhccCccc----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-
Confidence            999998755332110    11122335678999999988889999999999999999998 999999888877776664 


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+..+.   .+..++..+.+++.+||+.+|++|||+.+++..|+
T Consensus       236 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DGGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            332222   24567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=317.28  Aligned_cols=246  Identities=20%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      -|.+...+|.|.||.+     +.++-..|.|++...   ..+.++.|+-|++||...+||+||+++++|...+.+|++.|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            4777778999999865     334445677887643   46778999999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||.||-...++-. ...+++.++.-+++|++.||.|||+++   |||||||..|||++-+|.++|+|||.+...      
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn------  180 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN------  180 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc------
Confidence            9999999988765 455999999999999999999999999   999999999999999999999999997432      


Q ss_pred             ccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      .........+.|||+|||||+..     ..+|+.++||||||+++.||..+.+|-...++..++..|.. .. |+-...|
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK-Se-PPTLlqP  258 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SE-PPTLLQP  258 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-cC-CCcccCc
Confidence            22233456788999999999875     45899999999999999999999999999999888887733 33 3334468


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.++..+.+|+.+||..||..||++++|++|
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            8899999999999999999999999999875

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-37  Score=296.29  Aligned_cols=248  Identities=29%  Similarity=0.454  Sum_probs=202.8

Q ss_pred             HhhccCceeeeEEEEE---E-ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~-~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      .|++.+.+|.|+|+.+   . .++..||+|++......    .+.+.+|+++++.++||||+++++.+.. ...++||||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            5788889999988744   2 23457999999754321    2468899999999999999999998754 567999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||.++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999999763  34789999999999999999999999   999999999999999999999999998755332111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                      .     .....++..|+|||...+..++.++|||||||++|++++ |..||......+....+.. ....+   .+..++
T Consensus       159 ~-----~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~  229 (262)
T cd05071         159 A-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMP---CPPECP  229 (262)
T ss_pred             c-----ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCC---CccccC
Confidence            1     112335567999999988889999999999999999999 8999988877776665532 22221   234678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      +.+.+++.+|++.||++||+++++++.|+..+
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            99999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-37  Score=294.55  Aligned_cols=246  Identities=20%  Similarity=0.396  Sum_probs=207.7

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |+..+.+|.|+|+.+     ..+++.+++|.+...... ......+.+|++++++++|+||+++++++......+++|||
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            566778999988733     456889999998765433 34557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++++|.+++...  ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999775  45899999999999999999999999   99999999999999999999999999875533221 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||......+....+.. +..++   .+..++.
T Consensus       157 -----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  227 (256)
T cd08221         157 -----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTP---VVSVYSS  227 (256)
T ss_pred             -----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCC---CccccCH
Confidence                 12234578899999999888889999999999999999999999998887777666643 22222   2356789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ++.+++.+||..+|.+||+++++++++
T Consensus       228 ~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         228 ELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-37  Score=295.80  Aligned_cols=252  Identities=29%  Similarity=0.507  Sum_probs=205.9

Q ss_pred             HhhccCceeeeEEEEEE-----ecC---cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK-----WNG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      .|...+.+|.|+|+.+.     .++   ..+|+|.+....  .....+.+..|+++++.++||||+++.+++...+..++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            45667789999887441     223   379999986542  24445788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++++|.+++... +.+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999764 56899999999999999999999999   999999999999999999999999998755332


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      .....   .......+..|+|||.+.+..++.++|||||||++|++++ |..||...+..+....+... ...+   .+.
T Consensus       161 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~---~~~  233 (268)
T cd05063         161 PEGTY---TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP---APM  233 (268)
T ss_pred             cccce---eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCC---CCC
Confidence            11111   1111223456999999988889999999999999999997 99999888777776666432 2222   134


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            5788999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-37  Score=302.18  Aligned_cols=243  Identities=28%  Similarity=0.468  Sum_probs=206.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.+|+|.+.............+.+|+++++.++||||+++++++......++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            3566778898888744     23679999999976544445556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.+||+|||++......    
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998754332    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.. + .+.   .+..+++.
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~-~~~---~~~~~~~~  224 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-G-KVR---FPSFFSPD  224 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-C-Ccc---CCccCCHH
Confidence                 1234578889999999888889999999999999999999999988776666555532 2 122   24557899


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +.+++.+||..||.+||     +++|++++
T Consensus       225 l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            99999999999999999     88888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.9e-37  Score=294.74  Aligned_cols=253  Identities=24%  Similarity=0.459  Sum_probs=206.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+     ..+|+.||+|.+.............+.+|++++++++|+||+++++++..++..++|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4667778999988754     23689999999976444455556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999864    234889999999999999999999999   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhhCCCCCCcccC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP--PEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ..      ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....  .......+. .+..++.  ..
T Consensus       160 ~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~  230 (267)
T cd08224         160 TT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPL--PA  230 (267)
T ss_pred             Cc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCC--Ch
Confidence            11      1122347788999999988889999999999999999999999996543  223333332 2222221  12


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ..++..+.++|.+||..+|++||++.+|++.|+++.
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            367889999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.9e-38  Score=312.22  Aligned_cols=247  Identities=21%  Similarity=0.288  Sum_probs=196.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------C
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  258 (473)
                      .+|.+.+.||.|+||.+     ...++.||||.+..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            47888899999999866     24678999999975432 344557788999999999999999999988643      3


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..++||||+++ +|.+.+..  .+++..+..++.|++.||.|||++|   |+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            47999999975 78777754  4889999999999999999999999   999999999999999999999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-----
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-----  413 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  413 (473)
                      ....       ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+     
T Consensus       170 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         170 GTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             CCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            3221       1233467899999999999899999999999999999999999998776544333221111000     


Q ss_pred             ---------------C-----------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 ---------------P-----------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ---------------~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                     .                 ....+...+..+.+||.+||..||++|||+.|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                           0                 000112235678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.2e-37  Score=296.92  Aligned_cols=256  Identities=23%  Similarity=0.424  Sum_probs=209.1

Q ss_pred             HHHhhccCceeeeEEEEE---E-ec-----CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-CC
Q 011991          189 ELQVRKADGITKGSYQVA---K-WN-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NI  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~---~-~~-----~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~  258 (473)
                      ..+|.+.+.+|.|+|+.+   . ..     +..|++|.+...  ......+.+.+|+.+++.++||||+++++++.. +.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            446777889999999755   2 22     578999998643  245566889999999999999999999998765 56


Q ss_pred             ceEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEE
Q 011991          259 PMMIVLEYHAKGDLASYLQKK--------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~  330 (473)
                      ..++++||+++++|.+++...        ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998763        34889999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 011991          331 GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       331 DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~  409 (473)
                      |||+++.........    ......++..|+|||.+.+..++.++|||||||++|++++ |+.||...++.+....+. .
T Consensus       160 d~g~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~  234 (280)
T cd05043         160 DNALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-D  234 (280)
T ss_pred             CCCCcccccCCceEE----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-c
Confidence            999997543321110    0112234567999999988889999999999999999998 999998887776655543 3


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +..+.   .+..+++.+.+++.+||+.||++|||+.++++.|+++..+
T Consensus       235 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         235 GYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            32222   2345788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=298.92  Aligned_cols=244  Identities=23%  Similarity=0.436  Sum_probs=211.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+..++|.|+||.+     +.+|+.+|||.+..+     ..++++.+|+.+|++.+.|+||+++|.+.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            5777889999999855     789999999999753     346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||..||..++++. ++.+++.++..+++..++||+|||...   =||||||..|||++.+|..||+|||.+....+.   
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---  182 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---  182 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh---
Confidence            9999999999976 467999999999999999999999998   899999999999999999999999998655432   


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                         .....+..|||.|||||++..-+|+.++||||||++..||..|++||.+..+...+.-|  ...+|+--..|...|.
T Consensus       183 ---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--PT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  183 ---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--PTKPPPTFKKPEEWSS  257 (502)
T ss_pred             ---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--cCCCCCCCCChHhhhh
Confidence               12234567999999999999999999999999999999999999999987775544433  1222333345667889


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.+||++||..+|++|-++-++++|
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            99999999999999999999999876

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-37  Score=302.70  Aligned_cols=256  Identities=25%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|+|+|+.+     ..+++.|++|.+.............+..|+++++.++||||+++++.+..++..++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            556678899988754     346789999998765433344557888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc-
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA-  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~-  345 (473)
                      ++|++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++......... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            999999999988888999999999999999999999999   9999999999999999999999999986421110000 


Q ss_pred             --------cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          346 --------KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       346 --------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                              ..........++..|+|||.+.+..++.++|+|||||++|++++|..||.+....+....+......  ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~  237 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--WPE  237 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--CCC
Confidence                    0000111234677899999998888999999999999999999999999988877776665333211  111


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      ....+++++.++|.+||+.||++||++.++.+.|+
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            23367899999999999999999999655555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2e-37  Score=296.60  Aligned_cols=254  Identities=26%  Similarity=0.501  Sum_probs=206.4

Q ss_pred             HhhccCceeeeEEEEEE-----ecC---cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK-----WNG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      .|++.+.+|.|+|+.+.     .++   ..||+|.+....  .......|..|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            46777889999887542     223   369999987542  35556789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++++|.+++... +.+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999764 56899999999999999999999999   999999999999999999999999998765432


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ....... .......+..|+|||.+.+..++.++|||||||++||+++ |..||...+.......+.. ....+   .+.
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-~~~~~---~~~  234 (269)
T cd05065         160 TSDPTYT-SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLP---PPM  234 (269)
T ss_pred             ccccccc-cccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCcCC---Ccc
Confidence            2111110 0011112346999999998899999999999999999886 9999988887777666632 22222   134


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .++..+.+++.+||..+|++||++++++..|+++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            6788999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=310.61  Aligned_cols=258  Identities=27%  Similarity=0.526  Sum_probs=215.1

Q ss_pred             ccccChhHHHhhccCceeeeEEEEE---Ee----cC--cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEe
Q 011991          182 EYELNPLELQVRKADGITKGSYQVA---KW----NG--TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG  252 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~---~~----~~--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  252 (473)
                      .|++....  ......||.|-||-+   .+    .|  -.||||..+.+.  +++..+.|+.|..+|+.++||||++++|
T Consensus       383 nyel~Re~--Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIG  458 (974)
T KOG4257|consen  383 NYELRREL--ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIG  458 (974)
T ss_pred             cceeehhh--ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheee
Confidence            34444333  344567888888743   22    22  368899987653  4556789999999999999999999999


Q ss_pred             eEeeCCceEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          253 AVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       253 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                      +|.+. +.|||||+++-|.|..|++.++ .++......++.||+.||+|||+..   ++||||-..||||.+..-|||+|
T Consensus       459 v~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  459 VCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             eeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence            99764 6799999999999999998764 4889999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ||+|+...++.     .+..+...-+.-|||||.+.-++++.+||||.||++|||++. |..||++..+.+++..+ ..|
T Consensus       535 FGLSR~~ed~~-----yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnG  608 (974)
T KOG4257|consen  535 FGLSRYLEDDA-----YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENG  608 (974)
T ss_pred             cchhhhccccc-----hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCC
Confidence            99999875541     111222223456999999999999999999999999999986 99999999888887776 455


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      .+++   .|+++|+.|..|+.+||+.||.+||.+.||...|.++..
T Consensus       609 eRlP---~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 ERLP---CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCC---CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            5554   378899999999999999999999999999999988877

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-37  Score=304.29  Aligned_cols=263  Identities=28%  Similarity=0.534  Sum_probs=212.8

Q ss_pred             CccccChhHHHhhccCceeeeEEEEEE---e---------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCee
Q 011991          181 PEYELNPLELQVRKADGITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNV  247 (473)
Q Consensus       181 ~~~~i~~~~~~~~~~~~ig~G~~~~~~---~---------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  247 (473)
                      |++++..  .+|.+.+.||+|+|+.+.   .         .+..+|+|.+....  .....+.+.+|+++++++ +||||
T Consensus         5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i   80 (334)
T cd05100           5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNI   80 (334)
T ss_pred             cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCe
Confidence            4565554  367888999999997542   1         12368999886432  344567899999999999 79999


Q ss_pred             eeEEeeEeeCCceEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 011991          248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (473)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  311 (473)
                      +++++++..++..+++|||+++|+|.+++....                .++...+..++.|++.||+|||+++   ++|
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH  157 (334)
T cd05100          81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH  157 (334)
T ss_pred             eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence            999999999999999999999999999997532                3678889999999999999999999   999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-C
Q 011991          312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G  390 (473)
Q Consensus       312 ~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g  390 (473)
                      |||||+||+++.++.+||+|||+++.........    ......++..|+|||++.+..++.++|||||||++|+|++ |
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g  233 (334)
T cd05100         158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG  233 (334)
T ss_pred             cccccceEEEcCCCcEEECCcccceecccccccc----cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcC
Confidence            9999999999999999999999987543321110    1111223457999999999899999999999999999998 8


Q ss_pred             CCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       391 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ..||...+..+....+.. ...+.   .+..++..+.+++.+||+.+|.+||++.|+++.|+++....
T Consensus       234 ~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         234 GSPYPGIPVEELFKLLKE-GHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             CCCCCCCCHHHHHHHHHc-CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            999998887777666532 22222   24567889999999999999999999999999999998543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-37  Score=298.17  Aligned_cols=254  Identities=24%  Similarity=0.435  Sum_probs=202.1

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC---CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK---DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      |.....+|+|+|+.+     ..+++.+|+|.+......   .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            556678899998754     357889999999754322   123457899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~~~~  342 (473)
                      |||+.+++|.+++...+.+++..++.++.|++.||.|||++|   ++|+||+|+||+++.++ .++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            999999999999988778999999999999999999999999   99999999999998776 59999999987654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      ...  ........++..|+|||.+.+..++.++|+||+||++++|++|..||...........+............+..+
T Consensus       159 ~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd06630         159 TGA--GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL  236 (268)
T ss_pred             ccC--CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence            111  011123357788999999988889999999999999999999999997544322222221111111112234567


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++++.+++.+||..+|.+||++.+++++
T Consensus       237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         237 SPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            8999999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-37  Score=298.35  Aligned_cols=254  Identities=26%  Similarity=0.503  Sum_probs=200.8

Q ss_pred             HHhhccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--C
Q 011991          190 LQVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  258 (473)
                      ..|.+.+.+|+|+|+.+.         .++..||+|.+....  .......+.+|+.+++.++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            356778889999998652         357889999986542  344557899999999999999999999998765  5


Q ss_pred             ceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||+++.
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            689999999999999999765 35899999999999999999999999   99999999999999999999999999876


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------------hHHHH
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP--------------PEEVV  403 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--------------~~~~~  403 (473)
                      .........   ......++..|+|||.+.+..++.++|||||||++|+|+++..|+....              .....
T Consensus       159 ~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         159 IETDKEYYT---VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             cccCcccee---ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            543221111   1122346667999999988889999999999999999999776543211              00111


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      ......+...+   .+..++..+.+|+.+||+.||++||+++++++.|+.+
T Consensus       236 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11112222221   2456889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-37  Score=294.24  Aligned_cols=247  Identities=29%  Similarity=0.479  Sum_probs=203.9

Q ss_pred             HHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|++.+.+|.|+|+.+    ..+++.+|+|.+......    ...+.+|+.+++.++||||+++++++. .+..+++||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            46778889999999755    346789999999754432    356889999999999999999999874 456899999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+.+++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999998763  35889999999999999999999999   99999999999999999999999999865432211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      ..     .....++..|+|||.+....++.++||||||+++|++++ |..||.+.+..+....+. .+..++   .+...
T Consensus       158 ~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~  228 (260)
T cd05067         158 TA-----REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMP---RPDNC  228 (260)
T ss_pred             cc-----ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCC---CCCCC
Confidence            10     112234567999999988889999999999999999998 999999888777666653 232222   24567


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      +..+.+++.+||..+|++||++++++..|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            8899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.2e-37  Score=293.67  Aligned_cols=246  Identities=30%  Similarity=0.474  Sum_probs=202.5

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|++.+.+|.|+|+.+    ...+..+|+|.+......    ...+.+|+.++++++||||+++++++.. ...+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            5778889999998754    245678999999765432    2468899999999999999999998754 567999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+++   ++|+||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999999763  34899999999999999999999999   999999999999999999999999998754332111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                      .     .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.. +..++   .+...+
T Consensus       159 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~  229 (260)
T cd05070         159 A-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMP---CPQDCP  229 (260)
T ss_pred             c-----ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---CCCcCC
Confidence            1     111224556999999988889999999999999999999 9999998887777766633 22222   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      ..+.+|+.+||..||++|||+.++.+.|+.
T Consensus       230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         230 ISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.1e-37  Score=298.40  Aligned_cols=251  Identities=29%  Similarity=0.466  Sum_probs=204.7

Q ss_pred             HHhhccCceeeeEEEEEE---e-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|+....+|.|+|+.+.   .       ++..+|+|++....  .......+.+|+.+++.++||||+++++++..+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            357777889999987542   1       46789999987543  34455779999999999999999999999999889


Q ss_pred             eEEEEeccCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 011991          260 MMIVLEYHAKGDLASYLQKKG----------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK  317 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~  317 (473)
                      .++||||+++++|.+++....                      .+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999997532                      3678889999999999999999999   999999999


Q ss_pred             CEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 011991          318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP  396 (473)
Q Consensus       318 Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~  396 (473)
                      ||+++.++.++|+|||++.........    ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYY----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             heEecCCCceEECccccceecccCccc----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999998654322110    01112223556999999988899999999999999999997 8889988


Q ss_pred             CChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       397 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      .+..+....+.. +...   ..+..++..+.+|+.+||+.||.+|||+.|+++.|++
T Consensus       236 ~~~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         236 MAHEEVIYYVRD-GNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCHHHHHHHHhc-CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            887777666532 2221   1245678999999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-37  Score=311.48  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=198.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------C
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  258 (473)
                      .+|.+.+.||+|+||.+     ...++.||||++..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            47888899999999865     34678999999975432 334456788999999999999999999987543      3


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..|+||||+++ +|.+.+..  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            57999999965 88887754  3889999999999999999999999   999999999999999999999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc--
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK--  416 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  416 (473)
                      ....       ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+...  
T Consensus       177 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         177 GTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            3221       1233457889999999999999999999999999999999999998877666555443221111000  


Q ss_pred             -----------------------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 -----------------------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 -----------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                                         ......++.+.+||.+||..||.+|||+.++++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                                               0011134678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=304.07  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=206.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...+.+|.|+|+.+     ..+++.+|+|.+.............+..|+++++.++||||+++++.+......|+|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            3566778898888754     23578999999987655444566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+.+++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999998764  45899999999999999999999999   99999999999999999999999999865432211


Q ss_pred             ccc-----------------------ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 011991          344 KAK-----------------------IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE  400 (473)
Q Consensus       344 ~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~  400 (473)
                      ...                       .........|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            000                       001112345788899999999888999999999999999999999999988877


Q ss_pred             HHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 011991          401 EVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN----FNEIIAR  450 (473)
Q Consensus       401 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ell~~  450 (473)
                      .....+.....  ... ....+++.+.+++.+||..||++||+    ++|++.+
T Consensus       239 ~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         239 ETFSNILKKEV--TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HHHHHHhcCCc--cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            66665532221  111 12237899999999999999999999    8888874

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-37  Score=299.48  Aligned_cols=253  Identities=25%  Similarity=0.423  Sum_probs=201.5

Q ss_pred             HhhccCceeeeEEEEEEe---------------------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeee
Q 011991          191 QVRKADGITKGSYQVAKW---------------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ  249 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~~---------------------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  249 (473)
                      +|++.+.+|.|+|+.+..                     ++..+|+|++....  .....+.+.+|+.+++.++||||++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence            577888899999986532                     23468999987542  3445678999999999999999999


Q ss_pred             EEeeEeeCCceEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCC
Q 011991          250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN  318 (473)
Q Consensus       250 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~N  318 (473)
                      +++++..++..++||||+++++|.+++....           .+++..+..++.|++.||+|||+++   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999997642           3667789999999999999999999   9999999999


Q ss_pred             EEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 011991          319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE--GVQPFHP  396 (473)
Q Consensus       319 ili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~--g~~pf~~  396 (473)
                      |+++.++.++|+|||+++........    .......+++.|++||...+..++.++|||||||++|+|++  |..||..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcce----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999998754322110    01112234567999998888889999999999999999998  7789987


Q ss_pred             CChHHHHHHHHh---hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          397 KPPEEVVKLMCC---EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       397 ~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+..+.......   ..........+..+++.+.+|+.+||+.||.+||++.+|++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            766555443211   11111111224567899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-37  Score=304.44  Aligned_cols=250  Identities=20%  Similarity=0.356  Sum_probs=190.8

Q ss_pred             Cceeee--EEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          196 DGITKG--SYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       196 ~~ig~G--~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      ..||+|  +|+.+     ..+|+.||+|.+..+.. .....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            456777  34322     45789999999976543 34455678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          269 KGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       269 ~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +|+|.+++..+  +.+++..++.++.|++.||+|||+++   |+||||||+||+++.++.++++|||.............
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999999653  45899999999999999999999999   99999999999999999999999987543221111110


Q ss_pred             ccc-cccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--------
Q 011991          347 IVF-PVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--------  415 (473)
Q Consensus       347 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------  415 (473)
                      ... ......++..|+|||++.+  ..++.++|||||||++|+|++|..||................ .+..        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT-VPCLLDTTTIPA  238 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCC-ccccccccchhh
Confidence            000 0112235667999999876  468999999999999999999999998765444332221111 0000        


Q ss_pred             ----------------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ----------------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ----------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                                        ......+++.+.+|+.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                                              00112356789999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=293.86  Aligned_cols=245  Identities=26%  Similarity=0.417  Sum_probs=216.8

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|+|+||.+     +.+++.+|+|+++++.....+.+..-+.|-.+++..+||.+..+...|+.++.+|+||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            445568999999965     568999999999998887788888889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      ..||.|.-.|.....+++...+.+...|+.||.|||+++   ||.||||.+|.|+|.+|++||.|||+.+.....     
T Consensus       250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-----  321 (516)
T KOG0690|consen  250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-----  321 (516)
T ss_pred             ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc-----
Confidence            999999999988888999999999999999999999999   999999999999999999999999998754322     


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHH
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL  426 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  426 (473)
                       ......++|||.|+|||++....|+.++|.|.+|++||||++|+.||...+....+..|..+..+.     |..+++++
T Consensus       322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF-----Pr~ls~eA  395 (516)
T KOG0690|consen  322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF-----PRTLSPEA  395 (516)
T ss_pred             -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC-----CccCCHHH
Confidence             223456789999999999999999999999999999999999999999999988888875554332     56789999


Q ss_pred             HHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          427 KELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       427 ~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      +.|+...|.+||.+|..     +.||.+|
T Consensus       396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             HHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            99999999999999953     5555543

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.4e-37  Score=296.39  Aligned_cols=244  Identities=23%  Similarity=0.402  Sum_probs=201.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |++.+.+|.|+|+.+     ..++..+++|.+...   .....+.+.+|+++++.++||||+++++++..+...++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            667788999998755     235678899998643   345567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++++|..++.. .+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......   
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---  157 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---  157 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc---
Confidence            999999998765 456899999999999999999999999   9999999999999999999999999986543211   


Q ss_pred             cccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          346 KIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                         .......+++.|+|||++.     +..++.++||||+||++|+|++|..||...+..+....+.... .+ ....+.
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~-~~~~~~  232 (282)
T cd06643         158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PP-TLAQPS  232 (282)
T ss_pred             ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC-CC-CCCCcc
Confidence               1122345788899999874     3467889999999999999999999998877766655553221 12 122355


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .++..+.+||.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            68899999999999999999999999887

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.8e-37  Score=293.35  Aligned_cols=244  Identities=29%  Similarity=0.546  Sum_probs=201.9

Q ss_pred             ceeeeEEEEE---Ee---cC--cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          197 GITKGSYQVA---KW---NG--TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       197 ~ig~G~~~~~---~~---~~--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      .+|+|+|+.+   .+   .+  ..+|+|.+......  ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            4688888754   21   22  26999999865432  566889999999999999999999999988 88999999999


Q ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          269 KGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       269 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +++|.+++....  .+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++......... 
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-  154 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY-  154 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce-
Confidence            999999997754  5899999999999999999999999   9999999999999999999999999997654322111 


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                        .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.......   ..+..+|..
T Consensus       155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  229 (257)
T cd05040         155 --VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL---ERPEACPQD  229 (257)
T ss_pred             --ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---CCCccCCHH
Confidence              01112346678999999988889999999999999999998 999998888877776664433222   234567899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +.+++.+||+.+|++||++.++++.|.
T Consensus       230 ~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         230 IYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-37  Score=289.29  Aligned_cols=242  Identities=31%  Similarity=0.512  Sum_probs=198.6

Q ss_pred             ceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          197 GITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       197 ~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      .||.|+|+.+    ..++..+|+|.+....  .......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            4677877644    3467889999987543  344456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccc
Q 011991          273 ASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV  351 (473)
Q Consensus       273 ~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~  351 (473)
                      .+++... ..+++..+..++.|++.+|.|+|+++   ++|+||||+||+++.++.++|+|||++.........     ..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~  151 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS  151 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence            9998754 45789999999999999999999999   999999999999999999999999998653221110     01


Q ss_pred             cCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       352 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      ....++..|+|||.+.+..++.++||||||+++|++++ |..||...........+. .+....   .+..++..+.+++
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~li  227 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMS---CPQKCPDDVYKVM  227 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCCHHHHHHH
Confidence            11223556999999988889999999999999999998 999999887776665553 232222   2456789999999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHH
Q 011991          431 EECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+|++.+|++||++.++++.|.
T Consensus       228 ~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         228 QRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHcccCcccCCCHHHHHHHhc
Confidence            9999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-37  Score=293.99  Aligned_cols=243  Identities=28%  Similarity=0.514  Sum_probs=196.5

Q ss_pred             ceeeeEEEEE---E--ecCc--EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          197 GITKGSYQVA---K--WNGT--KVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       197 ~ig~G~~~~~---~--~~~~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      .+|.|+|+.+   .  .++.  .+++|.+...  ......+.+..|+++++++ +||||+++++++...+..++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            4678888644   2  2333  4688888643  2344556889999999999 79999999999999999999999999


Q ss_pred             CCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          269 KGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       269 ~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                      +++|.+++....                .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            999999997542                3788999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |++.......       .......+..|+|||.+....++.++|||||||++|+|++ |..||...+..+....+.. ..
T Consensus       157 gl~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~  228 (270)
T cd05047         157 GLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY  228 (270)
T ss_pred             CCccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CC
Confidence            9985321110       0111123456999999988889999999999999999996 9999988777766665522 22


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ...   .+...+.++.+++.+||+.||.+|||+.+++..|++++
T Consensus       229 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            221   23457889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=315.71  Aligned_cols=244  Identities=25%  Similarity=0.515  Sum_probs=201.8

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcC-CCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC--ceEEEE
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDK-ESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVL  264 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~-~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~  264 (473)
                      +....+|+|+|..+     ..+|..||--.++. +....+..+++|..|+.+|+.|+||||++|++.+.+..  .+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34457888888655     35666776444432 22345677899999999999999999999999998654  489999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+|..|+|..|+++.++++...++.|++||++||.|||++.| +|||||||++||+|+. .|.|||+|+|+|.....+. 
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            999999999999999999999999999999999999999985 6999999999999985 5899999999998764432 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                             ..+..|||.|||||... ..|+..+|||||||+|.||.|+..||.. .++.++++++. .|..|..-  .+--
T Consensus       201 -------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl--~kV~  269 (632)
T KOG0584|consen  201 -------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAAL--SKVK  269 (632)
T ss_pred             -------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHh--hccC
Confidence                   23367999999999998 7899999999999999999999999986 55667777774 44444331  1222


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+++++||.+|+.. ..+|||+.|+|++
T Consensus       270 dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            68999999999999 8999999999874

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.9e-37  Score=295.05  Aligned_cols=250  Identities=20%  Similarity=0.390  Sum_probs=201.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC--CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~  261 (473)
                      .|...+.+|.|+|+.+     ..++..||+|.+......  .......+.+|+.+++.++||||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            4677788999999754     246889999998754322  23445778999999999999999999998875  35689


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ++|||+++++|.+++...+.+++...+.++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||+++.....
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            99999999999999988778999999999999999999999999   999999999999999999999999998654221


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ...   ........++..|+|||.+.+..++.++||||+||++|+|++|..||...........+......+.   .+..
T Consensus       160 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~  233 (266)
T cd06651         160 CMS---GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ---LPSH  233 (266)
T ss_pred             ccc---CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCC---Cchh
Confidence            100   0111234477889999999988899999999999999999999999987765555444433332222   2445


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++.+.+++ +||..+|++||+++|+++|
T Consensus       234 ~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         234 ISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             cCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            778899999 6888999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=281.79  Aligned_cols=244  Identities=24%  Similarity=0.434  Sum_probs=199.5

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEec
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      ....-+|+|+.|.+     ..+|...|||.+....  ..+..++++..+.++.+- ++|+||+.+|+|..+...++.||.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            34456788887754     4678999999998653  567778899999987776 589999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |.. .+.++++. .+.+++..+-++...+++||.||.++.  +|||||+||+|||+|..|++||||||++-...++... 
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-  248 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-  248 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence            954 77777755 456899888999999999999999876  5999999999999999999999999999766544221 


Q ss_pred             cccccccCCCCCCcccCCCCcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhCCCCCCcccCCC
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNE---EFDRSVDAYSFGLILYEMIEGVQPFHPKPP-EEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                            +..+|-+.|||||.+...   .|+.++||||||+.++||.||..||.+... .+++-.+.. ..+|.++ ...+
T Consensus       249 ------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~-~~~g  320 (391)
T KOG0983|consen  249 ------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLP-GHMG  320 (391)
T ss_pred             ------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCC-cccC
Confidence                  234567789999998654   789999999999999999999999998554 455555533 3333332 2345


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +|+++.+|+..||.+|+.+||.+.++++|
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            89999999999999999999999999986

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-37  Score=300.25  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=192.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc---CCCeeeeEEeeEee-----CC
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQ-----NI  258 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-----~~  258 (473)
                      |++.+.||.|+|+.+     ..+++.||+|.+....... .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            667788999999865     3468899999997543221 1123355677777665   79999999998764     24


Q ss_pred             ceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ..++||||+.+ +|.+++...  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence            58999999975 999988764  34899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC--
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP--  414 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--  414 (473)
                      ......       ......+|..|+|||++.+..++.++||||+||++|+|++|..||...........+......+.  
T Consensus       157 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         157 IYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  229 (288)
T ss_pred             cccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence            553221       11234578889999999988999999999999999999999999987776655444432111000  


Q ss_pred             --------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 --------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                          .......++..+.+++.+||+.||++|||+.|++.|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                000123467889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.7e-37  Score=296.25  Aligned_cols=247  Identities=21%  Similarity=0.403  Sum_probs=202.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|++.+.+|.|+|+.+     ..++..+++|.+...   .....+.+..|+.+++.++||||+++++.+..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            35788889999999755     245789999999753   3556678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++++|..++.+ ...+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999999988765 456899999999999999999999999   9999999999999999999999999876432211 


Q ss_pred             cccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                           .......+++.|+|||.+.     ...++.++|+|||||++|+|++|..||...+.......+.. ...+ ....
T Consensus       165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~-~~~~  237 (292)
T cd06644         165 -----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPP-TLSQ  237 (292)
T ss_pred             -----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCCc-cCCC
Confidence                 1112344778899999884     34578899999999999999999999988776655555422 2222 2223


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..++.++.+++.+||..||++||++++++++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            55678899999999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-37  Score=303.64  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=197.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+     ..+++.||+|.+......  .....+.+|+++++.++||||+++++++..++..++|||
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            4677788999999865     246788999999754322  222457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++ +|.+++... ..++...+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            9975 888888664 34889999999999999999999999   99999999999999999999999999865422211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--------  415 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------  415 (473)
                           ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+..        
T Consensus       160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         160 -----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             -----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence                 1122346788999998865 46889999999999999999999999887765554443221111100        


Q ss_pred             ------------c-----ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ------------K-----IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ------------~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                  .     .....+++++.+||.+||..||.+|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence                        0     0112467889999999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.4e-37  Score=293.54  Aligned_cols=250  Identities=19%  Similarity=0.358  Sum_probs=201.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCC--CCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKES--HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~  261 (473)
                      .|.+.+.+|+|+|+.+     ..++..||+|.+....  .......+.+.+|+.+++.+.||||+++++++.+.  ..++
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            3566778999988754     2467899999986432  22344567889999999999999999999998763  4688


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ++|||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            99999999999999988777899999999999999999999999   999999999999999999999999998754321


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ....   .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+......   ...+..
T Consensus       160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (265)
T cd06652         160 CLSG---TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN---PVLPPH  233 (265)
T ss_pred             cccc---cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC---CCCchh
Confidence            1110   1122345788899999998888999999999999999999999999876655544444322222   223556


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++..+.+++++|+. +|++||++++++++
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            77889999999994 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7e-37  Score=291.43  Aligned_cols=246  Identities=30%  Similarity=0.461  Sum_probs=200.4

Q ss_pred             HhhccCceeeeEEEEE---E-ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~-~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      .|.+...||.|+|+.+   . ..+..+|+|.+.....    ..+.+.+|+.+++.++||||+++++++.. +..+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            4677778999988754   2 2345799998865432    23568899999999999999999998754 568999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999764  24789999999999999999999999   999999999999999999999999998765332111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           ......++..|+|||...+..++.++||||||+++|+|++ |..||.+....+....+.. ...++   .+...+
T Consensus       159 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~  229 (260)
T cd05069         159 -----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMP---CPQGCP  229 (260)
T ss_pred             -----ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC---CCcccC
Confidence                 1112234567999999988889999999999999999999 9999998877776665533 22222   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      ..+.+++++||..||.+||+++++++.|++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-37  Score=292.66  Aligned_cols=248  Identities=30%  Similarity=0.473  Sum_probs=205.1

Q ss_pred             HHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|.+.+.+|.|+|+.+    ..++..+|+|.+......    .+.+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            35677788999988754    235578999998754322    3568899999999999999999999998889999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999997643  5899999999999999999999999   99999999999999999999999999875532111


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .     .......+..|+|||.+.+..++.++||||+|+++|++++ |..||.+.+.......+.. +...+   .+...
T Consensus       159 ~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~  229 (261)
T cd05034         159 T-----AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMP---RPPNC  229 (261)
T ss_pred             h-----hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCC
Confidence            1     0111223457999999998889999999999999999998 9999998887777776633 22221   24456


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      +..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         230 PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            8899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=308.02  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=212.8

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      ...++++||+|.||.+    ...+..||||.++....  ....+.|.+|+++|.+|+||||+.++|+|..++++++||||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            4567789999999865    23458999999987653  44568999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |++|+|.+|+..+.  .+.......++.||+.||+||.+.+   ++||||.+.|+|++.++++||+|||+++..+..+. 
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y-  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY-  692 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc-
Confidence            99999999998873  3455667789999999999999999   99999999999999999999999999986554321 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHH---hhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI--EGVQPFHPKPPEEVVKLMC---CEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell--~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~  419 (473)
                       ..  .-....-+.+|||||.+.-++++.++|+|+||+++||++  +.+.||...+.+++.+...   ..+........|
T Consensus       693 -y~--vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  693 -YR--VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             -ee--eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence             00  011222356799999999999999999999999999986  5889999998888776542   222223334467


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .-+|..+.++|-+||.+|-.+|||++++..+|++.
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            77899999999999999999999999999998764

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.5e-37  Score=290.58  Aligned_cols=249  Identities=28%  Similarity=0.534  Sum_probs=197.3

Q ss_pred             ceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe-eCCceEEEEecc
Q 011991          197 GITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-QNIPMMIVLEYH  267 (473)
Q Consensus       197 ~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~~  267 (473)
                      .||.|+|+.+.   .     .+..+|+|.+...  ......+.+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46888887542   1     2357999998532  23455678899999999999999999999765 456689999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      .+++|.+++... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~-  155 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS-  155 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee-
Confidence            999999999764 34677888999999999999999999   9999999999999999999999999987543221100 


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                       ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .+..+.   .+..+++.
T Consensus       156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~  230 (262)
T cd05058         156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLL---QPEYCPDP  230 (262)
T ss_pred             -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCC---CCCcCCHH
Confidence             011122335667999999988889999999999999999999 567787777666655543 222222   23456889


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      +.+++.+||..+|++||++.++++.|++++.
T Consensus       231 ~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         231 LYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            9999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-37  Score=299.75  Aligned_cols=247  Identities=21%  Similarity=0.427  Sum_probs=203.3

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ..+|.+.+.+|.|+|+.+     ..+++.+++|.+.....   ...+.+.+|+.+++.++||||+++++.+..+...|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            346777788999888754     24678999999976443   2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+++++|.+++... .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             ecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999999998654 5889999999999999999999999   99999999999999999999999999865322111


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+......+.... .+.. ..+..++
T Consensus       172 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~  243 (296)
T cd06654         172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL-QNPEKLS  243 (296)
T ss_pred             ------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCC-CCccccC
Confidence                  1123457888999999988888999999999999999999999998777654443332222 1211 1245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+.+++.+||..||++||++.+++.+
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         244 AIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            899999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.9e-37  Score=290.82  Aligned_cols=242  Identities=31%  Similarity=0.596  Sum_probs=201.8

Q ss_pred             HHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          190 LQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      .+|.+.+.+|.|+|+.+   ..+++.+|+|.+....     ....+.+|+.+++.++||||+++++++..+ ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            35778889999999754   5678899999986432     235788999999999999999999998765 47999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +.+++|.+++....  .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            99999999997653  4789999999999999999999999   9999999999999999999999999986532211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                             .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+.. +..+.   .+..++
T Consensus       155 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~  223 (254)
T cd05083         155 -------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRME---PPEGCP  223 (254)
T ss_pred             -------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCC---CCCcCC
Confidence                   11123456999999988889999999999999999997 9999998887776665533 33222   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      +.+.+++.+||+.+|++||++++++..|++
T Consensus       224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=296.07  Aligned_cols=246  Identities=24%  Similarity=0.408  Sum_probs=204.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+.+.+|.|+|+.+     ..++..+|+|.+...   .....+.+..|+++++.++||||+++++.+..+...++|||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            5778888999888754     235789999998643   35556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++++|.+++... ..+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            99999999998764 46899999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                           ......+++.|+|||.+.     ...++.++|+|||||++|+|++|..||...........+.. +..+.. ..+
T Consensus       159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~-~~~  231 (280)
T cd06611         159 -----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-SEPPTL-DQP  231 (280)
T ss_pred             -----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-CCCCCc-CCc
Confidence                 112345788899999874     34577899999999999999999999988877666555532 222222 224


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..++.++.+++.+||..||.+||++++++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            5678999999999999999999999999885

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-38  Score=300.70  Aligned_cols=249  Identities=31%  Similarity=0.535  Sum_probs=198.7

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |++.+.||+|+||.+     ..+++.+|+|++...... .........|+.+++.++||||+++++++......++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence            456788999999865     245678999999865422 22233445699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +.+++|.+++...+.+++..+..++.|++.||.+||+++   |+|+||||+||+++.++.++|+|||.+......     
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-----  151 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-----  151 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-----
Confidence            999999999987778999999999999999999999999   999999999999999999999999998653111     


Q ss_pred             ccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc--cCCCCC
Q 011991          347 IVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI--KARSYP  423 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~  423 (473)
                       ........+++.|+|||++. +..++.++||||+|+++++|++|..||...........+...........  .....+
T Consensus       152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T PF00069_consen  152 -NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKS  230 (260)
T ss_dssp             -TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSH
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhH
Confidence             11233456788899999998 78889999999999999999999999998743333322211111110000  011123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+.+++.+||+.||++||++.+++++
T Consensus       231 ~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  231 EELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            789999999999999999999999873

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.7e-37  Score=290.23  Aligned_cols=245  Identities=26%  Similarity=0.458  Sum_probs=201.8

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-CCceEEEEe
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLE  265 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e  265 (473)
                      |.+.+.+|.|+|+.+     ..+++.+|+|.+..... .......+.+|++++++++|||++++++.+.. +..++++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            566778888888643     34678999999975432 33445678999999999999999999998864 446899999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++++|.+++...  ..+++.+++.++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999763  35899999999999999999999999   99999999999999999999999999876532211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......+++.|+|||++.+..++.++|+||+||+++++++|..||...+.......+.. +..+.   .+..++
T Consensus       158 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~  227 (257)
T cd08223         158 ------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPP---MPKDYS  227 (257)
T ss_pred             ------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCC---CccccC
Confidence                  12234578889999999998999999999999999999999999988776665555433 22222   245688


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+.+++.+||+.||++||++.+++++
T Consensus       228 ~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         228 PELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=316.55  Aligned_cols=238  Identities=26%  Similarity=0.449  Sum_probs=198.3

Q ss_pred             ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCC
Q 011991          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (473)
Q Consensus       197 ~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (473)
                      .+|+|+||++     ..+..++|||-+...   +....+-+..|+.+-+.|+|.|||+++|++..++.+-|.||-++|||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            5799999976     244568999998754   34455678899999999999999999999999999999999999999


Q ss_pred             HHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-CCCcEEEEeeccccccccCcccccc
Q 011991          272 LASYLQKK-GRL--SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKI  347 (473)
Q Consensus       272 L~~~l~~~-~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-~~~~vkl~DfG~a~~~~~~~~~~~~  347 (473)
                      |.+++... |++  .+.++-.+.+||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++..-..      
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi------  729 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI------  729 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC------
Confidence            99999764 667  78999999999999999999999   99999999999997 4688999999998754222      


Q ss_pred             cccccCCCCCCcccCCCCcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCCcccCCCCCH
Q 011991          348 VFPVSHIDPANLYVAPEIYKNE--EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       348 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                      .....++.||..|||||++..+  +|+.++|||||||++.||.||++||...... ....+   -|..-..+..|..++.
T Consensus       730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~iPeelsa  806 (1226)
T KOG4279|consen  730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPPIPEELSA  806 (1226)
T ss_pred             CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCCCcHHHHH
Confidence            1122457799999999999765  7999999999999999999999999765433 22223   3433333445778899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      +++.||.+|+..||.+||+++++|.
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhcc
Confidence            9999999999999999999999975

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-36  Score=290.92  Aligned_cols=252  Identities=27%  Similarity=0.509  Sum_probs=205.7

Q ss_pred             HHhhccCceeeeEEEEEE---e-c----CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          190 LQVRKADGITKGSYQVAK---W-N----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~-~----~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+|.+.+.+|.|+|+.+.   . +    ...+++|......  .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            356677889999998552   1 1    2368999886543  24556789999999999999999999998875 4578


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+++++|.+++.... .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999997743 4899999999999999999999999   99999999999999999999999999875533


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ...     .......++..|+|||.+....++.++|||||||++|++++ |..||...+..+....+. .+..+.   .+
T Consensus       160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~---~~  230 (270)
T cd05056         160 ESY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLP---MP  230 (270)
T ss_pred             ccc-----eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCC---CC
Confidence            211     01112234457999999988889999999999999999986 999999888776666553 333222   24


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      ..+|+.+.+++.+|+..+|.+|||+.+++..|+.+..
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            5778999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.2e-37  Score=295.52  Aligned_cols=239  Identities=23%  Similarity=0.398  Sum_probs=194.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|.|+|+.+     ..+++.||+|.+..+.  .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            455667888888744     3578899999997542  344557799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +++++|..+    ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++......     
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-----  148 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----  148 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-----
Confidence            999999755    34788999999999999999999999   999999999999999999999999998654322     


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhhCCCCCCcccC
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-------EVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~  419 (473)
                         ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......       .....+.. ..  ......
T Consensus       149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~  222 (279)
T cd06619         149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-ED--PPVLPV  222 (279)
T ss_pred             ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cC--CCCCCC
Confidence               112345788899999999889999999999999999999999999653221       12222211 11  111123


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+++++.+++.+||+.||.+||+++|++++
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            4578899999999999999999999999885

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=307.99  Aligned_cols=246  Identities=25%  Similarity=0.333  Sum_probs=196.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------C
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  258 (473)
                      ..|.+.+.||.|+|+.+     ..+++.||||.+..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            46888889999999865     34678999999975432 223446678899999999999999999987543      3


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..|++||++ +++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence            479999998 6799988754 46999999999999999999999999   999999999999999999999999998754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc-
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK-  416 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  416 (473)
                      ...         .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......+... 
T Consensus       169 ~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         169 DDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             CCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            221         123457889999999876 578899999999999999999999998766554444332211111000 


Q ss_pred             -------------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 -------------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 -------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                               ......++.+.+|+.+||..||.+|||+.|++.|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                     0112456778999999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.7e-37  Score=296.70  Aligned_cols=246  Identities=25%  Similarity=0.448  Sum_probs=199.5

Q ss_pred             HhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.+|.|+|+.+   .  .++..+|+|.+....  .......+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            4677788999999754   2  368999999987542  34455788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          266 YHAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       266 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+ .+   |+|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999998763   368999999999999999999997 47   999999999999999999999999998654221


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNE------EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      .        .....+++.|+|||.+.+.      .++.++|+|||||++|+|++|..||...........+........ 
T Consensus       157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  227 (286)
T cd06622         157 L--------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-  227 (286)
T ss_pred             c--------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-
Confidence            1        1223467789999998554      357899999999999999999999987665544443322111111 


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+..+++++.+||.+||..+|++||++++++.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            12245689999999999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6e-37  Score=292.05  Aligned_cols=239  Identities=25%  Similarity=0.387  Sum_probs=198.0

Q ss_pred             eeeeEEEE---EEe--cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          198 ITKGSYQV---AKW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       198 ig~G~~~~---~~~--~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      +|.|+|+.   +..  +++.+|+|++...........+.+.+|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            35555543   333  4889999999866554455567899999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccccc
Q 011991          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS  352 (473)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~  352 (473)
                      .+++.....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......       ...
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------~~~  150 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------KTW  150 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------ccc
Confidence            999988777999999999999999999999999   9999999999999999999999999987653321       112


Q ss_pred             CCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP--PEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       353 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      ...+++.|++||.+.+..++.++|+||+|+++|+|++|..||....  +......+......+.   .+...++++.++|
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i  227 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLI  227 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---CCcccCHHHHHHH
Confidence            2356788999999988889999999999999999999999998776  5555555432222222   2344588999999


Q ss_pred             HHccCCCCCCCCC-----HHHHHH
Q 011991          431 EECWDPKPVIRPN-----FNEIIA  449 (473)
Q Consensus       431 ~~cl~~dP~~RPs-----~~ell~  449 (473)
                      .+||+.||++||+     ++|+++
T Consensus       228 ~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         228 KQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHccCChhhCcCCcccCHHHHhc
Confidence            9999999999999     777776

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=312.90  Aligned_cols=245  Identities=22%  Similarity=0.294  Sum_probs=195.7

Q ss_pred             HHhhccCceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          190 LQVRKADGITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      .+|.+.+.||.|+||.+.       ..+..||+|.+....        ...+|+++++.++||||+++++++......|+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            468888999999998652       234689999886432        24679999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||++. ++|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.++|+|||+++......
T Consensus       164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            999995 599999977778999999999999999999999999   9999999999999999999999999987543321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhCC--------
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE---EVVKLMCCEGK--------  411 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~---~~~~~i~~~~~--------  411 (473)
                      .    ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   ..+..+.....        
T Consensus       240 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        240 D----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             c----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            1    11123456899999999999999999999999999999999999999764321   11111111100        


Q ss_pred             -----------------CCCCc----ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 -----------------RPPLK----IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 -----------------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                       +++..    .....++.++.++|++||..||++||++.|++.+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                             01000    0112456789999999999999999999999985

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=306.44  Aligned_cols=258  Identities=27%  Similarity=0.503  Sum_probs=217.0

Q ss_pred             ccccChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee
Q 011991          182 EYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ  256 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  256 (473)
                      .|++...+  .....++|.|.||.+     +...-.||||.++.    +...+++|+.|+.+|+.++|||+|+++|+|..
T Consensus       261 kWEmeRtd--ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  261 KWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             hhhccchh--eeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            45544433  345568899988744     34456899999974    45678999999999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                      ...+|||+|||..|+|.+||..-.  .++.-..+.++-||..||+||..++   +|||||-..|+||..+..|||+|||+
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999998743  3777788899999999999999999   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      ++++..+--...     ....-.+-|.|||-+.-..++.++|||+||+++||+.| |..||++.+...++..+ ..+++.
T Consensus       412 sRlMtgDTYTAH-----AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM  485 (1157)
T KOG4278|consen  412 SRLMTGDTYTAH-----AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRM  485 (1157)
T ss_pred             hhhhcCCceecc-----cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccc
Confidence            998643311111     11112345999999999999999999999999999997 99999999999888877 455554


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .   .|.++|+.+.+||+.||++.|.+||++.|+.+.++.++..
T Consensus       486 ~---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  486 D---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             c---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            4   3789999999999999999999999999999999988763

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.4e-37  Score=294.67  Aligned_cols=252  Identities=28%  Similarity=0.512  Sum_probs=197.2

Q ss_pred             HhhccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCc
Q 011991          191 QVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~  259 (473)
                      .|++.+.+|.|+|+.+.         .++..||+|.+...   .....+.+.+|+++++.++||||+++++++..  ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            56677889999987652         25789999998643   34556788999999999999999999998753  346


Q ss_pred             eEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      .++||||+++++|.+++... +.+++..++.++.|++.||.|||++|   ++||||||+||+++.++.++|+|||+++..
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            89999999999999999764 45899999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH---------------H
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV---------------V  403 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~---------------~  403 (473)
                      ........   ......++..|+|||.+.+..++.++|||||||++|||++|..|+........               .
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         159 PQDKEYYK---VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             cCCCccee---ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            43211110   01112234459999999888899999999999999999998777643321100               0


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      ..+.......   ..+..++..+.+|+.+||..+|++|||+.||++.|+.+
T Consensus       236 ~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         236 IELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0111111111   12456788999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=291.60  Aligned_cols=254  Identities=22%  Similarity=0.469  Sum_probs=208.5

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      .+|++.+.||+|+|+.+.     .+|+    .+|+|.+....  .......+.+|+.+++.++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            467778899999997542     2233    68999886543  24556788999999999999999999999887 788


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++||||+++|+|.+++... +.+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999999774 45899999999999999999999998   9999999999999999999999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ......    ......++..|+|||.+....++.++|+|||||++|++++ |..||......+....+.. +...+   .
T Consensus       161 ~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~  232 (279)
T cd05057         161 VDEKEY----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLP---Q  232 (279)
T ss_pred             Ccccce----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCC---C
Confidence            221111    1112223567999999988889999999999999999998 9999998887777666543 22222   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +..++..+.+++.+||..||.+||++.++++.|+++...
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            445778999999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.6e-37  Score=290.61  Aligned_cols=246  Identities=24%  Similarity=0.427  Sum_probs=204.1

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCC--CCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      |+..+.+|.|+|+.+     ..+++.|++|.+.....  ...+..+.+.+|+.+++.++||||+++++++..+...+++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            456677899888754     23689999999875332  22445678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......  
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            99999999999988877999999999999999999999999   9999999999999999999999999986543221  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           ......+++.|++||.+.... ++.++|+|||||++|+|++|..||...........+......+   ..+..++
T Consensus       157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~  228 (258)
T cd06632         157 -----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---PIPDHLS  228 (258)
T ss_pred             -----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC---CcCCCcC
Confidence                 122345788899999987766 8999999999999999999999998776555444443222222   2355678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+.+++.+||+.+|.+||++++++.+
T Consensus       229 ~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         229 DEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            999999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=330.16  Aligned_cols=248  Identities=23%  Similarity=0.395  Sum_probs=198.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv  263 (473)
                      .|.+...||.|+|+.+     ..++..+|+|++..... .......+..|+.+++.++||||++++++|..  ...+|||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            6888899999999865     34678899999976543 34456788999999999999999999999864  4568999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEeCCCCCCCEEEcCC-----------
Q 011991          264 LEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKP----DPIIHCDLKPKNILLDNG-----------  324 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~iiH~Dlkp~Nili~~~-----------  324 (473)
                      |||+++++|.++|..    .+.+++..++.|+.||+.||.|||+.++    .+||||||||+||||+..           
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            999999999999875    2569999999999999999999998531    239999999999999642           


Q ss_pred             ------CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 011991          325 ------GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHP  396 (473)
Q Consensus       325 ------~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~  396 (473)
                            +.+||+|||++.......       ......||+.|+|||++.+  ..++.++|||||||++|+|++|..||..
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                  348999999987543221       1123468999999999854  4588999999999999999999999987


Q ss_pred             CChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       397 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..............  +..  ....+++++.+||..||..+|.+||++.|+|.+
T Consensus       246 ~~~~~qli~~lk~~--p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        246 ANNFSQLISELKRG--PDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCcHHHHHHHHhcC--CCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            65544333322222  211  234578999999999999999999999999864

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-36  Score=291.01  Aligned_cols=246  Identities=25%  Similarity=0.414  Sum_probs=190.0

Q ss_pred             ceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          197 GITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       197 ~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      .||+|+|+.+.       .++..+|+|.+.....  ......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            47888887542       2345799999875532  33345788999999999999999999999998899999999999


Q ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          270 GDLASYLQKKG-----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       270 gsL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+|.+++....     ..++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-  155 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-  155 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce-
Confidence            99999997532     3567788899999999999999999   99999999999999999999999999864322111 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhC-CCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE-------EFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEG-KRPPL  415 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~  415 (473)
                         ........++..|+|||++.+.       .++.++|||||||++|+|++ |..||......+......... .....
T Consensus       156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05087         156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK  232 (269)
T ss_pred             ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence               1111223467789999988642       35789999999999999996 999998877665544332222 11111


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +......++.+.+++++|| .+|++|||++||+..|.
T Consensus       233 ~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1122346788999999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-37  Score=296.75  Aligned_cols=246  Identities=22%  Similarity=0.412  Sum_probs=201.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.+|+|+|+.+     ..+|+.+|+|++....  .....+.+.+|+++++.++||||+++++++.....+++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            46778888999998755     2358899999987543  2445678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999999999887789999999999999999999997 46   9999999999999999999999999976432211 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhhCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-----------EVVKLMCCEGKR  412 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~  412 (473)
                             .....++..|+|||++.+..++.++|+|||||++|++++|..||......           +....+.. ...
T Consensus       159 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  230 (284)
T cd06620         159 -------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPP  230 (284)
T ss_pred             -------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccC
Confidence                   11235788899999998888999999999999999999999999865542           12222211 111


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      +.  .....++.++.+|+.+||+.||.+||+++|++++.
T Consensus       231 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PR--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CC--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11  11223788999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-38  Score=286.14  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=205.6

Q ss_pred             cCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       195 ~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      ...+|.|.|+.+     ..+|.++|||++.+.   ......+..+|++++... .|+||++++++|+++..+|||||-|.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            356899999755     578999999999875   244567889999999999 49999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC---cEEEEeeccccccccCcc-c
Q 011991          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLRLQYISPE-K  344 (473)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~---~vkl~DfG~a~~~~~~~~-~  344 (473)
                      ||+|...|.++..+++.++.++..+|+.||.|||.+|   |.||||||+|||-.+..   -||||||.+..-.....+ .
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9999999999989999999999999999999999999   99999999999997654   489999988643221111 1


Q ss_pred             ccccccccCCCCCCcccCCCCcC---C--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK---N--EEFDRSVDAYSFGLILYEMIEGVQPFHPKP---------------PEEVVK  404 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~---------------~~~~~~  404 (473)
                      ........+..|+..|||||+..   +  ..|+.+.|.||||+++|-|++|.+||.+..               ....+.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence            11112234566888899999763   2  368999999999999999999999998643               344566


Q ss_pred             HHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       405 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .| +.+....+...+..+|.+..++|+..+.+||.+|.++.+++.
T Consensus       317 sI-QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 SI-QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HH-hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            66 566655556667789999999999999999999999999887

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.2e-37  Score=318.24  Aligned_cols=244  Identities=20%  Similarity=0.265  Sum_probs=190.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC------CeeeeEEeeEeeC-
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH------PNVVQFVGAVTQN-  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~-  257 (473)
                      .+|++.+.||.|+||.|     ...++.||||++...    ......+..|+++++.+.|      +++++++++|..+ 
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            46888899999999866     235789999999642    1223455667787777754      4588999988754 


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCC-----------
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGG-----------  325 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~-----------  325 (473)
                      ...|+|||++ +++|.+++...+.+++..+..++.||+.||.|||+ .|   ||||||||+|||++.++           
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccccc
Confidence            5689999998 67999999888889999999999999999999998 48   99999999999998765           


Q ss_pred             -----cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 011991          326 -----QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE  400 (473)
Q Consensus       326 -----~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~  400 (473)
                           .+||+|||.+.....         ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             CCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                 499999998753211         123456899999999999999999999999999999999999999887765


Q ss_pred             HHHHHHHhhCCCCCCcc-----------------------cC--------------CCCCHHHHHHHHHccCCCCCCCCC
Q 011991          401 EVVKLMCCEGKRPPLKI-----------------------KA--------------RSYPPDLKELIEECWDPKPVIRPN  443 (473)
Q Consensus       401 ~~~~~i~~~~~~~~~~~-----------------------~~--------------~~~~~~l~~li~~cl~~dP~~RPs  443 (473)
                      +....+......++...                       .+              ...++.+.+||.+||..||.+|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            55444322211110000                       00              001356789999999999999999


Q ss_pred             HHHHHHH
Q 011991          444 FNEIIAR  450 (473)
Q Consensus       444 ~~ell~~  450 (473)
                      ++|+++|
T Consensus       432 a~e~L~H  438 (467)
T PTZ00284        432 ARQMTTH  438 (467)
T ss_pred             HHHHhcC
Confidence            9999984

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=286.50  Aligned_cols=243  Identities=30%  Similarity=0.510  Sum_probs=198.1

Q ss_pred             ceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          197 GITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       197 ~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      .+|.|+|+.+    ...++.||+|.+.....  ......+.+|+++++.++||||+++++++......++||||+.+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            4677766533    22389999999876532  24567899999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccc
Q 011991          273 ASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV  351 (473)
Q Consensus       273 ~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~  351 (473)
                      .+++... ..++...+..++.+++.+|.|||+++   ++||||||+||+++.++.++|+|||.+.........    ...
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~~~  152 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT----VSD  152 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce----ecc
Confidence            9999663 45889999999999999999999999   999999999999999999999999998654321100    000


Q ss_pred             cCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       352 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.. .....   .+..++..+.+++
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~li  228 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMP---APQLCPEEIYRLM  228 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCC---CCccCCHHHHHHH
Confidence            11223456999999988889999999999999999998 8999988877666655532 22221   2456789999999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHH
Q 011991          431 EECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+||..+|++||++.|+++.|+
T Consensus       229 ~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         229 LQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHhccChhhCcCHHHHHHHhh
Confidence            9999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-36  Score=290.88  Aligned_cols=245  Identities=27%  Similarity=0.438  Sum_probs=191.4

Q ss_pred             ceeeeEEEEEE----e---cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          197 GITKGSYQVAK----W---NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       197 ~ig~G~~~~~~----~---~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      .||+|+|+.+.    .   ....+|+|.+....  .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            47888887552    2   23468888775432  344556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          270 GDLASYLQKKG-----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       270 gsL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+|.+++....     ..++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  155 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-  155 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh-
Confidence            99999997642     2467788999999999999999999   99999999999999999999999999864322110 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCC-CC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-------EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRP-PL  415 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~-~~  415 (473)
                         ........+++.|+|||++..       ..++.++|||||||++|+|++ |..||......+....+....... +.
T Consensus       156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05042         156 ---YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK  232 (269)
T ss_pred             ---eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence               001122335667999998642       356789999999999999998 889998877766655543333221 22


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      +..+..+++.+.+++..|| .||++||++++|++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         233 PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            2234567889999999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-37  Score=295.83  Aligned_cols=243  Identities=21%  Similarity=0.341  Sum_probs=203.2

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+.+|.|+|+.+     ..+++.+|+|++...........+.+.+|++++++++||||+++++++..+...++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            567778898888643     235899999999876555556678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +.+++|.+++.....+++..+..++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||.+.......    
T Consensus        82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----  154 (258)
T cd05578          82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----  154 (258)
T ss_pred             CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence            999999999988778999999999999999999999999   9999999999999999999999999986543321    


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhCCCCCCcccCCCCC
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP---EEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.   ....... .. .   ....+..++
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~-~---~~~~~~~~~  226 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ET-A---DVLYPATWS  226 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-cc-c---cccCcccCc
Confidence               12234577789999999888899999999999999999999999987764   2222222 11 1   122345678


Q ss_pred             HHHHHHHHHccCCCCCCCCCH--HHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNF--NEIIA  449 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~--~ell~  449 (473)
                      ..+.++|.+||..||.+||++  +|++.
T Consensus       227 ~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         227 TEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            999999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.1e-37  Score=300.52  Aligned_cols=244  Identities=18%  Similarity=0.317  Sum_probs=182.8

Q ss_pred             cCceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceEEEEe
Q 011991          195 ADGITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLE  265 (473)
Q Consensus       195 ~~~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e  265 (473)
                      +..+|+|+||.+.       .+++.+|+|.+.....     ...+.+|+.+++.++||||+++++++..  +...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            3578999998652       2457899999975432     1346789999999999999999999854  456899999


Q ss_pred             ccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE----cCCCcEEEEee
Q 011991          266 YHAKGDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGF  332 (473)
Q Consensus       266 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili----~~~~~vkl~Df  332 (473)
                      |+. ++|.+++...         ..+++..++.++.|++.||.|||+++   |+||||||+|||+    +..+.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            996 4998887542         24889999999999999999999999   9999999999999    45578999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHH
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPP---------EEV  402 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~---------~~~  402 (473)
                      |+++........   ........+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.....         ...
T Consensus       157 G~a~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~  233 (317)
T cd07868         157 GFARLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  233 (317)
T ss_pred             CceeccCCCCcc---ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence            999765432111   112234567899999999876 4689999999999999999999999964331         111


Q ss_pred             HHHHHhhCCCCCC---------------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          403 VKLMCCEGKRPPL---------------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       403 ~~~i~~~~~~~~~---------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ...+......+..                                 .......+..+.+||.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111111100000                                 0000123456889999999999999999999987


Q ss_pred             H
Q 011991          450 R  450 (473)
Q Consensus       450 ~  450 (473)
                      |
T Consensus       314 h  314 (317)
T cd07868         314 D  314 (317)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.5e-37  Score=296.66  Aligned_cols=247  Identities=20%  Similarity=0.433  Sum_probs=204.6

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ...|...+.+|.|+|+.+     ..+++.|++|.+.....   ...+.+.+|+.+++.++||||+++++.+......++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            345777788999888754     35789999999975432   2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +||+++++|.+++... .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999999998654 5899999999999999999999999   99999999999999999999999999865432211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......+++.|+|||.+.+..++.++|+|||||++|++++|..||...+.......+.... .+. ...+..++
T Consensus       171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~  242 (296)
T cd06655         171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPE-LQNPEKLS  242 (296)
T ss_pred             ------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Ccc-cCCcccCC
Confidence                  1123457788999999998889999999999999999999999998877765554443222 222 12355688


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+.++|++||..||.+||++.+++.+
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            999999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.3e-37  Score=298.74  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=197.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.||+|.+......  .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            5777888999999855     246789999999754322  223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+. ++|.+++... ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            997 5999988764 45889999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--------  415 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------  415 (473)
                           ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....+......+..        
T Consensus       160 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 -----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             -----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence                 11223467889999988654 5788999999999999999999999987766554433222111100        


Q ss_pred             -----------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 -----------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                       ......+++.+.+||.+||+.||.+|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                             00113467889999999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-36  Score=291.18  Aligned_cols=250  Identities=28%  Similarity=0.485  Sum_probs=204.4

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      ..|.+...+|.|+|+.+.          .....+++|.+....  .......+.+|++++++++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            356777889999998552          134679999886432  33456789999999999999999999999999889


Q ss_pred             eEEEEeccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEE
Q 011991          260 MMIVLEYHAKGDLASYLQKKG---------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~  330 (473)
                      .++||||+++++|.+++....         .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence            999999999999999998755         6899999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 011991          331 GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       331 DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~  409 (473)
                      |||++........     .......++..|+|||.+.+..++.++||||||+++|++++ |..||...........+.. 
T Consensus       160 ~~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~-  233 (275)
T cd05046         160 LLSLSKDVYNSEY-----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA-  233 (275)
T ss_pred             ccccccccCcccc-----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence            9999864322111     11122334667999999988888999999999999999998 8899987776666555432 


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +...  ...+..++..+.+++.+||+.||.+||++.+++..|.
T Consensus       234 ~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE--LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            2211  1124567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-36  Score=290.72  Aligned_cols=252  Identities=25%  Similarity=0.446  Sum_probs=205.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.+|.|+|+.+     ..++..+|+|++..+...  .....+.+|+++++.++||||+++++.+..+...++|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4667778898888744     236789999999754432  256789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          266 YHAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       266 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ++++++|.+++...   +.+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999764   45899999999999999999999999   9999999999999999999999999987654432


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc--C
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK--A  419 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--~  419 (473)
                      ....  .......++..|+|||.+... .++.++|+|||||++++|++|+.||...+.......+... ..+.....  .
T Consensus       157 ~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (267)
T cd06610         157 DRTR--KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADY  233 (267)
T ss_pred             cccc--cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCcccc
Confidence            2110  111234578889999998776 7889999999999999999999999887766655554332 22222111  2


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+++.+.+++.+||..||++||++++++.|
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            3678999999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=292.14  Aligned_cols=245  Identities=24%  Similarity=0.457  Sum_probs=203.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...+.+|.|+|+.+     ..+++.+|+|.+....  .......+.+|+.+++.++||||+++++++..+...++|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            4666778888888754     3468899999997543  23445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++... .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.......  
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  153 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--  153 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence            99999999999765 7899999999999999999999999   99999999999999999999999999876543211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......+++.|+|||.+.+..++.++|||||||++|+|++|..||...++......+.. ...+..  ....++++
T Consensus       154 ----~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~  226 (274)
T cd06609         154 ----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSL--EGNKFSKP  226 (274)
T ss_pred             ----ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCC--cccccCHH
Confidence                12234577889999999988899999999999999999999999987776655554432 222222  12227899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+++.+||..||++||++++++++
T Consensus       227 ~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         227 FKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhhC
Confidence            9999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-36  Score=288.90  Aligned_cols=245  Identities=26%  Similarity=0.488  Sum_probs=205.7

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |++.+.+|.|+|+.+     ..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            667788999998744     346889999999754332 34456889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +.+++|.+++....  .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999987642  4789999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......+++.|+|||++.+..++.++|+|||||+++++++|..||......+....+.. +..+.   .+..++.
T Consensus       157 -----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  227 (256)
T cd08218         157 -----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPP---VSSHYSY  227 (256)
T ss_pred             -----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCC---CcccCCH
Confidence                 11233477889999999888899999999999999999999999988877777666633 32222   2456789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.++|.+||+.+|.+||++.+++++
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         228 DLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            99999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-36  Score=292.13  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=202.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC-------CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK-------DPERINAFTHELTIVEKARHPNVVQFVGAVTQNI  258 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  258 (473)
                      +|...+.+|.|+|+.+     ..+|+.+|+|.+......       .....+.+..|+++++.++||||+++++++..+.
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667778999998754     246889999988642211       1123467888999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999999999988888999999999999999999999999   999999999999999999999999998654


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC-
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-  415 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-  415 (473)
                      ......    .......++..|+|||.+....  ++.++|+||||+++|++++|..||......+....+......+.. 
T Consensus       159 ~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (272)
T cd06629         159 DDIYDN----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP  234 (272)
T ss_pred             cccccc----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence            221111    1122345778899999987654  789999999999999999999999766655444433222222222 


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ......++..+.+++.+||..+|++||++++++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11224568899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-36  Score=287.32  Aligned_cols=245  Identities=27%  Similarity=0.541  Sum_probs=201.4

Q ss_pred             HhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.+|.|+|+.+.    .++..+|+|.+......    ...+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            45566788999887542    34789999998754332    24688999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +.+++|.+++... +.+++..++.++.|++.+|+|||+.+   ++|+||||+||+++.++.++|+|||+++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            9999999999764 45899999999999999999999999   999999999999999999999999998754322110 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.. +..+.   .+...+.
T Consensus       157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  228 (256)
T cd05112         157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLY---KPRLASQ  228 (256)
T ss_pred             ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCC---CCCCCCH
Confidence                1112224567999999988889999999999999999998 9999988887777666532 22221   2345688


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      .+.+|+.+||+.+|++||++.++++.|
T Consensus       229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         229 SVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-36  Score=290.88  Aligned_cols=245  Identities=20%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeC------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN------  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~------  257 (473)
                      ..|...+.+|.|+|+.+     ..+++.+|+|.+.....    ....+..|+.+++.+ +||||+++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677788999988754     34678999999975431    234678899999998 699999999998753      


Q ss_pred             CceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          258 IPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      ...++||||+.+++|.+++...  ..+++..+..++.|++.||+|||+++   |+|+||||+||+++.++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            4589999999999999999863  35899999999999999999999999   999999999999999999999999998


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      .......      .......|++.|+|||++.     +..++.++||||+||++|+|++|..||...........+....
T Consensus       159 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~  232 (272)
T cd06637         159 AQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP  232 (272)
T ss_pred             eeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC
Confidence            6542211      1123345788899999986     3367889999999999999999999998766555444432222


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                         ........++..+.+|+.+||+.||.+|||+.+++++
T Consensus       233 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         233 ---APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ---CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence               1222344678899999999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-36  Score=289.07  Aligned_cols=250  Identities=26%  Similarity=0.503  Sum_probs=203.2

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|.|+|+.+     ..+++.|++|.+...... ....+.+..|+++++.++||||+++++.+......++|+||
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            566778999988744     236789999999866433 45678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            999999999988777899999999999999999999999   99999999999999999999999999876543322111


Q ss_pred             ccccccCCCCCCcccCCCCcCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCCcccCCCC
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                        .......+++.|+|||.+.+..   ++.++||||||++++++++|..||...... .....+ .....+..+ ....+
T Consensus       158 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~-~~~~~  233 (264)
T cd06626         158 --EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV-GAGHKPPIP-DSLQL  233 (264)
T ss_pred             --ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH-hcCCCCCCC-ccccc
Confidence              0012345778899999998765   889999999999999999999999765433 333233 223222221 12345


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ++.+.++|.+||+.+|.+||++++++.
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            889999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-37  Score=294.96  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=194.6

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+.+|.|+|+.+     ..++..||+|.+..... .......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            566678888888754     23688999999875432 222345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          267 HAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       267 ~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ++ ++|.+++...   +.+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 5898888653   45899999999999999999999999   9999999999999999999999999986543221 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC---------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP---------  413 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------  413 (473)
                           .......+++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+......+         
T Consensus       156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         156 -----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             -----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence                 111223457789999988654 57899999999999999999999998766543332221111000         


Q ss_pred             ---------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 ---------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ---------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                     ........+++++.++|++||..||.+|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                           0001123578899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=308.20  Aligned_cols=245  Identities=27%  Similarity=0.468  Sum_probs=215.2

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|.+.+.||+|.|+.|     ..++..||+|++.+.... ....+.+.+|+++|+.++|||||+++.+.+....+|+||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            35677789999999866     467899999999876544 444455899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+.+|.+.+++.+++++.+..+..++.|++.|++|||+++   |+|||||++|||++.+.++||+|||++.++....  
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--  209 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--  209 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc--
Confidence            99999999999999999999999999999999999999999   9999999999999999999999999998764321  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           ....+.|++.|.|||++.+..|+ +.+|+||+|+++|-|+.|..||.+.+..+....+.....+.+.     .++
T Consensus       210 -----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~-----~ms  279 (596)
T KOG0586|consen  210 -----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF-----YMS  279 (596)
T ss_pred             -----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc-----eee
Confidence                 23456799999999999998875 8999999999999999999999998887777766555554433     457


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .++.++|++++..+|.+|++.+++.++
T Consensus       280 ~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  280 CDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             chhHHHHHHhhccCccccCCHHHhhhh
Confidence            889999999999999999999999775

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-36  Score=287.70  Aligned_cols=244  Identities=25%  Similarity=0.469  Sum_probs=203.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.....+|.|+|+.+     ..+++.+|+|.+...... ....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            566678898888744     347889999999765433 34467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccccCcc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYISPE  343 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~~~~~  343 (473)
                      +++++|.+++...  ..+++..+..++.|++.+|+|||+++   ++|+||||+||+++.++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999764  34899999999999999999999999   99999999999998654 589999999876533211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                             .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..... .+   .+..++
T Consensus       158 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~  226 (256)
T cd08220         158 -------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-AP---ISDRYS  226 (256)
T ss_pred             -------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CC---CCCCcC
Confidence                   1224477889999999988889999999999999999999999988777666655533222 21   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++.+++.+||+.||++|||++|++.+
T Consensus       227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         227 PDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.9e-37  Score=297.92  Aligned_cols=250  Identities=20%  Similarity=0.416  Sum_probs=205.3

Q ss_pred             ChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          186 NPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ++...+|.+.+.+|.|+|+.+     ..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++..+...
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            445567888899999988755     24789999999975432   2346688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ++||||+++++|.+++... .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999999998654 5889999999999999999999999   99999999999999999999999999865422


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ...      ......+++.|+|||.+.+..++.++|+|||||++|++++|..||...++......+...+ .+.. ..+.
T Consensus       168 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~  239 (297)
T cd06656         168 EQS------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL-QNPE  239 (297)
T ss_pred             Ccc------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCC-CCcc
Confidence            211      1123457888999999998889999999999999999999999998766544333222211 2221 1245


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+++.+.+|+.+||..||++||++++++++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            678899999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-36  Score=290.54  Aligned_cols=219  Identities=26%  Similarity=0.413  Sum_probs=178.5

Q ss_pred             cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHH-cCCCCHHHHHH
Q 011991          211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLR  289 (473)
Q Consensus       211 ~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~  289 (473)
                      ..|++|++...   .......+..|+.+++.++||||+++++++..+...++||||+++|+|..++.. .+.+++..+..
T Consensus        45 ~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~  121 (274)
T cd05076          45 LRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT  121 (274)
T ss_pred             eeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH
Confidence            35899998643   234456788899999999999999999999999999999999999999999875 45689999999


Q ss_pred             HHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-------cEEEEeeccccccccCcccccccccccCCCCCCcccC
Q 011991          290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-------QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVA  362 (473)
Q Consensus       290 i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-------~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~a  362 (473)
                      ++.|++.||+|||+++   |+||||||+||+++..+       .++++|||++......          ....++..|+|
T Consensus       122 i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~a  188 (274)
T cd05076         122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----------EERVERIPWIA  188 (274)
T ss_pred             HHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----------cccccCCcccC
Confidence            9999999999999999   99999999999997643       3899999987543211          11235677999


Q ss_pred             CCCcCC-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCC
Q 011991          363 PEIYKN-EEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI  440 (473)
Q Consensus       363 PE~~~~-~~~~~~~DiwSlG~~l~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  440 (473)
                      ||.+.+ ..++.++|||||||++|+++ +|..||....+.+..... .....     .+...++.+.++|.+||+.+|++
T Consensus       189 Pe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~  262 (274)
T cd05076         189 PECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-EKKHR-----LPEPSCKELATLISQCLTYEPTQ  262 (274)
T ss_pred             chhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-HhccC-----CCCCCChHHHHHHHHHcccChhh
Confidence            998865 56899999999999999995 699999877665543332 21111     12334678999999999999999


Q ss_pred             CCCHHHHHHHH
Q 011991          441 RPNFNEIIARL  451 (473)
Q Consensus       441 RPs~~ell~~L  451 (473)
                      |||+.++++.|
T Consensus       263 Rps~~~il~~L  273 (274)
T cd05076         263 RPSFRTILRDL  273 (274)
T ss_pred             CcCHHHHHHhh
Confidence            99999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2e-36  Score=288.26  Aligned_cols=246  Identities=27%  Similarity=0.484  Sum_probs=202.3

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      .|++.+.+|+|+|+.+    ...+..+|+|.+...    ......+.+|+++++.++|+||+++++.+.. ...+++|||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            5777889999999755    235567999988643    2334678899999999999999999999887 778999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999999763  34788899999999999999999999   999999999999999999999999998654332111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           ......++..|+|||.+....++.++|+|||||++|++++ |..||...+.......+. .+...+   .+...+
T Consensus       159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~  229 (260)
T cd05073         159 -----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMP---RPENCP  229 (260)
T ss_pred             -----cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCC---CcccCC
Confidence                 1112234566999999988889999999999999999998 999999887766665553 222222   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      .++.+++.+||+.+|++||++.++++.|+.
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.7e-37  Score=294.94  Aligned_cols=250  Identities=21%  Similarity=0.370  Sum_probs=198.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|+....+|+|+|+.+     ..+|+.||+|++..... .....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            3566678898888754     23688999999875432 22233567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|..++.....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--  155 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence            9999888888777667999999999999999999999999   99999999999999999999999999876533211  


Q ss_pred             cccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC-------------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK-------------  411 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~-------------  411 (473)
                          ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....             
T Consensus       156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         156 ----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             ----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence                1122346778999999865 4678999999999999999999999988776554443322110             


Q ss_pred             -------CCCCc------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 -------RPPLK------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 -------~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                             .+...      .....++..+.+|+.+||+.||++||++.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                   00000      0123567889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-37  Score=302.70  Aligned_cols=248  Identities=21%  Similarity=0.319  Sum_probs=195.3

Q ss_pred             HHHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ...|.+.++||+|+-..|    ..+.+.+|+|.+.... .+...+.-|.+|+..|.+|+ |.+|++++++=..++.+|+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            457889999998876543    3345778888876543 46778899999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||-+ .+|.++|++.+. ++.-.++.+..|+++++.++|.+|   |||.||||.|+|+-+ |.+||+|||+|..+..+.
T Consensus       439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            99875 499999988765 444588999999999999999999   999999999999974 899999999997654331


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCC-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNE-----------EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEG  410 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~  410 (473)
                          .........||+.||+||.+...           ..++++|||||||++|+|+.|+.||..-... ..+..|.   
T Consensus       514 ----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~---  586 (677)
T KOG0596|consen  514 ----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT---  586 (677)
T ss_pred             ----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc---
Confidence                12223456799999999988643           2568899999999999999999999754422 2222332   


Q ss_pred             CCCCCcccCCCCC--HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPLKIKARSYP--PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       .|..++..+..|  .++.++++.||.+||++||++.|+|+|
T Consensus       587 -~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  587 -DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             222222222222  239999999999999999999999875

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-36  Score=290.74  Aligned_cols=244  Identities=25%  Similarity=0.478  Sum_probs=203.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|...+.+|.|+|+.+     ..++..||+|++....  .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            4666778999988754     2357899999987543  23456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++.. +.+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            9999999999865 46899999999999999999999999   99999999999999999999999999865432211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+. ....+.   .+..++..
T Consensus       157 ----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~  228 (277)
T cd06640         157 ----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPT---LTGEFSKP  228 (277)
T ss_pred             ----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCC---CchhhhHH
Confidence                1123356778999999988889999999999999999999999998877666555442 222221   24457889


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+++.+||..+|++||++++++.+
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         229 FKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHhC
Confidence            9999999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-36  Score=288.72  Aligned_cols=244  Identities=23%  Similarity=0.462  Sum_probs=200.3

Q ss_pred             HhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...+.+|.|.|+.+   .  .++..+++|.+....     ..+.+.+|+++++.++||||+++++.+..+...|+++|
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            4666777888888643   2  347899999986432     15789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++++|.+++.. ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999999999976 346899999999999999999999999   99999999999999999999999999875533211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+......+...  .+.....+..++.
T Consensus       155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  227 (256)
T cd06612         155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--PPPTLSDPEKWSP  227 (256)
T ss_pred             -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--CCCCCCchhhcCH
Confidence                 112234677899999998889999999999999999999999999877665544333211  1111112445778


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.+++.+||+.||++|||++|++.+
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            99999999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.6e-36  Score=290.22  Aligned_cols=243  Identities=30%  Similarity=0.511  Sum_probs=196.4

Q ss_pred             ceeeeEEEEEE---e--------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          197 GITKGSYQVAK---W--------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       197 ~ig~G~~~~~~---~--------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|.|+|+.+.   .        .+..+|+|.+....  .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            47888887542   1        12578999886432  23345678899999999999999999999999899999999


Q ss_pred             ccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-----cEEEEeec
Q 011991          266 YHAKGDLASYLQKK-------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-----QLKISGFG  333 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-----~vkl~DfG  333 (473)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999652       23788999999999999999999999   99999999999999877     89999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +++........    .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.. +..
T Consensus       157 ~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~  231 (269)
T cd05044         157 LARDIYKSDYY----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGR  231 (269)
T ss_pred             ccccccccccc----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCc
Confidence            98754322110    11112234677999999998899999999999999999998 9999988777666555432 222


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +.   .+..+|..+.+++.+||..+|.+||++.++++.|+
T Consensus       232 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         232 LQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            22   24567899999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.8e-36  Score=293.10  Aligned_cols=255  Identities=24%  Similarity=0.487  Sum_probs=205.2

Q ss_pred             HhhccCceeeeEEEEEE-----ecCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      +|+..+.+|.|+|+.+.     .+|.    .+|+|.+....  .......+.+|+.+++.++||||+++++++... ..+
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            56677889999997542     2344    57899886543  234445789999999999999999999998754 467


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +++||+++|+|.+++.... .+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence            9999999999999997754 5889999999999999999999999   99999999999999999999999999976532


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ....    .......++..|+|||.+.+..++.++|||||||++|++++ |..||.+....+....+ ..+..++.   +
T Consensus       162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~---~  233 (303)
T cd05110         162 DEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQ---P  233 (303)
T ss_pred             cccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCC---C
Confidence            2111    11122334667999999988899999999999999999997 99999887766655554 33333322   3


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ..++.++.+++.+||..+|++||+++++++.|+++.....
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            4578899999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-36  Score=286.45  Aligned_cols=245  Identities=26%  Similarity=0.435  Sum_probs=203.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceEEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~  264 (473)
                      |.+.+.+|.|+|+.+     ..++..+|+|.+..... .....+.+..|+++++.++||||+++++.+..  +...+++|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            556677888888754     34678999999976543 34556788999999999999999999998764  45689999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLH-----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       265 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||     +.+   ++|+||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999876    356899999999999999999999     777   999999999999999999999999998


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      ........      ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+. .+..+  
T Consensus       158 ~~~~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~--  228 (265)
T cd08217         158 KILGHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFR--  228 (265)
T ss_pred             ccccCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCC--
Confidence            76543211      0123457888999999998889999999999999999999999999887666655553 23222  


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ..+..++..+.+++.+||+.+|++||++.+|+++
T Consensus       229 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             2355788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-36  Score=292.04  Aligned_cols=241  Identities=26%  Similarity=0.366  Sum_probs=192.3

Q ss_pred             eeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       198 ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      +|.|+|+.+     ..+|+.+|+|.+.............+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            466666644     346889999999765433334456678899999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccc
Q 011991          273 ASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP  350 (473)
Q Consensus       273 ~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~  350 (473)
                      .+++...+  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......       .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-------~  150 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-------K  150 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-------c
Confidence            99997765  6899999999999999999999999   9999999999999999999999999986543211       1


Q ss_pred             ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       351 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      .....++..|+|||.+.+..++.++||||+||++|+|++|..||...........+.... .......+..+++.+.++|
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  229 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLC  229 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHH
Confidence            122346778999999988889999999999999999999999997654421111111111 1111123456789999999


Q ss_pred             HHccCCCCCCCC-----CHHHHHH
Q 011991          431 EECWDPKPVIRP-----NFNEIIA  449 (473)
Q Consensus       431 ~~cl~~dP~~RP-----s~~ell~  449 (473)
                      .+||+.||.+||     ++.+++.
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHh
Confidence            999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-36  Score=287.35  Aligned_cols=244  Identities=28%  Similarity=0.512  Sum_probs=203.4

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+.+|.|+|+.+     ..+++.+++|++.....  ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            556678888888643     34689999999976543  24567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++++|.+++.....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            9999999999887789999999999999999999999 99   999999999999999999999999998755332111 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhCCCCCCcccCCC-
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVVKLMCCEGKRPPLKIKARS-  421 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~-  421 (473)
                           .....++..|+|||.+....++.++|+||||+++|+|++|..||....   ..+....+. ....+.   .+.. 
T Consensus       157 -----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~  227 (264)
T cd06623         157 -----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPS---LPAEE  227 (264)
T ss_pred             -----ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCC---CCccc
Confidence                 123346778999999988889999999999999999999999998764   334444442 221121   2334 


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++..+.++|.+||..+|++||++.+++++
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            88999999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-36  Score=294.94  Aligned_cols=243  Identities=24%  Similarity=0.433  Sum_probs=200.4

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      .....+|.|+|+.+     ..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            34446888888744     34688999999965432   23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccc
Q 011991          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI  347 (473)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  347 (473)
                      ++++|.+++.. ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........    
T Consensus       101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----  172 (297)
T cd06659         101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----  172 (297)
T ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc----
Confidence            99999998765 46899999999999999999999999   99999999999999999999999999864432211    


Q ss_pred             cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          348 VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       348 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                        ......++..|+|||.+.+..++.++|||||||++|+|++|..||......+....+.. . .+.....+..+++.+.
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~l~  248 (297)
T cd06659         173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-S-PPPKLKNAHKISPVLR  248 (297)
T ss_pred             --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-c-CCCCccccCCCCHHHH
Confidence              11234578889999999888899999999999999999999999988777666655422 1 1222223456788999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHH
Q 011991          428 ELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       428 ~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++++||+.+|++||++++++++
T Consensus       249 ~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         249 DFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHhcCCcccCcCHHHHhhC
Confidence            99999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.8e-36  Score=291.40  Aligned_cols=244  Identities=25%  Similarity=0.476  Sum_probs=201.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|...+.+|.|+|+.+     ..++..||+|.+....  .....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4666677888888754     3357889999987543  23455788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            9999999999865 46899999999999999999999999   99999999999999999999999999875432211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+. ....+.   .+..++..
T Consensus       157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~  228 (277)
T cd06642         157 ----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPT---LEGQYSKP  228 (277)
T ss_pred             ----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCC---CCcccCHH
Confidence                1122346788999999998889999999999999999999999998766655544432 222221   23457889


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         229 FKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.2e-36  Score=286.56  Aligned_cols=218  Identities=24%  Similarity=0.398  Sum_probs=177.1

Q ss_pred             EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHH
Q 011991          212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF  290 (473)
Q Consensus       212 ~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i  290 (473)
                      .+++|.+...   .......+..|+.+++.++||||+++++++..+...++||||+++++|..++... +.+++..++.+
T Consensus        34 ~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i  110 (262)
T cd05077          34 KVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV  110 (262)
T ss_pred             eEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHH
Confidence            5888987643   2344567888999999999999999999999988999999999999999998754 56899999999


Q ss_pred             HHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc-------EEEEeeccccccccCcccccccccccCCCCCCcccCC
Q 011991          291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-------LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP  363 (473)
Q Consensus       291 ~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~-------vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aP  363 (473)
                      +.|++.||+|||+++   |+||||||+|||++.++.       ++++|||++......          ....++..|+||
T Consensus       111 ~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----------~~~~~~~~y~aP  177 (262)
T cd05077         111 AKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR----------QECVERIPWIAP  177 (262)
T ss_pred             HHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc----------ccccccccccCh
Confidence            999999999999999   999999999999987654       899999998543211          123467779999


Q ss_pred             CCcC-CCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCC
Q 011991          364 EIYK-NEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR  441 (473)
Q Consensus       364 E~~~-~~~~~~~~DiwSlG~~l~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  441 (473)
                      |.+. +..++.++|||||||++|+|+ .|..||......+..... .... .    .....++++.+||.+||+.||.+|
T Consensus       178 E~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~-~----~~~~~~~~~~~li~~cl~~dp~~R  251 (262)
T cd05077         178 ECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQC-M----LVTPSCKELADLMTHCMNYDPNQR  251 (262)
T ss_pred             hhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCc-c----CCCCChHHHHHHHHHHcCCChhhC
Confidence            9886 467899999999999999998 588898776554433221 1111 1    122346789999999999999999


Q ss_pred             CCHHHHHHHH
Q 011991          442 PNFNEIIARL  451 (473)
Q Consensus       442 Ps~~ell~~L  451 (473)
                      |++.+|++.+
T Consensus       252 p~~~~il~~~  261 (262)
T cd05077         252 PFFRAIMRDI  261 (262)
T ss_pred             cCHHHHHHhc
Confidence            9999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=286.21  Aligned_cols=238  Identities=25%  Similarity=0.389  Sum_probs=191.6

Q ss_pred             CceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHH-hcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVE-KARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       196 ~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      +.+|.|+|+.+     ..+++.||+|.+.............+..|..++. ..+||||+++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            35777777644     2367899999997543322333344555655544 44899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF  349 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~  349 (473)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....         
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------  149 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------  149 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---------
Confidence            999999988778999999999999999999999999   99999999999999999999999999864322         


Q ss_pred             cccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHH
Q 011991          350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL  429 (473)
Q Consensus       350 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~l  429 (473)
                       .....+++.|+|||.+.+..++.++||||+|+++|+|++|..||...+.......+...... ........+++.+.++
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  227 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-WPEEVKEFCSPEAVDL  227 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-CCCcccccCCHHHHHH
Confidence             12234677899999998888899999999999999999999999988877766665332221 1112234678999999


Q ss_pred             HHHccCCCCCCCCCHHHH
Q 011991          430 IEECWDPKPVIRPNFNEI  447 (473)
Q Consensus       430 i~~cl~~dP~~RPs~~el  447 (473)
                      +.+||+.||++||++.++
T Consensus       228 i~~~l~~~p~~R~~~~~~  245 (260)
T cd05611         228 INRLLCMDPAKRLGANGY  245 (260)
T ss_pred             HHHHccCCHHHccCCCcH
Confidence            999999999999976544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5e-36  Score=292.77  Aligned_cols=244  Identities=22%  Similarity=0.410  Sum_probs=201.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|...+.+|.|+|+.+     ..+++.||+|.+.............+.+|+++++.++||||+++++++..+...++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34777788999988754     2368999999997655455566678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+. |+|.+++.. .+.+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9997 588777754 456899999999999999999999999   999999999999999999999999998653211  


Q ss_pred             cccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                              ....+++.|+|||++.   ...++.++||||||+++|+|++|..||...+.......+.. ...+  ...+.
T Consensus       169 --------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~--~~~~~  237 (307)
T cd06607         169 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSP--TLSSN  237 (307)
T ss_pred             --------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CCCC--CCCch
Confidence                    2234677899999874   35688999999999999999999999988776665544422 2222  22234


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .++..+.+++.+||+.||++||++.+++.+
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            578899999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-36  Score=286.21  Aligned_cols=250  Identities=19%  Similarity=0.366  Sum_probs=203.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCC--CCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKES--HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~  261 (473)
                      .|++.+.+|+|+|+.+     ..++..+|+|.+....  .........+.+|+++++.++||||+++++++...  ..++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            4667788999988754     3468899999986432  12344567889999999999999999999998753  4588


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ++|||+++++|.+++...+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            99999999999999988777999999999999999999999999   999999999999999999999999998754321


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ...   ........++..|+|||.+.+..++.++|+|||||++|++++|..||...........+......   +..+..
T Consensus       160 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~p~~  233 (264)
T cd06653         160 CMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK---PMLPDG  233 (264)
T ss_pred             ccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC---CCCCcc
Confidence            110   01112345788899999998888899999999999999999999999877665555544332222   234667


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++.+.+++.+||. +|..||++.+++.|
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            88999999999999 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.1e-36  Score=285.01  Aligned_cols=244  Identities=35%  Similarity=0.606  Sum_probs=201.2

Q ss_pred             ccCceeeeEEEEE---Eec------CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          194 KADGITKGSYQVA---KWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       194 ~~~~ig~G~~~~~---~~~------~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +.+.+|.|+|+.+   ...      +..+|+|.+....  .......+..|+.+++.++||||+++++.+...+..+++|
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567888888744   222      3889999996543  2235578899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+++++|.+++.....  +++..+..++.|++.||++||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999976544  899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ..     ......+++.|+|||.+.+..++.++||||+||++++|++ |..||...+.......+... ..+.   .+..
T Consensus       158 ~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~---~~~~  228 (258)
T smart00219      158 YY-----KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-YRLP---KPEN  228 (258)
T ss_pred             cc-----ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCC---CCCc
Confidence            11     0111225678999999988889999999999999999998 88999887777776665332 2222   2445


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ++..+.+++.+||..||++|||+.++++.|
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      229 CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            889999999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-36  Score=289.97  Aligned_cols=243  Identities=28%  Similarity=0.501  Sum_probs=197.2

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|.|.|+.+     ..+++.+|+|.+....  .......+.+|+++++.++||||+++++.+..+...++++||
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            445566787777643     2358899999997653  235567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++++|.+++... ..+++..+..++.|++.||+|||+ .+   ++|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999876 678999999999999999999999 88   99999999999999999999999999865432111 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP-----PEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~  419 (473)
                             ....++..|+|||.+.+..++.++||||+||++|+|++|..||....     .......+. ....+..  ..
T Consensus       157 -------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~  226 (265)
T cd06605         157 -------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRL--PS  226 (265)
T ss_pred             -------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCC--Ch
Confidence                   11457778999999988899999999999999999999999997642     222332322 1211211  11


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+++.+.++|.+||..||++||++.+++.+
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            2278899999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-36  Score=290.47  Aligned_cols=238  Identities=24%  Similarity=0.342  Sum_probs=187.7

Q ss_pred             eeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc---CCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       198 ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      +|+|+|+.+     ..+++.+|+|.+.............+..|..+++.+   .||||+.+++.+..++..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            677877754     245789999999765433333333445555444443   799999999999998999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF  349 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~  349 (473)
                      ++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......       
T Consensus        82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-------  151 (279)
T cd05633          82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------  151 (279)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-------
Confidence            999999988888999999999999999999999999   9999999999999999999999999986442211       


Q ss_pred             cccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhCCCCCCcccCCCCCHHH
Q 011991          350 PVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE--EVVKLMCCEGKRPPLKIKARSYPPDL  426 (473)
Q Consensus       350 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~l  426 (473)
                       .....|++.|+|||.+. +..++.++||||+||++|+|++|..||......  ........ ..   ....+..+++++
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~  226 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TV---NVELPDSFSPEL  226 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cC---CcCCccccCHHH
Confidence             12235788999999886 456899999999999999999999999754322  12221111 11   112355688999


Q ss_pred             HHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          427 KELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       427 ~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      .++|++||..||.+||     +++|+++|
T Consensus       227 ~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            9999999999999999     59999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.3e-36  Score=290.53  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+.+|.|.|+.+     ..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            567778899988754     236889999999765432 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      + +++|.+++... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--  154 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--
Confidence            9 99999998653 55899999999999999999999999   99999999999999999999999999876543221  


Q ss_pred             cccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC---------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL---------  415 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---------  415 (473)
                         .......++..|+|||.+.+. .++.++||||+||++++|++|..||.+.........+......+..         
T Consensus       155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence               112234578889999998654 4689999999999999999998888877765555444332211110         


Q ss_pred             ----------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ----------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                      .......+..+.+++.+||+.||.+||++++++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                            00113457889999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-35  Score=284.56  Aligned_cols=245  Identities=23%  Similarity=0.397  Sum_probs=189.1

Q ss_pred             ceeeeEEEEEE----ecC---cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          197 GITKGSYQVAK----WNG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       197 ~ig~G~~~~~~----~~~---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      .||.|+|+.+.    .++   ..+++|.+....  .....+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            47888887542    222   346677765432  234567899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          270 GDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       270 gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+|.+++...    ..++...++.++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh--
Confidence            9999999764    23567778899999999999999999   99999999999999999999999999753221110  


Q ss_pred             cccccccCCCCCCcccCCCCcCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCC-CCc
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKN-------EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRP-PLK  416 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~-~~~  416 (473)
                        ........++..|+|||++..       ..++.++|||||||++|+|++ |..||......+....+....... ..+
T Consensus       155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (268)
T cd05086         155 --IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP  232 (268)
T ss_pred             --hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC
Confidence              011123446778999998753       245789999999999999996 677998777766666553333221 112


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ..+..+++.+.+++..|| .+|++||++++|++.|
T Consensus       233 ~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         233 QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            223457889999999999 6899999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-36  Score=289.87  Aligned_cols=253  Identities=27%  Similarity=0.546  Sum_probs=200.7

Q ss_pred             HhhccCceeeeEEEEE---Ee------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCc
Q 011991          191 QVRKADGITKGSYQVA---KW------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~  259 (473)
                      .|...+.+|+|+|+.+   ..      ++..+|||.+......  .....+.+|+++++.++||||+++++++..  ...
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            4556678999988755   22      3679999999765432  456789999999999999999999999877  557


Q ss_pred             eEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      .++||||+++++|.+++.... .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            899999999999999997754 5899999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHH
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE--------------VVK  404 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~--------------~~~  404 (473)
                      .......   .......++..|++||.+.+..++.++|||||||++++|++|..||.......              ...
T Consensus       160 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         160 PEDKDYY---YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             ccCCcce---eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            4221110   01112234556999999988889999999999999999999999986543221              111


Q ss_pred             HHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       405 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .........   ..+..++..+.+++.+||+.+|++||++.||++.|+++
T Consensus       237 ~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111222211   12446778999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=335.61  Aligned_cols=254  Identities=23%  Similarity=0.411  Sum_probs=215.8

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ...++..+..||.|.||.+     ..+|+..|+|-+...... ......+.+|+.++..++|||+|+++|+=.+.+..+|
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3446777788999999854     467899999988755433 4556778899999999999999999999888889999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      .||||++|+|.+++..++..++....-+..|++.|++|||++|   ||||||||.||+++.+|.+|++|||.|..+....
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999999988877888888899999999999999999   9999999999999999999999999997654331


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNE---EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                        ...........|||.|||||++.+.   +-..++||||+|||+.||+||+.||...+..-.+..-...+..|++   |
T Consensus      1389 --~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~---P 1463 (1509)
T KOG4645|consen 1389 --QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI---P 1463 (1509)
T ss_pred             --hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC---c
Confidence              1222345577899999999999764   4557999999999999999999999988777655555566777776   5


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..++.+-++||..||..||+.|.++.||+++
T Consensus      1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            5689999999999999999999999988775

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.1e-36  Score=291.87  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=197.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC--CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      |...+.+|.|+|+.+     ..+++.||+|.+......  .......+..|+++++.++||||+++++++......++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            455667899888744     236789999999765432  1233456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+ +++|.+++.... .+++..++.++.|+++||.|||+++   |+|+||||+||+++.++.++|+|||+++.......
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 889999998765 7999999999999999999999999   99999999999999999999999999876543211


Q ss_pred             cccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC-------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-------  415 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------  415 (473)
                            ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+....+......+..       
T Consensus       158 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         158 ------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             ------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence                  1122345678999998854 46789999999999999999998888876665544444222111100       


Q ss_pred             ----------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          416 ----------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       416 ----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                                      .......+..+.++|.+||+.||++|||++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                            0012345688999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.6e-36  Score=285.75  Aligned_cols=250  Identities=25%  Similarity=0.450  Sum_probs=199.4

Q ss_pred             hccCceeeeEEEEEE--------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------
Q 011991          193 RKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------  258 (473)
Q Consensus       193 ~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  258 (473)
                      .+.+.||.|+|+.+.        .++..+|||++..+. ......+.+.+|+++++.++||||+++++++....      
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678888887442        246889999997544 33455678899999999999999999999876432      


Q ss_pred             ceEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          259 PMMIVLEYHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                      ..++++||+.+|+|.+++...      ..++...+..++.|++.||+|||+++   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247899999999999887532      13788999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |+++.......    ........+++.|++||.+....++.++|||||||++|+|++ |..||......+....+.... 
T Consensus       158 g~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-  232 (273)
T cd05074         158 GLSKKIYSGDY----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-  232 (273)
T ss_pred             cccccccCCcc----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-
Confidence            99875432211    001112234567999999988889999999999999999998 899998877766666553322 


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      ...   .+..+++.+.+++.+||+.+|++|||+.+++..|+.+
T Consensus       233 ~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 RLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            211   2345778999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.3e-36  Score=288.48  Aligned_cols=245  Identities=23%  Similarity=0.435  Sum_probs=201.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+.....||.|+++.+     ..+++.+++|.+...   .....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            3445567888888744     346789999998643   23344668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+.+++|.+++.. +.+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||.+........  
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999999999977 56899999999999999999999999   99999999999999999999999998764432111  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......+++.|+|||.+.+..++.++||||+||++|+|++|..||...++......+... ..+.. ..+..++..
T Consensus       171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~  244 (285)
T cd06648         171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKL-KNLHKVSPR  244 (285)
T ss_pred             ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCC-cccccCCHH
Confidence                112245788899999998888999999999999999999999999887776666555332 22221 223347889


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+++.+||+.+|++||++.+++++
T Consensus       245 l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         245 LRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             HHHHHHHHcccChhhCcCHHHHccC
Confidence            9999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-36  Score=292.86  Aligned_cols=244  Identities=23%  Similarity=0.419  Sum_probs=200.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.....||.|+|+.+     ..++..||||.+...   .....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            444556888888754     246789999998643   234456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +++++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++........   
T Consensus       101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---  173 (292)
T cd06658         101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---  173 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---
Confidence            999999998854 46899999999999999999999999   99999999999999999999999999865432211   


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHH
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL  426 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  426 (473)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. ...+.. .....++..+
T Consensus       174 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~  248 (292)
T cd06658         174 ---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRV-KDSHKVSSVL  248 (292)
T ss_pred             ---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCcc-ccccccCHHH
Confidence               11223478889999999888899999999999999999999999988777665554422 211211 1233568899


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 011991          427 KELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       427 ~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+++.+||..||.+|||+++++++
T Consensus       249 ~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         249 RGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHccCChhHCcCHHHHhhC
Confidence            999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.2e-36  Score=290.86  Aligned_cols=248  Identities=24%  Similarity=0.376  Sum_probs=196.2

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEe-----eC
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVT-----QN  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-----~~  257 (473)
                      ..+|.+.+.||.|+|+.+     ..+++.+|+|++....    .....+..|+.+++.+ +||||+++++++.     .+
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            346778888999998755     3467899999986422    1235678899999999 6999999999874     34


Q ss_pred             CceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          258 IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      ...++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCC
Confidence            568999999999999998753    345889999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-----EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      +++.......      ......|++.|+|||++..     ..++.++||||+||++|+|++|..||...........+..
T Consensus       170 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~  243 (286)
T cd06638         170 VSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR  243 (286)
T ss_pred             ceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence            9875432111      1223457888999998753     4578899999999999999999999987765444433311


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                       .. +.....+..++..+.+++.+||+.||++|||+.|++++.
T Consensus       244 -~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         244 -NP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -cC-CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             11 111123445688999999999999999999999999863

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.3e-35  Score=285.36  Aligned_cols=244  Identities=26%  Similarity=0.492  Sum_probs=203.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|...+.||.|+|+.+     ..++..+|+|.+....  .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            4667778999998755     2467899999986543  23445778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++... .+++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          83 YLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             eCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            99999999998654 6899999999999999999999999   99999999999999999999999999865432211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......++..|+|||.+.+..++.++|+||+||++|+|++|..||...........+. ....+.   .+..++.+
T Consensus       157 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~  228 (277)
T cd06641         157 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPT---LEGNYSKP  228 (277)
T ss_pred             ----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCC---CCcccCHH
Confidence                1123457788999999988888999999999999999999999998777666555542 222222   24567899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+++.+||+.+|.+||++.+++.+
T Consensus       229 ~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         229 LKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-36  Score=308.09  Aligned_cols=243  Identities=21%  Similarity=0.249  Sum_probs=189.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+...+|.|+|+.+     ...++.||||....         ..+.+|++++++++||||+++++++..++..++|||
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5777888999999865     23578899996432         235689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ++. ++|.+++... +.+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++........
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            995 6999888764 45999999999999999999999999   999999999999999999999999999765322111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhhCCC----
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP--------PEEVVKLMCCEGKR----  412 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--------~~~~~~~i~~~~~~----  412 (473)
                          .......||+.|+|||++.+..++.++|||||||++|||++|..|+....        ...+...+......    
T Consensus       317 ----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        317 ----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence                01123468999999999999999999999999999999999876553221        22232222211110    


Q ss_pred             CC---------------------Cc----ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PP---------------------LK----IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~---------------------~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.                     ..    .....++.++.+||.+||+.||.+|||+.|+|+|
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00                     00    0011345689999999999999999999999984

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-36  Score=293.83  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=192.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|.|+|+.+     ..+|+.+|+|.+..... .......+.+|+++++.++||||+++++++.+....++|+||
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            556677888888744     23688999999975432 222335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++ +|.+++.. .+.+++..++.++.||++||.|||+++   ++||||||+||+++.++.++|+|||+++.......  
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            974 88888765 466999999999999999999999999   99999999999999999999999999875432211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhhCCCC----------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEGKRP----------  413 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf-~~~~~~~~~~~i~~~~~~~----------  413 (473)
                          ......+++.|+|||.+.+. .++.++|||||||++|+|++|..|| .+.+..+....+......+          
T Consensus       155 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             ----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence                11233467889999988664 5789999999999999999998885 4444433333332111100          


Q ss_pred             --------CCc------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 --------PLK------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 --------~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                              ...      .....+++++.+||.+||+.||.+|||+++++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence                    000      0123467899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-36  Score=287.81  Aligned_cols=234  Identities=25%  Similarity=0.390  Sum_probs=186.5

Q ss_pred             ceeeeEEEEEE---e---------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          197 GITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       197 ~ig~G~~~~~~---~---------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .||.|+|+.+.   .         ....+++|.+...   .....+.+..|+.+++.++||||+++++++..+...++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            57888886441   1         2335888887543   2344567889999999999999999999999988999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc--------EEEEeeccc
Q 011991          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--------LKISGFGLL  335 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~--------vkl~DfG~a  335 (473)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.        ++++|||.+
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999997654 4899999999999999999999999   999999999999987664        699999987


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEG-VQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      .....          .....+++.|+|||.+.+. .++.++|||||||++|+|++| ..||............ ..  ..
T Consensus       156 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~--~~  222 (258)
T cd05078         156 ITVLP----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED--RH  222 (258)
T ss_pred             cccCC----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc--cc
Confidence            54321          1223467789999999764 578999999999999999998 5677665554433322 11  11


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .   .+...+.++.+++.+||+.||++|||++++++.|+
T Consensus       223 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 Q---LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c---CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1   23345678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.9e-35  Score=290.11  Aligned_cols=246  Identities=20%  Similarity=0.391  Sum_probs=203.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.....+|+|+|+.+     ..++..+|+|.+.............+.+|+++++.++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677778999988754     23678999999976544455566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+.| +|.+++.. ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.....    
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            9975 88887754 455899999999999999999999999   99999999999999999999999998764321    


Q ss_pred             ccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                            .....+++.|+|||.+.   ...++.++|||||||++|+|++|..||...........+......+   .....
T Consensus       178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  248 (317)
T cd06635         178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---LQSNE  248 (317)
T ss_pred             ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---CCCcc
Confidence                  12234778899999874   4568899999999999999999999998877666666554433222   12345


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      +++.+.+++.+||+.+|.+||++.++++++-.
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            78899999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-36  Score=292.61  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=198.9

Q ss_pred             HhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+   .  .+++.+|+|.+...... ....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            3566788999988754   2  35789999998754432 2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.++....+.+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........  
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  155 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence            9999999888776667999999999999999999999999   99999999999999999999999999865432211  


Q ss_pred             cccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC------------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR------------  412 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~------------  412 (473)
                          ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+....+......            
T Consensus       156 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         156 ----VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             ----ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence                1223456788999998865 35788999999999999999999999876654433332211100            


Q ss_pred             --------CCC------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 --------PPL------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 --------~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                              +..      ....+.++..+.+|+.+||+.+|++||++++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                    000      01134578899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.7e-36  Score=288.06  Aligned_cols=246  Identities=22%  Similarity=0.414  Sum_probs=197.0

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee------
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ------  256 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~------  256 (473)
                      ...|.+...+|.|+|+.+     ..+++.+|+|++...    ......+..|+.+++++ +||||+++++++..      
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            346777788999999754     246789999998643    23345688899999998 69999999999853      


Q ss_pred             CCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                      ....|++|||+.+|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcc
Confidence            45689999999999999999763  34888889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~  409 (473)
                      +........      ......+++.|+|||.+.     ...++.++|+|||||++|+|++|..||....+......+.. 
T Consensus       168 ~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-  240 (282)
T cd06636         168 SAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-  240 (282)
T ss_pred             hhhhhcccc------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-
Confidence            865422111      122345788899999875     34678899999999999999999999977665444433321 


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                        ..........++..+.+||++||+.||.+||++.||+++
T Consensus       241 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         241 --NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             --CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence              122223345688999999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=283.24  Aligned_cols=226  Identities=24%  Similarity=0.392  Sum_probs=187.9

Q ss_pred             EEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee----CCceEEEEeccCCCCHHHHHHHcC
Q 011991          206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ----NIPMMIVLEYHAKGDLASYLQKKG  280 (473)
Q Consensus       206 ~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~  280 (473)
                      .+.+++.+|+|++...        ....+|+++-=.. .|||||.++++|++    ...+.+|||.|+||.|.+.++.++
T Consensus        83 ~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g  154 (400)
T KOG0604|consen   83 HKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRG  154 (400)
T ss_pred             eccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcc
Confidence            3678999999999632        3457788875444 69999999999864    334789999999999999999876


Q ss_pred             C--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeeccccccccCcccccccccccCCC
Q 011991          281 R--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHID  355 (473)
Q Consensus       281 ~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~  355 (473)
                      .  +++.++.+|++||..|+.|||+.+   |.||||||+|+|++.   +..+||+|||+|+.-...       ....+..
T Consensus       155 ~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-------~~L~TPc  224 (400)
T KOG0604|consen  155 DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-------GDLMTPC  224 (400)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCC-------ccccCCc
Confidence            5  999999999999999999999999   999999999999974   456999999999754321       2233455


Q ss_pred             CCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHH
Q 011991          356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP----PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE  431 (473)
Q Consensus       356 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~  431 (473)
                      -||+|.|||++...+|+...|+||+|++||-|++|.+||-+..    ...+..+| ..++...+...++.+|+..+++|+
T Consensus       225 ~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI-~~gqy~FP~pEWs~VSe~aKdlIR  303 (400)
T KOG0604|consen  225 FTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI-RTGQYEFPEPEWSCVSEAAKDLIR  303 (400)
T ss_pred             ccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh-hccCccCCChhHhHHHHHHHHHHH
Confidence            7999999999999999999999999999999999999996543    33455566 344444445567889999999999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 011991          432 ECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       432 ~cl~~dP~~RPs~~ell~~  450 (473)
                      .+|..+|.+|.++.+++.|
T Consensus       304 ~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  304 KLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HHhcCCchhheeHHHhhcC
Confidence            9999999999999999874

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=290.42  Aligned_cols=250  Identities=23%  Similarity=0.392  Sum_probs=199.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.+|.|+|+.+     ..+++.||+|.+..... .....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3667778899888744     23578999999875432 23345778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++++.+..+......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--  155 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA--  155 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence            9998777766666666999999999999999999999999   99999999999999999999999999876543321  


Q ss_pred             cccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-----------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-----------  413 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  413 (473)
                         .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+.......           
T Consensus       156 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         156 ---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             ---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence               112334567889999999887 88999999999999999999999998766544433322111000           


Q ss_pred             ---------CCc-------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          414 ---------PLK-------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       414 ---------~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                               ...       ..+..+++.+.+||++||..+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                     000       012234788999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.3e-36  Score=292.89  Aligned_cols=256  Identities=18%  Similarity=0.291  Sum_probs=197.1

Q ss_pred             HhhccCceeeeEEE---EEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          191 QVRKADGITKGSYQ---VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       191 ~~~~~~~ig~G~~~---~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      .+.++++.|+|++.   ....+++.||||++..... .......+..|+++++.++||||+++++++..+...+++|||+
T Consensus         3 ~~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            35566677776664   2345789999999986532 3456678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          268 AKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       268 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ++++|.+++...  ..+++..+..++.|+++||+|||+++   |+||||||+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999999763  45889999999999999999999999   9999999999999999999999999886543221110


Q ss_pred             -cccccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC-------
Q 011991          346 -KIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-------  415 (473)
Q Consensus       346 -~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------  415 (473)
                       ..........++..|+|||++.+  ..++.++||||+||++|+|++|..||.....................       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence             01111223446778999999866  36889999999999999999999999876654433221111100000       


Q ss_pred             ----------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ----------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                            ......++.++.+|+.+||..||++|||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                                  00011234678899999999999999999999885

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-35  Score=283.65  Aligned_cols=248  Identities=23%  Similarity=0.447  Sum_probs=201.3

Q ss_pred             hhccCceeeeEEEEE---Ee---cCcEEEEEEEcCCCC-------CCHHHHHHHHHHHHHHHh-cCCCeeeeEEeeEeeC
Q 011991          192 VRKADGITKGSYQVA---KW---NGTKVWVKILDKESH-------KDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQN  257 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~~---~~~~vavK~l~~~~~-------~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~  257 (473)
                      |.+.+.+|.|+|+.+   ..   .++.+|+|.+.....       ........+..|+.++.+ ++||||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            456677888888744   22   468899998864321       234455678889998875 6899999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          258 IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                      +..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999998743    3458999999999999999999996 66   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      |++.......       ......++..|++||.+.+..++.++|+||||+++|+|++|..||...........+......
T Consensus       159 g~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~  231 (269)
T cd08528         159 GLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE  231 (269)
T ss_pred             cceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence            9987543221       123345788899999999888999999999999999999999999877766666555333222


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +.   ....+++.+.++|.+||+.||++||++.|+..+++
T Consensus       232 ~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         232 PL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            21   23357899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-36  Score=301.27  Aligned_cols=240  Identities=23%  Similarity=0.359  Sum_probs=186.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+.+.||.|+||.+     ..+++.||+|+.....         ...|+.+++.++||||+++++++......++|||
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            5888889999999855     2356789999854321         3468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ++. ++|.+++.. .+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            995 588888865 456899999999999999999999999   9999999999999999999999999986432211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCh----------HHHHHHHHhhCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPP----------EEVVKLMCCEGKRP  413 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf-~~~~~----------~~~~~~i~~~~~~~  413 (473)
                           ......||+.|+|||++.+..++.++|||||||++|+|+++..|+ .....          ......+...+..+
T Consensus       212 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  286 (357)
T PHA03209        212 -----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP  286 (357)
T ss_pred             -----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence                 112345889999999999999999999999999999999865544 32211          11111111111111


Q ss_pred             CC-c---------------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PL-K---------------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~-~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .. .                           .....++.++.+||.+||+.||.+|||+.|+++|
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            00 0                           0012456778889999999999999999999985

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.9e-36  Score=292.53  Aligned_cols=243  Identities=19%  Similarity=0.334  Sum_probs=180.9

Q ss_pred             CceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceEEEEec
Q 011991          196 DGITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEY  266 (473)
Q Consensus       196 ~~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~  266 (473)
                      ..+|.|+||.+.       .++..||+|.+.....     ...+.+|+++++.++||||+++++++..  +...++||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            468999998652       1347899999875432     2357789999999999999999999853  5678999999


Q ss_pred             cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE----cCCCcEEEEeec
Q 011991          267 HAKGDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFG  333 (473)
Q Consensus       267 ~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili----~~~~~vkl~DfG  333 (473)
                      +.+ +|.+++...         ..+++..++.++.|++.||.|||+.+   |+||||||+||++    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            965 888887532         24788999999999999999999999   9999999999999    456789999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHH
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE---------EVV  403 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~---------~~~  403 (473)
                      +++........   ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......         ...
T Consensus       158 ~a~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07867         158 FARLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL  234 (317)
T ss_pred             ceeccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence            99765432211   112234457889999999876 45889999999999999999999999643211         111


Q ss_pred             HHHHhhCCCCC---------------C------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          404 KLMCCEGKRPP---------------L------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       404 ~~i~~~~~~~~---------------~------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+......+.               .                  .......+..+.+|+.+||..||.+|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            11111000000               0                  00011234568899999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-35  Score=279.62  Aligned_cols=244  Identities=26%  Similarity=0.525  Sum_probs=201.5

Q ss_pred             hhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|.|+++.+   .  .++..+++|++.....   .....+.+|+++++.++||||+++++++..+...++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            455677888877643   2  3588999999976432   3557889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++++|.+++... +.+++..+..++.|++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||.+........  
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999999999776 57899999999999999999999998   99999999999999999999999999876543211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......... ...+.. .....++..
T Consensus       154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~  226 (253)
T cd05122         154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGL-RNPEKWSDE  226 (253)
T ss_pred             -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCc-CcccccCHH
Confidence                 1234467789999999888889999999999999999999999988765555544432 222221 112234889


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+++.+||+.||++|||+.+++++
T Consensus       227 ~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcC
Confidence            9999999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-35  Score=286.54  Aligned_cols=245  Identities=24%  Similarity=0.506  Sum_probs=202.3

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|.....+|.|.|+.+   .  .++..+++|++.....    ....+.+|+++++.++|+||+++++++......++|+
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34666677888777633   2  2588999999975432    4567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++++|.+++...+ .+++..+..++.|++.||+|||+.|   ++|+||+|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999999998876 7999999999999999999999999   99999999999999999999999998764432211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+......+.... .+.. ..+..++
T Consensus       172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~  243 (286)
T cd06614         172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPPL-KNPEKWS  243 (286)
T ss_pred             ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCC-cchhhCC
Confidence                  1122346778999999988889999999999999999999999998877765555543322 2221 1234478


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ..+.++|.+||+.+|.+||++.+++.
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhh
Confidence            99999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.2e-36  Score=283.06  Aligned_cols=231  Identities=24%  Similarity=0.399  Sum_probs=184.3

Q ss_pred             ceeeeEEEEE---Ee--cC----------cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          197 GITKGSYQVA---KW--NG----------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       197 ~ig~G~~~~~---~~--~~----------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .||.|+|+.+   ..  .+          ..+++|.+.....    ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            4788887644   22  22          2478887754321    15778899999999999999999999887 7789


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-------cEEEEeec
Q 011991          262 IVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-------QLKISGFG  333 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-------~vkl~DfG  333 (473)
                      +||||+++|+|.+++...+ .++...+..++.|++.||.|||+++   |+||||||+||+++.++       .+||+|||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999999998765 6899999999999999999999999   99999999999999887       79999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE--EFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ++......          ....++..|+|||.+.+.  .++.++|||||||++|+|++ |..||...+..+.........
T Consensus       154 ~a~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~  223 (259)
T cd05037         154 IPITVLSR----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH  223 (259)
T ss_pred             cccccccc----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence            98754321          122355679999998876  78899999999999999998 688887765444433332111


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ..      +......+.+++.+||..+|.+||++.++++.|
T Consensus       224 ~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         224 RL------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CC------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            11      111237899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6e-36  Score=284.86  Aligned_cols=237  Identities=28%  Similarity=0.437  Sum_probs=194.4

Q ss_pred             cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHH
Q 011991          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL  288 (473)
Q Consensus       209 ~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~  288 (473)
                      +|+.+++|++...........+.+.+|+++++.++||||+++++.+..+...|++|||+++++|.+++...+.+++..++
T Consensus        17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~   96 (265)
T cd05579          17 TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR   96 (265)
T ss_pred             CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHH
Confidence            48999999997655444566788999999999999999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc--cccccccCCCCCCcccCCCCc
Q 011991          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA--KIVFPVSHIDPANLYVAPEIY  366 (473)
Q Consensus       289 ~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~  366 (473)
                      .++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..........  ..........++..|++||.+
T Consensus        97 ~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  173 (265)
T cd05579          97 IYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI  173 (265)
T ss_pred             HHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHh
Confidence            99999999999999999   9999999999999999999999999986543221100  000112234467789999999


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 011991          367 KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE  446 (473)
Q Consensus       367 ~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  446 (473)
                      ....++.++|+||||+++|++++|..||......+....+..... +..  ....+++.+.+++.+||+.+|.+||++..
T Consensus       174 ~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~  250 (265)
T cd05579         174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWP--EDVEVSDEAIDLISKLLVPDPEKRLGAKS  250 (265)
T ss_pred             cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCC--ccccCCHHHHHHHHHHhcCCHhhcCCCcc
Confidence            888889999999999999999999999998888777766643221 111  11224899999999999999999999944


Q ss_pred             HHHHH
Q 011991          447 IIARL  451 (473)
Q Consensus       447 ll~~L  451 (473)
                      +.+.|
T Consensus       251 ~~~~l  255 (265)
T cd05579         251 IEEIK  255 (265)
T ss_pred             HHHHh
Confidence            44433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-35  Score=287.25  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=196.9

Q ss_pred             HhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceEEE
Q 011991          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv  263 (473)
                      .|...+.+|.|+|+.+   .  .+++.+|+|.+...... ......+.+|+.++++++||||+++++++...  ...|+|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            5777788999988754   2  35789999999754332 22334577899999999999999999998877  889999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||+.+ +|.+++.... .+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 9999987643 4899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC------
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL------  415 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------  415 (473)
                      .      ......+++.|+|||.+.+. .++.++||||+|+++|+|++|..||...+.......+......+..      
T Consensus       161 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         161 K------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             c------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            1      11223467789999988664 4689999999999999999999999887766555443221111000      


Q ss_pred             --------------------cccCCC-CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 --------------------KIKARS-YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 --------------------~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                          ...+.. +++.+.++|++||+.||++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                                001111 47889999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-35  Score=287.30  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=196.7

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeC-----
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN-----  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~-----  257 (473)
                      ..+|.+...+|.|+|+.+     ..+++.+|+|++....    .....+.+|+.+++++ +||||+++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            345777788999988754     2468899999986432    2235677899999999 799999999998753     


Q ss_pred             CceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          258 IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      +..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecc
Confidence            358999999999999998863    356899999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-----EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      ++........      ......++..|+|||.+...     .++.++|||||||++|+|++|..||...........+..
T Consensus       174 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~  247 (291)
T cd06639         174 VSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR  247 (291)
T ss_pred             cchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence            9875432211      11223577889999987543     368899999999999999999999988776555544422


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ...+.. ..+..++..+.++|.+||+.||++||++.|++++
T Consensus       248 -~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         248 -NPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -CCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             212211 1234567889999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.7e-35  Score=281.69  Aligned_cols=240  Identities=23%  Similarity=0.416  Sum_probs=191.2

Q ss_pred             CceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCC
Q 011991          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (473)
Q Consensus       196 ~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (473)
                      ..+|+|+|+.+     ..++..|++|.+....   ....+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            36888888754     3356789999987542   344568899999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeeccccccccCccccc
Q 011991          271 DLASYLQKK-GRL--SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       271 sL~~~l~~~-~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +|.+++... +.+  ++..+..++.|++.||+|||+++   |+||||||+||+++. ++.++|+|||++........   
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~---  164 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---  164 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC---
Confidence            999999764 445  78889999999999999999999   999999999999976 67899999999865432111   


Q ss_pred             ccccccCCCCCCcccCCCCcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhCCCCCCcccCCCCC
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNE--EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV-VKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  423 (473)
                         ......+++.|+|||.+.+.  .++.++|+||+|+++|+|++|..||........ ..........+   ..+..++
T Consensus       165 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  238 (268)
T cd06624         165 ---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP---EIPESLS  238 (268)
T ss_pred             ---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC---CCCcccC
Confidence               11223478889999998654  478999999999999999999999976443222 11111111112   2255678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++.+|+.+||+.+|++||++.|++.+
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            899999999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.5e-36  Score=289.57  Aligned_cols=247  Identities=20%  Similarity=0.418  Sum_probs=202.9

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ..+|.+.+.+|.|+|+.+     ..+++.+|+|.+....   ....+.+.+|+.+++.++||||+++++.+......++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            457888889999999754     2367899999986432   23346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +||+++++|.+++... .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999999998764 5889999999999999999999999   99999999999999999999999998865432211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......+++.|++||.+....++.++|+|||||++|++++|..||...+.......+... ..+.. ..+..++
T Consensus       171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~-~~~~~~~  242 (293)
T cd06647         171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL-QNPEKLS  242 (293)
T ss_pred             ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCCC-CCccccC
Confidence                  112345778899999998888999999999999999999999999877655443333221 12221 1244567


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+.++|++||..+|++||++.+++.|
T Consensus       243 ~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         243 AIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            889999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=284.78  Aligned_cols=246  Identities=24%  Similarity=0.406  Sum_probs=196.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC-----
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI-----  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~-----  258 (473)
                      .+|.+.+.+|.|+|+.+     ..+++.+++|++....    .....+.+|+.+++++ .||||+++++++....     
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            46777888998888644     2367899999987543    2346789999999999 6999999999997644     


Q ss_pred             -ceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          259 -PMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                       ..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999999865    346899999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-----EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      ++........      ......++..|+|||.+..     ..++.++|||||||++|++++|..||...........+..
T Consensus       159 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  232 (275)
T cd06608         159 VSAQLDSTLG------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR  232 (275)
T ss_pred             cceecccchh------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence            9865432211      1123447888999998754     3467899999999999999999999987666555554432


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      . ..+.. ..+..++..+.+|+.+||..||++|||+.+++++
T Consensus       233 ~-~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         233 N-PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             c-CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            2 11111 1233478899999999999999999999999873

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=284.77  Aligned_cols=243  Identities=23%  Similarity=0.472  Sum_probs=198.0

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC---CCeeeeEEeeEeeCCceEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR---HPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv  263 (473)
                      |...+.+|.|+|+.+     ..+++.+|+|.+....  .......+.+|+.+++.+.   |||++++++++..+...++|
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            556677898888744     3478999999987543  2344567889999999996   99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+++++|.+++... .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            9999999999998664 6899999999999999999999999   99999999999999999999999999876533211


Q ss_pred             cccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                            ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.. ...+  ......+
T Consensus       157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~--~~~~~~~  227 (277)
T cd06917         157 ------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPP--RLEDNGY  227 (277)
T ss_pred             ------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCC--CCCcccC
Confidence                  1223457888999998865 4578999999999999999999999987765544433311 1111  1222347


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      +.++.+++.+||..||++||++.+++.
T Consensus       228 ~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         228 SKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            889999999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.3e-35  Score=291.91  Aligned_cols=273  Identities=22%  Similarity=0.306  Sum_probs=206.0

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeC--Cce
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN--IPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~  260 (473)
                      ..+|.+.+.+|.|+|+.+     ..+++.+|+|.+..... .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            456888888999988754     23678999999865432 233446678899999999 999999999998653  358


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ++||||+. ++|.+++..+ .+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            99999997 4999998765 6889999999999999999999999   99999999999999999999999999876543


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC-------
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR-------  412 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~-------  412 (473)
                      ..... .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+......       
T Consensus       160 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         160 LEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             ccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            22110 0112233457888999998755 46789999999999999999999999876655443333222111       


Q ss_pred             -------------------CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCccccccccCC
Q 011991          413 -------------------PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLP  471 (473)
Q Consensus       413 -------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~~~~~~~~~  471 (473)
                                         .......+.++.++.++|.+||+.||++|||+.+++++  .++.++.... |..++..|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~--~~~~~~~~~~-~~~~~~~~  313 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH--PYVAQFHNPS-DEPVLPYP  313 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC--hhhhhhccCC-CCCCCCCC
Confidence                               01111123478899999999999999999999999985  3455544433 33344433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.1e-36  Score=288.06  Aligned_cols=252  Identities=26%  Similarity=0.417  Sum_probs=208.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.+|.|+|+.+     ..++..+|+|++.............+.+|+++++.+. ||||+++++++..++..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            3566778899988744     2378999999998654444555678899999999998 999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |++++++|.+++...+.+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            99999999999998888999999999999999999999999   999999999999999999999999998765432210


Q ss_pred             cc--------------ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          345 AK--------------IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       345 ~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ..              .........++..|+|||.+....++.++|+||||++++++++|..||...........+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE  238 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence            00              0112233456788999999988889999999999999999999999999877665555553221


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF----NEIIAR  450 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ell~~  450 (473)
                      .     ..+..+++.+.+++.+||+.||.+||++    ++++++
T Consensus       239 ~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         239 Y-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             C-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            1     1245678999999999999999999999    888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-35  Score=283.11  Aligned_cols=236  Identities=23%  Similarity=0.386  Sum_probs=187.0

Q ss_pred             HhhccCce--eeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGI--TKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~i--g~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  262 (473)
                      .|.+.+.+  |.|+|+.+     ..++..+|+|.+.......        .|+.....+ +||||+++++.+..++..++
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            34444444  99998754     3567899999987543221        122233323 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++++|.+++...+.+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9999999999999988778999999999999999999999999   99999999999999988 9999999998654321


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV-VKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  420 (473)
                                ....++..|+|||++.+..++.++||||+||++|+|++|..||........ ...+..... . ....++
T Consensus       164 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~  231 (267)
T PHA03390        164 ----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-K-KLPFIK  231 (267)
T ss_pred             ----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-c-cCCccc
Confidence                      123477889999999988999999999999999999999999986544332 111211111 1 112345


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPN-FNEIIA  449 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs-~~ell~  449 (473)
                      .+++.+.+||.+||+.||.+||+ ++++++
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            68999999999999999999996 699886

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=278.17  Aligned_cols=244  Identities=25%  Similarity=0.485  Sum_probs=205.5

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+.+|.|.++.+     ..+++.+++|.+...... ......+.+|++++++++|||++++++++..+...+++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            556778898888644     236789999999866433 34567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +++++|.+++...+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+.........  
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            999999999988888999999999999999999999999   999999999999999999999999998765432211  


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHH
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL  426 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  426 (473)
                          .....++..|+|||...+..++.++|+||+|+++|+|++|..||...........+.. ...+   ..+..+++.+
T Consensus       156 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~  227 (254)
T cd06627         156 ----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHP---PLPEGISPEL  227 (254)
T ss_pred             ----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCC---CCCCCCCHHH
Confidence                1234577889999999888889999999999999999999999987776555544432 2222   2355678999


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 011991          427 KELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       427 ~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .+++.+||..+|++||++.+++.
T Consensus       228 ~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         228 KDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHHHHHhCChhhCcCHHHHhc
Confidence            99999999999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-35  Score=286.30  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=192.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ++.....+|.|+|+.+     ..+++.+|+|.+.....  ......+.+|+.++.++. ||||+++++++..+...+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            3445567898888755     34678999999975432  245577899999999996 999999999999888999999


Q ss_pred             eccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          265 EYHAKGDLASYLQ-----KKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       265 e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ||+.. +|.++..     ..+.+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||+++..
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99864 6665432     235699999999999999999999975 7   999999999999999999999999998754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCC
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNE---EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPP  414 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~  414 (473)
                      .....       .....+++.|+|||.+.+.   .++.++||||+||++|+|++|..||...... +....+ ..+..+.
T Consensus       159 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~  230 (288)
T cd06616         159 VDSIA-------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV-VKGDPPI  230 (288)
T ss_pred             ccCCc-------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh-cCCCCCc
Confidence            33211       1223477889999998776   6889999999999999999999999765421 222222 1122222


Q ss_pred             Cc-ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LK-IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .. ..+..++..+.+|+.+||+.||.+|||+++|+++
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11 1123578999999999999999999999999885

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.5e-36  Score=297.31  Aligned_cols=247  Identities=22%  Similarity=0.316  Sum_probs=196.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------C
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  258 (473)
                      .+|...+.+|.|+|+.+     ..+|+.||+|.+.... ........+.+|+.+++.++||||++++++|..+      .
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            46888889999999855     3478999999986543 2344456778899999999999999999998643      3


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..|+||||+.+ +|.+.+...  ++...+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||+++..
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            47999999964 999888654  899999999999999999999999   999999999999999999999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC---
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL---  415 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---  415 (473)
                      .....       .....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+......+..   
T Consensus       169 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         169 GTSFM-------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             CCCCC-------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            32211       12335778899999999999999999999999999999999999876654433333221111100   


Q ss_pred             -----------------------c------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 -----------------------K------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 -----------------------~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                             .            ..+...++.+.++|.+||+.||++|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                   0            0012345678999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.3e-36  Score=287.30  Aligned_cols=248  Identities=22%  Similarity=0.379  Sum_probs=195.1

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |+..+.+|.|+++.+     ..+|+.||||.+..... .......+.+|++++++++||||+++++++..++..++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            556677888888644     24688999999875432 223345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +. ++|.+++..  ...+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 589998865  345899999999999999999999999   99999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--------  415 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------  415 (473)
                           ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+......+..        
T Consensus       156 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 -----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             -----ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence                 11223457789999988664 4688999999999999999999999877655444333222211110        


Q ss_pred             ----------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ----------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                      ......+++++.++|.+||+.||.+||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                            00123467889999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-35  Score=284.19  Aligned_cols=236  Identities=25%  Similarity=0.357  Sum_probs=186.6

Q ss_pred             eeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHH---HHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTI---VEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       198 ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~---l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      ||+|+|+.+     ..+++.||+|.+.............+..|..+   ++...||+|+.+++++...+..++||||+.|
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            677777654     24678999999976543322222234444443   4445799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF  349 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~  349 (473)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......       
T Consensus        82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-------  151 (278)
T cd05606          82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------  151 (278)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-------
Confidence            999999988888999999999999999999999999   9999999999999999999999999986543211       


Q ss_pred             cccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          350 PVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPP---EEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       350 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                       .....|+..|+|||.+.+. .++.++||||+||++|+|++|..||.....   .......  ....+.   .+..+++.
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~---~~~~~s~~  225 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVE---LPDSFSPE  225 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCC---CCCcCCHH
Confidence             1123578899999998754 689999999999999999999999987632   2222221  111111   24457899


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHH
Q 011991          426 LKELIEECWDPKPVIRP-----NFNEIIA  449 (473)
Q Consensus       426 l~~li~~cl~~dP~~RP-----s~~ell~  449 (473)
                      +.+++.+||..+|.+||     ++.++++
T Consensus       226 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            99999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=293.89  Aligned_cols=244  Identities=27%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .++.-+.+|+|+||.|     ..+|+.+|.|.+.++.......-.-.++|-.++++++.+.||.+-.+|++.+.+|+||.
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt  265 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT  265 (591)
T ss_pred             ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence            4555667899999743     67899999999987665544444667899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      .|.||+|.-.|.+.+  .+++..++.++.+|+.||++||..+   ||.|||||+|||+|+.|+++|+|+|+|..+.... 
T Consensus       266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-  341 (591)
T KOG0986|consen  266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-  341 (591)
T ss_pred             eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC-
Confidence            999999999998865  6999999999999999999999999   9999999999999999999999999997654432 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            +.....||.+|||||++.+..|+.+.|.|||||++|||+.|+.||...........+.......+ ...+..+|
T Consensus       342 ------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-~ey~~kFS  414 (591)
T KOG0986|consen  342 ------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-EEYSDKFS  414 (591)
T ss_pred             ------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-hhcccccC
Confidence                  23445799999999999999999999999999999999999999976443222222211111111 12356789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFN  445 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~  445 (473)
                      +++++|.+..|.+||.+|....
T Consensus       415 ~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  415 EEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHHHHHHccCHHHhccCC
Confidence            9999999999999999997644

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-35  Score=284.27  Aligned_cols=245  Identities=27%  Similarity=0.493  Sum_probs=193.5

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceEEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~  264 (473)
                      |...+.+|.|+|+.+     ..+++.+|+|.+.....  ......+.+|+++++.++||||+++++++..  ...+++||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            455667888888744     24678999999975432  3445778999999999999999999998865  34689999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       265 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988753    345889999999999999999999999   99999999999999999999999999865432


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhhCCCCCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK-----PPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~  415 (473)
                      ...        ....++..|+|||.+.+..++.++||||+||++|+|++|..||...     ...+....+.. ...+..
T Consensus       158 ~~~--------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (287)
T cd06621         158 SLA--------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPEL  228 (287)
T ss_pred             ccc--------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhh
Confidence            211        1234677899999999889999999999999999999999999765     22333333321 112221


Q ss_pred             cccC---CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 KIKA---RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+   ..+++.+.+++.+||..+|.+|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            1111   2346789999999999999999999999883

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.1e-36  Score=296.24  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=198.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee----CCce
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~  260 (473)
                      .+|.+.+.+|.|+|+.+     ..+|+.||+|++..... .......+.+|+.+++.++||||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            45777788999988754     35689999999975432 22345677889999999999999999998753    3468


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ++||||+. ++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            99999995 599999987777999999999999999999999999   99999999999999999999999999875433


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC-----
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP-----  414 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----  414 (473)
                      ....  .........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+......++     
T Consensus       160 ~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         160 SPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            2111  1111223457888999998865 4688999999999999999999999987665433322221111110     


Q ss_pred             -------------------C--cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 -------------------L--KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 -------------------~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         .  .......++++.++|.+||+.+|++||++++++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                               0  00123468899999999999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.3e-35  Score=277.64  Aligned_cols=248  Identities=25%  Similarity=0.464  Sum_probs=203.1

Q ss_pred             hhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceEEEE
Q 011991          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~  264 (473)
                      |...+.+|.|+++.+   .  .++..+++|++...... ....+.+.+|++++++++||||+++++.+...  ...++++
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            455667888887643   2  35889999999765432 45668899999999999999999999999888  8899999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++.....+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            99999999999988778999999999999999999999999   999999999999999999999999998765433211


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP-PEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                          .......++..|+|||.+.+..++.++||||||+++++|++|..||.... .......+......   ...+...+
T Consensus       158 ----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd06606         158 ----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP---PEIPEHLS  230 (260)
T ss_pred             ----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC---cCCCcccC
Confidence                01123457778999999988889999999999999999999999998765 22222222211122   22355678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+.+++.+|+..||++||++.+++.+
T Consensus       231 ~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         231 EEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             HHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            999999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3e-35  Score=278.74  Aligned_cols=245  Identities=24%  Similarity=0.454  Sum_probs=205.5

Q ss_pred             hhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+.+|.|+|+.+   .  .++..+++|.+..... .......+..|+++++.++|||++++++.+......++|+|+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            556677888887643   2  3588999999976443 345567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          267 HAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       267 ~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999764    66999999999999999999999999   9999999999999999999999999987553321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                            .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...........+.... .+   ..+..+
T Consensus       158 ------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---~~~~~~  227 (258)
T cd08215         158 ------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YP---PIPSQY  227 (258)
T ss_pred             ------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CC---CCCCCC
Confidence                  11223457888999999988889999999999999999999999998887766666553322 22   234578


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..+.+++.+||..+|++||++.+++++
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            8999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-35  Score=287.27  Aligned_cols=258  Identities=22%  Similarity=0.308  Sum_probs=196.0

Q ss_pred             ChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC--
Q 011991          186 NPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--  258 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  258 (473)
                      ...-.+|.+.+.+|.|+|+.+     ..+++.||||.+....... .....+.+|++++++++||||+++++++....  
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            334446888899999999755     2468899999987543221 22234578999999999999999999886543  


Q ss_pred             ------ceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          259 ------PMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       259 ------~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                            ..++||||+.+ +|.+++... ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence                  35999999964 888888664 36899999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ||++..........  ........++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+....
T Consensus       163 fg~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         163 FGLARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CCCcccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99997654332211  1112234467789999988664 47889999999999999999999998877655444332211


Q ss_pred             CCCCCcc---------------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPLKI---------------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+...                           .+...++.+.+||.+||..||.+|||++++++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            1110000                           011135678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=320.47  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=216.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+||.|     +.+++.||.|++++-..........|..|-.+|..-+.+-|++++.+|.++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            47888899999999844     4678999999998643333445578999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |||+||+|-.+|.+.+.+++.-++.++..|+.||.-||+.|   +|||||||+|||+|..|++||+|||.+-.+...+  
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG--  229 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG--  229 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC--
Confidence            99999999999999989999999999999999999999999   9999999999999999999999999875543221  


Q ss_pred             ccccccccCCCCCCcccCCCCcC----C-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK----N-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                         ...+....|||-|.|||++.    + +.|++.+|.||+|+++|||+.|..||...+..+.+.+|..+.....++ ..
T Consensus       230 ---~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~  305 (1317)
T KOG0612|consen  230 ---TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DE  305 (1317)
T ss_pred             ---cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cc
Confidence               12345667999999999984    2 578999999999999999999999999999999999987776555554 22


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPN---FNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~  450 (473)
                      ..+|+.+++||.+.+. +|..|..   ++++..|
T Consensus       306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            4589999999999885 7888988   8888765

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.8e-35  Score=283.71  Aligned_cols=244  Identities=23%  Similarity=0.444  Sum_probs=190.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHH-HHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.+|.|+|+.+     ..+|+.||+|.+.......  ....+..|+.+ ++.++||||+++++++..++..+++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            3566778999999855     2468999999997653322  22345556665 66678999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       265 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ||++ ++|.+++..    ...+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9996 589888764    23589999999999999999999997 7   9999999999999999999999999987543


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhCCCCC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN----EEFDRSVDAYSFGLILYEMIEGVQPFHPKP-PEEVVKLMCCEGKRPP  414 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~  414 (473)
                      ...       ......++..|+|||.+.+    ..++.++|+||+||++|+|++|..||.... ..+....+. ....+.
T Consensus       156 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~  227 (283)
T cd06617         156 DSV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQ  227 (283)
T ss_pred             ccc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCC
Confidence            211       1122346778999998865    456889999999999999999999997532 223333332 222222


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                        .....+|.++.++|.+||..+|++||++++++++
T Consensus       228 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         228 --LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              2234578999999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.8e-35  Score=289.13  Aligned_cols=249  Identities=29%  Similarity=0.392  Sum_probs=197.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv  263 (473)
                      +|.+.+.||.|+|+.+     ..+|+.||+|.+..+.... .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            5777788999998755     3468899999997543221 2223456799999999999999999998754  468999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||+.+ +|.+++... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999965 898888763 56899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc----
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI----  417 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----  417 (473)
                      .      ......+++.|+|||.+.+ ..++.++||||+||++|+|++|..||...+..+....+......+....    
T Consensus       163 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         163 K------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             C------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            1      1122335677999999865 4678999999999999999999999998887777666544322111100    


Q ss_pred             ---------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 ---------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ---------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                           .....++.+.++|.+||+.||++|||+++++.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                                 012257889999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=286.31  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=191.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+.+.+|.|+|+.+     ..+++.||+|.+......  .....+.+|+++++.++||||+++++++..+...++|||
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            4667788999988755     236789999998754321  122346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+.+ +|.+++... +.+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+++....... 
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            9975 999988764 45899999999999999999999999   99999999999999999999999999864322111 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhCCCCCCc------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKP-PEEVVKLMCCEGKRPPLK------  416 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~------  416 (473)
                           ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.... ..+....+......+...      
T Consensus       159 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         159 -----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             -----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence                 1122235778999998865 468899999999999999999999997655 222222221111100000      


Q ss_pred             -------------------ccCCCCC--HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 -------------------IKARSYP--PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 -------------------~~~~~~~--~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         ......+  .++.+++.+||+.||++||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                               0011233  788999999999999999999998863

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=278.11  Aligned_cols=238  Identities=29%  Similarity=0.457  Sum_probs=199.1

Q ss_pred             eeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       198 ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      +|.|+|+.+   .  .+++.+|+|++.............+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            456666533   2  35889999999876555555677899999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccccccc
Q 011991          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS  352 (473)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~  352 (473)
                      .+++...+.+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......      ....
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~  151 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTN  151 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC------Cccc
Confidence            999988878999999999999999999999999   9999999999999999999999999986543321      1123


Q ss_pred             CCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHH
Q 011991          353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE  432 (473)
Q Consensus       353 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~  432 (473)
                      ...++..|+|||.+.+..++.++|+||||+++|++++|..||...........+.. . ...   .+...+..+.+++++
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~-~~~---~~~~~~~~l~~~i~~  226 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-D-PLR---FPEFLSPEARDLISG  226 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-C-CCC---CCCCCCHHHHHHHHH
Confidence            34577789999999888889999999999999999999999988776666555533 1 111   244568899999999


Q ss_pred             ccCCCCCCCCCH---HHHHH
Q 011991          433 CWDPKPVIRPNF---NEIIA  449 (473)
Q Consensus       433 cl~~dP~~RPs~---~ell~  449 (473)
                      ||..||++||++   +++++
T Consensus       227 ~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         227 LLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             HhcCCHhhCCCcccHHHHHh
Confidence            999999999999   55554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.4e-35  Score=279.57  Aligned_cols=243  Identities=29%  Similarity=0.467  Sum_probs=203.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+...+|.|+|+.+     ..+++.+|+|.+...... ......+.+|+++++.++||||+++++++......++||||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            455667888877643     336789999999765432 34557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          267 HAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       267 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      +++++|.+++..    ...+++..++.++.|++.||+|||+.|   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999876    345899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                              .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..+....+.. +..+.   .+..+
T Consensus       158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~  225 (256)
T cd08530         158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPP---IPPIY  225 (256)
T ss_pred             --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCC---Cchhh
Confidence                    1123467789999999988899999999999999999999999998887766555532 22222   23467


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.++.+++.+|++.+|++||++.+++++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            8999999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.7e-35  Score=284.81  Aligned_cols=242  Identities=22%  Similarity=0.417  Sum_probs=198.7

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.....+|.|+|+.+     ..+++.+++|.+.............+..|+++++.++|||++++++++......|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555567898888754     246889999999765544555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +. ++|.+++.. ...+++..+..++.|++.+|.|||++|   ++|+||+|+||+++.++.++|+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            96 588888765 446899999999999999999999999   99999999999999999999999998753211     


Q ss_pred             cccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          346 KIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                           .....++..|+|||.+.   ...++.++|||||||++|+|++|..||...........+.... .+.  .....+
T Consensus       174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~  245 (313)
T cd06633         174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPT--LQSNEW  245 (313)
T ss_pred             -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC--CCcccc
Confidence                 12345778899999984   3568899999999999999999999998877666555543222 221  223457


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..+.+|+.+||+.+|.+||++.+++.+
T Consensus       246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         246 TDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            7889999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-35  Score=281.04  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=200.1

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |...+.+|.|+|+.+     ..+|..+|+|.+...... ....+.+.+|+++++.++||||+++++.+..+...++|+||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            455667888877643     346789999999764322 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccccCcc
Q 011991          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYISPE  343 (473)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~~~~~  343 (473)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999997643  4789999999999999999999999   99999999999999876 469999999875533211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......|++.|+|||.+.+..++.++|+||||++++++++|..||...+.......+.... .+   .....++
T Consensus       158 ------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---~~~~~~~  227 (257)
T cd08225         158 ------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-FA---PISPNFS  227 (257)
T ss_pred             ------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-CC---CCCCCCC
Confidence                  1122457888999999988889999999999999999999999998777666655543222 11   1234678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .++.+++.+||..+|++|||+.+++++
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         228 RDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            899999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.8e-35  Score=289.32  Aligned_cols=239  Identities=24%  Similarity=0.409  Sum_probs=184.3

Q ss_pred             ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHc--CCCCHH
Q 011991          208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK--GRLSPS  285 (473)
Q Consensus       208 ~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~  285 (473)
                      .+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|..++..++||||+.+++|.+++...  ..+++.
T Consensus        23 ~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~  101 (328)
T cd08226          23 PTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEA  101 (328)
T ss_pred             CCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHH
Confidence            4789999999976543 3455688999999999999999999999999999999999999999999998764  348899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc-cccCCCCCCcccCCC
Q 011991          286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF-PVSHIDPANLYVAPE  364 (473)
Q Consensus       286 ~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~-~~~~~~gt~~y~aPE  364 (473)
                      .+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+.............. ......++..|+|||
T Consensus       102 ~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (328)
T cd08226         102 LIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE  178 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChh
Confidence            99999999999999999999   99999999999999999999999986533221111110000 011122455699999


Q ss_pred             CcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC---------------------------
Q 011991          365 IYKNE--EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL---------------------------  415 (473)
Q Consensus       365 ~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---------------------------  415 (473)
                      ++.+.  .++.++||||+||++|+|++|..||...................+.                           
T Consensus       179 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (328)
T cd08226         179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESV  258 (328)
T ss_pred             hhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccch
Confidence            98763  5789999999999999999999999876654443322111100000                           


Q ss_pred             ---------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ---------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                     ......+++.+.+|+++||+.||.+|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         259 VAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                           00112356789999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.3e-35  Score=282.98  Aligned_cols=245  Identities=18%  Similarity=0.306  Sum_probs=190.7

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeC--CceEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQN--IPMMIV  263 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv  263 (473)
                      |++.+.+|.|+|+.+     ..+++.+|+|.+...... ... ....+|+.+++++. ||||+++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            345667888888644     346889999998754322 222 23457889999885 99999999999887  889999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||+.+ +|.+.+... +.+++..++.++.|++.||.|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            999975 888888763 56899999999999999999999999   999999999999999 999999999987553321


Q ss_pred             ccccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC------
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL------  415 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------  415 (473)
                      .       .....+++.|+|||.+. +..++.++||||+||++|+|++|..||.+.+..+....+......+..      
T Consensus       154 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         154 P-------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             C-------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            1       12234678899999764 455788999999999999999999999887765554443221111100      


Q ss_pred             ------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                        ......++..+.++|.+||+.||++||++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                              00123567899999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=283.62  Aligned_cols=247  Identities=25%  Similarity=0.411  Sum_probs=195.1

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      .+.+.+|.|.++.+     ..+|..||+|++..+... ......+.+|+++++.++||||+++++++..++..+++|||+
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            45567888877644     247899999999755322 223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          268 AKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       268 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      + ++|.+++....  .+++..++.++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 59999997765  6899999999999999999999999   99999999999999999999999999865432211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-----------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-----------  413 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  413 (473)
                          ......++..|+|||++.+. .++.++||||||+++|+|++|..||...+.......+......+           
T Consensus       155 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 ----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             ----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence                11222457789999987654 57899999999999999999999998776654433332211111           


Q ss_pred             -------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 -------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 -------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                   ........++..+.++|.+||+.||.+||+++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                         1111234577899999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=287.71  Aligned_cols=239  Identities=25%  Similarity=0.370  Sum_probs=208.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ++.....+|+|+||.+     +-+.+.+|||+++++.....+.++--+.|-.+|.... -|.+++++.+|+.-+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            5667788999999966     3456789999999876655555666677888887774 678999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+.||+|-..+++-+++.+..+..++.+|+-||.+||++|   ||.||||.+|||++.+|++||.|||+++...     
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-----  501 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI-----  501 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-----
Confidence            99999999999999999999999999999999999999999   9999999999999999999999999986432     


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                       .......+..|||-|+|||++...+|+.++|.||+|+++|||+.|.+||.+.+..+++..|..+.-.     .|+.+|.
T Consensus       502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-----yPKslSk  575 (683)
T KOG0696|consen  502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-----YPKSLSK  575 (683)
T ss_pred             -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-----CcccccH
Confidence             2223345678999999999999999999999999999999999999999999999999988654422     2677899


Q ss_pred             HHHHHHHHccCCCCCCCCC
Q 011991          425 DLKELIEECWDPKPVIRPN  443 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs  443 (473)
                      ++.++.+..|...|.+|..
T Consensus       576 EAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  576 EAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHHHHHhhcCCccccC
Confidence            9999999999999999954

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-35  Score=292.23  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             hhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----ceE
Q 011991          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----PMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~  261 (473)
                      |.+.+.||.|+|+.+   .  .+++.+|+|.+.... ......+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            567778999988754   2  357899999997543 22444577899999999999999999999987765     789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+. ++|.+++.....+++..++.++.|++.||+|||++|   |+|+||||+||+++.++.++|+|||++......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999997 489999988778999999999999999999999999   999999999999999999999999998765433


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc----
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK----  416 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  416 (473)
                      ...   ........+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....+......+...    
T Consensus       157 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         157 EDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             ccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            210   1112334578889999999887 88999999999999999999999999888766655554332222111    


Q ss_pred             ----------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 ----------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                            .....+++.+.++|.+||+.||.+||++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                                  0123467889999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.6e-35  Score=283.10  Aligned_cols=247  Identities=25%  Similarity=0.435  Sum_probs=195.4

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |++.+.+|.|+++.+     ..+|..||||.+.....  ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            566778898888744     24688999999976432  22235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          267 HAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       267 ~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +++ +|.+++...+   .+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            975 8999887643   5899999999999999999999999   99999999999999999999999999865432211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK------  416 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  416 (473)
                            ......++..|++||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+......+...      
T Consensus       156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence                  11223457789999988654 57899999999999999999999998877665544443221111000      


Q ss_pred             ------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 ------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                        ...+.+++.+.+++.+||+.||.+||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                              0012457789999999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=292.17  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=194.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----Cc
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~  259 (473)
                      .+|.+.+.+|.|+|+.+     ..+|+.||+|.+....  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            36778889999998754     3468899999986432  233456788899999999999999999886543     34


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .++|+||+.+ +|.+++.. +.+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++....
T Consensus        83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            8999999965 89888854 46999999999999999999999999   9999999999999999999999999987653


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-----
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-----  413 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  413 (473)
                      ......   .......+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+.......+......+     
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         158 PEHDHT---GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             cccccc---CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            321111   11233457889999998654 568899999999999999999999998765433322221111000     


Q ss_pred             -------------------CC--cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 -------------------PL--KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 -------------------~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         ..  ......+++.+.+++.+||+.||.+||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                               00  00123457889999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.9e-35  Score=284.89  Aligned_cols=245  Identities=22%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|...+.+|.|+|+.+     ..++..+|+|.+.............+.+|+++++.++|||++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666778898888744     3467899999987544444555677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 588887754 445899999999999999999999999   999999999999999999999999998653211  


Q ss_pred             cccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                              ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||......+....+... ..+.  ....
T Consensus       169 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~  237 (308)
T cd06634         169 --------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPA--LQSG  237 (308)
T ss_pred             --------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc-CCCC--cCcc
Confidence                    2234678899999874   346788999999999999999999999877665554444322 2222  1244


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      .++..+.+||++||+.+|.+||++++++++-
T Consensus       238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             cccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            6788999999999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.5e-35  Score=284.12  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=193.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCc-----
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP-----  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~-----  259 (473)
                      +|.+.+.+|.|+|+.+     ..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....     
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3566778898888754     24688999999875432 2223356788999999995 6999999999887665     


Q ss_pred             eEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeec
Q 011991          260 MMIVLEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFG  333 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG  333 (473)
                      .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 898888653     34799999999999999999999999   999999999999998 8899999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +++.......      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+......
T Consensus       157 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  230 (295)
T cd07837         157 LGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT  230 (295)
T ss_pred             cceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9875432211      1122345778999998765 46789999999999999999999999887665544443222111


Q ss_pred             CCC-----------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPL-----------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~-----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..                       ......+++.+.+||.+||..||.+||+++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            110                       00113478889999999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.8e-35  Score=282.41  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=189.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+.+.||.|+|+.+     ..+|+.+|+|++..+...  .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            4677788999998755     246889999999754322  122356789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+. ++|.+++.. .+.+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||+++....... 
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence            996 577777654 345788899999999999999999999   99999999999999999999999999865322111 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCC--------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPP--------  414 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~--------  414 (473)
                           ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... +....+......|.        
T Consensus       159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         159 -----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             -----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence                 11223467889999998654 5788999999999999999999999765432 22222111000000        


Q ss_pred             -----------------CcccC--CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 -----------------LKIKA--RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 -----------------~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                       .....  -..++.+.+++.+|+..||.+|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                             00000  0125689999999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=295.66  Aligned_cols=246  Identities=28%  Similarity=0.538  Sum_probs=208.8

Q ss_pred             HhhccCceeeeEEEEEE---ec---C--cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK---WN---G--TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~~---~--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +....+.||.|+||+|.   |+   |  -.||||++......  .....|++|+.+|-+|+|||++++||...+ ...-+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            45666789999999874   22   2  37999999876543  267899999999999999999999999887 67889


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          263 VLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      |||+++.|||.+.|.+.  +.|.....-.++.||+.||.||.+++   .|||||-..|+|+-....|||||||+.+-.+.
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999999999873  34778888999999999999999999   99999999999999999999999999987655


Q ss_pred             Cccccccccccc-CCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          341 SPEKAKIVFPVS-HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       341 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      .++-.    ... ...-...|+|||.+....++-++|+|+||+++|||++ |+.||.+.....++..|. .+.+.+   .
T Consensus       265 ned~Y----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLp---R  336 (1039)
T KOG0199|consen  265 NEDMY----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLP---R  336 (1039)
T ss_pred             CCcce----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCC---C
Confidence            43221    111 1223345999999999999999999999999999997 999999999999999885 555444   3


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |+.+|+++.+++..||..+|.+||+|..|.+.
T Consensus       337 Pk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            77899999999999999999999999999743

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-36  Score=274.48  Aligned_cols=256  Identities=20%  Similarity=0.317  Sum_probs=198.5

Q ss_pred             hHHHhhccCceeeeEEEEEEe-------c--CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-C
Q 011991          188 LELQVRKADGITKGSYQVAKW-------N--GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-N  257 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~~-------~--~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~  257 (473)
                      ....|+..+.||.|+||.|..       +  ...+|+|.++.+...+ .......+|+.+++.++||||+.+..+|.. +
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345788889999999986622       1  3479999998653222 233567899999999999999999999877 7


Q ss_pred             CceEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC----CcEE
Q 011991          258 IPMMIVLEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG----GQLK  328 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~----~~vk  328 (473)
                      ..+++++||.++ +|+++|+-+     ..++...+..+++||+.|+.|||++.   |+||||||.||||..+    |.||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            889999999987 999999653     35899999999999999999999999   9999999999999877    8999


Q ss_pred             EEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC---------
Q 011991          329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKP---------  398 (473)
Q Consensus       329 l~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~---------  398 (473)
                      |+|||+++.+...-....   ......-|..|+|||.+.+. -|+++.|||+.||++.||++-++.|.+..         
T Consensus       177 IaDlGlaR~~~~plkpl~---s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLA---SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             eecccHHHHhhccccccc---cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            999999998765433221   22334457789999998775 69999999999999999999998886532         


Q ss_pred             hHHHHHHHHhhCCCCCCcc------c--------------------------CCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 011991          399 PEEVVKLMCCEGKRPPLKI------K--------------------------ARSYPPDLKELIEECWDPKPVIRPNFNE  446 (473)
Q Consensus       399 ~~~~~~~i~~~~~~~~~~~------~--------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~e  446 (473)
                      ......+|..-...|....      .                          .+.-++...+|+.++|..||.+|.|+++
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q  333 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ  333 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence            1122333332222222110      0                          1112456889999999999999999999


Q ss_pred             HHHHH
Q 011991          447 IIARL  451 (473)
Q Consensus       447 ll~~L  451 (473)
                      .+++.
T Consensus       334 Aleh~  338 (438)
T KOG0666|consen  334 ALEHP  338 (438)
T ss_pred             Hhccc
Confidence            98864

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.7e-35  Score=282.75  Aligned_cols=241  Identities=24%  Similarity=0.428  Sum_probs=197.8

Q ss_pred             cCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       195 ~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      ...+|.|+|+.+     ..+++.||+|.+...   .......+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            356788877644     346889999998543   234456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF  349 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~  349 (473)
                      ++|.+++.. +.+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus       102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------  171 (292)
T cd06657         102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------  171 (292)
T ss_pred             CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc------
Confidence            999998754 45899999999999999999999999   99999999999999999999999998765432111      


Q ss_pred             cccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHH
Q 011991          350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL  429 (473)
Q Consensus       350 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~l  429 (473)
                      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+. ....+.. .....+++.+.++
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~l~~l  249 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPKL-KNLHKVSPSLKGF  249 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hhCCccc-CCcccCCHHHHHH
Confidence            1123457888999999988888999999999999999999999998877665554442 2222222 1234578899999


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 011991          430 IEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       430 i~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||..||.+||++.+++.+
T Consensus       250 i~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         250 LDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHhCCcccCcCHHHHhcC
Confidence            999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=294.17  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=218.8

Q ss_pred             HhhccCceeeeEEEEE---EecCcE--EEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---KWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~--vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +++...-+|-|+||.+   ...++.  +|+|++++....+....+....|-.+|...+.|.||++|..|.++.++|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3445556788888844   445544  89999999888888888999999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      -|-||.|+..|..++.+++.+++.++.-+++|++|||++|   ||.|||||+|.+++.+|-+||.|||+|+......   
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---  574 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC---
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999998775542   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ...+++|||.|.|||++...+.+.++|.||||+++|||++|.+||++.++...+..|...-....+   |..++..
T Consensus       575 ----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~---Pr~I~k~  647 (732)
T KOG0614|consen  575 ----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF---PRRITKT  647 (732)
T ss_pred             ----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc---ccccchh
Confidence                235678999999999999999999999999999999999999999999999988888554443333   5778899


Q ss_pred             HHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      ..+||++....+|.+|..     +.+|.+|
T Consensus       648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  648 ATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             HHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            999999999999999987     5666554

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.8e-35  Score=282.44  Aligned_cols=249  Identities=23%  Similarity=0.363  Sum_probs=193.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+...||.|.++.+     ..+|+.||+|.+..... .......+.+|+++++.++||||+++++++..+...++|||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            3566678888887644     24688999999865432 22334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeeccccccccCc
Q 011991          266 YHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~~~~~~~  342 (473)
                      |++ ++|.+++.....  +++..++.++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 588888865433  578888999999999999999999   999999999999985 4579999999986543221


Q ss_pred             ccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC------
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL------  415 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------  415 (473)
                      .      ......+++.|+|||.+.+ ..++.++||||+||++|+|++|..||......+....+......+..      
T Consensus       158 ~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        158 R------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             c------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence            1      1122346778999998865 45789999999999999999999999877665554443221111100      


Q ss_pred             ------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                        ......+++.+.+++.+||+.+|++||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              00123567889999999999999999999999874

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.8e-35  Score=284.03  Aligned_cols=258  Identities=15%  Similarity=0.159  Sum_probs=186.2

Q ss_pred             HHhhccCceeeeEEEEEE---e--c---CcEEEEEEEcCCCCCCHHHH--------HHHHHHHHHHHhcCCCeeeeEEee
Q 011991          190 LQVRKADGITKGSYQVAK---W--N---GTKVWVKILDKESHKDPERI--------NAFTHELTIVEKARHPNVVQFVGA  253 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~--~---~~~vavK~l~~~~~~~~~~~--------~~~~~E~~~l~~l~hpnIv~l~~~  253 (473)
                      .+|.+.+.||+|+||.+.   .  +   +..+|+|+............        .....+...+..++|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            468888999999998662   2  2   34667776543321110000        112233344556689999999998


Q ss_pred             EeeCC----ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 011991          254 VTQNI----PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI  329 (473)
Q Consensus       254 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl  329 (473)
                      +....    ..++++|++. .++.+.+......++..++.++.|++.||+|||+++   |+||||||+|||++.++.++|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence            66543    3578889874 488888776656788899999999999999999999   999999999999999999999


Q ss_pred             EeeccccccccCccccc-ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Q 011991          330 SGFGLLRLQYISPEKAK-IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP-EEVVKLMC  407 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~~~~~i~  407 (473)
                      +|||+|+.......... .........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99999976543211111 01112234689999999999999999999999999999999999999987632 22211110


Q ss_pred             hh--CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          408 CE--GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       408 ~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      ..  .............++.+.++++.|+..+|++||++.++++.|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00  000111112445688999999999999999999999999876

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=307.38  Aligned_cols=253  Identities=17%  Similarity=0.190  Sum_probs=184.7

Q ss_pred             HHHhhccCceeeeEEEEEEe------cCcEEEEEE--------------EcCCCCCCHHHHHHHHHHHHHHHhcCCCeee
Q 011991          189 ELQVRKADGITKGSYQVAKW------NGTKVWVKI--------------LDKESHKDPERINAFTHELTIVEKARHPNVV  248 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~~------~~~~vavK~--------------l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  248 (473)
                      ..+|++.+.||+|+||.+..      .+...++|.              +.+...........+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            45799999999999985531      122222221              1111112233456788999999999999999


Q ss_pred             eEEeeEeeCCceEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC
Q 011991          249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN  323 (473)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~  323 (473)
                      ++++++...+..|+|+|++. ++|.+++...     .......++.++.||+.||.|||+++   |+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence            99999999999999999995 5888877543     12345678889999999999999999   999999999999999


Q ss_pred             CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCC--hH
Q 011991          324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP-FHPKP--PE  400 (473)
Q Consensus       324 ~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~p-f~~~~--~~  400 (473)
                      ++.+||+|||+++........     ......||+.|+|||++.+..++.++|||||||++|||++|..+ |....  +.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA-----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             CCCEEEEeCCCceecCccccc-----ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999999765332111     11235689999999999999999999999999999999998754 43221  21


Q ss_pred             HHHHHHHhhCCCCCC---------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          401 EVVKLMCCEGKRPPL---------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       401 ~~~~~i~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .....+.........                           ......++.++.++|.+||+.||.+|||+.|++.+
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            222211111100000                           00112356778889999999999999999999874

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.7e-35  Score=282.83  Aligned_cols=246  Identities=23%  Similarity=0.372  Sum_probs=195.8

Q ss_pred             hhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCC-CCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceE
Q 011991          192 VRKADGITKGSYQVAK--------WNGTKVWVKILDKESH-KDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  261 (473)
                      |++.+.+|.|+|+.+.        .+|..||+|++..... ......+.+..|+.+++.+ +||||+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            5567789999987542        3688999999975332 1223346788899999999 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999999999988878999999999999999999999999   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhCCCCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNE--EFDRSVDAYSFGLILYEMIEGVQPFHPKPP----EEVVKLMCCEGKRPPL  415 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~  415 (473)
                      ...     ......++..|+|||.+.+.  .++.++||||||+++|+|++|..||.....    ......+.. . .++ 
T Consensus       159 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~-~~~-  230 (290)
T cd05613         159 EVE-----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-S-EPP-  230 (290)
T ss_pred             ccc-----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-c-CCC-
Confidence            111     11234578889999998753  467899999999999999999999974332    222222211 1 111 


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                        .+..+++.+.+++.+||+.||++||     ++++++.+
T Consensus       231 --~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         231 --YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             --CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence              2456788999999999999999997     77887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=280.90  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=196.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceEEEE
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~  264 (473)
                      |.+.+.+|.|+|+.+     ..+++.+|+|.+.... ........+.+|+++++.++|||++++++++...  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            345667888888744     2357899999998654 2334446788999999999999999999999887  8899999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++ +|.+++... ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            99975 999988765 56999999999999999999999999   99999999999999999999999999876543321


Q ss_pred             cccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-----
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-----  417 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----  417 (473)
                      .     ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+......+....     
T Consensus       156 ~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         156 A-----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence            1     1122345778999998765 4678999999999999999999999988776555444432211111000     


Q ss_pred             --------------------cCCC-CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 --------------------KARS-YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 --------------------~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                          .... +++.+.+++++||+.+|.+||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                                0112 37889999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=286.78  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=197.0

Q ss_pred             ccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHH-----------HHHHHHHHHHHHHhcCCCeeeeEEeeEeeC
Q 011991          194 KADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPE-----------RINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (473)
Q Consensus       194 ~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  257 (473)
                      +.+.||.|+|+.+     ..+++.||||.+.........           ....+.+|+++++.++||||+++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            3456899988755     346889999998754322100           012477899999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ...++||||+. ++|.+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence            99999999997 599999988778999999999999999999999999   99999999999999999999999999876


Q ss_pred             cccCccc-------c-cccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          338 QYISPEK-------A-KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       338 ~~~~~~~-------~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      .......       . ..........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~  248 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE  248 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            5411100       0 001112233467789999998764 468999999999999999999999998877665554433


Q ss_pred             hCCCCCCc-----------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          409 EGKRPPLK-----------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       409 ~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ....+...                       ......+..+.++|.+||+.+|++||++++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            22211110                       012345788999999999999999999999997

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.7e-35  Score=290.44  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=198.9

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----Cce
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~  260 (473)
                      +|.+.+.+|.|+|+.+     ..+++.||||.+..... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            5777788999988754     34688999999875432 233345678899999999999999999987644     348


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      |+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            99999996 699999988888999999999999999999999999   99999999999999999999999999875433


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC-------
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR-------  412 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~-------  412 (473)
                      ...      ......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+.......+......       
T Consensus       161 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         161 KGD------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             Ccc------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            211      1123346788999998764 46889999999999999999999999876544333222111100       


Q ss_pred             -------------------CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHH
Q 011991          413 -------------------PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR--LDRI  454 (473)
Q Consensus       413 -------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~  454 (473)
                                         +........+++.+.++|++||+.||.+|||+++++++  ++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                               11111234578899999999999999999999999988  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=271.84  Aligned_cols=246  Identities=25%  Similarity=0.372  Sum_probs=196.8

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEe
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+....||.|.||.+     +.+|+..|||.+....  ......+++.|.++..+- ++||||+|+|+...++..|+.||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            445567899999966     6789999999998654  356678899999876555 69999999999999999999999


Q ss_pred             ccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          266 YHAKGDLASYLQ-----KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       266 ~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +|+- ||..+-+     +...+++...-.|+.-.+.||.||.+.-  .|||||+||+|||++..|.+||||||++.....
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            9964 8877643     2356999999999999999999998755  499999999999999999999999999865443


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCCcc
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNE--EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  417 (473)
                      +-.       .+.-.|-..|||||.+...  +|+.+||+||||+++||+.||..||...+.. +.+.++ ..+.+|.+..
T Consensus       221 SiA-------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V-v~gdpp~l~~  292 (361)
T KOG1006|consen  221 SIA-------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV-VIGDPPILLF  292 (361)
T ss_pred             HHH-------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH-HcCCCCeecC
Confidence            321       2233466679999998643  6999999999999999999999999887653 333333 4444443322


Q ss_pred             c--CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 K--ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .  .-+++..+..+|..|+.+|-..||++.+++++
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1  12478999999999999999999999998764

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-35  Score=286.60  Aligned_cols=252  Identities=21%  Similarity=0.327  Sum_probs=191.2

Q ss_pred             hhccCceeeeEEEEE---E--e--cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceEE
Q 011991          192 VRKADGITKGSYQVA---K--W--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMI  262 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~--~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l  262 (473)
                      |.+.+.+|+|+|+.+   .  .  .++.||+|.+...........+.+.+|+.+++.++||||+++++++...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            556677899988754   2  2  6789999999864322233346678899999999999999999999887  78999


Q ss_pred             EEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC----CCcEEEEeec
Q 011991          263 VLEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN----GGQLKISGFG  333 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~----~~~vkl~DfG  333 (473)
                      ||||+.+ +|.+++...     ..+++..++.++.|++.||.|||+++   |+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 787776532     25889999999999999999999999   999999999999999    8999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---------HH
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE---------VV  403 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~---------~~  403 (473)
                      +++........   ........+++.|+|||.+.+ ..++.++|||||||++++|++|..||.+.....         ..
T Consensus       158 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         158 LARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             cccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            98765332211   112233457788999998766 467899999999999999999999997654321         11


Q ss_pred             HHHHhhC------------------------CCCCCc--c------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          404 KLMCCEG------------------------KRPPLK--I------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       404 ~~i~~~~------------------------~~~~~~--~------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+....                        ......  .      .....+..+.+++.+|++.||++|||+.|++.+
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1110000                        000000  0      001456789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.9e-35  Score=281.96  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             hhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCC-CCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceE
Q 011991          192 VRKADGITKGSYQVAK--------WNGTKVWVKILDKESH-KDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  261 (473)
                      |.+.+.+|.|+|+.+.        .+++.+|||.+..... ........+..|+.+++.+ +||||+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            4566778999887542        3567899999874322 1223446788999999999 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+++++|.+++...+.+++..+..++.|++.+|.|||+.+   ++|+||||.||+++.++.++|+|||+++.....
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999999999987777999999999999999999999999   999999999999999999999999998754332


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhCCCCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFHPKPP----EEVVKLMCCEGKRPPL  415 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~  415 (473)
                      ...     ......++..|+|||.+.+..  .+.++|+||||+++|+|++|..||.....    .+....+.. .. +  
T Consensus       159 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-~--  229 (288)
T cd05583         159 EEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SK-P--  229 (288)
T ss_pred             ccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cC-C--
Confidence            111     112234778899999987654  78899999999999999999999964322    222222211 11 1  


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                       ..+..+++.+.+++.+||+.||++|||+.++...|+.
T Consensus       230 -~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         230 -PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             1245578899999999999999999998877666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=293.64  Aligned_cols=235  Identities=27%  Similarity=0.445  Sum_probs=194.5

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ...|.....+|.|+|+++     ..++...++|++......       -.+|+.++... +||||+++.+.+.++...|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence            346777778999998765     457889999999865222       24567666666 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE-cCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili-~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |||++.|+-|.+.+.....+. ..+.+|+.+|+.|+.|||++|   |+||||||+|||+ ++.++++|+|||.++....+
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999999998888776655444 788899999999999999999   9999999999999 68899999999999765433


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  420 (473)
                               +.+.+-|..|.|||++....|+.++|+||||+++|+|++|..||...... ++...+    ..+..   ..
T Consensus       470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~---s~  533 (612)
T KOG0603|consen  470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKF---SE  533 (612)
T ss_pred             ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcc---cc
Confidence                     22334567799999999999999999999999999999999999887766 444333    12222   15


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+|..+++|+++||+.||.+||++.+++.+
T Consensus       534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  534 CVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            789999999999999999999999999773

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-34  Score=281.46  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=196.4

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----  258 (473)
                      ..+|.+.+.+|.|+|+.+     ..+|+.||+|.+...... ......+.+|+++++.++||||+++++++....     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            346778888999988754     236789999999754322 222346778999999999999999999887654     


Q ss_pred             -----ceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          259 -----PMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       259 -----~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                           .+++|+||+++ +|.+++... ..+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence                 78999999976 787777654 45899999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |++........     .......++..|+|||.+.+ ..++.++|||||||++++|++|..||...+..+....+.....
T Consensus       161 g~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         161 GLARLYNSEES-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             cccccccCCcc-----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99875533211     11112234667999998865 3578999999999999999999999987776655554433221


Q ss_pred             CCCCc-------------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 RPPLK-------------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ~~~~~-------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+...                         .....+|+.+.+++.+||+.||.+||++++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11100                         0123468899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.2e-34  Score=307.76  Aligned_cols=143  Identities=25%  Similarity=0.461  Sum_probs=129.6

Q ss_pred             HhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|.+.+.||.|.|+.+   .  .+++.||||++.............+..|+.+++.++||||+++++++......|+|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            4677788999999855   2  3588999999986655556667889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      |+.+++|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999988778999999999999999999999999   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=278.00  Aligned_cols=247  Identities=23%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      .+.+.+|.|+++.+     ..+++.+++|.+...... ......+.+|+++++.++||||+++++++..+...++||||+
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            44567888877643     246889999998765432 234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      ++ +|.+++... ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||.+.......    
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----  152 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----  152 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc----
Confidence            75 888888764 56899999999999999999999999   9999999999999999999999999987654331    


Q ss_pred             ccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC----------
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL----------  415 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------  415 (473)
                        .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....+......+..          
T Consensus       153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence              112233467789999998776 7899999999999999999999999887765554443322211100          


Q ss_pred             ---------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ---------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                     ....+.++.++.++|.+||+.||.+||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                           00123467889999999999999999999999873

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=276.94  Aligned_cols=247  Identities=24%  Similarity=0.366  Sum_probs=193.2

Q ss_pred             hhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc---CCCeeeeEEeeEeeCCc----
Q 011991          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQNIP----  259 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~----  259 (473)
                      |++...+|.|+|+.+   .  .+++.+|+|.+..... .......+.+|+.+++++   +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            345567888888644   2  3578999999975433 222334566788877766   59999999999988776    


Q ss_pred             -eEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          260 -MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       260 -~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                       .+++|||+.+ +|.+++....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence             9999999975 8999887643  4899999999999999999999999   9999999999999999999999999986


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC-
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-  415 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-  415 (473)
                      .......       .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+......+.. 
T Consensus       156 ~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07838         156 IYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE  228 (287)
T ss_pred             eccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence            6432211       12234677899999999888999999999999999999999999988776665555332111000 


Q ss_pred             ---------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ---------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                           ......+++.+.++|.+||+.||++||++++++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                                 00012345778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.5e-35  Score=284.15  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=194.4

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  258 (473)
                      .+|.+.+.||.|+|+.+     ..+++.+|+|.+....... .....+.+|+++++.++||||+++++.+....      
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46778888999998755     2367899999987543222 11235678999999999999999999875432      


Q ss_pred             --ceEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          259 --PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       259 --~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                        .+++||||+.+ +|...+.. ...+++..+..++.|+++||+|||+++   ++|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence              46999999965 77777754 346999999999999999999999999   999999999999999999999999998


Q ss_pred             cccccCccccc-----ccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 011991          336 RLQYISPEKAK-----IVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       336 ~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~  409 (473)
                      +..........     .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            75433221111     11122334567889999987654 5789999999999999999999999887766555544322


Q ss_pred             CCCCCCc-------------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          410 GKRPPLK-------------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       410 ~~~~~~~-------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+...                         .....+++.+.+++.+||..||.+|||+.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1111100                         0012345788999999999999999999999863

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=247.01  Aligned_cols=249  Identities=22%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|...++||.|+||.+     ..+++.||+|.+..+... ...-....+|+-+++.++|.|||++++....+..+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            3556678999999976     356789999999865422 2222457899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+. +|.++... ++.++.+.++.++.|++.||.|+|+++   ++||||||.|.||+.+|.+|+.|||+++-++.... 
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr-  156 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-  156 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence            9965 99999866 677999999999999999999999999   99999999999999999999999999987755421 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCc------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLK------  416 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~------  416 (473)
                           ..+.-.-|..|++|.++.+. -|+.+.|+||.||++.|+.. |.+.|++.+..+.+.+|......|.-.      
T Consensus       157 -----cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  157 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             -----eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence                 22334457789999998775 68999999999999999985 888999998888777775444333211      


Q ss_pred             ccCC------------------CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 IKAR------------------SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ~~~~------------------~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+.                  .++..-++++.+.+.-+|.+|.++++.+++
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1110                  122345789999999999999999998874

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.1e-34  Score=283.31  Aligned_cols=252  Identities=20%  Similarity=0.287  Sum_probs=192.8

Q ss_pred             hhccCceeeeEEEEE---E--ec--CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeC----Cc
Q 011991          192 VRKADGITKGSYQVA---K--WN--GTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN----IP  259 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~--~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~----~~  259 (473)
                      |.+.+.||.|+|+.+   .  .+  +..+|+|.+.... ......+.+.+|+.+++.+ +||||+++++.+...    ..
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            556677898888754   2  23  6789999987432 2233456788899999999 599999999875432    45


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .++++||+. ++|.+++.....+++..++.++.|++.||.|||++|   ++||||||+||+++.++.++|+|||+++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            789999985 599999988778999999999999999999999999   9999999999999999999999999997543


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC------
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR------  412 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~------  412 (473)
                      .....  .........|++.|+|||.+.+ ..++.++||||+||++|++++|..||...+.......+......      
T Consensus       157 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         157 ENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            32111  1111223457889999998765 56899999999999999999999999876544433322211110      


Q ss_pred             --------------------CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 --------------------PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 --------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                          .........++..+.+++.+||+.||.+|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                11111123457889999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.7e-34  Score=277.33  Aligned_cols=245  Identities=24%  Similarity=0.440  Sum_probs=191.8

Q ss_pred             HhhccCceeeeEEEEE---Ee--cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~--~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+...+|.|+|+.+   ..  +++.||||.+.....  ......+..|+.++... +||||+++++++......+++|
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            5677788999988754   33  388999999975432  23345667788777666 5999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+. ++|.+++.. .+.+++..+..++.|++.||.|||+ .+   |+||||+|+||++++++.++|+|||++.......
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 488888765 4568999999999999999999997 47   9999999999999999999999999986543221


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhCCCCCCcc
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEE----FDRSVDAYSFGLILYEMIEGVQPFHPKPP-EEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~  417 (473)
                      .       .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||..... .+....+.... .+..+ 
T Consensus       170 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-  240 (296)
T cd06618         170 A-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLP-  240 (296)
T ss_pred             c-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCC-
Confidence            1       11224677899999987553    78899999999999999999999976433 23333332222 22211 


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....+++++.+|+.+||+.||++||++++++.+
T Consensus       241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            123578899999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-34  Score=284.20  Aligned_cols=245  Identities=23%  Similarity=0.376  Sum_probs=195.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------c
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~  259 (473)
                      +|.+.+.||.|+|+.+     ..++..||||++.... ........+.+|+.+++.++||||+++++++..+.      .
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            5778888999998755     3468899999986543 23344567889999999999999999999987654      3


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++....
T Consensus        95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            58999999 6799988864 46999999999999999999999999   9999999999999999999999999986542


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC----
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP----  414 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  414 (473)
                      ..         .....+++.|+|||.+.+ ..++.++|+|||||++|++++|..||.+.........+......++    
T Consensus       170 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         170 SE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            21         122346788999998876 4578999999999999999999999987765444333322111110    


Q ss_pred             ----------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 ----------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                            .......+++.+.++|.+|++.||++|||+.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                  001124567889999999999999999999999863

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=277.14  Aligned_cols=247  Identities=28%  Similarity=0.448  Sum_probs=196.0

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      +....+|.|.|+.+     ..+++.+|+|.+.... ......+.+..|+.+++.++||||+++++++......++||||+
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            34456787777643     3458999999998654 22333467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      . ++|.+++... ..+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||+++.......   
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---  153 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---  153 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc---
Confidence            7 5999999876 57999999999999999999999999   99999999999999999999999999876533211   


Q ss_pred             ccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC----------
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL----------  415 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------  415 (473)
                         ......++..|+|||.+.+. .++.++|||||||+++++++|..||...+..+....+......+..          
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         154 ---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             ---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence               11223356679999998766 7899999999999999999999999887765554443221111100          


Q ss_pred             --------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 --------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                    ....+.++..+.+++++||..||++||++++++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                          00112347889999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.5e-34  Score=281.53  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=194.4

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-CCceEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMI  262 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l  262 (473)
                      ...|.+.+.||.|+|+.+     ..+++.||+|.+..... .....+.+..|+++++.++||||++++++|.. ....++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            346788889999998755     34788999999865432 23344677899999999999999999999875 557899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||+ +++|.+++... .+++..+..++.|+++||.|||+.+   |+|+||+|+||+++.++.++|+|||++...... 
T Consensus        88 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          88 VTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             Eeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            99999 56999888653 5888999999999999999999999   999999999999999999999999998643211 


Q ss_pred             ccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC---------
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR---------  412 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~---------  412 (473)
                              .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+......         
T Consensus       162 --------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         162 --------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             --------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence                    122346778999998765 57899999999999999999999999876653332222111000         


Q ss_pred             ---------------C--CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 ---------------P--PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ---------------~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                     .  +.......+++.+.++|.+||+.+|++||++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                           0  0001123567899999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=274.68  Aligned_cols=246  Identities=22%  Similarity=0.361  Sum_probs=193.0

Q ss_pred             hhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEe
Q 011991          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      |.+.+.||.|+|+.+   .  .+++.|++|.+......  .......+|+..+++++ ||||+++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            345667888888754   2  35788999998754332  12233457899999998 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+ +++|.+++....  .+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence            99 779999987754  6899999999999999999999999   9999999999999999999999999986543221 


Q ss_pred             cccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC-------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-------  415 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------  415 (473)
                            ......++..|+|||++. ...++.++|+||||+++++|++|..||......+....+......+..       
T Consensus       154 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07830         154 ------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY  227 (283)
T ss_pred             ------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence                  112345778899999874 446789999999999999999999999877665544433222111110       


Q ss_pred             ------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                        .......+.++.+++++||+.||++||+++|++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence                              00011236789999999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=286.25  Aligned_cols=244  Identities=24%  Similarity=0.402  Sum_probs=202.1

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      .--.+.+|+|-||++     +.+|+.||||++.+....... -..+.+|+.+++.+.||.||.+..-|+..+..|.|||-
T Consensus       566 if~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK  644 (888)
T KOG4236|consen  566 IFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK  644 (888)
T ss_pred             hhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence            334467899999865     688999999999876655433 37789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC---CcEEEEeeccccccccC
Q 011991          267 HAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRLQYIS  341 (473)
Q Consensus       267 ~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~---~~vkl~DfG~a~~~~~~  341 (473)
                      +.| +..+++-.  .+++++.....++.||+.||.|||.++   |+|+||||+|||+.+.   .++||||||+|++++..
T Consensus       645 l~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  645 LHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            965 66666533  578999999999999999999999999   9999999999999764   37999999999987654


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ..       .....|||.|+|||++...+|+++-||||.|+++|--+.|..||..  .+++-++|.... ..-++..++.
T Consensus       721 sF-------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAa-FMyPp~PW~e  790 (888)
T KOG4236|consen  721 SF-------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAA-FMYPPNPWSE  790 (888)
T ss_pred             hh-------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccc-cccCCCchhh
Confidence            22       2345799999999999999999999999999999999999999953  334555553322 2222234678


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++.+.+||...|+.+-.+|-|...-+.|
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            89999999999999999999998877664

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-34  Score=282.87  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=193.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------C
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  258 (473)
                      .+|.+.+.||+|+|+.+     ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            35777788999999754     35688999999975432 233346788899999999999999999988643      3


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..+++++++ +++|.+++... .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+++..
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence            478899987 77999888654 5999999999999999999999999   999999999999999999999999998643


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC----
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP----  413 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~----  413 (473)
                      ...         .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......+    
T Consensus       171 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T cd07877         171 DDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  241 (345)
T ss_pred             ccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            211         123457788999998866 468899999999999999999999998766544433322211110    


Q ss_pred             --------------------CC--cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 --------------------PL--KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 --------------------~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                          ..  .......++.+.++|.+|++.||.+||++.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                                00  00112357889999999999999999999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=275.21  Aligned_cols=258  Identities=29%  Similarity=0.510  Sum_probs=207.6

Q ss_pred             HHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc--CCCeeeeEEeeEeeCC----ce
Q 011991          190 LQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA--RHPNVVQFVGAVTQNI----PM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~~----~~  260 (473)
                      .+....+.||+|.||.|   .|.|+.||||++....   +   ..+.+|.++++..  +|+||+.|+++...+.    .+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---E---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccc---h---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            36667788999999855   7999999999997432   1   3477888888875  9999999999875432    48


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-----CKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      |||++|.+.|||+|||..+ .++....++++..++.||++||.     +|.+.|.|||||+.||||.+++.+-|+|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            9999999999999999874 69999999999999999999994     56678999999999999999999999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCC----C--CCchhHHHHHHHHHHHHhC----------CCCCCC---
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE----F--DRSVDAYSFGLILYEMIEG----------VQPFHP---  396 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwSlG~~l~ell~g----------~~pf~~---  396 (473)
                      -.....  ......+.....||.+|||||++...-    +  -..+||||||.|+||+...          ..||.+   
T Consensus       364 v~h~~~--t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  364 VRHDSD--TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             EEeccc--CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            543322  122334456678999999999996542    1  2579999999999999753          367743   


Q ss_pred             --CChHHHHHHHHhhCCCCCCcccCCCCC--HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          397 --KPPEEVVKLMCCEGKRPPLKIKARSYP--PDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       397 --~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                        .+-+++.+.+.....+|.++..+...+  ..+.++|+.||..||.-|.|+=-+-+.|.++..
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence              344566666677777887766565544  458889999999999999999999999988875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.3e-34  Score=303.98  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=192.8

Q ss_pred             ChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe-----
Q 011991          186 NPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-----  255 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----  255 (473)
                      ..+..+|+....+|+|+||.|     +.+|..||||++....  .......+.+|+.++.+|+|||||+++.++.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            455668888889999999855     5789999999998765  4556678899999999999999999982110     


Q ss_pred             -------------------------------------------------------------------------e------
Q 011991          256 -------------------------------------------------------------------------Q------  256 (473)
Q Consensus       256 -------------------------------------------------------------------------~------  256 (473)
                                                                                               +      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                     0      


Q ss_pred             ---------------------------C--------CceEEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHH
Q 011991          257 ---------------------------N--------IPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALDLARGMNY  300 (473)
Q Consensus       257 ---------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~qi~~~L~~  300 (473)
                                                 .        ..+||-||||+.-+|.+++..+... ....+|+++++|+.||+|
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence                                       0        1278999999997777777766433 477899999999999999


Q ss_pred             HhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc------cC------cccccccccccCCCCCCcccCCCCcCC
Q 011991          301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY------IS------PEKAKIVFPVSHIDPANLYVAPEIYKN  368 (473)
Q Consensus       301 LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~------~~------~~~~~~~~~~~~~~gt~~y~aPE~~~~  368 (473)
                      +|++|   ||||||||.||+++.++.|||+|||+|+...      ..      ..........+...||..|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999   9999999999999999999999999997611      00      111112224556789999999999977


Q ss_pred             C---CCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 011991          369 E---EFDRSVDAYSFGLILYEMIEGVQPFHPKP-PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF  444 (473)
Q Consensus       369 ~---~~~~~~DiwSlG~~l~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  444 (473)
                      .   .|+.|+||||||+|++||+.   ||...- ...++..+. .+..|.....+..--+.-..+|++|++.||.+||||
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA  865 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA  865 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence            6   49999999999999999984   564322 222333332 222221111122223567889999999999999999


Q ss_pred             HHHHH
Q 011991          445 NEIIA  449 (473)
Q Consensus       445 ~ell~  449 (473)
                      .|+|+
T Consensus       866 ~eLL~  870 (1351)
T KOG1035|consen  866 TELLN  870 (1351)
T ss_pred             HHHhh
Confidence            99986

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-34  Score=285.79  Aligned_cols=246  Identities=25%  Similarity=0.349  Sum_probs=196.4

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc-----
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-----  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----  259 (473)
                      .+|.+...||.|+|+.+     ..+++.||+|++.... ........+.+|+.+++.++||||+++++++.....     
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            35777888999988754     2357899999987543 223445677889999999999999999998866554     


Q ss_pred             -eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          260 -MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       260 -~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                       .++|+||+ +++|.+++.. +.+++..++.++.|++.||.|||+.|   |+||||||+||+++.++.++|+|||++...
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence             89999999 5699999875 46999999999999999999999999   999999999999999999999999998654


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--  415 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  415 (473)
                      ...         .....++..|+|||.+.+ ..++.++|||||||++|++++|..||...........+......+..  
T Consensus       169 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         169 DDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            221         223456788999998765 36789999999999999999999999877766555544332211110  


Q ss_pred             ------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                              ......+++.+.+||++||+.||++|||+.+|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                                    00112458899999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-34  Score=282.85  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=193.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------c
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~  259 (473)
                      +|.....+|.|+|+.+     ..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++....      .
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            5677788999988754     24689999999875432 2233456789999999999999999999987543      3


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .++||||+.. +|.+++.  ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||+++...
T Consensus        95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            6999999964 8877653  35899999999999999999999999   9999999999999999999999999986432


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC----
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP----  414 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  414 (473)
                      ..         .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+.    
T Consensus       169 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         169 AE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            11         122346778999999876 4688999999999999999999999988765544443322111110    


Q ss_pred             ----------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHH
Q 011991          415 ----------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR--LDRI  454 (473)
Q Consensus       415 ----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~  454 (473)
                                            .....+..++.+.+||.+||+.||.+||++++++.|  ++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                                  000123467889999999999999999999999976  5443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.1e-34  Score=284.47  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=192.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-------  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------  257 (473)
                      .+|.+.+.||.|+|+.+     ..+|+.||+|.+.....   ...+.+.+|+++++.++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            46778888999998755     34688999999875432   3446788999999999999999999876543       


Q ss_pred             -------CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEE
Q 011991          258 -------IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKI  329 (473)
Q Consensus       258 -------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl  329 (473)
                             ...|+||||++ ++|.+++.. +.+++..++.++.|++.||.|||+.|   |+||||||+||+++. ++.++|
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                   35799999997 599988864 46899999999999999999999999   999999999999985 457899


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........   ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+..
T Consensus       157 ~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         157 GDFGLARIVDPHYSH---KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             CCcccceecCCcccc---ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999998754321110   011122346778999997654 5678999999999999999999999987765444333221


Q ss_pred             hCC-----------------------CCCC--cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          409 EGK-----------------------RPPL--KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       409 ~~~-----------------------~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...                       .+..  ......++.++.+|+.+||+.||.+||++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            110                       0000  00123567889999999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=276.01  Aligned_cols=245  Identities=21%  Similarity=0.304  Sum_probs=195.0

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC--CC----eeeeEEeeEeeC
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--HP----NVVQFVGAVTQN  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--hp----nIv~l~~~~~~~  257 (473)
                      ..+|.+...+|.|+||.|     ..++..||||+++.    .....+..+-|+++++++.  .|    -+|++.++|...
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            557888999999999865     34578999999974    2445567788999999993  23    388999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC------------
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN------------  323 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~------------  323 (473)
                      ++.|||+|.+ |-|++++|..++  .++...++.+++|++++++|||+.+   ++|.||||+|||+.+            
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            9999999998 669999998864  4889999999999999999999999   999999999999942            


Q ss_pred             --------CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 011991          324 --------GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH  395 (473)
Q Consensus       324 --------~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~  395 (473)
                              ...|+|+|||.|.+.....         +....|+-|+|||++.+-+++..+||||+||+++|+++|...|+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                    2358999999997654332         34557888999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhhCCCCCCcc---------------c----------------CC-------CCC---HHHHHHHHHcc
Q 011991          396 PKPPEEVVKLMCCEGKRPPLKI---------------K----------------AR-------SYP---PDLKELIEECW  434 (473)
Q Consensus       396 ~~~~~~~~~~i~~~~~~~~~~~---------------~----------------~~-------~~~---~~l~~li~~cl  434 (473)
                      ...+.+.+.-+.....+.+...               .                +.       ..+   ..|.+|+++||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            8776664332211111111000               0                00       001   34899999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 011991          435 DPKPVIRPNFNEIIAR  450 (473)
Q Consensus       435 ~~dP~~RPs~~ell~~  450 (473)
                      ..||.+|+|+.|+|.|
T Consensus       391 ~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  391 EFDPARRITLREALSH  406 (415)
T ss_pred             ccCccccccHHHHhcC
Confidence            9999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.7e-34  Score=271.19  Aligned_cols=245  Identities=28%  Similarity=0.455  Sum_probs=195.2

Q ss_pred             hhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCC--CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          192 VRKADGITKGSYQVAK-----WNGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      |.+.+.||+|+|+.+.     ..+..+++|++......  .......+..|+.+++.++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            5667789999997552     23445666666532211  1223345778999999999999999999999888999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       265 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+++   ++|+||||+||+++. +.++|+|||.+.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999998864    345899999999999999999999999   999999999999975 5699999999865532


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ...      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+. .+..+.   .+.
T Consensus       158 ~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~  227 (260)
T cd08222         158 SCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPS---LPE  227 (260)
T ss_pred             Ccc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCC---Ccc
Confidence            211      1123457788999999988888999999999999999999999998776655555442 222222   355


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .++.++.++|.+||..||++||++.+++++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-36  Score=263.79  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee------
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ------  256 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------  256 (473)
                      ....|....++|+|+|+.+     ..+|+.||+|++..+..... .-...++|+++++.|+|+|++.+++.|..      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG-fpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC-CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            3457788889999999844     56788899987754322111 11346789999999999999999987642      


Q ss_pred             --CCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          257 --NIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       257 --~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                        ...+|+||.+|++ +|.-++... -+++..++..++.++..||.|+|...   |+|||+||.|+||+.+|.+||+|||
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence              2348999999987 999998765 56999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC-
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK-  411 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~-  411 (473)
                      +++.+..+.......  .+...-|..|++||.+.+ ..|+++.|||..||+|.+|+++.+.+++.+....+..|..-.. 
T Consensus       170 lar~fs~~~n~~kpr--ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPR--YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cccceecccccCCCC--cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            998876654433322  344556888999998765 5899999999999999999999999998887766554422111 


Q ss_pred             -CCCCcc---------------c-------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 -RPPLKI---------------K-------------ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 -~~~~~~---------------~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       .+...+               .             |-.-+++..+|+.++|..||.+|+++.+++.|
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence             111000               0             11123578899999999999999999999875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=296.69  Aligned_cols=261  Identities=28%  Similarity=0.536  Sum_probs=213.2

Q ss_pred             ccccChhHHHhhccCceeeeEEEEEEe------------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeee
Q 011991          182 EYELNPLELQVRKADGITKGSYQVAKW------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVV  248 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~~~------------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  248 (473)
                      .+++....+  .+.+.+|.|.||.+..            ....||||.++....  ....+.+..|+++|+.+ .||||+
T Consensus       290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchh
Confidence            456665544  4445899999985411            145899999986543  36678999999999999 599999


Q ss_pred             eEEeeEeeCCceEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeC
Q 011991          249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHC  312 (473)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~  312 (473)
                      .++|++...+..++|+||+..|+|.+++...+                .++....+.++.||+.||+||++..   +|||
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR  442 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR  442 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence            99999999999999999999999999998765                3888999999999999999999999   9999


Q ss_pred             CCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CC
Q 011991          313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GV  391 (473)
Q Consensus       313 Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~  391 (473)
                      ||-..|||++.+..+||+|||+++.......-..   ..+...-...|||||.+....|+.++||||||+++||+++ |.
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~---~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRT---KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCCceEe---cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence            9999999999999999999999985443321110   0010001334999999999999999999999999999997 99


Q ss_pred             CCCCCCC-hHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          392 QPFHPKP-PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       392 ~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      .||.+.. ..++.. ....|.+...   |..+++++.++++.||+.+|++||++.++.+.++..+.
T Consensus       520 ~PYp~~~~~~~l~~-~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  520 TPYPGIPPTEELLE-FLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCCCCCcHHHHHH-HHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            9999866 555544 4466665543   77889999999999999999999999999999998654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-33  Score=263.77  Aligned_cols=209  Identities=23%  Similarity=0.299  Sum_probs=170.6

Q ss_pred             EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHH
Q 011991          207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK  286 (473)
Q Consensus       207 ~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~  286 (473)
                      ..+++.+|+|.+....        .+..|...+....||||+++++++......++||||+++|+|.+++.....+++..
T Consensus        15 ~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~   86 (237)
T cd05576          15 TRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC   86 (237)
T ss_pred             ccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHH
Confidence            4578999999997542        12344555555679999999999999999999999999999999998877799999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCc
Q 011991          287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY  366 (473)
Q Consensus       287 ~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  366 (473)
                      +..++.|++.||.|||+++   |+||||||+||+++.++.++++|||.+......         .....++..|+|||.+
T Consensus        87 ~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~~~~~y~aPE~~  154 (237)
T cd05576          87 VKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEAVENMYCAPEVG  154 (237)
T ss_pred             HHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCCcCccccCCccc
Confidence            9999999999999999999   999999999999999999999999987544321         1122346679999999


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 011991          367 KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF  444 (473)
Q Consensus       367 ~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  444 (473)
                      .+..++.++|+||+||++|+|++|..||...... .     ....  .. ..+..+++.+.++|.+||+.||++||++
T Consensus       155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~--~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         155 GISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHT--TL-NIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----cccc--cc-CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            8888999999999999999999999887543211 0     0000  11 1245678999999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-34  Score=289.20  Aligned_cols=245  Identities=24%  Similarity=0.424  Sum_probs=204.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEe-----eCCc
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVT-----QNIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-----~~~~  259 (473)
                      .+.+...+|.|+|+.+     +.+++..|+|++......+    +++..|.++++.+ .|||++.++++|.     .++.
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            4556667888888644     5788999999998765333    5677899999998 5999999999986     3567


Q ss_pred             eEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      +|||||||.|||.-++++..  .++.+..+..|++.++.|+.+||.+.   +||||||-.|||++.++.|||+|||.+..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence            99999999999999999763  56899999999999999999999998   99999999999999999999999999876


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-----EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      ....      .....+..|||.|||||++...     -|+..+|+||||++..||-.|.+|+.+..+...+..|.  ..+
T Consensus       173 ldsT------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip--RNP  244 (953)
T KOG0587|consen  173 LDST------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--RNP  244 (953)
T ss_pred             eecc------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--CCC
Confidence            5433      2234567799999999999654     46789999999999999999999999988876665552  222


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |+-...|+..+.++.+||..|+.+|-..||+..++++|
T Consensus       245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            22223477889999999999999999999999998764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-34  Score=261.91  Aligned_cols=240  Identities=26%  Similarity=0.402  Sum_probs=203.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.....||.|+|..+     +.+.+.+|+|+++++...+.+.+.-...|-.+.... +||.+|-+..+|.....+++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            6777889999999744     577899999999988777777777778888888877 6999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++||+|--.+++...++++.++.+...|..||.|||++|   ||.||||.+|||++..|++||.|+|+.+..-..   
T Consensus       331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~---  404 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP---  404 (593)
T ss_pred             EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC---
Confidence            99999999888888888999999999999999999999999   999999999999999999999999998643222   


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHHhhCCCCCCcc
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-------KPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~  417 (473)
                         ....+++.|||.|.|||++.+..|..++|.|+||++|+||+.|+.||.-       .+.++.+.+++.+.+.   . 
T Consensus       405 ---gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---r-  477 (593)
T KOG0695|consen  405 ---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---R-  477 (593)
T ss_pred             ---CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc---c-
Confidence               2234678899999999999999999999999999999999999999952       3334444444333321   1 


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCC
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPN  443 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs  443 (473)
                      .|..+|-.+..+++.-+++||.+|..
T Consensus       478 iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ccceeehhhHHHHHHhhcCCcHHhcC
Confidence            14566778888999999999999965

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=268.27  Aligned_cols=258  Identities=23%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCC----HHHHHHHHHHHHHHHhcCCCeeeeEEeeEe-eCC
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD----PERINAFTHELTIVEKARHPNVVQFVGAVT-QNI  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~  258 (473)
                      ...|.....+|.|+|+.+     ....+.||||+-..+....    ....+...+|..+-+.|+||.||+++++|. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            457888889999999744     4667899999976543322    234567889999999999999999999997 456


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeeccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLL  335 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG~a  335 (473)
                      .+|.|+|||+|.+|.-||+.++.+++.+++.|+.||+.||.||-+.. .+|||-||||.|||+.+   .|.+||.|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            79999999999999999999999999999999999999999999987 46999999999999964   567999999999


Q ss_pred             cccccCcccccc-cccccCCCCCCcccCCCCcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHH--HHH
Q 011991          336 RLQYISPEKAKI-VFPVSHIDPANLYVAPEIYKN----EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVK--LMC  407 (473)
Q Consensus       336 ~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~--~i~  407 (473)
                      +.+.+...+... ..-.+...||-+|++||.+.-    ...+.++||||+|+++|.++.|+.||...... .++.  .|.
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            987654332211 222345679999999997742    25678999999999999999999999765433 3332  121


Q ss_pred             hhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .... -.++. -+.+++++..||++||++--++|.+..++..
T Consensus       701 kAtE-VqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  701 KATE-VQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ccee-ccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            1111 11221 2357899999999999999999998887743

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=264.29  Aligned_cols=253  Identities=29%  Similarity=0.453  Sum_probs=203.1

Q ss_pred             ccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc--CCCeeeeEEeeEeeCC----ceEEEE
Q 011991          194 KADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA--RHPNVVQFVGAVTQNI----PMMIVL  264 (473)
Q Consensus       194 ~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~~----~~~lv~  264 (473)
                      ....+|+|.||.|   ..+++.||||++..      ...+.|.+|-++++..  +|+||++|+++-....    .++||+
T Consensus       214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hHHHhhcCccceeehhhccCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3456899999866   57889999999963      3456789999998876  7999999999866544    699999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC------CCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKP------DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~------~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ||.+.|||.+||+.+ .+++....+++..+++||+|||+.-|      .+|+|||||+.||||.+|++.-|+|||+|..+
T Consensus       288 ~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             eeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            999999999999887 69999999999999999999997543      37999999999999999999999999999876


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCC-CCC-----CchhHHHHHHHHHHHHhCCCC------------CC-----
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFD-----RSVDAYSFGLILYEMIEGVQP------------FH-----  395 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwSlG~~l~ell~g~~p------------f~-----  395 (473)
                      ......    .....-.||.+|||||++.+. .+.     .+.||||+|.|+||+++...-            |.     
T Consensus       367 ~p~~~~----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  367 EPGKPQ----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             cCCCCC----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            533222    223346799999999999765 222     479999999999999975432            22     


Q ss_pred             CCChHHHHHHHHhhCCCCCCcccCCC--CCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          396 PKPPEEVVKLMCCEGKRPPLKIKARS--YPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       396 ~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+-+++...+.....+|.++..+..  ....+.+.+..||..||+-|.|+.=+-+++.++...
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            13345566677777788877543322  346699999999999999999999998888877664

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=281.43  Aligned_cols=253  Identities=27%  Similarity=0.428  Sum_probs=193.1

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------ce
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------PM  260 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~  260 (473)
                      +.....+|+|+||.|     +.+|+.||||.++...  ....+++..+|++++++|+|||||++++.=+...      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            344467899999855     5789999999998754  3455688999999999999999999998754433      47


Q ss_pred             EEEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc--CCC--cEEEEeec
Q 011991          261 MIVLEYHAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGG--QLKISGFG  333 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~--~~~--~vkl~DfG  333 (473)
                      .+|||||.||||..+|.+.   ..+++.+.+.++.+++.||.|||++|   |+||||||.||++-  .+|  .-||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            8999999999999999752   45999999999999999999999999   99999999999995  334  36999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHh
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKP----PEEVVKLMCC  408 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~----~~~~~~~i~~  408 (473)
                      .|+...+..       .+.+..||+.|.+||... ...|+..+|.|||||++|++.||..||-+..    ..++...+..
T Consensus       170 ~Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  170 AARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             ccccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            998765432       456788999999999998 4889999999999999999999999996532    2334433322


Q ss_pred             hCCCCC-----------Cc-----ccCCCCCH----HHHHHHHHccCCCCCCCC--CHHHHHHHHHHHHH
Q 011991          409 EGKRPP-----------LK-----IKARSYPP----DLKELIEECWDPKPVIRP--NFNEIIARLDRIVC  456 (473)
Q Consensus       409 ~~~~~~-----------~~-----~~~~~~~~----~l~~li~~cl~~dP~~RP--s~~ell~~L~~~~~  456 (473)
                      ......           ..     ..+...++    .+...+..+|..+|++|-  .+.+.-..+..|..
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            221110           00     01222232    245566778888999997  66655555555544

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-33  Score=280.00  Aligned_cols=255  Identities=23%  Similarity=0.457  Sum_probs=214.7

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecC----cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNG----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      +...+..+.||+|+||.+.     ..|    -+||+|++...  ...+...+++.|+-+|.+++|||++++++++.... 
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            3456777899999998652     123    47999998754  34556688999999999999999999999998755 


Q ss_pred             eEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      +-||++|+++|+|.++++.+ +.+.....+.|+.||++||.|||++.   ++||||-..||||.....+||.|||+++..
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            78999999999999999875 55889999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      ...+....    .....-.+-|||-|.+....|+.++|||||||++||++| |..||.+....++...+ ..+.+.   .
T Consensus       849 ~~d~~ey~----~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-e~geRL---s  920 (1177)
T KOG1025|consen  849 APDEKEYS----APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-EKGERL---S  920 (1177)
T ss_pred             Cccccccc----ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-hccccC---C
Confidence            54432221    112223455999999999999999999999999999998 99999999999988877 444442   2


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .|+.++-++.-++.+||..|+..||+|+++...+.++.+.
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            4677899999999999999999999999999998888764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1e-31  Score=251.59  Aligned_cols=228  Identities=32%  Similarity=0.521  Sum_probs=189.5

Q ss_pred             ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHH
Q 011991          208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKV  287 (473)
Q Consensus       208 ~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~  287 (473)
                      .+|+.+|+|++........  ...+.+|++.+++++|+||+++++.+......++++|++.+++|.+++.....++...+
T Consensus        12 ~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~   89 (244)
T smart00220       12 KTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEA   89 (244)
T ss_pred             CCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHH
Confidence            3579999999976543221  57899999999999999999999999998999999999999999999987666899999


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcC
Q 011991          288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK  367 (473)
Q Consensus       288 ~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  367 (473)
                      +.++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......       ......++..|++||.+.
T Consensus        90 ~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~  159 (244)
T smart00220       90 RFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFVGTPEYMAPEVLL  159 (244)
T ss_pred             HHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------ccccccCCcCCCCHHHHc
Confidence            999999999999999999   9999999999999999999999999987654331       122345677899999998


Q ss_pred             CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 011991          368 NEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE  446 (473)
Q Consensus       368 ~~~~~~~~DiwSlG~~l~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  446 (473)
                      +..++.++||||+|++++++++|..||.. .........+ ........ .....++..+.+++.+|+..+|++||++.+
T Consensus       160 ~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  237 (244)
T smart00220      160 GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI-GKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRLTAEE  237 (244)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hccCCCCc-cccccCCHHHHHHHHHHccCCchhccCHHH
Confidence            88889999999999999999999999987 4444444433 22222111 111127889999999999999999999999


Q ss_pred             HHH
Q 011991          447 IIA  449 (473)
Q Consensus       447 ll~  449 (473)
                      +++
T Consensus       238 ~~~  240 (244)
T smart00220      238 ALQ  240 (244)
T ss_pred             Hhh
Confidence            987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=236.77  Aligned_cols=206  Identities=24%  Similarity=0.394  Sum_probs=169.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .......+|+|+||.+     ..+|...|+|.+....  .....++.++|+.+..+. .+|.+|.|+|+....+..|+.|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            4445567899999855     5789999999997543  345567888899886555 7999999999999999999999


Q ss_pred             eccCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          265 EYHAKGDLASYL----QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       265 e~~~~gsL~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      |.|+. ||..+-    +.++.+++..+-+++..++.||.|||++-  .+||||+||+||||+.+|+||+||||++-...+
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99975 988774    44677999999999999999999999986  499999999999999999999999999977655


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHh
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKN----EEFDRSVDAYSFGLILYEMIEGVQPFHPK-PPEEVVKLMCC  408 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~-~~~~~~~~i~~  408 (473)
                      +-.+.       ...|-..|||||.+..    ..|+.+|||||||+++.||.+++.||... ++.+.+.++..
T Consensus       202 SiAkt-------~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  202 SIAKT-------MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhHHH-------HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            42222       1234556999998854    37999999999999999999999999864 56667766643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.9e-32  Score=304.59  Aligned_cols=247  Identities=21%  Similarity=0.375  Sum_probs=186.5

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..+.....+|.|+||.+     ..++..||||.+......       ...|++++++++|||||++++++..+...++||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            34556678999999855     257889999998643221       134688999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++|+|.+++.   .+++..+..++.|++.||+|||.....+|+||||||+||+++.++..++. ||........   
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            9999999999995   38899999999999999999995422339999999999999998887775 6654322111   


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH--hhC------CCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP--EEVVKLMC--CEG------KRPP  414 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~i~--~~~------~~~~  414 (473)
                             ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.....  ........  ...      ..+.
T Consensus       836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence                   122477889999999999999999999999999999999999854221  11111110  000      0011


Q ss_pred             Cccc---CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          415 LKIK---ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       415 ~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ....   ......++.+++.+||+.||++||+++|+++.|+++...
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            1000   001123577899999999999999999999999998774

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=255.20  Aligned_cols=230  Identities=22%  Similarity=0.318  Sum_probs=188.2

Q ss_pred             EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------ceEEEEeccCCCCHHHHHHHcC
Q 011991          207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------PMMIVLEYHAKGDLASYLQKKG  280 (473)
Q Consensus       207 ~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~  280 (473)
                      ...+++||+|.+..... .....++..+|..++..+.|+||+.++.+|.-..      ..|+|||+|+. +|.+.+... 
T Consensus        38 ~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e-  114 (369)
T KOG0665|consen   38 QVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILME-  114 (369)
T ss_pred             hhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHh-
Confidence            45789999999987643 3444577889999999999999999999996443      48999999965 999998743 


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcc
Q 011991          281 RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY  360 (473)
Q Consensus       281 ~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y  360 (473)
                       ++-.++..++.|++.|+.|||+.+   |+||||||+||++..++.+||+|||+|+.....       ...+.+..|+.|
T Consensus       115 -lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-------~~mtpyVvtRyy  183 (369)
T KOG0665|consen  115 -LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-------FMMTPYVVTRYY  183 (369)
T ss_pred             -cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc-------cccCchhheeec
Confidence             778899999999999999999999   999999999999999999999999999754332       234566788999


Q ss_pred             cCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-----------------------
Q 011991          361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-----------------------  417 (473)
Q Consensus       361 ~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------------  417 (473)
                      +|||++.+..|...+||||+||++.||++|...|.+....+.+.++......|..+.                       
T Consensus       184 rapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f  263 (369)
T KOG0665|consen  184 RAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISF  263 (369)
T ss_pred             cCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccch
Confidence            999999999999999999999999999999999998766555554443333321110                       


Q ss_pred             ---c-----------CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 ---K-----------ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ---~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                         .           ++.-+..+++++.+||..||++|.|+.++|.|
T Consensus       264 ~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  264 SELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence               0           00112458899999999999999999999986

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2e-33  Score=271.24  Aligned_cols=246  Identities=24%  Similarity=0.393  Sum_probs=198.6

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC------CeeeeEEeeEeeC
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH------PNVVQFVGAVTQN  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~  257 (473)
                      ...|.+..-.|+|+|+.|     ...|..||||++..+..    ..+.=+.|+++|++|..      -++++|+..|...
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            347888888899999865     34577999999986543    23556789999999942      4899999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeec
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFG  333 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG  333 (473)
                      +++|||+|-+. .+|.++|++.|.   |....+..++.|++.||..|...|   |+|.||||+||||+... .+||||||
T Consensus       507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            99999999985 599999998654   888999999999999999999999   99999999999998754 58999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-hCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC-EGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~-~~~~  412 (473)
                      .|.+.+...        .+++.-+..|+|||++.+.+|+...|+||.||++|||+||+..|++.++..++..... .|..
T Consensus       583 SA~~~~ene--------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  583 SASFASENE--------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             ccccccccc--------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            997654321        2334455679999999999999999999999999999999999999988877765432 2221


Q ss_pred             CCCc------------------------------------ccC-----------CCCC-------HHHHHHHHHccCCCC
Q 011991          413 PPLK------------------------------------IKA-----------RSYP-------PDLKELIEECWDPKP  438 (473)
Q Consensus       413 ~~~~------------------------------------~~~-----------~~~~-------~~l~~li~~cl~~dP  438 (473)
                      |.--                                    ..|           ..+|       ..+.+|+.+||..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence            1000                                    001           0122       348899999999999


Q ss_pred             CCCCCHHHHHHH
Q 011991          439 VIRPNFNEIIAR  450 (473)
Q Consensus       439 ~~RPs~~ell~~  450 (473)
                      .+|.|.++.|+|
T Consensus       735 ~KRit~nqAL~H  746 (752)
T KOG0670|consen  735 EKRITVNQALKH  746 (752)
T ss_pred             hhcCCHHHHhcC
Confidence            999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.9e-32  Score=268.40  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=198.3

Q ss_pred             hhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      |.+.+-||-|.||.|     ..+...+|.|.+.+...-....+.....|-.||..-+.+-||+|+..|.+.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            344567899999855     234668999999877665666778888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc---------
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~---------  337 (473)
                      ++||++-.+|.+-+-|.+..++.++.++..|+++.|..|   +|||||||+|||||.+|++||.|||++.-         
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999999999999889999999999999999999999999   99999999999999999999999999631         


Q ss_pred             cccCc---c------------------------cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhC
Q 011991          338 QYISP---E------------------------KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG  390 (473)
Q Consensus       338 ~~~~~---~------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g  390 (473)
                      +....   .                        ............||+.|+|||++...+|+..+|.||.|+++|||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence            11000   0                        00001122356799999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCC
Q 011991          391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP  442 (473)
Q Consensus       391 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  442 (473)
                      .+||...++.+...+++.......+. ...++++++.+||.+++ .+++.|.
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~~l~~~-~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRNFLHIP-YQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhhccccc-cccccCHHHHHHHHHHh-cChhhhh
Confidence            99999888776655554333322221 13467899999997755 3456664

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-33  Score=253.55  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=198.9

Q ss_pred             ccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----ceEEE
Q 011991          194 KADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----PMMIV  263 (473)
Q Consensus       194 ~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv  263 (473)
                      -.+-||.|.||++.     .+|+.||+|.+..- ...--..+++.+|++++..++|.|++..+++..-..     .+|.+
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34579999999763     57899999998643 233445688899999999999999999998865432     37899


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +|+|. .+|.+++-.-..++...++-++.||+.||+|||+-+   |+||||||.|.|++++..+||||||+++.......
T Consensus       136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            99995 599999988778999999999999999999999999   99999999999999999999999999987654433


Q ss_pred             cccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-----
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-----  417 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----  417 (473)
                      .-     .+.-.-|.+|+|||++.+. .|+.+.||||.||++.|++..+..|+..++.+.+..|..-...|..+.     
T Consensus       212 ~h-----MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  212 LN-----MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hh-----hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            22     2233457789999999875 799999999999999999999999998887776665544333332211     


Q ss_pred             ------------c------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          418 ------------K------------ARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       418 ------------~------------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                                  +            +..-..+...+..+++..||++|.+.++.+.++
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                        0            111234577888999999999999999998876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=277.53  Aligned_cols=229  Identities=26%  Similarity=0.419  Sum_probs=180.2

Q ss_pred             EEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCC--
Q 011991          205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--  281 (473)
Q Consensus       205 ~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--  281 (473)
                      .+.+.|+.||||++-.+.      .....+|+..++.- +|||||++++.=.++...||..|+|.. +|.+++...+.  
T Consensus       528 ~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~  600 (903)
T KOG1027|consen  528 RGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDV  600 (903)
T ss_pred             EEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccch
Confidence            457889999999996443      34678999999998 599999999998899999999999976 99999987411  


Q ss_pred             --CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CC--cEEEEeeccccccccCcccccccccccCC
Q 011991          282 --LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GG--QLKISGFGLLRLQYISPEKAKIVFPVSHI  354 (473)
Q Consensus       282 --l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~--~vkl~DfG~a~~~~~~~~~~~~~~~~~~~  354 (473)
                        ......+.++.|+++||++||+.+   ||||||||.||||+.   ++  +++|+|||+++...........   ....
T Consensus       601 ~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r---~s~~  674 (903)
T KOG1027|consen  601 EMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR---LSGG  674 (903)
T ss_pred             hhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc---ccCC
Confidence              122455788999999999999999   999999999999986   33  6899999999876554333322   4567


Q ss_pred             CCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHc
Q 011991          355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC  433 (473)
Q Consensus       355 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~c  433 (473)
                      .||-+|+|||++.....+.++||||+||++|+.++ |.+||.+....+.-  | ..+........+. -..++.+||.+|
T Consensus       675 sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--I-l~~~~~L~~L~~~-~d~eA~dLI~~m  750 (903)
T KOG1027|consen  675 SGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--I-LTGNYTLVHLEPL-PDCEAKDLISRM  750 (903)
T ss_pred             CCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--h-hcCccceeeeccC-chHHHHHHHHHh
Confidence            79999999999999888889999999999999998 59999765543321  2 1122111111111 112899999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 011991          434 WDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       434 l~~dP~~RPs~~ell~~  450 (473)
                      ++.||..||++.+||.|
T Consensus       751 l~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  751 LNPDPQLRPSATDVLNH  767 (903)
T ss_pred             cCCCcccCCCHHHHhCC
Confidence            99999999999999865

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.3e-31  Score=232.97  Aligned_cols=243  Identities=20%  Similarity=0.348  Sum_probs=189.1

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeC--Cce
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQN--IPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~  260 (473)
                      ..+|++..++|.|.|+.+     ..+++.++||++++-      ..+.+.+|+++++.|. ||||+++++...++  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            457889999999999643     467889999999753      2356899999999996 99999999998764  458


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~  339 (473)
                      .||+||+.+.+...+-   ..++...++.++.+++.||.|+|++|   |+|||+||.||||+... .++|+|||+|.+..
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            8999999887766554   35888999999999999999999999   99999999999999754 69999999998775


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhhCC------
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFH-PKPPEEVVKLMCCEGK------  411 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~-~~~~~~~~~~i~~~~~------  411 (473)
                      ....       ..-...++.|--||.+..- .|+.+-|+|||||++..|+..+.||. +.++.+.+-+|..-..      
T Consensus       185 p~~e-------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  185 PGKE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             CCce-------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence            4321       1223456779999998764 68899999999999999999888874 4443333322211110      


Q ss_pred             ---------CCCCc----------------ccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 ---------RPPLK----------------IKAR-SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ---------~~~~~----------------~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                               .|...                .... -+++++.+|+.+.|..|-++|||+.|.+.|
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                     00000                0011 246899999999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=264.06  Aligned_cols=247  Identities=22%  Similarity=0.405  Sum_probs=212.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.....+|+|+||-+     +.+++..|+|+++.+...   ...-+..|+-+++..+|||||.+++.+...+.+|+.||
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            5666778999999854     567899999999876533   33456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||.||+|.+.-.-.+.+++.++..+++..++||+|||+.+   =+|||||-.||++++.|.+|+.|||.+..+...    
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat----  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT----  165 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh----
Confidence            9999999999888889999999999999999999999999   899999999999999999999999998655432    


Q ss_pred             cccccccCCCCCCcccCCCCc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          346 KIVFPVSHIDPANLYVAPEIY---KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                        ......+.|||.|||||+-   ..+.|+..+|||++|+...|+-.-.+|.....+......+...+..|+-.......
T Consensus       166 --i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kw  243 (829)
T KOG0576|consen  166 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKW  243 (829)
T ss_pred             --hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccc
Confidence              2233457799999999975   45689999999999999999998888988888887777776666655554455667


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ++.+.+|++.++..+|++||+++-+|.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee
Confidence            899999999999999999999998875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.2e-29  Score=265.15  Aligned_cols=244  Identities=19%  Similarity=0.188  Sum_probs=159.7

Q ss_pred             HhhccCceeeeEEEEEE-----ec----CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEee------Ee
Q 011991          191 QVRKADGITKGSYQVAK-----WN----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA------VT  255 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~----~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~------~~  255 (473)
                      +|...+.||+|+||.+.     .+    +..||+|.+......     +....|  .++...+.++..++..      ..
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            57788899999998662     23    789999998643211     111111  1222222233322222      23


Q ss_pred             eCCceEEEEeccCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCC
Q 011991          256 QNIPMMIVLEYHAKGDLASYLQKKGR--------------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK  315 (473)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlk  315 (473)
                      .+...++||||+.+++|.+++.....                    .....+..++.|++.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            45679999999999999999875421                    113346689999999999999999   9999999


Q ss_pred             CCCEEEcC-CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC----------------------CCC
Q 011991          316 PKNILLDN-GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE----------------------EFD  372 (473)
Q Consensus       316 p~Nili~~-~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~  372 (473)
                      |+|||++. ++.+||+|||+|+.......     .......+++.|+|||.+...                      .++
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            99999986 57899999999975432211     112345678899999965322                      234


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC---------CCC--c-----ccCCCCCHHHHHHHHHccCC
Q 011991          373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR---------PPL--K-----IKARSYPPDLKELIEECWDP  436 (473)
Q Consensus       373 ~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~---------~~~--~-----~~~~~~~~~l~~li~~cl~~  436 (473)
                      .++||||+||++|||+++..|+.... ......+...+..         +..  .     ......+....+||.+||+.
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            56799999999999998766543211 1111111111100         000  0     00011123456899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 011991          437 KPVIRPNFNEIIAR  450 (473)
Q Consensus       437 dP~~RPs~~ell~~  450 (473)
                      ||++|||++++++|
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999986

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-30  Score=238.53  Aligned_cols=256  Identities=22%  Similarity=0.409  Sum_probs=208.7

Q ss_pred             HhhccCceeeeEEEEEE---e-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-CCc
Q 011991          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~  259 (473)
                      +++....+..|+||.+.   |       +.+.|-+|.++...  .+-.+..++.|.-.+..+.|||+.++.+.... ...
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            44455556788887441   1       23456677776432  45667889999999999999999999998765 456


Q ss_pred             eEEEEeccCCCCHHHHHHH-----c---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          260 MMIVLEYHAKGDLASYLQK-----K---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~-----~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                      .+.++.++.-|+|..++..     .   ..++..+...++.|++.|++|||.++   |||.||...|.+|++.-+|||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence            7889999989999999973     1   23677788999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      =.+++.....+-.+    -...-..+..||+||.+....|+.++|+||||+++|||++ |+.||...++.++...+ ..|
T Consensus       440 saLSRDLFP~DYhc----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-kdG  514 (563)
T KOG1024|consen  440 SALSRDLFPGDYHC----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-KDG  514 (563)
T ss_pred             chhccccCcccccc----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-hcc
Confidence            99998654332111    1112223456999999999999999999999999999997 99999999999988776 566


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ++...   |-++|+++..++.-||..+|++||+++|+..-|.++..++.
T Consensus       515 yRlaQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  515 YRLAQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             ceecC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            66554   67899999999999999999999999999999999887764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=6.8e-29  Score=253.44  Aligned_cols=251  Identities=16%  Similarity=0.195  Sum_probs=174.8

Q ss_pred             HhhccCceeeeEEEEEE---------------------ecCcEEEEEEEcCCCCCCHH-----------HHHHHHHHHHH
Q 011991          191 QVRKADGITKGSYQVAK---------------------WNGTKVWVKILDKESHKDPE-----------RINAFTHELTI  238 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---------------------~~~~~vavK~l~~~~~~~~~-----------~~~~~~~E~~~  238 (473)
                      +|.+.+.||+|+||.+.                     ..++.||||.+.........           ..+....|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            57788899999998663                     23467999998753211100           11233446777


Q ss_pred             HHhcCCCe-----eeeEEeeEee--------CCceEEEEeccCCCCHHHHHHHcC------------------------C
Q 011991          239 VEKARHPN-----VVQFVGAVTQ--------NIPMMIVLEYHAKGDLASYLQKKG------------------------R  281 (473)
Q Consensus       239 l~~l~hpn-----Iv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~------------------------~  281 (473)
                      +.+++|.+     +++++++|..        .+..+|||||+++++|.+++....                        .
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            77776654     4677777653        356899999999999999886421                        1


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCccc
Q 011991          282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV  361 (473)
Q Consensus       282 l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~  361 (473)
                      +++..++.++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++........     .......+|+.|+
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~g~~tp~Y~  377 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-----FNPLYGMLDPRYS  377 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-----cCccccCCCccee
Confidence            356678899999999999999999   99999999999999999999999999865432211     1111223478899


Q ss_pred             CCCCcCCCC--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCChHHH--------HHHHH-hh
Q 011991          362 APEIYKNEE--------------------F--DRSVDAYSFGLILYEMIEGVQ-PFHPKPPEEV--------VKLMC-CE  409 (473)
Q Consensus       362 aPE~~~~~~--------------------~--~~~~DiwSlG~~l~ell~g~~-pf~~~~~~~~--------~~~i~-~~  409 (473)
                      |||.+....                    +  ..+.||||+||++++|+++.. ||.+......        ...+. ..
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            999875432                    1  134799999999999999875 7754321110        11110 11


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKP---VIRPNFNEIIAR  450 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ell~~  450 (473)
                      ....... .....++...+|+.+||..+|   .+|+|++|+|+|
T Consensus       458 ~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        458 GQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            1111121 244568899999999999876   689999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=9.5e-28  Score=219.13  Aligned_cols=195  Identities=37%  Similarity=0.677  Sum_probs=169.8

Q ss_pred             CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHc-CCCCHHHHH
Q 011991          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVL  288 (473)
Q Consensus       210 ~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~  288 (473)
                      ++.+++|++.......  ....+.+|+..++.++|++|+++++++......+++||++.+++|.+++... ..++...++
T Consensus        18 ~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~   95 (215)
T cd00180          18 GKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL   95 (215)
T ss_pred             CcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHH
Confidence            8999999998654321  3567899999999999999999999999989999999999989999999876 468999999


Q ss_pred             HHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcC
Q 011991          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK  367 (473)
Q Consensus       289 ~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  367 (473)
                      .++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........      ......+...|++||.+.
T Consensus        96 ~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~  166 (215)
T cd00180          96 RILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------LLKTIVGTPAYMAPEVLL  166 (215)
T ss_pred             HHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------hhhcccCCCCccChhHhc
Confidence            99999999999999999   999999999999999 89999999999875533211      122234667799999988


Q ss_pred             CC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHH
Q 011991          368 NE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE  446 (473)
Q Consensus       368 ~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  446 (473)
                      .. .++.++|+|++|++++++                                    +.+.+++.+|++.||.+||++.+
T Consensus       167 ~~~~~~~~~D~~~lg~~~~~l------------------------------------~~~~~~l~~~l~~~p~~R~~~~~  210 (215)
T cd00180         167 GKGYYSEKSDIWSLGVILYEL------------------------------------PELKDLIRKMLQKDPEKRPSAKE  210 (215)
T ss_pred             ccCCCCchhhhHHHHHHHHHH------------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence            77 788999999999999999                                    47999999999999999999999


Q ss_pred             HHHHH
Q 011991          447 IIARL  451 (473)
Q Consensus       447 ll~~L  451 (473)
                      +++++
T Consensus       211 l~~~~  215 (215)
T cd00180         211 ILEHL  215 (215)
T ss_pred             HhhCC
Confidence            98753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-28  Score=235.65  Aligned_cols=125  Identities=24%  Similarity=0.338  Sum_probs=106.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-----C---CeeeeEEeeEee
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----H---PNVVQFVGAVTQ  256 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l~~~~~~  256 (473)
                      .+|.+.+++|.|-|++|     ....+.||+|+.+.    .....+..+.|+++|+.++     |   ..||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            47889999999999876     34568999999974    3445577899999999983     3   369999999974


Q ss_pred             ----CCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE
Q 011991          257 ----NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (473)
Q Consensus       257 ----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili  321 (473)
                          +.++|+|+|++ |.+|..+|...  ..++...+++|++||+.||.|||...  +|||.||||+|||+
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence                45799999999 66999999764  56999999999999999999999987  59999999999999

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-29  Score=223.48  Aligned_cols=248  Identities=20%  Similarity=0.292  Sum_probs=192.7

Q ss_pred             hhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEe-eEeeCCc
Q 011991          187 PLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVG-AVTQNIP  259 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~-~~~~~~~  259 (473)
                      .+...|.+.+.+|.|.||..     +.+...+++|.+....    -.+.+|.+|+.---.|. |.||+.-++ +|+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            34568999999999999843     4577899999997653    33578899988777774 889998766 5788888


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc--CCCcEEEEeeccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLKISGFGLLRL  337 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~--~~~~vkl~DfG~a~~  337 (473)
                      ++++|||++.|+|.+-+...| +.+.....++.|+++||.|+|+++   +||||||.+||||-  +..+|||||||+++.
T Consensus        97 YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence            999999999999999887654 888999999999999999999999   99999999999994  335899999999875


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHh
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-----EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----EVVKLMCC  408 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~----~~~~~i~~  408 (473)
                      .+.....         ..-+..|.+||.....     ..++.+|+|.||++++.+++|..||+.....    -...++ .
T Consensus       173 ~g~tV~~---------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~  242 (378)
T KOG1345|consen  173 VGTTVKY---------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-L  242 (378)
T ss_pred             cCceehh---------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-h
Confidence            5433211         1123459999976432     4568999999999999999999999843221    222233 4


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      .+..+..+.....+++.+..+.++-++.+|++|=-..+.-+...
T Consensus       243 ~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  243 KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            55555665667778999999999999999999955555544443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-29  Score=246.02  Aligned_cols=195  Identities=22%  Similarity=0.387  Sum_probs=167.9

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCC-----HHHHHHHHHHHHHHHhcC---CCeeeeEEeeEeeC
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD-----PERINAFTHELTIVEKAR---HPNVVQFVGAVTQN  257 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~-----~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~  257 (473)
                      .|...+.+|.|.||.+     +.+...|+||.+.++..-.     ...+-....|+++|..|+   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            5777888999999865     4567899999998754321     112234567999999996   99999999999999


Q ss_pred             CceEEEEecc-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          258 IPMMIVLEYH-AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       258 ~~~~lv~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      +++||+||-. +|.+|.+++..+..+++.++..|++|++.|+++||+.|   |||||||-+||.++.+|-+||+|||.|.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence            9999999984 55799999999999999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCC
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHP  396 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~  396 (473)
                      +....        +...+.||..|.|||++.+.+| +..-|||++|+++|.+...+.||-+
T Consensus       719 ~~ksg--------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKSG--------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcCC--------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            65433        3445679999999999999887 5788999999999999999998853

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.4e-26  Score=214.51  Aligned_cols=204  Identities=32%  Similarity=0.577  Sum_probs=168.1

Q ss_pred             hccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          193 RKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       193 ~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      .....+|.|.++.+   .  .+++.+|+|.+......  ...+.+.+|++.++.++|+|++++++++......++++|++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            34456777776533   2  34789999999865432  25678999999999999999999999999888999999999


Q ss_pred             CCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          268 AKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       268 ~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      ++++|.+++..... +++..+..++.+++.++.+||+.+   ++|+||+|.||+++..+.++|+|||.+.........  
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~--  154 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA--  154 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--
Confidence            99999999988766 899999999999999999999998   999999999999999999999999998765443200  


Q ss_pred             ccccccCCCCCCcccCCCCc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHH
Q 011991          347 IVFPVSHIDPANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPE-EVVKLM  406 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~ell~g~~pf~~-~~~~-~~~~~i  406 (473)
                         ......++..|++||.+ ....++.++|+||||+++++|++|+.||.. ..+. .+...+
T Consensus       155 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~  214 (225)
T smart00221      155 ---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW  214 (225)
T ss_pred             ---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence               11223466779999998 666788899999999999999999999977 4444 455544

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.6e-27  Score=210.89  Aligned_cols=166  Identities=20%  Similarity=0.342  Sum_probs=130.4

Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      |||.+++... +.+++..++.++.|++.||.|||+++         ||+|||++.++.+++  ||+++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6999999874 45999999999999999999999975         999999999999999  9998764321       


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCC--cccCCCCCH-
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPL--KIKARSYPP-  424 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~--~~~~~~~~~-  424 (473)
                          ...||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.........  ...+..+++ 
T Consensus        63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (176)
T smart00750       63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA  138 (176)
T ss_pred             ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence                114788999999999999999999999999999999999999765432 223332221111100  011222333 


Q ss_pred             -HHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          425 -DLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       425 -~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                       .+.+++.+||..||.+||++.|+++++..+...
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence             699999999999999999999999999877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.8e-27  Score=260.50  Aligned_cols=200  Identities=17%  Similarity=0.242  Sum_probs=142.0

Q ss_pred             hcCC-CeeeeEEeeE-------eeCCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 011991          241 KARH-PNVVQFVGAV-------TQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (473)
Q Consensus       241 ~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  311 (473)
                      .++| +||+.+++.|       .....++++||++ +++|.+++... ..+++..++.++.||+.||.|||++|   |+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            3455 5788888877       2334678889988 55999999753 45999999999999999999999999   999


Q ss_pred             CCCCCCCEEEcCCCc-------------------EEEEeeccccccccCccc----c------cccccccCCCCCCcccC
Q 011991          312 CDLKPKNILLDNGGQ-------------------LKISGFGLLRLQYISPEK----A------KIVFPVSHIDPANLYVA  362 (473)
Q Consensus       312 ~Dlkp~Nili~~~~~-------------------vkl~DfG~a~~~~~~~~~----~------~~~~~~~~~~gt~~y~a  362 (473)
                      |||||+||||+..+.                   +|++|||+++........    .      ..........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965444                   455555555432110000    0      00000112357889999


Q ss_pred             CCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCC
Q 011991          363 PEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP  442 (473)
Q Consensus       363 PE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  442 (473)
                      ||++.+..++.++|||||||++|||++|..|+....  .....+... ..++.   .....+....++.+||+.||.+||
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~L~~~P~~Rp  257 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VLPPQ---ILLNWPKEASFCLWLLHPEPSCRP  257 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hcChh---hhhcCHHHHHHHHHhCCCChhhCc
Confidence            999999999999999999999999999888875322  122222111 11111   111245677899999999999999


Q ss_pred             CHHHHHHH
Q 011991          443 NFNEIIAR  450 (473)
Q Consensus       443 s~~ell~~  450 (473)
                      ++.|++++
T Consensus       258 s~~eil~h  265 (793)
T PLN00181        258 SMSELLQS  265 (793)
T ss_pred             ChHHHhhc
Confidence            99999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=7.7e-27  Score=221.84  Aligned_cols=251  Identities=21%  Similarity=0.341  Sum_probs=189.7

Q ss_pred             HHHhhccCceeeeEEEEE-----Ee---cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCc
Q 011991          189 ELQVRKADGITKGSYQVA-----KW---NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP  259 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~---~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  259 (473)
                      ...|....+||.|+|+++     ..   ..+.||+|.+.....  +   .++..|+++|..+. +.||+++.+++..++.
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--P---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--c---hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            446788889999999866     12   578999999975432  2   45889999999994 8999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC-CcEEEEeecccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLRLQ  338 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~-~~vkl~DfG~a~~~  338 (473)
                      ..+||||+++....++...   ++...+..+++.++.||.++|.+|   ||||||||.|+|++.. ++-.|+|||+|...
T Consensus       110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence            9999999999998888754   678999999999999999999999   9999999999999864 57899999998611


Q ss_pred             -ccC--------------c----------------c-------cccccccccCCCCCCcccCCCCcCCC-CCCCchhHHH
Q 011991          339 -YIS--------------P----------------E-------KAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYS  379 (473)
Q Consensus       339 -~~~--------------~----------------~-------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS  379 (473)
                       ...              .                .       ..+.........||++|+|||++... ..++++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence             000              0                0       00111122356799999999998654 5689999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChH--------------HHHHHHHhhCC--------CCC-----------------------
Q 011991          380 FGLILYEMIEGVQPFHPKPPE--------------EVVKLMCCEGK--------RPP-----------------------  414 (473)
Q Consensus       380 lG~~l~ell~g~~pf~~~~~~--------------~~~~~i~~~~~--------~~~-----------------------  414 (473)
                      .|+++..++++..||.....+              ++...-...+.        .+.                       
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            999999999999998542211              11111001111        000                       


Q ss_pred             --CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 --LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                        .....+.++..+.+|+.+|+..||.+|.|+++.|+|
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              000012245689999999999999999999999876

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-26  Score=208.24  Aligned_cols=264  Identities=17%  Similarity=0.254  Sum_probs=222.8

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l  262 (473)
                      ...|+++++||.|+||+.     ..++++||||.-......     -++..|...++.|. .++|++.+.+..++.+-.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            357899999999999854     578899999998654322     34678999999995 7999999999888888899


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-----cEEEEeecccc
Q 011991          263 VLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-----QLKISGFGLLR  336 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-----~vkl~DfG~a~  336 (473)
                      |||++ |.||.++..- +.+++..++..++.|++.-++|+|++.   .|.|||||+|+||...+     .+.++|||+|+
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            99999 7899999864 456999999999999999999999999   99999999999997544     48999999999


Q ss_pred             ccccCccccccccc-ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhhCCC
Q 011991          337 LQYISPEKAKIVFP-VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK---PPEEVVKLMCCEGKR  412 (473)
Q Consensus       337 ~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~---~~~~~~~~i~~~~~~  412 (473)
                      ...+...+...... .....||.+||+--.+.+...+++.|+-|||=++.+.+-|..||++.   +..+.+.+|......
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            88766544443322 23677999999999999999999999999999999999999999975   455677777655555


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      .++.....++|.++...++..=..+-.+-|+++-+...+.+++...+..
T Consensus       258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t  306 (449)
T KOG1165|consen  258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGET  306 (449)
T ss_pred             CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCc
Confidence            5666667789999999999999999999999999999999999977643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-25  Score=196.79  Aligned_cols=264  Identities=16%  Similarity=0.222  Sum_probs=219.6

Q ss_pred             HhhccCceeeeEEE-----EEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC-CeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQ-----VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~-----~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~  264 (473)
                      .|++.++||+|+||     ....+|+.||||+-..... .    ..+..|..+++.|++ ..|+.+..++.+..+-.+||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-H----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-C----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            68899999999997     3367899999999875432 2    347889999999975 78888888888888999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeecccccccc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYI  340 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG~a~~~~~  340 (473)
                      +++ |.||.++..- ...++..+++-++-|++.-++|+|.++   +|||||||+|+|..-   ..++.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 8899998754 456999999999999999999999999   999999999999963   45799999999987765


Q ss_pred             Cccccccccc-ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhCCCCCCc
Q 011991          341 SPEKAKIVFP-VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE---EVVKLMCCEGKRPPLK  416 (473)
Q Consensus       341 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~  416 (473)
                      .......+.. -....||..|.+--.+.+...+.+.|+-|+|.++.++..|..||++..+.   +..+.|.......++.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            5443333222 23567999999998888888899999999999999999999999986543   4555665555666666


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCcc
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGW  463 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~  463 (473)
                      ...+++|.++.-.+..|=..--.+-|++.-+.+.++-++..++-+.+
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d  293 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD  293 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence            67889999999999999999999999999999999999888776654

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.93  E-value=4.4e-26  Score=191.63  Aligned_cols=135  Identities=28%  Similarity=0.347  Sum_probs=118.4

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHc-CCCCcccCCCCCcHHHHHHHcCCH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~-ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      .++.=+|..|..+.+.-|+...+.+++. |..||||||+||..|+.++|+.|+.+ |+|+|+.++.|.|||||||..|+.
T Consensus        40 t~LHwa~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~  119 (226)
T KOG4412|consen   40 TPLHWACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRL  119 (226)
T ss_pred             ceeeeeeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChh
Confidence            3455566777777777677555555554 88899999999999999999999998 999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      ||+++|+++||.++++|..|.||||.|+..|+.+++++|+..|+.+|.++.   ||++.|
T Consensus       120 eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL~~a  179 (226)
T KOG4412|consen  120 EIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPLHHA  179 (226)
T ss_pred             hHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHHHHH
Confidence            999999999999999999999999999999999999999999999988764   555554

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.92  E-value=1e-25  Score=189.44  Aligned_cols=136  Identities=21%  Similarity=0.271  Sum_probs=125.9

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHH
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      |.....++..||..|+.+.|+.|+...+.+++. +..|.|+|||||.+|.++|+++|+++|+.|+.+|..|.||||.||.
T Consensus        69 DdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAa  148 (226)
T KOG4412|consen   69 DDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAA  148 (226)
T ss_pred             cccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHh
Confidence            444667788899999999999999986777776 8889999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcCCC
Q 011991          115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTP  171 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~t~  171 (473)
                      .|+++++++|+..||.+|.+|+.|+||||+|...|+.++..+|+.+|+++...++.+
T Consensus       149 vGklkvie~Li~~~a~~n~qDk~G~TpL~~al~e~~~d~a~lLV~~gAd~~~edke~  205 (226)
T KOG4412|consen  149 VGKLKVIEYLISQGAPLNTQDKYGFTPLHHALAEGHPDVAVLLVRAGADTDREDKEG  205 (226)
T ss_pred             ccchhhHHHHHhcCCCCCcccccCccHHHHHHhccCchHHHHHHHhccceeeccccC
Confidence            999999999999999999999999999999988899999999999999998776544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-23  Score=206.44  Aligned_cols=261  Identities=17%  Similarity=0.224  Sum_probs=200.2

Q ss_pred             HhhccCceeeeEEEEE---Ee-c--CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC----CeeeeEEeeE-eeCCc
Q 011991          191 QVRKADGITKGSYQVA---KW-N--GTKVWVKILDKESHKDPERINAFTHELTIVEKARH----PNVVQFVGAV-TQNIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~-~--~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~~~~~  259 (473)
                      .|.+.+.||+|+||.+   .. .  ...+|+|..........   ..+..|..++..+..    +++..+++.+ ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            6889999999999854   21 2  24789998876432221   147788899988862    5899999998 57788


Q ss_pred             eEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC-----CcEEEEee
Q 011991          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-----GQLKISGF  332 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~-----~~vkl~Df  332 (473)
                      .|+||+.+ |.+|.++....  +.++..++..++.|++.+|.+||+.|   ++||||||+|+++...     -.+.|.||
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99999998 78999988654  46999999999999999999999999   9999999999999865     35999999


Q ss_pred             ccccccc--cCcccc-ccccc-ccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          333 GLLRLQY--ISPEKA-KIVFP-VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       333 G~a~~~~--~~~~~~-~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      |+++...  ...... ....+ .....||..|.++.++.+...+++.|+||++.++.+++.|..||...........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence            9998322  221111 11111 2345699999999999999999999999999999999999999987664333332222


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ..............+..+.++...+-..+...+|.+..+...|+......
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            22111111123345678899999888899999999999999998888865

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=4.3e-22  Score=194.09  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=198.4

Q ss_pred             hhccCceeeeEEEEEE--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCC-eeeeEEeeEeeCCceEEEEeccC
Q 011991          192 VRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-NVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      |.....+|.|+|+.+.  .....+++|.+.............+.+|+.+++.+.|+ +|+++.+.+......+++++++.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            3455667788885431  22378899999876655544678899999999999988 79999999977777899999999


Q ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccccCccc
Q 011991          269 KGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       269 ~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~~~~~~  344 (473)
                      ++++.+++....   .++......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||+++........
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999998887764   6999999999999999999999999   99999999999999988 7999999998754332211


Q ss_pred             ccccccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhCCCCCCcc
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKPP----EEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~  417 (473)
                      ...........|+..|++||.+.+   ..++...|+||+|++++++++|..||.....    ......+...........
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence            110012345678999999999987   5788999999999999999999999877663    444444433332201111


Q ss_pred             cCCCC----CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSY----PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~----~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .....    ...+.+++..|+..+|..|.+..+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11111    2578999999999999999999987775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=1.8e-24  Score=225.70  Aligned_cols=212  Identities=29%  Similarity=0.422  Sum_probs=168.7

Q ss_pred             HHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 011991          232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (473)
Q Consensus       232 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  311 (473)
                      +..|+-+-..+.|||++..+..+.+.....-+||||++ +|..++...+.++..++-.++.|++.|++|+|+.|   +.|
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iah  443 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAH  443 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---cee
Confidence            67788888889999998887777665555556999999 99999998878999999999999999999999999   999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCC-CchhHHHHHHHHHHHHhC
Q 011991          312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEG  390 (473)
Q Consensus       312 ~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ell~g  390 (473)
                      ||+|++|++++..|.+||+|||.+..+.......  ........|+..|+|||++.+..|+ +..||||.|++++.|.+|
T Consensus       444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~--~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~  521 (601)
T KOG0590|consen  444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKN--IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG  521 (601)
T ss_pred             ccCccccEEEecCCceEEeecCcceeeccCcchh--hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence            9999999999999999999999987654432221  1223456688889999999999998 568999999999999999


Q ss_pred             CCCCCCCChHHHH-HHHHhhCCCC---CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          391 VQPFHPKPPEEVV-KLMCCEGKRP---PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       391 ~~pf~~~~~~~~~-~~i~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      +.||......+.. ..........   ........++...+.+|.+||+.||.+|.++++|++
T Consensus       522 ~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  522 RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            9999866544332 1110000000   001123346788999999999999999999999988

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.1e-22  Score=199.64  Aligned_cols=171  Identities=17%  Similarity=0.178  Sum_probs=127.2

Q ss_pred             cChhHHHhhccCceeeeEEEEEE---e---cCcEEEEEEEcCCCC--CCHHHHHHHHHHHHHHHhcCCCeeee-EEeeEe
Q 011991          185 LNPLELQVRKADGITKGSYQVAK---W---NGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQ-FVGAVT  255 (473)
Q Consensus       185 i~~~~~~~~~~~~ig~G~~~~~~---~---~~~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~  255 (473)
                      +......|.....||+|+|+.+.   .   +++.+|||++.....  ........+.+|+++++.++|+||++ +++.  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            34445578889999999998662   1   466789998764321  13345677999999999999999985 4432  


Q ss_pred             eCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCC-CCCCEEEcCCCcEEEEeecc
Q 011991          256 QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL-KPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl-kp~Nili~~~~~vkl~DfG~  334 (473)
                        +..|+||||++|++|.. +..   ..   ...++.|++++|.|||++|   |+|||| ||+|||++.++.+||+|||+
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence              45799999999999973 211   11   1467899999999999999   999999 99999999999999999999


Q ss_pred             ccccccCccccc--ccccccCCCCCCcccCCCCcCCC
Q 011991          335 LRLQYISPEKAK--IVFPVSHIDPANLYVAPEIYKNE  369 (473)
Q Consensus       335 a~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~  369 (473)
                      |+..........  .........+++.|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            987654321111  01222455678889999988654

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.88  E-value=2.7e-23  Score=206.47  Aligned_cols=135  Identities=24%  Similarity=0.307  Sum_probs=124.2

Q ss_pred             CCcceeeccCCCCccccCCCCC-ccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCcHHHHHHHcCC
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQ-DELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGH  117 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~-~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~A~~~g~  117 (473)
                      ...++.|+.+|+++.++.+++. +....+.|.+|.|+||+||.+++++++++||++|||||+.+ .-|.||||+||++|+
T Consensus        45 ~~~~v~A~q~G~l~~v~~lve~~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~  124 (600)
T KOG0509|consen   45 LDDIVKATQYGELETVKELVESEGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGH  124 (600)
T ss_pred             hhhhhhHhhcchHHHHHHHHhhcCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCc
Confidence            3457899999999999999999 66666669999999999999999999999999999999998 778999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcCCCCcC
Q 011991          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV  174 (473)
Q Consensus       118 ~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~t~l~~  174 (473)
                      ..+|++|+++|||++++|.+|.||+|+|++.|+.-+|-+|+.++++++.++..+.+.
T Consensus       125 ~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTp  181 (600)
T KOG0509|consen  125 ISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTP  181 (600)
T ss_pred             HHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCH
Confidence            999999999999999999999999999999999999999999999998776444433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-23  Score=218.29  Aligned_cols=240  Identities=19%  Similarity=0.300  Sum_probs=178.4

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCC-CCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESH-KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      .+...+.+|++.|..+   +.....|+||++-+... -.-....+-+.|++ ...+++||++++.-....+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5666778999999633   44555699999876541 12222233334444 5556899999999988888889999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc-c
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK-A  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~-~  345 (473)
                      +.+ +|+|.+..+.-+...+.+-|+.|++.||..+|..|   |+|+|||.+||||++-..+.|+||..-+..+..+++ .
T Consensus       103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            976 99999988877888899999999999999999999   999999999999999999999999876544433221 1


Q ss_pred             cccccccCCCCCCcccCCCCcCCC----------C-CCCchhHHHHHHHHHHHHh-CCCCCCC-----------CChHHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNE----------E-FDRSVDAYSFGLILYEMIE-GVQPFHP-----------KPPEEV  402 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~~l~ell~-g~~pf~~-----------~~~~~~  402 (473)
                      ...+-..+...-..|.|||.+...          + .+++-||||+||++.||++ |.+||.-           ..++..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence            111112222223469999987541          2 5688999999999999997 6777731           111112


Q ss_pred             HHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       403 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.|               -++.+++||..|+++||.+|.|++++|+.
T Consensus       259 Le~I---------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKI---------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhC---------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            2221               13479999999999999999999999987

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.87  E-value=4e-22  Score=176.07  Aligned_cols=133  Identities=22%  Similarity=0.196  Sum_probs=114.4

Q ss_pred             cCCCCcceeeccCCCCccccC----CCCCccCCCCCCCCCChHHHHHHHcCCHHH---HHHHHHcCCCCcccC-CCCCcH
Q 011991           37 PRRNNMRFSFGRQSSLDPIRR----SPVQDELTVPENLDSTMQLLFMACRGDVKG---VEDLLNEGSDVNSID-LDGRTA  108 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~----~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~---v~~Ll~~ga~~n~~d-~~g~T~  108 (473)
                      ...+..++.||+.|+++.+++    ++..+......|.+|+||||+||..|+.++   +++|+++|+++|.+| ..|+||
T Consensus        18 ~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~Tp   97 (166)
T PHA02743         18 EDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTL   97 (166)
T ss_pred             cCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcH
Confidence            345567888999999965554    344444334458899999999999988654   899999999999998 589999


Q ss_pred             HHHHHHcCCHHHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          109 LHIAACEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       109 lh~A~~~g~~~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      ||+|+..|+.+++++|+. .|++++.+|..|.||||+|+..++.+++++|+.+|++++..+.
T Consensus        98 Lh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~  159 (166)
T PHA02743         98 LHIAASTKNYELAEWLCRQLGVNLGAINYQHETAYHIAYKMRDRRMMEILRANGAVCDDPLS  159 (166)
T ss_pred             HHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccc
Confidence            999999999999999995 8999999999999999999999999999999999999976543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.8e-21  Score=182.33  Aligned_cols=202  Identities=22%  Similarity=0.277  Sum_probs=147.7

Q ss_pred             CCCeeeeEEeeEeeC---------------------------CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHH
Q 011991          243 RHPNVVQFVGAVTQN---------------------------IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA  295 (473)
Q Consensus       243 ~hpnIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~  295 (473)
                      +|||||++.++|.+.                           .++|+||..++. +|.+++..+. .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            699999999877432                           248999999976 9999997763 66777788899999


Q ss_pred             HHHHHHhhcCCCCeEeCCCCCCCEEEc--CCC--cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCC-
Q 011991          296 RGMNYLHECKPDPIIHCDLKPKNILLD--NGG--QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-  370 (473)
Q Consensus       296 ~~L~~LH~~~~~~iiH~Dlkp~Nili~--~~~--~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  370 (473)
                      +|+.|||.+|   |.|||+|++|||+.  +|+  .+.|+|||++--.....-............|.-..||||+....+ 
T Consensus       352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            9999999999   99999999999995  333  589999999742211111111111122334666799999886432 


Q ss_pred             ----CC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 011991          371 ----FD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFN  445 (473)
Q Consensus       371 ----~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  445 (473)
                          .+ .++|.|+.|.+.||++....||-.......-..-.++.+   .+..++.+|+.+++++...++.||.+|+|..
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh---CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                11 589999999999999999999976333222111123333   3345788999999999999999999999977


Q ss_pred             HHHHHHH
Q 011991          446 EIIARLD  452 (473)
Q Consensus       446 ell~~L~  452 (473)
                      -....|.
T Consensus       506 iAANvl~  512 (598)
T KOG4158|consen  506 IAANVLN  512 (598)
T ss_pred             HHHhHHH
Confidence            5555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-22  Score=201.47  Aligned_cols=229  Identities=24%  Similarity=0.316  Sum_probs=186.8

Q ss_pred             eeeeEEEEE--------EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccC
Q 011991          198 ITKGSYQVA--------KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       198 ig~G~~~~~--------~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      +|.|+|+.+        ...|+.+|.|++.+......... ....|..++...+ ||.++++..+|+.+...++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            456666532        45678899999987654433333 6677888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      ||.|...+.+...+.+.....+...++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+++..-....     
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----  152 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence            9999999988888899999999999999999999999   99999999999999999999999999986533211     


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHH
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE  428 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~  428 (473)
                           .+||..|||||++.  +...++|.||+|+++++|++|..||.+    +....|.....     ..|...+..+++
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~-----~~p~~l~~~a~~  216 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL-----EMPRELSAEARS  216 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc-----CCchhhhHHHHH
Confidence                 15788999999998  567899999999999999999999988    44444422111     124567789999


Q ss_pred             HHHHccCCCCCCCCCH--HHHHHHH
Q 011991          429 LIEECWDPKPVIRPNF--NEIIARL  451 (473)
Q Consensus       429 li~~cl~~dP~~RPs~--~ell~~L  451 (473)
                      ++..++.++|..|...  ..+.++.
T Consensus       217 ~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  217 LFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             HHHHHHhhCHHHHhccCcchhHHHh
Confidence            9999999999999665  3444444

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.85  E-value=4.6e-22  Score=189.92  Aligned_cols=134  Identities=25%  Similarity=0.370  Sum_probs=121.4

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      .+++.|+..|.++.|+.|++.+ .++|. .....|||--||..|++++|++|+++|||++..|..|.|.||+||+.||.+
T Consensus        86 ppLWaAsaAGHl~vVk~L~~~g-a~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~  164 (615)
T KOG0508|consen   86 PPLWAASAAGHLEVVKLLLRRG-ASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVD  164 (615)
T ss_pred             chhhHHhccCcHHHHHHHHHhc-CccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchH
Confidence            4468889999999999999999 55555 555669999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC--cCCCCcCC
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT--KRTPMTVA  175 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~--~~t~l~~a  175 (473)
                      |+++|++.|||+|.++..|+|+||.|++.|+.|++++|+++|+.+...  +.||+..|
T Consensus       165 I~qyLle~gADvn~ks~kGNTALH~caEsG~vdivq~Ll~~ga~i~~d~~GmtPL~~A  222 (615)
T KOG0508|consen  165 IAQYLLEQGADVNAKSYKGNTALHDCAESGSVDIVQLLLKHGAKIDVDGHGMTPLLLA  222 (615)
T ss_pred             HHHHHHHhCCCcchhcccCchHHHhhhhcccHHHHHHHHhCCceeeecCCCCchHHHH
Confidence            999999999999999999999999999999999999999999987554  45665555

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=3.7e-21  Score=175.82  Aligned_cols=170  Identities=12%  Similarity=0.183  Sum_probs=130.8

Q ss_pred             HHHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHH------HHHHHHHHHhcCCCeeeeEEeeEeeC--
Q 011991          189 ELQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINA------FTHELTIVEKARHPNVVQFVGAVTQN--  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~------~~~E~~~l~~l~hpnIv~l~~~~~~~--  257 (473)
                      +.+|+..+.+|.|+|+.+   ..++..+|+|++..+....+.....      +.+|+..+.++.||+|..+.+++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            457888889999888754   3467789999998766555555445      57999999999999999998886643  


Q ss_pred             ------CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          258 ------IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       258 ------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                            +..+|||||++|.+|.++..    +++    ....+++.+|..+|+.|   ++|||+||+||+++.++ ++|+|
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEE
Confidence                  35799999999999988732    333    24569999999999999   99999999999999988 99999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHH
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI  388 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell  388 (473)
                      ||.+......  ...                ........|+.++|+||||+++..+.
T Consensus       178 fg~~~~~~e~--~a~----------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQR--KAK----------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccch--hhH----------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9987543111  110                01334446778999999999886654

>PHA02791 ankyrin-like protein; Provisional

Probab=99.84  E-value=8.5e-21  Score=180.70  Aligned_cols=128  Identities=11%  Similarity=0.023  Sum_probs=92.0

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCC-cHHHHHHHcCCH
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR-TALHIAACEGHV  118 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~-T~lh~A~~~g~~  118 (473)
                      ..+++.|+..|+.+.++.|+..+......|..|+||||+||..|+.+++++|+++|+++|.++..|+ ||||+|+..|+.
T Consensus        62 ~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~  141 (284)
T PHA02791         62 EFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDV  141 (284)
T ss_pred             CCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCH
Confidence            3455666677777777777766644444577788888888888888888888888888877777764 677777777777


Q ss_pred             HHHHHHHhCCCCCCccC-CCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          119 EVVKLLLSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      ++|++|+++|++.  .| ..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus       142 eivk~LL~~~~~~--~d~~~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~  191 (284)
T PHA02791        142 SIVSYFLSEIPST--FDLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNNS  191 (284)
T ss_pred             HHHHHHHhcCCcc--cccccCccHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence            7777777776543  22 2467888888888888888888888877776654

>PHA02791 ankyrin-like protein; Provisional

Probab=99.84  E-value=4.4e-21  Score=182.65  Aligned_cols=141  Identities=19%  Similarity=0.123  Sum_probs=118.9

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      .|.....+++.|+..|+.+.++.|+..+.. .+. .+|+||||+||..|+.++|++|++.|+++|.+|..|+||||+|+.
T Consensus        26 ~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~-~n~-~d~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~  103 (284)
T PHA02791         26 ADVHGHSALYYAIADNNVRLVCTLLNAGAL-KNL-LENEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVD  103 (284)
T ss_pred             CCCCCCcHHHHHHHcCCHHHHHHHHHCcCC-CcC-CCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Confidence            345566778888899999988888887743 333 257999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHhCCCCCCccCCCCC-cHHHHHHHcCChhhhhhhhhcCCcCcc--CcCCCCcCCCC
Q 011991          115 EGHVEVVKLLLSKKANIDARDRWGS-TAAADAKYYGNVEVYNILKARGAKVPK--TKRTPMTVANP  177 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~~~~~~g~-t~l~~A~~~~~~~~~~~L~~~g~~i~~--~~~t~l~~a~~  177 (473)
                      .|+.+++++|+++|++++.++..|+ ||||+|+..|+.+++++|++++.+...  .+.||++.|..
T Consensus       104 ~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~~d~~~g~TpLh~Aa~  169 (284)
T PHA02791        104 SGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPSTFDLAILLSCIHITIK  169 (284)
T ss_pred             cCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcccccccCccHHHHHHH
Confidence            9999999999999999999999885 899999999999999999998754421  24566666533

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.83  E-value=1.2e-20  Score=191.96  Aligned_cols=133  Identities=18%  Similarity=0.227  Sum_probs=120.2

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      +....+++.|+..|+.+.++.+++.+....+. +.+|.||||+||..|+.+++++|+++|+|+|.+|..|.||||+|+..
T Consensus        66 ~~~~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~  145 (413)
T PHA02875         66 PDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMM  145 (413)
T ss_pred             CCcccHHHHHHHCCCHHHHHHHHHcCCcccccccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHc
Confidence            44556788899999999999999887654443 67899999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus       146 ~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~  199 (413)
T PHA02875        146 GDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGK  199 (413)
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCC
Confidence            999999999999999999999999999999999999999999999999976543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.7e-20  Score=186.02  Aligned_cols=212  Identities=31%  Similarity=0.540  Sum_probs=165.8

Q ss_pred             HHhcCCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-EeCCCCC
Q 011991          239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPI-IHCDLKP  316 (473)
Q Consensus       239 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i-iH~Dlkp  316 (473)
                      |+.+.|.|+.+|+|.+.++...+.|.+||..|+|.+.+... -.+++.....++++++.||+|||...   | .|+.|++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence            35678999999999999999999999999999999999874 45888999999999999999999976   5 9999999


Q ss_pred             CCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC---C----CCCchhHHHHHHHHHHHHh
Q 011991          317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE---E----FDRSVDAYSFGLILYEMIE  389 (473)
Q Consensus       317 ~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DiwSlG~~l~ell~  389 (473)
                      .|.+++....+||+|||+.............    ....-...|.|||.+...   .    .+.+.||||+|++++|+++
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~----~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAH----HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             ccceeeeeEEEEechhhhccccccccccccc----chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            9999999999999999998665321000000    001122359999998764   1    4677999999999999999


Q ss_pred             CCCCCCCC----ChHHHHHHHHhhCCCCCCcccC--CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          390 GVQPFHPK----PPEEVVKLMCCEGKRPPLKIKA--RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       390 g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ...||...    .+.++...+...+..+..+...  ...++.+..++.+||..+|.+||+++++-..++.+...
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99999763    3345666654423322222111  14566899999999999999999999999988877764

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.83  E-value=3e-21  Score=161.36  Aligned_cols=124  Identities=22%  Similarity=0.184  Sum_probs=109.2

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      +.++-|+..+.+..|+++|.....-+|. |.+|+||||-||.+|+++||+.|+..|||++++...||||||-||...+.+
T Consensus        65 rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~  144 (228)
T KOG0512|consen   65 RLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFE  144 (228)
T ss_pred             HHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchh
Confidence            4477889999999999999988766665 999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCCh-hhhhhhhh-cCCcC
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNV-EVYNILKA-RGAKV  164 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~-~~~~~L~~-~g~~i  164 (473)
                      ++-+||++|||+|+..+..+||||+|+...+. +.+.+|+. .+.+.
T Consensus       145 va~~LLqhgaDVnA~t~g~ltpLhlaa~~rn~r~t~~~Ll~dryi~p  191 (228)
T KOG0512|consen  145 VAGRLLQHGADVNAQTKGLLTPLHLAAGNRNSRDTLELLLHDRYIHP  191 (228)
T ss_pred             HHHHHHhccCcccccccccchhhHHhhcccchHHHHHHHhhccccCh
Confidence            99999999999999999999999999966654 45555543 34444

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.83  E-value=2e-20  Score=171.52  Aligned_cols=134  Identities=15%  Similarity=0.198  Sum_probs=98.0

Q ss_pred             CCcCCCCcceeecc--CCCCccccCCCCCccCCCCCC-CCCChHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCcH
Q 011991           35 FDPRRNNMRFSFGR--QSSLDPIRRSPVQDELTVPEN-LDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTA  108 (473)
Q Consensus        35 ~~~~~~~~~~~~~~--~g~~~~~~~~l~~~~~~~~~~-~~g~t~L~~aa~~---g~~~~v~~Ll~~ga~~n~~d~~g~T~  108 (473)
                      .|.....+++.++.  .|+.+.++.+++.+......+ ..|.||||+|+..   ++.+++++|+++|+|+|.+|..|.||
T Consensus        47 ~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~Tp  126 (209)
T PHA02859         47 CNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNL  126 (209)
T ss_pred             cCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCH
Confidence            34444444444443  346777777777764443344 4688888887753   46888888888888888888888888


Q ss_pred             HHHHHH--cCCHHHHHHHHhCCCCCCccCCCCCcHHHH-HHHcCChhhhhhhhhcCCcCccCc
Q 011991          109 LHIAAC--EGHVEVVKLLLSKKANIDARDRWGSTAAAD-AKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       109 lh~A~~--~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~-A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ||+|+.  .++.+++++|+++|+|++.+|..|.||||. |+..++.+++++|+++|++++.++
T Consensus       127 Lh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d  189 (209)
T PHA02859        127 LHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETN  189 (209)
T ss_pred             HHHHHHhccCCHHHHHHHHHcCCCcccccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCC
Confidence            888765  467888888888888888888888888885 556778888888888888887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4e-20  Score=166.90  Aligned_cols=137  Identities=20%  Similarity=0.223  Sum_probs=103.5

Q ss_pred             CceeeeEEEEE----EecCcEEEEEEEcCCCCCCHH-----------------------HHHHHHHHHHHHHhcCCCeee
Q 011991          196 DGITKGSYQVA----KWNGTKVWVKILDKESHKDPE-----------------------RINAFTHELTIVEKARHPNVV  248 (473)
Q Consensus       196 ~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hpnIv  248 (473)
                      ..||.|+++.+    ..+|+.||||++.........                       .......|++.++.+.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            46899998754    237899999999764321111                       012234599999999877764


Q ss_pred             eEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeCCCCCCCEEEcCCCcE
Q 011991          249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYL-HECKPDPIIHCDLKPKNILLDNGGQL  327 (473)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiH~Dlkp~Nili~~~~~v  327 (473)
                      ........  ..+|||||++|+++...+...+.++...+..++.|++.+|.++ |+.|   |+||||||+|||++ ++.+
T Consensus        83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence            43332222  2389999999887776644556799999999999999999999 6888   99999999999998 4789


Q ss_pred             EEEeecccccc
Q 011991          328 KISGFGLLRLQ  338 (473)
Q Consensus       328 kl~DfG~a~~~  338 (473)
                      +|+|||+|...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.82  E-value=2.5e-20  Score=170.91  Aligned_cols=128  Identities=16%  Similarity=0.113  Sum_probs=112.6

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHc--CCHHHHHHHHHcCCCCcccC-CCCCcHHHHHHHc
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR--GDVKGVEDLLNEGSDVNSID-LDGRTALHIAACE  115 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~--g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~A~~~  115 (473)
                      ...+++.|+..|+++.|+.++...   ...+..|.||||+|+..  |+.+++++|+++|+|+|.++ ..|+||||+|+..
T Consensus        21 ~~~pL~~A~~~~~~~~vk~Li~~~---n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~   97 (209)
T PHA02859         21 YCNPLFYYVEKDDIEGVKKWIKFV---NDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSF   97 (209)
T ss_pred             cCcHHHHHHHhCcHHHHHHHHHhh---hccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHh
Confidence            457788999999999999998652   23578899999999985  48999999999999999997 5899999998864


Q ss_pred             ---CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHH--cCChhhhhhhhhcCCcCccCcC
Q 011991          116 ---GHVEVVKLLLSKKANIDARDRWGSTAAADAKY--YGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       116 ---g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~--~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                         ++.+++++|+++|+|++.+|..|.||||+|+.  .++.+++++|+++|++++.++.
T Consensus        98 ~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~  156 (209)
T PHA02859         98 NKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDF  156 (209)
T ss_pred             CccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccccC
Confidence               57999999999999999999999999999875  4689999999999999987654

>PHA02741 hypothetical protein; Provisional

Probab=99.81  E-value=2.8e-20  Score=164.97  Aligned_cols=127  Identities=19%  Similarity=0.221  Sum_probs=109.4

Q ss_pred             cCCCCcceeeccCCCCccccCCCC-----CccCCCC-CCCCCChHHHHHHHcCC----HHHHHHHHHcCCCCcccCC-CC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPV-----QDELTVP-ENLDSTMQLLFMACRGD----VKGVEDLLNEGSDVNSIDL-DG  105 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~-----~~~~~~~-~~~~g~t~L~~aa~~g~----~~~v~~Ll~~ga~~n~~d~-~g  105 (473)
                      ......++.|++.|+.+.++.++.     ..+.+.+ .|..|.||||+||..|+    .+++++|+++|+++|.+|. .|
T Consensus        19 ~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g   98 (169)
T PHA02741         19 SEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEG   98 (169)
T ss_pred             cCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCC
Confidence            345567788899999998887642     1223444 48889999999999998    5889999999999999985 89


Q ss_pred             CcHHHHHHHcCCHHHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          106 RTALHIAACEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       106 ~T~lh~A~~~g~~~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      +||||+|+..|+.+++++|++ .|++++.+|..|+||||+|...++.+++++|++.++.
T Consensus        99 ~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~  157 (169)
T PHA02741         99 DTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAIDNEDVAMMQILREIVAT  157 (169)
T ss_pred             CCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence            999999999999999999997 5999999999999999999999999999999987654

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.81  E-value=5.7e-20  Score=201.37  Aligned_cols=135  Identities=23%  Similarity=0.218  Sum_probs=118.6

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      -+|.....++.||..|+.+.++.++..|......|.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.
T Consensus       521 ~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~  600 (823)
T PLN03192        521 DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS  600 (823)
T ss_pred             CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHH
Confidence            34555567889999999999999998876555569999999999999999999999999999999999999999986655


Q ss_pred             c-------------------------------CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          115 E-------------------------------GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       115 ~-------------------------------g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      .                               |+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++
T Consensus       601 ~g~~~iv~~L~~~~~~~~~~~~~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAd  680 (823)
T PLN03192        601 AKHHKIFRILYHFASISDPHAAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGAD  680 (823)
T ss_pred             hCCHHHHHHHHhcCcccCcccCchHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCC
Confidence            4                               555566778889999999999999999999999999999999999999


Q ss_pred             CccCcC
Q 011991          164 VPKTKR  169 (473)
Q Consensus       164 i~~~~~  169 (473)
                      ++..+.
T Consensus       681 v~~~~~  686 (823)
T PLN03192        681 VDKANT  686 (823)
T ss_pred             CCCCCC
Confidence            987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=1e-20  Score=178.15  Aligned_cols=230  Identities=19%  Similarity=0.286  Sum_probs=146.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC----------CeeeeEEeeE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH----------PNVVQFVGAV  254 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h----------pnIv~l~~~~  254 (473)
                      .++..+..||.|.++++     ..+|+.+|||+............+.+.+|.-....+.+          -.++-.++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            35566778888888754     35689999999876554444456777777755555322          1222222221


Q ss_pred             ---------eeC---C-----ceEEEEeccCCCCHHHHHHH---cCC----CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 011991          255 ---------TQN---I-----PMMIVLEYHAKGDLASYLQK---KGR----LSPSKVLRFALDLARGMNYLHECKPDPII  310 (473)
Q Consensus       255 ---------~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~----l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  310 (473)
                               ...   .     ..+++|+-+. ++|.+++..   ...    +.......+..|+++.+++||+.|   ++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence                     111   1     2478899885 499988643   222    223445677799999999999999   99


Q ss_pred             eCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCC--------CCCCCchhHHHHHH
Q 011991          311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN--------EEFDRSVDAYSFGL  382 (473)
Q Consensus       311 H~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~  382 (473)
                      |+||+|+|++++.+|.+.|+||+.....+.....         ...+..|.+||....        -.++.+.|.|+||+
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceeec---------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence            9999999999999999999999876544322110         123456999997643        25788999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCC
Q 011991          383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR  441 (473)
Q Consensus       383 ~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  441 (473)
                      ++|.|+++..||...........        .+.... ++|+.++.||+.+|+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEW--------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGG--------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccc--------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999986544322111        122223 678999999999999999987

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.80  E-value=7.5e-20  Score=182.11  Aligned_cols=161  Identities=29%  Similarity=0.246  Sum_probs=130.1

Q ss_pred             cccccchhhhhhhhcccCCC---CCcCCCCcceeeccCCCCccccCCCCCccCCCCCC-CCCChHHHHHHHcCCHHHHHH
Q 011991           15 QFSTGSLRRSLTRQMSRQSS---FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPEN-LDSTMQLLFMACRGDVKGVED   90 (473)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~-~~g~t~L~~aa~~g~~~~v~~   90 (473)
                      +...|++.++.-...+..++   .|...-..+.=||-.++++.++.+++++++.+... .-+.||||+||.+|++.+|.+
T Consensus        51 A~q~G~l~~v~~lve~~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~l  130 (600)
T KOG0509|consen   51 ATQYGELETVKELVESEGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDL  130 (600)
T ss_pred             HhhcchHHHHHHHHhhcCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHH
Confidence            34456665554444332333   33323333444556778888888998887655554 678999999999999999999


Q ss_pred             HHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc--
Q 011991           91 LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK--  168 (473)
Q Consensus        91 Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~--  168 (473)
                      |+++|||++.+|..|.||||+||..||.-+|.|||.+|+|+|.+|.+|+|||++|+.+|+...+..|++.++.+..++  
T Consensus       131 LlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~  210 (600)
T KOG0509|consen  131 LLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDN  210 (600)
T ss_pred             HHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHHHHHHHhcccHHHHHHHHhcccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999988999999999886554  


Q ss_pred             --CCCCcCC
Q 011991          169 --RTPMTVA  175 (473)
Q Consensus       169 --~t~l~~a  175 (473)
                        .||++-|
T Consensus       211 ~g~TpLHwa  219 (600)
T KOG0509|consen  211 HGNTPLHWA  219 (600)
T ss_pred             cCCchHHHH
Confidence              5666654

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.80  E-value=3.1e-19  Score=140.65  Aligned_cols=88  Identities=41%  Similarity=0.571  Sum_probs=83.1

Q ss_pred             HHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhh
Q 011991           76 LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYN  155 (473)
Q Consensus        76 L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~  155 (473)
                      ||+||..|+.+++++|++.|++++.    |+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.++++
T Consensus         1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~   76 (89)
T PF12796_consen    1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK   76 (89)
T ss_dssp             HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred             CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence            7999999999999999999999987    889999999999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCcCccC
Q 011991          156 ILKARGAKVPKT  167 (473)
Q Consensus       156 ~L~~~g~~i~~~  167 (473)
                      +|+++|++++.+
T Consensus        77 ~Ll~~g~~~~~~   88 (89)
T PF12796_consen   77 LLLEHGADVNIR   88 (89)
T ss_dssp             HHHHTTT-TTSS
T ss_pred             HHHHcCCCCCCc
Confidence            999999999765

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.80  E-value=5.2e-20  Score=176.00  Aligned_cols=140  Identities=24%  Similarity=0.302  Sum_probs=124.6

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCC---------CCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCc
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTV---------PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRT  107 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~---------~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T  107 (473)
                      +....+++.+|+.|..+.|++++++-....         ....+|-+||--|+..||+++|+.|+++||+||.......|
T Consensus        40 ~~g~tPL~iaaRnGH~~vVeyLle~~~a~~e~~GsV~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNSt  119 (615)
T KOG0508|consen   40 QNGGTPLLIAARNGHADVVEYLLEHCRASPEQGGSVRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNST  119 (615)
T ss_pred             cCCCCceeeehhcCcHHHHHHHHHHhcCCccCCceEEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCc
Confidence            556788999999999999999998543322         22557889999999999999999999999999999888889


Q ss_pred             HHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          108 ALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       108 ~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      ||--||..||.|||++|+++|||+++.|+.|.|.|++||.+||.+|+++|++.|+|++++.   .|.++.+.
T Consensus       120 PLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTALH~ca  191 (615)
T KOG0508|consen  120 PLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTALHDCA  191 (615)
T ss_pred             cHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchHHHhhh
Confidence            9999999999999999999999999999999999999999999999999999999998764   56666653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=8e-19  Score=158.83  Aligned_cols=138  Identities=17%  Similarity=0.139  Sum_probs=105.3

Q ss_pred             cCceeeeEEEEE----EecCcEEEEEEEcCCCCCC---------------------H--HHHHHHHHHHHHHHhcCCCee
Q 011991          195 ADGITKGSYQVA----KWNGTKVWVKILDKESHKD---------------------P--ERINAFTHELTIVEKARHPNV  247 (473)
Q Consensus       195 ~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~---------------------~--~~~~~~~~E~~~l~~l~hpnI  247 (473)
                      ...||+|+++.+    ..+|+.||||++.......                     .  .....+..|.+.+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            356888888755    2369999999998653210                     0  012334689999999999987


Q ss_pred             eeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCc
Q 011991          248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      .....+....  .++||||++|+++.........++......++.|++.++.++|+ .|   |+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence            5444433332  48999999987655443344568889999999999999999999 88   99999999999999 789


Q ss_pred             EEEEeecccccc
Q 011991          327 LKISGFGLLRLQ  338 (473)
Q Consensus       327 vkl~DfG~a~~~  338 (473)
                      ++|+|||++...
T Consensus       156 ~~liDFG~a~~~  167 (190)
T cd05145         156 PYIIDVSQAVEL  167 (190)
T ss_pred             EEEEEcccceec
Confidence            999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.79  E-value=1.6e-19  Score=186.86  Aligned_cols=135  Identities=22%  Similarity=0.224  Sum_probs=106.5

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCH-----------------------------------
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDV-----------------------------------   85 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~-----------------------------------   85 (473)
                      .+++.|+..|+.+.|+.|++.|......+.+|+||||+||..|+.                                   
T Consensus        39 tPLh~A~~~g~~e~vk~Ll~~gadvn~~d~~g~TpLh~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~l~~a~~~~~~ei~~  118 (477)
T PHA02878         39 IPLHQAVEARNLDVVKSLLTRGHNVNQPDHRDLTPLHIICKEPNKLGMKEMIRSINKCSVFYTLVAIKDAFNNRNVEIFK  118 (477)
T ss_pred             chHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCccHhHHHHHHHHHhccccccchhhHHHHHHcCCHHHHH
Confidence            457778888888888888877644334478888888888876543                                   


Q ss_pred             -----------------------------HHHHHHHHcCCCCcccCCC-CCcHHHHHHHcCCHHHHHHHHhCCCCCCccC
Q 011991           86 -----------------------------KGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDARD  135 (473)
Q Consensus        86 -----------------------------~~v~~Ll~~ga~~n~~d~~-g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~  135 (473)
                                                   +++++|+++|+|+|.+|.. |+||||+||..|+.+++++|+++|++++.+|
T Consensus       119 ~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~~Ll~~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d  198 (477)
T PHA02878        119 IILTNRYKNIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPD  198 (477)
T ss_pred             HHHhCcccCcccCcHHHHhhccchhhHHHHHHHHHHHcCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcC
Confidence                                         2667777788888888877 8888888888888888888888888888888


Q ss_pred             CCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       136 ~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      ..|.||||+|+..|+.+++++|+++|++++..+   .||++.|
T Consensus       199 ~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A  241 (477)
T PHA02878        199 KTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHIS  241 (477)
T ss_pred             CCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence            888888888888888888888888888887654   3455444

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.79  E-value=2.4e-19  Score=182.41  Aligned_cols=130  Identities=24%  Similarity=0.239  Sum_probs=118.9

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~  117 (473)
                      ....+++.|+..|+.+.++.|++.|......+.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus       101 ~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~  180 (413)
T PHA02875        101 DGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGD  180 (413)
T ss_pred             CCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCC
Confidence            34567778889999999999998886555558899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCCCCC-cHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          118 VEVVKLLLSKKANIDARDRWGS-TAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       118 ~~iv~~Ll~~ga~~~~~~~~g~-t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      .+++++|+++|++++..+..|. ||+|+|+..|+.+++++|+++|++++..
T Consensus       181 ~eiv~~Ll~~ga~~n~~~~~~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~~  231 (413)
T PHA02875        181 IAICKMLLDSGANIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGADCNIM  231 (413)
T ss_pred             HHHHHHHHhCCCCCCcCCCCCCchHHHHHHHcCCHHHHHHHHHCCcCcchH
Confidence            9999999999999999998875 7899999999999999999999998754

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.79  E-value=5.9e-20  Score=160.48  Aligned_cols=127  Identities=20%  Similarity=0.220  Sum_probs=103.3

Q ss_pred             CCCcceeeccCCCCccccCC---CCCc-c-CCCCCCCCCChHHHHHHHcCCH---HHHHHHHHcCCCCcccC-CCCCcHH
Q 011991           39 RNNMRFSFGRQSSLDPIRRS---PVQD-E-LTVPENLDSTMQLLFMACRGDV---KGVEDLLNEGSDVNSID-LDGRTAL  109 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~---l~~~-~-~~~~~~~~g~t~L~~aa~~g~~---~~v~~Ll~~ga~~n~~d-~~g~T~l  109 (473)
                      ...++..|++.|++..+...   +... . .....|.+|.||||+||..|+.   +++++|++.|+++|.+| ..|+|||
T Consensus        17 g~tpLh~A~~~g~~~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~L   96 (154)
T PHA02736         17 GENILHYLCRNGGVTDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPL   96 (154)
T ss_pred             CCCHHHHHHHhCCHHHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHH
Confidence            44555567788874322211   1110 1 1112478999999999999987   46889999999999998 4999999


Q ss_pred             HHHHHcCCHHHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCc
Q 011991          110 HIAACEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP  165 (473)
Q Consensus       110 h~A~~~g~~~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~  165 (473)
                      |+|+..|+.+++++|+. .|++++.+|..|.||||+|+..|+.+++++|+.+|++.+
T Consensus        97 h~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~~~~~~~i~~~Ll~~ga~~~  153 (154)
T PHA02736         97 HIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQCK  153 (154)
T ss_pred             HHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHHHcCCHHHHHHHHHcCCCCC
Confidence            99999999999999998 599999999999999999999999999999999998764

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.79  E-value=2.5e-19  Score=185.45  Aligned_cols=123  Identities=22%  Similarity=0.236  Sum_probs=96.2

Q ss_pred             ccccCCCCCccCCCCCCCC-CChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCC
Q 011991           53 DPIRRSPVQDELTVPENLD-STMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI  131 (473)
Q Consensus        53 ~~~~~~l~~~~~~~~~~~~-g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~  131 (473)
                      +.++.+++.|......+.+ |.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|+++
T Consensus       148 ~iv~~Ll~~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~i  227 (477)
T PHA02878        148 EITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGAST  227 (477)
T ss_pred             HHHHHHHHcCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCC
Confidence            3556666655433334666 888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CccCCCCCcHHHHHHHc-CChhhhhhhhhcCCcCccC----cCCCCcCC
Q 011991          132 DARDRWGSTAAADAKYY-GNVEVYNILKARGAKVPKT----KRTPMTVA  175 (473)
Q Consensus       132 ~~~~~~g~t~l~~A~~~-~~~~~~~~L~~~g~~i~~~----~~t~l~~a  175 (473)
                      +.+|..|.||||+|+.. ++.+++++|+++|++++..    +.||++.|
T Consensus       228 n~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g~TpLh~A  276 (477)
T PHA02878        228 DARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSS  276 (477)
T ss_pred             CCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCCCCHHHHH
Confidence            88888888888888865 6788888888888888654    35666666

>PHA02795 ankyrin-like protein; Provisional

Probab=99.78  E-value=1.6e-19  Score=178.50  Aligned_cols=143  Identities=17%  Similarity=0.058  Sum_probs=117.2

Q ss_pred             cccCCCCCcC-CCCcceeeccCCCCccccCCCCCccCCCCCC------CCCChHHHHHHHcCCHHHHHHHHHcCCCCccc
Q 011991           29 MSRQSSFDPR-RNNMRFSFGRQSSLDPIRRSPVQDELTVPEN------LDSTMQLLFMACRGDVKGVEDLLNEGSDVNSI  101 (473)
Q Consensus        29 ~~~~~~~~~~-~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~------~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~  101 (473)
                      +.....++-. ...+++.|+..|+.+.++.++.+|..+.+..      ..+.|++|.|+..|+.+++++|+++|||+|.+
T Consensus       138 I~~GADIn~~~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~k  217 (437)
T PHA02795        138 VDHGAVIYKIECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQL  217 (437)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcC
Confidence            4455555432 2456667777788888888888875333332      34789999999999999999999999999999


Q ss_pred             CCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCC--------hhhhhhhhhcCCcCccCcCCC
Q 011991          102 DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN--------VEVYNILKARGAKVPKTKRTP  171 (473)
Q Consensus       102 d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~--------~~~~~~L~~~g~~i~~~~~t~  171 (473)
                      |..|.||||+|+..|+.+++++|+++||+++.+|..|.||||+|+..|+        .+++++|+++|++++....+.
T Consensus       218 D~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g~~~~~~~~~~eIvelLL~~gadI~~~~~~~  295 (437)
T PHA02795        218 DAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRGSVIARRETHLKILEILLREPLSIDCIKLAI  295 (437)
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCcccccccHHHHHHHHHhCCCCCCchhHHh
Confidence            9999999999999999999999999999999999999999999999884        689999999999987754433

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.78  E-value=3.1e-19  Score=169.98  Aligned_cols=119  Identities=19%  Similarity=0.097  Sum_probs=103.7

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC----CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCcHHHHHHHc
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE----NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACE  115 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~----~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~A~~~  115 (473)
                      ..++.|++.|+.+.++.|++.|......    +..|.||||+||..|+.+++++|+++|||+|.++ ..|.||||+|+..
T Consensus        35 ~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~  114 (300)
T PHA02884         35 NILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLH  114 (300)
T ss_pred             HHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHc
Confidence            3456667778899999898888543322    3589999999999999999999999999999974 6899999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhh
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKA  159 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~  159 (473)
                      |+.+++++|+++|||++.+|..|.||||+|+..++.+++.++..
T Consensus       115 ~~~eivklLL~~GAdin~kd~~G~TpL~~A~~~~~~~~~~~~~~  158 (300)
T PHA02884        115 GCLKCLEILLSYGADINIQTNDMVTPIELALMICNNFLAFMICD  158 (300)
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHhCChhHHHHhcC
Confidence            99999999999999999999999999999999999888876653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=9.4e-19  Score=156.71  Aligned_cols=189  Identities=13%  Similarity=0.037  Sum_probs=130.6

Q ss_pred             cCceeeeEEEEEE---ecCcEEEEEEEcCCCCCCH-HHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          195 ADGITKGSYQVAK---WNGTKVWVKILDKESHKDP-ERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       195 ~~~ig~G~~~~~~---~~~~~vavK~l~~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      ...+++|+|+.+.   ..+..++.+.+........ -....+.+|+++|++|. |++|++++++    ...+++|||+.|
T Consensus         7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            3467888887653   3566777777754332111 11236889999999995 5889999886    346999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCC-CCCCEEEcCCCcEEEEeeccccccccCccc----
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL-KPKNILLDNGGQLKISGFGLLRLQYISPEK----  344 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl-kp~Nili~~~~~vkl~DfG~a~~~~~~~~~----  344 (473)
                      .+|.+.+...       ...++.|++.+|.++|++|   |+|||| ||+|||++.++.++|+|||++........-    
T Consensus        83 ~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         83 AAMYQRPPRG-------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             ccHHhhhhhh-------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence            9997654211       1357789999999999999   999999 799999999999999999999754322110    


Q ss_pred             c-ccccc--ccCCCCCCcccCCCCcCCC-CCC-CchhHHHHHHHHHHHHhCCCCCCCC
Q 011991          345 A-KIVFP--VSHIDPANLYVAPEIYKNE-EFD-RSVDAYSFGLILYEMIEGVQPFHPK  397 (473)
Q Consensus       345 ~-~~~~~--~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~~l~ell~g~~pf~~~  397 (473)
                      . .....  ......++.|++|+...-- ..+ ...+.++.|+-+|.++|+..|+.+.
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            0 00000  0011235557777643221 233 5778899999999999998887543

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.78  E-value=4.8e-19  Score=181.25  Aligned_cols=137  Identities=23%  Similarity=0.316  Sum_probs=117.5

Q ss_pred             CCCcceeeccCCCCccccCCCCCcc----------------------CCCC-CCCCCChHHHHHHHcCCHHHHHHHHHcC
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDE----------------------LTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEG   95 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~----------------------~~~~-~~~~g~t~L~~aa~~g~~~~v~~Ll~~g   95 (473)
                      ...+++.|+..|+.+.++.|++.|.                      .+++ .+..|.||||+||..|+.++|++|+++|
T Consensus        68 ~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~g  147 (434)
T PHA02874         68 IPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYG  147 (434)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCC
Confidence            3456677788888887777776552                      2233 3778999999999999999999999999


Q ss_pred             CCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCC
Q 011991           96 SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPM  172 (473)
Q Consensus        96 a~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l  172 (473)
                      +++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+   .|++
T Consensus       148 ad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~TpL  227 (434)
T PHA02874        148 ADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPL  227 (434)
T ss_pred             CCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCCCHH
Confidence            9999999999999999999999999999999999999999999999999999999999999999999886654   3444


Q ss_pred             cCC
Q 011991          173 TVA  175 (473)
Q Consensus       173 ~~a  175 (473)
                      +.|
T Consensus       228 ~~A  230 (434)
T PHA02874        228 HNA  230 (434)
T ss_pred             HHH
Confidence            444

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.78  E-value=5.8e-19  Score=180.60  Aligned_cols=139  Identities=20%  Similarity=0.176  Sum_probs=121.0

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCC--------------------
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGS--------------------   96 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga--------------------   96 (473)
                      .....+++.|+..|+.+.++.|++.|......+..|.||||.|+..|+.+++++|+++|+                    
T Consensus        33 ~~~~tpL~~A~~~g~~~iv~~Ll~~Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~  112 (434)
T PHA02874         33 DETTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILD  112 (434)
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHH
Confidence            345677888999999999999998875444458889999999999999999999987764                    


Q ss_pred             ---CCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CC
Q 011991           97 ---DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RT  170 (473)
Q Consensus        97 ---~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t  170 (473)
                         |+|.+|..|.||||+|+..|+.++|++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+   .+
T Consensus       113 ~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~t  192 (434)
T PHA02874        113 CGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGES  192 (434)
T ss_pred             CcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence               567789999999999999999999999999999999999999999999999999999999999999887654   45


Q ss_pred             CCcCC
Q 011991          171 PMTVA  175 (473)
Q Consensus       171 ~l~~a  175 (473)
                      +++.|
T Consensus       193 pL~~A  197 (434)
T PHA02874        193 PLHNA  197 (434)
T ss_pred             HHHHH
Confidence            55554

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=1.4e-18  Score=158.39  Aligned_cols=133  Identities=14%  Similarity=0.195  Sum_probs=102.0

Q ss_pred             ccCceeeeEEEEEEe--cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-----CCCeeeeEEeeEeeCC---c-eEE
Q 011991          194 KADGITKGSYQVAKW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-----RHPNVVQFVGAVTQNI---P-MMI  262 (473)
Q Consensus       194 ~~~~ig~G~~~~~~~--~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~---~-~~l  262 (473)
                      ....||+|+|+.+..  .....+||++.....   ...+.+.+|+.+++.+     +||||++++|+++++.   . +.+
T Consensus         6 ~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEECCCCcCeEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            446799999987632  122346888865432   2346789999999999     5799999999998863   3 337


Q ss_pred             EEec--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEeCCCCCCCEEEcCC----CcEEEEeeccc
Q 011991          263 VLEY--HAKGDLASYLQKKGRLSPSKVLRFALDLARGM-NYLHECKPDPIIHCDLKPKNILLDNG----GQLKISGFGLL  335 (473)
Q Consensus       263 v~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~iiH~Dlkp~Nili~~~----~~vkl~DfG~a  335 (473)
                      ||||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++   |+||||||+|||++..    +.++|+||+.+
T Consensus        83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            8999  5579999999764 46655  35678888777 9999999   9999999999999743    37999995443

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.77  E-value=5.2e-19  Score=153.50  Aligned_cols=138  Identities=22%  Similarity=0.283  Sum_probs=115.3

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccC------------------------------CCCC-CCCCChHHHHHHHcC
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDEL------------------------------TVPE-NLDSTMQLLFMACRG   83 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~------------------------------~~~~-~~~g~t~L~~aa~~g   83 (473)
                      .||.....++.++..|+.+.+...|.++.-                              .+|. |..|.|||+|||..|
T Consensus        92 t~p~g~~~~~v~ap~~s~~k~sttltN~~rgnevs~~p~s~~slsVhql~L~~~~~~~~n~VN~~De~GfTpLiWAaa~G  171 (296)
T KOG0502|consen   92 TDPEGWSALLVAAPCGSVDKVSTTLTNGARGNEVSLMPWSPLSLSVHQLHLDVVDLLVNNKVNACDEFGFTPLIWAAAKG  171 (296)
T ss_pred             CCchhhhhhhhcCCCCCcceeeeeecccccCCccccccCChhhHHHHHHHHHHHHHHhhccccCccccCchHhHHHHhcC
Confidence            456666667788888888888887776621                              1233 778899999999999


Q ss_pred             CHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991           84 DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus        84 ~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      ++++|++||+.|||+++.-+...|+|++|+..|..+||++||+++.|+|.-|-+|-|||-+|++.||.+|++.|++.|++
T Consensus       172 ~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvrgnhvkcve~Ll~sGAd  251 (296)
T KOG0502|consen  172 HIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVRGNHVKCVESLLNSGAD  251 (296)
T ss_pred             chHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeeeecCChHHHHHHHHhcCCC
Confidence            99999999999999998888888999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCcCCCC
Q 011991          164 VPKTKRTPM  172 (473)
Q Consensus       164 i~~~~~t~l  172 (473)
                      ++..++.+.
T Consensus       252 ~t~e~dsGy  260 (296)
T KOG0502|consen  252 VTQEDDSGY  260 (296)
T ss_pred             cccccccCC
Confidence            877655444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=3.3e-18  Score=182.46  Aligned_cols=245  Identities=20%  Similarity=0.263  Sum_probs=182.7

Q ss_pred             HHHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC---CCeeeeEEeeEeeCCceE
Q 011991          189 ELQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR---HPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~  261 (473)
                      ...|.+.+.+|.|+|+.|    ..+|+.||+|+-++.....-..      -.+++.+|+   -+.|..+..++...+..+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            447888889999999844    4569999999998765443222      234444554   345667777777788889


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-------CCcEEEEeecc
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-------GGQLKISGFGL  334 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-------~~~vkl~DfG~  334 (473)
                      ||+||.+.|||.+++...+.+++..+..++.|++..++.||..+   |||+||||+|.|+..       ...++|+|||.
T Consensus       771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            99999999999999998888999999999999999999999999   999999999999952       34599999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      |-.+....+.    .......+|-.+-++|...+++|+..+|-|.++.+++-|+.|+.-           .. ..+..-.
T Consensus       848 siDm~lfp~~----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------q~-~~g~~~~  911 (974)
T KOG1166|consen  848 SIDMKLFPDG----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------EV-KNGSSWM  911 (974)
T ss_pred             ceeeeEcCCC----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------Hh-cCCccee
Confidence            8655433332    223445678889999999999999999999999999999998531           11 1111111


Q ss_pred             CcccCCCC-C-HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          415 LKIKARSY-P-PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       415 ~~~~~~~~-~-~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      .....+.+ - +-..+|+..+|+.|=..=|...+|...++.++.+-
T Consensus       912 ~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  912 VKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             ccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence            11111111 1 23567888899855445599999999888877653

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.77  E-value=9.8e-19  Score=184.36  Aligned_cols=130  Identities=12%  Similarity=0.098  Sum_probs=96.9

Q ss_pred             CCcceeec---cCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCC--HHHHHHHHHcCCCCcccCCCCCcHHHHH--
Q 011991           40 NNMRFSFG---RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD--VKGVEDLLNEGSDVNSIDLDGRTALHIA--  112 (473)
Q Consensus        40 ~~~~~~~~---~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~--~~~v~~Ll~~ga~~n~~d~~g~T~lh~A--  112 (473)
                      +.+.+.++   ..++.+.++.|+++|......|.+|.||||+||..|+  .++|++||++|||+|.+|..|+||||+|  
T Consensus       177 G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~  256 (764)
T PHA02716        177 GYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYII  256 (764)
T ss_pred             CCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Confidence            44444443   2355677777777664444447788888888888885  4888888888888888888888888864  


Q ss_pred             -----------------------------------HHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHH--cCChhhhh
Q 011991          113 -----------------------------------ACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY--YGNVEVYN  155 (473)
Q Consensus       113 -----------------------------------~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~--~~~~~~~~  155 (473)
                                                         |..|+.+++++|+++|++++.+|..|+||||+|+.  .++.++++
T Consensus       257 ~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVk  336 (764)
T PHA02716        257 NIDNINPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIK  336 (764)
T ss_pred             hhhccCHHHHHHHHHhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHH
Confidence                                               34577888888888888888888888888887653  45778888


Q ss_pred             hhhhcCCcCccCcC
Q 011991          156 ILKARGAKVPKTKR  169 (473)
Q Consensus       156 ~L~~~g~~i~~~~~  169 (473)
                      +|+++|++++.++.
T Consensus       337 lLLe~GADIN~kD~  350 (764)
T PHA02716        337 LLHEYGNDLNEPDN  350 (764)
T ss_pred             HHHHcCCCCccCCC
Confidence            88888888876653

>PHA03095 ankyrin-like protein; Provisional

Probab=99.76  E-value=1.3e-18  Score=180.24  Aligned_cols=125  Identities=23%  Similarity=0.240  Sum_probs=104.3

Q ss_pred             eeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcC---CHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC-CHHH
Q 011991           45 SFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG-HVEV  120 (473)
Q Consensus        45 ~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g---~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g-~~~i  120 (473)
                      .++..++++.|+.+++.|......+..|.||||+|+..|   +.+++++|+++|+|+|.+|..|+||||+|+..| +.++
T Consensus        20 ~~~~~~~~~~v~~Ll~~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~i   99 (471)
T PHA03095         20 LNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDV   99 (471)
T ss_pred             HcCCCCCHHHHHHHHHcCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHH
Confidence            457778888888888877544444778889999999888   889999999999999999888999999999988 5899


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHH--HcCChhhhhhhhhcCCcCccCcC
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAK--YYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~--~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      +++|+++|++++.+|..|.||||+|+  ..++.+++++|+++|++++..+.
T Consensus       100 v~lLl~~ga~in~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~  150 (471)
T PHA03095        100 IKLLIKAGADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDL  150 (471)
T ss_pred             HHHHHHcCCCCCCCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCC
Confidence            99999999999999988999999888  55678889999999988876543

>KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms]

Probab=99.76  E-value=4.7e-19  Score=172.78  Aligned_cols=175  Identities=24%  Similarity=0.237  Sum_probs=135.1

Q ss_pred             Hhhhhhhcccccccch-hhhhhhhcccCCCCCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCC
Q 011991            6 AQLKRGISRQFSTGSL-RRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD   84 (473)
Q Consensus         6 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~   84 (473)
                      |+..+.-+...|.+++ ++..+....|...+-....--.+.||..|+.+.+.++|..+....-.+.||.|+||.+|...+
T Consensus         6 a~~rR~~qlr~w~~~~~~~~~~~r~rR~~~v~f~~sa~~l~A~~~~d~~ev~~ll~~ga~~~~~n~DglTalhq~~id~~   85 (527)
T KOG0505|consen    6 ARKRRAEQLRRWAGSETRAEPPPRPRRKPKVRFEDSAVFLEACSRGDLEEVRKLLNRGASPNLCNVDGLTALHQACIDDN   85 (527)
T ss_pred             HHHHHHHHHhhhhhhhhccCCCccccCCCcccCCchHHHHhccccccHHHHHHHhccCCCccccCCccchhHHHHHhccc
Confidence            4455555555566555 344444444434444445555779999999999999999885555559999999999999999


Q ss_pred             HHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCC--------------------------
Q 011991           85 VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG--------------------------  138 (473)
Q Consensus        85 ~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g--------------------------  138 (473)
                      .+||++|+++|++||.+|+.||||||.|+.+||..|+++|+.+||++-+.|.+|                          
T Consensus        86 ~e~v~~l~e~ga~Vn~~d~e~wtPlhaaascg~~~i~~~li~~gA~~~avNsdg~~P~dl~e~ea~~~~l~~~~~r~gi~  165 (527)
T KOG0505|consen   86 LEMVKFLVENGANVNAQDNEGWTPLHAAASCGYLNIVEYLIQHGANLLAVNSDGNMPYDLAEDEATLDVLETEMARQGID  165 (527)
T ss_pred             HHHHHHHHHhcCCccccccccCCcchhhcccccHHHHHHHHHhhhhhhhccCCCCCccccccCcchhHHHHHHHHHhccc
Confidence            999999999999999999999999999999999999999888877766666433                          


Q ss_pred             ---------------------------------CcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCCCCCC
Q 011991          139 ---------------------------------STAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVANPREV  180 (473)
Q Consensus       139 ---------------------------------~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~~~~~  180 (473)
                                                       -|+||.|+..|..++.++|+++|++++..+   .+|++.|..+..
T Consensus       166 iea~R~~~e~~ml~D~~q~l~~G~~~d~~~~rG~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~D~dgWtPlHAAA~Wg~  243 (527)
T KOG0505|consen  166 IEAARKAEEQTMLDDARQWLNAGAELDARHARGATALHVAAANGYTEVAALLLQAGYSVNIKDYDGWTPLHAAAHWGQ  243 (527)
T ss_pred             HHHHhhhhHHHHHHHHHHHHhccccccccccccchHHHHHHhhhHHHHHHHHHHhccCcccccccCCCcccHHHHhhh
Confidence                                             467888888888888888888888886654   677777766544

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.76  E-value=1.5e-18  Score=180.15  Aligned_cols=139  Identities=26%  Similarity=0.266  Sum_probs=103.4

Q ss_pred             cCCCCcceeec--cCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcC--CHHHHHHHHHcCCCCcccCCCCCcHHHHH
Q 011991           37 PRRNNMRFSFG--RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG--DVKGVEDLLNEGSDVNSIDLDGRTALHIA  112 (473)
Q Consensus        37 ~~~~~~~~~~~--~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g--~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A  112 (473)
                      .....+++.|+  ..|+.+.++.+++.|......+.+|.||||+|+..|  +.+++++|+++|+++|.+|..|.||||+|
T Consensus       104 ~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A  183 (480)
T PHA03100        104 NNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIA  183 (480)
T ss_pred             CCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHH
Confidence            33456666677  777777777777766544444777888888888888  78888888888888888888888888888


Q ss_pred             HHcCCHHHHHHHHhCCCCCCccCCCC------CcHHHHHHHcCC--hhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          113 ACEGHVEVVKLLLSKKANIDARDRWG------STAAADAKYYGN--VEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       113 ~~~g~~~iv~~Ll~~ga~~~~~~~~g------~t~l~~A~~~~~--~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      +..|+.+++++|+++|++++..+..|      .||||.|+..|+  .+++++|+++|++++..+   .||++.|
T Consensus       184 ~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A  257 (480)
T PHA03100        184 VEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYA  257 (480)
T ss_pred             HHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence            88888888888888888887777777      777777777777  777777777777776554   3455444

>PHA02741 hypothetical protein; Provisional

Probab=99.76  E-value=4.1e-18  Score=151.11  Aligned_cols=110  Identities=21%  Similarity=0.229  Sum_probs=97.4

Q ss_pred             CCCCCChHHHHHHHcCCHHHHHHHHH------cCCCCcccCCCCCcHHHHHHHcCC----HHHHHHHHhCCCCCCccCC-
Q 011991           68 ENLDSTMQLLFMACRGDVKGVEDLLN------EGSDVNSIDLDGRTALHIAACEGH----VEVVKLLLSKKANIDARDR-  136 (473)
Q Consensus        68 ~~~~g~t~L~~aa~~g~~~~v~~Ll~------~ga~~n~~d~~g~T~lh~A~~~g~----~~iv~~Ll~~ga~~~~~~~-  136 (473)
                      .+.+|.||||+||..|+.++++.|+.      .|+++|.+|..|+||||+|+..|+    .+++++|+++|++++.+|. 
T Consensus        17 ~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~   96 (169)
T PHA02741         17 KNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEML   96 (169)
T ss_pred             cccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcC
Confidence            47789999999999999999999864      378999999999999999999999    5899999999999999995 


Q ss_pred             CCCcHHHHHHHcCChhhhhhhhh-cCCcCccCc---CCCCcCCCC
Q 011991          137 WGSTAAADAKYYGNVEVYNILKA-RGAKVPKTK---RTPMTVANP  177 (473)
Q Consensus       137 ~g~t~l~~A~~~~~~~~~~~L~~-~g~~i~~~~---~t~l~~a~~  177 (473)
                      .|+||||+|+..++.+++++|+. .|++++..+   .+|++.|..
T Consensus        97 ~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~  141 (169)
T PHA02741         97 EGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAID  141 (169)
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHH
Confidence            99999999999999999999997 588887654   456655543

>PHA02946 ankyin-like protein; Provisional

Probab=99.75  E-value=2.7e-18  Score=175.02  Aligned_cols=119  Identities=18%  Similarity=0.126  Sum_probs=97.0

Q ss_pred             CCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC--CHHHHHHHHhC
Q 011991           50 SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG--HVEVVKLLLSK  127 (473)
Q Consensus        50 g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g--~~~iv~~Ll~~  127 (473)
                      ++.+.++.++..|......|.+|.||||+||..|+.++|++||++|||+|.+|..|+||||+|+..+  +.+++++|+++
T Consensus        50 ~~~~iv~~Ll~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~  129 (446)
T PHA02946         50 LDERFVEELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQY  129 (446)
T ss_pred             CCHHHHHHHHHCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHc
Confidence            3445667777766544445888999999999999999999999999999999999999999988765  47889999999


Q ss_pred             CCCCCc-cCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          128 KANIDA-RDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       128 ga~~~~-~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      ||+++. .|..|.|||+ |+..|+.+++++|+++|++++..+.
T Consensus       130 Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~  171 (446)
T PHA02946        130 GAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDK  171 (446)
T ss_pred             CCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCC
Confidence            999985 6888999997 6667888899999998888876653

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.75  E-value=2.1e-18  Score=181.86  Aligned_cols=145  Identities=17%  Similarity=0.164  Sum_probs=116.9

Q ss_pred             cccCCCCCc---CCCCcceeeccCCCC--ccccCCCCCccCCCCCCCCCChHHHHH------------------------
Q 011991           29 MSRQSSFDP---RRNNMRFSFGRQSSL--DPIRRSPVQDELTVPENLDSTMQLLFM------------------------   79 (473)
Q Consensus        29 ~~~~~~~~~---~~~~~~~~~~~~g~~--~~~~~~l~~~~~~~~~~~~g~t~L~~a------------------------   79 (473)
                      ++....++.   ....+++.|++.|+.  +.|+.|++.|......+..|+||||+|                        
T Consensus       199 Le~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~  278 (764)
T PHA02716        199 CNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKV  278 (764)
T ss_pred             HHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhcccccc
Confidence            444444442   244556667778865  667778877754444588999999975                        


Q ss_pred             -------------HHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHH--cCCHHHHHHHHhCCCCCCccCCCCCcHHHH
Q 011991           80 -------------ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC--EGHVEVVKLLLSKKANIDARDRWGSTAAAD  144 (473)
Q Consensus        80 -------------a~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~--~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~  144 (473)
                                   |..|+.+++++|+++|+++|.+|..|+||||+|+.  .++.+++++|+++|||++.+|..|+||||+
T Consensus       279 ~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TPLH~  358 (764)
T PHA02716        279 KNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVLHT  358 (764)
T ss_pred             ccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCHHHH
Confidence                         44688999999999999999999999999999864  568999999999999999999999999999


Q ss_pred             HHH--------------cCChhhhhhhhhcCCcCccCcC---CCCc
Q 011991          145 AKY--------------YGNVEVYNILKARGAKVPKTKR---TPMT  173 (473)
Q Consensus       145 A~~--------------~~~~~~~~~L~~~g~~i~~~~~---t~l~  173 (473)
                      |+.              .++.+++++|+++|++++..+.   ||++
T Consensus       359 A~~~lav~~~ld~~~~~~~~~eVVklLL~~GADIn~kn~~G~TPLh  404 (764)
T PHA02716        359 YLSMLSVVNILDPETDNDIRLDVIQCLISLGADITAVNCLGYTPLT  404 (764)
T ss_pred             HHHhhhhhccccccccccChHHHHHHHHHCCCCCCCcCCCCCChHH
Confidence            865              3688999999999999987654   5554

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.75  E-value=1.1e-18  Score=130.71  Aligned_cols=98  Identities=27%  Similarity=0.327  Sum_probs=85.6

Q ss_pred             ccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHh
Q 011991           47 GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS  126 (473)
Q Consensus        47 ~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~  126 (473)
                      .+.|.++.|++.+..+ .+++....|+||||+||-.|+++++++|+..|||++.+|+.|.|||.-|++.||.++|++||+
T Consensus        10 vkNG~~DeVk~~v~~g-~nVn~~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~   88 (117)
T KOG4214|consen   10 VKNGEIDEVKQSVNEG-LNVNEIYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQ   88 (117)
T ss_pred             hccCcHHHHHHHHHcc-ccHHHHhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHH
Confidence            4778888898888777 677777788999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccCCCCCcHHHHH
Q 011991          127 KKANIDARDRWGSTAAADA  145 (473)
Q Consensus       127 ~ga~~~~~~~~g~t~l~~A  145 (473)
                      +|||-+.+..+|.+.+..+
T Consensus        89 ~GAdrt~~~PdG~~~~eat  107 (117)
T KOG4214|consen   89 NGADRTIHAPDGTALIEAT  107 (117)
T ss_pred             cCcccceeCCCchhHHhhc
Confidence            9999998888888877654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=1.9e-18  Score=180.96  Aligned_cols=215  Identities=30%  Similarity=0.503  Sum_probs=153.5

Q ss_pred             cChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          185 LNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       185 i~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      ..+...+|...+.+..|.|+.+     +.+.+++|+|+ +++..        +.+-  ++.....|.+|           
T Consensus        78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             cCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee-----------
Confidence            3444556777788889988754     33467788843 33211        0000  22222344333           


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                                |+-...++.-+.++..-        +.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++..-
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence                      56666666656665433        88999999999   9999999999999999999999999986432


Q ss_pred             cCc---------ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          340 ISP---------EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       340 ~~~---------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ...         .+......-....|||.|+|||++...+|+..+|.|++|+++|+.+-|+.||.+.++++.+..++..-
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            110         00111111123469999999999999999999999999999999999999999999999988775433


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF  444 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  444 (473)
                      .. ..+ ....+++++++++.++|..+|..|.-.
T Consensus       275 i~-wpE-~dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  275 IE-WPE-EDEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             cc-ccc-cCcCCCHHHHHHHHHHHHhChHhhccc
Confidence            21 111 244578999999999999999999443

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.74  E-value=1e-17  Score=159.59  Aligned_cols=108  Identities=18%  Similarity=0.128  Sum_probs=93.3

Q ss_pred             CCCCCChHH-HHHHHcCCHHHHHHHHHcCCCCcccC----CCCCcHHHHHHHcCCHHHHHHHHhCCCCCCcc-CCCCCcH
Q 011991           68 ENLDSTMQL-LFMACRGDVKGVEDLLNEGSDVNSID----LDGRTALHIAACEGHVEVVKLLLSKKANIDAR-DRWGSTA  141 (473)
Q Consensus        68 ~~~~g~t~L-~~aa~~g~~~~v~~Ll~~ga~~n~~d----~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~-~~~g~t~  141 (473)
                      .|.+|.|++ |.|+..|+.+++++|+++|||+|.+|    ..|.||||+|+..|+.+++++|+++|||++.+ +..|.||
T Consensus        28 ~d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~Tp  107 (300)
T PHA02884         28 KNKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITP  107 (300)
T ss_pred             cCcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCH
Confidence            466676655 55555689999999999999999974    68999999999999999999999999999996 5689999


Q ss_pred             HHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          142 AADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       142 l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      ||+|+..|+.+++++|+.+|++++..+.   ||++.|
T Consensus       108 Lh~Aa~~~~~eivklLL~~GAdin~kd~~G~TpL~~A  144 (300)
T PHA02884        108 LYISVLHGCLKCLEILLSYGADINIQTNDMVTPIELA  144 (300)
T ss_pred             HHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            9999999999999999999999987654   444444

>KOG0515 consensus p53-interacting protein 53BP/ASPP, contains ankyrin and SH3 domains [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=6.9e-19  Score=169.99  Aligned_cols=137  Identities=26%  Similarity=0.273  Sum_probs=113.3

Q ss_pred             hhhhhhhhccc-CCCCCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCc
Q 011991           21 LRRSLTRQMSR-QSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVN   99 (473)
Q Consensus        21 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n   99 (473)
                      |||..+...++ ...|||..  .+++|+-.|.+|.|++.+.+-.+....+.+|-|+||.|+|.||.+||++||+.|+|||
T Consensus       533 LRk~gser~a~GRvrfnPLa--LLLDaaLeGEldlVq~~i~ev~DpSqpNdEGITaLHNAiCaghyeIVkFLi~~ganVN  610 (752)
T KOG0515|consen  533 LRKAGSERMAHGRVRFNPLA--LLLDAALEGELDLVQRIIYEVTDPSQPNDEGITALHNAICAGHYEIVKFLIEFGANVN  610 (752)
T ss_pred             hccCCCccccccceecchHH--HHHhhhhcchHHHHHHHHHhhcCCCCCCccchhHHhhhhhcchhHHHHHHHhcCCccc
Confidence            34444444444 45577774  4889999999999999887766555668899999999999999999999999999999


Q ss_pred             ccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccC-CCCCcHHHHHH--HcCChhhhhhhhh
Q 011991          100 SIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD-RWGSTAAADAK--YYGNVEVYNILKA  159 (473)
Q Consensus       100 ~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~-~~g~t~l~~A~--~~~~~~~~~~L~~  159 (473)
                      +.|.+||||||+||.++++.+++.|++.||-+.+.. .++.||.+-|.  +.|..+|.+||-.
T Consensus       611 a~DSdGWTPLHCAASCNnv~~ckqLVe~GaavfAsTlSDmeTa~eKCee~eeGY~~CsqyL~~  673 (752)
T KOG0515|consen  611 AADSDGWTPLHCAASCNNVPMCKQLVESGAAVFASTLSDMETAAEKCEEMEEGYDQCSQYLYG  673 (752)
T ss_pred             CccCCCCchhhhhhhcCchHHHHHHHhccceEEeeecccccchhhhcchhhhhHHHHHHHHHH
Confidence            999999999999999999999999999999887655 57889988664  6678888888854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=7e-19  Score=172.78  Aligned_cols=177  Identities=28%  Similarity=0.437  Sum_probs=132.7

Q ss_pred             ceEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      ++|+.|++|.-.+|.++|....   ..+......++.|++.|+.|   ++   .+|+|+||.||++..++.+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            5899999999999999997542   36788899999999999999   77   999999999999999999999999998


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      ................+...||..||+||.+.+..|+.++||||||.+++|++.   +|...............+..|+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~  480 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPE  480 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChH
Confidence            655443311112223456679999999999999999999999999999999996   23222222222222233433322


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEI  447 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el  447 (473)
                      .  ..++ +.-..|+.+++...|.+||++.+.
T Consensus       481 ~--~~d~-p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  481 F--LQDY-PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             H--hhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence            1  1222 455689999999999999955443

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.74  E-value=5.3e-18  Score=142.00  Aligned_cols=106  Identities=36%  Similarity=0.431  Sum_probs=97.2

Q ss_pred             CCChHHHHHHHcCCHHHHHHHHHcCCC-CcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcC
Q 011991           71 DSTMQLLFMACRGDVKGVEDLLNEGSD-VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYG  149 (473)
Q Consensus        71 ~g~t~L~~aa~~g~~~~v~~Ll~~ga~-~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~  149 (473)
                      +-...+.+||..+.+..|+.||+..|+ ||.+|.+|.||||.|+++||.+||+.|+..||+++++...||||||-||.++
T Consensus        62 dp~rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWn  141 (228)
T KOG0512|consen   62 DPIRLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWN  141 (228)
T ss_pred             CHHHHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhccc
Confidence            334568899999999999999998887 8999999999999999999999999999999999999999999999999999


Q ss_pred             ChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          150 NVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       150 ~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      +.+++-+|+++|+|+++..   .+|++.+.
T Consensus       142 N~~va~~LLqhgaDVnA~t~g~ltpLhlaa  171 (228)
T KOG0512|consen  142 NFEVAGRLLQHGADVNAQTKGLLTPLHLAA  171 (228)
T ss_pred             chhHHHHHHhccCcccccccccchhhHHhh
Confidence            9999999999999998764   46666653

>PHA02798 ankyrin-like protein; Provisional

Probab=99.74  E-value=4.2e-18  Score=176.74  Aligned_cols=121  Identities=17%  Similarity=0.199  Sum_probs=108.5

Q ss_pred             ccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHc-----CCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC---CH
Q 011991           47 GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR-----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG---HV  118 (473)
Q Consensus        47 ~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~-----g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g---~~  118 (473)
                      ...++.+.++.|++.|......+.+|.||||.|+.+     ++.+++++|+++|||+|.+|..|+||||+|+..|   +.
T Consensus        46 ~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~  125 (489)
T PHA02798         46 RDSPSTDIVKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNL  125 (489)
T ss_pred             CCCCCHHHHHHHHHCCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChH
Confidence            345577888888888764444589999999999864     7799999999999999999999999999999886   78


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCC---hhhhhhhhhcCCcCccC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGN---VEVYNILKARGAKVPKT  167 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~---~~~~~~L~~~g~~i~~~  167 (473)
                      +++++|+++|||++.+|..|.||||+|+..|+   .+++++|+++|++++..
T Consensus       126 ~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~  177 (489)
T PHA02798        126 EILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH  177 (489)
T ss_pred             HHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence            99999999999999999999999999999998   89999999999999765

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.73  E-value=5.9e-18  Score=175.65  Aligned_cols=129  Identities=16%  Similarity=0.166  Sum_probs=88.6

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHH-----HHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHH-
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLF-----MACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA-  113 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~-----aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~-  113 (473)
                      ..+++.|+..|+.+.|+.+++.|......+.+|.||||+     |+..|+.+++++|+++|+++|..|..|.||||+|+ 
T Consensus        36 ~t~L~~A~~~~~~~ivk~Ll~~g~~~~~~~~~~~t~L~~~~~~~a~~~~~~~iv~~Ll~~ga~i~~~d~~g~tpL~~A~~  115 (480)
T PHA03100         36 VLPLYLAKEARNIDVVKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAIS  115 (480)
T ss_pred             chhhhhhhccCCHHHHHHHHHcCCCCCCccccCcCHHHHHHHHHHHhhchHHHHHHHHHCCCCCCCCCCCCCchhhHHHh
Confidence            345566667777777777776664333335666677777     77777777777777777777777777777777777 


Q ss_pred             -HcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcC--ChhhhhhhhhcCCcCccCc
Q 011991          114 -CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYG--NVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       114 -~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~--~~~~~~~L~~~g~~i~~~~  168 (473)
                       ..|+.+++++|+++|++++.+|..|.||||+|+..|  +.+++++|+++|++++..+
T Consensus       116 ~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d  173 (480)
T PHA03100        116 KKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKN  173 (480)
T ss_pred             cccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCccccc
Confidence             777777777777777777777777777777777777  6777777777777665543

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.73  E-value=3.7e-18  Score=173.32  Aligned_cols=132  Identities=31%  Similarity=0.306  Sum_probs=119.6

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHH-cC-CCCcccCCCCCcHHHHHHH
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLN-EG-SDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~-~g-a~~n~~d~~g~T~lh~A~~  114 (473)
                      .-...++..||++|+++.+--++..|......+.++.||||.||..|+.+.|+.||+ .| ..+|..|..|.||||+|+.
T Consensus       271 ~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~  350 (929)
T KOG0510|consen  271 NDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAK  350 (929)
T ss_pred             ccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhh
Confidence            335567788899999999999999987777779999999999999999999999999 44 4579999999999999999


Q ss_pred             cCCHHHHHHHHhCCCCCC---ccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          115 EGHVEVVKLLLSKKANID---ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~---~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      +||..++++||+.||+..   ..|.+|.||||.|+.+|+..+|++|+.+|+++...+
T Consensus       351 ~gH~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n  407 (929)
T KOG0510|consen  351 SGHDRVVQLLLNKGALFLNMSEADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKN  407 (929)
T ss_pred             cCHHHHHHHHHhcChhhhcccccccCCchhhhHHHHhccHHHHHHHHHcCCceeecc
Confidence            999999999999999987   569999999999999999999999999999995543

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.72  E-value=7.1e-18  Score=171.29  Aligned_cols=142  Identities=22%  Similarity=0.261  Sum_probs=125.3

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccC---------------CCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCc
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDEL---------------TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVN   99 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~---------------~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n   99 (473)
                      +++....++..|...|+++.++.+|.++.-               .+..|.+|.||||+||..|+.+.|+.|+..||++|
T Consensus       221 ~~n~~~~pLhlAve~g~~e~lk~~L~n~~~~a~~~~~~~~q~kelv~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~  300 (929)
T KOG0510|consen  221 DNNEKATPLHLAVEGGDIEMLKMCLQNGKKIADVQLDAMQQEKELVNDEDNDGCTPLHYAARQGGPESVDNLLGFGASIN  300 (929)
T ss_pred             ccCCCCcchhhhhhcCCHHHHHHHHhCccccchhhhHHHHHHHHHhhcccccCCchHHHHHHcCChhHHHHHHHcCCccc
Confidence            447788889999999999999999988732               22458899999999999999999999999999999


Q ss_pred             ccCCCCCcHHHHHHHcCCHHHHHHHHh-CC-CCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCcc------CcCCC
Q 011991          100 SIDLDGRTALHIAACEGHVEVVKLLLS-KK-ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK------TKRTP  171 (473)
Q Consensus       100 ~~d~~g~T~lh~A~~~g~~~iv~~Ll~-~g-a~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~------~~~t~  171 (473)
                      .++.++.||||.||.+|+.+.|+-||+ .| ..+|..|-.|.||||+|+..||.+++++|+++|+....      .+.|+
T Consensus       301 ~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~~e~D~dg~Ta  380 (929)
T KOG0510|consen  301 SKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNMSEADSDGNTA  380 (929)
T ss_pred             ccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhcccccccCCchh
Confidence            999999999999999999999999998 55 67889999999999999999999999999999998763      23566


Q ss_pred             CcCCC
Q 011991          172 MTVAN  176 (473)
Q Consensus       172 l~~a~  176 (473)
                      ++.|.
T Consensus       381 LH~Aa  385 (929)
T KOG0510|consen  381 LHLAA  385 (929)
T ss_pred             hhHHH
Confidence            66653

>PHA03095 ankyrin-like protein; Provisional

Probab=99.72  E-value=1.6e-17  Score=172.02  Aligned_cols=130  Identities=25%  Similarity=0.239  Sum_probs=113.7

Q ss_pred             CCCcceeeccCC---CCccccCCCCCccCCCCCCCCCChHHHHHHHcC-CHHHHHHHHHcCCCCcccCCCCCcHHHHHH-
Q 011991           39 RNNMRFSFGRQS---SLDPIRRSPVQDELTVPENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTALHIAA-  113 (473)
Q Consensus        39 ~~~~~~~~~~~g---~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g-~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~-  113 (473)
                      ...++..|+..|   +.+.++.+++.|......+..|.||||+|+..| +.+++++|+++|+++|.+|..|+||||+|+ 
T Consensus        47 g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~~g~tpLh~a~~  126 (471)
T PHA03095         47 GKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKVGRTPLHVYLS  126 (471)
T ss_pred             CCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHhh
Confidence            445666677777   778788888877554445889999999999999 599999999999999999999999999999 


Q ss_pred             -HcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcC--ChhhhhhhhhcCCcCccCc
Q 011991          114 -CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYG--NVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       114 -~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~--~~~~~~~L~~~g~~i~~~~  168 (473)
                       ..++.+++++|+++|++++.+|..|.||||+|...+  +.+++++|+++|++++..+
T Consensus       127 ~~~~~~~iv~~Ll~~gad~~~~d~~g~tpL~~a~~~~~~~~~iv~~Ll~~g~~~~~~d  184 (471)
T PHA03095        127 GFNINPKVIRLLLRKGADVNALDLYGMTPLAVLLKSRNANVELLRLLIDAGADVYAVD  184 (471)
T ss_pred             CCcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCcccC
Confidence             567899999999999999999999999999998766  6789999999999986654

>PHA02946 ankyin-like protein; Provisional

Probab=99.72  E-value=1.6e-17  Score=169.32  Aligned_cols=148  Identities=14%  Similarity=0.155  Sum_probs=121.2

Q ss_pred             cccCCCCC---cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcC--CHHHHHHHHHcCCCCcc-cC
Q 011991           29 MSRQSSFD---PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG--DVKGVEDLLNEGSDVNS-ID  102 (473)
Q Consensus        29 ~~~~~~~~---~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g--~~~~v~~Ll~~ga~~n~-~d  102 (473)
                      +.+...++   .....++.-|+..|+.+.++.|++.|......|.+|.||||+|+..+  ..+++++|+++|+++|. .|
T Consensus        59 l~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d  138 (446)
T PHA02946         59 LHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVD  138 (446)
T ss_pred             HHCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccC
Confidence            44444444   34556777888999999888888887444445999999999999866  48999999999999995 68


Q ss_pred             CCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCC--hhhhhhhhhcCCcCccCc---CCCCcCCCC
Q 011991          103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN--VEVYNILKARGAKVPKTK---RTPMTVANP  177 (473)
Q Consensus       103 ~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~--~~~~~~L~~~g~~i~~~~---~t~l~~a~~  177 (473)
                      .+|.|||| ||..|+.+++++|++.|++++.+|..|+||||+|+..++  .+++++|+++|++++..+   .||++.|..
T Consensus       139 ~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~TpLH~Aa~  217 (446)
T PHA02946        139 EEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGKNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNTPLHIVCS  217 (446)
T ss_pred             CCCCcHHH-HHHCCChHHHHHHHhccccccccCCCCCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence            99999998 677799999999999999999999999999999887654  589999999999997654   577776643

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.72  E-value=1.9e-17  Score=178.84  Aligned_cols=101  Identities=26%  Similarity=0.354  Sum_probs=73.6

Q ss_pred             CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC-HHHHHHHHhCCCCCCccCCCCCcHHHHHH
Q 011991           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH-VEVVKLLLSKKANIDARDRWGSTAAADAK  146 (473)
Q Consensus        68 ~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~-~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~  146 (473)
                      .|..|.||||+||..|+.+++++|+++|++++..+..|.||||+|+..++ .+++++|+++|+++|.+|..|+||||+|+
T Consensus       371 ~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~TpLh~Aa  450 (682)
T PHA02876        371 RDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLHYAC  450 (682)
T ss_pred             CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCChHHHHHH
Confidence            36677777777777777777777777777777777777777777766554 45677777777777777778888888877


Q ss_pred             HcC-ChhhhhhhhhcCCcCccCc
Q 011991          147 YYG-NVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       147 ~~~-~~~~~~~L~~~g~~i~~~~  168 (473)
                      ..| +.+++++|+++|++++..+
T Consensus       451 ~~~~~~~iv~lLl~~Gad~n~~d  473 (682)
T PHA02876        451 KKNCKLDVIEMLLDNGADVNAIN  473 (682)
T ss_pred             HhCCcHHHHHHHHHCCCCCCCCC
Confidence            765 5677888888887776654

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.71  E-value=7.5e-18  Score=132.70  Aligned_cols=88  Identities=32%  Similarity=0.465  Sum_probs=77.9

Q ss_pred             eeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHH
Q 011991           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (473)
Q Consensus        44 ~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~  123 (473)
                      +.|++.|+++.++.+++.+ .+.+.   |.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++
T Consensus         2 ~~A~~~~~~~~~~~ll~~~-~~~~~---~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~   77 (89)
T PF12796_consen    2 HIAAQNGNLEILKFLLEKG-ADINL---GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKL   77 (89)
T ss_dssp             HHHHHTTTHHHHHHHHHTT-STTTS---SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHCc-CCCCC---CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHH
Confidence            4578999999999999865 23222   8999999999999999999999999999999999999999999999999999


Q ss_pred             HHhCCCCCCccC
Q 011991          124 LLSKKANIDARD  135 (473)
Q Consensus       124 Ll~~ga~~~~~~  135 (473)
                      |+++|++++.+|
T Consensus        78 Ll~~g~~~~~~n   89 (89)
T PF12796_consen   78 LLEHGADVNIRN   89 (89)
T ss_dssp             HHHTTT-TTSS-
T ss_pred             HHHcCCCCCCcC
Confidence            999999999886

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PHA02798 ankyrin-like protein; Provisional

Probab=99.71  E-value=2.1e-17  Score=171.56  Aligned_cols=116  Identities=20%  Similarity=0.279  Sum_probs=86.9

Q ss_pred             CCCccccCCCCCccCCCCCCCCCChHHHHHHHcC---CHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC---HHHHHH
Q 011991           50 SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVVKL  123 (473)
Q Consensus        50 g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g---~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~---~~iv~~  123 (473)
                      +..+.++.|++.|......+.+|.||||+|+..|   +.+++++|+++|||+|.+|..|.||||+|+..|+   .+++++
T Consensus        87 ~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~  166 (489)
T PHA02798         87 HMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKL  166 (489)
T ss_pred             hHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHH
Confidence            4566677777766543344888999999998875   7899999999999999999999999999998887   888888


Q ss_pred             HHhCCCCCCccC-CCCCcHHHHHHHc----CChhhhhhhhhcCCcCc
Q 011991          124 LLSKKANIDARD-RWGSTAAADAKYY----GNVEVYNILKARGAKVP  165 (473)
Q Consensus       124 Ll~~ga~~~~~~-~~g~t~l~~A~~~----~~~~~~~~L~~~g~~i~  165 (473)
                      |+++|+|++.++ ..|.||||.+...    ++.+++++|+++|++++
T Consensus       167 Ll~~gadin~~~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~  213 (489)
T PHA02798        167 LLEKGVDINTHNNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIIN  213 (489)
T ss_pred             HHHhCCCcccccCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCcc
Confidence            888888887664 3566666665543    25566666666665543

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.71  E-value=9e-18  Score=156.07  Aligned_cols=136  Identities=27%  Similarity=0.296  Sum_probs=111.1

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHc-----CCHHHHHHHHHcCCCCcccC-CCCCcHHHH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACR-----GDVKGVEDLLNEGSDVNSID-LDGRTALHI  111 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~-----g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~  111 (473)
                      .+.++..+...+|++.|..||+.+-.+++. |.-|+||+++||..     .+..+|..|.+. .|||++- ..|+|+||+
T Consensus       268 GNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~m-gnVNaKAsQ~gQTALML  346 (452)
T KOG0514|consen  268 GNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKM-GDVNAKASQHGQTALML  346 (452)
T ss_pred             CCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhc-cCcchhhhhhcchhhhh
Confidence            444455555788999999999999998887 88899999998874     567888888866 4888874 679999999


Q ss_pred             HHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhc-CCcCccCc---CCCCcCC
Q 011991          112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR-GAKVPKTK---RTPMTVA  175 (473)
Q Consensus       112 A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~-g~~i~~~~---~t~l~~a  175 (473)
                      |+.+|+.++|+.||..|||+|++|.+|.|+|++|++.||.+|+++|+.. ++++..++   .|.+.+|
T Consensus       347 AVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IA  414 (452)
T KOG0514|consen  347 AVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIA  414 (452)
T ss_pred             hhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhH
Confidence            9999999999999999999999999999999999999999999987764 56665554   4555554

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.71  E-value=1.3e-17  Score=179.22  Aligned_cols=118  Identities=28%  Similarity=0.261  Sum_probs=96.1

Q ss_pred             eccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHH
Q 011991           46 FGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL  125 (473)
Q Consensus        46 ~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll  125 (473)
                      ++..+.....+.+++.+...-..+.+|.||||.||.+|+.++|++||++|||+|++|+.|+||||.||..|+.+|+.+|+
T Consensus       514 a~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLl  593 (1143)
T KOG4177|consen  514 AADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLL  593 (1143)
T ss_pred             hhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHH
Confidence            34444444444444444322233667889999999999999999999999999999999999999999999999999999


Q ss_pred             hCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          126 SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       126 ~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      ++||++|..|.+|.|||++|.+.|+.+++++|...+.+
T Consensus       594 k~GA~vna~d~~g~TpL~iA~~lg~~~~~k~l~~~~~~  631 (1143)
T KOG4177|consen  594 KHGASVNAADLDGFTPLHIAVRLGYLSVVKLLKVVTAT  631 (1143)
T ss_pred             HcCCCCCcccccCcchhHHHHHhcccchhhHHHhccCc
Confidence            99999999999999999999999999999999888887

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.71  E-value=3.9e-17  Score=144.17  Aligned_cols=108  Identities=22%  Similarity=0.269  Sum_probs=95.0

Q ss_pred             CCCCCChHHHHHHHcCCH----HHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH---HHHHHhCCCCCCccC-CCCC
Q 011991           68 ENLDSTMQLLFMACRGDV----KGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV---VKLLLSKKANIDARD-RWGS  139 (473)
Q Consensus        68 ~~~~g~t~L~~aa~~g~~----~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i---v~~Ll~~ga~~~~~~-~~g~  139 (473)
                      .+.++.++||.||..|+.    +++++|++.|+++|.+|..|+||||+||..|+.++   +++|+++|++++.+| ..|.
T Consensus        16 ~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~   95 (166)
T PHA02743         16 IDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGN   95 (166)
T ss_pred             hccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCC
Confidence            366788999999999998    66778889999999999999999999999998764   899999999999998 5899


Q ss_pred             cHHHHHHHcCChhhhhhhhh-cCCcCccCc---CCCCcCC
Q 011991          140 TAAADAKYYGNVEVYNILKA-RGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       140 t~l~~A~~~~~~~~~~~L~~-~g~~i~~~~---~t~l~~a  175 (473)
                      ||||+|+..|+.+++++|+. .|++++..+   .++++.|
T Consensus        96 TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tpL~~A  135 (166)
T PHA02743         96 TLLHIAASTKNYELAEWLCRQLGVNLGAINYQHETAYHIA  135 (166)
T ss_pred             cHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCHHHHH
Confidence            99999999999999999995 899987765   4555554

>PHA02917 ankyrin-like protein; Provisional

Probab=99.70  E-value=3.4e-17  Score=173.49  Aligned_cols=119  Identities=12%  Similarity=0.063  Sum_probs=86.8

Q ss_pred             ccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHH----HHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHH
Q 011991           47 GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVK----GVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (473)
Q Consensus        47 ~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~----~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~  122 (473)
                      +..|+.+.++.||+.|......+.+|+||||+|+..|+.+    +++.|++.+..+|..|.  .+++|+|+..|+.|+|+
T Consensus        43 ~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~~~~--~~~~~~a~~~~~~e~vk  120 (661)
T PHA02917         43 EHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNINDF--NIFSYMKSKNVDVDLIK  120 (661)
T ss_pred             hhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCCCCc--chHHHHHhhcCCHHHHH
Confidence            4446667777776666444444666777777777777643    44566665433444332  25666677777889999


Q ss_pred             HHHhCCCCCCccCCCCCcHHHHH--HHcCChhhhhhhhhcCCcCccC
Q 011991          123 LLLSKKANIDARDRWGSTAAADA--KYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       123 ~Ll~~ga~~~~~~~~g~t~l~~A--~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      +|+++|||+|.+|..|.||||.|  +..|+.+++++|+++|++++..
T Consensus       121 ~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~  167 (661)
T PHA02917        121 VLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYE  167 (661)
T ss_pred             HHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCcccc
Confidence            99999999999999999999964  3578999999999999999754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=3.3e-16  Score=144.24  Aligned_cols=134  Identities=26%  Similarity=0.386  Sum_probs=110.1

Q ss_pred             CceeeeEEEEE---EecCcEEEEEEEcCCCCCCHH-----HHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          196 DGITKGSYQVA---KWNGTKVWVKILDKESHKDPE-----RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       196 ~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      +.+|+|+++.+   ...|..+++|+..........     ....+.+|+.++..+.|++|+....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            35788887754   567899999987654433221     2356788999999999999887777777777889999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      +|++|.+++....   . ....++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++|+|||++..
T Consensus        82 ~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986542   2 78899999999999999999   99999999999999 78999999998753

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.70  E-value=5.8e-17  Score=168.47  Aligned_cols=137  Identities=16%  Similarity=0.140  Sum_probs=107.1

Q ss_pred             cccCCCCCcC--CCCcceeeccC--CCCccccCCCCCccCCCCCCCCCChHHHHHHHcC------CHHHHHHHHHcCCCC
Q 011991           29 MSRQSSFDPR--RNNMRFSFGRQ--SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG------DVKGVEDLLNEGSDV   98 (473)
Q Consensus        29 ~~~~~~~~~~--~~~~~~~~~~~--g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g------~~~~v~~Ll~~ga~~   98 (473)
                      +....+++-.  ...+++.++..  ++.+.++.|+++| ++++....+.||||.|+..+      +.++|++|+++|||+
T Consensus        23 L~~GadvN~~~~g~t~l~~~~~~~~~~~~iv~~Ll~~G-Advn~~~~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadi  101 (494)
T PHA02989         23 LRTGFDVNEEYRGNSILLLYLKRKDVKIKIVKLLIDNG-ADVNYKGYIETPLCAVLRNREITSNKIKKIVKLLLKFGADI  101 (494)
T ss_pred             HHcCCCcccccCCCCHHHHHHhcCCCChHHHHHHHHcC-CCccCCCCCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCC
Confidence            4444445532  23333333433  3567777777766 45555446799999988754      578999999999999


Q ss_pred             cccCCCCCcHHHHHHHc---CCHHHHHHHHhCCCCC-CccCCCCCcHHHHHHHc--CChhhhhhhhhcCCcCcc
Q 011991           99 NSIDLDGRTALHIAACE---GHVEVVKLLLSKKANI-DARDRWGSTAAADAKYY--GNVEVYNILKARGAKVPK  166 (473)
Q Consensus        99 n~~d~~g~T~lh~A~~~---g~~~iv~~Ll~~ga~~-~~~~~~g~t~l~~A~~~--~~~~~~~~L~~~g~~i~~  166 (473)
                      |.+|..|+||||.|+..   |+.+++++|+++|||+ +.+|..|.||||+|+..  ++.+++++|+++|++++.
T Consensus       102 n~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~  175 (494)
T PHA02989        102 NLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE  175 (494)
T ss_pred             CCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence            99999999999988765   6899999999999999 89999999999998754  588999999999999876

>PHA02795 ankyrin-like protein; Provisional

Probab=99.69  E-value=3.1e-17  Score=162.38  Aligned_cols=135  Identities=19%  Similarity=0.191  Sum_probs=113.6

Q ss_pred             CCcceeecc--CCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCC-ccc-----CCCCCcHHHH
Q 011991           40 NNMRFSFGR--QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDV-NSI-----DLDGRTALHI  111 (473)
Q Consensus        40 ~~~~~~~~~--~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~-n~~-----d~~g~T~lh~  111 (473)
                      ...++.++.  .|+.+.++.|+++|.. ++. .++.||||.|+..|+.+++++|+++|++. |..     +..|.|++|.
T Consensus       117 ~~~L~~~~~n~~n~~eiV~~LI~~GAD-In~-~~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~  194 (437)
T PHA02795        117 QDLLLYYLSNAYVEIDIVDFMVDHGAV-IYK-IECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFL  194 (437)
T ss_pred             cHHHHHHHHhcCCCHHHHHHHHHCCCC-CCC-CCCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHH
Confidence            444555666  7888999999988854 333 35689999999999999999999999854 332     2347899999


Q ss_pred             HHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       112 A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      |+..++.|++++|+++|||+|.+|..|.||||+|+..|+.+++++|+++|++++.++   .|+++.|.
T Consensus       195 a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa  262 (437)
T PHA02795        195 VDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAV  262 (437)
T ss_pred             HHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            999999999999999999999999999999999999999999999999999998775   45555553

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=2.6e-16  Score=143.56  Aligned_cols=129  Identities=25%  Similarity=0.330  Sum_probs=102.9

Q ss_pred             eeeeEEEEE---EecCcEEEEEEEcCCCCCCH-----HHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          198 ITKGSYQVA---KWNGTKVWVKILDKESHKDP-----ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       198 ig~G~~~~~---~~~~~~vavK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      ||+|+++.+   .++|..+++|..........     ....++.+|+++++.+.|+++....-++......++||||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            577777643   57888999999765432221     1246788999999999988765555555566677999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ++|.+++.....       .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998765321       78999999999999999   99999999999999 78999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.69  E-value=6.4e-17  Score=168.15  Aligned_cols=128  Identities=21%  Similarity=0.190  Sum_probs=93.0

Q ss_pred             cCCCCccccCCCCCccCC-CCCCCCCChHHHHHHHc--CCHHHHHHHHHcCCCCcc-cCCCCCcHHHHHHHcC----CHH
Q 011991           48 RQSSLDPIRRSPVQDELT-VPENLDSTMQLLFMACR--GDVKGVEDLLNEGSDVNS-IDLDGRTALHIAACEG----HVE  119 (473)
Q Consensus        48 ~~g~~~~~~~~l~~~~~~-~~~~~~g~t~L~~aa~~--g~~~~v~~Ll~~ga~~n~-~d~~g~T~lh~A~~~g----~~~  119 (473)
                      ..|+.+.++.|++.|... ...+..|+||||+|+..  ++.++|++|+++|+|++. .|..|.||||+|+..+    +.+
T Consensus       120 ~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~~~~~g~tpL~~a~~~~~~~~~~~  199 (494)
T PHA02989        120 NINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEKTSLYGLTPMNIYLRNDIDVISIK  199 (494)
T ss_pred             ccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccccccCCChHHHHHhcccccccHH
Confidence            346677777777776433 23477888888887653  578888888888888887 5778888888877654    788


Q ss_pred             HHHHHHhCCCCCCc--------------------------------------cCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          120 VVKLLLSKKANIDA--------------------------------------RDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       120 iv~~Ll~~ga~~~~--------------------------------------~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      ++++|+++|++++.                                      +|..|+||||+|+..|+.+++++|+++|
T Consensus       200 iv~~Ll~~Ga~vn~~~~~~~t~l~~~~~~~~~~~~~~~~il~~l~~~advn~~d~~G~TpL~~Aa~~~~~~~v~~LL~~G  279 (494)
T PHA02989        200 VIKYLIKKGVNIETNNNGSESVLESFLDNNKILSKKEFKVLNFILKYIKINKKDKKGFNPLLISAKVDNYEAFNYLLKLG  279 (494)
T ss_pred             HHHHHHhCCCCccccCCccccHHHHHHHhchhhcccchHHHHHHHhCCCCCCCCCCCCCHHHHHHHhcCHHHHHHHHHcC
Confidence            88888888776554                                      3455888888888888888888888888


Q ss_pred             CcCccCcC---CCCcCC
Q 011991          162 AKVPKTKR---TPMTVA  175 (473)
Q Consensus       162 ~~i~~~~~---t~l~~a  175 (473)
                      ++++..+.   |+++.|
T Consensus       280 adin~~d~~G~TpL~~A  296 (494)
T PHA02989        280 DDIYNVSKDGDTVLTYA  296 (494)
T ss_pred             CCccccCCCCCCHHHHH
Confidence            88876643   444444

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.69  E-value=7e-17  Score=150.20  Aligned_cols=112  Identities=34%  Similarity=0.366  Sum_probs=104.1

Q ss_pred             cCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhC
Q 011991           48 RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK  127 (473)
Q Consensus        48 ~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~  127 (473)
                      ...+.+.|.+|+..|+.|......|+|+|++|+..|+.++|+.||..|||||.+|.+|.|+||+||.+||.|||++||..
T Consensus       316 ~~~d~~vV~~LF~mgnVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~  395 (452)
T KOG0514|consen  316 QPADRTVVERLFKMGDVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAV  395 (452)
T ss_pred             chhhHHHHHHHHhccCcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhcc
Confidence            45566778899999988887888999999999999999999999999999999999999999999999999999999976


Q ss_pred             -CCCCCccCCCCCcHHHHHHHcCChhhhhhhhh
Q 011991          128 -KANIDARDRWGSTAAADAKYYGNVEVYNILKA  159 (473)
Q Consensus       128 -ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~  159 (473)
                       ++|+...|.+|.|+|.+|-..||.||.-+|-.
T Consensus       396 p~cd~sLtD~DgSTAl~IAleagh~eIa~mlYa  428 (452)
T KOG0514|consen  396 PSCDISLTDVDGSTALSIALEAGHREIAVMLYA  428 (452)
T ss_pred             CcccceeecCCCchhhhhHHhcCchHHHHHHHH
Confidence             79999999999999999999999999887754

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=2.4e-16  Score=147.14  Aligned_cols=140  Identities=17%  Similarity=0.133  Sum_probs=106.6

Q ss_pred             HhhccCceeeeEEEEE------EecCcEEEEEEEcCCCCC-------------------CH--HHHHHHHHHHHHHHhcC
Q 011991          191 QVRKADGITKGSYQVA------KWNGTKVWVKILDKESHK-------------------DP--ERINAFTHELTIVEKAR  243 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~------~~~~~~vavK~l~~~~~~-------------------~~--~~~~~~~~E~~~l~~l~  243 (473)
                      .|.+.+.+|.|+++.+      ..+|+.||+|++......                   ..  .....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5677788999998744      257899999999754311                   00  01234678999999997


Q ss_pred             CC--eeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE
Q 011991          244 HP--NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (473)
Q Consensus       244 hp--nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili  321 (473)
                      +.  .++++++.    ...++||||++|++|.........+....+..++.|++.++.+||+.|  +++||||||+||++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli  182 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILV  182 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEE
Confidence            53  33444432    234899999999888776544445667778899999999999999987  49999999999999


Q ss_pred             cCCCcEEEEeeccccc
Q 011991          322 DNGGQLKISGFGLLRL  337 (473)
Q Consensus       322 ~~~~~vkl~DfG~a~~  337 (473)
                      + ++.++|+|||.+..
T Consensus       183 ~-~~~i~LiDFg~a~~  197 (237)
T smart00090      183 H-DGKVVIIDVSQSVE  197 (237)
T ss_pred             E-CCCEEEEEChhhhc
Confidence            9 78999999999753

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.68  E-value=9.4e-17  Score=120.34  Aligned_cols=99  Identities=30%  Similarity=0.467  Sum_probs=90.3

Q ss_pred             hHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhh
Q 011991           74 MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEV  153 (473)
Q Consensus        74 t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~  153 (473)
                      .-+.|+..+|.++-|+..+..|.|||..- .|+||||+||-+|+++|+++|+..||+++.+|+.|-|||--|.+.||.++
T Consensus         4 ~~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~c   82 (117)
T KOG4214|consen    4 MSVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDC   82 (117)
T ss_pred             hhHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHH
Confidence            45789999999999999999999999775 89999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcCccCcCCCCc
Q 011991          154 YNILKARGAKVPKTKRTPMT  173 (473)
Q Consensus       154 ~~~L~~~g~~i~~~~~t~l~  173 (473)
                      |++|++.|++-......+..
T Consensus        83 VklLL~~GAdrt~~~PdG~~  102 (117)
T KOG4214|consen   83 VKLLLQNGADRTIHAPDGTA  102 (117)
T ss_pred             HHHHHHcCcccceeCCCchh
Confidence            99999999987655444433

>PHA02917 ankyrin-like protein; Provisional

Probab=99.68  E-value=8.3e-17  Score=170.54  Aligned_cols=123  Identities=15%  Similarity=0.063  Sum_probs=99.8

Q ss_pred             ceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHH--HcCCHHHHHHHHHcCCCCcccCC---CC-----------C
Q 011991           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMA--CRGDVKGVEDLLNEGSDVNSIDL---DG-----------R  106 (473)
Q Consensus        43 ~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa--~~g~~~~v~~Ll~~ga~~n~~d~---~g-----------~  106 (473)
                      ++.|+..|+.+.|+.|++.|......|.+|+||||.|+  ..|+.++|++|+++|||+|.+|.   .|           .
T Consensus       107 ~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~  186 (661)
T PHA02917        107 SYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCG  186 (661)
T ss_pred             HHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccc
Confidence            34567777888888888776544445889999999654  46899999999999999987653   34           5


Q ss_pred             cHHHHHHH-----------cCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCCh--hhhhhhhhcCCcCcc
Q 011991          107 TALHIAAC-----------EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNV--EVYNILKARGAKVPK  166 (473)
Q Consensus       107 T~lh~A~~-----------~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~--~~~~~L~~~g~~i~~  166 (473)
                      ||||+|+.           .|+.++|++|+++|||++.+|.+|.||||+|+..|+.  +++++|++ |++++.
T Consensus       187 t~L~~a~~~~~~~~~~~~~~~~~eiv~~Li~~Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~Li~-g~d~~~  258 (661)
T PHA02917        187 TVLHLYIISHLYSESDTRAYVRPEVVKCLINHGIKPSSIDKNYCTALQYYIKSSHIDIDIVKLLMK-GIDNTA  258 (661)
T ss_pred             cHHHHHHhhcccccccccccCcHHHHHHHHHCCCCcccCCCCCCcHHHHHHHcCCCcHHHHHHHHh-CCcccc
Confidence            99999986           5689999999999999999999999999999999986  69999975 776643

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.67  E-value=1.2e-16  Score=172.64  Aligned_cols=130  Identities=28%  Similarity=0.303  Sum_probs=103.6

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCC-CCCCCChHHHHHHHcC-CHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc-
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVP-ENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTALHIAACE-  115 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~-~~~~g~t~L~~aa~~g-~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~-  115 (473)
                      ...+++.|+..|+...+.++|...+.+++ .|.+|.||||+||..| +.+++++|+..|+++|.+|..|+||||+|+.. 
T Consensus       273 g~TpLh~Aa~~~~~~~iv~lLl~~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~  352 (682)
T PHA02876        273 KNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLD  352 (682)
T ss_pred             CCCHHHHHHhCCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhC
Confidence            44566677777777555554444444444 4788899999999888 58888888888999998888899999998875 


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ++.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       353 ~~~~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~  405 (682)
T PHA02876        353 RNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALS  405 (682)
T ss_pred             CcHHHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccC
Confidence            46888888889999999999999999999999999999999999988886554

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.67  E-value=1.1e-16  Score=172.19  Aligned_cols=138  Identities=24%  Similarity=0.279  Sum_probs=119.7

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ....+..++..|+.+.+.-+++.+.........|-|+||.|+..+...+++.++++|++++.++.+|.||||.||.+|+.
T Consensus       474 G~T~Lhlaaq~Gh~~~~~llle~~~~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v  553 (1143)
T KOG4177|consen  474 GFTPLHLAAQEGHTEVVQLLLEGGANDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNV  553 (1143)
T ss_pred             cCcchhhhhccCCchHHHHhhhcCCccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCc
Confidence            33445557788887766666666644444466789999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      .+|++||++|||++++++.|+||||.|+..|+.+|+.+|+++|+++|..+   .|++..|.
T Consensus       554 ~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL~iA~  614 (1143)
T KOG4177|consen  554 DLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGFTPLHIAV  614 (1143)
T ss_pred             hHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCcchhHHHH
Confidence            99999999999999999999999999999999999999999999998765   56666553

>PHA02730 ankyrin-like protein; Provisional

Probab=99.67  E-value=1.3e-16  Score=165.31  Aligned_cols=118  Identities=20%  Similarity=0.187  Sum_probs=99.3

Q ss_pred             CCccccCCCCCccCCCCCCCCCChHHHHHHHcCC----HHHHHHHHHcCC--CCcccCCCCCcHHHH---HHHcC-----
Q 011991           51 SLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD----VKGVEDLLNEGS--DVNSIDLDGRTALHI---AACEG-----  116 (473)
Q Consensus        51 ~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~----~~~v~~Ll~~ga--~~n~~d~~g~T~lh~---A~~~g-----  116 (473)
                      +++.++-|+++| ++++.+..|.||||+||..++    .+++++|+++|+  |+|.+|..|.||||.   |+..+     
T Consensus       358 ~ieIvelLIs~G-AdIN~k~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~  436 (672)
T PHA02730        358 SIPILRCMLDNG-ATMDKTTDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHC  436 (672)
T ss_pred             cHHHHHHHHHCC-CCCCcCCCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccc
Confidence            345555566665 566667899999999999875    899999999998  699999999999994   33332     


Q ss_pred             ----CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          117 ----HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       117 ----~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                          ..+++++|+.+|||+|++|..|.||||+|+..++.+++++|+++|++++..+.
T Consensus       437 ~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~  493 (672)
T PHA02730        437 YETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR  493 (672)
T ss_pred             cchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence                23679999999999999999999999999999999999999999999987653

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.65  E-value=2.2e-16  Score=137.83  Aligned_cols=107  Identities=25%  Similarity=0.368  Sum_probs=87.1

Q ss_pred             CCCCCCChHHHHHHHcCCHHHHHHHHHcCC--C-----CcccCCCCCcHHHHHHHcCCH---HHHHHHHhCCCCCCccC-
Q 011991           67 PENLDSTMQLLFMACRGDVKGVEDLLNEGS--D-----VNSIDLDGRTALHIAACEGHV---EVVKLLLSKKANIDARD-  135 (473)
Q Consensus        67 ~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga--~-----~n~~d~~g~T~lh~A~~~g~~---~iv~~Ll~~ga~~~~~~-  135 (473)
                      ..|.+|.||||+||..|+.  +++++..++  +     ++.+|..|+||||+|+..|+.   +++++|+++|++++.+| 
T Consensus        12 ~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~   89 (154)
T PHA02736         12 EPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKER   89 (154)
T ss_pred             hcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCC
Confidence            3477899999999999984  444443332  2     346789999999999999987   46899999999999998 


Q ss_pred             CCCCcHHHHHHHcCChhhhhhhhh-cCCcCccCc---CCCCcCC
Q 011991          136 RWGSTAAADAKYYGNVEVYNILKA-RGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       136 ~~g~t~l~~A~~~~~~~~~~~L~~-~g~~i~~~~---~t~l~~a  175 (473)
                      ..|+||||+|+..|+.+++++|+. .|++++..+   .+++..|
T Consensus        90 ~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A  133 (154)
T PHA02736         90 VFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVA  133 (154)
T ss_pred             CCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHH
Confidence            599999999999999999999997 589887664   3555444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=1.2e-15  Score=159.85  Aligned_cols=134  Identities=22%  Similarity=0.232  Sum_probs=108.3

Q ss_pred             hhccCceeeeEEEEEE---ecCcEEEEEEEcCCCCCC-----HHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          192 VRKADGITKGSYQVAK---WNGTKVWVKILDKESHKD-----PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~---~~~~~vavK~l~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      |...+.||+|+|+.+.   +.+..+++|+........     ....+++.+|+++++.++|++|+....++......++|
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            3557789999998663   456666666543322111     12346789999999999999998887777777778999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      |||++|++|.+++.        ....++.+++.+|.+||+.+   ++||||||+|||+ .++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999885        35678999999999999999   9999999999999 578999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1e-17  Score=175.07  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=191.4

Q ss_pred             HhhccCceeeeEEEEE------EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEE
Q 011991          191 QVRKADGITKGSYQVA------KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~------~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .|....-+|.|+|+.+      ......+|+|.+.... ...........|..+-+.+. |+|++.+++........+++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4566667899999743      1233456777766543 23344456667888888886 99999999999999999999


Q ss_pred             EeccCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccc
Q 011991          264 LEYHAKGDLASYL-QKKG-RLSPSKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQY  339 (473)
Q Consensus       264 ~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~  339 (473)
                      +++..|+++.+.+ .... ..+...+..++.|+..++.|+| ..+   +.|+|+||+|.+++..+ .+++.|||+|....
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999988 5543 5778888999999999999999 888   99999999999999999 99999999997665


Q ss_pred             cCcccccccccccCCCC-CCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhCCCCCCc
Q 011991          340 ISPEKAKIVFPVSHIDP-ANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPPLK  416 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~  416 (473)
                      .....   ........| ++.|+|||...+..+ .+..|+||.|+++.-+++|..||......... ..+.... .....
T Consensus       177 ~~~g~---~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~  252 (601)
T KOG0590|consen  177 NKNGA---ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQ  252 (601)
T ss_pred             ccCCc---ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-ccccc
Confidence            52111   112233446 889999999988544 58899999999999999999999765544322 1111111 11112


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ..+...+....+++.+++..+|..|.+.+++-.
T Consensus       253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             CccccCChhhhhcccccccCCchhccccccccc
Confidence            235677889999999999999999999988743

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=2.1e-15  Score=141.08  Aligned_cols=137  Identities=18%  Similarity=0.182  Sum_probs=105.6

Q ss_pred             hccCceeeeEEEEEEecCcEEEEEEEcCCCC----------CCHHHHHHHHHHHHHHHhcCCCee--eeEEeeEeeC-Cc
Q 011991          193 RKADGITKGSYQVAKWNGTKVWVKILDKESH----------KDPERINAFTHELTIVEKARHPNV--VQFVGAVTQN-IP  259 (473)
Q Consensus       193 ~~~~~ig~G~~~~~~~~~~~vavK~l~~~~~----------~~~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~-~~  259 (473)
                      .+++..|.|+++.+...+..++||.......          .+......+.+|++++..+.|++|  +..+++.... ..
T Consensus        38 ~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~  117 (239)
T PRK01723         38 VVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL  117 (239)
T ss_pred             eeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence            3445677888888888899999998854221          112334678899999999988774  6677664432 22


Q ss_pred             ---eEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          260 ---MMIVLEYHAK-GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       260 ---~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                         .++|||+++| .+|.+++... .+++..    +.+++.+|.+||+.|   |+||||||.|||++.++.++|+|||.+
T Consensus       118 ~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        118 FYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             ceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCc
Confidence               3599999997 6999988653 455543    578999999999999   999999999999999889999999987


Q ss_pred             cc
Q 011991          336 RL  337 (473)
Q Consensus       336 ~~  337 (473)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            54

>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A

Probab=99.63  E-value=2.9e-16  Score=111.52  Aligned_cols=55  Identities=49%  Similarity=0.613  Sum_probs=33.0

Q ss_pred             HHHcC-CCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHH
Q 011991           91 LLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (473)
Q Consensus        91 Ll~~g-a~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A  145 (473)
                      ||++| +++|.+|..|.||||+||..|+.++|++|++.|+|++.+|..|+||||+|
T Consensus         1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A   56 (56)
T PF13857_consen    1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA   56 (56)
T ss_dssp             -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred             CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence            67888 89999999999999999999999999999999999999999999999987

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.63  E-value=1.9e-16  Score=142.97  Aligned_cols=120  Identities=22%  Similarity=0.247  Sum_probs=98.5

Q ss_pred             eeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHH
Q 011991           45 SFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (473)
Q Consensus        45 ~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~  123 (473)
                      =+|+.|....+..||..| ..+|. +.-..||||.||..||.++|+.||++.+|||+.+..|+|||||||..|.-.|++-
T Consensus        40 waakegh~aivemll~rg-arvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaed  118 (448)
T KOG0195|consen   40 WAAKEGHVAIVEMLLSRG-ARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAED  118 (448)
T ss_pred             hhhhcccHHHHHHHHhcc-cccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHH
Confidence            356677766666566555 44554 6666899999999999999999999999999999999999999999999999999


Q ss_pred             HHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCc
Q 011991          124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP  165 (473)
Q Consensus       124 Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~  165 (473)
                      |+..||.+++.|+.|.|||+-|.-.-..-+.+.-.++|..++
T Consensus       119 li~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~n  160 (448)
T KOG0195|consen  119 LISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPN  160 (448)
T ss_pred             HHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999998854333334445556776665

>PHA02730 ankyrin-like protein; Provisional

Probab=99.62  E-value=9.1e-16  Score=159.13  Aligned_cols=113  Identities=16%  Similarity=0.122  Sum_probs=95.3

Q ss_pred             ccCCCCCc-cCCCCCCCCCChHHHHHHHcC---CHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC--CHHHHHHHHhCC
Q 011991           55 IRRSPVQD-ELTVPENLDSTMQLLFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG--HVEVVKLLLSKK  128 (473)
Q Consensus        55 ~~~~l~~~-~~~~~~~~~g~t~L~~aa~~g---~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g--~~~iv~~Ll~~g  128 (473)
                      ++..+++. +.+...|.+|+||||+|+..|   +.++|++||++|||+|++|..|+||||+|+..|  +.|+|++|+++|
T Consensus        23 ~~~~~~~~~~in~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~  102 (672)
T PHA02730         23 IKLEIETCHNLSKHIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSY  102 (672)
T ss_pred             HHHHHHHhcchhhhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcC
Confidence            44555555 444445889999999999987   599999999999999999999999999999977  799999999996


Q ss_pred             C--CCCccCCCCCcHHHHHHH--cCChhhhhhhhh-cCCcCccC
Q 011991          129 A--NIDARDRWGSTAAADAKY--YGNVEVYNILKA-RGAKVPKT  167 (473)
Q Consensus       129 a--~~~~~~~~g~t~l~~A~~--~~~~~~~~~L~~-~g~~i~~~  167 (473)
                      +  +++..+.-+.+||+.++.  .++.+++++|+. .+++++..
T Consensus       103 ~~~~~~~~~~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~~  146 (672)
T PHA02730        103 SNASNELTSNINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPSKN  146 (672)
T ss_pred             CCCCcccccccCCchHHHHHHhcCCcHHHHHHHHHhcCCChhhh
Confidence            5  557788779999998887  889999999996 66776544

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.61  E-value=3.2e-15  Score=136.28  Aligned_cols=134  Identities=16%  Similarity=0.074  Sum_probs=101.9

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCH-------------------HHHHHHHHHHHHHHhcCCCe-
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDP-------------------ERINAFTHELTIVEKARHPN-  246 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hpn-  246 (473)
                      .|.+.+.||.|+|+.+    ..+|+.||||++........                   .....+..|+.++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            4666778999998755    23689999999765321100                   11124678899999997773 


Q ss_pred             -eeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC
Q 011991          247 -VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (473)
Q Consensus       247 -Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~  325 (473)
                       ++..++.    ...++||||++|++|.++...      .....++.+++.++.++|+.+   ++|+||||.||+++.++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~  162 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence             4444432    345899999999999775421      345678899999999999999   99999999999999999


Q ss_pred             cEEEEeeccccc
Q 011991          326 QLKISGFGLLRL  337 (473)
Q Consensus       326 ~vkl~DfG~a~~  337 (473)
                      .++|+|||++..
T Consensus       163 ~~~liDfg~~~~  174 (198)
T cd05144         163 KIYIIDWPQMVS  174 (198)
T ss_pred             cEEEEECCcccc
Confidence            999999999853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PHA02792 ankyrin-like protein; Provisional

Probab=99.61  E-value=6.2e-16  Score=158.72  Aligned_cols=127  Identities=17%  Similarity=0.163  Sum_probs=99.7

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCC--CChHHHHHHHcCCH---HHHHHHHHcCCCCcccCCCCCcHHHHHH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLD--STMQLLFMACRGDV---KGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~--g~t~L~~aa~~g~~---~~v~~Ll~~ga~~n~~d~~g~T~lh~A~  113 (473)
                      +...++.||..|+.+.++.|+.+|......|.+  +.||||.|+..+..   +++++|+++|||+|.+|..|+||||+|+
T Consensus       339 ~~n~~~~Aa~~gn~eIVelLIs~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa  418 (631)
T PHA02792        339 HINKYFQKFDNRDPKVVEYILKNGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCI  418 (631)
T ss_pred             cchHHHHHHHcCCHHHHHHHHHcCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHH
Confidence            445577788889988888888877443333555  46899987776554   4578888999999999999999999999


Q ss_pred             HcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHH---cC-------ChhhhhhhhhcCCcCc
Q 011991          114 CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY---YG-------NVEVYNILKARGAKVP  165 (473)
Q Consensus       114 ~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~---~~-------~~~~~~~L~~~g~~i~  165 (473)
                      ..++.+++++|+++|||++.+|..|.|||++|..   .+       ..+++++|++++.++.
T Consensus       419 ~~~n~eivelLLs~GADIN~kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i~  480 (631)
T PHA02792        419 ESHSVSLVEWLIDNGADINITTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTIE  480 (631)
T ss_pred             HcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCChh
Confidence            9999999999999999999999999999999875   22       2456888888887664

>KOG1710 consensus MYND Zn-finger and ankyrin repeat protein [General function prediction only]

Probab=99.60  E-value=6.3e-16  Score=139.50  Aligned_cols=120  Identities=24%  Similarity=0.210  Sum_probs=108.3

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCccc-CCCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSI-DLDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~-d~~g~T~lh~A~~~g~~~  119 (473)
                      ..+|++...|+.+....||..-.-.+..|..|+|+|..||.+|+++.|++||+.|||||.. +..+.||||+||..|+.+
T Consensus        14 ~~Lle~i~Kndt~~a~~LLs~vr~vn~~D~sGMs~LahAaykGnl~~v~lll~~gaDvN~~qhg~~YTpLmFAALSGn~d   93 (396)
T KOG1710|consen   14 SPLLEAIDKNDTEAALALLSTVRQVNQRDPSGMSVLAHAAYKGNLTLVELLLELGADVNDKQHGTLYTPLMFAALSGNQD   93 (396)
T ss_pred             hHHHHHHccCcHHHHHHHHHHhhhhhccCCCcccHHHHHHhcCcHHHHHHHHHhCCCcCcccccccccHHHHHHHcCCch
Confidence            4578999999999999888764434445999999999999999999999999999999965 678899999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhc
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~  160 (473)
                      |.++|++.||.+...|.-|.|+-..|+.-|+.++|..+-++
T Consensus        94 vcrllldaGa~~~~vNsvgrTAaqmAAFVG~H~CV~iINN~  134 (396)
T KOG1710|consen   94 VCRLLLDAGARMYLVNSVGRTAAQMAAFVGHHECVAIINNH  134 (396)
T ss_pred             HHHHHHhccCccccccchhhhHHHHHHHhcchHHHHHHhcc
Confidence            99999999999999999999999999999999999976543

>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

Probab=99.60  E-value=3.4e-15  Score=124.48  Aligned_cols=96  Identities=45%  Similarity=0.621  Sum_probs=53.9

Q ss_pred             CCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcC
Q 011991           70 LDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYG  149 (473)
Q Consensus        70 ~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~  149 (473)
                      .+|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..++.+++++|++.|++++..|..|.||+|.|+..+
T Consensus         5 ~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~~~   84 (126)
T cd00204           5 EDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNG   84 (126)
T ss_pred             cCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcC
Confidence            44555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             ChhhhhhhhhcCCcCc
Q 011991          150 NVEVYNILKARGAKVP  165 (473)
Q Consensus       150 ~~~~~~~L~~~g~~i~  165 (473)
                      +.+++++|+..+.+++
T Consensus        85 ~~~~~~~L~~~~~~~~  100 (126)
T cd00204          85 NLDVVKLLLKHGADVN  100 (126)
T ss_pred             cHHHHHHHHHcCCCCc
Confidence            5555555555554443

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.

>KOG0507 consensus CASK-interacting adaptor protein (caskin) and related proteins with ankyrin repeats and SAM domain [Signal transduction mechanisms]

Probab=99.60  E-value=5.8e-16  Score=156.40  Aligned_cols=120  Identities=24%  Similarity=0.247  Sum_probs=84.6

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv  121 (473)
                      .+..|+-.|+...++.+++...+..-.+..|.+|||+||+.|+.++|++|+.++..+|+.+..|.||||.||..||.+++
T Consensus        52 alhha~Lng~~~is~llle~ea~ldl~d~kg~~plhlaaw~g~~e~vkmll~q~d~~na~~~e~~tplhlaaqhgh~dvv  131 (854)
T KOG0507|consen   52 LLHHAVLNGQNQISKLLLDYEALLDLCDTKGILPLHLAAWNGNLEIVKMLLLQTDILNAVNIENETPLHLAAQHGHLEVV  131 (854)
T ss_pred             HHHHHHhcCchHHHHHHhcchhhhhhhhccCcceEEehhhcCcchHHHHHHhcccCCCcccccCcCccchhhhhcchHHH
Confidence            34455556665544444444333222357777777777777777777777777777777777777777777777777777


Q ss_pred             HHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       122 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      .+|+++|+|+-.+|..+.|+|++|++.|..+++++|+...
T Consensus       132 ~~Ll~~~adp~i~nns~~t~ldlA~qfgr~~Vvq~ll~~~  171 (854)
T KOG0507|consen  132 FYLLKKNADPFIRNNSKETVLDLASRFGRAEVVQMLLQKK  171 (854)
T ss_pred             HHHHhcCCCccccCcccccHHHHHHHhhhhHHHHHHhhhc
Confidence            7777777777777777777777777777777777777763

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.59  E-value=5.4e-15  Score=162.28  Aligned_cols=96  Identities=31%  Similarity=0.386  Sum_probs=87.6

Q ss_pred             CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHH
Q 011991           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY  147 (473)
Q Consensus        68 ~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~  147 (473)
                      .+.++.++||.||..|+.++++.|+++|+|+|.+|..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.
T Consensus       521 ~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~  600 (823)
T PLN03192        521 DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS  600 (823)
T ss_pred             CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHH
Confidence            45567899999999999999999999999999999999999999999999999999999999999999999999998888


Q ss_pred             cCChhhhhhhhhcCCc
Q 011991          148 YGNVEVYNILKARGAK  163 (473)
Q Consensus       148 ~~~~~~~~~L~~~g~~  163 (473)
                      .|+.+++++|.+.+..
T Consensus       601 ~g~~~iv~~L~~~~~~  616 (823)
T PLN03192        601 AKHHKIFRILYHFASI  616 (823)
T ss_pred             hCCHHHHHHHHhcCcc
Confidence            8887777777665543

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.59  E-value=6.2e-16  Score=134.49  Aligned_cols=136  Identities=19%  Similarity=0.073  Sum_probs=116.9

Q ss_pred             CCCCCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHH
Q 011991           32 QSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHI  111 (473)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~  111 (473)
                      -...|-+.-.+++=|++.|.++.|+-||..|...-.......|+|..|+..|..+||++||.++.|||..|-+|-|||-|
T Consensus       153 VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLly  232 (296)
T KOG0502|consen  153 VNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLY  232 (296)
T ss_pred             ccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeee
Confidence            33444555566677889999998888888875443336677899999999999999999999999999999999999999


Q ss_pred             HHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       112 A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      |++.||.++|+.||+.|||++..+..|.+++..|...|+. +|+..+++.+....++
T Consensus       233 Avrgnhvkcve~Ll~sGAd~t~e~dsGy~~mdlAValGyr-~Vqqvie~h~lkl~Q~  288 (296)
T KOG0502|consen  233 AVRGNHVKCVESLLNSGADVTQEDDSGYWIMDLAVALGYR-IVQQVIEKHALKLCQD  288 (296)
T ss_pred             eecCChHHHHHHHHhcCCCcccccccCCcHHHHHHHhhhH-HHHHHHHHHHHHHhhc
Confidence            9999999999999999999999999999999999999988 7887777777665543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	473
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-37
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-37
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-25
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-25
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-24
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-24
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-24
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-24
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-24
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-24
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-23
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-23
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-23
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-23
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-23
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-23
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-23
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-23
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-23
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-23
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-23
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-23
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-23
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-23
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-23
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-23
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-23
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-23
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-23
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-23
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-23
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-23
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-22
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-22
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-21
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-21
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-21
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-21
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-21
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-20
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-20
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-20
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-20
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-20
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-20
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-20
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-20
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-20
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-20
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-20
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-20
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-20
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-20
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-20
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-20
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-20
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-20
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-20
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-20
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-20
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-20
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-20
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-20
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-20
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-20
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-20
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-20
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-20
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-20
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-20
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-20
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-20
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-20
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-20
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-20
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-20
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-20
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-20
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-20
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-20
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-20
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-20
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-20
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-20
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-20
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-20
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-20
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-20
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-20
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-20
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-20
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-20
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-20
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-20
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-20
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-19
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-19
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-19
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-19
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-19
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-19
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-19
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-19
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-19
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-19
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-19
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-19
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-19
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-19
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-19
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-18
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-18
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-18
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-18
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-18
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-18
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-18
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-18
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-18
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-18
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-18
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-18
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-18
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-18
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-18
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-18
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-18
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-18
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-18
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-18
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-18
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-18
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-18
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-18
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-18
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-18
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-18
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-18
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-18
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-18
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-18
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-18
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-18
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-17
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-17
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-17
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-17
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-17
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-17
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-17
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-17
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-17
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-17
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-17
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-17
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-17
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-17
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-17
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-17
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-17
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-17
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-17
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-17
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-17
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-17
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-16
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-16
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-16
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-16
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-16
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-16
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-15
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-15
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-14
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-14
4hqd_A	169	Crystal Structure Of Engineered Protein. Northeast		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-14
4gpm_A	169	Crystal Structure Of Engineered Protein. Northeast		2e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-14
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
1n0r_A	126	4ank: A Designed Ankyrin Repeat Protein With Four I		2e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
2l6b_A	115	Nrc Consensus Ankyrin Repeat Protein Solution Struc		3e-13
4gmr_A	169	Crystal Structure Of Engineered Protein. Northeast		3e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-13
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-13
4atz_D	154	Ad5 Knob In Complex With A Designed Ankyrin Repeat		6e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-13
4dui_A	169	Darpin D1 Binding To Tubulin Beta Chain (not In Com		8e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-12
4hb5_A	169	Crystal Structure Of Engineered Protein. Northeast		1e-12
4drx_E	169	Gtp-Tubulin In Complex With A Darpin Length = 169		1e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-12
2xee_A	157	Structural Determinants For Improved Thermal Stabil		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-12
2xeh_A	157	Structural Determinants For Improved Thermal Stabil		2e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-12
4f6r_D	169	Tubulin:stathmin-Like Domain Complex Length = 169		3e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-12
1n0q_A	93	3ank: A Designed Ankyrin Repeat Protein With Three		7e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
2xzd_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
1mj0_A	166	Sank E3_5: An Artificial Ankyrin Repeat Protein Len		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-11
1svx_A	169	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2y0b_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4_		2e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-11
2xzt_G	136	Caspase-3 In Complex With Darpin-3.4_i78s Length =		5e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-11
2j8s_D	169	Drug Export Pathway Of Multidrug Exporter Acrb Reve		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-11
2qyj_A	166	Crystal Structure Of A Designed Full Consensus Anky		8e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-10
2v5q_C	167	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-10
3zuv_B	136	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-10
2bkg_A	166	Crystal Structure Of E3_19 An Designed Ankyrin Repe		1e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-10
3q9u_C	158	In Silico And In Vitro Co-Evolution Of A High Affin		2e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-10
3noc_D	169	Designed Ankyrin Repeat Protein (Darpin) Binders To		2e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
2bkk_B	169	Crystal Structure Of Aminoglycoside Phosphotransfer		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-10
2xen_A	91	Structural Determinants For Improved Thermal Stabil		3e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-10
2v4h_C	136	Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13		4e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-10
2y1l_E	169	Caspase-8 In Complex With Darpin-8.4 Length = 169		6e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-10
3zu7_B	169	Crystal Structure Of A Designed Selected Ankyrin Re		8e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-10
3hg0_D	136	Crystal Structure Of A Darpin In Complex With Orf49		8e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
2jab_A	136	A Designed Ankyrin Repeat Protein Evolved To Picomo		2e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-09
3nog_D	169	Designed Ankyrin Repeat Protein (Darpin) Binders To		2e-09
2p2c_P	169	Inhibition Of Caspase-2 By A Designed Ankyrin Repea		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
2zgg_A	92	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-09
4grg_A	135	Crystal Structure Of Ige Complexed With E2_79, An A		4e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
2zgd_A	110	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		4e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
1n11_A	437	D34 Region Of Human Ankyrin-R And Linker Length = 4		1e-08
1n11_A	437	D34 Region Of Human Ankyrin-R And Linker Length = 4		4e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-08
3c5r_A	137	Crystal Structure Of The Bard1 Ankyrin Repeat Domai		1e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-07
3aaa_C	123	Crystal Structure Of Actin Capping Protein In Compl		1e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
1myo_A	118	Solution Structure Of Myotrophin, Nmr, 44 Structure		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3twr_A	165	Crystal Structure Of Arc4 From Human Tankyrase 2 In		2e-07
1s70_B	299	Complex Between Protein Ser/thr Phosphatase-1 (delt		2e-07
3twu_A	167	Crystal Structure Of Arc4 From Human Tankyrase 2 In		2e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-07
3twq_A	175	Crystal Structure Of Arc4 From Human Tankyrase 2 (A		3e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-07
1mx4_A	168	Structure Of P18ink4c (F82q) Length = 168		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
1mx6_A	168	Structure Of P18ink4c (F92n) Length = 168		4e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-07
1ihb_A	162	Crystal Structure Of P18-Ink4c(Ink6) Length = 162		6e-07
1bu9_A	168	Solution Structure Of P18-Ink4c, 21 Structures Leng		7e-07
2rfm_A	192	Structure Of A Thermophilic Ankyrin Repeat Protein		7e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-07
1mx2_A	168	Structure Of F71n Mutant Of P18ink4c Length = 168		8e-07

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 98/258 (37%), Positives = 143/258 (55%), Gaps = 14/258 (5%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G+   A+W+G+ V VKIL  E     ER+N F  E+ I+++ RHPN+V F+GAVTQ   +
Sbjct: 51  GTVHRAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 261 MIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            IV EY ++G L   L K G   +L   + L  A D+A+GMNYLH   P PI+H DLK  
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 168
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+L+D    +K+  FGL RL      KA              ++APE+ ++E  +   D 
Sbjct: 169 NLLVDKKYTVKVCDFGLSRL------KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           YSFG+IL+E+    QP+    P +VV  +  + KR  L+I  R+  P +  +IE CW  +
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--LEI-PRNLNPQVAAIIEGCWTNE 279
Query: 438 PVIRPNFNEIIARLDRIV 455
           P  RP+F  I+  L  ++
Sbjct: 280 PWKRPSFATIMDLLRPLI 297

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 102/280 (36%), Positives = 152/280 (54%), Gaps = 18/280 (6%)
Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++P  +LN  E    K    + G+   A+W+G+ V VKIL  E     ER+N F  E+ I
Sbjct: 33  DIPWCDLNIKE----KIGAGSFGTVHRAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAI 87
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLA 295
           +++ RHPN+V F+GAVTQ   + IV EY ++G L   L K G   +L   + L  A D+A
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
           +GMNYLH   P PI+H +LK  N+L+D    +K+  FGL RL      KA          
Sbjct: 148 KGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL------KASTFLSSKSAA 200
Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL 415
               ++APE+ ++E  +   D YSFG+IL+E+    QP+    P +VV  +  + KR  L
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--L 258
Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +I  R+  P +  +IE CW  +P  RP+F  I+  L  ++
Sbjct: 259 EI-PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 29/275 (10%)
Query: 189 ELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP 245
           E++V +  G  +G++ V   AKW    V +K ++ ES +      AF  EL  + +  HP
Sbjct: 10  EIEVEEVVG--RGAFGVVCKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALDLARGMNYLH 302
           N+V+  GA     P+ +V+EY   G L + L     L   + +  + + L  ++G+ YLH
Sbjct: 63  NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQ-LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV 361
             +P  +IH DLKP N+LL  GG  LKI  FG             I   +++   +  ++
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---------TACDIQTHMTNNKGSAAWM 171
Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLMCCEGKRPPLKIKAR 420
           APE+++   +    D +S+G+IL+E+I   +PF     P   +      G RPPL    +
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL---IK 228
Query: 421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           + P  ++ L+  CW   P  RP+  EI+  +  ++
Sbjct: 229 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 29/275 (10%)
Query: 189 ELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP 245
           E++V +  G  +G++ V   AKW    V +K ++ ES +      AF  EL  + +  HP
Sbjct: 9   EIEVEEVVG--RGAFGVVCKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALDLARGMNYLH 302
           N+V+  GA     P+ +V+EY   G L + L     L   + +  + + L  ++G+ YLH
Sbjct: 62  NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQ-LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV 361
             +P  +IH DLKP N+LL  GG  LKI  FG             I   +++   +  ++
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---------TACDIQTHMTNNKGSAAWM 170
Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLMCCEGKRPPLKIKAR 420
           APE+++   +    D +S+G+IL+E+I   +PF     P   +      G RPPL    +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL---IK 227
Query: 421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           + P  ++ L+  CW   P  RP+  EI+  +  ++
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 136/281 (48%), Gaps = 22/281 (7%)
Query: 184 ELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKD-PERINAFTHELTIVEK 241
           E++  EL + +  GI   G    A W G +V VK    +  +D  + I     E  +   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYL 301
            +HPN++   G   +   + +V+E+   G L   L  K R+ P  ++ +A+ +ARGMNYL
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYL 121
Query: 302 HECKPDPIIHCDLKPKNILL----DNGGQ----LKISGFGLLRLQYISPEKAKIVFPVSH 353
           H+    PIIH DLK  NIL+    +NG      LKI+ FGL R  + + + +        
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA------- 174
Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
              A  ++APE+ +   F +  D +S+G++L+E++ G  PF       V   +       
Sbjct: 175 -AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           P+     + P    +L+E+CW+P P  RP+F  I+ +L  I
Sbjct: 234 PIP---STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 140/278 (50%), Gaps = 28/278 (10%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 70
Query: 242 ARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV       
Sbjct: 131 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVK------ 179
Query: 359 LYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
            + APE  + ++F    D +SFG++L+E+   G  P+   P ++VV  +         K+
Sbjct: 180 -WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKM 233
Query: 418 KA-RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            A    PP + E+++ CW     +RP+F ++  +L+ I
Sbjct: 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/320 (28%), Positives = 162/320 (50%), Gaps = 26/320 (8%)
Query: 149 GNVEVYNILKARGAKVPKTKRTPMTVANP-REVPEY--ELNPLELQVRKADG------IT 199
           G+ E+Y   K  G K   T   P T  +P R V ++  EL+   +++ +  G      + 
Sbjct: 4   GDEELYFHFKFPGTK---TYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVC 60
Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
            G  ++       V +K L K  + + +R + F  E +I+ +  HPNVV   G VT+  P
Sbjct: 61  SGRLKLPGKRDVAVAIKTL-KVGYTEKQRRD-FLCEASIMGQFDHPNVVHLEGVVTRGKP 118
Query: 260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +MIV+E+   G L ++L+K  G+ +  +++     +A GM YL +      +H DL  +N
Sbjct: 119 VMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMG---YVHRDLAARN 175
Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
           IL+++    K+S FGL R+    PE    V+  +       + APE  +  +F  + D +
Sbjct: 176 ILVNSNLVCKVSDFGLSRVIEDDPEA---VYTTTGGKIPVRWTAPEAIQYRKFTSASDVW 232
Query: 379 SFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           S+G++++E++  G +P+     ++V+K +  EG R P  +     P  L +L+ +CW  +
Sbjct: 233 SYGIVMWEVMSYGERPYWDMSNQDVIKAI-EEGYRLPAPMDC---PAGLHQLMLDCWQKE 288
Query: 438 PVIRPNFNEIIARLDRIVCN 457
              RP F +I+  LD+++ N
Sbjct: 289 RAERPKFEQIVGILDKMIRN 308

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 140/278 (50%), Gaps = 28/278 (10%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 55
Query: 242 ARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV       
Sbjct: 116 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVK------ 164
Query: 359 LYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
            + APE  + ++F    D +SFG++L+E+   G  P+   P ++VV  +         K+
Sbjct: 165 -WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKM 218
Query: 418 KA-RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            A    PP + E+++ CW     +RP+F ++  +L+ I
Sbjct: 219 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 28/278 (10%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 61
Query: 242 ARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV       
Sbjct: 122 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVK------ 170
Query: 359 LYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
            + APE  +   F    D +SFG++L+E+   G  P+   P ++VV  +         K+
Sbjct: 171 -WTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKM 224
Query: 418 KA-RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            A    PP + E+++ CW     +RP+F ++  +L+ I
Sbjct: 225 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 61  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 118
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 119 GNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 175
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVK-------WMAPEALFDRI 228
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 229 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHR---MDKPSNCTNELYMM 284
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 316

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 101/357 (28%), Positives = 169/357 (47%), Gaps = 49/357 (13%)
Query: 113 ACEGHVEVVKLLL-SKKANIDARDRWGSTAAADAKYYGN----VEVYNILKARG--AKVP 165
           +CEG VE  +++  + K +ID           +  Y+ N    VE Y    A G   ++ 
Sbjct: 121 SCEGKVEHYRIMYHASKLSID-----------EEVYFENLMQLVEHYTT-DADGLCTRLI 168
Query: 166 KTKRTPMTVANPREV--PEYELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKES 222
           K K    TVA   E     + LN  EL++ +  G  + G   +  + G KV VK +    
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI---- 224
Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR 281
            K+     AF  E +++ + RH N+VQ +G + +    + IV EY AKG L  YL+ +GR
Sbjct: 225 -KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 283
Query: 282 --LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             L    +L+F+LD+   M YL   + +  +H DL  +N+L+      K+S FGL +   
Sbjct: 284 SVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340
Query: 340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKP 398
            + +  K+  PV        + APE  + ++F    D +SFG++L+E+   G  P+   P
Sbjct: 341 STQDTGKL--PVK-------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391
Query: 399 PEEVVKLMCCEGKRPPLKIKA-RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            ++VV  +         K+ A    PP + ++++ CW      RP F ++  +L+ I
Sbjct: 392 LKDVVPRV-----EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 38/291 (13%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTH 234
           PR      ++P EL   +  G  + G   +  W N  KV +K + + S  + +    F  
Sbjct: 16  PRGSLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD----FIE 71
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALD 293
           E  ++ K  HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVF 349
           +  GM YL E     +IH DL  +N L+     +K+S FG+ R     QY S    K  F
Sbjct: 132 VCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--F 186
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCC 408
           PV        + +PE++    +    D +SFG++++E+  EG  P+  +   EVV+    
Sbjct: 187 PVK-------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---- 235
Query: 409 EGKRPPLKIKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLDRI 454
                 +    R Y P L      +++  CW  +P  RP F+ ++ +L  I
Sbjct: 236 -----DISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADGITK------GSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  E++   +++ K  G+ +      G  +V       V +K
Sbjct: 4   RTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIK 63
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + D +R + F  E +I+ +  HPN++   G VT+  P+MI+ EY   G L ++L
Sbjct: 64  TL-KAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 121
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K  GR +  +++     +  GM YL +      +H DL  +NIL+++    K+S FG+ 
Sbjct: 122 RKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMS 178
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + APE     +F  + D +S+G++++E++  G
Sbjct: 179 RVLEDDPEAAYTTRGGKIPIR-------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 231
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW  +   RP F +I+
Sbjct: 232 ERPYWDMSNQDVIKAI-EEGYRLPPPMDC-----PIALHQLMLDCWQKERSDRPKFGQIV 285
Query: 449 ARLDRIVCN 457
             LD+++ N
Sbjct: 286 NMLDKLIRN 294

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 139/281 (49%), Gaps = 26/281 (9%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   ARGM+YLH    
Sbjct: 83  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH----IDPANLYVA 362
             IIH DLK  NI L     +KI  FGL      + EK++  +  SH    +  + L++A
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSR--WSGSHQFEQLSGSILWMA 190
Query: 363 PEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           PE+ + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K 
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 420 RSY-PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
           RS  P  +K L+ EC   K   RP+F  I+A ++ +    S
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELS 291

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 123/232 (53%), Gaps = 20/232 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN++   G VT++ P+MIV EY   G L ++L+K  G+ +  +++  
Sbjct: 70  FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGM 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV-- 348
              ++ GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A     
Sbjct: 130 LRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 186
Query: 349 --FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              P+        + APE     +F  + D +S+G++++E++  G +P+     ++V+K 
Sbjct: 187 GKIPIR-------WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKA 239
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
           +  EG R P  +     P  L +L+ +CW  +   RP F+EI+  LD+++ N
Sbjct: 240 V-EEGYRLPSPMDC---PAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 53  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 110
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 111 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 167
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 168 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 220
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 221 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 276
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 277 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 308

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 61  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 118
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 119 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 175
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 228
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 229 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 284
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 316

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 50  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 107
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 108 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 164
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 165 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 217
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 218 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 273
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 274 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 305

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 37/274 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 61  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 118
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 119 GNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 175
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 228
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 229 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 284
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGW 463
           + +CW   P  RP F +++  LDRIV   S Q +
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEY 318

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 140/276 (50%), Gaps = 16/276 (5%)
Query: 182 EYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           E E + + L  R   G + G+    KW+G  V VKIL K     PE+  AF +E+ ++ K
Sbjct: 32  EIEASEVMLSTRIGSG-SFGTVYKGKWHG-DVAVKIL-KVVDPTPEQFQAFRNEVAVLRK 88
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNY 300
            RH N++ F+G +T++  + IV ++     L  +L  ++ +    +++  A   A+GM+Y
Sbjct: 89  TRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDY 147
Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY 360
           LH      IIH D+K  NI L  G  +KI  FGL  ++       ++  P   +    L+
Sbjct: 148 LH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV----LW 200
Query: 361 VAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEGKRPPLK 416
           +APE+ +   N  F    D YS+G++LYE++ G  P+ H    ++++ ++      P L 
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260
Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
              ++ P  +K L+ +C       RP F +I++ ++
Sbjct: 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 61  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 118
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 119 GNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 175
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 228
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 229 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 284
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 285 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 316

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 54  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 111
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 112 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 168
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 169 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 221
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 222 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 277
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 278 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 309

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 102 TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 159
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 216
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 269
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHR---MDKPSNCTNELYMM 325
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 326 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 136/272 (50%), Gaps = 37/272 (13%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 46  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 103
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 104 GNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 160
Query: 314 LKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEE 370
           L  +N+L+     +KI+ FGL R + +I   K       PV        ++APE   +  
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-------WMAPEALFDRI 213
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 214 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 269
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 270 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 301

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLA 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 131/253 (51%), Gaps = 26/253 (10%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K L K  + D +R + F  E +I+ +  HPN++   G VT+  P+MI+ EY   G L
Sbjct: 45  VAIKTL-KAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 102
Query: 273 ASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
            ++L+K  GR +  +++     +  GM YL +      +H DL  +NIL+++    K+S 
Sbjct: 103 DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSD 159
Query: 332 FGLLRLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           FG+ R+    PE A        P+        + APE     +F  + D +S+G++++E+
Sbjct: 160 FGMSRVLEDDPEAAYTTRGGKIPIR-------WTAPEAIAYRKFTSASDVWSYGIVMWEV 212
Query: 388 IE-GVQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNF 444
           +  G +P+     ++V+K +  EG R  PP+       P  L +L+ +CW  +   RP F
Sbjct: 213 MSYGERPYWDMSNQDVIKAI-EEGYRLPPPMDC-----PIALHQLMLDCWQKERSDRPKF 266
Query: 445 NEIIARLDRIVCN 457
            +I+  LD+++ N
Sbjct: 267 GQIVNMLDKLIRN 279

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 137/277 (49%), Gaps = 26/277 (9%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T    + IV ++     L  +L   + +    K++  A   ARGM+YLH    
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH----IDPANLYVA 362
             IIH DLK  NI L     +KI  FGL      + EK++  +  SH    +  + L++A
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSR--WSGSHQFEQLSGSILWMA 190
Query: 363 PEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           PE+ + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K 
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 420 RSY-PPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           RS  P  +K L+ EC   K   RP+F  I+A ++ + 
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 18/277 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 13  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   ARGM+YLH    
Sbjct: 71  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 126
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 182
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 242
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
           P  +K L+ EC   K   RP+F  I+A ++ +    S
Sbjct: 243 PKRMKRLMAECLKKKRDERPSFPRILAEIEELARELS 279

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 127/246 (51%), Gaps = 25/246 (10%)
Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K  + D +R + F  E +I+ +  HPN++   G VT+  P+MI+ EY   G L ++L+K 
Sbjct: 45  KAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 103
Query: 280 -GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
            GR +  +++     +  GM YL +      +H DL  +NIL+++    K+S FG+ R+ 
Sbjct: 104 DGRFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVL 160
Query: 339 YISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQP 393
              PE A        P+        + APE     +F  + D +S+G++++E++  G +P
Sbjct: 161 EDDPEAAYTTRGGKIPIR-------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213
Query: 394 FHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
           +     ++V+K +  EG R  PP+       P  L +L+ +CW  +   RP F +I+  L
Sbjct: 214 YWDMSNQDVIKAI-EEGYRLPPPMDC-----PIALHQLMLDCWQKERSDRPKFGQIVNML 267
Query: 452 DRIVCN 457
           D+++ N
Sbjct: 268 DKLIRN 273

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 18  RTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 77
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 78  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 136 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 192
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 193 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 245
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 246 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 299
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 300 SILDKLIRN 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 38/286 (13%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 59
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV      
Sbjct: 120 EEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVK----- 169
Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             + +PE++    +    D +SFG++++E+  EG  P+  +   EVV+          + 
Sbjct: 170 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---------DIS 218
Query: 417 IKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
              R Y P L      +++  CW  +P  RP F+ ++ +L  I  +
Sbjct: 219 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 123/234 (52%), Gaps = 24/234 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 123
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV-- 348
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A     
Sbjct: 124 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 349 --FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              P+        + +PE     +F  + D +S+G++L+E++  G +P+     ++V+K 
Sbjct: 181 GKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 233
Query: 406 MCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
           +  EG R  PP+       P  L +L+ +CW      RP F +I++ LD+++ N
Sbjct: 234 V-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 59
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV      
Sbjct: 120 EEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVK----- 169
Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             + +PE++    +    D +SFG++++E+  EG  P+  +   EVV+          + 
Sbjct: 170 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---------DIS 218
Query: 417 IKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLDRI 454
              R Y P L      +++  CW  +P  RP F+ ++ +L  I
Sbjct: 219 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 123/234 (52%), Gaps = 24/234 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 81  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 140
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV-- 348
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A     
Sbjct: 141 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 197
Query: 349 --FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              P+        + +PE     +F  + D +S+G++L+E++  G +P+     ++V+K 
Sbjct: 198 GKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 250
Query: 406 MCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
           +  EG R  PP+       P  L +L+ +CW      RP F +I++ LD+++ N
Sbjct: 251 V-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 298

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 136/282 (48%), Gaps = 38/282 (13%)
Query: 184 ELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEK 241
           EL   E+ + K  G  + G  ++ KW G   V VK++ + S  + E    F  E   + K
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTMMK 59
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNY 300
             HP +V+F G  ++  P+ IV EY + G L +YL+  G+ L PS++L    D+  GM +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           L   +    IH DL  +N L+D    +K+S FG+ R     QY+S    K  FPV     
Sbjct: 120 L---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK--FPVK---- 170
Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              + APE++   ++    D ++FG++++E+   G  P+      EVV L   +G R   
Sbjct: 171 ---WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGHRL-- 224
Query: 416 KIKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLD 452
                 Y P L      +++  CW   P  RP F ++++ ++
Sbjct: 225 ------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 57
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV      
Sbjct: 118 EEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVK----- 167
Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             + +PE++    +    D +SFG++++E+  EG  P+  +   EVV+          + 
Sbjct: 168 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---------DIS 216
Query: 417 IKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLDRI 454
              R Y P L      +++  CW  +P  RP F+ ++ +L  I
Sbjct: 217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 7   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 62
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 63  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 122
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV      
Sbjct: 123 EEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVK----- 172
Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             + +PE++    +    D +SFG++++E+  EG  P+  +   EVV+          + 
Sbjct: 173 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---------DIS 221
Query: 417 IKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLDRI 454
              R Y P L      +++  CW  +P  RP F+ ++ +L  I
Sbjct: 222 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 60
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV      
Sbjct: 121 EEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVK----- 170
Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             + +PE++    +    D +SFG++++E+  EG  P+  +   EVV+          + 
Sbjct: 171 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---------DIS 219
Query: 417 IKARSYPPDLK-----ELIEECWDPKPVIRPNFNEIIARLDRI 454
              R Y P L      +++  CW  +P  RP F+ ++ +L  I
Sbjct: 220 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 123/240 (51%), Gaps = 34/240 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT ++P+MI+ E+   G L S+L+   G+ +  +++  
Sbjct: 62  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM 121
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------QYISP 342
              +A GM YL E      +H DL  +NIL+++    K+S FGL R          Y S 
Sbjct: 122 LRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178
Query: 343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEE 401
              KI  P+        + APE     +F  + DA+S+G++++E++  G +P+     ++
Sbjct: 179 LGGKI--PIR-------WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 229
Query: 402 VVKLMCCEGKRPPLKIKARSYPPD----LKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
           V+  +  + + PP        PPD    L +L+ +CW      RP F ++++ LD+++ N
Sbjct: 230 VINAIEQDYRLPP--------PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 281

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 153/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV E    G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 153/309 (49%), Gaps = 35/309 (11%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV E    G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           R+    PE A        P+        + +PE     +F  + D +S+G++L+E++  G
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +P+     ++V+K +  EG R  PP+       P  L +L+ +CW      RP F +I+
Sbjct: 248 ERPYWEMSNQDVIKAV-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 449 ARLDRIVCN 457
           + LD+++ N
Sbjct: 302 SILDKLIRN 310

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 122/234 (52%), Gaps = 24/234 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV E    G L S+L+K   + +  +++  
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGM 123
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV-- 348
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A     
Sbjct: 124 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 349 --FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              P+        + +PE     +F  + D +S+G++L+E++  G +P+     ++V+K 
Sbjct: 181 GKIPIR-------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 233
Query: 406 MCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
           +  EG R  PP+       P  L +L+ +CW      RP F +I++ LD+++ N
Sbjct: 234 V-DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 128/256 (50%), Gaps = 26/256 (10%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +++V I   +S    ++   F  E +I+ +  HPNV+   G VT++ P+MI+ E+   G 
Sbjct: 61  EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 120
Query: 272 LASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L S+L Q  G+ +  +++     +A GM YL +      +H DL  +NIL+++    K+S
Sbjct: 121 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 177
Query: 331 GFGLLRL--------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            FGL R          Y S    KI  P+        + APE  +  +F  + D +S+G+
Sbjct: 178 DFGLSRFLEDDTSDPTYTSALGGKI--PIR-------WTAPEAIQYRKFTSASDVWSYGI 228
Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           +++E++  G +P+     ++V+  +  + + PP        P  L +L+ +CW      R
Sbjct: 229 VMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP----PMDCPSALHQLMLDCWQKDRNHR 284
Query: 442 PNFNEIIARLDRIVCN 457
           P F +I+  LD+++ N
Sbjct: 285 PKFGQIVNTLDKMIRN 300

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 26/274 (9%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 95  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 150
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH----IDPANLYVA 362
             IIH DLK  NI L     +KI  FGL      + EK++  +  SH    +  + L++A
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGL------ATEKSR--WSGSHQFEQLSGSILWMA 202
Query: 363 PEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           PE+ + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K 
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 262
Query: 420 RSY-PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           RS  P  +K L+ EC   K   RP F +I+A ++
Sbjct: 263 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 26/274 (9%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 29  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 87  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 142
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH----IDPANLYVA 362
             IIH DLK  NI L     +KI  FGL      + EK++  +  SH    +  + L++A
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGL------ATEKSR--WSGSHQFEQLSGSILWMA 194
Query: 363 PEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           PE+ + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K 
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 254
Query: 420 RSY-PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           RS  P  +K L+ EC   K   RP F +I+A ++
Sbjct: 255 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 123/259 (47%), Gaps = 25/259 (9%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N TKV VK L   +      + AF  E  +++  +H  +V+    VT+  P+ I+ EY A
Sbjct: 36  NSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMA 91
Query: 269 KGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           KG L  +L+  + G++   K++ F+  +A GM Y+        IH DL+  N+L+     
Sbjct: 92  KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLM 148
Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            KI+ FGL R+    +Y + E AK  FP+        + APE      F    D +SFG+
Sbjct: 149 CKIADFGLARVIEDNEYTAREGAK--FPIK-------WTAPEAINFGCFTIKSDVWSFGI 199
Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           +LYE++   +  +P      V     +G R P   +  + P +L ++++ CW  K   RP
Sbjct: 200 LLYEIVTYGKIPYPGRTNADVMTALSQGYRMP---RVENCPDELYDIMKMCWKEKAEERP 256
Query: 443 NFNEIIARLDRIVCNCSKQ 461
            F+ + + LD        Q
Sbjct: 257 TFDYLQSVLDDFYTATEGQ 275

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 126/245 (51%), Gaps = 14/245 (5%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K L K  + + +R++ F  E  I+ +  H N+++  G +++  PMMI+ EY   G L
Sbjct: 76  VAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 273 ASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             +L++K G  S  +++     +A GM YL        +H DL  +NIL+++    K+S 
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSD 190
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEG 390
           FGL R+    PE     +  S       + APE     +F  + D +SFG++++E M  G
Sbjct: 191 FGLSRVLEDDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
            +P+      EV+K +  +G R P  +     P  + +L+ +CW  +   RP F +I++ 
Sbjct: 248 ERPYWELSNHEVMKAI-NDGFRLPTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSI 303
Query: 451 LDRIV 455
           LD+++
Sbjct: 304 LDKLI 308

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 26/274 (9%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 67  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH----IDPANLYVA 362
             IIH DLK  NI L     +KI  FGL      + EK++  +  SH    +  + L++A
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGL------ATEKSR--WSGSHQFEQLSGSILWMA 174
Query: 363 PEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           PE+ + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K 
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 420 RSY-PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           RS  P  +K L+ EC   K   RP F +I+A ++
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT ++P+MI+ E+   G L S+L+   G+ +  +++  
Sbjct: 64  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM 123
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              +A GM YL E      +H DL  +NIL+++    K+S FGL R    +         
Sbjct: 124 LRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCE 409
           +    P   + APE     +F  + DA+S+G++++E++  G +P+     ++V+  +  +
Sbjct: 181 LGGKIPIR-WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQD 239
Query: 410 GKRPPLKIKARSYPPD----LKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
            + PP        PPD    L +L+ +CW      RP F ++++ LD+++ N
Sbjct: 240 YRLPP--------PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 283

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 95  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 150
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 206
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 266
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P  +K L+ EC   K   RP F +I+A ++
Sbjct: 267 PKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 36  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 94  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 149
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 205
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 265
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P  +K L+ EC   K   RP F +I+A ++
Sbjct: 266 PKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 127/256 (49%), Gaps = 26/256 (10%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +++V I   +S    ++   F  E +I+ +  HPNV+   G VT++ P+MI+ E+   G 
Sbjct: 35  EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 94
Query: 272 LASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L S+L Q  G+ +  +++     +A GM YL +      +H  L  +NIL+++    K+S
Sbjct: 95  LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRALAARNILVNSNLVCKVS 151
Query: 331 GFGLLRL--------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            FGL R          Y S    KI  P+        + APE  +  +F  + D +S+G+
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKI--PIR-------WTAPEAIQYRKFTSASDVWSYGI 202
Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           +++E++  G +P+     ++V+  +  + + PP        P  L +L+ +CW      R
Sbjct: 203 VMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP----PMDCPSALHQLMLDCWQKDRNHR 258
Query: 442 PNFNEIIARLDRIVCN 457
           P F +I+  LD+++ N
Sbjct: 259 PKFGQIVNTLDKMIRN 274

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 72  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 183
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P  +K L+ EC   K   RP F +I+A ++
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 72  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 183
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P  +K L+ EC   K   RP F +I+A ++
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 69  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 124
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 180
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 240
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P  +K L+ EC   K   RP F +I+A ++
Sbjct: 241 PKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 18/270 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 67  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 178
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P  +K L+ EC   K   RP F +I+A ++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 131/270 (48%), Gaps = 18/270 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T    + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 67  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             IIH DLK  NI L     +KI  FGL  ++     +         +  + L++APE+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMAPEVI 178
Query: 367 KNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY- 422
           + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P   K RS  
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P  +K L+ EC   K   RP F +I+A ++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 132/267 (49%), Gaps = 26/267 (9%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-- 255
           +  G Y     N  +  +K L + +  + +++ AF  E  ++    HPNV+  +G +   
Sbjct: 37  VYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94
Query: 256 QNIPMMIVLEYHAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDL 314
           + +P  ++L Y   GDL  +++   R    K ++ F L +ARGM YL E K    +H DL
Sbjct: 95  EGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDL 150
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIV-FPVSHIDPANLYVAPEIYKNE 369
             +N +LD    +K++ FGL R     +Y S ++ +    PV        + A E  +  
Sbjct: 151 AARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK-------WTALESLQTY 203
Query: 370 EFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE 428
            F    D +SFG++L+E++  G  P+    P ++   +  +G+R P   +    P  L +
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLP---QPEYCPDSLYQ 259
Query: 429 LIEECWDPKPVIRPNFNEIIARLDRIV 455
           ++++CW+  P +RP F  ++  +++IV
Sbjct: 260 VMQQCWEADPAVRPTFRVLVGEVEQIV 286

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 133/281 (47%), Gaps = 58/281 (20%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +   P  +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 54  TTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 271 DLASYLQKKGRLSP------------------------SKVLRFALDLARGMNYLHECKP 306
            L  +L++  ++ P                          ++ FA  +++GM YL E K 
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK- 170
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYV 361
             ++H DL  +NIL+  G ++KIS FGL R       Y+   + +I  PV  +   +L+ 
Sbjct: 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI--PVKWMAIESLF- 225
Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
              IY  +      D +SFG++L+E++  G  P+   PPE +  L         LK   R
Sbjct: 226 -DHIYTTQS-----DVWSFGVLLWEIVTLGGNPYPGIPPERLFNL---------LKTGHR 270
Query: 421 SYPPD-----LKELIEECWDPKPVIRPNFNEIIARLDRIVC 456
              PD     +  L+ +CW  +P  RP F +I   L++++ 
Sbjct: 271 MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 133/279 (47%), Gaps = 54/279 (19%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +   P  +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 54  TTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 271 DLASYLQKKGRLSP------------------------SKVLRFALDLARGMNYLHECKP 306
            L  +L++  ++ P                          ++ FA  +++GM YL E K 
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK- 170
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY---ISPEKAKIVFPVSHIDPANLYVAP 363
             ++H DL  +NIL+  G ++KIS FGL R  Y      ++++   PV  +   +L+   
Sbjct: 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF--D 226
Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY 422
            IY  +      D +SFG++L+E++  G  P+   PPE +  L         LK   R  
Sbjct: 227 HIYTTQS-----DVWSFGVLLWEIVTLGGNPYPGIPPERLFNL---------LKTGHRME 272
Query: 423 PPD-----LKELIEECWDPKPVIRPNFNEIIARLDRIVC 456
            PD     +  L+ +CW  +P  RP F +I   L++++ 
Sbjct: 273 RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 127/260 (48%), Gaps = 27/260 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N TKV VK L   +      + AF  E  +++  +H  +V+    VT+  P+ I+ E+ A
Sbjct: 35  NSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMA 90
Query: 269 KGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           KG L  +L+  + G++   K++ F+  +A GM Y+        IH DL+  N+L+     
Sbjct: 91  KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLM 147
Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            KI+ FGL R+    +Y + E AK  FP+        + APE      F    + +SFG+
Sbjct: 148 CKIADFGLARVIEDNEYTAREGAK--FPIK-------WTAPEAINFGCFTIKSNVWSFGI 198
Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           +LYE++  G  P+  +   +V+  +  +G R P   +  + P +L ++++ CW  K   R
Sbjct: 199 LLYEIVTYGKIPYPGRTNADVMSAL-SQGYRMP---RMENCPDELYDIMKMCWKEKAEER 254
Query: 442 PNFNEIIARLDRIVCNCSKQ 461
           P F+ + + LD        Q
Sbjct: 255 PTFDYLQSVLDDFYTATEGQ 274

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 144/304 (47%), Gaps = 29/304 (9%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 22  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 81
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 82  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 140
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD    +K++ FGL
Sbjct: 141 IRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 197
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
            R  Y      K  + V +   A L   ++A E  + ++F    D +SFG++L+E++   
Sbjct: 198 ARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 252
Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEIIAR 450
            P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E+++R
Sbjct: 253 APPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 308
Query: 451 LDRI 454
           +  I
Sbjct: 309 ISAI 312

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 188 LELQVRKADG----ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           L L  +  DG    + +G +         V VK L  +    PE ++ F  E+  +    
Sbjct: 14  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLH 302
           H N+++  G V    PM +V E    G L   L+K +G      + R+A+ +A GM YL 
Sbjct: 74  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDP 356
             +    IH DL  +N+LL     +KI  FGL+R        Y+  E  K+ F       
Sbjct: 133 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA------ 183
Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              + APE  K   F  + D + FG+ L+EM   G +P+      +++  +  EG+R P 
Sbjct: 184 ---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP- 239
Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNF 444
             +    P D+  ++ +CW  KP  RP F
Sbjct: 240 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 144/304 (47%), Gaps = 29/304 (9%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 23  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 82
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 83  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 141
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD    +K++ FGL
Sbjct: 142 IRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 198
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
            R  Y      K  + V +   A L   ++A E  + ++F    D +SFG++L+E++   
Sbjct: 199 ARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 253
Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEIIAR 450
            P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E+++R
Sbjct: 254 APPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 309
Query: 451 LDRI 454
           +  I
Sbjct: 310 ISAI 313

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 30  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 85
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 145
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 146 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 195
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 251
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 252 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 144/304 (47%), Gaps = 29/304 (9%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 4   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 122
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD    +K++ FGL
Sbjct: 123 IRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
            R  Y      K  + V +   A L   ++A E  + ++F    D +SFG++L+E++   
Sbjct: 180 ARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 234
Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEIIAR 450
            P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E+++R
Sbjct: 235 APPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 290
Query: 451 LDRI 454
           +  I
Sbjct: 291 ISAI 294

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 36  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 91
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 151
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 152 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 201
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 257
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 258 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 37  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 92
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 152
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 153 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 202
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 258
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 259 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 36  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 91
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 151
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 152 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 201
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 257
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 258 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 188 LELQVRKADG----ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           L L  +  DG    + +G +         V VK L  +    PE ++ F  E+  +    
Sbjct: 14  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLH 302
           H N+++  G V    PM +V E    G L   L+K +G      + R+A+ +A GM YL 
Sbjct: 74  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDP 356
             +    IH DL  +N+LL     +KI  FGL+R        Y+  E  K+ F       
Sbjct: 133 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA------ 183
Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              + APE  K   F  + D + FG+ L+EM   G +P+      +++  +  EG+R P 
Sbjct: 184 ---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP- 239
Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNF 444
             +    P D+  ++ +CW  KP  RP F
Sbjct: 240 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 34  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 89
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 90  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 149
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 150 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 199
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 200 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 255
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 256 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 110/234 (47%), Gaps = 19/234 (8%)
Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSP 284
           P+    F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +G RL  
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV 212
Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
             +L+   D A GM YL   +    IH DL  +N L+     LKIS FG+ R      E+
Sbjct: 213 KTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSR------EE 263
Query: 345 AKIVFPVS---HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPE 400
           A  V+  S      P   + APE      +    D +SFG++L+E    G  P+ P    
Sbjct: 264 ADGVYAASGGLRQVPVK-WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-PNLSN 321
Query: 401 EVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +  +    +G R P        P  +  L+E+CW  +P  RP+F+ I   L  I
Sbjct: 322 QQTREFVEKGGRLPC---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 188 LELQVRKADG----ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           L L  +  DG    + +G +         V VK L  +    PE ++ F  E+  +    
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLH 302
           H N+++  G V    PM +V E    G L   L+K +G      + R+A+ +A GM YL 
Sbjct: 80  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDP 356
             +    IH DL  +N+LL     +KI  FGL+R        Y+  E  K+ F       
Sbjct: 139 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA------ 189
Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              + APE  K   F  + D + FG+ L+EM   G +P+      +++  +  EG+R P 
Sbjct: 190 ---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP- 245
Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNF 444
             +    P D+  ++ +CW  KP  RP F
Sbjct: 246 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 128/253 (50%), Gaps = 20/253 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 47  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 105
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 106 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 162
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGL 382
            +K++ FGL R  Y      K  + V +   A L   ++A E  + ++F    D +SFG+
Sbjct: 163 TVKVADFGLARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 217
Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIR 441
           +L+E++    P +P      + +   +G+R    +    Y PD L E++ +CW PK  +R
Sbjct: 218 LLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMR 273
Query: 442 PNFNEIIARLDRI 454
           P+F+E+++R+  I
Sbjct: 274 PSFSELVSRISAI 286

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 33  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 88
Query: 256 QNIPMMIVLEYHAKGDLASYLQK-------KGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL+           L+P   SK+++ A ++A GM YL+  K
Sbjct: 89  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 148
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 149 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 198
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 199 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 254
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 255 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 31  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 87
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 88  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 142
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 199
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 200 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 259
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 260 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 301

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 144/304 (47%), Gaps = 29/304 (9%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 4   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 122
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD    +K++ FGL
Sbjct: 123 IRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
            R  Y      K  + V +   A L   ++A E  + ++F    D +SFG++L+E++   
Sbjct: 180 ARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 234
Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEIIAR 450
            P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E+++R
Sbjct: 235 APPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 290
Query: 451 LDRI 454
           +  I
Sbjct: 291 ISAI 294

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 28  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 84
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 85  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 139
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 140 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 196
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 197 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 256
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 257 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 298

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 27  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 84  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 138
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 195
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 255
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 256 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 43  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 98
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 159 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 208
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 264
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 265 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 29  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 85
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 86  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 140
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 141 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 197
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 198 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 257
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 258 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 299

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 65  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 120
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 121 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 180
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 181 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 230
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 231 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 286
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 287 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 188 LELQVRKADG----ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           L L  +  DG    + +G +         V VK L  +    PE ++ F  E+  +    
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLH 302
           H N+++  G V    PM +V E    G L   L+K +G      + R+A+ +A GM YL 
Sbjct: 70  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDP 356
             +    IH DL  +N+LL     +KI  FGL+R        Y+  E  K+ F       
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA------ 179
Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              + APE  K   F  + D + FG+ L+EM   G +P+      +++  +  EG+R P 
Sbjct: 180 ---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP- 235
Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNF 444
             +    P D+  ++ +CW  KP  RP F
Sbjct: 236 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 144/304 (47%), Gaps = 29/304 (9%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 3   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 62
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 63  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 121
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD    +K++ FGL
Sbjct: 122 IRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 178
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
            R  Y      K  + V +   A L   ++A E  + ++F    D +SFG++L+E++   
Sbjct: 179 ARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 233
Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEIIAR 450
            P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E+++R
Sbjct: 234 APPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 289
Query: 451 LDRI 454
           +  I
Sbjct: 290 ISAI 293

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 30  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 86
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 87  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 141
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 142 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 198
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 199 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 258
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 259 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 300

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 128/253 (50%), Gaps = 20/253 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 53  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 111
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 112 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 168
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGL 382
            +K++ FGL R  Y      K  + V +   A L   ++A E  + ++F    D +SFG+
Sbjct: 169 TVKVADFGLARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 223
Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIR 441
           +L+E++    P +P      + +   +G+R    +    Y PD L E++ +CW PK  +R
Sbjct: 224 LLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMR 279
Query: 442 PNFNEIIARLDRI 454
           P+F+E+++R+  I
Sbjct: 280 PSFSELVSRISAI 292

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 188 LELQVRKADG----ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           L L  +  DG    + +G +         V VK L  +    PE ++ F  E+  +    
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLH 302
           H N+++  G V    PM +V E    G L   L+K +G      + R+A+ +A GM YL 
Sbjct: 70  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDP 356
             +    IH DL  +N+LL     +KI  FGL+R        Y+  E  K+ F       
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA------ 179
Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPL 415
              + APE  K   F  + D + FG+ L+EM   G +P+      +++  +  EG+R P 
Sbjct: 180 ---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP- 235
Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNF 444
             +    P D+  ++ +CW  KP  RP F
Sbjct: 236 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 81  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 135
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 192
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 253 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 81  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 135
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 192
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 253 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 42  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 98
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 99  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 153
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 210
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 211 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 270
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 271 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 312

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 135/281 (48%), Gaps = 42/281 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 112 YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 166
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 223
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
               +    P ++  ++ ECW+     RP+F ++  R+D+I
Sbjct: 284 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 23  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 79
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 80  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 134
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 135 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 191
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 192 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 251
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 252 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 54/279 (19%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +   P  +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 54  TTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 271 DLASYLQKKGRLSP------------------------SKVLRFALDLARGMNYLHECKP 306
            L  +L++  ++ P                          ++ FA  +++GM YL E   
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS- 170
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY---ISPEKAKIVFPVSHIDPANLYVAP 363
             ++H DL  +NIL+  G ++KIS FGL R  Y      ++++   PV  +   +L+   
Sbjct: 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF--D 226
Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY 422
            IY  +      D +SFG++L+E++  G  P+   PPE +  L         LK   R  
Sbjct: 227 HIYTTQS-----DVWSFGVLLWEIVTLGGNPYPGIPPERLFNL---------LKTGHRME 272
Query: 423 PPD-----LKELIEECWDPKPVIRPNFNEIIARLDRIVC 456
            PD     +  L+ +CW  +P  RP F +I   L++++ 
Sbjct: 273 RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 128/253 (50%), Gaps = 20/253 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 52  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 110
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 167
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGL 382
            +K++ FGL R  Y      K  + V +   A L   ++A E  + ++F    D +SFG+
Sbjct: 168 TVKVADFGLARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222
Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIR 441
           +L+E++    P +P      + +   +G+R    +    Y PD L E++ +CW PK  +R
Sbjct: 223 LLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMR 278
Query: 442 PNFNEIIARLDRI 454
           P+F+E+++R+  I
Sbjct: 279 PSFSELVSRISAI 291

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 135/281 (48%), Gaps = 42/281 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 22  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 78
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 79  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 133
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 134 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 190
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 191 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 250
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
               +    P ++  ++ ECW+     RP+F ++  R+D+I
Sbjct: 251 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 19/229 (8%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 46  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 105
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY-- 339
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 106 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162
Query: 340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKP 398
                A   FP+        + APE     +F    D ++FG++L+E+   G+ P+    
Sbjct: 163 TXTAHAGAKFPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215
Query: 399 PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           P +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 PSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 42/284 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 42  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 98
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 99  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 153
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 210
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 211 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 270
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N
Sbjct: 271 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 310

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 128/253 (50%), Gaps = 20/253 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 50  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 108
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 165
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGL 382
            +K++ FGL R  Y      K  + V +   A L   ++A E  + ++F    D +SFG+
Sbjct: 166 TVKVADFGLARDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220
Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIR 441
           +L+E++    P +P      + +   +G+R    +    Y PD L E++ +CW PK  +R
Sbjct: 221 LLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMR 276
Query: 442 PNFNEIIARLDRI 454
           P+F+E+++R+  I
Sbjct: 277 PSFSELVSRISAI 289

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 43  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 98
Query: 256 QNIPMMIVLEYHAKGDLASYLQK-------KGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL+           L+P   SK+++ A ++A GM YL+  K
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 159 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 208
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 264
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 265 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 132/275 (48%), Gaps = 41/275 (14%)
Query: 210 GTKVWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYH 267
              V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY 
Sbjct: 54  AVTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 110
Query: 268 AKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
           +KG+L  YL+ +                 +++   ++     LARGM YL   K    IH
Sbjct: 111 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIH 167
Query: 312 CDLKPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
            DL  +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   
Sbjct: 168 RDLTARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALF 219
Query: 368 NEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL 426
           +  +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L
Sbjct: 220 DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNEL 275
Query: 427 KELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
             ++ +CW   P  RP F +++  LDRI+   + Q
Sbjct: 276 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNQ 310

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT+    MIV EY   G L ++L+   G+ +  +++  
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV-- 348
              +  GM YL +      +H DL  +N+L+D+    K+S FGL R+    P+ A     
Sbjct: 157 LRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTG 213
Query: 349 --FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              P+        + APE      F  + D +SFG++++E++  G +P+      +V+  
Sbjct: 214 GKIPIR-------WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS- 265
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
              EG R P  +     P  L +L+ +CW      RP F++I++ LD ++
Sbjct: 266 SVEEGYRLPAPMGC---PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 113/226 (50%), Gaps = 12/226 (5%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT+    MIV EY   G L ++L+   G+ +  +++  
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              +  GM YL +      +H DL  +N+L+D+    K+S FGL R+    P+ A   + 
Sbjct: 157 LRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA---YT 210
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCE 409
            +       + APE      F  + D +SFG++++E++  G +P+      +V+     E
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS-SVEE 269
Query: 410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           G R P  +     P  L +L+ +CW      RP F++I++ LD ++
Sbjct: 270 GYRLPAPMGC---PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 39/268 (14%)
Query: 210 GTKVWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYH 267
              V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY 
Sbjct: 67  AVTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 123
Query: 268 AKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
           +KG+L  YL+ +                 +++   ++     LARGM YL   K    IH
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIH 180
Query: 312 CDLKPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKN 368
            DL  +N+L+     +KI+ FGL R +  I   K       PV        ++APE   +
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK-------WMAPEALFD 233
Query: 369 EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
             +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L 
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELY 289
Query: 428 ELIEECWDPKPVIRPNFNEIIARLDRIV 455
            ++ +CW   P  RP F +++  LDRI+
Sbjct: 290 MMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 39/265 (14%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEEF 371
             +N+L+     +KI+ FGL R +  I   K       PV        ++APE   +  +
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK-------WMAPEALFDRVY 236
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
               D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  ++
Sbjct: 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMMM 292
Query: 431 EECWDPKPVIRPNFNEIIARLDRIV 455
            +CW   P  RP F +++  LDRI+
Sbjct: 293 RDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 131/255 (51%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 47  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 104
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 105 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 161
Query: 321 LDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R  Y +    +  K + PV        ++APE  K+  F  S D 
Sbjct: 162 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 214
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 215 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 270
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 271 NPKMRPTFLEIVNLL 285

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G  
Sbjct: 37  GSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 94  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 150
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DL  +NIL+++   +KI+ FGL +L  +  +K   V       P   Y APE   +  F
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKL--LPLDKDYYVVREPGQSPIFWY-APESLSDNIF 207
Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR----------- 420
            R  D +SFG++LYE+          P  E +++M CE   P L                
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAP 266
Query: 421 -SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            + P ++ EL++ CW P P  RP+F+ +  +LD +
Sbjct: 267 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 63  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 122 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 179 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 230 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 131/255 (51%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R  Y +    +  K + PV        ++APE  K+  F  S D 
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 215
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 216 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 271
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 272 NPKMRPTFLEIVNLL 286

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 142/308 (46%), Gaps = 33/308 (10%)
Query: 165 PKTKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWV 215
           P T    ++  NP   + V    + P  L V   + I +G +           +G K+  
Sbjct: 2   PGTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 61
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLA 273
            +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLR 120
Query: 274 SYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
           ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ F
Sbjct: 121 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF 177
Query: 333 GLLRLQYISP-----EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           GL R  Y         K     PV        ++A E  + ++F    D +SFG++L+E+
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 388 IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNE 446
           +    P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E
Sbjct: 231 MTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 286
Query: 447 IIARLDRI 454
           +++R+  I
Sbjct: 287 LVSRISAI 294

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 138/270 (51%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 30  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 85
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 145
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVA 362
               +H DL  +N  +     +KI  FG+ R  Y +    +  K + PV        +++
Sbjct: 146 ---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMS 195
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 251
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 252 CPDMLLELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 130/260 (50%), Gaps = 29/260 (11%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 22  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 76
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 133
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+        + APE      F  
Sbjct: 134 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIK-------WTAPEAINYGTFTI 184
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 185 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 240
Query: 433 CWDPKPVIRPNFNEIIARLD 452
           CW  +P  RP F+ + + L+
Sbjct: 241 CWKERPEDRPTFDYLRSVLE 260

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 61  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 119
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 120 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 176
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 177 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 227
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 228 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 273

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 143/304 (47%), Gaps = 29/304 (9%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 3   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 62
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 63  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 121
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD    +K++ FGL
Sbjct: 122 IRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 178
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
            R  Y      K    V +   A L   ++A E  + ++F    D +SFG++L+E++   
Sbjct: 179 ARDMY-----DKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 233
Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEIIAR 450
            P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E+++R
Sbjct: 234 APPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 289
Query: 451 LDRI 454
           +  I
Sbjct: 290 ISAI 293

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 86  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 144
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 145 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 201
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 202 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 252
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 253 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 298

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 40/262 (15%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKKGR--------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           DL ++L++K R              LS   +L F+  +A+GM +L        IH D+  
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192
Query: 317 KNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
           +N+LL NG   KI  FGL R       YI    A++  PV        ++APE   +  +
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVK-------WMAPESIFDCVY 243
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP-DLKEL 429
               D +S+G++L+E+   G+ P+    P  +V     +  +   ++   ++ P ++  +
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSI 299
Query: 430 IEECWDPKPVIRPNFNEIIARL 451
           ++ CW  +P  RP F +I + L
Sbjct: 300 MQACWALEPTHRPTFQQICSFL 321

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 131/269 (48%), Gaps = 29/269 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 37  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 91
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 148
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+        + APE      F  
Sbjct: 149 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIK-------WTAPEAINYGTFTI 199
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 200 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 255
Query: 433 CWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           CW  +P  RP F+ + + L+        Q
Sbjct: 256 CWKERPEDRPTFDYLRSVLEDFFTATEGQ 284

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 131/255 (51%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R  Y +    +  K + PV        ++APE  K+  F  S D 
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 215
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 216 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 271
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 272 NPKMRPTFLEIVNLL 286

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 27  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++E+   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 84  YSAGRRNLKL--IMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 138
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 195
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 255
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 256 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 46  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 105
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY-- 339
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 106 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162
Query: 340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKP 398
                A   FP+        + APE     +F    D ++FG++L+E+   G+ P+    
Sbjct: 163 TXTAHAGAKFPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215
Query: 399 PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           P +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 PSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 130/260 (50%), Gaps = 29/260 (11%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+        + APE      F  
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIK-------WTAPEAINYGTFTI 189
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 245
Query: 433 CWDPKPVIRPNFNEIIARLD 452
           CW  +P  RP F+ + + L+
Sbjct: 246 CWKERPEDRPTFDYLRSVLE 265

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 81  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 135
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG---ESPIFWYAPESLTES 192
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 253 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 116 VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 172
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 173 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 229
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 230 AARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 281
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHR---MDKPANCTNELYMM 337
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 338 MRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 139
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 140 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 196
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 197 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 250 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 174 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 225 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 62  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 118
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 119 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 175
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 176 AARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 227
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 228 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 283
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 284 MRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 130/260 (50%), Gaps = 29/260 (11%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+        + APE      F  
Sbjct: 145 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIK-------WTAPEAINYGTFTI 195
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 251
Query: 433 CWDPKPVIRPNFNEIIARLD 452
           CW  +P  RP F+ + + L+
Sbjct: 252 CWKERPEDRPTFDYLRSVLE 271

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 174 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 225 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 60  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 118
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 119 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 175
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 176 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 226
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 227 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 272

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 165
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 166 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 222
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 223 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 275
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 276 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 130/265 (49%), Gaps = 39/265 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L  ++ +  E ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG+
Sbjct: 70  VAVKMLKDDATE--EDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 127
Query: 272 LASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
           L  YL+ +                 +++   ++     LARGM YL   K    IH DL 
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 184
Query: 316 PKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  +
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRVY 236
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
               D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  ++
Sbjct: 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMMM 292
Query: 431 EECWDPKPVIRPNFNEIIARLDRIV 455
            +CW   P  RP F +++  LDRI+
Sbjct: 293 RDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 145
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 146 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 202
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 203 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 255
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 256 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 46  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 105
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 106 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            + +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 163 TFTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
             P +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 214 IDPSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 42/256 (16%)
Query: 220 KESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           K+ H+D      F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K
Sbjct: 66  KDDHRD------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119
Query: 279 K----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
                              LS  ++L FA D+ARGM+YL +      IH DL  +NIL+ 
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG 176
Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
                KI+ FGL R Q +  +K     PV        ++A E      +  + D +S+G+
Sbjct: 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGV 229
Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPV 439
           +L+E++  G  P+      E+ + +  +G R   PL      Y     +L+ +CW  KP 
Sbjct: 230 LLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVY-----DLMRQCWREKPY 283
Query: 440 IRPNFNEIIARLDRIV 455
            RP+F +I+  L+R++
Sbjct: 284 ERPSFAQILVSLNRML 299

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 130/260 (50%), Gaps = 29/260 (11%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 32  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 86
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 143
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+        + APE      F  
Sbjct: 144 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIK-------WTAPEAINYGTFTI 194
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 195 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 250
Query: 433 CWDPKPVIRPNFNEIIARLD 452
           CW  +P  RP F+ + + L+
Sbjct: 251 CWKERPEDRPTFDYLRSVLE 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSP 284
           P+    F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +G RL  
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV 212
Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
             +L+   D A GM YL   +    IH DL  +N L+     LKIS FG+ R      E+
Sbjct: 213 KTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSR------EE 263
Query: 345 AKIVFPVS---HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPE 400
           A  V   S      P   + APE      +    D +SFG++L+E    G  P+ P    
Sbjct: 264 ADGVXAASGGLRQVPVK-WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-PNLSN 321
Query: 401 EVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +  +    +G R P        P  +  L+E+CW  +P  RP+F+ I   L  I
Sbjct: 322 QQTREFVEKGGRLPC---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 31/275 (11%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G  
Sbjct: 21  GSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 77
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 78  YGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 134
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DL  +NIL+++   +KI+ FGL +L  +  +   +  P         + APE   +  F
Sbjct: 135 RDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS---PIFWYAPESLSDNIF 191
Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-----------KIKAR 420
            R  D +SFG++LYE+          P  E +++M CE   P L           ++ A 
Sbjct: 192 SRQSDVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAP 250
Query: 421 -SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            + P ++ EL++ CW P P  RP+F+ +  +LD +
Sbjct: 251 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 285

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 59  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 115
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 116 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 172
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 173 AARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 224
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 225 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 280
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 281 MRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 42/256 (16%)
Query: 220 KESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           K+ H+D      F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K
Sbjct: 56  KDDHRD------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 109
Query: 279 K----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
                              LS  ++L FA D+ARGM+YL +      IH DL  +NIL+ 
Sbjct: 110 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG 166
Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
                KI+ FGL R Q +  +K     PV        ++A E      +  + D +S+G+
Sbjct: 167 ENYVAKIADFGLSRGQEVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGV 219
Query: 383 ILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPV 439
           +L+E++  G  P+      E+ + +  +G R   PL      Y     +L+ +CW  KP 
Sbjct: 220 LLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVY-----DLMRQCWREKPY 273
Query: 440 IRPNFNEIIARLDRIV 455
            RP+F +I+  L+R++
Sbjct: 274 ERPSFAQILVSLNRML 289

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 235
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 291
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 139
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 140 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 196
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 197 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 250 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 117/261 (44%), Gaps = 25/261 (9%)
Query: 193 RKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
            K  G   G   V  W    + V +  K   +D   +  F  E  ++++ +HPN+VQ +G
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAV--KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKV--LRFALDLARGMNYLHECKPDPII 310
             T   P  IV EY   G+L  YL++  R   + V  L  A  ++  M YL +      I
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK---KNFI 152
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAKIVFPVSHIDPANLYVAPEIY 366
           H DL  +N L+     +K++ FGL RL     Y +   AK  FP+        + APE  
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAK--FPIK-------WTAPESL 203
Query: 367 KNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD 425
               F    D ++FG++L+E+   G+ P+      +V  L+  +G R     +    PP 
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLL-EKGYRME---QPEGCPPK 259
Query: 426 LKELIEECWDPKPVIRPNFNE 446
           + EL+  CW   P  RP+F E
Sbjct: 260 VYELMRACWKWSPADRPSFAE 280

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 235
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 291
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 153
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 154 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 211 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 264 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 55  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 114 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 171 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 222 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 155
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 156 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 212
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 213 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 265
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 266 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 39/265 (14%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR-LQYISPEKAKI--VFPVSHIDPANLYVAPEIYKNEEF 371
             +N+L+     +KI+ FGL R +  I   K       PV        ++APE   +  +
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVK-------WMAPEALFDRVY 236
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
               D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  ++
Sbjct: 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMMM 292
Query: 431 EECWDPKPVIRPNFNEIIARLDRIV 455
            +CW   P  RP F +++  LDRI+
Sbjct: 293 RDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 31/275 (11%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G  
Sbjct: 25  GSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVS 81
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 82  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 138
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DL  +NIL+++   +KI+ FGL +L  +  +K   V       P   Y APE   +  F
Sbjct: 139 RDLAARNILVESEAHVKIADFGLAKL--LPLDKDYYVVREPGQSPIFWY-APESLSDNIF 195
Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-----------KIKAR 420
            R  D +SFG++LYE+          P  E +++M CE   P L           ++ A 
Sbjct: 196 SRQSDVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAP 254
Query: 421 -SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            + P ++ EL++ CW P P  RP+F+ +  +LD +
Sbjct: 255 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 289

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 49  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 108
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 109 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +P  AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 166 TYTAPAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 216
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 217 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L++  R  PS+     
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLA 156
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 157 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 213
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 214 AGYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 266
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 267 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 116/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 497 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 554 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 605 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 138
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 139 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 196 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 249 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 126/256 (49%), Gaps = 32/256 (12%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +V VK L  E + + + ++ F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GD
Sbjct: 77  QVAVKTL-PEVYSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 272 LASYLQKKGRLSPSK--------VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           L S+L ++ R  PS+        +L  A D+A G  YL E   +  IH D+  +N LL  
Sbjct: 135 LKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTC 190
Query: 324 GGQ---LKISGFGLLRLQYISPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
            G     KI  FG+ R  Y +    K    + PV        ++ PE +    F    D 
Sbjct: 191 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDT 243
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+   G  P+  K  +EV++ +   G+  P K    + P  +  ++ +CW  
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQH 299
Query: 437 KPVIRPNFNEIIARLD 452
           +P  RPNF  I+ R++
Sbjct: 300 QPEDRPNFAIILERIE 315

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L++  R  PS+     
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLA 130
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 131 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 187
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 188 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 240
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 241 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 179
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 180 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 237 AGYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 290 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 113/238 (47%), Gaps = 25/238 (10%)
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPS 285
           E+   F  E+ I+    HPN+V+  G +  N P M V+E+   GDL   L  K   +  S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRLQYI 340
             LR  LD+A G+ Y+    P PI+H DL+  NI L +  +      K++ FGL      
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------ 175
Query: 341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFHPKP 398
                + V  VS +     ++APE    EE  +    D YSF +ILY ++ G  PF    
Sbjct: 176 ---SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 399 PEEV--VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             ++  + ++  EG RP +       PP L+ +IE CW   P  RP+F+ I+  L  +
Sbjct: 233 YGKIKFINMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 138/299 (46%), Gaps = 30/299 (10%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 224
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 225 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 283 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEV 402
            AK  FP+        + APE      F    D +SFG++L E+  +G  P+      EV
Sbjct: 340 GAK--FPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390
Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +      G R P   +    P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 391 LD-QVERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 138/299 (46%), Gaps = 30/299 (10%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 224
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 225 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 283 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEV 402
            AK  FP+        + APE      F    D +SFG++L E+  +G  P+      EV
Sbjct: 340 GAK--FPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390
Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +      G R P   +    P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 391 LD-QVERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 50  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 109
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 110 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +P  AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 167 TYTAPAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 218 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 137/270 (50%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 28  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 83
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 84  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 143
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLR---LQYISPEKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R         +  K + PV        +++
Sbjct: 144 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-------WMS 193
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 249
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 250 CPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 141/281 (50%), Gaps = 30/281 (10%)
Query: 181 PEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTI 238
           PE+E+    L++ +  G  + G   +  +NG TKV VK L K+    P   +AF  E  +
Sbjct: 2   PEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANL 57
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLAR 296
           +++ +H  +V+    VTQ  P+ I+ EY   G L  +L+     +L+ +K+L  A  +A 
Sbjct: 58  MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVS 352
           GM ++ E      IH +L+  NIL+ +    KI+ FGL RL    +Y + E AK  FP+ 
Sbjct: 117 GMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIK 171
Query: 353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGK 411
                  + APE      F    D +SFG++L E++  G  P+      EV++ +    +
Sbjct: 172 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----E 220
Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           R    ++  + P +L +L+  CW  +P  RP F+ + + L+
Sbjct: 221 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 138/299 (46%), Gaps = 30/299 (10%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 252 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 307
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 308 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 366 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEV 402
            AK  FP+        + APE      F    D +SFG++L E+  +G  P+      EV
Sbjct: 423 GAK--FPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473
Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +      G R P   +    P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 474 LD-QVERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 137/270 (50%), Gaps = 32/270 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 37  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 92
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 152
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLR---LQYISPEKAKIVFPVSHIDPANLYVA 362
               +H DL  +N ++     +KI  FG+ R         +  K + PV        +++
Sbjct: 153 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-------WMS 202
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K+  F    D +SFG++L+E+     QP+     E+V++ +   G    L  K  +
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----LLDKPDN 258
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P  L EL+  CW   P +RP+F EII+ +
Sbjct: 259 CPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 126/262 (48%), Gaps = 40/262 (15%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKKGRL--------------SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           DL ++L++K R+              S   +L F+  +A+GM +L        IH D+  
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192
Query: 317 KNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
           +N+LL NG   KI  FGL R       YI    A++  PV        ++APE   +  +
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVK-------WMAPESIFDCVY 243
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP-DLKEL 429
               D +S+G++L+E+   G+ P+    P  +V     +  +   ++   ++ P ++  +
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSI 299
Query: 430 IEECWDPKPVIRPNFNEIIARL 451
           ++ CW  +P  RP F +I + L
Sbjct: 300 MQACWALEPTHRPTFQQICSFL 321

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 130/265 (49%), Gaps = 29/265 (10%)
Query: 206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
           ++ NG    +K+L KE     +++     E  ++    HP +++  G       + ++++
Sbjct: 27  SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86
Query: 266 YHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           Y   G+L S L+K  R  P+ V +F A ++   + YLH      II+ DLKP+NILLD  
Sbjct: 87  YIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKN 142
Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSH-IDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
           G +KI+ FG           AK V  V++ +     Y+APE+   + +++S+D +SFG++
Sbjct: 143 GHIKITDFGF----------AKYVPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 192
Query: 384 LYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           +YEM+ G  PF+     +   K++  E + PP       +  D+K+L+        +I  
Sbjct: 193 IYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF------FNEDVKDLLSR------LITR 240
Query: 443 NFNEIIARLDRIVCNCSKQGWWKDT 467
           + ++ +  L     +     W+K+ 
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 115/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+     +K+  FGL R      Y    K K
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 174 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 224
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 225 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     ++I+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 184 AARNVLVTENNVMRIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 235
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 291
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 147/322 (45%), Gaps = 53/322 (16%)
Query: 161 GAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QVAKWNGTK------V 213
           GA   K K  P    +P   P  + N ++ Q    D I +G++ QV K    K       
Sbjct: 1   GALNRKVKNNP----DPTIYPVLDWNDIKFQ----DVIGEGNFGQVLKARIKKDGLRMDA 52
Query: 214 WVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
            +K + + + KD  R   F  EL ++ K   HPN++  +GA      + + +EY   G+L
Sbjct: 53  AIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 110
Query: 273 ASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
             +L+K                   LS  ++L FA D+ARGM+YL +      IH +L  
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAA 167
Query: 317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVD 376
           +NIL+      KI+ FGL R Q +  +K     PV        ++A E      +  + D
Sbjct: 168 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSD 220
Query: 377 AYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEEC 433
            +S+G++L+E++  G  P+      E+ + +  +G R   PL      Y     +L+ +C
Sbjct: 221 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVY-----DLMRQC 274
Query: 434 WDPKPVIRPNFNEIIARLDRIV 455
           W  KP  RP+F +I+  L+R++
Sbjct: 275 WREKPYERPSFAQILVSLNRML 296

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I++E  A GDL S+L ++ R  PS+     
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLA 153
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 154 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 211 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 264 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 116/263 (44%), Gaps = 16/263 (6%)
Query: 188 LELQVRKADG----ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           L L  +  DG    + +G +         V VK L  +    PE ++ F  E+  +    
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLH 302
           H N+++  G V    PM +V E    G L   L+K +G      + R+A+ +A GM YL 
Sbjct: 80  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVA 362
             +    IH DL  +N+LL     +KI  FGL+R     P+         H      + A
Sbjct: 139 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMR---ALPQNDDHXVMQEHRKVPFAWCA 192
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K   F  + D + FG+ L+EM   G +P+      +++  +  EG+R P   +   
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---RPED 249
Query: 422 YPPDLKELIEECWDPKPVIRPNF 444
            P D+  ++ +CW  KP  RP F
Sbjct: 250 CPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I++E  A GDL S+L ++ R  PS+     
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLA 138
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y 
Sbjct: 139 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 196 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 249 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 138/288 (47%), Gaps = 42/288 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 25  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 81
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQK K R+   K+L++   + +GM YL   +    
Sbjct: 82  YSAGRRNLKL--IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---Y 136
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH +L  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 137 IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG---ESPIFWYAPESLTES 193
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 194 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 253
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N + +
Sbjct: 254 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGE 297

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 116/228 (50%), Gaps = 19/228 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP--EKAKIV 348
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R    S   + +K  
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGK 173
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKLMC 407
            P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  + 
Sbjct: 174 LPIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 226
Query: 408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
             G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 227 -NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 116/263 (44%), Gaps = 16/263 (6%)
Query: 188 LELQVRKADG----ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           L L  +  DG    + +G +         V VK L  +    PE ++ F  E+  +    
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLH 302
           H N+++  G V    PM +V E    G L   L+K +G      + R+A+ +A GM YL 
Sbjct: 70  HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVA 362
             +    IH DL  +N+LL     +KI  FGL+R     P+         H      + A
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMR---ALPQNDDHXVMQEHRKVPFAWCA 182
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE  K   F  + D + FG+ L+EM   G +P+      +++  +  EG+R P   +   
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---RPED 239
Query: 422 YPPDLKELIEECWDPKPVIRPNF 444
            P D+  ++ +CW  KP  RP F
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 33/306 (10%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 5   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 64
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 65  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 123
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL
Sbjct: 124 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 335 LRLQYISP-----EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
            R  Y         K     PV        ++A E  + ++F    D +SFG++L+E++ 
Sbjct: 181 ARDMYDKEFDSVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLLWELMT 233
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEII 448
              P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E++
Sbjct: 234 RGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 289
Query: 449 ARLDRI 454
           +R+  I
Sbjct: 290 SRISAI 295

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 165 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 165 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 131/255 (51%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 49  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 106
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H +L  +N +
Sbjct: 107 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCM 163
Query: 321 LDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R  Y +    +  K + PV        ++APE  K+  F  S D 
Sbjct: 164 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 216
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 217 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 272
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 273 NPNMRPTFLEIVNLL 287

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 138/299 (46%), Gaps = 30/299 (10%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K  +  PE  
Sbjct: 170 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGNMSPE-- 225
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 226 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 283
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 284 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ 340
Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEV 402
            AK  FP+        + APE      F    D +SFG++L E+  +G  P+      EV
Sbjct: 341 GAK--FPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 391
Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +      G R P   +    P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 392 LD-QVERGYRMPCPPEC---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 446

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 115/230 (50%), Gaps = 23/230 (10%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+     +K+  FGL R      Y    K K
Sbjct: 497 AYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKL 405
           +  P+        ++APE      F  + D + FG+ ++E ++ GV+PF      +V+  
Sbjct: 554 L--PIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           +   G+R P+       PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 605 IE-NGERLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 135/286 (47%), Gaps = 42/286 (14%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-- 252
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 27  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 253 --AVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPI 309
             A  +N+ +  ++EY   G L  YLQ    R+   K+L++   + +GM YL   +    
Sbjct: 84  YSAGRRNLKL--IMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR---Y 138
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
           IH DL  +NIL++N  ++KI  FGL ++     E  K+  P    +    + APE     
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG---ESPIFWYAPESLTES 195
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------EVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+   ++     P E                 +++L+   G+ P
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 255
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
               +    P ++  ++ ECW+     RP+F ++  R+D+I  N +
Sbjct: 256 ----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 131/255 (51%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H +L  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCM 162
Query: 321 LDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R  Y +    +  K + PV        ++APE  K+  F  S D 
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 215
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 216 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 271
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 272 NPNMRPTFLEIVNLL 286

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 138/299 (46%), Gaps = 30/299 (10%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 224
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 225 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 283 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEV 402
            AK  FP+        + APE      F    D +SFG++L E+  +G  P+      EV
Sbjct: 340 GAK--FPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390
Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +      G R P   +    P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 391 LD-QVERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 33/306 (10%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 9   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 68
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 69  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 127
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL
Sbjct: 128 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 184
Query: 335 LRLQYISP-----EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
            R  Y         K     PV        ++A E  + ++F    D +SFG++L+E++ 
Sbjct: 185 ARDMYDKEFDSVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLLWELMT 237
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEII 448
              P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E++
Sbjct: 238 RGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 293
Query: 449 ARLDRI 454
           +R+  I
Sbjct: 294 SRISAI 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 33/306 (10%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 4   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 122
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL
Sbjct: 123 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 335 LRLQYISP-----EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
            R  Y         K     PV        ++A E  + ++F    D +SFG++L+E++ 
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEII 448
              P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E++
Sbjct: 233 RGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288
Query: 449 ARLDRI 454
           +R+  I
Sbjct: 289 SRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 33/306 (10%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 63  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 181
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL
Sbjct: 182 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 335 LRLQYISP-----EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
            R  Y         K     PV        ++A E  + ++F    D +SFG++L+E++ 
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLLWELMT 291
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEII 448
              P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E++
Sbjct: 292 RGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 347
Query: 449 ARLDRI 454
           +R+  I
Sbjct: 348 SRISAI 353

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 141/306 (46%), Gaps = 33/306 (10%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 2   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 61
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 62  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 120
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL
Sbjct: 121 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 177
Query: 335 LRLQYISP-----EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
            R  Y         K     PV        ++A E  + ++F    D +SFG++L+E++ 
Sbjct: 178 ARDMYDKEFDSVHNKTGAKLPVK-------WMALESLQTQKFTTKSDVWSFGVLLWELMT 230
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEII 448
              P +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E++
Sbjct: 231 RGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286
Query: 449 ARLDRI 454
           +R+  I
Sbjct: 287 SRISAI 292

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 115/236 (48%), Gaps = 30/236 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 139
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI 340
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ +  Y 
Sbjct: 140 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYR 196
Query: 341 SPEKAK---IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
           +    K    + PV        ++ PE +    F    D +SFG++L+E+   G  P+  
Sbjct: 197 ASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           K  +EV++ +   G+  P K    + P  +  ++ +CW  +P  RPNF  I+ R++
Sbjct: 250 KSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 129/255 (50%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 45  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 102
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 103 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 159
Query: 321 LDNGGQLKISGFGLLR---LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R         +  K + PV        ++APE  K+  F  S D 
Sbjct: 160 VAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 212
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 213 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 268
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 269 NPKMRPTFLEIVNLL 283

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++ Y +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 235
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 291
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 165 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 165 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 170 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 221 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 112/238 (47%), Gaps = 25/238 (10%)
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPS 285
           E+   F  E+ I+    HPN+V+  G +  N P M V+E+   GDL   L  K   +  S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRLQYI 340
             LR  LD+A G+ Y+    P PI+H DL+  NI L +  +      K++ FG       
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFG------- 174
Query: 341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFHPKP 398
                + V  VS +     ++APE    EE  +    D YSF +ILY ++ G  PF    
Sbjct: 175 --TSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 399 PEEV--VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             ++  + ++  EG RP +       PP L+ +IE CW   P  RP+F+ I+  L  +
Sbjct: 233 YGKIKFINMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHEL 236
           ++V E     L+L  R  +G   G   +  WNG TKV +K L K     PE   +F  E 
Sbjct: 1   KDVWEIPRESLQLIKRLGNG-QFGEVWMGTWNGNTKVAIKTL-KPGTMSPE---SFLEEA 55
Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGR-LSPSKVLRFALDL 294
            I++K +H  +VQ    V++  P+ IV EY  KG L  +L+  +GR L    ++  A  +
Sbjct: 56  QIMKKLKHDKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQV 114
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFP 350
           A GM Y+        IH DL+  NIL+ NG   KI+ FGL RL    +  + + AK  FP
Sbjct: 115 AAGMAYIERMN---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAK--FP 169
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCE 409
           +        + APE      F    D +SFG++L E++ +G  P+      EV++     
Sbjct: 170 IK-------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE-QVER 221
Query: 410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           G R P     +  P  L EL+  CW   P  RP F  + + L+
Sbjct: 222 GYRMPC---PQDCPISLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 139/292 (47%), Gaps = 35/292 (11%)
Query: 179 EVPEYELNPLE-LQVRKADGITKGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHEL 236
           EVP   L  +E L   +A  +  G Y     NG TKV VK L K+    P   +AF  E 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYY-----NGHTKVAVKSL-KQGSMSP---DAFLAEA 59
Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDL 294
            ++++ +H  +V+    VTQ  P+ I+ EY   G L  +L+     +L+ +K+L  A  +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFP 350
           A GM ++ E      IH DL+  NIL+ +    KI+ FGL RL    +  + E AK  FP
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAK--FP 173
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCE 409
           +        + APE      F    D +SFG++L E++  G  P+      EV++ +   
Sbjct: 174 IK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--- 223
Query: 410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
            +R    ++  + P +L +L+  CW  +P  RP F+ + + L+        Q
Sbjct: 224 -ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 129/255 (50%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLR---LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R         +  K + PV        ++APE  K+  F  S D 
Sbjct: 163 VAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 215
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 216 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 271
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 272 NPNMRPTFLEIVNLL 286

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 129/255 (50%), Gaps = 30/255 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLR---LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           + +   +KI  FG+ R         +  K + PV        ++APE  K+  F  S D 
Sbjct: 163 VAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-------WMAPESLKDGVFTTSSDM 215
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++L+E+     QP+     E+V+K +   G       +  + P  + +L+  CW  
Sbjct: 216 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD----QPDNCPERVTDLMRMCWQF 271
Query: 437 KPVIRPNFNEIIARL 451
            P +RP F EI+  L
Sbjct: 272 NPKMRPTFLEIVNLL 286

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 133/282 (47%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV+EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 41/266 (15%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++ Y +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
             +N+L+     +KI+ FGL R    + Y   +      PV        ++APE   +  
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVK-------WMAPEALFDRV 235
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++++E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMD---KPANCTNELYMM 291
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW   P  RP F +++  LDRI+
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 29/269 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 35  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 89
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 146
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +  + E AK  FP+        + APE      F  
Sbjct: 147 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIK-------WTAPEAINYGTFTI 197
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 198 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 253
Query: 433 CWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           CW  +P  RP F+ + + L+        Q
Sbjct: 254 CWKERPEDRPTFDYLRSVLEDFFTATEGQ 282

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 29/269 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +  + E AK  FP+        + APE      F  
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIK-------WTAPEAINYGTFTI 189
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 245
Query: 433 CWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           CW  +P  RP F+ + + L+        Q
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 133/282 (47%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 13  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 67
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 68  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 127 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 174
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 233
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 234 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 29/269 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 36  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 90
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 147
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +  + E AK  FP+        + APE      F  
Sbjct: 148 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIK-------WTAPEAINYGTFTI 198
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 199 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 254
Query: 433 CWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           CW  +P  RP F+ + + L+        Q
Sbjct: 255 CWKERPEDRPTFDYLRSVLEDFFTATEGQ 283

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 29/269 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +  + E AK  FP+        + APE      F  
Sbjct: 145 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIK-------WTAPEAINYGTFTI 195
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 251
Query: 433 CWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           CW  +P  RP F+ + + L+        Q
Sbjct: 252 CWKERPEDRPTFDYLRSVLEDFFTATEGQ 280

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 36/258 (13%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 70  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 127
Query: 271 DLASYLQKK---------GR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL ++L++K         GR L    +L F+  +A+GM +L        IH D+  +N+L
Sbjct: 128 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 184
Query: 321 LDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSV 375
           L NG   KI  FGL R       YI    A++  PV        ++APE   +  +    
Sbjct: 185 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVK-------WMAPESIFDCVYTVQS 235
Query: 376 DAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP-DLKELIEEC 433
           D +S+G++L+E+   G+ P+    P  +V     +  +   ++   ++ P ++  +++ C
Sbjct: 236 DVWSYGILLWEIFSLGLNPY----PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 291
Query: 434 WDPKPVIRPNFNEIIARL 451
           W  +P  RP F +I + L
Sbjct: 292 WALEPTHRPTFQQICSFL 309

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 129/260 (49%), Gaps = 29/260 (11%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 28  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 82
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 139
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +  + E AK  FP+        + APE      F  
Sbjct: 140 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIK-------WTAPEAINYGTFTI 190
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 191 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 246
Query: 433 CWDPKPVIRPNFNEIIARLD 452
           CW  +P  RP F+ + + L+
Sbjct: 247 CWKERPEDRPTFDYLRSVLE 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 129/260 (49%), Gaps = 29/260 (11%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +  + E AK  FP+        + APE      F  
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIK-------WTAPEAINYGTFTI 189
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 245
Query: 433 CWDPKPVIRPNFNEIIARLD 452
           CW  +P  RP F+ + + L+
Sbjct: 246 CWKERPEDRPTFDYLRSVLE 265

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 112/238 (47%), Gaps = 25/238 (10%)
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPS 285
           E+   F  E+ I+    HPN+V+  G +  N P M V+E+   GDL   L  K   +  S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRLQYI 340
             LR  LD+A G+ Y+    P PI+H DL+  NI L +  +      K++ F L      
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSL------ 175
Query: 341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFHPKP 398
                + V  VS +     ++APE    EE  +    D YSF +ILY ++ G  PF    
Sbjct: 176 ---SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 399 PEEV--VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             ++  + ++  EG RP +       PP L+ +IE CW   P  RP+F+ I+  L  +
Sbjct: 233 YGKIKFINMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 170 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 221 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 36/258 (13%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKK---------GR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL ++L++K         GR L    +L F+  +A+GM +L        IH D+  +N+L
Sbjct: 136 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 192
Query: 321 LDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSV 375
           L NG   KI  FGL R       YI    A++  PV        ++APE   +  +    
Sbjct: 193 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVK-------WMAPESIFDCVYTVQS 243
Query: 376 DAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP-DLKELIEEC 433
           D +S+G++L+E+   G+ P+    P  +V     +  +   ++   ++ P ++  +++ C
Sbjct: 244 DVWSYGILLWEIFSLGLNPY----PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 299
Query: 434 WDPKPVIRPNFNEIIARL 451
           W  +P  RP F +I + L
Sbjct: 300 WALEPTHRPTFQQICSFL 317

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 129/260 (49%), Gaps = 29/260 (11%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 29  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 83
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 140
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           NIL+ +    KI+ FGL RL    +  + E AK  FP+        + APE      F  
Sbjct: 141 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIK-------WTAPEAINYGTFTI 191
Query: 374 SVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D +SFG++L E++  G  P+      EV++ +    +R    ++  + P +L +L+  
Sbjct: 192 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELYQLMRL 247
Query: 433 CWDPKPVIRPNFNEIIARLD 452
           CW  +P  RP F+ + + L+
Sbjct: 248 CWKERPEDRPTFDYLRSVLE 267

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G  
Sbjct: 24  GSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVS 80
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 81  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 137
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DL  +NIL+++   +KI+ FGL +L  +  +K   V       P   Y APE   +  F
Sbjct: 138 RDLAARNILVESEAHVKIADFGLAKL--LPLDKDYYVVREPGQSPIFWY-APESLSDNIF 194
Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR----------- 420
            R  D +SFG++LYE+          P  E +++M  E   P L                
Sbjct: 195 SRQSDVWSFGVVLYELFTYCDK-SCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAP 253
Query: 421 -SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            + P ++ EL++ CW P P  RP+F+ +  +LD +
Sbjct: 254 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 288

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 141/301 (46%), Gaps = 23/301 (7%)
Query: 167 TKRTPMTVANP---REVPEYELNPLELQVRKADGITKGSYQVAKW------NGTKVWVKI 217
           T    ++  NP   + V    + P  L V   + I +G +           +G K+   +
Sbjct: 5   TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 64
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
                  D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL ++
Sbjct: 65  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNF 123
Query: 276 LQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL
Sbjct: 124 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            R   +  E   +        P   ++A E  + ++F    D +SFG++L+E++    P 
Sbjct: 181 AR-DMLDKEFDSVHNKTGAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 238
Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPD-LKELIEECWDPKPVIRPNFNEIIARLDR 453
           +P      + +   +G+R    +    Y PD L E++ +CW PK  +RP+F+E+++R+  
Sbjct: 239 YPDVNTFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 294
Query: 454 I 454
           I
Sbjct: 295 I 295

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 20/227 (8%)
Query: 190 LQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
            QVRK  G   G     K    KV  K +   + KD     A   E  I+E+ +HP +V 
Sbjct: 34  FQVRKVTGANTG-----KIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVKHPFIVD 85
Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
            + A      + ++LEY + G+L   L+++G         +  +++  + +LH+     I
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGI 142
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-YVAPEIYKN 368
           I+ DLKP+NI+L++ G +K++ FGL +              V+H     + Y+APEI   
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-------TVTHTFCGTIEYMAPEILMR 195
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPP 414
              +R+VD +S G ++Y+M+ G  PF  +  ++ + K++ C+   PP
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP 242

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKIRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 131/273 (47%), Gaps = 30/273 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV+EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
              P  L +L+ +CW   P  RP F  + A L+
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 11  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 65
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 66  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 124
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 125 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 172
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 231
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 232 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 130/273 (47%), Gaps = 30/273 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
              P  L +L+ +CW   P  RP F  + A L+
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 50  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 109
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 110 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 167 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 218 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 42/266 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 56  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRD 170
Query: 314 LKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           L  +NILL +G   KI  FGL R       Y+    A++  PV        ++APE   N
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL--PVK-------WMAPESIFN 221
Query: 369 EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
             +    D +S+G+ L+E+   G  P+   P +     M  EG R    +     P ++ 
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR---MLSPEHAPAEMY 278
Query: 428 ELIEECWDPKPVIRPNFNEIIARLDR 453
           ++++ CWD  P+ RP F +I+  +++
Sbjct: 279 DIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 170 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 221 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 42/266 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 72  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 129
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 130 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRD 186
Query: 314 LKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           L  +NILL +G   KI  FGL R       Y+    A++  PV        ++APE   N
Sbjct: 187 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL--PVK-------WMAPESIFN 237
Query: 369 EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
             +    D +S+G+ L+E+   G  P+   P +     M  EG R    +     P ++ 
Sbjct: 238 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR---MLSPEHAPAEMY 294
Query: 428 ELIEECWDPKPVIRPNFNEIIARLDR 453
           ++++ CWD  P+ RP F +I+  +++
Sbjct: 295 DIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 50  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 109
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL   +    IH DL  +N L+     +K++ FGL RL    
Sbjct: 110 VNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 167 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 218 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 20/227 (8%)
Query: 190 LQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
            QVRK  G   G     K    KV  K +   + KD     A   E  I+E+ +HP +V 
Sbjct: 34  FQVRKVTGANTG-----KIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVKHPFIVD 85
Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
            + A      + ++LEY + G+L   L+++G         +  +++  + +LH+     I
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGI 142
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-YVAPEIYKN 368
           I+ DLKP+NI+L++ G +K++ FGL +              V+H     + Y+APEI   
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-------TVTHXFCGTIEYMAPEILMR 195
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPP 414
              +R+VD +S G ++Y+M+ G  PF  +  ++ + K++ C+   PP
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP 242

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 9   LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 63
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 64  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 122
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 123 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 170
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 229
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 230 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 165 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 86/175 (49%), Gaps = 15/175 (8%)
Query: 235 ELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        HP +            +  V+EY   GDL  ++Q   +   S+  
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 121
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++  G+ +LH      I++ DLK  NILLD  G +KI+ FG+ +   +   K    
Sbjct: 122 FYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                      Y+APEI   ++++ SVD +SFG++LYEM+ G  PFH +  EE+ 
Sbjct: 179 CGTPD------YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 165 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 216 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 42/264 (15%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           DL ++L++K                 +LS   +L F+  +A+GM +L        IH D+
Sbjct: 136 DLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDV 192
Query: 315 KPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
             +N+LL NG   KI  FGL R       YI    A++  PV        ++APE   + 
Sbjct: 193 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVK-------WMAPESIFDC 243
Query: 370 EFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP-DLK 427
            +    D +S+G++L+E+   G+ P+    P  +V     +  +   ++   ++ P ++ 
Sbjct: 244 VYTVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYKLVKDGYQMAQPAFAPKNIY 299
Query: 428 ELIEECWDPKPVIRPNFNEIIARL 451
            +++ CW  +P  RP F +I + L
Sbjct: 300 SIMQACWALEPTHRPTFQQICSFL 323

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 170 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 221 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 138/294 (46%), Gaps = 30/294 (10%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTH 234
           P E   +E+    L++ K  G  + G   +A +N  TKV VK +   S      + AF  
Sbjct: 177 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLA 232
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP-SKVLRFAL 292
           E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+  +G   P  K++ F+ 
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIV 348
            +A GM ++ +      IH DL+  NIL+      KI+ FGL R+    +Y + E AK  
Sbjct: 292 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK-- 346
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMC 407
           FP+        + APE      F    D +SFG++L E++  G  P+      EV++ + 
Sbjct: 347 FPIK-------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
Query: 408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
             G R P   +  + P +L  ++  CW  +P  RP F  I + LD        Q
Sbjct: 400 -RGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 61  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 120
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL   +    IH DL  +N L+     +K++ FGL RL    
Sbjct: 121 VNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 178 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 228
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 229 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 42/266 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 74  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 131
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 132 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRD 188
Query: 314 LKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           L  +NILL +G   KI  FGL R       Y+    A++  PV        ++APE   N
Sbjct: 189 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL--PVK-------WMAPESIFN 239
Query: 369 EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
             +    D +S+G+ L+E+   G  P+   P +     M  EG R    +     P ++ 
Sbjct: 240 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR---MLSPEHAPAEMY 296
Query: 428 ELIEECWDPKPVIRPNFNEIIARLDR 453
           ++++ CWD  P+ RP F +I+  +++
Sbjct: 297 DIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 52  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 111
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 112 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 169 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 220 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 AFGNLKNGVNDIKNHKWFATT 300

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 255 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 314
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH +L  +N L+     +K++ FGL RL    
Sbjct: 315 VSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 372 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 423 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 42/266 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 79  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRD 193
Query: 314 LKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           L  +NILL +G   KI  FGL R       Y+    A++  PV        ++APE   N
Sbjct: 194 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL--PVK-------WMAPESIFN 244
Query: 369 EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
             +    D +S+G+ L+E+   G  P+   P +     M  EG R    +     P ++ 
Sbjct: 245 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR---MLSPEHAPAEMY 301
Query: 428 ELIEECWDPKPVIRPNFNEIIARLDR 453
           ++++ CWD  P+ RP F +I+  +++
Sbjct: 302 DIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 136/290 (46%), Gaps = 31/290 (10%)
Query: 177 PREVPEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERIN 230
           PR  P+Y +   ++ + +  G      + +G Y   K     V VK   K+   D +   
Sbjct: 13  PRGSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-- 70
Query: 231 AFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLR 289
            F  E  I++   HP++V+ +G + +  P  I++E +  G+L  YL++ K  L    ++ 
Sbjct: 71  KFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVL 129
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE---KAK 346
           ++L + + M YL        +H D+  +NIL+ +   +K+  FGL R  YI  E   KA 
Sbjct: 130 YSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR--YIEDEDYYKAS 184
Query: 347 IV-FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVK 404
           +   P+        +++PE      F  + D + F + ++E++  G QPF     ++V+ 
Sbjct: 185 VTRLPIK-------WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 237
Query: 405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           ++  +G R P   K    PP L  L+  CWD  P  RP F E++  L  +
Sbjct: 238 VLE-KGDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 49  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 108
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY-- 339
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 109 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165
Query: 340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKP 398
                A   FP+        + APE     +F    D ++FG++L+E+   G+ P+    
Sbjct: 166 TXTAHAGAKFPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 218
Query: 399 PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
             +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 219 LSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 42/266 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 79  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRD 193
Query: 314 LKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           L  +NILL +G   KI  FGL R       Y+    A++  PV        ++APE   N
Sbjct: 194 LAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL--PVK-------WMAPESIFN 244
Query: 369 EEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
             +    D +S+G+ L+E+   G  P+   P +     M  EG R    +     P ++ 
Sbjct: 245 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR---MLSPEHAPAEMY 301
Query: 428 ELIEECWDPKPVIRPNFNEIIARLDR 453
           ++++ CWD  P+ RP F +I+  +++
Sbjct: 302 DIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            GD+ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +K
Sbjct: 125 GGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIK 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VADFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 144 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 200
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 201 IQVTDFGFAK---------RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 252 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 300
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 301 RFGNLKNGVNDIKNHKWFATT 321

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            GD+ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +K
Sbjct: 125 GGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIK 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VADFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 131/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL   NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 134 N---YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 235 ELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        HP +            +  V+EY   GDL  ++Q   +   S+  
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 122
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++  G+ +LH      I++ DLK  NILLD  G +KI+ FG+ +   +   K    
Sbjct: 123 FYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--- 176
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
              +       Y+APEI   ++++ SVD +SFG++LYEM+ G  PFH +  EE+ 
Sbjct: 177 ---NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 228

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 130/273 (47%), Gaps = 30/273 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
              P  L +L+ +CW   P  RP F  + A L+
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 17  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 71
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY  KG L  +L+ + G+ L   +++  +  +A GM Y+   
Sbjct: 72  LVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+        +
Sbjct: 131 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIK-------W 178
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 237
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 238 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 276

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADEPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 35/262 (13%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSK-----------VLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +L++YL+ K+    P K           ++ ++  +A+GM +L   K    IH DL  +N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 319 ILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSV 375
           ILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +    
Sbjct: 175 ILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQS 227
Query: 376 DAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKELIEEC 433
           D +SFG++L+E+   G  P+     +E       EG R    ++A  Y  P++ + + +C
Sbjct: 228 DVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTR----MRAPDYTTPEMYQTMLDC 283
Query: 434 WDPKPVIRPNFNEIIARLDRIV 455
           W  +P  RP F+E++  L  ++
Sbjct: 284 WHGEPSQRPTFSELVEHLGNLL 305

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 112/224 (50%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 269

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 64  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 124 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 180
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 181 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 232 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 280
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 281 RFGNLKNGVNDIKNHKWFATT 301

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY-- 339
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKP 398
                A   FP+        + APE     +F    D ++FG++L+E+   G+ P+    
Sbjct: 170 TXTAHAGAKFPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222
Query: 399 PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
             +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 223 LSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 137/285 (48%), Gaps = 30/285 (10%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTH 234
           P E   +E+    L++ K  G  + G   +A +N  TKV VK +   S      + AF  
Sbjct: 4   PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLA 59
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP-SKVLRFAL 292
           E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+  +G   P  K++ F+ 
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 118
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIV 348
            +A GM ++ +      IH DL+  NIL+      KI+ FGL R+    +Y + E AK  
Sbjct: 119 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK-- 173
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMC 407
           FP+        + APE      F    D +SFG++L E++  G  P+      EV++ + 
Sbjct: 174 FPIK-------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 226
Query: 408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
             G R P   +  + P +L  ++  CW  +P  RP F  I + LD
Sbjct: 227 -RGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 17/222 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
            G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 269

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 112/224 (50%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 50  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 109
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 110 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDEQGY 166
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 167 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 217
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 218 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 256

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 112/224 (50%), Gaps = 13/224 (5%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 170 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 230 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 287
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +      E  K    +        Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 288 IKITDFGLCK------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E++ +L+  E  R P     R+  P+ K L+
Sbjct: 342 MMCGRLPFYNQDHEKLFELILMEEIRFP-----RTLGPEAKSLL 380

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV+EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +  + + AK  FP+        +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAK--FPIK-------W 181
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 240
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW   P  RP F  + A L+    +   Q
Sbjct: 241 ---PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 59
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 120 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSK--FPVR--- 171
Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP 414
               +  PE+    +F    D ++FG++++E+   G  P+      E  +          
Sbjct: 172 ----WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---------H 218
Query: 415 LKIKARSYPPDLKE-----LIEECWDPKPVIRPNFNEIIARL 451
           +    R Y P L       ++  CW  K   RP F  +++ +
Sbjct: 219 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 112/224 (50%), Gaps = 13/224 (5%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 173 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 232
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 233 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 290
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +      E  K    +        Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 291 IKITDFGLCK------EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 344
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E++ +L+  E  R P     R+  P+ K L+
Sbjct: 345 MMCGRLPFYNQDHEKLFELILMEEIRFP-----RTLGPEAKSLL 383

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 10  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 64
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 65  LVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 123
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    +  + + AK  FP+        +
Sbjct: 124 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAK--FPIK-------W 171
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 230
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 231 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 269

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 25/263 (9%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G Y   K     V VK   K+   D +    F  E  I++   HP++V+ +G + + 
Sbjct: 24  VYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIGIIEEE 81
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P  I++E +  G+L  YL++ K  L    ++ ++L + + M YL        +H D+  
Sbjct: 82  -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAV 137
Query: 317 KNILLDNGGQLKISGFGLLRLQYISPE---KAKIV-FPVSHIDPANLYVAPEIYKNEEFD 372
           +NIL+ +   +K+  FGL R  YI  E   KA +   P+        +++PE      F 
Sbjct: 138 RNILVASPECVKLGDFGLSR--YIEDEDYYKASVTRLPIK-------WMSPESINFRRFT 188
Query: 373 RSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
            + D + F + ++E++  G QPF     ++V+ ++  +G R P   K    PP L  L+ 
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLP---KPDLCPPVLYTLMT 244
Query: 432 ECWDPKPVIRPNFNEIIARLDRI 454
            CWD  P  RP F E++  L  +
Sbjct: 245 RCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 36/241 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F HE  +  + +HPNVV  +G VT++ P+ ++  Y + GDL  +L               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
              K  L P   +     +A GM YL       ++H DL  +N+L+ +   +KIS  GL 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 336 RLQYISPEKAKI---VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GV 391
           R  Y +     +   + P+        ++APE     +F    D +S+G++L+E+   G+
Sbjct: 176 REVYAADYYKLLGNSLLPIR-------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
Query: 392 QPFHPKPPEEVVKLMCCEGKRP-PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           QP+     ++VV+++      P P    A  Y      L+ ECW+  P  RP F +I +R
Sbjct: 229 QPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYA-----LMIECWNEFPSRRPRFKDIHSR 283
Query: 451 L 451
           L
Sbjct: 284 L 284

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 126/262 (48%), Gaps = 35/262 (13%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSK-----------VLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +L++YL+ K+    P K           ++ ++  +A+GM +L   K    IH DL  +N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 319 ILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSV 375
           ILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +    
Sbjct: 175 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQS 227
Query: 376 DAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKELIEEC 433
           D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + + +C
Sbjct: 228 DVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 283
Query: 434 WDPKPVIRPNFNEIIARLDRIV 455
           W  +P  RP F+E++  L  ++
Sbjct: 284 WHGEPSQRPTFSELVEHLGNLL 305

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 36/241 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F HE  +  + +HPNVV  +G VT++ P+ ++  Y + GDL  +L               
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
              K  L P   +     +A GM YL       ++H DL  +N+L+ +   +KIS  GL 
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 192
Query: 336 RLQYISPEKAKI---VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GV 391
           R  Y +     +   + P+        ++APE     +F    D +S+G++L+E+   G+
Sbjct: 193 REVYAADYYKLLGNSLLPIR-------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245
Query: 392 QPFHPKPPEEVVKLMCCEGKRP-PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           QP+     ++VV+++      P P    A  Y      L+ ECW+  P  RP F +I +R
Sbjct: 246 QPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYA-----LMIECWNEFPSRRPRFKDIHSR 300
Query: 451 L 451
           L
Sbjct: 301 L 301

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLK-------WMAPETIFDRVY 227
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 283
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++Y+
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQ 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 294 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 353
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH +L  +N L+     +K++ FGL RL    
Sbjct: 354 VNAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 410
Query: 339 -YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHP 396
            Y +   AK  FP+        + APE     +F    D ++FG++L+E+   G+ P+  
Sbjct: 411 TYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 461
Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
               +V +L+    ++     +    P  + EL+  CW   P  RP+F EI
Sbjct: 462 IDLSQVYELL----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 112/224 (50%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLIIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 269

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVY 227
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 283
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 97  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVY 264
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 265 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 320
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 321 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 352

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 25/263 (9%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G Y   K     V VK   K+   D +    F  E  I++   HP++V+ +G + + 
Sbjct: 28  VYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIGIIEEE 85
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P  I++E +  G+L  YL++ K  L    ++ ++L + + M YL        +H D+  
Sbjct: 86  -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAV 141
Query: 317 KNILLDNGGQLKISGFGLLRLQYISPE---KAKIV-FPVSHIDPANLYVAPEIYKNEEFD 372
           +NIL+ +   +K+  FGL R  YI  E   KA +   P+        +++PE      F 
Sbjct: 142 RNILVASPECVKLGDFGLSR--YIEDEDYYKASVTRLPIK-------WMSPESINFRRFT 192
Query: 373 RSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
            + D + F + ++E++  G QPF     ++V+ ++  +G R P   K    PP L  L+ 
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLP---KPDLCPPVLYTLMT 248
Query: 432 ECWDPKPVIRPNFNEIIARLDRI 454
            CWD  P  RP F E++  L  +
Sbjct: 249 RCWDYDPSDRPRFTELVCSLSDV 271

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 124/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR +      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 112/224 (50%), Gaps = 13/224 (5%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 30  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 89
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 90  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 147
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +      E  K    +        Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 148 IKITDFGLCK------EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 201
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E++ +L+  E  R P     R+  P+ K L+
Sbjct: 202 MMCGRLPFYNQDHEKLFELILMEEIRFP-----RTLGPEAKSLL 240

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 112/224 (50%), Gaps = 13/224 (5%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 31  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 90
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 91  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 148
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +      E  K    +        Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 149 IKITDFGLCK------EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 202
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E++ +L+  E  R P     R+  P+ K L+
Sbjct: 203 MMCGRLPFYNQDHEKLFELILMEEIRFP-----RTLGPEAKSLL 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVY 218
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 275 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +K+L K + K  +R+     E  I+    HP VV+   A      + ++L++  
Sbjct: 55  SGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLR 113
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            GDL + L K+   +   V  +  +LA G+++LH      II+ DLKP+NILLD  G +K
Sbjct: 114 GGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLG---IIYRDLKPENILLDEEGHIK 170
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FGL + + I  EK    F    ++    Y+APE+   +    S D +S+G++++EM+
Sbjct: 171 LTDFGLSK-EAIDHEKKAYSF-CGTVE----YMAPEVVNRQGHSHSADWWSYGVLMFEML 224
Query: 389 EGVQPFHPKPPEEVVKLMC 407
            G  PF  K  +E + L+ 
Sbjct: 225 TGSLPFQGKDRKETMTLIL 243

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     + I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIK 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FGL +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGLAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 112/224 (50%), Gaps = 13/224 (5%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 32  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 91
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 92  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 149
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +      E  K    +        Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 150 IKITDFGLCK------EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 203
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E++ +L+  E  R P     R+  P+ K L+
Sbjct: 204 MMCGRLPFYNQDHEKLFELILMEEIRFP-----RTLGPEAKSLL 242

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 17  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 71
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY  KG L  +L+ + G+ L   +++  +  +A GM Y+   
Sbjct: 72  LVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLY 360
                +H DL+  NIL+      K++ FGL RL    ++ + + AK  FP+        +
Sbjct: 131 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAK--FPIK-------W 178
Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
            APE      F    D +SFG++L E+  +G  P+      EV+      G R P   + 
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPEC 237
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 238 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 276

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 109/218 (50%), Gaps = 15/218 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFAL 292
           E+ ++   +HPN+VQ+  +  +N  + IV++Y   GDL   +  QK       ++L + +
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS 352
            +   + ++H+ K   I+H D+K +NI L   G +++  FG+ R+   + E A+      
Sbjct: 133 QICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR 412
           +      Y++PEI +N+ ++   D ++ G +LYE+      F     + +V L    G  
Sbjct: 190 Y------YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-LKIISGSF 242
Query: 413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           PP+ +    Y  DL+ L+ + +   P  RP+ N I+ +
Sbjct: 243 PPVSLH---YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVY 218
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 275 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 49/271 (18%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 63  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 120
Query: 271 DLASYLQKKGR--LSPS---------------------KVLRFALDLARGMNYLHECKPD 307
           DL ++L++K    L PS                      +L F+  +A+GM +L      
Sbjct: 121 DLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASK 177
Query: 308 PIIHCDLKPKNILLDNGGQLKISGFGLLR-----LQYISPEKAKIVFPVSHIDPANLYVA 362
             IH D+  +N+LL NG   KI  FGL R       YI    A++  PV        ++A
Sbjct: 178 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVK-------WMA 228
Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           PE   +  +    D +S+G++L+E+   G+ P+    P  +V     +  +   ++   +
Sbjct: 229 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYKLVKDGYQMAQPA 284
Query: 422 YPP-DLKELIEECWDPKPVIRPNFNEIIARL 451
           + P ++  +++ CW  +P  RP F +I + L
Sbjct: 285 FAPKNIYSIMQACWALEPTHRPTFQQICSFL 315

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 121/261 (46%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I +    P +V+   +   N  + +VLEY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEY 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 124 APGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 180
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +K++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 181 IKVADFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 232 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 280
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 281 RFGNLKNGVNDIKNHKWFATT 301

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 65
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 66  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 125
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 126 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVR--- 177
Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP 414
               +  PE+    +F    D ++FG++++E+   G  P+      E  +          
Sbjct: 178 ----WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---------H 224
Query: 415 LKIKARSYPPDLKE-----LIEECWDPKPVIRPNFNEIIARL 451
           +    R Y P L       ++  CW  K   RP F  +++ +
Sbjct: 225 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 266

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G 
Sbjct: 124 APGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGY 180
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +K++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 181 IKVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 232 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 280
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 281 RFGNLKNGVNDIKNHKWFATT 301

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 144 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 200
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 201 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 252 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 300
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 301 RFGNLKNGVNDIKNHKWFATT 321

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 111/224 (49%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 269

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 58
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 59  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 118
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 119 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVR--- 170
Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP 414
               +  PE+    +F    D ++FG++++E+   G  P+      E  +          
Sbjct: 171 ----WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---------H 217
Query: 415 LKIKARSYPPDLKE-----LIEECWDPKPVIRPNFNEIIARL 451
           +    R Y P L       ++  CW  K   RP F  +++ +
Sbjct: 218 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 259

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIK 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 59
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 120 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVR--- 171
Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP 414
               +  PE+    +F    D ++FG++++E+   G  P+      E  +          
Sbjct: 172 ----WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---------H 218
Query: 415 LKIKARSYPPDLKE-----LIEECWDPKPVIRPNFNEIIARL 451
           +    R Y P L       ++  CW  K   RP F  +++ +
Sbjct: 219 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 74
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVR--- 186
Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP 414
               +  PE+    +F    D ++FG++++E+   G  P+      E  +          
Sbjct: 187 ----WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---------H 233
Query: 415 LKIKARSYPPDLKE-----LIEECWDPKPVIRPNFNEIIARL 451
           +    R Y P L       ++  CW  K   RP F  +++ +
Sbjct: 234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 58  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 117
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 118 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 174
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 175 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 225
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 226 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 274
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 275 RFGNLKNGVNDIKNHKWFATT 295

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +K
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIK 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VADFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+AP I  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 115/259 (44%), Gaps = 20/259 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +GT   V +   ++   P+  + +  E+ I+    H +++++ G         + +V+EY
Sbjct: 57  DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH DL  +N+LLDN   
Sbjct: 117 VPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRL 172
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI  FGL +     PE  +        D    + APE  K  +F  + D +SFG+ LYE
Sbjct: 173 VKIGDFGLAK---AVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-----------KARSYPPDLKELIEECWD 435
           ++         P + +  +   +G+   L++           +    P ++  L++ CW+
Sbjct: 230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWE 289
Query: 436 PKPVIRPNFNEIIARLDRI 454
            +   RP F  +I  L  +
Sbjct: 290 TEASFRPTFENLIPILKTV 308

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 129/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 271 DLASYLQ-KKGRLSPSK---------------VLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P K               ++ ++  +A+GM +L   K    IH DL
Sbjct: 120 NLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 176
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R  Y  P+   K     P+        ++APE   +  +
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVY 229
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 230 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 285
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 286 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 317

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     + I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FGL +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGLAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 74
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI--VFPVSHIDPA 357
           YL   +    +H DL  +N L+++ G +K+S FGL R      E + +   FPV      
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR----- 186
Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             +  PE+    +F    D ++FG++++E+   G  P+      E  +          + 
Sbjct: 187 --WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---------HIA 235
Query: 417 IKARSYPPDLKE-----LIEECWDPKPVIRPNFNEIIARL 451
              R Y P L       ++  CW  K   RP F  +++ +
Sbjct: 236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 199 TKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           T G  +V K    G KV VKIL+++  +  + +     E+  ++  RHP++++    ++ 
Sbjct: 28  TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
              + +V+EY + G+L  Y+ K GRL   +  R    +  G++Y   C    ++H DLKP
Sbjct: 88  PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY---CHRHMVVHRDLKP 144
Query: 317 KNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           +N+LLD     KI+ FGL  +    +++        +    +    LY  PE        
Sbjct: 145 ENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPE-------- 196
Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC 407
             VD +S G+ILY ++ G  PF       + K +C
Sbjct: 197 --VDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 84  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 144 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 200
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 201 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 252 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 300
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 301 RFGNLKNGVNDIKNHKWFATT 321

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 269

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 180
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 181 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 232 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 280
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 281 RFGNLKNGVNDIKNHKWFATT 301

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 269

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 180
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 181 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 232 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 280
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 281 RFGNLKNGVNDIXNHKWFATT 301

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 180
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 181 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 232 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 280
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 281 RFGNLKNGVNDIKNHKWFATT 301

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 182
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 183 VTDFGFAK---------RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 234 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 282
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 283 GNLKNGVNDIKNHKWFATT 301

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 182
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 183 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 234 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 282
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 283 GNLKNGVNDIKNHKWFATT 301

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 98/181 (54%), Gaps = 10/181 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 50  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 109
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 110 FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           + + + + P      F  +   P   Y+APEI + E++  SVD ++ G++++EM+ G  P
Sbjct: 167 MCK-EGLRPGDTTSXFCGT---PN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 220
Query: 394 F 394
           F
Sbjct: 221 F 221

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 116 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 172
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 173 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 223
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 224 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 262

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 109/222 (49%), Gaps = 17/222 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
            G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 269

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 37/270 (13%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 271 DLASYLQ-KKGRLSPSK-------------VLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +L++YL+ K+    P K             ++ ++  +A+GM +L   K    IH DL  
Sbjct: 120 NLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAA 176
Query: 317 KNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           +NILL     +KI  FGL R     P+   K     P+        ++APE   +  +  
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-------WMAPETIFDRVYTI 229
Query: 374 SVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP-PDLKELIE 431
             D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + + 
Sbjct: 230 QSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 285
Query: 432 ECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 286 DCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 120/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P + +   +   N  + +V+EY  
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAP 125
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIK 182
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 183 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 234 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 282
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 283 GNLKNGVNDIKNHKWFATT 301

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +      +APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAK---------RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M  G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTK 279
Query: 447 IIARLDRIVCNCSKQGWWKDT 467
               L   V +     W+  T
Sbjct: 280 RFGNLKNGVNDIKNHKWFATT 300

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 120/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P + +   +   N  + +V+EY  
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAP 125
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIK 182
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 183 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 234 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 282
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 283 GNLKNGVNDIKNHKWFATT 301

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 109/222 (49%), Gaps = 17/222 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 51  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 110
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 111 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 167
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 168 VTDFGFAK---------RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 218
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
            G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 219 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 255

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 98/181 (54%), Gaps = 10/181 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 39  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 98
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 99  FHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           + + + + P      F  +   P   Y+APEI + E++  SVD ++ G++++EM+ G  P
Sbjct: 156 MCK-EGLRPGDTTSXFCGT---PN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
Query: 394 F 394
           F
Sbjct: 210 F 210

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY  +G++   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 175
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 176 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 144 IKITDFGLCK-EGISDGATMKTFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 236

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 144 IKITDFGLCK-EGISDGATMKTFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 236

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 30  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 89
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 90  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 146
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 147 IKITDFGLCK-EGISDGATMKTFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 200
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 201 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 239

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 98/181 (54%), Gaps = 10/181 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           ++++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 82  MRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 141
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 142 FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           + + + + P      F  +   P   Y+APEI + E++  SVD ++ G++++EM+ G  P
Sbjct: 199 MCK-EGLRPGDTTSTFCGT---PN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
Query: 394 F 394
           F
Sbjct: 253 F 253

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R     P+   K     P+        ++APE   +  +
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-------WMAPETIFDRVY 218
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP-PDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 275 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 98/181 (54%), Gaps = 10/181 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 35  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 94
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 95  FHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 151
Query: 334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
           + + + + P      F  +   P   Y+APEI + E++  SVD ++ G++++EM+ G  P
Sbjct: 152 MCK-EGLRPGDTTSXFCGT---PN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 205
Query: 394 F 394
           F
Sbjct: 206 F 206

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 120/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+++D  G +K
Sbjct: 125 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIK 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 144 IKITDFGLCK-EGISDGATMKXFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 236

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   GDL +
Sbjct: 57  MKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K++ FGL
Sbjct: 116 RLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + + I  EK    F    ++    Y+APE+       +S D +SFG++++EM+ G  PF
Sbjct: 173 SK-ESIDHEKKAYSF-CGTVE----YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 395 HPKPPEEVVKLMC 407
             K  +E + ++ 
Sbjct: 227 QGKDRKETMTMIL 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   GDL +
Sbjct: 58  MKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 116
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K++ FGL
Sbjct: 117 RLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 173
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + + I  EK    F    ++    Y+APE+       +S D +SFG++++EM+ G  PF
Sbjct: 174 SK-ESIDHEKKAYSF-CGTVE----YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227
Query: 395 HPKPPEEVVKLMC 407
             K  +E + ++ 
Sbjct: 228 QGKDRKETMTMIL 240

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V +KI+DK +  +P  +     E+ I++   HPN+V+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +++EY + G++  YL   GR+   +       +   + Y H+ +   I+H 
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHR 138
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG          +  +   +     A  Y APE+++ +++D
Sbjct: 139 DLKAENLLLDADMNIKIADFGF-------SNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              VD +S G+ILY ++ G  PF  +  +E+ + +     R P  +       D + L++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST-----DCENLLK 246
Query: 432 ECWDPKPVIRPNFNEII 448
                 P+ R    +I+
Sbjct: 247 RFLVLNPIKRGTLEQIM 263

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   GDL +
Sbjct: 57  MKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K++ FGL
Sbjct: 116 RLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + + I  EK    F    ++    Y+APE+       +S D +SFG++++EM+ G  PF
Sbjct: 173 SK-ESIDHEKKAYSF-CGTVE----YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 395 HPKPPEEVVKLMC 407
             K  +E + ++ 
Sbjct: 227 QGKDRKETMTMIL 239

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 32  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 91
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 92  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 148
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 149 IKITDFGLCK-EGISDGATMKXFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 202
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 203 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R     P+   K     P+        ++APE   +  +
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-------WMAPETIFDRVY 227
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP-PDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 283
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY  +G++   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG      +    ++       +
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLXGTL 175
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 176 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 144 IKITDFGLCK-EGISDGATMKXFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 236

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 14/224 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL + + IS       F  +   P   Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 144 IKITDFGLCK-EGISDGATMKXFCGT---PE--YLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLL 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 127/272 (46%), Gaps = 39/272 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEF 371
             +NILL     +KI  FGL R     P+   K     P+        ++APE   +  +
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-------WMAPETIFDRVY 218
Query: 372 DRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP-PDLKEL 429
               D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 275 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 32/290 (11%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTH 234
           P E   +E+    L++ K  G  + G   +A +N  TKV VK +   S      + AF  
Sbjct: 171 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLA 226
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP-SKVLRFAL 292
           E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+  +G   P  K++ F+ 
Sbjct: 227 EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 285
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS 352
            +A GM ++ +      IH DL+  NIL+      KI+ FGL R+       AK  FP+ 
Sbjct: 286 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV------GAK--FPIK 334
Query: 353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK 411
                  + APE      F    D +SFG++L E++  G  P+      EV++ +   G 
Sbjct: 335 -------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGY 386
Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           R P   +  + P +L  ++  CW  +P  RP F  I + LD        Q
Sbjct: 387 RMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 433

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 116 VPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 172
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YE
Sbjct: 173 IQVTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 223
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           M  G  PF    P ++ + +     R P       +  DLK+L+
Sbjct: 224 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL 262

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++   
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNL 56
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYL 301
            H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPA 357
              +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV      
Sbjct: 117 ---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVR----- 166
Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             +  PE+    +F    D ++FG++++E+   G  P+      E  +          + 
Sbjct: 167 --WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---------HIA 215
Query: 417 IKARSYPPDLKE-----LIEECWDPKPVIRPNFNEIIARL 451
              R Y P L       ++  CW  K   RP F  +++ +
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 38/271 (14%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 61  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 118
Query: 271 DLASYLQ-KKGRLSPSK--------------VLRFALDLARGMNYLHECKPDPIIHCDLK 315
           +L++YL+ K+    P K              ++ ++  +A+GM +L   K    IH DL 
Sbjct: 119 NLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175
Query: 316 PKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
            +NILL     +KI  FGL R     P+   K     P+        ++APE   +  + 
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-------WMAPETIFDRVYT 228
Query: 373 RSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP-PDLKELI 430
              D +SFG++L+E+   G  P+    P   +    C   +   +++A  Y  P++ + +
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 284
Query: 431 EECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
            +CW  +P  RP F+E++  L  ++   ++Q
Sbjct: 285 LDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 120/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 120/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 182 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 281
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 282 GNLKNGVNDIKNHKWFATT 300

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 120/259 (46%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 126 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 182
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 183 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 234 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 282
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 283 GNLKNGVNDIKNHKWFATT 301

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 115/259 (44%), Gaps = 20/259 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
           +GT   V +   ++   P+  + +  E+ I+    H +++++ G         + +V+EY
Sbjct: 40  DGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH +L  +N+LLDN   
Sbjct: 100 VPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRL 155
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI  FGL +     PE  +        D    + APE  K  +F  + D +SFG+ LYE
Sbjct: 156 VKIGDFGLAK---AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 212
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-----------KARSYPPDLKELIEECWD 435
           ++         P + +  +   +G+   L++           +    P ++  L++ CW+
Sbjct: 213 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWE 272
Query: 436 PKPVIRPNFNEIIARLDRI 454
            +   RP F  +I  L  +
Sbjct: 273 TEASFRPTFENLIPILKTV 291

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 13/221 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 52  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 111
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I     + V 
Sbjct: 112 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDEMANEFVG 168
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             S       Y++PE  +   +    D +S GL L EM  G    +P+PP  + +L+   
Sbjct: 169 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR---YPRPPMAIFELLDYI 218
Query: 410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
              PP K+ +  +  + ++ + +C    P  R +  +++  
Sbjct: 219 VNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVH 259

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 120/257 (46%), Gaps = 22/257 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V +KI+DK +  +P  +     E+ I++   HPN+V+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +++EY + G++  YL   GR+   +       +   + Y H+ +   I+H 
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHR 135
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG          +  +   +     +  Y APE+++ +++D
Sbjct: 136 DLKAENLLLDADMNIKIADFGF-------SNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              VD +S G+ILY ++ G  PF  +  +E+ + +     R P  +       D + L++
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST-----DCENLLK 243
Query: 432 ECWDPKPVIRPNFNEII 448
                 P+ R    +I+
Sbjct: 244 RFLVLNPIKRGTLEQIM 260

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 119/259 (45%), Gaps = 23/259 (8%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P + +   +   N  + +V+EY  
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAP 125
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+++D  G +K
Sbjct: 126 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIK 182
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           ++ FG  +         ++      +     Y+APEI  ++ ++++VD ++ G+++YEM 
Sbjct: 183 VTDFGFAK---------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G  PF    P ++ + +     R P       +  DLK+L+      + +++ +  +  
Sbjct: 234 AGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLL------RNLLQVDLTKRF 282
Query: 449 ARLDRIVCNCSKQGWWKDT 467
             L   V +     W+  T
Sbjct: 283 GNLKNGVNDIKNHKWFATT 301

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 115/259 (44%), Gaps = 20/259 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
           +GT   V +   ++   P+  + +  E+ I+    H +++++ G         + +V+EY
Sbjct: 40  DGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH +L  +N+LLDN   
Sbjct: 100 VPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRL 155
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI  FGL +     PE  +        D    + APE  K  +F  + D +SFG+ LYE
Sbjct: 156 VKIGDFGLAK---AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 212
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-----------KARSYPPDLKELIEECWD 435
           ++         P + +  +   +G+   L++           +    P ++  L++ CW+
Sbjct: 213 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWE 272
Query: 436 PKPVIRPNFNEIIARLDRI 454
            +   RP F  +I  L  +
Sbjct: 273 TEASFRPTFENLIPILKTV 291

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG   +   S  +A +   +   
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRAALCGTLD-- 174
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 175 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G    +  + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y H  K   +IH D+KP+N+LL + G+LKI+ FG   +   S  +A +   +   
Sbjct: 118 ANALSYCHSKK---VIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRAALCGTLD-- 171
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     ++  K +        
Sbjct: 172 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 130/307 (42%), Gaps = 58/307 (18%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+   + + KG Y       W G  V VKI      K   R      EL      RH N+
Sbjct: 38  QITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFR----ETELYNTVMLRHENI 93
Query: 248 VQFVGAVT----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ +       +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH 
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 152
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
                + KP  I H DLK KNIL+   GQ  I+  GL  +   S  +         +D  
Sbjct: 153 EIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ---------LDVG 202
Query: 358 N-------LYVAPEIYKN----EEFD--RSVDAYSFGLILYE---------MIEGVQ-PF 394
           N        Y+APE+       + FD  + VD ++FGL+L+E         ++E  + PF
Sbjct: 203 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 262
Query: 395 HPKPP-----EEVVKLMCCEGKRPPLKIKARSYP--PDLKELIEECWDPKPVIRPNFNEI 447
           +   P     E++ K++C + +RP +  +  S P    L +L++ECW   P  R     I
Sbjct: 263 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 322
Query: 448 IARLDRI 454
              L +I
Sbjct: 323 KKTLTKI 329

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG   +   S  +A +   +   
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRAALCGTLD-- 171
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 172 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 15/211 (7%)
Query: 198 ITKGSYQ---VAKWNGTKVW--VKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFV 251
           I KGS+    +A+    +V+  VK+L K++  K  E  +  +    +++  +HP +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      +  VL+Y   G+L  +LQ++      +   +A ++A  + YLH      I++
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVY 162
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            DLKP+NILLD+ G + ++ FGL +      E  +     S       Y+APE+   + +
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
           DR+VD +  G +LYEM+ G+ PF+ +   E+
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 120 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIANFG---WSVHAPSSRRTTL-CGTL 172
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 173 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 228
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +P  +     E+ I++   HPN+V+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y   C    I+H 
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY---CHQKYIVHR 138
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG          +  +   +     +  Y APE+++ +++D
Sbjct: 139 DLKAENLLLDGDMNIKIADFGF-------SNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 175
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE  +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 176 D----YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 131/307 (42%), Gaps = 58/307 (18%)
Query: 191 QVRKADGITKGSY---QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+   + + KG Y       W G  V VKI      K   R     + + +    RH N+
Sbjct: 9   QITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI 64
Query: 248 VQFVGAVT----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ +       +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
                + KP  I H DLK KNIL+   GQ  I+  GL  +   S  +         +D  
Sbjct: 124 EIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ---------LDVG 173
Query: 358 N-------LYVAPEIYKN----EEFD--RSVDAYSFGLILYE---------MIEGVQ-PF 394
           N        Y+APE+       + FD  + VD ++FGL+L+E         ++E  + PF
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 395 HPKPP-----EEVVKLMCCEGKRPPLKIKARSYP--PDLKELIEECWDPKPVIRPNFNEI 447
           +   P     E++ K++C + +RP +  +  S P    L +L++ECW   P  R     I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 448 IARLDRI 454
              L +I
Sbjct: 294 KKTLTKI 300

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +     + +
Sbjct: 119 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSCHAPSSRRTTLSGT-L 171
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 172 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 227
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIANFG---WSVHAPSSRRTTL-CGTL 173
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 174 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 134
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 135 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 187
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 188 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 243
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 244 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 175
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 176 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 170
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 171 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 173
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 174 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 173
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 174 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 144 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 196
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 197 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 252
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 253 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG   +   S  + ++   +   
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRTELCGTLD-- 171
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 172 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 116
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 117 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 169
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 170 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 225
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 226 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG      +    ++       +
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTXLCGTL 170
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 171 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 17/228 (7%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 165
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-------KPPEEV 402
             S       Y++PE  +   +    D +S GL L EM  G  P  P       +PP  +
Sbjct: 166 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAI 218
Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
            +L+      PP K+ +  +  + ++ + +C    P  R +  +++  
Sbjct: 219 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 121
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 122 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 174
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 175 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 230
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 231 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 11/170 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  R    +   +  +L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 122 ANALSY---CHSKRVIHRDIKPENLLLGSNGELKIADFG---WSVHAPSSRRTTL-CGTL 174
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
           D    Y+ PE+ +    D  VD +S G++ YE + G+ PF     +E  +
Sbjct: 175 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYR 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 114
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG       +P   +       +
Sbjct: 115 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPSSRRTTL-CGTL 167
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 168 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 223
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 224 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG   +   S  +  +   +   
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRTDLCGTLD-- 176
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 177 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG   +   S  +  +   +   
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRTDLCGTLD-- 171
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 172 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG             +  P S  
Sbjct: 119 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPSSRR 164
Query: 355 DP--ANL-YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM----- 406
           D     L Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +     
Sbjct: 165 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
Query: 407 -----CCEGKRPPLKIKARSYP---PDLKELIEECW 434
                  EG R  +    +  P   P L+E++E  W
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG   +   S  +  +   +   
Sbjct: 119 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRTDLCGTLD-- 172
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 173 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 227
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG      +    ++       +
Sbjct: 120 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTL 172
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 173 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 228
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 139/287 (48%), Gaps = 36/287 (12%)
Query: 187 PLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           P E Q+   + I KG + QV   +W+G +V ++++D E   + +++ AF  E+    + R
Sbjct: 31  PFE-QLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIE-RDNEDQLKAFKREVMAYRQTR 87
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYL 301
           H NVV F+GA   + P + ++    KG     + +  +  L  +K  + A ++ +GM YL
Sbjct: 88  HENVVLFMGACM-SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI-----SPEKAKIVFPVSHIDP 356
           H      I+H DLK KN+  DN G++ I+ FGL  +  +       +K +I       + 
Sbjct: 147 H---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQ------NG 196
Query: 357 ANLYVAPEIYK-----NEE----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC 407
              ++APEI +      EE    F +  D ++ G I YE+     PF  +P E ++  M 
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256
Query: 408 CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             G +P L         ++ +++  CW  +   RP F +++  L+++
Sbjct: 257 T-GMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 22/269 (8%)
Query: 185 LNPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIV 239
           L+P EL   K + I KGS+ +V K   N T+  V +KI+D E  +  + I     E+T++
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVL 59
Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
            +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     ++ +G++
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           YLH  K    IH D+K  N+LL   G++K++ FG+   Q    +  +  F  +       
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGT-----PF 169
Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           ++APE+ K   +D   D +S G+   E+  G  P     P +V  L       PP     
Sbjct: 170 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFLIPKNNPP--TLE 225
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +Y   LKE +E C + +P  RP   E++
Sbjct: 226 GNYSKPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 110/245 (44%), Gaps = 37/245 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK------------ 279
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L+              
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 280 ---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G L   ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 206
Query: 337 LQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQ 392
             Y +       + + P+        ++ PE     +F    D +SFG++L+E+   G Q
Sbjct: 207 DIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 393 PFHPKPPEEVVKLMCC--EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           P++     E +  +    E +RP      R+ PP++  ++  CW  +P  R +  ++ AR
Sbjct: 260 PWYQLSNTEAIDCITQGRELERP------RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
Query: 451 LDRIV 455
           L  + 
Sbjct: 314 LQALA 318

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 125/294 (42%), Gaps = 55/294 (18%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT----Q 256
           G      W G  V VKI      K   R     + + +    RH N++ F+ +       
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIASDMTSRHS 77
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
           +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH      + KP  I 
Sbjct: 78  STQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIA 135
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN-------LYVAP 363
           H DLK KNIL+   GQ  I+  GL  +   S          + +D  N        Y+AP
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQS---------TNQLDVGNNPRVGTKRYMAP 186
Query: 364 EIYKN----EEFD--RSVDAYSFGLILYE---------MIEGVQ-PFHPKPP-----EEV 402
           E+       + FD  + VD ++FGL+L+E         ++E  + PF+   P     E++
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 403 VKLMCCEGKRPPLKIKARSYP--PDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            K++C + +RP +  +  S P    L +L++ECW   P  R     I   L +I
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG      +    ++       +
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTL 173
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 174 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG   +   S  +  +   +   
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG-WSVHAPSSRRTDLCGTLD-- 171
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
                Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 172 -----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG      +    ++       +
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRXXLCGTL 170
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-------- 406
           D    Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +        
Sbjct: 171 D----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 407 --CCEGKRPPLKIKARSYP---PDLKELIEECW 434
               EG R  +    +  P   P L+E++E  W
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 110/244 (45%), Gaps = 37/244 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK------------ 279
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L+              
Sbjct: 61  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 120
Query: 280 ---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G L   ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 121 VAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 177
Query: 337 LQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQ 392
             Y +       + + P+        ++ PE     +F    D +SFG++L+E+   G Q
Sbjct: 178 DIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230
Query: 393 PFHPKPPEEVVKLMCC--EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           P++     E +  +    E +RP      R+ PP++  ++  CW  +P  R +  ++ AR
Sbjct: 231 PWYQLSNTEAIDCITQGRELERP------RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 284
Query: 451 LDRI 454
           L  +
Sbjct: 285 LQAL 288

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 110/244 (45%), Gaps = 37/244 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK------------ 279
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L+              
Sbjct: 67  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 126
Query: 280 ---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G L   ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 127 VAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 183
Query: 337 LQYISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQ 392
             Y +       + + P+        ++ PE     +F    D +SFG++L+E+   G Q
Sbjct: 184 DIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236
Query: 393 PFHPKPPEEVVKLMCC--EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           P++     E +  +    E +RP      R+ PP++  ++  CW  +P  R +  ++ AR
Sbjct: 237 PWYQLSNTEAIDCITQGRELERP------RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 290
Query: 451 LDRI 454
           L  +
Sbjct: 291 LQAL 294

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 127/269 (47%), Gaps = 22/269 (8%)
Query: 185 LNPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIV 239
           L+P EL   K + I KGS+ +V K   N T+  V +KI+D E  +  + I     E+T++
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVL 59
Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
            +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     ++ +G++
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           YLH  K    IH D+K  N+LL   G++K++ FG      ++ +        +       
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFG------VAGQLTDTQIKRNXFVGTPF 169
Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           ++APE+ K   +D   D +S G+   E+  G  P     P +V  L       PP     
Sbjct: 170 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFLIPKNNPP--TLE 225
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEII 448
            +Y   LKE +E C + +P  RP   E++
Sbjct: 226 GNYSKPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 17/173 (9%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  R    +   +  +L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG             +  P S  
Sbjct: 122 ANALSY---CHSKRVIHRDIKPENLLLGSNGELKIADFGW-----------SVHAPSSRR 167
Query: 355 DP--ANL-YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
           D     L Y+ PE+ +    D  VD +S G++ YE + G+ PF     +E  +
Sbjct: 168 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYR 220

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 112/246 (45%), Gaps = 24/246 (9%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKG 270
           VW K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+EY   G
Sbjct: 35  VW-KELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92
Query: 271 DLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPD---PIIHCDLKPKNILLDN 323
           DLAS + K  +    L    VLR    L   +   H  + D    ++H DLKP N+ LD 
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG 151
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +K+  FGL R+       AK      +      Y++PE      ++   D +S G +
Sbjct: 152 KQNVKLGDFGLARILNHDTSFAKTFVGTPY------YMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 384 LYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           LYE+   + PF     +E+  K+   + +R P +     Y  +L E+I    + K   RP
Sbjct: 206 LYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDELNEIITRMLNLKDYHRP 260
Query: 443 NFNEII 448
           +  EI+
Sbjct: 261 SVEEIL 266

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            E+T++ +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     +
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 127
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           + +G++YLH  K    IH D+K  N+LL   G++K++ FG      ++ +        + 
Sbjct: 128 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFG------VAGQLTDTQIKRNX 178
Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
                 ++APE+ K   +D   D +S G+   E+  G  P     P +V  L       P
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFLIPKNNP 236
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           P      S P  LKE +E C + +P  RP   E++
Sbjct: 237 PTLEGNYSKP--LKEFVEACLNKEPSFRPTAKELL 269

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG             +  P S  
Sbjct: 144 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPSSRR 189
Query: 355 DP--ANL-YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM----- 406
           D     L Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +     
Sbjct: 190 DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 249
Query: 407 -----CCEGKRPPLKIKARSYP---PDLKELIEECW 434
                  EG R  +    +  P   P L+E++E  W
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 18/231 (7%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VK+++K S K+ +  +    E+ +++K  HPN+++    +  +    IV E +  G+L  
Sbjct: 52  VKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISG 331
            + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++  +   +KI  
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 332 FGLLR-LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           FGL    Q  +  K +I            Y+APE+ +   +D   D +S G+ILY ++ G
Sbjct: 168 FGLSTCFQQNTKMKDRI--------GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218
Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
             PF+ K   +++K +   GK      + R+   D K+LI +     P +R
Sbjct: 219 TPPFYGKNEYDILKRVET-GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 92/192 (47%), Gaps = 17/192 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +  G KV VKIL+++  +  + +     E+  ++  RHP++++    ++      +V+EY
Sbjct: 33  QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            + G+L  Y+ K GR+   +  R    +   ++Y   C    ++H DLKP+N+LLD    
Sbjct: 93  VSGGELFDYICKHGRVEEMEARRLFQQILSAVDY---CHRHMVVHRDLKPENVLLDAHMN 149
Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            KI+ FGL  +    +++        +    +    LY  PE          VD +S G+
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE----------VDIWSCGV 199
Query: 383 ILYEMIEGVQPF 394
           ILY ++ G  PF
Sbjct: 200 ILYALLCGTLPF 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 126/264 (47%), Gaps = 28/264 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G +V VK L  ES  +   I     E+ I+    H N+V++ G  T++    + +++E+
Sbjct: 49  TGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G L  YL K K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEH 163
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           Q+KI  FGL +   I  +K           P   Y APE     +F  + D +SFG+ L+
Sbjct: 164 QVKIGDFGLTKA--IETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLH 220
Query: 386 EM--------------IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
           E+              ++ + P H +     +     EGKR P      + P ++ +L+ 
Sbjct: 221 ELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC---PPNCPDEVYQLMR 277
Query: 432 ECWDPKPVIRPNFNEIIARLDRIV 455
           +CW+ +P  R +F  +I   + ++
Sbjct: 278 KCWEFQPSNRTSFQNLIEGFEALL 301

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 112/246 (45%), Gaps = 24/246 (9%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKG 270
           VW K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+EY   G
Sbjct: 35  VW-KELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92
Query: 271 DLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPD---PIIHCDLKPKNILLDN 323
           DLAS + K  +    L    VLR    L   +   H  + D    ++H DLKP N+ LD 
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG 151
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +K+  FGL R+       AK      +      Y++PE      ++   D +S G +
Sbjct: 152 KQNVKLGDFGLARILNHDTSFAKAFVGTPY------YMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 384 LYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           LYE+   + PF     +E+  K+   + +R P +     Y  +L E+I    + K   RP
Sbjct: 206 LYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDELNEIITRMLNLKDYHRP 260
Query: 443 NFNEII 448
           +  EI+
Sbjct: 261 SVEEIL 266

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 125/264 (47%), Gaps = 28/264 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G +V VK L  ES  +   I     E+ I+    H N+V++ G  T++    + +++E+
Sbjct: 37  TGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 94
Query: 267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G L  YL K K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  
Sbjct: 95  LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEH 151
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           Q+KI  FGL +   I  +K           P   Y APE     +F  + D +SFG+ L+
Sbjct: 152 QVKIGDFGLTKA--IETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLH 208
Query: 386 EM--------------IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
           E+              ++ + P H +     +     EGKR P        P ++ +L+ 
Sbjct: 209 ELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNC---PDEVYQLMR 265
Query: 432 ECWDPKPVIRPNFNEIIARLDRIV 455
           +CW+ +P  R +F  +I   + ++
Sbjct: 266 KCWEFQPSNRTSFQNLIEGFEALL 289

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++          + ++LE+  +G+L   LQK GR    +   F  +L
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y HE K   +IH D+KP+N+L+   G+LKI+ FG   +   S  +  +   +   
Sbjct: 125 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG-WSVHAPSLRRRXMCGTLD-- 178
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEGKRP 413
                Y+ PE+ + +  D  VD +  G++ YE + G+ PF  P   E   +++  + K P
Sbjct: 179 -----YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP 233
Query: 414 PLKIKA---------RSYPPD---LKELIEECW 434
           P              R +PP    LK ++E  W
Sbjct: 234 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 266

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG             +  P S  
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPSSRR 166
Query: 355 DP--ANL-YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM----- 406
           D     L Y+ PE+ +    D  VD +S G++ YE + G  PF     +E  K +     
Sbjct: 167 DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 226
Query: 407 -----CCEGKRPPLKIKARSYP---PDLKELIEECW 434
                  EG R  +    +  P   P L+E++E  W
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K N   + +K+L K   +     +    E+ I    RHPN+++          + ++LE+
Sbjct: 36  KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             +G+L   LQK GR    +   F  +LA  ++Y HE K   +IH D+KP+N+L+   G+
Sbjct: 96  APRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGE 152
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           LKI+ FG   +   S  +  +   +        Y+ PE+ + +  D  VD +  G++ YE
Sbjct: 153 LKIADFG-WSVHAPSLRRRXMCGTLD-------YLPPEMIEGKTHDEKVDLWCAGVLCYE 204
Query: 387 MIEGVQPF-HPKPPEEVVKLMCCEGKRPPLKIKA---------RSYPPD---LKELIEEC 433
            + G+ PF  P   E   +++  + K PP              R +PP    LK ++E  
Sbjct: 205 FLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 434 W 434
           W
Sbjct: 265 W 265

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            E+T++ +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     +
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 132
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           + +G++YLH  K    IH D+K  N+LL   G++K++ FG+   Q    +  +  F  + 
Sbjct: 133 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGT- 187
Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
                 ++APE+ K   +D   D +S G+   E+  G  P     P +V  L       P
Sbjct: 188 ----PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFLIPKNNP 241
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           P      +Y   LKE +E C + +P  RP   E++
Sbjct: 242 P--TLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 274

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           E +  F  E+    +  H N+V  +    ++    +V+EY     L+ Y++  G LS   
Sbjct: 53  ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDT 112
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-LQYISPEKA 345
            + F   +  G+ + H+ +   I+H D+KP+NIL+D+   LKI  FG+ + L   S    
Sbjct: 113 AINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS---- 165
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
             +   +H+     Y +PE  K E  D   D YS G++LYEM+ G  PF+
Sbjct: 166 --LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ GR      +
Sbjct: 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV 445
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++A G+ +L   +   II+ DLK  N++LD+ G +KI+ FG+ +         K  
Sbjct: 446 FYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF 502
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
                      Y+APEI   + + +SVD ++FG++LYEM+ G  PF  +  +E+ +
Sbjct: 503 CGTPD------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 92/192 (47%), Gaps = 17/192 (8%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +  G KV VKIL+++  +  + +     E+  ++  RHP++++    ++      +V+EY
Sbjct: 33  QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            + G+L  Y+ K GR+   +  R    +   ++Y   C    ++H DLKP+N+LLD    
Sbjct: 93  VSGGELFDYICKHGRVEEMEARRLFQQILSAVDY---CHRHMVVHRDLKPENVLLDAHMN 149
Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
            KI+ FGL  +    +++        +    +    LY  PE          VD +S G+
Sbjct: 150 AKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPE----------VDIWSCGV 199
Query: 383 ILYEMIEGVQPF 394
           ILY ++ G  PF
Sbjct: 200 ILYALLCGTLPF 211

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 31/240 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------- 280
           F  E  ++   +H ++V+F G   +  P+++V EY   GDL  +L+  G           
Sbjct: 62  FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP 121
Query: 281 --RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
              L+ S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ R  
Sbjct: 122 PTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 178
Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y +         + P+        ++ PE     +F    D +S G++L+E+   G QP+
Sbjct: 179 YSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231
Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +     EV++   C  +   L+ + R+ P ++ EL+  CW  +P +R N   I   L  +
Sbjct: 232 YQLSNNEVIE---CITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y   C    I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY---CHQKFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG    ++    K      +     A  Y APE+++ +++D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSN-EFTFGNK------LDAFCGAPPYAAPELFQGKKYD 190
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 113/246 (45%), Gaps = 24/246 (9%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKG 270
           VW K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+EY   G
Sbjct: 35  VW-KELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92
Query: 271 DLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPD---PIIHCDLKPKNILLDN 323
           DLAS + K  +    L    VLR    L   +   H  + D    ++H DLKP N+ LD 
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG 151
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +K+  FGL R+     + AK      +      Y++PE      ++   D +S G +
Sbjct: 152 KQNVKLGDFGLARILNHDEDFAKEFVGTPY------YMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 384 LYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           LYE+   + PF     +E+  K+   + +R P +     Y  +L E+I    + K   RP
Sbjct: 206 LYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDELNEIITRMLNLKDYHRP 260
Query: 443 NFNEII 448
           +  EI+
Sbjct: 261 SVEEIL 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 18/231 (7%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VK+++K S K+ +  +    E+ +++K  HPN+++    +  +    IV E +  G+L  
Sbjct: 52  VKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISG 331
            + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++  +   +KI  
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 332 FGLLR-LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           FGL    Q  +  K +I            Y+APE+ +   +D   D +S G+ILY ++ G
Sbjct: 168 FGLSTCFQQNTKMKDRI--------GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218
Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
             PF+ K   +++K +   GK      + R+   D K+LI +     P +R
Sbjct: 219 TPPFYGKNEYDILKRVET-GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 18/231 (7%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VK+++K S K+ +  +    E+ +++K  HPN+++    +  +    IV E +  G+L  
Sbjct: 52  VKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISG 331
            + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++  +   +KI  
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 332 FGLLR-LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           FGL    Q  +  K +I            Y+APE+ +   +D   D +S G+ILY ++ G
Sbjct: 168 FGLSTCFQQNTKMKDRI--------GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218
Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
             PF+ K   +++K +   GK      + R+   D K+LI +     P +R
Sbjct: 219 TPPFYGKNEYDILKRVET-GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----MMIVLEYHA 268
            W ++ D++  K  ER   F  E   ++  +HPN+V+F  +    +     +++V E   
Sbjct: 55  AWCELQDRKLTK-SER-QRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXT 112
Query: 269 KGDLASYLQKKGRLSPSKVLR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQ 326
            G L +YL K+ ++   KVLR +   + +G+ +LH   P PIIH DLK  NI +    G 
Sbjct: 113 SGTLKTYL-KRFKVXKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGS 170
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI   GL  L+  S  KA I  P         + APE Y+ E++D SVD Y+FG    E
Sbjct: 171 VKIGDLGLATLKRASFAKAVIGTPE--------FXAPEXYE-EKYDESVDVYAFGXCXLE 221
Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
                 P+        +      G +P    K     P++KE+IE C      IR N +E
Sbjct: 222 XATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA--IPEVKEIIEGC------IRQNKDE 273

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 138/325 (42%), Gaps = 52/325 (16%)
Query: 165 PKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNG-------TKVWVKI 217
           P  +R P+ +       EY  N +E      +G     +Q A+  G       T V VK+
Sbjct: 26  PMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQ-ARAPGLLPYEPFTMVAVKM 84
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L +E+  D +    F  E  ++ +  +PN+V+ +G      PM ++ EY A GDL  +L+
Sbjct: 85  LKEEASADMQ--ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 142
Query: 278 K----------------KGR--------LSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
                            + R        LS ++ L  A  +A GM YL E K    +H D
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199
Query: 314 LKPKNILLDNGGQLKISGFGLLRLQYIS---PEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           L  +N L+     +KI+ FGL R  Y +           P+  + P +++          
Sbjct: 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NR 252
Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +++G++L+E+   G+QP++    EEV+  +    +   +     + P +L  L
Sbjct: 253 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV----RDGNILACPENCPLELYNL 308
Query: 430 IEECWDPKPVIRPNFNEIIARLDRI 454
           +  CW   P  RP+F  I   L R+
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRM 333

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 191 QVRKADGITKGSY---QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q++    I KG Y    + KW G KV VK+          R       + +    RH N+
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM----RHENI 93
Query: 248 VQFVGAVTQNI----PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ A  +       + ++ +YH  G L  YL K   L    +L+ A     G+ +LH 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
                + KP  I H DLK KNIL+   G   I+  G L +++IS      + P + +   
Sbjct: 153 EIFSTQGKP-AIAHRDLKSKNILVKKNGTCCIADLG-LAVKFISDTNEVDIPPNTRVGTK 210
Query: 358 NLYVAPEIYKNEEFDRS-------VDAYSFGLILYE---------MIEGVQ-PFH---PK 397
             Y+ PE+  +E  +R+        D YSFGLIL+E         ++E  Q P+H   P 
Sbjct: 211 R-YMPPEVL-DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 398 PP--EEVVKLMCCEGKRP--PLKIKARSYPPDLKELIEECWDPKPVIR 441
            P  E++ +++C +  RP  P +  +      + +L+ ECW   P  R
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ GR      +
Sbjct: 65  ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV 124
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
            +A ++A G+ +L   +   II+ DLK  N++LD+ G +KI+ FG+ +         K  
Sbjct: 125 FYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF 181
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
                      Y+APEI   + + +SVD ++FG++LYEM+ G  PF  +  +E+ +
Sbjct: 182 CGTPD------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y   C    I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY---CHQKFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG    ++    K      +     +  Y APE+++ +++D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSN-EFTFGNK------LDTFCGSPPYAAPELFQGKKYD 190
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y   C    I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY---CHQKFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG    ++    K      +     +  Y APE+++ +++D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSN-EFTFGNK------LDTFCGSPPYAAPELFQGKKYD 190
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 142/306 (46%), Gaps = 51/306 (16%)
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH 244
           L  LE++ R   G    +  + ++   K++  I DK+S ++        +E+  +   +H
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLNEYVAVKIF-PIQDKQSWQNE-------YEVYSLPGMKH 77
Query: 245 PNVVQFVGA----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNY 300
            N++QF+GA     + ++ + ++  +H KG L+ +L K   +S +++   A  +ARG+ Y
Sbjct: 78  ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAY 136
Query: 301 LHECKPD-------PIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           LHE  P         I H D+K KN+LL N     I+ FGL     +  E  K       
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA----LKFEAGKSAGDTHG 192
Query: 354 IDPANLYVAPEI------YKNEEFDRSVDAYSFGLILYEMI-----------EGVQPF-- 394
                 Y+APE+      ++ + F R +D Y+ GL+L+E+            E + PF  
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 395 ----HPKPPEEVVKLMCCEGKRPPLKIKARSYP--PDLKELIEECWDPKPVIRPNFNEII 448
               HP   E++ +++  + KRP L+   + +     L E IEECWD     R +   + 
Sbjct: 252 EIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 449 ARLDRI 454
            R+ ++
Sbjct: 311 ERITQM 316

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V V+I+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y   C    I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY---CHQKFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG    ++    K      +     +  Y APE+++ +++D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSN-EFTFGNK------LDEFCGSPPYAAPELFQGKKYD 190
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 185 LNPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIV 239
           ++P EL   K D I KGS+ +V K   N TK  V +KI+D E  +  + I     E+T++
Sbjct: 15  VDPEEL-FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAE--DEIEDIQQEITVL 71
Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
            +   P + ++ G+  ++  + I++EY   G  A  L K G L  + +     ++ +G++
Sbjct: 72  SQCDSPYITRYFGSYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLD 130
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           YLH  +    IH D+K  N+LL   G +K++ FG      ++ +        +       
Sbjct: 131 YLHSERK---IHRDIKAANVLLSEQGDVKLADFG------VAGQLTDTQIKRNXFVGTPF 181
Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           ++APE+ K   +D   D +S G+   E+ +G  P     P  V+ L+    K  P  ++ 
Sbjct: 182 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP---KNSPPTLEG 238
Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEII 448
           +   P  KE +E C +  P  RP   E++
Sbjct: 239 QHSKP-FKEFVEACLNKDPRFRPTAKELL 266

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 10/206 (4%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +  FG+ R   I+     +    + I  A  Y++PE  + +  D   D YS G +LYE++
Sbjct: 157 VMDFGIARA--IADSGNSVTQTAAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPP 414
            G  PF    P+ V      E   PP
Sbjct: 214 TGEPPFTGDSPDSVAYQHVREDPIPP 239

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 28/233 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F  E  ++   +H ++V+F G      P+++V EY   GDL  +L               
Sbjct: 64  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            Q KG L  S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ 
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           R  Y S +  ++     H      ++ PE     +F    D +SFG+IL+E+   G QP+
Sbjct: 181 RDVY-STDYYRV---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
                 EV++  C    R  +  + R  P ++ +++  CW  +P  R N  EI
Sbjct: 237 FQLSNTEVIE--CITQGR--VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V V+I+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y   C    I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY---CHQKFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG    ++    K      +     +  Y APE+++ +++D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSN-EFTFGNK------LDTFCGSPPYAAPELFQGKKYD 190
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 134/307 (43%), Gaps = 58/307 (18%)
Query: 191 QVRKADGITKGSY-QVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           QV   + + KG Y +V +  W+G  V VKI      +   R     + + +    RH N+
Sbjct: 9   QVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNI 64
Query: 248 VQFVGA----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ +       +  + ++  YH  G L  +LQ++  L P   LR A+  A G+ +LH 
Sbjct: 65  LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ-TLEPHLALRLAVSAACGLAHLHV 123
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
                + KP  I H D K +N+L+ +  Q  I+  GL  +     +         ++D  
Sbjct: 124 EIFGTQGKP-AIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSD---------YLDIG 173
Query: 358 N-------LYVAPEIYKNE------EFDRSVDAYSFGLILYEM-----IEGVQ-----PF 394
           N        Y+APE+   +      E  +  D ++FGL+L+E+     + G+      PF
Sbjct: 174 NNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPF 233
Query: 395 HPKPP-----EEVVKLMCCEGKRP--PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           +   P     E++ K++C + + P  P ++ A      L +++ ECW P P  R     I
Sbjct: 234 YDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRI 293
Query: 448 IARLDRI 454
              L +I
Sbjct: 294 KKTLQKI 300

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G+     ++ + +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
            ++  G+  LH    + I++ DLKP+NILLD+ G ++IS  GL       PE   I   V
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEGQTIKGRV 346
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP----EEVVKLMC 407
             +     Y+APE+ KNE +  S D ++ G +LYEMI G  PF  +      EEV +L+ 
Sbjct: 347 GTVG----YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV- 401
Query: 408 CEGKRPPLKIKARSYPPDLKELIEE--CWDP 436
              K  P +   R + P  + L  +  C DP
Sbjct: 402 ---KEVPEEYSER-FSPQARSLCSQLLCKDP 428

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G+     ++ + +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
            ++  G+  LH    + I++ DLKP+NILLD+ G ++IS  GL       PE   I   V
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEGQTIKGRV 346
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP----EEVVKLMC 407
             +     Y+APE+ KNE +  S D ++ G +LYEMI G  PF  +      EEV +L+ 
Sbjct: 347 GTVG----YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV- 401
Query: 408 CEGKRPPLKIKARSYPPDLKELIEE--CWDP 436
              K  P +   R + P  + L  +  C DP
Sbjct: 402 ---KEVPEEYSER-FSPQARSLCSQLLCKDP 428

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           D E    F  E+ ++    HPNV++F+G + ++  +  + EY   G L   ++      P
Sbjct: 47  DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP 106
Query: 285 -SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
            S+ + FA D+A GM YLH      IIH DL   N L+     + ++ FGL RL      
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 344 KAKIVFPVSHIDPANLY--------VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
           + + +  +   D    Y        +APE+     +D  VD +SFG++L E+I  V    
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN--- 220
Query: 396 PKPPEEVVKLMCCEGKRPPLKIKARSY---------PPDLKELIEECWDPKPVIRPNF 444
              P+ + + M          +  R +         PP    +   C D  P  RP+F
Sbjct: 221 -ADPDYLPRTM-------DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSF 270

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +  FG+ R   I+     +    + I  A  Y++PE  + +  D   D YS G +LYE++
Sbjct: 157 VMDFGIARA--IADSGNSVTQTAAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPP 414
            G  PF    P  V      E   PP
Sbjct: 214 TGEPPFTGDSPVSVAYQHVREDPIPP 239

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I +   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V EY + G++  YL   GR    +       +   + Y   C    I+H 
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQY---CHQKFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG    ++    K      +     A  Y APE+++ +++D
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSN-EFTFGNK------LDAFCGAPPYAAPELFQGKKYD 190
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 7/180 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 63  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 122
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 123 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 179
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            ++  +SPE +K     S +  A  YV+PE+   +   +S D ++ G I+Y+++ G+ PF
Sbjct: 180 AKV--LSPE-SKQARANSFVGTAQ-YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NIL+     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANILISATNAVK 156
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +  FG+ R   I+     +    + I  A  Y++PE  + +  D   D YS G +LYE++
Sbjct: 157 VVDFGIARA--IADSGNSVXQTAAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPP 414
            G  PF    P  V      E   PP
Sbjct: 214 TGEPPFTGDSPVSVAYQHVREDPIPP 239

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 115/256 (44%), Gaps = 28/256 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G  V VK L +     P+  + +  E+ I+    H ++V++ G         + +V+EY
Sbjct: 37  TGEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH  L  +N+LLDN   
Sbjct: 95  VPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRL 150
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI  FGL +     PE  +        D    + APE  K  +F  + D +SFG+ LYE
Sbjct: 151 VKIGDFGLAK---AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYE 207
Query: 387 MI---EGVQPFHPKPPE---------EVVKL--MCCEGKRPPLKIKARSYPPDLKELIEE 432
           ++   +  Q  H K  E          V++L  +   G+R P   +    P ++  L++ 
Sbjct: 208 LLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP---RPDRCPCEIYHLMKN 264
Query: 433 CWDPKPVIRPNFNEII 448
           CW+ +   RP F  ++
Sbjct: 265 CWETEASFRPTFQNLV 280

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 115/256 (44%), Gaps = 26/256 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
           +GT   V +   +    P+  + +  E+ I+    H ++V++ G         + +V+EY
Sbjct: 34  DGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH  L  +N+LLDN   
Sbjct: 94  VPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRL 149
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI  FGL +     PE  +        D    + APE  K  +F  + D +SFG+ LYE
Sbjct: 150 VKIGDFGLAK---AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYE 206
Query: 387 MI---EGVQPFHPKPPE---------EVVKL--MCCEGKRPPLKIKARSYPPDLKELIEE 432
           ++   +  Q  H K  E          V++L  +   G+R P   +    P ++  L++ 
Sbjct: 207 LLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP---RPDRCPCEIYHLMKN 263
Query: 433 CWDPKPVIRPNFNEII 448
           CW+ +   RP F  ++
Sbjct: 264 CWETEASFRPTFQNLV 279

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 197 GITKGSYQ---VAKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
            I KGS+    + + N TK    +K ++K+   +   +     EL I++   HP +V   
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      M +V++    GDL  +LQ+        V  F  +L   ++YL   +   IIH
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIH 138
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY---KN 368
            D+KP NILLD  G + I+ F +  +    P + +I   ++   P   Y+APE++   K 
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAM---LPRETQIT-TMAGTKP---YMAPEMFSSRKG 191
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFH 395
             +  +VD +S G+  YE++ G +P+H
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYH 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 18/187 (9%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           KV +K + ++  K  +       E++ ++  RHP++++    +T    +++V+EY A G+
Sbjct: 36  KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGE 94
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L  Y+ +K R++  +  RF   +   + Y H  K   I+H DLKP+N+LLD+   +KI+ 
Sbjct: 95  LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIAD 151
Query: 332 FGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           FGL  +     ++        +    +    LY  PE          VD +S G++LY M
Sbjct: 152 FGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE----------VDVWSCGIVLYVM 201
Query: 388 IEGVQPF 394
           + G  PF
Sbjct: 202 LVGRLPF 208

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 7/180 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 59  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 118
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 119 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 175
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            ++  +SPE +K     S +  A  YV+PE+   +   +S D ++ G I+Y+++ G+ PF
Sbjct: 176 AKV--LSPE-SKQARANSFVGTAQ-YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 11/222 (4%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 68  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 127
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 128 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 184
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCC 408
             S       Y++PE  +   +    D +S GL L EM  G  P         + +L+  
Sbjct: 185 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDY 237
Query: 409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
               PP K+ +  +  + ++ + +C    P  R +  +++  
Sbjct: 238 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 279

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +  FG+ R   I+     +    + I  A  Y++PE  + +  D   D YS G +LYE++
Sbjct: 157 VMDFGIARA--IADSGNSVTQTAAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPP 414
            G  PF    P  V      E   PP
Sbjct: 214 TGEPPFTGDSPVSVAYQHVREDPIPP 239

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +  FG+ R   I+     +    + I  A  Y++PE  + +  D   D YS G +LYE++
Sbjct: 157 VMDFGIARA--IADSGNSVTQTAAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPP 414
            G  PF    P  V      E   PP
Sbjct: 214 TGEPPFTGDSPVSVAYQHVREDPIPP 239

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 89/180 (49%), Gaps = 7/180 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            ++  +SPE +K     S +  A  YV+PE+   +   +S D ++ G I+Y+++ G+ PF
Sbjct: 179 AKV--LSPE-SKQARANSFVGTAQ-YVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 198 ITKGSY---QVAKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEK------ARHPN 246
           + KGS+    +A   GT+    +KIL K+     + +     E T+VEK       + P 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDV-----ECTMVEKRVLALLDKPPF 81
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + Q          +  V+EY   GDL  ++Q+ G+    + + +A +++ G+ +LH+   
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHK--- 138
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
             II+ DLK  N++LD+ G +KI+ FG+ +   +     +             Y+APEI 
Sbjct: 139 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPD------YIAPEII 192
Query: 367 KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
             + + +SVD +++G++LYEM+ G  PF  +  +E+ +
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 230

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 120/262 (45%), Gaps = 25/262 (9%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G     +W G  + VK+L K       +   F  E   +    HPNV+  +GA  Q+ P 
Sbjct: 24  GELWKGRWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC-QSPPA 81
Query: 261 ---MIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++  +   G L + L +     +  S+ ++FALD+ARGM +LH  +P    H  L 
Sbjct: 82  PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LN 140
Query: 316 PKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD--- 372
            +++++D     +IS    ++  + SP +            A  +VAPE  + +  D   
Sbjct: 141 SRSVMIDEDMTARIS-MADVKFSFQSPGRMY----------APAWVAPEALQKKPEDTNR 189
Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
           RS D +SF ++L+E++    PF      E+   +  EG RP +        P + +L++ 
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI---PPGISPHVSKLMKI 246
Query: 433 CWDPKPVIRPNFNEIIARLDRI 454
           C +  P  RP F+ I+  L+++
Sbjct: 247 CMNEDPAKRPKFDMIVPILEKM 268

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169
Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL 384
              KIS FGL R    + EK       S I     Y+APE  + E   +S D YSFG++L
Sbjct: 170 FTAKISDFGLAR----ASEKFAQTVMXSRIVGTTAYMAPEALRGEITPKS-DIYSFGVVL 224
Query: 385 YEMIEGV 391
            E+I G+
Sbjct: 225 LEIITGL 231

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 116
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 117 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 173
Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +  FG+ R   I+     +    + I  A  Y++PE  + +  D   D YS G +LYE++
Sbjct: 174 VMDFGIARA--IADSGNSVTQTAAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVL 230
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPP 414
            G  PF    P  V      E   PP
Sbjct: 231 TGEPPFTGDSPVSVAYQHVREDPIPP 256

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPN 246
           +EL       + +G Y++ K     V +K+L + + K D E +     E  I+ +  +P 
Sbjct: 16  IELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPY 71
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECK 305
           +V+ +G V Q   +M+V+E    G L  +L  K+  +  S V      ++ GM YL E  
Sbjct: 72  IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-- 128
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI 365
               +H DL  +N+LL N    KIS FGL +   +  + +      +   P   Y APE 
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWY-APEC 184
Query: 366 YKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR---PPLKIKARS 421
               +F    D +S+G+ ++E +  G +P+      EV+  +  +GKR   PP       
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP------E 237
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            PP+L  L+ +CW  K   RP+F  +  R+
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 7/180 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 176
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            ++  +SPE +K     + +  A  YV+PE+   +   +S D ++ G I+Y+++ G+ PF
Sbjct: 177 AKV--LSPE-SKQARANAFVGTAQ-YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 7/180 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            ++  +SPE +K       +  A  YV+PE+   +   +S D ++ G I+Y+++ G+ PF
Sbjct: 179 AKV--LSPE-SKQARANXFVGTAQ-YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + I++EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYI-SPEKAKIVFPVSHIDPANL 359
             +   I H DLK +N LLD     +LKI  FG  +   + S  K+ +  P         
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 182
Query: 360 YVAPEIYKNEEFDRSV-DAYSFGLILYEMIEGVQPFHPKPPEE 401
           Y+APE+   +E+D  + D +S G+ LY M+ G  PF  + PEE
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEE 223

>pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 89/155 (57%), Gaps = 9/155 (5%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DL+  G+DVN+ D DGRT LH AA EGH E+VKLL+SK A+++A+
Sbjct: 7   RLIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHYAAKEGHKEIVKLLISKGADVNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYELNP- 187
           D  G T    A   G+ E+  +L ++GA V       RTP+  A     +E+ +  ++  
Sbjct: 67  DSDGRTPLHYAAKEGHKEIVKLLISKGADVNAKDSDGRTPLHYAAKEGHKEIVKLLISKG 126
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKES 222
            ++    +DG T     +A+ +G +  VK+L+K+ 
Sbjct: 127 ADVNTSDSDGRT--PLDLAREHGNEEIVKLLEKQG 159

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 39  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 98
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 99  YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 154
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 155 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 205
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 206 AGLPPF 211

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G K+  KI+     KD E +    +E++++ +  H N++Q   A      +++V+EY   
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 270 GDLAS-YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQ 326
           G+L    + +   L+    + F   +  G+ ++H+     I+H DLKP+NIL  N    Q
Sbjct: 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227
Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI  FGL R +Y   EK K+ F          ++APE+   +      D +S G+I Y 
Sbjct: 228 IKIIDFGLAR-RYKPREKLKVNFGTPE------FLAPEVVNYDFVSFPTDMWSVGVIAYM 280
Query: 387 MIEGVQPF-HPKPPEEVVKLMCC 408
           ++ G+ PF      E +  ++ C
Sbjct: 281 LLSGLSPFLGDNDAETLNNILAC 303

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 38  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 98  YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 153
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 154 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 205 AGLPPF 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 40  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 99
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 100 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 155
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 156 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 206
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 207 AGLPPF 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 195 ADGITKGSYQVAKW----------------NGTKVWVKILDKESHKDPERINAFTHELTI 238
           ADG   G+YQ+ K                  G KV +KI++K+     +       E++ 
Sbjct: 8   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 67
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +   RHP++++    +     +++V+EY A  +L  Y+ ++ ++S  +  RF   +   +
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 126
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHI 354
            Y H  K   I+H DLKP+N+LLD    +KI+ FGL  +     ++        +    +
Sbjct: 127 EYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
               LY  PE          VD +S G+ILY M+    PF
Sbjct: 184 ISGKLYAGPE----------VDVWSCGVILYVMLCRRLPF 213

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 37  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 96
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 97  YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 152
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 153 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 203
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 204 AGLPPF 209

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 175
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 176 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 227 AGLPPF 232

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ 256
           I  G++ VA+    K   +++  +  +  E+I A      I  ++ RHPN+V+F   +  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
              + IV+EY + G+L   +   GR S  +   F   L  G++Y H  +   + H DLK 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKL 143
Query: 317 KNILLDN--GGQLKISGFGLLRLQYI-SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           +N LLD     +LKI  FG  +   + S  K+ +  P         Y+APE+   +E+D 
Sbjct: 144 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLLKKEYDG 195
Query: 374 SV-DAYSFGLILYEMIEGVQPFHPKPPEE 401
            V D +S G+ LY M+ G  PF  + PEE
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPF--EDPEE 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   G +   +       +   + Y   C    I+H 
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY---CHQKFIVHR 130
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           DLK +N+LLD    +KI+ FG    ++    K      +     +  Y APE+++ +++D
Sbjct: 131 DLKAENLLLDADMNIKIADFGFSN-EFTFGNK------LDTFCGSPPYAAPELFQGKKYD 183
Query: 373 R-SVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              VD +S G+ILY ++ G  PF  +  +E+
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 195 ADGITKGSYQVAKW----------------NGTKVWVKILDKESHKDPERINAFTHELTI 238
           ADG   G+YQ+ K                  G KV +KI++K+     +       E++ 
Sbjct: 7   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 66
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +   RHP++++    +     +++V+EY A  +L  Y+ ++ ++S  +  RF   +   +
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 125
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHI 354
            Y H  K   I+H DLKP+N+LLD    +KI+ FGL  +     ++        +    +
Sbjct: 126 EYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
               LY  PE          VD +S G+ILY M+    PF
Sbjct: 183 ISGKLYAGPE----------VDVWSCGVILYVMLCRRLPF 212

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYI-SPEKAKIVFPVSHIDPANL 359
             +   + H DLK +N LLD     +LKI+ FG  +   + S  K+ +  P         
Sbjct: 133 AMQ---VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPA-------- 181
Query: 360 YVAPEIYKNEEFDRSV-DAYSFGLILYEMIEGVQPFHPKPPEE 401
           Y+APE+   +E+D  V D +S G+ LY M+ G  PF  + PEE
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 222

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 175
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 176 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 227 AGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 177
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 178 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 229 AGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 177
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 178 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 229 AGLPPF 234

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 195 ADGITKGSYQVAKW----------------NGTKVWVKILDKESHKDPERINAFTHELTI 238
           ADG   G+YQ+ K                  G KV +KI++K+     +       E++ 
Sbjct: 2   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 61
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +   RHP++++    +     +++V+EY A  +L  Y+ ++ ++S  +  RF   +   +
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHI 354
            Y H  K   I+H DLKP+N+LLD    +KI+ FGL  +     ++        +    +
Sbjct: 121 EYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
               LY  PE          VD +S G+ILY M+    PF
Sbjct: 178 ISGKLYAGPE----------VDVWSCGVILYVMLCRRLPF 207

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 63  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 122
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 123 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 178
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 179 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 230 AGLPPF 235

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 175
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 176 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 227 AGLPPF 232

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 67  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLK 126
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 127 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 182
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 183 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 233
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 234 AGLPPF 239

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYI-SPEKAKIVFPVSHIDPANL 359
             +   + H DLK +N LLD     +LKI  FG  +   + S  K+ +  P         
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPA-------- 181
Query: 360 YVAPEIYKNEEFDRSV-DAYSFGLILYEMIEGVQPFHPKPPEE 401
           Y+APE+   +E+D  V D +S G+ LY M+ G  PF  + PEE
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 222

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 177
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 178 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 229 AGLPPF 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 177
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 178 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 229 AGLPPF 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 44  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 103
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 104 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 159
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 160 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 210
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 211 AGLPPF 216

>pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 88/155 (56%), Gaps = 9/155 (5%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DL+  G+DVN+ D DGRT LH AA  GH EVVKLL+SK A+++A+
Sbjct: 7   RLIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYELNP- 187
           D  G T    A   G+ EV  +L ++GA V       RTP+  A     +EV +  ++  
Sbjct: 67  DSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKG 126
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKES 222
            ++    +DG T     +A+ +G +  VK+L+K+ 
Sbjct: 127 ADVNTSDSDGRT--PLDLAREHGNEEVVKLLEKQG 159

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 65  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 125 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 180
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 181 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 231
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 232 AGLPPF 237

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 86/187 (45%), Gaps = 12/187 (6%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ +  K +H N+V+ +G  +    + +V  Y 
Sbjct: 44  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYX 103
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 104 PNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 160
Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL 384
              KIS FGL R    + EK       S I     Y APE  + E   +S D YSFG++L
Sbjct: 161 FTAKISDFGLAR----ASEKFAQXVXXSRIVGTTAYXAPEALRGEITPKS-DIYSFGVVL 215
Query: 385 YEMIEGV 391
            E+I G+
Sbjct: 216 LEIITGL 222

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 33  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 90  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 146
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 147 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202
Query: 391 VQPF 394
             P+
Sbjct: 203 ELPW 206

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 59  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 118
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 119 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG- 174
Query: 335 LRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                     AK++ P S    AN       YV+PE+   +   +S D ++ G I+Y+++
Sbjct: 175 ---------TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 389 EGVQPF 394
            G+ PF
Sbjct: 226 AGLPPF 231

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 15/162 (9%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY 360
             +   + H DLK +N LLD     +LKI  FG  +   +  +    V       PA  Y
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVG-----TPA--Y 182
Query: 361 VAPEIYKNEEFDRSV-DAYSFGLILYEMIEGVQPFHPKPPEE 401
           +APE+   +E+D  V D +S G+ LY M+ G  PF  + PEE
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 222

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMXGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 111/238 (46%), Gaps = 31/238 (13%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA---SYLQKKGRLSPSK-VLRF 290
           E+ ++++  HPNV+++  +  ++  + IVLE    GDL+    + +K+ RL P + V ++
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            + L   + ++H  +   ++H D+KP N+ +   G +K+   GL R        A  +  
Sbjct: 142 FVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
             +      Y++PE      ++   D +S G +LYEM     PF+    +++     C+ 
Sbjct: 199 TPY------YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLYSLCK- 248
Query: 411 KRPPLKIKARSYPP--------DLKELIEECWDPKPVIRPNFNEIIARLDRI-VCNCS 459
                KI+   YPP        +L++L+  C +P P  RP+   +     R+  C  S
Sbjct: 249 -----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYI-SPEKAKIVFPVSHIDPANL 359
             +   + H DLK +N LLD     +LKI  FG  +   + S  K+ +  P         
Sbjct: 132 AMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 180
Query: 360 YVAPEIYKNEEFDRSV-DAYSFGLILYEMIEGVQPFHPKPPEE 401
           Y+APE+   +E+D  V D +S G+ LY M+ G  PF  + PEE
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 221

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMXGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMXGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 68  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+ S++          +NYLH+ K   IIH DLK  NIL    G +K++ FG 
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFG- 180
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIY-----KNEEFDRSVDAYSFGLILYEMIE 389
                +S +  + +           ++APE+      K+  +D   D +S G+ L EM E
Sbjct: 181 -----VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
              P H   P  V  L+      PP   +   +  + K+ +++C
Sbjct: 236 IEPPHHELNPMRV--LLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMXGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 148 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 391 VQPF 394
             P+
Sbjct: 204 ELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMXGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 87/187 (46%), Gaps = 12/187 (6%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169
Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL 384
              KIS FGL R    + EK         I     Y+APE  + E   +S D YSFG++L
Sbjct: 170 FTAKISDFGLAR----ASEKFAQTVMXXRIVGTTAYMAPEALRGEITPKS-DIYSFGVVL 224
Query: 385 YEMIEGV 391
            E+I G+
Sbjct: 225 LEIITGL 231

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 35/267 (13%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +GT V VK L +E  +  E    F  E+ ++  A H N+++  G        ++V  Y A
Sbjct: 61  DGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 118
Query: 269 KGDLASYLQKKGRLSPS----KVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDN 323
            G +AS L+++    P     K  R AL  ARG+ YLH+ C P  IIH D+K  NILLD 
Sbjct: 119 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDE 177
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL----YVAPEIYKNEEFDRSVDAYS 379
             +  +  FGL +L         + +   H+  A      ++APE     +     D + 
Sbjct: 178 EFEAVVGDFGLAKL---------MDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFG 228
Query: 380 FGLILYEMIEGVQPF---HPKPPEEVVKLMCCEGKRPPLKIKA--------RSYPPDLKE 428
           +G++L E+I G + F        ++V+ L   +G     K++A             ++++
Sbjct: 229 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQ 288
Query: 429 LIEE---CWDPKPVIRPNFNEIIARLD 452
           LI+    C    P+ RP  +E++  L+
Sbjct: 289 LIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 93/186 (50%), Gaps = 15/186 (8%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K + KE+ +  E   +  +E+ ++ K +HPN+V           + ++++  + G+L
Sbjct: 46  VAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKI 329
              + +KG  +     R    +   + YLH+     I+H DLKP+N+L   LD   ++ I
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMI 160
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
           S FGL ++     E    V   +   P   YVAPE+   + + ++VD +S G+I Y ++ 
Sbjct: 161 SDFGLSKM-----EDPGSVLSTACGTPG--YVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 390 GVQPFH 395
           G  PF+
Sbjct: 214 GYPPFY 219

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 93/186 (50%), Gaps = 15/186 (8%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K + KE+ +  E   +  +E+ ++ K +HPN+V           + ++++  + G+L
Sbjct: 46  VAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKI 329
              + +KG  +     R    +   + YLH+     I+H DLKP+N+L   LD   ++ I
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMI 160
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
           S FGL ++     E    V   +   P   YVAPE+   + + ++VD +S G+I Y ++ 
Sbjct: 161 SDFGLSKM-----EDPGSVLSTACGTPG--YVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 390 GVQPFH 395
           G  PF+
Sbjct: 214 GYPPFY 219

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 93/186 (50%), Gaps = 15/186 (8%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K + KE+ +  E   +  +E+ ++ K +HPN+V           + ++++  + G+L
Sbjct: 46  VAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKI 329
              + +KG  +     R    +   + YLH+     I+H DLKP+N+L   LD   ++ I
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
           S FGL ++     E    V   +   P   YVAPE+   + + ++VD +S G+I Y ++ 
Sbjct: 161 SDFGLSKM-----EDPGSVLSTACGTPG--YVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 390 GVQPFH 395
           G  PF+
Sbjct: 214 GYPPFY 219

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/184 (33%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I     H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEG 390
           FGL  + +    + +++  +    P   YVAPE+ K  EF    VD +S G++L  M+ G
Sbjct: 149 FGLATV-FRYNNRERLLNKMCGTLP---YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 391 VQPF 394
             P+
Sbjct: 205 ELPW 208

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 68  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+ S++          +NYLH+ K   IIH DLK  NIL    G +K++ FG 
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFG- 180
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIY-----KNEEFDRSVDAYSFGLILYEMIE 389
                +S +  + +           ++APE+      K+  +D   D +S G+ L EM E
Sbjct: 181 -----VSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
              P H   P  V  L+      PP   +   +  + K+ +++C
Sbjct: 236 IEPPHHELNPMRV--LLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 68  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+ S++          +NYLH+ K   IIH DLK  NIL    G +K++ FG 
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFG- 180
Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIY-----KNEEFDRSVDAYSFGLILYEMIE 389
                +S +  + +           ++APE+      K+  +D   D +S G+ L EM E
Sbjct: 181 -----VSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
              P H   P  V  L+      PP   +   +  + K+ +++C
Sbjct: 236 IEPPHHELNPMRV--LLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 111 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 170
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 171 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 227
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  +  C+
Sbjct: 228 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 280

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 135
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 136 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 192
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  +  C+
Sbjct: 193 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 205 VAKWNGTKVWVKILDKESHK-DPERIN----AFTHELTIVEK-ARHPNVVQFVGAVTQNI 258
           V +  G +  VKI++  + +  PE++     A   E  I+ + A HP+++  + +   + 
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
            M +V +   KG+L  YL +K  LS  +       L   +++LH    + I+H DLKP+N
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPEN 230
Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYK-- 367
           ILLD+  Q+++S FG                   H++P            Y+APEI K  
Sbjct: 231 ILLDDNMQIRLSDFGF----------------SCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 368 ----NEEFDRSVDAYSFGLILYEMIEGVQPF 394
               +  + + VD ++ G+IL+ ++ G  PF
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 43  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 98
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 99  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 156
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-- 368
           H DLK KNIL+   G   I+  GL  +++ S      + P +H      Y+APE+  +  
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSI 214
Query: 369 -----EEFDRSVDAYSFGLILYEM-----IEGVQ-----PFH---PKPP--EEVVKLMCC 408
                E F R+ D Y+ GL+ +E+     I G+      P++   P  P  EE+ K++C 
Sbjct: 215 NMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 273
Query: 409 EGKRP--PLKIKARSYPPDLKELIEECWDPKPVIR 441
           +  RP  P + ++      + +++ ECW      R
Sbjct: 274 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 308

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 20  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 75
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 76  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 133
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-- 368
           H DLK KNIL+   G   I+  GL  +++ S      + P +H      Y+APE+  +  
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSI 191
Query: 369 -----EEFDRSVDAYSFGLILYEM-----IEGVQ-----PFH---PKPP--EEVVKLMCC 408
                E F R+ D Y+ GL+ +E+     I G+      P++   P  P  EE+ K++C 
Sbjct: 192 NMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 250
Query: 409 EGKRP--PLKIKARSYPPDLKELIEECWDPKPVIR 441
           +  RP  P + ++      + +++ ECW      R
Sbjct: 251 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 285

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 165
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  +  C+
Sbjct: 166 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 165
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  +  C+
Sbjct: 166 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 87/187 (46%), Gaps = 12/187 (6%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 47  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 106
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 107 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 163
Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL 384
              KIS FGL R    + EK         I     Y+APE  + E   +S D YSFG++L
Sbjct: 164 FTAKISDFGLAR----ASEKFAQXVMXXRIVGTTAYMAPEALRGEITPKS-DIYSFGVVL 218
Query: 385 YEMIEGV 391
            E+I G+
Sbjct: 219 LEIITGL 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 165
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  +  C+
Sbjct: 166 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 165
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             S       Y++PE  +   +    D +S GL L EM  G  P  P   +E+  +  C+
Sbjct: 166 TRS-------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 23  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 78
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 79  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 136
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-- 368
           H DLK KNIL+   G   I+  GL  +++ S      + P +H      Y+APE+  +  
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSI 194
Query: 369 -----EEFDRSVDAYSFGLILYEM-----IEGVQ-----PFH---PKPP--EEVVKLMCC 408
                E F R+ D Y+ GL+ +E+     I G+      P++   P  P  EE+ K++C 
Sbjct: 195 NMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 253
Query: 409 EGKRP--PLKIKARSYPPDLKELIEECWDPKPVIR 441
           +  RP  P + ++      + +++ ECW      R
Sbjct: 254 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 288

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 18  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 73
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 74  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 131
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-- 368
           H DLK KNIL+   G   I+  GL  +++ S      + P +H      Y+APE+  +  
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSI 189
Query: 369 -----EEFDRSVDAYSFGLILYEM-----IEGVQ-----PFH---PKPP--EEVVKLMCC 408
                E F R+ D Y+ GL+ +E+     I G+      P++   P  P  EE+ K++C 
Sbjct: 190 NMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 248
Query: 409 EGKRP--PLKIKARSYPPDLKELIEECWDPKPVIR 441
           +  RP  P + ++      + +++ ECW      R
Sbjct: 249 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 283

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKW----NGTKVWVKILDKE-SHKDPERINAFTH 234
           +P     P E++ R   G   G   V +W     G +V +K   +E S K+ ER   +  
Sbjct: 9   LPTQTCGPWEMKERLGTG---GFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCL 62
Query: 235 ELTIVEKARHPNVVQF------VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPS 285
           E+ I++K  HPNVV        +  +  N   ++ +EY   GDL  YL +      L   
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
            +     D++  + YLHE +   IIH DLKP+NI+L  G Q  I    ++ L Y + E  
Sbjct: 123 PIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLI--HKIIDLGY-AKELD 176
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
           +       +     Y+APE+ + +++  +VD +SFG + +E I G +PF P
Sbjct: 177 QGELCTEFVGTLQ-YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 43/275 (15%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 72
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 73  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 130
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-- 368
           H DLK KNIL+   G   I+  GL  +++ S      + P +H      Y+APE+  +  
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSI 188
Query: 369 -----EEFDRSVDAYSFGLILYEM-----IEGVQ-----PFHPKPP-----EEVVKLMCC 408
                E F R+ D Y+ GL+ +E+     I G+      P++   P     EE+ K++C 
Sbjct: 189 NMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 409 EGKRP--PLKIKARSYPPDLKELIEECWDPKPVIR 441
           +  RP  P + ++      + +++ ECW      R
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 43/268 (16%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 111
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 169
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-- 368
           H DLK KNIL+   G   I+  GL  +++ S      + P +H      Y+APE+  +  
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAP-NHRVGTKRYMAPEVLDDSI 227
Query: 369 -----EEFDRSVDAYSFGLILYEM-----IEGVQ-----PFH---PKPP--EEVVKLMCC 408
                E F R+ D Y+ GL+ +E+     I G+      P++   P  P  EE+ K++C 
Sbjct: 228 NMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 286
Query: 409 EGKRP--PLKIKARSYPPDLKELIEECW 434
           +  RP  P + ++      + +++ ECW
Sbjct: 287 QKLRPNIPNRWQSCEALRVMAKIMRECW 314

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKW----NGTKVWVKILDKE-SHKDPERINAFTH 234
           +P     P E++ R   G   G   V +W     G +V +K   +E S K+ ER   +  
Sbjct: 8   LPTQTCGPWEMKERLGTG---GFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCL 61
Query: 235 ELTIVEKARHPNVVQF------VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPS 285
           E+ I++K  HPNVV        +  +  N   ++ +EY   GDL  YL +      L   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
            +     D++  + YLHE +   IIH DLKP+NI+L  G Q  I    ++ L Y + E  
Sbjct: 122 PIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLI--HKIIDLGY-AKELD 175
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
           +       +     Y+APE+ + +++  +VD +SFG + +E I G +PF P
Sbjct: 176 QGELCTEFVGTLQ-YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I  GSY V K         +  VKI+DK S +DP      T E+ I+ +  +HPN++   
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDP------TEEIEILLRYGQHPNIITLK 82
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V E    G+L   + ++   S  +       + + + YLH      ++H
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139
Query: 312 CDLKPKNIL-LDNGG---QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
            DLKP NIL +D  G    ++I  FG  +   +  E   ++ P      AN +VAPE+ +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCY---TAN-FVAPEVLE 193
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVV 403
            + +D + D +S G++LY M+ G  PF   P   PEE++
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVL 264
            K  G    VK+L K+     + +     E  I+  AR HP + Q          +  V+
Sbjct: 44  VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E+   GDL  ++QK  R   ++   +A ++   + +LH+     II+ DLK  N+LLD+ 
Sbjct: 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHE 160
Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLIL 384
           G  K++ FG+ + + I        F  +   P   Y+APEI +   +  +VD ++ G++L
Sbjct: 161 GHCKLADFGMCK-EGICNGVTTATFCGT---PD--YIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 385 YEMIEGVQPFHPKPPEEVVK 404
           YEM+ G  PF  +  +++ +
Sbjct: 215 YEMLCGHAPFEAENEDDLFE 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 53/287 (18%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA 253
           A GI+K    +      +V VK+L KE     ER  A   EL ++ +   H N+V  +GA
Sbjct: 66  AYGISKTGVSI------QVAVKML-KEKADSSER-EALMSELKMMTQLGSHENIVNLLGA 117
Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKK-----------------------GRLSPSKVLRF 290
            T + P+ ++ EY   GDL +YL+ K                         L+   +L F
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----LQYISPEKA 345
           A  +A+GM +L   +    +H DL  +N+L+ +G  +KI  FGL R       Y+    A
Sbjct: 178 AYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVK 404
           ++  PV  + P +L+      K+       D +S+G++L+E+   GV P+   P +    
Sbjct: 235 RL--PVKWMAPESLFEGIYTIKS-------DVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            +   G +      A     ++  +++ CW      RP+F  + + L
Sbjct: 286 KLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 13/169 (7%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
            +  +E+ ++ K +HPN+V           + ++++  + G+L   + +KG  +     R
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKISGFGLLRLQYISPEKAK 346
               +   + YLH+     I+H DLKP+N+L   LD   ++ IS FGL ++     E   
Sbjct: 121 LIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-----EDPG 172
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
            V   +   P   YVAPE+   + + ++VD +S G+I Y ++ G  PF+
Sbjct: 173 SVLSTACGTPG--YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 127/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E EL  +++    A G       +      K+ V I     +  P+       E  
Sbjct: 12  RILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLAR 296
           ++     P V + +G +     + +V +    G L  ++ + +GRL    +L + + +A+
Sbjct: 72  VMAGVGSPYVSRLLG-ICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GM+YL + +   ++H DL  +N+L+ +   +KI+ FGL RL  I   +        H D 
Sbjct: 131 GMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE-------YHADG 180
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E      F    D +S+G+ ++E++  G +P+   P  E+  L+  +G+R
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGER 239
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+++   R+
Sbjct: 240 LP-------QPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 56  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 109
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 165
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 166 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 218 GDTKQETL 225

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 56  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 109
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 165
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 166 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 218 GDTKQETL 225

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 32  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 86
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           K  NILL   G +K++ FG      I+PE++K     S +     ++APE+   + +   
Sbjct: 143 KSDNILLGMDGSVKLTDFGFC--AQITPEQSK----RSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
           VD +S G++  EMIEG  P+  + P   + L+   G
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232

>pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 46/103 (44%), Positives = 65/103 (63%), Gaps = 4/103 (3%)
Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           + G T    A   G++EV  +L   GA V    K  RTP+ +A
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLA 108

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 15/230 (6%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            E+T++ +     V ++ G+  +   + I++EY   G  A  L + G     ++     +
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKE 128
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           + +G++YLH  K    IH D+K  N+LL   G +K++ FG+   Q    +  +  F  + 
Sbjct: 129 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGT- 183
Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
                 ++APE+ +   +D   D +S G+   E+ +G  P     P  V  L       P
Sbjct: 184 ----PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFLIPKNNP 237
Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGW 463
           P  +    +    KE I+ C +  P  RP   E++ +   IV N  K  +
Sbjct: 238 PTLVG--DFTKSFKEFIDACLNKDPSFRPTAKELL-KHKFIVKNSKKTSY 284

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 124/298 (41%), Gaps = 40/298 (13%)
Query: 184 ELNPLELQVRK--ADGITKGSYQVAKWNGTKVWV--KILDKESHKDPERINAFTHELTIV 239
           EL  L L+VR+  A+G     Y+       + +   ++L  E  K+     A   E+  +
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN----RAIIQEVCFM 79
Query: 240 EK-ARHPNVVQFVGAVT-------QNIPMMIVLEYHAKGDLASYLQK---KGRLSPSKVL 288
           +K + HPN+VQF  A +             ++L    KG L  +L+K   +G LS   VL
Sbjct: 80  KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP------ 342
           +      R + ++H  KP PIIH DLK +N+LL N G +K+  FG        P      
Sbjct: 140 KIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 343 EKAKIVFPVSHIDPANLYVAPEI---YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP 399
           ++  +V      +   +Y  PEI   Y N       D ++ G ILY +      F   P 
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC-----FRQHPF 253
Query: 400 EEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           E+  KL    GK   PP   +   +      LI       P  R +  E++ +L  I 
Sbjct: 254 EDGAKLRIVNGKYSIPPHDTQYTVF----HSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPN 246
           +EL       + +G Y++ K     V +K+L + + K D E +     E  I+ +  +P 
Sbjct: 342 IELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPY 397
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECK 305
           +V+ +G V Q   +M+V+E    G L  +L  K+  +  S V      ++ GM YL E  
Sbjct: 398 IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-- 454
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI 365
               +H +L  +N+LL N    KIS FGL +   +  + +      +   P   Y APE 
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWY-APEC 510
Query: 366 YKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR---PPLKIKARS 421
               +F    D +S+G+ ++E +  G +P+      EV+  +  +GKR   PP       
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP------E 563
Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            PP+L  L+ +CW  K   RP+F  +  R+
Sbjct: 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRM 593

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 2   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 61
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 121
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL        E+ K++   
Sbjct: 122 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
            +      Y+APE+   +     VD +S G I+Y ++ G      KPP E   L     K
Sbjct: 179 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG------KPPFETSCL-----K 221
Query: 412 RPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEII 448
              L+IK   Y       P    LI++     P  RP  NE++
Sbjct: 222 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 32  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 86
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           K  NILL   G +K++ FG      I+PE++K     S +     ++APE+   + +   
Sbjct: 143 KSDNILLGMDGSVKLTDFGFC--AQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
           VD +S G++  EMIEG  P+  + P   + L+   G
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 32  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 86
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           K  NILL   G +K++ FG      I+PE++K     S +     ++APE+   + +   
Sbjct: 143 KSDNILLGMDGSVKLTDFGFC--AQITPEQSK----RSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
           VD +S G++  EMIEG  P+  + P   + L+   G
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G  K +Y      G KV +KI++K+     +       E++ +   RHP++++    +  
Sbjct: 18  GKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 75
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
              +++V+EY A  +L  Y+ ++ ++S  +  RF   +   + Y H  K   I+H DLKP
Sbjct: 76  KDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKP 131
Query: 317 KNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           +N+LLD    +KI+ FGL  +     ++        +    +    LY  PE        
Sbjct: 132 ENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE-------- 183
Query: 373 RSVDAYSFGLILYEMIEGVQPF 394
             VD +S G+ILY M+    PF
Sbjct: 184 --VDVWSCGVILYVMLCRRLPF 203

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 33  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 87
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 143
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           K  NILL   G +K++ FG      I+PE++K     S +     ++APE+   + +   
Sbjct: 144 KSDNILLGMDGSVKLTDFGFC--AQITPEQSK----RSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
           VD +S G++  EMIEG  P+  + P   + L+   G
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 233

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 121/267 (45%), Gaps = 35/267 (13%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK L +E  +  E    F  E+ ++  A H N+++  G        ++V  Y A
Sbjct: 53  DGXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 110
Query: 269 KGDLASYLQKKGRLSPS----KVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDN 323
            G +AS L+++    P     K  R AL  ARG+ YLH+ C P  IIH D+K  NILLD 
Sbjct: 111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDE 169
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL----YVAPEIYKNEEFDRSVDAYS 379
             +  +  FGL +L         + +   H+  A      ++APE     +     D + 
Sbjct: 170 EFEAVVGDFGLAKL---------MDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFG 220
Query: 380 FGLILYEMIEGVQPF---HPKPPEEVVKLMCCEGKRPPLKIKA--------RSYPPDLKE 428
           +G++L E+I G + F        ++V+ L   +G     K++A             ++++
Sbjct: 221 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQ 280
Query: 429 LIEE---CWDPKPVIRPNFNEIIARLD 452
           LI+    C    P+ RP  +E++  L+
Sbjct: 281 LIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 26  KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 85
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 86  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 145
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL        E+ K++   
Sbjct: 146 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 202
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
            +      Y+APE+   +     VD +S G I+Y ++ G      KPP E   L     K
Sbjct: 203 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG------KPPFETSCL-----K 245
Query: 412 RPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEII 448
              L+IK   Y       P    LI++     P  RP  NE++
Sbjct: 246 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 14/266 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 21  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 77
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 78  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 134
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 135 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 191
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 192 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 247
Query: 437 KPVIRPNFNEIIARLDRIVCNCSKQG 462
               RP F  +  RL     +   +G
Sbjct: 248 DVENRPGFAAVELRLRNYYYDVVNEG 273

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++++++  HPN+V  +  +     + +V E+  K DL   L + K  L  S++  +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L RG+ + H+ +   I+H DLKP+N+L+++ G LK++ FGL R   I       V   +H
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP------VRSYTH 178
Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP--KPPEEVVKLMCCEG 410
                 Y AP++   ++++  SVD +S G I  EMI G +P  P     +++ K+    G
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQLPKIFSILG 237
Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKP--VIRPNF-NEIIARLDRIVC 456
              P +       P  K+   + ++ KP   I P F  E I  L  ++C
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLC 286

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++++++  HPN+V  +  +     + +V E+  K DL   L + K  L  S++  +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L RG+ + H+ +   I+H DLKP+N+L+++ G LK++ FGL R   I       V   +H
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP------VRSYTH 178
Query: 354 IDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHP--KPPEEVVKLMCCEG 410
                 Y AP++   ++++  SVD +S G I  EMI G +P  P     +++ K+    G
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQLPKIFSILG 237
Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKP--VIRPNF-NEIIARLDRIVC 456
              P +       P  K+   + ++ KP   I P F  E I  L  ++C
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLC 286

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  HPN++           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL   +     + K +F 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFG 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF     +E +
Sbjct: 181 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 28  KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 87
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 147
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL        E+ K++   
Sbjct: 148 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
            +      Y+APE+   +     VD +S G I+Y ++ G      KPP E   L     K
Sbjct: 205 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG------KPPFETSCL-----K 247
Query: 412 RPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEII 448
              L+IK   Y       P    LI++     P  RP  NE++
Sbjct: 248 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 14/266 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 33  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 89
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 90  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 146
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 203
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 204 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 259
Query: 437 KPVIRPNFNEIIARLDRIVCNCSKQG 462
               RP F  +  RL     +   +G
Sbjct: 260 DVENRPGFAAVELRLRNYYYDVVNEG 285

>pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 41/94 (43%), Positives = 59/94 (62%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D    L   A  G  + V+ LL++G+DVN+   DG T LH+AA  GH E+VKLLL+K A+
Sbjct: 8   DGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGAD 67
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++AR + G+T    AK  G+ E+  +L A+GA V
Sbjct: 68  VNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADV 101

>pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 89/156 (57%), Gaps = 11/156 (7%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DLL  G+DVN+ D DG+T LH+AA  GH EVVKLLLS+ A+ +A+
Sbjct: 7   RLIEAAENGNKDRVKDLLENGADVNASDSDGKTPLHLAAENGHKEVVKLLLSQGADPNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA---NPREVPEYELNP 187
           D  G T    A   G+ EV  +L ++GA  P  K    +TP+ +A     +EV +  L+ 
Sbjct: 67  DSDGKTPLHLAAENGHKEVVKLLLSQGAD-PNAKDSDGKTPLHLAAENGHKEVVKLLLSQ 125
Query: 188 -LELQVRKADGITKGSYQVAKWNGTKVWVKILDKES 222
             +     +DG T     +A+ +G +  VK+L+K+ 
Sbjct: 126 GADPNTSDSDGRT--PLDLAREHGNEEVVKLLEKQG 159

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +V VK +D    +  +R     +E+ I+    H NVV    +      + +V+E+
Sbjct: 67  KHTGKQVAVKKMDL---RKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEF 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   +    R++  ++    L + R ++YLH      +IH D+K  +ILL + G+
Sbjct: 124 LEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGR 179
Query: 327 LKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           +K+S FG   ++    P++  +V           ++APE+     +   VD +S G+++ 
Sbjct: 180 IKLSDFGFCAQVSKEVPKRKXLV-------GTPYWMAPEVISRLPYGTEVDIWSLGIMVI 232
Query: 386 EMIEGVQPFHPKPPEEVVK 404
           EMI+G  P+  +PP + ++
Sbjct: 233 EMIDGEPPYFNEPPLQAMR 251

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 27  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 83
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 84  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 140
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 141 NVLLVTQHYAKISDFGLSKALRADENXYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 197
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 198 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 253
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 254 DVENRPGFAAVELRL 268

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 198 ITKGSYQ-----VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I  GSY      V K    +  VK++DK S +DP      + E+ I+ +  +HPN++   
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDK-SKRDP------SEEIEILLRYGQHPNIITLK 87
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V E    G+L   + ++   S  +       + + + YLH      ++H
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS---QGVVH 144
Query: 312 CDLKPKNIL-LDNGGQ---LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
            DLKP NIL +D  G    L+I  FG  +   +  E   ++ P      AN +VAPE+ K
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPCY---TAN-FVAPEVLK 198
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVV 403
            + +D   D +S G++LY M+ G  PF   P   PEE++
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 23  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 79
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 80  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 136
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 137 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 193
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 249
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 250 DVENRPGFAAVELRL 264

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAF 232
           ++ P Y+   L+L   K   + +GS+ +      K +     VKI+ K    + ++    
Sbjct: 2   KDSPFYQHYDLDL---KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---- 54
Query: 233 THELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
             E+T ++    HPN+V+        +   +V+E    G+L   ++KK   S ++     
Sbjct: 55  --EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM 112
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQYISPEKAKIV 348
             L   ++++H+     ++H DLKP+N+L    ++  ++KI  FG  RL+   P+   + 
Sbjct: 113 RKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK--PPDNQPLK 167
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            P   +     Y APE+     +D S D +S G+ILY M+ G  PF
Sbjct: 168 TPCFTLH----YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 198 ITKGSYQ-----VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I  GSY      V K    +  VK++DK S +DP      + E+ I+ +  +HPN++   
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDK-SKRDP------SEEIEILLRYGQHPNIITLK 87
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V E    G+L   + ++   S  +       + + + YLH      ++H
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS---QGVVH 144
Query: 312 CDLKPKNIL-LDNGGQ---LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
            DLKP NIL +D  G    L+I  FG  +   +  E   ++ P      AN +VAPE+ K
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPCY---TAN-FVAPEVLK 198
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVV 403
            + +D   D +S G++LY M+ G  PF   P   PEE++
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 27  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 83
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 84  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 140
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 141 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 197
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 198 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 253
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 254 DVENRPGFAAVELRL 268

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 71  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 130
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++   
Sbjct: 131 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 187
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              ++I  FG L   + + +K K     ++      Y+APE+     +D   D +S G+I
Sbjct: 188 DANIRIIDFG-LSTHFEASKKMKDKIGTAY------YIAPEVLHG-TYDEKCDVWSTGVI 239
Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF+     +++K
Sbjct: 240 LYILLSGCPPFNGANEYDILK 260

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 72  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 131
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++   
Sbjct: 132 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 188
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              ++I  FG L   + + +K K     ++      Y+APE+     +D   D +S G+I
Sbjct: 189 DANIRIIDFG-LSTHFEASKKMKDKIGTAY------YIAPEVLHG-TYDEKCDVWSTGVI 240
Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF+     +++K
Sbjct: 241 LYILLSGCPPFNGANEYDILK 261

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 115/261 (44%), Gaps = 25/261 (9%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G     +W G  + VK+L K       +   F  E   +    HPNV+  +GA  Q+ P 
Sbjct: 24  GELWKGRWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC-QSPPA 81
Query: 261 ---MIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++  +   G L + L +     +  S+ ++FALD ARG  +LH  +P    H  L 
Sbjct: 82  PHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA-LN 140
Query: 316 PKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD--- 372
            +++ +D     +IS    ++  + SP +            A  +VAPE  + +  D   
Sbjct: 141 SRSVXIDEDXTARISX-ADVKFSFQSPGRXY----------APAWVAPEALQKKPEDTNR 189
Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
           RS D +SF ++L+E++    PF      E+   +  EG RP +        P + +L + 
Sbjct: 190 RSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTI---PPGISPHVSKLXKI 246
Query: 433 CWDPKPVIRPNFNEIIARLDR 453
           C +  P  RP F+ I+  L++
Sbjct: 247 CXNEDPAKRPKFDXIVPILEK 267

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 4   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 63
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 123
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL        E+ K +   
Sbjct: 124 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
            +      Y+APE+   +     VD +S G I+Y ++ G      KPP E   L     K
Sbjct: 181 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG------KPPFETSCL-----K 223
Query: 412 RPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEII 448
              L+IK   Y       P    LI++     P  RP  NE++
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 41  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 97
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 98  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 154
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 155 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 211
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 212 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 267
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 268 DVENRPGFAAVELRL 282

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 8   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 67
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 68  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 127
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL        E+ K +   
Sbjct: 128 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 184
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
            +      Y+APE+   +     VD +S G I+Y ++ G      KPP E   L     K
Sbjct: 185 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG------KPPFETSCL-----K 227
Query: 412 RPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEII 448
              L+IK   Y       P    LI++     P  RP  NE++
Sbjct: 228 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 43  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 99
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 100 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 156
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 157 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 213
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 214 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 269
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 270 DVENRPGFAAVELRL 284

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 43  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 99
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 100 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 156
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 157 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 213
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 214 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 269
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 270 DVENRPGFAAVELRL 284

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++   
Sbjct: 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 164
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              ++I  FG L   + + +K K     ++      Y+APE+     +D   D +S G+I
Sbjct: 165 DANIRIIDFG-LSTHFEASKKMKDKIGTAY------YIAPEVLHG-TYDEKCDVWSTGVI 216
Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF+     +++K
Sbjct: 217 LYILLSGCPPFNGANEYDILK 237

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I+ + RHPN++           ++++LE  + G+L  +L +K  L+  +  +F   +
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G++YLH  +   I H DLKP+NI+L +      ++K+  FG+   +  +  + K +F 
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFG 173
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF  +  +E +
Sbjct: 174 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 220

>pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 38/103 (36%), Positives = 56/103 (54%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+D N+ D  GRT LH+AA  GH+E+V++LL   A+
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGADANAYDHYGRTPLHMAAAVGHLEIVEVLLRNGAD 60
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           ++A D  G+T    A   G++E+  +L   GA V     T +T
Sbjct: 61  VNAVDTNGTTPLHLAASLGHLEIVEVLLKYGADVNAKDATGIT 103

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 4   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 63
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 123
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL        E+ K +   
Sbjct: 124 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
            +      Y+APE+   +     VD +S G I+Y ++ G      KPP E   L     K
Sbjct: 181 PN------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG------KPPFETSCL-----K 223
Query: 412 RPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEII 448
              L+IK   Y       P    LI++     P  RP  NE++
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 34/286 (11%)
Query: 182 EYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           +YEL   E+    A  + + +Y   K    KV +K ++ E  K    ++    E+  + +
Sbjct: 11  DYELQ--EVIGSGATAVVQAAYCAPK--KEKVAIKRINLE--KCQTSMDELLKEIQAMSQ 64
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--------KKGRLSPSKVLRFALD 293
             HPN+V +  +      + +V++  + G +   ++        K G L  S +     +
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY----ISPEKAKIVF 349
           +  G+ YLH+   +  IH D+K  NILL   G ++I+ FG+         I+  K +  F
Sbjct: 125 VLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 350 PVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC 408
             +       ++APE+ +    +D   D +SFG+   E+  G  P+H  PP +V+ ++  
Sbjct: 182 VGT-----PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-MLTL 235
Query: 409 EGKRPPLKIKA------RSYPPDLKELIEECWDPKPVIRPNFNEII 448
           +   P L+         + Y    +++I  C    P  RP   E++
Sbjct: 236 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I+ + RHPN++           ++++LE  + G+L  +L +K  L+  +  +F   +
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G++YLH  +   I H DLKP+NI+L +      ++K+  FG+   +  +  + K +F 
Sbjct: 125 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFG 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF  +  +E +
Sbjct: 181 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I+ + RHPN++           ++++LE  + G+L  +L +K  L+  +  +F   +
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G++YLH  +   I H DLKP+NI+L +      ++K+  FG+   +  +  + K +F 
Sbjct: 139 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFG 194
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF  +  +E +
Sbjct: 195 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 241

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/257 (21%), Positives = 117/257 (45%), Gaps = 22/257 (8%)
Query: 198 ITKGSY-----QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + +GSY      + K  G  V +K +  ES      +     E++I+++   P+VV++ G
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYG 91
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIH 311
           +  +N  + IV+EY   G ++  ++ + + L+  ++        +G+ YLH  +    IH
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IH 148
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
            D+K  NILL+  G  K++ FG      ++ +    +   + +     ++APE+ +   +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFG------VAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
           +   D +S G+   EM EG  P+    P   + ++      PP   K   +  +  + ++
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT--NPPPTFRKPELWSDNFTDFVK 260
Query: 432 ECWDPKPVIRPNFNEII 448
           +C    P  R    +++
Sbjct: 261 QCLVKSPEQRATATQLL 277

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K      P++ ++   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+         +V  +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                   Y APE+     +   VD +S G I  EM 
Sbjct: 184 -------WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 385 VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 441
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 498
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 499 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 555
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 556 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 611
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 612 DVENRPGFAAVELRL 626

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 34/286 (11%)
Query: 182 EYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           +YEL   E+    A  + + +Y   K    KV +K ++ E  K    ++    E+  + +
Sbjct: 16  DYELQ--EVIGSGATAVVQAAYCAPK--KEKVAIKRINLE--KCQTSMDELLKEIQAMSQ 69
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--------KKGRLSPSKVLRFALD 293
             HPN+V +  +      + +V++  + G +   ++        K G L  S +     +
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY----ISPEKAKIVF 349
           +  G+ YLH+   +  IH D+K  NILL   G ++I+ FG+         I+  K +  F
Sbjct: 130 VLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 350 PVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC 408
             +       ++APE+ +    +D   D +SFG+   E+  G  P+H  PP +V+ ++  
Sbjct: 187 VGT-----PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-MLTL 240
Query: 409 EGKRPPLKIKA------RSYPPDLKELIEECWDPKPVIRPNFNEII 448
           +   P L+         + Y    +++I  C    P  RP   E++
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 14/255 (5%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 386 VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 442
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 443 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 499
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           N+LL      KIS FGL +         K     +H      + APE     +F    D 
Sbjct: 500 NVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDV 556
Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +SFG++++E    G +P+      EV   M  +G+R          P ++ +L+  CW  
Sbjct: 557 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTY 612
Query: 437 KPVIRPNFNEIIARL 451
               RP F  +  RL
Sbjct: 613 DVENRPGFAAVELRL 627

>pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAI 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA---NPREVPEYELNPL 188
           D  GST    A   G++E+  +L   GA V        TP+ +A      E+ E  L   
Sbjct: 77  DIXGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKH- 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
              V   D   K ++ ++  NG +   +IL K
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K      P++ ++   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+         +V  +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                   Y APE+     +   VD +S G I  EM 
Sbjct: 184 -------WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I  GSY V K         +  VKI+DK S +DP      T E+ I+ +  +HPN++   
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDK-SKRDP------TEEIEILLRYGQHPNIITLK 82
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V E    G+L   + ++   S  +       + + + YLH      ++H
Sbjct: 83  DVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139
Query: 312 CDLKPKNIL-LDNGG---QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
            DLKP NIL +D  G    ++I  FG  +   +  E   +  P      AN +VAPE+ +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLXTPCY---TAN-FVAPEVLE 193
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVV 403
            + +D + D +S G++LY  + G  PF   P   PEE++
Sbjct: 194 RQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL 232

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 33  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 87
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH ++
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRNI 143
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           K  NILL   G +K++ FG      I+PE++K     S +     ++APE+   + +   
Sbjct: 144 KSDNILLGMDGSVKLTDFGFC--AQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
           VD +S G++  EMIEG  P+  + P   + L+   G
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 233

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K      P++ ++   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+         +V  +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                   Y APE+     +   VD +S G I  EM 
Sbjct: 184 -------WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 54  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 113
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++  +
Sbjct: 114 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 170
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              ++I  FG L   + + +K K     ++      Y+APE+     +D   D +S G+I
Sbjct: 171 DANIRIIDFG-LSTHFEASKKMKDKIGTAY------YIAPEVLHG-TYDEKCDVWSTGVI 222
Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF+     +++K
Sbjct: 223 LYILLSGCPPFNGANEYDILK 243

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 132/291 (45%), Gaps = 32/291 (10%)
Query: 175 ANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
           A  R + E EL  +++    A G       V +    K+ V I        P+    F  
Sbjct: 7   AQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD 66
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E  I+    HP++V+ +G V  +  + +V +    G L  Y+ + K  +    +L + + 
Sbjct: 67  EALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ 125
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIV 348
           +A+GM YL E +   ++H DL  +N+L+ +   +KI+ FGL RL     +  + +  K+ 
Sbjct: 126 IAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM- 181
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMC 407
            P+        ++A E     +F    D +S+G+ ++E++  G +P+   P  E+  L+ 
Sbjct: 182 -PIK-------WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL- 232
Query: 408 CEGKRPPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            +G+R P        PP    D+  ++ +CW      RP F E+ A   R+
Sbjct: 233 EKGERLP-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 276

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 116/248 (46%), Gaps = 24/248 (9%)
Query: 209 NGTKVWVKILDKESHKDP-ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           +G +  +K ++K+  + P E+I A   E+ +++   HPN+++          M IV+E  
Sbjct: 46  SGLERVIKTINKDRSQVPMEQIEA---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102
Query: 268 AKGDLASYL---QKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
             G+L   +   Q +G+ LS   V      +   + Y H      ++H DLKP+NIL  +
Sbjct: 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQD 159
Query: 324 G---GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSF 380
                 +KI  FGL  L + S E +      ++     LY+APE++K  +     D +S 
Sbjct: 160 TSPHSPIKIIDFGLAEL-FKSDEHS------TNAAGTALYMAPEVFKR-DVTFKCDIWSA 211
Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           G+++Y ++ G  PF     EEV +      K P   ++ R   P   +L+++     P  
Sbjct: 212 GVVMYFLLTGCLPFTGTSLEEVQQKATY--KEPNYAVECRPLTPQAVDLLKQMLTKDPER 269
Query: 441 RPNFNEII 448
           RP+  +++
Sbjct: 270 RPSAAQVL 277

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 132/291 (45%), Gaps = 32/291 (10%)
Query: 175 ANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
           A  R + E EL  +++    A G       V +    K+ V I        P+    F  
Sbjct: 30  AQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD 89
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E  I+    HP++V+ +G V  +  + +V +    G L  Y+ + K  +    +L + + 
Sbjct: 90  EALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ 148
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIV 348
           +A+GM YL E +   ++H DL  +N+L+ +   +KI+ FGL RL     +  + +  K+ 
Sbjct: 149 IAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM- 204
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMC 407
            P+        ++A E     +F    D +S+G+ ++E++  G +P+   P  E+  L+ 
Sbjct: 205 -PIK-------WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL- 255
Query: 408 CEGKRPPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            +G+R P        PP    D+  ++ +CW      RP F E+ A   R+
Sbjct: 256 EKGERLP-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 299

>pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 85/157 (54%), Gaps = 13/157 (8%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DLL  G+D N+ D DGRT LH AA  GH E+VKLLLSK A+ +A+
Sbjct: 7   RLIEAAENGNKDRVKDLLENGADPNASDSDGRTPLHYAAENGHKEIVKLLLSKGADPNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVANPREVPEYELNPLEL 190
           D  G T    A   G+ E+  +L ++GA  P  K    RTP+  A   E    E+  L L
Sbjct: 67  DSDGRTPLHYAAENGHKEIVKLLLSKGAD-PNAKDSDGRTPLHYA--AENGHKEIVKL-L 122
Query: 191 QVRKADGITKGS-----YQVAKWNGTKVWVKILDKES 222
             + AD  T  S       +A+ +G +  VK+L+K+ 
Sbjct: 123 LSKGADPNTSDSDGRTPLDLAREHGNEEIVKLLEKQG 159

>pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAI 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA---NPREVPEYELNPL 188
           D  GST    A   G++E+  +L   GA V        TP+ +A      E+ E  L   
Sbjct: 77  DIMGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKH- 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
              V   D   K ++ ++  NG +   +IL K
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++ E  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL 337
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL   
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 338 QYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                   KI F     +I     +VAPEI   E      D +S G+I Y ++ G  PF 
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 396 PKPPEEVV 403
               +E +
Sbjct: 219 GDTKQETL 226

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQF 250
           VRK  G   G     K       V+      H   ER         ++E  R  P +V  
Sbjct: 73  VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER--------QVLEHIRQSPFLVTL 124
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             A      + ++L+Y   G+L ++L ++ R +  +V  +  ++   + +LH+     II
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GII 181
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           + D+K +NILLD+ G + ++ FGL + ++++ E  +       I+    Y+AP+I +  +
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIE----YMAPDIVRGGD 236
Query: 371 --FDRSVDAYSFGLILYEMIEGVQPF 394
              D++VD +S G+++YE++ G  PF
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 43/108 (39%), Positives = 63/108 (58%), Gaps = 3/108 (2%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D    L   A  G ++ VE LL  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+
Sbjct: 34  DGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGAD 93
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           ++A+D+ G T    A   G++E+  +L   GA V    K  +TP  +A
Sbjct: 94  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAQDKFGKTPFDLA 141

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 52/293 (17%)
Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           VP   L  LE++ R   G    +  +  +   K++  + DK+S +  ER      E+   
Sbjct: 12  VPRGSLQLLEIKARGRFGCVWKAQLMNDFVAVKIF-PLQDKQSWQS-ER------EIFST 63
Query: 240 EKARHPNVVQFVGAVTQN----IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
              +H N++QF+ A  +     + + ++  +H KG L  YL K   ++ +++   A  ++
Sbjct: 64  PGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL-KGNIITWNELCHVAETMS 122
Query: 296 RGMNYLHE----CKPD----PIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI 347
           RG++YLHE    C+ +     I H D K KN+LL +     ++ FGL     +  E  K 
Sbjct: 123 RGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGL----AVRFEPGKP 178
Query: 348 VFPVSHIDPANLYVAPEI------YKNEEFDRSVDAYSFGLILYEMI-----------EG 390
                       Y+APE+      ++ + F R +D Y+ GL+L+E++           E 
Sbjct: 179 PGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELVSRCKAADGPVDEY 237
Query: 391 VQPF------HPKPPEEVVKLMCCEGKRPPLKIKARSYP--PDLKELIEECWD 435
           + PF      HP   EE+ +++  +  RP +K     +P    L   IEECWD
Sbjct: 238 MLPFEEEIGQHPS-LEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWD 289

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 175
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
           +V+  ALD    M +         IH D+KP N+LLD  G LK++ FG      +   K 
Sbjct: 176 EVV-LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC----MKMNKE 221
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFD----RSVDAYSFGLILYEMIEGVQPFH 395
            +V   + +   + Y++PE+ K++  D    R  D +S G+ LYEM+ G  PF+
Sbjct: 222 GMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
           +V+  ALD    M +         IH D+KP N+LLD  G LK++ FG      +   K 
Sbjct: 181 EVV-LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC----MKMNKE 226
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFD----RSVDAYSFGLILYEMIEGVQPFH 395
            +V   + +   + Y++PE+ K++  D    R  D +S G+ LYEM+ G  PF+
Sbjct: 227 GMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 43/108 (39%), Positives = 63/108 (58%), Gaps = 3/108 (2%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D    L   A  G ++ VE LL  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+
Sbjct: 34  DGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGAD 93
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           ++A+D+ G T    A   G++E+  +L   GA V    K  +TP  +A
Sbjct: 94  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAQDKFGKTPFDLA 141

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+ +            +V E 
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEV 107
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + R S     R    +  G+ Y H+ K   I+H DLKP+N+LL++   
Sbjct: 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSK 164
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              ++I  FG L   + + +K K     ++      Y+APE+     +D   D +S G+I
Sbjct: 165 DANIRIIDFG-LSTHFEASKKXKDKIGTAY------YIAPEVLHG-TYDEKCDVWSTGVI 216
Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF+     +++K
Sbjct: 217 LYILLSGCPPFNGANEYDILK 237

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
           +V+  ALD    M +         IH D+KP N+LLD  G LK++ FG      +   K 
Sbjct: 181 EVV-LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC----MKMNKE 226
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFD----RSVDAYSFGLILYEMIEGVQPFH 395
            +V   + +   + Y++PE+ K++  D    R  D +S G+ LYEM+ G  PF+
Sbjct: 227 GMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  +KI+ K S        A   E+ ++++  HPN+++            +V+E 
Sbjct: 26  KLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEV 85
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + + S          +  G  YLH+     I+H DLKP+N+LL++  +
Sbjct: 86  YRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSR 142
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +KI  FG L   +    K K     ++      Y+APE+ + +++D   D +S G+I
Sbjct: 143 DALIKIVDFG-LSAHFEVGGKMKERLGTAY------YIAPEVLR-KKYDEKCDVWSCGVI 194
Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF  +  +E++K
Sbjct: 195 LYILLCGYPPFGGQTDQEILK 215

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 126/310 (40%), Gaps = 37/310 (11%)
Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKG----------SYQVA 206
           L +  A + K    P    +P+  P  E+  + +  R      +G           Y++ 
Sbjct: 3   LGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEIT 62
Query: 207 KWNGTKVWV-KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
             +  +V+  K++ K     P +    + E+ I +   +P+VV F G    +  + +VLE
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              +  L    +++  ++  +   F     +G+ YLH  +   +IH DLK  N+ L++  
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDM 179
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
            +KI  FGL        E+ K +    +      Y+APE+   +     VD +S G ILY
Sbjct: 180 DVKIGDFGLATKIEFDGERKKTLCGTPN------YIAPEVLCKKGHSFEVDIWSLGCILY 233
Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP------PDLKELIEECWDPKPV 439
            ++ G      KPP E   L     K   ++IK   Y       P    LI       P 
Sbjct: 234 TLLVG------KPPFETSCL-----KETYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 440 IRPNFNEIIA 449
           +RP+  E++ 
Sbjct: 283 LRPSVAELLT 292

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 235 ELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           E+ I+ K   HPN++Q       N    +V +   KG+L  YL +K  LS  +  +    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L   +  LH+     I+H DLKP+NILLD+   +K++ FG    Q    EK + V     
Sbjct: 133 LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG-FSCQLDPGEKLRSVCGT-- 186
Query: 354 IDPANLYVAPEIYK------NEEFDRSVDAYSFGLILYEMIEGVQPF 394
             P+  Y+APEI +      +  + + VD +S G+I+Y ++ G  PF
Sbjct: 187 --PS--YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL   +     + K +F 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFG 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF     +E +
Sbjct: 181 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 191 QVRKADGITKGSY-QVAKWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPNV 247
           Q ++ + +  G+Y  V K       V +  KE   D E     T   E++++++ +H N+
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG------RLSPSKVLRFALDLARGMNYL 301
           V+    +     + +V E+    DL  Y+  +        L  + V  F   L +G+ + 
Sbjct: 66  VRLYDVIHTENKLTLVFEF-MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-- 359
           HE K   I+H DLKP+N+L++  GQLK+  FGL R             PV+      +  
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR---------AFGIPVNTFSSEVVTL 172
Query: 360 -YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
            Y AP++   +  +  S+D +S G IL EMI G   F     EE +KL+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL   +     + K +F 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFG 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF     +E +
Sbjct: 181 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  +KI+ K S        A   E+ ++++  HPN+++            +V+E 
Sbjct: 43  KLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEV 102
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + + S          +  G  YLH+     I+H DLKP+N+LL++  +
Sbjct: 103 YRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSR 159
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +KI  FG L   +    K K     ++      Y+APE+ + +++D   D +S G+I
Sbjct: 160 DALIKIVDFG-LSAHFEVGGKMKERLGTAY------YIAPEVLR-KKYDEKCDVWSCGVI 211
Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF  +  +E++K
Sbjct: 212 LYILLCGYPPFGGQTDQEILK 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 126/310 (40%), Gaps = 37/310 (11%)
Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKG----------SYQVA 206
           L +  A + K    P    +P+  P  E+  + +  R      +G           Y++ 
Sbjct: 3   LGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEIT 62
Query: 207 KWNGTKVWV-KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
             +  +V+  K++ K     P +    + E+ I +   +P+VV F G    +  + +VLE
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              +  L    +++  ++  +   F     +G+ YLH  +   +IH DLK  N+ L++  
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDM 179
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
            +KI  FGL        E+ K +    +      Y+APE+   +     VD +S G ILY
Sbjct: 180 DVKIGDFGLATKIEFDGERKKXLCGTPN------YIAPEVLCKKGHSFEVDIWSLGCILY 233
Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP------PDLKELIEECWDPKPV 439
            ++ G      KPP E   L     K   ++IK   Y       P    LI       P 
Sbjct: 234 TLLVG------KPPFETSCL-----KETYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 440 IRPNFNEIIA 449
           +RP+  E++ 
Sbjct: 283 LRPSVAELLT 292

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 235 ELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           E+ I+ K   HPN++Q       N    +V +   KG+L  YL +K  LS  +  +    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L   +  LH+     I+H DLKP+NILLD+   +K++ FG    Q    EK + V     
Sbjct: 133 LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG-FSCQLDPGEKLREVCGT-- 186
Query: 354 IDPANLYVAPEIYK------NEEFDRSVDAYSFGLILYEMIEGVQPF 394
             P+  Y+APEI +      +  + + VD +S G+I+Y ++ G  PF
Sbjct: 187 --PS--YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 235 ELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           E+ I+ K   HPN++Q       N    +V +   KG+L  YL +K  LS  +  +    
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L   +  LH+     I+H DLKP+NILLD+   +K++ FG    Q    EK + V     
Sbjct: 120 LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG-FSCQLDPGEKLREVCGT-- 173
Query: 354 IDPANLYVAPEIYK------NEEFDRSVDAYSFGLILYEMIEGVQPF 394
             P+  Y+APEI +      +  + + VD +S G+I+Y ++ G  PF
Sbjct: 174 --PS--YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL   +     + K +F 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFG 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF     +E +
Sbjct: 181 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 115/244 (47%), Gaps = 19/244 (7%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G +V VK++D    +  +R     +E+ I+   +H NVV+   +      + +++E+
Sbjct: 67  KHSGRQVAVKMMDL---RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   + +  RL+  ++      + + + YLH      +IH D+K  +ILL   G+
Sbjct: 124 LQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGR 179
Query: 327 LKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           +K+S FG   ++    P++  +V           ++APE+     +   VD +S G+++ 
Sbjct: 180 VKLSDFGFCAQISKDVPKRKXLV-------GTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK-ARSYPPDLKELIEECWDPKPVIRPNF 444
           EM++G  P+    P + +K +      PP K+K +    P L++ +E      P  R   
Sbjct: 233 EMVDGEPPYFSDSPVQAMKRL---RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATA 289
Query: 445 NEII 448
            E++
Sbjct: 290 QELL 293

>pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 7/152 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G+T LH+AA +GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNAEDDSGKTPLHLAAIKGHLEIVEVLLKHGADVNAA 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTV---ANPREVPEYELNPL 188
           D+ G T    A  YG++E+  +L   GA V  T     TP+ +   A   E+ E  L   
Sbjct: 77  DKMGDTPLHLAALYGHLEIVEVLLKNGADVNATDTYGFTPLHLAADAGHLEIVEVLL-KY 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
              V   D   K ++ ++  NG +   +IL K
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL   +     + K +F 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFG 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF     +E +
Sbjct: 181 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRLQYISPEKAKIVFP 350
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL   +     + K +F 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFG 180
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                    +VAPEI   E      D +S G+I Y ++ G  PF     +E +
Sbjct: 181 TPE------FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L+KE    P   +    E++I+++ +H N+V+    +     +++V E H   DL   L 
Sbjct: 36  LEKEDEGIP---STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLLD 91
Query: 278 K-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
Query: 337 LQYISPEKAKIVFPVSHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
              I   K       +H      Y AP++   ++++  ++D +S G I  EM+ G  P  
Sbjct: 149 AFGIPVRK------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLF 201
Query: 396 PKPPE 400
           P   E
Sbjct: 202 PGVSE 206

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 126/310 (40%), Gaps = 37/310 (11%)
Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKG----------SYQVA 206
           L +  A + K    P    +P+  P  E+  + +  R      +G           Y++ 
Sbjct: 3   LGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEIT 62
Query: 207 KWNGTKVWV-KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
             +  +V+  K++ K     P +    + E+ I +   +P+VV F G    +  + +VLE
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              +  L    +++  ++  +   F     +G+ YLH  +   +IH DLK  N+ L++  
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDM 179
Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
            +KI  FGL        E+ K +    +      Y+APE+   +     VD +S G ILY
Sbjct: 180 DVKIGDFGLATKIEFDGERKKDLCGTPN------YIAPEVLCKKGHSFEVDIWSLGCILY 233
Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP------PDLKELIEECWDPKPV 439
            ++ G      KPP E   L     K   ++IK   Y       P    LI       P 
Sbjct: 234 TLLVG------KPPFETSCL-----KETYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 440 IRPNFNEIIA 449
           +RP+  E++ 
Sbjct: 283 LRPSVAELLT 292

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L+KE    P   +    E++I+++ +H N+V+    +     +++V E H   DL   L 
Sbjct: 36  LEKEDEGIP---STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLLD 91
Query: 278 K-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
Query: 337 LQYISPEKAKIVFPVSHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
              I   K       +H      Y AP++   ++++  ++D +S G I  EM+ G  P  
Sbjct: 149 AFGIPVRK------YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLF 201
Query: 396 PKPPE 400
           P   E
Sbjct: 202 PGVSE 206

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L+KE    P   +    E++I+++ +H N+V+    +     +++V E H   DL   L 
Sbjct: 36  LEKEDEGIP---STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLLD 91
Query: 278 K-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
Query: 337 LQYISPEKAKIVFPVSHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
              I   K       +H      Y AP++   ++++  ++D +S G I  EM+ G  P  
Sbjct: 149 AFGIPVRK------YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGA-PLF 201
Query: 396 PKPPE 400
           P   E
Sbjct: 202 PGVSE 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 126/275 (45%), Gaps = 34/275 (12%)
Query: 198 ITKGSYQVAKWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV- 254
           + +G+ +       KV VK   LD  S ++   I  F  E   ++   HPNV++ +G   
Sbjct: 50  VMEGNLKQEDGTSLKVAVKTMKLDNSSQRE---IEEFLSEAACMKDFSHPNVIRLLGVCI 106
Query: 255 ---TQNIPM-MIVLEYHAKGDLASYL-QKKGRLSPSKV-----LRFALDLARGMNYLHEC 304
              +Q IP  M++L +   GDL +YL   +    P  +     L+F +D+A GM YL   
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP--EKAKIV-FPVSHIDPANLYV 361
                +H DL  +N +L +   + ++ FGL +  Y      + +I   PV        ++
Sbjct: 167 N---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-------WI 216
Query: 362 APEIYKNEEFDRSVDAYSFGLILYEM-IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
           A E   +  +    D ++FG+ ++E+   G+ P+      E+   +   G R  LK +  
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HGHR--LK-QPE 272
Query: 421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
               +L E++  CW   P+ RP F+ +  +L++++
Sbjct: 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 126/264 (47%), Gaps = 29/264 (10%)
Query: 198 ITKGSYQVAKWNGTKV--WVKILDKESHKDPERINAFTH----ELTIVEKARHPNVVQFV 251
           + KG+Y +  + G  +   V+I  KE    PER + ++     E+ + +  +H N+VQ++
Sbjct: 30  LGKGTYGIV-YAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSK--VLRFALDLARGMNYLHECKPDP 308
           G+ ++N  + I +E    G L++ L+ K G L  ++  +  +   +  G+ YLH+   + 
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 309 IIHCDLKPKNILLDN-GGQLKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
           I+H D+K  N+L++   G LKIS FG   RL  I+P        +        Y+APEI 
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-------YMAPEII 195
Query: 367 KN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
                 + ++ D +S G  + EM  G  PF+     +         K  P   ++ S   
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS--A 253
Query: 425 DLKELIEECWDPKPVIRPNFNEII 448
           + K  I +C++P P  R   N+++
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLL 277

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 168 KRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWV-KILDKESHKDP 226
           K  P  + +PR +  Y    +  +     G  K  Y++   +  +V+  K++ K     P
Sbjct: 13  KEIPDVLVDPRTMKRY----MRGRFLGKGGFAK-CYEITDMDTKEVFAGKVVPKSMLLKP 67
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
            +    + E+ I +   +P+VV F G    +  + +VLE   +  L    +++  ++  +
Sbjct: 68  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPE 127
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
              F     +G+ YLH  +   +IH DLK  N+ L++   +KI  FGL        E+ K
Sbjct: 128 ARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK 184
Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
            +    +      Y+APE+   +     VD +S G ILY ++ G      KPP E   L 
Sbjct: 185 DLCGTPN------YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG------KPPFETSCL- 231
Query: 407 CCEGKRPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEIIA 449
               K   ++IK   Y       P    LI       P +RP+  E++ 
Sbjct: 232 ----KETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLT 276

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 19/174 (10%)
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE--- 343
           ++ ++  +ARGM +L   K    IH DL  +NILL     +KI  FGL R  Y +P+   
Sbjct: 201 LISYSFQVARGMEFLSSRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR 257
Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEV 402
           K     P+        ++APE   ++ +    D +S+G++L+E+   G  P+     +E 
Sbjct: 258 KGDTRLPLK-------WMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDED 310
Query: 403 VKLMCCEGKRPPLKIKARSYP-PDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
                C   R  ++++A  Y  P++ +++ +CW   P  RP F E++ +L  ++
Sbjct: 311 F----CSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLL 360

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 13/164 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++  HPN++  + A      + +V ++  + DL   ++     L+PS +  + L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDF-METDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
             +G+ YLH+     I+H DLKP N+LLD  G LK++ FGL +  + SP +A       H
Sbjct: 121 TLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRA-----YXH 171
Query: 354 IDPANLYVAPE-IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y APE ++    +   VD ++ G IL E++  V PF P
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLP 214

>pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 40/87 (45%), Positives = 57/87 (65%), Gaps = 1/87 (1%)
Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
           + G T    A   G++EV  +L   GA
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGA 92

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 122/244 (50%), Gaps = 16/244 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K+++ +S +  +   A T  +  +    H ++V+ +G +     + +V +Y   G L
Sbjct: 45  VCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSL 101
Query: 273 ASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             ++ Q +G L P  +L + + +A+GM YL E     ++H +L  +N+LL +  Q++++ 
Sbjct: 102 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVAD 158
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           FG+  L  + P+  ++++  S       ++A E     ++    D +S+G+ ++E++  G
Sbjct: 159 FGVADL--LPPDDKQLLY--SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
            +P+      EV  L+  +G+R     + +    D+  ++ +CW     IRP F E+   
Sbjct: 215 AEPYAGLRLAEVPDLL-EKGER---LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270
Query: 451 LDRI 454
             R+
Sbjct: 271 FTRM 274

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/261 (22%), Positives = 115/261 (44%), Gaps = 21/261 (8%)
Query: 195 ADGITKGSYQVA-KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA 253
            DG     Y+   K  G     K+++ +S    E +  +  E+ I+    HP +V+ +GA
Sbjct: 28  GDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
              +  + I++E+   G + + + +  R L+  ++      +   +N+LH  +   IIH 
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHR 141
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI-----YK 367
           DLK  N+L+   G ++++ FG      +S +  K +           ++APE+      K
Sbjct: 142 DLKAGNVLMTLEGDIRLADFG------VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
           +  +D   D +S G+ L EM +   P H   P  V  L+      PP  +    +  + +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSDPPTLLTPSKWSVEFR 253
Query: 428 ELIEECWDPKPVIRPNFNEII 448
           + ++   D  P  RP+  +++
Sbjct: 254 DFLKIALDKNPETRPSAAQLL 274

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 122/244 (50%), Gaps = 16/244 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K+++ +S +  +   A T  +  +    H ++V+ +G +     + +V +Y   G L
Sbjct: 63  VCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSL 119
Query: 273 ASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             ++ Q +G L P  +L + + +A+GM YL E     ++H +L  +N+LL +  Q++++ 
Sbjct: 120 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVAD 176
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G 390
           FG+  L  + P+  ++++  S       ++A E     ++    D +S+G+ ++E++  G
Sbjct: 177 FGVADL--LPPDDKQLLY--SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 232
Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
            +P+      EV  L+  +G+R     + +    D+  ++ +CW     IRP F E+   
Sbjct: 233 AEPYAGLRLAEVPDLL-EKGER---LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 288
Query: 451 LDRI 454
             R+
Sbjct: 289 FTRM 292

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 10/173 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L++  R+    + +
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            ++ + RG+ YL E     I+H D+KP NIL+++ G++K+  FG +  Q I       V 
Sbjct: 119 VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFG-VSGQLIDSMANSFVG 175
Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
             S       Y+APE  +   +    D +S GL L E+  G  P  P   +E+
Sbjct: 176 TRS-------YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKEL 221

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 126/264 (47%), Gaps = 29/264 (10%)
Query: 198 ITKGSYQVAKWNGTKV--WVKILDKESHKDPERINAFTH----ELTIVEKARHPNVVQFV 251
           + KG+Y +  + G  +   V+I  KE    PER + ++     E+ + +  +H N+VQ++
Sbjct: 16  LGKGTYGIV-YAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSK--VLRFALDLARGMNYLHECKPDP 308
           G+ ++N  + I +E    G L++ L+ K G L  ++  +  +   +  G+ YLH+   + 
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 128
Query: 309 IIHCDLKPKNILLDN-GGQLKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIY 366
           I+H D+K  N+L++   G LKIS FG   RL  I+P        +        Y+APEI 
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-------YMAPEII 181
Query: 367 KN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
                 + ++ D +S G  + EM  G  PF+     +         K  P   ++ S   
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS--A 239
Query: 425 DLKELIEECWDPKPVIRPNFNEII 448
           + K  I +C++P P  R   N+++
Sbjct: 240 EAKAFILKCFEPDPDKRACANDLL 263

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/261 (22%), Positives = 115/261 (44%), Gaps = 21/261 (8%)
Query: 195 ADGITKGSYQVA-KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA 253
            DG     Y+   K  G     K+++ +S    E +  +  E+ I+    HP +V+ +GA
Sbjct: 20  GDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
              +  + I++E+   G + + + +  R L+  ++      +   +N+LH  +   IIH 
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHR 133
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI-----YK 367
           DLK  N+L+   G ++++ FG      +S +  K +           ++APE+      K
Sbjct: 134 DLKAGNVLMTLEGDIRLADFG------VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
           +  +D   D +S G+ L EM +   P H   P  V  L+      PP  +    +  + +
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSDPPTLLTPSKWSVEFR 245
Query: 428 ELIEECWDPKPVIRPNFNEII 448
           + ++   D  P  RP+  +++
Sbjct: 246 DFLKIALDKNPETRPSAAQLL 266

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
               RG+++LH    + I+H DLKP+NIL+ +GG +K++ FGL R+       A +V  +
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                   Y APE+     +   VD +S G I  EM 
Sbjct: 176 -------WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 17/196 (8%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIV 263
           ++K  G +   K L K       R     HE+ ++E A+  P V+           ++++
Sbjct: 49  ISKSTGQEYAAKFLKKRRRGQDCRAEIL-HEIAVLELAKSCPRVINLHEVYENTSEIILI 107
Query: 264 LEYHAKGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           LEY A G++ S    +    +S + V+R    +  G+ YLH+   + I+H DLKP+NILL
Sbjct: 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILL 164
Query: 322 DN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
            +    G +KI  FG+ R       K      +  I     Y+APEI   +    + D +
Sbjct: 165 SSIYPLGDIKIVDFGMSR-------KIGHACELREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 379 SFGLILYEMIEGVQPF 394
           + G+I Y ++    PF
Sbjct: 218 NIGIIAYMLLTHTSPF 233

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 17/241 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 55  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 111
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 112 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 167
Query: 329 ISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           +S FG   ++    P +  +V           ++APE+     +   VD +S G+++ EM
Sbjct: 168 LSDFGFCAQVSKEVPRRKXLV-------GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 220
Query: 388 IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++G  P+  +PP + +K++      PP         P LK  ++      P  R    E+
Sbjct: 221 VDGEPPYFNEPPLKAMKMI--RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 278
Query: 448 I 448
           +
Sbjct: 279 L 279

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 17/241 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 48  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 104
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 105 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 160
Query: 329 ISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           +S FG   ++    P +  +V           ++APE+     +   VD +S G+++ EM
Sbjct: 161 LSDFGFCAQVSKEVPRRKXLV-------GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 213
Query: 388 IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++G  P+  +PP + +K++      PP         P LK  ++      P  R    E+
Sbjct: 214 VDGEPPYFNEPPLKAMKMI--RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 271
Query: 448 I 448
           +
Sbjct: 272 L 272

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 250
Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y  P+   K     P+        ++APE   +  +    D +SFG++L+E+   G  P+
Sbjct: 251 YKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 303
Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKELIEECWDPKPVIRPNFNEIIARLDR 453
               P   +    C   +   +++A  Y  P++ + + +CW  +P  RP F+E++  L  
Sbjct: 304 ----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 359
Query: 454 IVCNCSKQ 461
           ++   ++Q
Sbjct: 360 LLQANAQQ 367

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 19/188 (10%)
Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 248
Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y  P+   K     P+        ++APE   +  +    D +SFG++L+E+   G  P+
Sbjct: 249 YKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 301
Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKELIEECWDPKPVIRPNFNEIIARLDR 453
               P   +    C   +   +++A  Y  P++ + + +CW  +P  RP F+E++  L  
Sbjct: 302 ----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 357
Query: 454 IVCNCSKQ 461
           ++   ++Q
Sbjct: 358 LLQANAQQ 365

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 17/241 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 53  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 109
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 110 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 165
Query: 329 ISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           +S FG   ++    P +  +V           ++APE+     +   VD +S G+++ EM
Sbjct: 166 LSDFGFCAQVSKEVPRRKXLV-------GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 218
Query: 388 IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++G  P+  +PP + +K++      PP         P LK  ++      P  R    E+
Sbjct: 219 VDGEPPYFNEPPLKAMKMI--RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 276
Query: 448 I 448
           +
Sbjct: 277 L 277

>pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 36/83 (43%), Positives = 56/83 (67%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RG ++ VE LL  G+DVN+ D+ GRT LH+AA  GH+E+V++LL   A+++A+D
Sbjct: 51  LHLAAKRGHLEIVEVLLKHGADVNASDIWGRTPLHLAATVGHLEIVEVLLEYGADVNAQD 110
Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 111 KFGKTAFDISIDNGNEDLAEILQ 133

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 17/241 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 44  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 101 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 156
Query: 329 ISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           +S FG   ++    P +  +V           ++APE+     +   VD +S G+++ EM
Sbjct: 157 LSDFGFCAQVSKEVPRRKXLV-------GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 388 IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++G  P+  +PP + +K++      PP         P LK  ++      P  R    E+
Sbjct: 210 VDGEPPYFNEPPLKAMKMI--RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267
Query: 448 I 448
           +
Sbjct: 268 L 268

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 85/174 (48%), Gaps = 14/174 (8%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           +E+++++   HPN+++            +V E++  G+L   +  + +            
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL---KISGFGLLRLQYISPEKAKIVFP 350
           +  G+ YLH      I+H D+KP+NILL+N   L   KI  FGL    + S +     + 
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGL--SSFFSKD-----YK 204
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
           +        Y+APE+ K ++++   D +S G+I+Y ++ G  PF  +  ++++K
Sbjct: 205 LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257

>pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 55/94 (58%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D    L   A  G ++ VE LL  G+DVN+ DL G T LH+AA  GH+E+V++LL   A+
Sbjct: 46  DGYTPLHLAASNGHLEIVEVLLKNGADVNASDLTGITPLHLAAATGHLEIVEVLLKHGAD 105
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A D  G T    A  YG++E+  +L   GA V
Sbjct: 106 VNAYDNDGHTPLHLAAKYGHLEIVEVLLKHGADV 139

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY  K DL  YL   G + +   V  F   
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L RG+ Y H  K   ++H DLKP+N+L++  G+LK++ FGL R + I         P   
Sbjct: 109 LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI---------PTKT 156
Query: 354 IDPANL---YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
            D   +   Y  P+I   + ++   +D +  G I YEM  G +P  P
Sbjct: 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFP 202

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 19/182 (10%)
Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 241
Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y  P+   K     P+        ++APE   +  +    D +SFG++L+E+   G  P+
Sbjct: 242 YKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 294
Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKELIEECWDPKPVIRPNFNEIIARLDR 453
               P   +    C   +   +++A  Y  P++ + + +CW  +P  RP F+E++  L  
Sbjct: 295 ----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 350
Query: 454 IV 455
           ++
Sbjct: 351 LL 352

>pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 56/99 (56%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A++DA 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDAS 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           D +G T    A Y+G++E+  +L   GA V       MT
Sbjct: 77  DVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMT 115

>pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 36/83 (43%), Positives = 56/83 (67%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RG ++ VE LL  G+DVN+ D+ GRT LH+AA  GH+E+V++LL   A+++A+D
Sbjct: 51  LHLAAKRGHLEIVEVLLKHGADVNARDIWGRTPLHLAATVGHLEIVEVLLEYGADVNAQD 110
Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 111 KFGKTAFDISIDNGNEDLAEILQ 133

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 19/182 (10%)
Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y  P+   K     P+        ++APE   +  +    D +SFG++L+E+   G  P+
Sbjct: 244 YKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSY-PPDLKELIEECWDPKPVIRPNFNEIIARLDR 453
               P   +    C   +   +++A  Y  P++ + + +CW  +P  RP F+E++  L  
Sbjct: 297 ----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352
Query: 454 IV 455
           ++
Sbjct: 353 LL 354

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 17/241 (7%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 98  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 155 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 210
Query: 329 ISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           +S FG   ++    P +  +V           ++APE+     +   VD +S G+++ EM
Sbjct: 211 LSDFGFCAQVSKEVPRRKXLVG-------TPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263
Query: 388 IEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++G  P+  +PP + +K++      PP         P LK  ++      P  R    E+
Sbjct: 264 VDGEPPYFNEPPLKAMKMI--RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 321
Query: 448 I 448
           +
Sbjct: 322 L 322

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 110/245 (44%), Gaps = 17/245 (6%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             + +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+
Sbjct: 171 TVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E+   G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + 
Sbjct: 228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHD 283
Query: 325 GQLKISGFGLL-RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
           G++K+S FG   ++    P +  +V           ++APE+     +   VD +S G++
Sbjct: 284 GRVKLSDFGFCAQVSKEVPRRKXLVG-------TPYWMAPELISRLPYGPEVDIWSLGIM 336
Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           + EM++G  P+  +PP + +K++      PP         P LK  ++      P  R  
Sbjct: 337 VIEMVDGEPPYFNEPPLKAMKMI--RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 394
Query: 444 FNEII 448
             E++
Sbjct: 395 AAELL 399

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 235 ELTIVEKARHPNVV---QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
           E+ I+ + RH N++     + A T      + L  H  G     L K   LS   +  F 
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 150
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
             + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F  
Sbjct: 151 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLT 205
Query: 352 SHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
            ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 206 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 249

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+    Y+    +G KV +K    ES +  E        L+     RHP++V  +G   +
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF---CRHPHLVSLIGFCDE 106
Query: 257 NIPMMIVLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
              M+++ +Y   G+L  +L         +S  + L   +  ARG++YLH      IIH 
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHR 163
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH----IDPANLYVAPEIYKN 368
           D+K  NILLD     KI+ FG+         K       +H    +     Y+ PE +  
Sbjct: 164 DVKSINILLDENFVPKITDFGI--------SKKGTELDQTHLXXVVKGTLGYIDPEYFIK 215
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
                  D YSFG++L+E++          P E+V L
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+    Y+    +G KV +K    ES +  E        L+     RHP++V  +G   +
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF---CRHPHLVSLIGFCDE 106
Query: 257 NIPMMIVLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
              M+++ +Y   G+L  +L         +S  + L   +  ARG++YLH      IIH 
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHR 163
Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH----IDPANLYVAPEIYKN 368
           D+K  NILLD     KI+ FG+         K       +H    +     Y+ PE +  
Sbjct: 164 DVKSINILLDENFVPKITDFGI--------SKKGTELGQTHLXXVVKGTLGYIDPEYFIK 215
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
                  D YSFG++L+E++          P E+V L
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 15/169 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF- 290
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +       P K  +F 
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY 179
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
             ++   ++ +H      +IH D+KP N+LLD  G LK++ FG      +  ++  +V  
Sbjct: 180 TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC----MKMDETGMVHC 232
Query: 351 VSHIDPANLYVAPEIYKNEEFD----RSVDAYSFGLILYEMIEGVQPFH 395
            + +   + Y++PE+ K++  D    R  D +S G+ L+EM+ G  PF+
Sbjct: 233 DTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
            G+ ++H      +++ DLKP NILLD  G ++IS  GL         K K   P + + 
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKK---PHASVG 352
Query: 356 PANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPFH---PKPPEEVVKLMCCEGK 411
               Y+APE+  K   +D S D +S G +L++++ G  PF     K   E+ ++      
Sbjct: 353 THG-YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 412 RPPLKIKARSYPPDLKELIE 431
             P      S+ P+L+ L+E
Sbjct: 412 ELP-----DSFSPELRSLLE 426

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
            G+ ++H      +++ DLKP NILLD  G ++IS  GL         K K   P + + 
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKK---PHASVG 352
Query: 356 PANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPFH---PKPPEEVVKLMCCEGK 411
               Y+APE+  K   +D S D +S G +L++++ G  PF     K   E+ ++      
Sbjct: 353 THG-YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 412 RPPLKIKARSYPPDLKELIE 431
             P      S+ P+L+ L+E
Sbjct: 412 ELP-----DSFSPELRSLLE 426

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
            G+ ++H      +++ DLKP NILLD  G ++IS  GL         K K   P + + 
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKK---PHASVG 352
Query: 356 PANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPFH---PKPPEEVVKLMCCEGK 411
               Y+APE+  K   +D S D +S G +L++++ G  PF     K   E+ ++      
Sbjct: 353 THG-YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 412 RPPLKIKARSYPPDLKELIE 431
             P      S+ P+L+ L+E
Sbjct: 412 ELP-----DSFSPELRSLLE 426

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
            G+ ++H      +++ DLKP NILLD  G ++IS  GL         K K   P + + 
Sbjct: 302 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKK---PHASVG 351
Query: 356 PANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEGVQPFH---PKPPEEVVKLMCCEGK 411
               Y+APE+  K   +D S D +S G +L++++ G  PF     K   E+ ++      
Sbjct: 352 THG-YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 410
Query: 412 RPPLKIKARSYPPDLKELIE 431
             P      S+ P+L+ L+E
Sbjct: 411 ELP-----DSFSPELRSLLE 425

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
               RG+++LH    + I+H DLKP+NIL+ +GG +K++ FGL R+         +V  +
Sbjct: 127 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                   Y APE+     +   VD +S G I  EM 
Sbjct: 184 -------WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
               RG+++LH    + I+H DLKP+NIL+ +GG +K++ FGL R+          +FPV
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALFPV 171
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                   Y APE+     +   VD +S G I  EM 
Sbjct: 172 VV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTH------ELTIVEKARH 244
           + I  G+Y V      +  G +V +K       K P   +  T+      EL I++  +H
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKH 113
Query: 245 PNVVQFVGAVTQNIP------MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
            N++     +   +P      + +VL+   + DL   +     L+   V  F   L RG+
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDL-MESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
            Y+H  +   +IH DLKP N+L++   +LKI  FG+ R    SP + +  + ++      
Sbjct: 173 KYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ--YFMTEYVATR 227
Query: 359 LYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF 394
            Y APE+  +  E+ +++D +S G I  EM+   Q F
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 264

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS----KVLRF 290
           E  I+ K     +V    A      + +V+     GD+  ++      +P     + + +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              +  G+ +LH+     II+ DLKP+N+LLD+ G ++IS  GL         K K    
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
                    ++APE+   EE+D SVD ++ G+ LYEMI    PF  +
Sbjct: 352 TPG------FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 109/243 (44%), Gaps = 32/243 (13%)
Query: 196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTH------ELTIVEKARH 244
           + I  G+Y V      +  G +V +K       K P   +  T+      EL I++  +H
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKH 112
Query: 245 PNVVQFVGAVTQNIP------MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
            N++     +   +P      + +VL+   + DL   +     L+   V  F   L RG+
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDL-MESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
            Y+H  +   +IH DLKP N+L++   +LKI  FG+ R    SP + +  + ++      
Sbjct: 172 KYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ--YFMTEYVATR 226
Query: 359 LYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL-MCCEGKRPPLK 416
            Y APE+  +  E+ +++D +S G I  EM+   Q F  K     ++L M   G   P  
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286
Query: 417 IKA 419
           I+A
Sbjct: 287 IQA 289

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS----KVLRF 290
           E  I+ K     +V    A      + +V+     GD+  ++      +P     + + +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              +  G+ +LH+     II+ DLKP+N+LLD+ G ++IS  GL         K K    
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
                    ++APE+   EE+D SVD ++ G+ LYEMI    PF  +
Sbjct: 352 TPG------FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS----KVLRF 290
           E  I+ K     +V    A      + +V+     GD+  ++      +P     + + +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              +  G+ +LH+     II+ DLKP+N+LLD+ G ++IS  GL         K K    
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
                    ++APE+   EE+D SVD ++ G+ LYEMI    PF  +
Sbjct: 352 TPG------FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS----KVLRF 290
           E  I+ K     +V    A      + +V+     GD+  ++      +P     + + +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              +  G+ +LH+     II+ DLKP+N+LLD+ G ++IS  GL         K K    
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
                    ++APE+   EE+D SVD ++ G+ LYEMI    PF  +
Sbjct: 352 TPG------FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 36/83 (43%), Positives = 55/83 (66%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RG ++ VE LL  G+DVN+ D  GRT LH+AA  GH+E+V++LL   A+++A+D
Sbjct: 51  LHLAAKRGHLEIVEVLLKHGADVNASDSWGRTPLHLAATVGHLEIVEVLLEYGADVNAQD 110
Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 111 KFGKTAFDISIDNGNEDLAEILQ 133

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 21/195 (10%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    VK + K++ K  E  ++  +E+ ++ K +H N+V           + +V++ 
Sbjct: 44  KATGKLFAVKCIPKKALKGKE--SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQL 101
Query: 267 HAKGDLASYLQKKGRLS---PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-- 321
            + G+L   + +KG  +    S ++R  LD    + YLH      I+H DLKP+N+L   
Sbjct: 102 VSGGELFDRIVEKGFYTEKDASTLIRQVLD---AVYYLHRM---GIVHRDLKPENLLYYS 155
Query: 322 -DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSF 380
            D   ++ IS FGL ++     E    V   +   P   YVAPE+   + + ++VD +S 
Sbjct: 156 QDEESKIMISDFGLSKM-----EGKGDVMSTACGTPG--YVAPEVLAQKPYSKAVDCWSI 208
Query: 381 GLILYEMIEGVQPFH 395
           G+I Y ++ G  PF+
Sbjct: 209 GVIAYILLCGYPPFY 223

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V E+    DL  Y     G L P  V  F   
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L +G+ +   C    ++H DLKP+N+L++  G+LK++ FGL R   I             
Sbjct: 110 LLKGLGF---CHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLW 166
Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
             P ++    ++Y       S+D +S G I  E+    +P  P
Sbjct: 167 YRPPDVLFGAKLYST-----SIDMWSAGCIFAELANAARPLFP 204

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 135/307 (43%), Gaps = 24/307 (7%)
Query: 172 MTVANPREVPEYELNPLELQVRKADGITKGSYQVA-KWNGTKVWVKILDKESHKDPERIN 230
           +T+   R   + E+N LE       G     +++  +  G  + VK + +  +K+  +  
Sbjct: 13  LTIGGQRY--QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-- 68
Query: 231 AFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVL 288
               +L +V K+   P +VQ  G    N  + I +E    G  A  L+K+ +   P ++L
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERIL 126
Query: 289 -RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI 347
            +  + + + + YL E     +IH D+KP NILLD  GQ+K+  FG+         K + 
Sbjct: 127 GKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184
Query: 348 VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLM 406
               +++ P    + P      ++D   D +S G+ L E+  G  P+ + K   EV+  +
Sbjct: 185 AGCAAYMAPER--IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI-----IARLDRIVCNCSKQ 461
             E   PPL      +  D +  +++C       RP +N++     I R + +  + +  
Sbjct: 243 LQE--EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVAS- 299
Query: 462 GWWKDTF 468
            W+KD  
Sbjct: 300 -WFKDVM 305

>pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D+ G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGRDDEVRILMANGADVNAADVVGWTPLHLAAYWGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPR---EVPEYE 184
           ++A D  GST    A ++G++E+  +L   GA V        TP+ +A  R   E+ E  
Sbjct: 73  VNAYDTLGSTPLHLAAHFGHLEIVEVLLKNGADVNAKDDNGITPLHLAANRGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 L-KYGADVNAQDKFGKTAFDISINNGNEDLAEILQK 167

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
               RG+++LH    + I+H DLKP+NIL+ +GG +K++ FGL R+         +V  +
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTL 175
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
                   Y APE+     +   VD +S G I  EM 
Sbjct: 176 -------WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 6/233 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KI++K        ++ F  E  ++       + Q   A      + +V+EY
Sbjct: 83  KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
           +  GDL + L K G   P+++ RF L ++   ++ +H       +H D+KP NILLD  G
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199
Query: 326 QLKISGFG-LLRLQYISPEKAKIVFPV-SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
            ++++ FG  L+L+     ++ +      ++ P  L           +    D ++ G+ 
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259
Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
            YEM  G  PF+     E    +    +   L +     P + ++ I+    P
Sbjct: 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCP 312

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
           E Q+++ DG           +  KV VK+L  +     + I  F  E   +++  HP+V 
Sbjct: 41  EAQLKQEDG-----------SFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVA 88
Query: 249 QFVGAVTQN-----IPM-MIVLEYHAKGDLASYL------QKKGRLSPSKVLRFALDLAR 296
           + VG   ++     +P+ M++L +   GDL ++L      +    L    ++RF +D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSH 353
           GM YL        IH DL  +N +L     + ++ FGL R  Y      +      PV  
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204
Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE-MIEGVQPFHPKPPEEVVKLMCCEG-- 410
                 ++A E   +  +    D ++FG+ ++E M  G  P+      E+   +      
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258
Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
           K+PP  ++      ++ +L+ +CW   P  RP+F  +   L+ I+ + S
Sbjct: 259 KQPPECME------EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 87/180 (48%), Gaps = 15/180 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ ++ +  HPN+++          + +VLE    G+L   + +KG  S          +
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPV 351
              + YLHE   + I+H DLKP+N+L         LKI+ FGL ++      + +++   
Sbjct: 158 LEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-----EHQVLMKT 209
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV--KLMCCE 409
               P   Y APEI +   +   VD +S G+I Y ++ G +PF+ +  ++ +  +++ CE
Sbjct: 210 VCGTPG--YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 114/256 (44%), Gaps = 20/256 (7%)
Query: 197 GITKGSYQVAKWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           G   G Y+    + G +V +K++DK++      +    +E+ I  + +HP++++      
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 256 QNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
            +  + +VLE    G++  YL+ + +  S ++   F   +  GM YLH      I+H DL
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDL 138
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
              N+LL     +KI+ FGL     +  EK   +    +      Y++PEI         
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN------YISPEIATRSAHGLE 192
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPP-LKIKARSYPPDLKELIEE 432
            D +S G + Y ++ G  PF     +  + K++  + + P  L I+A       K+LI +
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA-------KDLIHQ 245
Query: 433 CWDPKPVIRPNFNEII 448
                P  R + + ++
Sbjct: 246 LLRRNPADRLSLSSVL 261

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 114/254 (44%), Gaps = 30/254 (11%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA-VTQNIPMM----- 261
            G    +K++D    ++ E       E+ +++K + H N+  + GA + +N P M     
Sbjct: 48  TGQLAAIKVMDVTGDEEEE----IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103
Query: 262 IVLEYHAKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           +V+E+   G +   ++  K   L    +     ++ RG+++LH+ K   +IH D+K +N+
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV 160
Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-----FDRS 374
           LL    ++K+  FG      +S +  + V   +       ++APE+   +E     +D  
Sbjct: 161 LLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK 214
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECW 434
            D +S G+   EM EG  P     P   + L+    + P  ++K++ +    +  IE C 
Sbjct: 215 SDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPAPRLKSKKWSKKFQSFIESCL 271
Query: 435 DPKPVIRPNFNEII 448
                 RP   +++
Sbjct: 272 VKNHSQRPATEQLM 285

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 17/230 (7%)
Query: 209 NGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N  KV+ +KIL+K           F  E  ++       +     A   +  + +V++Y+
Sbjct: 97  NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156
Query: 268 AKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             GDL + L K     P ++ RF L ++   ++ +H+      +H D+KP NIL+D  G 
Sbjct: 157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213
Query: 327 LKISGFG-LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-----FDRSVDAYSF 380
           ++++ FG  L+L     E   +   V+   P   Y++PEI +  E     +    D +S 
Sbjct: 214 IRLADFGSCLKLM----EDGTVQSSVAVGTPD--YISPEILQAMEGGKGRYGPECDWWSL 267
Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
           G+ +YEM+ G  PF+ +   E    +    +R     +      + K+LI
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E H   DL +++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-HVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 171
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 7/154 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYE 184
           ++A+D+ G T    A   G++E+  +L   GA V    K   TP+ +A      E+ E  
Sbjct: 73  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL 218
           L      V   D   K ++ ++  NG +   +IL
Sbjct: 133 LKA-GADVNAQDKFGKTAFDISIDNGNEDLAEIL 165

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V E+    DL  Y     G L P  V  F   
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L +G+ +   C    ++H DLKP+N+L++  G+LK++ FGL R   I             
Sbjct: 110 LLKGLGF---CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
             P ++    ++Y       S+D +S G I  E+    +P  P
Sbjct: 167 YRPPDVLFGAKLYST-----SIDMWSAGCIFAELANAGRPLFP 204

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 107/259 (41%), Gaps = 33/259 (12%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   ++++G L   +
Sbjct: 127 RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR 186
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLRLQYISPEK- 344
            L +      G+ YLH  +   I+H D+K  N+LL  +G    +  FG      + P+  
Sbjct: 187 ALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGL 241
Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
            K +    +I     ++APE+      D  VD +S   ++  M+ G  P+          
Sbjct: 242 GKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW---------- 291
Query: 405 LMCCEGKRPPLKIKARSYPPDLKEL-----------IEECWDPKPVIRPNFNEIIARLDR 453
               +  R PL +K  S PP ++E+           I+E    +P+ R +  E+  +++R
Sbjct: 292 ---TQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNR 348
Query: 454 IVCNCSK-QGWWKDTFKLP 471
            +      +  W+  +K P
Sbjct: 349 ALQQVGGLKSPWRGEYKEP 367

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 138 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 192
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 193 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 184
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQ----FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH NV+        +  + +  + +++   + DL   L K  +LS   +  F
Sbjct: 91  EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLL-KSQQLSNDHICYF 149
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+L++    LKI  FGL R+    PE     F 
Sbjct: 150 LYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIA--DPEHDHTGFL 204
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
              +     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 205 TEXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 249

>pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN++D  G T LH+AA  GH+E+V++LL   A++DA 
Sbjct: 17  KLLEAARAGQDDEVRILIANGADVNAVDNTGLTPLHLAAVSGHLEIVEVLLKHGADVDAA 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPK---TKRTPMTVANPREVPEYELNPLEL- 190
           D +G T    A   G++E+  +L   GA V     T  TP+ +A      E  L  +E+ 
Sbjct: 77  DVYGFTPLHLAAMTGHLEIVEVLLKYGADVNAFDMTGSTPLHLA----ADEGHLEIVEVL 132
Query: 191 -----QVRKADGITKGSYQVAKWNGTKVWVK 216
                 V   D   K ++ ++  NG +   K
Sbjct: 133 LKYGADVNAQDKFGKTAFDISIDNGNEDLAK 163

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFL 184
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 133
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFL 188
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFL 184
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 133
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 188
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVA--DPDHDHTGFL 184
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           V+  NG +  VKI++K++     R+  F    T+ +   + N+++ +     +    +V 
Sbjct: 33  VSLQNGKEYAVKIIEKQAGHSRSRV--FREVETLYQCQGNKNILELIEFFEDDTRFYLVF 90
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E    G + +++QK+   +  +  R   D+A  +++LH      I H DLKP+NIL ++ 
Sbjct: 91  EKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLH---TKGIAHRDLKPENILCESP 147
Query: 325 GQ---LKISGFGLLRLQYISPEKAKIVFP-VSHIDPANLYVAPEIY-----KNEEFDRSV 375
            +   +KI  F L     ++     I  P ++    +  Y+APE+      +   +D+  
Sbjct: 148 EKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRC 207
Query: 376 DAYSFGLILYEMIEGVQPF 394
           D +S G++LY M+ G  PF
Sbjct: 208 DLWSLGVVLYIMLSGYPPF 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 127
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 128 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 182
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 183 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 131
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 132 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 186
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 187 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 231

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 134
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 135 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 189
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 190 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 136 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 190
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 191 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 127 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 181
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 182 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 133
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 188
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 127
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 128 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 182
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 183 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 133
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFL 188
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 184
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 229

>pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 37/94 (39%), Positives = 55/94 (58%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN++D DG T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNALDEDGLTPLHLAAQLGHLEIVEVLLKYGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A D +G T    A   G++E+  +L   GA V
Sbjct: 73  VNAEDNFGITPLHLAAIRGHLEIVEVLLKHGADV 106

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 149
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 150 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 204
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 205 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 249

>pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNAEDTYGDTPLHLAARVGHLEIVEVLLKNGADVNAL 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPR---EVPEYELNPL 188
           D  GST    A   G++E+  +L   GA V        TP+ +A      E+ E  L   
Sbjct: 77  DFSGSTPLHLAAKRGHLEIVEVLLKYGADVNADDTIGSTPLHLAADTGHLEIVEVLL-KY 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKIL 218
              V   D   K ++ ++  NG +   +IL
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEIL 165

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+   RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 131
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 132 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVA--DPDHDHTGFL 186
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 187 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 231

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 107/259 (41%), Gaps = 33/259 (12%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   ++++G L   +
Sbjct: 108 RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR 167
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLRLQYISPEK- 344
            L +      G+ YLH  +   I+H D+K  N+LL  +G    +  FG      + P+  
Sbjct: 168 ALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGL 222
Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
            K +    +I     ++APE+      D  VD +S   ++  M+ G  P+          
Sbjct: 223 GKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW---------- 272
Query: 405 LMCCEGKRPPLKIKARSYPPDLKEL-----------IEECWDPKPVIRPNFNEIIARLDR 453
               +  R PL +K  S PP ++E+           I+E    +P+ R +  E+  +++R
Sbjct: 273 ---TQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNR 329
Query: 454 IVCNCSK-QGWWKDTFKLP 471
            +      +  W+  +K P
Sbjct: 330 ALQQVGGLKSPWRGEYKEP 348

>pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D +G T LH+AA  G +E+V++LL   A+++A 
Sbjct: 9   KLLEAAAAGQDDEVRILMANGADVNATDDNGLTPLHLAAANGQLEIVEVLLKNGADVNAS 68
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA 175
           D  G T    A Y G++E+  +L   GA V    R   TP+ +A
Sbjct: 69  DSAGITPLHLAAYDGHLEIVEVLLKHGADVNAYDRAGWTPLHLA 112

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 228 RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKV 287
           R ++  +E+ +++K +H N+V             +V++  + G+L   + ++G  +    
Sbjct: 49  RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA 108
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQYISPEK 344
                 +   + YLHE   + I+H DLKP+N+L    +   ++ I+ FGL +++      
Sbjct: 109 SLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME------ 159
Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
              +   +   P   YVAPE+   + + ++VD +S G+I Y ++ G  PF+
Sbjct: 160 QNGIMSTACGTPG--YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFAL 292
           +E++I+ +  HP ++    A      M+++LE+ + G+L   +  +  ++S ++V+ +  
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFP 350
               G+ ++HE     I+H D+KP+NI+ +      +KI  FGL     ++P++      
Sbjct: 157 QACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGL--ATKLNPDEI----- 206
Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
           V        + APEI   E      D ++ G++ Y ++ G+ PF
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNARDFTGWTPLHLAAHFGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPR---EVPEYE 184
           ++A+D  G T    A   G++E+  +L   GA V  +     TP+ +A  R   E+ E  
Sbjct: 73  VNAKDSLGVTPLHLAARRGHLEIVEVLLKNGADVNASDSHGFTPLHLAAKRGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 LKN-GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 244 HPNVVQFVGA---VTQNIPM--MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           H N+ +F+     VT +  M  ++V+EY+  G L  YL        S   R A  + RG+
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC-RLAHSVTRGL 124
Query: 299 NYLHECKPD------PIIHCDLKPKNILLDNGGQLKISGFGL-LRL---QYISP---EKA 345
            YLH   P        I H DL  +N+L+ N G   IS FGL +RL   + + P   + A
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 346 KI--VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP---- 399
            I  V  + ++ P  L  A  +   E   + VD Y+ GLI +E+        P       
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 400 --------------EEVVKLMCCEGKRP--PLKIKARSYPP-DLKELIEECWD 435
                         E++  L+  E +RP  P   K  S     LKE IE+CWD
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KCQHLSNDHICYF 133
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 188
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|2BKK|B Chain B, Crystal Structure Of Aminoglycoside Phosphotransferase Aph (3')-Iiia In Complex With The Inhibitor Ar_3a Length = 169

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+    GH+E++++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNANDWFGITPLHLVVNNGHLEIIEVLLKYAAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA---NPREVPEYE 184
           ++A D+ G T    A Y G++E+  +L   GA V        TP+ +A      E+ E  
Sbjct: 73  VNASDKSGWTPLHLAAYRGHLEIVEVLLKYGADVNAMDYQGYTPLHLAAEDGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 L-KYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 129/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I++      P+       E  
Sbjct: 44  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 162
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 163 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKE-----YHAEG 212
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 213 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 271
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 272 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 310

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G +     + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 77  VMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 185
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 244
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 245 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+   RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 131
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 132 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 186
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
             ++     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 187 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 231

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G +     + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 71  VMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 179
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 238
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 239 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 229 INAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           I     E+ I++K  HPNVV+ V  +       + +V E   +G +      K  LS  +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQ 138
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL-RLQYISPEKA 345
              +  DL +G+ YLH  K   IIH D+KP N+L+   G +KI+ FG+    +      +
Sbjct: 139 ARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
             V   + + P +L    +I+      +++D ++ G+ LY  + G  PF  +      ++
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSG----KALDVWAMGVTLYCFVFGQCPFMDE------RI 245
Query: 406 MCCEGKRPPLKIKARSYP------PDLKELIEECWDPKPVIRPNFNEI 447
           MC   K   +K +A  +P       DLK+LI    D  P  R    EI
Sbjct: 246 MCLHSK---IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 25/196 (12%)
Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL--DLARGMNYLHECKPDPIIHCDLKPK 317
           + I +E+  KG L  +++K+      KVL   L   + +G++Y+H  K   +IH DLKP 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LIHRDLKPS 165
Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           NI L +  Q+KI  FGL+       ++ +    +        Y++PE   ++++ + VD 
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR-------YMSPEQISSQDYGKEVDL 218
Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK--IKARSYPPDLKELIEECWD 435
           Y+ GLIL E++            E  K          L+  I +  +    K L+++   
Sbjct: 219 YALGLILAELLHVCD-----TAFETSKFF------TDLRDGIISDIFDKKEKTLLQKLLS 267
Query: 436 PKPVIRPNFNEIIARL 451
            KP  RPN +EI+  L
Sbjct: 268 KKPEDRPNTSEILRTL 283

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKG--DLASYLQKKGRLSPSKVLRF 290
           E+ ++ + RH NV+Q V  +   +   M +V+EY   G  ++   + +K R    +   +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGY 114
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              L  G+ YLH      I+H D+KP N+LL  GG LKIS  G+   + + P  A     
Sbjct: 115 FCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV--AEALHPFAADDTCR 169
Query: 351 VSHIDPANLYVAPEIYKN-EEFDR-SVDAYSFGLILYEMIEGVQPF 394
            S   PA  +  PEI    + F    VD +S G+ LY +  G+ PF
Sbjct: 170 TSQGSPA--FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|2XEN|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module Length = 91

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 36/88 (40%), Positives = 55/88 (62%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGAD 60
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           ++A+D++G TA   +   GN ++  IL+
Sbjct: 61  VNAQDKFGKTAFDISIDNGNEDLAEILQ 88

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E H   DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 175
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINA--FTHELTIVEKARHPNVVQF 250
           I KG++ V +       G +  VKI+D         ++      E +I    +HP++V+ 
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKP 306
           +   + +  + +V E+    DL   + K+       S +    +   +   + Y H+   
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--- 148
Query: 307 DPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
           + IIH D+KP+N+LL   +N   +K+  FG+     I   ++ +V       P   ++AP
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVA----IQLGESGLVAGGRVGTPH--FMAP 202
Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
           E+ K E + + VD +  G+IL+ ++ G  PF+
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+++ H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 74  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 182
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 241
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 242 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 181
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 240
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 241 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G +     + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKE-----YHAEG 178
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 237
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 238 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G +     + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 180
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 239
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 240 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 71  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 179
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 238
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 239 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 133
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 188
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
              +     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 189 XEXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 13/167 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV----TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     +     + +  + +++   + DL   L K   LS   +  F
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 134
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+    P+     F 
Sbjct: 135 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFL 189
Query: 351 VSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHP 396
              +     Y APEI  N + + +S+D +S G IL EM+   +P  P
Sbjct: 190 XEXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 234

>pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 36/94 (38%), Positives = 53/94 (56%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA   H+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNANDRKGNTPLHLAADYDHLEIVEVLLKHGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A D  GST    A  +G++E+  +L   GA V
Sbjct: 73  VNAHDNDGSTPLHLAALFGHLEIVEVLLKHGADV 106

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKE-----YHAEG 178
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 237
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 238 LP-------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPER 228
            P   PE+  N      +K + I +G+Y V      K  G  V +K   LD E+   P  
Sbjct: 1   GPLGSPEFMEN-----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-- 53
Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKV 287
            +    E++++++  HPN+V+ +  +     + +V E+  + DL  ++        P  +
Sbjct: 54  -STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 111
Query: 288 LR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           ++ +   L +G+ + H  +   ++H DLKP+N+L++  G +K++ FGL R  +  P +  
Sbjct: 112 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT- 166
Query: 347 IVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMI 388
                +H      Y APEI    + +  +VD +S G I  EM+
Sbjct: 167 ----YTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPER 228
            P   PE+  N      +K + I +G+Y V      K  G  V +K   LD E+   P  
Sbjct: 1   GPLGSPEFMEN-----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-- 53
Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKV 287
            +    E++++++  HPN+V+ +  +     + +V E+  + DL  ++        P  +
Sbjct: 54  -STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 111
Query: 288 LR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           ++ +   L +G+ + H  +   ++H DLKP+N+L++  G +K++ FGL R  +  P +  
Sbjct: 112 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT- 166
Query: 347 IVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMI 388
                +H      Y APEI    + +  +VD +S G I  EM+
Sbjct: 167 ----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 181
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 240
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 241 LP-------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 279

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 20  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 139 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 188
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 189 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 247
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 248 LP-------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 286

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 172
Query: 364 EIYKNEE-FDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 185
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 244
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 245 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKE-----YHAEG 178
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 237
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 238 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+  +   RHP +V    A   +  M+++ E+ + G+L   +  +  ++S  + + +   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPV 351
           + +G+ ++HE   +  +H DLKP+NI+       +LK+  FGL    ++ P+++     V
Sbjct: 264 VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQS-----V 313
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
                   + APE+ + +      D +S G++ Y ++ G+ PF  +  +E ++
Sbjct: 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 366

>pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 7/136 (5%)
Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN 150
           L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A D  G T    A  +G+
Sbjct: 33  LMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92
Query: 151 VEVYNILKARGAKVPKTK---RTPMTVA---NPREVPEYELNPLELQVRKADGITKGSYQ 204
           +E+  +L   GA V        TP+ +A      E+ E  L      V   D   K ++ 
Sbjct: 93  LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKN-GADVNAQDKFGKTAFD 151
Query: 205 VAKWNGTKVWVKILDK 220
           ++  NG +   +IL K
Sbjct: 152 ISIDNGNEDLAEILQK 167

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL +++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 175
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 173
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 178
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 237
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 238 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 171
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 185
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 244
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 245 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/286 (20%), Positives = 129/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G +     + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  R + +  E+ +      H + 
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEY-----HAEG 180
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 239
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 240 LP-------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+  +   RHP +V    A   +  M+++ E+ + G+L   +  +  ++S  + + +   
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPV 351
           + +G+ ++HE   +  +H DLKP+NI+       +LK+  FGL    ++ P+++     V
Sbjct: 158 VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQS-----V 207
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
                   + APE+ + +      D +S G++ Y ++ G+ PF  +  +E ++
Sbjct: 208 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 260

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 10  QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 66
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 176
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI GFGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 123 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKE-----YHAEG 172
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 231
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 232 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 171
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAHDDQGSTPLHLAAWIGHPEIVEVLLKHGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPR---EVPEYE 184
           ++ARD  G T    A   G++E+  +L   GA V        TP+ +A  R   E+ E  
Sbjct: 73  VNARDTDGWTPLHLAADNGHLEIVEVLLKYGADVNAQDAYGLTPLHLAADRGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 LKH-GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/293 (21%), Positives = 128/293 (43%), Gaps = 42/293 (14%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 16  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 238 IVEKARHPNVVQFVGA--------VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           ++    +P+V + +G         +TQ +P   +L+Y          + K  +    +L 
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--------VREHKDNIGSQYLLN 127
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           + + +A+GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +   
Sbjct: 128 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-- 180
Query: 350 PVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              H +   +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  +
Sbjct: 181 ---HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 237
Query: 406 MCCEGKRPPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +  +G+R P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 238 L-EKGERLP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 282

>pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 35/94 (37%), Positives = 51/94 (54%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA   H+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAEDKVGLTPLHLAAMNDHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A D  G T       YG++E+  +L   GA V
Sbjct: 73  VNAIDAIGETPLHLVAMYGHLEIVEVLLKHGADV 106

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINA--FTHELTIVEKARHPNVVQF 250
           I KG + V +       G +  VKI+D         ++      E +I    +HP++V+ 
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKP 306
           +   + +  + +V E+    DL   + K+       S +    +   +   + Y H+   
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--- 150
Query: 307 DPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
           + IIH D+KP  +LL   +N   +K+ GFG+     I   ++ +V       P   ++AP
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA----IQLGESGLVAGGRVGTPH--FMAP 204
Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
           E+ K E + + VD +  G+IL+ ++ G  PF+
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSGCLPFY 236

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 180
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 239
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 240 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKE-----YHAEG 181
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 240
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 241 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 175
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 178
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 237
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 238 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 174
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINA--FTHELTIVEKARHPNVVQF 250
           I KG + V +       G +  VKI+D         ++      E +I    +HP++V+ 
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKP 306
           +   + +  + +V E+    DL   + K+       S +    +   +   + Y H+   
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--- 148
Query: 307 DPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
           + IIH D+KP  +LL   +N   +K+ GFG+     I   ++ +V       P   ++AP
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA----IQLGESGLVAGGRVGTPH--FMAP 202
Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
           E+ K E + + VD +  G+IL+ ++ G  PF+
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/293 (21%), Positives = 128/293 (43%), Gaps = 42/293 (14%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 35  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 238 IVEKARHPNVVQFVGA--------VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           ++    +P+V + +G         +TQ +P   +L+Y          + K  +    +L 
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--------VREHKDNIGSQYLLN 146
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           + + +A+GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +   
Sbjct: 147 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-- 199
Query: 350 PVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              H +   +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  +
Sbjct: 200 ---HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 256
Query: 406 MCCEGKRPPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +  +G+R P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 257 L-EKGERLP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 301

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEY-----HAEG 181
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 240
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 241 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           VR+   I  G    AK   TK     L    H+  ER      E  I    +HPN+V+  
Sbjct: 20  VRRCMKIPTGQEYAAKIINTKK----LSARDHQKLER------EARICRLLKHPNIVRLH 69
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            ++++     +V +    G+L   +  +   S +        +   +N+   C  + I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH---CHLNGIVH 126
Query: 312 CDLKPKNILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
            DLKP+N+LL     G  +K++ FGL  ++    ++A   F  +   P   Y++PE+ + 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGL-AIEVQGDQQAWFGFAGT---PG--YLSPEVLRK 180
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPF 394
           + + + VD ++ G+ILY ++ G  PF
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 173
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 125 HR---VLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 175
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 89/173 (51%), Gaps = 14/173 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ +++   HPN+++            +V+E +  G+L   +  + + +          +
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYISPEKAKIVFPV 351
             G+ YLH+     I+H DLKP+N+LL++  +   +KI  FGL  + + + +K K     
Sbjct: 146 LSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKKMKERLGT 201
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
           ++      Y+APE+ + +++D   D +S G+IL+ ++ G  PF  +  +E+++
Sbjct: 202 AY------YIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 10  QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 66
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 176
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 174
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/286 (20%), Positives = 129/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G +     + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  R + +  E+ +      H + 
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEY-----HAEG 180
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 239
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 240 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 173
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 175
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 174
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/286 (20%), Positives = 129/286 (45%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 74  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  R + +  E+ +      H + 
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKE-----YHAEG 182
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 241
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 242 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E A  V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 175
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           ++I++E    G+L S +Q++G    +  +      D+   + +LH      I H D+KP+
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPE 138
Query: 318 NILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           N+L    +    LK++ FG  +    +  +     P         YVAPE+   E++D+S
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP--------YYVAPEVLGPEKYDKS 190
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP-PDLKELIEEC 433
            D +S G+I+Y ++ G  PF+    + +       G +  +++    +P P+  E+ E  
Sbjct: 191 CDMWSLGVIMYILLCGFPPFYSNTGQAI-----SPGMKRRIRLGQYGFPNPEWSEVSE-- 243
Query: 434 WDPKPVIR 441
            D K +IR
Sbjct: 244 -DAKQLIR 250

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           VR+   I  G    AK   TK     L    H+  ER      E  I    +HPN+V+  
Sbjct: 20  VRRCMKIPTGQEYAAKIINTKK----LSARDHQKLER------EARICRLLKHPNIVRLH 69
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            ++++     +V +    G+L   +  +   S +        +   +N+   C  + I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH---CHLNGIVH 126
Query: 312 CDLKPKNILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
            DLKP+N+LL     G  +K++ FGL  ++    ++A   F  +   P   Y++PE+ + 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGL-AIEVQGDQQAWFGFAGT---PG--YLSPEVLRK 180
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPF 394
           + + + VD ++ G+ILY ++ G  PF
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E A  V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLAQM 265

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 171
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 171
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 18/185 (9%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY  
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-C 136
Query: 269 KGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G  +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   G +
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 193
Query: 328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI---YKNEEFDRSVDAYSFGLIL 384
           K+  FG           A I+ P +       ++APE+       ++D  VD +S G+  
Sbjct: 194 KLGDFG----------SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243
Query: 385 YEMIE 389
            E+ E
Sbjct: 244 IELAE 248

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 124 HR---VLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 174
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E A  V  
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFV-- 179
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 180 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLAQM 261

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           ++I++E    G+L S +Q++G    +  +      D+   + +LH      I H D+KP+
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPE 157
Query: 318 NILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           N+L    +    LK++ FG  +    +  +     P         YVAPE+   E++D+S
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY--------YVAPEVLGPEKYDKS 209
Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP-PDLKELIEEC 433
            D +S G+I+Y ++ G  PF+    + +       G +  +++    +P P+  E+ E  
Sbjct: 210 CDMWSLGVIMYILLCGFPPFYSNTGQAI-----SPGMKRRIRLGQYGFPNPEWSEVSE-- 262
Query: 434 WDPKPVIR 441
            D K +IR
Sbjct: 263 -DAKQLIR 269

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 122 HR---VLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 173
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 89/183 (48%), Gaps = 18/183 (9%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
            K L    H+  ER      E  I    +HPN+V+   ++++     +V +    G+L  
Sbjct: 66  TKKLSARDHQKLER------EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISG 331
            +  +   S +        +   +N++H+     I+H DLKP+N+LL +   G  +K++ 
Sbjct: 120 DIVAREYYSEADASHCIHQILESVNHIHQ---HDIVHRDLKPENLLLASKCKGAAVKLAD 176
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
           FGL  ++    ++A   F  +   P   Y++PE+ + + + + VD ++ G+ILY ++ G 
Sbjct: 177 FGL-AIEVQGEQQAWFGFAGT---PG--YLSPEVLRKDPYGKPVDIWACGVILYILLVGY 230
Query: 392 QPF 394
            PF
Sbjct: 231 PPF 233

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +        H      Y AP
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRT-----YXHEVVTLWYRAP 173
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/293 (20%), Positives = 127/293 (43%), Gaps = 42/293 (14%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGA--------VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           ++    +P+V + +G         +TQ +P   +L+Y          + K  +    +L 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--------VREHKDNIGSQYLLN 123
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           + + +A+GMNYL + +   ++H DL  +N+L+     +KI+ FG  R + +  E+ +   
Sbjct: 124 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEY-- 176
Query: 350 PVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              H +   +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  +
Sbjct: 177 ---HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 406 MCCEGKRPPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +  +G+R P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 234 L-EKGERLP-------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 127/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 7   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A 
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L  +  E+ +      H + 
Sbjct: 126 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKE-----YHAEG 175
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 234
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 235 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 273

>pdb|2JAB|A Chain A, A Designed Ankyrin Repeat Protein Evolved To Picomolar Affinity To Her2 Length = 136

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 34/94 (36%), Positives = 52/94 (55%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T L++A   GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A D  G T    A + G++E+  +L   GA V
Sbjct: 73  VNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADV 106

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 41/237 (17%)
Query: 235 ELTIVEKARHPNVVQFVG----------------AVTQNIPMMIVLEYHAKGDLASYLQK 278
           E+  + K  H N+V + G                + ++   + I +E+  KG L  +++K
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 279 KGRLSPSKVLRFAL--DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +      KVL   L   + +G++Y+H  K   +I+ DLKP NI L +  Q+KI  FGL+ 
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 ++ +    +        Y++PE   ++++ + VD Y+ GLIL E++        
Sbjct: 171 SLKNDGKRXRSKGTLR-------YMSPEQISSQDYGKEVDLYALGLILAELLHVCD---- 219
Query: 397 KPPEEVVKLMCCEGKRPPLK--IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
               E  K          L+  I +  +    K L+++    KP  RPN +EI+  L
Sbjct: 220 -TAFETSKFF------TDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 31/244 (12%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-C 97
Query: 269 KGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G  +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   G +
Sbjct: 98  LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 154
Query: 328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI---YKNEEFDRSVDAYSFGLIL 384
           K+  FG           A I+ P +       ++APE+       ++D  VD +S G+  
Sbjct: 155 KLGDFG----------SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 385 YEMIEGVQPFHPKPPEEVVKLMC-----CEGKRPPLKIKARSYPPDLKELIEECWDPKPV 439
            E+ E       KPP   +  M       + + P L  ++  +    +  ++ C    P 
Sbjct: 205 IELAE------RKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQ 256
Query: 440 IRPN 443
            RP 
Sbjct: 257 DRPT 260

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWV-KI-LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V + KI LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 172
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWV-KI-LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V + KI LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAP 363
            +   ++H DLKP+N+L++  G +K++ FGL R  +  P +       +H      Y AP
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT-----YTHEVVTLWYRAP 171
Query: 364 EIYKN-EEFDRSVDAYSFGLILYEMI 388
           EI    + +  +VD +S G I  EM+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3NOG|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNASDHVGWTPLHLAAYFGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPREVPEYELNP 187
           ++A D  G T    A   G++EV  +L   GA V        TP+ +A    +   E+  
Sbjct: 73  VNADDSLGVTPLHLAADRGHLEVVEVLLKNGADVNANDHNGFTPLHLA--ANIGHLEIVE 130
Query: 188 LELQ----VRKADGITKGSYQVAKWNGTKVWVKILDK 220
           + L+    V   D   K ++ ++  NG +   +IL K
Sbjct: 131 VLLKHGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNATDWLGHTPLHLAAKTGHLEIVEVLLKYGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYE--LNPL 188
           ++A D +G+T    A   G++E+  +L   GA V        T   P  +  Y+  L  +
Sbjct: 73  VNAWDNYGATPLHLAADNGHLEIVEVLLKHGADVNAKDYEGFT---PLHLAAYDGHLEIV 129
Query: 189 EL------QVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           E+       V   D   K ++ ++  NG +   +IL K
Sbjct: 130 EVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/293 (20%), Positives = 127/293 (43%), Gaps = 42/293 (14%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGA--------VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           ++    +P+V + +G         +TQ +P   +L+Y          + K  +    +L 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--------VREHKDNIGSQYLLN 128
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           + + +A+GMNYL + +   ++H DL  +N+L+     +KI+ FG  R + +  E+ +   
Sbjct: 129 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEY-- 181
Query: 350 PVSHIDPANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL 405
              H +   +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  +
Sbjct: 182 ---HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 406 MCCEGKRPPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +  +G+R P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 239 L-EKGERLP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 18/191 (9%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G KV +K L +    +     A+  EL +++  RH NV+  +   T +  +    +++ 
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107
Query: 269 ----KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
                G     L K  +L   ++      + +G+ Y+H      IIH DLKP N+ ++  
Sbjct: 108 VMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 164
Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLI 383
            +LKI  FGL R Q  S     +V           Y APE+  N   + ++VD +S G I
Sbjct: 165 CELKILDFGLAR-QADSEMXGXVV--------TRWYRAPEVILNWMRYTQTVDIWSVGCI 215
Query: 384 LYEMIEGVQPF 394
           + EMI G   F
Sbjct: 216 MAEMITGKTLF 226

>pdb|2ZGG|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 92

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 36/88 (40%), Positives = 53/88 (60%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DV + D +G T LH+AA  GH+EVVKLLL   A+
Sbjct: 5   DLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGAD 64
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           ++A+D++G TA   +   GN ++  IL+
Sbjct: 65  VNAQDKFGKTAFDISIDNGNEDLAEILQ 92

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYV-- 185
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 186 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 241 VGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGYV-- 189
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 190 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 245 VGTPGAELLKKISSESARNYIQSLTQM 271

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/286 (20%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G +     + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  R + +  E+ +      H + 
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEY-----HAEG 178
Query: 357 ANL---YVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR 412
             +   ++A E   +  +    D +S+G+ ++E++  G +P+   P  E+  ++  +G+R
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER 237
Query: 413 PPLKIKARSYPP----DLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P        PP    D+  ++ +CW      RP F E+I    ++
Sbjct: 238 LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  + + E    V  
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYV-- 190
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 191 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 246 VGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  + + E    V  
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYV-- 190
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 191 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 246 VGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 17/261 (6%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+ +      + + T+V +K+LDK      E   +F    +++ K  H ++V   G    
Sbjct: 27  GVRREVGDYGQLHETEVLLKVLDKAHRNYSE---SFFEAASMMSKLSHKHLVLNYGVCVC 83
Query: 257 NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++V E+   G L +YL+K K  ++    L  A  LA  M++L E   + +IH ++ 
Sbjct: 84  GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVC 140
Query: 316 PKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRS 374
            KNILL      K      ++L    P  +  V P   +     +V PE  +N +  + +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLS--DPGISITVLPKDILQERIPWVPPECIENPKNLNLA 198
Query: 375 VDAYSFGLILYEMIEGV-QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
            D +SFG  L+E+  G  +P      +  ++      + P  K        +L  LI  C
Sbjct: 199 TDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK------AAELANLINNC 252
Query: 434 WDPKPVIRPNFNEIIARLDRI 454
            D +P  RP+F  II  L+ +
Sbjct: 253 MDYEPDHRPSFRAIIRDLNSL 273

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  + + E    V  
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYV-- 190
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 191 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 246 VGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 179
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 180 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLAQM 261

>pdb|4GRG|A Chain A, Crystal Structure Of Ige Complexed With E2_79, An Anti-Ige Inhibitor Length = 135

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 34/94 (36%), Positives = 50/94 (53%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L   G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILTANGADVNANDYWGHTPLHLAAMLGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A    G T    A +  ++E+  +L   GA V
Sbjct: 73  VNATGNTGRTPLHLAAWADHLEIVEVLLKHGADV 106

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV-- 188
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 189 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 244 VGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV-- 188
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 189 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 244 VGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|2ZGD|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 110

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 36/88 (40%), Positives = 52/88 (59%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DV + D +G T LH+AA  GH+EVVKLLL   A+
Sbjct: 23  DLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGAD 82
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           + A+D++G TA   +   GN ++  IL+
Sbjct: 83  VXAQDKFGKTAFDISIDNGNEDLAEILQ 110

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 198 ITKGSYQVA-----KWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARHPNVVQF 250
           + KG++ V      K  G +   KI++  K S +D +++     E  I  K +HPN+V+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRL 93
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             ++ +     +V +    G+L   +  +   S +        +   + Y   C  + I+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY---CHSNGIV 150
Query: 311 HCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
           H +LKP+N+LL +   G  +K++ FGL     ++  +A   F  +   P   Y++PE+ K
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT---PG--YLSPEVLK 203
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + + + VD ++ G+ILY ++ G  PF
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 188
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 189 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 244 VGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 130 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 182
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 183 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 237
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 238 VGTPGAELLKKISSESARNYIQSLTQM 264

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 142 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGYV-- 194
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 195 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 249
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 250 VGTPGAELLKKISSESARNYIQSLTQM 276

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 143 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 195
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 196 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 250
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 251 VGTPGAELLKKISSESARNYIQSLTQM 277

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 112/262 (42%), Gaps = 19/262 (7%)
Query: 180 VPEYELNPLELQVRKADGITK-GSYQVAKWNGTK--VWVKILDKESHKDPERINAFTHEL 236
           V E +L+  + ++ K  G    G   V K   T+    +KIL+K           F  E 
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLA 295
            ++       +     A      + +V++Y+  GDL + L K     P  + RF + ++ 
Sbjct: 142 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 201
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG-LLRLQYISPEKAKIVFPVSHI 354
             ++ +H+      +H D+KP N+LLD  G ++++ FG  L++     +   +   V+  
Sbjct: 202 LAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMN----DDGTVQSSVAVG 254
Query: 355 DPANLYVAPEIYKNEE-----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
            P   Y++PEI +  E     +    D +S G+ +YEM+ G  PF+ +   E    +   
Sbjct: 255 TPD--YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 312
Query: 410 GKRPPLKIKARSYPPDLKELIE 431
            +R            + K+LI+
Sbjct: 313 EERFQFPSHVTDVSEEAKDLIQ 334

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 143 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 195
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 196 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 250
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 251 VGTPGAELLKKISSESARNYIQSLTQM 277

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 190
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 191 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 246 VGTPGAELLKKISSESARNYIQSLTQM 272

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 112/262 (42%), Gaps = 19/262 (7%)
Query: 180 VPEYELNPLELQVRKADGITK-GSYQVAKWNGTK--VWVKILDKESHKDPERINAFTHEL 236
           V E +L+  + ++ K  G    G   V K   T+    +KIL+K           F  E 
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLA 295
            ++       +     A      + +V++Y+  GDL + L K     P  + RF + ++ 
Sbjct: 126 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 185
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG-LLRLQYISPEKAKIVFPVSHI 354
             ++ +H+      +H D+KP N+LLD  G ++++ FG  L++     +   +   V+  
Sbjct: 186 LAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMN----DDGTVQSSVAVG 238
Query: 355 DPANLYVAPEIYKNEE-----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
            P   Y++PEI +  E     +    D +S G+ +YEM+ G  PF+ +   E    +   
Sbjct: 239 TPD--YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
Query: 410 GKRPPLKIKARSYPPDLKELIE 431
            +R            + K+LI+
Sbjct: 297 EERFQFPSHVTDVSEEAKDLIQ 318

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 185
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 186 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 241 VGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 143 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 195
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 196 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 250
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 251 VGTPGAELLKKISSESARNYIQSLTQM 277

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 189
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 190 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 245 VGTPGAELLKKISSESARNYIQSLTQM 271

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 188
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 189 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 243
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 244 VGTPGAELLKKISSESARNYIQSLTQM 270

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 185
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 186 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 241 VGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 150 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 202
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 203 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 257
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 258 VGTPGAELLKKISSESARNYIQSLTQM 284

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 142 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 194
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 195 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 249
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 250 VGTPGAELLKKISSESARNYIQSLTQM 276

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLAQM 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 198 ITKGSYQVA-----KWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARHPNVVQF 250
           + KG++ V      K  G +   KI++  K S +D +++     E  I  K +HPN+V+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRL 69
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             ++ +     +V +    G+L   +  +   S +        +   + Y   C  + I+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY---CHSNGIV 126
Query: 311 HCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
           H +LKP+N+LL +   G  +K++ FGL     ++  +A   F  +   P   Y++PE+ K
Sbjct: 127 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT---PG--YLSPEVLK 179
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + + + VD ++ G+ILY ++ G  PF
Sbjct: 180 KDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 198 ITKGSYQVA-----KWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARHPNVVQF 250
           + KG++ V      K  G +   KI++  K S +D +++     E  I  K +HPN+V+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRL 70
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             ++ +     +V +    G+L   +  +   S +        +   + Y   C  + I+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY---CHSNGIV 127
Query: 311 HCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
           H +LKP+N+LL +   G  +K++ FGL     ++  +A   F  +   P   Y++PE+ K
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT---PG--YLSPEVLK 180
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + + + VD ++ G+ILY ++ G  PF
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 179
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 180 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQM 261

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 151 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 203
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 204 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 258
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 259 VGTPGAELLKKISSESARNYIQSLTQM 285

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 128
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 129 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 181
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 182 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 236
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 237 VGTPGAELLKKISSESARNYIQSLTQM 263

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 28/197 (14%)
Query: 212 KVWVKILDKE-----SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           KV +KI+ K      S ++ +       E+ I++K  HP +++            IVLE 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLEL 95
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL +  +
Sbjct: 96  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEE 152
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDP---ANLYVAPEIY---KNEEFDRSVDA 377
              +KI+ FG           +KI+   S +        Y+APE+        ++R+VD 
Sbjct: 153 DCLIKITDFG----------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 378 YSFGLILYEMIEGVQPF 394
           +S G+IL+  + G  PF
Sbjct: 203 WSLGVILFICLSGYPPF 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 128 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 180
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 181 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 235
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 236 VGTPGAELLKKISSESARNYIQSLTQM 262

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 179
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 180 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLAQM 261

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 189
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 190 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 245 VGTPGAELLKKISSESARNYIQSLTQM 271

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 28/197 (14%)
Query: 212 KVWVKILDKE-----SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           KV +KI+ K      S ++ +       E+ I++K  HP +++            IVLE 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLEL 95
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL +  +
Sbjct: 96  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEE 152
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDP---ANLYVAPEIY---KNEEFDRSVDA 377
              +KI+ FG           +KI+   S +        Y+APE+        ++R+VD 
Sbjct: 153 DCLIKITDFG----------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 378 YSFGLILYEMIEGVQPF 394
           +S G+IL+  + G  PF
Sbjct: 203 WSLGVILFICLSGYPPF 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 140
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 141 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 193
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 194 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 248
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 249 VGTPGAELLKKISSESARNYIQSLAQM 275

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 154 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 206
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 207 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 261
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 262 VGTPGAELLKKISSESARNYIQSLTQM 288

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 128 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 180
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 181 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 235
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 236 VGTPGAELLKKISSESARNYIQSLTQM 262

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 28/197 (14%)
Query: 212 KVWVKILDKE-----SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           KV +KI+ K      S ++ +       E+ I++K  HP +++            IVLE 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLEL 95
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL +  +
Sbjct: 96  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEE 152
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDP---ANLYVAPEIY---KNEEFDRSVDA 377
              +KI+ FG           +KI+   S +        Y+APE+        ++R+VD 
Sbjct: 153 DCLIKITDFG----------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 378 YSFGLILYEMIEGVQPF 394
           +S G+IL+  + G  PF
Sbjct: 203 WSLGVILFICLSGYPPF 219

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 23/186 (12%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I++K  HP +++            IVLE    G+L   +    RL  +    +   +
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYISPEKAKIVFPV 351
              + YLHE   + IIH DLKP+N+LL +  +   +KI+ FG           +KI+   
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG----------HSKILGET 295
Query: 352 SHIDP---ANLYVAPEIY---KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
           S +        Y+APE+        ++R+VD +S G+IL+  + G  PF     +  +K 
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 406 MCCEGK 411
               GK
Sbjct: 356 QITSGK 361

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 185
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 186 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 240
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 241 VGTPGAELLKKISSESARNYIQSLTQM 267

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 154 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYV-- 206
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 207 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 261
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 262 VGTPGAELLKKISSESARNYIQSLTQM 288

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 28/197 (14%)
Query: 212 KVWVKILDKE-----SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           KV +KI+ K      S ++ +       E+ I++K  HP +++            IVLE 
Sbjct: 36  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLEL 94
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL +  +
Sbjct: 95  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEE 151
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDP---ANLYVAPEIY---KNEEFDRSVDA 377
              +KI+ FG           +KI+   S +        Y+APE+        ++R+VD 
Sbjct: 152 DCLIKITDFG----------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 201
Query: 378 YSFGLILYEMIEGVQPF 394
           +S G+IL+  + G  PF
Sbjct: 202 WSLGVILFICLSGYPPF 218

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 151 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 203
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 204 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 258
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 259 VGTPGAELLKKISSESARNYIQSLAQM 285

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 189
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 190 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 244
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 245 VGTPGAELLKKISSESARNYIQSLAQM 271

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 23/186 (12%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I++K  HP +++            IVLE    G+L   +    RL  +    +   +
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYISPEKAKIVFPV 351
              + YLHE   + IIH DLKP+N+LL +  +   +KI+ FG           +KI+   
Sbjct: 263 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG----------HSKILGET 309
Query: 352 SHIDP---ANLYVAPEIY---KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
           S +        Y+APE+        ++R+VD +S G+IL+  + G  PF     +  +K 
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 369
Query: 406 MCCEGK 411
               GK
Sbjct: 370 QITSGK 375

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 28/197 (14%)
Query: 212 KVWVKILDKE-----SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           KV +KI+ K      S ++ +       E+ I++K  HP +++            IVLE 
Sbjct: 43  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLEL 101
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL +  +
Sbjct: 102 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEE 158
Query: 327 ---LKISGFGLLRLQYISPEKAKIVFPVSHIDP---ANLYVAPEIY---KNEEFDRSVDA 377
              +KI+ FG           +KI+   S +        Y+APE+        ++R+VD 
Sbjct: 159 DCLIKITDFG----------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 208
Query: 378 YSFGLILYEMIEGVQPF 394
           +S G+IL+  + G  PF
Sbjct: 209 WSLGVILFICLSGYPPF 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 150 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-- 202
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 203 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 257
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 258 VGTPGAELLKKISSESARNYIQSLAQM 284

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 17/261 (6%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+ +      + + T+V +K+LDK      E   +F    +++ K  H ++V   G    
Sbjct: 27  GVRREVGDYGQLHETEVLLKVLDKAHRNYSE---SFFEAASMMSKLSHKHLVLNYGVCFC 83
Query: 257 NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++V E+   G L +YL+K K  ++    L  A  LA  M++L E   + +IH ++ 
Sbjct: 84  GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEE---NTLIHGNVC 140
Query: 316 PKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRS 374
            KNILL      K      ++L    P  +  V P   +     +V PE  +N +  + +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLS--DPGISITVLPKDILQERIPWVPPECIENPKNLNLA 198
Query: 375 VDAYSFGLILYEMIEGV-QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
            D +SFG  L+E+  G  +P      +  ++      + P  K        +L  LI  C
Sbjct: 199 TDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK------AAELANLINNC 252
Query: 434 WDPKPVIRPNFNEIIARLDRI 454
            D +P  RP+F  II  L+ +
Sbjct: 253 MDYEPDHRPSFRAIIRDLNSL 273

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 28/235 (11%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    SY V   +G K+ VK L +           +  EL +++  +H NV+  +   
Sbjct: 63  AYGSVCSSYDVK--SGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVF 119
Query: 255 TQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
           T    +     + L  H  G   + + K  +L+   V      + RG+ Y+H      II
Sbjct: 120 TPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---II 176
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-E 369
           H DLKP N+ ++   +LKI  FGL R  +   E    V           Y APEI  N  
Sbjct: 177 HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV-------ATRWYRAPEIMLNWM 227
Query: 370 EFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKLMCCEGKRPPLKIKAR 420
            ++ +VD +S G I+ E++ G   F    H    +++++L       PP  + +R
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGT----PPASVISR 278

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 198 ITKGSYQVA-----KWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARHPNVVQF 250
           + KG++ V      K  G +   KI++  K S +D +++     E  I  K +HPN+V+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRL 70
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             ++ +     +V +    G+L   +  +   S +        +   + Y   C  + I+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY---CHSNGIV 127
Query: 311 HCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK 367
           H +LKP+N+LL +   G  +K++ FGL     ++  +A   F  +   P   Y++PE+ K
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT---PG--YLSPEVLK 180
Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + + + VD ++ G+ILY ++ G  PF
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 8/170 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   +++ G L   +
Sbjct: 92  RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 151
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLRLQYISPEK- 344
            L +      G+ YLH  +   I+H D+K  N+LL  +G +  +  FG      + P+  
Sbjct: 152 ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGL 206
Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            K +    +I     ++APE+   +  D  VD +S   ++  M+ G  P+
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 24/224 (10%)
Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS---PSKVL-RFAL 292
            ++  +  P +VQF GA+ +     I +E  +      Y      L    P ++L +  L
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS 352
              + +N+L E     IIH D+KP NILLD  G +K+  FG+           ++V  ++
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI---------SGQLVDSIA 181
Query: 353 HIDPANL--YVAPE----IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
               A    Y+APE        + +D   D +S G+ LYE+  G  P+ PK      +L 
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY-PKWNSVFDQLT 240
Query: 407 CCEGKRPPL--KIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
                 PP     + R + P     +  C       RP + E++
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R  +   E    V  
Sbjct: 151 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXV-- 203
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 204 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 258
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 259 VGTPGAELLKKISSESARNYIQSLAQM 285

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKG-DLASYLQKKGRLS--PSKVLRFALDLARGMNY 300
           HP V++ +         M+VLE      DL  Y+ +KG L   PS+         + +  
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF-----FGQVVAA 151
Query: 301 LHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           +  C    ++H D+K +NIL+D   G  K+  FG   L +  P         +  D   +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--------YTDFDGTRV 203
Query: 360 YVAPE-IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK 418
           Y  PE I +++        +S G++LY+M+ G  PF     E   +++  E   P     
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF-----ERDQEILEAELHFP----- 253
Query: 419 ARSYPPDLKELIEECWDPKPVIRPNFNEII 448
                PD   LI  C  PKP  RP+  EI+
Sbjct: 254 -AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 8/170 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   +++ G L   +
Sbjct: 108 RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 167
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLRLQYISPEK- 344
            L +      G+ YLH  +   I+H D+K  N+LL  +G +  +  FG      + P+  
Sbjct: 168 ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGL 222
Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            K +    +I     ++APE+   +  D  VD +S   ++  M+ G  P+
Sbjct: 223 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 26/235 (11%)
Query: 193 RKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           R A   T G+ Q+ K   T + V I  K+  +DP   N     +  +    HPN+VQ   
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAI--KKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQS 86
Query: 253 AVT-------QNIPMMIVLEY---HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
                     ++I + +V+EY          +Y +++    P  +  F   L R +  LH
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 303 ECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV 361
               + + H D+KP N+L++   G LK+  FG    + +SP +  + +  S       Y 
Sbjct: 147 LPSVN-VCHRDIKPHNVLVNEADGTLKLCDFG--SAKKLSPSEPNVAYICS-----RYYR 198
Query: 362 APE-IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP----EEVVKLMCCEGK 411
           APE I+ N+ +  +VD +S G I  EM+ G   F          E+V+++ C  +
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253

>pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A +  V+    LL  G   N+  + G T LH+AA EGH E+V LLLSK+AN +  +
Sbjct: 216 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 275
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVAN 176
           + G T        G+V V ++L   G  V  T R   TP+ VA+
Sbjct: 276 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVAS 319

>pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAA 142
           G +  V++LL  G+  N  ++   T LH+AA  GH EV K LL  KA ++A+ +   T  
Sbjct: 25  GHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPL 84
Query: 143 ADAKYYGNVEVYNILKARGAK---VPKTKRTPMTVANPREVPEYELNPLELQVRKADGIT 199
             A   G+  +  +L    A          TP+ +A      E  L  LE +  +A    
Sbjct: 85  HCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTK 144
Query: 200 KGS---YQVAKWNGTKVWVKILDKESHKDPERINAFT 233
           KG    +  AK+   +V   +L++++H +    N  T
Sbjct: 145 KGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLT 181

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 8/170 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   +++ G L   +
Sbjct: 106 RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 165
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLRLQYISPEK- 344
            L +      G+ YLH  +   I+H D+K  N+LL  +G +  +  FG      + P+  
Sbjct: 166 ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGL 220
Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            K +    +I     ++APE+   +  D  VD +S   ++  M+ G  P+
Sbjct: 221 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++++++ +H N+++    +  N  + ++ EY A+ DL  Y+ K   +S   +  F   L
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRLQYISPEKAKIVF 349
             G+N+ H  +    +H DLKP+N+LL          LKI  FGL R   I       + 
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP------IR 192
Query: 350 PVSHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMI 388
             +H      Y  PEI   +  +  SVD +S   I  EM+
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  +GL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 69  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 128 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 179
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 180 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 232
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 233 IRMGQYEFPNPEWSEVSEE 251

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 70  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 129 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 180
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 181 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 233
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 234 IRMGQYEFPNPEWSEVSEE 252

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 115 PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 174 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 225
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 226 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 278
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 279 IRMGQYEFPNPEWSEVSEE 297

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     ++   + ++      DL + ++ +  LS   V  
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA-LSDEHVQF 135
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R      E    V 
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYV- 189
Query: 350 PVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF 394
                     Y APEI  N   ++++VD +S G I+ E+++G   F
Sbjct: 190 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 71  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 181
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 182 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 234
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 235 IRMGQYEFPNPEWSEVSEE 253

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDP----ERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G  ++A   GT++      + + K P    E ++ F  E+ I++   HPN+++       
Sbjct: 23  GEVKIAVQKGTRI-----RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           N  + +V+E    G+L   +  K     S   R   D+   + Y H+     + H DLKP
Sbjct: 78  NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKP 134
Query: 317 KNILL---DNGGQLKISGFGL-LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           +N L         LK+  FGL  R +     + K+  P         YV+P++ +   + 
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP--------YYVSPQVLEG-LYG 185
Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
              D +S G+++Y ++ G  PF   P +  V L   EG
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFS-APTDXEVMLKIREG 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 77  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 136 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 187
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 188 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 240
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 241 IRMGQYEFPNPEWSEVSEE 259

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 76  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 135 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 186
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 187 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 239
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 240 IRMGQYEFPNPEWSEVSEE 258

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 85  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 143
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 144 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 195
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 196 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 248
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 249 IRMGQYEFPNPEWSEVSEE 267

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 75  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 134 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 185
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 186 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 238
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 239 IRMGQYEFPNPEWSEVSEE 257

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 71  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 181
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+
Sbjct: 182 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 220

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 27/199 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 121 PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 180 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 231
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +  
Sbjct: 232 --TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTR 284
Query: 415 LKIKARSYP-PDLKELIEE 432
           +++    +P P+  E+ EE
Sbjct: 285 IRMGQYEFPNPEWSEVSEE 303

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/173 (20%), Positives = 85/173 (49%), Gaps = 13/173 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALD 293
           E++I+  ARH N++    +      ++++ E+ +  D+   +      L+  +++ +   
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPV 351
           +   + +LH      I H D++P+NI+        +KI  FG  R Q    +  +++F  
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNFRLLFT- 165
Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
                A  Y APE+++++    + D +S G ++Y ++ G+ PF  +  +++++
Sbjct: 166 -----APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDP----ERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G  ++A   GT++      + + K P    E ++ F  E+ I++   HPN+++       
Sbjct: 40  GEVKIAVQKGTRI-----RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 94
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           N  + +V+E    G+L   +  K     S   R   D+   + Y H+     + H DLKP
Sbjct: 95  NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKP 151
Query: 317 KNILL---DNGGQLKISGFGL-LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           +N L         LK+  FGL  R +     + K+  P         YV+P++ +   + 
Sbjct: 152 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP--------YYVSPQVLEG-LYG 202
Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
              D +S G+++Y ++ G  PF   P +  V L   EG
Sbjct: 203 PECDEWSAGVMMYVLLCGYPPFS-APTDXEVMLKIREG 239

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 31/201 (15%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV+E    G+L S +Q +G    +  +       +   
Sbjct: 69  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +         +     S  
Sbjct: 128 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---------ETTSHNSLT 175
Query: 355 DPAN--LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR 412
           +P     YVAPE+   E++D+S D +S G+I+Y ++ G  PF+         L    G +
Sbjct: 176 EPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMK 230
Query: 413 PPLKIKARSYP-PDLKELIEE 432
             +++    +P P+  E+ EE
Sbjct: 231 TRIRMGQYEFPNPEWSEVSEE 251

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 123/284 (43%), Gaps = 43/284 (15%)
Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           VR+   +  G    AK   TK     L    H+  ER      E  I    +HPN+V+  
Sbjct: 38  VRRCVKVLAGQEYAAKIINTKK----LSARDHQKLER------EARICRLLKHPNIVRLH 87
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            ++++     ++ +    G+L   +  +   S +        +   + + H+     ++H
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 144
Query: 312 CDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
            DLKP+N+LL +   G  +K++ FGL  ++    ++A   F  +   P   Y++PE+ + 
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGL-AIEVEGEQQAWFGFAGT---PG--YLSPEVLRK 198
Query: 369 EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKE 428
           + + + VD ++ G+ILY ++ G  PF  +    + +           +IKA +Y     E
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ-----------QIKAGAYDFPSPE 247
Query: 429 LIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPW 472
                WD    + P   ++I ++  +  N SK+    +  K PW
Sbjct: 248 -----WD---TVTPEAKDLINKM--LTINPSKRITAAEALKHPW 281

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 152
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 153 IDFGSGAL------LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++      G +   + +  S   + + LI  C   +P  RP F EI
Sbjct: 205 CGDIPF--EHDEEII------GGQVFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEI 252

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 235 ELTIVEKARHPNVVQFVGA------------VTQNIPMMIVLEYHAKGDLASYLQKKGRL 282
           E+  + K  HP +V++  A             +  + + I ++   K +L  ++  +  +
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 283 SP---SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
                S  L   L +A  + +LH      ++H DLKP NI       +K+  FGL+    
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 340 ISPEKAKIVFPV----SHIDPAN--LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP 393
              E+  ++ P+     H       LY++PE      +   VD +S GLIL+E++    P
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP 226
Query: 394 FHPKPPEEVVKLMCCEG-KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           F  +  E V  L      K PPL    + YP +   ++++   P P+ RP    II
Sbjct: 227 FSTQ-MERVRTLTDVRNLKFPPL--FTQKYPCEYV-MVQDMLSPSPMERPEAINII 278

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VKI++K+      R+  F     + +   H NV++ +    +     +V E    G + S
Sbjct: 43  VKIIEKQPGHIRSRV--FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL---KISG 331
           ++ K+   +  +      D+A  +++LH      I H DLKP+NIL ++  Q+   KI  
Sbjct: 101 HIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANL--YVAPEIYK--NEE---FDRSVDAYSFGLIL 384
           FGL     ++ + + I  P   + P     Y+APE+ +  +EE   +D+  D +S G+IL
Sbjct: 158 FGLGSGIKLNGDCSPISTP-ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
Query: 385 YEMIEGVQPF 394
           Y ++ G  PF
Sbjct: 217 YILLSGYPPF 226

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 152
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 153 IDFGSGAL------LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 205 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 155
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 156 IDFGSGAL------LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 208 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 185 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++      G +   + +  S   + + LI  C   +P  RP F EI
Sbjct: 237 CGDIPF--EHDEEII------GGQVFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 156
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 157 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 209 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 157
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 158 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 210 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 185 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++      G +   + +  S   + + LI  C   +P  RP F EI
Sbjct: 237 CGDIPF--EHDEEII------GGQVFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 186 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++      G +   + +  S   + + LI  C   +P  RP F EI
Sbjct: 238 CGDIPF--EHDEEII------GGQVFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 186 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++      G +   + +  S   + + LI  C   +P  RP F EI
Sbjct: 238 CGDIPF--EHDEEII------GGQVFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 196 DGITKGSYQVAK-----WNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARHPNVV 248
           + I KG++ V +       G +   KI++  K S +D +++     E  I    +H N+V
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE---REARICRLLKHSNIV 66
Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           +   ++++     +V +    G+L   +  +   S +        +   +  LH C    
Sbjct: 67  RLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV--LH-CHQMG 123
Query: 309 IIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI 365
           ++H DLKP+N+LL +   G  +K++ FGL  ++    ++A   F  +   P   Y++PE+
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGL-AIEVQGDQQAWFGFAGT---PG--YLSPEV 177
Query: 366 YKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            + E + + VD ++ G+ILY ++ G  PF
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 157
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 158 IDFGSGAL------LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 210 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 156
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 157 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 209 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 171
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 172 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 224 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 185 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 237 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 199
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 200 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 252 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 199
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 200 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 252 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 172
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 173 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 225 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 172
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 173 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 225 CGDIPF--EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 157
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 158 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 210 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     ++   + ++      DL + ++ +  LS   V  
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA-LSDEHVQF 135
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R      E    V 
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYV- 189
Query: 350 PVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF 394
                     Y APEI  N   ++++VD +S G I+ E+++G   F
Sbjct: 190 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 192 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 244 CGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 172
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 173 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 225 CGDIPF--EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 204
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 205 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 257 CGDIPF--EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 171
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 172 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 224 CGDIPF--EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  F L R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI   GL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 199
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 200 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 252 CGDIPF--EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     ++   + ++      DL + ++ +  LS   V  
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA-LSDEHVQF 127
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R      E    V 
Sbjct: 128 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYV- 181
Query: 350 PVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF 394
                     Y APEI  N   ++++VD +S G I+ E+++G   F
Sbjct: 182 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 179
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 180 IDFGSGAL------LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 232 CGDIPF--EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI   GL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
              + RG+ Y+H      IIH DLKP N+ ++   +LKI   GL R  +   E    V  
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGYV-- 183
Query: 351 VSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKL 405
                    Y APEI  N   ++++VD +S G I+ E++ G   F    H    + +++L
Sbjct: 184 -----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 238
Query: 406 MCCEGKRPPLKI---KARSYPPDLKEL 429
           +   G     KI    AR+Y   L ++
Sbjct: 239 VGTPGAELLKKISSESARNYIQSLTQM 265

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 245 PNVVQFVGAVTQNI-----PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARG 297
           P++V+ V  V +N+      ++IV E    G+L S +Q +G    +  +       +   
Sbjct: 115 PHIVRIVD-VYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEA 173
Query: 298 MNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + YLH      I H D+KP+N+L  +      LK++ FG  +    +     +  P    
Sbjct: 174 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCY-- 225
Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                YVAPE+   E++D+S D +S G+I Y ++ G  PF+
Sbjct: 226 --TPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFY 264

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L+  +Q +  L   ++ 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLSQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G+I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L+  +Q +  L   ++ 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLSQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G+I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3C5R|A Chain A, Crystal Structure Of The Bard1 Ankyrin Repeat Domain And Its Functional Consequences Length = 137

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 32/81 (39%), Positives = 45/81 (55%)
Query: 82  RGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           +GD+  VE LL  GSD N  D  G T LH A   GH++VV+LLL  KA ++       + 
Sbjct: 20  KGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSP 79
Query: 142 AADAKYYGNVEVYNILKARGA 162
             DA   G+V++  +L + GA
Sbjct: 80  LHDAAKNGHVDIVKLLLSYGA 100

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 186 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++       +R            + + LI  C   +P  RP F EI
Sbjct: 238 CGDIPF--EHDEEIIGGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 185 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++       +R            + + LI  C   +P  RP F EI
Sbjct: 237 CGDIPF--EHDEEIIGGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3AAA|C Chain C, Crystal Structure Of Actin Capping Protein In Complex With V-1 Length = 123

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 2/89 (2%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAA 142
           GD+  V+D + +G DVN     GR  LH AA  G +E+++ LL K A+I+A D+   T  
Sbjct: 18  GDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPL 77
Query: 143 ADAKYYGNVEVYNILKARGAKVPKTKRTP 171
             A Y G+V    +L ++GA   KT + P
Sbjct: 78  LSAVYEGHVSCVKLLLSKGAD--KTVKGP 104

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+LK+
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 186 IDFGSGALL------KDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE++       +R            + + LI  C   +P  RP F EI
Sbjct: 238 CGDIPF--EHDEEIIGGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|1MYO|A Chain A, Solution Structure Of Myotrophin, Nmr, 44 Structures Length = 118

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 2/89 (2%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAA 142
           GD+  V+D + +G DVN     GR  LH AA  G +E+++ LL K A+I+A D+   T  
Sbjct: 13  GDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPL 72
Query: 143 ADAKYYGNVEVYNILKARGAKVPKTKRTP 171
             A Y G+V    +L ++GA   KT + P
Sbjct: 73  LSAVYEGHVSCVKLLLSKGAD--KTVKGP 99

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 28/227 (12%)
Query: 228 RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS---- 283
           + + F +EL I+   ++   +   G +T    + I+ EY     +  + +    L     
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 284 ---PSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
              P +V++  +  +    +Y+H  K   I H D+KP NIL+D  G++K+S FG    +Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG--ESEY 201
Query: 340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS--VDAYSFGLILYEMIEGVQPFHPK 397
           +  +K K         P      PE + NE       VD +S G+ LY M   V PF  K
Sbjct: 202 MVDKKIKGSRGTYEFMP------PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 398 PPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF 444
               +V+L         ++ K   YP D    +    + K     NF
Sbjct: 256 IS--LVELF------NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/261 (21%), Positives = 115/261 (44%), Gaps = 39/261 (14%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
            K L    H+  ER      E  I    +HPN+V+   ++++     ++ +    G+L  
Sbjct: 46  TKKLSARDHQKLER------EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE 99
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISG 331
            +  +   S +        +   + + H+     ++H +LKP+N+LL +   G  +K++ 
Sbjct: 100 DIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLAD 156
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
           FGL  ++    ++A   F  +   P   Y++PE+ + + + + VD ++ G+ILY ++ G 
Sbjct: 157 FGLA-IEVEGEQQAWFGFAGT---PG--YLSPEVLRKDPYGKPVDLWACGVILYILLVGY 210
Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            PF  +    + +           +IKA +Y     E     WD    + P   ++I ++
Sbjct: 211 PPFWDEDQHRLYQ-----------QIKAGAYDFPSPE-----WD---TVTPEAKDLINKM 251
Query: 452 DRIVCNCSKQGWWKDTFKLPW 472
             +  N SK+    +  K PW
Sbjct: 252 --LTINPSKRITAAEALKHPW 270

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L+  +Q +  L   ++ 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLSQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 11/182 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K+L K   +     +    E+ I     HPN+++          + ++LEY  +G+L
Sbjct: 51  VALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL 110
Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
              LQK       +      +LA  + Y H  K   +IH D+KP+N+LL   G+LKI+ F
Sbjct: 111 YKELQKSCTFDEQRTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADF 167
Query: 333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQ 392
           G   +   S  +  +   +        Y+ PE+ +    +  VD +  G++ YE++ G  
Sbjct: 168 G-WSVHAPSLRRKTMCGTLD-------YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNP 219
Query: 393 PF 394
           PF
Sbjct: 220 PF 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           + K +G KV +K L +    +     A+  EL +++  +H NV+  +   T    +    
Sbjct: 44  IDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLDVFTPASSLRNFY 102
Query: 265 EYH-----AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           +++      + DL   +  K   S  K+      + +G+ Y+H      ++H DLKP N+
Sbjct: 103 DFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNL 157
Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAY 378
            ++   +LKI  FGL R  +   E    V           Y APE+  +   ++++VD +
Sbjct: 158 AVNEDCELKILDFGLAR--HADAEMTGYVV-------TRWYRAPEVILSWMHYNQTVDIW 208
Query: 379 SFGLILYEMIEGVQPFHPK 397
           S G I+ EM+ G   F  K
Sbjct: 209 SVGCIMAEMLTGKTLFKGK 227

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L+  +Q +  L   ++ 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLSQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK---VLRFALDLARGMNYLH 302
           N V  +   +  + + I ++   K +L  ++ ++  L   +    L   + +A  + +LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV----SHIDPAN 358
                 ++H DLKP NI       +K+  FGL+       E+  ++ P+    +H     
Sbjct: 182 S---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVG 238
Query: 359 --LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             LY++PE      +   VD +S GLIL+E++           E V  +      + PL 
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS----TQMERVRIITDVRNLKFPL- 293
Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           +  + YP +   ++++   P P  RP   +II
Sbjct: 294 LFTQKYPQE-HMMVQDMLSPSPTERPEATDII 324

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 47/248 (18%)
Query: 227 ERINAFTHELTIVEKARHPNVVQF-------------VGAVTQNIPMMIVLEYHAKGDLA 273
           E+++    E+ ++    H  VV++             + AV +   + I +EY   G L 
Sbjct: 44  EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY 103
Query: 274 SYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
             +  +       +  R    +   ++Y+H      IIH DLKP NI +D    +KI  F
Sbjct: 104 DLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 333 GLLRLQYISPEKAKI---VFP------VSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGL 382
           GL +  + S +  K+     P       S I  A +YVA E+      ++  +D YS G+
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA-MYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL--------KELIEECW 434
           I +EMI    PF      E V ++        L+  +  +PPD         K++I    
Sbjct: 220 IFFEMI---YPF--STGMERVNIL------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268
Query: 435 DPKPVIRP 442
           D  P  RP
Sbjct: 269 DHDPNKRP 276

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 30/189 (15%)
Query: 225 DPERINAFTHELTIVEKARHPNVVQF--------------VGAVTQNIPMMIVLEYHAKG 270
           DP+ +     E+ I+ +  H N+V+               VG++T+   + IV EY  + 
Sbjct: 48  DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-MET 106
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LKI 329
           DLA+ L+ +G L       F   L RG+ Y+H      ++H DLKP N+ ++     LKI
Sbjct: 107 DLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANL---YVAPEIYKN-EEFDRSVDAYSFGLILY 385
             FGL R+  + P  +       H+    +   Y +P +  +   + +++D ++ G I  
Sbjct: 163 GDFGLARI--MDPHYSH----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216
Query: 386 EMIEGVQPF 394
           EM+ G   F
Sbjct: 217 EMLTGKTLF 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L+  +Q +  L   ++ 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLSQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR--TALHIAACEGHVEVVKLLLS 126
           N ++  QLL  A  GDV+ V+ L    S VN  D++GR  T LH AA    V VV+ LL 
Sbjct: 5   NSEADRQLLEAAKAGDVETVKKLCTVQS-VNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQ 63
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT---KRTPMTVANPREVPEY 183
             A++ A+D+ G     +A  YG+ EV  +L   GA V      K TP+  A  +   +Y
Sbjct: 64  HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAK--GKY 121
Query: 184 ELNPLELQ 191
           E+  L LQ
Sbjct: 122 EICKLLLQ 129

>pdb|1S70|B Chain B, Complex Between Protein Ser/thr Phosphatase-1 (delta) And The Myosin Phosphatase Targeting Subunit 1 (mypt1) Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 7/140 (5%)
Query: 38  RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD 97
           R   ++   G ++ L+P    PV          D     L     GD + V  LL  G+D
Sbjct: 10  RNEQLKRWIGSETDLEP----PVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65
Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
           +N  ++DG TALH A  + +V++VK L+   ANI+  D  G      A   G +++   L
Sbjct: 66  INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYL 125
Query: 158 KARGAKVPKTKR---TPMTV 174
            ++GA V        TP+ +
Sbjct: 126 ISQGAHVGAVNSEGDTPLDI 145

>pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR--TALHIAACEGHVEVVKLLLS 126
           N ++  QLL  A  GDV+ V+ L    S VN  D++GR  T LH AA    V VV+ LL 
Sbjct: 7   NSEADRQLLEAAKAGDVETVKKLCTVQS-VNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQ 65
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT---KRTPMTVANPREVPEY 183
             A++ A+D+ G     +A  YG+ EV  +L   GA V      K TP+  A  +   +Y
Sbjct: 66  HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAK--GKY 123
Query: 184 ELNPLELQ 191
           E+  L LQ
Sbjct: 124 EICKLLLQ 131

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 91/190 (47%), Gaps = 16/190 (8%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VKI++K+      R+  F     + +   H NV++ +    +     +V E    G + S
Sbjct: 43  VKIIEKQPGHIRSRV--FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL---KISG 331
           ++ K+   +  +      D+A  +++LH      I H DLKP+NIL ++  Q+   KI  
Sbjct: 101 HIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANL--YVAPEIYK--NEE---FDRSVDAYSFGLIL 384
           F L     ++ + + I  P   + P     Y+APE+ +  +EE   +D+  D +S G+IL
Sbjct: 158 FDLGSGIKLNGDCSPISTP-ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
Query: 385 YEMIEGVQPF 394
           Y ++ G  PF
Sbjct: 217 YILLSGYPPF 226

>pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR--TALHIAACEGHVEVVKLLLS 126
           N ++  QLL  A  GDV+ V+ L    S VN  D++GR  T LH AA    V VV+ LL 
Sbjct: 9   NSEADRQLLEAAKAGDVETVKKLCTVQS-VNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQ 67
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT---KRTPMTVANPREVPEY 183
             A++ A+D+ G     +A  YG+ EV  +L   GA V      K TP+  A  +   +Y
Sbjct: 68  HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAK--GKY 125
Query: 184 ELNPLELQ 191
           E+  L LQ
Sbjct: 126 EICKLLLQ 133

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 112/254 (44%), Gaps = 36/254 (14%)
Query: 160 RGAKVPKTK---RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQV---AKWNGTKV 213
           RG+KV + K   +    VA P + P+    P E+       I  GS+ V   AK   +  
Sbjct: 2   RGSKVSRDKDGSKVTTVVATPGQGPD---RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 58
Query: 214 WVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF------VGAVTQNIPMMIVLEYH 267
            V I  K+  +D    N    EL I+ K  H N+V+        G     + + +VL+Y 
Sbjct: 59  LVAI--KKVLQDKRFKN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 113
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-N 323
            +        Y + K  L    V  +   L R + Y+H      I H D+KP+N+LLD +
Sbjct: 114 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPD 170
Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE-IYKNEEFDRSVDAYSFGL 382
              LK+  FG  + Q +  E       VS I  +  Y APE I+   ++  S+D +S G 
Sbjct: 171 TAVLKLCDFGSAK-QLVRGEPN-----VSXIC-SRYYRAPELIFGATDYTSSIDVWSAGC 223
Query: 383 ILYEMIEGVQPFHP 396
           +L E++ G QP  P
Sbjct: 224 VLAELLLG-QPIFP 236

>pdb|1MX4|A Chain A, Structure Of P18ink4c (F82q) Length = 168

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GQLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           + K +G KV +K L +    +     A+  EL +++  +H NV+  +   T    +    
Sbjct: 62  IDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLDVFTPASSLRNFY 120
Query: 265 EYH-----AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           +++      + DL   +  +   S  K+      + +G+ Y+H      ++H DLKP N+
Sbjct: 121 DFYLVMPFMQTDLQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNL 175
Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAY 378
            ++   +LKI  FGL R  +   E    V           Y APE+  +   ++++VD +
Sbjct: 176 AVNEDCELKILDFGLAR--HADAEMTGYVV-------TRWYRAPEVILSWMHYNQTVDIW 226
Query: 379 SFGLILYEMIEGVQPFHPK 397
           S G I+ EM+ G   F  K
Sbjct: 227 SVGCIMAEMLTGKTLFKGK 245

>pdb|1MX6|A Chain A, Structure Of P18ink4c (F92n) Length = 168

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 46/76 (60%), Gaps = 1/76 (1%)
Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTAAADAK 146
           ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA   A+
Sbjct: 86  LQTLLENQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLAR 145
Query: 147 YYGNVEVYNILKARGA 162
            YG  EV ++++A GA
Sbjct: 146 LYGRNEVVSLMQANGA 161

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L+  +Q +  L   ++ 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLSQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L+ +  K  ++I     E+ ++++ RH N+V  +    +     +V E+     L   
Sbjct: 57  KFLESDDDKMVKKIA--MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114
Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
                 L    V ++   +  G+ +   C    IIH D+KP+NIL+   G +K+  FG  
Sbjct: 115 ELFPNGLDYQVVQKYLFQIINGIGF---CHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
Query: 336 RLQYISPEKAKIVFPVSHID---PANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGV 391
           R          +  P    D       Y APE+   + ++ ++VD ++ G ++ EM  G 
Sbjct: 172 R---------TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG- 221
Query: 392 QPFHPKPP--EEVVKLMCCEGKRPP 414
           +P  P     +++  +M C G   P
Sbjct: 222 EPLFPGDSDIDQLYHIMMCLGNLIP 246

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 38/239 (15%)
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEY---------HAKGDLASYLQKKGRLSPSKVL 288
           + E   HPNV+++  + T +  + I LE           +K      L+ +   +P  +L
Sbjct: 80  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK-------------ISGFGLL 335
           R    +A G+ +LH  K   IIH DLKP+NIL+    +               IS FGL 
Sbjct: 140 R---QIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 193
Query: 336 RLQYISPEKAKIVFPVSHIDPANL--YVAPEIYKNE---EFDRSVDAYSFGLILYEMI-E 389
           +      +  +  F  +  +P+    + APE+ +        RS+D +S G + Y ++ +
Sbjct: 194 K----KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           G  PF  K   E   +           +  RS   +  +LI +  D  P+ RP   +++
Sbjct: 250 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 38/239 (15%)
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEY---------HAKGDLASYLQKKGRLSPSKVL 288
           + E   HPNV+++  + T +  + I LE           +K      L+ +   +P  +L
Sbjct: 80  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK-------------ISGFGLL 335
           R    +A G+ +LH  K   IIH DLKP+NIL+    +               IS FGL 
Sbjct: 140 R---QIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 193
Query: 336 RLQYISPEKAKIVFPVSHIDPANL--YVAPEIYKNE---EFDRSVDAYSFGLILYEMI-E 389
           +      +  +  F  +  +P+    + APE+ +        RS+D +S G + Y ++ +
Sbjct: 194 K----KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249
Query: 390 GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
           G  PF  K   E   +           +  RS   +  +LI +  D  P+ RP   +++
Sbjct: 250 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L   +Q +  L   ++ 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L   +Q +  L   ++ 
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 130
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTS 180
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L   +Q +  L   ++ 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTS 179
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F ++       Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI 329
           DL  ++ ++G L       F   +   + +   C    ++H D+K +NIL+D N G+LK+
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRH---CHNXGVLHRDIKDENILIDLNRGELKL 152
Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMI 388
             FG   L          V+  +  D   +Y  PE  +   +  RS   +S G++LY+M+
Sbjct: 153 IDFGSGAL------LKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
            G  PF  +  EE+++      +R            + + LI  C   +P  RP F EI
Sbjct: 205 CGDIPF--EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|1IHB|A Chain A, Crystal Structure Of P18-Ink4c(Ink6) Length = 162

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|1BU9|A Chain A, Solution Structure Of P18-Ink4c, 21 Structures Length = 168

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|2RFM|A Chain A, Structure Of A Thermophilic Ankyrin Repeat Protein Length = 192

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 60/121 (49%), Gaps = 2/121 (1%)
Query: 77  LFMACRGDVKGV-EDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A + +  G+ E LL++GS+VN+ D  G+T L  +   G+ E+   LL   AN++ R+
Sbjct: 72  LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV-ANPREVPEYELNPLELQVRK 194
             G T    A  YG  E+   L   GA +     T +T  A+ R     E+  +  +VR+
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191
Query: 195 A 195
           A
Sbjct: 192 A 192

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 19/162 (11%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++   H N++  +   T    +       IV+E     +L   +Q +  L   ++ 
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 131
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                +  G+ +LH      IIH DLKP NI++ +   LKI  FGL R        A   
Sbjct: 132 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTS 181
Query: 349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           F +        Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 182 FMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1MX2|A Chain A, Structure Of F71n Mutant Of P18ink4c Length = 168

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 46/76 (60%), Gaps = 1/76 (1%)
Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTAAADAK 146
           ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA   A+
Sbjct: 86  LQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLAR 145
Query: 147 YYGNVEVYNILKARGA 162
            YG  EV ++++A GA
Sbjct: 146 LYGRNEVVSLMQANGA 161

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	473
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-84
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-81
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-80
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-75
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-75
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-75
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-73
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-72
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-71
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-67
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-67
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-65
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-58
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-58
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-50
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-49
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-49
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-47
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-47
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-47
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-46
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-46
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-46
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-46
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-46
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-45
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-45
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-45
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-44
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-44
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-43
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-43
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-43
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-42
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-42
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-42
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-42
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-42
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-42
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-41
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-41
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-41
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-41
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-41
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-40
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-40
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-40
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-39
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-39
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-38
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-30
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-29
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-28
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-28
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-28
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-28
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-27
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	5e-27
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	7e-24
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	6e-20
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	4e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-27
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	7e-27
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	4e-23
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	3e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-27
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	1e-26
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	9e-22
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	1e-17
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	5e-09
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-26
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-26
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-23
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	3e-20
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-20
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	3e-17
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	3e-16
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	6e-26
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-23
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	7e-20
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	1e-07
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-05
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-26
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	8e-26
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	2e-23
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	1e-21
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	3e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-25
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-25
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-25
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	5e-24
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-18
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	1e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-25
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	2e-25
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	8e-16
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-15
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	1e-13
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	1e-09
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-25
3v30_A	172	DNA-binding protein rfxank; structural genomics co	3e-25
3v30_A	172	DNA-binding protein rfxank; structural genomics co	4e-25
3v30_A	172	DNA-binding protein rfxank; structural genomics co	2e-23
3v30_A	172	DNA-binding protein rfxank; structural genomics co	3e-15
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	3e-25
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	2e-21
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	1e-20
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-16
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-13
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	3e-11
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-25
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	6e-22
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	8e-22
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	2e-20
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	5e-18
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	1e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-25
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	6e-25
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	7e-23
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	2e-19
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	1e-13
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-25
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	2e-24
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	7e-24
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	3e-21
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	2e-13
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	2e-12
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	2e-24
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	6e-24
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	2e-15
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	4e-24
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	4e-22
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	3e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	7e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	5e-19
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-17
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	8e-16
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	7e-13
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	5e-24
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	4e-19
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	6e-24
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-23
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	7e-23
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	7e-23
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	8e-23
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	3e-18
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	7e-15
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	7e-24
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	5e-23
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	2e-18
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	8e-24
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	9e-21
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	2e-19
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	9e-24
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	1e-21
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	6e-18
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	2e-11
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	9e-24
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	2e-22
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	7e-18
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	9e-18
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	4e-15
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	5e-12
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	4e-04
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	1e-23
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	8e-23
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	1e-21
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	5e-18
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	2e-23
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	2e-18
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	3e-14
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	4e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-23
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	3e-23
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	5e-23
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	3e-14
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	9e-10
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	3e-23
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	7e-20
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	2e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	1e-12
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	5e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-23
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	4e-23
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-21
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	5e-20
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-18
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	2e-13
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	3e-13
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	4e-23
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	5e-23
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	9e-10
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-23
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	5e-23
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	2e-22
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	5e-22
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	3e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	2e-19
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	2e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-23
3hra_A	201	Ankyrin repeat family protein; structural protein;	7e-23
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-18
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-18
3hra_A	201	Ankyrin repeat family protein; structural protein;	3e-16
3hra_A	201	Ankyrin repeat family protein; structural protein;	8e-12
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-23
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	8e-23
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	2e-20
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	4e-19
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	7e-15
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	4e-13
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	8e-23
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-22
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	2e-21
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	2e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	1e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	2e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	1e-21
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	1e-16
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	2e-22
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	2e-22
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	4e-22
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	1e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-22
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	4e-22
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	8e-21
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	9e-21
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-20
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	3e-16
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-12
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	1e-09
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-22
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-22
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	6e-22
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-21
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-20
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	2e-20
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-19
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-17
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	3e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-22
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	7e-22
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	7e-21
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-20
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-19
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	5e-17
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-16
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	2e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	2e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	3e-20
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	3e-19
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	4e-19
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	2e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	3e-21
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	9e-20
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	2e-18
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	2e-18
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	1e-14
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	5e-12
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	4e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	6e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	8e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	7e-19
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	1e-11
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	3e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-21
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	7e-21
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	5e-19
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	7e-19
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	4e-17
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-16
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	8e-14
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-19
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-18
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-18
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	5e-18
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	9e-18
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-20
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	1e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	4e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	3e-13
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	1e-06
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-19
2rfa_A	232	Transient receptor potential cation channel subfa	4e-19
2rfa_A	232	Transient receptor potential cation channel subfa	1e-16
2rfa_A	232	Transient receptor potential cation channel subfa	1e-16
2rfa_A	232	Transient receptor potential cation channel subfa	7e-16
2rfa_A	232	Transient receptor potential cation channel subfa	4e-13
2rfa_A	232	Transient receptor potential cation channel subfa	1e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-19
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	2e-18
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	2e-15
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	9e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	2e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	1e-13
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	6e-11
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	3e-10
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	4e-10
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	9e-16
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	2e-14
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	1e-07
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	1e-05
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	2e-04
2pnn_A	273	Transient receptor potential cation channel subfa	1e-15
2pnn_A	273	Transient receptor potential cation channel subfa	5e-13
2pnn_A	273	Transient receptor potential cation channel subfa	2e-11
2pnn_A	273	Transient receptor potential cation channel subfa	5e-11
2pnn_A	273	Transient receptor potential cation channel subfa	4e-08
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-15
2etb_A	256	Transient receptor potential cation channel subfam	6e-15
2etb_A	256	Transient receptor potential cation channel subfam	2e-14
2etb_A	256	Transient receptor potential cation channel subfam	8e-14
2etb_A	256	Transient receptor potential cation channel subfam	9e-12
2etb_A	256	Transient receptor potential cation channel subfam	9e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-14
3jxi_A	260	Vanilloid receptor-related osmotically activated p	5e-14
3jxi_A	260	Vanilloid receptor-related osmotically activated p	6e-13
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-10
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-06
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-14
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	2e-13
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	1e-08
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	6e-05
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	3e-13
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	2e-08
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	4e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-13
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	8e-13
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	1e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-11
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	2e-10
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	5e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
3uo9_A	534	Glutaminase kidney isoform, mitochondrial; hydrola	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  260 bits (666), Expect = 5e-84
 Identities = 98/303 (32%), Positives = 156/303 (51%), Gaps = 27/303 (8%)

Query: 162 AKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKIL 218
           +         +      +  + ++   +L +++   I  GS+  V  A+W+G+ V VKIL
Sbjct: 11  SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK--IGAGSFGTVHRAEWHGSDVAVKIL 68

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
             E     ER+N F  E+ I+++ RHPN+V F+GAVTQ   + IV EY ++G L   L K
Sbjct: 69  -MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127

Query: 279 KGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            G    L   + L  A D+A+GMNYLH   P PI+H +LK  N+L+D    +K+  FGL 
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLS 186

Query: 336 RLQYISPEKAKIVFPVSHIDPAN----LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
           RL+  +   +K          +      ++APE+ ++E  +   D YSFG+IL+E+    
Sbjct: 187 RLKASTFLSSK----------SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236

Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
           QP+    P +VV  +  + KR  +    R+  P +  +IE CW  +P  RP+F  I+  L
Sbjct: 237 QPWGNLNPAQVVAAVGFKCKRLEI---PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

Query: 452 DRI 454
             +
Sbjct: 294 RPL 296

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  252 bits (645), Expect = 6e-81
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 29/281 (10%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
            + ++  E++V +   + +G++  V  AKW    V +K ++ ES +      AF  EL  
Sbjct: 2   LHMIDYKEIEVEEV--VGRGAFGVVCKAKWRAKDVAIKQIESESERK-----AFIVELRQ 54

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLA 295
           + +  HPN+V+  GA     P+ +V+EY   G L + L         + +  + + L  +
Sbjct: 55  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LKISGFGLLRLQYISPEKAKIVFPVSHI 354
           +G+ YLH  +P  +IH DLKP N+LL  GG  LKI  FG            K        
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA---- 168

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLMCCEGKRP 413
                ++APE+++   +    D +S+G+IL+E+I   +PF     P   +      G RP
Sbjct: 169 -----WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           PL    ++ P  ++ L+  CW   P  RP+  EI+  +  +
Sbjct: 224 PL---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  248 bits (635), Expect = 6e-80
 Identities = 80/283 (28%), Positives = 136/283 (48%), Gaps = 26/283 (9%)

Query: 184 ELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPER-INAFTHELTIV 239
           E++  EL + +   I  G + +V  A W G +V VK    +  +D  + I     E  + 
Sbjct: 3   EIDFAELTLEEI--IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
              +HPN++   G   +   + +V+E+   G L   L  K R+ P  ++ +A+ +ARGMN
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQ--------LKISGFGLLRLQYISPEKAKIVFPV 351
           YLH+    PIIH DLK  NIL+    +        LKI+ FGL R  + + + +      
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAY 178

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
           +       ++APE+ +   F +  D +S+G++L+E++ G  PF       V   +     
Sbjct: 179 A-------WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231

Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             P+     + P    +L+E+CW+P P  RP+F  I+ +L  I
Sbjct: 232 ALPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  238 bits (609), Expect = 1e-75
 Identities = 81/292 (27%), Positives = 129/292 (44%), Gaps = 36/292 (12%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKW--NGTKVWVKIL----DKESHKDPERINAF 232
              L   E++  K   I KG +  V   +   + + V +K L     +   +  E+   F
Sbjct: 13  LPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFA 291
             E+ I+    HPN+V+  G +    P  +V+E+   GDL   L  K   +  S  LR  
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRLQYISPEKAK 346
           LD+A G+ Y+    P PI+H DL+  NI L +  +      K++ FGL +    S     
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL 187

Query: 347 IVFPVSHIDPANLYVAPEIY--KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV-- 402
             F          ++APE    + E +    D YSF +ILY ++ G  PF      ++  
Sbjct: 188 GNFQ---------WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           + ++  EG RP +       PP L+ +IE CW   P  RP+F+ I+  L  +
Sbjct: 239 INMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  236 bits (604), Expect = 3e-75
 Identities = 64/283 (22%), Positives = 121/283 (42%), Gaps = 28/283 (9%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
              ++  +L       + +    ++   +W G  + VK+L K       +   F  E   
Sbjct: 4   HSGIDFKQLNFLTK--LNENHSGELWKGRWQGNDIVVKVL-KVRDWSTRKSRDFNEECPR 60

Query: 239 VEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDL 294
           +    HPNV+  +GA          ++  +   G L + L +     +  S+ ++FALD+
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           ARGM +LH  +P  I    L  +++++D     +IS   +           ++  P    
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQ---SPGRMYAP---- 172

Query: 355 DPANLYVAPEIYKNEEFD---RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
                +VAPE  + +  D   RS D +SF ++L+E++    PF      E+   +  EG 
Sbjct: 173 ----AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228

Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           RP +        P + +L++ C +  P  RP F+ I+  L+++
Sbjct: 229 RPTI---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  237 bits (607), Expect = 5e-75
 Identities = 69/292 (23%), Positives = 132/292 (45%), Gaps = 25/292 (8%)

Query: 176 NPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAF 232
               + E+++   +L++ +   I KG + QV   +W+G  V ++++      + +++ AF
Sbjct: 21  TSIFLQEWDIPFEQLEIGEL--IGKGRFGQVYHGRWHGE-VAIRLI-DIERDNEDQLKAF 76

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFA 291
             E+    + RH NVV F+GA      + I+        L S ++  K  L  +K  + A
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
            ++ +GM YLH      I+H DLK KN+  DN G++ I+ FGL  +  +     +     
Sbjct: 137 QEIVKGMGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLR 192

Query: 352 SHIDPANLYVAPEIYKNEE---------FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
                   ++APEI +            F +  D ++ G I YE+     PF  +P E +
Sbjct: 193 IQNGWL-CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251

Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +      G +P   +       ++ +++  CW  +   RP F +++  L+++
Sbjct: 252 I-WQMGTGMKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  229 bits (586), Expect = 2e-72
 Identities = 78/284 (27%), Positives = 142/284 (50%), Gaps = 26/284 (9%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++E+   ++ V +   I  GS+  V   KW+G  V VK+L   +   P+++ AF +E+ +
Sbjct: 18  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGV 73

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARG 297
           + K RH N++ F+G  T    + IV ++     L  +L   + +    K++  A   ARG
Sbjct: 74  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ---YISPEKAKIVFPVSHI 354
           M+YLH      IIH DLK  NI L     +KI  FGL   +     S +  ++   +   
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI--- 186

Query: 355 DPANLYVAPEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLMCCEG 410
               L++APE+ + ++   +    D Y+FG++LYE++ G  P+ +    +++++++    
Sbjct: 187 ----LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             P L     + P  +K L+ EC   K   RP+F  I+A ++ +
Sbjct: 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  227 bits (580), Expect = 4e-71
 Identities = 69/295 (23%), Positives = 116/295 (39%), Gaps = 22/295 (7%)

Query: 180 VPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHEL 236
           +P     P +L   +   + KG + Q        T   + +  +    D E    F  E+
Sbjct: 2   MPHRIFRPSDLIHGEV--LGKGCFGQAIKVTHRETGEVMVMK-ELIRFDEETQRTFLKEV 58

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLA 295
            ++    HPNV++F+G + ++  +  + EY   G L   ++        S+ + FA D+A
Sbjct: 59  KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
            GM YLH      IIH DL   N L+     + ++ FGL RL      + + +  +   D
Sbjct: 119 SGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 356 PANLYV--------APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEEVVKLM 406
               Y         APE+     +D  VD +SFG++L E+I  V       P      L 
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235

Query: 407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
                         + PP    +   C D  P  RP+F ++   L+ +  + +  
Sbjct: 236 VRGFLDRYC---PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  218 bits (558), Expect = 2e-67
 Identities = 72/316 (22%), Positives = 118/316 (37%), Gaps = 52/316 (16%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFT 233
           P  V       +++  +      KG Y +V   KW G KV VK+              + 
Sbjct: 28  PLLVQRTIAKQIQMVKQIG----KGRYGEVWMGKWRGEKVAVKVFFTTEEAS------WF 77

Query: 234 HELTI--VEKARHPNVVQFVGAVTQ----NIPMMIVLEYHAKGDLASYLQKKGRLSPSKV 287
            E  I      RH N++ F+ A  +       + ++ +YH  G L  YL+    L    +
Sbjct: 78  RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136

Query: 288 LRFALDLARGMNYLHE------CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
           L+ A     G+ +LH        KP  I H DLK KNIL+   G   I+  GL       
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVK--FI 193

Query: 342 PEKAKIVFPVSHIDPANLYVAPEI------YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
            +  ++  P +       Y+ PE+        + +     D YSFGLIL+E+        
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

Query: 396 PKPP---------------EEVVKLMCCEGKRP--PLKIKARSYPPDLKELIEECWDPKP 438
                              E++ +++C +  RP  P +  +      + +L+ ECW   P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313

Query: 439 VIRPNFNEIIARLDRI 454
             R     +   L ++
Sbjct: 314 ASRLTALRVKKTLAKM 329

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  215 bits (550), Expect = 9e-67
 Identities = 74/295 (25%), Positives = 118/295 (40%), Gaps = 48/295 (16%)

Query: 198 ITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI--VEKARHPNVVQFVG 252
           + KG Y +V    W G  V VKI      K       +  E  +      RH N++ F+ 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKS------WFRETELYNTVMLRHENILGFIA 69

Query: 253 AVT----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE----- 303
           +       +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 304 -CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVA 362
             KP  I H DLK KNIL+   GQ  I+  GL  +   S    ++    +       Y+A
Sbjct: 129 QGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMA 185

Query: 363 PEIYKNE------EFDRSVDAYSFGLILYEMIEGVQPFHPKPP---------------EE 401
           PE+          +  + VD ++FGL+L+E+   +                       E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 402 VVKLMCCEGKRPPL--KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           + K++C + +RP +  +  +      L +L++ECW   P  R     I   L +I
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  212 bits (542), Expect = 3e-65
 Identities = 76/316 (24%), Positives = 122/316 (38%), Gaps = 52/316 (16%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFT 233
           P  V       + LQ      I KG + +V   KW G +V VKI      +       + 
Sbjct: 33  PLLVQRTIARTIVLQES----IGKGRFGEVWRGKWRGEEVAVKIFSSREERS------WF 82

Query: 234 HELTI--VEKARHPNVVQFVGAVTQN----IPMMIVLEYHAKGDLASYLQKKGRLSPSKV 287
            E  I      RH N++ F+ A  ++      + +V +YH  G L  YL +   ++   +
Sbjct: 83  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGM 141

Query: 288 LRFALDLARGMNYLHE------CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
           ++ AL  A G+ +LH        KP  I H DLK KNIL+   G   I+  GL       
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRH--D 198

Query: 342 PEKAKIVFPVSHIDPANLYVAPEI------YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                I    +H      Y+APE+       K+ E  +  D Y+ GL+ +E+        
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258

Query: 396 PKPP---------------EEVVKLMCCEGKRP--PLKIKARSYPPDLKELIEECWDPKP 438
                              EE+ K++C +  RP  P + ++      + +++ ECW    
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318

Query: 439 VIRPNFNEIIARLDRI 454
             R     I   L ++
Sbjct: 319 AARLTALRIKKTLSQL 334

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (497), Expect = 1e-58
 Identities = 74/323 (22%), Positives = 117/323 (36%), Gaps = 55/323 (17%)

Query: 179 EVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHE 235
              E  L+   L++ +   I +G Y  V     +   V VK+    + ++      F +E
Sbjct: 4   AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVFSFANRQN------FINE 55

Query: 236 LTIVE--KARHPNVVQFVGA-----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
             I       H N+ +F+           +  ++V+EY+  G L  YL            
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 289 RFALDLARGMNYLHECKPD------PIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
           R A  + RG+ YLH   P        I H DL  +N+L+ N G   IS FGL      + 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 343 EKAKIVFPVSHIDPA--NLYVAPEIYKN-------EEFDRSVDAYSFGLILYEMI---EG 390
                    + I       Y+APE+ +        E   + VD Y+ GLI +E+      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 391 VQPFHPKPP---------------EEVVKLMCCEGKRPPLK---IKARSYPPDLKELIEE 432
           + P    P                E++  L+  E +RP       +       LKE IE+
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 433 CWDPKPVIRPNFNEIIARLDRIV 455
           CWD     R        R+  ++
Sbjct: 295 CWDQDAEARLTAQXAEERMAELM 317

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  194 bits (494), Expect = 2e-58
 Identities = 73/312 (23%), Positives = 128/312 (41%), Gaps = 50/312 (16%)

Query: 181 PEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELT 237
                  + LQ+ +     +G +  V  A+     V VKI   +  +  +       E+ 
Sbjct: 17  ENLYFQSMPLQLLEV--KARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY----EVY 70

Query: 238 IVEKARHPNVVQFVGAVTQ----NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            +   +H N++QF+GA  +    ++ + ++  +H KG L+ +L+    +S +++   A  
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129

Query: 294 LARGMNYLHE--------CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
           +ARG+ YLHE         KP  I H D+K KN+LL N     I+ FGL        E  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLALKF----EAG 184

Query: 346 KIVFPVSHIDPANLYVAPE-----IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP- 399
           K             Y+APE     I    +    +D Y+ GL+L+E+             
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 400 ---------------EEVVKLMCCEGKRPPLK--IKARSYPPDLKELIEECWDPKPVIRP 442
                          E++ +++  + KRP L+   +  +    L E IEECWD     R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 443 NFNEIIARLDRI 454
           +   +  R+ ++
Sbjct: 305 SAGCVGERITQM 316

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  176 bits (449), Expect = 2e-50
 Identities = 83/299 (27%), Positives = 139/299 (46%), Gaps = 30/299 (10%)

Query: 163 KVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILD 219
             PK     +   +      + LN  EL++ +  G  KG +  V    + G KV VK + 
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIG--KGEFGDVMLGDYRGNKVAVKCI- 224

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQK 278
           K          AF  E +++ + RH N+VQ +G + +    + IV EY AKG L  YL+ 
Sbjct: 225 KNDATA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

Query: 279 KGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +GR  L    +L+F+LD+   M YL        +H DL  +N+L+      K+S FGL +
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

Query: 337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFH 395
               + +  K   PV        + APE  + ++F    D +SFG++L+E+   G  P+ 
Sbjct: 338 EASSTQDTGK--LPVK-------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388

Query: 396 PKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             P ++VV  +  +G +          PP + ++++ CW      RP F ++  +L+ I
Sbjct: 389 RIPLKDVVPRV-EKGYKMD---APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  175 bits (446), Expect = 1e-49
 Identities = 80/317 (25%), Positives = 136/317 (42%), Gaps = 34/317 (10%)

Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG--T 211
           L          +  P          ++E+   ++ ++   G   G Y +V    W     
Sbjct: 189 LITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLG--GGQYGEVYEGVWKKYSL 246

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V VK L KE   + E    F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+
Sbjct: 247 TVAVKTL-KEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302

Query: 272 LASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           L  YL++  R  +S   +L  A  ++  M YL +      IH +L  +N L+     +K+
Sbjct: 303 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKV 359

Query: 330 SGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
           + FGL RL     Y +   AK  FP+        + APE     +F    D ++FG++L+
Sbjct: 360 ADFGLSRLMTGDTYTAHAGAK--FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLW 410

Query: 386 EMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNF 444
           E+   G+ P+      +V +L+  +  R     +    P  + EL+  CW   P  RP+F
Sbjct: 411 EIATYGMSPYPGIDLSQVYELL-EKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSF 466

Query: 445 NEIIARLDRIVCNCSKQ 461
            EI    + +    S  
Sbjct: 467 AEIHQAFETMFQESSIS 483

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  171 bits (436), Expect = 4e-49
 Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 34/303 (11%)

Query: 165 PKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY---QVAKWNG--TKVWVKILD 219
           P TK++ + +       ++ LN  +L + +  G  +G++      +     T V VK   
Sbjct: 91  PLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIG--RGNFGEVFSGRLRADNTLVAVKSC- 147

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           +E+     +   F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +
Sbjct: 148 RETLPPDLKA-KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 206

Query: 280 GR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL- 337
           G  L    +L+   D A GM YL        IH DL  +N L+     LKIS FG+ R  
Sbjct: 207 GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263

Query: 338 ---QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQP 393
               Y +    +   PV        + APE      +    D +SFG++L+E    G  P
Sbjct: 264 ADGVYAASGGLRQ-VPVK-------WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

Query: 394 FHPKPPEEVVKLMCCEGKR--PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
           +     ++  +    +G R   P        P  +  L+E+CW  +P  RP+F+ I   L
Sbjct: 316 YPNLSNQQTRE-FVEKGGRLPCPELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

Query: 452 DRI 454
             I
Sbjct: 370 QSI 372

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  168 bits (427), Expect = 6e-49
 Identities = 82/281 (29%), Positives = 137/281 (48%), Gaps = 30/281 (10%)

Query: 181 PEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELT 237
             + LN  EL++ +  G  KG +  V    + G KV VK + K          AF  E +
Sbjct: 14  SGWALNMKELKLLQTIG--KGEFGDVMLGDYRGNKVAVKCI-KNDATA----QAFLAEAS 66

Query: 238 IVEKARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDL 294
           ++ + RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
              M YL        +H DL  +N+L+      K+S FGL +    + +  K   PV   
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPVK-- 179

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRP 413
                + APE  + ++F    D +SFG++L+E+   G  P+   P ++VV  +  +G + 
Sbjct: 180 -----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKM 233

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                    PP + E+++ CW     +RP+F ++  +L+ I
Sbjct: 234 D---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  165 bits (419), Expect = 1e-47
 Identities = 79/293 (26%), Positives = 133/293 (45%), Gaps = 34/293 (11%)

Query: 181 PEYELNPLELQVRKADGITKGSY-QV--AKWNG--TKVWVKILDKESHKDPERINAFTHE 235
            ++E+   ++ ++   G   G Y +V    W      V VK L KE   + E    F  E
Sbjct: 6   DKWEMERTDITMKHKLG--GGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE---EFLKE 59

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALD 293
             ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  +S   +L  A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVF 349
           ++  M YL +      IH DL  +N L+     +K++ FGL RL     Y +   AK  F
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK--F 174

Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCC 408
           P+        + APE     +F    D ++FG++L+E+   G+ P+      +V +L+  
Sbjct: 175 PIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-E 226

Query: 409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +  R     +    P  + EL+  CW   P  RP+F EI    + +    S  
Sbjct: 227 KDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  163 bits (415), Expect = 4e-47
 Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 30/292 (10%)

Query: 177 PREVPEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERIN 230
           P +     +   +L++ +  G      + +G +         V VK L  +    PE ++
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66

Query: 231 AFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLR 289
            F  E+  +    H N+++  G V    PM +V E    G L   L+K +G      + R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPE 343
           +A+ +A GM YL   +    IH DL  +N+LL     +KI  FGL+R        Y+  E
Sbjct: 126 YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

Query: 344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEV 402
             K   P +       + APE  K   F  + D + FG+ L+EM   G +P+      ++
Sbjct: 183 HRK--VPFA-------WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233

Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +  +  EG+R P   +    P D+  ++ +CW  KP  RP F  +   L   
Sbjct: 234 LHKIDKEGERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  162 bits (413), Expect = 4e-47
 Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 32/284 (11%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAFTHELT 237
           ++ ++P EL   +  G   G +  V    W    KV +K + +E     E    F  E  
Sbjct: 2   KWVIDPSELTFVQEIG--SGQFGLVHLGYWLNKDKVAIKTI-REGAMSEE---DFIEEAE 55

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++ K  HP +VQ  G   +  P+ +V E+   G L+ YL+  +G  +   +L   LD+  
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVS 352
           GM YL E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV 
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVK 170

Query: 353 HIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGK 411
                  + +PE++    +    D +SFG++++E+  EG  P+  +   EVV+ +   G 
Sbjct: 171 -------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGF 222

Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           R     K R     + +++  CW  +P  RP F+ ++ +L  I 
Sbjct: 223 RLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  162 bits (413), Expect = 5e-47
 Identities = 80/281 (28%), Positives = 134/281 (47%), Gaps = 32/281 (11%)

Query: 184 ELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAFTHELTIV 239
           EL   E+ + K  G   G +  V   KW G   V VK++ KE     +    F  E   +
Sbjct: 4   ELKREEITLLKELG--SGQFGVVKLGKWKGQYDVAVKMI-KEGSMSED---EFFQEAQTM 57

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGM 298
            K  HP +V+F G  ++  P+ IV EY + G L +YL+  G+ L PS++L    D+  GM
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHI 354
            +L   +    IH DL  +N L+D    +K+S FG+ R     QY+S    K  FPV   
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK--FPVK-- 170

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRP 413
                + APE++   ++    D ++FG++++E+   G  P+      EVV  +  +G R 
Sbjct: 171 -----WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRL 224

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
               +       + +++  CW   P  RP F ++++ ++ +
Sbjct: 225 Y---RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  161 bits (410), Expect = 2e-46
 Identities = 87/296 (29%), Positives = 141/296 (47%), Gaps = 34/296 (11%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAF 232
           P    E+E+    L++ +  G   G + +V    +NG TKV VK L K+    P+   AF
Sbjct: 2   PWWEDEWEVPRETLKLVERLG--AGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD---AF 55

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRF 290
             E  ++++ +H  +V+    VTQ  P+ I+ EY   G L  +L+      L+ +K+L  
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAK 346
           A  +A GM ++ E      IH DL+  NIL+ +    KI+ FGL RL    +Y + E AK
Sbjct: 115 AAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171

Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKL 405
             FP+        + APE      F    D +SFG++L E++  G  P+      EV++ 
Sbjct: 172 --FPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +   G R     +  + P +L +L+  CW  +P  RP F+ + + L+        Q
Sbjct: 223 LE-RGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  161 bits (410), Expect = 2e-46
 Identities = 76/295 (25%), Positives = 135/295 (45%), Gaps = 31/295 (10%)

Query: 179 EVPEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAF 232
              +YE+    +++ +  G      + +G Y   +     V +K   K    D  R   F
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVRE-KF 63

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFA 291
             E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ  K  L  + ++ +A
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKI 347
             L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K 
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK- 178

Query: 348 VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLM 406
             P+        ++APE      F  + D + FG+ ++E++  GV+PF      +V+  +
Sbjct: 179 -LPI-------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

Query: 407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              G+R P      + PP L  L+ +CW   P  RP F E+ A+L  I+     Q
Sbjct: 231 E-NGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  161 bits (409), Expect = 3e-46
 Identities = 75/299 (25%), Positives = 131/299 (43%), Gaps = 34/299 (11%)

Query: 167 TKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKES 222
           +K  P T         +E++P +L   K  G   G +  V   KW G   V +K++ KE 
Sbjct: 5   SKNAPSTAGLGYG--SWEIDPKDLTFLKELG--TGQFGVVKYGKWRGQYDVAIKMI-KEG 59

Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGR 281
               +    F  E  ++    H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R
Sbjct: 60  SMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 116

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---- 337
               ++L    D+   M YL   +    +H DL  +N L+++ G +K+S FGL R     
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

Query: 338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHP 396
           +Y S   +K  FPV        +  PE+    +F    D ++FG++++E+   G  P+  
Sbjct: 174 EYTSSVGSK--FPVR-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224

Query: 397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
               E  +    +G R     +       +  ++  CW  K   RP F  +++ +  ++
Sbjct: 225 FTNSETAE-HIAQGLRLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  165 bits (420), Expect = 3e-46
 Identities = 85/291 (29%), Positives = 135/291 (46%), Gaps = 34/291 (11%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAFTHELT 237
            +E+    L++    G  +G + +V    WNG T+V +K L K     PE   AF  E  
Sbjct: 178 AWEIPRESLRLEVKLG--QGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQ 231

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLA 295
           +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ +    L   +++  A  +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPI 345

Query: 352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEG 410
                   + APE      F    D +SFG++L E+  +G  P+      EV+  +   G
Sbjct: 346 K-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RG 397

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
            R P        P  L +L+ +CW  +P  RP F  + A L+    +   Q
Sbjct: 398 YRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  161 bits (410), Expect = 5e-46
 Identities = 77/308 (25%), Positives = 137/308 (44%), Gaps = 35/308 (11%)

Query: 165 PKTKRTPMTVANPREVP---EYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWV 215
           P+    P T   P         E+    + + K  G      +  G  +V       V +
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L K  + + +R + F  E +I+ +  HPN+++  G VT+    MIV EY   G L ++
Sbjct: 83  KAL-KAGYTERQRRD-FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140

Query: 276 LQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           L+   G+ +  +++     +  GM YL +      +H DL  +N+L+D+    K+S FGL
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL 197

Query: 335 LRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
            R+         +    K   P+        + APE      F  + D +SFG++++E++
Sbjct: 198 SRVLEDDPDAAYTTTGGK--IPI-------RWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

Query: 389 -EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
             G +P+      +V+  +  EG R P        P  L +L+ +CW      RP F++I
Sbjct: 249 AYGERPYWNMTNRDVISSV-EEGYRLP---APMGCPHALHQLMLDCWHKDRAQRPRFSQI 304

Query: 448 IARLDRIV 455
           ++ LD ++
Sbjct: 305 VSVLDALI 312

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  165 bits (418), Expect = 2e-45
 Identities = 88/309 (28%), Positives = 140/309 (45%), Gaps = 38/309 (12%)

Query: 164 VPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILD 219
            P +K     +A       +E+    L++    G  +G + +V    WNG T+V +K L 
Sbjct: 247 CPTSKPQTQGLAKD----AWEIPRESLRLEVKLG--QGCFGEVWMGTWNGTTRVAIKTL- 299

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K     PE   AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ +
Sbjct: 300 KPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGE 355

Query: 280 GR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
               L   +++  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412

Query: 338 ----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQ 392
               +Y + + AK  FP+        + APE      F    D +SFG++L E+  +G  
Sbjct: 413 IEDNEYTARQGAK--FPIK-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463

Query: 393 PFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
           P+      EV+  +   G R P        P  L +L+ +CW  +P  RP F  + A L+
Sbjct: 464 PYPGMVNREVLDQVE-RGYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

Query: 453 RIVCNCSKQ 461
               +   Q
Sbjct: 520 DYFTSTEPQ 528

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  159 bits (404), Expect = 5e-45
 Identities = 78/326 (23%), Positives = 149/326 (45%), Gaps = 39/326 (11%)

Query: 151 VEVYNILKARGAKVPKTKRT---PMTVANPREVP---EYELNPLELQVRKADG------I 198
           +  Y+        +P T+         ++P +       E++P  +  +K  G      +
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEV 60

Query: 199 TKGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
            KG  + +       V +K L K  + + +R++ F  E  I+ +  H N+++  G +++ 
Sbjct: 61  YKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKY 118

Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PMMI+ EY   G L  +L++  G  S  +++     +A GM YL        +H DL  
Sbjct: 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAA 175

Query: 317 KNILLDNGGQLKISGFGLLRLQ------YISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           +NIL+++    K+S FGL R+         +    K   P+        + APE     +
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK--IPI-------RWTAPEAISYRK 226

Query: 371 FDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           F  + D +SFG++++E++  G +P+      EV+K +  +G R P        P  + +L
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLP---TPMDCPSAIYQL 282

Query: 430 IEECWDPKPVIRPNFNEIIARLDRIV 455
           + +CW  +   RP F +I++ LD+++
Sbjct: 283 MMQCWQQERARRPKFADIVSILDKLI 308

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  162 bits (411), Expect = 7e-45
 Identities = 88/310 (28%), Positives = 139/310 (44%), Gaps = 37/310 (11%)

Query: 163 KVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKIL 218
            VP     P     P E   +E+    L++ K  G   G + +V  A +N  TKV VK +
Sbjct: 166 SVPCMSSKPQ---KPWEKDAWEIPRESLKLEKKLG--AGQFGEVWMATYNKHTKVAVKTM 220

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
            K      E   AF  E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+ 
Sbjct: 221 -KPGSMSVE---AFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKS 275

Query: 279 KGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
                    K++ F+  +A GM ++ +      IH DL+  NIL+      KI+ FGL R
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332

Query: 337 L----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGV 391
           +    +Y + E AK  FP+        + APE      F    D +SFG++L E++  G 
Sbjct: 333 VIEDNEYTAREGAK--FPIK-------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
            P+      EV++ +   G R P   +  + P +L  ++  CW  +P  RP F  I + L
Sbjct: 384 IPYPGMSNPEVIRALE-RGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

Query: 452 DRIVCNCSKQ 461
           D        Q
Sbjct: 440 DDFYTATESQ 449

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  157 bits (399), Expect = 7e-45
 Identities = 70/286 (24%), Positives = 129/286 (45%), Gaps = 31/286 (10%)

Query: 181 PEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
           P+Y +   ++ + +  G      + +G Y   K     V VK   K+      +   F  
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKE-KFMS 62

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E  I++   HP++V+ +G + +  P  I++E +  G+L  YL++ K  L    ++ ++L 
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVF 349
           + + M YL        +H D+  +NIL+ +   +K+  FGL R      Y      +   
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR--L 176

Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCC 408
           P+        +++PE      F  + D + F + ++E++  G QPF     ++V+ ++  
Sbjct: 177 PIK-------WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE- 228

Query: 409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +G R P   K    PP L  L+  CWD  P  RP F E++  L  +
Sbjct: 229 KGDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  165 bits (418), Expect = 9e-45
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 25/268 (9%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G Y   +     V +K   K    D  R   F  E   + +  HP++V+ +G +T+N P
Sbjct: 408 QGIYMSPENPAMAVAIKTC-KNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVITEN-P 464

Query: 260 MMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           + I++E    G+L S+LQ  K  L  + ++ +A  L+  + YL   +    +H D+  +N
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARN 521

Query: 319 ILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           +L+ +   +K+  FGL R      Y    K K+  P+        ++APE      F  +
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIK-------WMAPESINFRRFTSA 572

Query: 375 VDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
            D + FG+ ++E++  GV+PF      +V+  +   G+R P      + PP L  L+ +C
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLP---MPPNCPPTLYSLMTKC 628

Query: 434 WDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           W   P  RP F E+ A+L  I+     Q
Sbjct: 629 WAYDPSRRPRFTELKAQLSTILEEEKLQ 656

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  157 bits (400), Expect = 2e-44
 Identities = 56/263 (21%), Positives = 118/263 (44%), Gaps = 27/263 (10%)

Query: 200 KGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           KG +          V +K L +E+            E  ++    +P+V + +G    + 
Sbjct: 33  KGLWIPEGEKVKIPVAIKEL-REATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTS- 89

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            + ++ +    G L  Y+++ K  +    +L + + +A+GMNYL + +   ++H DL  +
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 318 NILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           N+L+     +KI+ FGL +L     +    E  K   P+        ++A E   +  + 
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPIK-------WMALESILHRIYT 197

Query: 373 RSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              D +S+G+ ++E++  G +P+   P  E+  ++  +G+R P   +      D+  ++ 
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLP---QPPICTIDVYMIMR 253

Query: 432 ECWDPKPVIRPNFNEIIARLDRI 454
           +CW      RP F E+I    ++
Sbjct: 254 KCWMIDADSRPKFRELIIEFSKM 276

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  156 bits (396), Expect = 6e-44
 Identities = 57/263 (21%), Positives = 123/263 (46%), Gaps = 27/263 (10%)

Query: 200 KGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           KG +     +    V +K++ ++         A T  +  +    H ++V+ +G    + 
Sbjct: 31  KGVWIPEGESIKIPVCIKVI-EDKSGRQSF-QAVTDHMLAIGSLDHAHIVRLLGLCPGS- 87

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            + +V +Y   G L  ++++ +G L P  +L + + +A+GM YL E     ++H +L  +
Sbjct: 88  SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAAR 144

Query: 318 NILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           N+LL +  Q++++ FG+  L     + +   +AK   P+        ++A E     ++ 
Sbjct: 145 NVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK--TPIK-------WMALESIHFGKYT 195

Query: 373 RSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              D +S+G+ ++E++  G +P+      EV  L+  +G+R     + +    D+  ++ 
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLA---QPQICTIDVYMVMV 251

Query: 432 ECWDPKPVIRPNFNEIIARLDRI 454
           +CW     IRP F E+     R+
Sbjct: 252 KCWMIDENIRPTFKELANEFTRM 274

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  154 bits (392), Expect = 9e-44
 Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 29/268 (10%)

Query: 206 AKWNG----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
             +        V VKIL K    DP   +    E  ++++  +P +V+ +G        M
Sbjct: 36  GYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWM 93

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           +V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +N+LL
Sbjct: 94  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLL 150

Query: 322 DNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSV 375
                 KIS FGL +        Y +    K  +PV        + APE     +F    
Sbjct: 151 VTQHYAKISDFGLSKALRADENYYKAQTHGK--WPVK-------WYAPECINYYKFSSKS 201

Query: 376 DAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECW 434
           D +SFG++++E    G +P+      EV  ++  +G+R          P ++ +L+  CW
Sbjct: 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMG---CPAGCPREMYDLMNLCW 257

Query: 435 DPKPVIRPNFNEIIARLDRIVCNCSKQG 462
                 RP F  +  RL     +   +G
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDVVNEG 285

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  156 bits (396), Expect = 2e-43
 Identities = 83/310 (26%), Positives = 150/310 (48%), Gaps = 33/310 (10%)

Query: 163 KVPKTKR--TPMTVANPREVP---EYELNPLELQVRKADG------ITKGSYQVAKWNGT 211
           K+P  +    P T  +P +       EL+   + + K  G      +  G  ++      
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V +K L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G 
Sbjct: 75  SVAIKTL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGS 132

Query: 272 LASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L S+L+K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189

Query: 331 GFGLLRLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
            FGL R+    PE A        P+        + +PE     +F  + D +S+G++L+E
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPI-------RWTSPEAIAYRKFTSASDVWSYGIVLWE 242

Query: 387 MI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFN 445
           ++  G +P+     ++V+K +  EG R P        P  L +L+ +CW      RP F 
Sbjct: 243 VMSYGERPYWEMSNQDVIKAV-DEGYRLP---PPMDCPAALYQLMLDCWQKDRNNRPKFE 298

Query: 446 EIIARLDRIV 455
           +I++ LD+++
Sbjct: 299 QIVSILDKLI 308

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  154 bits (391), Expect = 2e-43
 Identities = 68/270 (25%), Positives = 121/270 (44%), Gaps = 24/270 (8%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-I 258
            G+            VK L        E    F  E  I++   HPNV+  +G   ++  
Sbjct: 43  HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEG 100

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             ++VL Y   GDL ++++      +   ++ F L +A+GM YL   K    +H DL  +
Sbjct: 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAAR 157

Query: 318 NILLDNGGQLKISGFGLLRLQ-----YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           N +LD    +K++ FGL R       Y    K     PV        ++A E  + ++F 
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK-------WMALESLQTQKFT 210

Query: 373 RSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              D +SFG++L+E++  G  P+      ++   +  +G+R     +    P  L E++ 
Sbjct: 211 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLL---QPEYCPDPLYEVML 266

Query: 432 ECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +CW PK  +RP+F+E+++R+  I      +
Sbjct: 267 KCWHPKAEMRPSFSELVSRISAIFSTFIGE 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  152 bits (387), Expect = 9e-43
 Identities = 85/317 (26%), Positives = 145/317 (45%), Gaps = 54/317 (17%)

Query: 172 MTVANPR--------EVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKV 213
           M   NP            E+E+   ++ + +  G  +GS+  V      G       T+V
Sbjct: 1   MASVNPEYFSAADVYVPDEWEVAREKITMSRELG--QGSFGMVYEGVAKGVVKDEPETRV 58

Query: 214 WVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
            +K +  E+    ERI  F +E +++++    +VV+ +G V+Q  P ++++E   +GDL 
Sbjct: 59  AIKTV-NEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116

Query: 274 SYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           SYL+               S SK+++ A ++A GM YL+  K    +H DL  +N ++  
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173

Query: 324 GGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
              +KI  FG+ R       Y    K     PV        +++PE  K+  F    D +
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGKGL--LPVR-------WMSPESLKDGVFTTYSDVW 224

Query: 379 SFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           SFG++L+E+     QP+     E+V++ +  EG       K  + P  L EL+  CW   
Sbjct: 225 SFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGLLD---KPDNCPDMLFELMRMCWQYN 280

Query: 438 PVIRPNFNEIIARLDRI 454
           P +RP+F EII+ +   
Sbjct: 281 PKMRPSFLEIISSIKEE 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  152 bits (387), Expect = 1e-42
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 36/276 (13%)

Query: 200 KGSYQ-VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
              Y  +    G  V VK L + S   P++   F  E+ I++      +V++ G      
Sbjct: 41  LCRYDPLGDNTGALVAVKQL-QHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97

Query: 259 --PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
              + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H DL 
Sbjct: 98  RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLA 154

Query: 316 PKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
            +NIL+++   +KI+ FGL +L       Y+  E  +   P+        + APE   + 
Sbjct: 155 ARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ--SPIF-------WYAPESLSDN 205

Query: 370 EFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPP--LKIKARSY---- 422
            F R  D +SFG++LYE+     +   P      +     +       L++         
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265

Query: 423 ----PPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
               P ++ EL++ CW P P  RP+F+ +  +LD +
Sbjct: 266 PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  152 bits (387), Expect = 1e-42
 Identities = 78/342 (22%), Positives = 144/342 (42%), Gaps = 60/342 (17%)

Query: 147 YYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV 205
           ++ +   Y+I             +     +P +  E  L       +    + KG++  V
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHL-------KFLQQLGKGNFGSV 57

Query: 206 --AKWNG------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
              +++         V VK L + S ++  R   F  E+ I++  +H N+V++ G     
Sbjct: 58  EMCRYDPLQDNTGEVVAVKKL-QHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 258 I--PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
               + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH DL
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDL 171

Query: 315 KPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
             +NIL++N  ++KI  FGL ++       Y   E  +   P+        + APE    
Sbjct: 172 ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE--SPIF-------WYAPESLTE 222

Query: 369 EEFDRSVDAYSFGLILYEMI----------------EGVQPFHPKPPEEVVKLMCCEGKR 412
            +F  + D +SFG++LYE+                  G           +++L+     R
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGR 281

Query: 413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            P   +    P ++  ++ ECW+     RP+F ++  R+D+I
Sbjct: 282 LP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  152 bits (386), Expect = 2e-42
 Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 35/280 (12%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +   +    +  KV VK+L K        I  F  E   +++  HP+V + VG   ++  
Sbjct: 41  EAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99

Query: 260 ------MMIVLEYHAKGDLASYLQK------KGRLSPSKVLRFALDLARGMNYLHECKPD 307
                  M++L +   GDL ++L           L    ++RF +D+A GM YL      
Sbjct: 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-- 157

Query: 308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVA 362
             IH DL  +N +L     + ++ FGL R       Y     +K   PV        ++A
Sbjct: 158 -FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK--LPVK-------WLA 207

Query: 363 PEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
            E   +  +    D ++FG+ ++E++  G  P+      E+   +   G R     +   
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GGNRLK---QPPE 263

Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              ++ +L+ +CW   P  RP+F  +   L+ I+ + S  
Sbjct: 264 CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  151 bits (383), Expect = 2e-42
 Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 45/281 (16%)

Query: 200 KGSYQVAKWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
              Y   + N G  V VK L + S ++  R   F  E+ I++  +H N+V++ G      
Sbjct: 28  MCRYDPLQDNTGEVVAVKKL-QHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSAG 84

Query: 259 --PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
              + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH DL 
Sbjct: 85  RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLA 141

Query: 316 PKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNE 369
            +NIL++N  ++KI  FGL ++       +   E  +   P+        + APE     
Sbjct: 142 TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE--SPIF-------WYAPESLTES 192

Query: 370 EFDRSVDAYSFGLILYEMI----------------EGVQPFHPKPPEEVVKLMCCEGKRP 413
           +F  + D +SFG++LYE+                  G           +++L+     R 
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRL 251

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           P   +    P ++  ++ ECW+     RP+F ++  R+D+I
Sbjct: 252 P---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  153 bits (388), Expect = 2e-42
 Identities = 67/272 (24%), Positives = 123/272 (45%), Gaps = 28/272 (10%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-I 258
            G+            VK L        E    F  E  I++   HPNV+  +G   ++  
Sbjct: 107 HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEG 164

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             ++VL Y   GDL ++++      +   ++ F L +A+GM +L   K    +H DL  +
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAAR 221

Query: 318 NILLDNGGQLKISGFGLLRL-------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           N +LD    +K++ FGL R           +   AK+  PV        ++A E  + ++
Sbjct: 222 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL--PVK-------WMALESLQTQK 272

Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           F    D +SFG++L+E++  G  P+      ++   +  +G+R     +    P  L E+
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLL---QPEYCPDPLYEV 328

Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW PK  +RP+F+E+++R+  I      +
Sbjct: 329 MLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  150 bits (382), Expect = 3e-42
 Identities = 69/264 (26%), Positives = 125/264 (47%), Gaps = 24/264 (9%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
            G Y     N  +  +K L     +  +   AF  E  ++    HPNV+  +G +     
Sbjct: 39  HGEYIDQAQNRIQCAIKSL-SRITEMQQV-EAFLREGLLMRGLNHPNVLALIGIMLPPEG 96

Query: 260 M-MIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           +  ++L Y   GDL  +++   R  +   ++ F L +ARGM YL E K    +H DL  +
Sbjct: 97  LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAAR 153

Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIV-FPVSHIDPANLYVAPEIYKNEEFD 372
           N +LD    +K++ FGL R     +Y S ++ +    PV        + A E  +   F 
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK-------WTALESLQTYRFT 206

Query: 373 RSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              D +SFG++L+E++  G  P+    P ++   +  +G+R P   +    P  L ++++
Sbjct: 207 TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLP---QPEYCPDSLYQVMQ 262

Query: 432 ECWDPKPVIRPNFNEIIARLDRIV 455
           +CW+  P +RP F  ++  +++IV
Sbjct: 263 QCWEADPAVRPTFRVLVGEVEQIV 286

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  150 bits (381), Expect = 4e-42
 Identities = 63/269 (23%), Positives = 109/269 (40%), Gaps = 33/269 (12%)

Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+ +      + + T+V +K+LDK      E   +F    +++ K  H ++V   G    
Sbjct: 27  GVRREVGDYGQLHETEVLLKVLDKAHRNYSE---SFFEAASMMSKLSHKHLVLNYGVCVC 83

Query: 257 NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++V E+   G L +YL+K K  ++    L  A  LA  M++L E     +IH ++ 
Sbjct: 84  GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVC 140

Query: 316 PKNILLDNGGQL--------KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE-IY 366
            KNILL              K+S  G+                +        +V PE I 
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL---QERIP-------WVPPECIE 190

Query: 367 KNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD 425
             +  + + D +SFG  L+E+   G +P      +  ++    +  + P          +
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQLP-----APKAAE 244

Query: 426 LKELIEECWDPKPVIRPNFNEIIARLDRI 454
           L  LI  C D +P  RP+F  II  L+ +
Sbjct: 245 LANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  152 bits (387), Expect = 4e-42
 Identities = 94/332 (28%), Positives = 153/332 (46%), Gaps = 55/332 (16%)

Query: 165 PKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG---------TK 212
            +     ++     E P +EL    L + K  G  +G++ QV  A+  G         TK
Sbjct: 46  FQGMLAGVSEYELPEDPRWELPRDRLVLGKPLG--EGAFGQVVLAEAIGLDKDKPNRVTK 103

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L K    + +  +    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG+
Sbjct: 104 VAVKML-KSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161

Query: 272 LASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
           L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH DL 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218

Query: 316 PKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
            +N+L+     +KI+ FGL R       Y      +   PV        ++APE   +  
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR--LPVK-------WMAPEALFDRI 269

Query: 371 FDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           +    D +SFG++L+E+   G  P+   P EE+ KL+  EG R     K  +   +L  +
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMD---KPSNCTNELYMM 325

Query: 430 IEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           + +CW   P  RP F +++  LDRIV   S Q
Sbjct: 326 MRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  150 bits (381), Expect = 8e-42
 Identities = 56/263 (21%), Positives = 118/263 (44%), Gaps = 27/263 (10%)

Query: 200 KGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           KG +          V +K L +E+            E  ++    +P+V + +G    + 
Sbjct: 33  KGLWIPEGEKVKIPVAIKEL-REATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTS- 89

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            + ++ +    G L  Y+++ K  +    +L + + +A+GMNYL + +   ++H DL  +
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 318 NILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           N+L+     +KI+ FGL +L     +    E  K   P+        ++A E   +  + 
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPIK-------WMALESILHRIYT 197

Query: 373 RSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              D +S+G+ ++E++  G +P+   P  E+  ++  +G+R P   +      D+  ++ 
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLP---QPPICTIDVYMIMV 253

Query: 432 ECWDPKPVIRPNFNEIIARLDRI 454
           +CW      RP F E+I    ++
Sbjct: 254 KCWMIDADSRPKFRELIIEFSKM 276

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  151 bits (382), Expect = 8e-42
 Identities = 62/264 (23%), Positives = 124/264 (46%), Gaps = 33/264 (12%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           +GS+  A       +G +  +K ++       ER  +   E+ ++   +HPN+VQ+  + 
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHPNIVQYRESF 92

Query: 255 TQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +N  + IV++Y   GDL   +  QK       ++L + + +   + ++H+ K   I+H 
Sbjct: 93  EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHR 149

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN------LYVAPEIY 366
           D+K +NI L   G +++  FG+          A+++   S ++ A        Y++PEI 
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGI----------ARVL--NSTVELARACIGTPYYLSPEIC 197

Query: 367 KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL 426
           +N+ ++   D ++ G +LYE+      F     + +V  +   G  PP+      Y  DL
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVS---LHYSYDL 253

Query: 427 KELIEECWDPKPVIRPNFNEIIAR 450
           + L+ + +   P  RP+ N I+ +
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEK 277

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  150 bits (380), Expect = 1e-41
 Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 41/275 (14%)

Query: 206 AKWNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
            + +G        +V VK L  E   + + ++ F  E  I+ K  H N+V+ +G   Q++
Sbjct: 49  GQVSGMPNDPSPLQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSL 106

Query: 259 PMMIVLEYHAKGDLASYLQK-------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
           P  I++E  A GDL S+L++          L+   +L  A D+A G  YL E      IH
Sbjct: 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIH 163

Query: 312 CDLKPKNILLDNGGQ---LKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAP 363
            D+  +N LL   G     KI  FG+ R       Y     A    PV        ++ P
Sbjct: 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM--LPVK-------WMPP 214

Query: 364 EIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY 422
           E +    F    D +SFG++L+E+   G  P+  K  +EV++ +   G R       ++ 
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMD---PPKNC 270

Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
           P  +  ++ +CW  +P  RPNF  I+ R++    +
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  149 bits (379), Expect = 2e-41
 Identities = 74/288 (25%), Positives = 132/288 (45%), Gaps = 41/288 (14%)

Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVT 255
               G  +        V VK+L K+   + +  +    E+ +++   +H N++  +GA T
Sbjct: 54  AEAVGIDKDKPKEAVTVAVKML-KDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACT 111

Query: 256 QNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMN 299
           Q+ P+ +++EY +KG+L  YL+ +                 +++   ++     LARGM 
Sbjct: 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 171

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHI 354
           YL   K    IH DL  +N+L+     +KI+ FGL R       Y      +   PV   
Sbjct: 172 YLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR--LPVK-- 224

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRP 413
                ++APE   +  +    D +SFG++++E+   G  P+   P EE+ KL+  EG R 
Sbjct: 225 -----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRM 278

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
               K  +   +L  ++ +CW   P  RP F +++  LDRI+   + +
Sbjct: 279 D---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  149 bits (378), Expect = 2e-41
 Identities = 86/318 (27%), Positives = 138/318 (43%), Gaps = 57/318 (17%)

Query: 176 NPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKVWVKILDKES 222
           +P ++P   ++E     L   K  G   G++ +V  A   G         V VK+L K S
Sbjct: 8   DPTQLPYDHKWEFPRNRLSFGKTLG--AGAFGKVVEATAYGLIKSDAAMTVAVKML-KPS 64

Query: 223 HKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-- 279
               ER  A   EL ++     H N+V  +GA T   P +++ EY   GDL ++L++K  
Sbjct: 65  AHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 280 ----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                             L    +L F+  +A+GM +L        IH DL  +NILL +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTH 180

Query: 324 GGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
           G   KI  FGL R       Y+    A+   PV        ++APE   N  +    D +
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNAR--LPVK-------WMAPESIFNCVYTFESDVW 231

Query: 379 SFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           S+G+ L+E+   G  P+   P +     M  EG R          P ++ ++++ CWD  
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDAD 288

Query: 438 PVIRPNFNEIIARLDRIV 455
           P+ RP F +I+  +++ +
Sbjct: 289 PLKRPTFKQIVQLIEKQI 306

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  148 bits (376), Expect = 3e-41
 Identities = 73/321 (22%), Positives = 139/321 (43%), Gaps = 56/321 (17%)

Query: 167 TKRTPMTVANPREVPEYELNPLEL-------QVRKADGITKGSYQVAKWN-GTKVWVKIL 218
           +++ P T  +P    +  L  +         +V          Y     N G +V VK L
Sbjct: 5   SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVEL------CRYDPEGDNTGEQVAVKSL 58

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYHAKGDLASYL 276
            K              E+ I+    H N+V++ G  T++    + +++E+   G L  YL
Sbjct: 59  -KPESGGNHI-ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116

Query: 277 QK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            K K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  Q+KI  FGL 
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173

Query: 336 RL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI- 388
           +        Y   +      PV        + APE     +F  + D +SFG+ L+E++ 
Sbjct: 174 KAIETDKEYYTVKDDRD--SPVF-------WYAPECLMQSKFYIASDVWSFGVTLHELLT 224

Query: 389 -------------EGVQPFHPKPP-EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECW 434
                        + + P H +     +V  +  EGKR P      + P ++ +L+ +CW
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK-EGKRLP---CPPNCPDEVYQLMRKCW 280

Query: 435 DPKPVIRPNFNEIIARLDRIV 455
           + +P  R +F  +I   + ++
Sbjct: 281 EFQPSNRTSFQNLIEGFEALL 301

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  148 bits (375), Expect = 4e-41
 Identities = 60/295 (20%), Positives = 118/295 (40%), Gaps = 36/295 (12%)

Query: 170 TPMTVANPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK 224
            P         P+   N L    R    I +G +          +G  V +K +      
Sbjct: 13  VPQFQPQKALRPDMGYNTLA-NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--- 281
           D +       E+ ++++  HPNV+++  +  ++  + IVLE    GDL+  ++   +   
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131

Query: 282 -LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI 340
            +    V ++ + L   + ++H  +   ++H D+KP N+ +   G +K+   GL      
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL------ 182

Query: 341 SPEKAKIVFPVSHIDPAN------LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
                +     S    A+       Y++PE      ++   D +S G +LYEM     PF
Sbjct: 183 ----GRFF--SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

Query: 395 HPKPPEEVVKLMC--CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           +      +  L     +   PP  + +  Y  +L++L+  C +P P  RP+   +
Sbjct: 237 YGD-KMNLYSLCKKIEQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  149 bits (379), Expect = 4e-41
 Identities = 74/288 (25%), Positives = 132/288 (45%), Gaps = 41/288 (14%)

Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVT 255
               G  +        V VK+L K+   + +  +    E+ +++   +H N++  +GA T
Sbjct: 100 AEAVGIDKDKPKEAVTVAVKML-KDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACT 157

Query: 256 QNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMN 299
           Q+ P+ +++EY +KG+L  YL+ +                 +++   ++     LARGM 
Sbjct: 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 217

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHI 354
           YL   K    IH DL  +N+L+     +KI+ FGL R       Y      +   PV   
Sbjct: 218 YLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR--LPVK-- 270

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRP 413
                ++APE   +  +    D +SFG++++E+   G  P+   P EE+ KL+  EG R 
Sbjct: 271 -----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRM 324

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
               K  +   +L  ++ +CW   P  RP F +++  LDRI+   + +
Sbjct: 325 D---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  149 bits (379), Expect = 4e-41
 Identities = 83/330 (25%), Positives = 138/330 (41%), Gaps = 49/330 (14%)

Query: 157 LKARGAKVPKTKRTPMTVANPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG 210
           L         T   P      +        E+    + + +  G   G++ +V   + +G
Sbjct: 37  LSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLG--HGAFGEVYEGQVSG 94

Query: 211 -------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
                   +V VK L  E   + + ++ F  E  I+ K  H N+V+ +G   Q++P  I+
Sbjct: 95  MPNDPSPLQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152

Query: 264 LEYHAKGDLASYLQK-------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           LE  A GDL S+L++          L+   +L  A D+A G  YL E      IH D+  
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAA 209

Query: 317 KNILLDNGGQ---LKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
           +N LL   G     KI  FG+ R       Y     A    PV        ++ PE +  
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM--LPVK-------WMPPEAFME 260

Query: 369 EEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK 427
             F    D +SFG++L+E+   G  P+  K  +EV++ +   G R       ++ P  + 
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMD---PPKNCPGPVY 316

Query: 428 ELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
            ++ +CW  +P  RPNF  I+ R++    +
Sbjct: 317 RIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  147 bits (373), Expect = 5e-41
 Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 35/296 (11%)

Query: 181 PEYELNPLELQVRKADGITKGSY---QVAKWNG----TKVWVKILDKESHKDPERINAFT 233
            +  L    L +   + +  G++   +   +        V +K+L K+  +  +      
Sbjct: 2   KKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADT-EEMM 58

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFAL 292
            E  I+ +  +P +V+ +G       +M+V+E    G L  +L   +  +  S V     
Sbjct: 59  REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAK 346
            ++ GM YL E      +H DL  +N+LL N    KIS FGL +        Y +    K
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174

Query: 347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKL 405
             +P+        + APE     +F    D +S+G+ ++E +  G +P+      EV+  
Sbjct: 175 --WPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225

Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +  +GKR          PP+L  L+ +CW  K   RP+F  +  R+     + + +
Sbjct: 226 IE-QGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  147 bits (373), Expect = 9e-41
 Identities = 57/300 (19%), Positives = 107/300 (35%), Gaps = 31/300 (10%)

Query: 182 EYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHEL 236
              ++       +   + +G +          +G    +K +     +D E       E 
Sbjct: 23  MVIIDNKHYLFIQK--LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ---REA 77

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYL----QKKGRLSPSKVL 288
            +     HPN+++ V    +         ++L +  +G L + +     K   L+  ++L
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
              L + RG+  +H        H DLKP NILL + GQ  +   G +    I  E ++  
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 349 FPVSHIDPAN---LYVAPEI---YKNEEFDRSVDAYSFGLILYEMIEGVQPF-HPKPPEE 401
             +           Y APE+     +   D   D +S G +LY M+ G  P+       +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

Query: 402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
            V L        P       +   L +L+       P  RP+   ++++L+ +      Q
Sbjct: 255 SVALAVQNQLSIPQS---PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  147 bits (373), Expect = 1e-40
 Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 41/282 (14%)

Query: 203 YQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPM 260
           + + K +   KV VK+L K +    E+  A   EL I+    +H N+V  +GA T   P+
Sbjct: 68  FGLGKEDAVLKVAVKML-KSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPV 125

Query: 261 MIVLEYHAKGDLASYLQKKGR--------------LSPSKVLRFALDLARGMNYLHECKP 306
           +++ EY   GDL ++L++K R               S   +L F+  +A+GM +L     
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN- 184

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYV 361
              IH D+  +N+LL NG   KI  FGL R       YI    A+   PV        ++
Sbjct: 185 --CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR--LPVK-------WM 233

Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFH-PKPPEEVVKLMCCEGKRPPLKIKA 419
           APE   +  +    D +S+G++L+E+   G+ P+       +  KL+  +G +     + 
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV-KDGYQMA---QP 289

Query: 420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              P ++  +++ CW  +P  RP F +I + L        ++
Sbjct: 290 AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  147 bits (373), Expect = 1e-40
 Identities = 80/318 (25%), Positives = 143/318 (44%), Gaps = 47/318 (14%)

Query: 164 VPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG----TKVWVK 216
           + K         NP       L+  +++ +   G  +G++ QV  A+           +K
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIG--EGNFGQVLKARIKKDGLRMDAAIK 58

Query: 217 ILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
            + KE     +    F  EL ++ K   HPN++  +GA      + + +EY   G+L  +
Sbjct: 59  RM-KEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116

Query: 276 LQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           L+K                   LS  ++L FA D+ARGM+YL + +    IH DL  +NI
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 173

Query: 320 LLDNGGQLKISGFGLLRLQ--YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           L+      KI+ FGL R Q  Y+     ++  PV        ++A E      +  + D 
Sbjct: 174 LVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVR-------WMAIESLNYSVYTTNSDV 224

Query: 378 YSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
           +S+G++L+E++  G  P+      E+ + +  +G R     K  +   ++ +L+ +CW  
Sbjct: 225 WSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLE---KPLNCDDEVYDLMRQCWRE 280

Query: 437 KPVIRPNFNEIIARLDRI 454
           KP  RP+F +I+  L+R+
Sbjct: 281 KPYERPSFAQILVSLNRM 298

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  145 bits (369), Expect = 2e-40
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 47/276 (17%)

Query: 206 AKWNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
               G         V +K L K+  + P R   F HE  +  + +HPNVV  +G VT++ 
Sbjct: 28  GHLFGPAPGEQTQAVAIKTL-KDKAEGPLR-EEFRHEAMLRARLQHPNVVCLLGVVTKDQ 85

Query: 259 PMMIVLEYHAKGDLASYLQK----------------KGRLSPSKVLRFALDLARGMNYLH 302
           P+ ++  Y + GDL  +L                  K  L P   +     +A GM YL 
Sbjct: 86  PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 145

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPA 357
                 ++H DL  +N+L+ +   +KIS  GL R       Y     +    P+      
Sbjct: 146 SHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL--LPIR----- 195

Query: 358 NLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLK 416
             ++APE     +F    D +S+G++L+E+   G+QP+     ++VV+++    +  P  
Sbjct: 196 --WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-RNRQVLP-- 250

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD 452
                 P  +  L+ ECW+  P  RP F +I +RL 
Sbjct: 251 -CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  145 bits (368), Expect = 2e-40
 Identities = 71/266 (26%), Positives = 114/266 (42%), Gaps = 28/266 (10%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
            GSY        K +G  +  K LD  S  + E+      E+ ++ + +HPN+V++   +
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPNIVRYYDRI 74

Query: 255 --TQNIPMMIVLEYHAKGDLASYL----QKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
               N  + IV+EY   GDLAS +    +++  L    VLR    L   +   H      
Sbjct: 75  IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGG 134

Query: 309 --IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF--PVSHIDPANLYVAPE 364
             ++H DLKP N+ LD    +K+  FGL R+       AK     P         Y++PE
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP--------YYMSPE 186

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
                 ++   D +S G +LYE+   + PF     +E+   +  EGK   +      Y  
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIP---YRYSD 242

Query: 425 DLKELIEECWDPKPVIRPNFNEIIAR 450
           +L E+I    + K   RP+  EI+  
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILEN 268

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  146 bits (371), Expect = 2e-40
 Identities = 61/273 (22%), Positives = 116/273 (42%), Gaps = 34/273 (12%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G+ +       KV VK +  ++    E    F  E   ++   HPNV++ +G   +   
Sbjct: 52  EGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNVIRLLGVCIEMSS 110

Query: 260 M-----MIVLEYHAKGDLASYLQK------KGRLSPSKVLRFALDLARGMNYLHECKPDP 308
                 M++L +   GDL +YL           +    +L+F +D+A GM YL       
Sbjct: 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--- 167

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAP 363
            +H DL  +N +L +   + ++ FGL +       Y     AK   PV        ++A 
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK--MPVK-------WIAI 218

Query: 364 EIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY 422
           E   +  +    D ++FG+ ++E+   G+ P+      E+   +   G R     +    
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HGHRLK---QPEDC 274

Query: 423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
             +L E++  CW   P+ RP F+ +  +L++++
Sbjct: 275 LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  146 bits (370), Expect = 3e-40
 Identities = 73/322 (22%), Positives = 139/322 (43%), Gaps = 51/322 (15%)

Query: 166 KTKRTPMTVANPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG-------TK 212
            +      + NP+       + +   ++ ++   G  +G++ +V  A+ +          
Sbjct: 16  GSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELG--EGAFGKVFLAECHNLLPEQDKML 73

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK L KE+ +       F  E  ++   +H ++V+F G  T+  P+++V EY   GDL
Sbjct: 74  VAVKAL-KEASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130

Query: 273 ASYLQK---------------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             +L+                 G L   ++L  A  +A GM YL        +H DL  +
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATR 187

Query: 318 NILLDNGGQLKISGFGLLRLQYIS---PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
           N L+  G  +KI  FG+ R  Y +       + + P+        ++ PE     +F   
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTE 240

Query: 375 VDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
            D +SFG++L+E+   G QP++     E +  +  +G+      + R+ PP++  ++  C
Sbjct: 241 SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-TQGRELE---RPRACPPEVYAIMRGC 296

Query: 434 WDPKPVIRPNFNEIIARLDRIV 455
           W  +P  R +  ++ ARL  + 
Sbjct: 297 WQREPQQRHSIKDVHARLQALA 318

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  145 bits (369), Expect = 3e-40
 Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 54/294 (18%)

Query: 194 KADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA 253
            A  +   +        T V VK+L KE+    E       E  ++++  HP+V++  GA
Sbjct: 43  TAFHLKGRA------GYTTVAVKML-KENASPSEL-RDLLSEFNVLKQVNHPHVIKLYGA 94

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKK------------------------GRLSPSKVLR 289
            +Q+ P+++++EY   G L  +L++                           L+   ++ 
Sbjct: 95  CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEK 344
           FA  +++GM YL E K   ++H DL  +NIL+  G ++KIS FGL R       Y+   +
Sbjct: 155 FAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ 211

Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV 403
            +   PV        ++A E   +  +    D +SFG++L+E++  G  P+   PPE + 
Sbjct: 212 GR--IPVK-------WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262

Query: 404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN 457
            L+   G R     +  +   ++  L+ +CW  +P  RP F +I   L++++  
Sbjct: 263 NLL-KTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (367), Expect = 4e-40
 Identities = 58/277 (20%), Positives = 106/277 (38%), Gaps = 37/277 (13%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA- 253
           +G + V      K +     +K +    +++  R      E+  + K  HP +V++  A 
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKV-MREVKALAKLEHPGIVRYFNAW 72

Query: 254 -----------VTQNIPMMIVLEYHAKGDLASYLQKKGRLSP---SKVLRFALDLARGMN 299
                       +  + + I ++   K +L  ++  +  +     S  L   L +A  + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN- 358
           +LH      ++H DLKP NI       +K+  FGL+       E+  ++ P+        
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189

Query: 359 -----LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
                LY++PE      +   VD +S GLIL+E++    PF  +             K P
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFP 246

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR 450
           PL        P    ++++   P P+ RP    II  
Sbjct: 247 PLF---TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  145 bits (367), Expect = 5e-40
 Identities = 68/277 (24%), Positives = 113/277 (40%), Gaps = 44/277 (15%)

Query: 206 AKWNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           A+            V VK L   +         F  E  ++   +H ++V+F G      
Sbjct: 34  AECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGD 90

Query: 259 PMMIVLEYHAKGDLASYLQK----------------KGRLSPSKVLRFALDLARGMNYLH 302
           P+++V EY   GDL  +L+                 KG L  S++L  A  +A GM YL 
Sbjct: 91  PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 150

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDPANL 359
                  +H DL  +N L+     +KI  FG+ R  Y +         + P+        
Sbjct: 151 SQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR------- 200

Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIK 418
           ++ PE     +F    D +SFG+IL+E+   G QP+      EV++ +  +G+      +
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-TQGRVLE---R 256

Query: 419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
            R  P ++ +++  CW  +P  R N  EI   L  + 
Sbjct: 257 PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  145 bits (368), Expect = 9e-40
 Identities = 80/347 (23%), Positives = 142/347 (40%), Gaps = 62/347 (17%)

Query: 158 KARGAKVPKTKRTPMTVANPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG- 210
           + +  +V  +        + RE     ++E     L+  K  G   G++ +V  A   G 
Sbjct: 12  QLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLG--SGAFGKVMNATAYGI 69

Query: 211 ------TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIV 263
                  +V VK+L KE     ER  A   EL ++ +   H N+V  +GA T + P+ ++
Sbjct: 70  SKTGVSIQVAVKML-KEKADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127

Query: 264 LEYHAKGDLASYLQKK-----------------------GRLSPSKVLRFALDLARGMNY 300
            EY   GDL +YL+ K                         L+   +L FA  +A+GM +
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPVSHID 355
           L        +H DL  +N+L+ +G  +KI  FGL R       Y+    A+   PV    
Sbjct: 188 LEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR--LPVK--- 239

Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP 414
               ++APE      +    D +S+G++L+E+   GV P+   P +     +   G +  
Sbjct: 240 ----WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD 295

Query: 415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
              +      ++  +++ CW      RP+F  + + L   + +  + 
Sbjct: 296 ---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  144 bits (364), Expect = 1e-39
 Identities = 54/257 (21%), Positives = 102/257 (39%), Gaps = 26/257 (10%)

Query: 200 KGS----YQVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
            GS    ++V      +++ VK          +R        +  +  +HP  V+   A 
Sbjct: 67  HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
            +   + +  E      L  + +  G  L  ++V  +  D    + +LH      ++H D
Sbjct: 127 EEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLD 182

Query: 314 LKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI-DPANLYVAPEIYKNEEFD 372
           +KP NI L   G+ K+  FGLL  +  +    +         DP   Y+APE+     + 
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGE-----VQEGDP--RYMAPELL-QGSYG 233

Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
            + D +S GL + E+   ++  H    E   +L   +G  PP +  A     +L+ ++  
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGG--EGWQQLR--QGYLPP-EFTA-GLSSELRSVLVM 287

Query: 433 CWDPKPVIRPNFNEIIA 449
             +P P +R     ++A
Sbjct: 288 MLEPDPKLRATAEALLA 304

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  144 bits (365), Expect = 2e-39
 Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 40/298 (13%)

Query: 183 YELNPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELT 237
            EL  L L+VR+   + +G +          +G +  +K L      + E+  A   E+ 
Sbjct: 23  VELGELRLRVRRV--LAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVC 77

Query: 238 IVEKAR-HPNVVQFVGAVTQNIPMM-------IVLEYHAKGDLASYLQK---KGRLSPSK 286
            ++K   HPN+VQF  A +             ++L    KG L  +L+K   +G LS   
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           VL+      R + ++H  KP PIIH DLK +N+LL N G +K+  FG        P+ + 
Sbjct: 138 VLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 347 IVFPVSHIDPAN------LYVAPEI---YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK 397
                + ++         +Y  PEI   Y N       D ++ G ILY +     PF   
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--- 253

Query: 398 PPEEVVKLMCCEGK-RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
             E+  KL    GK   P      +       LI       P  R +  E++ +L  I
Sbjct: 254 --EDGAKLRIVNGKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  143 bits (363), Expect = 5e-39
 Identities = 83/340 (24%), Positives = 135/340 (39%), Gaps = 62/340 (18%)

Query: 155 NILKARGAKVPKTKRTPMTVANPREVPEYELNPLEL----------QVRK--ADGITKGS 202
            +L  R    P  +R P+ +       EY  N +E           +V +  A G+    
Sbjct: 16  ELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYE 75

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
                   T V VK+L KE      +   F  E  ++ +  +PN+V+ +G      PM +
Sbjct: 76  PF------TMVAVKML-KEEASADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127

Query: 263 VLEYHAKGDLASYLQKK------------------------GRLSPSKVLRFALDLARGM 298
           + EY A GDL  +L+                            LS ++ L  A  +A GM
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHID 355
            YL E K    +H DL  +N L+     +KI+ FGL R  Y +           P+    
Sbjct: 188 AYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR--- 241

Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP 414
               ++ PE      +    D +++G++L+E+   G+QP++    EEV+  +  +G    
Sbjct: 242 ----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-RDGNILA 296

Query: 415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                 + P +L  L+  CW   P  RP+F  I   L R+
Sbjct: 297 ---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  142 bits (361), Expect = 5e-39
 Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 42/268 (15%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYH 267
           G  V VK L K     P+  + +  E+ I+    H +++++ G         + +V+EY 
Sbjct: 60  GEMVAVKAL-KADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
             G L  YL +   +  +++L FA  +  GM YLH       IH DL  +N+LLDN   +
Sbjct: 118 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLV 173

Query: 328 KISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFG 381
           KI  FGL +        Y   E      PV        + APE  K  +F  + D +SFG
Sbjct: 174 KIGDFGLAKAVPEGHEYYRVREDGD--SPVF-------WYAPECLKEYKFYYASDVWSFG 224

Query: 382 LILYEMI---------------EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDL 426
           + LYE++                            + +L+   G+R P   +    P ++
Sbjct: 225 VTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE-RGERLP---RPDKCPAEV 280

Query: 427 KELIEECWDPKPVIRPNFNEIIARLDRI 454
             L++ CW+ +   RP F  +I  L  +
Sbjct: 281 YHLMKNCWETEASFRPTFENLIPILKTV 308

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (371), Expect = 2e-38
 Identities = 65/270 (24%), Positives = 117/270 (43%), Gaps = 28/270 (10%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G Y++ K     V +K+L + +  +         E  I+ +  +P +V+ +G       
Sbjct: 354 QGVYRMRKKQ-IDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A 409

Query: 260 MMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +M+V+E    G L  +L   +  +  S V      ++ GM YL E      +H +L  +N
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARN 466

Query: 319 ILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
           +LL N    KIS FGL +        Y +    K  +P+        + APE     +F 
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGK--WPL-------KWYAPECINFRKFS 517

Query: 373 RSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
              D +S+G+ ++E +  G +P+      EV+  +  +GKR          PP+L  L+ 
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRME---CPPECPPELYALMS 573

Query: 432 ECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +CW  K   RP+F  +  R+     + + +
Sbjct: 574 DCWIYKWEDRPDFLTVEQRMRACYYSLASK 603

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  141 bits (357), Expect = 2e-38
 Identities = 87/321 (27%), Positives = 146/321 (45%), Gaps = 57/321 (17%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKVWVKILDKESHKDP 226
           P +  ++E     L++ K  G  +G++ QV  A   G         V VK+L KE     
Sbjct: 16  PYDASKWEFPRDRLKLGKPLG--RGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHS 72

Query: 227 ERINAFTHELTIVEK-ARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQK------ 278
           E   A   EL I+     H NVV  +GA T+   P+M+++E+   G+L++YL+       
Sbjct: 73  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131

Query: 279 ----------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
                     K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +K
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 188

Query: 329 ISGFGLLRL-----QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
           I  FGL R       Y+    A+   P+        ++APE   +  +    D +SFG++
Sbjct: 189 ICDFGLARDIYKDPDYVRKGDAR--LPLK-------WMAPETIFDRVYTIQSDVWSFGVL 239

Query: 384 LYEMIE-GVQPFHP--KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           L+E+   G  P+ P  K  EE  + +  EG R           P++ + + +CW  +P  
Sbjct: 240 LWEIFSLGASPY-PGVKIDEEFCRRLK-EGTRMR---APDYTTPEMYQTMLDCWHGEPSQ 294

Query: 441 RPNFNEIIARLDRIVCNCSKQ 461
           RP F+E++  L  ++   ++Q
Sbjct: 295 RPTFSELVEHLGNLLQANAQQ 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  138 bits (349), Expect = 1e-37
 Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 23/281 (8%)

Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERIN 230
              E     ++     ++    I +GS++            +V    L  +         
Sbjct: 12  EELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQ 70

Query: 231 AFTHELTIVEKARHPNVVQFVGA----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
            F  E  +++  +HPN+V+F  +    V     +++V E    G L +YL++   +    
Sbjct: 71  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV 130

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKA 345
           +  +   + +G+ +LH   P PIIH DLK  NI +    G +KI   GL  L+  S  KA
Sbjct: 131 LRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189

Query: 346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
            I  P         ++APE+Y+ E++D SVD Y+FG+ + EM     P+        +  
Sbjct: 190 VIGTPE--------FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240

Query: 406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
               G +P    K     P++KE+IE C       R +  +
Sbjct: 241 RVTSGVKPASFDKVAI--PEVKEIIEGCIRQNKDERYSIKD 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  137 bits (348), Expect = 1e-37
 Identities = 58/275 (21%), Positives = 108/275 (39%), Gaps = 55/275 (20%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA- 253
            G +        + +G    +K +   + K          E+  + K  H N+V + G  
Sbjct: 21  SGGFGQVFKAKHRIDGKTYVIKRVKYNNEK-------AEREVKALAKLDHVNIVHYNGCW 73

Query: 254 ---------------VTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLAR 296
                           ++   + I +E+  KG L  ++  ++  +L     L     + +
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV-FPVSHID 355
           G++Y+H  K   +I+ DLKP NI L +  Q+KI  FGL+       ++ +          
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL----- 185

Query: 356 PANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC--CEGKRP 413
               Y++PE   ++++ + VD Y+ GLIL E++            E  K      +G   
Sbjct: 186 ---RYMSPEQISSQDYGKEVDLYALGLILAELLHV-----CDTAFETSKFFTDLRDGIIS 237

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
                   +    K L+++    KP  RPN +EI+
Sbjct: 238 D------IFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  137 bits (347), Expect = 9e-37
 Identities = 54/271 (19%), Positives = 109/271 (40%), Gaps = 41/271 (15%)

Query: 200 KGS----YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFVGA 253
            G     +QV         +K ++ E   D + ++++ +E+  + K +  +  +++    
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
              +  + +V+E     DL S+L+KK  + P +   +  ++   ++ +H+     I+H D
Sbjct: 78  EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSD 133

Query: 314 LKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN------LYVAPEI-- 365
           LKP N L+ + G LK+  FG+          A  + P +     +       Y+ PE   
Sbjct: 134 LKPANFLIVD-GMLKLIDFGI----------ANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 366 ---------YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
                        +     D +S G ILY M  G  PF  +   ++ KL         ++
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIE 241

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
                   DL+++++ C    P  R +  E+
Sbjct: 242 FP-DIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  136 bits (344), Expect = 1e-36
 Identities = 49/247 (19%), Positives = 96/247 (38%), Gaps = 24/247 (9%)

Query: 214 WVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
                       P  ++A + ++  ++     N V  +   +  + + I ++   K +L 
Sbjct: 90  LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149

Query: 274 SYLQKKGRLSP---SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
            ++ ++  L        L   + +A  + +LH      ++H DLKP NI       +K+ 
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 206

Query: 331 GFGLLRLQYISPEKAKIVFPVSHIDPAN------LYVAPEIYKNEEFDRSVDAYSFGLIL 384
            FGL+       E+  ++ P+             LY++PE      +   VD +S GLIL
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266

Query: 385 YEMIEGVQPFHPKPPE-EVVKLM--CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           +E+       +    + E V+++      K P L        P    ++++   P P  R
Sbjct: 267 FEL------LYSFSTQMERVRIITDVRNLKFPLL---FTQKYPQEHMMVQDMLSPSPTER 317

Query: 442 PNFNEII 448
           P   +II
Sbjct: 318 PEATDII 324

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  136 bits (344), Expect = 1e-36
 Identities = 53/274 (19%), Positives = 108/274 (39%), Gaps = 47/274 (17%)

Query: 200 KGS----YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFVGA 253
            G     +QV         +K ++ E   D + ++++ +E+  + K +  +  +++    
Sbjct: 38  SGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
              +  + +V+E     DL S+L+KK  + P +   +  ++   ++ +H+     I+H D
Sbjct: 97  EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSD 152

Query: 314 LKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN------LYVAPEI-- 365
           LKP N L+ + G LK+  FG+          A  + P +     +       Y+ PE   
Sbjct: 153 LKPANFLIVD-GMLKLIDFGI----------ANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 366 ---------YKNEEFDRSVDAYSFGLILYEMIEGVQPFH--PKPPEEVVKLMCCEGKRP- 413
                        +     D +S G ILY M  G  PF        ++  ++    +   
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           P          DL+++++ C    P  R +  E+
Sbjct: 262 PDIP-----EKDLQDVLKCCLKRDPKQRISIPEL 290

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  135 bits (341), Expect = 2e-36
 Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 52/261 (19%)

Query: 207 KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K +   + +K+L K          ++     E+ I    RHPN+++  G       + ++
Sbjct: 31  KQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILRLYGYFHDATRVYLI 87

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           LEY   G +   LQK  +    +   +  +LA  ++Y H  +   +IH D+KP+N+LL +
Sbjct: 88  LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGS 144

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEFDRS 374
            G+LKI+ FG                  S   P++          Y+ PE+ +    D  
Sbjct: 145 AGELKIADFGW-----------------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 187

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKE 428
           VD +S G++ YE + G  PF     +E  K           +I    +          ++
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYK-----------RISRVEFTFPDFVTEGARD 236

Query: 429 LIEECWDPKPVIRPNFNEIIA 449
           LI       P  RP   E++ 
Sbjct: 237 LISRLLKHNPSQRPMLREVLE 257

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  137 bits (347), Expect = 2e-36
 Identities = 55/273 (20%), Positives = 110/273 (40%), Gaps = 41/273 (15%)

Query: 198 ITKGS----YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFV 251
           I  G     +QV         +K ++ E   D + ++++ +E+  + K +  +  +++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                +  + +V+E     DL S+L+KK  + P +   +  ++   ++ +H+     I+H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVH 178

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN------LYVAPEI 365
            DLKP N L+ + G LK+  FG+          A  + P +     +       Y+ PE 
Sbjct: 179 SDLKPANFLIVD-GMLKLIDFGI----------ANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 366 -----------YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
                          +     D +S G ILY M  G  PF  +   ++ KL         
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHE 286

Query: 415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
           ++        DL+++++ C    P  R +  E+
Sbjct: 287 IEFPDIP-EKDLQDVLKCCLKRDPKQRISIPEL 318

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  134 bits (339), Expect = 4e-36
 Identities = 61/259 (23%), Positives = 102/259 (39%), Gaps = 52/259 (20%)

Query: 207 KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K N   + +K+L K          ++     E+ I    RHPN+++          + ++
Sbjct: 36  KQNKFIMALKVLFKSQLEKEGVEHQLR---REIEIQSHLRHPNILRMYNYFHDRKRIYLM 92

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           LE+  +G+L   LQK GR    +   F  +LA  ++Y HE K   +IH D+KP+N+L+  
Sbjct: 93  LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGY 149

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEFDRS 374
            G+LKI+ FG                  S   P+           Y+ PE+ + +  D  
Sbjct: 150 KGELKIADFGW-----------------SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEK 192

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKE 428
           VD +  G++ YE + G+ PF      E  +           +I               K+
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHR-----------RIVNVDLKFPPFLSDGSKD 241

Query: 429 LIEECWDPKPVIRPNFNEI 447
           LI +     P  R     +
Sbjct: 242 LISKLLRYHPPQRLPLKGV 260

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  133 bits (338), Expect = 6e-36
 Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 36/251 (14%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
                  KI+ K     P +    + E++I     H +VV F G    N  + +VLE   
Sbjct: 39  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
           +  L    +++  L+  +   +   +  G  YLH  +   +IH DLK  N+ L+   ++K
Sbjct: 99  RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 155

Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEIYKNEEFDRSVDAYSFGLI 383
           I  FGL           K+ +           P   Y+APE+   +     VD +S G I
Sbjct: 156 IGDFGL---------ATKVEYDGERKKVLCGTPN--YIAPEVLSKKGHSFEVDVWSIGCI 204

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELIEECWDPK 437
           +Y ++ G  PF     +E              +IK   Y       P    LI++     
Sbjct: 205 MYTLLVGKPPFETSCLKETYL-----------RIKKNEYSIPKHINPVAASLIQKMLQTD 253

Query: 438 PVIRPNFNEII 448
           P  RP  NE++
Sbjct: 254 PTARPTINELL 264

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  134 bits (340), Expect = 7e-36
 Identities = 71/309 (22%), Positives = 112/309 (36%), Gaps = 54/309 (17%)

Query: 158 KARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAK-------WNG 210
               A  P  K  P  + +PR    Y              + KG +  AK          
Sbjct: 18  PGAPAAAPPAKEIPEVLVDPRSRRRYVRGRF---------LGKGGF--AKCFEISDADTK 66

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
                KI+ K     P +    + E++I     H +VV F G    N  + +VLE   + 
Sbjct: 67  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
            L    +++  L+  +   +   +  G  YLH  +   +IH DLK  N+ L+   ++KI 
Sbjct: 127 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG 183

Query: 331 GFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
            FGL           K+ +           P   Y+APE+   +     VD +S G I+Y
Sbjct: 184 DFGL---------ATKVEYDGERKKVLCGTPN--YIAPEVLSKKGHSFEVDVWSIGCIMY 232

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELIEECWDPKPV 439
            ++ G  PF     +E              +IK   Y       P    LI++     P 
Sbjct: 233 TLLVGKPPFETSCLKETYL-----------RIKKNEYSIPKHINPVAASLIQKMLQTDPT 281

Query: 440 IRPNFNEII 448
            RP  NE++
Sbjct: 282 ARPTINELL 290

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  133 bits (336), Expect = 9e-36
 Identities = 46/271 (16%), Positives = 99/271 (36%), Gaps = 30/271 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           + +G    +K   K      +  NA           +H +VV++  A  ++  M+I  EY
Sbjct: 33  RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92

Query: 267 HAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
              G LA  + +  R       +++    L + RG+ Y+H      ++H D+KP NI + 
Sbjct: 93  CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFIS 149

Query: 323 NGGQLKISGFGLLRLQYISPEK----------AKIVFPVSHI-DPANLYVAPEIYK-NEE 370
                  +        + S +            +I  P     D    ++A E+ + N  
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS--RFLANEVLQENYT 207

Query: 371 FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
                D ++  L +               ++  ++   +G+ P +    +    +  EL+
Sbjct: 208 HLPKADIFALALTVVCAAGAEPLPRNG--DQWHEIR--QGRLPRI---PQVLSQEFTELL 260

Query: 431 EECWDPKPVIRPNFNEIIARLDRIVCNCSKQ 461
           +    P P  RP+   ++     ++ + S++
Sbjct: 261 KVMIHPDPERRPSAMALVK--HSVLLSASRK 289

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  132 bits (334), Expect = 3e-35
 Identities = 55/277 (19%), Positives = 97/277 (35%), Gaps = 38/277 (13%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           +G++          +     +K +     K    ++    E+ ++    H  VV++  A 
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS----EVMLLASLNHQYVVRYYAAW 71

Query: 255 TQNIPMM-------------IVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNY 300
            +    +             I +EY   G L   +  +       +  R    +   ++Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL- 359
           +H      IIH DLKP NI +D    +KI  FGL +  + S +  K+          NL 
Sbjct: 132 IHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188

Query: 360 -------YVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK 411
                  YVA E+       +  +D YS G+I +EMI             ++K +     
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSI 246

Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
             P      +     K++I    D  P  RP    ++
Sbjct: 247 EFPPDFD-DNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  131 bits (330), Expect = 6e-33
 Identities = 67/297 (22%), Positives = 117/297 (39%), Gaps = 44/297 (14%)

Query: 200 KGSY-QVAKW----NGTKVWVKILDKE-SHKDPERINAFTHELTIVEKARHPNVVQFV-- 251
            G +  V +W     G +V +K   +E S K+ ER      E+ I++K  HPNVV     
Sbjct: 24  TGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSAREV 80

Query: 252 ----GAVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHEC 304
                 +  N   ++ +EY   GDL  YL +      L    +     D++  + YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 305 KPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYISPEKAKIVFPVSHID-----P 356
           +   IIH DLKP+NI+L  G Q    KI   G           AK +             
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGY----------AKELDQGELCTEFVGTL 187

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK-PPEEVVKLMCCEGKRPPL 415
              Y+APE+ + +++  +VD +SFG + +E I G +PF P   P +    +  +     +
Sbjct: 188 --QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDTFKLPW 472
                +       ++        ++       +  +  ++ +  ++G       +  
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM--LMWHQRQRGTDPQNPNVGC 300

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  124 bits (313), Expect = 3e-32
 Identities = 55/306 (17%), Positives = 111/306 (36%), Gaps = 52/306 (16%)

Query: 200 KGSY-QVAKW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VG 252
           +G+   V +      G    +K+ +  S   P   +    E  +++K  H N+V+   + 
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPI 309
             T     ++++E+   G L + L++      L  S+ L    D+  GMN+L E     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133

Query: 310 IHCDLKPKNILL----DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLY 360
           +H ++KP NI+     D     K++ FG           A+ +                Y
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGA----------ARELEDDEQFVSLYGTE--EY 181

Query: 361 VAPEIYK--------NEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLMCCEGK 411
           + P++Y+         +++  +VD +S G+  Y    G  PF P + P    ++M     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 412 RPPLKIKARSYPPDLKELIEECWDPKPV-----IRPNFNEIIARLDRIVCNCSKQGWWKD 466
             P    +     +   +      P        ++     ++A +  +  +  K   +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI--LEADQEKCWGFDQ 299

Query: 467 TFKLPW 472
            F    
Sbjct: 300 FFAETS 305

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (309), Expect = 5e-32
 Identities = 54/254 (21%), Positives = 101/254 (39%), Gaps = 41/254 (16%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG--AVTQNIPMMIVLEY 266
            G +V +K++DK++      +    +E+ I  + +HP++++       +  +   +VLE 
Sbjct: 35  TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV--YLVLEM 92

Query: 267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G++  YL+ +    S ++   F   +  GM YLH      I+H DL   N+LL    
Sbjct: 93  CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNM 149

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEIYKNEEFDRSVDAYSF 380
            +KI+ FGL           ++  P          P   Y++PEI          D +S 
Sbjct: 150 NIKIADFGL---------ATQLKMPHEKHYTLCGTPN--YISPEIATRSAHGLESDVWSL 198

Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELIEECW 434
           G + Y ++ G  PF     +  +            K+    Y        + K+LI +  
Sbjct: 199 GCMFYTLLIGRPPFDTDTVKNTLN-----------KVVLADYEMPSFLSIEAKDLIHQLL 247

Query: 435 DPKPVIRPNFNEII 448
              P  R + + ++
Sbjct: 248 RRNPADRLSLSSVL 261

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  122 bits (308), Expect = 2e-31
 Identities = 51/300 (17%), Positives = 94/300 (31%), Gaps = 72/300 (24%)

Query: 200 KGSY---QVAKWNGTKVWVKILDK---ESHKDPERINAFTH-----------ELTIVEKA 242
           +G +    + + +     +K  +K   E  +D  + N               EL I+   
Sbjct: 41  QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR------ 296
           ++   +   G +T    + I+ EY     +  + +    L  +      + + +      
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 297 --GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
               +Y+H  K   I H D+KP NIL+D  G++K+S FG                  S  
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGE-----------------SEY 201

Query: 355 DPANL---------YVAPEIYKNEEF--DRSVDAYSFGLILYEMIEGVQPFHPKP----- 398
                         ++ PE + NE       VD +S G+ LY M   V PF  K      
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

Query: 399 -----------PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI 447
                      P +    +     +            +  + ++      P  R    + 
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTC-SNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  123 bits (309), Expect = 3e-31
 Identities = 50/235 (21%), Positives = 95/235 (40%), Gaps = 45/235 (19%)

Query: 200 KGSY-QVAKW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VG 252
           +G+   V +      G    +K+ +  S   P   +    E  +++K  H N+V+   + 
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPI 309
             T     ++++E+   G L + L++      L  S+ L    D+  GMN+L E     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133

Query: 310 IHCDLKPKNILL----DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLY 360
           +H ++KP NI+     D     K++ FG           A+ +                Y
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGA----------ARELEDDEQFVSLYGTE--EY 181

Query: 361 VAPEIYK--------NEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEVVKLM 406
           + P++Y+         +++  +VD +S G+  Y    G  PF P + P    ++M
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  120 bits (304), Expect = 7e-31
 Identities = 59/246 (23%), Positives = 112/246 (45%), Gaps = 29/246 (11%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V +KI+DK +  +P  +     E+ I++   HPN+V+    +     + +++EY + 
Sbjct: 40  GREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++  YL   GR+   +       +   + Y H+ +   I+H DLK +N+LLD    +KI
Sbjct: 99  GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155

Query: 330 SGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEIYKNEEFD-RSVDAYSFGLI 383
           + FG           +        +D     P   Y APE+++ +++D   VD +S G+I
Sbjct: 156 ADFGF----------SNEFTVGGKLDAFCGAPP--YAAPELFQGKKYDGPEVDVWSLGVI 203

Query: 384 LYEMIEGVQPFH-PKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           LY ++ G  PF      E   +++  + + P           D + L++      P+ R 
Sbjct: 204 LYTLVSGSLPFDGQNLKELRERVLRGKYRIPF------YMSTDCENLLKRFLVLNPIKRG 257

Query: 443 NFNEII 448
              +I+
Sbjct: 258 TLEQIM 263

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (300), Expect = 1e-30
 Identities = 62/263 (23%), Positives = 103/263 (39%), Gaps = 47/263 (17%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYHAK 269
           KV +K +     +  E +  F  E+    +  H N+V    V     +    +V+EY   
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-EEDDCYY-LVMEYIEG 95

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
             L+ Y++  G LS    + F   +  G+ + H+ +   I+H D+KP+NIL+D+   LKI
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKI 152

Query: 330 SGFGLLRL----------------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
             FG+ +                 QY SPE+A                     K E  D 
Sbjct: 153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQA---------------------KGEATDE 191

Query: 374 SVDAYSFGLILYEMIEGVQPFHPKPPEEV-VKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             D YS G++LYEM+ G  PF+ +    + +K +          +  +  P  L  +I  
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV-RKDIPQSLSNVILR 250

Query: 433 CWDPKPVIRP-NFNEIIARLDRI 454
             +     R     E+   L  +
Sbjct: 251 ATEKDKANRYKTIQEMKDDLSSV 273

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (301), Expect = 1e-30
 Identities = 64/265 (24%), Positives = 99/265 (37%), Gaps = 48/265 (18%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMM--IVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V     G        +  IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+     IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156

Query: 329 ISGFGLLRL------------------QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           +  FG+ R                   QY+SPE+A+       +D               
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR----GDSVDA-------------- 198

Query: 371 FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
             RS D YS G +LYE++ G  PF    P  V           P   +      DL  ++
Sbjct: 199 --RS-DVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVREDPIPPSARHEGLSADLDAVV 254

Query: 431 EECWDPKPVIRP-NFNEIIARLDRI 454
            +     P  R     E+ A L R+
Sbjct: 255 LKALAKNPENRYQTAAEMRADLVRV 279

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  117 bits (295), Expect = 1e-29
 Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 44/268 (16%)

Query: 209 NGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           +G KV +K    ES +   E    F  E+  +   RHP++V  +G   +   M+++ +Y 
Sbjct: 62  DGAKVALKRRTPESSQGIEE----FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 268 AKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
             G+L  +L         +S  + L   +  ARG++YLH      IIH D+K  NILLD 
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDE 174

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL----YVAPEIYKNEEF-DRSVDAY 378
               KI+ FG+ +      E  +     +H+         Y+ PE +      ++S D Y
Sbjct: 175 NFVPKITDFGISKK---GTELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKS-DVY 225

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKL----MCCEGKR-------PPLKIKARSYPPD-L 426
           SFG++L+E++          P E+V L    +             P L  K     P+ L
Sbjct: 226 SFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK---IRPESL 282

Query: 427 K---ELIEECWDPKPVIRPNFNEIIARL 451
           +   +   +C       RP+  +++ +L
Sbjct: 283 RKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (291), Expect = 3e-29
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 39/248 (15%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKES---HKDPERINAFTHELTIVEKARHPNVVQFV 251
           +GS+       +   ++ + +KIL+K           +     E  ++ +  HP  V+  
Sbjct: 40  EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKLY 96

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
                +  +   L Y   G+L  Y++K G    +   RF   ++   + YLH      II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVSALEYLHGKG---II 152

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------YVAPE 364
           H DLKP+NILL+    ++I+ FG           AK++ P S    AN       YV+PE
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGT----------AKVLSPESKQARANSFVGTAQYVSPE 202

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV-KLMCCEGKRPPLKIKARSYP 423
           +   +   +S D ++ G I+Y+++ G+ PF       +  K++  E   P        + 
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE------KFF 256

Query: 424 PDLKELIE 431
           P  ++L+E
Sbjct: 257 PKARDLVE 264

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  114 bits (288), Expect = 4e-29
 Identities = 71/266 (26%), Positives = 103/266 (38%), Gaps = 39/266 (14%)

Query: 200 KGSYQVAK-----WNGTKVWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGA 253
           +G+Y   +          V VKI+D +   D PE I     E+ I +   H NVV+F G 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFYGH 73

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
             +     + LEY + G+L   ++    +      RF   L  G+ YLH      I H D
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130

Query: 314 LKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL--------YVAPEI 365
           +KP+N+LLD    LKIS FGL  +               +     L        YVAPE+
Sbjct: 131 IKPENLLLDERDNLKISDFGLATV------------FRYNNRERLLNKMCGTLPYVAPEL 178

Query: 366 YKNEEFD-RSVDAYSFGLILYEMIEGVQPFH--PKPPEEVVKLMCCEGKRPPLKIKARSY 422
            K  EF    VD +S G++L  M+ G  P+       +E       +    P K      
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK----KI 234

Query: 423 PPDLKELIEECWDPKPVIRPNFNEII 448
                 L+ +     P  R    +I 
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIK 260

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (290), Expect = 5e-29
 Identities = 65/321 (20%), Positives = 122/321 (38%), Gaps = 35/321 (10%)

Query: 138 GSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVANPREVP-EYELNPLELQV 192
           GS + +  + +    +     +  AK+    P+T+     +   +  P +YE       +
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60

Query: 193 RKADGITKGSY-QV----AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
                + +GS+ +V     K  G +  VK +  E  +          EL        P +
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGLSSPRI 112

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPD 307
           V   GAV +   + I +E    G L   +++ G L   + L +      G+ YLH  +  
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-- 170

Query: 308 PIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-----YV 361
            I+H D+K  N+LL  +G +  +  FG       +          S +    +     ++
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFG------HALCLQPDGLGKSLLTGDYIPGTETHM 223

Query: 362 APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS 421
           APE+   +  D  VD +S   ++  M+ G  P+       +   +    + PP++    S
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIASEPPPIREIPPS 281

Query: 422 YPPDLKELIEECWDPKPVIRP 442
             P   + I+E    +PV R 
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRA 302

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  113 bits (286), Expect = 9e-29
 Identities = 62/257 (24%), Positives = 107/257 (41%), Gaps = 50/257 (19%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYH 267
           G KV VKIL+++  +  + +     E+  ++  RHP++++   V +   +    +V+EY 
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF--FMVMEYV 93

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
           + G+L  Y+ K GR+   +  R    +   ++Y H      ++H DLKP+N+LLD     
Sbjct: 94  SGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA 150

Query: 328 KISGFGLLRLQYI---------SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDA 377
           KI+ FGL  +            SP                 Y APE+     +    VD 
Sbjct: 151 KIADFGLSNMMSDGEFLRTSCGSPN----------------YAAPEVISGRLYAGPEVDI 194

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELIE 431
           +S G+ILY ++ G  PF     +E V  +         KI+   +         +  L+ 
Sbjct: 195 WSCGVILYALLCGTLPFD----DEHVPTLF-------KKIRGGVFYIPEYLNRSVATLLM 243

Query: 432 ECWDPKPVIRPNFNEII 448
                 P+ R    +I 
Sbjct: 244 HMLQVDPLKRATIKDIR 260

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  113 bits (285), Expect = 2e-28
 Identities = 71/266 (26%), Positives = 103/266 (38%), Gaps = 39/266 (14%)

Query: 200 KGSYQVAK-----WNGTKVWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGA 253
           +G+Y   +          V VKI+D +   D PE I     E+ I +   H NVV+F G 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFYGH 73

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
             +     + LEY + G+L   ++    +      RF   L  G+ YLH      I H D
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130

Query: 314 LKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL--------YVAPEI 365
           +KP+N+LLD    LKIS FGL  +               +     L        YVAPE+
Sbjct: 131 IKPENLLLDERDNLKISDFGLATV------------FRYNNRERLLNKMCGTLPYVAPEL 178

Query: 366 YKNEEFD-RSVDAYSFGLILYEMIEGVQPFH--PKPPEEVVKLMCCEGKRPPLKIKARSY 422
            K  EF    VD +S G++L  M+ G  P+       +E       +    P K      
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK----KI 234

Query: 423 PPDLKELIEECWDPKPVIRPNFNEII 448
                 L+ +     P  R    +I 
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIK 260

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  113 bits (285), Expect = 3e-28
 Identities = 64/255 (25%), Positives = 111/255 (43%), Gaps = 47/255 (18%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
             KV +K + ++  K  +       E++ ++  RHP++++    +T    +++V+EY A 
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AG 92

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G+L  Y+ +K R++  +  RF   +   + Y H  K   I+H DLKP+N+LLD+   +KI
Sbjct: 93  GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149

Query: 330 SGFGLLRLQYI---------SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYS 379
           + FGL  +            SP                 Y APE+   + +    VD +S
Sbjct: 150 ADFGLSNIMTDGNFLKTSCGSPN----------------YAAPEVINGKLYAGPEVDVWS 193

Query: 380 FGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELIEEC 433
            G++LY M+ G  PF     +E +  +         K+ +  Y       P  + LI   
Sbjct: 194 CGIVLYVMLVGRLPFD----DEFIPNLF-------KKVNSCVYVMPDFLSPGAQSLIRRM 242

Query: 434 WDPKPVIRPNFNEII 448
               P+ R    EI 
Sbjct: 243 IVADPMQRITIQEIR 257

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  113 bits (286), Expect = 3e-28
 Identities = 76/303 (25%), Positives = 120/303 (39%), Gaps = 62/303 (20%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESH 223
             P+ +    +   Y+             I  G++ VA+          V VK +++   
Sbjct: 8   TGPLDMPIMHDSDRYDFVKD---------IGSGNFGVARLMRDKLTKELVAVKYIERG-A 57

Query: 224 KDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
              E +     E+      RHPN+V+F  V     ++   I++EY + G+L   +   GR
Sbjct: 58  AIDENV---QREIINHRSLRHPNIVRFKEVILTPTHL--AIIMEYASGGELYERICNAGR 112

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLKISGFGLLRLQY 339
            S  +   F   L  G++Y H  +   I H DLK +N LLD     +LKI  FG      
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY----- 164

Query: 340 ISPEKAKIVFPVSHID-----PANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEGVQP 393
                +K     S        PA  Y+APE+   +E+D +  D +S G+ LY M+ G  P
Sbjct: 165 -----SKSSVLHSQPKSTVGTPA--YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

Query: 394 FH-PKPPEEVVKLMCCEGKRPPLKIKARSY--------PPDLKELIEECWDPKPVIRPNF 444
           F  P+ P +  K +         +I +  Y         P+   LI   +   P  R + 
Sbjct: 218 FEDPEEPRDYRKTI--------QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISI 269

Query: 445 NEI 447
            EI
Sbjct: 270 PEI 272

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  113 bits (284), Expect = 3e-28
 Identities = 52/260 (20%), Positives = 95/260 (36%), Gaps = 48/260 (18%)

Query: 207 KWNGTKVWVKILDKE-----SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
           K    +V VK + KE        +  ++   T E+ I+ +  H N+++ +          
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105

Query: 262 IVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           +V+E H  G DL +++ +  RL           L   + YL       IIH D+K +NI+
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIV 162

Query: 321 LDNGGQLKISGFGL---------LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF 371
           +     +K+  FG                + E                Y APE+     +
Sbjct: 163 IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE----------------YCAPEVLMGNPY 206

Query: 372 D-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK-RPPLKIKARSYPPDLKEL 429
               ++ +S G+ LY ++    PF      E+ + +  E    PP  +       +L  L
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPF-----CELEETV--EAAIHPPYLV-----SKELMSL 254

Query: 430 IEECWDPKPVIRPNFNEIIA 449
           +     P P  R    +++ 
Sbjct: 255 VSGLLQPVPERRTTLEKLVT 274

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  112 bits (283), Expect = 5e-28
 Identities = 75/273 (27%), Positives = 119/273 (43%), Gaps = 45/273 (16%)

Query: 208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
            +GT V VK L +E  +  E    F  E+ ++  A H N+++  G        ++V  Y 
Sbjct: 52  ADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 109

Query: 268 AKGDLASYLQKKGRLSPSKVL----RF--ALDLARGMNYLHE-CKPDPIIHCDLKPKNIL 320
           A G +AS L+   R      L    R   AL  ARG+ YLH+ C P  IIH D+K  NIL
Sbjct: 110 ANGSVASCLR--ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANIL 166

Query: 321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL----YVAPEIYKNEEFDRSVD 376
           LD   +  +  FGL +L      K       +H+  A      ++APE     +     D
Sbjct: 167 LDEEFEAVVGDFGLAKLM---DYK------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 217

Query: 377 AYSFGLILYEMIEGVQPFHP-KPPEEV-------VKLMCCEGKR-----PPLKIKARSYP 423
            + +G++L E+I G + F   +   +        VK +  E K        L+     Y 
Sbjct: 218 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN---YK 274

Query: 424 PD-LKELIE---ECWDPKPVIRPNFNEIIARLD 452
            + +++LI+    C    P+ RP  +E++  L+
Sbjct: 275 DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  110 bits (277), Expect = 3e-27
 Identities = 61/318 (19%), Positives = 111/318 (34%), Gaps = 76/318 (23%)

Query: 170 TPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAK----------------WNGTKV 213
           + +        P  +L+  +L   K     +  YQV                   +   V
Sbjct: 12  SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71

Query: 214 WVKILDKESHKDPERINAFTH---ELTIVEKARH--PNVVQFVGAVTQNIPMMIVLEYHA 268
            +K ++K+   D   +   T    E+ +++K       V++ +    +    +++LE   
Sbjct: 72  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131

Query: 269 -KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQ 326
              DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+
Sbjct: 132 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 188

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEFD-RSVD 376
           LK+  FG                    +    +         Y  PE  +   +  RS  
Sbjct: 189 LKLIDFGS-----------------GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231

Query: 377 AYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELI 430
            +S G++LY+M+ G  PF              E      +I             + + LI
Sbjct: 232 VWSLGILLYDMVCGDIPF--------------EHDE---EIIRGQVFFRQRVSSECQHLI 274

Query: 431 EECWDPKPVIRPNFNEII 448
             C   +P  RP F EI 
Sbjct: 275 RWCLALRPSDRPTFEEIQ 292

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  110 bits (277), Expect = 4e-27
 Identities = 36/278 (12%), Positives = 64/278 (23%), Gaps = 50/278 (17%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV------ 263
                +K+    +      +           +    +  +        +P   V      
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 264 -------------------LEYHAKGDLASYL-------QKKGRLSPSKVLRFALDLARG 297
                              L   A  DL             +G      +      L R 
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
              L       ++H    P N+ +   G+L +     L    +         PV      
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASSVPV------ 255

Query: 358 NLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFH---PKPPEEVVKLMCCEGKR 412
             Y   E        F  +++A+  GL +Y +     PF    P       +        
Sbjct: 256 -TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGT 314

Query: 413 PPLKIKA-RSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
             L   +    P  +K LI    +     R    E + 
Sbjct: 315 DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score =  104 bits (262), Expect = 5e-27
 Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   GD+  VE LL  GSD N  D  G T LH A   GH++VV+LLL  KA ++   
Sbjct: 14  LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               +   DA   G+V++  +L + GA           P+   
Sbjct: 74  YQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYT 116

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 96.0 bits (240), Expect = 7e-24
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  AC  G +K VE LL   + VN+      + LH AA  GHV++VKLLLS  A+ +A +
Sbjct: 47  LHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVN 106

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
            +G              +  + +   +
Sbjct: 107 IFGLRPVDYTDDESMKSLLLLPEKNES 133

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 84.8 bits (211), Expect = 6e-20
 Identities = 21/70 (30%), Positives = 37/70 (52%), Gaps = 1/70 (1%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G D  + +  G T LHIA+ +G +  V+ LL   ++ + +D  G T   +A  +G+++V 
Sbjct: 1   GIDPFT-NHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59

Query: 155 NILKARGAKV 164
            +L    A V
Sbjct: 60  ELLLQHKALV 69

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 62.8 bits (154), Expect = 4e-12
 Identities = 12/55 (21%), Positives = 26/55 (47%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A + G V  V+ LL+ G+  N++++ G   +     E    ++ L    +++
Sbjct: 80  LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESS 134

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (277), Expect = 6e-27
 Identities = 42/254 (16%), Positives = 84/254 (33%), Gaps = 42/254 (16%)

Query: 215 VKILDKESH-KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA----- 268
           +++L    + K  +    F     +V+  +   +++          +     Y       
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 269 ---KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
                 L S+      L     L+  L + R +  LH      ++H  L+P +I+LD  G
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRG 243

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI-----------YKNEEFDRS 374
            + ++GF  L       + A++V  VS       +  PE+            +      S
Sbjct: 244 GVFLTGFEHLV-----RDGARVVSSVS-----RGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECW 434
            DA++ GL++Y +     P          + +     R    I     P  ++ L+E   
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNI-----PQPVRALLEGFL 344

Query: 435 DPKPVIRPNFNEII 448
                 R    + +
Sbjct: 345 RYPKEDRLLPLQAM 358

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score =  104 bits (263), Expect = 7e-27
 Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 6/110 (5%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEGHVEVVKLLLSKKANIDARD 135
           + +   G  +  E LL  G++ N  D    T  +H AA EG ++ + +L    A +D RD
Sbjct: 49  IQVMMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRD 108

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA---NPREVPE 182
            WG      A+  G+ +V   L+A              +     P ++P+
Sbjct: 109 AWGRLPVDLAEELGHRDVARYLRAAAGGT--RGSNHARIDAAEGPSDIPD 156

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 94.5 bits (236), Expect = 4e-23
 Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 6/104 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G V+ V  LL  G++ N+ +  GR  + +    G   V +LLL   A  +  D
Sbjct: 16  LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74

Query: 136 RWGSTAAA-DAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    DA   G ++   +L   GA++  +    R P+ +A
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLA 118

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 80.6 bits (200), Expect = 3e-18
 Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 9/76 (11%)

Query: 92  LNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYY 148
           +   +  +         L  AA  G VE V+ LL   AN +A + +G             
Sbjct: 1   MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM----M 54

Query: 149 GNVEVYNILKARGAKV 164
           G+  V  +L   GA+ 
Sbjct: 55  GSARVAELLLLHGAEP 70

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (277), Expect = 7e-27
 Identities = 34/255 (13%), Positives = 72/255 (28%), Gaps = 55/255 (21%)

Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN----IPMMIVLEYHAKGD------- 271
            K+ ++       +   +  + P   + +          +     L    + +       
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197

Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L S+      L     L+  L + R +  LH      ++H  L+P +I+LD  G + ++G
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254

Query: 332 FGLLRLQ-----------YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-----RSV 375
           F  L              +  PE                  A  +    +        + 
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPE----------------TTAERMLPFGQHHPTLMTFAF 298

Query: 376 DAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWD 435
           D ++ GL +Y +     P          + +    K           P  ++ L+E    
Sbjct: 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNI---------PQPVRALLEGFLR 349

Query: 436 PKPVIRPNFNEIIAR 450
                R    + +  
Sbjct: 350 YPKEDRLLPLQAMET 364

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score =  102 bits (258), Expect = 1e-26
 Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 4/110 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
              A + GD+  V+D + +G DVN     GR  LH AA  G +E+++ LL K A+I+A D
Sbjct: 11  FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVANPREVPE 182
           +   T    A Y G+V    +L ++GA    K     T     + + +  
Sbjct: 71  KHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKA 120

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 89.4 bits (223), Expect = 9e-22
 Identities = 25/66 (37%), Positives = 33/66 (50%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           +E LL +G+D+N+ D    T L  A  EGHV  VKLLLSK A+   +   G TA      
Sbjct: 56  LEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDN 115

Query: 148 YGNVEV 153
                +
Sbjct: 116 QAIKAL 121

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 77.4 bits (192), Expect = 1e-17
 Identities = 12/61 (19%), Positives = 23/61 (37%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
                   A   G ++ VK  ++K  +++     G      A   G +E+   L  +GA 
Sbjct: 6   MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGAD 65

Query: 164 V 164
           +
Sbjct: 66  I 66

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 53.2 bits (129), Expect = 5e-09
 Identities = 13/47 (27%), Positives = 21/47 (44%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK 122
           LL     G V  V+ LL++G+D      DG TA      +    +++
Sbjct: 77  LLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  110 bits (276), Expect = 2e-26
 Identities = 57/270 (21%), Positives = 95/270 (35%), Gaps = 44/270 (16%)

Query: 200 KGSY----QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAV 254
            G+         ++   V VK +  E     +R      E+ ++ +   HPNV+++    
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTE 87

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
                  I +E      L  Y+++K       + +        G+ +LH      I+H D
Sbjct: 88  KDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRD 143

Query: 314 LKPKNILLDNGGQ-----LKISGFGLLRLQYISPEKAKIVFPVSHIDPAN-------LYV 361
           LKP NIL+            IS FGL           K +    H             ++
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGL----------CKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 362 APEIYK---NEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
           APE+      E    +VD +S G + Y +I EG  PF      +   ++        L  
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLGACSLDCLHP 252

Query: 418 KARSYPPDLKELIEECWDPKPVIRPNFNEI 447
             +      +ELIE+     P  RP+   +
Sbjct: 253 -EKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (268), Expect = 4e-26
 Identities = 42/248 (16%), Positives = 76/248 (30%), Gaps = 46/248 (18%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYHAKG 270
           V +K++ +    DP        E     + + P+VV     G         + +      
Sbjct: 62  VALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-EIDGQLY-VDMRLINGV 119

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           DLA+ L+++G L+P + +     +   ++  H        H D+KP+NIL+       + 
Sbjct: 120 DLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLV 176

Query: 331 GFGLLR----------------LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS 374
            FG+                  L Y++PE+                              
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERF---------------------SESHATYR 215

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECW 434
            D Y+   +LYE + G  P+       +   +      P         P     +I    
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVMGAHI--NQAIPRPSTVRPGIPVAFDAVIARGM 273

Query: 435 DPKPVIRP 442
              P  R 
Sbjct: 274 AKNPEDRY 281

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  109 bits (274), Expect = 4e-26
 Identities = 66/257 (25%), Positives = 110/257 (42%), Gaps = 50/257 (19%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYH 267
           G KV VKIL+++  +  + +     E+  ++  RHP++++   V +   +I M  V+EY 
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM--VMEYV 98

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
           + G+L  Y+ K GRL   +  R    +  G++Y H      ++H DLKP+N+LLD     
Sbjct: 99  SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNA 155

Query: 328 KISGFGLLRLQYI---------SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDA 377
           KI+ FGL  +            SP                 Y APE+     +    VD 
Sbjct: 156 KIADFGLSNMMSDGEFLRTSCGSP----------------NYAAPEVISGRLYAGPEVDI 199

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELIE 431
           +S G+ILY ++ G  PF     ++ V  +         KI    +       P +  L++
Sbjct: 200 WSSGVILYALLCGTLPFD----DDHVPTLF-------KKICDGIFYTPQYLNPSVISLLK 248

Query: 432 ECWDPKPVIRPNFNEII 448
                 P+ R    +I 
Sbjct: 249 HMLQVDPMKRATIKDIR 265

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score =  104 bits (263), Expect = 6e-26
 Identities = 39/146 (26%), Positives = 58/146 (39%), Gaps = 9/146 (6%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LLF+A  G  K V  L   G+D++  D+  G TALH+AA     EVV+ L+   A+I+  
Sbjct: 81  LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVE 140

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRK 194
           D  G TA   A+              G ++   K   +      E  E      E+  ++
Sbjct: 141 DERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFEYAE----VDEIVEKR 196

Query: 195 ADGITKGSYQVAKWNGTK--VWVKIL 218
             G         +W       WVK +
Sbjct: 197 GKGKDVEYL--VRWKDGGDCEWVKGV 220

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 14/173 (8%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A R  D + +  LL E  DV+++D +GRTAL   A  G  + V+LL    A++D RD
Sbjct: 49  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107

Query: 136 -RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELNPL 188
            R G TA   A  Y   EV   L   GA +  + +   T + +A              P+
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGN---PM 164

Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESH-KDPERINAFTHELTIVE 240
           +   R          +   +   +V  +I++K    KD E +  +        
Sbjct: 165 QFGRRIGLEKVINVLEGQVFEYAEV-DEIVEKRGKGKDVEYLVRWKDGGDCEW 216

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 8/109 (7%)

Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           +  M+ L     G            +DV S   +  T    AA +   + +  LL +  +
Sbjct: 14  EGAMEYLIEWKDGHSPSWVPSSYIAADVVS---EYETPWWTAARKADEQALSQLL-EDRD 69

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVA 175
           +DA D  G TA       G+ +   +L   GA +     +   T + +A
Sbjct: 70  VDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMA 118

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 5/43 (11%), Positives = 14/43 (32%)

Query: 93  NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            E  ++      G+   ++   +   +   +     A   A+D
Sbjct: 187 AEVDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD 229

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 8/97 (8%), Positives = 24/97 (24%), Gaps = 13/97 (13%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A          + +  G  +    +     +       + EV +++  +        
Sbjct: 148 LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEYAEVDEIVEKRG------- 197

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTKRTP 171
             G       ++    +   +     A+   K     
Sbjct: 198 -KGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKDYEDG 233

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (267), Expect = 6e-26
 Identities = 56/258 (21%), Positives = 94/258 (36%), Gaps = 50/258 (19%)

Query: 210 GTKVWVKILDKESHKDPERINAFTH---ELTIVEKAR----HPNVVQFVGAVTQNIPMMI 262
             +V +K++ +        ++       E+ ++ K      HP V++ +         M+
Sbjct: 56  RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115

Query: 263 VLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           VLE      DL  Y+ +KG L       F   +   + + H      ++H D+K +NIL+
Sbjct: 116 VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILI 172

Query: 322 D-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEF 371
           D   G  K+  FG                    +              Y  PE     ++
Sbjct: 173 DLRRGCAKLIDFGS-----------------GALLHDEPYTDFDGTRVYSPPEWISRHQY 215

Query: 372 D-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI 430
                  +S G++LY+M+ G  PF     E   +++  E   P          PD   LI
Sbjct: 216 HALPATVWSLGILLYDMVCGDIPF-----ERDQEILEAELHFPA------HVSPDCCALI 264

Query: 431 EECWDPKPVIRPNFNEII 448
             C  PKP  RP+  EI+
Sbjct: 265 RRCLAPKPSSRPSLEEIL 282

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score =  101 bits (254), Expect = 8e-26
 Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 1/87 (1%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEGHVEVVKLLLSKKANIDARD 135
           + +   G  +  E LL  G++ N  D    T  +H AA EG ++ + +L    A +D  D
Sbjct: 49  IQVMMMGSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCD 108

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
            WG      A+  G+ ++   L A   
Sbjct: 109 AWGRLPVDLAEEQGHRDIARYLHAATG 135

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 94.8 bits (237), Expect = 2e-23
 Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 6/104 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G V+ V  LL  G+D N+++  GR  + +    G  +V +LLL   A  +  D
Sbjct: 16  LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGSAQVAELLLLHGAEPNCAD 74

Query: 136 RWGSTAA-ADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    DA   G ++   +L   GA++       R P+ +A
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLA 118

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 89.8 bits (224), Expect = 1e-21
 Identities = 18/73 (24%), Positives = 30/73 (41%), Gaps = 7/73 (9%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNV 151
              ++ +       L  AA  G VE V+ LL   A+ +A +R+G             G+ 
Sbjct: 2   SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM----MGSA 57

Query: 152 EVYNILKARGAKV 164
           +V  +L   GA+ 
Sbjct: 58  QVAELLLLHGAEP 70

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 71.3 bits (176), Expect = 3e-15
 Identities = 12/62 (19%), Positives = 26/62 (41%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK 128
               T  +   A  G +  +  L   G+ ++  D  GR  + +A  +GH ++ + L +  
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAAT 134

Query: 129 AN 130
            +
Sbjct: 135 GD 136

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  106 bits (267), Expect = 1e-25
 Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 42/247 (17%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFV 251
            GS+     V        + +KILDK+     K  E       E  I++    P +V+  
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---EKRILQAVNFPFLVKLE 107

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
            +   N  + +V+EY A G++ S+L++ GR       RF A  +     YLH      +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHSLD---LI 163

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------YVAPE 364
           + DLKP+N+L+D  G ++++ FG           AK V                  +APE
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGF----------AKRV-----KGRTWTLCGTPEALAPE 208

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
           I  ++ ++++VD ++ G+++YEM  G  PF    P ++ + +     R P       +  
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSS 263

Query: 425 DLKELIE 431
           DLK+L+ 
Sbjct: 264 DLKDLLR 270

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (264), Expect = 1e-25
 Identities = 53/242 (21%), Positives = 107/242 (44%), Gaps = 27/242 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
              G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ +      + +V+EY
Sbjct: 42  VATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G L   +  +  +   ++     +  + + +LH  +   +IH D+K  NILL   G 
Sbjct: 99  LAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV------APEIYKNEEFDRSVDAYSF 380
           +K++ FG      I+PE++K           +  V      APE+   + +   VD +S 
Sbjct: 155 VKLTDFGFC--AQITPEQSK----------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202

Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           G++  EMIEG  P+  + P   + L+   G  P L+          ++ +  C +     
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQ-NPEKLSAIFRDFLNRCLEMDVEK 260

Query: 441 RP 442
           R 
Sbjct: 261 RG 262

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (266), Expect = 1e-25
 Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 70/314 (22%)

Query: 183 YELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELT 237
            EL   + +     G   G+   V K     +G  +  K++  E    P   N    EL 
Sbjct: 28  GELKDDDFEKISELG--AGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQ 83

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
           ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + + ++ + +G
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
           + YL E     I+H D+KP NIL+++ G++K+  FG      +S +    +        A
Sbjct: 144 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG------VSGQLIDSM--------A 187

Query: 358 N------LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP--------------- 396
           N       Y++PE  +   +    D +S GL L EM  G  P  P               
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247

Query: 397 ------------------------KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
                                   +PP  + +L+      PP K+ +  +  + ++ + +
Sbjct: 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 307

Query: 433 CWDPKPVIRPNFNE 446
           C    P  R +  +
Sbjct: 308 CLIKNPAERADLKQ 321

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score =  101 bits (254), Expect = 2e-25
 Identities = 21/89 (23%), Positives = 41/89 (46%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  +A +G++  +   + + + +N  D +G T L  AA  G + VV+ LL   A+     
Sbjct: 7   VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           +   +A + A   G  ++  +L   G  V
Sbjct: 67  KGRESALSLACSKGYTDIVKMLLDCGVDV 95

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score =  101 bits (254), Expect = 2e-25
 Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 5/91 (5%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           L +AC     D+  V+ LL+ G DVN  D +G T L  A    HV+ VK+LL   A+   
Sbjct: 73  LSLACSKGYTDI--VKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTI 130

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
               G  +   A   G   V  ++++   K+
Sbjct: 131 ETDSGYNSMDLAVALGYRSVQQVIESHLLKL 161

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 97.5 bits (244), Expect = 5e-24
 Identities = 28/103 (27%), Positives = 47/103 (45%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G +  VE LL  G+D   +     +AL +A  +G+ ++VK+LL    +++  D
Sbjct: 40  LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYD 99

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A +  +V+   +L   GA    +T      M +A
Sbjct: 100 WNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLA 142

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 81.3 bits (202), Expect = 2e-18
 Identities = 14/61 (22%), Positives = 25/61 (40%), Gaps = 1/61 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A     VK V+ LL  G+D       G  ++ +A   G+  V +++ S    +    
Sbjct: 106 LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLLQNI 165

Query: 136 R 136
           +
Sbjct: 166 K 166

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 79.4 bits (197), Expect = 1e-17
 Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 3/75 (4%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
               ++H  A +G +  +   + ++  I+  D  G T    A  +G + V   L   GA 
Sbjct: 2   ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61

Query: 164 V-PKTK--RTPMTVA 175
                K   + +++A
Sbjct: 62  PQLLGKGRESALSLA 76

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  105 bits (264), Expect = 2e-25
 Identities = 67/292 (22%), Positives = 122/292 (41%), Gaps = 43/292 (14%)

Query: 162 AKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV----AKWNGTKVWVK 216
            +     R  +   +PR +       L+  V+    I +GS   V     K +G +V VK
Sbjct: 28  EQFKAALRMVVDQGDPRLL-------LDSYVK----IGEGSTGIVCLAREKHSGRQVAVK 76

Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
           ++D    +  E +    +E+ I+   +H NVV+   +      + +++E+   G L   +
Sbjct: 77  MMDLRKQQRRELL---FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-I 132

Query: 277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             + RL+  ++      + + + YLH      +IH D+K  +ILL   G++K+S FG   
Sbjct: 133 VSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGF-- 187

Query: 337 LQYISPEKAKIVFPVSHIDPANLYV------APEIYKNEEFDRSVDAYSFGLILYEMIEG 390
              IS +  K              V      APE+     +   VD +S G+++ EM++G
Sbjct: 188 CAQISKDVPK----------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
             P+    P + +K +      P LK   +   P L++ +E      P  R 
Sbjct: 238 EPPYFSDSPVQAMKRLRDSPP-PKLKNSHK-VSPVLRDFLERMLVRDPQERA 287

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score =  103 bits (257), Expect = 2e-25
 Identities = 42/183 (22%), Positives = 63/183 (34%), Gaps = 8/183 (4%)

Query: 76  LLFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +  +A  G +    E +L + S     D D RTALH A   GH E+V+ LL     ++ +
Sbjct: 10  ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYELNPL 188
           D  G +    A   G  E+   L  +GA V    +   TP+  A   N  E+    L   
Sbjct: 70  DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128

Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
                  D     +   A   G    V IL         +       L +          
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188

Query: 249 QFV 251
           +F+
Sbjct: 189 KFL 191

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 75.7 bits (186), Expect = 8e-16
 Identities = 23/158 (14%), Positives = 48/158 (30%), Gaps = 15/158 (9%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
                 ++A      E+ + +L+ K+     D+   TA   A      G+ E+   L   
Sbjct: 6   SNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWAC---SAGHTEIVEFLLQL 62

Query: 161 GAKV-PKTK--RTPMTVA---NPREVPEYEL-NPLELQVRKADGITKGSYQVAKWNGTKV 213
           G  V  K     +P+ +A      E+ +  L     +     +G T      A       
Sbjct: 63  GVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCT--PLHYAASKNRHE 120

Query: 214 WVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
              +L +       + +     +       +  +V  +
Sbjct: 121 IAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHIL 158

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 73.7 bits (181), Expect = 3e-15
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 3/112 (2%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
            N +    L + A +   +    LL  G++ ++ D    TA+H AA +G++++V +LL  
Sbjct: 102 VNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFY 161

Query: 128 KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN 176
           KA+ + +D  G+T    A     VE    L  +GA +    K ++TP+ VA 
Sbjct: 162 KASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK 213

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 2/97 (2%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           ++      +   A +G++K V  LL   +  N  D +G T LH+A  E  VE  K L+++
Sbjct: 135 KDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQ 194

Query: 128 KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            A+I   ++   T    AK  G + +     A G + 
Sbjct: 195 GASIYIENKEEKTPLQVAK--GGLGLILKRLAEGEEA 229

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 9/65 (13%), Positives = 27/65 (41%), Gaps = 2/65 (3%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           ++ +    L        V+  + L+ +G+ +   + + +T L +A   G + ++   L++
Sbjct: 168 QDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GGLGLILKRLAE 225

Query: 128 KANID 132
                
Sbjct: 226 GEEAS 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (265), Expect = 2e-25
 Identities = 38/272 (13%), Positives = 90/272 (33%), Gaps = 37/272 (13%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N  K  +K+    +  +          +  ++ +     ++F  A       ++V E ++
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150

Query: 269 KGDLASYLQKKGR-----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-- 321
            G L + +          +    V+ FA+ +   +  +H+C+   IIH D+KP N +L  
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207

Query: 322 ---------DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
                    D    L +   G      + P+    +F          +   E+  N+ ++
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG--TIFTAKCETSG--FQCVEMLSNKPWN 263

Query: 373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEE 432
             +D +     +Y M+ G          E          +P    +   +     E    
Sbjct: 264 YQIDYFGVAATVYCMLFGTYMKVKNEGGE---------CKPEGLFRRLPHLDMWNEFFHV 314

Query: 433 CWDPKPVIR-PNFNEIIARLDRIVC-NCSKQG 462
             +       P+ + +  +L ++   + + + 
Sbjct: 315 MLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (263), Expect = 2e-25
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 41/284 (14%)

Query: 182 EYELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHEL 236
            Y+    +L+     G   G+  QV K      G  + VK + +    + E       +L
Sbjct: 19  RYQAEINDLENLGEMG--SGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDL 74

Query: 237 TIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
            +V K+   P +VQ  G    N  + I +E           + +G +    + +  + + 
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE----KAKIVF-- 349
           + + YL E     +IH D+KP NILLD  GQ+K+  FG      IS      KAK     
Sbjct: 135 KALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFG------ISGRLVDDKAKDRSAG 186

Query: 350 -PVSHIDPANLYVAPE-----IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP-KPPEEV 402
                      Y+APE          ++D   D +S G+ L E+  G  P+   K   EV
Sbjct: 187 CA--------AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           +  +  E   PPL      +  D +  +++C       RP +N+
Sbjct: 239 LTKVLQE--EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  104 bits (263), Expect = 3e-25
 Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 42/247 (17%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFV 251
            GS+     +   +  + + +K+L KE     K  E  N    E  ++    HP +++  
Sbjct: 16  TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ERLMLSIVTHPFIIRMW 72

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
           G       + ++++Y   G+L S L+K  R       +F A ++   + YLH      II
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-KFYAAEVCLALEYLHSKD---II 128

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------YVAPE 364
           + DLKP+NILLD  G +KI+ FG           AK V      D          Y+APE
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGF----------AKYV-----PDVTYTLCGTPDYIAPE 173

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
           +   + +++S+D +SFG+++YEM+ G  PF+     +  + +     R P       +  
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP-----PFFNE 228

Query: 425 DLKELIE 431
           D+K+L+ 
Sbjct: 229 DVKDLLS 235

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score =  100 bits (253), Expect = 3e-25
 Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G+++ V  LL  G+D + +  +  +AL +A+  G+ ++V LLL +  +I+  D
Sbjct: 40  LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A    +V+    L ARGA +  +     TPM +A
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLA 142

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score =  100 bits (251), Expect = 4e-25
 Identities = 27/101 (26%), Positives = 42/101 (41%), Gaps = 8/101 (7%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           L +A  G   D+  V  LL    D+N  D +G T L  A    HV+ V+ LL++ A++  
Sbjct: 73  LSLASTGGYTDI--VGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTT 130

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTP 171
               G T    A   G  +V  +++    K+         P
Sbjct: 131 EADSGYTPMDLAVALGYRKVQQVIENHILKLFQSNLVPADP 171

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 95.9 bits (240), Expect = 2e-23
 Identities = 21/90 (23%), Positives = 40/90 (44%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSD-VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +      G++  +++ L +G + VN  D  G T L  A+  G +E V+ LL   A+    
Sbjct: 6   IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            +   +A + A   G  ++  +L  R   +
Sbjct: 66  AKERESALSLASTGGYTDIVGLLLERDVDI 95

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 72.4 bits (179), Expect = 3e-15
 Identities = 18/78 (23%), Positives = 33/78 (42%), Gaps = 10/78 (12%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKKAN-IDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
              ++H  A +G ++ +K  L K  N ++  D  G T    A+    +G +E    L   
Sbjct: 2   DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWAS---AFGEIETVRFLLEW 58

Query: 161 GAKV-PKTK--RTPMTVA 175
           GA      K   + +++A
Sbjct: 59  GADPHILAKERESALSLA 76

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score =  104 bits (262), Expect = 3e-25
 Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 14/144 (9%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            L     GD + V  LL  G+D+N  ++DG TALH A  + +V++VK L+   ANI+  D
Sbjct: 44  FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELN 186
             G      AA     G +++   L ++GA V        TP+ +A      E+ + E+N
Sbjct: 104 NEGWIPLHAAA---SCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVN 160

Query: 187 PLELQVRKAD--GITKGSYQVAKW 208
              + +  A             +W
Sbjct: 161 RQGVDIEAARKEEERIMLRDARQW 184

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 92.9 bits (232), Expect = 2e-21
 Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 9/94 (9%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
            + L +   +       G TALH+AA +G+ EV+KLL+  + +++ +D  G T    AA 
Sbjct: 182 RQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA- 240

Query: 145 AKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             ++G  E   IL      +    K  +T   VA
Sbjct: 241 --HWGKEEACRILVENLCDMEAVNKVGQTAFDVA 272

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 91.0 bits (227), Expect = 1e-20
 Identities = 25/94 (26%), Positives = 42/94 (44%), Gaps = 1/94 (1%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           A +G  + ++ L+    DVN  D DG T LH AA  G  E  ++L+    +++A ++ G 
Sbjct: 207 AAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQ 266

Query: 140 TAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           TA   A       +  + K +       KR   +
Sbjct: 267 TAFDVADEDILGYLEELQKKQNLLH-SEKREKKS 299

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 77.5 bits (192), Expect = 4e-16
 Identities = 20/80 (25%), Positives = 30/80 (37%), Gaps = 7/80 (8%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
           +E  + +         DG      A   G  E V  LL + A+I+  +  G TA   A  
Sbjct: 24  LEPPVVKRKKTKVKFDDG-AVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQAC- 81

Query: 145 AKYYGNVEVYNILKARGAKV 164
                NV++   L   GA +
Sbjct: 82  --IDDNVDMVKFLVENGANI 99

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 69.1 bits (170), Expect = 4e-13
 Identities = 16/80 (20%), Positives = 25/80 (31%), Gaps = 12/80 (15%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
           +++ +N         +D   A          +  + L S   N     + G TA   AA 
Sbjct: 155 LQNEVNRQ------GVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAA- 207

Query: 145 AKYYGNVEVYNILKARGAKV 164
               G  EV  +L      V
Sbjct: 208 --AKGYTEVLKLLIQARYDV 225

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 63.3 bits (155), Expect = 3e-11
 Identities = 11/69 (15%), Positives = 22/69 (31%), Gaps = 5/69 (7%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA--AADAKYYGNVEVYN 155
           +   D   +    +    G    ++  + K+     +   G+    A      G+ E   
Sbjct: 1   MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAAC---SSGDTEEVL 57

Query: 156 ILKARGAKV 164
            L  RGA +
Sbjct: 58  RLLERGADI 66

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score =  103 bits (260), Expect = 3e-25
 Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 3/102 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A   G    + +L+++G  VN I  D  + LH A   GH+  VK+LL   A ++   
Sbjct: 63  MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK--RTPMTVA 175
               T   +A   G+ +  N+L   GA V       +P+  A
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASVQPESDLASPIHEA 164

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 94.5 bits (236), Expect = 6e-22
 Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 3/93 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L++AC       V+ LL  G+DVN       + LH        E+  LL+   A+  A++
Sbjct: 194 LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTASEELACLLMDFGADTQAKN 252

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK 168
             G            +     L+  GA +PK K
Sbjct: 253 AEGKRPVELVPPESPLAQL-FLEREGASLPKPK 284

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 94.1 bits (235), Expect = 8e-22
 Identities = 31/105 (29%), Positives = 41/105 (39%), Gaps = 10/105 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LF AC  G    V  LL  G+ V   + D  + +H AA  GHVE V  L++   NID + 
Sbjct: 129 LFNACVSGSWDCVNLLLQHGASVQP-ESDLASPIHEAARRGHVECVNSLIAYGGNIDHKI 187

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKVPKTK--RTPMTVA 175
               T    A              L   GA V + K   +P+   
Sbjct: 188 SHLGTPLYLAC---ENQQRACVKKLLESGADVNQGKGQDSPLHAV 229

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 90.2 bits (225), Expect = 2e-20
 Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 5/103 (4%)

Query: 77  LFMAC-RGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A  RG V+ V  L+  G +++       T L++A        VK LL   A+++   
Sbjct: 161 IHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQ-G 219

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           +   +         + E+  +L   GA    K    + P+ + 
Sbjct: 220 KGQDSPLHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELV 262

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 82.9 bits (206), Expect = 5e-18
 Identities = 20/118 (16%), Positives = 36/118 (30%), Gaps = 32/118 (27%)

Query: 79  MACR-GDVKGVEDLLNEGSDVNSIDL-------------------------------DGR 106
           M            L+  GS + S+D                                   
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGIRLLSNPLMGDAVSDW 60

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           + +H AA  GH   ++ L+S+   ++       +   +A   G++    IL   GA+V
Sbjct: 61  SPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQV 118

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 52.1 bits (126), Expect = 1e-07
 Identities = 9/67 (13%), Positives = 21/67 (31%), Gaps = 3/67 (4%)

Query: 111 IAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK-- 168
           + +   H      L+ + +++ + D         +K  G  +   I       +      
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDG-SKPAGPRDFPGIRLLSNPLMGDAVSD 59

Query: 169 RTPMTVA 175
            +PM  A
Sbjct: 60  WSPMHEA 66

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  106 bits (266), Expect = 3e-25
 Identities = 56/247 (22%), Positives = 104/247 (42%), Gaps = 21/247 (8%)

Query: 198 ITKGSY---QVAKWNGTKVW--VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I +G++    V K   T     +KI++K        ++ F  E  ++       + Q   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIH 311
           A      + +V+EY+  GDL + L K G   P+++ RF   ++   ++ +H       +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVH 185

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI------ 365
            D+KP NILLD  G ++++ FG   L+  +    + +  V   D    Y++PEI      
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSC-LKLRADGTVRSLVAVGTPD----YLSPEILQAVGG 240

Query: 366 -YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
                 +    D ++ G+  YEM  G  PF+     E    +    +   L +     P 
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300

Query: 425 DLKELIE 431
           + ++ I+
Sbjct: 301 EARDFIQ 307

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  107 bits (269), Expect = 5e-25
 Identities = 53/245 (21%), Positives = 90/245 (36%), Gaps = 47/245 (19%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ---FVGAVTQNIPMM--IV 263
           NG  V +K L      D E       E   + +  HP++VQ   FV    ++   +  IV
Sbjct: 105 NGRPVVLKGLV--HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           +EY     L        +L  ++ + + L++   ++YLH      +++ DLKP+NI+L  
Sbjct: 163 MEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTE 217

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDA 377
              LK+   G                 VS I+          + APEI +      + D 
Sbjct: 218 EQ-LKLIDLGA----------------VSRINSFGYLYGTPGFQAPEIVRTGPTVAT-DI 259

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           Y+ G  L  +   +   + +  + + +        P LK            L+    DP 
Sbjct: 260 YTVGRTLAALTLDLPTRNGRYVDGLPE------DDPVLKT-----YDSYGRLLRRAIDPD 308

Query: 438 PVIRP 442
           P  R 
Sbjct: 309 PRQRF 313

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score =  101 bits (255), Expect = 6e-25
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 20/151 (13%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR---DR 136
            C G  + V+ L+  G +VN+ D DG T LH AA   +V+V K L+   A + A    D 
Sbjct: 78  VCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDM 137

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPREVPEYELNPLELQVR 193
             +    +    G  +    L     K+    K     +    P+       N  EL ++
Sbjct: 138 QTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQ-------NDDELPMK 190

Query: 194 KADGIT---KGSYQVAKWNGTKVWVKILDKE 221
           + D +T   +      +W     W ++ DKE
Sbjct: 191 EGDCMTIIHREDEDEIEW----WWARLNDKE 217

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 96.1 bits (240), Expect = 7e-23
 Identities = 32/89 (35%), Positives = 45/89 (50%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  +  G+   V+ ++ E  D +  + +G TALH A C GH E+VK L+    N++A D
Sbjct: 41  LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    A    NV+V   L   GA V
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGAAV 129

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 5/103 (4%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L    R    K   + +  G  V   +      L  ++ EG  ++V+ ++ +  +    +
Sbjct: 9   LPPGKRTNLRKTGSERIAHGMRVK-FNPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPN 67

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G TA  +A   G+ E+   L   G  V        TP+  A
Sbjct: 68  DEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCA 110

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 4/63 (6%), Positives = 16/63 (25%), Gaps = 1/63 (1%)

Query: 102 DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
           ++ G+ +L         +     ++    +            D+   G  ++   +    
Sbjct: 2   EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60

Query: 162 AKV 164
              
Sbjct: 61  DDP 63

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  103 bits (259), Expect = 6e-25
 Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 34/247 (13%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N  ++ +K + +    D         E+ + +  +H N+VQ++G+ ++N  + I +E   
Sbjct: 46  NQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102

Query: 269 KGDLASYLQKK-GRLSPSKVL--RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-G 324
            G L++ L+ K G L  ++     +   +  G+ YLH+ +   I+H D+K  N+L++   
Sbjct: 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYS 159

Query: 325 GQLKISGFGL-LRLQYISPEKAKIV---FPVSHIDPANLYVAPEIYKNEE--FDRSVDAY 378
           G LKIS FG   RL  I+P                    Y+APEI       + ++ D +
Sbjct: 160 GVLKISDFGTSKRLAGINPCTETFTGTLQ----------YMAPEIIDKGPRGYGKAADIW 209

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKLM---CCEGKRPPLKIKARSYPPDLKELIEECWD 435
           S G  + EM  G  PF+     E    M         P +     S   + K  I +C++
Sbjct: 210 SLGCTIIEMATGKPPFYEL--GEPQAAMFKVGMFKVHPEIP---ESMSAEAKAFILKCFE 264

Query: 436 PKPVIRP 442
           P P  R 
Sbjct: 265 PDPDKRA 271

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (264), Expect = 6e-25
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 34/206 (16%)

Query: 207 KWNGTKVWVKILDK-----ESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPM 260
           +    KV ++I+ K      S ++ +       E+ I++K  HP +++       ++   
Sbjct: 157 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-- 214

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            IVLE    G+L   +    RL  +    +   +   + YLHE     IIH DLKP+N+L
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVL 271

Query: 321 L---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEI---YKNE 369
           L   +    +KI+ FG           +KI+   S +      P   Y+APE+       
Sbjct: 272 LSSQEEDCLIKITDFGH----------SKILGETSLMRTLCGTPT--YLAPEVLVSVGTA 319

Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFH 395
            ++R+VD +S G+IL+  + G  PF 
Sbjct: 320 GYNRAVDCWSLGVILFICLSGYPPFS 345

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (263), Expect = 9e-25
 Identities = 54/248 (21%), Positives = 103/248 (41%), Gaps = 25/248 (10%)

Query: 198 ITKGSY---QVAKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQ 249
           I +G++    V K         +KIL+K       +         E  ++       +  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDSKWITT 138

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDP 308
              A   +  + +V++Y+  GDL + L K     P ++ RF   ++   ++ +H+     
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--- 195

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN 368
            +H D+KP NIL+D  G ++++ FG   L+ +     +    V   D    Y++PEI + 
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPD----YISPEILQA 250

Query: 369 EE-----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP 423
            E     +    D +S G+ +YEM+ G  PF+ +   E    +    +R     +     
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 424 PDLKELIE 431
            + K+LI 
Sbjct: 311 ENAKDLIR 318

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  103 bits (258), Expect = 1e-24
 Identities = 66/269 (24%), Positives = 105/269 (39%), Gaps = 38/269 (14%)

Query: 209 NGTKVWVKILDKESHKDPERINA-FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 268 AKGDLASYLQKKGRLSP---SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L   L       P       + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169

Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL----YVAPEIYKNEEFDRSVDAYSF 380
              KIS FGL R    S + A+     + +    +    Y+APE     E     D YSF
Sbjct: 170 FTAKISDFGLARA---SEKFAQ-----TVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSF 220

Query: 381 GLILYEMIEGVQPFHPKPPEEV----VKLMCCEGKR------PPLKIKARSYPPD-LKEL 429
           G++L E+I G+         ++     + +  E K         +           ++ +
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM----NDADSTSVEAM 276

Query: 430 IE---ECWDPKPVIRPNFNEIIARLDRIV 455
                +C   K   RP+  ++   L  + 
Sbjct: 277 YSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  105 bits (264), Expect = 1e-24
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++   
Sbjct: 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 164

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              ++I  FGL    +    K K+   +        Y+APE+     +D   D +S G+I
Sbjct: 165 DANIRIIDFGLST--HFEASK-KMKDKIGTAY----YIAPEVLH-GTYDEKCDVWSTGVI 216

Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF+     +++K
Sbjct: 217 LYILLSGCPPFNGANEYDILK 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (256), Expect = 2e-24
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 40/279 (14%)

Query: 178 REVPEYELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAF 232
             +   + +P E    K + I KGS+ +V K         V +KI+D E  +D   I   
Sbjct: 11  PGMQNLKADP-EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDI 67

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK---VLR 289
             E+T++ +   P V ++ G+  ++  + I++EY   G     L + G L  ++   +LR
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILR 126

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
             L   +G++YLH  K    IH D+K  N+LL   G++K++ FG+           ++  
Sbjct: 127 EIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGV---------AGQL-- 169

Query: 350 PVSHIDPANLYV------APEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV 403
                   N +V      APE+ K   +D   D +S G+   E+  G  P     P +V+
Sbjct: 170 -TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228

Query: 404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
            L+    K  P  ++   Y   LKE +E C + +P  RP
Sbjct: 229 FLI---PKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRP 263

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (260), Expect = 2e-24
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 36/224 (16%)

Query: 200 KGSY----QVAKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQF 250
           KGS+     V K N TK    +K ++K+      +   +     EL I++   HP +V  
Sbjct: 25  KGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFK---ELQIMQGLEHPFLVNL 80

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             +      M +V++    GDL  +LQ+        V  F  +L   ++YL   +   II
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---II 137

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEI 365
           H D+KP NILLD  G + I+ F +          A ++   + I          Y+APE+
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNI----------AAMLPRETQITTMAGTKP--YMAPEM 185

Query: 366 YKNEEF---DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
           + + +      +VD +S G+  YE++ G +P+H +      +++
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (256), Expect = 2e-24
 Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 32/253 (12%)

Query: 209 NGTKVWVKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI--VLE 265
              +  VKIL K+   + P        E+ ++ + RH NV+Q V  +       +  V+E
Sbjct: 29  TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88

Query: 266 YHAKG--DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           Y   G  ++   +  + R    +   +   L  G+ YLH      I+H D+KP N+LL  
Sbjct: 89  YCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTT 144

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-FD-RSVDAYSFG 381
           GG LKIS  G+       P  A      S   PA  +  PEI    + F    VD +S G
Sbjct: 145 GGTLKISALGVAEAL--HPFAADDTCRTSQGSPA--FQPPEIANGLDTFSGFKVDIWSAG 200

Query: 382 LILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY------PPDLKELIEECWD 435
           + LY +  G+ PF      + +  +          I   SY       P L +L++   +
Sbjct: 201 VTLYNITTGLYPFE----GDNIYKLF-------ENIGKGSYAIPGDCGPPLSDLLKGMLE 249

Query: 436 PKPVIRPNFNEII 448
            +P  R +  +I 
Sbjct: 250 YEPAKRFSIRQIR 262

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 97.9 bits (245), Expect = 2e-24
 Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 5/104 (4%)

Query: 76  LLFMACRGDVKGVEDLLN-EGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L   A RGDV+ V  LL+ E    ++++  G+TAL +    G   +   LL + A+ + +
Sbjct: 6   LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           D  G++   DA   G ++   +L   GA V         P+ +A
Sbjct: 65  DTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLA 108

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 96.7 bits (242), Expect = 7e-24
 Identities = 25/102 (24%), Positives = 47/102 (46%), Gaps = 4/102 (3%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           L +   G      +LL +G+  N  D  G + +H AA  G ++ +K+L+   A+++  D 
Sbjct: 40  LQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDG 99

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
            G+     A   G+  V + L A  + +  +     TP+ +A
Sbjct: 100 TGALPIHLAVQEGHTAVVSFLAA-ESDLHRRDARGLTPLELA 140

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 89.0 bits (222), Expect = 3e-21
 Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 2/82 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A R G +  ++ L+  G+DVN  D  G   +H+A  EGH  VV  L ++ +++  RD
Sbjct: 72  VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRD 130

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
             G T    A   G  ++ +IL
Sbjct: 131 ARGLTPLELALQRGAQDLVDIL 152

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 67.1 bits (165), Expect = 2e-13
 Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 8/64 (12%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
               L  AA  G V+ V+ LL ++  + DA +R+G TA         +G+  +   L  +
Sbjct: 2   AGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM----FGSTAIALELLKQ 57

Query: 161 GAKV 164
           GA  
Sbjct: 58  GASP 61

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 63.6 bits (156), Expect = 2e-12
 Identities = 13/50 (26%), Positives = 22/50 (44%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           + +A +     V   L   SD++  D  G T L +A   G  ++V +L  
Sbjct: 105 IHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 98.7 bits (247), Expect = 2e-24
 Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 8/93 (8%)

Query: 77  LFMACR-GDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +F  CR G+   V   L+   +D+N  D  G + LH A  EG   VV++L+ + A I+  
Sbjct: 9   IFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVM 68

Query: 135 DRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
           +R   T    AA    +G+ ++   L    A +
Sbjct: 69  NRGDDTPLHLAA---SHGHRDIVQKLLQYKADI 98

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 97.5 bits (244), Expect = 6e-24
 Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  ACR G    VE L+  G+ +N ++    T LH+AA  GH ++V+ LL  KA+I+A +
Sbjct: 43  LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVN 102

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELNPLE 189
             G+     A ++G  +V   L A GA V    K    P+  A       + E       
Sbjct: 103 EHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRER------ 156

Query: 190 LQVRKADGITKGSYQVAKWNGT 211
            +    + + +  Y+   W GT
Sbjct: 157 AEKMGQN-LNRIPYKDTFWKGT 177

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 73.6 bits (182), Expect = 2e-15
 Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 1/62 (1%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKAN-IDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
           +    +     EG+   V+L L    N ++  D  G +    A   G   V  +L  RGA
Sbjct: 4   EFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGA 63

Query: 163 KV 164
           ++
Sbjct: 64  RI 65

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score =  102 bits (256), Expect = 4e-24
 Identities = 39/120 (32%), Positives = 55/120 (45%), Gaps = 13/120 (10%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A     V+ V+ LL  G+DV++ D  G   LH A   GH EV +LLL   A ++A D
Sbjct: 62  LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELN 186
            W  T    AA       VEV ++L + GA         ++ + +A     RE   YE  
Sbjct: 122 LWQFTPLHEAA---SKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFK 178

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 96.0 bits (240), Expect = 4e-22
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 7/93 (7%)

Query: 76  LLFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LL  A  G+ +  +  L     + ++ D    T LH+AA    V +V+LLL   A++ A+
Sbjct: 28  LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAK 87

Query: 135 DRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
           D+ G      A     YG+ EV  +L   GA V
Sbjct: 88  DKGGLVPLHNAC---SYGHYEVTELLLKHGACV 117

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 94.1 bits (235), Expect = 2e-21
 Identities = 29/87 (33%), Positives = 38/87 (43%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  AC  G  +  E LL  G+ VN++DL   T LH AA +  VEV  LLLS  A+    +
Sbjct: 95  LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVN 154

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
             G +A   A      E         +
Sbjct: 155 CHGKSAVDMAPTPELRERLTYEFKGHS 181

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 93.7 bits (234), Expect = 3e-21
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 11/104 (10%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
            E LL +G++VN  + D  T LH+AA   H +V+++L    A ++A D  G TA   AA 
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAA- 288

Query: 145 AKYYGNVEVYNILKARGAKV-PKTK--RTPMTVANPREVPEYEL 185
               G+++   +L + G+     +    T   + N  E  +  L
Sbjct: 289 --LAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN--EAVQQIL 328

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 92.6 bits (231), Expect = 7e-21
 Identities = 28/105 (26%), Positives = 42/105 (40%), Gaps = 12/105 (11%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVVKLLLSKKANID 132
           LL  A   D+  V+  L              TALH A    H    +V +LLL K AN++
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241

Query: 133 ARDRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
            +++   T    AA      + +V  +L   GAK+       +T 
Sbjct: 242 EKNKDFMTPLHVAA---ERAHNDVMEVLHKHGAKMNALDSLGQTA 283

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 7/101 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A        +E L   G+ +N++D  G+TALH AA  GH++  +LLLS  ++     
Sbjct: 251 LHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIIS 310

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTKRTPMTVA 175
             G TAA      GN  V  IL +    +        +  A
Sbjct: 311 LQGFTAA----QMGNEAVQQIL-SESTPMRTSDVDYRLLEA 346

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 82.5 bits (205), Expect = 2e-17
 Identities = 24/93 (25%), Positives = 33/93 (35%), Gaps = 10/93 (10%)

Query: 86  KGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV-EVVKLLLSKKANIDARDRWGSTA--- 141
           K   DL +  +         +  L  AA  G+  +++ LL     N  A D   ST    
Sbjct: 5   KSALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHL 64

Query: 142 AADAKYYGNVEVYNILKARGAKV---PKTKRTP 171
           AA    Y  V +  +L   GA V    K    P
Sbjct: 65  AA---GYNRVRIVQLLLQHGADVHAKDKGGLVP 94

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 77.5 bits (192), Expect = 8e-16
 Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 27/123 (21%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL---------------- 123
           A +  V+    LL+ G+D   ++  G++A+ +A      E +                  
Sbjct: 132 ASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREADL 191

Query: 124 -----LLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPM 172
                 L+ +     + +   TA   A  + +    +V  +L  +GA V  K K   TP+
Sbjct: 192 AKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPL 251

Query: 173 TVA 175
            VA
Sbjct: 252 HVA 254

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 68.7 bits (169), Expect = 7e-13
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 10/76 (13%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G ++    LL+ GSD + I L G TA  +       E V+ +LS+   +   D
Sbjct: 284 LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN-----EAVQQILSESTPMRTSD 338

Query: 136 RWGST-AAADAKYYGN 150
                  A+     G+
Sbjct: 339 VDYRLLEAS---KAGD 351

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 94.7 bits (237), Expect = 5e-24
 Identities = 40/87 (45%), Positives = 57/87 (65%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
           + G T    A   G++EV  +L   GA
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGA 92

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 80.9 bits (201), Expect = 4e-19
 Identities = 29/61 (47%), Positives = 40/61 (65%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +GRT LH+AA  GH+EVVKLLL   A+++A+D+ G T    A   G++EV  +L   GA 
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAD 60

Query: 164 V 164
           V
Sbjct: 61  V 61

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score =  102 bits (257), Expect = 6e-24
 Identities = 40/103 (38%), Positives = 48/103 (46%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A R G    V+ LL   ++ N     G T LHIAA EGHVE V  LL K+A+     
Sbjct: 84  LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMT 143

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           + G T    A  YG V V  +L  R A      K   TP+ VA
Sbjct: 144 KKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVA 186

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score =  100 bits (252), Expect = 4e-23
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 10/106 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   G +  V++LL  G+  N  ++   T LH+AA  GH EV K LL  KA ++A+ 
Sbjct: 18  LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 77

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           +   T    AA     G+  +  +L    A          TP+ +A
Sbjct: 78  KDDQTPLHCAA---RIGHTNMVKLLLENNANPNLATTAGHTPLHIA 120

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 99.5 bits (249), Expect = 7e-23
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A    ++  V+ LL  G   +S   +G T LHIAA +  VEV + LL    + +A  
Sbjct: 183 LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAES 242

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A   G+ E+  +L ++ A      K   TP+ + 
Sbjct: 243 VQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLV 285

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 99.5 bits (249), Expect = 7e-23
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 7/107 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   G++K V+ LL   +DVN+    G + LH AA +GH ++V LLL   A+ +   
Sbjct: 315 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 374

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVP------KTKRTPMTVAN 176
             G+T  A AK  G + V ++LK    +        K + +     +
Sbjct: 375 SDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPETVD 421

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 99.5 bits (249), Expect = 8e-23
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G V+ V  LL + +    +   G T LH+AA  G V V +LLL + A+ +A  
Sbjct: 117 LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAG 176

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           + G T    A ++ N+++  +L  RG           TP+ +A
Sbjct: 177 KNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIA 219

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 98.3 bits (246), Expect = 2e-22
 Identities = 27/103 (26%), Positives = 53/103 (51%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +  + G V   + L+  G  V++    G T LH+A+  G++++VK LL  +A+++A+ 
Sbjct: 282 LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKT 341

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           + G +    A   G+ ++  +L   GA     +    TP+ +A
Sbjct: 342 KLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIA 384

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 98.3 bits (246), Expect = 2e-22
 Identities = 38/103 (36%), Positives = 48/103 (46%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L MA R G  +  + LL   + VN+   D +T LH AA  GH  +VKLLL   AN +   
Sbjct: 51  LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 110

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A   G+VE    L  + A     TK   TP+ VA
Sbjct: 111 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVA 153

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.6 bits (244), Expect = 4e-22
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 10/106 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A + G  + V  LL++ ++ N  +  G T LH+ A EGHV V  +L+     +DA  
Sbjct: 249 LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATT 308

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           R G T    A+   +YGN+++   L    A V  KTK   +P+  A
Sbjct: 309 RMGYTPLHVAS---HYGNIKLVKFLLQHQADVNAKTKLGYSPLHQA 351

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.2 bits (243), Expect = 4e-22
 Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 10/106 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A + G V+  E LL   +  N+   +G T LH+A    ++++VKLLL +  +  +  
Sbjct: 150 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 209

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    AA       VEV   L   G     ++    TP+ +A
Sbjct: 210 WNGYTPLHIAA---KQNQVEVARSLLQYGGSANAESVQGVTPLHLA 252

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 86.0 bits (214), Expect = 3e-18
 Identities = 27/87 (31%), Positives = 38/87 (43%), Gaps = 9/87 (10%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNV 151
           G         G T LH+A+  GH+ +VK LL + A+ +  +    T    AA     G+ 
Sbjct: 4   GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAA---RAGHT 60

Query: 152 EVYNILKARGAKV---PKTKRTPMTVA 175
           EV   L    AKV    K  +TP+  A
Sbjct: 61  EVAKYLLQNKAKVNAKAKDDQTPLHCA 87

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 75.2 bits (186), Expect = 7e-15
 Identities = 18/75 (24%), Positives = 29/75 (38%), Gaps = 4/75 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL---LSKKANID 132
           L  A + G    V  LL  G+  N +  DG T L IA   G++ V  +L     + + + 
Sbjct: 348 LHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVL 407

Query: 133 ARDRWGSTAAADAKY 147
             D+   +       
Sbjct: 408 VSDKHRMSFPETVDE 422

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 95.5 bits (239), Expect = 7e-24
 Identities = 47/103 (45%), Positives = 66/103 (64%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           + G T    A   G++EV  +L   GA V  K K  RTP+ +A
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLA 108

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 93.2 bits (233), Expect = 5e-23
 Identities = 36/75 (48%), Positives = 50/75 (66%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D+ G T    A  
Sbjct: 51  VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 110

Query: 148 YGNVEVYNILKARGA 162
            G++EV  +L   GA
Sbjct: 111 NGHLEVVKLLLEAGA 125

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 80.1 bits (199), Expect = 2e-18
 Identities = 34/71 (47%), Positives = 45/71 (63%), Gaps = 3/71 (4%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +GRT LH+AA  GH+EVVKLLL   A+++A+D+ G T    A   G++EV  +L   GA 
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAD 60

Query: 164 V-PKTK--RTP 171
           V  K K  RTP
Sbjct: 61  VNAKDKNGRTP 71

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 95.1 bits (238), Expect = 8e-24
 Identities = 40/89 (44%), Positives = 58/89 (65%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A  G  + V+ LL++G+DVN+   DG T LH+AA  GH E+VKLLL+K A+++AR 
Sbjct: 13  LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           + G+T    AK  G+ E+  +L A+GA V
Sbjct: 73  KDGNTPEHLAKKNGHHEIVKLLDAKGADV 101

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 86.3 bits (215), Expect = 9e-21
 Identities = 24/54 (44%), Positives = 34/54 (62%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           V+ LL +G+DVN+   DG T  H+A   GH E+VKLL +K A+++AR    S  
Sbjct: 58  VKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHH 111

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 82.4 bits (205), Expect = 2e-19
 Identities = 34/84 (40%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G        DG T LH AA  GH E VK LLSK A+++AR + G+T    A   G+ E+ 
Sbjct: 1   GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58

Query: 155 NILKARGAKV-PKTK--RTPMTVA 175
            +L A+GA V  ++K   TP  +A
Sbjct: 59  KLLLAKGADVNARSKDGNTPEHLA 82

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 95.5 bits (239), Expect = 9e-24
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 6/114 (5%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G    V  L+  G+DVN+ D  G T L++A   GH+E+V++LL   A+++A D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEY 183
             G T    A + G++E+  +L   GA V  + K  +T   ++      ++ E 
Sbjct: 78  AIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEI 131

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 89.4 bits (223), Expect = 1e-21
 Identities = 30/70 (42%), Positives = 47/70 (67%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN++D  G T LH+AA  GH+E+ ++LL   A+++A+D++G TA   +  
Sbjct: 63  VEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIG 122

Query: 148 YGNVEVYNIL 157
            GN ++  IL
Sbjct: 123 NGNEDLAEIL 132

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 79.4 bits (197), Expect = 6e-18
 Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 7/80 (8%)

Query: 85  VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD 144
           ++G     + GSD+          L  AA  G  + V++L++  A+++A+D +G T    
Sbjct: 1   MRGSHHHHHHGSDLG-------KKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYL 53

Query: 145 AKYYGNVEVYNILKARGAKV 164
           A  +G++E+  +L   GA V
Sbjct: 54  ATAHGHLEIVEVLLKNGADV 73

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 60.9 bits (149), Expect = 2e-11
 Identities = 14/39 (35%), Positives = 23/39 (58%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
            E LL  G+DVN+ D  G+TA  I+   G+ ++ ++L  
Sbjct: 96  AEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQK 134

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 98.1 bits (245), Expect = 9e-24
 Identities = 25/90 (27%), Positives = 50/90 (55%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDAR 134
           L  A + G++  + + L+    VN +D  G TAL+ A   GH ++V++L ++    ++ +
Sbjct: 77  LHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQ 136

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++ G TA   A + G  ++  +L A+GA+ 
Sbjct: 137 NKLGDTALHAAAWKGYADIVQLLLAKGART 166

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 6/92 (6%)

Query: 77  LFMACRG---DVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
           L+ AC G   D+  VE L  +   ++N  +  G TALH AA +G+ ++V+LLL+K A  D
Sbjct: 110 LYWACHGGHKDI--VEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTD 167

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            R+     A   A       +    +   A  
Sbjct: 168 LRNIEKKLAFDMATNAACASLLKKKQGTDAVR 199

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 11/92 (11%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
            +       KG   L+   + V          LH AA  G++  ++  L  +  ++  D+
Sbjct: 49  WWKGTS---KGRTGLI-PSNYVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDK 104

Query: 137 WGSTA---AADAKYYGNVEVYNIL-KARGAKV 164
            GSTA   A    + G+ ++  +L      ++
Sbjct: 105 AGSTALYWAC---HGGHKDIVEMLFTQPNIEL 133

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 81.1 bits (201), Expect = 9e-18
 Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 1/74 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G    V+ LL +G+  +  +++ + A  +A       ++K      A     +
Sbjct: 144 LHAAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSN 203

Query: 136 RWGSTAAADAKYYG 149
                   D+    
Sbjct: 204 AEDYLDDEDSDLEH 217

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 73.4 bits (181), Expect = 4e-15
 Identities = 12/89 (13%), Positives = 25/89 (28%), Gaps = 6/89 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +F A    + +  ++L  E  D+  I     T       +G   ++         +  + 
Sbjct: 16  VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
                   +A   GN+            V
Sbjct: 71  ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 64.2 bits (157), Expect = 5e-12
 Identities = 10/72 (13%), Positives = 20/72 (27%), Gaps = 2/72 (2%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
            G+  +  A           L  ++ +I        T        G   +  I     A+
Sbjct: 11  PGQVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGL--IPSNYVAE 68

Query: 164 VPKTKRTPMTVA 175
             ++   P+  A
Sbjct: 69  QAESIDNPLHEA 80

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 40.7 bits (96), Expect = 4e-04
 Identities = 4/43 (9%), Positives = 10/43 (23%), Gaps = 1/43 (2%)

Query: 77  LFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHV 118
             MA        ++      +     + +       +  E H 
Sbjct: 177 FDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDSDLEHHH 219

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 96.7 bits (242), Expect = 1e-23
 Identities = 35/89 (39%), Positives = 51/89 (57%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A D
Sbjct: 18  LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    A  +G++E+  +L   GA V
Sbjct: 78  HAGMTPLRLAALFGHLEIVEVLLKNGADV 106

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 94.0 bits (235), Expect = 8e-23
 Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 3/91 (3%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN++D  G T L +AA  GH+E+V++LL   A+++A D  G T    A  
Sbjct: 63  VEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAM 122

Query: 148 YGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           +G++E+  +L   GA V  + K  +T   ++
Sbjct: 123 FGHLEIVEVLLKNGADVNAQDKFGKTAFDIS 153

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 90.9 bits (227), Expect = 1e-21
 Identities = 31/70 (44%), Positives = 49/70 (70%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN+ D++G T LH+AA  GH+E+V++LL   A+++A+D++G TA   +  
Sbjct: 96  VEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDISID 155

Query: 148 YGNVEVYNIL 157
            GN ++  IL
Sbjct: 156 NGNEDLAEIL 165

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 80.1 bits (199), Expect = 5e-18
 Identities = 21/71 (29%), Positives = 35/71 (49%), Gaps = 1/71 (1%)

Query: 95  GSDVN-SIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEV 153
           GS  +     D    L  AA  G  + V++L++  A+++A D  G T    A + G++E+
Sbjct: 3   GSHHHHHHGSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEI 62

Query: 154 YNILKARGAKV 164
             +L   GA V
Sbjct: 63  VEVLLKNGADV 73

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 64.7 bits (159), Expect = 1e-12
 Identities = 15/40 (37%), Positives = 24/40 (60%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           VE LL  G+DVN+ D  G+TA  I+   G+ ++ ++L   
Sbjct: 129 VEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  100 bits (252), Expect = 1e-23
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 28/220 (12%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFV 251
           KG++ +V   +   T  +  +KIL KE   +  +         E  +++  RHP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTRHPFLTALK 71

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
            A   +  +  V+EY   G+L  +L ++   +  +  RF   ++   + YLH      ++
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGAEIVSALEYLHSRD---VV 127

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF---PVSHIDPANLYVAPEIYK 367
           + D+K +N++LD  G +KI+ FGL +   IS       F   P         Y+APE+ +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPE--------YLAPEVLE 178

Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC 407
           + ++ R+VD +  G+++YEM+ G  PF+ +  E + +L+ 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (256), Expect = 1e-23
 Identities = 41/203 (20%), Positives = 85/203 (41%), Gaps = 34/203 (16%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             +  G     K +      D E +     E+  +   RHP +V    A   +  M+++ 
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233

Query: 265 EYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           E+ + G+L   +  +  ++S  + + +   + +G+ ++HE      +H DLKP+NI+   
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTT 290

Query: 324 --GGQLKISGFGL---------LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
               +LK+  FGL         +++   + E                + APE+ + +   
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAE----------------FAAPEVAEGKPVG 334

Query: 373 RSVDAYSFGLILYEMIEGVQPFH 395
              D +S G++ Y ++ G+ PF 
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFG 357

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (250), Expect = 2e-23
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 23/199 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K  G +   K + K   +   R         E++I+ +  H NV+           ++++
Sbjct: 34  KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-- 321
           LE  + G+L  +L +K  LS  +   F   +  G+NYLH  K   I H DLKP+NI+L  
Sbjct: 94  LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLD 150

Query: 322 --DNGGQLKISGFGLLRLQYISP-EKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVD 376
                  +K+  FGL     I    + K +F  P         +VAPEI   E      D
Sbjct: 151 KNIPIPHIKLIDFGLAH--EIEDGVEFKNIFGTP--------EFVAPEIVNYEPLGLEAD 200

Query: 377 AYSFGLILYEMIEGVQPFH 395
            +S G+I Y ++ G  PF 
Sbjct: 201 MWSIGVITYILLSGASPFL 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (256), Expect = 2e-23
 Identities = 57/195 (29%), Positives = 81/195 (41%), Gaps = 36/195 (18%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
            K L+K+  K  +      +E  I+EK     VV    A      + +VL     GDL  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273

Query: 275 YLQKKGRLSPSKVLRFALDLAR--------GMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           ++   G+        F    A         G+  LH  +   I++ DLKP+NILLD+ G 
Sbjct: 274 HIYHMGQA------GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGH 324

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------YVAPEIYKNEEFDRSVDAYSF 380
           ++IS  GL          A     V              Y+APE+ KNE +  S D ++ 
Sbjct: 325 IRISDLGL----------AV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371

Query: 381 GLILYEMIEGVQPFH 395
           G +LYEMI G  PF 
Sbjct: 372 GCLLYEMIAGQSPFQ 386

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 27/106 (25%), Positives = 47/106 (44%), Gaps = 4/106 (3%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G+++ V+  + E +D +  + +G TALH A C  +  +V  L++  AN+++ D
Sbjct: 25  LLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPD 84

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVANP 177
             G T    A    +  +   L   GA +         T     +P
Sbjct: 85  SHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDP 130

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 22/105 (20%), Positives = 37/105 (35%), Gaps = 9/105 (8%)

Query: 88  VEDLLNEGSDVNSID---LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD 144
           +  +L +           L+    L  AA  G +EVV+  + +  +    +  G TA  +
Sbjct: 1   MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHN 60

Query: 145 AKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEY 183
           A    N  + + L   GA V        TP+  A   N   +   
Sbjct: 61  AICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMA 105

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 7/102 (6%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAAC--EGHVEVVKLLLSKKANIDARDR 136
           A   D      L+  G+ + +  L DG TA        EG+ +    L   + ++   + 
Sbjct: 95  ASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNS 154

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
               A  D       E+ +  +     V      + T    A
Sbjct: 155 GAVYALWDYSAEFGDEL-SFREGESVTVLRRDGPEETDWWWA 195

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 9/61 (14%), Positives = 14/61 (22%), Gaps = 1/61 (1%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV-KLLLSKKANIDARD 135
           L+         +     E   V   D    T    AA  G    V +        +  + 
Sbjct: 160 LWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALHGQEGYVPRNYFGLFPRVKPQR 219

Query: 136 R 136
            
Sbjct: 220 S 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 23/201 (11%)

Query: 205 VAKWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
             K  G +   K + K       R         E+ I+ + RHPN++           ++
Sbjct: 25  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           ++LE  + G+L  +L +K  L+  +  +F   +  G++YLH  +   I H DLKP+NI+L
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIML 141

Query: 322 DN----GGQLKISGFGLLRLQYISP-EKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRS 374
            +      ++K+  FG+     I    + K +F  P         +VAPEI   E     
Sbjct: 142 LDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIFGTP--------EFVAPEIVNYEPLGLE 191

Query: 375 VDAYSFGLILYEMIEGVQPFH 395
            D +S G+I Y ++ G  PF 
Sbjct: 192 ADMWSIGVITYILLSGASPFL 212

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  101 bits (252), Expect = 2e-23
 Identities = 61/279 (21%), Positives = 104/279 (37%), Gaps = 59/279 (21%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLE 265
            + G  V VK +  +             E+ ++ +   HPNV+++  + T +  + I LE
Sbjct: 36  SFQGRPVAVKRMLIDFCDIALM------EIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89

Query: 266 YHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
                +L   ++ K               +     +A G+ +LH  K   IIH DLKP+N
Sbjct: 90  L-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQN 145

Query: 319 ILLDNGG-------------QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------ 359
           IL+                 ++ IS FGL           K +         NL      
Sbjct: 146 ILVSTSSRFTADQQTGAENLRILISDFGL----------CKKLDSGQSSFRTNLNNPSGT 195

Query: 360 --YVAPEIYKNEEF-------DRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCE 409
             + APE+ +            RS+D +S G + Y ++ +G  PF  K   E   ++   
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SNIIRGI 254

Query: 410 GKRPPLKIKA-RSYPPDLKELIEECWDPKPVIRPNFNEI 447
                +K    RS   +  +LI +  D  P+ RP   ++
Sbjct: 255 FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 95.6 bits (239), Expect = 3e-23
 Identities = 37/107 (34%), Positives = 53/107 (49%), Gaps = 12/107 (11%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A R  D + +  LL E  DV+++D +GRTAL   A  G  + V+LL    A++D RD
Sbjct: 48  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106

Query: 136 -RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
            R G TA   AA    Y   EV   L   GA +  + +   T + +A
Sbjct: 107 MRGGLTALHMAA---GYVRPEVVEALVELGADIEVEDERGLTALELA 150

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 94.9 bits (237), Expect = 5e-23
 Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 1/90 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LLF+A  G  K V  L   G+D++  D+  G TALH+AA     EVV+ L+   A+I+  
Sbjct: 80  LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVE 139

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D  G TA   A+              G ++
Sbjct: 140 DERGLTALELAREILKTTPKGNPMQFGRRI 169

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 69.8 bits (172), Expect = 3e-14
 Identities = 13/56 (23%), Positives = 19/56 (33%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           A     + VE L+  G+D+   D  G TAL +A            +     I    
Sbjct: 118 AGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 56.7 bits (138), Expect = 9e-10
 Identities = 16/115 (13%), Positives = 28/115 (24%), Gaps = 33/115 (28%)

Query: 94  EGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID--------------------- 132
                +    +G     I   +GH           A++                      
Sbjct: 3   NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYETPWWTAARKADEQALSQ 62

Query: 133 --------ARDRWGSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVA 175
                   A D  G TA       G+ +   +L   GA +     +   T + +A
Sbjct: 63  LLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMA 117

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 96.7 bits (242), Expect = 3e-23
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 10/106 (9%)

Query: 77  LFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R  V+G +EDL+N  +DVN++D  G++ALH AA   +V+   +LL   AN D ++
Sbjct: 96  LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    AA     G+ E   +L    A         R P  +A
Sbjct: 156 NREETPLFLAA---REGSYETAKVLLDHFANRDITDHMDRLPRDIA 198

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 87.1 bits (217), Expect = 7e-20
 Identities = 26/93 (27%), Positives = 40/93 (43%), Gaps = 5/93 (5%)

Query: 88  VEDLLNEGSDV-NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK 146
           + D + +G+ + N  D  G TALH+AA     +  K LL   A+ + +D  G T    A 
Sbjct: 7   ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66

Query: 147 YYGNVEVYNILKARGAKVPKTK----RTPMTVA 175
                 V+ IL    A     +     TP+ +A
Sbjct: 67  SADAQGVFQILIRNRATDLDARMHDGTTPLILA 99

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 85.9 bits (214), Expect = 2e-19
 Identities = 29/103 (28%), Positives = 48/103 (46%), Gaps = 11/103 (10%)

Query: 77  LFMACRGDVKGVEDLL--NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A   D +GV  +L  N  +D+++   DG T L +AA      +++ L++  A+++A 
Sbjct: 62  LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 121

Query: 135 DRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
           D  G +A   AA      NV+   +L   GA    +     TP
Sbjct: 122 DDLGKSALHWAA---AVNNVDAAVVLLKNGANKDMQNNREETP 161

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 66.3 bits (163), Expect = 1e-12
 Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           LF+A R G  +  + LL+  ++ +  D   R    IA    H ++V+LL       
Sbjct: 162 LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVR 217

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 46.6 bits (112), Expect = 5e-06
 Identities = 12/53 (22%), Positives = 19/53 (35%), Gaps = 7/53 (13%)

Query: 116 GHVEVVKLLLSKKANI-DARDRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
               V+   + + A++ +  DR G TA   AA    Y   +    L    A  
Sbjct: 2   DAPAVISDFIYQGASLHNQTDRTGETALHLAA---RYSRSDAAKRLLEASADA 51

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  100 bits (251), Expect = 4e-23
 Identities = 61/240 (25%), Positives = 118/240 (49%), Gaps = 24/240 (10%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           KG++     V +    + + +KIL KE     + +     E  +++ +RHP +     + 
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
             +  +  V+EY   G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DL
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDL 275

Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF---PVSHIDPANLYVAPEIYKNEEF 371
           K +N++LD  G +KI+ FGL +   I        F   P         Y+APE+ ++ ++
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPE--------YLAPEVLEDNDY 326

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIE 431
            R+VD +  G+++YEM+ G  PF+ +  E++ +L+  E  R P     R+  P+ K L+ 
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-----RTLGPEAKSLLS 381

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 97.2 bits (243), Expect = 4e-23
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 10/106 (9%)

Query: 77  LFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R  V+G +EDL+N  +DVN++D  G++ALH AA   +V+   +LL   AN D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    AA     G+ E   +L    A         R P  +A
Sbjct: 188 NREETPLFLAA---REGSYETAKVLLDHFANRDITDHMDRLPRDIA 230

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 92.5 bits (231), Expect = 1e-21
 Identities = 21/83 (25%), Positives = 33/83 (39%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           A   +V     LL  G++ +  +    T L +AA EG  E  K+LL   AN D  D    
Sbjct: 165 AAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDR 224

Query: 140 TAAADAKYYGNVEVYNILKARGA 162
                A+   + ++  +L     
Sbjct: 225 LPRDIAQERMHHDIVRLLDLEHH 247

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 88.3 bits (220), Expect = 5e-20
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 8/93 (8%)

Query: 77  LFMACRGDVKGVEDLL--NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A   D +GV  +L  N  +D+++   DG T L +AA      +++ L++  A+++A 
Sbjct: 94  LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 153

Query: 135 DRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
           D  G +A   AA      NV+   +L   GA  
Sbjct: 154 DDLGKSALHWAA---AVNNVDAAVVLLKNGANK 183

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 25/89 (28%), Positives = 37/89 (41%), Gaps = 5/89 (5%)

Query: 88  VEDLLNEGSDV-NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK 146
           + D + +G+ + N  D  G TALH+AA     +  K LL   A+ + +D  G T    A 
Sbjct: 39  ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98

Query: 147 YYGNVEVYNILKARGAKVPKTK----RTP 171
                 V+ IL    A     +     TP
Sbjct: 99  SADAQGVFQILIRNRATDLDARMHDGTTP 127

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 69.0 bits (170), Expect = 2e-13
 Identities = 15/56 (26%), Positives = 27/56 (48%), Gaps = 1/56 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           LF+A R G  +  + LL+  ++ +  D   R    IA    H ++V+LL  +  + 
Sbjct: 194 LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHHHH 249

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 68.3 bits (168), Expect = 3e-13
 Identities = 22/82 (26%), Positives = 30/82 (36%), Gaps = 14/82 (17%)

Query: 97  DVNSIDLDGRTALHIAACEG-------------HVEVVKLLLSKKANI-DARDRWGSTAA 142
           DVN    DG T L IA+C G                V+   + + A++ +  DR G TA 
Sbjct: 2   DVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETAL 61

Query: 143 ADAKYYGNVEVYNILKARGAKV 164
             A  Y   +    L    A  
Sbjct: 62  HLAARYSRSDAAKRLLEASADA 83

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 92.6 bits (231), Expect = 4e-23
 Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 6/99 (6%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           +          L+  GS + S   D    L  AA  G  + V++L++  A++ A+D+ GS
Sbjct: 2   SSHHHHHHSSGLVPRGSHMGS---DLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGS 58

Query: 140 TAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           T    A   G++EV  +L   GA V    K  +T   ++
Sbjct: 59  TPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDIS 97

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 92.6 bits (231), Expect = 5e-23
 Identities = 35/83 (42%), Positives = 50/83 (60%), Gaps = 1/83 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A R G    V  L+  G+DV + D +G T LH+AA  GH+EVVKLLL   A++ A+D
Sbjct: 28  LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87

Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 88  KFGKTAFDISIDNGNEDLAEILQ 110

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 54.9 bits (133), Expect = 9e-10
 Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 6/67 (8%)

Query: 112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK-- 168
            +   H      L+ + +++ +          +A   G  +   IL A GA V  K K  
Sbjct: 1   GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGADVAAKDKNG 57

Query: 169 RTPMTVA 175
            TP+ +A
Sbjct: 58  STPLHLA 64

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 99.6 bits (248), Expect = 4e-23
 Identities = 46/271 (16%), Positives = 97/271 (35%), Gaps = 16/271 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G  V V+ ++ E+  + E +     EL + +   HPN+V +      +  + +V  +
Sbjct: 49  KPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107

Query: 267 HAKGDLASYLQ--KKGRLSPSK---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
            A G     +       ++      +L+  L   + ++Y+H       +H  +K  +IL+
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHMG---YVHRSVKASHILI 161

Query: 322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY-VAPEIYK--NEEFDRSVDAY 378
              G++ +SG           ++ ++V          L  ++PE+ +   + +D   D Y
Sbjct: 162 SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKP 438
           S G+   E+  G  PF   P  +++ L    G  P L   +     +L            
Sbjct: 222 SVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSG 280

Query: 439 VIRPNFNEIIARLDRIVCNCSKQGWWKDTFK 469
           +            +    +      +   F 
Sbjct: 281 LSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 23/201 (11%)

Query: 205 VAKWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
             K  G +   K + K   +   R         E++I+ +  HPN++           ++
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           ++LE  + G+L  +L +K  LS  +   F   +  G+NYLH  K   I H DLKP+NI+L
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIML 148

Query: 322 ----DNGGQLKISGFGLLRLQYISP-EKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRS 374
                    +K+  FGL     I    + K +F  P         +VAPEI   E     
Sbjct: 149 LDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIFGTPE--------FVAPEIVNYEPLGLE 198

Query: 375 VDAYSFGLILYEMIEGVQPFH 395
            D +S G+I Y ++ G  PF 
Sbjct: 199 ADMWSIGVITYILLSGASPFL 219

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 96.3 bits (241), Expect = 5e-23
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 5/104 (4%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G V     L+  G+++++   D RT L  AA   H+E VK L+   A +D +D
Sbjct: 15  LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA 175
             GST    A   G+ EV   L + G      +     TPM  A
Sbjct: 75  AEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWA 118

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 94.8 bits (237), Expect = 2e-22
 Identities = 19/75 (25%), Positives = 35/75 (46%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            E LL    D++++++ G + LHIAA E   + V L LS+ +++  +++ G T    A  
Sbjct: 160 AEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASL 219

Query: 148 YGNVEVYNILKARGA 162
              V     +     
Sbjct: 220 NSQVWSALQMSKALQ 234

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 93.6 bits (234), Expect = 5e-22
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 10/106 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A     V  V+ LL++GSD+N  D +    LH AA  G V++ ++LL+ K ++ A +
Sbjct: 115 MIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVN 174

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G +    AA        +   +  +R + V  K K   TP+  A
Sbjct: 175 IHGDSPLHIAA---RENRYDCVVLFLSRDSDVTLKNKEGETPLQCA 217

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 88.6 bits (221), Expect = 3e-20
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L +A + G  + V+ LL+ G  DVN  D  G T +  A    HV++VKLLLSK ++I+ R
Sbjct: 81  LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIR 140

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D   +     A + G V++  IL A    +
Sbjct: 141 DNEENICLHWAAFSGCVDIAEILLAAKCDL 170

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 86.3 bits (215), Expect = 2e-19
 Identities = 23/78 (29%), Positives = 33/78 (42%), Gaps = 3/78 (3%)

Query: 97  DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNI 156
           +      + R+ LH AA  GHV++  +L+   ANID       T   +A    ++E    
Sbjct: 3   NFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKY 62

Query: 157 LKARGAKV-PKTK--RTP 171
           L   GA V PK     T 
Sbjct: 63  LIKAGALVDPKDAEGSTC 80

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 65.9 bits (162), Expect = 2e-12
 Identities = 13/55 (23%), Positives = 20/55 (36%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L +A R      V   L+  SDV   + +G T L  A+    V     +     +
Sbjct: 181 LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQD 235

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (251), Expect = 5e-23
 Identities = 47/201 (23%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K    +  +KI+ K S       +    E+ +++   HPN+++            +V+E 
Sbjct: 59  KVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + + +          +  G+ YLH+     I+H DLKP+N+LL++   
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEK 174

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +KI  FGL        +K K+   +        Y+APE+ + +++D   D +S G+I
Sbjct: 175 DALIKIVDFGLSA--VFENQK-KMKERLGTAY----YIAPEVLR-KKYDEKCDVWSIGVI 226

Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           L+ ++ G  PF  +  +E+++
Sbjct: 227 LFILLAGYPPFGGQTDQEILR 247

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 55/284 (19%), Positives = 105/284 (36%), Gaps = 42/284 (14%)

Query: 183 YELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELT 237
            E+   +L+     G  +G+Y  V K     +G  + VK +      + +       +L 
Sbjct: 2   MEVKADDLEPIMELG--RGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLD 57

Query: 238 IVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG---DLASYLQKKGRLSPSKVLRFALD 293
           I  +    P  V F GA+ +   + I +E             + K   +    + + A+ 
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 117

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE----KAKIVF 349
           + + + +LH      +IH D+KP N+L++  GQ+K+  FG      IS       AK + 
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG------ISGYLVDDVAKDID 169

Query: 350 ---PVSHIDPANLYVAPEIYKNEE----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
                        Y+APE    E     +    D +S G+ + E+     P+        
Sbjct: 170 AGCK--------PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--SWGTP 219

Query: 403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
            + +    + P  ++ A  +  +  +   +C       RP + E
Sbjct: 220 FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.4 bits (248), Expect = 6e-23
 Identities = 44/203 (21%), Positives = 89/203 (43%), Gaps = 34/203 (16%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           V K  G     K ++     D   +    +E++I+ +  HP ++    A      M+++L
Sbjct: 71  VEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127

Query: 265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           E+ + G+L   +  +  ++S ++V+ +      G+ ++HE     I+H D+KP+NI+ + 
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCET 184

Query: 324 --GGQLKISGFGL---------LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
                +KI  FGL         +++   + E                + APEI   E   
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTTATAE----------------FAAPEIVDREPVG 228

Query: 373 RSVDAYSFGLILYEMIEGVQPFH 395
              D ++ G++ Y ++ G+ PF 
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFA 251

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 95.2 bits (238), Expect = 7e-23
 Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 5/105 (4%)

Query: 76  LLFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LL  A + D K   E L +    V+ +D +G T L+IA     +E+ K L+ + A+I+ +
Sbjct: 9   LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA 175
           +    +    A   G  E+   +                  +  A
Sbjct: 69  NSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPA 113

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 83.3 bits (207), Expect = 1e-18
 Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 10/110 (9%)

Query: 76  LLFMACRGDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDA 133
            L+   +G  + +  +L     D+N  +  G  AL  AA +GH++ VKLLL   + +ID 
Sbjct: 76  YLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDF 135

Query: 134 RDRWGSTA---AA--DAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           ++ +G TA   A           ++  +L   GA    K    RT M  A
Sbjct: 136 QNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSGRTAMDYA 185

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 83.3 bits (207), Expect = 1e-18
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 7/88 (7%)

Query: 77  LFMAC-RGDVKGVEDLLNEGS-DVNSIDLDGRTALHIAAC-----EGHVEVVKLLLSKKA 129
           L  A  +G +  V+ LL +G  D++  +  G TAL  A       + + ++VKLL+   A
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169

Query: 130 NIDARDRWGSTAAADAKYYGNVEVYNIL 157
           +   +D  G TA   A   G  E+  IL
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKIL 197

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 76.3 bits (189), Expect = 3e-16
 Identities = 14/63 (22%), Positives = 25/63 (39%)

Query: 102 DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
             +    L  A      +V ++L      +D  D  G+T    A +  ++E+   L  RG
Sbjct: 3   TYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRG 62

Query: 162 AKV 164
           A +
Sbjct: 63  ADI 65

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 63.2 bits (155), Expect = 8e-12
 Identities = 14/39 (35%), Positives = 23/39 (58%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           V+ L+  G+D +  D  GRTA+  A  +G+ E+ K+L  
Sbjct: 161 VKLLMENGADQSIKDNSGRTAMDYANQKGYTEISKILAQ 199

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 97.2 bits (243), Expect = 8e-23
 Identities = 44/208 (21%), Positives = 84/208 (40%), Gaps = 32/208 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +   KI++               E  I  K +HPN+V+   ++ +     +V + 
Sbjct: 28  KTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   +  +   S +        +   + Y H      I+H +LKP+N+LL     
Sbjct: 87  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 143

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEFDRS 374
           G  +K++ FGL          A        ++ +           Y++PE+ K + + + 
Sbjct: 144 GAAVKLADFGL----------AIE------VNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEV 402
           VD ++ G+ILY ++ G  PF  +    +
Sbjct: 188 VDIWACGVILYILLVGYPPFWDEDQHRL 215

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 96.0 bits (240), Expect = 8e-23
 Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A     +  V+ LL  G++VN+    G +ALH A+  G + +V+ L+   A+   ++
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
               T    A+    +++      R A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 89.0 bits (222), Expect = 2e-20
 Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 12/107 (11%)

Query: 77  LFMACR-GDVKGVEDLLNE----GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           L +A   G++  V  L+N     G +++  +   +T LH+A       VV+LL++  A+ 
Sbjct: 13  LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 72

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVP-----KTK--RTP 171
            A DR G TAA  A  + +      L    A        +     T 
Sbjct: 73  MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTA 119

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 85.2 bits (212), Expect = 4e-19
 Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 15/111 (13%)

Query: 77  LFMACR-GDVKGVEDLLNEG----SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
             +AC       +  LL+       D+ + + DG TALH+A      E V+LLL + A+I
Sbjct: 83  AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADI 142

Query: 132 DARDR-WGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           DA D   G +    A       ++ +  +L   GA V  +     + +  A
Sbjct: 143 DAVDIKSGRSPLIHAV---ENNSLSMVQLLLQHGANVNAQMYSGSSALHSA 190

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 73.3 bits (181), Expect = 7e-15
 Identities = 18/71 (25%), Positives = 26/71 (36%), Gaps = 4/71 (5%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLS----KKANIDARDRWGSTAAADAKYYGNVEV 153
               D DG T LHIA  +G++  V  L++        +D  +    T    A       V
Sbjct: 2   ATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSV 61

Query: 154 YNILKARGAKV 164
             +L   GA  
Sbjct: 62  VRLLVTAGASP 72

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 67.9 bits (167), Expect = 4e-13
 Identities = 10/51 (19%), Positives = 25/51 (49%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           + RG +  V  L+  G+D +  +    T L +A     +++++   ++ A+
Sbjct: 191 SGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGKATRPAS 241

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 93.6 bits (234), Expect = 8e-23
 Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 7/114 (6%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           L +   G+ +    LL  G++ +  D  G   +H AA  G ++ ++ LL  +A+++  D 
Sbjct: 42  LQVMKLGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDN 101

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA---NPREVPEY 183
            G+     A   G++ V   L    A     +     T   +A      EV   
Sbjct: 102 EGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSL 155

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 93.2 bits (233), Expect = 1e-22
 Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 1/89 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RGD++ +  LL    +VN+ +  GRTAL +    G+ E+ + LL + AN D +D
Sbjct: 9   LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           R G     DA   G ++    L    A V
Sbjct: 68  RTGFAVIHDAARAGFLDTLQTLLEFQADV 96

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 90.1 bits (225), Expect = 2e-21
 Identities = 31/76 (40%), Positives = 46/76 (60%), Gaps = 1/76 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTAAADAK 146
           ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA   A+
Sbjct: 86  LQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLAR 145

Query: 147 YYGNVEVYNILKARGA 162
            YG  EV ++++A GA
Sbjct: 146 LYGRNEVVSLMQANGA 161

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 75.5 bits (187), Expect = 2e-16
 Identities = 19/64 (29%), Positives = 27/64 (42%), Gaps = 7/64 (10%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
                L  AA  G +E +  LL    N++A++ +G TA          GN E+   L  R
Sbjct: 4   PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK----LGNPEIARRLLLR 59

Query: 161 GAKV 164
           GA  
Sbjct: 60  GANP 63

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 98.1 bits (245), Expect = 9e-23
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           KGS+ +V  A++  T  +  +K L K+      D E       E  ++  A  HP +   
Sbjct: 27  KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV---EKRVLSLAWEHPFLTHM 83

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
                    +  V+EY   GDL  ++Q   +   S+   F A ++  G+ +LH      I
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-TFYAAEIILGLQFLHSKG---I 139

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF---PVSHIDPANLYVAPEIY 366
           ++ DLK  NILLD  G +KI+ FG+ +   +  +     F   P         Y+APEI 
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKEN-MLGDAKTNTFCGTPD--------YIAPEIL 190

Query: 367 KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
             ++++ SVD +SFG++LYEM+ G  PFH +  EE+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 23/199 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K  G +   K + K   K   R         E++I+++ +HPNV+           ++++
Sbjct: 33  KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-- 321
           LE  A G+L  +L +K  L+  +   F   +  G+ YLH  +   I H DLKP+NI+L  
Sbjct: 93  LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLD 149

Query: 322 --DNGGQLKISGFGLLRLQYISP-EKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVD 376
                 ++KI  FGL     I    + K +F  P         +VAPEI   E      D
Sbjct: 150 RNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTP--------EFVAPEIVNYEPLGLEAD 199

Query: 377 AYSFGLILYEMIEGVQPFH 395
            +S G+I Y ++ G  PF 
Sbjct: 200 MWSIGVITYILLSGASPFL 218

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 27/197 (13%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLE 265
           K +     VKI+ K    + ++      E+T ++    HPN+V+        +   +V+E
Sbjct: 33  KKSNQAFAVKIISKRMEANTQK------EITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---D 322
               G+L   ++KK   S ++       L   ++++H+     ++H DLKP+N+L    +
Sbjct: 87  LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDEN 143

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHI--DPAN--LYVAPEIYKNEEFDRSVDAY 378
           +  ++KI  FG           A++  P +     P     Y APE+     +D S D +
Sbjct: 144 DNLEIKIIDFGF----------ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLW 193

Query: 379 SFGLILYEMIEGVQPFH 395
           S G+ILY M+ G  PF 
Sbjct: 194 SLGVILYTMLSGQVPFQ 210

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 55/249 (22%), Positives = 93/249 (37%), Gaps = 39/249 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
             N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY
Sbjct: 76  VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135

Query: 267 HAKGDLASYLQKKGRLSPSK---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                       K  L   +   V   AL   +G+ YLH      +IH D+K  NILL  
Sbjct: 136 CLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHN---MIHRDVKAGNILLSE 189

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVS-HIDPANLYV------APEI---YKNEEFDR 373
            G +K+  FG                  +  + PAN +V      APE+       ++D 
Sbjct: 190 PGLVKLGDFG-----------------SASIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232

Query: 374 SVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEEC 433
            VD +S G+   E+ E   P         +  +    +     +++  +    +  ++ C
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPALQSGHWSEYFRNFVDSC 289

Query: 434 WDPKPVIRP 442
               P  RP
Sbjct: 290 LQKIPQDRP 298

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 68/276 (24%), Positives = 107/276 (38%), Gaps = 61/276 (22%)

Query: 210 GTKVWVKILDKE-----------------------SHKDPERINAFTHELTIVEKARHPN 246
            T   +K+L K+                         +    I     E+ I++K  HPN
Sbjct: 38  NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97

Query: 247 VVQFV----GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           VV+ V         ++   +V E   +G +         LS  +   +  DL +G+ YLH
Sbjct: 98  VVKLVEVLDDPNEDHL--YMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLH 154

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVA 362
             K   IIH D+KP N+L+   G +KI+ FG+      S          +   PA  ++A
Sbjct: 155 YQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS-NTVGT---PA--FMA 205

Query: 363 PEIYKNE--EFD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA 419
           PE        F  +++D ++ G+ LY  + G  PF     E ++ L          KIK+
Sbjct: 206 PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM---DERIMCLH--------SKIKS 254

Query: 420 RSY--------PPDLKELIEECWDPKPVIRPNFNEI 447
           ++           DLK+LI    D  P  R    EI
Sbjct: 255 QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 93.2 bits (233), Expect = 1e-22
 Identities = 30/85 (35%), Positives = 40/85 (47%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           A    V  VE LL  G+DV++ D  G   LH A   GH EV +LL+   A ++  D W  
Sbjct: 50  AGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKF 109

Query: 140 TAAADAKYYGNVEVYNILKARGAKV 164
           T   +A   G  E+  +L   GA  
Sbjct: 110 TPLHEAAAKGKYEICKLLLQHGADP 134

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 92.5 bits (231), Expect = 2e-22
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 7/78 (8%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
            E L+  G+ VN  DL   T LH AA +G  E+ KLLL   A+   ++R G+T       
Sbjct: 91  AELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK- 149

Query: 145 AKYYGNVEVYNILKARGA 162
               G+ ++ ++L+   A
Sbjct: 150 ---DGDTDIQDLLRGDAA 164

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 90.5 bits (226), Expect = 1e-21
 Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 1/97 (1%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           N ++  QLL  A  GDV+ V+ L      +   I+    T LH AA    V VV+ LL  
Sbjct: 5   NSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQH 64

Query: 128 KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            A++ A+D+ G     +A  YG+ EV  +L   GA V
Sbjct: 65  GADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVV 101

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 76.3 bits (189), Expect = 1e-16
 Identities = 26/81 (32%), Positives = 31/81 (38%), Gaps = 7/81 (8%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEV 153
           G+  NS   +    L  AA  G VE VK L + +  N    +   ST    A  Y  V V
Sbjct: 1   GAMGNS---EADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57

Query: 154 YNILKARGAKV-PKTK--RTP 171
              L   GA V  K K    P
Sbjct: 58  VEYLLQHGADVHAKDKGGLVP 78

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 63/293 (21%), Positives = 117/293 (39%), Gaps = 45/293 (15%)

Query: 172 MTVANPREVPEYELNPLELQVRKADG---------ITKGSYQVA-----KWNGTKVWVKI 217
           +     R  P  +L  L+                 + +GSY        K  G  V +K 
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS-YL 276
           +  E   D + I     E++I+++   P+VV++ G+  +N  + IV+EY   G ++    
Sbjct: 62  VPVE--SDLQEI---IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR 116

Query: 277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   L+  ++        +G+ YLH  +    IH D+K  NILL+  G  K++ FG+  
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGV-- 171

Query: 337 LQYISPEKAKIVFPVSHIDPANLYV------APEIYKNEEFDRSVDAYSFGLILYEMIEG 390
              ++   AK           N  +      APE+ +   ++   D +S G+   EM EG
Sbjct: 172 AGQLTDTMAK----------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

Query: 391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARS-YPPDLKELIEECWDPKPVIRP 442
             P+    P   + ++      PP   +    +  +  + +++C    P  R 
Sbjct: 222 KPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 41/221 (18%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           +GSY +V   +   T     +K++ KE     +D + +     E  + E+A  HP +V  
Sbjct: 19  RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQASNHPFLVGL 75

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
                    +  V+EY   GDL  ++Q++ +L      RF + +++  +NYLHE     I
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERG---I 131

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------Y 360
           I+ DLK  N+LLD+ G +K++ +G+           K       + P +          Y
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGM----------CK-----EGLRPGDTTSTFCGTPNY 176

Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
           +APEI + E++  SVD ++ G++++EM+ G  PF      +
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =   99 bits (249), Expect = 2e-22
 Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 32/222 (14%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHE---LTIVEKARHPNVVQFV 251
           +G +       K +  K++ +K LDK+  K  +      +E   L++V     P +V   
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            A      +  +L+    GDL  +L + G  S + +  +A ++  G+ ++H      +++
Sbjct: 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVY 315

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------YVAPEI 365
            DLKP NILLD  G ++IS  GL          A            +       Y+APE+
Sbjct: 316 RDLKPANILLDEHGHVRISDLGL----------ACDFSK----KKPHASVGTHGYMAPEV 361

Query: 366 -YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
             K   +D S D +S G +L++++ G  PF     ++  ++ 
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 45/205 (21%), Positives = 88/205 (42%), Gaps = 39/205 (19%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             +  G    +K + K        +     E+ +++K +H N+V             +V+
Sbjct: 29  KQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHENIVTLEDIYESTTHYYLVM 85

Query: 265 EYHAKGDLASYLQKKGRLS---PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           +  + G+L   + ++G  +    S V++    +   + YLHE     I+H DLKP+N+L 
Sbjct: 86  QLVSGGELFDRILERGVYTEKDASLVIQ---QVLSAVKYLHENG---IVHRDLKPENLLY 139

Query: 322 ---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL--------YVAPEIYKNEE 370
              +   ++ I+ FGL          +K+           +        YVAPE+   + 
Sbjct: 140 LTPEENSKIMITDFGL----------SKM------EQNGIMSTACGTPGYVAPEVLAQKP 183

Query: 371 FDRSVDAYSFGLILYEMIEGVQPFH 395
           + ++VD +S G+I Y ++ G  PF+
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFY 208

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 28/232 (12%), Positives = 58/232 (25%), Gaps = 40/232 (17%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +  +D +     + +         + +   P V + +  V      ++V E+   G L
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL 118

Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
                     SP   +R    LA   +  H      +      P  + +   G + ++  
Sbjct: 119 QEVAD--TSPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP 173

Query: 333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQ 392
                  +              +P +                 D    G  LY ++    
Sbjct: 174 A-----TMPDA-----------NPQD-----------------DIRGIGASLYALLVNRW 200

Query: 393 PFHPKPPEEVVKLMCCE--GKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           P         +     +  G+        R  P  +  +          IR 
Sbjct: 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.5 bits (248), Expect = 2e-22
 Identities = 58/258 (22%), Positives = 97/258 (37%), Gaps = 53/258 (20%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           +G +            K++  K L+K+  K  +       E  I+ K     +V    A 
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR--------GMNYLHECKP 306
                + +V+     GD+  ++      +P     F    A         G+ +LH+   
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNP----GFQEPRAIFYTAQIVSGLEHLHQRN- 309

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------- 359
             II+ DLKP+N+LLD+ G ++IS  GL          A                     
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGL----------AVE-----LKAGQTKTKGYAGT 352

Query: 360 --YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF----HPKPPEEVVKLMCCEGKRP 413
             ++APE+   EE+D SVD ++ G+ LYEMI    PF         +E+ + +  +    
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412

Query: 414 PLKIKARSYPPDLKELIE 431
           P       + P  K+  E
Sbjct: 413 P-----DKFSPASKDFCE 425

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 29/209 (13%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLE 265
           K    +  VKI+DK S +DP        E+ I+ +  +HPN++           + +V E
Sbjct: 44  KATNMEFAVKIIDK-SKRDPTE------EIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---- 321
               G+L   + ++   S  +       + + + YLH      ++H DLKP NIL     
Sbjct: 97  LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDES 153

Query: 322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI--DPAN--LYVAPEIYKNEEFDRSVDA 377
            N   ++I  FG           AK +   + +   P     +VAPE+ + + +D + D 
Sbjct: 154 GNPESIRICDFGF----------AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDI 203

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
           +S G++LY M+ G  PF   P +   +++
Sbjct: 204 WSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 62/263 (23%), Positives = 107/263 (40%), Gaps = 46/263 (17%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
                KV +K ++ E  +    ++    E+  + +  HPN+V +  +      + +V++ 
Sbjct: 37  APKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94

Query: 267 HAKG---DLASYLQKKGRLSPSK--------VLRFALDLARGMNYLHECKPDPIIHCDLK 315
            + G   D+  ++  KG              +LR  L    G+ YLH+      IH D+K
Sbjct: 95  LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL---EGLEYLHKNG---QIHRDVK 148

Query: 316 PKNILLDNGGQLKISGFG----LLRLQYISPEKAKIVF---PVSHIDPANLYVAPE-IYK 367
             NILL   G ++I+ FG    L     I+  K +  F   P         ++APE + +
Sbjct: 149 AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP--------CWMAPEVMEQ 200

Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP--------LKIKA 419
              +D   D +SFG+   E+  G  P+H  PP +V+ L     +  P         K   
Sbjct: 201 VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT---LQNDPPSLETGVQDKEML 257

Query: 420 RSYPPDLKELIEECWDPKPVIRP 442
           + Y    +++I  C    P  RP
Sbjct: 258 KKYGKSFRKMISLCLQKDPEKRP 280

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 17/186 (9%)

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 339 YISPE---KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF 394
           Y  P+   K     P+  +       APE   +  +    D +SFG++L+E+   G  P+
Sbjct: 244 YKDPDYVRKGDARLPLKWM-------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296

Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                +E       EG R           P++ + + +CW  +P  RP F+E++  L  +
Sbjct: 297 PGVKIDEEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

Query: 455 VCNCSK 460
           +   ++
Sbjct: 354 LQANAQ 359

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 47/186 (25%), Positives = 76/186 (40%), Gaps = 23/186 (12%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKVWVKILDKESHKDP 226
           P +  ++E     L++ K  G  +G++ QV  A   G         V VK+L KE     
Sbjct: 11  PYDASKWEFPRDRLKLGKPLG--RGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHS 67

Query: 227 ERINAFTHELTI-VEKARHPNVVQFVGAVTQNI-PMMIVLEYHAKGDLASYLQKKGRLSP 284
           E   A   EL I +    H NVV  +GA T+   P+M+++E+   G+L++YL+ K R   
Sbjct: 68  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEF 125

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
                      +G +Y+        I  DLK +   + +      SGF   +      E+
Sbjct: 126 VPYKTKGARFRQGKDYVG------AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

Query: 345 AKIVFP 350
                 
Sbjct: 180 EAPEDL 185

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 92.1 bits (230), Expect = 2e-22
 Identities = 27/71 (38%), Positives = 41/71 (57%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN+ D+   TALH A    H EVV+LL+   A++  + ++  TA   +  
Sbjct: 83  VEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISID 142

Query: 148 YGNVEVYNILK 158
            GN ++  IL+
Sbjct: 143 NGNEDLAEILQ 153

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 92.1 bits (230), Expect = 2e-22
 Identities = 28/77 (36%), Positives = 41/77 (53%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            E LL  G   ++     RT LH+AA EGH  +V++LL   A+++A+D    TA   A  
Sbjct: 50  TEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109

Query: 148 YGNVEVYNILKARGAKV 164
           + + EV  +L   GA V
Sbjct: 110 HNHQEVVELLIKYGADV 126

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 91.7 bits (229), Expect = 4e-22
 Identities = 27/89 (30%), Positives = 39/89 (43%), Gaps = 1/89 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G    V  L+  G+   + D  G + LH+AA  GH    ++LL    + DAR 
Sbjct: 6   LLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           +   T    A   G+  +  +L   GA V
Sbjct: 65  KVDRTPLHMAASEGHANIVEVLLKHGADV 93

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 70.5 bits (174), Expect = 1e-14
 Identities = 21/74 (28%), Positives = 31/74 (41%), Gaps = 10/74 (13%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
           D    L  AA  G  + V++L++  A     D  G++    AA    YG+     +L   
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAA---QYGHFSTTEVLLRA 56

Query: 161 GAKV-PKTK--RTP 171
           G     +TK  RTP
Sbjct: 57  GVSRDARTKVDRTP 70

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 66/247 (26%), Positives = 117/247 (47%), Gaps = 37/247 (14%)

Query: 200 KGSY----QVAKWNGTKVW----VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           +GS+     V K +G+       +K+L K + K  +R+     E  I+ +  HP +V+  
Sbjct: 34  QGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVKLH 92

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
            A      + ++L++   GDL + L K+   +   V +F   +LA  +++LH      II
Sbjct: 93  YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSLG---II 148

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------YVAPE 364
           + DLKP+NILLD  G +K++ FGL          +K    + H   A        Y+APE
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGL----------SKE--SIDHEKKAYSFCGTVEYMAPE 196

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
           +       +S D +SFG++++EM+ G  PF  K  +E + ++        L +  +   P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----KLGMP-QFLSP 251

Query: 425 DLKELIE 431
           + + L+ 
Sbjct: 252 EAQSLLR 258

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 36/225 (16%)

Query: 183 YELNPLEL-------QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHE 235
           Y ++  E+       QV K               G K+  KI+     KD E +    +E
Sbjct: 89  YTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKIIKTRGMKDKEEVK---NE 136

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDL 294
           ++++ +  H N++Q   A      +++V+EY   G+L   +  +   L+    + F   +
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVF--P 350
             G+ ++H+     I+H DLKP+NIL  N    Q+KI  FGL R +Y   EK K+ F  P
Sbjct: 197 CEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLKVNFGTP 252

Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
                    ++APE+   +      D +S G+I Y ++ G+ PF 
Sbjct: 253 --------EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.8 bits (244), Expect = 4e-22
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +    +  VK+++K +    +  +    E+ +++K  HPN+++    +  +    IV E 
Sbjct: 44  RITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++   
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEK 159

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +KI  FGL           K+   +        Y+APE+ +   +D   D +S G+I
Sbjct: 160 DCDIKIIDFGLST--CFQQNT-KMKDRIGTAY----YIAPEVLR-GTYDEKCDVWSAGVI 211

Query: 384 LYEMIEGVQPFHPKPPEEVVK 404
           LY ++ G  PF+ K   +++K
Sbjct: 212 LYILLSGTPPFYGKNEYDILK 232

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 94.9 bits (237), Expect = 4e-22
 Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 10/99 (10%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
               D + V  L + G+D+N  +   GRT LH+A       V++LLL   A+  AR   G
Sbjct: 166 VIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGG 225

Query: 139 STA---AADAKYYGNVEVYNILKARGAKVP-KTK--RTP 171
            T    A       N  +  +L+A GA  P       +P
Sbjct: 226 RTPLGSAL---LRPNPILARLLRAHGAPEPEDGGDKLSP 261

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 91.1 bits (227), Expect = 8e-21
 Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 1/78 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A        +E LL  G+D  +    GRT L  A    +  + +LL +  A      
Sbjct: 196 LHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDG 255

Query: 136 RWGSTAAADAKYYGNVEV 153
               +  + +    + + 
Sbjct: 256 GDKLSPCSSSGSDSDSDN 273

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 25/142 (17%), Positives = 42/142 (29%), Gaps = 17/142 (11%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDL---DGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
                   ++ LL   +    +DL    G+TALH+AA  G    V+ L +  A +   +R
Sbjct: 17  VIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAER 76

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKAD 196
            G TA   A          +L       P+         +    P+    P  +      
Sbjct: 77  GGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVD----- 131

Query: 197 GITKGSYQVAKWNGTKVWVKIL 218
                    ++ N         
Sbjct: 132 ---------SQPNPENEEEPRD 144

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 21/103 (20%), Positives = 37/103 (35%), Gaps = 10/103 (9%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            +      + +      +    + + + DG T LH+A      E+V+LL    A+++  +
Sbjct: 129 AVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPE 188

Query: 136 R-WGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
              G T    A          V  +L   GA    +    RTP
Sbjct: 189 PTCGRTPLHLAV---EAQAASVLELLLKAGADPTARMYGGRTP 228

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 23/73 (31%), Positives = 29/73 (39%), Gaps = 9/73 (12%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN---IDARDRWGSTA---AADAKYYGNV 151
              +  DG TALH+A    H   +  LL   A    +D ++  G TA   AA     G  
Sbjct: 2   FGYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAA---ILGEA 58

Query: 152 EVYNILKARGAKV 164
                L A GA V
Sbjct: 59  STVEKLYAAGAGV 71

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 21/117 (17%), Positives = 33/117 (28%), Gaps = 25/117 (21%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRT--------------ALHIAACEGHVEVV 121
           L +ACR         LL           D                 A   +      E  
Sbjct: 82  LHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEE 141

Query: 122 KLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKARGAKV----PKTKRTP 171
                 +  ++A +  G T    A     + + E+  +L+  GA +    P   RTP
Sbjct: 142 PRDEDWRLQLEAENYDGHTPLHVAV---IHKDAEMVRLLRDAGADLNKPEPTCGRTP 195

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 5/51 (9%), Positives = 11/51 (21%), Gaps = 1/51 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           L  A    +      L   G+       D  +    +  +   +       
Sbjct: 229 LGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGSDSDSDNRDEGDE 279

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 34/206 (16%)

Query: 207 KWNGTKVWVKILDK-----ESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPM 260
           +    KV +KI+ K      S ++ +       E+ I++K  HP +++       ++   
Sbjct: 32  RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-- 89

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            IVLE    G+L   +    RL  +    +   +   + YLHE     IIH DLKP+N+L
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVL 146

Query: 321 L---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEI---YKNE 369
           L   +    +KI+ FG           +KI+   S +      P   Y+APE+       
Sbjct: 147 LSSQEEDCLIKITDFGH----------SKILGETSLMRTLCGTPT--YLAPEVLVSVGTA 194

Query: 370 EFDRSVDAYSFGLILYEMIEGVQPFH 395
            ++R+VD +S G+IL+  + G  PF 
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFS 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 43/222 (19%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           +GSY     V      +++ ++++ KE     +D + +     E  + E+A  HP +V  
Sbjct: 62  RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQASNHPFLVGL 118

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
                    +  V+EY   GDL  ++Q++ +L      RF + +++  +NYLHE     I
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERG---I 174

Query: 310 IHCDLKPKNILLDNGGQLKISGFGL--LRLQYIS--------PEKAKIVFPVSHIDPANL 359
           I+ DLK  N+LLD+ G +K++ +G+    L+           P                 
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN---------------- 218

Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
           Y+APEI + E++  SVD ++ G++++EM+ G  PF      +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 36/222 (16%)

Query: 198 ITKGSY---QVAKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQ 249
           I +G++   Q+ +   T+    +K+L K       D         E  I+  A  P VVQ
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQ 133

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDP 308
              A   +  + +V+EY   GDL + +     + P K  RF   ++   ++ +H      
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDV-PEKWARFYTAEVVLALDAIHSMG--- 188

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-----YVAP 363
            IH D+KP N+LLD  G LK++ FG              +     +          Y++P
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGT----------CMKMNKEGMVRCDTAVGTPDYISP 238

Query: 364 EIYKNE----EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
           E+ K++     + R  D +S G+ LYEM+ G  PF+      
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 98.2 bits (244), Expect = 5e-22
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 31/217 (14%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKESHKDPERINAFTHELTIVEK------ARHPNVV 248
           KGS+ +V  ++  GT     VKIL K+     + +     E T+VEK       + P + 
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV-----ECTMVEKRVLALPGKPPFLT 405

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           Q          +  V+EY   GDL  ++Q+ GR      + +A ++A G+ +L       
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--- 462

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF---PVSHIDPANLYVAPEI 365
           II+ DLK  N++LD+ G +KI+ FG+ +   I        F   P         Y+APEI
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTTKTFCGTPD--------YIAPEI 513

Query: 366 YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              + + +SVD ++FG++LYEM+ G  PF  +  +E+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 31/217 (14%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEK------ARHPNVV 248
           KGS+       +    +++ VKIL K+     + +     E T+VEK       + P + 
Sbjct: 30  KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV-----ECTMVEKRVLALPGKPPFLT 84

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           Q          +  V+EY   GDL  ++Q+ GR      + +A ++A G+ +L       
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--- 141

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF---PVSHIDPANLYVAPEI 365
           II+ DLK  N++LD+ G +KI+ FG+ +   I        F   P         Y+APEI
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTTKTFCGTPD--------YIAPEI 192

Query: 366 YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
              + + +SVD ++FG++LYEM+ G  PF  +  +E+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 93.3 bits (233), Expect = 6e-22
 Identities = 24/90 (26%), Positives = 38/90 (42%), Gaps = 1/90 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           ++     G  +   +L+  G DV   D +  T LH AA    +++VK  +SK A +D   
Sbjct: 13  IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72

Query: 136 R-WGSTAAADAKYYGNVEVYNILKARGAKV 164
               ST    A   G++ +   L   GA  
Sbjct: 73  GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 92.5 bits (231), Expect = 1e-21
 Identities = 27/78 (34%), Positives = 35/78 (44%), Gaps = 1/78 (1%)

Query: 88  VEDLLNEGSDVNSID-LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK 146
              LL     VN  D     TALH A   G+  V+ LLL   AN+DA++  G +A   AK
Sbjct: 159 TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAK 218

Query: 147 YYGNVEVYNILKARGAKV 164
              NV + N L+      
Sbjct: 219 QRKNVWMINHLQEARQAK 236

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 89.4 bits (223), Expect = 1e-20
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 1/78 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V  L+  G+D + ID +G + +H+AA  GH  +V  L++K  ++D  D+ G T    A Y
Sbjct: 92  VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151

Query: 148 YGN-VEVYNILKARGAKV 164
             + V+   +L      V
Sbjct: 152 RTHSVDPTRLLLTFNVSV 169

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 89.0 bits (222), Expect = 2e-20
 Identities = 26/116 (22%), Positives = 48/116 (41%), Gaps = 9/116 (7%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A     +  V+  +++G+ V+ +  D   T LH A  +GH+ +V  L+   A+    
Sbjct: 46  LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLI 105

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA----NPREVPEY 183
           D  G +    A  +G+  +   L A+G  V    +   TP+  A    +  +    
Sbjct: 106 DGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRL 161

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 86.7 bits (216), Expect = 1e-19
 Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 6/105 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH-VEVVKLLLSKKANIDAR 134
           + +A + G    V  L+ +G DV+ +D +G T L  AA   H V+  +LLL+   +++  
Sbjct: 113 IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLG 172

Query: 135 DRW-GSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           D++  +TA   A   GN  V ++L   GA V  +     + + +A
Sbjct: 173 DKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLA 217

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 81.3 bits (202), Expect = 1e-17
 Identities = 12/67 (17%), Positives = 24/67 (35%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
           +  ID      +  A   G  E  + L+    ++   D+   T    A     +++    
Sbjct: 2   MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61

Query: 158 KARGAKV 164
            ++GA V
Sbjct: 62  ISKGAIV 68

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 74.0 bits (183), Expect = 3e-15
 Identities = 13/60 (21%), Positives = 28/60 (46%), Gaps = 1/60 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G+   +  LL  G++V++ ++ G +AL +A    +V ++  L   +      +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 95.3 bits (238), Expect = 6e-22
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 38/222 (17%)

Query: 200 KGSY----QVAKWNG---TKVW-VKILDKES----HKDPERINAFTHELTIVEKARHPNV 247
           KG Y    QV K  G    K++ +K+L K       KD     A   E  I+E+ +HP +
Sbjct: 27  KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVKHPFI 83

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKP 306
           V  + A      + ++LEY + G+L   L+++G         F   +++  + +LH+   
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYLAEISMALGHLHQKG- 141

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------Y 360
             II+ DLKP+NI+L++ G +K++ FGL           K    +      +       Y
Sbjct: 142 --IIYRDLKPENIMLNHQGHVKLTDFGL----------CKE--SIHDGTVTHTFCGTIEY 187

Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
           +APEI      +R+VD +S G ++Y+M+ G  PF  +  ++ 
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 94.5 bits (236), Expect = 7e-22
 Identities = 33/89 (37%), Positives = 46/89 (51%), Gaps = 1/89 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A +      VE LL  G+D      +G T   +AA  G V+++KL LSK A+++  D
Sbjct: 43  LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECD 102

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
            +G TA  +A  YG V+    L  RGA V
Sbjct: 103 FYGFTAFMEAAVYGKVKALKFLYKRGANV 131

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 91.4 bits (228), Expect = 7e-21
 Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 1/78 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAK 146
              LL+ G+DVN     G+T L +A  + H+ +V+ LL ++   I+  D  G TA   A 
Sbjct: 202 THLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAV 261

Query: 147 YYGNVEVYNILKARGAKV 164
                ++  +L  RGA  
Sbjct: 262 ELKLKKIAELLCKRGAST 279

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 91.0 bits (227), Expect = 1e-20
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A +  DV  V+ LL  G++VN  + + G T LH A      ++V+LLL   A+   R
Sbjct: 9   LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            + G+T    A   G+V++  +  ++GA V
Sbjct: 69  KKNGATPFLLAAIAGSVKLLKLFLSKGADV 98

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 87.1 bits (217), Expect = 2e-19
 Identities = 38/110 (34%), Positives = 52/110 (47%), Gaps = 14/110 (12%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD---- 135
           A  G VK ++  L++G+DVN  D  G TA   AA  G V+ +K L  + AN++ R     
Sbjct: 80  AIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKE 139

Query: 136 ------RWGSTAAADAKYYGNVEVYNIL-KARGAKV-PKTK--RTPMTVA 175
                 + G+TA  DA   G+VEV  IL    GA V       R  +  A
Sbjct: 140 DQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHA 189

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 80.2 bits (199), Expect = 5e-17
 Identities = 28/109 (25%), Positives = 49/109 (44%), Gaps = 9/109 (8%)

Query: 76  LLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHV----EVVKLLLSKKAN 130
           L+  A +G V+ ++ LL+E G+DVN+ D  GR AL  A           +  LLL   A+
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGAD 211

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNIL-KARGAKV-PKTK--RTPMTVA 175
           ++ R   G T    A    ++ +   L +    ++       +T + +A
Sbjct: 212 VNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLA 260

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 79.4 bits (197), Expect = 1e-16
 Identities = 17/57 (29%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 80  ACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
             +  +  V+ LL  E  ++N  D DG+TAL +A      ++ +LL  + A+ D  D
Sbjct: 227 VEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 72.9 bits (180), Expect = 1e-14
 Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 7/65 (10%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDR-WGSTA---AADAKYYGNVEVYNILKA 159
           +    L  A     V++V+ LL   AN++ ++   G T    A         ++  +L  
Sbjct: 4   EDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAV---QMSREDIVELLLR 60

Query: 160 RGAKV 164
            GA  
Sbjct: 61  HGADP 65

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 95.8 bits (239), Expect = 9e-22
 Identities = 69/251 (27%), Positives = 123/251 (49%), Gaps = 46/251 (18%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           KGS+ +V  A+    +V+  VK+L K+     K+ + I +   E  ++ K  +HP +V  
Sbjct: 48  KGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS---ERNVLLKNVKHPFLVGL 104

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
             +      +  VL+Y   G+L  +LQ++      +  RF A ++A  + YLH      I
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLN---I 160

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------Y 360
           ++ DLKP+NILLD+ G + ++ FGL           K      +I+  +          Y
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGL----------CK-----ENIEHNSTTSTFCGTPEY 205

Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
           +APE+   + +DR+VD +  G +LYEM+ G+ PF+ +   E+   +  +    PL++K  
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PLQLK-P 260

Query: 421 SYPPDLKELIE 431
           +     + L+E
Sbjct: 261 NITNSARHLLE 271

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 41/218 (18%)

Query: 207 KWNGTKVWVKILDKESHKDPERIN------AFTHELTIVEK-ARHPNVVQFVGAVTQNIP 259
           K    +  VKI+D                 A   E+ I+ K + HPN++Q       N  
Sbjct: 39  KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
             +V +   KG+L  YL +K  LS  +  +    L   +  LH+     I+H DLKP+NI
Sbjct: 99  FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENI 155

Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEE 370
           LLD+   +K++ FG           +        +DP            Y+APEI +   
Sbjct: 156 LLDDDMNIKLTDFGF----------SCQ------LDPGEKLREVCGTPSYLAPEIIECSM 199

Query: 371 F------DRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
                   + VD +S G+I+Y ++ G  PF  +    +
Sbjct: 200 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 60/266 (22%), Positives = 115/266 (43%), Gaps = 45/266 (16%)

Query: 198 ITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           +  G++ +V K      G     K+++ +S ++ E       E+ I+    HP +V+ +G
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY---IVEIEILATCDHPYIVKLLG 83

Query: 253 AVTQNIPMMIVLEYHAKGDLAS-YLQKKGRLSPSK---VLRFALDLARGMNYLHECKPDP 308
           A   +  + I++E+   G + +  L+    L+  +   V R  L     +N+LH  +   
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKR--- 137

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV------A 362
           IIH DLK  N+L+   G ++++ FG+          AK    +  +   + ++      A
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGV---------SAKN---LKTLQKRDSFIGTPYWMA 185

Query: 363 PEI-----YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI 417
           PE+      K+  +D   D +S G+ L EM +   P H   P  V+  +    K  P  +
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSDPPTL 242

Query: 418 KARS-YPPDLKELIEECWDPKPVIRP 442
              S +  + ++ ++   D  P  RP
Sbjct: 243 LTPSKWSVEFRDFLKIALDKNPETRP 268

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 46/208 (22%), Positives = 79/208 (37%), Gaps = 35/208 (16%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K    +   K + K   +D +R      E+ I++   HPN+++       N  + +V+E 
Sbjct: 31  KGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
              G+L   +  K     S   R   D+   + Y H+     + H DLKP+N L      
Sbjct: 88  CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSP 144

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEFDRS 374
              LK+  FGL                     P  +         YV+P++ +   +   
Sbjct: 145 DSPLKLIDFGLAA----------------RFKPGKMMRTKVGTPYYVSPQVLEG-LYGPE 187

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEV 402
            D +S G+++Y ++ G  PF      EV
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDSEV 215

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 44/208 (21%), Positives = 86/208 (41%), Gaps = 32/208 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +   KI++ +     +       E  I  K +HPN+V+   ++ +     +V + 
Sbjct: 51  KTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   +  +   S +        +   + Y H      I+H +LKP+N+LL     
Sbjct: 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 166

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEFDRS 374
           G  +K++ FGL          A        ++ +           Y++PE+ K + + + 
Sbjct: 167 GAAVKLADFGL----------AIE------VNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210

Query: 375 VDAYSFGLILYEMIEGVQPFHPKPPEEV 402
           VD ++ G+ILY ++ G  PF  +    +
Sbjct: 211 VDIWACGVILYILLVGYPPFWDEDQHRL 238

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 42/210 (20%)

Query: 207 KWNGTKVWVKILDKE--SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           +  G +  VKI+D    +            E +I    +HP++V+ +   + +  + +V 
Sbjct: 46  RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105

Query: 265 EYHAKGDLASYLQKKGRLSP-------SKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           E+    DL   + K+            S  +R    +   + Y H+     IIH D+KP 
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QILEALRYCHDNN---IIHRDVKPH 159

Query: 318 NILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEI 365
            +LL   +N   +K+ GFG+          A  +      +   +         ++APE+
Sbjct: 160 CVLLASKENSAPVKLGGFGV----------AIQLG-----ESGLVAGGRVGTPHFMAPEV 204

Query: 366 YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
            K E + + VD +  G+IL+ ++ G  PF+
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFY 234

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A    D K V+ LL  G D +  D  G TAL+ A   G+++ VKL + K   +    
Sbjct: 66  LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125

Query: 136 RWG-STAAADAKYYGNVEVYNILKARGAKVPKTK--RTPMTVA 175
           + G  T+   A    +V + +   +            + + + 
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIPSTFDLAILLSCIHIT 168

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 3/89 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A    +V+ V  LLN G+  N ++      LH AA     ++VK+LL    +    D
Sbjct: 35  SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G+TA   A   GN++   +   +  ++
Sbjct: 93  DKGNTALYYAVDSGNMQTVKLFVKKNWRL 121

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 13/104 (12%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           M L  +      K ++  L+   D    D+ G +A + A  + +V +V  LL+  A  + 
Sbjct: 2   MDLSRINT-WKSKQLKSFLS-SKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNL 59

Query: 134 RDRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
            +         AA      + ++  IL   G           T 
Sbjct: 60  LE--NEFPLHQAA---TLEDTKIVKILLFSGLDDSQFDDKGNTA 98

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 15/127 (11%), Positives = 46/127 (36%), Gaps = 10/127 (7%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEGHVEVVKLLLSKKANIDAR 134
           + +  + G V  +  LL+  +  N+ +       + +A     +E+++ L     NI + 
Sbjct: 165 IHITIKNGHVDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIYSA 224

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTKRTPMTVANPREVPEYELNPLELQVR 193
           +              + E+  ++  +  +    +    + +    ++ E      EL++ 
Sbjct: 225 NLENV-------LLDDAEIAKMIIEKHVEYKSDSYTKDLDIVKNNKLDEIISKNKELRLM 277

Query: 194 KADGITK 200
             + + K
Sbjct: 278 YVNCVKK 284

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 3/90 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A    DV  V   L+E            + +HI    GHV+++ LLL    + +  +
Sbjct: 133 FYHAVMLNDVSIVSYFLSEIPSTFD-LAILLSCIHITIKNGHVDMMILLLDYMTSTNTNN 191

Query: 136 RWGSTAA-ADAKYYGNVEVYNILKARGAKV 164
                     A    ++E+   L      +
Sbjct: 192 SLLFIPDIKLAIDNKDIEMLQALFKYDINI 221

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 8/83 (9%), Positives = 23/83 (27%), Gaps = 8/83 (9%)

Query: 76  LLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
            + +A    D++ ++ L     ++        +A          E+ K+++ K     + 
Sbjct: 198 DIKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDDAEIAKMIIEKHVEYKSD 250

Query: 135 DRWGSTAAADAKYYGNVEVYNIL 157
                           +   N  
Sbjct: 251 SYTKDLDIVKNNKLDEIISKNKE 273

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 41/222 (18%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           KGS+ +V  A+   T     VK+L K+      D E       E  I+  A  HP + Q 
Sbjct: 33  KGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT---EKRILSLARNHPFLTQL 89

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
                    +  V+E+   GDL  ++QK  R   ++   +A ++   + +LH+     II
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---II 146

Query: 311 HCDLKPKNILLDNGGQLKISGFGL--LRLQYIS--------PEKAKIVFPVSHIDPANLY 360
           + DLK  N+LLD+ G  K++ FG+    +            P+                Y
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD----------------Y 190

Query: 361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV 402
           +APEI +   +  +VD ++ G++LYEM+ G  PF  +  +++
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 67/282 (23%), Positives = 111/282 (39%), Gaps = 32/282 (11%)

Query: 182 EYELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHEL 236
            ++    +L+     G  +G+Y  V K     +G  + VK +      D +       +L
Sbjct: 16  HWDFTAEDLKDLGEIG--RGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDL 71

Query: 237 TIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG---DLASYLQKKGRLSPSKVL-RFA 291
            +V ++   P +VQF GA+ +     I +E  +                + P ++L +  
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
           L   + +N+L E     IIH D+KP NILLD  G +K+  FG      IS    ++V  +
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG------IS---GQLVDSI 180

Query: 352 SHIDPA--NLYVAPEI----YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL 405
           +    A    Y+APE        + +D   D +S G+ LYE+  G  P+           
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240

Query: 406 MCCEGKRPPLKIK-ARSYPPDLKELIEECWDPKPVIRPNFNE 446
              +G  P L     R + P     +  C       RP + E
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 1/86 (1%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           +  G +  VE L++ G+DVN+ +  +GRTALH+A    + ++V LLL   A+++     G
Sbjct: 125 SIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQG 184

Query: 139 STAAADAKYYGNVEVYNILKARGAKV 164
            +         +  +   L     + 
Sbjct: 185 YSPYQLTWGRPSTRIQQQLGQLTLEN 210

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 87.2 bits (217), Expect = 9e-20
 Identities = 15/78 (19%), Positives = 30/78 (38%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           +  +  + + +N  +   +T LH+A      E+ + LL    + + RD  G+T    A  
Sbjct: 28  IRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACE 87

Query: 148 YGNVEVYNILKARGAKVP 165
            G +    +L        
Sbjct: 88  QGCLASVGVLTQSCTTPH 105

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 29/109 (26%), Positives = 53/109 (48%), Gaps = 17/109 (15%)

Query: 77  LFMACR-GDVKGVEDLLNEGSD------VNSIDLDGRTALHIAACEGHVEVVKLLLSKKA 129
           L +AC  G +  V  L    +       + + + +G T LH+A+  G++ +V+LL+S  A
Sbjct: 82  LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGA 141

Query: 130 NIDARDRW-GSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
           +++A++   G TA   A       N ++ ++L   GA V   T    +P
Sbjct: 142 DVNAQEPCNGRTALHLAV---DLQNPDLVSLLLKCGADVNRVTYQGYSP 187

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 23/86 (26%), Positives = 35/86 (40%), Gaps = 12/86 (13%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN------IDARDRWGSTA 141
            E LL  G D    D  G T LH+A  +G +  V +L            + A +  G T 
Sbjct: 61  AEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTC 120

Query: 142 ---AADAKYYGNVEVYNILKARGAKV 164
              A+    +G + +  +L + GA V
Sbjct: 121 LHLAS---IHGYLGIVELLVSLGADV 143

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 72.2 bits (178), Expect = 1e-14
 Identities = 10/74 (13%), Positives = 18/74 (24%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
               +   V  LL  G+DVN +   G +   +        + + L               
Sbjct: 159 VDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESE 218

Query: 140 TAAADAKYYGNVEV 153
              +        E 
Sbjct: 219 DEESYDTESEFTEF 232

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 64.5 bits (158), Expect = 5e-12
 Identities = 13/71 (18%), Positives = 25/71 (35%), Gaps = 10/71 (14%)

Query: 101 IDLDGRTALHIAACEGH----VEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEV 153
           +  DG + LH+A         +EV++ +    A ++ ++    T    A         E+
Sbjct: 4   LTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAV---ITNQPEI 60

Query: 154 YNILKARGAKV 164
              L   G   
Sbjct: 61  AEALLGAGCDP 71

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 89.8 bits (224), Expect = 4e-21
 Identities = 27/77 (35%), Positives = 40/77 (51%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            E LL++GS+VN+ D  G+T L  +   G+ E+   LL   AN++ R+  G T    A  
Sbjct: 84  AEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASK 143

Query: 148 YGNVEVYNILKARGAKV 164
           YG  E+   L   GA +
Sbjct: 144 YGRSEIVKKLLELGADI 160

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 89.4 bits (223), Expect = 6e-21
 Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 1/89 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +AC  G    ++ L+     +   D++G TAL  A     + + + LLSK +N++ +D
Sbjct: 39  LMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKD 98

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    +  +G  E+   L   GA V
Sbjct: 99  FSGKTPLMWSIIFGYSEMSYFLLEHGANV 127

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 89.0 bits (222), Expect = 8e-21
 Identities = 30/70 (42%), Positives = 40/70 (57%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
              LL  G++VN  +L+G T L +A+  G  E+VK LL   A+I ARD  G TA A A+ 
Sbjct: 117 SYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARI 176

Query: 148 YGNVEVYNIL 157
           +G  EV  I 
Sbjct: 177 FGRQEVIKIF 186

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 83.6 bits (208), Expect = 7e-19
 Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 6/89 (6%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
                 +   + ++ L N        D   RT L +A   G    +  L+     ++ +D
Sbjct: 12  EKIKDEKSINQNLDFLRNYR------DSYNRTPLMVACMLGMENAIDKLVENFDKLEDKD 65

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             GSTA   A     + +   L ++G+ V
Sbjct: 66  IEGSTALIWAVKNNRLGIAEKLLSKGSNV 94

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 62.8 bits (154), Expect = 1e-11
 Identities = 15/42 (35%), Positives = 23/42 (54%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA 129
           V+ LL  G+D+++ DL G TA   A   G  EV+K+    + 
Sbjct: 150 VKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 52.4 bits (127), Expect = 3e-08
 Identities = 11/66 (16%), Positives = 21/66 (31%), Gaps = 6/66 (9%)

Query: 99  NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILK 158
           + +D +G     I   +   + +  L       + RD +  T    A   G     + L 
Sbjct: 2   SHMDKNGEIVEKIKDEKSINQNLDFL------RNYRDSYNRTPLMVACMLGMENAIDKLV 55

Query: 159 ARGAKV 164
               K+
Sbjct: 56  ENFDKL 61

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 38/228 (16%)

Query: 183 YELNPLEL------QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHEL 236
           Y L   EL       VR+          ++K  G +   K L K   +  +      HE+
Sbjct: 30  YILTSKELGRGKFAVVRQC---------ISKSTGQEYAAKFLKK-RRRGQDCRAEILHEI 79

Query: 237 TIVEKARH-PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALD 293
            ++E A+  P V+           ++++LEY A G++ S    +    +S + V+R    
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYISP-EKAKIVF 349
           +  G+ YLH+     I+H DLKP+NILL +    G +KI  FG+ R   I    + + + 
Sbjct: 140 ILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIM 194

Query: 350 --PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
             P         Y+APEI   +    + D ++ G+I Y ++    PF 
Sbjct: 195 GTPE--------YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 42/237 (17%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLE 265
                +  VKI++K+      R+     E+ ++ + + H NV++ +    +     +V E
Sbjct: 35  LITSQEYAVKIIEKQPGHIRSRV---FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91

Query: 266 YHAKGDLASYLQKKGRLS---PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
               G + S++ K+   +    S V++   D+A  +++LH      I H DLKP+NIL +
Sbjct: 92  KMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKG---IAHRDLKPENILCE 145

Query: 323 NGGQ---LKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-----------YVAPEI--- 365
           +  Q   +KI  F L             +       P +            Y+APE+   
Sbjct: 146 HPNQVSPVKICDFDL----------GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 366 --YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR 420
              +   +D+  D +S G+ILY ++ G  PF  +   +               +   
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 39/203 (19%), Positives = 82/203 (40%), Gaps = 35/203 (17%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           V   +      K +      D   +     E++I+  ARH N++    +      ++++ 
Sbjct: 25  VETSSKKTYMAKFVKV-KGTDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIF 80

Query: 265 EYHAKGDLASY-LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           E+ +  D+          L+  +++ +   +   + +LH      I H D++P+NI+   
Sbjct: 81  EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQT 137

Query: 324 --GGQLKISGFGL---------LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD 372
                +KI  FG           RL + +PE                Y APE+++++   
Sbjct: 138 RRSSTIKIIEFGQARQLKPGDNFRLLFTAPE----------------YYAPEVHQHDVVS 181

Query: 373 RSVDAYSFGLILYEMIEGVQPFH 395
            + D +S G ++Y ++ G+ PF 
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFL 204

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.4 bits (235), Expect = 6e-21
 Identities = 46/211 (21%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 207 KWNGTKVWVKILDK----------ESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           K   ++  +K++ K          ++    +      +E+++++   HPN+++       
Sbjct: 58  KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117

Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
                +V E++  G+L   +  + +            +  G+ YLH+     I+H D+KP
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174

Query: 317 KNILLDN---GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           +NILL+N      +KI  FGL    + S +  K+   +        Y+APE+ K ++++ 
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSS--FFSKDY-KLRDRLGTAY----YIAPEVLK-KKYNE 226

Query: 374 SVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
             D +S G+I+Y ++ G  PF  +  ++++K
Sbjct: 227 KCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 1/86 (1%)

Query: 80  ACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           A   ++  V+ L+ E GS+ +  D DG+T + +AA EG +EVV  L+ + A+++A D   
Sbjct: 287 AQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATD 346

Query: 139 STAAADAKYYGNVEVYNILKARGAKV 164
            TA   A+   +  + +I      + 
Sbjct: 347 HTARQLAQANNHHNIVDIFDRCRPER 372

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 6/91 (6%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK---ANIDARDR 136
                 + V  L+  G+D    +   R+ALH AA      ++  +L+      +I+  DR
Sbjct: 174 VLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDR 233

Query: 137 WGSTA---AADAKYYGNVEVYNILKARGAKV 164
            G TA    A  +    V    +L  +GAKV
Sbjct: 234 NGMTALMIVAHNEGRDQVASAKLLVEKGAKV 264

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 14/82 (17%), Positives = 31/82 (37%), Gaps = 3/82 (3%)

Query: 86  KGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA 145
              ++ +  G+DVN++D D  T L +A       +V  L+   A+    ++   +A   A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206

Query: 146 KYYGNVEVYNIL---KARGAKV 164
               +  +   +         +
Sbjct: 207 AANRDFGMMVYMLNSTKLKGDI 228

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 18/110 (16%)

Query: 81  CRGDVKGVEDLLNEGSDVN--------SIDLDGRTALHIAACEGHVEVVKLLLSKK-ANI 131
            R  V   + L+ +G+ V+        S    GRTALH AA   ++ +VK L+ +K +N 
Sbjct: 247 GRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNK 306

Query: 132 DARDRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           D +D  G T    AA     G +EV   L  +GA V        T   +A
Sbjct: 307 DKQDEDGKTPIMLAA---QEGRIEVVMYLIQQGASVEAVDATDHTARQLA 353

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 19/96 (19%), Positives = 30/96 (31%), Gaps = 9/96 (9%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-------- 128
           L     G     E +  E  ++       RT LH  A     E  + L+  +        
Sbjct: 98  LHTEAAGSYAITEPITRESVNIIDPR-HNRTVLHWIASNSSAEKSEDLIVHEAKECIAAG 156

Query: 129 ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           A+++A D   +T    A       +   L   GA  
Sbjct: 157 ADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADP 192

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 12/57 (21%), Positives = 27/57 (47%), Gaps = 1/57 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
           + +A + G ++ V  L+ +G+ V ++D    TA  +A    H  +V +    +   +
Sbjct: 317 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPERE 373

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 11/110 (10%), Positives = 24/110 (21%), Gaps = 18/110 (16%)

Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
            S   LL  +  G +K            N +              G+  +     +    
Sbjct: 36  SSQHSLLEASYDGYIKRQR---------NELQHYSLYPNPQGYGNGNDFLGDFNHTNLQI 86

Query: 131 IDARDRWGSTA---AADAKYYGNVEVYNILKARGAKVPKTK--RTPMTVA 175
               +          A     G+  +   +      +   +  RT +   
Sbjct: 87  PTEPEPESPIKLHTEA----AGSYAITEPITRESVNIIDPRHNRTVLHWI 132

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 25/204 (12%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +    +  VK+++K S K  +  +    E+ +++K  HPN+++    +  +    IV E 
Sbjct: 44  RITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
           +  G+L   + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL   + 
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEK 159

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEIYKNEEFDRSVDAY 378
              +KI  FGL          +      + +          Y+APE+ +   +D   D +
Sbjct: 160 DCDIKIIDFGL----------STCFQQNTKMKDRIGTA--YYIAPEVLR-GTYDEKCDVW 206

Query: 379 SFGLILYEMIEGVQPFHPKPPEEV 402
           S G+ILY ++ G  PF+ K   ++
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDI 230

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           + +G +  +K ++K+  +    +     E+ +++   HPN+++          M IV+E 
Sbjct: 44  RSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101

Query: 267 HAKGDL----ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
              G+L     S   +   LS   V      +   + Y H      ++H DLKP+NIL  
Sbjct: 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQ 158

Query: 323 N---GGQLKISGFGLLRLQYISPEKAKIVF--PVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           +      +KI  FGL  L + S E +               LY+APE++K  +     D 
Sbjct: 159 DTSPHSPIKIIDFGLAEL-FKSDEHSTNAAGTA--------LYMAPEVFK-RDVTFKCDI 208

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVK 404
           +S G+++Y ++ G  PF     EEV +
Sbjct: 209 WSAGVVMYFLLTGCLPFTGTSLEEVQQ 235

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 28/127 (22%), Positives = 43/127 (33%), Gaps = 14/127 (11%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           + +A R G    V  L+  G      +  G TALH+A   G V+  K L S         
Sbjct: 24  IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA---NPREVPEYELNPLELQV 192
             G      A      ++   L     +     + P ++    + REV E   +     V
Sbjct: 84  --GQKPIHLAVMANKTDLVVALVEGAKER---GQMPESLLNECDEREVNEIGSH-----V 133

Query: 193 RKADGIT 199
           +   G T
Sbjct: 134 KHCKGQT 140

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 18/106 (16%), Positives = 33/106 (31%), Gaps = 4/106 (3%)

Query: 73  TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
             + L +             + G+ V    +     +  AA     EV++LL  K   + 
Sbjct: 259 LTKEL-LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVV 317

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
                G+  A   K      V  +  A  A V  +++       V+
Sbjct: 318 RSLNTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSSAVS 363

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 11/121 (9%), Positives = 33/121 (27%), Gaps = 12/121 (9%)

Query: 77  LFMACR-GDVKGVEDLLNE-----GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A    + + ++ +++         ++  +  G + LH A      +V    +    +
Sbjct: 177 LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGID 236

Query: 131 IDARDRWGSTA---AADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNP 187
           ++  D   +     +        V +   L  +                        L+ 
Sbjct: 237 VNMEDNEHTVPLYLSV---RAAMVLLTKELLQKTDVFLIQACPYHNGTTVLPDRVVWLDF 293

Query: 188 L 188
           +
Sbjct: 294 V 294

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 1/89 (1%)

Query: 59  PVQDELTVPENLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
           P  +  TV  +    +  +  A      + ++ L  +  +V      G         +  
Sbjct: 276 PYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAA 335

Query: 118 VEVVKLLLSKKANIDARDRWGSTAAADAK 146
             V ++ L+  A +  R R  + ++A +K
Sbjct: 336 PAVKRMKLAPSAPVRTRSRSRARSSAVSK 364

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 84.5 bits (210), Expect = 5e-18
 Identities = 17/79 (21%), Positives = 33/79 (41%), Gaps = 7/79 (8%)

Query: 97  DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEV 153
           +    D +    +H+AA +G  + V+ L+    +   ++R+G TA   A     +G V+ 
Sbjct: 12  NRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLAC---KFGCVDT 68

Query: 154 YNILKARGAKV-PKTKRTP 171
              L + G        + P
Sbjct: 69  AKYLASVGEVHSLWHGQKP 87

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 83.8 bits (208), Expect = 9e-18
 Identities = 15/99 (15%), Positives = 34/99 (34%), Gaps = 14/99 (14%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL-----SKKANIDARDRWGSTA- 141
           ++ L+  G+   + D    T L  A    + E + L++          +D  ++ G++  
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215

Query: 142 --AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             A         +V       G  V  +      P+ ++
Sbjct: 216 HWAI---LINWEDVAMRFVEMGIDVNMEDNEHTVPLYLS 251

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 18/83 (21%), Positives = 37/83 (44%), Gaps = 7/83 (8%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG--HVEVVKLLLSKKANIDAR 134
             +    D + V ++       +     G+TALH     G  ++E++K+L+   A+  A+
Sbjct: 115 ESLLNECDEREVNEI-----GSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAK 169

Query: 135 DRWGSTAAADAKYYGNVEVYNIL 157
           D+   T    A  + N E  +++
Sbjct: 170 DKADETPLMRAMEFRNREALDLM 192

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 46/243 (18%), Positives = 88/243 (36%), Gaps = 67/243 (27%)

Query: 207 KWNGTKVWVKILDKE--SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
                   +KI++K      +P+ +     E+ +++K  HPN+ +          + +V+
Sbjct: 48  NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107

Query: 265 EYHAKGDLASYLQKKGRLSPSKVL------------------------------------ 288
           E    G L   L      S  K                                      
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167

Query: 289 RFALDLAR----GMNYLHECKPDPIIHCDLKPKNILL--DNGGQLKISGFGLLRLQYISP 342
           +   ++ R     ++YLH      I H D+KP+N L   +   ++K+  FGL        
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGL-------- 216

Query: 343 EKAKIVFPVSHIDPANL--------YVAPEI--YKNEEFDRSVDAYSFGLILYEMIEGVQ 392
             +K  + +++ +   +        +VAPE+    NE +    DA+S G++L+ ++ G  
Sbjct: 217 --SKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274

Query: 393 PFH 395
           PF 
Sbjct: 275 PFP 277

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 12/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V E+  + DL  Y     G L P  V  F   
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L +G+ + H      ++H DLKP+N+L++  G+LK++ FGL R  +  P +       S 
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVR-----CYSA 160

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y  P++ +  + +  S+D +S G I  E+    +P  P
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 40/210 (19%)

Query: 207 KWNGTKVWVKILDK-----ESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPM 260
           +  G +  VKI++         +  E   A   E  I+ + A HP+++  + +   +  M
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            +V +   KG+L  YL +K  LS  +       L   +++LH      I+H DLKP+NIL
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232

Query: 321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEF 371
           LD+  Q+++S FG           +        ++P            Y+APEI K    
Sbjct: 233 LDDNMQIRLSDFGF----------SCH------LEPGEKLRELCGTPGYLAPEILKCSMD 276

Query: 372 ------DRSVDAYSFGLILYEMIEGVQPFH 395
                  + VD ++ G+IL+ ++ G  PF 
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFW 306

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 39/215 (18%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA----VTQNIPMM 261
           +  G K  +K+L         +      E+    + +  P++V  +            ++
Sbjct: 51  RRTGQKCALKLLYD--SPKARQ------EVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102

Query: 262 IVLEYHAKGDLASYLQKKGRLS-----PSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           I++E    G+L S +Q++G  +      ++++R   D+   + +LH      I H D+KP
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMR---DIGTAIQFLHSHN---IAHRDVKP 156

Query: 317 KNILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN--LYVAPEIYKNEEF 371
           +N+L    +    LK++ FG           AK     +   P     YVAPE+   E++
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGF----------AKETTQNALQTPCYTPYYVAPEVLGPEKY 206

Query: 372 DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
           D+S D +S G+I+Y ++ G  PF+    + +   M
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)

Query: 200 KGSY----QVAKWNGTKVW----VKILDKES----HKDPERINAFTHELTIVEKARH-PN 246
            G+Y     V K +G        +K+L K +     K  E       E  ++E  R  P 
Sbjct: 64  TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVLEHIRQSPF 120

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECK 305
           +V    A      + ++L+Y   G+L ++L ++ R +  +V +    ++   + +LH+  
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVGEIVLALEHLHKLG 179

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------ 359
              II+ D+K +NILLD+ G + ++ FGL          +K        + A        
Sbjct: 180 ---IIYRDIKLENILLDSNGHVVLTDFGL----------SKEFVA-DETERAYDFCGTIE 225

Query: 360 YVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM 406
           Y+AP+I +  +   D++VD +S G+++YE++ G  PF     +     +
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 90.4 bits (225), Expect = 9e-20
 Identities = 38/201 (18%), Positives = 81/201 (40%), Gaps = 31/201 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
              G +    I++ +     +       E  I    +HPN+V+   ++++     ++ + 
Sbjct: 33  VLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   +  +   S +        +   + + H+     ++H +LKP+N+LL     
Sbjct: 92  VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLK 148

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL---------YVAPEIYKNEEFDRS 374
           G  +K++ FGL          A  V                    Y++PE+ + + + + 
Sbjct: 149 GAAVKLADFGL----------AIEV-----EGEQQAWFGFAGTPGYLSPEVLRKDPYGKP 193

Query: 375 VDAYSFGLILYEMIEGVQPFH 395
           VD ++ G+ILY ++ G  PF 
Sbjct: 194 VDLWACGVILYILLVGYPPFW 214

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 51/168 (30%), Positives = 92/168 (54%), Gaps = 21/168 (12%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++++++  HPN+V  +  +     + +V E+  K DL   L + K  L  S++  +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA---KIVFP 350
           L RG+ + H+ +   I+H DLKP+N+L+++ G LK++ FGL R  +  P ++   ++V  
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-- 181

Query: 351 VSHIDPANL-YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                   L Y AP++   ++++  SVD +S G I  EMI G +P  P
Sbjct: 182 -------TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFP 221

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 86.7 bits (216), Expect = 1e-19
 Identities = 25/113 (22%), Positives = 49/113 (43%), Gaps = 6/113 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDAR 134
           L +A      +  + L+  G+ V   D   +  LH AA  G +++++LL    K+ ++ +
Sbjct: 111 LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQ 170

Query: 135 DRWGSTAAADAKYYGNVEVYNIL-KARGAKV-PKTK--RTPMTVANPREVPEY 183
           D+ G T    A   G+ +   +L +  GA+             VA   +V ++
Sbjct: 171 DKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNEQVKKF 223

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 86.3 bits (215), Expect = 2e-19
 Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 77  LFMACR-GDVKGVEDLLN--EGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
             +AC  G+++ V+ L +     D+N I   G T LH+A  +   EV + L+   A++  
Sbjct: 76  FHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRI 135

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGA 162
           +D++       A   G++++  +L   G 
Sbjct: 136 KDKFNQIPLHRAASVGSLKLIELLCGLGK 164

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 84.8 bits (211), Expect = 4e-19
 Identities = 31/105 (29%), Positives = 43/105 (40%), Gaps = 10/105 (9%)

Query: 77  LFMACR-GDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI--- 131
           L  AC   +   V++LL ++ S +   D DGR  LH +      E+   LLSK  N+   
Sbjct: 6   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65

Query: 132 DARDRWGSTAAADAKYYGNVEVYNIL--KARGAKV-PKTK--RTP 171
           D  D  G T    A   GN+EV   L  +     +   T    T 
Sbjct: 66  DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTC 110

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 67.9 bits (167), Expect = 3e-13
 Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 7/64 (10%)

Query: 105 GRTALHIAACEGHV-EVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
               LH A  E    +V +LL SK + +  +D+ G      +     +   E+ + L ++
Sbjct: 2   SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSV---SFQAHEITSFLLSK 58

Query: 161 GAKV 164
              V
Sbjct: 59  MENV 62

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 48.6 bits (117), Expect = 1e-06
 Identities = 13/52 (25%), Positives = 22/52 (42%), Gaps = 5/52 (9%)

Query: 77  LFMACR-GDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           LF A   G       L+   G++ + +D  G  A  +A    + +V K  L+
Sbjct: 178 LFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLN 226

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 28/197 (14%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K       +K+L K    D + +     E+ ++ +  HPN+++          + +VLE 
Sbjct: 75  KGTQKPYALKVLKKT--VDKKIVRT---EIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   + +KG  S          +   + YLHE     I+H DLKP+N+L      
Sbjct: 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAP 186

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHID-----PANLYVAPEIYKNEEFDRSVDAY 378
              LKI+ FGL          +KIV     +      P   Y APEI +   +   VD +
Sbjct: 187 DAPLKIADFGL----------SKIVEHQVLMKTVCGTPG--YCAPEILRGCAYGPEVDMW 234

Query: 379 SFGLILYEMIEGVQPFH 395
           S G+I Y ++ G +PF+
Sbjct: 235 SVGIITYILLCGFEPFY 251

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+ ++++  HPN++  + A      + +V ++    DL   +      L+PS +  + L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
             +G+ YLH+     I+H DLKP N+LLD  G LK++ FGL +  + SP +       +H
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNR-----AYTH 171

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y APE+ +    +   VD ++ G IL E++  V PF P
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLP 214

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 47/164 (28%), Positives = 86/164 (52%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++I+++ +H N+V+    +     +++V E+  + DL   L   +G L       F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R  +  P +       +H
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVR-----KYTH 159

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y AP++   ++++  ++D +S G I  EM+ G  P  P
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFP 202

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 53/273 (19%)

Query: 198 ITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIV-EKARHPNVVQFV 251
           +  G+Y QV K      G    +K++D       +       E+ ++ + + H N+  + 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 252 GA------VTQNIPMMIVLEYHAKGDLASYLQ--KKGRLSPSK---VLRFALDLARGMNY 300
           GA         +  + +V+E+   G +   ++  K   L       + R  L   RG+++
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGLSH 144

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY 360
           LH+ K   +IH D+K +N+LL    ++K+  FG+     +     +           N +
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGR----------RNTF 189

Query: 361 V------APEIYKNEEF-----DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
           +      APE+   +E      D   D +S G+   EM EG  P     P   + L+   
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 246

Query: 410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
            + P  ++K++ +    +  IE C       RP
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP 279

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 85.3 bits (212), Expect = 4e-19
 Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 12/98 (12%)

Query: 76  LLFMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI--- 131
           LL  A   DV+ +  LL  EG +V+     G TALHIAA   ++E   +L+     +   
Sbjct: 7   LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66

Query: 132 --DARDRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
              +    G TA   A       NV +   L ARGA V
Sbjct: 67  PMTSELYEGQTALHIAV---INQNVNLVRALLARGASV 101

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 27/109 (24%), Positives = 39/109 (35%), Gaps = 23/109 (21%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLD-------------GRTALHIAACEGHVEVVK 122
           L       +V  V  LL  G+ V++                 G   L  AAC G  E+V+
Sbjct: 79  LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138

Query: 123 LLLSKKANIDARDRWGSTA---AADAKYYGNVEV----YNILKARGAKV 164
           LL+   A+I A+D  G+T            N       YN+L +     
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILI---LQPNKTFACQMYNLLLSYDGGD 184

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 18/103 (17%)

Query: 80  ACRGDVKGVEDLLNEGSDV-----NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           A   +++    L+    ++      S   +G+TALHIA    +V +V+ LL++ A++ AR
Sbjct: 45  ALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSAR 104

Query: 135 DR-------------WGSTAAADAKYYGNVEVYNILKARGAKV 164
                          +G    + A   G+ E+  +L   GA +
Sbjct: 105 ATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADI 147

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 75.7 bits (187), Expect = 7e-16
 Identities = 25/99 (25%), Positives = 38/99 (38%), Gaps = 10/99 (10%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV----KLLLSKKANI 131
           L F AC G  + V  L+  G+D+ + D  G T LHI   + +         LLLS     
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184

Query: 132 DA------RDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
                    +  G T    A   GN+ ++  L  +   +
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHI 223

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 18/67 (26%), Positives = 28/67 (41%), Gaps = 7/67 (10%)

Query: 105 GRTALHIAACEGHVEVV-KLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
             + L +AA E  V+ + KLL  +   +  R   G TA   AA    Y N+E   +L   
Sbjct: 3   WESPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAA---LYDNLEAAMVLMEA 59

Query: 161 GAKVPKT 167
             ++   
Sbjct: 60  APELVFE 66

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 13/164 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY  K DL  YL      ++   V  F   
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           L RG+ Y H  K   ++H DLKP+N+L++  G+LK++ FGL R     P K        +
Sbjct: 109 LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTK-----TYDN 159

Query: 354 IDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                 Y  P+I   + ++   +D +  G I YEM  G +P  P
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFP 202

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 17/168 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++++++ +H N+++    +  N  + ++ EY    DL  Y+ K   +S   +  F   L
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLD-----NGGQLKISGFGLLRLQYISPEKAKIVF 349
             G+N+ H  +    +H DLKP+N+LL          LKI  FGL R  +  P +     
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIR----- 192

Query: 350 PVSHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
             +H      Y  PEI   +  +  SVD +S   I  EM+    P  P
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFP 239

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 82.0 bits (203), Expect = 2e-18
 Identities = 16/102 (15%), Positives = 36/102 (35%), Gaps = 14/102 (13%)

Query: 77  LFMACR-------GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE------VVKL 123
            F   +       G  +  +  L +G+D+ ++    +  +        V+      + KL
Sbjct: 79  FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKL 138

Query: 124 LLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           + S+    +  +D+WG TA    K         +++    K 
Sbjct: 139 IFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 73.6 bits (181), Expect = 2e-15
 Identities = 21/120 (17%), Positives = 40/120 (33%), Gaps = 13/120 (10%)

Query: 69  NLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSI---DLDGRTALHIAACEGHVEVVKLL 124
           N  S  + +  A   G  +   +L  +G +              L     E   ++   L
Sbjct: 2   NAMSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFL 61

Query: 125 LSKKANIDARDRWGSTAAADAKYYGN------VEVYNILKARGAKV-PKTK--RTPMTVA 175
           ++K A+I +R + G+T        G        E+  I   +GA +    K  +  +   
Sbjct: 62  INKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKN 121

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 68.5 bits (168), Expect = 9e-14
 Identities = 9/67 (13%), Positives = 17/67 (25%), Gaps = 7/67 (10%)

Query: 76  LLFMACRGDVKGVED-------LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK 128
           +        V   E            G  +   D  G TAL           +K++    
Sbjct: 118 VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYI 177

Query: 129 ANIDARD 135
              + ++
Sbjct: 178 KKYNLKE 184

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 36/170 (21%), Positives = 69/170 (40%), Gaps = 25/170 (14%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++ +HPN+V  +    +   + +V EY     +   L +  R +    V      
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
             + +N+ H+      IH D+KP+NIL+     +K+  FG  R     P           
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSD-----YYDD 161

Query: 354 IDPANLYV------APEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                  V      +PE+   + ++   VD ++ G +  E++ G  P  P
Sbjct: 162 ------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWP 204

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 26/173 (15%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPSKVL 288
           E++++++ +H N+V+    +     + +V E+    DL  Y+           L  + V 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA--- 345
            F   L +G+ + HE K   I+H DLKP+N+L++  GQLK+  FGL R  +  P      
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSS 167

Query: 346 KIVFPVSHIDPANL-YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
           ++V          L Y AP++   +  +  S+D +S G IL EMI G +P  P
Sbjct: 168 EVV---------TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFP 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 36/176 (20%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP--------MMIVLEY--HAKGDLASYL-QKKGRLS 283
           E+ I++  +H NVV  +                + +V ++  H   DLA  L     + +
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFT 122

Query: 284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
            S++ R    L  G+ Y+H  K   I+H D+K  N+L+   G LK++ FGL R  +   +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA-FSLAK 178

Query: 344 KAKIVFPVSHIDPANL--------YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEG 390
            ++         P           Y  PE+     ++   +D +  G I+ EM   
Sbjct: 179 NSQ---------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 25/170 (14%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++ RH N+V  +    +     +V E+     +   L+     L    V ++   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           +  G+ + H      IIH D+KP+NIL+   G +K+  FG  R    +P +         
Sbjct: 133 IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGE-----VYDD 183

Query: 354 IDPANLYV------APEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
                  V      APE+   + ++ ++VD ++ G ++ EM  G +P  P
Sbjct: 184 ------EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFP 226

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 24/161 (14%)

Query: 240 EKARHPNVVQ----FVGAVTQNIP-MMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFAL 292
           E   HPNVV+       + T     + +V E+  + DL +YL    +  +    +     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK--AKIVFP 350
            L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R  Y       + +V  
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV-- 181

Query: 351 VSHIDPANL-YVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
                   L Y APE+     +   VD +S G I  EM   
Sbjct: 182 -------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 48/161 (29%), Positives = 70/161 (43%), Gaps = 24/161 (14%)

Query: 240 EKARHPNVVQ----FVGAVTQNIP-MMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFAL 292
           E   HPNVV+       + T     + +V E+  + DL +YL       L    +     
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK--AKIVFP 350
              RG+++LH      I+H DLKP+NIL+ +GG +K++ FGL R  Y         +V  
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPVVV-- 181

Query: 351 VSHIDPANL-YVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
                   L Y APE+     +   VD +S G I  EM   
Sbjct: 182 -------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 40/211 (18%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA----VTQNIPMM 261
           K    K  +K+L         R      E+ +  + ++ P++V+ V            ++
Sbjct: 84  KRTQEKFALKMLQD--CPKARR------EVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135

Query: 262 IVLEYHAKGDLASYLQKKGRLS-----PSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           IV+E    G+L S +Q +G  +      S++++    +   + YLH      I H D+KP
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSIN---IAHRDVKP 189

Query: 317 KNILL---DNGGQLKISGFGLLRLQYISPEK--AKIVF-PVSHIDPANLYVAPEIYKNEE 370
           +N+L         LK++ FG  +    +         + P         YVAPE+   E+
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTP--------YYVAPEVLGPEK 239

Query: 371 FDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
           +D+S D +S G+I+Y ++ G  PF+      
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 41/215 (19%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFV 251
           + +G Y          N  KV VKIL     K  +R      E+ I+E  R  PN++   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR------EIKILENLRGGPNIITLA 97

Query: 252 GAVTQNIPMMIVL--EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             V   +     L  E+    D     Q    L+   +  +  ++ + ++Y H      I
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---I 151

Query: 310 IHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV------A 362
           +H D+KP N+++D    +L++  +GL    +  P +             N+ V       
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQ-----------EYNVRVASRYFKG 198

Query: 363 PEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHP 396
           PE+  + + +D S+D +S G +L  MI   +PF  
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 18/87 (20%), Positives = 26/87 (29%), Gaps = 2/87 (2%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD--RW 137
            C   +  +  LL     V  I  +   A  +AA  GH+ V+  L               
Sbjct: 103 GCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAE 162

Query: 138 GSTAAADAKYYGNVEVYNILKARGAKV 164
              A   A   G++ V N L       
Sbjct: 163 NYHAFRLAAENGHLHVLNRLCELAPTE 189

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 17/102 (16%), Positives = 27/102 (26%), Gaps = 12/102 (11%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDL--DGRTALHIAACEGHVEVVKLLLSKKANI 131
             +A       V  +  L           +  +   A  +AA  GH+ V+  L       
Sbjct: 132 FRLAAENGHLHV--LNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTE 189

Query: 132 DARD--RWGSTAA--ADAKYYGNVEVYNILKARGAKVPKTKR 169
                      A   A A   G+  V N L      +   + 
Sbjct: 190 ATAMIQAENYYAFRWA-AVGRGHHNVINFLLDCPVMLAYAEI 230

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 16/106 (15%), Positives = 29/106 (27%), Gaps = 16/106 (15%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDL--DGRTALHIAACE-GHVEVVKLLLSKKAN 130
             +A       V  +  L        +  +  +   A   AA   GH  V+  LL     
Sbjct: 167 FRLAAENGHLHV--LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVM 224

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
           +   +            YG   V   +     ++ K       ++N
Sbjct: 225 LAYAEIHEFE-------YGEKYVNPFIARHVNRL-KEMHDAFKLSN 262

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 13/83 (15%), Positives = 25/83 (30%), Gaps = 9/83 (10%)

Query: 63  ELTVPENLDSTMQLLFMACRGDVKGVEDLL---------NEGSDVNSIDLDGRTALHIAA 113
           +L           +L    R + + + D +            +   +I  D    L +A 
Sbjct: 268 DLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLAL 327

Query: 114 CEGHVEVVKLLLSKKANIDARDR 136
             G+     LLLS  + +     
Sbjct: 328 RLGNQGACALLLSIPSVLALTKA 350

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 20/115 (17%), Positives = 36/115 (31%), Gaps = 11/115 (9%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA---CEGHVEVVKLLL 125
           N++   QLL +      +  + L    SD +   +       +AA   C   ++ + LLL
Sbjct: 59  NMEQVRQLLCLYYAHYNRNAKQLW---SDAHKKGIKSEVICFVAAITGCSSALDTLCLLL 115

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK-----RTPMTVA 175
           +    +         A   A   G++ V N L                     +A
Sbjct: 116 TSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLA 170

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 23/133 (17%), Positives = 45/133 (33%), Gaps = 6/133 (4%)

Query: 24  SLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTV----PENLDSTMQLLFM 79
            + + +      D  +     +F ++     I+  P            E   S  Q   +
Sbjct: 44  KIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHV 103

Query: 80  ACRGDVK-GVEDLLNEGSDVNS-IDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRW 137
           +    ++   +   N   ++N  +D  G T LH      ++E+VK L+   +N    D  
Sbjct: 104 SFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNM 163

Query: 138 GSTAAADAKYYGN 150
           G +    A    N
Sbjct: 164 GESCLVKAVKSVN 176

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 14/57 (24%), Positives = 29/57 (50%)

Query: 85  VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           ++ ++      + +N+ D +G T L+IAA  G++ +V  LL   A+    ++ G   
Sbjct: 263 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 319

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 12/82 (14%), Positives = 29/82 (35%), Gaps = 4/82 (4%)

Query: 87  GVEDLLNEGSDVNSIDLDGRTALHIAA----CEGHVEVVKLLLSKKANIDARDRWGSTAA 142
            +  ++ + +       + + +          +  +E + L       ++A+D  G T  
Sbjct: 228 LMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL 287

Query: 143 ADAKYYGNVEVYNILKARGAKV 164
             A   GN+ + + L   GA  
Sbjct: 288 NIAARLGNISIVDALLDYGADP 309

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 8/81 (9%)

Query: 89  EDLLNEGSDVNSIDLDGRTALHIAACEGHV-EVVKLLLSKKANIDA-RDRWGSTA---AA 143
             L N+ S+ NS            + +  + EV     + + N++   D  G+T      
Sbjct: 80  TSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLT 139

Query: 144 DAKYYGNVEVYNILKARGAKV 164
                 N+E+   L   G+  
Sbjct: 140 ---SIANLELVKHLVKHGSNR 157

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 9/34 (26%), Positives = 16/34 (47%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA 113
           A  G++  V+ LL+ G+D    +  G   +   A
Sbjct: 291 ARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 324

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 16/102 (15%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            L +        ++  +N           G+TALHIA    ++ +V LL+   A++ A  
Sbjct: 74  ALLLDVARKTDSLKQFVNA--SYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAA 131

Query: 136 R--------------WGSTAAADAKYYGNVEVYNILKARGAK 163
                          +G    + A     + +   L     +
Sbjct: 132 NGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 28/136 (20%), Positives = 43/136 (31%), Gaps = 24/136 (17%)

Query: 77  LFMAC-RGDVKGVEDLLN-------EGSDVNSIDLD-GRTALHIAAC---EGHVEVVKLL 124
           +F A  + + + +E LL          +D    D + G+T L  A      G  + + LL
Sbjct: 17  IFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALL 76

Query: 125 LSKKANIDA-----------RDRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTKRTPM 172
           L      D+               G TA   A    N+ +  +L   GA V         
Sbjct: 77  LDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFF 136

Query: 173 TVANPREVPEYELNPL 188
                R    +   PL
Sbjct: 137 KKTKGRPGFYFGELPL 152

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 23/119 (19%)

Query: 76  LLFMACRGDVKGVEDLLNEGS---DVNSIDLDGRTALHIAACEGH--------------- 117
           L   AC   +  V+ LL       D+++ D  G T LH                      
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211

Query: 118 -VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA 175
            + +   L       +  +R G T  A A   G + V   +  R              A
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHE----PECRHAA 266

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 10/63 (15%), Positives = 21/63 (33%), Gaps = 7/63 (11%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
              L          +  G T L +AA  G + V+  +L ++ +              A +
Sbjct: 216 GAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAH 268

Query: 148 YGN 150
           + +
Sbjct: 269 HHH 271

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 15/105 (14%), Positives = 33/105 (31%), Gaps = 13/105 (12%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLL-------SKKANIDARDR-WGSTA---AA 143
            +      L  R ++  A  + + + ++ LL        +  + + +D   G T    A 
Sbjct: 3   SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62

Query: 144 DAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPL 188
              + G  +   +L     K    K+     A+  +        L
Sbjct: 63  LNLHNGQNDTIALLLDVARKTDSLKQ--FVNASYTDSYYKGQTAL 105

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 39/195 (20%)

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDL- 272
           K+  +D    N    EL I+   +HPNVV        N          +VLEY     + 
Sbjct: 70  KKVLQDKRFKN---RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY-VPETVY 125

Query: 273 ---ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLK 328
                Y + K  +    +  +   L R + Y+H      I H D+KP+N+LLD   G LK
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLK 182

Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV------APE-IYKNEEFDRSVDAYSFG 381
           +  FG           AKI+      +P   Y+      APE I+    +  ++D +S G
Sbjct: 183 LIDFGS----------AKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG 229

Query: 382 LILYEMIEGVQPFHP 396
            ++ E+++G QP  P
Sbjct: 230 CVMAELMQG-QPLFP 243

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 45/225 (20%)

Query: 198 ITKGSY-QVA----KWNGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKAR 243
           + +G+Y  V     K  G  V +K           +I  F           E+ I++  +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIK-----------KIEPFDKPLFALRTLREIKILKHFK 67

Query: 244 HPNVVQFVGAVTQNIPMM-----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           H N++        +         I+ E   + DL   +     LS   +  F     R +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDLHRVI-STQMLSDDHIQYFIYQTLRAV 125

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
             LH      +IH DLKP N+L+++   LK+  FGL R+  I    A    P        
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMV 180

Query: 359 LYV------APEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP 396
            +V      APE+   + ++ R++D +S G IL E+    +P  P
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFP 224

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 54/239 (22%), Positives = 90/239 (37%), Gaps = 52/239 (21%)

Query: 198 ITKGSY-QVA----KWNGTKVWVKILDKESHKDPERI-NAFTH---------ELTIVEKA 242
           I +GSY  V     K     V +K           ++   F           E+TI+ + 
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIK-----------KVNRMFEDLIDCKRILREITILNRL 82

Query: 243 RHPNVVQFVGAVT-QNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
           +   +++    +   ++       IVLE  A  DL    +    L+   +     +L  G
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
            N++HE     IIH DLKP N LL+    +K+  FGL R      +   +     + +P 
Sbjct: 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 358 NL----------YV------APEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP 399
                       +V      APE+    E + +S+D +S G I  E++  +Q     P 
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 29/180 (16%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI--VLEYHAKGDLASYL---------QKKGRLS 283
           E+ ++ + +HPNV+        +    +  + +Y A+ DL   +         +K  +L 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126

Query: 284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQY 339
              V      +  G++YLH      ++H DLKP NIL+       G++KI+  G  RL +
Sbjct: 127 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL-F 182

Query: 340 ISPEKAKIVFPVSHIDPANL---YVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFH 395
            SP K     P++ +DP  +   Y APE+      + +++D ++ G I  E++     FH
Sbjct: 183 NSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 59/275 (21%), Positives = 96/275 (34%), Gaps = 62/275 (22%)

Query: 198 ITKGSY-QVAK---WNGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKARH 244
           I+ GSY  V       G  V +K +   +  D   +N  +          E+ ++    H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFN-TVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 245 PNVVQFVGAVT-QNIPMM----IVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGM 298
           PN++           P M    +V E   + DLA  +  ++  +SP  +  F   +  G+
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
           + LHE     ++H DL P NILL +   + I  F L R       K              
Sbjct: 148 HVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH------------ 192

Query: 359 LYV------APEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP--------------- 396
            YV      APE+  + + F + VD +S G ++ EM    +                   
Sbjct: 193 -YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQLNKIVEVV 250

Query: 397 -KPPEEVVKLMCCEGKRPPLKIKARSYPP-DLKEL 429
             P  E V +      R  L+    + P      +
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV 285

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 13/82 (15%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR-------------WGSTA 141
            +        G +ALHIA  +  ++ VKLL+   A++  R               +G   
Sbjct: 80  NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139

Query: 142 AADAKYYGNVEVYNILKARGAK 163
            + A      +V   L     +
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQ 161

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 20/109 (18%), Positives = 32/109 (29%), Gaps = 19/109 (17%)

Query: 76  LLFMACRGDVKGVEDLLNEGS---DVNSIDLDGRTALH----------------IAACEG 116
           L   AC      V  LL        + + D  G T LH                I   +G
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDG 199

Query: 117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP 165
            +++   L       +  +  G T    A   G +E++  +  R     
Sbjct: 200 LLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 70.2 bits (172), Expect = 8e-14
 Identities = 12/54 (22%), Positives = 23/54 (42%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
              G ++    L          +  G T L +AA EG +E+ + +L ++ +  A
Sbjct: 196 MYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAA 249

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 64.4 bits (157), Expect = 9e-12
 Identities = 23/138 (16%), Positives = 36/138 (26%), Gaps = 29/138 (21%)

Query: 77  LFMAC-RGDVKGVEDLL--------NEGSDVNSIDLDGRTALHIAAC---EGHVEVVKLL 124
           LF    RG  + +  LL               +    G+T L  A     +G    +  L
Sbjct: 6   LFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMPL 65

Query: 125 LS-----------KKANIDARDRWGSTA---AADAKYYGNVEVYNILKARGAKVPKTKRT 170
           L              A        G +A   A       +++   +L   GA V      
Sbjct: 66  LQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAI---EKRSLQCVKLLVENGADVHLRACG 122

Query: 171 PMTVANPREVPEYELNPL 188
                +      +   PL
Sbjct: 123 RFFQKHQGTCFYFGELPL 140

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 42.9 bits (101), Expect = 9e-05
 Identities = 15/95 (15%), Positives = 20/95 (21%), Gaps = 13/95 (13%)

Query: 105 GRTALHIAACEGHVEVVKLLLSK--------KANIDARDRWGSTA---AADAKYYGNVEV 153
            R  L      G  E +  LL            +       G T    A      G    
Sbjct: 2   DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61

Query: 154 YNILKARGAKVPKTKRTPMTVANPREVPEYELNPL 188
              L          K  P+  A   +      + L
Sbjct: 62  IMPLLQIDKDSGNPK--PLVNAQCTDEFYQGHSAL 94

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 55/208 (26%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA----VTQNIPMM 261
           K    K  +K+L         R      E+ +  + ++ P++V+ V            ++
Sbjct: 40  KRTQEKFALKMLQD--CPKARR------EVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91

Query: 262 IVLEYHAKGDLASYLQKKGRLSPS-----KVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           IV+E    G+L S +Q +G  + +     ++++    +   + YLH      I H D+KP
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSIN---IAHRDVKP 145

Query: 317 KNILL---DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDR 373
           +N+L         LK++ FG                            A E    E++D+
Sbjct: 146 ENLLYTSKRPNAILKLTDFGF---------------------------AKETTG-EKYDK 177

Query: 374 SVDAYSFGLILYEMIEGVQPFHPKPPEE 401
           S D +S G+I+Y ++ G  PF+      
Sbjct: 178 SCDMWSLGVIMYILLCGYPPFYSNHGLA 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 66/249 (26%), Positives = 101/249 (40%), Gaps = 47/249 (18%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKD 225
           +    VA P + P+    P E+       I  GS+ V   AK   +   V I  K+  +D
Sbjct: 36  KVTTVVATPGQGPDR---PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAI--KKVLQD 90

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDL----ASY 275
               N    EL I+ K  H N+V+       +          +VL+Y     +      Y
Sbjct: 91  KRFKN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY-VPETVYRVARHY 146

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGL 334
            + K  L    V  +   L R + Y+H      I H D+KP+N+LLD +   LK+  FG 
Sbjct: 147 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 203

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYV------APE-IYKNEEFDRSVDAYSFGLILYEM 387
                     AK +      +P   Y+      APE I+   ++  S+D +S G +L E+
Sbjct: 204 ----------AKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 250

Query: 388 IEGVQPFHP 396
           + G QP  P
Sbjct: 251 LLG-QPIFP 258

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 59/297 (19%), Positives = 104/297 (35%), Gaps = 41/297 (13%)

Query: 138 GSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADG 197
           GS+  A A    N    + +     +  + K+   +         +    +  +      
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60

Query: 198 ITKGSY-QVAK----WNGTKVWVKILDK--ESHKDPERINAFTHELTIVEKARHPNVVQF 250
           I  GSY  V +         V +K + +  E   D +RI     E+ I+ +  H +VV+ 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNRLNHDHVVKV 117

Query: 251 VGAVTQNIPMM-----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
           +  V            +VLE  A  D     +    L+   +     +L  G+ Y+H   
Sbjct: 118 LDIVIPKDVEKFDELYVVLEI-ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL------ 359
              I+H DLKP N L++    +K+  FGL R           +      D  NL      
Sbjct: 177 ---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 360 ---------YV------APEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE 400
                    +V      APE+    E +  ++D +S G I  E++  ++       +
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 47/238 (19%), Positives = 89/238 (37%), Gaps = 60/238 (25%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F           EL +++  +H NV+  +   T    +       +V+ +  + DL  
Sbjct: 59  RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDLQK 117

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +    + S  K+      + +G+ Y+H      ++H DLKP N+ ++   +LKI  FGL
Sbjct: 118 IM--GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYV------APEI-YKNEEFDRSVDAYSFGLILYEM 387
            R      E                YV      APE+      ++++VD +S G I+ EM
Sbjct: 173 ARH--ADAEMTG-------------YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217

Query: 388 IEGVQPFHP----------------KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           + G +                     P  E V+ +  +  +  ++   ++   D  +L
Sbjct: 218 LTG-KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL 274

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 16/101 (15%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           + +        + + +N       +   G+TALHIA        V+LL+ K A++ A+ R
Sbjct: 67  ILLDIAEKTGNMREFINS--PFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQAR 124

Query: 137 --------------WGSTAAADAKYYGNVEVYNILKARGAK 163
                         +G    + A       + + L   G K
Sbjct: 125 GRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHK 165

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 24/140 (17%), Positives = 39/140 (27%), Gaps = 30/140 (21%)

Query: 76  LLFMA-CRGDVKG----VEDLLNEGSDVNSIDL----DGRTALHIAA---CEGHVEVVKL 123
           +LF    RG   G    +  LL     +   +      G+T L  A      G  + + +
Sbjct: 8   ILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPI 67

Query: 124 LLSK-----------KANIDARDRWGSTA---AADAKYYGNVEVYNILKARGAKVP-KTK 168
           LL              +        G TA   A             +L  +GA V  + +
Sbjct: 68  LLDIAEKTGNMREFINSPFRDVYYRGQTALHIAI---ERRCKHYVELLVEKGADVHAQAR 124

Query: 169 RTPMTVANPREVPEYELNPL 188
                  +      +   PL
Sbjct: 125 GRFFQPKDEGGYFYFGELPL 144

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 22/115 (19%), Positives = 32/115 (27%), Gaps = 25/115 (21%)

Query: 76  LLFMACRGDVKGVEDLLNEGS---DVNSIDLDGRTALHIAACEGH---------VEVVKL 123
           L   AC      V  L   G    D+   D  G T LH                 ++  L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203

Query: 124 LLSKKANIDA-------RDRWGSTA---AADAKYYGNVEVYNILKARGAKVPKTK 168
           LL K A +          +  G +    AA     G + ++  +  R        
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAA---KTGKIGIFQHIIRREIADAAAH 255

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 16/95 (16%), Positives = 26/95 (27%), Gaps = 13/95 (13%)

Query: 105 GRTALHIAA----CEGHVEVVKLLLSKKANIDARDRW----GSTA---AADAKYYGNVEV 153
            R  L         +G   ++  LL+ K  +   +      G T    A      G  + 
Sbjct: 5   NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64

Query: 154 YNILKARGAKVPKTKRTPMTVANPREVPEYELNPL 188
             IL     K    +      +  R+V       L
Sbjct: 65  IPILLDIAEKTGNMR--EFINSPFRDVYYRGQTAL 97

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 54/262 (20%), Positives = 104/262 (39%), Gaps = 57/262 (21%)

Query: 161 GAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQV---AKWNGTKVWV-- 215
           G+ +           + +E+  +++     ++       +G++      K   T + V  
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQV----ERM-----AGQGTFGTVQLGKEKSTGMSVAI 53

Query: 216 -KILDKESHKDPERINAFTHELTIVEKARHPNVVQ---FVGAVTQNIP----MMIVLEY- 266
            K++     ++ E        +  +    HPN+VQ   +   + +       + +V+EY 
Sbjct: 54  KKVIQDPRFRNRE-----LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108

Query: 267 ----HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
               H      +Y +++    P  +  F   L R +  LH    + + H D+KP N+L++
Sbjct: 109 PDTLHRC--CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVN 165

Query: 323 NG-GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV------APE-IYKNEEFDRS 374
              G LK+  FG           AK + P    +P   Y+      APE I+ N+ +  +
Sbjct: 166 EADGTLKLCDFGS----------AKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTA 212

Query: 375 VDAYSFGLILYEMIEGVQPFHP 396
           VD +S G I  EM+ G +P   
Sbjct: 213 VDIWSVGCIFAEMMLG-EPIFR 233

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 28/176 (15%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F +         EL +++   H N++  +   T    +       IV+E     +L  
Sbjct: 60  RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQ 118

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +Q +  L   ++      +  G+ +LH      IIH DLKP NI++ +   LKI  FGL
Sbjct: 119 VIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
            R    S      V           Y APE+     +  +VD +S G I+ EMI+G
Sbjct: 174 ARTAGTSFMMTPYV-------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 52/238 (21%), Positives = 87/238 (36%), Gaps = 59/238 (24%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F           EL +++  RH NV+  +   T +  +       +V+ +    DL  
Sbjct: 60  RPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDLGK 118

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            + K  +L   ++      + +G+ Y+H      IIH DLKP N+ ++   +LKI  FGL
Sbjct: 119 LM-KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYV------APEI-YKNEEFDRSVDAYSFGLILYEM 387
            R      E                YV      APE+      + ++VD +S G I+ EM
Sbjct: 175 ARQ--ADSEMTG-------------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

Query: 388 IEGVQPFHP----------------KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
           I G +                     PP E V+ +  +  +  +K        D   +
Sbjct: 220 ITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 63/258 (24%), Positives = 95/258 (36%), Gaps = 63/258 (24%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKARHPNVVQFVGAVTQNIP 259
           N  +V +K           +I+ F H         E+ I+ + RH N++     +     
Sbjct: 51  NKVRVAIK-----------KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99

Query: 260 MM-----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                  IV +   + DL   L K   LS   +  F   + RG+ Y+H      ++H DL
Sbjct: 100 EQMKDVYIVQDL-METDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDL 154

Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYV------APEIYKN 368
           KP N+LL+    LKI  FGL R+    P+     F          YV      APEI  N
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTE-------YVATRWYRAPEIMLN 205

Query: 369 -EEFDRSVDAYSFGLILYEMIEGVQPFHP----------------KPPEEVVKLMCCEGK 411
            + + +S+D +S G IL EM+   +P  P                 P +E +  +     
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264

Query: 412 RPPLKIKARSYPPDLKEL 429
           R  L             L
Sbjct: 265 RNYLLSLPHKNKVPWNRL 282

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 22/80 (27%), Positives = 40/80 (50%)

Query: 79  MACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           +A +  +  V+ ++  G  +++   DG TALH AA     + +KLLL  +A +   +  G
Sbjct: 200 VANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAG 259

Query: 139 STAAADAKYYGNVEVYNILK 158
            TA   A+   + E   +L+
Sbjct: 260 ETALDIARKKHHKECEELLE 279

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 12/107 (11%)

Query: 81  CRGDVKGVEDLLNEGSDVNSIDL------DGRTALHIA---ACEGHVEVVKLLLSKKANI 131
           C  D+  V +    G D                 LH+A   A +  + +V  ++    ++
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           DA+   G+TA   A  Y   +   +L    A V    +   T + +A
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIA 266

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A        ++ LL   + V +++  G TAL IA  + H E  +LL   +A 
Sbjct: 230 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAG 284

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 4/86 (4%)

Query: 76  LLFMACR----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
            L +A R      +  V+ L+    +++     G TALH      + E +KLLL  KA+I
Sbjct: 172 ALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231

Query: 132 DARDRWGSTAAADAKYYGNVEVYNIL 157
           +  +  G T    AK   +     +L
Sbjct: 232 EIANESGETPLDIAKRLKHEHCEELL 257

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 12/107 (11%)

Query: 81  CRGDVKGVEDLLNEGSDVNSI------DLDGRTALHIAACEG---HVEVVKLLLSKKANI 131
              D+ G+     +G D+              TALH+A        + +V  L+    N+
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           D +   GSTA        N E   +L    A +    ++  TP+ +A
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 245

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 12/55 (21%), Positives = 21/55 (38%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L   C   + + ++ LL   + +   +  G T L IA    H    +LL    + 
Sbjct: 209 LHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSG 263

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 38/218 (17%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++  +H NV+  +   T    +       +V       DL + ++ + +L+   V 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQ-KLTDDHVQ 135

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV 348
                + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R    + E    V
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYV 190

Query: 349 FPVSHIDPANLYVAPEI-YKNEEFDRSVDAYSFGLILYEMIEGVQPFHP----------- 396
                      Y APEI      ++++VD +S G I+ E++ G +   P           
Sbjct: 191 -------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLI 242

Query: 397 -----KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKEL 429
                 P  E++K +  E  R  ++   +    +   +
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 28/176 (15%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F +         EL +++   H N++  +   T    +       +V+E     +L  
Sbjct: 97  RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQ 155

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +Q +  L   ++      +  G+ +LH      IIH DLKP NI++ +   LKI  FGL
Sbjct: 156 VIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
            R    S      V           Y APE+     +  +VD +S G I+ EM+  
Sbjct: 211 ARTAGTSFMMTPYV-------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 68.7 bits (167), Expect = 8e-13
 Identities = 36/152 (23%), Positives = 51/152 (33%), Gaps = 1/152 (0%)

Query: 8   LKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVP 67
           +    S +   GSLR           S  P     R S    S            ++   
Sbjct: 170 VPPKPSIRPRPGSLRSKPEPPSEDLGSLHPGALLFRASGHPPSLPTMADALAHGADVNWV 229

Query: 68  ENLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
                    L  A     +   E LL  G++VN  D  GR  LH A   GH  +  L L 
Sbjct: 230 NGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLK 289

Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILK 158
           + A++ ARD  G      A    N ++  +L+
Sbjct: 290 RGADLGARDSEGRDPLTIAMETANADIVTLLR 321

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 31/176 (17%), Positives = 52/176 (29%), Gaps = 8/176 (4%)

Query: 14  RQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDST 73
           ++F T        R    +    P           +     +R  P      +       
Sbjct: 145 KKFLTKLPEIRGRRGGRGRPRGQPPVPP---KPSIRPRPGSLRSKPEPPSEDLGSLHPGA 201

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSI--DLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           +          +  + D L  G+DVN +    D  T L  A     +   + LL   AN+
Sbjct: 202 LLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANV 261

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAK---VPKTKRTPMTVANPREVPEYE 184
           +  D  G      A   G+  +  +   RGA         R P+T+A      +  
Sbjct: 262 NQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIV 317

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 36/159 (22%), Positives = 60/159 (37%), Gaps = 44/159 (27%)

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
           + + YLH      ++H D+KP NILL+    +K++ FGL R           +    + +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 356 PANL---------YV------APEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHP--- 396
             N          YV      APEI     ++ + +D +S G IL E++ G +P  P   
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSS 235

Query: 397 -------------KPPEEVVKLMCCEGKRPPLKIKARSY 422
                         P  E V+ +            A++ 
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSP--------FAKTM 266

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 45/220 (20%), Positives = 83/220 (37%), Gaps = 44/220 (20%)

Query: 198 ITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           +  G    V          +V +K +     +  +       E+ I+ +  H N+V+   
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLDHDNIVKVFE 75

Query: 253 AVTQNIPMM--------------IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
            +  +   +              IV EY  + DLA+ L ++G L       F   L RG+
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVL-EQGPLLEEHARLFMYQLLRGL 133

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
            Y+H      ++H DLKP N+ ++     LKI  FGL R+          +         
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE------- 183

Query: 358 NLYV------APEIYKN-EEFDRSVDAYSFGLILYEMIEG 390
              +      +P +  +   + +++D ++ G I  EM+ G
Sbjct: 184 --GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 44/217 (20%), Positives = 84/217 (38%), Gaps = 61/217 (28%)

Query: 262 IVLEY-----HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +++EY     H    L S+++    +  + +  +   L R + ++H      I H D+KP
Sbjct: 115 VIMEYVPDTLHKV--LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKP 169

Query: 317 KNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL-YV------APE-IYK 367
           +N+L++     LK+  FG           AK + P       ++ Y+      APE +  
Sbjct: 170 QNLLVNSKDNTLKLCDFGS----------AKKLIP----SEPSVAYICSRFYRAPELMLG 215

Query: 368 NEEFDRSVDAYSFGLILYEMIEGVQPFHP----------------KPPEEVVKLMCCEGK 411
             E+  S+D +S G +  E+I G +P                    P +E +  M     
Sbjct: 216 ATEYTPSIDLWSIGCVFGELILG-KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT 274

Query: 412 RPPL-KIKARSY--------PPDLKELIEEC--WDPK 437
                 +KA+ +        P    +L+E+   ++P 
Sbjct: 275 EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 39/128 (30%), Positives = 57/128 (44%), Gaps = 25/128 (19%)

Query: 276 LQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKIS 330
           L KK +    S   V +FA  + + ++ LH+ +   IIHCDLKP+NILL   G   +K+ 
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI 244

Query: 331 GFGL--LRLQYISPEKAKIV--FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
            FG      Q +      I   F          Y APE+     +   +D +S G IL E
Sbjct: 245 DFGSSCYEHQRVYTY---IQSRF----------YRAPEVILGARYGMPIDMWSLGCILAE 291

Query: 387 MIEGVQPF 394
           ++ G    
Sbjct: 292 LLTGYPLL 299

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 29/138 (21%), Positives = 50/138 (36%), Gaps = 31/138 (22%)

Query: 280 GRLSPSKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQ------LKISGF 332
             +    V + +  L  G++Y+H  C    IIH D+KP+N+L++          +KI+  
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADL 182

Query: 333 GL------LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           G            I                   Y +PE+     +    D +S   +++E
Sbjct: 183 GNACWYDEHYTNSIQT---------------REYRSPEVLLGAPWGCGADIWSTACLIFE 227

Query: 387 MIEGVQPFHPKPPEEVVK 404
           +I G   F P       K
Sbjct: 228 LITGDFLFEPDEGHSYTK 245

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 22/80 (27%), Positives = 40/80 (50%)

Query: 79  MACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           +A +  +  V+ ++  G  +++   DG TALH AA     + +KLLL  +A +   +  G
Sbjct: 181 VANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAG 240

Query: 139 STAAADAKYYGNVEVYNILK 158
            TA   A+   + E   +L+
Sbjct: 241 ETALDIARKKHHKECEELLE 260

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 23/118 (19%), Positives = 41/118 (34%), Gaps = 12/118 (10%)

Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNS------IDLDGRTALHIA---ACEGHVEVV 121
               +L    C  D+  V +    G D                 LH+A   A +  + +V
Sbjct: 131 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLV 190

Query: 122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN 176
             ++    ++DA+   G+TA   A  Y   +   +L    A V    +   T + +A 
Sbjct: 191 DFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIAR 248

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 16/113 (14%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKISGFG--LLRL 337
           +S +   +FA  +   + +L   +   IIHCDLKP+NILL N     +KI  FG      
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212

Query: 338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG 390
           Q I        +  S       Y +PE+     +D ++D +S G IL EM  G
Sbjct: 213 QRIYQ------YIQSR-----FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 29/123 (23%), Positives = 42/123 (34%), Gaps = 21/123 (17%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
                V   A  L   + +LHE +   + H DLKP+NIL  N     +        +  S
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC-EEKS 175

Query: 342 PEKAKI--------VFPVSHIDPANLYV------APEIYKNEEFDRSVDAYSFGLILYEM 387
            +   I         F   H       V       PE+     + +  D +S G IL+E 
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTT---IVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232

Query: 388 IEG 390
             G
Sbjct: 233 YRG 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 25/128 (19%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI-----SGFGLLR 336
                +  + +++ + +NYL +     + H DLKP+NILLD+    K            +
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190

Query: 337 LQYISPEKAKI--------VFPVSHIDPANLYV------APEIYKNEEFDRSVDAYSFGL 382
           +Q    +   I         F   +       +      APE+  N  +D S D +SFG 
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGS---IINTRQYRAPEVILNLGWDVSSDMWSFGC 247

Query: 383 ILYEMIEG 390
           +L E+  G
Sbjct: 248 VLAELYTG 255

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 28/119 (23%), Positives = 46/119 (38%), Gaps = 13/119 (10%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
                + + A  + + +N+LH  K   + H DLKP+NIL       +     + R +   
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171

Query: 342 PEKA-KIV-FPVSHIDPANLYV--------APEIYKNEEFDRSVDAYSFGLILYEMIEG 390
                K+V F  +  D  +           APE+     + +  D +S G IL E   G
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 33/163 (20%), Positives = 52/163 (31%), Gaps = 44/163 (26%)

Query: 280 GRLSPSKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
             L    V +    + +G++YLH +C+   IIH D+KP+NILL    Q            
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEW 197

Query: 339 YISPEKAKIVFPVSH------------IDPANL--------------------------- 359
             S         VS             ++P N                            
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR 257

Query: 360 -YVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
            Y + E+     ++   D +S   + +E+  G   F P   EE
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 4e-07
 Identities = 68/507 (13%), Positives = 143/507 (28%), Gaps = 146/507 (28%)

Query: 40  NNMRFSFGRQ----SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG 95
           ++M F  G        +  +      D     +  D    +L        + ++ ++   
Sbjct: 5   HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSIL------SKEEIDHIIMSK 58

Query: 96  SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYN 155
             V+         L         E+V+  + +   I+ +           +      +Y 
Sbjct: 59  DAVSGTLR-----LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113

Query: 156 ILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGIT----KGS--------- 202
             + R     +       V   R  P  +L    L++R A  +      GS         
Sbjct: 114 EQRDRLYNDNQ-VFAKYNV--SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170

Query: 203 ---YQVAKWNGTKV-WVKI-------------------LDKE-------SHKDPERINAF 232
              Y+V      K+ W+ +                   +D         S     RI++ 
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230

Query: 233 THEL-TIVEKARHPNV------VQ-------F-VGA----VTQNIPMMIVLEYHAKGDLA 273
             EL  +++   + N       VQ       F +       T+   +   L       ++
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 274 SYLQKKGRLSPSKVLR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
                   L+P +V             YL +C+P      DL P+ +L       ++S  
Sbjct: 291 LDHHSMT-LTPDEVKSLLL-------KYL-DCRPQ-----DL-PREVL--TTNPRRLSII 333

Query: 333 GLL---------RLQYISPEKAKIVFPVS--HIDPA---NLYVAPEIYKNEEFDRSVD-- 376
                         ++++ +K   +   S   ++PA    ++    +     F  S    
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV-----FPPSAHIP 388

Query: 377 AYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG---KRPP--------LKIKARSYPPD 425
                LI +++I+            VV  +       K+P         + ++ +    +
Sbjct: 389 TILLSLIWFDVIKSD-------VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLEN 441

Query: 426 LKEL---------IEECWDPKPVIRPN 443
              L         I + +D   +I P 
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPY 468

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 2e-05
 Identities = 63/425 (14%), Positives = 118/425 (27%), Gaps = 140/425 (32%)

Query: 19  GSLRRSLTRQMSRQSSFDPRRNNMRF--SFGRQSS--------------LDPIRRSPVQD 62
           GS +  +   +        + +   F  +    +S              +DP   S    
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 63  ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNS-IDLDG-RTALHIAA----CEG 116
              +   + S    L             LL      N  + L   + A    A    C  
Sbjct: 220 SSNIKLRIHSIQAEL-----------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-- 266

Query: 117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
                K+LL+       R +   T    A    ++ + +          + K   +   +
Sbjct: 267 -----KILLT------TRFK-QVTDFLSAATTTHISLDHHSM--TLTPDEVKSLLLKYLD 312

Query: 177 ------PREVPEYELNPLELQV---RKADGITKGSYQVAKWNGTKVWVKI-LDKESHK-- 224
                 PREV     NP  L +      DG+       A W+    W  +  DK +    
Sbjct: 313 CRPQDLPREVLT--TNPRRLSIIAESIRDGL-------ATWDN---WKHVNCDKLTTIIE 360

Query: 225 ------DPERINAFTHELTIVEKARH--PNVVQFV-GAVTQNIPMMIVLEYHAKGDLASY 275
                 +P         L++   + H    ++  +   V ++  M++V + H      S 
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY----SL 416

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           ++K                      +        I+ +LK K   L+N   L        
Sbjct: 417 VEK--------------QPKESTISIPS------IYLELKVK---LENEYALH------- 446

Query: 336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILY-----EMIE 389
                      IV         + Y  P+ + +++     +D Y +  I +     E  E
Sbjct: 447 ---------RSIV---------DHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488

Query: 390 GVQPF 394
            +  F
Sbjct: 489 RMTLF 493

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 20/76 (26%), Positives = 35/76 (46%), Gaps = 6/76 (7%)

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLK 328
           DL     + G    S VL+  + +   + Y+HE +    +H D+K  N+LL   N  Q+ 
Sbjct: 137 DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVY 193

Query: 329 ISGFGLLRLQYISPEK 344
           ++ +GL   +Y     
Sbjct: 194 LADYGLSY-RYCPNGN 208

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 21/80 (26%), Positives = 30/80 (37%), Gaps = 8/80 (10%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQ 326
            L        R  S   VL  A  +   + Y+H       IH D+KP N L+     G  
Sbjct: 90  SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNL 146

Query: 327 LKISGFGLLRLQYISPEKAK 346
           + I  FGL + +Y      +
Sbjct: 147 VYIIDFGLAK-KYRDARTHQ 165

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 21/79 (26%), Positives = 37/79 (46%), Gaps = 7/79 (8%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQL 327
           DL    +   +  S   VL+ +L +   + Y+HE +    +H D+K  N+LL+  N  Q+
Sbjct: 137 DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQV 193

Query: 328 KISGFGLLRLQYISPEKAK 346
            +  +GL   +Y      K
Sbjct: 194 YLVDYGLAY-RYCPEGVHK 211

>3uo9_A Glutaminase kidney isoform, mitochondrial; hydrolase-hydrolase inhibitor complex; HET: 04A; 2.30A {Homo sapiens} PDB: 3unw_A* 3ss3_A 3ss4_A 3ss5_A* Length = 534

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 12/95 (12%), Positives = 31/95 (32%), Gaps = 17/95 (17%)

Query: 23  RSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR 82
             L    +   ++D  R+  +        LDP R           +   S   L + + +
Sbjct: 449 HDLVSLCNF-HNYDNLRHFAK-------KLDPRREGG--------DQRHSFGPLDYESLQ 492

Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
            ++  +++ + +     S +    T ++     G 
Sbjct: 493 QEL-ALKETVWKKVSPESNEDISTTVVYRMESLGE 526

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 27/90 (30%), Positives = 36/90 (40%), Gaps = 16/90 (17%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK- 328
            L        R  S   VL  A+ L   M Y+H      +I+ D+KP+N L+   G    
Sbjct: 90  SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQ 146

Query: 329 ----ISGFGLLRLQYISPEKAKIVFPVSHI 354
               I  F L + +YI PE  K      HI
Sbjct: 147 QVIHIIDFALAK-EYIDPETKK------HI 169

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 16/90 (17%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---- 325
            L   L   GR  S   V   A  +   +  +HE     +++ D+KP N L+        
Sbjct: 91  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNA 147

Query: 326 -QLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             + +  FG+++  Y  P   +      HI
Sbjct: 148 NMIYVVDFGMVK-FYRDPVTKQ------HI 170

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 23/90 (25%), Positives = 34/90 (37%), Gaps = 14/90 (15%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---Q 326
            L        R LS   VL  A  +   + ++H       +H D+KP N L+  G    Q
Sbjct: 88  SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQ 144

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           + I  FGL + +Y      +      HI  
Sbjct: 145 VYIIDFGLAK-KYRDTSTHQ------HIPY 167

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.0 bits (95), Expect = 6e-04
 Identities = 41/255 (16%), Positives = 69/255 (27%), Gaps = 60/255 (23%)

Query: 198 ITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFT--------------HELTIVE 240
           I +G + +V     + T V +KI+  E        +  T                L+   
Sbjct: 28  IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87

Query: 241 KARHPNVVQFVGA--VTQNIP----------------------------MMIVLEY-HAK 269
             R    +       V  + P                            + IVLE+    
Sbjct: 88  CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
            DL     K    S +        L   +            H DL   N+LL      K+
Sbjct: 148 IDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKL 203

Query: 330 SGFGLLRLQYISPEKAKIV----FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFG---L 382
                 +   I P     V    + +S ++   + V  ++  +E+       Y F    L
Sbjct: 204 HYTLNGKSSTI-PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262

Query: 383 ILYEMIEGVQPFHPK 397
           +  E       +HP 
Sbjct: 263 MKKENNNRWGEYHPY 277

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 19/68 (27%), Positives = 33/68 (48%), Gaps = 7/68 (10%)

Query: 271 DLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            L S L    +  LS   VL+ A  L   + +LHE +    +H ++  +NI +D   Q +
Sbjct: 143 SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQ 199

Query: 329 I--SGFGL 334
           +  +G+G 
Sbjct: 200 VTLAGYGF 207

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	473
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.94
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.91
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.91
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.91
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.91
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.9
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.9
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.9
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.9
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.9
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.9
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.89
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.89
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.89
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.89
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.89
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.89
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.88
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.88
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.88
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.88
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.88
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.88
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.88
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.87
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.87
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.87
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.87
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.87
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.87
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.87
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.87
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.87
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.87
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.87
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.87
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.87
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.87
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.87
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.87
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.87
2rfa_A	232	Transient receptor potential cation channel subfa	99.87
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.86
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.86
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.86
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.86
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.86
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.86
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.86
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.86
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.86
2etb_A	256	Transient receptor potential cation channel subfam	99.86
2rfa_A	232	Transient receptor potential cation channel subfa	99.85
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.85
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.85
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.85
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.85
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.85
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.85
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.85
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.85
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.85
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.85
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.84
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.84
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.84
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.84
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.84
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.84
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.84
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.84
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.84
2pnn_A	273	Transient receptor potential cation channel subfa	99.84
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.84
2etb_A	256	Transient receptor potential cation channel subfam	99.84
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.83
2pnn_A	273	Transient receptor potential cation channel subfa	99.83
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.83
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.83
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.83
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.83
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.83
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.83
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.83
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.83
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.83
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.82
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.82
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.82
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.82
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.82
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.82
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.82
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.82
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.81
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.81
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.8
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.8
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.8
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.8
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.79
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.78
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.75
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.75
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.73
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.73
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.72
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.69
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.68
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.68
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.61
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.56
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.01
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.94
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.35
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.84
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.67
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.65
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.58
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.52
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.29
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.2
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.59
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.4
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.38
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.36
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.26
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.06
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.87
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.52
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	85.99
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.08
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.25

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-55  Score=429.58  Aligned_cols=267  Identities=23%  Similarity=0.344  Sum_probs=223.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|...+.||+|+||.|     ..+|+.||||+++.+..        ..+|+.+++.++|||||+++++|.+++.+|||||
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5677788999999866     35689999999986543        2469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+||+|.+++...+.+++..++.++.||+.||+|||+++   ||||||||+|||++.+| .+||+|||+|+........
T Consensus       131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            9999999999998889999999999999999999999999   99999999999999987 6999999999876433211


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                      . .........||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..++...+....  ++....+..+|+
T Consensus       208 ~-~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~s~  284 (336)
T 4g3f_A          208 K-SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PPIREIPPSCAP  284 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CGGGGSCTTSCH
T ss_pred             c-ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CCchhcCccCCH
Confidence            1 1112234579999999999999999999999999999999999999999888777777764432  223334678999


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC-ccccccccCC
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ-GWWKDTFKLP  471 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~-~~~~~~~~~~  471 (473)
                      .+.+||.+||+.||.+|||+.|++++|.........- -=|...++-|
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            9999999999999999999999999999998875531 2255666665

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-56  Score=428.14  Aligned_cols=248  Identities=21%  Similarity=0.369  Sum_probs=217.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++.+.........+.+.+|+++++.++|||||+++++|.+++.+|||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999976     35689999999975432222335779999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|.+++.+.+.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+........ 
T Consensus       113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~-  188 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-  188 (311)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC-
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc-
Confidence            9999999999999889999999999999999999999999   999999999999999999999999999876432211 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                         .......||+.|||||++.+..|+.++||||+||++|+|++|..||.+.+..++...+......     .|..+|++
T Consensus       189 ---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----~p~~~s~~  260 (311)
T 4aw0_A          189 ---ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD-----FPEKFFPK  260 (311)
T ss_dssp             ---CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----CCTTCCHH
T ss_pred             ---ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----CCcccCHH
Confidence               1234567999999999999999999999999999999999999999999998888888654322     24578999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||++||..||++|||++|++.+
T Consensus       261 ~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          261 ARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             HHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             HHHHHHHHccCCHhHCcChHHHcCC
Confidence            9999999999999999999997654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.4e-55  Score=420.24  Aligned_cols=253  Identities=26%  Similarity=0.459  Sum_probs=217.0

Q ss_pred             HhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +|.+.+.||+|+||.|.          .++..||||+++..   .....+.|.+|+++|++++|||||++++++.+++.+
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            56677899999998652          24678999999753   456678899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcE
Q 011991          261 MIVLEYHAKGDLASYLQKK-------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~v  327 (473)
                      |||||||++|+|.++|...             ..+++..++.++.||+.||+|||+++   ||||||||+|||++.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            9999999999999999764             25899999999999999999999999   9999999999999999999


Q ss_pred             EEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011991          328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLM  406 (473)
Q Consensus       328 kl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i  406 (473)
                      ||+|||+|+........    .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+
T Consensus       168 Ki~DFGla~~~~~~~~~----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             EECCCSCHHHHTGGGCE----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             EECCcccceecCCCCce----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999865432211    11223458899999999999999999999999999999998 89999999998888887


Q ss_pred             HhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .. +..++   .|..+|+++.+||.+||+.||++|||++||++.|+++.+.
T Consensus       244 ~~-~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 TQ-GRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HH-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Hc-CCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            54 44433   2667899999999999999999999999999999998765

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.1e-55  Score=427.60  Aligned_cols=246  Identities=23%  Similarity=0.454  Sum_probs=210.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++..... .....+.+.+|+++++.++|||||+++++|.+++.+|||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5888899999999865     34689999999987654 45567889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+||+|.++|...  ..+++..++.|+.||+.||+|||++|   ||||||||+|||++.++.+||+|||+|+.......
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999764  34789999999999999999999999   99999999999999999999999999986543211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+.... .++   .+..+|
T Consensus       181 ------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~---~~~~~s  250 (350)
T 4b9d_A          181 ------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPP---VSLHYS  250 (350)
T ss_dssp             ------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCC---CCTTSC
T ss_pred             ------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCC---CCccCC
Confidence                  1123459999999999999999999999999999999999999999999988888885543 332   256789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +++.+||.+||..||++|||++|+++|
T Consensus       251 ~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          251 YDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-54  Score=415.12  Aligned_cols=266  Identities=28%  Similarity=0.475  Sum_probs=215.9

Q ss_pred             cccChhHHHhhccCceeeeEEEEEE--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          183 YELNPLELQVRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       183 ~~i~~~~~~~~~~~~ig~G~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      |+++..  ++.+.+.||+|+||.|.  .....||||+++... ......+.|.+|++++++++|||||++++++.. +.+
T Consensus        31 Wei~~~--~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           31 WEIEAS--EVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CBCCTT--SCCEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cEEcHH--HeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            455443  35567789999998663  234579999997544 346677899999999999999999999998754 568


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      +||||||+||+|.+++... +.+++..+..|+.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+...
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999999999764 56999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC-CCCCC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG-KRPPL  415 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~  415 (473)
                      .....    .......||+.|||||++.+   .+|+.++|||||||++|||++|+.||.+.+.......+...+ ..|..
T Consensus       184 ~~~~~----~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          184 RWSGS----QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             cCCcc----eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            32111    12344579999999999853   468999999999999999999999999877665555444444 34444


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ...+..+|+.+.+||.+||+.||++|||+.||+++|+.+...++
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            44567889999999999999999999999999999998876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.5e-54  Score=420.36  Aligned_cols=253  Identities=26%  Similarity=0.465  Sum_probs=212.6

Q ss_pred             HhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ++.+.+.||+|+||.|.          .++..||||+++..   .....+.|.+|+++|++++|||||+++++|.+++.+
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45667789999999763          24788999999743   456678899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC
Q 011991          261 MIVLEYHAKGDLASYLQKK---------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~  325 (473)
                      |||||||++|+|.+++...               +.+++..++.|+.|++.||+|||+++   ||||||||+|||++.++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            9999999999999999753               34899999999999999999999999   99999999999999999


Q ss_pred             cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011991          326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVK  404 (473)
Q Consensus       326 ~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  404 (473)
                      .+||+|||+|+.......    ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++..
T Consensus       196 ~~Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             EEEECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             cEEEcccccceeccCCCc----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999986543221    111234568999999999999999999999999999999998 899999999988888


Q ss_pred             HHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       405 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .+.. +.+++.   |..+|+++.+|+.+||+.||++|||++||+++|+.+...
T Consensus       272 ~i~~-g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CITQ-GRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHH-TCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHc-CCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            7744 444433   567899999999999999999999999999999998765

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-54  Score=412.13  Aligned_cols=244  Identities=25%  Similarity=0.414  Sum_probs=201.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++.+.........+.+.+|+++++.++|||||++++++.+++.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            6888899999999865     34689999999987665555666789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      || +|+|.+++.+.+.+++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+|+......   
T Consensus        94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---  166 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---  166 (275)
T ss_dssp             CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---
Confidence            99 6799999999889999999999999999999999999   9999999999999999999999999997653321   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......||+.|||||++.+..| +.++||||+||++|+|++|..||.+.+..+....+.....  .   .+..+|+
T Consensus       167 ----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--~---~p~~~s~  237 (275)
T 3hyh_A          167 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--T---LPKFLSP  237 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--C---CCTTSCH
T ss_pred             ----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--C---CCCCCCH
Confidence                1234579999999999998876 5899999999999999999999999888888877754332  1   2567899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.+||++||+.||++|||++|+++|
T Consensus       238 ~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          238 GAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHcC
Confidence            99999999999999999999999884

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-54  Score=422.50  Aligned_cols=245  Identities=23%  Similarity=0.408  Sum_probs=213.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|...+.||+|+||.|     ..+|+.||||++.......   .+.+.+|+++|+.++|||||+++++|.+++.+|||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4778889999999866     3468999999997654332   3568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|.+++... .+++..++.++.||+.||+|||++|   ||||||||+|||++.++.+||+|||+|+.......  
T Consensus       152 y~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          152 FLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             CCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            99999999999764 6999999999999999999999999   99999999999999999999999999986543321  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+... ..+.. ..+..+|++
T Consensus       226 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~-~~~~~~s~~  299 (346)
T 4fih_A          226 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRL-KNLHKVSPS  299 (346)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCC-SCGGGSCHH
T ss_pred             ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCC-CccccCCHH
Confidence                124567999999999999999999999999999999999999999999988888777443 22222 234568999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||.+||..||++|||++|+++|
T Consensus       300 ~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          300 LKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcC
Confidence            9999999999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-54  Score=418.15  Aligned_cols=250  Identities=27%  Similarity=0.504  Sum_probs=213.8

Q ss_pred             HhhccCceeeeEEEEEE---e-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +++..+.||+|+||.|.   +       +++.||||+++...  .....+.|.+|+.++++++|||||+++|++..++.+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            35566789999998662   2       46789999997543  234457899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC
Q 011991          261 MIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~  324 (473)
                      +||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++   ||||||||+|||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence            9999999999999999643                34899999999999999999999999   9999999999999999


Q ss_pred             CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV  403 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  403 (473)
                      +.+||+|||+|+.......    ........||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..++.
T Consensus       182 ~~~Ki~DFGlar~~~~~~~----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADY----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGC----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             CCEEECCcccceeccCCCc----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999986543321    112344568999999999999999999999999999999998 89999999998888


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      ..+.. +..++   .|..+|+.+.+|+.+||+.||++|||++||+++|+.
T Consensus       258 ~~i~~-~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          258 EMIRN-RQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHc-CCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            87744 44333   366889999999999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-53  Score=409.18  Aligned_cols=245  Identities=25%  Similarity=0.432  Sum_probs=204.9

Q ss_pred             hccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee----CCceEEE
Q 011991          193 RKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMMIV  263 (473)
Q Consensus       193 ~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv  263 (473)
                      +..+.||+|+||.|.     .++..||+|++..... .....+.|.+|++++++++|||||+++++|..    +..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            555679999999762     4578999999976543 45566889999999999999999999999875    3458999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++++ +||||||||+|||++. ++.+||+|||+|+..... 
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence            9999999999999998889999999999999999999999863 4999999999999985 789999999999754322 


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                             ......||+.|||||++.+ +|+.++|||||||++|||++|..||.+.............+..|.  ..+..+
T Consensus       186 -------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~  255 (290)
T 3fpq_A          186 -------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVA  255 (290)
T ss_dssp             -------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCC
T ss_pred             -------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC--CCCccC
Confidence                   1234579999999999865 699999999999999999999999987655444443334443322  234567


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++++.+||.+||..||++|||++|+++|
T Consensus       256 ~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            8999999999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.7e-53  Score=423.80  Aligned_cols=245  Identities=23%  Similarity=0.408  Sum_probs=214.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|+..+.||+|+||.|     ..+|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            5788889999999866     3468999999998654333   3568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|.+++... .+++..+..++.||+.||+|||++|   ||||||||+|||++.+|.+||+|||+|+.......  
T Consensus       229 y~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          229 FLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             CCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            99999999999764 6999999999999999999999999   99999999999999999999999999986543321  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+... ..+.. ..+..+|++
T Consensus       303 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~-~~~~~~s~~  376 (423)
T 4fie_A          303 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRL-KNLHKVSPS  376 (423)
T ss_dssp             ----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCC-SCTTSSCHH
T ss_pred             ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCC-cccccCCHH
Confidence                123456999999999999999999999999999999999999999999988888877443 22222 235678999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||.+||..||++|||++|+++|
T Consensus       377 ~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcC
Confidence            9999999999999999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.9e-54  Score=413.25  Aligned_cols=245  Identities=25%  Similarity=0.363  Sum_probs=205.2

Q ss_pred             HhhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|++.+.||+|+||.|.        .+++.||||++.+..... .....+.+|+++++.++|||||+++++|.+++.+|+
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            68899999999998662        246799999997543221 112357889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999999889999999999999999999999999   9999999999999999999999999997643321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .      ......||+.|||||++.+..|+.++||||+||++|||++|..||.+.+..+....+.....  .   .|..+
T Consensus       181 ~------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--~---~p~~~  249 (304)
T 3ubd_A          181 K------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--G---MPQFL  249 (304)
T ss_dssp             C------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C---CCTTS
T ss_pred             c------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--C---CCCcC
Confidence            1      12346799999999999999999999999999999999999999999999888888754332  1   25678


Q ss_pred             CHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNF-----NEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~-----~ell~~  450 (473)
                      |+++.+||++||+.||++|||+     +|+++|
T Consensus       250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            9999999999999999999995     566653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-52  Score=414.08  Aligned_cols=255  Identities=27%  Similarity=0.498  Sum_probs=216.2

Q ss_pred             HhhccCceeeeEEEEEEe----------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC-CeeeeEEeeEee-CC
Q 011991          191 QVRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQ-NI  258 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~~----------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~-~~  258 (473)
                      +|++.+.||+|+||.|..          .++.||||.+....  .....+.|.+|+++|++++| ||||+++|+|.. ++
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            678889999999997632          23589999997543  45566789999999999976 899999999876 45


Q ss_pred             ceEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD  322 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~  322 (473)
                      .++||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++   ||||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence            789999999999999999753                23889999999999999999999999   99999999999999


Q ss_pred             CCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 011991          323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEE  401 (473)
Q Consensus       323 ~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~  401 (473)
                      .++.+||+|||+|+.........    ......||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..+
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~----~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSE----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             CCCCEEECcchhhhhcccCCCce----eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999998654332111    1233457899999999999999999999999999999998 999999877655


Q ss_pred             HHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       402 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .+......+.++..   |..+|+++.+||.+||+.||++|||++||+++|+++++.
T Consensus       296 ~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          296 EFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            55555566655543   567899999999999999999999999999999999865

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.2e-51  Score=393.89  Aligned_cols=250  Identities=22%  Similarity=0.370  Sum_probs=190.6

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-----
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----  258 (473)
                      ..+|++.+.||+|+||.|     ..+|+.||||++....  .....+.+.+|++++++++|||||+++++|.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            346888999999999866     2468999999997543  4556678999999999999999999999987544     


Q ss_pred             -------ceEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 011991          259 -------PMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK  328 (473)
Q Consensus       259 -------~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vk  328 (473)
                             .+|+|||||+||+|.+++...+.   .++..++.++.||++||+|||++|   ||||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEE
Confidence                   37999999999999999987654   455678999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCcccccc------cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-H
Q 011991          329 ISGFGLLRLQYISPEKAKI------VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-E  401 (473)
Q Consensus       329 l~DfG~a~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~  401 (473)
                      |+|||+|+...........      ........||+.|||||++.+..|+.++|||||||++|||++   ||.+.... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            9999999876543221111      112234579999999999999999999999999999999996   77653322 1


Q ss_pred             HHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       402 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....+ .....|+   .+...++.+.+||.+||+.||.+|||+.|+++|
T Consensus       236 ~~~~~-~~~~~p~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTDV-RNLKFPP---LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHH-HTTCCCH---HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHH-hcCCCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            22222 2222221   233456778999999999999999999999873

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-50  Score=391.86  Aligned_cols=260  Identities=26%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC----ceEEE
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----PMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv  263 (473)
                      +|.+.+.||+|+||.|   .++|+.||||++....    .....+..|+..+..++|||||++++++..++    .+|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4667788999999755   6789999999996432    22223345666667889999999999998654    47999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK-----PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ||||++|+|.+++... .+++..+..++.|++.||+|||++.     ..+||||||||+|||++.++.+||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999999775 5999999999999999999999871     112999999999999999999999999999876


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCC------CCCCchhHHHHHHHHHHHHhCCCCCCC----------C-----
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNE------EFDRSVDAYSFGLILYEMIEGVQPFHP----------K-----  397 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~ell~g~~pf~~----------~-----  397 (473)
                      .......  ........||+.|||||++.+.      .++.++|||||||++|||++|..||..          .     
T Consensus       159 ~~~~~~~--~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          159 DSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             ETTTTEE--SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cCCCCce--eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            4432211  1122345699999999998764      367899999999999999999766532          1     


Q ss_pred             ChHHHHHHHHhhCCCCCCcccCC--CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          398 PPEEVVKLMCCEGKRPPLKIKAR--SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       398 ~~~~~~~~i~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ........+.....+|..+....  ..++.+.+|+.+||+.||++|||+.||++.|+++..+
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            22334444434444454432222  2335789999999999999999999999999998765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-50  Score=400.95  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=211.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee------CCc
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ------NIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~  259 (473)
                      +|.+.+.||+|+||.|     ..+|+.||||++.... ......+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5888899999999866     3468999999997654 345566788999999999999999999998764      356


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      +|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++|   ||||||||+|||++.++.+||+|||+|+...
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999996 589999988888999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-  417 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  417 (473)
                      ....  ..........||+.|||||++.+. .++.++||||+||++|||++|..||.+.+..+.+..|......++... 
T Consensus       210 ~~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          210 TSPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             --------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cCcc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            3321  112233457899999999998775 569999999999999999999999999998888777754433332211 


Q ss_pred             -------------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 -------------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 -------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                               ..+++++++.+||.+||..||.+|||++|+|+|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                     123568899999999999999999999999885

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-47  Score=378.87  Aligned_cols=251  Identities=20%  Similarity=0.252  Sum_probs=196.8

Q ss_pred             HHHhhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCc
Q 011991          189 ELQVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  259 (473)
                      ...|++.+.||+|+||.|.        .+++.||+|.+....  .   ..++.+|+++++.+ +||||++++++|.+++.
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            3468899999999999762        136789999997543  1   24578899999998 69999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC-CcEEEEeecccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLRLQ  338 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~-~~vkl~DfG~a~~~  338 (473)
                      +|+|||||+||+|.+++.   .+++..++.++.||+.||+|||++|   |+||||||+|||++.+ +.+||+|||+|+..
T Consensus        95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            999999999999999983   5999999999999999999999999   9999999999999876 79999999999765


Q ss_pred             ccCccccc----------------------ccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 011991          339 YISPEKAK----------------------IVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFH  395 (473)
Q Consensus       339 ~~~~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~  395 (473)
                      ........                      .........||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            43221110                      01123345799999999998775 58999999999999999999999996


Q ss_pred             CCC-hHHHHHHHHhhCC---------------------------------------CCC----------CcccCCCCCHH
Q 011991          396 PKP-PEEVVKLMCCEGK---------------------------------------RPP----------LKIKARSYPPD  425 (473)
Q Consensus       396 ~~~-~~~~~~~i~~~~~---------------------------------------~~~----------~~~~~~~~~~~  425 (473)
                      ..+ ..+.+..+.....                                       .|.          .......+|++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            543 3333333211000                                       000          00113457899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||++||..||++|||++|+++|
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcC
Confidence            9999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-47  Score=402.92  Aligned_cols=247  Identities=19%  Similarity=0.341  Sum_probs=215.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||+|+||.|     +.+|+.||+|++...   .....+.+.+|+++|+.++|||||+++++|.++..+||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999876     357899999999754   3445678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC--CcEEEEeeccccccccC
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG--GQLKISGFGLLRLQYIS  341 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~--~~vkl~DfG~a~~~~~~  341 (473)
                      |||+||+|.+++.. .+.+++..++.++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.....
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999999964 457999999999999999999999999   9999999999999854  79999999999876432


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      .       ......||+.|||||++.+..|+.++||||+||++|+|++|..||.+.+..+....+....... ....+..
T Consensus       311 ~-------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~  382 (573)
T 3uto_A          311 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-DDSAFSG  382 (573)
T ss_dssp             S-------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-CSGGGTT
T ss_pred             C-------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC-CcccccC
Confidence            1       1233469999999999999999999999999999999999999999999988888875544332 2334567


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +|+++.+||++||..||.+|||+.|+++|
T Consensus       383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          383 ISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            89999999999999999999999999885

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.6e-48  Score=405.80  Aligned_cols=244  Identities=23%  Similarity=0.332  Sum_probs=202.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCC---CCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESH---KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|.+.+.||.|+||.|     ..+|+.||||++.+...   ...........++.+++.++|||||+++++|.+++.+||
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            5788899999999976     35789999999975321   122223333445666777799999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||||+||+|.++|.+.+.+++..++.++.||+.||.|||++|   ||||||||+|||++.+|.+||+|||+|+......
T Consensus       270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            9999999999999999889999999999999999999999999   9999999999999999999999999997653321


Q ss_pred             ccccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhCCCCCCccc
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~  418 (473)
                              .....||+.|||||++. +..|+.++|||||||++|||++|..||.+.+   ..++...+....  +.   .
T Consensus       347 --------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~---~  413 (689)
T 3v5w_A          347 --------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VE---L  413 (689)
T ss_dssp             --------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CC---C
T ss_pred             --------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CC---C
Confidence                    23457999999999996 4589999999999999999999999997643   333444443222  11   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      |..+|+++.+||.+||..||.+|++     ++||++|
T Consensus       414 p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            5678999999999999999999998     6888764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.8e-45  Score=354.79  Aligned_cols=260  Identities=36%  Similarity=0.629  Sum_probs=214.9

Q ss_pred             HHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          190 LQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      .+|++.+.||.|+||.+   ..+|..||||++..... .....+.+.+|++++++++||||+++++++......++||||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             hHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            36888899999999855   56899999999976543 456678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          267 HAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      +++|+|.+++...+.   +++..++.++.|++.||+|||++++ +|+||||||+||+++.++.+||+|||+++...... 
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-  193 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-  193 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccccccc-
Confidence            999999999987543   9999999999999999999999862 49999999999999999999999999997543221 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........   .+..++
T Consensus       194 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~  265 (309)
T 3p86_A          194 -----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---IPRNLN  265 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC---CCTTSC
T ss_pred             -----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCccCC
Confidence                 112345689999999999999999999999999999999999999999988887776654444333   356789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      +.+.+||.+||+.||.+|||++++++.|+.++....+
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999999999876543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.6e-45  Score=356.75  Aligned_cols=244  Identities=26%  Similarity=0.481  Sum_probs=215.0

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.+.     .+|+.||||++..... .....+.+.+|+++++.++||||+++++++...+..|+|||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            68888999999998662     5789999999976543 45667889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......   
T Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  168 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---  168 (328)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999997553321   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+....+.......     |..+++
T Consensus       169 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----p~~~s~  239 (328)
T 3fe3_A          169 ----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI-----PFYMST  239 (328)
T ss_dssp             ----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----CTTSCH
T ss_pred             ----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----CCCCCH
Confidence                12345689999999999888765 79999999999999999999999999888888775543322     446789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.+|+++||..||.+|||++|+++|
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            99999999999999999999999885

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.9e-45  Score=353.45  Aligned_cols=264  Identities=23%  Similarity=0.361  Sum_probs=221.4

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||+|+|+.+.     .++..||+|++...........+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            468888999999998652     468899999998766667777889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  166 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-  166 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999976533211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....................+..+|+
T Consensus       167 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          167 ----TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             ----cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence                1123356899999999999999999999999999999999999999998877766555443332222233567899


Q ss_pred             HHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHhccCC
Q 011991          425 DLKELIEECWDPKPVIRP-NFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~~~~~~  461 (473)
                      .+.++|.+||..||.+|| +++++.+.|+.+....+..
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence            999999999999999998 8999999998877654433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-44  Score=359.39  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=216.1

Q ss_pred             hhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCH---HHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC
Q 011991          187 PLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKARHPNVVQFVGAVTQNI  258 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  258 (473)
                      .....|.+.+.||.|+||.+     ..+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            34557889999999999866     23689999999986543211   12467899999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC----cEEEEeecc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL  334 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~----~vkl~DfG~  334 (473)
                      ..++||||++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++    .+||+|||+
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            99999999999999999988888999999999999999999999999   99999999999998876    799999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      +.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... 
T Consensus       166 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-  237 (361)
T 2yab_A          166 AHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF-  237 (361)
T ss_dssp             CEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-
T ss_pred             ceEcCCCC-------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-
Confidence            97653321       1234568999999999999999999999999999999999999999998888887775433222 


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....+..+++.+.+||.+||..||.+|||+.|+++|
T Consensus       238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            222346789999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=364.07  Aligned_cols=255  Identities=18%  Similarity=0.341  Sum_probs=218.7

Q ss_pred             cChhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          185 LNPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       185 i~~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      ......+|.+.+.||.|+||.+.     .+|+.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            34566789999999999998662     4789999999986543 34456789999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc---CCCcEEEEeecccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD---NGGQLKISGFGLLR  336 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~---~~~~vkl~DfG~a~  336 (473)
                      .|+||||++||+|.+++...+.+++..+..++.||+.||.|||++|   |+||||||+|||++   .++.+||+|||++.
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999999999999888999999999999999999999999   99999999999998   45789999999997


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                      .......      ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+.......+ .
T Consensus       162 ~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-~  234 (444)
T 3soa_A          162 EVEGEQQ------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP-S  234 (444)
T ss_dssp             CCCTTCC------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-T
T ss_pred             EecCCCc------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-c
Confidence            6543211      12345689999999999999999999999999999999999999999998888888755443322 2


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus       235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            3346789999999999999999999999999885

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-44  Score=347.58  Aligned_cols=248  Identities=19%  Similarity=0.397  Sum_probs=213.1

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ...+|++.+.||.|+||.+     ..+|+.||||++.......   .+.+.+|+.+++.++||||+++++++...+..++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            4457888899999999866     3568899999997654333   3568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||+++|+|.+++... .+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999999999775 5999999999999999999999999   9999999999999999999999999987654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........  ..+..+
T Consensus       171 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  242 (297)
T 3fxz_A          171 S------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKL  242 (297)
T ss_dssp             C------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SCGGGS
T ss_pred             c------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCcccc
Confidence            1      12345689999999999999999999999999999999999999999888777666654443222  125568


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.+.+||.+||+.||.+|||++|++++
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          243 SAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            8999999999999999999999999873

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.1e-44  Score=358.42  Aligned_cols=258  Identities=27%  Similarity=0.514  Sum_probs=218.4

Q ss_pred             HHhhccCceeeeEEEEEE------------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee
Q 011991          190 LQVRKADGITKGSYQVAK------------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ  256 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~------------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  256 (473)
                      .+|.+.+.||.|+||.+.            .++..||||++...  ......+.+.+|+.+++.+ +||||+++++++..
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            467888899999998652            13457999999754  2456678899999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEE
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL  320 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nil  320 (473)
                      ++.+|+||||+++|+|.+++...+                .+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            999999999999999999998753                3789999999999999999999999   999999999999


Q ss_pred             EcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 011991          321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPP  399 (473)
Q Consensus       321 i~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~  399 (473)
                      ++.++.+||+|||+++........    .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTT----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             ECCCCCEEEccccCCcccCcccce----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999765432111    11223446788999999999999999999999999999999 9999999888


Q ss_pred             HHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          400 EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       400 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      .+....+.. +..+.   .+..+++.+.++|.+||+.||.+||++.|++++|+++......
T Consensus       312 ~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~  368 (370)
T 2psq_A          312 EELFKLLKE-GHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  368 (370)
T ss_dssp             GGHHHHHHT-TCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHhc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence            777766633 33332   2567899999999999999999999999999999999876544

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-44  Score=356.27  Aligned_cols=246  Identities=24%  Similarity=0.420  Sum_probs=211.9

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+.     .+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            57788899999998652     3689999999975321112234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.......  
T Consensus        86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--  160 (337)
T 1o6l_A           86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  160 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999875322211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......     .+..++++
T Consensus       161 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~  231 (337)
T 1o6l_A          161 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-----FPRTLSPE  231 (337)
T ss_dssp             ----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----CCTTSCHH
T ss_pred             ----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCCHH
Confidence                123456899999999999999999999999999999999999999998888887777543322     24578999


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +.+||.+||..||.+||     +++|+++|
T Consensus       232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            99999999999999999     89999886

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.1e-44  Score=349.61  Aligned_cols=260  Identities=25%  Similarity=0.460  Sum_probs=218.6

Q ss_pred             HHHhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          189 ELQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ..+|.+.+.||+|+||.+.   .     .+..||||++....  .....+.+.+|+.+++.++||||+++++++...+..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            3478888999999998652   1     34569999997543  456668899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++||||+++++|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999754 56999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ......   .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+... ..++   .
T Consensus       203 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~---~  275 (325)
T 3kul_A          203 DDPDAA---YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLP---A  275 (325)
T ss_dssp             ----CC---EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCC---C
T ss_pred             cCccce---eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCC---C
Confidence            432211   11223346778999999988889999999999999999998 99999999988888777443 2222   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      +..+++.+.+||.+||..||.+|||+.++++.|+.+......
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            557899999999999999999999999999999999886543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.8e-44  Score=354.02  Aligned_cols=252  Identities=21%  Similarity=0.362  Sum_probs=217.6

Q ss_pred             hhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          187 PLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      ....+|.+.+.||.|+||.+.     .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            445689999999999998662     3588999999986554 3556678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC---cEEEEeecccccc
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLRLQ  338 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~---~vkl~DfG~a~~~  338 (473)
                      +||||+++|+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||++...
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999999988888999999999999999999999999   99999999999998654   5999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ....       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......+ ...
T Consensus       182 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~  253 (362)
T 2bdw_A          182 NDSE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-SPE  253 (362)
T ss_dssp             TTCC-------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-TTG
T ss_pred             cCCc-------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-ccc
Confidence            4221       12345689999999999999999999999999999999999999999888888777755443322 223


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+++++.+||.+||..||.+||++.++++|
T Consensus       254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            45689999999999999999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=349.47  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=216.3

Q ss_pred             ChhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCC---HHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC
Q 011991          186 NPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKD---PERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  257 (473)
                      ......|.+.+.||.|+|+.+.     .+|+.||+|++.......   ....+.+.+|+.+++.++||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3456689999999999998662     358899999997644321   11346789999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC----cEEEEeec
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFG  333 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~----~vkl~DfG  333 (473)
                      ...++||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999999988888999999999999999999999999   99999999999999877    79999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      +++......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus       164 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  236 (326)
T 2y0a_A          164 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  236 (326)
T ss_dssp             TCEECCTTS-------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             CCeECCCCC-------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence            997653321       1234568999999999999999999999999999999999999999988888777765433322


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ....+..+++.+.+||.+||..||.+|||++|+++|
T Consensus       237 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          237 -EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             222345788999999999999999999999999984

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-44  Score=350.38  Aligned_cols=243  Identities=24%  Similarity=0.424  Sum_probs=210.9

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+.     .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            57788899999998652     4689999999975321111234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----  159 (318)
T 1fot_A           87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  159 (318)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999754321    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......     .+..++++
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~p~~~~~~  229 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-----FPPFFNED  229 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-----CCTTSCHH
T ss_pred             -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCCCCCHH
Confidence                 22356899999999999999999999999999999999999999998888888777554321     24568899


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +.++|++||..||.+||     +++++++|
T Consensus       230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            99999999999999999     89998874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.4e-44  Score=357.66  Aligned_cols=255  Identities=29%  Similarity=0.477  Sum_probs=216.1

Q ss_pred             HhhccCceeeeEEEEE---Ee--cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~--~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+   ..  +++.||||++...  ......+.+.+|+++++.++||||+++++++..++..++|||
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            6778889999999865   22  6889999999754  245566788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++|+|.+++...+ .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            999999999997653 5999999999999999999999999   999999999999999999999999999754322111


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                          .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. +..++   .+..+|
T Consensus       270 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~  341 (377)
T 3cbl_A          270 ----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLP---CPELCP  341 (377)
T ss_dssp             ----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-TCCCC---CCTTCC
T ss_pred             ----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCC
Confidence                01111224567999999988889999999999999999998 9999999988877776643 33332   256789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      +.+.+||.+||+.||.+|||++++++.|+++..+.
T Consensus       342 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          342 DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence            99999999999999999999999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=358.58  Aligned_cols=246  Identities=23%  Similarity=0.374  Sum_probs=208.7

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|++.+.||.|+||.+.     .+|+.||||++...........+.+..|..+++.+ +||||+++++++.+.+.+|+||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            57888899999998652     45889999999754222233456788999999998 6999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus       104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--  178 (353)
T 3txo_A          104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--  178 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC--
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999987532221  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......     .+..+++
T Consensus       179 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~~~  249 (353)
T 3txo_A          179 ----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-----YPTWLHE  249 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----CCTTSCH
T ss_pred             ----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCCH
Confidence                1223456899999999999888999999999999999999999999999998888887554322     2456889


Q ss_pred             HHHHHHHHccCCCCCCCCCH------HHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNF------NEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~------~ell~~  450 (473)
                      ++.+||++||..||.+||++      +|+++|
T Consensus       250 ~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             HHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            99999999999999999998      777764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=352.25  Aligned_cols=259  Identities=30%  Similarity=0.532  Sum_probs=221.2

Q ss_pred             HHhhccCceeeeEEEEEEe------------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee
Q 011991          190 LQVRKADGITKGSYQVAKW------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ  256 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~------------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  256 (473)
                      .+|.+.+.||+|+||.+..            .+..||||++...  ........+.+|+++++.+ +||||+++++++..
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4788889999999986631            2257999999765  3456678899999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEE
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL  320 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nil  320 (473)
                      ++..++||||+++|+|.+++....                .+++..++.++.|++.||.|||+++   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            999999999999999999998753                4899999999999999999999999   999999999999


Q ss_pred             EcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 011991          321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPP  399 (473)
Q Consensus       321 i~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~  399 (473)
                      ++.++.+||+|||+++........    .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTT----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EcCCCcEEEcccCccccccccccc----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999765432111    11233456788999999999999999999999999999999 9999999988


Q ss_pred             HHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          400 EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       400 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      .+....+.. +..+.   .+..+++.+.+|+.+||+.||.+|||++|++++|+++......+
T Consensus       300 ~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          300 EELFKLLKE-GHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHHHHHHHT-TCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHHHHHHHc-CCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            887777643 33322   25678999999999999999999999999999999999876544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=347.79  Aligned_cols=246  Identities=16%  Similarity=0.310  Sum_probs=211.7

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+||.+.     .+++.+|+|++...    ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            367888899999998662     36889999999743    234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC--CCcEEEEeeccccccccC
Q 011991          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~--~~~vkl~DfG~a~~~~~~  341 (473)
                      ||++|++|.+++... ..+++..++.++.|++.||.|||++|   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999999765 36999999999999999999999999   999999999999987  789999999999765432


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ..       .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... ....+..
T Consensus       158 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~  229 (321)
T 1tki_A          158 DN-------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-DEEAFKE  229 (321)
T ss_dssp             CE-------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-CHHHHTT
T ss_pred             Cc-------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC-Chhhhcc
Confidence            11       123457899999999999889999999999999999999999999999888888775544332 2223457


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +|+++.+||.+||..||.+|||+.|+++|
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            89999999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-43  Score=345.20  Aligned_cols=264  Identities=27%  Similarity=0.553  Sum_probs=221.6

Q ss_pred             CCccccChhHHHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeee
Q 011991          180 VPEYELNPLELQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ  249 (473)
Q Consensus       180 ~~~~~i~~~~~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  249 (473)
                      .+.+.+.  ..+|.+.+.||.|+|+.+.          .++..||||++....  .....+.+.+|+++++.++||||++
T Consensus        15 ~~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~   90 (314)
T 2ivs_A           15 DPKWEFP--RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIK   90 (314)
T ss_dssp             CTTTBCC--GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             Ccccccc--hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceee
Confidence            3444444  3468888999999997552          234789999997543  4566788999999999999999999


Q ss_pred             EEeeEeeCCceEEEEeccCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHhhcC
Q 011991          250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR------------------------LSPSKVLRFALDLARGMNYLHECK  305 (473)
Q Consensus       250 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~qi~~~L~~LH~~~  305 (473)
                      +++++...+..++||||+++++|.+++...+.                        +++..++.++.|++.||.|||+++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  170 (314)
T 2ivs_A           91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK  170 (314)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999987543                        889999999999999999999999


Q ss_pred             CCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHH
Q 011991          306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY  385 (473)
Q Consensus       306 ~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~  385 (473)
                         |+||||||+||+++.++.+||+|||+++.........    ......+|+.|+|||++.+..++.++|||||||++|
T Consensus       171 ---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  243 (314)
T 2ivs_A          171 ---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW  243 (314)
T ss_dssp             ---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE----CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             ---CcccccchheEEEcCCCCEEEccccccccccccccce----eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHH
Confidence               9999999999999999999999999997654332111    122344678899999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          386 EMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       386 ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      +|++ |..||.+.........+.. +..+.   .+..+++.+.+++.+||+.||.+|||+.+++++|+++..+.
T Consensus       244 el~t~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          244 EIVTLGGNPYPGIPPERLFNLLKT-GHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             HHHTTSCCSSTTCCGGGHHHHHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHhCCCCCCCCCCHHHHHHHhhc-CCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence            9999 9999999888777766643 32222   35678999999999999999999999999999999998753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-43  Score=348.01  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=208.9

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.||+|+||.+.     .+++.||+|++...........+.+.+|..+++.+ +||||+++++++.....+|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            57888899999998652     35889999999877666677778899999999988 8999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--  164 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--  164 (345)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC--
Confidence            99999999999988888999999999999999999999999   9999999999999999999999999997532221  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhhCCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK---------PPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~  415 (473)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||...         ........+....  .. 
T Consensus       165 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~-  237 (345)
T 3a8x_A          165 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IR-  237 (345)
T ss_dssp             ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CC-
T ss_pred             ----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CC-
Confidence                1223457899999999999999999999999999999999999999652         2233344443322  11 


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNF------NEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~  450 (473)
                        .+..+++.+.+||.+||+.||.+||++      +|+++|
T Consensus       238 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          238 --IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             --CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence              245789999999999999999999996      566654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-43  Score=354.87  Aligned_cols=246  Identities=25%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.||+|+||.+     ..+++.||+|++.+.........+.+..|..+++++ +||||++++++|.+...+|+||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            6788899999999866     245789999999876555555567788999999887 8999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus       133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--  207 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--  207 (396)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred             EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC--
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999997532221  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHhhCCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---------PEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~---------~~~~~~~i~~~~~~~~~  415 (473)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||....         .......+....  +. 
T Consensus       208 ----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~-  280 (396)
T 4dc2_A          208 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IR-  280 (396)
T ss_dssp             ----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CC-
T ss_pred             ----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cC-
Confidence                12345678999999999999999999999999999999999999996421         222334443222  11 


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNF------NEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~  450 (473)
                        .|..+++++.+||++||+.||.+||++      +|+++|
T Consensus       281 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          281 --IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             --CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence              245689999999999999999999996      566553

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.7e-44  Score=348.60  Aligned_cols=261  Identities=23%  Similarity=0.367  Sum_probs=212.0

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc----
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----  259 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----  259 (473)
                      ..+|.+.+.||.|+|+.+.     .+++.||||++.............+.+|+.+++.++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            3468888999999998652     5788999999988766677777899999999999999999999999886554    


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .|+||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence            4999999999999999998888999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+................+ .....
T Consensus       168 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~  243 (311)
T 3ork_A          168 DSGNSV---TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-PSARH  243 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-HHHHS
T ss_pred             cccccc---ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-ccccc
Confidence            332111   12234568999999999999999999999999999999999999999988887776664444332 22335


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHH-HHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEII-ARLDRIVC  456 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell-~~L~~~~~  456 (473)
                      ..+++++.++|.+||+.||.+||++.+++ +.+.++..
T Consensus       244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            67899999999999999999999766654 45555544

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.7e-44  Score=353.58  Aligned_cols=243  Identities=26%  Similarity=0.432  Sum_probs=211.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+     ..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            6788889999999755     23689999999975322112234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.....    
T Consensus       122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC----
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999764321    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......     .+..+++.
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~~~~  264 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSD  264 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----CCTTCCHH
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC-----CCCCCCHH
Confidence                 12345899999999999999999999999999999999999999999888888877554321     24578999


Q ss_pred             HHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      +.+||.+||+.||.+||+     ++++++|
T Consensus       265 ~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            999999999999999998     8888775

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-43  Score=336.29  Aligned_cols=251  Identities=25%  Similarity=0.502  Sum_probs=214.9

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.+|.|+|+.+    ..+++.||+|++......    .+.+.+|++++++++||||+++++++.++...++||||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            6788889999999855    236788999999865432    25689999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++++|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.......  
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  161 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--  161 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH--
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc--
Confidence            9999999999764 45899999999999999999999999   99999999999999999999999999976533211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                         .......+|+.|+|||++.+..++.++||||+||++|+|++ |..||......+....+.... .+.   .+..+++
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~---~~~~~~~  234 (269)
T 4hcu_A          162 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLY---KPRLAST  234 (269)
T ss_dssp             ---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCC---CCTTSCH
T ss_pred             ---ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCC---CCCcCCH
Confidence               11233446778999999988899999999999999999999 999999999888877774432 222   2556789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .+.+++.+||+.||.+|||+++++++|+++...
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            999999999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-43  Score=336.38  Aligned_cols=252  Identities=25%  Similarity=0.468  Sum_probs=213.4

Q ss_pred             HHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|++.+.||+|+|+.+    ..++..||+|++......    .+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            46888899999999855    234568999999765432    2568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++++|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999997754 4999999999999999999999999   999999999999999999999999999765433211


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.... .+.   .+..++
T Consensus       161 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~---~~~~~~  231 (268)
T 3sxs_A          161 -----SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLY---RPHLAS  231 (268)
T ss_dssp             -----ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCC---CCTTSC
T ss_pred             -----cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCC---CCCcCh
Confidence                 1223446778999999988889999999999999999998 999999988887777664332 222   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +.+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            9999999999999999999999999999877543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=347.07  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=210.8

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+||.+.     .+++.||+|++..   ......+.+.+|+++++.++||||+++++++..++..++||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            367788899999998652     3588999999854   24667788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++++|.+++.. .+.+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.......
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999987 466999999999999999999999999   99999999999999999999999999976543321


Q ss_pred             ccc--------ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhC
Q 011991          344 KAK--------IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV-----VKLMCCEG  410 (473)
Q Consensus       344 ~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~-----~~~i~~~~  410 (473)
                      ...        .........||+.|+|||++.+..++.++|||||||++|+|++|..||........     ....... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-  242 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-  242 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence            110        00111245689999999999999999999999999999999999999875332110     1111111 


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                            ..+..+|+.+.+++.+||+.||.+|||++++++.|+.+...+.
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence                  1245678899999999999999999999999999999987643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-43  Score=351.29  Aligned_cols=256  Identities=27%  Similarity=0.495  Sum_probs=214.2

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      .+|.+.+.||.|+||.+.          .+++.||||++....  .....+.+.+|+++++.+ +||||+++++++...+
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            468888999999998662          234789999997542  455567899999999999 7899999999998754


Q ss_pred             -ceEEEEeccCCCCHHHHHHHcCC--------------------------------------------------------
Q 011991          259 -PMMIVLEYHAKGDLASYLQKKGR--------------------------------------------------------  281 (473)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  281 (473)
                       ..++||||+++|+|.+++.....                                                        
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence             48999999999999999976533                                                        


Q ss_pred             ----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccc
Q 011991          282 ----------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV  351 (473)
Q Consensus       282 ----------l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~  351 (473)
                                +++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++........    ...
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----~~~  252 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRK  252 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC----EEC
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc----hhc
Confidence                      889999999999999999999999   999999999999999999999999999765332211    112


Q ss_pred             cCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHH
Q 011991          352 SHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELI  430 (473)
Q Consensus       352 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li  430 (473)
                      ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+........+..+..   +..+++.+.+++
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li  329 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTM  329 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC---CCCCCHHHHHHH
Confidence            33457888999999998899999999999999999998 99999987765555544455544333   566899999999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          431 EECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .+||+.||.+|||++|++++|+.+...
T Consensus       330 ~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            999999999999999999999998864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.6e-43  Score=336.64  Aligned_cols=252  Identities=22%  Similarity=0.416  Sum_probs=212.7

Q ss_pred             HHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|.+.+.||.|+|+.+    ..++..||+|++......    .+.+.+|+++++.++||||+++++++..+...++|||
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            46888899999999865    234568999999865432    2568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++++|.+++.. .+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....... 
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            9999999999976 456999999999999999999999999   99999999999999999999999999976533211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                          .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.... ...   .+..++
T Consensus       176 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~---~~~~~~  247 (283)
T 3gen_A          176 ----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLY---RPHLAS  247 (283)
T ss_dssp             ----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCC---CCTTCC
T ss_pred             ----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-CCC---CCCcCC
Confidence                11223446778999999998899999999999999999998 999999988888777764432 222   245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +.+.+++.+||+.||.+|||+++++++|+++..+
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            9999999999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-43  Score=358.62  Aligned_cols=246  Identities=29%  Similarity=0.578  Sum_probs=211.5

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC-ceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-PMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~e~  266 (473)
                      +|.+.+.||.|+||.+   ...|+.||||++....     ..+.|.+|+.++++++||||+++++++.... ..++||||
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             HeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            5778889999999855   5678999999997643     2367899999999999999999999987654 79999999


Q ss_pred             cCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++|+|.+++...+.  +++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999987644  799999999999999999999999   999999999999999999999999999743221   


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            .....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. .+.++.   .+..+|
T Consensus       343 ------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~---~p~~~~  412 (450)
T 1k9a_A          343 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMD---APDGCP  412 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCC---CCTTCC
T ss_pred             ------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC---CCCcCC
Confidence                  112246778999999999999999999999999999998 999999888777777663 333333   356789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +.+.+||.+||+.||.+|||+.++++.|+.+..+
T Consensus       413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.2e-43  Score=337.57  Aligned_cols=263  Identities=14%  Similarity=0.235  Sum_probs=216.3

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .+|.+.+.||.|+|+.+   .  .+|+.||||++......     +.+.+|+.+++.+ .|+||+++++++......++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            36888889999998754   2  57899999999754322     3478899999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc-----EEEEeeccccc
Q 011991          264 LEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRL  337 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~-----vkl~DfG~a~~  337 (473)
                      |||+ +++|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.     +||+|||+++.
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999 889999998754 5999999999999999999999999   999999999999987765     99999999986


Q ss_pred             cccCcccccc-cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhhCCCC
Q 011991          338 QYISPEKAKI-VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK---PPEEVVKLMCCEGKRP  413 (473)
Q Consensus       338 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~---~~~~~~~~i~~~~~~~  413 (473)
                      .......... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...   ........+......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543221111 11234566899999999999999999999999999999999999999874   3344444443333223


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      +.......+|+.+.+++.+||+.||.+||++++|++.|+++..+.+..
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            333334578999999999999999999999999999999999987644

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.5e-44  Score=353.41  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=209.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .+|.+.+.||+|+||.+     ..+|+.||+|++...........+.+..|..+++.+ +||||+++++++.+...+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            36778889999999755     246889999999753211112245678899999887 899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.......
T Consensus        97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence            999999999999998888999999999999999999999999   99999999999999999999999999975322211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....  .   .+..++
T Consensus       174 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~---~p~~~s  242 (345)
T 1xjd_A          174 ------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--F---YPRWLE  242 (345)
T ss_dssp             ------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C---CCTTSC
T ss_pred             ------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC--C---CCcccC
Confidence                  12345689999999999999999999999999999999999999999998888887754332  1   245689


Q ss_pred             HHHHHHHHHccCCCCCCCCCHH-HHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFN-EIIA  449 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~-ell~  449 (473)
                      +++.+||.+||..||.+||++. ++++
T Consensus       243 ~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          243 KEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            9999999999999999999997 6654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8e-43  Score=341.44  Aligned_cols=256  Identities=23%  Similarity=0.338  Sum_probs=217.2

Q ss_pred             ccChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCH---HHHHHHHHHHHHHHhcCCCeeeeEEeeEe
Q 011991          184 ELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKARHPNVVQFVGAVT  255 (473)
Q Consensus       184 ~i~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  255 (473)
                      ........|.+.+.||.|+||.+     ..+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   85 (321)
T 2a2a_A            6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE   85 (321)
T ss_dssp             BCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            33456678999999999999865     23688999999976443221   13467899999999999999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC----cEEEEe
Q 011991          256 QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISG  331 (473)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~----~vkl~D  331 (473)
                      .....++||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++    .+||+|
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            99999999999999999999988888999999999999999999999999   99999999999999887    799999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      ||++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus       163 fg~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  235 (321)
T 2a2a_A          163 FGLAHEIEDGV-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY  235 (321)
T ss_dssp             CTTCEECCTTC-------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred             CccceecCccc-------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence            99997654321       12344589999999999999999999999999999999999999999888887777644332


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      . .....+..+++.+.+||.+||..||.+|||++|+++|
T Consensus       236 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 D-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             C-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             c-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            2 2222245788999999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=346.33  Aligned_cols=257  Identities=27%  Similarity=0.441  Sum_probs=216.4

Q ss_pred             HHhhccCceeeeEEEEE---Ee-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+.+.||.|+|+.+   ..       +++.||||++....  .....+.+.+|+.+++.++||||+++++++..++.
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            46788889999999755   22       23789999997543  45667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCC
Q 011991          260 MMIVLEYHAKGDLASYLQKK------------------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK  315 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlk  315 (473)
                      .++||||+++|+|.+++...                        ..+++..++.++.||+.||.|||+++   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            99999999999999999773                        46899999999999999999999999   9999999


Q ss_pred             CCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 011991          316 PKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF  394 (473)
Q Consensus       316 p~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf  394 (473)
                      |+||+++.++.+||+|||+++.......    ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cceEEECCCCeEEEeecCCCcccccCcc----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999999976533211    111233457888999999988889999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       395 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      .+....+....+... ..+.   .+..+++.+.+++.+||+.||.+|||+.+++++|+++..++.
T Consensus       278 ~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          278 YGMAHEEVIYYVRDG-NILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TTSCHHHHHHHHHTT-CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCCChHHHHHHHhCC-CcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            998888877776433 2222   356789999999999999999999999999999999887654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.9e-43  Score=336.96  Aligned_cols=255  Identities=25%  Similarity=0.474  Sum_probs=205.7

Q ss_pred             HHhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          190 LQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+|.+.+.||.|+||.+.   .     .+..||+|.+...  ......+.+.+|+.+++.++||||+++++++. ++..+
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            478888999999997552   1     2457999998753  34566788999999999999999999999984 46789


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+++++|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999999998754 5999999999999999999999999   99999999999999999999999999976543


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ...     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.... .++   .+
T Consensus       169 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~---~~  239 (281)
T 1mp8_A          169 STY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLP---MP  239 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCC---CC
T ss_pred             ccc-----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCC---CC
Confidence            211     11223346778999999988899999999999999999996 999999888877777664332 222   35


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ..+++.+.+++.+||+.||.+|||+.+++++|+++..+..
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            6789999999999999999999999999999999987643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6e-43  Score=340.53  Aligned_cols=258  Identities=27%  Similarity=0.474  Sum_probs=217.8

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      .+|.+.+.||.|+||.+.          .+++.||+|++....  .....+.+.+|+.+++.+ +||||+++++++..++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            468888999999998652          245789999997543  345568899999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEE
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL  320 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nil  320 (473)
                      ..++||||+++|+|.+++....                  .+++..++.++.|++.||.|||+++   |+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            9999999999999999998754                  3899999999999999999999999   999999999999


Q ss_pred             EcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 011991          321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPP  399 (473)
Q Consensus       321 i~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~  399 (473)
                      ++.++.+||+|||+++.........    ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSE----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EcCCCCEEEccccccccccccccce----eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999997654332111    1223346778999999988899999999999999999998 9999988776


Q ss_pred             HHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          400 EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       400 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      .............+.   .+..+++.+.+++.+||+.||.+|||+.|++++|++++....
T Consensus       254 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          254 DSKFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             hhHHHHHhccCCCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            555555544444333   245789999999999999999999999999999999988654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-42  Score=342.36  Aligned_cols=267  Identities=26%  Similarity=0.513  Sum_probs=221.2

Q ss_pred             CccccChhHHHhhccCceeeeEEEEEE------------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCee
Q 011991          181 PEYELNPLELQVRKADGITKGSYQVAK------------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNV  247 (473)
Q Consensus       181 ~~~~i~~~~~~~~~~~~ig~G~~~~~~------------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  247 (473)
                      +.+.+..  .+|.+.+.||.|+||.+.            .++..||||++....  .....+.+.+|+++++.+ +||||
T Consensus        28 ~~~~~~~--~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i  103 (334)
T 2pvf_A           28 PKWEFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNI  103 (334)
T ss_dssp             TTTBCCG--GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccccCCH--hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCE
Confidence            3444433  478888999999998652            346789999997543  456678899999999999 89999


Q ss_pred             eeEEeeEeeCCceEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 011991          248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (473)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  311 (473)
                      +++++++..++..++||||+++|+|.+++....                .+++..++.++.|++.||.|||+++   |+|
T Consensus       104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH  180 (334)
T 2pvf_A          104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIH  180 (334)
T ss_dssp             CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeC
Confidence            999999999999999999999999999997653                3889999999999999999999999   999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-C
Q 011991          312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G  390 (473)
Q Consensus       312 ~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g  390 (473)
                      |||||+||+++.++.+||+|||+++........    .......+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus       181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  256 (334)
T 2pvf_A          181 RDLAARNVLVTENNVMKIADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG  256 (334)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECTTTSSE----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             CCCccceEEEcCCCCEEEccccccccccccccc----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999765432211    11223346788999999988889999999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCc
Q 011991          391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQG  462 (473)
Q Consensus       391 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~  462 (473)
                      ..||.+.+..+....+... ..+.   .+..+++.+.+++.+||+.||.+|||+.|++++|+++......+.
T Consensus       257 ~~p~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~  324 (334)
T 2pvf_A          257 GSPYPGIPVEELFKLLKEG-HRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE  324 (334)
T ss_dssp             CCSSTTCCHHHHHHHHHHT-CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             CCCcCcCCHHHHHHHHhcC-CCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence            9999998888777766443 3222   256789999999999999999999999999999999998766553

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.9e-43  Score=334.87  Aligned_cols=252  Identities=30%  Similarity=0.550  Sum_probs=202.4

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCC-HHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.||.|+|+.+   ...++.||||++....... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF   87 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred             heeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence            5777889999999754   5679999999987543222 23357789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC--------CCcEEEEeecccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--------GGQLKISGFGLLRLQ  338 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~--------~~~vkl~DfG~a~~~  338 (473)
                      +++++|.+++.. +.+++..++.++.|++.||.|||+++..+|+||||||+||+++.        ++.+||+|||++...
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~  166 (271)
T 3dtc_A           88 ARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW  166 (271)
T ss_dssp             CTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred             CCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence            999999999854 46999999999999999999999987444889999999999986        678999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ....        .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+........   .
T Consensus       167 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~  235 (271)
T 3dtc_A          167 HRTT--------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP---I  235 (271)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC---C
T ss_pred             cccc--------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC---C
Confidence            3321        1234588999999999888999999999999999999999999999888777766654443333   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      +..+++.+.+++.+||+.||.+|||+.|++++|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            567899999999999999999999999999999854

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.6e-43  Score=342.19  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=202.7

Q ss_pred             HHhhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCCC-CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          190 LQVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      .+|.+.+.||.|+||.+.        .+|+.||+|++...... .......+.+|+.+++.++||||+++++++..++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            368888999999998663        37889999999865322 233456688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            999999999999999998888999999999999999999999999   99999999999999999999999999875322


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ...      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......     .+.
T Consensus       174 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-----~p~  242 (327)
T 3a62_A          174 DGT------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN-----LPP  242 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----CCT
T ss_pred             CCc------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----CCC
Confidence            211      123456899999999999999999999999999999999999999998888887777544321     245


Q ss_pred             CCCHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      .+++.+.+||.+||..||.+||     +++|+++|
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            6789999999999999999999     78888874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.8e-43  Score=338.66  Aligned_cols=257  Identities=28%  Similarity=0.530  Sum_probs=206.5

Q ss_pred             HHhhccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CC
Q 011991          190 LQVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~  258 (473)
                      .+|++.+.||+|+||.+.         .+++.||||++...   .....+.+.+|+++++.++||||+++++++..  ..
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            478888999999998662         26789999999743   45667889999999999999999999999864  35


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            6899999999999999998754 4999999999999999999999999   99999999999999999999999999976


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------E  401 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~----------------~  401 (473)
                      .......   ........+++.|+|||++.+..++.++|||||||++|+|++|..||......                .
T Consensus       164 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          164 LPQDKEF---FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccCCcce---eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            5433211   11122344677799999999889999999999999999999999998653221                1


Q ss_pred             HHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       402 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ....+ ......+   .+..+++.+.+||.+||+.||.+|||++|+++.|+++..++.
T Consensus       241 ~~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          241 LIELL-KNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHH-HTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHH-hccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            11222 2222222   356789999999999999999999999999999999987653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.3e-43  Score=351.98  Aligned_cols=260  Identities=19%  Similarity=0.326  Sum_probs=207.2

Q ss_pred             hhHHHhhccCceeee--EEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          187 PLELQVRKADGITKG--SYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G--~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      +...+|++.+.||.|  +|+.+     ..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++..++.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            344578999999999  77654     23689999999986543 35667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      .|+||||+++|+|.+++...  +.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999999875  66999999999999999999999999   99999999999999999999999999865


Q ss_pred             cccCccccccc-ccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC--
Q 011991          338 QYISPEKAKIV-FPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR--  412 (473)
Q Consensus       338 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~--  412 (473)
                      ........... .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.+.......+......  
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            43322111111 11223468889999999987  57899999999999999999999999876554443322111100  


Q ss_pred             ---------------------------------------CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 ---------------------------------------PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ---------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                                             ......+..+++.+.+||++||+.||.+|||++|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                                   00001234578899999999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.5e-43  Score=350.66  Aligned_cols=246  Identities=24%  Similarity=0.364  Sum_probs=209.5

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.||.|+||.+.     .+|+.||+|++...........+.+..|..++..+ .||+|+++++++...+.+|+||
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            57788899999998652     35688999999753211122346688899999988 7999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++......  
T Consensus       101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  175 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--  175 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999997532211  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......     .+..+++
T Consensus       176 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~  246 (353)
T 2i0e_A          176 ----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-----YPKSMSK  246 (353)
T ss_dssp             ----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----CCTTSCH
T ss_pred             ----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----CCCCCCH
Confidence                1233456899999999999999999999999999999999999999999988888877554322     2457899


Q ss_pred             HHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      ++.+||.+||..||.+||+     ++++++|
T Consensus       247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            9999999999999999995     5777664

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-42  Score=332.89  Aligned_cols=250  Identities=21%  Similarity=0.365  Sum_probs=215.7

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ..+|.+.+.||.|+|+.+.     .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3468888999999998652     3588999999986543 455668899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc---EEEEeecccccccc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQYI  340 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~---vkl~DfG~a~~~~~  340 (473)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.   +||+|||++.....
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999999988888999999999999999999999999   999999999999986655   99999999975533


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ..       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.......+ .....
T Consensus       161 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  232 (284)
T 3kk8_A          161 SE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-SPEWD  232 (284)
T ss_dssp             SC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-TTTTT
T ss_pred             Cc-------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC-chhhc
Confidence            21       12335689999999999999999999999999999999999999999988888877755443322 22345


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+++.+.+|+.+||+.||.+|||++|++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          233 TVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            789999999999999999999999999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=350.49  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=214.6

Q ss_pred             HHhhccCceeeeEEEEE---E-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+.+.||+|+||.+   .       .++..||||++...  ........+.+|+.+++.++||||+++++++.....
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            46788889999999744   2       24568999999643  245556789999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC---cEEE
Q 011991          260 MMIVLEYHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKI  329 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~---~vkl  329 (473)
                      .++||||+++|+|.+++...+       .+++..++.++.|++.||.|||++|   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999998743       4899999999999999999999999   99999999999999555   5999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++.......    ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus       226 ~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          226 GDFGMARDIYRAGY----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             CCCHHHHHHHHHSS----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             CCCccccccccccc----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999975432211    111223446888999999988899999999999999999998 9999999998888877754


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .. .+.   .+..+++.+.+|+.+||+.||.+|||+++|+++|+.+...
T Consensus       302 ~~-~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          302 GG-RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             TC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC-CCC---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            33 222   2557889999999999999999999999999999988774

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-42  Score=335.61  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=213.8

Q ss_pred             HHhhccC-ceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          190 LQVRKAD-GITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       190 ~~~~~~~-~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+|.+.. .||.|+|+.+.       ..++.||||++.... ......+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            3566766 89999998652       236789999997653 2344567899999999999999999999999 567789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            99999999999999998888999999999999999999999999   999999999999999999999999999765433


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ....   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. +..+.   .+.
T Consensus       171 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~  243 (291)
T 1xbb_A          171 ENYY---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMG---CPA  243 (291)
T ss_dssp             CSEE---EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC---CCT
T ss_pred             CCcc---cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---CCC
Confidence            2211   11223346788999999988888999999999999999999 9999999888877766643 33332   256


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      .+++.+.++|.+||+.||.+|||+.++++.|++++.+.
T Consensus       244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            78999999999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-43  Score=345.99  Aligned_cols=259  Identities=24%  Similarity=0.424  Sum_probs=211.3

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      .+|.+.+.||.|+||.+.          .++..||||++....  .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            468888999999998652          145689999997542  234457899999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCC
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG-----------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK  315 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlk  315 (473)
                      ..++||||+++|+|.+++....                       .+++..++.++.|++.||.|||++|   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            9999999999999999997643                       2789999999999999999999999   9999999


Q ss_pred             CCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 011991          316 PKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPF  394 (473)
Q Consensus       316 p~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf  394 (473)
                      |+||+++.++.+||+|||++..........    ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSE----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccce----eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999997654332111    1223346778999999988899999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       395 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      .+.........+...+..+..   +..+++.+.+|+.+||+.||.+|||+.+++++|+.+......
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             ccCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            887766555555455443332   456799999999999999999999999999999998876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-43  Score=349.74  Aligned_cols=257  Identities=28%  Similarity=0.503  Sum_probs=207.7

Q ss_pred             HHhhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          190 LQVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+|.+.+.||.|+||.+.        .++..||||++....  .....+.+.+|+.+++.++||||+++++++......+
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            468888999999998663        246679999997543  4566688999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+++|+|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999998754 5999999999999999999999999   99999999999999999999999999976543


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      .....   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.. +...+   .+
T Consensus       200 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~---~~  272 (373)
T 2qol_A          200 DPEAA---YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLP---PP  272 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECC---CC
T ss_pred             CCccc---eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC---CC
Confidence            32111   11122335678999999998899999999999999999997 9999999888887776643 32222   24


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ..+++.+.+++.+||+.||.+||+++++++.|+++....
T Consensus       273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            568899999999999999999999999999999998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=332.98  Aligned_cols=262  Identities=25%  Similarity=0.394  Sum_probs=219.3

Q ss_pred             HhhccC-ceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKAD-GITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~-~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|.+.. .||.|+||.+.       .++..||||++...  ......+.+.+|+++++.++||||+++++++ ..+..++
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            344444 79999988652       25778999999764  2456678899999999999999999999999 5567899


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++++|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999654 45999999999999999999999999   999999999999999999999999999765433


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ...   ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. +..+.   .+.
T Consensus       164 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~~~~~---~~~  236 (287)
T 1u59_A          164 DSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRME---CPP  236 (287)
T ss_dssp             SCE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCC---CCT
T ss_pred             cce---eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-CCcCC---CCC
Confidence            211   112233446788999999988889999999999999999998 9999998888777766643 33332   256


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCcccc
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWK  465 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~~~  465 (473)
                      .+++.+.++|.+||+.||.+||++.+++++|+.++.......|..
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~  281 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH  281 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence            789999999999999999999999999999999999887776643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-42  Score=331.30  Aligned_cols=250  Identities=24%  Similarity=0.412  Sum_probs=214.6

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--CceEEEEe
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e  265 (473)
                      +|.+.+.+|.|+||.+   ...++.||||++..... .....+.+.+|+.+++.++||||+++++++...  ...++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            5778889999998754   56799999999986543 456667899999999999999999999999876  77899999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++|+|.+++...+  .+++..++.++.|++.||.|||+++ ..|+||||||+||+++.++.++|+|||++.....   
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---  165 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---  165 (271)
T ss_dssp             CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred             ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence            999999999998765  4899999999999999999999976 3499999999999999999999999988643211   


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCC---chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDR---SVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                              ....+|+.|+|||++.+..++.   ++|||||||++|+|++|..||...+.......+......+..   +.
T Consensus       166 --------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~  234 (271)
T 3kmu_A          166 --------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI---PP  234 (271)
T ss_dssp             --------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC---CT
T ss_pred             --------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC---CC
Confidence                    2234788999999998765544   899999999999999999999999888887777666555443   56


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      .+++.+.+++.+||+.||.+|||++++++.|+++..
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            789999999999999999999999999999998753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.1e-44  Score=362.72  Aligned_cols=253  Identities=20%  Similarity=0.307  Sum_probs=210.4

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+||.|     ..+++.||+|++.+...........+..|..++..++||||++++++|.+++.+|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            36788889999999866     2357899999997421111111234788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||++||+|.+++.. .+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999987 467999999999999999999999999   99999999999999999999999999976533211


Q ss_pred             cccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                           .......||+.|+|||++.     ...++.++|||||||++|||++|..||.+.+..+....+.........+..
T Consensus       231 -----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  305 (437)
T 4aw2_A          231 -----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ  305 (437)
T ss_dssp             -----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS
T ss_pred             -----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc
Confidence                 1123456999999999986     557899999999999999999999999999988888877543322333333


Q ss_pred             CCCCCHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVI--RPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~  450 (473)
                      ...+++++.+||++||..+|++  ||+++|+++|
T Consensus       306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            4568999999999999998888  9999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.9e-43  Score=344.75  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=204.6

Q ss_pred             HHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc----eEE
Q 011991          190 LQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----MMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~l  262 (473)
                      .+|++.+.||+|+||.+   ...++.||||++...    ......+..|+.+++.++||||+++++++.....    +++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            46888889999998754   667999999999643    2334556679999999999999999999987543    699


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC----------KPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                      ||||+++|+|.+++... .+++..++.++.|++.||.|||+.          +   |+||||||+|||++.++.+||+||
T Consensus       100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999999775 599999999999999999999999          8   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC---------
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-----EFDRSVDAYSFGLILYEMIEGVQPFHPKP---------  398 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~~l~ell~g~~pf~~~~---------  398 (473)
                      |+++........    .......||+.|+|||++.+.     .++.++|||||||++|+|++|..||.+..         
T Consensus       176 g~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          176 GLALKFEAGKSA----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             TTCEEECTTSCC----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             CcccccccccCc----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999765433211    112335689999999998763     45678999999999999999999997532         


Q ss_pred             -------hHHHHHHHHhhCCCCCCccc--CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          399 -------PEEVVKLMCCEGKRPPLKIK--ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       399 -------~~~~~~~i~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                             .......+......+.....  ....++.+.+||.+||+.||.+|||+.|+++.|+++.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                   22233333233333322211  1122456999999999999999999999999999988753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-42  Score=335.85  Aligned_cols=271  Identities=25%  Similarity=0.464  Sum_probs=221.8

Q ss_pred             ccccChhHHHhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEee
Q 011991          182 EYELNPLELQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA  253 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  253 (473)
                      ...+++....|.+.+.||.|+||.+.   .     ....+|+|.+...  ......+.+.+|+.++++++||||++++++
T Consensus        17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            45566777789999999999998662   1     1235899998753  356667889999999999999999999998


Q ss_pred             Ee-eCCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          254 VT-QNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       254 ~~-~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                      +. .++..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus        95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A           95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred             EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECc
Confidence            54 566789999999999999999763 45899999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ||+++.......  ..........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus       172 fg~a~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 3f66_A          172 FGLARDMYDKEY--YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  249 (298)
T ss_dssp             CGGGCCCSCGGG--CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC
T ss_pred             ccccccccccch--hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC
Confidence            999976543221  11122334457788999999998899999999999999999999 677887777666666553332


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCcc
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGW  463 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~  463 (473)
                       .+.   .+..+++.+.+++.+||+.||.+|||++|+++.|+++..++..+.|
T Consensus       250 -~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~y  298 (298)
T 3f66_A          250 -RLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  298 (298)
T ss_dssp             -CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCSCC
T ss_pred             -CCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccCCC
Confidence             222   2566889999999999999999999999999999999998877654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.5e-43  Score=348.42  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=206.1

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCC--CCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ....|++.+.||.|+|+.+.     .+|+.||||++.....  ......+.+.+|+.+++.++||||+++++++..++..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34579999999999998662     4689999999964211  0111246789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc---EEEEeec
Q 011991          261 MIVLEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFG  333 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~---vkl~DfG  333 (473)
                      |+||||+++++|.+++...    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999887643    24899999999999999999999999   999999999999986654   9999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      +++.......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ......+..... .
T Consensus       179 ~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~-~  250 (351)
T 3c0i_A          179 VAIQLGESGL------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY-K  250 (351)
T ss_dssp             TCEECCTTSC------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCC-C
T ss_pred             ceeEecCCCe------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCC-C
Confidence            9976543211      1234568999999999999999999999999999999999999998753 444444433332 2


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .....+..+++.+.+||.+||..||.+|||+.|+++|
T Consensus       251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            2222345789999999999999999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.7e-43  Score=345.14  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=203.2

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||.|+||.+.     .+++.||||++.....  ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            368888999999998652     3688999999975432  223467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999999988778999999999999999999999999   999999999999999999999999999765432211


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCCcccCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                          .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.......   .....+
T Consensus       162 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~  234 (323)
T 3tki_A          162 ----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---NPWKKI  234 (323)
T ss_dssp             ----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS---TTGGGS
T ss_pred             ----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC---CccccC
Confidence                12234568999999999977765 78999999999999999999999876553 2222222222111   123567


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ++.+.+||.+||..||.+|||++|+++
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            899999999999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.2e-44  Score=350.26  Aligned_cols=244  Identities=25%  Similarity=0.417  Sum_probs=203.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+     ..+++.||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            5788899999999865     24788999999964321111123568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+ +|+|.+++...+.+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++.......   
T Consensus        90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---  162 (336)
T 3h4j_B           90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---  162 (336)
T ss_dssp             CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---
T ss_pred             CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---
Confidence            99 6799999988888999999999999999999999999   9999999999999999999999999997653321   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+     .......+..+++
T Consensus       163 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----~~~~~~~p~~~s~  233 (336)
T 3h4j_B          163 ----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-----NSCVYVMPDFLSP  233 (336)
T ss_dssp             ----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----CSSCCCCCTTSCH
T ss_pred             ----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----HcCCCCCcccCCH
Confidence                1234468999999999988776 68999999999999999999999876544332222     1111123566899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.+||++||..||.+|||++|++++
T Consensus       234 ~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          234 GAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            99999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-42  Score=334.26  Aligned_cols=257  Identities=28%  Similarity=0.485  Sum_probs=203.4

Q ss_pred             HhhccCceeeeEEEEEE--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          191 QVRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      +|++.+.||+|+|+.+.  .....+|+|++.... ......+.+.+|+.+++.++||||++++++. .....++||||++
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~  102 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE  102 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred             ceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecC
Confidence            57888999999998663  345679999997654 3466678899999999999999999999965 5567899999999


Q ss_pred             CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccc
Q 011991          269 KGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI  347 (473)
Q Consensus       269 ~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  347 (473)
                      +++|.+++... ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++........   
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---  176 (289)
T 3og7_A          103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS---  176 (289)
T ss_dssp             EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccc---
Confidence            99999999653 45999999999999999999999999   999999999999999999999999998754332111   


Q ss_pred             cccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhhCCCCCCcccCCCCC
Q 011991          348 VFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM-CCEGKRPPLKIKARSYP  423 (473)
Q Consensus       348 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~  423 (473)
                       .......||+.|+|||++.   +..++.++|||||||++|+|++|..||......+..... ......+........+|
T Consensus       177 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          177 -HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             -ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence             1223456899999999986   567889999999999999999999999886655444443 33333344444456789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      +.+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            999999999999999999999999999998753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.1e-43  Score=361.33  Aligned_cols=246  Identities=24%  Similarity=0.420  Sum_probs=203.8

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+.     .+|+.||||++.............+.+|+.+++.++||||+++++++...+.+++|||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            57888999999998663     4688999999976433334455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++|+|.+++...+.+++..++.++.||+.||+|||+ +|   |+||||||+|||++.++.+||+|||+++......  
T Consensus       229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  303 (446)
T 4ejn_A          229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--  303 (446)
T ss_dssp             CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC--
Confidence            99999999999888889999999999999999999998 88   9999999999999999999999999987532221  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......     .+..+++
T Consensus       304 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~~~  374 (446)
T 4ejn_A          304 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-----FPRTLGP  374 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----CCTTSCH
T ss_pred             ----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----CCccCCH
Confidence                1223456899999999999999999999999999999999999999999888888777554332     2456889


Q ss_pred             HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      ++.+||.+||+.||.+||     +++|+++|
T Consensus       375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            999999999999999999     99999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.6e-43  Score=342.57  Aligned_cols=259  Identities=16%  Similarity=0.219  Sum_probs=210.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.||.|+||.+     ..+|+.||||++......     +.+.+|+.+++.+ +||||+++++++......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            5788889999988643     257899999999754322     3578999999999 8999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc-----EEEEeecccccc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRLQ  338 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~-----vkl~DfG~a~~~  338 (473)
                      ||+ +++|.+++.. .+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.     +||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 8899999987 367999999999999999999999999   999999999999998887     999999999865


Q ss_pred             ccCccccc-ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhCCCCC
Q 011991          339 YISPEKAK-IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP---EEVVKLMCCEGKRPP  414 (473)
Q Consensus       339 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~  414 (473)
                      ........ .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...   .+....+.......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            44322111 11122456799999999999999999999999999999999999999987543   333444322222222


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      .......+| .+.+++.+||+.||.+||++++|++.|+++..+.+
T Consensus       241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            222233455 99999999999999999999999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=347.80  Aligned_cols=249  Identities=20%  Similarity=0.364  Sum_probs=212.1

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ....|.+.+.||.|+||.+.     .+|+.||+|++....   ......+.+|+.+++.++||||+++++++......++
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            34578899999999998652     468899999997542   3445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC--CCcEEEEeeccccccc
Q 011991          263 VLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQY  339 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~--~~~vkl~DfG~a~~~~  339 (473)
                      ||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++   |+||||||+|||++.  .+.+||+|||+++...
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999999999997653 6999999999999999999999999   999999999999974  4679999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ....       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... .....+
T Consensus       203 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~  274 (387)
T 1kob_A          203 PDEI-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAF  274 (387)
T ss_dssp             TTSC-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-CCSSTT
T ss_pred             CCcc-------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCcccc
Confidence            3211       12235899999999999999999999999999999999999999998887777776544322 222335


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+++++.+||.+||..||.+|||+.|++++
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            6789999999999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=358.87  Aligned_cols=252  Identities=20%  Similarity=0.318  Sum_probs=207.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||+|+||.+     ..+|+.||+|++.+.........+.+.+|..++..++||||++++++|.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            36788889999999855     2468999999997432111222345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||++||+|.+++... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            999999999999875 47999999999999999999999999   99999999999999999999999999976533211


Q ss_pred             cccccccccCCCCCCcccCCCCcC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYK-------NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                           .......||+.|+|||++.       ...++.++|||||||++|||++|..||.+.+..+....+.........+
T Consensus       218 -----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  292 (412)
T 2vd5_A          218 -----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP  292 (412)
T ss_dssp             -----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             -----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence                 1123456899999999986       3578999999999999999999999999999888877775432222222


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIR---PNFNEIIAR  450 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~  450 (473)
                      ..+..+|+++.+||++||. +|.+|   |+++|+++|
T Consensus       293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            2245789999999999999 99998   589998774

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=344.33  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=195.0

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ....|.+.+.||.|+||.+.     .+++.||||++....     ..+.+.+|+++++.++||||+++++++......++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            34568888999999998652     357899999997542     23567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeeccccccc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQY  339 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG~a~~~~  339 (473)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999999988888999999999999999999999999   999999999999975   7899999999987643


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE-VVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  418 (473)
                      ...       ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.. .........
T Consensus       203 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~-~~~~~~~~~  274 (349)
T 2w4o_A          203 HQV-------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN-CEYYFISPW  274 (349)
T ss_dssp             -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT-TCCCCCTTT
T ss_pred             ccc-------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh-CCCccCCch
Confidence            221       1223458999999999999999999999999999999999999998766554 4444433 332222233


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+++++.+||++||..||++|||+.|++++
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            46789999999999999999999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=350.39  Aligned_cols=245  Identities=23%  Similarity=0.422  Sum_probs=203.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+||.+     ..+++.||+|++...........+.+.+|+.+++.++||||++++++|.+....|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            36888899999999754     3467899999997532212223467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+.||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC---
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999765322   


Q ss_pred             ccccccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhCCCCCCccc
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~  418 (473)
                          .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||....   ..+....+....  .   ..
T Consensus       169 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~---~~  239 (384)
T 4fr4_A          169 ----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--V---TY  239 (384)
T ss_dssp             ----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--C---CC
T ss_pred             ----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--c---CC
Confidence                12344669999999999864   468999999999999999999999997533   334444432221  1   12


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPN-FNEIIA  449 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~  449 (473)
                      +..+++.+.+||.+||+.||.+||+ ++++++
T Consensus       240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            4578999999999999999999999 666655

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-42  Score=340.52  Aligned_cols=257  Identities=23%  Similarity=0.421  Sum_probs=202.1

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCc---EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce-
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGT---KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM-  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~---~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-  260 (473)
                      .+|.+.+.||+|+||.+.     .++.   .||||++...... ....+.+.+|+++++.++||||+++++++...... 
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            468888999999998662     1222   7999999765433 34568899999999999999999999999876554 


Q ss_pred             -----EEEEeccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 011991          261 -----MIVLEYHAKGDLASYLQKKG------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI  329 (473)
Q Consensus       261 -----~lv~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl  329 (473)
                           ++||||+++|+|.+++....      .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999996532      5899999999999999999999999   999999999999999999999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........    .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus       179 ~Dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          179 ADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             eeccccccccccccc----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            999999765432211    11223446778999999999899999999999999999999 9999999888887777644


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ... +.   .+..+++.+.+|+.+||+.||.+|||+.++++.|+++..+.
T Consensus       255 ~~~-~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          255 GNR-LK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             TCC-CC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCC-CC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            332 22   25578899999999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.1e-42  Score=342.30  Aligned_cols=246  Identities=22%  Similarity=0.408  Sum_probs=210.5

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ....|...+.||.|+||.+.     .+|+.||||++...........+.+.+|+++++.++||||+++++++..++..++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            34568888999999998652     5788999999987655556667889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+. |+|.+++.. .+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            999997 588888754 466999999999999999999999999   999999999999999999999999998754321


Q ss_pred             cccccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                                ....||+.|+|||++.   ...++.++|||||||++|+|++|..||.+.+.......+..... +.  ..
T Consensus       208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~--~~  274 (348)
T 1u5q_A          208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA--LQ  274 (348)
T ss_dssp             ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC--CC
T ss_pred             ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC--CC
Confidence                      2346899999999884   56789999999999999999999999998887776666644332 22  22


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..+++.+.+||.+||+.||.+|||+++++++
T Consensus       275 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            45689999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-42  Score=338.30  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=202.7

Q ss_pred             HHHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          189 ELQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..+|++.+.||.|+|+.+    ..+|+.||+|++..... .......+.+|+++++.++||||+++++++..+...++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            346888899999999755    23688999999975432 2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++ +|.+++... ..+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++.......
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            99975 888888765 45999999999999999999999999   99999999999999999999999999976533211


Q ss_pred             cccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK------  416 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  416 (473)
                            ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......+...      
T Consensus       175 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          175 ------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             ---------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             ------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence                  1233467999999999876 568999999999999999999999998877666555543322211110      


Q ss_pred             -------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 -------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         .....+++++.+||.+||+.||.+|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                               1123577899999999999999999999999973

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=336.28  Aligned_cols=247  Identities=28%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCC-----------------------HHHHHHHHHHHHHHHhc
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD-----------------------PERINAFTHELTIVEKA  242 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~-----------------------~~~~~~~~~E~~~l~~l  242 (473)
                      +|.+.+.||.|+||.+     ..+++.||||++.......                       ....+.+.+|+++++.+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            5788889999999865     2468899999997653211                       12246789999999999


Q ss_pred             CCCeeeeEEeeEee--CCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEE
Q 011991          243 RHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL  320 (473)
Q Consensus       243 ~hpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nil  320 (473)
                      +||||+++++++..  ....++||||+++++|.+++. .+.+++..++.++.|++.||.|||+++   |+||||||+|||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil  169 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL  169 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence            99999999999986  567999999999999988654 346999999999999999999999999   999999999999


Q ss_pred             EcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 011991          321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPK  397 (473)
Q Consensus       321 i~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~~l~ell~g~~pf~~~  397 (473)
                      ++.++.+||+|||+++.......      ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||...
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDA------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSC------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ECCCCCEEEecCCCccccccccc------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999976543211      123456899999999998765   378899999999999999999999988


Q ss_pred             ChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          398 PPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       398 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ........+.......+   ....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SHHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             cHHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            87777666644332221   235688999999999999999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-42  Score=334.46  Aligned_cols=248  Identities=23%  Similarity=0.393  Sum_probs=201.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.+     ..+++.||+|++..... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4777889999998755     23688999999986543 34445778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++ +|.+++.. .+.+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9976 66665554 567999999999999999999999999   9999999999999999999999999997653221  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhhCCCCCCc------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQP-FHPKPPEEVVKLMCCEGKRPPLK------  416 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~------  416 (473)
                          .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+......+...      
T Consensus       156 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             ----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             ----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence                1123456789999999987765 89999999999999999987777 55666666655554322211110      


Q ss_pred             ------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          417 ------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       417 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                                        .....+++.+.+||++||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                              112357889999999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-42  Score=338.37  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=192.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||.|+||.+     ..+|+.||+|++.....  ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            36788889999999865     24688999999975432  122356789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          265 EYHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       265 e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ||++ ++|.+++...      ..+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 5999998764      34899999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--  415 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  415 (473)
                      .....      ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+..  
T Consensus       159 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          159 GIPVN------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             TSCCC------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             CCCcc------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            32211      1234468999999999876 46899999999999999999999999998887776665432211110  


Q ss_pred             ---------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ---------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                                 ......+++++.+||.+||+.||.+|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                                       00123578899999999999999999999999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.9e-42  Score=329.10  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=212.4

Q ss_pred             hhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          187 PLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      ....+|.+.+.||.|+|+.+.     .++..+|+|++.......   .+.+.+|+++++.++||||+++++++......+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            345689999999999998652     356799999997654333   457889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE---cCCCcEEEEeecccccc
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili---~~~~~vkl~DfG~a~~~  338 (473)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||++   +.++.++|+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999999999988888999999999999999999999999   9999999999999   77889999999998765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ....       ......+|+.|+|||++.+. ++.++|||||||++|+|++|..||......+....+..... ......
T Consensus       160 ~~~~-------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~  230 (277)
T 3f3z_A          160 KPGK-------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF-TFPEKD  230 (277)
T ss_dssp             CTTS-------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCHHH
T ss_pred             cCcc-------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCchh
Confidence            3321       12334689999999998764 89999999999999999999999999888888777754433 222222


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+++.+.+||.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            34689999999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-42  Score=338.66  Aligned_cols=260  Identities=17%  Similarity=0.242  Sum_probs=209.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||.|+|+.+     ..+++.||+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            36888899999988754     2468899999998765556666788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++........ 
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  189 (309)
T 2h34_A          114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-  189 (309)
T ss_dssp             ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc-
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999875533211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...........+ . ...+.....+..+|+
T Consensus       190 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          190 ----TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-N-QAIPRPSTVRPGIPV  263 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-H-SCCCCGGGTSTTCCT
T ss_pred             ----ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-c-cCCCCccccCCCCCH
Confidence                1123445889999999999999999999999999999999999999887766444443 2 222333334667899


Q ss_pred             HHHHHHHHccCCCCCCCC-CHHHHHHHHHHHHHhcc
Q 011991          425 DLKELIEECWDPKPVIRP-NFNEIIARLDRIVCNCS  459 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~~~~  459 (473)
                      .+.++|.+||+.||.+|| +++++++.|+.+.....
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            999999999999999999 99999999998766543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-42  Score=330.83  Aligned_cols=271  Identities=24%  Similarity=0.471  Sum_probs=222.0

Q ss_pred             CccccChhHHHhhccCceeeeEEEEEEe-----cC---cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEe
Q 011991          181 PEYELNPLELQVRKADGITKGSYQVAKW-----NG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG  252 (473)
Q Consensus       181 ~~~~i~~~~~~~~~~~~ig~G~~~~~~~-----~~---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  252 (473)
                      .++.+......|...+.||+|+||.+..     ++   ..+|+|++...  ......+.+.+|+.+++.++||||+++++
T Consensus        12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   89 (298)
T 3pls_A           12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIG   89 (298)
T ss_dssp             GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            3455666667788889999999986621     22   27999999753  34566788999999999999999999999


Q ss_pred             eEeeCCce-EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEE
Q 011991          253 AVTQNIPM-MIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (473)
Q Consensus       253 ~~~~~~~~-~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~  330 (473)
                      ++...+.. ++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++|   |+||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A           90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             EECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeC
Confidence            99876554 999999999999999976 355899999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 011991          331 GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       331 DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~  409 (473)
                      |||+++.......  ..........+|+.|+|||.+.+..++.++|||||||++|+|++ +.+||...+.......+...
T Consensus       167 Dfg~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~  244 (298)
T 3pls_A          167 DFGLARDILDREY--YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG  244 (298)
T ss_dssp             CTTSSCTTTTGGG--GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred             cCCCcccccCCcc--cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence            9999975533211  11122334567888999999999999999999999999999999 55666666666666655433


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCc
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQG  462 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~  462 (473)
                      . .+.   .+..+++.+.+++.+||+.||.+|||++++++.|+++..++..+.
T Consensus       245 ~-~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          245 R-RLP---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             C-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             C-CCC---CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence            3 222   255688999999999999999999999999999999999876653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.3e-43  Score=348.74  Aligned_cols=242  Identities=25%  Similarity=0.375  Sum_probs=200.1

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHH-HHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      .+|.+.+.||.|+||.+     ..+++.||+|++.+...........+..|..+ ++.++||||+++++++...+.+|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            36888899999999865     24678999999987654444555667778777 5678999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            999999999999998888999999999999999999999999   9999999999999999999999999997532221 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                           .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......     .+..++
T Consensus       194 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~  263 (373)
T 2r5t_A          194 -----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ-----LKPNIT  263 (373)
T ss_dssp             -----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC-----CCSSSC
T ss_pred             -----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC-----CCCCCC
Confidence                 1233456899999999999999999999999999999999999999999888888877554321     245689


Q ss_pred             HHHHHHHHHccCCCCCCCCCHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFN  445 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~  445 (473)
                      +.+.+||.+||+.||.+||++.
T Consensus       264 ~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          264 NSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTTT
T ss_pred             HHHHHHHHHHcccCHHhCCCCC
Confidence            9999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-42  Score=327.81  Aligned_cols=251  Identities=25%  Similarity=0.497  Sum_probs=214.3

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.+|.|+|+.+    ..++..||+|++......    .+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            6778889999998855    236789999999865432    25689999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++++|.+++... +.+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........  
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  159 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--  159 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH--
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc--
Confidence            9999999999875 45899999999999999999999999   99999999999999999999999999876532211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                         .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.... .+.   .+..+++
T Consensus       160 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~---~~~~~~~  232 (267)
T 3t9t_A          160 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLY---KPRLAST  232 (267)
T ss_dssp             ---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCC---CCTTSCH
T ss_pred             ---cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCC---CCccCcH
Confidence               11223456778999999988889999999999999999999 899999988888777764432 222   2456789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .+.+++.+||+.||.+|||+++++++|+++...
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999999998763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-42  Score=356.71  Aligned_cols=261  Identities=27%  Similarity=0.465  Sum_probs=218.0

Q ss_pred             ccccChhHHHhhccCceeeeEEEEE---E-ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC
Q 011991          182 EYELNPLELQVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~---~-~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  257 (473)
                      .+++..  .+|.+.+.||.|+||.+   . .++..||||++.....    ..+.|.+|+.+++.++||||+++++++. .
T Consensus       182 ~~~i~~--~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          182 AWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             CSBCCG--GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ceeech--HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            344443  36778889999999865   2 2477899999986432    2467999999999999999999999986 5


Q ss_pred             CceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          258 IPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      ...++||||+++|+|.+++...  ..++...++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            6789999999999999999753  35899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      +.......     .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+.. +.+.+
T Consensus       332 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~  405 (454)
T 1qcf_A          332 RVIEDNEY-----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMP  405 (454)
T ss_dssp             GGBCCHHH-----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCC
T ss_pred             eEcCCCce-----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence            76533211     11123345678999999988899999999999999999999 9999999998888877744 33332


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                         .+..+|+.+.+||.+||+.||.+|||+++|++.|+.+......+
T Consensus       406 ---~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~  449 (454)
T 1qcf_A          406 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ  449 (454)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence               25678999999999999999999999999999999887765544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-43  Score=357.11  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=207.8

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+.     .+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.++..+|+|||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            67888899999998662     3588999999964211001112347889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |++||+|.+++... .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  
T Consensus       150 ~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~--  223 (410)
T 3v8s_A          150 YMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM--  223 (410)
T ss_dssp             CCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE--
T ss_pred             CCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc--
Confidence            99999999999765 6999999999999999999999999   99999999999999999999999999976543211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEE----FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                         .......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+..+....+.........+ ....
T Consensus       224 ---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~  299 (410)
T 3v8s_A          224 ---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDND  299 (410)
T ss_dssp             ---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-TTCC
T ss_pred             ---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC-Cccc
Confidence               1123457999999999987655    7899999999999999999999999999888888775432211111 1346


Q ss_pred             CCHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVI--RPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~--RPs~~ell~~  450 (473)
                      +++++.+||.+||..+|.+  ||+++||++|
T Consensus       300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            8999999999999999988  9999999885

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-42  Score=333.41  Aligned_cols=244  Identities=25%  Similarity=0.408  Sum_probs=207.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+     ..++..||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   89 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence            5788889999999865     24567899999965322222234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++...+.+++..++.++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++......    
T Consensus        90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----  162 (279)
T 3fdn_A           90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----  162 (279)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc----
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998543222    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......     .+..+++.
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  233 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEG  233 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-----CCTTSCHH
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC-----CCCcCCHH
Confidence                112346889999999999999999999999999999999999999998888877776443221     24567899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||.+||+.||.+|||++|+++|
T Consensus       234 ~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          234 ARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHhccChhhCCCHHHHhhC
Confidence            9999999999999999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.5e-42  Score=334.61  Aligned_cols=246  Identities=23%  Similarity=0.404  Sum_probs=208.4

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|.....||.|+||.+.     .+|+.||||++......   ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            345666789999998652     36899999999765433   2456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++........ 
T Consensus       122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  196 (321)
T 2c30_A          122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-  196 (321)
T ss_dssp             CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-
Confidence            99999999999865 46999999999999999999999999   99999999999999999999999999876543211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... .+.. ..+..+++
T Consensus       197 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~  269 (321)
T 2c30_A          197 -----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKL-KNSHKVSP  269 (321)
T ss_dssp             -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCC-TTGGGSCH
T ss_pred             -----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCc-CccccCCH
Confidence                 1234568999999999999999999999999999999999999999888877776664332 2222 12345789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.+++.+||+.||.+|||++|++++
T Consensus       270 ~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          270 VLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            99999999999999999999999884

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-42  Score=342.21  Aligned_cols=246  Identities=24%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceE
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  261 (473)
                      ....|.+.+.||.|+||.+     ..+|+.||||++......       ..+|++++.++ +||||+++++++.++...|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            4567999999999999865     236889999999865432       35688888888 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC----CcEEEEeeccccc
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG----GQLKISGFGLLRL  337 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~----~~vkl~DfG~a~~  337 (473)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++|   |+||||||+|||+...    +.+||+|||+++.
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999999988888999999999999999999999999   9999999999998543    3599999999976


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhhCCCCC
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP---KPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~  414 (473)
                      ......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||..   .+..++...+... ....
T Consensus       170 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~~~~  242 (342)
T 2qr7_A          170 LRAENG------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-KFSL  242 (342)
T ss_dssp             CBCTTC------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-CCCC
T ss_pred             CcCCCC------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-Cccc
Confidence            543211      12345689999999999888889999999999999999999999986   3455666666433 3332


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....+..+++.+.+||++||..||.+||+++++++|
T Consensus       243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            223356789999999999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-42  Score=347.61  Aligned_cols=255  Identities=21%  Similarity=0.317  Sum_probs=199.2

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCC--ceE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI--PMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~~~  261 (473)
                      .+|.+.+.||.|+||.+     ..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++..++  .+|
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            47888999999999855     3468999999997543 34566788899999999997 999999999997544  689


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      +|||||+ ++|.+++... .+++..+..++.|++.||+|||+.|   |+||||||+|||++.++.+||+|||+++.....
T Consensus        88 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            9999997 5999999764 6999999999999999999999999   999999999999999999999999999765321


Q ss_pred             cccc---------------cccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011991          342 PEKA---------------KIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL  405 (473)
Q Consensus       342 ~~~~---------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  405 (473)
                      ....               ..........||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            1100               01112345679999999999876 6789999999999999999999999999888777766


Q ss_pred             HHhhCCCCCCcc------------------------------------------cCCCCCHHHHHHHHHccCCCCCCCCC
Q 011991          406 MCCEGKRPPLKI------------------------------------------KARSYPPDLKELIEECWDPKPVIRPN  443 (473)
Q Consensus       406 i~~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs  443 (473)
                      +......|....                                          .+..+++++.+|+++||..||.+|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            643332222100                                          11267889999999999999999999


Q ss_pred             HHHHHHH
Q 011991          444 FNEIIAR  450 (473)
Q Consensus       444 ~~ell~~  450 (473)
                      ++|+++|
T Consensus       323 ~~e~l~H  329 (388)
T 3oz6_A          323 ANDALKH  329 (388)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhCC
Confidence            9999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.9e-42  Score=332.09  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=215.8

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||+|+||.+.     .+++.+|+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            478889999999998652     357899999998766566777788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++........ 
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  170 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  170 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence            99999999999988888999999999999999999999999   99999999999999999999999999976532211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.....  .   .+..+++
T Consensus       171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~---~~~~~~~  240 (294)
T 2rku_A          171 -----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--S---IPKHINP  240 (294)
T ss_dssp             -----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--C---CCTTSCH
T ss_pred             -----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--C---CccccCH
Confidence                 12335688999999999998899999999999999999999999999888777666643321  1   2457889


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.+++.+||+.||.+|||+++++++
T Consensus       241 ~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          241 VAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhC
Confidence            99999999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.9e-43  Score=360.79  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=217.3

Q ss_pred             hhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          187 PLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      ....+|++.+.||.|+||.+.     .+|+.||||++...........+.+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            355689999999999998662     478999999997655443444577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE---cCCCcEEEEeecccccc
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili---~~~~~vkl~DfG~a~~~  338 (473)
                      +||||+.+|+|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999999988888999999999999999999999999   9999999999999   46789999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      .....       .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......... ..
T Consensus       180 ~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~  250 (484)
T 3nyv_A          180 EASKK-------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL-PQ  250 (484)
T ss_dssp             CCCCS-------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-GG
T ss_pred             ccccc-------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-cc
Confidence            43211       223458999999999876 6899999999999999999999999999998888887555433332 23


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..+|+.+.+||++||+.||.+|||++|+++|
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            45789999999999999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.8e-42  Score=355.67  Aligned_cols=252  Identities=20%  Similarity=0.343  Sum_probs=210.9

Q ss_pred             ChhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          186 NPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +.....|.+.+.||.|+||.+.     .++..||+|++...... ......+.+|+.+++.++||||+++++++......
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3456689999999999998662     36889999999864322 12246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC---CcEEEEeeccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRL  337 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~---~~vkl~DfG~a~~  337 (473)
                      |+|||||++|+|.+++.....+++..++.++.||+.||.|||++|   |+||||||+|||++..   +.+||+|||+++.
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999999999988888999999999999999999999999   9999999999999764   4599999999976


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      .....       ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+....... ...
T Consensus       189 ~~~~~-------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~  259 (494)
T 3lij_A          189 FENQK-------KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF-DSP  259 (494)
T ss_dssp             CBTTB-------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-CSG
T ss_pred             CCCCc-------cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-Cch
Confidence            54321       1234568999999999864 68999999999999999999999999999988888875544333 223


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+..+|+.+.+||++||+.||.+|||+.|+++|
T Consensus       260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            356789999999999999999999999999876

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-43  Score=359.75  Aligned_cols=245  Identities=25%  Similarity=0.451  Sum_probs=210.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+     ..+|+.||||++.............+.+|+.+++.++||||+++++++......|+|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5778889999999754     24689999999975321111234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++|+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......   
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---  170 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---  170 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc---
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999997653321   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......     .+..+++
T Consensus       171 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~  241 (476)
T 2y94_A          171 ----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY-----TPQYLNP  241 (476)
T ss_dssp             ----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC-----CCTTCCH
T ss_pred             ----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC-----CCccCCH
Confidence                1234568999999999988765 68999999999999999999999998888777777443221     2456889


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.+||++||..||.+|||++|+++|
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            99999999999999999999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-42  Score=336.35  Aligned_cols=257  Identities=27%  Similarity=0.491  Sum_probs=210.3

Q ss_pred             HhhccCceeeeEEEEEE---e--c----CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          191 QVRKADGITKGSYQVAK---W--N----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~--~----~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .|...+.||.|+||.+.   .  +    +..||||++....  .......+.+|+.+++.++||||+++++++...+..+
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            56777889999987552   1  1    2359999997543  4556678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+++++|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999775 56999999999999999999999999   99999999999999999999999999976543


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      .....   .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+... ..++   .+
T Consensus       200 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~---~~  272 (333)
T 1mqb_A          200 DPEAT---YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP---TP  272 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCC---CC
T ss_pred             ccccc---cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCC---Cc
Confidence            32111   11223345778999999998899999999999999999998 99999998888877776433 2222   24


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ..+++.+.+++.+||+.||.+||++.+++++|+++.....
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            5789999999999999999999999999999999987544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-42  Score=333.43  Aligned_cols=248  Identities=23%  Similarity=0.379  Sum_probs=200.9

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.||+|+||.+    ..+|+.||+|++..... .....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4677889999999855    23588999999975432 122235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++ +|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence            976 999998764 56999999999999999999999999   99999999999999999999999999976532211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC---------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL---------  415 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---------  415 (473)
                          ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......+..         
T Consensus       156 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          156 ----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ----ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence                12334578999999998764 5899999999999999999999999988877666655432111110         


Q ss_pred             ---------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          416 ---------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       416 ---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                                     ......+++.+.+||.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                           0112457899999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-42  Score=337.76  Aligned_cols=258  Identities=27%  Similarity=0.491  Sum_probs=214.1

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      .+|++.+.||.|+||.+.          .+++.||||++....  .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            478889999999998652          245789999997543  455667899999999999 6899999999987654


Q ss_pred             -ceEEEEeccCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE
Q 011991          259 -PMMIVLEYHAKGDLASYLQKKGR----------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (473)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili  321 (473)
                       ..++||||+++++|.+++.....                +++..++.++.|++.||.|||+++   |+||||||+||++
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~  181 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  181 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEE
Confidence             59999999999999999987543                789999999999999999999999   9999999999999


Q ss_pred             cCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 011991          322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPE  400 (473)
Q Consensus       322 ~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~  400 (473)
                      +.++.+||+|||+++.........    ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSE----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             CCCCCEEECCCccccccccCccce----eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999999999999997654322111    1223346788999999988899999999999999999998 99999887655


Q ss_pred             HHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          401 EVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       401 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      .........+..+.   .+..+++.+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus       258 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          258 EEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            44444334443333   245688999999999999999999999999999999987644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.7e-42  Score=337.41  Aligned_cols=238  Identities=25%  Similarity=0.424  Sum_probs=181.5

Q ss_pred             CceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          196 DGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       196 ~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      +.||+|+||.+.     .+++.||||++...      ....+.+|+.+++.+. ||||+++++++.++...|+||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            679999998652     36889999999643      2356788999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC---cEEEEeeccccccccCccccc
Q 011991          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~---~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      |+|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||+++.......   
T Consensus        91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---  164 (325)
T 3kn6_A           91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---  164 (325)
T ss_dssp             CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence            999999999888999999999999999999999999   99999999999998766   799999999975433211   


Q ss_pred             ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhhCCCCCCcccC
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP-------EEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~  419 (473)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .+....+. .+..+.....+
T Consensus       165 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~  240 (325)
T 3kn6_A          165 ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK-KGDFSFEGEAW  240 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT-TTCCCCCSHHH
T ss_pred             ---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH-cCCCCCCcccc
Confidence               12334578999999999999999999999999999999999999986432       34444442 23222222223


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ..+++++.+||.+||..||.+|||++|+++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            468999999999999999999999999886

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=343.30  Aligned_cols=244  Identities=22%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      ...+.||.|+||.+     ..+|+.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            33567999999855     2468899999997643   345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE--cCCCcEEEEeeccccccccCccc
Q 011991          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL--DNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili--~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ++++|.+++... ..+++..++.++.||+.||.|||+++   |+||||||+|||+  +.++.+||+|||+++....... 
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            999999988664 45999999999999999999999999   9999999999999  5667899999999976543211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                            .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ......+++
T Consensus       245 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~  317 (373)
T 2x4f_A          245 ------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE-DEEFQDISE  317 (373)
T ss_dssp             ------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-SGGGTTSCH
T ss_pred             ------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-hhhhccCCH
Confidence                  2234589999999999988999999999999999999999999999988888777755443322 223467899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.+||.+||+.||.+|||++|+++|
T Consensus       318 ~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          318 EAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99999999999999999999999884

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-42  Score=344.31  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=194.5

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ..+|.+.+.||+|+||.+     ..+++.||||++.......    +.+.+|+.+++.++||||+++++++......++|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            346888899999998744     3478999999998654333    4578999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc--EEEEeeccccccccC
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--LKISGFGLLRLQYIS  341 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~--vkl~DfG~a~~~~~~  341 (473)
                      |||+++|+|.+++...+.+++..++.++.|++.||.|||++|   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999988888999999999999999999999999   999999999999987665  999999998643221


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhCCCCCCc
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS-VDAYSFGLILYEMIEGVQPFHPKPP----EEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~  416 (473)
                      .       ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+...    ......+.......+  
T Consensus       172 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--  242 (361)
T 3uc3_A          172 S-------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--  242 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--
T ss_pred             C-------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--
Confidence            1       1223458999999999988777655 9999999999999999999987543    233333322222111  


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ....+++.+.+||++||+.||.+|||++|+++|
T Consensus       243 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 -DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             133578999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.4e-42  Score=336.57  Aligned_cols=258  Identities=27%  Similarity=0.506  Sum_probs=212.0

Q ss_pred             hhccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--Cce
Q 011991          192 VRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPM  260 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~  260 (473)
                      |++.+.||+|+||.+.         .+++.||||++...  ......+.+.+|+++++.++||||+++++++...  ..+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            4888999999998762         27889999999765  3456678899999999999999999999999874  568


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ++||||+++++|.+++... .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999999765 4999999999999999999999999   99999999999999999999999999986643


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHH
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE--------------VVKLM  406 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~--------------~~~~i  406 (473)
                      ....   ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.......              .....
T Consensus       187 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          187 GHEY---YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             TCSE---EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             cccc---cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            3211   112234457888999999998889999999999999999999999997532210              11122


Q ss_pred             HhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      ...+..+.   .+..+++.+.+||.+||+.||.+|||++|+++.|+.+..++..+
T Consensus       264 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          264 LERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            22232222   35678999999999999999999999999999999999887654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.6e-42  Score=356.67  Aligned_cols=251  Identities=21%  Similarity=0.346  Sum_probs=211.0

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCH----------HHHHHHHHHHHHHHhcCCCeeeeEEe
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP----------ERINAFTHELTIVEKARHPNVVQFVG  252 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~  252 (473)
                      ....|.+.+.||.|+||.+.     .+++.||+|++........          ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45579999999999998663     4678999999986543211          23467899999999999999999999


Q ss_pred             eEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC---cEEE
Q 011991          253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKI  329 (473)
Q Consensus       253 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~---~vkl  329 (473)
                      ++......|+|||||++|+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence            99999999999999999999999988888999999999999999999999999   99999999999998776   6999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~  409 (473)
                      +|||+++......       ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+...
T Consensus       191 ~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          191 VDFGLSSFFSKDY-------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             CCCTTCEECCTTS-------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             EECCCCEEcCCCC-------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            9999997653321       1234568999999999874 6899999999999999999999999999998888887554


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..... ...+..+|+.+.+||++||..||.+|||++|+++|
T Consensus       263 ~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          263 KYYFD-FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCC-ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            43222 22346789999999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.4e-42  Score=339.61  Aligned_cols=259  Identities=25%  Similarity=0.438  Sum_probs=216.2

Q ss_pred             HHhhccCceeeeEEEEEEe-----c-----CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCC
Q 011991          190 LQVRKADGITKGSYQVAKW-----N-----GTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~-----~-----~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  258 (473)
                      .+|.+.+.||.|+||.+..     +     ...||+|++....  .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            3678888999999986521     1     2479999997543  455668899999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC
Q 011991          259 PMMIVLEYHAKGDLASYLQKK--------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~  324 (473)
                      ..++||||+++|+|.+++...              ..+++..++.++.|++.||.|||+++   |+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            999999999999999999753              34799999999999999999999999   9999999999999999


Q ss_pred             CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVV  403 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  403 (473)
                      +.+||+|||+++.........    ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYI----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSE----ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CeEEECcccccccccccccee----ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            999999999997654322111    1223346778999999988899999999999999999998 99999887766555


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      ..+...+..+..   +..+++.+.+++.+||+.||.+|||+.+++++|+++....+.
T Consensus       277 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          277 YKLVKDGYQMAQ---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            555455543332   456789999999999999999999999999999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-41  Score=329.77  Aligned_cols=257  Identities=23%  Similarity=0.428  Sum_probs=205.8

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||.|+||.+.     .+|+.||+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            368899999999998552     468999999998765566777889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       265 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999865    355899999999999999999999999   99999999999999999999999999876533


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhhCCCCCCccc
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP--PEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ...      ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+..  .......+.. ...+..  .
T Consensus       189 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--~  259 (310)
T 2wqm_A          189 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPL--P  259 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCCC--C
T ss_pred             CCc------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCCC--c
Confidence            211      1223457889999999999999999999999999999999999997643  3334444432 222221  2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ...+++.+.+|+.+||..||.+|||++++++.|+++....
T Consensus       260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            3568999999999999999999999999999999998763

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-41  Score=330.63  Aligned_cols=248  Identities=20%  Similarity=0.329  Sum_probs=210.4

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ...+|.+.+.||.|+||.+.     .+|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            45688999999999998652     3689999999985432   223568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE---cCCCcEEEEeeccccccc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili---~~~~~vkl~DfG~a~~~~  339 (473)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||++   +.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999999999988888999999999999999999999999   9999999999999   678899999999986542


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ..        ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...... .....+
T Consensus       161 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~  231 (304)
T 2jam_A          161 NG--------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FESPFW  231 (304)
T ss_dssp             CB--------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-CCTTTT
T ss_pred             CC--------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCcccc
Confidence            21        112234788999999999999999999999999999999999999998888877777544322 222234


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+++.+.+||.+||..||.+|||++|++++
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          232 DDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            6789999999999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.9e-42  Score=328.30  Aligned_cols=251  Identities=22%  Similarity=0.375  Sum_probs=210.8

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCH---HHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ..+|.+.+.||.|+|+.+.     .+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            4578899999999998652     3588999999976543221   1346789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC----cEEEEeecccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLR  336 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~----~vkl~DfG~a~  336 (473)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++    .+||+|||++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            999999999999999988778999999999999999999999999   99999999999998877    89999999987


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                      ......       ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...... ...
T Consensus       161 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~  232 (283)
T 3bhy_A          161 KIEAGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD-FDE  232 (283)
T ss_dssp             ECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC-CCH
T ss_pred             eccCCC-------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC-Ccc
Confidence            553321       122345889999999999989999999999999999999999999998887777766443322 222


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+..+++.+.+|+.+||..||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            2345788999999999999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.2e-42  Score=333.72  Aligned_cols=258  Identities=22%  Similarity=0.413  Sum_probs=206.4

Q ss_pred             HHhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC---
Q 011991          190 LQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI---  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---  258 (473)
                      .+|.+.+.||.|+|+.+.   .     ++..||+|++..... .....+.+.+|+.+++.++||||+++++++....   
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            468888999999997542   1     345899999976543 4566688999999999999999999999987654   


Q ss_pred             --ceEEEEeccCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEE
Q 011991          259 --PMMIVLEYHAKGDLASYLQK------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (473)
Q Consensus       259 --~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~  330 (473)
                        ..++||||+++++|.+++..      .+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence              35999999999999999953      345999999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 011991          331 GFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCE  409 (473)
Q Consensus       331 DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~  409 (473)
                      |||+++.......    ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+...
T Consensus       190 Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          190 DFGLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             SCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             ecCcceecccccc----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            9999976533211    111223446778999999999999999999999999999999 99999988887777766433


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                       ..+.   .+..+++.+.+++.+||..||.+|||+++++++|+++..+++
T Consensus       266 -~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          266 -HRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             -CCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -CCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence             2222   256789999999999999999999999999999999998765

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.6e-42  Score=355.98  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=214.2

Q ss_pred             ccChhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC
Q 011991          184 ELNPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI  258 (473)
Q Consensus       184 ~i~~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  258 (473)
                      .-+....+|.+.+.||.|+||.+.     .+++.||||++....... .....+.+|+++++.++||||+++++++....
T Consensus        16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (486)
T ss_dssp             TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence            334567789999999999998652     368999999996432111 12367889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc---CCCcEEEEeeccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD---NGGQLKISGFGLL  335 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~---~~~~vkl~DfG~a  335 (473)
                      ..++||||+.+|+|.+++...+.+++..++.++.|++.||.|||++|   |+||||||+|||++   .++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            99999999999999999988888999999999999999999999999   99999999999995   4567999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      +......       ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+.........
T Consensus       172 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (486)
T 3mwu_A          172 TCFQQNT-------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL  243 (486)
T ss_dssp             TTBCCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred             eECCCCC-------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            7553321       1234568999999999876 5899999999999999999999999999988888887554433322


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ..+..+|+.+.+||++||+.||.+|||+.++++|
T Consensus       244 -~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 -PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             2345789999999999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-42  Score=341.89  Aligned_cols=261  Identities=20%  Similarity=0.307  Sum_probs=209.9

Q ss_pred             ccChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCC--CCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee
Q 011991          184 ELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQFVGAVTQ  256 (473)
Q Consensus       184 ~i~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  256 (473)
                      .+.....+|.+.+.||.|+||.+     ..++..||+|++.....  ......+.+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34456678999999999999865     24678999999975321  123445789999999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHc----------------------------------------CCCCHHHHHHHHHHHHH
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKK----------------------------------------GRLSPSKVLRFALDLAR  296 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qi~~  296 (473)
                      .+..++||||+++|+|.+++...                                        ..+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998521                                        11357788999999999


Q ss_pred             HHHHHhhcCCCCeEeCCCCCCCEEEcCCC--cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCC--CCCC
Q 011991          297 GMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN--EEFD  372 (473)
Q Consensus       297 ~L~~LH~~~~~~iiH~Dlkp~Nili~~~~--~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~  372 (473)
                      ||.|||+++   |+||||||+||+++.++  .+||+|||+++.........  ........||+.|+|||++.+  ..++
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~  254 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE--YYGMTTKAGTPYFVAPEVLNTTNESYG  254 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSSSCCC
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc--cccccccCCCccccCchhhccCCCCCC
Confidence            999999999   99999999999998776  89999999997654322111  112334568999999999865  6789


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          373 RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       373 ~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .++|||||||++|+|++|..||.+.+..+....+......... .....+++.+.+||.+||+.||.+||++.+++++
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            9999999999999999999999999888887777554433322 2334578999999999999999999999999884

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-42  Score=338.59  Aligned_cols=254  Identities=21%  Similarity=0.444  Sum_probs=206.1

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      .+|++.+.||.|+||.+.     .+++    .||+|.+....  .....+.+.+|+.+++.++||||+++++++..+. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            468888999999998662     2344    35888775432  2334578999999999999999999999998754 7


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++|+||+.+|+|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            8999999999999999874 56999999999999999999999999   9999999999999999999999999998664


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ......    ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.. +...+   .
T Consensus       169 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~---~  240 (327)
T 3poz_A          169 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLP---Q  240 (327)
T ss_dssp             TTCC-----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCC---C
T ss_pred             CCcccc----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-CCCCC---C
Confidence            332211    1223446778999999999999999999999999999999 9999998888777666643 32222   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +..++..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            456789999999999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-42  Score=346.06  Aligned_cols=268  Identities=15%  Similarity=0.164  Sum_probs=204.2

Q ss_pred             HHhhccCceeeeEEEEEEe----------cCcEEEEEEEcCCCCCCHHH--------HHHHHHHHHHHHhcCCCeeeeEE
Q 011991          190 LQVRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPER--------INAFTHELTIVEKARHPNVVQFV  251 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~~----------~~~~vavK~l~~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~  251 (473)
                      .+|.+.+.||.|+||.+..          .++.||||++..........        ...+..|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3788999999999986521          25789999997543110000        02233455566677899999999


Q ss_pred             eeEeeC----CceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc--CC
Q 011991          252 GAVTQN----IPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NG  324 (473)
Q Consensus       252 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~--~~  324 (473)
                      +++...    ...++||||+ +++|.+++... +.+++..++.++.||+.||.|||+++   |+||||||+|||++  .+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCT
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCC
Confidence            998764    4589999999 89999999876 57999999999999999999999999   99999999999999  88


Q ss_pred             CcEEEEeeccccccccCccccc-ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAK-IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV  403 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~  403 (473)
                      +.+||+|||+++.......... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            9999999999976543321111 111223455999999999999999999999999999999999999999864332222


Q ss_pred             HHHHhhCCCCCCc------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          404 KLMCCEGKRPPLK------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       404 ~~i~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      .........+...      .....+|+.+.+++..||+.||.+||++.+|++.|+++....+.+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            1111111000100      012567899999999999999999999999999999999976543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-41  Score=326.48  Aligned_cols=255  Identities=28%  Similarity=0.458  Sum_probs=212.7

Q ss_pred             HHhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|++.+.||.|+||.+.    .++..||+|.+......    .+.+.+|+++++.++||||+++++++.. +..++|||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            468888999999988552    34668999999754322    3578999999999999999999999864 56899999


Q ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++++|.+++....  .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999996542  5999999999999999999999999   99999999999999999999999999976543221


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .     ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. +..+.   .+..+
T Consensus       165 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~  235 (279)
T 1qpc_A          165 T-----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMV---RPDNC  235 (279)
T ss_dssp             E-----CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC---CCTTC
T ss_pred             c-----cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-ccCCC---Ccccc
Confidence            1     1223446778999999988889999999999999999999 9999999888877776643 22222   35678


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      ++.+.+++.+||+.||.+|||++++++.|+++......+
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  274 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ  274 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence            999999999999999999999999999999998876544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-42  Score=344.47  Aligned_cols=274  Identities=26%  Similarity=0.472  Sum_probs=214.1

Q ss_pred             cccChhHHHhhccCceeeeEEEEEE---e--c---CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeE
Q 011991          183 YELNPLELQVRKADGITKGSYQVAK---W--N---GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV  254 (473)
Q Consensus       183 ~~i~~~~~~~~~~~~ig~G~~~~~~---~--~---~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  254 (473)
                      +.+......|...+.||+|+||.+.   .  +   +..||+|.+...  ......+.+.+|+.+++.++||||+++++++
T Consensus        82 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~  159 (373)
T 3c1x_A           82 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC  159 (373)
T ss_dssp             TBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE
T ss_pred             cccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            3444455567788899999997652   1  2   236899998643  3455678899999999999999999999986


Q ss_pred             e-eCCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          255 T-QNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       255 ~-~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                      . .++..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             CCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeec
Confidence            5 456789999999999999999765 35889999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |+++.........  ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.. +.
T Consensus       237 G~a~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~-~~  313 (373)
T 3c1x_A          237 GLARDMYDKEFDS--VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GR  313 (373)
T ss_dssp             -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-TC
T ss_pred             ccccccccccccc--ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-CC
Confidence            9997654321111  111233456788999999998899999999999999999999 7888988776666655533 33


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCcccccc
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDT  467 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~~~~~  467 (473)
                      .+.   .+..+++.+.+++.+||+.||.+|||++|++++|+++...+..+.++.-+
T Consensus       314 ~~~---~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~~~  366 (373)
T 3c1x_A          314 RLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN  366 (373)
T ss_dssp             CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCCC
T ss_pred             CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceeecc
Confidence            222   25678999999999999999999999999999999999999988775544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=332.64  Aligned_cols=250  Identities=21%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+.     .+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            47788899999998652     358899999997653 345556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++...+.+++..++.++.|++.||.|||++|   |+||||||+||+++.++.+||+|||++........  
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--  157 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999976543211  


Q ss_pred             cccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC------------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR------------  412 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~------------  412 (473)
                          ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......            
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          158 ----YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             ----ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence                1223457889999999865 57899999999999999999999999988877665544322111            


Q ss_pred             --------CCC------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 --------PPL------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 --------~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                              +..      ......+++.+.+||.+||+.||.+|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                    000      01124678899999999999999999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.8e-42  Score=336.52  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=216.6

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ..+|.+.+.||+|+|+.+.     .+++.+|+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            3478889999999998652     35789999999876666677778899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++........
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999988888999999999999999999999999   99999999999999999999999999976532211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......     .+..++
T Consensus       197 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~  265 (335)
T 2owb_A          197 ------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHIN  265 (335)
T ss_dssp             ------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-----CCTTSC
T ss_pred             ------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC-----CCccCC
Confidence                  123356889999999999888999999999999999999999999988877777666443221     245678


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+.+||.+||+.||.+|||++|++++
T Consensus       266 ~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          266 PVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999999999999999999999999884

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.8e-42  Score=327.45  Aligned_cols=253  Identities=25%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             HHhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          190 LQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+|.+.+.+|.|+|+.+.   .     ++..||+|++....  .....+.+.+|+.+++.++||||+++++++.. +..+
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            468888899999987552   1     12359999997643  45566889999999999999999999999865 4569


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999765 45999999999999999999999999   99999999999999999999999999976543


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ...     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.... .++   .+
T Consensus       166 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~---~~  236 (281)
T 3cc6_A          166 EDY-----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLP---KP  236 (281)
T ss_dssp             ------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCC---CC
T ss_pred             ccc-----cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCC---CC
Confidence            211     11223446778999999988899999999999999999998 999998877777766664433 222   24


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+++.+.+++.+||+.||.+|||+.|++++|+++...
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            56889999999999999999999999999999998765

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-41  Score=333.31  Aligned_cols=254  Identities=27%  Similarity=0.458  Sum_probs=214.8

Q ss_pred             HHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+.+.||.|+||.+.          .+++.||+|++....  .......+.+|+.+++.++||||+++++++.....
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            478888999999987552          346789999997542  45556789999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 011991          260 MMIVLEYHAKGDLASYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI  329 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl  329 (473)
                      .++||||+++|+|.+++...          ..+++..++.++.|++.||.|||++|   |+||||||+||+++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence            99999999999999999753          34689999999999999999999999   999999999999999999999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........    .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus       180 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          180 GDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CCTTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             CcCcccccccccccc----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            999999755332111    11223346788999999988889999999999999999999 8999999888877777644


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      ... +.   .+..+++.+.++|.+||+.||.+|||+.|++++|+++..
T Consensus       256 ~~~-~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          256 GGL-LD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             TCC-CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCc-CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            332 22   256789999999999999999999999999999987654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.9e-42  Score=328.68  Aligned_cols=250  Identities=30%  Similarity=0.531  Sum_probs=203.5

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHH----HHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERI----NAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      .+|.+.+.||.|+|+.+     ..+++.||+|++...........    +.+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            35778889999988744     24688999999976543332222    67899999999999999999999987654  


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc-----EEEEeecc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGL  334 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~-----vkl~DfG~  334 (473)
                      ++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ .+|+||||||+||+++.++.     +||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence            7999999999999888654 46999999999999999999999986 34999999999999988776     99999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK--NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV--VKLMCCEG  410 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~--~~~i~~~~  410 (473)
                      ++.....         .....||+.|+|||++.  ...++.++|||||||++|+|++|..||........  ...+....
T Consensus       176 ~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          176 SQQSVHS---------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             CBCCSSC---------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             ccccccc---------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            8643221         23456899999999984  45678999999999999999999999987654433  33443334


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      ..+.   .+..+++.+.++|.+||+.||.+|||++++++.|+++
T Consensus       247 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 LRPT---IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCC---CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            3333   3567899999999999999999999999999999753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.3e-42  Score=329.06  Aligned_cols=247  Identities=30%  Similarity=0.578  Sum_probs=204.4

Q ss_pred             HHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-CCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e  265 (473)
                      .+|++.+.||.|+|+.+   ...|+.||||++....     ..+.+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            46888899999988744   5689999999997542     34678999999999999999999999754 457899999


Q ss_pred             ccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++++|.+++...+.  +++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++....... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999999999976543  899999999999999999999999   9999999999999999999999999987543221 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                              ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+. .+..+.   .+..+
T Consensus       172 --------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~  239 (278)
T 1byg_A          172 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMD---APDGC  239 (278)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCC---CCTTC
T ss_pred             --------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCC---CcccC
Confidence                    12346788999999988899999999999999999998 999999888777766653 232222   35678


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ++.+.++|.+||+.||.+|||+.++++.|+++...
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.3e-42  Score=351.94  Aligned_cols=255  Identities=28%  Similarity=0.461  Sum_probs=210.6

Q ss_pred             HHhhccCceeeeEEEEE---Ee-cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~-~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|.+.+.||.|+||.+   .. .+..||||++......    .+.|.+|+.+++.++||||+++++++.. +..++|||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            35778889999999755   33 3467999999865422    3578999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++|+|.+++...  ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999999753  45999999999999999999999999   99999999999999999999999999976543211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .     ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. +.+++   .+..+
T Consensus       336 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~---~~~~~  406 (452)
T 1fmk_A          336 T-----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMP---CPPEC  406 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC---CCTTS
T ss_pred             e-----cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCC
Confidence            1     1122346778999999988899999999999999999999 9999999998888877743 33332   25678


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      |+.+.+||.+||+.||.+|||+++|++.|+++.....++
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence            999999999999999999999999999999988766554

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.6e-42  Score=331.14  Aligned_cols=255  Identities=25%  Similarity=0.471  Sum_probs=205.3

Q ss_pred             HHhhccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC--C
Q 011991          190 LQVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  258 (473)
                      ..|++.+.||.|+||.+.         .+++.||+|++.....  ....+.+.+|+++++.++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            357888999999998652         3688999999975432  23346789999999999999999999999876  6


Q ss_pred             ceEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++||||+++++|.+++.. .+.+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            68999999999999999955 456999999999999999999999999   99999999999999999999999999976


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHH
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK--------------PPEEVV  403 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~--------------~~~~~~  403 (473)
                      .......   ........+|+.|+|||++.+..++.++|||||||++|+|++|..|+...              ......
T Consensus       176 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          176 IETDKEY---YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CCTTCCE---EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             ccCCCcc---eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            5443221   11233455788899999998888999999999999999999999876422              111112


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      ......+....   .+..+++.+.+|+.+||+.||.+|||++++++.|++++
T Consensus       253 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            22222232222   35678999999999999999999999999999999876

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-41  Score=327.26  Aligned_cols=247  Identities=22%  Similarity=0.413  Sum_probs=203.8

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ....|.+.+.||+|+||.+.     .++..+|+|++......  ...+.+.+|+++++.++||||+++++++......++
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            45689999999999998652     46889999999865422  224678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE---cCCCcEEEEeeccc
Q 011991          263 VLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLL  335 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili---~~~~~vkl~DfG~a  335 (473)
                      ||||+++|+|.+++..    ...+++..++.++.|++.||.|||+++   |+||||||+||++   +.++.+||+|||++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999854    366999999999999999999999999   9999999999999   45678999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      .......       ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.....  ..
T Consensus       175 ~~~~~~~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~  244 (285)
T 3is5_A          175 ELFKSDE-------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--NY  244 (285)
T ss_dssp             CC-----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC
T ss_pred             eecCCcc-------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--cc
Confidence            7543321       123345889999999986 4689999999999999999999999999888777666543332  22


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ......+++.+.+|+.+||+.||.+|||++|+++
T Consensus       245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2234457899999999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-41  Score=348.51  Aligned_cols=256  Identities=22%  Similarity=0.304  Sum_probs=189.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----Cc
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~  259 (473)
                      .+|.+.+.||.|+||.|     ..+++.||||++.... ......+.+.+|+.+++.++||||+++++++...     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36889999999999855     3478999999997543 4566678899999999999999999999998543     56


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      +|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            899999985 699999988888999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCccccc---------------------ccccccCCCCCCcccCCCCc-CCCCCCCchhHHHHHHHHHHHHh--------
Q 011991          340 ISPEKAK---------------------IVFPVSHIDPANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIE--------  389 (473)
Q Consensus       340 ~~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~ell~--------  389 (473)
                      .......                     .........||+.|+|||++ .+..++.++|||||||++|||++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            3211100                     01123456789999999976 56679999999999999999998        


Q ss_pred             ---CCCCCCCCCh--------------------HHHHHHHHhhCCCC--------------------------CCcccCC
Q 011991          390 ---GVQPFHPKPP--------------------EEVVKLMCCEGKRP--------------------------PLKIKAR  420 (473)
Q Consensus       390 ---g~~pf~~~~~--------------------~~~~~~i~~~~~~~--------------------------~~~~~~~  420 (473)
                         |.++|.+.+.                    ...+..+......+                          .......
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               6777766431                    11111111111111                          1111234


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..++++.+||++||..||.+|||++|+++|
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            568999999999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.4e-42  Score=331.26  Aligned_cols=254  Identities=26%  Similarity=0.475  Sum_probs=215.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+|+.+     ..++..||+|++....    ...+.+.+|+++++.++||||+++++++..+...++||
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            46788889999988744     2348899999997532    34567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+++++|.+++...  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999999874  34899999999999999999999999   9999999999999999999999999997654332


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ..     ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+... ..+.   .+..
T Consensus       166 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~---~~~~  236 (288)
T 3kfa_A          166 YT-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME---RPEG  236 (288)
T ss_dssp             SE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCC---CCTT
T ss_pred             cc-----cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCC---CCCC
Confidence            11     1122335778999999988899999999999999999999 99999988887777666433 2222   2567


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      +|+.+.+|+.+||..||.+|||++++++.|+.+.....
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            89999999999999999999999999999999988654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=330.28  Aligned_cols=248  Identities=28%  Similarity=0.594  Sum_probs=201.5

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      +|.+.+.||+|+||.+   ...++.||||++...     ...+.+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            5777888999988744   677899999998643     234678999999999999999999998873  579999999


Q ss_pred             CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhh---cCCCCeEeCCCCCCCEEEcCCCc-EEEEeecccccccc
Q 011991          268 AKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHE---CKPDPIIHCDLKPKNILLDNGGQ-LKISGFGLLRLQYI  340 (473)
Q Consensus       268 ~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~---~~~~~iiH~Dlkp~Nili~~~~~-vkl~DfG~a~~~~~  340 (473)
                      ++++|.+++...+.   ++...++.++.|+++||.|||+   ++   |+||||||+||+++.++. +||+|||++.....
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999987543   7889999999999999999999   66   999999999999998886 79999999865432


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhCCCCCCccc
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE--EVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  418 (473)
                      .         .....||+.|+|||++.+..++.++|||||||++|+|++|..||......  .....+ ..+..+.   .
T Consensus       159 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~---~  225 (307)
T 2eva_A          159 H---------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPP---L  225 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCC---C
T ss_pred             c---------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCC---c
Confidence            1         12235889999999999999999999999999999999999999865432  222222 2333332   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      +..+++.+.+++.+||+.||.+|||+++++++|+.+...+...
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence            5678999999999999999999999999999999998876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=335.35  Aligned_cols=255  Identities=21%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC--ceEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~l  262 (473)
                      .+|.+.+.||+|+||.+.     .+++.||||++.....  ....+.+.+|+++++.++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            368888999999998652     3488999999975432  122466789999999999999999999988655  7899


Q ss_pred             EEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE----cCCCcEEEEeeccc
Q 011991          263 VLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLL  335 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili----~~~~~vkl~DfG~a  335 (473)
                      ||||+++++|.+++.....   +++..++.++.|++.||.|||+++   |+||||||+|||+    +..+.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999976433   999999999999999999999999   9999999999999    77778999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHH
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYK--------NEEFDRSVDAYSFGLILYEMIEGVQPFHPKP----PEEVV  403 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~----~~~~~  403 (473)
                      +......       ......||+.|+|||++.        +..++.++|||||||++|+|++|..||....    ..+..
T Consensus       164 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          164 RELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             EECCTTC-------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             eecCCCC-------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            7654321       122346899999999875        5678999999999999999999999997433    23444


Q ss_pred             HHHHhhCCCCCC--------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          404 KLMCCEGKRPPL--------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       404 ~~i~~~~~~~~~--------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      ..+.........                    ......+++.+.+|+++||..||++|||++|++++..+-..
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            444333221100                    00112234678999999999999999999999999876543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.5e-42  Score=327.25  Aligned_cols=245  Identities=24%  Similarity=0.411  Sum_probs=201.4

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+.     .+|+.||||++...........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            57788899999988552     3689999999975321112234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++...+.+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.......   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---  165 (276)
T 2h6d_A           92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---  165 (276)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc---
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999987653321   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..... .    .+..+++
T Consensus       166 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----~~~~~~~  236 (276)
T 2h6d_A          166 ----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-Y----IPEYLNR  236 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C----CCTTSCH
T ss_pred             ----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c----CchhcCH
Confidence                1123457889999999988765 5899999999999999999999998888777776643321 1    2456789


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.++|.+||+.||.+|||+++++++
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhC
Confidence            99999999999999999999999984

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=338.55  Aligned_cols=246  Identities=25%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  258 (473)
                      ..|.+.+.||+|+||.+     ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36888889999999855     2468999999997543 34556688999999999999999999999997653      


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      .+|+||||+ +++|.+++.. +.+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            469999999 7799999976 46999999999999999999999999   999999999999999999999999999764


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC---
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP---  414 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  414 (473)
                      ...         .....+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+......++   
T Consensus       179 ~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          179 DSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             CSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccc---------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            321         234568999999999876 6899999999999999999999999998887766655543222221   


Q ss_pred             -----------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 -----------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 -----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                             .......+++.+.+|+.+||..||.+|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                                   111234678999999999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.9e-42  Score=329.71  Aligned_cols=244  Identities=24%  Similarity=0.384  Sum_probs=208.4

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+.     .++..||+|++...........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            57888899999988552     3578999999964321111123578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++......    
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----  167 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----  167 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS----
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc----
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998654321    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.....  .   .+..+++.
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~---~~~~~~~~  238 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--K---FPPFLSDG  238 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--C---CCTTSCHH
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc--C---CCCcCCHH
Confidence                11234588999999999999999999999999999999999999998887777766643221  1   24568899


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.++|.+||..||.+|||++++++|
T Consensus       239 ~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          239 SKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            9999999999999999999999885

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-42  Score=330.23  Aligned_cols=259  Identities=29%  Similarity=0.514  Sum_probs=205.7

Q ss_pred             HHHhhccCceeeeEEEEE---Ee---cCc--EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          189 ELQVRKADGITKGSYQVA---KW---NGT--KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~---~~---~~~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ..+|++.+.||.|+|+.+   .+   ++.  .||||++...........+.+.+|+++++.++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            347888899999999744   22   222  69999998765555567788999999999999999999999998765 8


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++||||+++++|.+++... +.+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence            9999999999999999764 56999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ......   .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+......++   .
T Consensus       173 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~  246 (291)
T 1u46_A          173 QNDDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---R  246 (291)
T ss_dssp             C-CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---C
T ss_pred             ccccch---hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC---C
Confidence            332111   11223456778999999988888999999999999999999 9999999988888777755443333   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +..+++.+.+++.+||..||.+|||+.+++++|+++...
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            567899999999999999999999999999999988664

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.2e-42  Score=333.19  Aligned_cols=254  Identities=21%  Similarity=0.275  Sum_probs=198.3

Q ss_pred             HHhhcc-CceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEE
Q 011991          190 LQVRKA-DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       190 ~~~~~~-~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ..|.+. +.||.|+|+.+     ..+++.||||++......   ..+.+.+|++++.++ +||||+++++++..++..++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            356663 67999999865     246899999999765322   245788999999985 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc---EEEEeeccccccc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY  339 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~---vkl~DfG~a~~~~  339 (473)
                      ||||+++++|.+++...+.+++..++.++.|++.||+|||+++   |+||||||+||+++.++.   +||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999999988888999999999999999999999999   999999999999998765   9999999987553


Q ss_pred             cCcccc-cccccccCCCCCCcccCCCCcCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------------
Q 011991          340 ISPEKA-KIVFPVSHIDPANLYVAPEIYKN-----EEFDRSVDAYSFGLILYEMIEGVQPFHPKPP--------------  399 (473)
Q Consensus       340 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--------------  399 (473)
                      ...... ..........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+...              
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            221111 01111233458999999999865     4578999999999999999999999987542              


Q ss_pred             -HHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          400 -EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       400 -~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ......+.. +...........+++.+.+||.+||+.||.+|||++|+++|
T Consensus       246 ~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          246 QNMLFESIQE-GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHH-CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhc-cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             233444433 32222222235688999999999999999999999999984

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.8e-41  Score=337.87  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=211.7

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCC-C----HHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHK-D----PERINAFTHELTIVEKA-RHPNVVQFVGAVTQ  256 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~-~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  256 (473)
                      ...+|.+...||.|+||.+.     .+|+.||||++...... .    ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            34578888999999998652     36899999999765322 1    22356788999999999 79999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ....++||||++|++|.+++.....+++..++.++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++.
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCccc
Confidence            9999999999999999999988878999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYK------NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ......       ......||+.|+|||++.      ...++.++|||||||++|+|++|..||...........+....
T Consensus       249 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  321 (365)
T 2y7j_A          249 HLEPGE-------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ  321 (365)
T ss_dssp             ECCTTC-------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccCCCc-------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            653321       123456899999999885      3368899999999999999999999999888777777664433


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ... ....+..+++.+.+||.+||+.||.+|||+++++++
T Consensus       322 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          322 YQF-SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CCC-CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCC-CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            322 222345778999999999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-41  Score=329.96  Aligned_cols=253  Identities=28%  Similarity=0.486  Sum_probs=198.6

Q ss_pred             HHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHh--cCCCeeeeEEeeEee----CCce
Q 011991          190 LQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK--ARHPNVVQFVGAVTQ----NIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~----~~~~  260 (473)
                      .+|.+.+.||+|+||.+   ..+++.||||++...      ....+..|.+++..  ++||||+++++++..    ....
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46888899999999854   578999999999643      22456677777777  789999999998654    3458


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH--------ECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                      ++||||+++|+|.+++.. ..+++..++.++.|++.||.|||        +++   |+||||||+|||++.++.+||+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence            999999999999999955 46999999999999999999999        888   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCC------CCCCchhHHHHHHHHHHHHhC----------CCCCCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE------EFDRSVDAYSFGLILYEMIEG----------VQPFHP  396 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~ell~g----------~~pf~~  396 (473)
                      |+++.........  ........||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||..
T Consensus       158 g~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          158 GLAVMHSQSTNQL--DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             TTCEEEETTTTEE--ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             CCeeecccccccc--cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9997654432211  1122345689999999999876      445799999999999999999          888865


Q ss_pred             CC-----hHHHHHHHHhhCCCCCCcc--cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          397 KP-----PEEVVKLMCCEGKRPPLKI--KARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       397 ~~-----~~~~~~~i~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      ..     .......+......+..+.  ....+++.+.+|+.+||+.||.+|||++++++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            32     1222222222222222211  1223457899999999999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.9e-42  Score=334.49  Aligned_cols=253  Identities=28%  Similarity=0.506  Sum_probs=209.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcE--EEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~--vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|.+.+.||.|+||.+     ..++..  +|+|.+....  .....+.+.+|+++++++ +||||+++++++...+..++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            5778889999988754     345664  4999987432  234456789999999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc
Q 011991          263 VLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      ||||+++++|.+++...+                .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999997654                6899999999999999999999999   999999999999999999


Q ss_pred             EEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011991          327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKL  405 (473)
Q Consensus       327 vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  405 (473)
                      +||+|||+++.....       .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       181 ~kL~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~  253 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  253 (327)
T ss_dssp             EEECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             EEEcccCcCcccccc-------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence            999999998643211       11123346778999999988889999999999999999998 9999999888877766


Q ss_pred             HHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       406 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      +.. +..+.   .+..+++.+.+||.+||..||.+|||+++++++|+++.....
T Consensus       254 ~~~-~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          254 LPQ-GYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             GGG-TCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             hhc-CCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            633 22222   245788999999999999999999999999999999998644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3e-42  Score=356.97  Aligned_cols=252  Identities=25%  Similarity=0.466  Sum_probs=213.2

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+||.+   .  .++..||||++.....    ..+.|.+|+.+++.++||||+++++++......++||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            35778889999988744   2  3478999999975432    2467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+++|+|.+++...  ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            999999999999874  34899999999999999999999999   9999999999999999999999999998653321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      .     .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. .+.+..   .+..
T Consensus       373 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~  443 (495)
T 1opk_A          373 Y-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRME---RPEG  443 (495)
T ss_dssp             E-----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCC---CCTT
T ss_pred             e-----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC---CCCC
Confidence            1     11123345678999999988889999999999999999998 999999988877776663 333332   2567


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +++.+.+||.+||+.||.+|||+.+|++.|+.++..
T Consensus       444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            899999999999999999999999999999877543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.1e-42  Score=335.11  Aligned_cols=258  Identities=27%  Similarity=0.512  Sum_probs=209.2

Q ss_pred             HHhhccCceeeeEEEEE---E------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe--eCC
Q 011991          190 LQVRKADGITKGSYQVA---K------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT--QNI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~  258 (473)
                      .+|++.+.||.|+|+.+   .      .+++.||||++...   .....+.+.+|+++++.++||||+++++++.  ...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            46888899999999865   2      36789999999754   4566678999999999999999999999886  455


Q ss_pred             ceEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            68999999999999999977 345999999999999999999999999   99999999999999999999999999986


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHH
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE--------------EVV  403 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--------------~~~  403 (473)
                      .......   ........+|+.|+|||++.+..++.++|||||||++|+|++|..||......              ...
T Consensus       177 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          177 LPLDKDY---YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CCTTCSE---EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             cccCCcc---ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            5433221   11223445788899999998888999999999999999999999998653322              111


Q ss_pred             HHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          404 KLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       404 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ......+..+.   .+..+++.+.+||.+||+.||.+|||++|++++|+.+.....
T Consensus       254 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          254 LELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            12222232222   256789999999999999999999999999999999887543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.4e-43  Score=340.88  Aligned_cols=264  Identities=24%  Similarity=0.366  Sum_probs=208.9

Q ss_pred             ccChhHHHhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          184 ELNPLELQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       184 ~i~~~~~~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+.....+|...+.||.|+||.+.    .+++.||||++....   ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            344444578888899999987552    358999999987543   2345678999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      .++||||+++|+|.+++....    .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999986543    4899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhh
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVV------KLMCCE  409 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~------~~i~~~  409 (473)
                      +........    .......||+.|+|||++.+..++.++|||||||++|+|++|..||....+.+..      ......
T Consensus       187 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          187 KKGTELDQT----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             EECSSSSCC----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             ccccccccc----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            754322111    1122344788999999998889999999999999999999999999765432211      011111


Q ss_pred             CCCCC-----C-cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          410 GKRPP-----L-KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       410 ~~~~~-----~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +....     . ...+..++..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            11000     0 011122456799999999999999999999999999998764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-41  Score=362.06  Aligned_cols=251  Identities=25%  Similarity=0.443  Sum_probs=209.8

Q ss_pred             CceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          196 DGITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       196 ~~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      +.||.|+||.+.       ..++.||||++.... ......+.+.+|+++++.++||||+++++++.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            469999998663       245789999997643 234445789999999999999999999999864 56899999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      +|+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........   .
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~---~  526 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---Y  526 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---c
Confidence            9999999998888999999999999999999999999   999999999999999999999999999865433211   1


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. +..+.   .+..+|+++.
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~---~p~~~~~~l~  602 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMG---CPAGCPREMY  602 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC---CCTTCCHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCCHHHH
Confidence            11223346778999999998899999999999999999998 9999999998888777743 33332   2567899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          428 ELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       428 ~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      +||.+||+.||.+||++++|++.|++++..+
T Consensus       603 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          603 DLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999988654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-42  Score=340.77  Aligned_cols=254  Identities=23%  Similarity=0.463  Sum_probs=207.7

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcE----EEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTK----VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~----vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      +|++.+.||.|+||.+.     .+++.    ||+|.+.....  ......+.+|+.+++.++||||+++++++. +...+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            57788899999998652     23443    88888764321  122345778999999999999999999886 45689


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+.+|+|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999764 56999999999999999999999999   99999999999999999999999999987643


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ....    .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. +..+.   .+
T Consensus       168 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~  239 (325)
T 3kex_A          168 DDKQ----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-GERLA---QP  239 (325)
T ss_dssp             CTTC----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-TCBCC---CC
T ss_pred             cccc----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCC---CC
Confidence            3221    12234457788999999998899999999999999999999 9999998887777776643 32222   24


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ..+++++.+++.+||..||.+|||+.+++++|+++....
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            557889999999999999999999999999999997654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-41  Score=326.28  Aligned_cols=263  Identities=17%  Similarity=0.228  Sum_probs=209.9

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeE-eeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv  263 (473)
                      .+|.+.+.||.|+|+.+   .  .+|+.||||++......     ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            36888899999998755   2  57899999999765432     3578999999999988766655554 567778999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc---CCCcEEEEeeccccccc
Q 011991          264 LEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD---NGGQLKISGFGLLRLQY  339 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~---~~~~vkl~DfG~a~~~~  339 (473)
                      |||+ +++|.+++.. .+.+++..++.++.|++.||.|||+++   |+||||||+||+++   .++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            9999 8899999974 456999999999999999999999999   99999999999994   78899999999998665


Q ss_pred             cCcccccc-cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhCCCCCC
Q 011991          340 ISPEKAKI-VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP---EEVVKLMCCEGKRPPL  415 (473)
Q Consensus       340 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~  415 (473)
                      ........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .+....+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            43221111 1122455689999999999999999999999999999999999999986432   2233333222222222


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      ...+..+|+.+.+++.+||+.||.+|||++++++.|+++....+..
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            2234678999999999999999999999999999999999976654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.2e-42  Score=335.87  Aligned_cols=251  Identities=20%  Similarity=0.353  Sum_probs=196.1

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC----
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----  258 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----  258 (473)
                      ...+|++.+.||+|+||.+     ..+|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            4457889999999999855     2368999999997543  2344578999999999999999999999986543    


Q ss_pred             -----------------------------------------------------ceEEEEeccCCCCHHHHHHHcCC---C
Q 011991          259 -----------------------------------------------------PMMIVLEYHAKGDLASYLQKKGR---L  282 (473)
Q Consensus       259 -----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~---l  282 (473)
                                                                           ..++||||+++++|.+++.....   .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 28999999999999999987543   5


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccc------cccccCCCC
Q 011991          283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI------VFPVSHIDP  356 (473)
Q Consensus       283 ~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~------~~~~~~~~g  356 (473)
                      ++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...........      ........|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            66678999999999999999999   999999999999999999999999999866543221110      112234568


Q ss_pred             CCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCC
Q 011991          357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP  436 (473)
Q Consensus       357 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  436 (473)
                      |+.|+|||++.+..++.++|||||||++|+|++|..|+..  .......+ ....   .+..+...++.+.+||.+||+.
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~-~~~~---~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDV-RNLK---FPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHH-HTTC---CCHHHHHHCHHHHHHHHHHHCS
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHh-hccC---CCcccccCChhHHHHHHHHccC
Confidence            9999999999999999999999999999999998665421  11122222 1221   1122334568899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 011991          437 KPVIRPNFNEIIA  449 (473)
Q Consensus       437 dP~~RPs~~ell~  449 (473)
                      ||.+|||++|+++
T Consensus       313 ~p~~Rps~~~~l~  325 (332)
T 3qd2_B          313 SPTERPEATDIIE  325 (332)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             CCCcCCCHHHHhh
Confidence            9999999999997

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.6e-42  Score=335.00  Aligned_cols=249  Identities=22%  Similarity=0.326  Sum_probs=198.2

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+|+.+     ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            47889999999999755     34788999999976532 3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-----CCCcEEEEeeccccccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-----NGGQLKISGFGLLRLQY  339 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-----~~~~vkl~DfG~a~~~~  339 (473)
                      ||+++ +|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++     ..+.+||+|||+++...
T Consensus       113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            99975 99999999888999999999999999999999999   99999999999995     44569999999997653


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ....      ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+......+.....
T Consensus       189 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          189 IPIR------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             Cccc------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            3211      12334578999999999774 5899999999999999999999999998887776666443222221110


Q ss_pred             -------------------------CCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          419 -------------------------ARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       419 -------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                                               +..+++++.+||.+||..||.+|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                                     1126789999999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-41  Score=341.73  Aligned_cols=242  Identities=22%  Similarity=0.347  Sum_probs=191.5

Q ss_pred             HHhhcc-CceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHh-cCCCeeeeEEeeEee----CC
Q 011991          190 LQVRKA-DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQ----NI  258 (473)
Q Consensus       190 ~~~~~~-~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~----~~  258 (473)
                      .+|.+. +.||.|+||.+     ..+|+.||||++...        ..+.+|++++.+ .+||||+++++++..    ..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            345554 57999999866     246889999999632        346788888754 489999999999875    56


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeec
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFG  333 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG  333 (473)
                      .+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            7899999999999999998753  4999999999999999999999999   999999999999997   7889999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhh
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE----VVKLMCCE  409 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~----~~~~i~~~  409 (473)
                      +++......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....    ....+...
T Consensus       210 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~  282 (400)
T 1nxk_A          210 FAKETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  282 (400)
T ss_dssp             TCEECC------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred             cccccCCCC-------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence            997543221       1234568999999999999999999999999999999999999997654322    33333322


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .. ......+..+++++.+||++||+.||.+|||++|+++|
T Consensus       283 ~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 QY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CC-CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc-cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22 22222345789999999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.6e-42  Score=351.80  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=198.8

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  258 (473)
                      .+|.+.+.||.|+||.+     ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            36888999999999866     3468899999997643 34566788999999999999999999999997553      


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..|+||||+++ +|.+.+..  .+++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            46999999976 67777743  4999999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-  417 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  417 (473)
                      ...       .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......|.... 
T Consensus       215 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          215 GTS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             --C-------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             CCC-------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            332       112345689999999999999999999999999999999999999999887776666544322221100 


Q ss_pred             -------------------------cCCC-----------CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 -------------------------KARS-----------YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 -------------------------~~~~-----------~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                               .+..           .++++.+||++||..||++|||++|+++|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                     0000           14578999999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-41  Score=338.19  Aligned_cols=246  Identities=24%  Similarity=0.421  Sum_probs=206.5

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+||.+.     .++..||+|++....  .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            368888899999998652     358899999998653  4566788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++......  
T Consensus       111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999999999888899999999999999999999996 8   999999999999999999999999998654221  


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----------------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC----------------  407 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~----------------  407 (473)
                            ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.                
T Consensus       186 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          186 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             ------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             ------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence                  1223468999999999999999999999999999999999999998776554322210                


Q ss_pred             -------------------------hhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          408 -------------------------CEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       408 -------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                               .....  .......+++++.+||.+||+.||.+|||++|+++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                     11111  111234578899999999999999999999999886

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=334.23  Aligned_cols=248  Identities=21%  Similarity=0.326  Sum_probs=199.8

Q ss_pred             HHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC--CeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH--PNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv  263 (473)
                      ..|.+.+.||.|+||.+    ..+++.||||++.... ......+.+.+|+.+++.++|  |||+++++++..+...++|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35888899999999866    2467899999998654 345667889999999999986  9999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+ .+++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||+++.......
T Consensus        88 ~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             ECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            995 57799999999888999999999999999999999999   99999999999997 57899999999976543211


Q ss_pred             cccccccccCCCCCCcccCCCCcCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKN-----------EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGK  411 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~  411 (473)
                      .    .......||+.|+|||++.+           ..++.++|||||||++|+|++|..||...... .....+.....
T Consensus       163 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          163 S----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             c----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            1    11234568999999999854           67889999999999999999999999875443 33333322222


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...   .+...++.+.+|+.+||..||.+|||+.|+++|
T Consensus       239 ~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          239 EIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccC---CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            221   245567899999999999999999999999886

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=330.32  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCC--HHHHHHHHHHHHHHHhc---CCCeeeeEEeeEeeCC-
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD--PERINAFTHELTIVEKA---RHPNVVQFVGAVTQNI-  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~-  258 (473)
                      .+|++.+.||.|+|+.+     ..+++.||||++.......  ......+.+|+.+++.+   +||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            46888899999999754     2578899999997432211  11123456777777766   4999999999998755 


Q ss_pred             ----ceEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          259 ----PMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       259 ----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                          ..++||||+. ++|.+++.....  +++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSC
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeC
Confidence                4899999997 599999987644  999999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      |+++......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus       165 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          165 GLARIYSYQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             SCTTTSTTCC-------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccCCCc-------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9997653221       123345899999999998889999999999999999999999999998888777666443222


Q ss_pred             CCCc----------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          413 PPLK----------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       413 ~~~~----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ++..                      .....+++.+.+||.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            2111                      012357889999999999999999999999987

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=330.85  Aligned_cols=247  Identities=22%  Similarity=0.390  Sum_probs=183.6

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+|+.+   .  .+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            36888889999998855   2  478899999996432111122467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||+++++|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999875 56999999999999999999999999   99999999999999999999999999876532211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                      .      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....     ...+..++
T Consensus       168 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~  236 (278)
T 3cok_A          168 K------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-----YEMPSFLS  236 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-----CCCCTTSC
T ss_pred             c------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-----cCCccccC
Confidence            1      123457899999999999899999999999999999999999998766554443331111     11245688


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+.+||.+||..||.+|||+++++++
T Consensus       237 ~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          237 IEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            999999999999999999999999873

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-41  Score=336.32  Aligned_cols=245  Identities=21%  Similarity=0.301  Sum_probs=204.1

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-----CCeeeeEEeeEeeCC
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----HPNVVQFVGAVTQNI  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~~~~~~~  258 (473)
                      ..+|.+.+.||.|+|+.+.     .+++.||||++..    .......+..|+.+++.+.     ||||+++++++...+
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            3478899999999998652     3788999999963    3455577888999999996     999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-------------
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-------------  323 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-------------  323 (473)
                      ..++||||+ +++|.+++....  .+++..++.++.||+.||.|||+++   |+||||||+|||++.             
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence            999999999 889999998754  4999999999999999999999999   999999999999975             


Q ss_pred             ------------CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCC
Q 011991          324 ------------GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV  391 (473)
Q Consensus       324 ------------~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~  391 (473)
                                  ++.+||+|||+++.....         .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY---------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC---------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC---------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence                        788999999999754321         12456899999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHhhCCCCCCcc-----------------------------------------cCCCCCHHHHHHH
Q 011991          392 QPFHPKPPEEVVKLMCCEGKRPPLKI-----------------------------------------KARSYPPDLKELI  430 (473)
Q Consensus       392 ~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------------------------------~~~~~~~~l~~li  430 (473)
                      .||...+..+....+.......+...                                         .....++.+.+||
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            99998887776666544332221100                                         0001236788999


Q ss_pred             HHccCCCCCCCCCHHHHHHH
Q 011991          431 EECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       431 ~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+||+.||.+|||++|+++|
T Consensus       337 ~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          337 YSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhcCChhhCCCHHHHhcC
Confidence            99999999999999999873

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.8e-41  Score=338.43  Aligned_cols=247  Identities=21%  Similarity=0.323  Sum_probs=200.8

Q ss_pred             HhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC--CCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--HPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .|.+.+.||.|+||.+.    .+++.||||++..... .....+.+.+|+.+++.++  ||||+++++++..++.+|+||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            58888999999998662    3488999999986543 4566788999999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      | +.+++|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++........
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9 457899999998888999999999999999999999999   99999999999995 589999999999765332111


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-----------EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKR  412 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~  412 (473)
                          .......||+.|+|||++.+           ..++.++|||||||++|+|++|..||...... .....+......
T Consensus       211 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          211 ----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             ----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence                11234568999999999864           36889999999999999999999999875433 344444332222


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..   .+...++.+.+||.+||..||.+|||+.|++++
T Consensus       287 ~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          287 IE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            22   244557899999999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.9e-41  Score=325.79  Aligned_cols=262  Identities=17%  Similarity=0.226  Sum_probs=207.2

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeE-eeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv  263 (473)
                      .+|.+.+.||+|+|+.+     ..+++.||||++......     ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            46888899999998754     267889999997654322     3478899999999988776665554 667788999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE---cCCCcEEEEeeccccccc
Q 011991          264 LEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili---~~~~~vkl~DfG~a~~~~  339 (473)
                      |||+ +++|.+++.. .+.+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 8899999985 456999999999999999999999999   9999999999999   788999999999998664


Q ss_pred             cCcccccc-cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhCCCCCC
Q 011991          340 ISPEKAKI-VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE---EVVKLMCCEGKRPPL  415 (473)
Q Consensus       340 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~  415 (473)
                      ........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   .....+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            43221111 11233556899999999999999999999999999999999999999864322   222222222222222


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      ......+|+.+.+|+.+||+.||.+|||++++++.|+++....+.
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            223467899999999999999999999999999999999997664

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=335.57  Aligned_cols=260  Identities=18%  Similarity=0.195  Sum_probs=206.9

Q ss_pred             HHHhhccCceeeeEEEEEE---e----------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeee------
Q 011991          189 ELQVRKADGITKGSYQVAK---W----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ------  249 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~---~----------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~------  249 (473)
                      ..+|.+.+.||.|+||.+.   .          .++.||+|++...        +.+.+|+++++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            3478889999999998652   1          3789999999754        24789999999999999987      


Q ss_pred             ---------EEeeEee-CCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 011991          250 ---------FVGAVTQ-NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK  317 (473)
Q Consensus       250 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~  317 (473)
                               +++++.. +...++||||+ +++|.+++...  +.+++..++.++.|++.||.|||+++   |+||||||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~  188 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE  188 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence                     5677765 67899999999 89999999875  67999999999999999999999999   999999999


Q ss_pred             CEEEcCCC--cEEEEeeccccccccCccccc-ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 011991          318 NILLDNGG--QLKISGFGLLRLQYISPEKAK-IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF  394 (473)
Q Consensus       318 Nili~~~~--~vkl~DfG~a~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf  394 (473)
                      |||++.++  .+||+|||+++.......... .........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999988  899999999976543322111 111223457899999999999999999999999999999999999999


Q ss_pred             CCCC--hHHHHHHHHh-hCCCCCCc---ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          395 HPKP--PEEVVKLMCC-EGKRPPLK---IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       395 ~~~~--~~~~~~~i~~-~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      ....  .......... ....+...   .....+++.+.+|+.+||..||.+|||++++++.|+++..+.+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            8754  3333222211 11111110   11235789999999999999999999999999999999998653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=322.44  Aligned_cols=245  Identities=20%  Similarity=0.266  Sum_probs=196.3

Q ss_pred             ChhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCc
Q 011991          186 NPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  259 (473)
                      +....+|.+.+.||+|+||.+.     .+|+.||||++..... .......+..|+..+..+ +||||+++++++...+.
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            3445689999999999998662     3689999999876543 344445556666666555 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      .++||||+ +++|.+++... ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            99999999 66999988764 45999999999999999999999999   999999999999999999999999998765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ....       ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+....   ....+ ..+..  ....
T Consensus       208 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~-~~~~~--~~~~  273 (311)
T 3p1a_A          208 GTAG-------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQL-RQGYL--PPEF  273 (311)
T ss_dssp             C-------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHH-TTTCC--CHHH
T ss_pred             ccCC-------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH-hccCC--Cccc
Confidence            3321       1223458999999999876 78999999999999999999977665432   22222 11211  1123


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      +..+++.+.+||.+||+.||.+|||++|+++
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            4578999999999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.3e-41  Score=321.78  Aligned_cols=247  Identities=24%  Similarity=0.413  Sum_probs=204.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee----CCce
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~  260 (473)
                      ..|++.+.||+|+||.+     ..++..||+|++..... .....+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            35677788999999865     24678999999986543 45667889999999999999999999999875    3558


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-CCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-~~~~vkl~DfG~a~~~~  339 (473)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ .+|+||||||+||+++ .++.+||+|||++....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999999999999998788999999999999999999999986 2499999999999998 78899999999986543


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ...        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...............+..+  ...+
T Consensus       184 ~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~  252 (290)
T 1t4h_A          184 ASF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFD  252 (290)
T ss_dssp             TTS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGG
T ss_pred             ccc--------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--cccC
Confidence            221        123458899999998864 58999999999999999999999998855544443333333222  2234


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ...++.+.+||.+||+.||.+|||++++++
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            567889999999999999999999999997

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.5e-41  Score=323.09  Aligned_cols=250  Identities=25%  Similarity=0.347  Sum_probs=206.6

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      ...+|.+.+.||.|+|+.+     ..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            4567889999999998755     236899999999754432  345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||+++++|.+++.....+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999999987777999999999999999999999999   9999999999999999999999999987653321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCCCCcccCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ..    .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+......   .....
T Consensus       160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  232 (276)
T 2yex_A          160 RE----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---LNPWK  232 (276)
T ss_dssp             EE----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---STTGG
T ss_pred             ch----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---cCchh
Confidence            11    11234568899999999987765 68999999999999999999999876543 233333222211   11234


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .+++.+.+||.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          233 KIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            67899999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=332.72  Aligned_cols=254  Identities=20%  Similarity=0.447  Sum_probs=205.0

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      .+|++.+.||.|+||.+.     .+++    .||+|.+....  .....+.+.+|+.+++.++||||+++++++..+. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            368888999999998652     2444    35777775432  2233467899999999999999999999998754 7


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++|+||+.+|+|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            8999999999999999874 56999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      .....    .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+... ..++   .
T Consensus       169 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~---~  240 (327)
T 3lzb_A          169 AEEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP---Q  240 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCC---C
T ss_pred             Ccccc----ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCC---C
Confidence            33211    11223446778999999999999999999999999999999 99999998887777666433 2222   2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +..+++++.++|.+||..||.+|||+.|+++.|+++...
T Consensus       241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            556889999999999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.7e-42  Score=328.99  Aligned_cols=245  Identities=25%  Similarity=0.391  Sum_probs=201.8

Q ss_pred             HHhhccCceeeeEEEEEE-----ecC-------cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC
Q 011991          190 LQVRKADGITKGSYQVAK-----WNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  257 (473)
                      .+|.+.+.||.|+|+.+.     .++       ..||+|++....   ....+.+.+|+.+++.++||||+++++++..+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            367888899999998652     233       579999996532   33457789999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc--------EE
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--------LK  328 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~--------vk  328 (473)
                      +..++||||+++++|.+++...+. +++..++.++.|++.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999987654 999999999999999999999999   999999999999998876        99


Q ss_pred             EEeeccccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 011991          329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEG-VQPFHPKPPEEVVKLM  406 (473)
Q Consensus       329 l~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~i  406 (473)
                      |+|||++......          ....+|+.|+|||++.+ ..++.++|||||||++|+|++| ..||............
T Consensus       162 l~Dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~  231 (289)
T 4fvq_A          162 LSDPGISITVLPK----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY  231 (289)
T ss_dssp             ECCCCSCTTTSCH----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             eccCcccccccCc----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence            9999998654221          11235778999999977 6789999999999999999994 5566665555544433


Q ss_pred             HhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          407 CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       407 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      . ....     .+...++.+.+|+.+||+.||.+|||+++++++|++++.
T Consensus       232 ~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          232 E-DRHQ-----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             H-TTCC-----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             h-ccCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2 2211     234557889999999999999999999999999998766

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.9e-41  Score=327.95  Aligned_cols=256  Identities=27%  Similarity=0.383  Sum_probs=203.2

Q ss_pred             hccCceeeeEEEEE---EecCcEEEEEEEcCCC-CCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          193 RKADGITKGSYQVA---KWNGTKVWVKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       193 ~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      ..++.||+|+||.+   ..+++.||||++.... .......+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  113 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP  113 (307)
T ss_dssp             TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence            34478999999855   5688999999997543 2334456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          269 KGDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       269 ~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++|.+++..   ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.........
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999974   345899999999999999999999999   9999999999999999999999999987654321111


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhCC------CCCC
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE----VVKLMCCEGK------RPPL  415 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~----~~~~i~~~~~------~~~~  415 (473)
                          ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......    ....+.....      ....
T Consensus       191 ----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          191 ----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             ----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             ----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence                1233568999999998876 47899999999999999999999998654322    1122111110      0011


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVC  456 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  456 (473)
                      ...+..+++.+.+++.+||+.||.+|||+++++++|+++..
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            11122345679999999999999999999999999998753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.5e-42  Score=348.37  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=197.7

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK-----DPERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  257 (473)
                      ...+|.+.+.||+|+||.+     ..+++.||||++......     .......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3457889999999999865     246789999999754321     12233458899999999999999999999854 


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC---cEEEEeecc
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGL  334 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~---~vkl~DfG~  334 (473)
                      ...++||||+++|+|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++..+   .+||+|||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence            457999999999999999988888999999999999999999999999   99999999999997544   599999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      ++......       ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||...............+.
T Consensus       289 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          289 SKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             TTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             ceecCCCc-------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            97654321       1234568999999999864   5778999999999999999999999987554433332223443


Q ss_pred             CCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 RPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....+..+..+++.+.+||.+||+.||.+|||++|+++|
T Consensus       362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            333333446789999999999999999999999999984

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.6e-41  Score=330.53  Aligned_cols=255  Identities=28%  Similarity=0.482  Sum_probs=210.1

Q ss_pred             HHhhccCceeeeEEEEE---E-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+.+.||.|+||.+   .       .++..||||++...  ........+.+|+.+++.++||||+++++++.....
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            46888899999988643   2       35668999999643  245566789999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEE
Q 011991          260 MMIVLEYHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKI  329 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl  329 (473)
                      .++||||+++++|.+++....       .+++..++.++.|++.||.|||+++   |+||||||+||+++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999998753       3889999999999999999999999   999999999999984   446999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........    .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus       185 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          185 GDFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             CCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             Ccccccccccccccc----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            999998754332111    11123346788999999988899999999999999999998 9999999888877776644


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      .. .+.   .+..+++.+.++|.+||+.||.+||++.+++++|+.+...
T Consensus       261 ~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          261 GG-RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             TC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC-CCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            33 222   2557899999999999999999999999999999988764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.4e-42  Score=355.58  Aligned_cols=245  Identities=27%  Similarity=0.376  Sum_probs=205.1

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.|.     .+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  264 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT  264 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            57788899999998662     3689999999975321111223568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |++||+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-  340 (576)
T 2acx_A          265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  340 (576)
T ss_dssp             CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred             cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence            9999999999977543  999999999999999999999999   9999999999999999999999999997653321 


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhhCCCCCCcccC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP----PEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~  419 (473)
                            ......||+.|+|||++.+..++.++|||||||++|+|++|..||....    ...+...+.. .. ..   .+
T Consensus       341 ------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~-~~---~p  409 (576)
T 2acx_A          341 ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VP-EE---YS  409 (576)
T ss_dssp             ------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CC-CC---CC
T ss_pred             ------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cc-cc---CC
Confidence                  1233468999999999999999999999999999999999999998753    3344444432 21 11   24


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      ..+++++.+||.+||..||.+||     +++|+++|
T Consensus       410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            57899999999999999999999     78998875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=337.19  Aligned_cols=244  Identities=20%  Similarity=0.328  Sum_probs=204.0

Q ss_pred             ChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCH-----HHHHHHHHHHHHHHhcCCCeeeeEEeeEe
Q 011991          186 NPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDP-----ERINAFTHELTIVEKARHPNVVQFVGAVT  255 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  255 (473)
                      +....+|.+.+.||.|+||.+     ..+++.||||++........     .....+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345568999999999998744     35688999999986543221     12345778999999999999999999999


Q ss_pred             eCCceEEEEeccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          256 QNIPMMIVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       256 ~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                      ..+..++||||+.+| +|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            999999999998776 99999998888999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      ++.......       .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......     + ..    
T Consensus       177 a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~-~~----  239 (335)
T 3dls_A          177 AAYLERGKL-------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V-EA----  239 (335)
T ss_dssp             CEECCTTCC-------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T-TT----
T ss_pred             ceECCCCCc-------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H-hh----
Confidence            976543211       123458999999999988876 78999999999999999999999763221     0 11    


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ....+..+++++.+||.+||+.||.+|||+++++++
T Consensus       240 -~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 -AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111245689999999999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7e-42  Score=335.25  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=197.9

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+||.+.     .+++.||+|++.....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            47778899999998652     3688999999975431  1222245679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |+++ +|.+++...+ .+++..++.++.|++.||.|||++|   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence            9975 9999987754 5899999999999999999999999   99999999999999999999999999875432211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI------  417 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  417 (473)
                           ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+....      
T Consensus       156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence                 1233457899999999876 5789999999999999999999999999888877766644332222111      


Q ss_pred             -------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 -------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 -------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         ....+++++.+||.+||+.||.+|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                               123568899999999999999999999999873

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8e-41  Score=323.33  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=210.9

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCC------HHHHHHHHHHHHHHHhcC-CCeeeeEEeeEee
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKD------PERINAFTHELTIVEKAR-HPNVVQFVGAVTQ  256 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~------~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  256 (473)
                      ..+|.+.+.||.|+|+.+.     .+|+.||||++.......      ....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            3478888999999998652     367899999997643211      234567889999999995 9999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      +...++||||+++++|.+++.....+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchh
Confidence            9999999999999999999988888999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYK------NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ......       ......+|+.|+|||++.      ...++.++|||||||++|+|++|..||...+.......+....
T Consensus       173 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  245 (298)
T 1phk_A          173 QLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  245 (298)
T ss_dssp             ECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             hcCCCc-------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence            653321       123346888999999874      4568899999999999999999999999888877777665443


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .... ......+++.+.+|+.+||+.||.+|||++|+++
T Consensus       246 ~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 YQFG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCCC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccC-cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            3322 2223568899999999999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=356.35  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=207.6

Q ss_pred             ceeeeEEEEEE---e----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccCC
Q 011991          197 GITKGSYQVAK---W----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (473)
Q Consensus       197 ~ig~G~~~~~~---~----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  269 (473)
                      .||.|+||.+.   .    ++..||||++....  .....+.+.+|+++++.++||||+++++++.. +..++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            68999997652   2    45679999997643  22345789999999999999999999999876 568999999999


Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      |+|.+++... +.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.........   
T Consensus       420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~---  493 (613)
T 2ozo_A          420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY---  493 (613)
T ss_dssp             CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee---
Confidence            9999999754 45999999999999999999999999   9999999999999999999999999998654321111   


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                      .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. .+.++.   .+..+++.+.
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~---~p~~~~~~l~  569 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRME---CPPECPPELY  569 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCC---CCTTCCHHHH
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCC---CCCcCCHHHH
Confidence            11122335678999999988899999999999999999998 999999988888877764 343333   2567899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          428 ELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       428 ~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      +||.+||..||.+||++++|++.|+.++......
T Consensus       570 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence            9999999999999999999999999998876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.9e-42  Score=365.12  Aligned_cols=246  Identities=24%  Similarity=0.372  Sum_probs=210.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.||+|+||.|     ..+++.||||++...........+.+..|..++..+ .||+|+++++++.+.+.+|+||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            5788889999999854     346789999999753211122346678899999988 6999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-  497 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-  497 (674)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred             eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999975322211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+......     .+..+++
T Consensus       498 -----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~  567 (674)
T 3pfq_A          498 -----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-----YPKSMSK  567 (674)
T ss_dssp             -----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC-----CCTTSCH
T ss_pred             -----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----CCccCCH
Confidence                 234467999999999999999999999999999999999999999999998888888543322     2457899


Q ss_pred             HHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNF-----NEIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~-----~ell~~  450 (473)
                      ++.+||++||..||.+||++     +||++|
T Consensus       568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            99999999999999999998     666653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-41  Score=333.61  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=201.0

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCC--HHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKD--PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ...+|.+.+.||.|+|+.+.     .+|+.||||++.......  ......+.+|+++++.++||||+++++++......
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            34578889999999998652     358899999997543221  11235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ++||||+++ +|.+++... ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999976 899988765 35899999999999999999999999   9999999999999999999999999997653


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-  417 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  417 (473)
                      ....      ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......+.... 
T Consensus       164 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          164 SPNR------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             SCCC------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CCcc------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            3211      12345689999999998664 589999999999999999999999999888777766644322221110 


Q ss_pred             ----------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 ----------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ----------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                            ....+++++.+||.+||..||.+|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                                  114567899999999999999999999999984

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-41  Score=331.71  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=200.3

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHK-----DPERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  257 (473)
                      ...+|.+.+.||.|+||.+.     .+++.||||++......     .......+.+|+++++.++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            45689999999999998652     35789999999754321     122345688999999999999999999998765


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc---EEEEeecc
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGL  334 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~---vkl~DfG~  334 (473)
                      . .++||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.   +||+|||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            4 8999999999999999988888999999999999999999999999   999999999999987654   99999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIY---KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE-VVKLMCCEG  410 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~  410 (473)
                      ++.......       .....||+.|+|||++   ....++.++|||||||++|+|++|..||....... ....+ ..+
T Consensus       164 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~  235 (322)
T 2ycf_A          164 SKILGETSL-------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI-TSG  235 (322)
T ss_dssp             CEECCCCHH-------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH-HHT
T ss_pred             ceecccccc-------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH-HhC
Confidence            976533211       1223478899999986   35678999999999999999999999998655432 33333 333


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .....+..+..+++.+.+||.+||..||.+||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            3333333346789999999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=354.16  Aligned_cols=255  Identities=28%  Similarity=0.458  Sum_probs=214.8

Q ss_pred             HHhhccCceeeeEEEEE---Ee-cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~-~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|.+.+.||.|+||.+   .. .+..||||++......    .+.|.+|+++++.++||||+++++++.. ...++|||
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            35778889999999865   33 3468999999865422    3578999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+++|+|.+++...  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999999753  45999999999999999999999999   99999999999999999999999999976532211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                           .......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. +.+..   .+..+
T Consensus       419 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~---~~~~~  489 (535)
T 2h8h_A          419 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMP---CPPEC  489 (535)
T ss_dssp             -----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCC---CCTTC
T ss_pred             -----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCC
Confidence                 11122345678999999988899999999999999999999 9999999998888877743 33332   25578


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      ++.+.+||.+||+.||++|||+++|++.|+.++....++
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  528 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  528 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence            999999999999999999999999999999988766555

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-41  Score=333.58  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||.|+||.+     ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            36888899999988744     2358899999997553 34556677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++|   |+||||||+||+++.++.+||+|||+++....... 
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence            99999999998877778999999999999999999999999   99999999999999999999999999976533211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC----------
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP----------  413 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  413 (473)
                           ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.......          
T Consensus       180 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          180 -----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             -----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence                 12334588999999998775 78999999999999999999999999888766655443221110          


Q ss_pred             ----------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 ----------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                      ........+++.+.+||.+||+.||.+|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                            0001123578999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.3e-42  Score=336.79  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=199.5

Q ss_pred             HHhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          190 LQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .+|.+.+.||+|+||.+.    .+|+.||||++......  .....+.+|+++++.++||||+++++++..+...++|||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  107 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP  107 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred             hccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence            478888999999997652    36889999999754321  112368899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc---CCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          266 YHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHEC---KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      |+++|+|.+++....    .+++..++.++.|++.||.|||++   +   |+||||||+|||++.++.+||+|||+++..
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999997643    389999999999999999999999   8   999999999999999999999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhhCCCC
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK-----PPEEVVKLMCCEGKRP  413 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~  413 (473)
                      ......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...     ........+.......
T Consensus       185 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (326)
T 3uim_A          185 DYKDTH-----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK  259 (326)
T ss_dssp             CSSSSC-----EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred             Cccccc-----ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence            432211     123445899999999998888999999999999999999999999521     1111111110000000


Q ss_pred             CCcc---------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          414 PLKI---------KARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       414 ~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      ....         .+...++.+.+++.+||+.||.+|||+.|++++|+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            0000         011123679999999999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-40  Score=339.46  Aligned_cols=255  Identities=23%  Similarity=0.328  Sum_probs=197.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----Cce
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~  260 (473)
                      +|.+.+.||+|+||.+     ..+++.||||++.... ......+++.+|+.+++.++||||+++++++...     ...
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            6888899999999865     2457899999997543 4556678899999999999999999999999765     569


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      |+||||+. ++|.+++.....+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            99999996 599999988888999999999999999999999999   99999999999999999999999999986543


Q ss_pred             Ccccc----------------cccccccCCCCCCcccCCCCc-CCCCCCCchhHHHHHHHHHHHHhC-----------CC
Q 011991          341 SPEKA----------------KIVFPVSHIDPANLYVAPEIY-KNEEFDRSVDAYSFGLILYEMIEG-----------VQ  392 (473)
Q Consensus       341 ~~~~~----------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~ell~g-----------~~  392 (473)
                      .....                ..........||+.|+|||++ .+..++.++||||+||++|||++|           .+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            22110                000123566789999999986 566799999999999999999984           44


Q ss_pred             CCCCCCh-----------------HHHHHHHHhhCCCCC------------------------C--cccCCCCCHHHHHH
Q 011991          393 PFHPKPP-----------------EEVVKLMCCEGKRPP------------------------L--KIKARSYPPDLKEL  429 (473)
Q Consensus       393 pf~~~~~-----------------~~~~~~i~~~~~~~~------------------------~--~~~~~~~~~~l~~l  429 (473)
                      +|.+.+.                 ...+..+......|.                        .  ....+.+++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence            4444321                 111111111111110                        0  01124678999999


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 011991          430 IEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       430 i~~cl~~dP~~RPs~~ell~~  450 (473)
                      |++||..||.+|||++|+++|
T Consensus       342 l~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHhcCCcccCCCHHHHhcC
Confidence            999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-41  Score=351.73  Aligned_cols=246  Identities=23%  Similarity=0.345  Sum_probs=204.2

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|...+.||.|+||.+.     .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            57777889999997552     3689999999975322112234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          266 YHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       266 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |++||+|.+++...    ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            99999999999764    35999999999999999999999999   999999999999999999999999999765332


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhhCCCCCCcc
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP----PEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~  417 (473)
                      ..      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....    ..++...+.....  .   
T Consensus       343 ~~------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~---  411 (543)
T 3c4z_A          343 QT------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--T---  411 (543)
T ss_dssp             CC------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--C---
T ss_pred             Cc------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--C---
Confidence            11      1233568999999999999999999999999999999999999998753    3455555533221  1   


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNF-----NEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~  450 (473)
                      .+..+++.+.+||++||+.||.+||++     +++++|
T Consensus       412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            246789999999999999999999965     677653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-40  Score=318.55  Aligned_cols=243  Identities=18%  Similarity=0.283  Sum_probs=200.8

Q ss_pred             hhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCce
Q 011991          187 PLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  260 (473)
                      ....+|.+.+.||.|+|+.+.     .+++.||+|++...... ......+.+|+..+..+ +||||+++++++..++..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            345689999999999998652     36899999999865443 34457788999999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC------------
Q 011991          261 MIVLEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG------------  324 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~------------  324 (473)
                      ++||||+++++|.+++...    +.+++..++.++.|++.||.|||+++   |+||||||+||+++.+            
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccc
Confidence            9999999999999999764    56999999999999999999999999   9999999999999844            


Q ss_pred             -------CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 011991          325 -------GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHP  396 (473)
Q Consensus       325 -------~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~  396 (473)
                             ..+||+|||++......          ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCS----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             ccccCCceEEEEcccccccccCCc----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                   47999999998765322          123488999999999776 566899999999999999999877754


Q ss_pred             CChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          397 KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       397 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...   ...+ ..+..+.   .+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       234 ~~~---~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          234 GDQ---WHEI-RQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             SHH---HHHH-HTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             hhH---HHHH-HcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            432   2233 2232222   356789999999999999999999999999873

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.4e-41  Score=330.78  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=209.7

Q ss_pred             ChhHHHhhcc-CceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCC
Q 011991          186 NPLELQVRKA-DGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI  258 (473)
Q Consensus       186 ~~~~~~~~~~-~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  258 (473)
                      ..+...|.+. +.||.|+||.+.     .+++.||+|++...... ......+.+|+.+++.+. ||||+++++++....
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            3445567776 789999998662     35899999999864332 233467889999999995 699999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeec
Q 011991          259 PMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFG  333 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG  333 (473)
                      ..++||||+++|+|.+++...  +.+++..++.++.|++.||+|||++|   |+||||||+||+++.   ++.+||+|||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            999999999999999998553  56999999999999999999999999   999999999999997   7899999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      +++......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......
T Consensus       180 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  252 (327)
T 3lm5_A          180 MSRKIGHAC-------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY  252 (327)
T ss_dssp             GCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cccccCCcc-------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc
Confidence            997653321       1233568999999999999999999999999999999999999999988888777765443332


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ....+..+++.+.+||.+||+.||.+|||+++++++
T Consensus       253 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          253 -SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             223356789999999999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.9e-41  Score=324.54  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=206.5

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l  262 (473)
                      .+|++.+.||.|+|+.+     ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..  +...++
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            36788889999988754     23689999999986543 45667889999999999999999999998754  567999


Q ss_pred             EEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          263 VLEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECK--PDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.+  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999763    23999999999999999999999976  1239999999999999999999999999987


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                      ........      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ..+.  
T Consensus       165 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~--  235 (279)
T 2w5a_A          165 ILNHDTSF------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRR--  235 (279)
T ss_dssp             HC---CHH------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCC--
T ss_pred             eecccccc------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-cccc--
Confidence            65332111      11234788999999998889999999999999999999999999998887777766443 3222  


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                       .+..+++.+.++|.+||+.||.+|||++|+++++
T Consensus       236 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          236 -IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             -CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence             2557899999999999999999999999999854

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=325.37  Aligned_cols=260  Identities=27%  Similarity=0.475  Sum_probs=202.0

Q ss_pred             hhHHHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc--CCCeeeeEEeeEeeC----
Q 011991          187 PLELQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA--RHPNVVQFVGAVTQN----  257 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~----  257 (473)
                      ....+|++.+.||.|+|+.+   ...++.||||++....      ...+..|.+++..+  +||||+++++++...    
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            34568999999999999854   5679999999996431      23445566666554  899999999999876    


Q ss_pred             CceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--------CCCCeEeCCCCCCCEEEcCCCcEEE
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC--------KPDPIIHCDLKPKNILLDNGGQLKI  329 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~~~~iiH~Dlkp~Nili~~~~~vkl  329 (473)
                      ...++||||+++|+|.+++... .+++..++.++.|++.||.|||++        +   |+||||||+|||++.++.+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEE
Confidence            6799999999999999999765 699999999999999999999998        8   999999999999999999999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCc------hhHHHHHHHHHHHHhC----------CCC
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRS------VDAYSFGLILYEMIEG----------VQP  393 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~~l~ell~g----------~~p  393 (473)
                      +|||+++........  .........||+.|+|||++.+..++..      +|||||||++|+|++|          ..|
T Consensus       184 ~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          184 ADLGLAVKFISDTNE--VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             CCCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EeCCCceeecccccc--ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999765433221  1112234568999999999988766654      9999999999999999          777


Q ss_pred             CCCCC-----hHHHHHHHHhhCCCCCCcc--cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          394 FHPKP-----PEEVVKLMCCEGKRPPLKI--KARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       394 f~~~~-----~~~~~~~i~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      |....     .......+......+..+.  ....+++.+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            75432     1222222322222222211  12345678999999999999999999999999999998764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-42  Score=347.43  Aligned_cols=238  Identities=15%  Similarity=0.173  Sum_probs=189.4

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHH---HHhcCCCeeeeEE-------eeE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTI---VEKARHPNVVQFV-------GAV  254 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~---l~~l~hpnIv~l~-------~~~  254 (473)
                      .+|.+.+.||.|+||.+     ..+|+.||||++...........+.+.+|+.+   ++.++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            46788889999999865     24689999999986554555567889999955   4455799999998       666


Q ss_pred             eeCC-----------------ceEEEEeccCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHhhcCCCCeE
Q 011991          255 TQNI-----------------PMMIVLEYHAKGDLASYLQKKGRLSP-------SKVLRFALDLARGMNYLHECKPDPII  310 (473)
Q Consensus       255 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l~~-------~~~~~i~~qi~~~L~~LH~~~~~~ii  310 (473)
                      ...+                 ..|+||||+ +|+|.+++...+.+++       ..++.++.||+.||+|||+++   |+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            5543                 289999999 5799999987554555       788899999999999999999   99


Q ss_pred             eCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC-----------CCCCchhHHH
Q 011991          311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-----------EFDRSVDAYS  379 (473)
Q Consensus       311 H~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwS  379 (473)
                      ||||||+|||++.++.+||+|||+++....         ......| +.|+|||++.+.           .++.++||||
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS  298 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA  298 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence            999999999999999999999999975322         1223456 889999999877           8999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          380 FGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       380 lG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |||++|+|++|..||...........+         ...+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus       299 lG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          299 LGLVIYWIWCADLPITKDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHHHHSSCCC------CCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHHHHCCCCCcccccccchhhh---------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999999999999765543322221         11235688999999999999999999999999873

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-40  Score=322.19  Aligned_cols=246  Identities=26%  Similarity=0.487  Sum_probs=210.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|.+.+.||.|+||.+     ..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            35788889999998754     245889999999865432  33577899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||+++++|.+++.. +.+++..++.++.|++.||.|||++|   |+|+||||+||+++.++.+||+|||++........ 
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            99999999999865 46999999999999999999999999   99999999999999999999999999976543211 


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.. ...+.   .+..+++
T Consensus       175 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  245 (303)
T 3a7i_A          175 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPT---LEGNYSK  245 (303)
T ss_dssp             -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCC---CCSSCCH
T ss_pred             -----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCC---CccccCH
Confidence                 12345688999999999999999999999999999999999999998887777666533 32222   2557899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARL  451 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L  451 (473)
                      .+.+|+.+||+.||.+|||+.+++++.
T Consensus       246 ~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          246 PLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            999999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=331.01  Aligned_cols=261  Identities=20%  Similarity=0.323  Sum_probs=204.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee----CCce
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPM  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~  260 (473)
                      .+|.+.+.||.|+|+.+     ..+++.||||++...   .....+.+.+|+++++.++||||+++++++..    ....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            36888899999999855     257899999998653   35667889999999999999999999999873    3468


Q ss_pred             EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          261 MIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ++||||+.+|+|.+++..    ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999999999976    456999999999999999999999999   9999999999999999999999999986


Q ss_pred             ccccCccccc---ccccccCCCCCCcccCCCCcCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHh
Q 011991          337 LQYISPEKAK---IVFPVSHIDPANLYVAPEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPP--EEVVKLMCC  408 (473)
Q Consensus       337 ~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~i~~  408 (473)
                      ..........   .........||+.|+|||++.+..   ++.++|||||||++|+|++|..||.....  ......+ .
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~  261 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-Q  261 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-H
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-h
Confidence            5432111100   001112234688899999987654   68999999999999999999999953211  1112222 2


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      .....+   .+..+++.+.++|.+||+.||.+|||+++++++|+.+....+.
T Consensus       262 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          262 NQLSIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             CC--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             ccCCCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence            221111   2456789999999999999999999999999999987665443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=336.09  Aligned_cols=268  Identities=16%  Similarity=0.153  Sum_probs=202.1

Q ss_pred             HHhhccCceeeeEEEEE---Ee-----cCcEEEEEEEcCCCCCCHH--------HHHHHHHHHHHHHhcCCCeeeeEEee
Q 011991          190 LQVRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPE--------RINAFTHELTIVEKARHPNVVQFVGA  253 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~-----~~~~vavK~l~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~l~~~  253 (473)
                      .+|.+.+.||+|+||.+   ..     ++..+|+|++.........        ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            47888999999999854   22     6789999999765321111        11346678889999999999999999


Q ss_pred             Eee----CCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC--cE
Q 011991          254 VTQ----NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QL  327 (473)
Q Consensus       254 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~--~v  327 (473)
                      +..    ....|+||||+ +++|.+++...+.+++..++.++.|++.||+|||+++   |+||||||+|||++.++  .+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence            987    67899999999 8999999988778999999999999999999999999   99999999999999877  99


Q ss_pred             EEEeeccccccccCccc-ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHH
Q 011991          328 KISGFGLLRLQYISPEK-AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK--PPEEVVK  404 (473)
Q Consensus       328 kl~DfG~a~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~--~~~~~~~  404 (473)
                      ||+|||+++........ ...........||+.|+|||++.+..++.++|||||||++|+|++|..||...  .......
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            99999999765432211 11112224557899999999999989999999999999999999999999652  2222221


Q ss_pred             HHHhh-CCCCC-Cc--ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          405 LMCCE-GKRPP-LK--IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       405 ~i~~~-~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      ..... ...+. ..  .....+++.+.++|.+||..||.+|||+++|++.|+++.....+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  333 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPL  333 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCC
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCC
Confidence            11110 01110 00  012268899999999999999999999999999998766544433

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.9e-41  Score=333.53  Aligned_cols=255  Identities=21%  Similarity=0.306  Sum_probs=203.6

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-------
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-------  256 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------  256 (473)
                      ..+|.+.+.||.|+||.+     ..+|+.||||++...... ......+.+|+.+++.++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            357888999999988644     246889999999755432 2223567899999999999999999999886       


Q ss_pred             -CCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          257 -NIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       257 -~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                       .+..++||||+++ +|.+.+... ..+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence             3468999999976 787777654 56999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~  413 (473)
                      ++........  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus       171 a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          171 ARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             CEECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9765432221  1122344568999999999876 468999999999999999999999999988877766664433222


Q ss_pred             CCcccCC---------------------------CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PLKIKAR---------------------------SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +....+.                           ..++.+.+||.+||..||.+|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            2211110                           026779999999999999999999999984

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9e-41  Score=333.58  Aligned_cols=247  Identities=22%  Similarity=0.284  Sum_probs=196.1

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  258 (473)
                      .+|.+.+.||.|+||.+     ..+++.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36888899999999866     2468899999997643 34566688999999999999999999999997654      


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..|+||||+++ +|.+++..  .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            68999999975 89888853  5999999999999999999999999   999999999999999999999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-  417 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  417 (473)
                      ....       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+.... 
T Consensus       178 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          178 GTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccc-------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            3221       12335689999999999999999999999999999999999999999887777666644322221100 


Q ss_pred             ------------------------------cCC------CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 ------------------------------KAR------SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ------------------------------~~~------~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                                    .+.      ..++.+.+||++||..||.+|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                                          000      014678999999999999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=330.83  Aligned_cols=261  Identities=26%  Similarity=0.382  Sum_probs=195.0

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHH--HHhcCCCeeeeEEeeEee-----CCce
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTI--VEKARHPNVVQFVGAVTQ-----NIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~~~-----~~~~  260 (473)
                      +|.+.+.||.|+||.+   ..+++.||||++....      ...+..|.++  +..++||||+++++.+..     ...+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            5778889999999855   5789999999997432      2334445555  445799999999986542     2357


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC---------KPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                      ++||||+++|+|.+++.... .++..++.++.|++.||.|||+.         +   |+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEee
Confidence            89999999999999997764 68999999999999999999999         8   99999999999999999999999


Q ss_pred             eccccccccCcccc--cccccccCCCCCCcccCCCCcCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 011991          332 FGLLRLQYISPEKA--KIVFPVSHIDPANLYVAPEIYKN-------EEFDRSVDAYSFGLILYEMIEGVQPFHPKP----  398 (473)
Q Consensus       332 fG~a~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~----  398 (473)
                      ||+++.........  ..........||+.|+|||++.+       ..++.++|||||||++|+|++|..||....    
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            99997654321110  11112234568999999999987       356678999999999999999977653311    


Q ss_pred             --------------hHHHHHHHHhhCCCCCCcccC---CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          399 --------------PEEVVKLMCCEGKRPPLKIKA---RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       399 --------------~~~~~~~i~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                                    .......+......+..+...   ..+++.+.+||.+||+.||.+|||++|+++.|+++...+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence                          111222222222233222111   113457999999999999999999999999999999876543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=321.53  Aligned_cols=246  Identities=22%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ...|.+.+.||.|+|+.+.     .+|+.||+|++.....     .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            3468888899999997552     3589999999976432     25688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||+++++|.+++.. ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999999974 567999999999999999999999999   9999999999999999999999999997653321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... ..+.. ..+..+
T Consensus       180 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~~~  251 (314)
T 3com_A          180 A------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTF-RKPELW  251 (314)
T ss_dssp             S------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCC-SSGGGS
T ss_pred             c------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-CCccc-CCcccC
Confidence            1      123346889999999999989999999999999999999999999988776665554332 22222 234567


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++.+.+||.+||..||.+|||+.+++++
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            8999999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.1e-41  Score=336.25  Aligned_cols=246  Identities=24%  Similarity=0.334  Sum_probs=188.8

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------C
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------I  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  258 (473)
                      .+|.+.+.||+|+||.+     ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46888899999999854     3468999999997543 3456668889999999999999999999998654      5


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++..
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            689999999 6799999876 46999999999999999999999999   999999999999999999999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--  415 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  415 (473)
                      ...         .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......|..  
T Consensus       183 ~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          183 ADE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccc---------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            321         233568999999999877 67899999999999999999999999998877666555332221110  


Q ss_pred             ------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                              .......++.+.+||++||..||.+|||++|+++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                                    01123568899999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=326.73  Aligned_cols=256  Identities=27%  Similarity=0.522  Sum_probs=208.6

Q ss_pred             HHhhccCceeeeEEEEEE---------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC--
Q 011991          190 LQVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  258 (473)
                      .+|++.+.||.|+||.+.         .+++.||||++...   .....+.+.+|+++++.++||||+++++++...+  
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            468888999999998652         26889999999753   3455678999999999999999999999987543  


Q ss_pred             ceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++||||+++++|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            789999999999999999876 45999999999999999999999999   99999999999999999999999999976


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----------------E  401 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~----------------~  401 (473)
                      ........   .......++..|+|||++.+..++.++|||||||++|+|++|..||......                .
T Consensus       195 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          195 LPQDKEYY---KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CCSSCSEE---ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccccc---ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            54332111   1122344677899999998888999999999999999999999988643111                1


Q ss_pred             HHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       402 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ....+ .....++   .+..+++.+.++|.+||+.||.+|||+.|+++.|+++..++
T Consensus       272 ~~~~~-~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          272 LIELL-KNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHH-HTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHh-hcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11122 2222222   25678999999999999999999999999999999998765

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.7e-41  Score=335.15  Aligned_cols=243  Identities=22%  Similarity=0.323  Sum_probs=197.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-------  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------  257 (473)
                      .+|.+.+.||+|+||.+     ..+|+.||||++......       ..+|+++++.++||||++++++|...       
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            46888899999999866     247899999999754322       24699999999999999999998543       


Q ss_pred             -------------------------------CceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh
Q 011991          258 -------------------------------IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLH  302 (473)
Q Consensus       258 -------------------------------~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH  302 (473)
                                                     ...++||||+++ +|.+.+..    .+.+++..++.++.|++.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           348999999985 88777653    467999999999999999999999


Q ss_pred             hcCCCCeEeCCCCCCCEEEc-CCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHH
Q 011991          303 ECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSF  380 (473)
Q Consensus       303 ~~~~~~iiH~Dlkp~Nili~-~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSl  380 (473)
                      ++|   |+||||||+|||++ .++.+||+|||+++.......       .....+|+.|+|||++.+. .++.++||||+
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------SVAYICSRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-------CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence            999   99999999999998 688999999999976533221       2334678999999998765 58999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC------------------------cccCCCCCHHHHHHHHHccCC
Q 011991          381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL------------------------KIKARSYPPDLKELIEECWDP  436 (473)
Q Consensus       381 G~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~l~~li~~cl~~  436 (473)
                      ||++|+|++|..||.+.+..+....+......|..                        ...+..+++++.+||.+||..
T Consensus       229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999999998887776665433222211                        012445789999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 011991          437 KPVIRPNFNEIIAR  450 (473)
Q Consensus       437 dP~~RPs~~ell~~  450 (473)
                      ||.+|||+.|+++|
T Consensus       309 dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          309 EPDLRINPYEAMAH  322 (383)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-40  Score=337.05  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=204.1

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc------CCCeeeeEEeeEee
Q 011991          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA------RHPNVVQFVGAVTQ  256 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~~~  256 (473)
                      ...+|.+.+.||.|+||.|.     .+++.||||++...    ......+.+|+.+++.+      .|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            34578999999999998662     35789999999742    44556788899998887      57799999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc--EEEEee
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--LKISGF  332 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~--vkl~Df  332 (473)
                      ....++||||+. ++|.+++....  .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.  +||+||
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999996 59999998753  4999999999999999999999999   999999999999999887  999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      |+++.....         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus       247 G~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~  317 (429)
T 3kvw_A          247 GSSCYEHQR---------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM  317 (429)
T ss_dssp             TTCEETTCC---------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccceecCCc---------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            999654321         23356899999999999989999999999999999999999999998877766655432221


Q ss_pred             CCCc------------------------------------------------------ccCCCCCHHHHHHHHHccCCCC
Q 011991          413 PPLK------------------------------------------------------IKARSYPPDLKELIEECWDPKP  438 (473)
Q Consensus       413 ~~~~------------------------------------------------------~~~~~~~~~l~~li~~cl~~dP  438 (473)
                      ++..                                                      ......++.+.+||++||..||
T Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP  397 (429)
T 3kvw_A          318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP  397 (429)
T ss_dssp             CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred             CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence            1110                                                      0112346889999999999999


Q ss_pred             CCCCCHHHHHHH
Q 011991          439 VIRPNFNEIIAR  450 (473)
Q Consensus       439 ~~RPs~~ell~~  450 (473)
                      .+|||++|+++|
T Consensus       398 ~~Rpta~e~L~H  409 (429)
T 3kvw_A          398 AVRMTPGQALRH  409 (429)
T ss_dssp             TTSCCHHHHHTS
T ss_pred             hhCCCHHHHhCC
Confidence            999999999983

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-40  Score=320.16  Aligned_cols=246  Identities=20%  Similarity=0.343  Sum_probs=188.6

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||.|+||.+   .  .+|+.||+|++.... ......+.+..+...++.++||||+++++++..++..++||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46888899999999865   2  378899999997543 22333344555555688889999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       265 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      ||+++ +|.+++..    .+.+++..++.++.|++.||.|||++ +   |+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 88887754    45799999999999999999999998 8   9999999999999999999999999997653


Q ss_pred             cCcccccccccccCCCCCCcccCCCCc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhhCCCCC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIY----KNEEFDRSVDAYSFGLILYEMIEGVQPFHPK-PPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~  414 (473)
                      ....       .....||+.|+|||++    .+..++.++|||||||++|+|++|..||... .............. +.
T Consensus       162 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~  233 (290)
T 3fme_A          162 DDVA-------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQ  233 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CC
T ss_pred             cccc-------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CC
Confidence            3211       1223588999999996    5567899999999999999999999999863 33344444433322 22


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                        ..+..+++.+.+|+.+||+.||.+|||++|+++|
T Consensus       234 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          234 --LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             --CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence              2245689999999999999999999999999884

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-40  Score=330.69  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=205.6

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----Cc
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~  259 (473)
                      .+|.+.+.||+|+||.+     ..++..||||++...  ......+.+.+|+++++.++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            36889999999999866     246789999999753  3455668899999999999999999999998754     36


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .|+||||+.+ +|.+++... .+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            8999999975 999999765 6999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC---
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL---  415 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---  415 (473)
                      .....   ........||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+....+......+..   
T Consensus       180 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          180 PDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             GGGCB---CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             CCCCc---cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            32211   11224457899999999864 456899999999999999999999999988776665555322221111   


Q ss_pred             -----------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 -----------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 -----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                             ......+++++.+||.+||..||.+|||++|+++|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                   11124678999999999999999999999999974

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-40  Score=326.33  Aligned_cols=261  Identities=25%  Similarity=0.437  Sum_probs=207.9

Q ss_pred             hhHHHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHh--cCCCeeeeEEeeEeeCC---
Q 011991          187 PLELQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK--ARHPNVVQFVGAVTQNI---  258 (473)
Q Consensus       187 ~~~~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~---  258 (473)
                      ....+|.+.+.||.|+|+.+   ..+|+.||||++...      ....+.+|+++++.  ++||||+++++++....   
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            34568999999999998754   568999999999643      23567889999988  68999999999998765   


Q ss_pred             -ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEeCCCCCCCEEEcCCCcEEE
Q 011991          259 -PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH--------ECKPDPIIHCDLKPKNILLDNGGQLKI  329 (473)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiH~Dlkp~Nili~~~~~vkl  329 (473)
                       ..++||||+++|+|.+++... .+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEE
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEE
Confidence             799999999999999999765 5999999999999999999999        788   999999999999999999999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCCC------CCCchhHHHHHHHHHHHHhC----------CCC
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE------FDRSVDAYSFGLILYEMIEG----------VQP  393 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~~l~ell~g----------~~p  393 (473)
                      +|||++..........  ........||+.|+|||++.+..      ++.++|||||||++|+|++|          ..|
T Consensus       189 ~Dfg~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             CCCTTCEEEETTTTEE--EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EECCCceecccccccc--ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            9999997654432211  11223456899999999987752      33689999999999999999          788


Q ss_pred             CCCCC-----hHHHHHHHHhhCCCCCCccc--CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          394 FHPKP-----PEEVVKLMCCEGKRPPLKIK--ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       394 f~~~~-----~~~~~~~i~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      |....     .......+......+..+..  ....++.+.+|+.+||+.||.+|||+++++++|+++..+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            87642     23333333333333332211  12334679999999999999999999999999999988754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-40  Score=320.11  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=210.4

Q ss_pred             ChhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          186 NPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +....+|++.+.||.|+|+.+.     .+++.||+|++...... ....+.+.+|+++++.++||||+++++++......
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            3445689999999999988552     36889999999754322 22346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC---CcEEEEeeccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRL  337 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~---~~vkl~DfG~a~~  337 (473)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++.+   +.+||+|||++..
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999999999988778999999999999999999999999   9999999999999754   4699999999875


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      ......       .....+|+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+........ ..
T Consensus       174 ~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~  244 (287)
T 2wei_A          174 FQQNTK-------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-LP  244 (287)
T ss_dssp             BCCCSS-------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-SG
T ss_pred             ecCCCc-------cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-ch
Confidence            433211       1122367789999998764 89999999999999999999999999888887777654433222 22


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....+++.+.++|.+||+.||.+|||+.|++++
T Consensus       245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            346789999999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.2e-41  Score=326.63  Aligned_cols=254  Identities=22%  Similarity=0.400  Sum_probs=186.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||.|+|+.+     ..+++.||||++.....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            5778889999998744     23688999999875432  2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          266 YHAKGDLASYLQK--------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       266 ~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      |+++++|.+++..        .+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            9999999999974        345899999999999999999999999   99999999999999999999999999876


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC-
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL-  415 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-  415 (473)
                      ....... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................... 
T Consensus       171 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          171 LATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             CC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            5432111 11112234568999999999865 56899999999999999999999999887766555444322211111 


Q ss_pred             ----cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ----KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                          ......+++.+.++|.+||+.||.+|||+++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                11235678999999999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.9e-41  Score=338.50  Aligned_cols=247  Identities=14%  Similarity=0.127  Sum_probs=183.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc--CCCeeeeEE-------eeEee
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA--RHPNVVQFV-------GAVTQ  256 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~-------~~~~~  256 (473)
                      +|.+.+.||.|+||.+     ..+|+.||||++...........+.+.+|+.+++.+  +||||++++       +++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            4778889999999865     246889999999987655566778888897666666  599988755       44443


Q ss_pred             C-----------------CceEEEEeccCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeEeC
Q 011991          257 N-----------------IPMMIVLEYHAKGDLASYLQKK-GRLSPSKV------LRFALDLARGMNYLHECKPDPIIHC  312 (473)
Q Consensus       257 ~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~iiH~  312 (473)
                      +                 ...|+||||++ |+|.+++... ..+++..+      +.++.||+.||+|||+++   |+||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence            3                 23799999998 7999999864 23455555      677899999999999999   9999


Q ss_pred             CCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhC
Q 011991          313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEG  390 (473)
Q Consensus       313 Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g  390 (473)
                      ||||+|||++.++.+||+|||+++......         ....+|+.|+|||++.+  ..++.++|||||||++|+|++|
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG---------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE---------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc---------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999997653211         12335688999999987  6899999999999999999999


Q ss_pred             CCCCCCCChHHHH--HHH--HhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          391 VQPFHPKPPEEVV--KLM--CCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       391 ~~pf~~~~~~~~~--~~i--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..||....+....  ...  ............+..+++.+.+||.+||+.||++|||+.++++|
T Consensus       290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9999876432110  000  00001111111235789999999999999999999999999763

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=323.05  Aligned_cols=247  Identities=21%  Similarity=0.410  Sum_probs=200.1

Q ss_pred             hHHHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee-----
Q 011991          188 LELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ-----  256 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-----  256 (473)
                      ...+|.+.+.||.|+|+.+   .  .+|+.||||++......    .+.+.+|+.+++.+ +||||+++++++..     
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3457888899999998855   2  37889999999754322    25688999999999 79999999999976     


Q ss_pred             -CCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          257 -NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       257 -~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                       ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||++|   |+|+||||+||+++.++.+||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence             46789999999999999999864  46999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      ++........      ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+..
T Consensus       175 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  248 (326)
T 2x7f_A          175 VSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  248 (326)
T ss_dssp             TTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CceecCcCcc------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence            9875432211      122345889999999987     55788999999999999999999999998887766665543


Q ss_pred             hCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          409 EGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       409 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ... +  ...+..+++.+.+||.+||..||.+||++++++++
T Consensus       249 ~~~-~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          249 NPA-P--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             SCC-C--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             Ccc-c--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            322 2  22356789999999999999999999999999885

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.2e-40  Score=328.10  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=202.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----Cc
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~  259 (473)
                      .+|.+.+.||.|+||.+     ..+|+.||||++...  ........+.+|+.+++.++||||+++++++...     ..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            46888899999999865     235889999999643  3455667889999999999999999999987654     67


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .++||||+. ++|.+++... .+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            899999997 5999998764 6999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCccccc----ccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          340 ISPEKAK----IVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       340 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      .......    .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            3221111    0111234568999999998754 6789999999999999999999999998887665554432211111


Q ss_pred             ---------------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 ---------------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                                 ....+..+++.+.+||.+||+.||.+|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                                       011124678999999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=337.93  Aligned_cols=249  Identities=23%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             HHhhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCCC-CHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  259 (473)
                      .+|.+.+.||.|+||.+.        .+++.||||++...... .....+.+.+|+++++.+ .||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            368888999999998653        27899999998643210 111224567899999999 69999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .++||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999999999998888999999999999999999999999   9999999999999999999999999997653


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhhCCCC
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFHPKP----PEEVVKLMCCEGKRP  413 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~----~~~~~~~i~~~~~~~  413 (473)
                      .....     ......||+.|+|||++.+  ..++.++|||||||++|+|++|..||....    ...+...+.. .. +
T Consensus       211 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~-~  283 (355)
T 1vzo_A          211 ADETE-----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SE-P  283 (355)
T ss_dssp             GGGGG-----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CC-C
T ss_pred             cCCCC-----cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cC-C
Confidence            32111     1223458999999999985  357899999999999999999999997532    2333333322 21 1


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRP-----NFNEIIARL  451 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L  451 (473)
                      .   .+..+++.+.+||.+||..||.+||     +++|++++.
T Consensus       284 ~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 P---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             C---CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1   2456889999999999999999999     999998864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-40  Score=318.17  Aligned_cols=247  Identities=24%  Similarity=0.409  Sum_probs=202.9

Q ss_pred             hHHHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee------
Q 011991          188 LELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ------  256 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------  256 (473)
                      ...+|.+.+.||.|+|+.+   .  .+++.||+|++....       +.+.+|+++++.++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            4568899999999988744   2  368999999997543       346789999999999999999998864      


Q ss_pred             ----------CCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC
Q 011991          257 ----------NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (473)
Q Consensus       257 ----------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~  324 (473)
                                ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence                      44589999999999999999764  56999999999999999999999999   9999999999999999


Q ss_pred             CcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 011991          325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK  404 (473)
Q Consensus       325 ~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~  404 (473)
                      +.+||+|||++.......       ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...  .....
T Consensus       159 ~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~  229 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT  229 (284)
T ss_dssp             TEEEECCCTTCEESSCCS-------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred             CCEEECcchhheeccccc-------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence            999999999987654321       122345889999999999889999999999999999999999887432  22222


Q ss_pred             HHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       405 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      .+. ...      .+..+++.+.++|.+||+.||.+|||+.|++++|+.+......
T Consensus       230 ~~~-~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          230 DLR-DGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHH-TTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             Hhh-ccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            221 111      2356789999999999999999999999999999988766543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-40  Score=321.81  Aligned_cols=248  Identities=21%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             HHHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ...|++.+.||.|+||.+   .  .+++.||+|++.....   ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            346888899999988744   2  3588999999975432   2346789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||+++++|.+++.. ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999999876 456999999999999999999999999   9999999999999999999999999975432110


Q ss_pred             ccccccccccCCCCCCcccCCCCc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIY-----KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                            .......||+.|+|||++     .+..++.++|||||||++|+|++|..||...+.......+.... .+. ..
T Consensus       172 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~  243 (302)
T 2j7t_A          172 ------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPT-LL  243 (302)
T ss_dssp             ------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCC-CS
T ss_pred             ------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC-Ccc-cC
Confidence                  112234588999999988     46678999999999999999999999999988877766664433 222 22


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+..++..+.++|.+||+.||.+|||++++++|
T Consensus       244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            355678999999999999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=332.58  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=204.2

Q ss_pred             HhhccCceeeeEEEEEE--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          191 QVRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      +|.+.+.||.|+|+.+.  ..+..+|+|++...... ....+.+.+|+.+++.++||||+++++++......++||||++
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             HeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            57888899999987552  23446999999754322 2223457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccc
Q 011991          269 KGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI  347 (473)
Q Consensus       269 ~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  347 (473)
                      +++|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+||+++ ++.+||+|||+++........ ..
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~-~~  187 (319)
T 2y4i_B          113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG-RR  187 (319)
T ss_dssp             SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----------
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccc-cc
Confidence            999999997754 5899999999999999999999999   99999999999998 689999999998754322111 11


Q ss_pred             cccccCCCCCCcccCCCCcCC---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          348 VFPVSHIDPANLYVAPEIYKN---------EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       348 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ........||+.|+|||++.+         ..++.++|||||||++|+|++|..||...........+... ..+..  .
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~  264 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-MKPNL--S  264 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT-CCCCC--C
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC-CCCCC--C
Confidence            122234457889999999864         35789999999999999999999999998888777766433 22222  2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ...+++.+.+++.+||..||.+|||+.++++.|+++....+
T Consensus       265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            34678899999999999999999999999999998887543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=338.74  Aligned_cols=257  Identities=21%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC--ceEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMI  262 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~l  262 (473)
                      .+|.+.+.||.|+||.+.     .+|+.||||++.....  ....+.+.+|+++++.++||||+++++++....  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            368888999999998652     3488999999975432  222466789999999999999999999998755  6899


Q ss_pred             EEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE----cCCCcEEEEeeccc
Q 011991          263 VLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLL  335 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili----~~~~~vkl~DfG~a  335 (473)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999997643   2999999999999999999999999   9999999999999    67778999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCC----ChHHHH
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN--------EEFDRSVDAYSFGLILYEMIEGVQPFHPK----PPEEVV  403 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~ell~g~~pf~~~----~~~~~~  403 (473)
                      +......       ......||+.|+|||++.+        ..++.++|||||||++|+|++|..||...    ...+..
T Consensus       164 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          164 RELEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             EECCCGG-------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             eEccCCC-------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            7653321       1233568999999998864        46778999999999999999999999642    233444


Q ss_pred             HHHHhhCCCCCC--------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          404 KLMCCEGKRPPL--------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       404 ~~i~~~~~~~~~--------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ..+.........                    ......+++.+.+++++||..||++||++.++++.++++..+.
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            444332211100                    0011223467889999999999999999999999999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=320.23  Aligned_cols=247  Identities=25%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC-CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe--eCCceEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l  262 (473)
                      +|.+.+.||+|+||.+     ..+++.||+|++...... .......+.+|+++++.++||||+++++++.  .....++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            5788889999999755     236789999999753211 1223577899999999999999999999984  4567999


Q ss_pred             EEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          263 VLEYHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ||||++++ |.+++..  .+.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999875 8888766  356999999999999999999999999   99999999999999999999999999976532


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEE--FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ....    .......||+.|+|||++.+..  ++.++|||||||++|+|++|..||.+.+..+....+......     .
T Consensus       162 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-----~  232 (305)
T 2wtk_C          162 FAAD----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-----I  232 (305)
T ss_dssp             TCSS----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-----C
T ss_pred             cccc----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC-----C
Confidence            2111    1223456899999999987654  378999999999999999999999998888777776443221     2


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..+++.+.+||.+||..||.+|||++|++++
T Consensus       233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            45688999999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.6e-40  Score=329.23  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce----
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----  260 (473)
                      .+|.+.+.||.|+||.+     ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++......    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            37888899999999865     2468999999997654 3456678899999999999999999999999877654    


Q ss_pred             --EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          261 --MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       261 --~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                        ++||||+. ++|.+++.  ..+++..++.++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence              99999997 59988874  34999999999999999999999999   999999999999999999999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC--
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL--  415 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  415 (473)
                      ...         .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+..  
T Consensus       195 ~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          195 DAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             --------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccC---------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            321         233567999999999877 68899999999999999999999999988877666655432222211  


Q ss_pred             ------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                              ...+..+++.+.+||.+||+.||.+|||++|+++|
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                                    01134578999999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=322.26  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=188.9

Q ss_pred             HHHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEe-------
Q 011991          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVT-------  255 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~-------  255 (473)
                      ..+|++.+.||.|+|+.+   .  .+++.||||++...   .....+.+.+|+.+++++. ||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            347889999999999865   2  37889999998654   3556678899999999996 999999999984       


Q ss_pred             -eCCceEEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          256 -QNIPMMIVLEYHAKGDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       256 -~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                       ....+++||||+. |+|.+++..   .+.+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence             3345899999996 699998865   456999999999999999999999986 2499999999999999999999999


Q ss_pred             eccccccccCccccc------ccccccCCCCCCcccCCCCc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 011991          332 FGLLRLQYISPEKAK------IVFPVSHIDPANLYVAPEIY---KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEV  402 (473)
Q Consensus       332 fG~a~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~  402 (473)
                      ||+++..........      .........+|+.|+|||++   .+..++.++|||||||++|+|++|..||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            999976543221110      00111234588999999998   566789999999999999999999999976554333


Q ss_pred             HHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          403 VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       403 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ...    ....+   .+...++.+.+||.+||+.||.+|||+.|++++|+.+....+
T Consensus       262 ~~~----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          262 VNG----KYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             hcC----cccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            221    11111   234567889999999999999999999999999999987543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.1e-40  Score=349.89  Aligned_cols=253  Identities=25%  Similarity=0.485  Sum_probs=211.8

Q ss_pred             HHhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          190 LQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .+|.+.+.||.|+||.+.   .     .+..||+|.+...  ......+.+.+|+.+++.++||||+++++++. ++..+
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            468888999999998552   2     2457999998653  34566688999999999999999999999985 45689


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +||||+++|+|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            9999999999999998654 5899999999999999999999999   99999999999999999999999999976533


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      ...     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+... ..++   .+
T Consensus       544 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~---~~  614 (656)
T 2j0j_A          544 STY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP---MP  614 (656)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCCC---CC
T ss_pred             Ccc-----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCC---CC
Confidence            211     11223446778999999988899999999999999999997 99999999888887777443 3332   25


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+++.+.+||.+||..||.+|||+.++++.|+++..+
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            67899999999999999999999999999999998765

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-39  Score=335.22  Aligned_cols=262  Identities=16%  Similarity=0.217  Sum_probs=210.7

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC-CeeeeEEeeEeeCCceEEE
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv  263 (473)
                      .+|.+.+.||.|+||.+.     .+++.||||++......     ..+.+|+++++.+.| ++|+.+..++......++|
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            368888999999998552     45899999998765432     247889999999987 5566666677778889999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE---cCCCcEEEEeeccccccc
Q 011991          264 LEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili---~~~~~vkl~DfG~a~~~~  339 (473)
                      |||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++...
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999 8899999975 456999999999999999999999999   9999999999999   578899999999998765


Q ss_pred             cCcccccc-cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhCCCCCC
Q 011991          340 ISPEKAKI-VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP---EEVVKLMCCEGKRPPL  415 (473)
Q Consensus       340 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~  415 (473)
                      ........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...   ...+..+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            43221111 1122356789999999999999999999999999999999999999987543   3333333222222222


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccC
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  460 (473)
                      ...+..+++++.+||.+||+.||.+||++++|++.|+.++....-
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~  282 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF  282 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence            233467899999999999999999999999999999999986553

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.6e-40  Score=329.85  Aligned_cols=244  Identities=24%  Similarity=0.345  Sum_probs=195.6

Q ss_pred             HHHhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc-----
Q 011991          189 ELQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-----  259 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----  259 (473)
                      ..+|.+.+.||.|+||.+.    ..+..+|+|.+......       ..+|+++++.++||||+++++++...+.     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            4478899999999998662    34567999988754322       2369999999999999999999865443     


Q ss_pred             -eEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-CCCcEEEEeec
Q 011991          260 -MMIVLEYHAKGDLASYLQ----KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFG  333 (473)
Q Consensus       260 -~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-~~~~vkl~DfG  333 (473)
                       +++||||+++ ++.+.+.    ..+.+++..++.++.|++.||.|||++|   |+||||||+|||++ .++.+||+|||
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence             8899999987 5544443    2467999999999999999999999999   99999999999999 78999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +++.......       .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus       188 ~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  260 (394)
T 4e7w_A          188 SAKILIAGEP-------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT  260 (394)
T ss_dssp             TCEECCTTCC-------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             CcccccCCCC-------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9976533221       2335678999999998765 5899999999999999999999999998877666655432211


Q ss_pred             CCC------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPL------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +..                        ...+..+++++.+||.+||..||.+|||+.|+++|
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            110                        01133578999999999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-40  Score=333.93  Aligned_cols=244  Identities=24%  Similarity=0.314  Sum_probs=194.9

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------  257 (473)
                      ...|...+.||.|+||.+.     .+|+.||||++.....       .+.+|+++++.++||||++++++|...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            3468888999999998662     3689999999975432       234699999999999999999998542      


Q ss_pred             CceEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC-CcEEEEee
Q 011991          258 IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGF  332 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~-~~vkl~Df  332 (473)
                      ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccc
Confidence            237899999976 77776643    456999999999999999999999999   9999999999999965 56899999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      |+++.......       .....+|+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus       202 G~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg  274 (420)
T 1j1b_A          202 GSAKQLVRGEP-------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG  274 (420)
T ss_dssp             TTCEECCTTCC-------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             hhhhhcccCCC-------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99976533211       2235689999999998765 789999999999999999999999999887665555433211


Q ss_pred             CCC------------------Cc------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          412 RPP------------------LK------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       412 ~~~------------------~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+.                  ..      ..+..+++++.+||.+||..||.+||++.|+++|
T Consensus       275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            111                  00      0124568999999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.3e-40  Score=325.49  Aligned_cols=250  Identities=16%  Similarity=0.207  Sum_probs=202.5

Q ss_pred             HHHhhccCceeeeEEEEE----------EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC---CCeeeeEEeeEe
Q 011991          189 ELQVRKADGITKGSYQVA----------KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR---HPNVVQFVGAVT  255 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~----------~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~  255 (473)
                      ..+|.+.+.||.|+||.+          ..+++.||||++....      ...+..|+++++.+.   |+||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            346888899999999855          2357899999997542      245777888888886   899999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-------
Q 011991          256 QNIPMMIVLEYHAKGDLASYLQK-----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-------  323 (473)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-------  323 (473)
                      .++..++||||+++|+|.+++..     .+.+++..++.++.||+.||+|||+++   |+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence            99999999999999999999974     456999999999999999999999999   999999999999988       


Q ss_pred             ----CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 011991          324 ----GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP  399 (473)
Q Consensus       324 ----~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~  399 (473)
                          ++.+||+|||+|+........    .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKG----TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTT----EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             cccccCCEEEeeCchhhhhhccCCC----ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                899999999999755322111    123445689999999999999999999999999999999999999964332


Q ss_pred             HHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHHHHhccC
Q 011991          400 EEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR-PNFNEIIARLDRIVCNCSK  460 (473)
Q Consensus       400 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ell~~L~~~~~~~~~  460 (473)
                      ...       ......  .....++.+.+++..|++.+|.+| |+++++.+.|++++.+...
T Consensus       291 ~~~-------~~~~~~--~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~  343 (365)
T 3e7e_A          291 GEC-------KPEGLF--RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT  343 (365)
T ss_dssp             TEE-------EECSCC--TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred             Cce-------eechhc--cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence            100       000001  111236789999999999999999 7889999999998887443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.8e-41  Score=330.77  Aligned_cols=250  Identities=20%  Similarity=0.345  Sum_probs=204.3

Q ss_pred             HHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCH--------------HHHHHHHHHHHHHHhcCCCeeeeEEe
Q 011991          190 LQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDP--------------ERINAFTHELTIVEKARHPNVVQFVG  252 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~l~~  252 (473)
                      .+|.+.+.||.|+|+.+   ..+|+.||||++........              ...+.+.+|+.+++.++||||+++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            36888889999988643   45899999999974321111              11267899999999999999999999


Q ss_pred             eEeeCCceEEEEeccCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcC
Q 011991          253 AVTQNIPMMIVLEYHAKGDLASY------LQK--KGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDN  323 (473)
Q Consensus       253 ~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~  323 (473)
                      ++...+..++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ +|   |+||||||+||+++.
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence            99999999999999999999998      655  4669999999999999999999999 88   999999999999999


Q ss_pred             CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCC-chhHHHHHHHHHHHHhCCCCCCCCCh-H
Q 011991          324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDR-SVDAYSFGLILYEMIEGVQPFHPKPP-E  400 (473)
Q Consensus       324 ~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~~l~ell~g~~pf~~~~~-~  400 (473)
                      ++.+||+|||++......        ......+|+.|+|||++.+. .++. ++|||||||++|+|++|..||..... .
T Consensus       188 ~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             TSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             CCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999765332        12345688999999999887 6666 99999999999999999999988776 5


Q ss_pred             HHHHHHHhhCCCCCCc--------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          401 EVVKLMCCEGKRPPLK--------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       401 ~~~~~i~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +....+.......+..              .....+++.+.+||.+||+.||.+|||++|+++|
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            5555553222111100              0015688999999999999999999999999884

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.6e-40  Score=321.06  Aligned_cols=244  Identities=22%  Similarity=0.325  Sum_probs=200.3

Q ss_pred             HHhhccCceeeeEEEEEE------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCC------eeeeEEeeEeeC
Q 011991          190 LQVRKADGITKGSYQVAK------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP------NVVQFVGAVTQN  257 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~~~  257 (473)
                      .+|++.+.||.|+||.+.      .+++.||||++..    .....+.+.+|+.+++.++|+      +|+++++++...
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            468888999999998652      2578999999964    245567889999999999765      499999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC------------
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN------------  323 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~------------  323 (473)
                      +..++||||+ +++|.+++...+  .+++..++.++.|++.||+|||+++   |+||||||+|||++.            
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999 789999998765  5889999999999999999999999   999999999999987            


Q ss_pred             -------CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 011991          324 -------GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHP  396 (473)
Q Consensus       324 -------~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~  396 (473)
                             ++.+||+|||+++.....         .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH---------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC---------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccCCCceEeeCcccccCccc---------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                   667999999998753221         2234689999999999999999999999999999999999999998


Q ss_pred             CChHHHHHHHHhhCCCCCCc---------------------------------------ccCCCCCHHHHHHHHHccCCC
Q 011991          397 KPPEEVVKLMCCEGKRPPLK---------------------------------------IKARSYPPDLKELIEECWDPK  437 (473)
Q Consensus       397 ~~~~~~~~~i~~~~~~~~~~---------------------------------------~~~~~~~~~l~~li~~cl~~d  437 (473)
                      .+..+....+.......+..                                       ......++.+.+||.+||..|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            88766555442221111100                                       001123467999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 011991          438 PVIRPNFNEIIAR  450 (473)
Q Consensus       438 P~~RPs~~ell~~  450 (473)
                      |.+|||++|+++|
T Consensus       317 P~~Rpt~~ell~h  329 (339)
T 1z57_A          317 PAKRITLREALKH  329 (339)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             cccccCHHHHhcC
Confidence            9999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-39  Score=314.61  Aligned_cols=251  Identities=21%  Similarity=0.339  Sum_probs=193.7

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee------
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ------  256 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------  256 (473)
                      ...+|++.+.+|.|+|+.+     ..+++.||||++..    .....+.+.+|+.+++.++||||+++++++..      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            3457889999999999855     24689999999964    24556789999999999999999999998864      


Q ss_pred             -------CCceEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEE
Q 011991          257 -------NIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK  328 (473)
Q Consensus       257 -------~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vk  328 (473)
                             ....++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence                   456899999999999999998653 4788999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCcccc--------cccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-C
Q 011991          329 ISGFGLLRLQYISPEKA--------KIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPK-P  398 (473)
Q Consensus       329 l~DfG~a~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~-~  398 (473)
                      |+|||++..........        ..........||+.|+|||++.+. .++.++|||||||++|+|++   ||... .
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999997653221000        001122345688999999999765 68999999999999999998   56533 2


Q ss_pred             hHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          399 PEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       399 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .......+.. .........+...++.+.++|.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RVNILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2333344322 2222222234567788999999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=319.08  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=195.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe---------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT---------  255 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---------  255 (473)
                      .+|.+.+.||.|+||.+     ..+++.||+|++...   .....+.+.+|+++++.++||||+++++++.         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            46888899999999854     234889999999753   4566788999999999999999999999873         


Q ss_pred             -----eCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-CCCcEEE
Q 011991          256 -----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKI  329 (473)
Q Consensus       256 -----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-~~~~vkl  329 (473)
                           .....++||||++ |+|.+++.. +.+++..++.++.|++.||.|||+++   |+||||||+||+++ .++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence                 3467899999997 599999865 46999999999999999999999999   99999999999997 5679999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++........   ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus       163 ~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          163 GDFGLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             CCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccCccccccCCCccc---ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999765322111   111223446888999998755 6789999999999999999999999998887666655533


Q ss_pred             hCCCC-------------------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          409 EGKRP-------------------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       409 ~~~~~-------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .....                         +....+..+++.+.+||++||+.||.+|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            22111                         1111235689999999999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=331.61  Aligned_cols=250  Identities=19%  Similarity=0.320  Sum_probs=181.9

Q ss_pred             HHHhhc-cCceeeeEEEEE---E----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CC
Q 011991          189 ELQVRK-ADGITKGSYQVA---K----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NI  258 (473)
Q Consensus       189 ~~~~~~-~~~ig~G~~~~~---~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~  258 (473)
                      ...|.+ ++.||.|+||.|   .    .+++.||||++......     ..+.+|+.+++.++||||+++++++..  +.
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            345655 457999999865   2    24778999999755332     357899999999999999999999954  66


Q ss_pred             ceEEEEeccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE----cCCC
Q 011991          259 PMMIVLEYHAKGDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGG  325 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili----~~~~  325 (473)
                      ..++||||+.+ +|.+++...         ..+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence            79999999965 898888632         14899999999999999999999999   9999999999999    6778


Q ss_pred             cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH----
Q 011991          326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE----  400 (473)
Q Consensus       326 ~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~----  400 (473)
                      .+||+|||+++........   ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....    
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             CEEECCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             cEEEEECCCceecCCCCcc---cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            9999999999865432111   1123345689999999998874 5899999999999999999999999765432    


Q ss_pred             -----HHHHHHHhhCCCCCCcc---------------------------------cCCCCCHHHHHHHHHccCCCCCCCC
Q 011991          401 -----EVVKLMCCEGKRPPLKI---------------------------------KARSYPPDLKELIEECWDPKPVIRP  442 (473)
Q Consensus       401 -----~~~~~i~~~~~~~~~~~---------------------------------~~~~~~~~l~~li~~cl~~dP~~RP  442 (473)
                           +....+......+....                                 .....++.+.+||.+||..||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                 33333322222221110                                 0011267899999999999999999


Q ss_pred             CHHHHHHH
Q 011991          443 NFNEIIAR  450 (473)
Q Consensus       443 s~~ell~~  450 (473)
                      |++|+++|
T Consensus       327 ta~e~L~h  334 (405)
T 3rgf_A          327 TSEQAMQD  334 (405)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99999984

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5e-40  Score=326.92  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             HHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCC--------CCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-
Q 011991          190 LQVRKADGITKGSYQVA----KWNGTKVWVKILDKESH--------KDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-  256 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  256 (473)
                      ..|.+.+.||.|+||.+    ..+|..||||++.....        ......+.+.+|+++++.++||||+++++++.. 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            46888889999999865    34588999999965332        233445789999999999999999999999854 


Q ss_pred             ----CCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          257 ----NIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       257 ----~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                          ....|+||||+. |+|.+++... ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence                235899999997 5888888654 36999999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ||+++......       ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus       178 fg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (362)
T 3pg1_A          178 FNLAREDTADA-------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV  250 (362)
T ss_dssp             TTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cCccccccccc-------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            99997443221       1233468889999999876 678999999999999999999999999988777666554322


Q ss_pred             CCCCC---------------------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPL---------------------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+..                           ...+..+++.+.+||.+||+.||.+|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            22211                           01234568899999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-39  Score=319.40  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=201.9

Q ss_pred             hHHHhhccCceeeeEEEEE---E---ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc---CCCeeeeEEeeEe---
Q 011991          188 LELQVRKADGITKGSYQVA---K---WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVT---  255 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~---~---~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~---  255 (473)
                      ...+|.+.+.||.|+||.+   .   .+|+.||+|++....... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457889999999999855   2   357889999997533211 1113456777777776   8999999999987   


Q ss_pred             --eCCceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEe
Q 011991          256 --QNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (473)
Q Consensus       256 --~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~D  331 (473)
                        .....++||||++ |+|.+++....  .+++..++.++.|++.||.|||++|   |+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence              4567999999997 59999998753  4999999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      ||+++......       ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....
T Consensus       164 fg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (326)
T 1blx_A          164 FGLARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  236 (326)
T ss_dssp             CCSCCCCCGGG-------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CcccccccCCC-------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            99987543221       12345688999999999999999999999999999999999999999887776666543211


Q ss_pred             CC----------------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          412 RP----------------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       412 ~~----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .+                      ........+++.+.+||.+||..||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11                      111123567899999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=313.51  Aligned_cols=242  Identities=24%  Similarity=0.405  Sum_probs=194.9

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEecc
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  267 (473)
                      .....||.|+||.+     ..++..||||.+....   ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34447899988754     2467899999997643   234567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeeccccccccCcc
Q 011991          268 AKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       268 ~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ++++|.+++....   .+++..++.++.|++.||.|||+++   |+|+||||+||+++. ++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999998752   3678899999999999999999999   999999999999987 89999999999876533211


Q ss_pred             cccccccccCCCCCCcccCCCCcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhCCCCCCcccCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNE--EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE-VVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  420 (473)
                            ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||....... ...........+.   .+.
T Consensus       179 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~  249 (295)
T 2clq_A          179 ------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE---IPE  249 (295)
T ss_dssp             --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC---CCT
T ss_pred             ------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc---ccc
Confidence                  12344688999999998664  37899999999999999999999997654332 2222222232222   256


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      .+++.+.+||.+||+.||++||+++++++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            78999999999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=322.72  Aligned_cols=245  Identities=22%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc-----
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-----  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----  259 (473)
                      .+|.....||.|+||.+     ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35788889999999865     2468999999997653 345566889999999999999999999999987654     


Q ss_pred             -eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          260 -MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       260 -~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                       .++||||+. ++|.+++..  .+++..++.++.|++.||.|||++|   |+||||||+||+++.++.+||+|||+++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence             499999997 599888743  4999999999999999999999999   999999999999999999999999998754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC-----
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR-----  412 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~-----  412 (473)
                      ...         .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......     
T Consensus       177 ~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          177 DAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             ----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             CCC---------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            221         223457889999999876 67899999999999999999999999988876655544322111     


Q ss_pred             ---------------------CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 ---------------------PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ---------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                           +.....+..+++.+.+||.+||..||.+|||++++++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                                 11112234678999999999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3e-39  Score=314.74  Aligned_cols=249  Identities=20%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             HHHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC--CCeeeeEEeeEeeCCceEE
Q 011991          189 ELQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--HPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~l  262 (473)
                      ..+|.+.+.||.|+||.+    ..+++.||||++..... .....+.+.+|+.+++.++  ||||+++++++..+...++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            346888899999999865    23588999999976543 4566788999999999997  5999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||+ .+++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||++++ +.+||+|||+++......
T Consensus       106 v~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          106 VMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             EEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            9995 57799999998888999999999999999999999999   999999999999975 899999999997653321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKN-----------EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEG  410 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~  410 (473)
                      ..    .......||+.|+|||++.+           ..++.++|||||||++|+|++|..||...... .....+....
T Consensus       181 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  256 (313)
T 3cek_A          181 TS----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  256 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             cc----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence            11    11233458999999999875           46888999999999999999999999875433 3333332222


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....   .+...++.+.++|.+||..||.+|||++|++++
T Consensus       257 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          257 HEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             SCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            2222   244568899999999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-39  Score=317.82  Aligned_cols=242  Identities=20%  Similarity=0.320  Sum_probs=194.7

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEee--CCce
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQ--NIPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~  260 (473)
                      ..+|.+.+.||.|+||.+     ..+++.||||++....      .+.+.+|+.+++.++ ||||+++++++..  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            357889999999999865     3468899999997432      256889999999997 9999999999987  6678


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeeccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQY  339 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~  339 (473)
                      ++||||+++++|.+++.   .+++..++.++.|++.||.|||++|   |+||||||+|||++.++ .+||+|||+++...
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999999874   3889999999999999999999999   99999999999999777 89999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHh---------
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKP-PEEVVKLMCC---------  408 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-~~~~~~~i~~---------  408 (473)
                      ...       ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+..         
T Consensus       183 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          183 PGQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  255 (330)
T ss_dssp             TTC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             CCC-------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence            321       1233468889999999877 678999999999999999999999995432 2222221111         


Q ss_pred             ----hCCCCC-------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          409 ----EGKRPP-------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       409 ----~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                          ......                   ....+..+++.+.+||.+||+.||.+|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                100000                   00012237899999999999999999999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-39  Score=322.10  Aligned_cols=247  Identities=20%  Similarity=0.260  Sum_probs=187.7

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc----
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----  259 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----  259 (473)
                      ..+|.+.+.||.|+||.+.     .+|+.||||++.......    ..+..|++.++.++||||+++++++...+.    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            3478899999999998552     468899999987543222    346678888899999999999999876443    


Q ss_pred             ---eEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEeCCCCCCCEEEcC-CCcEEE
Q 011991          260 ---MMIVLEYHAKGDLASYLQ----KKGRLSPSKVLRFALDLARGMNYLH--ECKPDPIIHCDLKPKNILLDN-GGQLKI  329 (473)
Q Consensus       260 ---~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~iiH~Dlkp~Nili~~-~~~vkl  329 (473)
                         .++||||+++ +|.+.+.    ....+++..++.++.|++.||.|||  +++   |+||||||+|||++. ++.+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence               8999999976 6655543    3456899999999999999999999  888   999999999999997 899999


Q ss_pred             EeeccccccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 011991          330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC  408 (473)
Q Consensus       330 ~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~  408 (473)
                      +|||+++.......       .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       174 ~Dfg~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          174 CDFGSAKKLSPSEP-------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             CCCTTCBCCCTTSC-------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             eeCCCceecCCCCC-------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            99999976543221       2234578999999998665 489999999999999999999999999888777666543


Q ss_pred             hCCCCCCc---------------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          409 EGKRPPLK---------------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       409 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ....+...                           .....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            22221100                           0112256789999999999999999999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-39  Score=319.24  Aligned_cols=246  Identities=24%  Similarity=0.443  Sum_probs=178.0

Q ss_pred             HhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHH-HHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|...+.||.|+||.+.     .+|+.||||++....  .......+..|+. +++.++||||+++++++..++..++||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            57778899999998652     358899999997643  3444556666666 677789999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          265 EYHAKGDLASYLQK-----KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       265 e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ||+++ +|.+++..     .+.+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88888764     46699999999999999999999998 8   999999999999999999999999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhCCCC
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIY----KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCCEGKRP  413 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~~~~~~  413 (473)
                      .....       .....||+.|+|||++    .+..++.++|||||||++|+|++|..||...... +....+ ..+..+
T Consensus       177 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~  248 (327)
T 3aln_A          177 VDSIA-------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPP  248 (327)
T ss_dssp             ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCSCCC
T ss_pred             ccccc-------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcCCCC
Confidence            33211       1223588999999998    4567899999999999999999999999865432 121111 111112


Q ss_pred             CC-cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 PL-KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .. ......+++.+.+|+.+||+.||.+|||+.+++++
T Consensus       249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            11 11234688999999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7e-40  Score=329.44  Aligned_cols=244  Identities=20%  Similarity=0.283  Sum_probs=193.3

Q ss_pred             HHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC--------CCeeeeEEeeEe-
Q 011991          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--------HPNVVQFVGAVT-  255 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~l~~~~~-  255 (473)
                      .+|.+.+.||.|+||.+.     .+++.||||++..    .....+.+.+|+.+++.++        ||||+++++++. 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            468899999999998662     4588999999964    2455678899999999995        788999999987 


Q ss_pred             ---eCCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCC----
Q 011991          256 ---QNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGG----  325 (473)
Q Consensus       256 ---~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~----  325 (473)
                         .....++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ |   |+||||||+|||++.++    
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence               456799999999 55777776554  4599999999999999999999998 8   99999999999999775    


Q ss_pred             ---------------------------------------------cEEEEeeccccccccCcccccccccccCCCCCCcc
Q 011991          326 ---------------------------------------------QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY  360 (473)
Q Consensus       326 ---------------------------------------------~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y  360 (473)
                                                                   .+||+|||+++.....         .....||+.|
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------~~~~~gt~~y  259 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---------SCSCCSCGGG
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---------CccCCCCCcc
Confidence                                                         7999999999765322         2334689999


Q ss_pred             cCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-hCCCCCC------------------
Q 011991          361 VAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP------EEVVKLMCC-EGKRPPL------------------  415 (473)
Q Consensus       361 ~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~------~~~~~~i~~-~~~~~~~------------------  415 (473)
                      +|||++.+..++.++|||||||++|+|++|..||.+.+.      ......+.. .+..+..                  
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            999999998999999999999999999999999976542      222222211 1111100                  


Q ss_pred             ----c--------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 ----K--------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ----~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                          .              ..+...++.+.+||.+||+.||.+|||++|+++|
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                0              0011224568899999999999999999999973

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-39  Score=319.52  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=170.3

Q ss_pred             hHHHhhccC-ceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee----C
Q 011991          188 LELQVRKAD-GITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----N  257 (473)
Q Consensus       188 ~~~~~~~~~-~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~  257 (473)
                      ...+|.+.+ .||.|+||.+.     .+|+.||||++...    ....   ......++.++||||+++++++..    .
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            345677754 58999998652     35899999999643    2222   222334566799999999999876    4


Q ss_pred             CceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEee
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGF  332 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~Df  332 (473)
                      ...++||||+++|+|.+++...+  .+++..++.++.|++.||.|||+++   |+||||||+||+++.   ++.+||+||
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence            45899999999999999998753  5999999999999999999999999   999999999999986   445999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hh
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC---CE  409 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~---~~  409 (473)
                      |+++.....        ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.............   ..
T Consensus       176 g~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          176 GFAKETTQN--------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             TTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             ccceecccc--------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            999754322        1223457899999999988889999999999999999999999997765543321111   11


Q ss_pred             CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       410 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ............+++.+.+||.+||+.||.+|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111112245789999999999999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.7e-39  Score=321.82  Aligned_cols=244  Identities=24%  Similarity=0.293  Sum_probs=198.3

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CC-----eeeeEEeeEeeC
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HP-----NVVQFVGAVTQN  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~~~~~  257 (473)
                      ..+|.+.+.||.|+||.+.     .+++.||||++..    .......+..|+.+++.+. |+     +|+++++++...
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            3478888999999998652     3578999999974    2445677888999998885 54     499999999999


Q ss_pred             CceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCCCeEeCCCCCCCEEEc--CCCcEEEEe
Q 011991          258 IPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHE--CKPDPIIHCDLKPKNILLD--NGGQLKISG  331 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~~~~iiH~Dlkp~Nili~--~~~~vkl~D  331 (473)
                      +..++||||+. ++|.+++...  +.+++..++.++.|++.||.|||+  .+   |+||||||+|||++  .++.+||+|
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999996 4999999875  459999999999999999999995  56   99999999999995  467899999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK  411 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~  411 (473)
                      ||+++.....         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus       205 FG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~  275 (382)
T 2vx3_A          205 FGSSCQLGQR---------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG  275 (382)
T ss_dssp             CTTCEETTCC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ccCceecccc---------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999765321         2345688999999999999999999999999999999999999999888777666544322


Q ss_pred             CCCCcc-------------------------------cCCC------------------------C----CHHHHHHHHH
Q 011991          412 RPPLKI-------------------------------KARS------------------------Y----PPDLKELIEE  432 (473)
Q Consensus       412 ~~~~~~-------------------------------~~~~------------------------~----~~~l~~li~~  432 (473)
                      .++...                               .+..                        .    ++.+.+||.+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            211100                               0000                        0    1378999999


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 011991          433 CWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       433 cl~~dP~~RPs~~ell~  449 (473)
                      ||+.||.+|||++|+++
T Consensus       356 mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             HTCSCTTTSCCHHHHTT
T ss_pred             hcCCChhhCCCHHHHhc
Confidence            99999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=310.86  Aligned_cols=247  Identities=21%  Similarity=0.384  Sum_probs=184.0

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||.|+|+.+   .  .+|+.||||++..... .....+.+..+..+++.++||||+++++++..++..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            36788889999999754   2  3689999999976532 2333344455556788889999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+ ++.+..+... .+.+++..++.++.|++.||.|||++ +   |+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5567666654 46799999999999999999999995 8   9999999999999999999999999986543321


Q ss_pred             ccccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhhCCCCCCc
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPK-PPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~  416 (473)
                      .       .....+|+.|+|||++.     ...++.++|||||||++|+|++|..||... ...+....+.. ...+..+
T Consensus       180 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~  251 (318)
T 2dyl_A          180 A-------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLP  251 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCCCC
T ss_pred             c-------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCCCC
Confidence            1       12345889999999984     457889999999999999999999999874 34444444433 3322221


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ....+++.+.+||.+||+.||.+||++++++++
T Consensus       252 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          252 -GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             234689999999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.8e-39  Score=316.76  Aligned_cols=245  Identities=20%  Similarity=0.309  Sum_probs=198.3

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecC-cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCe------eeeEEeeEee
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPN------VVQFVGAVTQ  256 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~-~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~  256 (473)
                      ..+|.+.+.||.|+||.+.     .++ ..||+|++..    .....+.+.+|+.+++.+.|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3478889999999998652     234 6899999964    2455678889999999997765      9999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE-------------
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-------------  321 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili-------------  321 (473)
                      .+..++||||+ +++|.+++....  .+++..++.++.||+.||.|||+++   |+||||||+|||+             
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            99999999999 568888776653  5999999999999999999999999   9999999999999             


Q ss_pred             ------cCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 011991          322 ------DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFH  395 (473)
Q Consensus       322 ------~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~  395 (473)
                            +.++.+||+|||+++.....         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH---------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccCCCcEEEeecCcccccccc---------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                  56789999999999753221         233468999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHhhCCCCCCc---------------------------------------ccCCCCCHHHHHHHHHccCC
Q 011991          396 PKPPEEVVKLMCCEGKRPPLK---------------------------------------IKARSYPPDLKELIEECWDP  436 (473)
Q Consensus       396 ~~~~~~~~~~i~~~~~~~~~~---------------------------------------~~~~~~~~~l~~li~~cl~~  436 (473)
                      .....+....+.......+..                                       ......++.+.+||.+||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            888766555443222111100                                       00111245789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 011991          437 KPVIRPNFNEIIAR  450 (473)
Q Consensus       437 dP~~RPs~~ell~~  450 (473)
                      ||.+|||++|+++|
T Consensus       321 dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          321 DPAQRITLAEALLH  334 (355)
T ss_dssp             STTTSCCHHHHTTS
T ss_pred             ChhhCcCHHHHhcC
Confidence            99999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.6e-39  Score=331.13  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=183.9

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|...+.||.|+||.+    ..+|+.||||++..+.      .+.+.+|+.+++.+ +||||+++++++..+...|+|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3555678999988744    5678999999997532      24578899999987 89999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC-------------C
Q 011991          266 YHAKGDLASYLQKKGRL-------SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-------------G  325 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l-------~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~-------------~  325 (473)
                      ||. |+|.+++...+..       ++..++.++.||+.||+|||+++   |+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            996 5999999875432       22345789999999999999999   9999999999999754             4


Q ss_pred             cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 011991          326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-------EEFDRSVDAYSFGLILYEMIE-GVQPFHPK  397 (473)
Q Consensus       326 ~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~ell~-g~~pf~~~  397 (473)
                      .+||+|||+++.........  ........||+.|+|||++.+       ..++.++|||||||++|+|++ |..||...
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSF--RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             EEEECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             EEEEcccccceecCCCCccc--eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            79999999998654332111  111234568999999999865       578999999999999999998 99999876


Q ss_pred             ChHHHHHHHHhhCCCCC-Cc-ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          398 PPEEVVKLMCCEGKRPP-LK-IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       398 ~~~~~~~~i~~~~~~~~-~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...+.  .+........ .. .....+++++.+||.+||+.||.+|||+.++++|
T Consensus       244 ~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          244 YSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            54432  2222221111 11 1112345789999999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=327.90  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=187.3

Q ss_pred             HHhhccCceeeeEEEE----EEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQV----AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|...+.||.|+||.    ...+|+.||||++..+..      ..+.+|+++++.+ +||||+++++++.+....|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            3577888999998874    356799999999975432      2356899999999 7999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---C--CcEEEEeecccccc
Q 011991          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---G--GQLKISGFGLLRLQ  338 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~--~~vkl~DfG~a~~~  338 (473)
                      |||. |+|.+++.... .+++..++.++.||+.||.|||+++   |+||||||+|||++.   +  ..+||+|||+++..
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9996 59999997653 3556677899999999999999999   999999999999953   2  35889999999765


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcC---CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYK---NEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      .......   .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||...........+  ......
T Consensus       174 ~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--~~~~~~  248 (432)
T 3p23_A          174 AVGRHSF---SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--GACSLD  248 (432)
T ss_dssp             ---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--TCCCCT
T ss_pred             cCCCcce---eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--ccCCcc
Confidence            4332111   1223456899999999997   4567889999999999999999 99999766554433222  221111


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ........+..+.+||.+||+.||.+|||++++++|
T Consensus       249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            111122345668999999999999999999999853

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.2e-39  Score=319.18  Aligned_cols=244  Identities=18%  Similarity=0.308  Sum_probs=191.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-----------CCeeeeEEee
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----------HPNVVQFVGA  253 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~  253 (473)
                      .+|.+.+.||.|+||.+     ..+++.||||++..    .....+.+.+|+.+++.+.           ||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            36888899999999865     24688999999964    3445577889999999886           8999999999


Q ss_pred             EeeCC----ceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEc----
Q 011991          254 VTQNI----PMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLD----  322 (473)
Q Consensus       254 ~~~~~----~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~----  322 (473)
                      +...+    ..++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ |   |+||||||+|||++    
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            88654    689999999 78999999873  4599999999999999999999998 8   99999999999995    


Q ss_pred             --CCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 011991          323 --NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP-  399 (473)
Q Consensus       323 --~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-  399 (473)
                        ..+.+||+|||+++.....         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... 
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             CcCcceEEEcccccccccCCC---------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence              3447999999999765322         2234589999999999999999999999999999999999999986542 


Q ss_pred             -----HHHHHHHHh-hCCCCCC------------------------------------cccCCCCCHHHHHHHHHccCCC
Q 011991          400 -----EEVVKLMCC-EGKRPPL------------------------------------KIKARSYPPDLKELIEECWDPK  437 (473)
Q Consensus       400 -----~~~~~~i~~-~~~~~~~------------------------------------~~~~~~~~~~l~~li~~cl~~d  437 (473)
                           ......+.. .+..|..                                    ...+..+++.+.+||.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence                 222222211 1111100                                    0001234567899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 011991          438 PVIRPNFNEIIAR  450 (473)
Q Consensus       438 P~~RPs~~ell~~  450 (473)
                      |.+|||++|+++|
T Consensus       322 P~~Rpt~~ell~h  334 (373)
T 1q8y_A          322 PRKRADAGGLVNH  334 (373)
T ss_dssp             TTTCBCHHHHHTC
T ss_pred             ccccCCHHHHhhC
Confidence            9999999999883

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-39  Score=312.03  Aligned_cols=243  Identities=25%  Similarity=0.400  Sum_probs=192.0

Q ss_pred             ChhHHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCH---HHHHHHHHHHHHHHhc----CCCeeeeEEee
Q 011991          186 NPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKA----RHPNVVQFVGA  253 (473)
Q Consensus       186 ~~~~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l----~hpnIv~l~~~  253 (473)
                      .....+|++.+.||.|+|+.+.     .+++.||||++........   .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3445679999999999998652     3688999999976543221   2234567799999999    89999999999


Q ss_pred             EeeCCceEEEEec-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-CCCcEEEEe
Q 011991          254 VTQNIPMMIVLEY-HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISG  331 (473)
Q Consensus       254 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-~~~~vkl~D  331 (473)
                      +...+..++|||+ +.+++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+||+++ .++.+||+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEE
Confidence            9998999999999 788999999998888999999999999999999999999   99999999999999 789999999


Q ss_pred             eccccccccCcccccccccccCCCCCCcccCCCCcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhC
Q 011991          332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG  410 (473)
Q Consensus       332 fG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~  410 (473)
                      ||++.......        .....||+.|+|||++.+..+. .++|||||||++|+|++|..||....  .    +....
T Consensus       184 fg~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~~  249 (312)
T 2iwi_A          184 FGSGALLHDEP--------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEAE  249 (312)
T ss_dssp             CSSCEECCSSC--------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHTC
T ss_pred             cchhhhcccCc--------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhhhc
Confidence            99987654321        2334588999999998776654 58999999999999999999997532  1    11111


Q ss_pred             CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       411 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                        .   ..+..+++.+.+||.+||+.||.+|||++|++++
T Consensus       250 --~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          250 --L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              1   1245688999999999999999999999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-39  Score=317.51  Aligned_cols=240  Identities=25%  Similarity=0.423  Sum_probs=198.0

Q ss_pred             hHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCH---HHHHHHHHHHHHHHhcC--CCeeeeEEeeEeeC
Q 011991          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKAR--HPNVVQFVGAVTQN  257 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~  257 (473)
                      ...+|.+.+.||.|+||.+     ..+++.||||++........   ...+.+.+|+.+++.+.  ||||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3456888899999998755     23688999999976533211   11245678999999996  59999999999999


Q ss_pred             CceEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-CCCcEEEEeeccc
Q 011991          258 IPMMIVLEYHAK-GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLL  335 (473)
Q Consensus       258 ~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-~~~~vkl~DfG~a  335 (473)
                      +..++|||++.+ ++|.+++...+.+++..++.++.|++.||.|||+++   |+||||||+|||++ .++.+||+|||++
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999999999976 899999998888999999999999999999999999   99999999999999 7889999999998


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      +.....        ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....  .    +.. ...  
T Consensus       198 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~-~~~--  260 (320)
T 3a99_A          198 ALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIR-GQV--  260 (320)
T ss_dssp             EECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH-CCC--
T ss_pred             cccccc--------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhc-ccc--
Confidence            765332        1223458999999999877665 688999999999999999999996532  1    111 111  


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                        ..+..+++.+.+||.+||+.||.+|||++|+++
T Consensus       261 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 --FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              124568999999999999999999999999987

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-38  Score=306.26  Aligned_cols=230  Identities=12%  Similarity=0.088  Sum_probs=189.2

Q ss_pred             HHhhccCceeeeEEEEE---E--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~---~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|++.+.||+|+|+.+   .  .+++.||||++...........+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            46888899999988754   2  348999999998776666777789999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++|++|.+++..+  .....+..++.|++.||.|||++|   |+||||||+|||++.++.+||+++|           
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999999543  466778999999999999999999   9999999999999999999997443           


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hhCCCCCCcccCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMC--CEGKRPPLKIKARSY  422 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~  422 (473)
                                     |++       +++.++|||||||++|+|++|..||.+.+.........  .....+........+
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI  232 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence                           333       36889999999999999999999998765432110000  011111112234578


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      ++.+.++|.+||+.||.+| |+.|+++.|+++....
T Consensus       233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            9999999999999999999 9999999999987653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-37  Score=297.76  Aligned_cols=223  Identities=22%  Similarity=0.360  Sum_probs=175.6

Q ss_pred             HHHhhcc-CceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHH-HhcCCCeeeeEEeeEee----C
Q 011991          189 ELQVRKA-DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIV-EKARHPNVVQFVGAVTQ----N  257 (473)
Q Consensus       189 ~~~~~~~-~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~----~  257 (473)
                      ..+|.+. +.||.|+||.+     ..+++.||+|++...        ..+.+|+.++ +.++||||+++++++..    .
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            3456665 67999999865     246889999999642        3467888888 55589999999999886    6


Q ss_pred             CceEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEee
Q 011991          258 IPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGF  332 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~Df  332 (473)
                      ...++||||+++|+|.+++...+  .+++..++.++.|++.||.|||+++   |+||||||+||+++.   ++.+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence            77999999999999999998764  5999999999999999999999999   999999999999998   788999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      |++....                            +..++.++|||||||++|+|++|..||...........+......
T Consensus       165 g~a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  216 (299)
T 3m2w_A          165 GFAKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  216 (299)
T ss_dssp             TTCEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT
T ss_pred             ccccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh
Confidence            9985321                            134678999999999999999999999876544332111111111


Q ss_pred             CCC---cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPL---KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ...   ...+..+++++.+||.+||+.||.+|||++|+++|
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            111   11125688999999999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.9e-38  Score=329.49  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=197.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee------CC
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ------NI  258 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~  258 (473)
                      .+|.+.+.||.|+||.+     ..+|+.||||++...  ......+.+.+|+++++.++||||+++++++..      ++
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            46889999999999865     246889999998754  245667889999999999999999999998765      67


Q ss_pred             ceEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc---EEEEee
Q 011991          259 PMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGF  332 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~---vkl~Df  332 (473)
                      ..++||||++||+|.+++...+   .+++..++.++.|++.||.|||+.|   |+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999998753   5899999999999999999999999   999999999999997764   999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKL-------  405 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~-------  405 (473)
                      |++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........       
T Consensus       169 G~a~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGE-------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCC-------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             cccccccccc-------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            9997653321       12345689999999999999999999999999999999999999976533221100       


Q ss_pred             --HH-hh---C------CCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHH-----HHHHHHHHH
Q 011991          406 --MC-CE---G------KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEI-----IARLDRIVC  456 (473)
Q Consensus       406 --i~-~~---~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el-----l~~L~~~~~  456 (473)
                        +. ..   +      ..+........+++.+.+||.+||..||.+|||++++     .+.++.+..
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence              00 00   0      0000111122356889999999999999999999884     455555554

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-36  Score=327.23  Aligned_cols=237  Identities=23%  Similarity=0.280  Sum_probs=190.3

Q ss_pred             HHhhccCceeeeEEEEEE---e---cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc----
Q 011991          190 LQVRKADGITKGSYQVAK---W---NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~---~---~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----  259 (473)
                      .+|++.+.||.|+||.+.   .   +|+.||||++...  ........+.+|+++++.++||||+++++++...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            478899999999998652   1   5789999998753  345667789999999999999999999999987665    


Q ss_pred             -eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          260 -MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       260 -~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                       .|+||||++|++|.+++..  .+++..++.++.||+.||.|||++|   |+||||||+|||++.+ .+||+|||+++..
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence             7999999999999998754  6999999999999999999999999   9999999999999875 8999999999754


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCccc
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIK  418 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  418 (473)
                      ...          ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....         .. + ....
T Consensus       232 ~~~----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~-~-~~~~  289 (681)
T 2pzi_A          232 NSF----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GL-P-EDDP  289 (681)
T ss_dssp             TCC----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SC-C-TTCH
T ss_pred             ccC----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------cc-c-cccc
Confidence            322          334589999999998665 488999999999999999999888652211         00 0 0001


Q ss_pred             CCCCCHHHHHHHHHccCCCCCCCCC-HHHHHHHHHHHHH
Q 011991          419 ARSYPPDLKELIEECWDPKPVIRPN-FNEIIARLDRIVC  456 (473)
Q Consensus       419 ~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L~~~~~  456 (473)
                      ....++.+.+||.+||+.||.+||+ ++++.+.|..+..
T Consensus       290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            1123578999999999999999995 6667777766654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.4e-38  Score=308.62  Aligned_cols=241  Identities=14%  Similarity=0.154  Sum_probs=183.7

Q ss_pred             HHHhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHhcC---------CCeeeeEE
Q 011991          189 ELQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHK-----DPERINAFTHELTIVEKAR---------HPNVVQFV  251 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hpnIv~l~  251 (473)
                      ..+|.+.+.||+|+||.|   ..+|+.||||++......     .....+.+.+|+.+++.++         ||||+++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            357899999999999855   568999999999865421     2233467889999999886         67776666


Q ss_pred             eeE-----------------ee-------------CCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 011991          252 GAV-----------------TQ-------------NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYL  301 (473)
Q Consensus       252 ~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L  301 (473)
                      +++                 ..             .+..|+||||+++|++.+.+.. +.+++..++.++.||+.||.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            654                 22             6789999999999976666644 5689999999999999999999


Q ss_pred             h-hcCCCCeEeCCCCCCCEEEcCCC--------------------cEEEEeeccccccccCcccccccccccCCCCCCcc
Q 011991          302 H-ECKPDPIIHCDLKPKNILLDNGG--------------------QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLY  360 (473)
Q Consensus       302 H-~~~~~~iiH~Dlkp~Nili~~~~--------------------~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y  360 (473)
                      | +++   |+||||||+|||++.++                    .+||+|||+|+.....           ...||+.|
T Consensus       178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----------~~~gt~~y  243 (336)
T 2vuw_A          178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----------IVVFCDVS  243 (336)
T ss_dssp             HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------EEECCCCT
T ss_pred             HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------cEEEeecc
Confidence            9 899   99999999999999887                    8999999999865422           12588999


Q ss_pred             cCCCCcCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhhCCCC--CCcccCCCCCHHHHHHHHHccCC
Q 011991          361 VAPEIYKNEEFDRSVDAYSFGLI-LYEMIEGVQPFHPKPP-EEVVKLMCCEGKRP--PLKIKARSYPPDLKELIEECWDP  436 (473)
Q Consensus       361 ~aPE~~~~~~~~~~~DiwSlG~~-l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~  436 (473)
                      +|||++.+.. +.++||||++++ .++++.|..||..... ......+.......  .....+..+++++.+||++||+.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~  322 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF  322 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence            9999998776 899999998777 6778889999854221 11222332221111  11112335678999999999997


Q ss_pred             CCCCCCCHHHHH-HH
Q 011991          437 KPVIRPNFNEII-AR  450 (473)
Q Consensus       437 dP~~RPs~~ell-~~  450 (473)
                      |     |++|++ +|
T Consensus       323 d-----sa~e~l~~H  332 (336)
T 2vuw_A          323 S-----SATDLLCQH  332 (336)
T ss_dssp             S-----SHHHHHHHC
T ss_pred             C-----CHHHHHhcC
Confidence            6     999998 63

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1e-36  Score=308.52  Aligned_cols=237  Identities=15%  Similarity=0.171  Sum_probs=179.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC-Cee-----------------
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNV-----------------  247 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-pnI-----------------  247 (473)
                      ++...+.||+|+||.|     ..+|+.||||++...........+.+.+|+.+++.+.| +|+                 
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4667788999999866     23589999999985544444446789999999999976 211                 


Q ss_pred             ----eeEEeeEee-----CCceEEEEeccCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 011991          248 ----VQFVGAVTQ-----NIPMMIVLEYHAKGDLASYLQK-------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (473)
Q Consensus       248 ----v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  311 (473)
                          ..+..++..     ....+++|+++ +++|.+++..       .+.+++..++.++.|++.||+|||+++   |+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence                111111121     22468888877 5699999852       223778889999999999999999999   999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCc----------CCCCCCCchhHHHHH
Q 011991          312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY----------KNEEFDRSVDAYSFG  381 (473)
Q Consensus       312 ~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlG  381 (473)
                      |||||+|||++.++.+||+|||+++.....         .....| +.|+|||++          .+..++.++||||||
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence            999999999999999999999998754322         233456 889999998          566788999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          382 LILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       382 ~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |++|+|++|..||...+..+....+.         .....+|+.+.+||.+||..||.+||++.+++++
T Consensus       305 vil~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAALGGSEWIF---------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGGSCSGGGG---------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHCCCCCCCcchhhhHHHHH---------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999999998766543322221         1124678999999999999999999998888654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.7e-32  Score=282.87  Aligned_cols=171  Identities=11%  Similarity=0.104  Sum_probs=129.4

Q ss_pred             EecCcEEEEEEEcCCCCC-------CHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHH
Q 011991          207 KWNGTKVWVKILDKESHK-------DPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK  278 (473)
Q Consensus       207 ~~~~~~vavK~l~~~~~~-------~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  278 (473)
                      ...|+.+|+|++......       .....++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|..
T Consensus       256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~  335 (569)
T 4azs_A          256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA  335 (569)
T ss_dssp             EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred             ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence            567999999999764321       123457799999999999 699999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCC
Q 011991          279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN  358 (473)
Q Consensus       279 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~  358 (473)
                      .+.+++.   +|+.||+.||+|+|++|   ||||||||+|||++.+|.+||+|||+|+.......      ......||+
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~------~~~t~vGTp  403 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS------WPTNLVQSF  403 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C------CSHHHHHHH
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc------cccCceech
Confidence            8888765   47899999999999999   99999999999999999999999999986543211      122345899


Q ss_pred             cccCCCCcCCCCCCCchhHHHHHHHHHHHHhC
Q 011991          359 LYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG  390 (473)
Q Consensus       359 ~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g  390 (473)
                      .|+|||++.+. +..++|+||+|++++++.++
T Consensus       404 ~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          404 FVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHC------------------CCCCTT
T ss_pred             hhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            99999999764 57789999999988776554

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.94  E-value=4e-27  Score=207.84  Aligned_cols=126  Identities=34%  Similarity=0.420  Sum_probs=82.6

Q ss_pred             ceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHH
Q 011991           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (473)
Q Consensus        43 ~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~  122 (473)
                      ++.||+.|+++.|+.||+.|......|.+|+||||+|+..|+.+++++|+++|+|+|.+|..|+||||+||..|+.++|+
T Consensus         8 L~~Aa~~G~~~~v~~Ll~~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~   87 (169)
T 4gpm_A            8 LIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVK   87 (169)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHH
Confidence            55666666666666666665433334666666666666666666666666666666666666666666666666666666


Q ss_pred             HHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       123 ~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      +|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++..+
T Consensus        88 ~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d  133 (169)
T 4gpm_A           88 LLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSD  133 (169)
T ss_dssp             HHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence            6666666666666666666666666666666666666666665543

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.94  E-value=9.3e-27  Score=205.47  Aligned_cols=138  Identities=29%  Similarity=0.352  Sum_probs=119.0

Q ss_pred             cccCCCCC---cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC
Q 011991           29 MSRQSSFD---PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDG  105 (473)
Q Consensus        29 ~~~~~~~~---~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g  105 (473)
                      +....+++   .....+++.++..|+.+.++.+++.+......|.+|+||||+||..|+.++|++|+++|+|+|.+|.+|
T Consensus        24 l~~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G  103 (169)
T 4gpm_A           24 IENGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDG  103 (169)
T ss_dssp             HHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             HHCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCC
Confidence            33444444   345567778889999998988888876555569999999999999999999999999999999999999


Q ss_pred             CcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCcc
Q 011991          106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK  166 (473)
Q Consensus       106 ~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~  166 (473)
                      +||||+||..|+.++|++|+++|+|++.+|..|+||||+|+..|+.+++++|+++|+++..
T Consensus       104 ~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GA~ie~  164 (169)
T 4gpm_A          104 RTPLHHAAENGHKEVVKLLISKGADVNTSDSDGRTPLDLAREHGNEEVVKLLEKQGGWLEH  164 (169)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC------
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCC
Confidence            9999999999999999999999999999999999999999999999999999999999853

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=3.8e-26  Score=237.93  Aligned_cols=190  Identities=18%  Similarity=0.177  Sum_probs=143.9

Q ss_pred             hccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHH-----HHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          193 RKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPE-----RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       193 ~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ...+.||+|+|+.+   ...+..+++|...........     ..+++.+|++++++++||||+++..++......|+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            34567999999865   457899999998765443322     2456899999999999999996666666777889999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++|++|.+++..        +..++.|+++||.|||+++   |+||||||+|||++.  .+||+|||+++........
T Consensus       419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            99999999999865        5689999999999999999   999999999999998  9999999999876443221


Q ss_pred             ccc-cccccCCCCCCcccCCCCcCC--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 011991          345 AKI-VFPVSHIDPANLYVAPEIYKN--EEFDRSVDAYSFGLILYEMIEGVQPFH  395 (473)
Q Consensus       345 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~  395 (473)
                      ... ........||+.|+|||++..  ..|+..+|+||..+-..+-..++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            100 001124458999999999977  578888999998888777777766663

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.91  E-value=7.1e-25  Score=195.12  Aligned_cols=139  Identities=27%  Similarity=0.327  Sum_probs=125.0

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |.....++.|+..|+++.++.+++.++.+++. +..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus         3 ~~~~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~   82 (179)
T 3f6q_A            3 PEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASH   82 (179)
T ss_dssp             ----CCHHHHHHHTCHHHHHHHHHCTTSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHT
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHhcCcccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHc
Confidence            44556788999999999999999987766665 88999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+   .+++..|
T Consensus        83 ~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A  145 (179)
T 3f6q_A           83 GHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKA  145 (179)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCGGGGS
T ss_pred             CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCcHHHH
Confidence            99999999999999999999999999999999999999999999999997665   4555554

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.91  E-value=8.5e-25  Score=191.78  Aligned_cols=138  Identities=25%  Similarity=0.381  Sum_probs=125.6

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~  117 (473)
                      ....++.|++.|+.+.++.+++.++.+.+. +..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus         8 ~~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~   87 (165)
T 3twr_A            8 ADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGH   87 (165)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHCCTTTTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             hhHHHHHHHHhCCHHHHHHHHHcCCCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCc
Confidence            345678899999999999999977666554 7789999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       118 ~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      .+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+   .++++.|.
T Consensus        88 ~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~a~  149 (165)
T 3twr_A           88 YEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK  149 (165)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTGGGSC
T ss_pred             HHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChhHhHh
Confidence            999999999999999999999999999999999999999999999997765   46665553

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.91  E-value=4.3e-24  Score=168.72  Aligned_cols=93  Identities=42%  Similarity=0.582  Sum_probs=89.5

Q ss_pred             CCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCC
Q 011991           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN  150 (473)
Q Consensus        71 ~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~  150 (473)
                      +|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~   80 (93)
T 1n0q_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (93)
T ss_dssp             --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhcCCc
Q 011991          151 VEVYNILKARGAK  163 (473)
Q Consensus       151 ~~~~~~L~~~g~~  163 (473)
                      .+++++|+++|++
T Consensus        81 ~~~~~~Ll~~ga~   93 (93)
T 1n0q_A           81 LEVVKLLLEAGAY   93 (93)
T ss_dssp             HHHHHHHHHTTCC
T ss_pred             HHHHHHHHHcCCC
Confidence            9999999999874

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.91  E-value=3.5e-25  Score=188.01  Aligned_cols=127  Identities=20%  Similarity=0.204  Sum_probs=116.1

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCC-CCcHHHHHHH
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLD-GRTALHIAAC  114 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~-g~T~lh~A~~  114 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|+||||+||. |+.+++++|+++|+++|.+|.. |+||||+|+.
T Consensus         9 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~   87 (136)
T 1d9s_A            9 GGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAR   87 (136)
T ss_dssp             CCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHH
T ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHH
Confidence            4456677888999999999999998875444458899999999999 9999999999999999999999 9999999999


Q ss_pred             cCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      .|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++
T Consensus        88 ~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~Gad  136 (136)
T 1d9s_A           88 EGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD  136 (136)
T ss_dssp             HTCHHHHHHHHHTCCCCCCCSSSSSCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred             cCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence            9999999999999999999999999999999999999999999998875

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.90  E-value=7.5e-25  Score=185.95  Aligned_cols=125  Identities=28%  Similarity=0.369  Sum_probs=115.3

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      +.....++.|+..|+.+.++.+++.+......|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus        12 ~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~   91 (136)
T 2jab_A           12 SDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIG   91 (136)
T ss_dssp             CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHT
T ss_pred             ccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcC
Confidence            44556778899999999999999987554455889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      +.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|
T Consensus        92 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~Ll~~G  136 (136)
T 2jab_A           92 HLEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKLN  136 (136)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHcCCCCcCcCCCCCCHHHHHHHCCCHHHHHHHHHcC
Confidence            999999999999999999999999999999999999999999876

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.90  E-value=2.7e-24  Score=189.87  Aligned_cols=128  Identities=23%  Similarity=0.304  Sum_probs=103.5

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      .+++.|+..|+++.++.+++.+...++. +..|+||||+||..|+.++|++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus         4 ~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~   83 (172)
T 3v30_A            4 LSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTD   83 (172)
T ss_dssp             CCHHHHHHTTCHHHHHHHHTTCSGGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             hhHHHHHHcCCHHHHHHHHHcCcccccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHH
Confidence            3566778888888888888877654444 777888888888888888888888888888888888888888888888888


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus        84 ~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~  132 (172)
T 3v30_A           84 IVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEA  132 (172)
T ss_dssp             HHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence            8888888888888888888888888888888888888888888876654

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.90  E-value=1.9e-24  Score=187.22  Aligned_cols=127  Identities=28%  Similarity=0.298  Sum_probs=116.5

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv  121 (473)
                      .++.|++.|+.+.++.+++.+. +.+.+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++
T Consensus         5 ~L~~A~~~g~~~~v~~Ll~~g~-~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v   83 (153)
T 1awc_B            5 KLLEAARAGQDDEVRILMANGA-PFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIV   83 (153)
T ss_dssp             HHHHHHHHTCHHHHHHHHHHTC-CCCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHH
T ss_pred             HHHHHHHcCCHHHHHHHHHcCC-CCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHH
Confidence            4667889999999999998875 445688899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       122 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      ++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus        84 ~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~  131 (153)
T 1awc_B           84 EVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSK  131 (153)
T ss_dssp             HHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCC
Confidence            999999999999999999999999999999999999999999876643

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.90  E-value=7.8e-25  Score=190.45  Aligned_cols=136  Identities=21%  Similarity=0.249  Sum_probs=114.8

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCc-HHHHHHHcC
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEG  116 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T-~lh~A~~~g  116 (473)
                      ....+++.|+..|+.+.++.+++.+......+..|+||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+..|
T Consensus        11 ~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~   89 (156)
T 1bi7_B           11 PSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREG   89 (156)
T ss_dssp             CSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHT
T ss_pred             cchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCC
Confidence            3456788899999999999999987544445889999999985 99999999999999999999999999 999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcCCCCcC
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV  174 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~t~l~~  174 (473)
                      +.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+..+.+.
T Consensus        90 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~  147 (156)
T 1bi7_B           90 FLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDA  147 (156)
T ss_dssp             CHHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSSCC-------------
T ss_pred             CHHHHHHHHHcCCCCcccCCCCCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCcc
Confidence            9999999999999999999999999999999999999999999999998776544443

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.90  E-value=3.4e-24  Score=188.95  Aligned_cols=131  Identities=30%  Similarity=0.397  Sum_probs=120.3

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ....++.|++.|+.+.++.+++.+......+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        14 ~~~~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~   93 (169)
T 2y1l_E           14 LGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHL   93 (169)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             ccchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCH
Confidence            44567889999999999999998755445588999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      +++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus        94 ~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  144 (169)
T 2y1l_E           94 EIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDK  144 (169)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            999999999999999999999999999999999999999999999876643

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.90  E-value=7.5e-24  Score=186.12  Aligned_cols=129  Identities=21%  Similarity=0.250  Sum_probs=113.3

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.++
T Consensus         5 t~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~   84 (167)
T 3v31_A            5 LSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDI   84 (167)
T ss_dssp             CCHHHHHHTTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred             chHHHHHHCCCHHHHHHHHHcCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHH
Confidence            46678889999999999888875544458889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      +++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus        85 v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  133 (167)
T 3v31_A           85 VKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETD  133 (167)
T ss_dssp             HHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            9999999999999999999999999999999999999999988876543

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.89  E-value=1.2e-23  Score=200.12  Aligned_cols=151  Identities=26%  Similarity=0.265  Sum_probs=127.3

Q ss_pred             hhhcccCCCCC---cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC
Q 011991           26 TRQMSRQSSFD---PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID  102 (473)
Q Consensus        26 ~~~~~~~~~~~---~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d  102 (473)
                      ...+....+++   .....+++-|+..|+.+.++.|+..+......+.+|.||||+|+..++.+++++|+++|+|+|.+|
T Consensus        70 ~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d  149 (269)
T 4b93_B           70 AKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKD  149 (269)
T ss_dssp             -----CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCC
T ss_pred             HHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCC
Confidence            33444444444   223456777888999998888888776555568889999999999999999999999999999999


Q ss_pred             CCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       103 ~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      ..|+||||+||..|+.++|++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++..+   +||++.|.
T Consensus       150 ~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~  226 (269)
T 4b93_B          150 LSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVDCAE  226 (269)
T ss_dssp             TTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSGGGSC
T ss_pred             CCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            999999999999999999999999999999999999999999999999999999999999997664   57777774

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.89  E-value=9.2e-24  Score=190.06  Aligned_cols=135  Identities=22%  Similarity=0.256  Sum_probs=124.5

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      .|.....+++.|+..|+.+.++.+++.+......+.+|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus        31 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~  110 (192)
T 2rfm_A           31 RDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSII  110 (192)
T ss_dssp             CCTTCCCHHHHHHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHH
T ss_pred             cCCCCCCHHHHHHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHH
Confidence            34556677888999999999999998876555558899999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      .|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus       111 ~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~  165 (192)
T 2rfm_A          111 FGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDL  165 (192)
T ss_dssp             HTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCT
T ss_pred             cCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCC
Confidence            9999999999999999999999999999999999999999999999999977653

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.89  E-value=8.6e-24  Score=186.67  Aligned_cols=136  Identities=21%  Similarity=0.164  Sum_probs=122.1

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus        33 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  112 (172)
T 3v30_A           33 DERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRG  112 (172)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Confidence            44556778889999999999999988755555588999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcCCC
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTP  171 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~t~  171 (473)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++++++...+..+
T Consensus       113 ~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~  168 (172)
T 3v30_A          113 NHVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKLFQSNLVP  168 (172)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHSCC----
T ss_pred             CCHHHHHHHHHcCCCccccCCCCCCHHHHHHHhCcHHHHHHHHHHHHHHhcccCCC
Confidence            99999999999999999999999999999999999999999999999886655433

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.89  E-value=2e-23  Score=173.73  Aligned_cols=123  Identities=33%  Similarity=0.427  Sum_probs=114.4

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.++
T Consensus         4 t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~   83 (126)
T 1n0r_A            4 TPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEV   83 (126)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHH
T ss_pred             cHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHH
Confidence            45667889999999999998875544558899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      +++|+++|++++.+|..|.|||++|+..|+.+++++|+++|++
T Consensus        84 ~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~Gad  126 (126)
T 1n0r_A           84 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY  126 (126)
T ss_dssp             HHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred             HHHHHHcCCCCcccCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Confidence            9999999999999999999999999999999999999999975

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.89  E-value=1.2e-23  Score=183.69  Aligned_cols=114  Identities=30%  Similarity=0.383  Sum_probs=71.2

Q ss_pred             CCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCC
Q 011991           50 SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA  129 (473)
Q Consensus        50 g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga  129 (473)
                      |+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+
T Consensus        48 ~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~  127 (162)
T 1ihb_A           48 GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTA  127 (162)
T ss_dssp             SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSC
T ss_pred             CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccC
Confidence            66666666665543333335566666666666666666666666666666666666666666666666666666666666


Q ss_pred             C-CCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          130 N-IDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       130 ~-~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      + ++.+|..|.||||+|+..|+.+++++|+++|++
T Consensus       128 ~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~GAd  162 (162)
T 1ihb_A          128 SNVGHRNHKGDTACDLARLYGRNEVVSLMQANGAG  162 (162)
T ss_dssp             CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred             CCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence            5 466666666666666666666666666666653

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.89  E-value=1.1e-23  Score=182.67  Aligned_cols=124  Identities=20%  Similarity=0.240  Sum_probs=81.0

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .++.|+..|+.+.++.+++..+.+.+. +..|.||||+ |..|+.+++++|+++|+++|.+|..|+||||+|+..|+.++
T Consensus         5 ~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~   83 (156)
T 1bd8_A            5 RLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDT   83 (156)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHH
T ss_pred             HHHHHHHhCCHHHHHHHHHhhCcCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHH
Confidence            345566666666666666663223333 5666677666 66666667776666666666666666677777766666777


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      +++|+++|++++.+|..|+||||+|+..|+.+++++|+++ ++++..
T Consensus        84 v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~  129 (156)
T 1bd8_A           84 LKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRR  129 (156)
T ss_dssp             HHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCC
T ss_pred             HHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCc
Confidence            7766666666666666666777776666666666666666 555444

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.88  E-value=4.5e-23  Score=180.00  Aligned_cols=134  Identities=22%  Similarity=0.209  Sum_probs=121.3

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      ..++.|+..|+.+.++.+++.+......+..|+||||+|+. |+.+++++|+++|+++|.+|..|+||||+|+..|+.++
T Consensus         7 ~~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~   85 (162)
T 1ihb_A            7 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDT   85 (162)
T ss_dssp             HHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHH
T ss_pred             hHHHHHHHcCCHHHHHHHHhCCCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence            45778999999999999998875554558899999999999 99999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc-CccCc---CCCCcCC
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK-VPKTK---RTPMTVA  175 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~-i~~~~---~t~l~~a  175 (473)
                      +++|+++|++++.+|..|.||||+|+..|+.+++++|+++|.+ ++..+   .|+++.|
T Consensus        86 v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~t~l~~A  144 (162)
T 1ihb_A           86 LQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLA  144 (162)
T ss_dssp             HHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCCCCCcHHHHH
Confidence            9999999999999999999999999999999999999999987 45544   4555554

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.88  E-value=1.6e-22  Score=171.57  Aligned_cols=112  Identities=31%  Similarity=0.414  Sum_probs=103.0

Q ss_pred             CCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHH
Q 011991           65 TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD  144 (473)
Q Consensus        65 ~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~  144 (473)
                      +...|.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus         3 d~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~   82 (137)
T 3c5r_A            3 DPFTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHD   82 (137)
T ss_dssp             -CCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHH
T ss_pred             CCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHH
Confidence            44668899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          145 AKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       145 A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      |+..|+.+++++|+++|++++..+   .++++.|.
T Consensus        83 A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~  117 (137)
T 3c5r_A           83 AAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTD  117 (137)
T ss_dssp             HHHTTCHHHHHHHHHTTCCTTCCCTTSCCGGGGCC
T ss_pred             HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHh
Confidence            999999999999999999997765   45555553

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.88  E-value=5.3e-23  Score=178.08  Aligned_cols=123  Identities=25%  Similarity=0.221  Sum_probs=113.6

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus        31 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  110 (153)
T 1awc_B           31 DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEH  110 (153)
T ss_dssp             CTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Confidence            44456778888999999999999988755555688999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhh
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILK  158 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~  158 (473)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|.
T Consensus       111 ~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~i~~~L~  153 (153)
T 1awc_B          111 NHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEILQ  153 (153)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHC
T ss_pred             CCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHhC
Confidence            9999999999999999999999999999999999999999873

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.88  E-value=8.5e-23  Score=179.90  Aligned_cols=125  Identities=28%  Similarity=0.339  Sum_probs=115.3

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      .....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus        45 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~  124 (169)
T 2y1l_E           45 ASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFG  124 (169)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence            34556778889999999999999887555455889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      +.+++++|+++|++++.+|..|.|||++|+..|+.+++++|++.|
T Consensus       125 ~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~G  169 (169)
T 2y1l_E          125 HLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKLN  169 (169)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC-
T ss_pred             CHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcC
Confidence            999999999999999999999999999999999999999999876

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.88  E-value=3.2e-23  Score=181.72  Aligned_cols=125  Identities=23%  Similarity=0.239  Sum_probs=113.9

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      .....+++.|+..|+.+.++.+++.+......+.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus        40 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~  119 (165)
T 3twr_A           40 GRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKG  119 (165)
T ss_dssp             TTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTT
T ss_pred             cCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcC
Confidence            33457788889999999999999887655556889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCC
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA  162 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~  162 (473)
                      +.+++++|+++|++++.+|..|.||||+|.. |+.+++++|+++|+
T Consensus       120 ~~~~v~~Ll~~ga~~~~~~~~g~t~l~~a~~-~~~~i~~~L~~~gA  164 (165)
T 3twr_A          120 KYEICKLLLQHGADPTKKNRDGNTPLDLVKD-GDTDIQDLLRGDAA  164 (165)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCTGGGSCT-TCHHHHHHHHTC--
T ss_pred             CHHHHHHHHHcCCCCcccCCCCCChhHhHhc-CChHHHHHHhhccc
Confidence            9999999999999999999999999999877 99999999999885

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.88  E-value=1.4e-23  Score=194.77  Aligned_cols=178  Identities=19%  Similarity=0.153  Sum_probs=139.6

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      ..++.|+..|+.+.++.+++.+......|.+|+||||+||..|+.++|++|+++|+|+|.+|..|+||||+|+..|+.++
T Consensus        23 t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~  102 (229)
T 2vge_A           23 VLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVI  102 (229)
T ss_dssp             HHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence            44677899999999999998775444458999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccC-CCCCcHHHHH--HHcCChhhhhhhhhcCCcCccCcCCCCcC---CCCCCCCccccChh-HHHhh
Q 011991          121 VKLLLSKKANIDARD-RWGSTAAADA--KYYGNVEVYNILKARGAKVPKTKRTPMTV---ANPREVPEYELNPL-ELQVR  193 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~-~~g~t~l~~A--~~~~~~~~~~~L~~~g~~i~~~~~t~l~~---a~~~~~~~~~i~~~-~~~~~  193 (473)
                      +++|+++|++++.++ ..|+||||+|  +..|+.+++++|+++|++++..+..+.+.   +......++.+... .....
T Consensus       103 v~~Ll~~ga~~~~~~~~~g~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~l~~~~~~~~~~~ll~~ga~~~~~  182 (229)
T 2vge_A          103 CMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFGDELSFREGESVTVL  182 (229)
T ss_dssp             HHHHHTTTCCTTCCCSSTTCCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGGGEEEESSCBCCSSTTBCCBCTTCEEEEE
T ss_pred             HHHHHHcCCCcccccCCCCCCHHHHHHHHhcChHHHHHHHHHcCCCcccccCCchHHHHHHhhccccccCcccccccccc
Confidence            999999999999986 6999999999  99999999999999999998776433332   22222222221110 00112


Q ss_pred             ccCceeeeEEEEEEecCcEEEEEEE
Q 011991          194 KADGITKGSYQVAKWNGTKVWVKIL  218 (473)
Q Consensus       194 ~~~~ig~G~~~~~~~~~~~vavK~l  218 (473)
                      ....-|......+...|..-+||..
T Consensus       183 ~~d~~G~TpL~~A~~~g~~~~v~~~  207 (229)
T 2vge_A          183 RRDGPEETDWWWAALHGQEGYVPRN  207 (229)
T ss_dssp             ESSCTTCSSEEEEEETTEEEEEEGG
T ss_pred             ccCCCcccHHHHHHHcCCcceeehh
Confidence            2223355566667778887777754

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.88  E-value=3.7e-23  Score=183.95  Aligned_cols=133  Identities=17%  Similarity=0.154  Sum_probs=122.3

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus        36 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~  115 (179)
T 3f6q_A           36 DDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFW  115 (179)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc
Confidence            34455678888999999999999988755545588999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      |+.+++++|+++|++++.+|..|.|||++|+..++.+++++|+++|++++...
T Consensus       116 ~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~g~~~~~~~  168 (179)
T 3f6q_A          116 GQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIP  168 (179)
T ss_dssp             TCHHHHHHHHHTTCCSSBCCTTSCCGGGGSCHHHHHHHHHHHHHTTCCCSCBC
T ss_pred             CCHHHHHHHHHCCCCcchhccCCCCcHHHHHHHHHHHHHHHHHHhhcCcccCC
Confidence            99999999999999999999999999999999999999999999999997653

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.87  E-value=1.3e-22  Score=189.31  Aligned_cols=126  Identities=28%  Similarity=0.227  Sum_probs=63.6

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv  121 (473)
                      .+..|++.|+.+.++.+++.+. +++.+..|.||||.||..|+.++|++|++.|+|+|.+|..|+||||+||..|+.++|
T Consensus         8 ~L~~a~~~~~~~~~~~ll~~g~-~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v   86 (239)
T 1ycs_B            8 SLPPGKRTNLRKTGSERIAHGM-RVKFNPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIV   86 (239)
T ss_dssp             ------------------------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHH
T ss_pred             cCchhhhhhhHHHHHHHhccCC-CcccCchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHH
Confidence            3445555566565565555542 333445556666666666666666666666666666666666666666666666666


Q ss_pred             HHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       122 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+
T Consensus        87 ~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~  133 (239)
T 1ycs_B           87 KFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMT  133 (239)
T ss_dssp             HHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceec
Confidence            66666666666666666666666666666666666666666665443

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.87  E-value=2.1e-23  Score=194.75  Aligned_cols=143  Identities=23%  Similarity=0.236  Sum_probs=120.5

Q ss_pred             hhhcccCCC--CCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCC
Q 011991           26 TRQMSRQSS--FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL  103 (473)
Q Consensus        26 ~~~~~~~~~--~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~  103 (473)
                      ...+.+...  ++|.....++.|+..|+.+.++.+++.+......|.+|+||||+||..|+.++|++|+++|+|+|.+|.
T Consensus        22 ~~ll~~g~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~  101 (239)
T 1ycs_B           22 SERIAHGMRVKFNPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADS  101 (239)
T ss_dssp             ---------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCT
T ss_pred             HHHhccCCCcccCchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCC
Confidence            334444433  335556778899999999999999998875444589999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCC-cHHHHH--HHcCChhhhhhhhhcCCcCccCc
Q 011991          104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS-TAAADA--KYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       104 ~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~-t~l~~A--~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      .|+||||+|+..|+.++|++|+++|++++.+|..|. ||||+|  +..|+.+++++|+++|++++..+
T Consensus       102 ~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~~  169 (239)
T 1ycs_B          102 DGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMN  169 (239)
T ss_dssp             TCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTTTG
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCCcchHHHHHHhhhccHHHHHHHHHhhhcccccc
Confidence            999999999999999999999999999999998887 999999  78899999999999999987654

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.87  E-value=2.4e-22  Score=174.27  Aligned_cols=120  Identities=23%  Similarity=0.243  Sum_probs=110.5

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      +...+.++..|+.+.++.+++.+......+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        36 g~t~L~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  115 (156)
T 1bd8_A           36 GKTALQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTA  115 (156)
T ss_dssp             SCCHHHHSCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHH
T ss_pred             CCcHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHH
Confidence            34444559999999999999887555555889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhc
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~  160 (473)
                      ++++|+++ ++++.+|..|.||||+|+..|+.+++++|+++
T Consensus       116 ~v~~Ll~~-~~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~  155 (156)
T 1bd8_A          116 VVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             HHHHHHTT-SCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             HHHHHHhc-cCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhh
Confidence            99999999 99999999999999999999999999999875

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.87  E-value=2.4e-22  Score=170.42  Aligned_cols=105  Identities=26%  Similarity=0.327  Sum_probs=99.1

Q ss_pred             CCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCC-CCcH
Q 011991           64 LTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRW-GSTA  141 (473)
Q Consensus        64 ~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~-g~t~  141 (473)
                      .+++. +..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |+||
T Consensus         3 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~   81 (136)
T 1d9s_A            3 PGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRP   81 (136)
T ss_dssp             CCCSCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCH
T ss_pred             CCccCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCH
Confidence            34444 8899999999999999999999999999999999999999999999 9999999999999999999999 9999


Q ss_pred             HHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          142 AADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       142 l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      ||+|+..|+.+++++|+++|++++..+.
T Consensus        82 L~~A~~~~~~~~v~~Ll~~ga~~~~~d~  109 (136)
T 1d9s_A           82 VHDAAREGFLDTLVVLHRAGARLDVCDA  109 (136)
T ss_dssp             HHHHHHHTCHHHHHHHHHTCCCCCCCSS
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCccCC
Confidence            9999999999999999999999877654

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.87  E-value=1.4e-22  Score=166.57  Aligned_cols=105  Identities=39%  Similarity=0.530  Sum_probs=99.8

Q ss_pred             CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHH
Q 011991           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY  147 (473)
Q Consensus        68 ~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~  147 (473)
                      .|.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+.
T Consensus         5 ~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~   84 (115)
T 2l6b_A            5 GSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKK   84 (115)
T ss_dssp             CSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHT
T ss_pred             cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence            47899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCChhhhhhhhhcCCcCccCcCCCC
Q 011991          148 YGNVEVYNILKARGAKVPKTKRTPM  172 (473)
Q Consensus       148 ~~~~~~~~~L~~~g~~i~~~~~t~l  172 (473)
                      .|+.+++++|+++|++++..+..+.
T Consensus        85 ~~~~~~~~~Ll~~ga~~n~~~~~~~  109 (115)
T 2l6b_A           85 NGHHEIVKLLDAKGADVNARSWGSS  109 (115)
T ss_dssp             TTCHHHHHHHHTTSSSHHHHSCCCC
T ss_pred             CCCHHHHHHHHHcCCCCCcCCcccc
Confidence            9999999999999999987655443

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.87  E-value=1.3e-22  Score=187.75  Aligned_cols=134  Identities=24%  Similarity=0.215  Sum_probs=110.7

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      .|.....+++.|+..|+.+.++.+++.+......+..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+.
T Consensus        36 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~  115 (231)
T 3aji_A           36 TDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAAS  115 (231)
T ss_dssp             CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Confidence            34555666777888888888888887765444457788888888888888888888888888888888888888888888


Q ss_pred             cCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      .|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       116 ~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  169 (231)
T 3aji_A          116 KNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQD  169 (231)
T ss_dssp             TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCC
T ss_pred             cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccC
Confidence            888888888888888888888888888888888888888888888888887654

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.87  E-value=4.1e-22  Score=189.77  Aligned_cols=140  Identities=24%  Similarity=0.218  Sum_probs=116.8

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccC----------------------------------------------CCC-CCC
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDEL----------------------------------------------TVP-ENL   70 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~----------------------------------------------~~~-~~~   70 (473)
                      ....++..|+..|+.+.++.+++.+..                                              +++ .+.
T Consensus        77 ~g~tpL~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (282)
T 1oy3_D           77 GGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENY  156 (282)
T ss_dssp             TSCCHHHHHTTTTCHHHHHHHSSSCCSSCCCC-----------------------------------CCCGGGGTTCCCT
T ss_pred             CCCCHHHHHHHcCCcchhHhhhccCCCCchhhHHHHhhcccccCcchhcchhhhccccccchhhhhhhhhhhhcCCCcCC
Confidence            345667777888998988888886632                                              123 377


Q ss_pred             CCChHHHHHHHcCCHHHHHHHHHcCCCCcccCC-CCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcC
Q 011991           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYG  149 (473)
Q Consensus        71 ~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~-~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~  149 (473)
                      .|.||||+||..|+.++|++|+++|+++|.++. .|+||||+|+..|+.++|++|+++|+|++.+|..|+||||+|+..|
T Consensus       157 ~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~  236 (282)
T 1oy3_D          157 DGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRP  236 (282)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTSS
T ss_pred             CCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCCHHHHHHHcC
Confidence            899999999999999999999999999999985 4999999999999999999999999999999999999999999999


Q ss_pred             ChhhhhhhhhcCCcCccCcC---CCCcCCCC
Q 011991          150 NVEVYNILKARGAKVPKTKR---TPMTVANP  177 (473)
Q Consensus       150 ~~~~~~~L~~~g~~i~~~~~---t~l~~a~~  177 (473)
                      +.+++++|+++|++++..+.   +|+..+..
T Consensus       237 ~~~~v~~Ll~~ga~~~~~~~~g~tpl~~a~~  267 (282)
T 1oy3_D          237 NPILARLLRAHGAPEPEDGGDKLSPCSSSGS  267 (282)
T ss_dssp             CHHHHHHHHHTTCCCCCCC------------
T ss_pred             CcHHHHHHHHcCCCcCcCCCcccccccccCC
Confidence            99999999999999987754   55555443

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.87  E-value=2.4e-23  Score=173.37  Aligned_cols=107  Identities=30%  Similarity=0.424  Sum_probs=86.7

Q ss_pred             CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHc
Q 011991           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYY  148 (473)
Q Consensus        69 ~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~  148 (473)
                      +..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus         4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~   83 (123)
T 3aaa_C            4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE   83 (123)
T ss_dssp             ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred             ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence            45677888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          149 GNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       149 ~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      |+.+++++|+++|++++..+.   ++++.|
T Consensus        84 ~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A  113 (123)
T 3aaa_C           84 GHVSCVKLLLSKGADKTVKGPDGLTAFEAT  113 (123)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHC
T ss_pred             CCHHHHHHHHHcCCCCCCcCCCCCCHHHHh
Confidence            888888888888888766543   444444

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.87  E-value=5.6e-22  Score=165.00  Aligned_cols=111  Identities=28%  Similarity=0.237  Sum_probs=100.8

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      ......++.|+..|+.+.++.+++.+......+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus         5 ~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~   84 (123)
T 3aaa_C            5 SMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEG   84 (123)
T ss_dssp             --CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred             cccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcC
Confidence            34445678899999999999999888654455889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHH
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKY  147 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~  147 (473)
                      +.+++++|+++|++++.+|..|.||||+|..
T Consensus        85 ~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~  115 (123)
T 3aaa_C           85 HVSCVKLLLSKGADKTVKGPDGLTAFEATDN  115 (123)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCHHHHCCC
T ss_pred             CHHHHHHHHHcCCCCCCcCCCCCCHHHHhCC
Confidence            9999999999999999999999999999943

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.87  E-value=8.2e-24  Score=189.62  Aligned_cols=135  Identities=16%  Similarity=0.104  Sum_probs=111.7

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCC-CCCChHHHHHHHcCCH----HHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPEN-LDSTMQLLFMACRGDV----KGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~-~~g~t~L~~aa~~g~~----~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      ..++.|++.|+++.++.++..+.  ...+ ..|+||||+|+..|+.    +++++||++|||+|.+|..|+||||+|+..
T Consensus         8 ~~l~~Aa~~g~~~~~~~l~~~~~--~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~   85 (186)
T 3t8k_A            8 RTVSAAAMLGTYEDFLELFEKGY--EDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQG   85 (186)
T ss_dssp             SSHHHHHHHSCHHHHHHHHHHSS--SCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHH
T ss_pred             cHHHHHHHcCCHHHHHHHHhcCc--ccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence            46788999999999888886652  2233 6799999999999875    589999999999999999999999999999


Q ss_pred             CC------HHHHHHHHhCCCCCCccCCCCC-cHHHHHHHcCC-----hhhhhhhhh-cCCcCccCc---CCCCcCCCC
Q 011991          116 GH------VEVVKLLLSKKANIDARDRWGS-TAAADAKYYGN-----VEVYNILKA-RGAKVPKTK---RTPMTVANP  177 (473)
Q Consensus       116 g~------~~iv~~Ll~~ga~~~~~~~~g~-t~l~~A~~~~~-----~~~~~~L~~-~g~~i~~~~---~t~l~~a~~  177 (473)
                      |+      .+++++|+++|||+|.+|..|+ ||||+|+..+.     .+++++|++ +|++++..+   .||++.|..
T Consensus        86 ~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~TpL~~A~~  163 (186)
T 3t8k_A           86 GGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKR  163 (186)
T ss_dssp             CTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHT
T ss_pred             CCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCHHHHHHH
Confidence            87      6889999999999999999999 99999998553     468999999 999997765   455555533

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.87  E-value=4.8e-22  Score=188.90  Aligned_cols=139  Identities=25%  Similarity=0.310  Sum_probs=104.8

Q ss_pred             CcCCCCcceeeccCCCCccc-cCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHH
Q 011991           36 DPRRNNMRFSFGRQSSLDPI-RRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~-~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~  113 (473)
                      ++....+++.++..++.+.+ ..++..| .+++. |.+|+||||+||..|+.++|++|++.|++++.++..|.||+|+|+
T Consensus        49 ~~~~~t~L~~a~~~~~~~~~v~~Ll~~G-advn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~  127 (269)
T 4b93_B           49 DPEFCHPLCQCPKCAPAQKRLAKVPASG-LGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLAC  127 (269)
T ss_dssp             --------------------------CC-CCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred             CccCCCHHHHHHHhCCHHHHHHHHHHCC-CCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCcccccc
Confidence            34455567777877877655 4455555 55554 899999999999999999999999999999999999999999999


Q ss_pred             HcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          114 CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       114 ~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      ..++.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+   .|+++.|
T Consensus       128 ~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A  192 (269)
T 4b93_B          128 QQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEA  192 (269)
T ss_dssp             HHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHH
T ss_pred             ccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHH
Confidence            9999999999999999999999999999999999999999999999999998765   3444444

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.87  E-value=2.6e-22  Score=181.51  Aligned_cols=130  Identities=15%  Similarity=0.279  Sum_probs=108.9

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~  117 (473)
                      ...+++.|+..|+.+.++.++..+..+++. +.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus         5 ~~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~   84 (201)
T 3hra_A            5 EVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGR   84 (201)
T ss_dssp             CTTHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             cccHHHHHHHhccHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCC
Confidence            445677888888888888888888755554 7788888888888888888888888888888888888888888888888


Q ss_pred             HHHHHHHH-hCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC-CcCccCc
Q 011991          118 VEVVKLLL-SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG-AKVPKTK  168 (473)
Q Consensus       118 ~~iv~~Ll-~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g-~~i~~~~  168 (473)
                      .+++++|+ ..+++++.+|..|.||||+|+..|+.+++++|+++| ++++..+
T Consensus        85 ~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  137 (201)
T 3hra_A           85 TEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQN  137 (201)
T ss_dssp             HHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCC
T ss_pred             HHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCC
Confidence            88888888 567788888888888888888888888888888888 7776554

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.87  E-value=1.2e-22  Score=194.07  Aligned_cols=123  Identities=17%  Similarity=0.128  Sum_probs=113.3

Q ss_pred             cceeeccCCCCccccCCCCCccCC-----C-CCCCCCChHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCcHHHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELT-----V-PENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIA  112 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~-----~-~~~~~g~t~L~~aa~~---g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A  112 (473)
                      .++.|+..|+++.++.++..+...     . ..+..|+||||+||..   |+.+++++|+++|+|+|.+|..|+||||+|
T Consensus       133 ~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A  212 (278)
T 1dcq_A          133 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYC  212 (278)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHH
T ss_pred             hhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHH
Confidence            467888999999999988887542     2 2277899999999999   899999999999999999999999999999


Q ss_pred             HHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcC
Q 011991          113 ACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (473)
Q Consensus       113 ~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i  164 (473)
                      +..|+.++|++|+++|||++.+|..|.||||+|+..|+.+++++|+++|++.
T Consensus       213 ~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~  264 (278)
T 1dcq_A          213 CLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSGR  264 (278)
T ss_dssp             HHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTTC
T ss_pred             HHcCCHHHHHHHHHcCCCCCCccCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            9999999999999999999999999999999999999999999999999853

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.87  E-value=9.6e-23  Score=196.89  Aligned_cols=134  Identities=20%  Similarity=0.179  Sum_probs=119.5

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCC------CCCCCChHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCcHHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVP------ENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHI  111 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~------~~~~g~t~L~~aa~~---g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~  111 (473)
                      ..++.|+..|+++.++.++..+.....      .+..|+||||+||..   |+.+++++||++|+|+|.+|..|+||||+
T Consensus       153 ~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~  232 (301)
T 2b0o_E          153 QRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHY  232 (301)
T ss_dssp             HHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHH
T ss_pred             HHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence            348899999999999999977744333      488999999999997   89999999999999999999999999999


Q ss_pred             HHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcCCCCcCCCC
Q 011991          112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANP  177 (473)
Q Consensus       112 A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~t~l~~a~~  177 (473)
                      |+..|+.++|++|+++|||++.+|..|.||||+|+..|+.+++++|+++|++   .+.|+++.|..
T Consensus       233 A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~---~g~tpLh~A~~  295 (301)
T 2b0o_E          233 AALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAG---TFAFPLHVDYS  295 (301)
T ss_dssp             HHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHH---TTSSCCC----
T ss_pred             HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCC---CCCChhHHHHh
Confidence            9999999999999999999999999999999999999999999999999987   35678877643

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.87  E-value=1.5e-22  Score=177.75  Aligned_cols=130  Identities=21%  Similarity=0.160  Sum_probs=119.4

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus        33 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  112 (167)
T 3v31_A           33 DEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHG  112 (167)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHc
Confidence            34455678888999999999999988755444588999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCc
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP  165 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~  165 (473)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++++.++.
T Consensus       113 ~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~  162 (167)
T 3v31_A          113 NHVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLL  162 (167)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999999999999887663

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.87  E-value=4e-22  Score=183.92  Aligned_cols=140  Identities=16%  Similarity=0.091  Sum_probs=120.4

Q ss_pred             CCCCcceeeccCCCCccccCCCCCc-cCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQD-ELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~-~~~~~-~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      ....+++.|+..|+.+.++.+++.+ ..+.+ .+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus        71 ~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~  150 (228)
T 2dzn_A           71 SGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASV  150 (228)
T ss_dssp             TSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHT
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHc
Confidence            3456677888889999999888887 23333 488899999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCC-CCCCccCCCCCcHHHHHHHcCChhhhhhhh-hcCCcCccCc---CCCCcCCCC
Q 011991          116 GHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNILK-ARGAKVPKTK---RTPMTVANP  177 (473)
Q Consensus       116 g~~~iv~~Ll~~g-a~~~~~~~~g~t~l~~A~~~~~~~~~~~L~-~~g~~i~~~~---~t~l~~a~~  177 (473)
                      |+.+++++|+++| ++++.+|..|+||||+|+..|+.+++++|+ ++|++++..+   .+++..|..
T Consensus       151 ~~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l~~A~~  217 (228)
T 2dzn_A          151 GSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALN  217 (228)
T ss_dssp             TCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGGGGCSS
T ss_pred             CCHHHHHHHHhcCcccccCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHHHHHHH
Confidence            9999999999999 999999999999999999999999999999 8899987664   466666643

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.87  E-value=2.3e-22  Score=189.18  Aligned_cols=127  Identities=24%  Similarity=0.183  Sum_probs=74.8

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      .++..|+..|+.+.++.+++.+..+++. +.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus        92 t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~  171 (253)
T 1yyh_A           92 TPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVD  171 (253)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHH
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHH
Confidence            3444455555555555555555433332 555666666666666666666666666666666666666666666666666


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      ++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..
T Consensus       172 ~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~  219 (253)
T 1yyh_A          172 AAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDIT  219 (253)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred             HHHHHHHcCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCcccc
Confidence            666666666666666666666666666666666666666666655444

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.87  E-value=2.8e-22  Score=185.71  Aligned_cols=126  Identities=21%  Similarity=0.300  Sum_probs=72.0

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCC-----cccCCCCCcHHHHHHHc
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDV-----NSIDLDGRTALHIAACE  115 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~-----n~~d~~g~T~lh~A~~~  115 (473)
                      +++.|+..|+.+.++.+++..+.+++. |.+|+||||+||..|+.+++++|+++|+++     +.+|..|+||||+|+..
T Consensus         6 ~L~~A~~~g~~~~v~~Ll~~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~   85 (232)
T 2rfa_A            6 PLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVIN   85 (232)
T ss_dssp             HHHHHHHTTCHHHHHHHHTTTCSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHT
T ss_pred             HHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHc
Confidence            344555556666666555553333333 555666666666666666666666665554     44555566666666666


Q ss_pred             CCHHHHHHHHhCCCCCCccCC-------------CCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          116 GHVEVVKLLLSKKANIDARDR-------------WGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~-------------~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      |+.+++++|+++|++++.++.             .|.||||+|+..|+.+++++|+++|++++..
T Consensus        86 ~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~  150 (232)
T 2rfa_A           86 QNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQ  150 (232)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred             CCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence            666666666666666555543             4666666666666666666666666555444

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.86  E-value=6e-22  Score=182.18  Aligned_cols=131  Identities=24%  Similarity=0.173  Sum_probs=106.3

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      ....++..|+..|+.+.++.+++.+..+.+. +.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus        57 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~  136 (223)
T 2f8y_A           57 MGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVN  136 (223)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTT
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcC
Confidence            3445667777888888888888777644444 778888888888888888888888888888888888888888888888


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      +.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       137 ~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~  188 (223)
T 2f8y_A          137 NVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITD  188 (223)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             CHHHHHHHHHcCCCCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence            8888888888888888888888888888888888888888888888876654

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.86  E-value=2.9e-22  Score=180.16  Aligned_cols=126  Identities=27%  Similarity=0.304  Sum_probs=116.1

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus        65 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  144 (192)
T 2rfm_A           65 DIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKY  144 (192)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHH
T ss_pred             cccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHc
Confidence            34456677888899999999999988755445588999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      |+.+++++|+++|++++.+|..|.|||++|+..|+.+++++|++++
T Consensus       145 ~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~~  190 (192)
T 2rfm_A          145 GRSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVR  190 (192)
T ss_dssp             TCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCcHHHHHHHHhcc
Confidence            9999999999999999999999999999999999999999998865

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.86  E-value=3.9e-23  Score=175.39  Aligned_cols=128  Identities=20%  Similarity=0.175  Sum_probs=112.8

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus         7 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~   86 (137)
T 3c5r_A            7 NHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKN   86 (137)
T ss_dssp             CTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHc
Confidence            34456677888999999999999988755555588999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      |+.+++++|+++|++++.+|..|.|||++|+..+..+++++|.+.+..
T Consensus        87 ~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~l~~l~~~~~s  134 (137)
T 3c5r_A           87 GHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESS  134 (137)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCGGGGCCCHHHHHHHSCC------
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhccHHHHHhhccccccC
Confidence            999999999999999999999999999999999999999988876543

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.86  E-value=1.1e-21  Score=182.36  Aligned_cols=141  Identities=18%  Similarity=0.180  Sum_probs=124.0

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCC------CcccCCCCCcHHH
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD------VNSIDLDGRTALH  110 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~------~n~~d~~g~T~lh  110 (473)
                      .....+++.|+..|+.+.++.|++.+......+..|.||||+||..|+.+++++|+++|++      ++..|..|+||||
T Consensus        43 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~  122 (236)
T 1ikn_D           43 NLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLH  122 (236)
T ss_dssp             TTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHH
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHH
Confidence            3355677888899999999999988755445588999999999999999999999999986      5788899999999


Q ss_pred             HHHHcCCHHHHHHHHhCCCCCCccCC-CCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCCC
Q 011991          111 IAACEGHVEVVKLLLSKKANIDARDR-WGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVANP  177 (473)
Q Consensus       111 ~A~~~g~~~iv~~Ll~~ga~~~~~~~-~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~~  177 (473)
                      +|+..|+.+++++|+++|++++.+|. .|.||||+|+..|+.+++++|+++|++++..+   .+++..|..
T Consensus       123 ~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~  193 (236)
T 1ikn_D          123 LASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWG  193 (236)
T ss_dssp             HHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTT
T ss_pred             HHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHHHHHc
Confidence            99999999999999999999999998 99999999999999999999999999987665   466666644

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.86  E-value=3e-22  Score=178.88  Aligned_cols=125  Identities=27%  Similarity=0.269  Sum_probs=106.1

Q ss_pred             eeeccCCCCccccCCCCCccCCCC-----------CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHH
Q 011991           44 FSFGRQSSLDPIRRSPVQDELTVP-----------ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIA  112 (473)
Q Consensus        44 ~~~~~~g~~~~~~~~l~~~~~~~~-----------~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A  112 (473)
                      +-+++.|+.+.+..++..+.....           .+.+|.||||+||..|+.+++++|++ |+++|.+|..|+||||+|
T Consensus         5 ~~aa~~~~~~~~~~li~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A   83 (183)
T 3deo_A            5 IIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFV   83 (183)
T ss_dssp             EEEEEEETTTEEEEEEEETTCCCCEEEEGGGSCHHHHHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHH
T ss_pred             HHHHHhcCCchhHHHHHHhCCCCccccchhcccccCCCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHH
Confidence            456777777777777754322211           25578999999999999999999999 999999999999999999


Q ss_pred             HHcCCHHHHHHHHhCCCCCCccC-CCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          113 ACEGHVEVVKLLLSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       113 ~~~g~~~iv~~Ll~~ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      +..|+.+++++|+++|++++.+| ..|+||||+|+..|+.+++++|+++|++++..+.
T Consensus        84 ~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~  141 (183)
T 3deo_A           84 AGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDE  141 (183)
T ss_dssp             HHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCT
T ss_pred             HHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCC
Confidence            99999999999999999999988 8899999999999999999999999999876654

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.86  E-value=6.4e-22  Score=183.01  Aligned_cols=139  Identities=23%  Similarity=0.220  Sum_probs=124.9

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      .....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|
T Consensus        71 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~  150 (231)
T 3aji_A           71 DAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKG  150 (231)
T ss_dssp             TTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred             CCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcC
Confidence            33556777888999999999999887655556889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      +.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.   +++..|
T Consensus       151 ~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A  212 (231)
T 3aji_A          151 NLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVA  212 (231)
T ss_dssp             CHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHS
T ss_pred             CHHHHHHHHhcCCCccccCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            99999999999999999999999999999999999999999999999976653   444444

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.86  E-value=8.5e-22  Score=193.47  Aligned_cols=130  Identities=26%  Similarity=0.300  Sum_probs=121.9

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ...++.|++.|+.+.|++++...+.+++. |..|.||||+||..|+.++|++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        25 ~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~  104 (351)
T 3utm_A           25 KDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHY  104 (351)
T ss_dssp             HHHHHHHHHHTCHHHHHHHCCTTTTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred             chhHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCH
Confidence            35688999999999999999987766665 88999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      +++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus       105 ~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  155 (351)
T 3utm_A          105 EVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNC  155 (351)
T ss_dssp             HHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccC
Confidence            999999999999999999999999999999999999999999999876543

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.86  E-value=1.4e-21  Score=181.39  Aligned_cols=137  Identities=20%  Similarity=0.257  Sum_probs=104.7

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~  117 (473)
                      ...+++.|+..|+.+.++.+++.+..+++. +..|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+
T Consensus        77 g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~  156 (237)
T 3b7b_A           77 GSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGC  156 (237)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCC
T ss_pred             CCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCC
Confidence            345566677777777777777777544444 6778888888888888888888888888888888888888888888888


Q ss_pred             HHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       118 ~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      .+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+   .|+++.|
T Consensus       157 ~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~l~~A  217 (237)
T 3b7b_A          157 VDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCA  217 (237)
T ss_dssp             HHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHS
T ss_pred             HHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhCCHhHHHHHHHcCCCCCccCCCCCCHHHHH
Confidence            888888888888888888888888888888888888888888888776554   3444444

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.86  E-value=3.3e-22  Score=188.28  Aligned_cols=129  Identities=22%  Similarity=0.220  Sum_probs=114.9

Q ss_pred             CcCCCCcceeeccC---CCCccccCCCCCccCCC-----------CCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCccc
Q 011991           36 DPRRNNMRFSFGRQ---SSLDPIRRSPVQDELTV-----------PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSI  101 (473)
Q Consensus        36 ~~~~~~~~~~~~~~---g~~~~~~~~l~~~~~~~-----------~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~  101 (473)
                      |.....+++.|+..   |+.+.++.|++.+....           ..|..|.||||+||..|+.++|++|+++|+++|.+
T Consensus        40 d~~g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~  119 (256)
T 2etb_A           40 GSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLR  119 (256)
T ss_dssp             TTTTBCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             CCCCCCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcc
Confidence            33455677777777   99999999998774322           12467999999999999999999999999999999


Q ss_pred             CCC-------------CCcHHHHHHHcCCHHHHHHHHh---CCCCCCccCCCCCcHHHHHHH--cCChh-------hhhh
Q 011991          102 DLD-------------GRTALHIAACEGHVEVVKLLLS---KKANIDARDRWGSTAAADAKY--YGNVE-------VYNI  156 (473)
Q Consensus       102 d~~-------------g~T~lh~A~~~g~~~iv~~Ll~---~ga~~~~~~~~g~t~l~~A~~--~~~~~-------~~~~  156 (473)
                      |..             |+||||+|+..|+.++|++|++   +|+|++.+|..|+||||+|+.  .++.+       ++++
T Consensus       120 ~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~  199 (256)
T 2etb_A          120 ACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDG  199 (256)
T ss_dssp             CCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHH
Confidence            986             9999999999999999999999   999999999999999999998  77888       9999


Q ss_pred             hhhcCCcC
Q 011991          157 LKARGAKV  164 (473)
Q Consensus       157 L~~~g~~i  164 (473)
                      |+++|+++
T Consensus       200 Ll~~ga~~  207 (256)
T 2etb_A          200 LLQMGARL  207 (256)
T ss_dssp             HHHHHHHH
T ss_pred             HHHcCCCc
Confidence            99999998

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.85  E-value=1e-21  Score=181.94  Aligned_cols=130  Identities=22%  Similarity=0.198  Sum_probs=116.9

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCC-----CCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCC-------
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELT-----VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL-------  103 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~-----~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~-------  103 (473)
                      |.....+++.|+..|+.+.++.+++.+...     ...+.+|.||||+||..|+.+++++|+++|++++.++.       
T Consensus        34 ~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~  113 (232)
T 2rfa_A           34 GAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYR  113 (232)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCC
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeec
Confidence            344566778889999999999999887543     33467899999999999999999999999999998876       


Q ss_pred             ------CCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhh----hhhhhcCCcCc
Q 011991          104 ------DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY----NILKARGAKVP  165 (473)
Q Consensus       104 ------~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~----~~L~~~g~~i~  165 (473)
                            .|+||||+|+..|+.+++++|+++|+|++.+|..|+||||+|+..|+.+++    ++|+++|++..
T Consensus       114 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~  185 (232)
T 2rfa_A          114 PHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH  185 (232)
T ss_dssp             TTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCS
T ss_pred             ccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchh
Confidence                  799999999999999999999999999999999999999999999999988    99999999763

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.85  E-value=4.5e-22  Score=187.68  Aligned_cols=126  Identities=21%  Similarity=0.200  Sum_probs=111.5

Q ss_pred             CCCcceeec---cCCCCccccCCCCCccC----------C-CCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC--
Q 011991           39 RNNMRFSFG---RQSSLDPIRRSPVQDEL----------T-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID--  102 (473)
Q Consensus        39 ~~~~~~~~~---~~g~~~~~~~~l~~~~~----------~-~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d--  102 (473)
                      ...+++.|+   +.|+.+.++.|++.+..          . ...|.+|+||||+||..|+.++|++|+++|+|+|.+|  
T Consensus        46 g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~  125 (260)
T 3jxi_A           46 GKTCLPKALLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARG  125 (260)
T ss_dssp             CCCHHHHHHTSCBTTBCTHHHHHHHHHHHTTCHHHHHTCCBCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEE
T ss_pred             CCcHHHHHHHHhhcCCHHHHHHHHHhcccccchHhhhcccccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccc
Confidence            444555455   68999999999987632          1 2225589999999999999999999999999999999  


Q ss_pred             ------------CCCCcHHHHHHHcCCHHHHHHHHh---CCCCCCccCCCCCcHHHHHHHcCC---------hhhhhhhh
Q 011991          103 ------------LDGRTALHIAACEGHVEVVKLLLS---KKANIDARDRWGSTAAADAKYYGN---------VEVYNILK  158 (473)
Q Consensus       103 ------------~~g~T~lh~A~~~g~~~iv~~Ll~---~ga~~~~~~~~g~t~l~~A~~~~~---------~~~~~~L~  158 (473)
                                  ..|+||||+|+..|+.++|++|++   +|++++.+|..|+||||+|+..|+         .+++++|+
T Consensus       126 ~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll  205 (260)
T 3jxi_A          126 RFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLL  205 (260)
T ss_dssp             CCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHH
T ss_pred             cccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHH
Confidence                        689999999999999999999999   999999999999999999999888         69999999


Q ss_pred             hcCCcC
Q 011991          159 ARGAKV  164 (473)
Q Consensus       159 ~~g~~i  164 (473)
                      ++|+++
T Consensus       206 ~~ga~~  211 (260)
T 3jxi_A          206 IKCAKL  211 (260)
T ss_dssp             HHHHHH
T ss_pred             HhCccc
Confidence            999987

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.85  E-value=1.4e-21  Score=188.05  Aligned_cols=138  Identities=23%  Similarity=0.270  Sum_probs=103.3

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCC--------------
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL--------------  103 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~--------------  103 (473)
                      ....+++.|+..|+.+.++.|++.+......+..|+||||+|+..|+.++|++|+++|++++.+|.              
T Consensus        72 ~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~  151 (299)
T 1s70_B           72 DGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAM  151 (299)
T ss_dssp             TCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHH
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHhcch
Confidence            344566667777887777777776644444477788888888888888888888888887776553              


Q ss_pred             ----------------------------------------------CCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCC
Q 011991          104 ----------------------------------------------DGRTALHIAACEGHVEVVKLLLSKKANIDARDRW  137 (473)
Q Consensus       104 ----------------------------------------------~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~  137 (473)
                                                                    .|.||||+|+..|+.+++++|+++|+|++.+|..
T Consensus       152 ~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~  231 (299)
T 1s70_B          152 EELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYD  231 (299)
T ss_dssp             HHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTT
T ss_pred             HHHHHHHHhhcCCCchhhhhhhhhHHHHHHHHHHhccCcchhhhcCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCC
Confidence                                                          3567777788888888888888888888888888


Q ss_pred             CCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          138 GSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       138 g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      |.||||+|+..|+.+++++|+++|++++..+   .|+++.|
T Consensus       232 g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~l~~A  272 (299)
T 1s70_B          232 GWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVA  272 (299)
T ss_dssp             CCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSC
T ss_pred             CCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence            8888888888888888888888888876554   4555555

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.85  E-value=2.9e-21  Score=181.66  Aligned_cols=118  Identities=23%  Similarity=0.187  Sum_probs=88.9

Q ss_pred             CCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCC
Q 011991           51 SLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA  129 (473)
Q Consensus        51 ~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga  129 (473)
                      +.+.++.+++.+....+. +.+|+||||+||..|+.++|++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+
T Consensus        35 ~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~  114 (253)
T 1yyh_A           35 APAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA  114 (253)
T ss_dssp             -----------------CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTT
T ss_pred             ChHHHHHHHHccCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence            778888888887655444 7888999999999999999999999999999888889999999999999999999998887


Q ss_pred             -CCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          130 -NIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       130 -~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                       +++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       115 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d  154 (253)
T 1yyh_A          115 TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVD  154 (253)
T ss_dssp             SCTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBC
T ss_pred             CCccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcC
Confidence             888888889999999999999999999998888887654

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.85  E-value=3.1e-21  Score=163.50  Aligned_cols=101  Identities=34%  Similarity=0.456  Sum_probs=96.2

Q ss_pred             CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHc
Q 011991           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYY  148 (473)
Q Consensus        69 ~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~  148 (473)
                      ...+.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus        11 ~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~   90 (136)
T 2jab_A           11 GSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFI   90 (136)
T ss_dssp             -CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHH
T ss_pred             cccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence            55689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhhhhhhhhcCCcCccCcC
Q 011991          149 GNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       149 ~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      |+.+++++|+++|++++..+.
T Consensus        91 ~~~~~v~~Ll~~g~~~~~~~~  111 (136)
T 2jab_A           91 GHLEIAEVLLKHGADVNAQDK  111 (136)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCT
T ss_pred             CCHHHHHHHHHcCCCCcCcCC
Confidence            999999999999999876643

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.85  E-value=2.1e-21  Score=178.59  Aligned_cols=133  Identities=20%  Similarity=0.134  Sum_probs=119.8

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCC-CCcccCCCCCcHHHHHHH
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGS-DVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga-~~n~~d~~g~T~lh~A~~  114 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++|+ +++.+|..|+||||+|+.
T Consensus        22 d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~  101 (223)
T 2f8y_A           22 DRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAAR  101 (223)
T ss_dssp             TTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHH
T ss_pred             CCCCCchHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHH
Confidence            3445667788899999999999998875555558899999999999999999999999987 899999999999999999


Q ss_pred             cCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      .|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       102 ~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  155 (223)
T 2f8y_A          102 LAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN  155 (223)
T ss_dssp             HTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             hCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence            999999999999999999999999999999999999999999999999987664

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.85  E-value=2.6e-21  Score=179.85  Aligned_cols=139  Identities=25%  Similarity=0.275  Sum_probs=118.2

Q ss_pred             CCCCcceeeccCCCCccccCCCCCcc---CCCC-CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCcHHHHH
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDE---LTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIA  112 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~---~~~~-~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~A  112 (473)
                      ....++..|+..|+.+.++.+++.+.   .+.+ .+..|.||||+|+..|+.+++++|+++|++++.+| ..|.||||+|
T Consensus        78 ~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A  157 (241)
T 1k1a_A           78 HGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHA  157 (241)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHH
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHcCCCccccccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHH
Confidence            34566677788888888888887764   1333 47789999999999999999999999999999988 7899999999


Q ss_pred             HHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          113 ACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       113 ~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      +..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+   .|++..|.
T Consensus       158 ~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~  224 (241)
T 1k1a_A          158 VENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVAR  224 (241)
T ss_dssp             HHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCS
T ss_pred             HHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHHHHHH
Confidence            99999999999999999999999999999999999999999999999999987664   45555553

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.85  E-value=1.7e-21  Score=176.07  Aligned_cols=134  Identities=22%  Similarity=0.239  Sum_probs=121.4

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHH-HcCCCCcccCCCCCcHHHHHHH
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll-~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      |.....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+ ..+++++.+|..|.||||+|+.
T Consensus        36 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~  115 (201)
T 3hra_A           36 DTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAE  115 (201)
T ss_dssp             CTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHH
Confidence            344566788889999999999999887655556889999999999999999999999 5678999999999999999999


Q ss_pred             cCCHHHHHHHHhCC-CCCCccCCCCCcHHHHHHHcCC-----hhhhhhhhhcCCcCccCcC
Q 011991          115 EGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGN-----VEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       115 ~g~~~iv~~Ll~~g-a~~~~~~~~g~t~l~~A~~~~~-----~~~~~~L~~~g~~i~~~~~  169 (473)
                      .|+.+++++|+++| ++++.+|..|.||||+|+..++     .+++++|+++|++++..+.
T Consensus       116 ~~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~  176 (201)
T 3hra_A          116 KGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDN  176 (201)
T ss_dssp             TTCHHHHHHHHHHCCCCTTCCCTTSCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCT
T ss_pred             cCCHHHHHHHHHcCCCCcCCCCCCCCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCC
Confidence            99999999999999 9999999999999999999998     8999999999999987654

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.85  E-value=1.4e-22  Score=186.80  Aligned_cols=107  Identities=25%  Similarity=0.408  Sum_probs=76.3

Q ss_pred             CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhC-CCCCCccCCCCCcHHHHHHH
Q 011991           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDARDRWGSTAAADAKY  147 (473)
Q Consensus        69 ~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~-ga~~~~~~~~g~t~l~~A~~  147 (473)
                      +.+|.||||+||..|+.++|++|++.|+++|.+|..|+||||+||..|+.++|++|+++ |++++.+|..|+||||+|+.
T Consensus        70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~  149 (222)
T 3ehr_A           70 AESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAW  149 (222)
T ss_dssp             EEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHH
T ss_pred             ccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHH
Confidence            55677777777777777777777777777777777777777777777777777777776 77777777777777777777


Q ss_pred             cCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          148 YGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       148 ~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      .|+.+++++|+++|++++..+   .+++..|
T Consensus       150 ~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A  180 (222)
T 3ehr_A          150 KGYADIVQLLLAKGARTDLRNIEKKLAFDMA  180 (222)
T ss_dssp             HTCHHHHHHHHHHTCCSCCCCTTSCCHHHHC
T ss_pred             cCCHHHHHHHHHcCCCCccccCCCCCHHHHh
Confidence            777777777777777765544   3444444

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.85  E-value=4.3e-21  Score=177.86  Aligned_cols=121  Identities=24%  Similarity=0.285  Sum_probs=102.7

Q ss_pred             ccCCCCCccCCCC---CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCC
Q 011991           55 IRRSPVQDELTVP---ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI  131 (473)
Q Consensus        55 ~~~~l~~~~~~~~---~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~  131 (473)
                      |+.+|+.+.....   .+.+|.||||+||..|+.++|++|++.|+|+|.+|..|+||||+||..|+.++|++|+++|+++
T Consensus         1 v~~ll~~~~~~~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~   80 (229)
T 2vge_A            1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANV   80 (229)
T ss_dssp             ---------CCCCCCCTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCT
T ss_pred             CeehhccCCCCccccccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCC
Confidence            4566776644332   2567889999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC----cCCCCcCC
Q 011991          132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT----KRTPMTVA  175 (473)
Q Consensus       132 ~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~----~~t~l~~a  175 (473)
                      +.+|..|+||||+|+..|+.+++++|+++|++++..    +.|++..|
T Consensus        81 n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A  128 (229)
T 2vge_A           81 NSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKC  128 (229)
T ss_dssp             TCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTCCTGGGC
T ss_pred             CCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCCHHHHH
Confidence            999999999999999999999999999999999754    35777776

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.85  E-value=8.7e-22  Score=189.50  Aligned_cols=137  Identities=23%  Similarity=0.253  Sum_probs=119.4

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ....++.|+..|+++.|+.+++.+......+.+|.||||+||..|+.++|++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        40 ~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~  119 (299)
T 1s70_B           40 DGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYL  119 (299)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCH
Confidence            34557889999999999999988854444588999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCC------------------------------------------------------------CC
Q 011991          119 EVVKLLLSKKANIDARDR------------------------------------------------------------WG  138 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~------------------------------------------------------------~g  138 (473)
                      ++|++|+++|++++.+|.                                                            .|
T Consensus       120 ~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g  199 (299)
T 1s70_B          120 DIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSG  199 (299)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTC
T ss_pred             HHHHHHHhCCCCCCCcCCCCCCHHHHHHhcchHHHHHHHHhhcCCCchhhhhhhhhHHHHHHHHHHhccCcchhhhcCCC
Confidence            999999999999988764                                                            46


Q ss_pred             CcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          139 STAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       139 ~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      .||||+|+..|+.+++++|+++|++++..+   .|+++.|
T Consensus       200 ~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A  239 (299)
T 1s70_B          200 GTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAA  239 (299)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHH
T ss_pred             CCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHH
Confidence            677888889999999999999999887664   3444444

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=2.9e-22  Score=191.58  Aligned_cols=129  Identities=12%  Similarity=0.049  Sum_probs=101.8

Q ss_pred             hccCceeeeEEEEE---E-ecCcEEEEEEEcCCCCCCH---------------HHHHHHHHHHHHHHhcCCCeeeeEEee
Q 011991          193 RKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDP---------------ERINAFTHELTIVEKARHPNVVQFVGA  253 (473)
Q Consensus       193 ~~~~~ig~G~~~~~---~-~~~~~vavK~l~~~~~~~~---------------~~~~~~~~E~~~l~~l~hpnIv~l~~~  253 (473)
                      .+.+.||.|+|+.+   . .+|+.||+|++........               .....+.+|+.+++.++  | +++.++
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            35688999998754   2 3688999999975322111               24567899999999999  4 566665


Q ss_pred             EeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       254 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      +.. +..|+||||++|++|.+ +.    .  .....++.|++.||.|||++|   |+||||||+|||++ ++.+||+|||
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             Eec-cceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECC
Confidence            544 56699999999999988 42    1  234579999999999999999   99999999999999 9999999999


Q ss_pred             ccc
Q 011991          334 LLR  336 (473)
Q Consensus       334 ~a~  336 (473)
                      +++
T Consensus       238 ~a~  240 (282)
T 1zar_A          238 QSV  240 (282)
T ss_dssp             TCE
T ss_pred             CCe
Confidence            985

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.85  E-value=2.5e-21  Score=179.87  Aligned_cols=134  Identities=19%  Similarity=0.146  Sum_probs=117.9

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccC---CCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDEL---TVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH  110 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~---~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh  110 (473)
                      .|.....+++.|+..|+.+.++.+++.+..   +++. +..|.||||+||..|+.++|++|+++|+++|.+|..|+||||
T Consensus         4 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~   83 (236)
T 1ikn_D            4 LTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLH   83 (236)
T ss_dssp             ---CCCCTTHHHHHTTCSSSSSCCCC-----CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHH
T ss_pred             CCCCCCchhHHHHHcCChhHHHHHHHHhhccHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHH
Confidence            456677888899999999999999988743   3444 888999999999999999999999999999999999999999


Q ss_pred             HHHHcCCHHHHHHHHhCCCC------CCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          111 IAACEGHVEVVKLLLSKKAN------IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       111 ~A~~~g~~~iv~~Ll~~ga~------~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      +|+..|+.+++++|+++|++      ++..|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus        84 ~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  147 (236)
T 1ikn_D           84 LACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQE  147 (236)
T ss_dssp             HHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCC
T ss_pred             HHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999987      57788999999999999999999999999999997654

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.84  E-value=2.7e-21  Score=178.28  Aligned_cols=141  Identities=18%  Similarity=0.162  Sum_probs=122.4

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCc--cCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHcC--CCCcccCCCCCcHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQD--ELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEG--SDVNSIDLDGRTAL  109 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~--~~~~~-~~~~g~t~L~~aa~~g~~~~v~~Ll~~g--a~~n~~d~~g~T~l  109 (473)
                      .|.....+++.|+..|+.+.++.+++.+  ..... .+..|.||||+|+..|+.+++++|+++|  ++++.+|..|+|||
T Consensus        32 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L  111 (228)
T 2dzn_A           32 KDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCL  111 (228)
T ss_dssp             CCTTSCCHHHHHHHTTCHHHHHHHHHTCTTCCGGGCCCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHH
T ss_pred             CCCCCCCHHHHHHHcCCHHHHHHHHhccccccccccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHH
Confidence            3455667788888999999999999887  22223 5778999999999999999999999998  89999999999999


Q ss_pred             HHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC-CcCccCc---CCCCcCC
Q 011991          110 HIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG-AKVPKTK---RTPMTVA  175 (473)
Q Consensus       110 h~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g-~~i~~~~---~t~l~~a  175 (473)
                      |+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++| ++++..+   .|+++.|
T Consensus       112 ~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A  181 (228)
T 2dzn_A          112 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHA  181 (228)
T ss_dssp             HHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHH
T ss_pred             HHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCHHHHH
Confidence            9999999999999999999999999999999999999999999999999999 8886654   4444444

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.84  E-value=1.1e-21  Score=175.10  Aligned_cols=122  Identities=26%  Similarity=0.226  Sum_probs=106.7

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCcHHHHHHHcCC
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGH  117 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~A~~~g~  117 (473)
                      ...+++.|+..|+.+.++.+++ +......|.+|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+
T Consensus        44 g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~  122 (183)
T 3deo_A           44 YETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVR  122 (183)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCc
Confidence            4466888999999999999998 43333348899999999999999999999999999999998 899999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       118 ~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      .+++++|+++|++++.+|..|+||||+|+..++.+.++.++..+
T Consensus       123 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~~l~~a  166 (183)
T 3deo_A          123 PEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFG  166 (183)
T ss_dssp             HHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHHHTCCCCSHHHHH
T ss_pred             HHHHHHHHHcCCCCcCCCCCCCCHHHHHHHhccCcccccHHHHH
Confidence            99999999999999999999999999999876555554444433

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.84  E-value=1e-21  Score=187.42  Aligned_cols=135  Identities=25%  Similarity=0.276  Sum_probs=118.4

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHH-----HcCCHHHHHHHHHcCCCCcccCCCCCcH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMA-----CRGDVKGVEDLLNEGSDVNSIDLDGRTA  108 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa-----~~g~~~~v~~Ll~~ga~~n~~d~~g~T~  108 (473)
                      .|.....+++.|+..|+.+.++.+++.+..+++. +..|.||||+|+     ..|+.+++++|++.|++++..|..|+||
T Consensus       107 ~d~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp  186 (276)
T 4hbd_A          107 ADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTA  186 (276)
T ss_dssp             CCTTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCH
T ss_pred             CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCH
Confidence            3455667888889999999999999998745554 888999999999     5688999999999999999999999999


Q ss_pred             HHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhh-cCCcCccCcC
Q 011991          109 LHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKA-RGAKVPKTKR  169 (473)
Q Consensus       109 lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~-~g~~i~~~~~  169 (473)
                      ||+|+..|+.++|++|+++|+|++.+|..|+||||+|+..|+.+++++|++ .|++++..+.
T Consensus       187 Lh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~  248 (276)
T 4hbd_A          187 LMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDR  248 (276)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCT
T ss_pred             HHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCC
Confidence            999999999999999999999999999999999999999999999999998 8988876654

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.84  E-value=1e-21  Score=187.47  Aligned_cols=123  Identities=28%  Similarity=0.301  Sum_probs=112.0

Q ss_pred             CCCcceeec-----cCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHH
Q 011991           39 RNNMRFSFG-----RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (473)
Q Consensus        39 ~~~~~~~~~-----~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~  113 (473)
                      ...+++.++     ..++.+.++.+++.+......+..|+||||+||..|+.++|++|+++|+|+|.+|..|+||||+|+
T Consensus       145 g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~  224 (276)
T 4hbd_A          145 GYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCAC  224 (276)
T ss_dssp             SCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHH
Confidence            334444445     668888899999888766666889999999999999999999999999999999999999999999


Q ss_pred             HcCCHHHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          114 CEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       114 ~~g~~~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      ..|+.++|++|++ .|+|++.+|..|+||||+|+..|+.+++++|+++.
T Consensus       225 ~~g~~~iv~~Ll~~~gad~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~~  273 (276)
T 4hbd_A          225 EHGHKEIAGLLLAVPSCDISLTDRDGSTALMVALDAGQSEIASMLYSRM  273 (276)
T ss_dssp             HHTCHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHC
T ss_pred             HCCCHHHHHHHHhcCCCCCcCcCCCCCCHHHHHHHcCCHHHHHHHHhcc
Confidence            9999999999999 89999999999999999999999999999999865

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.84  E-value=1.2e-21  Score=183.33  Aligned_cols=122  Identities=29%  Similarity=0.301  Sum_probs=80.8

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~A~~~g~~~  119 (473)
                      .+++.|+..|+.+.++.+++ +......|.+|+||||+||..|+.++|++|+++|+++|.+| ..|+||||+|+..|+.+
T Consensus        47 t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~  125 (244)
T 3ui2_A           47 TPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPE  125 (244)
T ss_dssp             HHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHH
T ss_pred             CHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHH
Confidence            45566667777777777766 32222236667777777777777777777777777777666 66777777777777777


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHH----------------HcCChhhhhhhhhcCCc
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAK----------------YYGNVEVYNILKARGAK  163 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~----------------~~~~~~~~~~L~~~g~~  163 (473)
                      +|++|+++|++++.+|..|+||||+|+                ..|+.+++++|.+++.+
T Consensus       126 ~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~~  185 (244)
T 3ui2_A          126 VVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFE  185 (244)
T ss_dssp             HHHHHHHTTCCTTCCCTTCCCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHEE
T ss_pred             HHHHHHHCCCCCCCCCCCCCcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhccc
Confidence            777777777777777777777766665                44555666666655443

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.84  E-value=5e-21  Score=156.09  Aligned_cols=94  Identities=38%  Similarity=0.487  Sum_probs=87.2

Q ss_pred             CCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHH
Q 011991           65 TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD  144 (473)
Q Consensus        65 ~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~  144 (473)
                      ..+.+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+
T Consensus        17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~   96 (110)
T 2zgd_A           17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDI   96 (110)
T ss_dssp             -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred             ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHH
Confidence            34568899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHcCChhhhhhhh
Q 011991          145 AKYYGNVEVYNILK  158 (473)
Q Consensus       145 A~~~~~~~~~~~L~  158 (473)
                      |+..|+.+++++|.
T Consensus        97 A~~~~~~~~~~~L~  110 (110)
T 2zgd_A           97 SIDNGNEDLAEILQ  110 (110)
T ss_dssp             HHHHTCHHHHHHHC
T ss_pred             HHHcCCHHHHHHhC
Confidence            99999999999873

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.84  E-value=3.1e-22  Score=179.32  Aligned_cols=129  Identities=13%  Similarity=0.104  Sum_probs=108.3

Q ss_pred             CCCcceeeccCCCCc----cccCCCCCccCCCCCCCCCChHHHHHHHcCC------HHHHHHHHHcCCCCcccCCCCC-c
Q 011991           39 RNNMRFSFGRQSSLD----PIRRSPVQDELTVPENLDSTMQLLFMACRGD------VKGVEDLLNEGSDVNSIDLDGR-T  107 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~----~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~------~~~v~~Ll~~ga~~n~~d~~g~-T  107 (473)
                      ...+++.|+..|+.+    .++.||+.|......+.+|+||||+|+..|+      .+++++||++|||+|.+|..|+ |
T Consensus        38 g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tt  117 (186)
T 3t8k_A           38 KSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIV  117 (186)
T ss_dssp             TTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBC
T ss_pred             CCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCch
Confidence            445566666777653    4666666664444459999999999999987      6889999999999999999999 9


Q ss_pred             HHHHHHHcC-----CHHHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          108 ALHIAACEG-----HVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       108 ~lh~A~~~g-----~~~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      |||+|+..|     +.+++++|++ +|+|++.+|..|.||||+|+..|+.+++++|.+...+.+..
T Consensus       118 pLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~~~~~  183 (186)
T 3t8k_A          118 VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKYNLK  183 (186)
T ss_dssp             TTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHHHhcc
Confidence            999999954     4679999999 99999999999999999999999999999999876655443

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.84  E-value=8.1e-22  Score=187.47  Aligned_cols=131  Identities=17%  Similarity=0.113  Sum_probs=114.1

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCC--------------CCChHHHHHHHcCCHHHHHHHHH---cCCCC
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENL--------------DSTMQLLFMACRGDVKGVEDLLN---EGSDV   98 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~--------------~g~t~L~~aa~~g~~~~v~~Ll~---~ga~~   98 (473)
                      |.....+++.|+..|+.+.++.|++.+......+.              .|.||||+||..|+.++|++|++   +|+|+
T Consensus        98 d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~  177 (273)
T 2pnn_A           98 YYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADI  177 (273)
T ss_dssp             TTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCT
T ss_pred             cCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCc
Confidence            34566778888999999999999988644333354              79999999999999999999999   99999


Q ss_pred             cccCCCCCcHHHHHHHcCC---------HHHHHHHHhCCCCCC-------ccCCCCCcHHHHHHHcCChhhhhhhhhcCC
Q 011991           99 NSIDLDGRTALHIAACEGH---------VEVVKLLLSKKANID-------ARDRWGSTAAADAKYYGNVEVYNILKARGA  162 (473)
Q Consensus        99 n~~d~~g~T~lh~A~~~g~---------~~iv~~Ll~~ga~~~-------~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~  162 (473)
                      |.+|..|+||||+|+..|+         .+++++|+++|++++       .+|..|+||||+|+..|+.+++++|+++|+
T Consensus       178 ~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga  257 (273)
T 2pnn_A          178 SARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREI  257 (273)
T ss_dssp             TCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHT
T ss_pred             eeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCC
Confidence            9999999999999999998         899999999999997       489999999999999999999999999998


Q ss_pred             -cCcc
Q 011991          163 -KVPK  166 (473)
Q Consensus       163 -~i~~  166 (473)
                       +...
T Consensus       258 ~dp~~  262 (273)
T 2pnn_A          258 HEPEC  262 (273)
T ss_dssp             C----
T ss_pred             CCchh
Confidence             5543

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.84  E-value=4.6e-22  Score=187.61  Aligned_cols=129  Identities=16%  Similarity=0.134  Sum_probs=116.6

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccCCCCCC--------------CCCChHHHHHHHcCCHHHHHHHHH---cCCCCcc
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPEN--------------LDSTMQLLFMACRGDVKGVEDLLN---EGSDVNS  100 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~--------------~~g~t~L~~aa~~g~~~~v~~Ll~---~ga~~n~  100 (473)
                      ....+++.|+..|+.+.++.|++.+......+              ..|+||||+||..|+.++|++|++   +|+|+|.
T Consensus        92 ~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~  171 (260)
T 3jxi_A           92 RGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRR  171 (260)
T ss_dssp             ESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTC
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcc
Confidence            45677888999999999999998874433335              579999999999999999999999   9999999


Q ss_pred             cCCCCCcHHHHHHHcCC---------HHHHHHHHhCCCCC-------CccCCCCCcHHHHHHHcCChhhhhhhhhcCCcC
Q 011991          101 IDLDGRTALHIAACEGH---------VEVVKLLLSKKANI-------DARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (473)
Q Consensus       101 ~d~~g~T~lh~A~~~g~---------~~iv~~Ll~~ga~~-------~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i  164 (473)
                      +|..|+||||+|+..|+         .+++++|+++|+++       +.+|..|+||||+|+..|+.+++++|+++|.+.
T Consensus       172 ~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~  251 (260)
T 3jxi_A          172 QDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIAD  251 (260)
T ss_dssp             CCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred             cCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCc
Confidence            99999999999999888         79999999999999       679999999999999999999999999999876


Q ss_pred             cc
Q 011991          165 PK  166 (473)
Q Consensus       165 ~~  166 (473)
                      ..
T Consensus       252 ~~  253 (260)
T 3jxi_A          252 AA  253 (260)
T ss_dssp             HC
T ss_pred             cc
Confidence            44

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.84  E-value=8.5e-22  Score=185.44  Aligned_cols=129  Identities=18%  Similarity=0.155  Sum_probs=116.4

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCC-------------CChHHHHHHHcCCHHHHHHHHH---cCCCCcc
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLD-------------STMQLLFMACRGDVKGVEDLLN---EGSDVNS  100 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~-------------g~t~L~~aa~~g~~~~v~~Ll~---~ga~~n~  100 (473)
                      .....+++.|+..|+.+.++.|++.+......+..             |.||||+||..|+.++|++|++   +|+|+|.
T Consensus        88 ~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~  167 (256)
T 2etb_A           88 YQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEA  167 (256)
T ss_dssp             TTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTC
T ss_pred             ccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCc
Confidence            34567778889999999999999887443333544             9999999999999999999999   9999999


Q ss_pred             cCCCCCcHHHHHHH--cCCHH-------HHHHHHhCCCCC-------CccCCCCCcHHHHHHHcCChhhhhhhhhcCCcC
Q 011991          101 IDLDGRTALHIAAC--EGHVE-------VVKLLLSKKANI-------DARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (473)
Q Consensus       101 ~d~~g~T~lh~A~~--~g~~~-------iv~~Ll~~ga~~-------~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i  164 (473)
                      +|..|+||||+|+.  .++.+       ++++|+++|+++       +.+|..|+||||+|+..|+.+++++|+++|.+.
T Consensus       168 ~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~  247 (256)
T 2etb_A          168 TDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSG  247 (256)
T ss_dssp             CCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHSTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCcccccccccccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCC
Confidence            99999999999999  88998       999999999999       999999999999999999999999999999876


Q ss_pred             c
Q 011991          165 P  165 (473)
Q Consensus       165 ~  165 (473)
                      .
T Consensus       248 ~  248 (256)
T 2etb_A          248 A  248 (256)
T ss_dssp             H
T ss_pred             C
Confidence            4

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.83  E-value=2.7e-21  Score=184.06  Aligned_cols=140  Identities=18%  Similarity=0.144  Sum_probs=113.1

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCC-------------------
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD-------------------   97 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~-------------------   97 (473)
                      .....+++.|+..|+.+.++.|++.+......+..|+||||+|+..|+.+++++|+++|++                   
T Consensus        43 ~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~~~~~~~  122 (282)
T 1oy3_D           43 DLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPD  122 (282)
T ss_dssp             TTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHHTTTTCHHHHHHHSSSCCSSCCCC--------------
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCcchhHhhhccCCCCchhhHHHHhhcccccCcc
Confidence            4455667778888888888888887754444577888899888888888888888887765                   


Q ss_pred             ----------------------------CcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCC-CCcHHHHHHHc
Q 011991           98 ----------------------------VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRW-GSTAAADAKYY  148 (473)
Q Consensus        98 ----------------------------~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~-g~t~l~~A~~~  148 (473)
                                                  +|.+|..|+||||+|+..|+.++|++|+++|++++.++.. |+||||+|+..
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~  202 (282)
T 1oy3_D          123 TSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEA  202 (282)
T ss_dssp             ---------------------CCCGGGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHT
T ss_pred             hhcchhhhccccccchhhhhhhhhhhhcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHc
Confidence                                        6778888899999999999999999999999999988854 99999999999


Q ss_pred             CChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          149 GNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       149 ~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      |+.+++++|+++|++++.++   .|+++.|.
T Consensus       203 ~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~  233 (282)
T 1oy3_D          203 QAASVLELLLKAGADPTARMYGGRTPLGSAL  233 (282)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCcccccCCCCHHHHHH
Confidence            99999999999998887664   45555553

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.83  E-value=2.5e-21  Score=184.14  Aligned_cols=128  Identities=23%  Similarity=0.255  Sum_probs=112.9

Q ss_pred             CCCCcceeecc---CCCCccccCCCCCccC--------CC---CCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCC
Q 011991           38 RRNNMRFSFGR---QSSLDPIRRSPVQDEL--------TV---PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL  103 (473)
Q Consensus        38 ~~~~~~~~~~~---~g~~~~~~~~l~~~~~--------~~---~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~  103 (473)
                      ....+++.|+.   .|+.+.++.|++.+..        +.   ..+..|.||||+||..|+.++|++|+++|+|+|.+|.
T Consensus        53 ~g~tpL~~A~~~~~~g~~~~v~~Ll~~ga~~~~~~~~i~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~  132 (273)
T 2pnn_A           53 TGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAAN  132 (273)
T ss_dssp             TCCCHHHHHHHSCBTTBCHHHHHHHHHHHHTTCHHHHHTCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBC
T ss_pred             CCCCHHHHHHHHHhcCChHHHHHHHHhhccccchhHHhhcccccccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCcccc
Confidence            34455555664   3999999999988632        11   1356899999999999999999999999999999997


Q ss_pred             --------------CCCcHHHHHHHcCCHHHHHHHHh---CCCCCCccCCCCCcHHHHHHHcCC---------hhhhhhh
Q 011991          104 --------------DGRTALHIAACEGHVEVVKLLLS---KKANIDARDRWGSTAAADAKYYGN---------VEVYNIL  157 (473)
Q Consensus       104 --------------~g~T~lh~A~~~g~~~iv~~Ll~---~ga~~~~~~~~g~t~l~~A~~~~~---------~~~~~~L  157 (473)
                                    .|+||||+|+..|+.++|++|++   +|++++.+|..|+||||+|+..|+         .+++++|
T Consensus       133 ~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~L  212 (273)
T 2pnn_A          133 GDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEI  212 (273)
T ss_dssp             SGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHH
Confidence                          79999999999999999999999   999999999999999999999998         7999999


Q ss_pred             hhcCCcCc
Q 011991          158 KARGAKVP  165 (473)
Q Consensus       158 ~~~g~~i~  165 (473)
                      +++|++++
T Consensus       213 l~~ga~~n  220 (273)
T 2pnn_A          213 LILGAKLH  220 (273)
T ss_dssp             HHHHHHHC
T ss_pred             HHhhhhcc
Confidence            99999885

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.83  E-value=6.5e-21  Score=193.68  Aligned_cols=130  Identities=20%  Similarity=0.265  Sum_probs=94.7

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ...++..|+..|+.+.++.|++.+......+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus       245 g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~  324 (437)
T 1n11_A          245 GVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNI  324 (437)
T ss_dssp             CCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCS
T ss_pred             CCCHHHHHHHCCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcH
Confidence            33455566677777777766666544434466777777777777777777777777777777777777777777777777


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ++|++|+++|+|++.+|..|+||||+|+..|+.+++++|+++|++++..+
T Consensus       325 ~~v~~Ll~~gad~n~~~~~g~t~L~~A~~~g~~~iv~~Ll~~ga~~~~~~  374 (437)
T 1n11_A          325 KLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS  374 (437)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCC
T ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHCChHHHHHHHHHCcCCCCCCC
Confidence            77777777777777777777777777777777777777777777776554

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.83  E-value=2.1e-20  Score=155.26  Aligned_cols=98  Identities=41%  Similarity=0.571  Sum_probs=95.1

Q ss_pred             CCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCC
Q 011991           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN  150 (473)
Q Consensus        71 ~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~  150 (473)
                      +|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~   80 (126)
T 1n0r_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (126)
T ss_dssp             CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhcCCcCccCc
Q 011991          151 VEVYNILKARGAKVPKTK  168 (473)
Q Consensus       151 ~~~~~~L~~~g~~i~~~~  168 (473)
                      .+++++|+++|++++..+
T Consensus        81 ~~~~~~Ll~~g~~~~~~~   98 (126)
T 1n0r_A           81 LEVVKLLLEAGADVNAKD   98 (126)
T ss_dssp             HHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHHHcCCCCcccC
Confidence            999999999999987654

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.83  E-value=7.4e-21  Score=182.26  Aligned_cols=131  Identities=22%  Similarity=0.172  Sum_probs=113.7

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      .....+++.|+..|+.+.++.+++.+......+.+|+||||+||..|+.++|++|+++|+++|.+|..|+||||+|+..|
T Consensus        57 ~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~  136 (285)
T 3d9h_A           57 VSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSG  136 (285)
T ss_dssp             CCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHT
T ss_pred             ccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcC
Confidence            33556678888999999999998877544444888999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      +.+++++|+++|++++..+ .|.||||+|+..|+.+++++|+++|++++..+
T Consensus       137 ~~~~v~~Ll~~g~~~~~~~-~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d  187 (285)
T 3d9h_A          137 SWDCVNLLLQHGASVQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKI  187 (285)
T ss_dssp             CHHHHHHHHHTTCCSSCSC-TTSCHHHHHHHHTCHHHHHHHHHTTCCTTCCB
T ss_pred             HHHHHHHHHHCCCCCCCCC-CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence            9999999999999998655 49999999999999999999999999887654

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.83  E-value=1.6e-20  Score=174.30  Aligned_cols=132  Identities=27%  Similarity=0.321  Sum_probs=107.6

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcC-CCCcccCCCCCcHHHHHHHc
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~g-a~~n~~d~~g~T~lh~A~~~  115 (473)
                      .....+++.|+..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+++| ++++.+|..|+||||+|+..
T Consensus        42 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~  121 (237)
T 3b7b_A           42 EDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEY  121 (237)
T ss_dssp             TTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCCCHHHHHHHc
Confidence            33455677777888888888888776554455778888888888888888888888887 78888888888888888888


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       122 ~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~  174 (237)
T 3b7b_A          122 KHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVN  174 (237)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCC
T ss_pred             CCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcC
Confidence            88888888888888888888888888888888888888888888888876654

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.83  E-value=1.2e-20  Score=180.84  Aligned_cols=134  Identities=19%  Similarity=0.173  Sum_probs=84.9

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .+++.|+..|+.+.++.|++.+. +.+.+.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.++
T Consensus       127 t~L~~A~~~~~~~~v~~Ll~~g~-~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~  205 (285)
T 3d9h_A          127 TPLFNACVSGSWDCVNLLLQHGA-SVQPESDLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRAC  205 (285)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTTC-CSSCSCTTSCHHHHHHHHTCHHHHHHHHHTTCCTTCCBTTTBCHHHHHHHTTCHHH
T ss_pred             CHHHHHHHcCHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHH
Confidence            44455556666665555555442 33344456666666666666666666666666666666667777777777777777


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      +++|+++|++++. |..|.||||+|+..|+.+++++|+++|++++.++   .|++..|.
T Consensus       206 v~~Ll~~ga~~~~-~~~g~t~L~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~l~~A~  263 (285)
T 3d9h_A          206 VKKLLESGADVNQ-GKGQDSPLHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVP  263 (285)
T ss_dssp             HHHHHHTTCCTTC-CBTTBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGGGGSC
T ss_pred             HHHHHHCCCCCCC-CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHhc
Confidence            7777777776663 6666777777777777777777777776665443   34454443

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.83  E-value=8.4e-21  Score=180.54  Aligned_cols=130  Identities=21%  Similarity=0.178  Sum_probs=120.4

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCC----HHHHHHHHHcCCCCcccCCCCCcHHHHHH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGD----VKGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~----~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~  113 (473)
                      ...+++.|+..|+.+.++.+++..+.+++. +..|.||||+|+..|+    .+++++|+++|+++|.+|..|+||||+|+
T Consensus       148 g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~  227 (285)
T 1wdy_A          148 GATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV  227 (285)
T ss_dssp             CCCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHH
T ss_pred             CCcHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence            456778888999999999999874455554 8899999999999999    99999999999999999999999999999


Q ss_pred             HcCCHHHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          114 CEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       114 ~~g~~~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ..|+.+++++|++ .|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       228 ~~~~~~~v~~Ll~~~g~~~~~~~~~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~d  283 (285)
T 1wdy_A          228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD  283 (285)
T ss_dssp             HTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred             HcCCHHHHHHHHhccCCCccccCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCCccc
Confidence            9999999999999 899999999999999999999999999999999999998764

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.83  E-value=5e-21  Score=189.32  Aligned_cols=122  Identities=25%  Similarity=0.308  Sum_probs=111.5

Q ss_pred             cceeeccC-CCCccccCCCCCccCCCCCC--CCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           42 MRFSFGRQ-SSLDPIRRSPVQDELTVPEN--LDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        42 ~~~~~~~~-g~~~~~~~~l~~~~~~~~~~--~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      .++.|+.. |+++.++.++..+......+  .+|.||||+||..|+.++|++|+++|+|+|.+|..|+||||+|+..|+.
T Consensus       202 ~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~  281 (368)
T 3jue_A          202 LLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHT  281 (368)
T ss_dssp             HHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred             HHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcH
Confidence            45667888 99999999998875443345  7899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      ++|++|+++|||++.+|..|.||||+|+..|+.+++++|+.++..
T Consensus       282 ~~v~~LL~~Gad~~~~d~~G~TpL~~A~~~g~~~iv~lLl~~~~~  326 (368)
T 3jue_A          282 GLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLRLAKMR  326 (368)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHCcCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence            999999999999999999999999999999999999999987743

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.83  E-value=5.5e-21  Score=178.89  Aligned_cols=123  Identities=27%  Similarity=0.249  Sum_probs=107.4

Q ss_pred             ceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHH
Q 011991           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (473)
Q Consensus        43 ~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~  122 (473)
                      ++-++..|+.+.+..+...+   ...+.+|.||||+||..|+.++|++|++ |+++|.+|..|+||||+||..|+.++|+
T Consensus        19 ~l~~~~~g~~~~~~~~~~~~---~~~~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~   94 (244)
T 3ui2_A           19 YLIEWKDGHSPSWVPSSYIA---ADVVSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVR   94 (244)
T ss_dssp             EEEEESSCCCCEEEEGGGSC---HHHHHHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHH
T ss_pred             HHHHHHcCCCcccccccccc---cccccCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHH
Confidence            44556666666665544332   2235689999999999999999999999 9999999999999999999999999999


Q ss_pred             HHHhCCCCCCccC-CCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          123 LLLSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       123 ~Ll~~ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      +|+++|++++.+| ..|+||||+|+..|+.+++++|+++|++++..+.
T Consensus        95 ~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~  142 (244)
T 3ui2_A           95 LLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDE  142 (244)
T ss_dssp             HHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Confidence            9999999999998 8899999999999999999999999999977654

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.83  E-value=1.3e-20  Score=175.24  Aligned_cols=133  Identities=23%  Similarity=0.167  Sum_probs=101.8

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCC---CccCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPV---QDELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH  110 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~---~~~~~~~-~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh  110 (473)
                      .|.....+++.|+..|+.+.++.+++   ..+.+++ .+.+|.||||+|+..|+.+++++|+++|++++.+|..|+||||
T Consensus         5 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~   84 (241)
T 1k1a_A            5 ADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAH   84 (241)
T ss_dssp             --CTTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred             cCCCCCcHHHHHHHcCCHHHHHHHHHHHHhcCCCCCcccccCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHH
Confidence            34556667777788888888777775   2333333 3777888888888888888888888888888888888888888


Q ss_pred             HHHHcCCHHHHHHHHhCCC----CCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          111 IAACEGHVEVVKLLLSKKA----NIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       111 ~A~~~g~~~iv~~Ll~~ga----~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      +|+..|+.+++++|+++|+    +++.+|..|.||||+|+..|+.+++++|+++|++++..
T Consensus        85 ~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~  145 (241)
T 1k1a_A           85 LACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAV  145 (241)
T ss_dssp             HHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred             HHHHcCCHHHHHHHHHcCCCccccccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccc
Confidence            8888888888888888876    77888888888888888888888888888888777654

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.82  E-value=1e-20  Score=164.28  Aligned_cols=107  Identities=27%  Similarity=0.328  Sum_probs=97.8

Q ss_pred             CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCc-HHHHHH
Q 011991           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGST-AAADAK  146 (473)
Q Consensus        68 ~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t-~l~~A~  146 (473)
                      .+..|.||||+||..|+.++|++|+++|+++|.+|..|+||||+|+ .|+.+++++|+++|++++.+|..|.| |||+|+
T Consensus         8 ~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~   86 (156)
T 1bi7_B            8 SMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAA   86 (156)
T ss_dssp             --CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHH
T ss_pred             CCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHH
Confidence            4678999999999999999999999999999999999999999985 99999999999999999999999999 999999


Q ss_pred             HcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          147 YYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       147 ~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      ..|+.+++++|+++|++++..+.   ++++.|
T Consensus        87 ~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  118 (156)
T 1bi7_B           87 REGFLDTLVVLHRAGARLDVRDAWGRLPVDLA  118 (156)
T ss_dssp             HHTCHHHHHHHHHHTCCSSCCCTTCCCHHHHH
T ss_pred             HCCCHHHHHHHHHcCCCCcccCCCCCCHHHHH
Confidence            99999999999999999987653   444444

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.82  E-value=3.6e-21  Score=190.83  Aligned_cols=129  Identities=9%  Similarity=-0.002  Sum_probs=118.5

Q ss_pred             CCCCcceeeccCC--CCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCC-----CcccCCCCCcHHH
Q 011991           38 RRNNMRFSFGRQS--SLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD-----VNSIDLDGRTALH  110 (473)
Q Consensus        38 ~~~~~~~~~~~~g--~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~-----~n~~d~~g~T~lh  110 (473)
                      ....+++.|+..|  +.+.++.|++.+......+..|+||||+||..|+.++|++|+++|++     +|.+|..|+||||
T Consensus       137 ~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~  216 (364)
T 3ljn_A          137 KGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLH  216 (364)
T ss_dssp             SCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTH
T ss_pred             CCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHH
Confidence            4556778888899  88999999988755445588999999999999999999999999999     9999999999999


Q ss_pred             HHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCcc
Q 011991          111 IAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK  166 (473)
Q Consensus       111 ~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~  166 (473)
                      +|+..|+.++|++|+++|+|++.+|..|.||||+|+..|+.+++++|+++|++++.
T Consensus       217 ~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~~~  272 (364)
T 3ljn_A          217 WAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLI  272 (364)
T ss_dssp             HHHTTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTCCHHHHHHHHHHSCHHHH
T ss_pred             HHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhChHHHHHHHHHcCCchhh
Confidence            99999999999999999999999999999999999999999999999999987643

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.82  E-value=3.7e-21  Score=184.43  Aligned_cols=126  Identities=20%  Similarity=0.145  Sum_probs=100.8

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      .....+++.|+..|+.+.++.+++.+.. ++.. +|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|
T Consensus        29 ~~g~t~L~~A~~~g~~~~v~~Ll~~g~~-~~~~-~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g  106 (285)
T 3kea_A           29 VHGHSASYYAIADNNVRLVCTLLNAGAL-KNLL-ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSG  106 (285)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHTTGG-GSCC-TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHhCCCC-CCCC-CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Confidence            4455667777788888888888877632 2322 5888888888888888888888888888888888888888888888


Q ss_pred             CHHHHHHHHhCCCCCCccCCCC-CcHHHHHHHcCChhhhhhhhhcCCcC
Q 011991          117 HVEVVKLLLSKKANIDARDRWG-STAAADAKYYGNVEVYNILKARGAKV  164 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g-~t~l~~A~~~~~~~~~~~L~~~g~~i  164 (473)
                      +.+++++|+++|++++.+|..| .||||+|+..|+.+++++|+++|.+.
T Consensus       107 ~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~~~~~v~~Ll~~g~~~  155 (285)
T 3kea_A          107 NMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST  155 (285)
T ss_dssp             CHHHHHHHHHHCGGGGGCSSSGGGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred             CHHHHHHHHhcCCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence            8888888888888888888888 68888888888888888888887665

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.82  E-value=2.1e-20  Score=172.15  Aligned_cols=130  Identities=22%  Similarity=0.173  Sum_probs=109.6

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHc-CCCCcccCCCCCcHHHHHHHcCC
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGH  117 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~-ga~~n~~d~~g~T~lh~A~~~g~  117 (473)
                      ....++.|+..|+.+.++.+++.+......+..|+||||+||..|+.++|++|+++ |+++|.+|..|+||||+|+..|+
T Consensus        73 g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~  152 (222)
T 3ehr_A           73 IDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGY  152 (222)
T ss_dssp             ESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTC
T ss_pred             cccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCC
Confidence            34677888999999999999987755444588999999999999999999999998 99999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       118 ~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      .++|++|+++|++++.+|..|.|||++|+..|+.++++.|++.++.....+
T Consensus       153 ~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~l~~l~~~~~~~~~~~  203 (222)
T 3ehr_A          153 ADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSN  203 (222)
T ss_dssp             HHHHHHHHHHTCCSCCCCTTSCCHHHHCCSHHHHHHHC-------------
T ss_pred             HHHHHHHHHcCCCCccccCCCCCHHHHhcchhHHHHHHHHhccchhhhccc
Confidence            999999999999999999999999999999999999999999998876554

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.82  E-value=1.7e-20  Score=178.50  Aligned_cols=127  Identities=26%  Similarity=0.272  Sum_probs=117.7

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      ..++.|++.|+++.++.+++.+...... +..|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+
T Consensus         7 ~~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~   86 (285)
T 1wdy_A            7 HLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVK   86 (285)
T ss_dssp             HHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHH
T ss_pred             hHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHH
Confidence            3466789999999999999987544334 778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      ++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..
T Consensus        87 ~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~  134 (285)
T 1wdy_A           87 LLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLR  134 (285)
T ss_dssp             HHHHHHHTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             HHHHHHHcCCCCCccCcccCCHHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence            999999999999999999999999999999999999999999988654

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.82  E-value=4.3e-21  Score=190.30  Aligned_cols=96  Identities=17%  Similarity=0.129  Sum_probs=48.9

Q ss_pred             CCChHHHHHHHcC--CHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCC-----CCccCCCCCcHHH
Q 011991           71 DSTMQLLFMACRG--DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN-----IDARDRWGSTAAA  143 (473)
Q Consensus        71 ~g~t~L~~aa~~g--~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~-----~~~~~~~g~t~l~  143 (473)
                      +|.||||+||..|  +.++|++|+++|+|+|.+|..|+||||+|+..|+.++|++|+++|++     ++.+|..|+||||
T Consensus       137 ~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~  216 (364)
T 3ljn_A          137 KGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLH  216 (364)
T ss_dssp             SCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTH
T ss_pred             CCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHH
Confidence            4445555555555  45555555555555555555555555555555555555555555444     5555555555555


Q ss_pred             HHHHcCChhhhhhhhhcCCcCcc
Q 011991          144 DAKYYGNVEVYNILKARGAKVPK  166 (473)
Q Consensus       144 ~A~~~~~~~~~~~L~~~g~~i~~  166 (473)
                      +|+..|+.+++++|+++|++++.
T Consensus       217 ~A~~~g~~~~v~~Ll~~gad~~~  239 (364)
T 3ljn_A          217 WAILINWEDVAMRFVEMGIDVNM  239 (364)
T ss_dssp             HHHTTTCHHHHHHHHTTTCCTTC
T ss_pred             HHHHcCCHHHHHHHHHcCCCCCC
Confidence            55555555555555555554443

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.82  E-value=2.8e-20  Score=172.44  Aligned_cols=136  Identities=18%  Similarity=0.161  Sum_probs=118.9

Q ss_pred             CCCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCcHHHHH
Q 011991           34 SFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIA  112 (473)
Q Consensus        34 ~~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~A  112 (473)
                      .+|+.....++.|+..|+++.++.+++.+......+..|.||||+|+..|+.+++++|+++|++++..+ ..|+||||+|
T Consensus         4 ~~d~~~~~~l~~A~~~g~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A   83 (240)
T 3eu9_A            4 HIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWA   83 (240)
T ss_dssp             CCSCGGGCCHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHH
T ss_pred             ccccccchHHHHHHHcCChHHHHHHHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHH
Confidence            355666677889999999999999998875444458889999999999999999999999999988665 4599999999


Q ss_pred             HHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          113 ACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       113 ~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      +..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus        84 ~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~  140 (240)
T 3eu9_A           84 TRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQ  140 (240)
T ss_dssp             HHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccCC
Confidence            999999999999999999999999999999999999999999999999998876543

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.82  E-value=1.1e-20  Score=181.05  Aligned_cols=123  Identities=20%  Similarity=0.176  Sum_probs=112.0

Q ss_pred             eeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHH
Q 011991           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (473)
Q Consensus        44 ~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~  123 (473)
                      ++..+..+.+.++++|..++ ....|.+|.||||+||..|+.++|++|+++|+++|.+|  |+||||+|+..|+.+++++
T Consensus         4 ls~i~~~~~~~v~~lL~~~~-~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~   80 (285)
T 3kea_A            4 LSRINTWKSKQLKSFLSSKD-TFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKI   80 (285)
T ss_dssp             CTTGGGCCHHHHHHHHHSTT-TTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHH
T ss_pred             cHHHHhcCHHHHHHHHHhCC-CCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHH
Confidence            45667778888988888774 23458899999999999999999999999999999985  9999999999999999999


Q ss_pred             HHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       124 Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      |+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+.
T Consensus        81 Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~  126 (285)
T 3kea_A           81 LLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGK  126 (285)
T ss_dssp             HHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSS
T ss_pred             HHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCC
Confidence            9999999999999999999999999999999999999999976653

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.81  E-value=2e-20  Score=190.11  Aligned_cols=129  Identities=25%  Similarity=0.187  Sum_probs=89.6

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ...+++.|+..|+++.|+.|++.+......+..|.||||+||..|+.++|++|+++|+++|.+|..|+||||+|+..|+.
T Consensus        14 g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~   93 (437)
T 1n11_A           14 GLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHT   93 (437)
T ss_dssp             -CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCH
T ss_pred             CCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCH
Confidence            44555666677777777777766543333466677777777777777777777777777777777777777777777777


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      ++|++|+++|++++..|..|.||||+|+..|+.+++++|++++.+.+..
T Consensus        94 ~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~  142 (437)
T 1n11_A           94 NMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACM  142 (437)
T ss_dssp             HHHHHHHHHTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCC
T ss_pred             HHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcCC
Confidence            7777777777777777777777777777777777777777777665443

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.81  E-value=6.5e-21  Score=186.38  Aligned_cols=140  Identities=18%  Similarity=0.101  Sum_probs=117.5

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCC---HHHHHHHHHcC-CCCcccCCCCCcHHHHH
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD---VKGVEDLLNEG-SDVNSIDLDGRTALHIA  112 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~---~~~v~~Ll~~g-a~~n~~d~~g~T~lh~A  112 (473)
                      .....+++.|+..|+.+.|+.||+.|......+.+|+||||+||..|+   .++++.|++.+ +++|.+|..|+||||+|
T Consensus       129 ~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d~~g~tpLh~A  208 (327)
T 1sw6_A          129 EHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHI  208 (327)
T ss_dssp             TTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHHH
T ss_pred             CCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCCCCCCCHHHHH
Confidence            345567777888899888888888875444458889999999999888   78888888876 78999999999999999


Q ss_pred             HH----cCCHHHHHHHHhCCC---------------------------------------------CCCccCCCCCcHHH
Q 011991          113 AC----EGHVEVVKLLLSKKA---------------------------------------------NIDARDRWGSTAAA  143 (473)
Q Consensus       113 ~~----~g~~~iv~~Ll~~ga---------------------------------------------~~~~~~~~g~t~l~  143 (473)
                      +.    .|+.+++++|++.++                                             +++.+|..|+||||
T Consensus       209 ~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n~~d~~G~TpLh  288 (327)
T 1sw6_A          209 IITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLN  288 (327)
T ss_dssp             HHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHHH
T ss_pred             HHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCCCCCCCCCCHHH
Confidence            98    899999999998753                                             68889999999999


Q ss_pred             HHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          144 DAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       144 ~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      +|+..|+.+++++|+++|++++..+   .||++.|.
T Consensus       289 ~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~  324 (327)
T 1sw6_A          289 IAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA  324 (327)
T ss_dssp             HHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred             HHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence            9999999999999999999997765   56666553

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.80  E-value=7.2e-20  Score=179.64  Aligned_cols=130  Identities=22%  Similarity=0.279  Sum_probs=120.0

Q ss_pred             ceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        43 ~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~---g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      ++.++..++.+.++.++.....+...+..|.||||+|+..   +..+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus       182 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~  261 (351)
T 3utm_A          182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHND  261 (351)
T ss_dssp             HHHHHHTTCHHHHHHHTTTCCTTCCCTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             HHHHHHhccHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHH
Confidence            4567788899999999988887777889999999999999   5589999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcCCCC
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPM  172 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~t~l  172 (473)
                      ++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+..+.
T Consensus       262 ~v~~Ll~~ga~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~  314 (351)
T 3utm_A          262 VMEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGF  314 (351)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCC
Confidence            99999999999999999999999999999999999999999999987764443

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.80  E-value=4.3e-20  Score=181.07  Aligned_cols=128  Identities=21%  Similarity=0.183  Sum_probs=112.5

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCC----HHHHHHHHHcCCCCcccCCCCCcHHHHHHH
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGD----VKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~----~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      ..+++.|+..|+.+.|+.||.+.+.+++. +..|.|+||+++..++    ..++++|+++|+|+|.+|..|+||||+|+.
T Consensus       169 ~T~L~~A~~~g~~~~v~~LL~~~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~  248 (337)
T 4g8k_A          169 ATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVE  248 (337)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHH
T ss_pred             CcHHHHHHHCCCHHHHHHHHhccCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHH
Confidence            34677888999999999998765556655 8899999999887543    468899999999999999999999999999


Q ss_pred             cCCHHHHHHHHhC-CCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccC
Q 011991          115 EGHVEVVKLLLSK-KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (473)
Q Consensus       115 ~g~~~iv~~Ll~~-ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~  167 (473)
                      .|+.+++++|++. |++++.+|..|+||||+|+..|+.++|++|+++|++++..
T Consensus       249 ~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~  302 (337)
T 4g8k_A          249 KKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG  302 (337)
T ss_dssp             TTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC
T ss_pred             hhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence            9999999999985 8999999999999999999999999999999999998764

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.80  E-value=8.8e-20  Score=181.68  Aligned_cols=132  Identities=23%  Similarity=0.252  Sum_probs=114.9

Q ss_pred             CCCCcceeeccCCCCccccCCCCCcc---CCCCCCCCCChHHHHHHHcC---CHHHHHHHHHcCCCCcc--------cCC
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDE---LTVPENLDSTMQLLFMACRG---DVKGVEDLLNEGSDVNS--------IDL  103 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~---~~~~~~~~g~t~L~~aa~~g---~~~~v~~Ll~~ga~~n~--------~d~  103 (473)
                      ....++..|+..|+.+.++.|++.+.   .....+..|.||||+||..|   +.+++++|+++|+++|.        +|.
T Consensus       198 ~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~d~  277 (373)
T 2fo1_E          198 SERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKY  277 (373)
T ss_dssp             TCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSC
T ss_pred             CCCCHHHHHHHCCCHHHHHHHHhcCccccChhhcCCCCCCHHHHHHHhCCcchHHHHHHHHHCCCCcccccccccCcccc
Confidence            34566777888899998888888772   33334889999999999988   89999999999999886        677


Q ss_pred             CCCcHHHHHHHcCCHHHHHHHHhCC-CCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991          104 DGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus       104 ~g~T~lh~A~~~g~~~iv~~Ll~~g-a~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      .|+||||+|+..|+.++|++|+++| ++++.+|..|+||||+|+..|+.+++++|+++|++++..+.
T Consensus       278 ~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~  344 (373)
T 2fo1_E          278 KGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDA  344 (373)
T ss_dssp             CCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCS
T ss_pred             cCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCC
Confidence            8999999999999999999999875 99999999999999999999999999999999999877654

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.80  E-value=8.2e-20  Score=179.05  Aligned_cols=130  Identities=28%  Similarity=0.249  Sum_probs=98.8

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCC-CCCChHHHHHHHcCCHHHHHHHHHcCCCCcc-----------------
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPEN-LDSTMQLLFMACRGDVKGVEDLLNEGSDVNS-----------------  100 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~-~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~-----------------  100 (473)
                      ....++.|++.|+++.|+.||+.|......+ ..|+||||+||..|+.++|++||++|++++.                 
T Consensus        25 ~~t~L~~Av~~g~~~~V~~LL~~Gadvn~~~~~~g~TpLh~A~~~g~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~  104 (337)
T 4g8k_A           25 DNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAIAGS  104 (337)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTC
T ss_pred             CChHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcCHHHHHHHcCCHHHHHHHHHcCCchhhhccCCCchhHHHHhccc
Confidence            3456889999999999999998874332334 4599999999999999999999999987654                 


Q ss_pred             ----------------cCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCcc----------CCCCCcHHHHHHHcCChhhh
Q 011991          101 ----------------IDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR----------DRWGSTAAADAKYYGNVEVY  154 (473)
Q Consensus       101 ----------------~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~----------~~~g~t~l~~A~~~~~~~~~  154 (473)
                                      +|..|+||||+|+..|+.+++++|+++|++++..          +..|.||||+|+..|+.+++
T Consensus       105 ~~~~~~~~~~~~~~~~~d~~g~t~l~~A~~~~~~~~~~~ll~~ga~~~~~~~~~~~~~~~~~~g~T~L~~A~~~g~~~~v  184 (337)
T 4g8k_A          105 VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVL  184 (337)
T ss_dssp             HHHHHHHHTTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCCCC-----CTTCSCCHHHHHHHHTCHHHH
T ss_pred             chhhHHhhhccchhhhhccCCCCHHHHHHHcCcHHHHHHHHHcCCCcchhhccccccccccCCCCcHHHHHHHCCCHHHH
Confidence                            5566777777777777777777777777777654          33567777777777777777


Q ss_pred             hhhhh-cCCcCccCc
Q 011991          155 NILKA-RGAKVPKTK  168 (473)
Q Consensus       155 ~~L~~-~g~~i~~~~  168 (473)
                      ++|++ .|++++..+
T Consensus       185 ~~LL~~~gad~n~~d  199 (337)
T 4g8k_A          185 KILLDEMGADVNACD  199 (337)
T ss_dssp             HHHHHHSCCCTTCCC
T ss_pred             HHHHhccCCCcCccC
Confidence            77764 467765543

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.79  E-value=7.4e-20  Score=182.20  Aligned_cols=128  Identities=23%  Similarity=0.237  Sum_probs=112.9

Q ss_pred             CCCcceeeccCCCCccccCCCC-------CccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPV-------QDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH  110 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~-------~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh  110 (473)
                      ...+++.|+..|+.+.++.++.       ..+.+++. |.+|.||||+||..|+.++|++|+++|+++|.+|..|.||||
T Consensus       125 g~t~Lh~Aa~~g~~~~v~~Ll~~~~~~ll~~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~  204 (373)
T 2fo1_E          125 NRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALH  204 (373)
T ss_dssp             CCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHH
T ss_pred             CCCHHHHHHHCCCHHHHHHHHHHHHHHHHhcCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHH
Confidence            3455666888899988888763       33344444 889999999999999999999999999999999999999999


Q ss_pred             HHHHcCCHHHHHHHHhCC---CCCCccCCCCCcHHHHHHHcC---ChhhhhhhhhcCCcCcc
Q 011991          111 IAACEGHVEVVKLLLSKK---ANIDARDRWGSTAAADAKYYG---NVEVYNILKARGAKVPK  166 (473)
Q Consensus       111 ~A~~~g~~~iv~~Ll~~g---a~~~~~~~~g~t~l~~A~~~~---~~~~~~~L~~~g~~i~~  166 (473)
                      +|+..|+.+++++|+++|   ++++.+|..|.||||+|+..+   +.+++++|+++|++++.
T Consensus       205 ~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~  266 (373)
T 2fo1_E          205 QAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDY  266 (373)
T ss_dssp             HHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSC
T ss_pred             HHHHCCCHHHHHHHHhcCccccChhhcCCCCCCHHHHHHHhCCcchHHHHHHHHHCCCCccc
Confidence            999999999999999998   899999999999999999988   88999999999999875

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.78  E-value=2.5e-19  Score=165.89  Aligned_cols=131  Identities=21%  Similarity=0.239  Sum_probs=117.5

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcC
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g  116 (473)
                      ....++..|+..|+.+.++.+++.+...... +..|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..|
T Consensus        41 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~  120 (240)
T 3eu9_A           41 ENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFG  120 (240)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred             CCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcC
Confidence            3455778888999999999999888655544 556999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCC-hhhhhhhhhcCCcCccCc
Q 011991          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN-VEVYNILKARGAKVPKTK  168 (473)
Q Consensus       117 ~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~-~~~~~~L~~~g~~i~~~~  168 (473)
                      +.+++++|+++|++++.+|..|.||||+|+..++ .+++++|++.|++++..+
T Consensus       121 ~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~  173 (240)
T 3eu9_A          121 HTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGD  173 (240)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhh
Confidence            9999999999999999999999999999997776 899999999999987654

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.75  E-value=2.4e-19  Score=147.04  Aligned_cols=107  Identities=27%  Similarity=0.320  Sum_probs=95.5

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      |......++.|+..|+.+.++.+++.+......+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus         6 d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~   85 (115)
T 2l6b_A            6 SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKN   85 (115)
T ss_dssp             SCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHC
Confidence            34556677888999999999999988755445588999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhCCCCCCccCCCCCcHH
Q 011991          116 GHVEVVKLLLSKKANIDARDRWGSTAA  142 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~~~~~~g~t~l  142 (473)
                      |+.+++++|+++|||++.++..|.||-
T Consensus        86 ~~~~~~~~Ll~~ga~~n~~~~~~~~~~  112 (115)
T 2l6b_A           86 GHHEIVKLLDAKGADVNARSWGSSHHH  112 (115)
T ss_dssp             TCHHHHHHHHTTSSSHHHHSCCCC---
T ss_pred             CCHHHHHHHHHcCCCCCcCCccccccc
Confidence            999999999999999999999999984

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.75  E-value=2.9e-19  Score=174.67  Aligned_cols=116  Identities=15%  Similarity=0.064  Sum_probs=100.2

Q ss_pred             ccCCCCccccCCCCCccCCCC--CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC---HHHH
Q 011991           47 GRQSSLDPIRRSPVQDELTVP--ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVV  121 (473)
Q Consensus        47 ~~~g~~~~~~~~l~~~~~~~~--~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~---~~iv  121 (473)
                      +..+.+..+.+++...+.+++  .+.+|+||||+||..|+.++|++||++|+|+|.+|..|+||||+|+..|+   .+++
T Consensus       104 a~~~~~~~~~~~l~~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~  183 (327)
T 1sw6_A          104 SFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTF  183 (327)
T ss_dssp             CHHHHHHHHHHHCTTSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCH
T ss_pred             HHHhhHHHHHHHHHhcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHH
Confidence            333444455555555445554  48899999999999999999999999999999999999999999999999   7899


Q ss_pred             HHHHhCC-CCCCccCCCCCcHHHHHHH----cCChhhhhhhhhcCC
Q 011991          122 KLLLSKK-ANIDARDRWGSTAAADAKY----YGNVEVYNILKARGA  162 (473)
Q Consensus       122 ~~Ll~~g-a~~~~~~~~g~t~l~~A~~----~~~~~~~~~L~~~g~  162 (473)
                      +.|++++ ++++.+|..|+||||+|+.    .|+.+++++|++.+.
T Consensus       184 ~~ll~~~~~~~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~  229 (327)
T 1sw6_A          184 EALLDYLYPCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILM  229 (327)
T ss_dssp             HHHHHHHGGGGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHH
T ss_pred             HHHHHhhhccccCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHH
Confidence            9999887 8899999999999999999    899999999998854

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.73  E-value=1.6e-18  Score=136.44  Aligned_cols=90  Identities=33%  Similarity=0.409  Sum_probs=82.5

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .+++.|+..|+.+.++.+++.+......|.+|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.++
T Consensus         4 t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~   83 (93)
T 1n0q_A            4 TPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEV   83 (93)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHH
T ss_pred             cHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHH
Confidence            45667888999999999998875555558999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCC
Q 011991          121 VKLLLSKKAN  130 (473)
Q Consensus       121 v~~Ll~~ga~  130 (473)
                      +++|+++||+
T Consensus        84 ~~~Ll~~ga~   93 (93)
T 1n0q_A           84 VKLLLEAGAY   93 (93)
T ss_dssp             HHHHHHTTCC
T ss_pred             HHHHHHcCCC
Confidence            9999999986

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.73  E-value=1e-17  Score=165.63  Aligned_cols=107  Identities=24%  Similarity=0.345  Sum_probs=98.5

Q ss_pred             CCCCChHHHHHHHc-CCHHHHHHHHHcCCCCcccC--CCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHH
Q 011991           69 NLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSID--LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (473)
Q Consensus        69 ~~~g~t~L~~aa~~-g~~~~v~~Ll~~ga~~n~~d--~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A  145 (473)
                      +.++.|+||.||.. |+++++++||++|+|+|..|  ..|+||||+||..|+.++|++|+++|+|++.+|..|+||||+|
T Consensus       196 ~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A  275 (368)
T 3jue_A          196 SLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHA  275 (368)
T ss_dssp             -CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             cCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence            44667999999999 99999999999999999998  8999999999999999999999999999999999999999999


Q ss_pred             HHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          146 KYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       146 ~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      +..|+.+++++|+++|++++..+.   ++++.|
T Consensus       276 ~~~g~~~~v~~LL~~Gad~~~~d~~G~TpL~~A  308 (368)
T 3jue_A          276 TILGHTGLACLFLKRGADLGARDSEGRDPLTIA  308 (368)
T ss_dssp             HHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHcCcHHHHHHHHHCcCCCCCcCCCCCCHHHHH
Confidence            999999999999999999977654   455544

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.72  E-value=1.3e-19  Score=179.71  Aligned_cols=132  Identities=13%  Similarity=-0.022  Sum_probs=109.6

Q ss_pred             CcceeeccCCCCccccCCCCCccCCC---CCCCCCChHHHHHHHcCCHHHHHHHHHcCCCC---cccCCCCCcHHHHHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTV---PENLDSTMQLLFMACRGDVKGVEDLLNEGSDV---NSIDLDGRTALHIAAC  114 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~---~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~---n~~d~~g~T~lh~A~~  114 (473)
                      .+++.||+.|+.+.++.+++.+....   ..+..|.||||+||..|+.++|++|+++|+|+   +..+.+ +||||+||.
T Consensus        94 T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~  172 (376)
T 2aja_A           94 VICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAE  172 (376)
T ss_dssp             HHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHH
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHH
Confidence            56788999999999999999886332   33567899999999999999999999999862   333333 899999999


Q ss_pred             cCCHHHHHHHHhCCCCCCc--cCCCCCcHHHHHH-HcCChhhhhhhhhcCCcCccCcCCCCcCCCC
Q 011991          115 EGHVEVVKLLLSKKANIDA--RDRWGSTAAADAK-YYGNVEVYNILKARGAKVPKTKRTPMTVANP  177 (473)
Q Consensus       115 ~g~~~iv~~Ll~~ga~~~~--~~~~g~t~l~~A~-~~~~~~~~~~L~~~g~~i~~~~~t~l~~a~~  177 (473)
                      .||.++|++|+++|++++.  +|..|.||||+|+ ..|+.+++++|+++|.+    ..+++..|..
T Consensus       173 ~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~Aa~~~G~~eiv~~Ll~~ga~----~~taL~~Aa~  234 (376)
T 2aja_A          173 NGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVM----LAYAEIHEFE  234 (376)
T ss_dssp             TTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHH----HHHHHHCTTT
T ss_pred             CCCHHHHHHHHHcCCccchhccCCCCCCHHHHHHHHCCCHHHHHHHHhCCCc----cchHHHHHHH
Confidence            9999999999999999998  9999999999999 99999999999998753    3455555533

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=9.4e-18  Score=158.21  Aligned_cols=134  Identities=19%  Similarity=0.222  Sum_probs=100.4

Q ss_pred             hhccCceeeeEEEEE---E--ecCcE--EEEEEEcCCCCCC---------------------HHHHHHHHHHHHHHHhcC
Q 011991          192 VRKADGITKGSYQVA---K--WNGTK--VWVKILDKESHKD---------------------PERINAFTHELTIVEKAR  243 (473)
Q Consensus       192 ~~~~~~ig~G~~~~~---~--~~~~~--vavK~l~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  243 (473)
                      |.+...||.|+|+.+   .  .+|+.  ||||++.......                     ......+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            445678999998755   2  47888  9999986432110                     112246889999999998


Q ss_pred             CCee--eeEEeeEeeCCceEEEEeccCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEeCCCC
Q 011991          244 HPNV--VQFVGAVTQNIPMMIVLEYHAK-G----DLASYLQKKGRLSPSKVLRFALDLARGMNYLH-ECKPDPIIHCDLK  315 (473)
Q Consensus       244 hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiH~Dlk  315 (473)
                      |++|  +.+++.    ...+|||||+.+ |    +|.++...   .++..+..++.|++.+|.||| +.|   |+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence            8753  444432    356899999942 3    77776432   234567889999999999999 998   9999999


Q ss_pred             CCCEEEcCCCcEEEEeeccccc
Q 011991          316 PKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       316 p~Nili~~~~~vkl~DfG~a~~  337 (473)
                      |+|||++.  .++|+|||+|..
T Consensus       199 p~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEE
T ss_pred             HHHEEEcC--cEEEEECccccc
Confidence            99999998  999999999854

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.69  E-value=6.5e-17  Score=155.91  Aligned_cols=105  Identities=21%  Similarity=0.317  Sum_probs=96.0

Q ss_pred             CCChHHHHHHHcCCHHHHHHHHHcCCCCcc------cCCCCCcHHHHHHHc---CCHHHHHHHHhCCCCCCccCCCCCcH
Q 011991           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNS------IDLDGRTALHIAACE---GHVEVVKLLLSKKANIDARDRWGSTA  141 (473)
Q Consensus        71 ~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~------~d~~g~T~lh~A~~~---g~~~iv~~Ll~~ga~~~~~~~~g~t~  141 (473)
                      .+.++||.|+..|+.+.|+.|++.|+|+|.      .|..|+||||+|+..   |+.+++++|+++|++++.+|..|+||
T Consensus       150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp  229 (301)
T 2b0o_E          150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA  229 (301)
T ss_dssp             -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred             chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            356889999999999999999999999998      699999999999997   99999999999999999999999999


Q ss_pred             HHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          142 AADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       142 l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      ||+|+..|+.+++++|+++|++++..+.   |++..|
T Consensus       230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A  266 (301)
T 2b0o_E          230 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIA  266 (301)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence            9999999999999999999999977654   444444

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E*

Probab=99.68  E-value=6.2e-17  Score=167.19  Aligned_cols=104  Identities=21%  Similarity=0.328  Sum_probs=96.0

Q ss_pred             CChHHHHHHHcCCHHHHHHHHHcCCCCccc------CCCCCcHHHHHHH---cCCHHHHHHHHhCCCCCCccCCCCCcHH
Q 011991           72 STMQLLFMACRGDVKGVEDLLNEGSDVNSI------DLDGRTALHIAAC---EGHVEVVKLLLSKKANIDARDRWGSTAA  142 (473)
Q Consensus        72 g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~------d~~g~T~lh~A~~---~g~~~iv~~Ll~~ga~~~~~~~~g~t~l  142 (473)
                      ..+.||.|+..|+.+.|+.||+.|+|+|.+      |..|+||||+||.   .|+.++|++|+++|||+|.+|..|+|||
T Consensus       132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL  211 (497)
T 3lvq_E          132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL  211 (497)
T ss_dssp             CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred             cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence            347899999999999999999999999988      8899999999966   9999999999999999999999999999


Q ss_pred             HHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          143 ADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       143 ~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      |+|+..|+.+++++|+++|++++..+.   |+++.|
T Consensus       212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  247 (497)
T 3lvq_E          212 HYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIA  247 (497)
T ss_dssp             HHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence            999999999999999999999987754   555554

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.68  E-value=1.5e-16  Score=151.71  Aligned_cols=104  Identities=24%  Similarity=0.296  Sum_probs=94.8

Q ss_pred             CChHHHHHHHcCCHHHHHHHHHcCCCCc------ccCCCCCcHHHHHHHc---CCHHHHHHHHhCCCCCCccCCCCCcHH
Q 011991           72 STMQLLFMACRGDVKGVEDLLNEGSDVN------SIDLDGRTALHIAACE---GHVEVVKLLLSKKANIDARDRWGSTAA  142 (473)
Q Consensus        72 g~t~L~~aa~~g~~~~v~~Ll~~ga~~n------~~d~~g~T~lh~A~~~---g~~~iv~~Ll~~ga~~~~~~~~g~t~l  142 (473)
                      ..++|+.|+..|+.+.+..+++.|++++      ..|..|+||||+||..   |+.+++++|+++|+++|.+|..|+|||
T Consensus       130 ~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpL  209 (278)
T 1dcq_A          130 KLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTAL  209 (278)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHH
T ss_pred             hhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHH
Confidence            4589999999999999999999999954      4588999999999999   999999999999999999999999999


Q ss_pred             HHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          143 ADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       143 ~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      |+|+..|+.+++++|+++|++++..+.   ||++.|
T Consensus       210 h~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A  245 (278)
T 1dcq_A          210 HYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA  245 (278)
T ss_dssp             HHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCCCccCCCCCHHHHH
Confidence            999999999999999999999987754   555444

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.61  E-value=1.7e-18  Score=171.77  Aligned_cols=123  Identities=15%  Similarity=0.098  Sum_probs=107.1

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCC--CCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcc--cCCCCCcHHHHHH-
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELT--VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNS--IDLDGRTALHIAA-  113 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~--~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~--~d~~g~T~lh~A~-  113 (473)
                      ...+++.||..|+.+.|+.|++.+...  .+.+..+.||||+||..|+.++|++|+++|++++.  +|..|+||||+|| 
T Consensus       128 ~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~Aa~  207 (376)
T 2aja_A          128 NYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAV  207 (376)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHHHH
Confidence            345788899999999999999888421  11222229999999999999999999999999988  8999999999999 


Q ss_pred             HcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          114 CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       114 ~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ..|+.++|++|+++|++       |.|||++|+..|+.+++++|+++|++++..+
T Consensus       208 ~~G~~eiv~~Ll~~ga~-------~~taL~~Aa~~g~~evv~lL~~~ga~~~~~~  255 (376)
T 2aja_A          208 GRGHHNVINFLLDCPVM-------LAYAEIHEFEYGEKYVNPFIARHVNRLKEMH  255 (376)
T ss_dssp             TTCCHHHHHHHTTSHHH-------HHHHHHCTTTTTTTTHHHHHHHHHHHHHHHH
T ss_pred             HCCCHHHHHHHHhCCCc-------cchHHHHHHHCCCHHHHHHHHhcCccccccc
Confidence            99999999999998853       8999999999999999999999999886554

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.56  E-value=9.1e-16  Score=124.63  Aligned_cols=90  Identities=21%  Similarity=0.282  Sum_probs=80.0

Q ss_pred             CCcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHH
Q 011991           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (473)
Q Consensus        35 ~~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~  114 (473)
                      +|......++.|+..|+.+.++.+++.+......|..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus        20 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~   99 (110)
T 2zgd_A           20 MGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISID   99 (110)
T ss_dssp             --CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred             cCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHHH
Confidence            44555667889999999999999998875444458899999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHH
Q 011991          115 EGHVEVVKLL  124 (473)
Q Consensus       115 ~g~~~iv~~L  124 (473)
                      .|+.+++++|
T Consensus       100 ~~~~~~~~~L  109 (110)
T 2zgd_A          100 NGNEDLAEIL  109 (110)
T ss_dssp             HTCHHHHHHH
T ss_pred             cCCHHHHHHh
Confidence            9999999987

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=7.2e-16  Score=151.65  Aligned_cols=133  Identities=15%  Similarity=0.066  Sum_probs=92.9

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCC---------------CHHH----HHHHHHHHHHHHhcCCCee
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHK---------------DPER----INAFTHELTIVEKARHPNV  247 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~---------------~~~~----~~~~~~E~~~l~~l~hpnI  247 (473)
                      -|.+...||.|+++.|    ..+|+.||||+++.....               ....    .-...+|...+.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3678889999998855    357899999998642110               0000    1112456667777744433


Q ss_pred             e--eEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC
Q 011991          248 V--QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (473)
Q Consensus       248 v--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~  325 (473)
                      .  ..+++    ...+|||||++|++|.++..    .  .....++.|++.+|.+||+.|   ||||||||.|||++.++
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS----V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence            2  22222    12379999999988865432    2  234578899999999999999   99999999999998766


Q ss_pred             ----------cEEEEeecccc
Q 011991          326 ----------QLKISGFGLLR  336 (473)
Q Consensus       326 ----------~vkl~DfG~a~  336 (473)
                                .+.|+||+-+-
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCE
T ss_pred             CcccccccccceEEEEeCCcc
Confidence                      38999999763

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.14  E-value=3.4e-10  Score=106.26  Aligned_cols=123  Identities=11%  Similarity=0.036  Sum_probs=94.2

Q ss_pred             EEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCH
Q 011991          206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP  284 (473)
Q Consensus       206 ~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~  284 (473)
                      +...++.+++|+........   ...+.+|+.+++.+. +..++++++++...+..|+|||+++|.+|.+.+.     +.
T Consensus        33 ~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~  104 (263)
T 3tm0_A           33 LVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DE  104 (263)
T ss_dssp             EECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TT
T ss_pred             EECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----Cc
Confidence            34457899999997532111   134788999999994 6778899999988889999999999999987631     12


Q ss_pred             HHHHHHHHHHHHHHHHHhhcC--------------------------------------------------------CCC
Q 011991          285 SKVLRFALDLARGMNYLHECK--------------------------------------------------------PDP  308 (473)
Q Consensus       285 ~~~~~i~~qi~~~L~~LH~~~--------------------------------------------------------~~~  308 (473)
                      .....++.+++.+|..||+..                                                        +..
T Consensus       105 ~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~  184 (263)
T 3tm0_A          105 QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV  184 (263)
T ss_dssp             TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEE
T ss_pred             ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCce
Confidence            234478889999999999811                                                        123


Q ss_pred             eEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          309 IIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       309 iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ++|+|++|.||+++.+..+.|+||+.+.
T Consensus       185 l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            9999999999999875556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.01  E-value=1.7e-09  Score=101.01  Aligned_cols=121  Identities=19%  Similarity=0.163  Sum_probs=88.3

Q ss_pred             EEEEEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCe--eeeEEeeEeeCCceEEEEeccCCCCHHHHHHHc
Q 011991          202 SYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK  279 (473)
Q Consensus       202 ~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  279 (473)
                      .|.+...+|..+++|+......      ..+..|+.+++.+.+.+  ++++++++..++..++||||++|.+|.  ..  
T Consensus        36 v~~~~~~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~--  105 (264)
T 1nd4_A           36 VFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS--  105 (264)
T ss_dssp             EEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS--
T ss_pred             EEEEecCCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC--
Confidence            3444334567899999865421      34778999999985434  566888888878899999999998884  21  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------------
Q 011991          280 GRLSPSKVLRFALDLARGMNYLHECK------------------------------------------------------  305 (473)
Q Consensus       280 ~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------------------------  305 (473)
                       ..+.   ..++.+++..|..||+..                                                      
T Consensus       106 -~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  181 (264)
T 1nd4_A          106 -HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG  181 (264)
T ss_dssp             -CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred             -cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCC
Confidence             1222   356777888888888743                                                      


Q ss_pred             -CCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          306 -PDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       306 -~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                       +..++|+|++|.||+++.++.+.|+|||.+.
T Consensus       182 ~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          182 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence             1129999999999999876666799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.94  E-value=2e-09  Score=106.00  Aligned_cols=128  Identities=14%  Similarity=0.175  Sum_probs=94.5

Q ss_pred             EEecCcEEEEEEEc--CCCCCCHHHHHHHHHHHHHHHhcC--CCeeeeEEeeEeeC---CceEEEEeccCCCCHHHHHHH
Q 011991          206 AKWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKAR--HPNVVQFVGAVTQN---IPMMIVLEYHAKGDLASYLQK  278 (473)
Q Consensus       206 ~~~~~~~vavK~l~--~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---~~~~lv~e~~~~gsL~~~l~~  278 (473)
                      +...+..+++|+..  ....  ......+.+|+.+++.+.  +..+++++.++.+.   +..|+||||++|.++.+..  
T Consensus        57 v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--  132 (359)
T 3dxp_A           57 LVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--  132 (359)
T ss_dssp             EECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--
T ss_pred             EEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--
Confidence            34456788999876  3221  112346788999999996  45688888888766   4589999999998775421  


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 011991          279 KGRLSPSKVLRFALDLARGMNYLHECK-----------------------------------------------------  305 (473)
Q Consensus       279 ~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------------------------------  305 (473)
                      ...++......++.+++..|..||+..                                                     
T Consensus       133 ~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  212 (359)
T 3dxp_A          133 LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQED  212 (359)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTT
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCcc
Confidence            224778888999999999999999731                                                     


Q ss_pred             --CCCeEeCCCCCCCEEEcCCCc--EEEEeeccccc
Q 011991          306 --PDPIIHCDLKPKNILLDNGGQ--LKISGFGLLRL  337 (473)
Q Consensus       306 --~~~iiH~Dlkp~Nili~~~~~--vkl~DfG~a~~  337 (473)
                        +..++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       213 ~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          213 ADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence              235999999999999997653  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=2.2e-09  Score=103.22  Aligned_cols=183  Identities=17%  Similarity=0.136  Sum_probs=118.1

Q ss_pred             eeeeEEEEEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCe--eeeEEeeEeeCC---ceEEEEeccCCCC
Q 011991          198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPN--VVQFVGAVTQNI---PMMIVLEYHAKGD  271 (473)
Q Consensus       198 ig~G~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~l~~~~~~~~---~~~lv~e~~~~gs  271 (473)
                      ++.|....+..-+..+++|+...     ......+.+|+.+++.+ .+..  +++.+.......   ..|+|||+++|.+
T Consensus        28 ~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~  102 (304)
T 3sg8_A           28 SGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVP  102 (304)
T ss_dssp             EEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEE
T ss_pred             cCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeE
Confidence            55665554444457799998642     24457789999999988 3332  445555543332   3589999999988


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 011991          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECK----------------------------------------------  305 (473)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------------  305 (473)
                      |.+....  .++..+...++.+++..|..||+..                                              
T Consensus       103 l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  180 (304)
T 3sg8_A          103 LTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI  180 (304)
T ss_dssp             CCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred             CCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence            8764432  4778888889999999999999621                                              


Q ss_pred             ---------CCCeEeCCCCCCCEEEcC--CCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcC------C
Q 011991          306 ---------PDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYK------N  368 (473)
Q Consensus       306 ---------~~~iiH~Dlkp~Nili~~--~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~  368 (473)
                               +..++|+|++|.||+++.  ...+.|+||+.+.......+-....   ...    .-..|+...      +
T Consensus       181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~---~~~----~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLM---EDD----EEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTC---CTT----TSCCHHHHHHHHHHHT
T ss_pred             HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHH---hhc----cccCHHHHHHHHHHcC
Confidence                     124899999999999998  4567899999986532111100000   000    001111110      0


Q ss_pred             C--------CCCCchhHHHHHHHHHHHHhCCCCC
Q 011991          369 E--------EFDRSVDAYSFGLILYEMIEGVQPF  394 (473)
Q Consensus       369 ~--------~~~~~~DiwSlG~~l~ell~g~~pf  394 (473)
                      .        ......+.|+++.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0        0112368999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.42  E-value=1.8e-06  Score=82.75  Aligned_cols=121  Identities=19%  Similarity=0.153  Sum_probs=86.1

Q ss_pred             CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC--C-eeeeEEeeEe-eCCceEEEEeccCCCCHHHHHHHcCCCCHH
Q 011991          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARH--P-NVVQFVGAVT-QNIPMMIVLEYHAKGDLASYLQKKGRLSPS  285 (473)
Q Consensus       210 ~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--p-nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~  285 (473)
                      |..+++|+-.     .......+.+|+.+++.+.+  + .|++.+.+.. ..+..++|||+++|.+|.+..-  ..++..
T Consensus        39 g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~  111 (306)
T 3tdw_A           39 NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDD  111 (306)
T ss_dssp             TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHH
T ss_pred             CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHH
Confidence            7889999853     23455788999999999964  2 3566666664 4566789999999988876422  124555


Q ss_pred             HHHHHHHHHHHHHHHHhhcC---------------------------------------------------------CCC
Q 011991          286 KVLRFALDLARGMNYLHECK---------------------------------------------------------PDP  308 (473)
Q Consensus       286 ~~~~i~~qi~~~L~~LH~~~---------------------------------------------------------~~~  308 (473)
                      ....++.++...|..||+..                                                         +..
T Consensus       112 ~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~  191 (306)
T 3tdw_A          112 AKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPR  191 (306)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCE
T ss_pred             HHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCe
Confidence            55666666666666666432                                                         224


Q ss_pred             eEeCCCCCCCEEEcC---CCc-EEEEeeccccc
Q 011991          309 IIHCDLKPKNILLDN---GGQ-LKISGFGLLRL  337 (473)
Q Consensus       309 iiH~Dlkp~Nili~~---~~~-vkl~DfG~a~~  337 (473)
                      ++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            699999999999987   455 48999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.35  E-value=3.1e-06  Score=79.33  Aligned_cols=118  Identities=14%  Similarity=0.123  Sum_probs=89.3

Q ss_pred             cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHH
Q 011991          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKV  287 (473)
Q Consensus       209 ~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~  287 (473)
                      .+..+++|+-...      ....+..|...++.+. +-.+++++.++.+++..|+|||+++|.++.+.....    ....
T Consensus        49 ~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~  118 (272)
T 4gkh_A           49 NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSG  118 (272)
T ss_dssp             TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGH
T ss_pred             CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHH
Confidence            4568999987532      3456888999999884 334778889988888999999999998888776432    2233


Q ss_pred             HHHHHHHHHHHHHHhhcC-------------------------------------------------------CCCeEeC
Q 011991          288 LRFALDLARGMNYLHECK-------------------------------------------------------PDPIIHC  312 (473)
Q Consensus       288 ~~i~~qi~~~L~~LH~~~-------------------------------------------------------~~~iiH~  312 (473)
                      ..+..+++..|..||+..                                                       +..++|+
T Consensus       119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG  198 (272)
T 4gkh_A          119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG  198 (272)
T ss_dssp             HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred             HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence            456677777777777532                                                       1137999


Q ss_pred             CCCCCCEEEcCCCcEEEEeecccc
Q 011991          313 DLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       313 Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      |+.+.|||++.++.+-|+||+.+.
T Consensus       199 Dl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          199 DFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCCCeEEEECCeEEEEEECcccc
Confidence            999999999987667799999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.84  E-value=6.3e-05  Score=73.40  Aligned_cols=61  Identities=8%  Similarity=0.025  Sum_probs=41.1

Q ss_pred             CcEEEEEEEcCCC---CCCHHHHHHHHHHHHHHHhcC-C--CeeeeEEeeEeeC---CceEEEEeccCCCCHH
Q 011991          210 GTKVWVKILDKES---HKDPERINAFTHELTIVEKAR-H--PNVVQFVGAVTQN---IPMMIVLEYHAKGDLA  273 (473)
Q Consensus       210 ~~~vavK~l~~~~---~~~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~---~~~~lv~e~~~~gsL~  273 (473)
                      +..+++|+-....   ...   ...+.+|+.+++.+. +  -.+++++.++.+.   +..|+|||+++|.++.
T Consensus        52 ~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             EEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             CceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            6789999865432   100   134678888888884 3  3577788877654   3578999999886653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.65  E-value=0.00075  Score=60.09  Aligned_cols=136  Identities=13%  Similarity=0.101  Sum_probs=90.3

Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccc
Q 011991          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI  347 (473)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  347 (473)
                      .||.++|... ..++++++|.++.|.+.+|.-+-. ..   -..+=+.|..|++..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc-----------
Confidence            4899999875 569999999999999999887622 11   11223346899999999987753 1110           


Q ss_pred             cccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          348 VFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       348 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                             .....+.|||... ...+.+.=|||||+++|..+--..|=                      ..+..+|+.|.
T Consensus        98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e----------------------~eE~eLS~~LE  147 (229)
T 2yle_A           98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE----------------------NEERELSPPLE  147 (229)
T ss_dssp             ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT----------------------TEEECCCHHHH
T ss_pred             -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc----------------------ccchhhCHHHH
Confidence                   0122377888764 34567889999999999988432111                      12345788999


Q ss_pred             HHHHHccCC-------------------------CCCCCCCHHHHHHH
Q 011991          428 ELIEECWDP-------------------------KPVIRPNFNEIIAR  450 (473)
Q Consensus       428 ~li~~cl~~-------------------------dP~~RPs~~ell~~  450 (473)
                      +||..|...                         .+..|+++++|++.
T Consensus       148 ~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          148 QLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             HHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHH
T ss_pred             HHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHH
Confidence            999888765                         24688999988753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.58  E-value=0.00089  Score=64.49  Aligned_cols=30  Identities=20%  Similarity=0.267  Sum_probs=26.7

Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            349999999999999877889999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.52  E-value=0.00016  Score=71.78  Aligned_cols=30  Identities=20%  Similarity=0.286  Sum_probs=25.3

Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++|+|+.|.|||++.+ .++|+||..+..
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            349999999999999865 489999987754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.29  E-value=0.0016  Score=62.21  Aligned_cols=60  Identities=20%  Similarity=0.121  Sum_probs=46.6

Q ss_pred             EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC---CCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR---HPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       207 ~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      ..++..+++|+-...      ....+..|+..++.|.   ...+++.+.+....+..++|||+++|.++
T Consensus        56 ~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           56 NDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             ESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            346788999987642      1356888999999883   35688888888877889999999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.20  E-value=0.0024  Score=63.64  Aligned_cols=31  Identities=13%  Similarity=0.247  Sum_probs=26.9

Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      ..++|+|++|.|||++.++ ++|+||+.+...
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            3499999999999998776 999999988653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.13  E-value=0.0026  Score=61.23  Aligned_cols=32  Identities=19%  Similarity=0.283  Sum_probs=27.3

Q ss_pred             CCeEeCCCCCCCEEEcCC----CcEEEEeecccccc
Q 011991          307 DPIIHCDLKPKNILLDNG----GQLKISGFGLLRLQ  338 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~----~~vkl~DfG~a~~~  338 (473)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            459999999999999874    67999999988643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.66  E-value=0.007  Score=57.87  Aligned_cols=29  Identities=21%  Similarity=0.084  Sum_probs=24.9

Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3489999999999999 4 899999987743

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.59  E-value=0.0038  Score=59.57  Aligned_cols=43  Identities=21%  Similarity=0.329  Sum_probs=30.9

Q ss_pred             HHHHHHHHhhc----CCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          294 LARGMNYLHEC----KPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       294 i~~~L~~LH~~----~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      +...+..+.+.    .+..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            33445555432    13359999999999999976556899998774

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.40  E-value=0.0063  Score=59.67  Aligned_cols=119  Identities=15%  Similarity=0.190  Sum_probs=71.5

Q ss_pred             CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccCCCCHH--------------H
Q 011991          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLA--------------S  274 (473)
Q Consensus       210 ~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~--------------~  274 (473)
                      ++.+++|+.... ..   ......+|..+++.|. +.-.+++++++.+    .+||||++|.+|.              +
T Consensus        82 ~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~  153 (379)
T 3feg_A           82 PREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT  153 (379)
T ss_dssp             CSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred             CCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence            478999985321 11   1244568999998884 3323567776653    3999999885542              1


Q ss_pred             HHHH-c------C-CCC--HHHHHHHHHHHHH-------------------HHHHH----hhc-CCCCeEeCCCCCCCEE
Q 011991          275 YLQK-K------G-RLS--PSKVLRFALDLAR-------------------GMNYL----HEC-KPDPIIHCDLKPKNIL  320 (473)
Q Consensus       275 ~l~~-~------~-~l~--~~~~~~i~~qi~~-------------------~L~~L----H~~-~~~~iiH~Dlkp~Nil  320 (473)
                      .|.+ +      + ...  +..+.++..++..                   .+..|    ... .+..++|+|+.+.||+
T Consensus       154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil  233 (379)
T 3feg_A          154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL  233 (379)
T ss_dssp             HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred             HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence            1111 1      1 111  3455555544422                   12222    221 2235999999999999


Q ss_pred             EcCC----CcEEEEeecccc
Q 011991          321 LDNG----GQLKISGFGLLR  336 (473)
Q Consensus       321 i~~~----~~vkl~DfG~a~  336 (473)
                      ++.+    +.+.|+||..+.
T Consensus       234 ~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          234 LLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EESCC---CCEEECCCTTCE
T ss_pred             EcCCCCccCcEEEEecccCC
Confidence            9876    689999998874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.38  E-value=0.028  Score=52.64  Aligned_cols=63  Identities=21%  Similarity=0.187  Sum_probs=40.9

Q ss_pred             EEEEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-C-C-eeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-H-P-NVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       203 ~~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h-p-nIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      |.+...+|+.+++|+-.......   ...|..|+..|+.|. . + .+++.+++.    ..++|||+++++..
T Consensus        32 yrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           32 YRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred             EEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence            44445678999999876443221   134788999999884 2 1 345555542    34899999987653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.36  E-value=0.018  Score=55.57  Aligned_cols=31  Identities=23%  Similarity=0.320  Sum_probs=27.2

Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999878899999987754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.26  E-value=0.0088  Score=56.53  Aligned_cols=29  Identities=28%  Similarity=0.467  Sum_probs=24.8

Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       308 ~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5667889999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.06  E-value=0.02  Score=57.09  Aligned_cols=53  Identities=13%  Similarity=0.099  Sum_probs=34.3

Q ss_pred             CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCe-eeeEEeeEeeCCceEEEEeccCCCC
Q 011991          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN-VVQFVGAVTQNIPMMIVLEYHAKGD  271 (473)
Q Consensus       210 ~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~gs  271 (473)
                      +..+++|+....  ..   ...+..|..+++.+...+ .+++++.+.+    .+|+||++|.+
T Consensus       105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~  158 (429)
T 1nw1_A          105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  158 (429)
T ss_dssp             CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence            578999998432  12   133557999998884323 3567776543    38999998743

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.87  E-value=0.03  Score=56.36  Aligned_cols=54  Identities=17%  Similarity=0.102  Sum_probs=33.8

Q ss_pred             cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCee-eeEEeeEeeCCceEEEEeccCCCCH
Q 011991          211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV-VQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       211 ~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      ..+++|+.......-   . .-.+|..+++.|...++ +++++++. +   .+||||++|.+|
T Consensus       134 ~~~vLRi~g~~~~~~---i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          134 AKYLIRLYGPKTDEI---I-NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEEEEECC-CCSC---S-CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred             ceEEEEECCCChhhh---c-CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence            789999875421110   0 11478999999964444 56777763 2   369999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=85.99  E-value=0.31  Score=47.13  Aligned_cols=29  Identities=28%  Similarity=0.392  Sum_probs=24.2

Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       308 ~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      .++|+|+.+.|||++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            499999999999998654 89999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.08  E-value=3.1  Score=36.67  Aligned_cols=113  Identities=12%  Similarity=0.197  Sum_probs=76.0

Q ss_pred             CCCeeeeEEeeEeeCCceEEEEeccC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE
Q 011991          243 RHPNVVQFVGAVTQNIPMMIVLEYHA-KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (473)
Q Consensus       243 ~hpnIv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili  321 (473)
                      .||+.++. .+-...+.+.+.++.-+ +-++.. +   ..++....++++.+|+....++++     -+|--|.|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence            57877765 45555566566565443 223333 2   237789999999999998855554     4788999999999


Q ss_pred             cCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHH-HHHHHHHHHHhCCCCC
Q 011991          322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY-SFGLILYEMIEGVQPF  394 (473)
Q Consensus       322 ~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw-SlG~~l~ell~g~~pf  394 (473)
                      +.++.+++.=.|+-..                       ++|.     ..+ ..|.| .+=|++..++.++..|
T Consensus       113 ~~~~~p~i~~RGik~~-----------------------l~P~-----~~~-ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNV-----------------------VDPL-----PVS-EAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CTTSCEEESCCEETTT-----------------------BSCC-----CCC-HHHHHHHHHHHHHHHHCTTCCH
T ss_pred             cCCCCEEEEEccCccC-----------------------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999976665311                       1222     112 23443 5888999999998877

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.25  E-value=7.9  Score=34.21  Aligned_cols=112  Identities=12%  Similarity=0.152  Sum_probs=75.0

Q ss_pred             CCCeeeeEEeeEeeCCceEEEEeccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEeCCCCCCCEE
Q 011991          243 RHPNVVQFVGAVTQNIPMMIVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMN-YLHECKPDPIIHCDLKPKNIL  320 (473)
Q Consensus       243 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~iiH~Dlkp~Nil  320 (473)
                      .||..  -...-.+++.+.+.++.-+++ ++.. +   ..++....++++.+|+.... +++.     -+|--|.|+|++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence            57777  223335566666666654332 3443 3   24788999999999988777 5544     578899999999


Q ss_pred             EcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHH-HHHHHHHHHHhCCCCC
Q 011991          321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY-SFGLILYEMIEGVQPF  394 (473)
Q Consensus       321 i~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw-SlG~~l~ell~g~~pf  394 (473)
                      ++.++.+++.=.|+-.                       -++|.-     . ...|.| ++=|++..++.++..|
T Consensus       117 f~~~~~p~i~hRGi~~-----------------------~lpP~e-----~-~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          117 FNRALEPFFLHVGVKE-----------------------SLPPDE-----W-DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             ECTTCCEEESCCEETT-----------------------TBSSCS-----C-CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EeCCCcEEEEEcCCcc-----------------------cCCCCC-----C-CHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999997666531                       223322     1 233444 4788888888887776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	473
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-48
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-47
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-22
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-21
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	4e-16
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	5e-14
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	1e-12
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-12
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-10
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-19
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	8e-17
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	1e-14
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	4e-10
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	4e-09
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	7e-09
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	1e-14
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	7e-11
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	2e-10
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	2e-04
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	4e-04
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-14
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-12
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-07
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-06
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	4e-06
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	7e-04
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	0.003
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	2e-13
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	2e-10
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	1e-08
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	2e-08
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	6e-06
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	3e-13
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	8e-13
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	9e-08
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	1e-04
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	7e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	4e-11
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-09
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-09
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	4e-12
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	2e-11
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	4e-11
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	1e-08
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	2e-11
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	3e-10
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	1e-09
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	4e-05
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	1e-09
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	2e-09
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	2e-08
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	0.001
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	4e-09
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	2e-08
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	2e-07
d1dcqa1	154	d.211.1.1 (A:369-522) Pyk2-associated protein beta	6e-09
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	8e-09
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	6e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-08
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-08
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-07
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	7e-07
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-06
d1ycsb1	130	d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens)	1e-07
d1ycsb1	130	d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens)	2e-04
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	1e-07
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	1e-05
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	0.001
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	2e-07
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	5e-06
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	1e-05
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	3e-05
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	5e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-58
 Identities = 81/281 (28%), Positives = 138/281 (49%), Gaps = 20/281 (7%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++E+   ++ V +   I  GS+  V   KW+G  V VK+L+  +   P+++ AF +E+ +
Sbjct: 2   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVKMLNV-TAPTPQQLQAFKNEVGV 57

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARG 297
           + K RH N++ F+G  T    + IV ++     L  +L   + +    K++  A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
           M+YLH      IIH DLK  NI L     +KI  FGL  ++       +       I   
Sbjct: 117 MDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI--- 170

Query: 358 NLYVAPEIYKNEE---FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP 414
            L++APE+ + ++   +    D Y+FG++LYE++ G  P+      + +  M   G   P
Sbjct: 171 -LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229

Query: 415 LKIKARS-YPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
              K RS  P  +K L+ EC   K   RP F +I+A ++ +
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 2e-54
 Identities = 77/278 (27%), Positives = 135/278 (48%), Gaps = 28/278 (10%)

Query: 183 YELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           + LN  EL++ +   I KG +  V    + G KV VK +  ++        AF  E +++
Sbjct: 2   WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ-----AFLAEASVM 54

Query: 240 EKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLAR 296
            + RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
            M YL        +H DL  +N+L+      K+S FGL +    + +  K+         
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------ 165

Query: 357 ANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK 416
              + APE  + ++F    D +SFG++L+E+    +  +P+ P + V     +G +    
Sbjct: 166 ---WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA- 221

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                 PP + E+++ CW     +RP+F ++  +L+ I
Sbjct: 222 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-51
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 16/242 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +   + +K+L K   +     +    E+ I    RHPN+++  G       + ++LEY
Sbjct: 28  KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G +   LQK  +    +   +  +LA  ++Y H  +   +IH D+KP+N+LL + G+
Sbjct: 88  APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGE 144

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           LKI+ FG       S                  Y+ PE+ +    D  VD +S G++ YE
Sbjct: 145 LKIADFGWSVHAPSSRRTTLCGTL--------DYLPPEMIEGRMHDEKVDLWSLGVLCYE 196

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
            + G  PF     +E  K +       P            ++LI       P  RP   E
Sbjct: 197 FLVGKPPFEANTYQETYKRISRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLRE 251

Query: 447 II 448
           ++
Sbjct: 252 VL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (438), Expect = 9e-51
 Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 19/245 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
             N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY
Sbjct: 37  VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
                       K  L   ++        +G+ YLH      +IH D+K  NILL   G 
Sbjct: 97  CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 153

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIY---KNEEFDRSVDAYSFGLI 383
           +K+  FG           A I+ P +       ++APE+       ++D  VD +S G+ 
Sbjct: 154 VKLGDFGS----------ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
             E+ E   P         +  +  + + P L+     +    +  ++ C    P  RP 
Sbjct: 204 CIELAERKPPLFNMNAMSALYHI-AQNESPALQSG--HWSEYFRNFVDSCLQKIPQDRPT 260

Query: 444 FNEII 448
              ++
Sbjct: 261 SEVLL 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-50
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 19/250 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMIVL 264
           K +G  +  K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+
Sbjct: 26  KSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84

Query: 265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHE--CKPDPIIHCDLKPKN 318
           EY   GDLAS + K    +  L    VLR    L   +   H        ++H DLKP N
Sbjct: 85  EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
           + LD    +K+  FGL R+       AK      +      Y++PE      ++   D +
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY------YMSPEQMNRMSYNEKSDIW 198

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKP 438
           S G +LYE+   + PF     +E+   +  EGK   +      Y  +L E+I    + K 
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIP---YRYSDELNEIITRMLNLKD 254

Query: 439 VIRPNFNEII 448
             RP+  EI+
Sbjct: 255 YHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-50
 Identities = 59/249 (23%), Positives = 114/249 (45%), Gaps = 20/249 (8%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K        K++D +S ++ E    +  E+ I+    HPN+V+ + A      + I++E+
Sbjct: 34  KETSVLAAAKVIDTKSEEELED---YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90

Query: 267 HAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
            A G + + + +  R L+ S++          +NYLH+ K   IIH DLK  NIL    G
Sbjct: 91  CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDG 147

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI-----YKNEEFDRSVDAYSF 380
            +K++ FG+      + ++        +      ++APE+      K+  +D   D +S 
Sbjct: 148 DIKLADFGVSAKNTRTIQRRDSFIGTPY------WMAPEVVMCETSKDRPYDYKADVWSL 201

Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           G+ L EM E   P H   P  V+  +  + + P L   +R +  + K+ +++C +     
Sbjct: 202 GITLIEMAEIEPPHHELNPMRVLLKI-AKSEPPTLAQPSR-WSSNFKDFLKKCLEKNVDA 259

Query: 441 RPNFNEIIA 449
           R   ++++ 
Sbjct: 260 RWTTSQLLQ 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 7e-50
 Identities = 65/245 (26%), Positives = 109/245 (44%), Gaps = 18/245 (7%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA----VTQNIPMMIVL 264
              +V    L        ER   F  E  +++  +HPN+V+F  +    V     +++V 
Sbjct: 33  TTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91

Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DN 323
           E    G L +YL++   +    +  +   + +G+ +LH   P PIIH DLK  NI +   
Sbjct: 92  ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGP 150

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
            G +KI   GL  L+  S  KA I  P         ++APE+Y+  ++D SVD Y+FG+ 
Sbjct: 151 TGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAPEMYEE-KYDESVDVYAFGMC 201

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           + EM     P+        +      G +P      +   P++KE+IE C       R +
Sbjct: 202 MLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVKEIIEGCIRQNKDERYS 259

Query: 444 FNEII 448
             +++
Sbjct: 260 IKDLL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-49
 Identities = 64/257 (24%), Positives = 109/257 (42%), Gaps = 13/257 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K     V VKIL  E+  DP   +    E  ++++  +P +V+ +G        M+V+E 
Sbjct: 31  KKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM 88

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YLQ+   +    ++     ++ GM YL E      +H DL  +N+LL     
Sbjct: 89  AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHY 145

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
            KIS FGL +   +  ++           P   + APE     +F    D +SFG++++E
Sbjct: 146 AKISDFGLSKA--LRADENYYKAQTHGKWPVK-WYAPECINYYKFSSKSDVWSFGVLMWE 202

Query: 387 MI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFN 445
               G +P+      EV  ++  +G+R          P ++ +L+  CW      RP F 
Sbjct: 203 AFSYGQKPYRGMKGSEVTAML-EKGERMGCP---AGCPREMYDLMNLCWTYDVENRPGFA 258

Query: 446 EIIARLDRIVCNCSKQG 462
            +  RL     +   +G
Sbjct: 259 AVELRLRNYYYDVVNEG 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 24/284 (8%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWN-GTKVWVKILDKESHKDPERINAF 232
           P    E+E+    L++ +   +  G + +V    +N  TKV VK L + S         F
Sbjct: 2   PWWEDEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----F 55

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRF 290
             E  ++++ +H  +V+    VTQ  P+ I+ EY   G L  +L+     +L+ +K+L  
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
           A  +A GM ++ E      IH DL+  NIL+ +    KI+ FGL RL   +   A+    
Sbjct: 115 AAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171

Query: 351 VSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEG 410
                    + APE      F    D +SFG++L E++   +  +P      V      G
Sbjct: 172 FPI-----KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            R        + P +L +L+  CW  +P  RP F+ + + L+  
Sbjct: 227 YRMVRP---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 3e-48
 Identities = 59/282 (20%), Positives = 112/282 (39%), Gaps = 51/282 (18%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G  +  K++  E    P   N    EL ++ +   P +V F GA   +  + I +E+
Sbjct: 28  KPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   L+K GR+    + + ++ + +G+ YL E     I+H D+KP NIL+++ G+
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGE 143

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +K+  FG+      S   + +            Y++PE  +   +    D +S GL L E
Sbjct: 144 IKLCDFGVSGQLIDSMANSFVGTR--------SYMSPERLQGTHYSVQSDIWSMGLSLVE 195

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEG------------------------------------ 410
           M  G  P  P   +E+  +  C+                                     
Sbjct: 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255

Query: 411 ---KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
                PP K+ +  +  + ++ + +C    P  R +  +++ 
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 4e-48
 Identities = 70/292 (23%), Positives = 115/292 (39%), Gaps = 42/292 (14%)

Query: 198 ITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           I KG + +V   KW G +V VKI      +   R      E+      RH N++ F+ A 
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQTVMLRHENILGFIAAD 66

Query: 255 TQN----IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-----CK 305
            ++      + +V +YH  G L  YL  +  ++   +++ AL  A G+ +LH        
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI 365
              I H DLK KNIL+   G   I+  GL            I    +H      Y+APE+
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 366 Y------KNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPP---------------EEVVK 404
                  K+ E  +  D Y+ GL+ +E+                           EE+ K
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 405 LMCCEGKRPPLKIKARS--YPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           ++C +  RP +  + +S      + +++ ECW      R     I   L ++
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (416), Expect = 8e-48
 Identities = 67/260 (25%), Positives = 125/260 (48%), Gaps = 12/260 (4%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
            G  ++       V +K L     +   R   F  E +I+ +  HPNV+   G VT++ P
Sbjct: 44  SGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKSTP 101

Query: 260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +MI+ E+   G L S+L++  G+ +  +++     +A GM YL +      +H DL  +N
Sbjct: 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARN 158

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
           IL+++    K+S FGL R              +    P   + APE  +  +F  + D +
Sbjct: 159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI-RWTAPEAIQYRKFTSASDVW 217

Query: 379 SFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           S+G++++E++  G +P+     ++V+  +  + + PP        P  L +L+ +CW   
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM----DCPSALHQLMLDCWQKD 273

Query: 438 PVIRPNFNEIIARLDRIVCN 457
              RP F +I+  LD+++ N
Sbjct: 274 RNHRPKFGQIVNTLDKMIRN 293

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 9e-48
 Identities = 71/257 (27%), Positives = 110/257 (42%), Gaps = 12/257 (4%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V    P
Sbjct: 26  RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 84

Query: 260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           M +V E    G L   L+K  G      + R+A+ +A GM YL        IH DL  +N
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
           +LL     +KI  FGL+R     P+         H      + APE  K   F  + D +
Sbjct: 142 LLLATRDLVKIGDFGLMRA---LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 198

Query: 379 SFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
            FG+ L+EM   G +P+      +++  +  EG+R P   +    P D+  ++ +CW  K
Sbjct: 199 MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---RPEDCPQDIYNVMVQCWAHK 255

Query: 438 PVIRPNFNEIIARLDRI 454
           P  RP F  +   L   
Sbjct: 256 PEDRPTFVALRDFLLEA 272

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-47
 Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 24/276 (8%)

Query: 185 LNPLELQVRKADGITKGSYQV---AKW-NGTKVWVKILDKESHKDPERINAFTHELTIVE 240
           ++P +L   K   +  G + V    KW     V +K++ + S  + E    F  E  ++ 
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL + + R    ++L    D+   M 
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANL 359
           YL        +H DL  +N L+++ G +K+S FGL R        + +            
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-----R 166

Query: 360 YVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIK 418
           +  PE+    +F    D ++FG++++E+   G  P+      E  + +  +G R      
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRP-- 223

Query: 419 ARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                  +  ++  CW  K   RP F  +++ +  +
Sbjct: 224 -HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-47
 Identities = 51/242 (21%), Positives = 105/242 (43%), Gaps = 15/242 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
              G +V ++ ++ +     E      +E+ ++ + ++PN+V ++ +      + +V+EY
Sbjct: 42  VATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G L   + +       ++     +  + + +LH  +   +IH D+K  NILL   G 
Sbjct: 99  LAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +K++ FG          K       S +     ++APE+   + +   VD +S G++  E
Sbjct: 155 VKLTDFGFCAQITPEQSKR------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           MIEG  P+  + P   + L+   G  P L+          ++ +  C D     R +  E
Sbjct: 209 MIEGEPPYLNENPLRALYLIATNG-TPELQNP-EKLSAIFRDFLNRCLDMDVEKRGSAKE 266

Query: 447 II 448
           ++
Sbjct: 267 LL 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-47
 Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 12/242 (4%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +     V VKI+D +  +  +       E+ I +   H NVV+F G   +     + LEY
Sbjct: 27  RVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            + G+L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    
Sbjct: 85  CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDN 141

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFGLILY 385
           LKIS FGL  +   +  +  +      +     YVAPE+ K  EF    VD +S G++L 
Sbjct: 142 LKISDFGLATVFRYNNRERLLNKMCGTLP----YVAPELLKRREFHAEPVDVWSCGIVLT 197

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFN 445
            M+ G +    +P +   +    + K+  L    +        L+ +     P  R    
Sbjct: 198 AMLAG-ELPWDQPSDSCQEYSDWKEKKTYLNPW-KKIDSAPLALLHKILVENPSARITIP 255

Query: 446 EI 447
           +I
Sbjct: 256 DI 257

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-47
 Identities = 53/246 (21%), Positives = 102/246 (41%), Gaps = 12/246 (4%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
                +  +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y
Sbjct: 30  LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    
Sbjct: 90  AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMH 146

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++I+ FG  ++     ++A+    V        YV+PE+   +   +S D ++ G I+Y+
Sbjct: 147 IQITDFGTAKVLSPESKQARANSFVGTAQ----YVSPELLTEKSACKSSDLWALGCIIYQ 202

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           ++ G+ PF       + + +       P       + P  ++L+E+        R    E
Sbjct: 203 LVAGLPPFRAGNEYLIFQKIIKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEE 257

Query: 447 IIARLD 452
           +     
Sbjct: 258 MEGYGP 263

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-47
 Identities = 64/248 (25%), Positives = 110/248 (44%), Gaps = 15/248 (6%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
               V +K+L + +  +         E  I+ +  +P +V+ +G V Q   +M+V+E   
Sbjct: 35  KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAG 91

Query: 269 KGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G L  +L  K+  +  S V      ++ GM YL E      +H DL  +N+LL N    
Sbjct: 92  GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA 148

Query: 328 KISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEM 387
           KIS FGL +   +  + +      +   P   + APE     +F    D +S+G+ ++E 
Sbjct: 149 KISDFGLSKA--LGADDSYYTARSAGKWPLK-WYAPECINFRKFSSRSDVWSYGVTMWEA 205

Query: 388 I-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           +  G +P+      EV+  +  +GKR          PP+L  L+ +CW  K   RP+F  
Sbjct: 206 LSYGQKPYKKMKGPEVMAFI-EQGKRMEC---PPECPPELYALMSDCWIYKWEDRPDFLT 261

Query: 447 IIARLDRI 454
           +  R+   
Sbjct: 262 VEQRMRAC 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 59/254 (23%), Positives = 108/254 (42%), Gaps = 16/254 (6%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
           +     N  KV +K + + +  + +    F  E  ++ K  HP +VQ  G   +  P+ +
Sbjct: 22  HLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77

Query: 263 VLEYHAKGDLASYLQKKGRL-SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           V E+   G L+ YL+ +  L +   +L   LD+  GM YL E     +IH DL  +N L+
Sbjct: 78  VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLV 134

Query: 322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFG 381
                +K+S FG+ R        +              + +PE++    +    D +SFG
Sbjct: 135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPEVFSFSRYSSKSDVWSFG 189

Query: 382 LILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIR 441
           ++++E+    +  +       V      G R     K R     + +++  CW  +P  R
Sbjct: 190 VLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWKERPEDR 246

Query: 442 PNFNEIIARLDRIV 455
           P F+ ++ +L  I 
Sbjct: 247 PAFSRLLRQLAEIA 260

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-46
 Identities = 62/268 (23%), Positives = 111/268 (41%), Gaps = 37/268 (13%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHA 268
             +V VK+L +++  D     A   EL ++ +   H N+V  +GA T + P+ ++ EY  
Sbjct: 67  SIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124

Query: 269 KGDLASYLQKK-----------------------GRLSPSKVLRFALDLARGMNYLHECK 305
            GDL +YL+ K                         L+   +L FA  +A+GM +L    
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEI 365
               +H DL  +N+L+ +G  +KI  FGL R                 +     ++APE 
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK----WMAPES 237

Query: 366 YKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP 424
                +    D +S+G++L+E+   GV P+   P +     +   G +            
Sbjct: 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY---ATE 294

Query: 425 DLKELIEECWDPKPVIRPNFNEIIARLD 452
           ++  +++ CW      RP+F  + + L 
Sbjct: 295 EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 20/286 (6%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHE 235
              ++E+   ++ ++    +  G Y       W    + V +  K   +D   +  F  E
Sbjct: 8   NYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAV--KTLKEDTMEVEEFLKE 63

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALD 293
             ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  +S   +L  A  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
           ++  M YL +      IH DL  +N L+     +K++ FGL RL       A        
Sbjct: 124 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 354 IDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
                 + APE     +F    D ++FG++L+E+       +P      V  +  +  R 
Sbjct: 181 K-----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS 459
                    P  + EL+  CW   P  RP+F EI    + +    S
Sbjct: 236 ERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 7e-46
 Identities = 68/285 (23%), Positives = 133/285 (46%), Gaps = 16/285 (5%)

Query: 178 REVPEYELNPLELQVRKADGITKGSY------QVAKWNGTKVWVKILDKESHKDPERINA 231
           + V    + P  L V   + I +G +       +   +G K+   +       D   ++ 
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLR 289
           F  E  I++   HPNV+  +G   +     ++VL Y   GDL ++++ +    +   ++ 
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL R  Y     +    
Sbjct: 135 FGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 350 PVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCE 409
             + +     ++A E  + ++F    D +SFG++L+E++    P +P      + +   +
Sbjct: 192 TGAKLPVK--WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

Query: 410 GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           G+R     +    P  L E++ +CW PK  +RP+F+E+++R+  I
Sbjct: 250 GRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  159 bits (403), Expect = 3e-45
 Identities = 46/246 (18%), Positives = 95/246 (38%), Gaps = 17/246 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +  G     K +      D E       E+  +   RHP +V    A   +  M+++ E+
Sbjct: 48  RATGNNFAAKFVMTPHESDKET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104

Query: 267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL--DN 323
            + G+L   +  +  ++S  + + +   + +G+ ++HE      +H DLKP+NI+     
Sbjct: 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKR 161

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
             +LK+  FGL                         + APE+ + +      D +S G++
Sbjct: 162 SNELKLIDFGLTAHLDPKQSVKVTTGTAE-------FAAPEVAEGKPVGYYTDMWSVGVL 214

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
            Y ++ G+ PF  +  +E ++ +                  D K+ I +     P  R  
Sbjct: 215 SYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273

Query: 444 FNEIIA 449
            ++ + 
Sbjct: 274 IHQALE 279

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-45
 Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 26/290 (8%)

Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGT-KVWVKILDKESHKDP 226
           P T    ++   +E+    L++     + +G + +V    WNGT +V +K L   +    
Sbjct: 2   PQTQGLAKD--AWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 57

Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSP 284
                F  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ +    L  
Sbjct: 58  A----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRL 112

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
            +++  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL   +   
Sbjct: 113 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169

Query: 345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVK 404
           A+             + APE      F    D +SFG++L E+    +  +P      V 
Sbjct: 170 ARQGAKFPI-----KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224

Query: 405 LMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
                G R P        P  L +L+ +CW  +P  RP F  + A L+  
Sbjct: 225 DQVERGYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (401), Expect = 5e-45
 Identities = 51/246 (20%), Positives = 108/246 (43%), Gaps = 17/246 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G     K ++     D        +E++I+ +  HP ++    A      M+++LE+
Sbjct: 51  KATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107

Query: 267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--N 323
            + G+L   +  +  ++S ++V+ +      G+ ++HE     I+H D+KP+NI+ +   
Sbjct: 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKK 164

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +KI  FGL     ++P++   V   +       + APEI   E      D ++ G++
Sbjct: 165 ASSVKIIDFGLAT--KLNPDEIVKVTTATAE-----FAAPEIVDREPVGFYTDMWAIGVL 217

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
            Y ++ G+ PF  +   E ++ +         +    S  P+ K+ I+     +P  R  
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNV-KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 276

Query: 444 FNEIIA 449
            ++ + 
Sbjct: 277 VHDALE 282

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 7e-45
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 38/271 (14%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
             T V VK+L +E+  D +    F  E  ++ +  +PN+V+ +G      PM ++ EY A
Sbjct: 42  PFTMVAVKMLKEEASADMQA--DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 99

Query: 269 KGDLASYLQKKGR------------------------LSPSKVLRFALDLARGMNYLHEC 304
            GDL  +L+                            LS ++ L  A  +A GM YL E 
Sbjct: 100 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159

Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE 364
           K    +H DL  +N L+     +KI+ FGL R  Y +            I     ++ PE
Sbjct: 160 K---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR----WMPPE 212

Query: 365 IYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP 423
                 +    D +++G++L+E+   G+QP++    EEV+  +  +G          + P
Sbjct: 213 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-RDGNILAC---PENCP 268

Query: 424 PDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
            +L  L+  CW   P  RP+F  I   L R+
Sbjct: 269 LELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  155 bits (393), Expect = 1e-44
 Identities = 62/253 (24%), Positives = 97/253 (38%), Gaps = 12/253 (4%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----MMI 262
                 V VK+L  +  +DP     F  E        HP +V          P      I
Sbjct: 29  LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           V+EY     L   +  +G ++P + +    D  + +N+ H+     IIH D+KP NI++ 
Sbjct: 89  VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMIS 145

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGL 382
               +K+  FG+ R    S          + +     Y++PE  + +  D   D YS G 
Sbjct: 146 ATNAVKVMDFGIARAIADSGNSVT---QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202

Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           +LYE++ G  PF    P  V      E   PP          DL  ++ +     P  R 
Sbjct: 203 VLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR-HEGLSADLDAVVLKALAKNPENRY 261

Query: 443 -NFNEIIARLDRI 454
               E+ A L R+
Sbjct: 262 QTAAEMRADLVRV 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (392), Expect = 2e-44
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 12/250 (4%)

Query: 207 KWNGTKVWVKILDKES------HKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP 259
           K    +  VKI+D          +  E   A   E+ I+ K   HPN++Q       N  
Sbjct: 25  KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
             +V +   KG+L  YL +K  LS  +  +    L   +  LH+     I+H DLKP+NI
Sbjct: 85  FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENI 141

Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYS 379
           LLD+   +K++ FG    Q    EK + V          +        +  + + VD +S
Sbjct: 142 LLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 200

Query: 380 FGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPV 439
            G+I+Y ++ G  PF  +    +++++   G       +   Y   +K+L+      +P 
Sbjct: 201 TGVIMYTLLAGSPPFWHRKQMLMLRMI-MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ 259

Query: 440 IRPNFNEIIA 449
            R    E +A
Sbjct: 260 KRYTAEEALA 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 74/301 (24%), Positives = 133/301 (44%), Gaps = 39/301 (12%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINA 231
           P   P  + N ++ Q    D I +G++        K +G ++   I   + +   +    
Sbjct: 1   PTIYPVLDWNDIKFQ----DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 232 FTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------- 279
           F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K            
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 280 -----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                  LS  ++L FA D+ARGM+YL +      IH DL  +NIL+      KI+ FGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 173

Query: 335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPF 394
            R Q +  +K     PV        ++A E      +  + D +S+G++L+E++      
Sbjct: 174 SRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226

Query: 395 HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI 454
           +       +     +G R    +       ++ +L+ +CW  KP  RP+F +I+  L+R+
Sbjct: 227 YCGMTCAELYEKLPQGYRLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

Query: 455 V 455
           +
Sbjct: 284 L 284

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 4e-44
 Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 15/243 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLE 265
           K       +K L K+     + +     E  ++  A  HP +            +  V+E
Sbjct: 24  KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
           Y   GDL  ++Q   +   S+   +A ++  G+ +LH      I++ DLK  NILLD  G
Sbjct: 84  YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 140

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILY 385
            +KI+ FG+ +   +   K       +       Y+APEI   ++++ SVD +SFG++LY
Sbjct: 141 HIKIADFGMCKENMLGDAK------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 194

Query: 386 EMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFN 445
           EM+ G  PFH +  EE+   +  +    P     R    + K+L+ + +  +P  R    
Sbjct: 195 EMLIGQSPFHGQDEEELFHSIRMDNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVR 249

Query: 446 EII 448
             I
Sbjct: 250 GDI 252

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 5e-44
 Identities = 74/313 (23%), Positives = 127/313 (40%), Gaps = 47/313 (15%)

Query: 176 NPREVP---EYELNPLELQVRKADGITKGSY----------QVAKWNGTKVWVKILDKES 222
           +P ++P   ++E     L   K   +  G++           +       V VK+L   +
Sbjct: 8   DPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 223 HKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG- 280
           H       A   EL ++     H N+V  +GA T   P +++ EY   GDL ++L++K  
Sbjct: 66  H--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 281 -----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                             L    +L F+  +A+GM +L        IH DL  +NILL +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTH 180

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
           G   KI  FGL R                 +     ++APE   N  +    D +S+G+ 
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGIF 236

Query: 384 LYEMIEGVQPFHP-KPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           L+E+       +P  P +     M  EG R          P ++ ++++ CWD  P+ RP
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRP 293

Query: 443 NFNEIIARLDRIV 455
            F +I+  +++ +
Sbjct: 294 TFKQIVQLIEKQI 306

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 77/304 (25%), Positives = 135/304 (44%), Gaps = 43/304 (14%)

Query: 181 PEYELNPLELQVRKADGITKGSY------------QVAKWNGTKVWVKILDKESHKDPER 228
           P +EL    L + K   + +G++            +      TKV VK+L  ++ +    
Sbjct: 6   PRWELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63

Query: 229 INAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ---------- 277
                 E+ +++   +H N++  +GA TQ+ P+ +++EY +KG+L  YLQ          
Sbjct: 64  --DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 278 ------KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
                  + +LS   ++  A  +ARGM YL        IH DL  +N+L+     +KI+ 
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178

Query: 332 FGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV 391
           FGL R  +      K       +     ++APE   +  +    D +SFG++L+E+    
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234

Query: 392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARL 451
              +P  P E +  +  EG R        +   +L  ++ +CW   P  RP F +++  L
Sbjct: 235 GSPYPGVPVEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

Query: 452 DRIV 455
           DRIV
Sbjct: 292 DRIV 295

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 67/282 (23%), Positives = 129/282 (45%), Gaps = 23/282 (8%)

Query: 182 EYELNPLELQVRKADGITKGSY------QVAKWNGTKVWVKILDKESHKDPERINAFTHE 235
           +YE+    +++ +   I +G +               + V I   ++         F  E
Sbjct: 1   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 58

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDL 294
              + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +   L  + ++ +A  L
Sbjct: 59  ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           +  + YL   +    +H D+  +N+L+ +   +K+  FGL R    S         +   
Sbjct: 118 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI- 173

Query: 355 DPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI-EGVQPFHPKPPEEVVKLMCCEGKRP 413
                ++APE      F  + D + FG+ ++E++  GV+PF      +V+  +   G+R 
Sbjct: 174 ----KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERL 228

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
           P+     + PP L  L+ +CW   P  RP F E+ A+L  I+
Sbjct: 229 PMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (385), Expect = 4e-43
 Identities = 51/246 (20%), Positives = 106/246 (43%), Gaps = 16/246 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K     V +K + K++ +  E   +  +E+ ++ K +HPN+V           + ++++ 
Sbjct: 31  KRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
            + G+L   + +KG  +     R    +   + YLH+     I+H DLKP+N+L    D 
Sbjct: 89  VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDE 145

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
             ++ IS FGL +++      +              YVAPE+   + + ++VD +S G+I
Sbjct: 146 DSKIMISDFGLSKMEDPGSVLSTACGTPG-------YVAPEVLAQKPYSKAVDCWSIGVI 198

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
            Y ++ G  PF+ +   ++ + +  + +               K+ I    +  P  R  
Sbjct: 199 AYILLCGYPPFYDENDAKLFEQI-LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257

Query: 444 FNEIIA 449
             + + 
Sbjct: 258 CEQALQ 263

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 6e-43
 Identities = 51/252 (20%), Positives = 111/252 (44%), Gaps = 14/252 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
              V +K L + +   P+       E  ++    +P+V + +G    +   +I       
Sbjct: 38  KIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFG 95

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
             L    + K  +    +L + + +A+GMNYL + +   ++H DL  +N+L+     +KI
Sbjct: 96  CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 152

Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI- 388
           + FGL +L  +  E+ +       +     ++A E   +  +    D +S+G+ ++E++ 
Sbjct: 153 TDFGLAKL--LGAEEKEYHAEGGKVPIK--WMALESILHRIYTHQSDVWSYGVTVWELMT 208

Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
            G +P+   P  E+  ++  +G+R P          D+  ++ +CW      RP F E+I
Sbjct: 209 FGSKPYDGIPASEISSIL-EKGERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELI 264

Query: 449 ARLDRIVCNCSK 460
               ++  +  +
Sbjct: 265 IEFSKMARDPQR 276

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 63/247 (25%), Positives = 114/247 (46%), Gaps = 12/247 (4%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
              V +K L        ++   F  E  I+ +  H N+++  G +++  PMMI+ EY   
Sbjct: 36  EVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 93

Query: 270 GDLASY-LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
           G L  +  +K G  S  +++     +A GM YL        +H DL  +NIL+++    K
Sbjct: 94  GALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCK 150

Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +S FGL R+    PE          I     + APE     +F  + D +SFG++++E++
Sbjct: 151 VSDFGLSRVLEDDPEATY-TTSGGKIPIR--WTAPEAISYRKFTSASDVWSFGIVMWEVM 207

Query: 389 EGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
              +  + +     V     +G R P  +     P  + +L+ +CW  +   RP F +I+
Sbjct: 208 TYGERPYWELSNHEVMKAINDGFRLPTPMD---CPSAIYQLMMQCWQQERARRPKFADIV 264

Query: 449 ARLDRIV 455
           + LD+++
Sbjct: 265 SILDKLI 271

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 39/244 (15%), Positives = 99/244 (40%), Gaps = 18/244 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
             +      K +  +   D         E++I+  ARH N++    +      ++++ E+
Sbjct: 27  TSSKKTYMAKFVKVKG-TDQVL---VKKEISILNIARHRNILHLHESFESMEELVMIFEF 82

Query: 267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-- 323
            +  D+   +      L+  +++ +   +   + +LH      I H D++P+NI+     
Sbjct: 83  ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRR 139

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLI 383
              +KI  FG  R       + K       +  A  Y APE+++++    + D +S G +
Sbjct: 140 SSTIKIIEFGQAR-------QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           +Y ++ G+ PF  +  +++++ +    +    +   +    +  + ++     +   R  
Sbjct: 193 VYVLLSGINPFLAETNQQIIENI-MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251

Query: 444 FNEI 447
            +E 
Sbjct: 252 ASEA 255

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-41
 Identities = 71/294 (24%), Positives = 135/294 (45%), Gaps = 34/294 (11%)

Query: 182 EYELNPLELQVRKADGITKGSY----------QVAKWNGTKVWVKILDKESHKDPERINA 231
           E+E+   ++ + +   + +GS+           V     T+V +K +++ +         
Sbjct: 14  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIE 69

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR---------- 281
           F +E +++++    +VV+ +G V+Q  P ++++E   +GDL SYL+              
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
            S SK+++ A ++A GM YL+       +H DL  +N ++     +KI  FG+ R  Y +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEE 401
               K    +  +     +++PE  K+  F    D +SFG++L+E+    +  +     E
Sbjct: 187 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242

Query: 402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV 455
            V     EG       K  + P  L EL+  CW   P +RP+F EII+ +   +
Sbjct: 243 QVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (370), Expect = 2e-40
 Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 17/248 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHE---LTIVEKARHPNVVQFVGAVTQNIPMMIV 263
              G    +K LDK+  K  +      +E   L++V     P +V    A      +  +
Sbjct: 26  ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           L+    GDL  +L + G  S + +  +A ++  G+ ++H      +++ DLKP NILLD 
Sbjct: 86  LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 142

Query: 324 GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPE-IYKNEEFDRSVDAYSFGL 382
            G ++IS  GL      S +K               Y+APE + K   +D S D +S G 
Sbjct: 143 HGHVRISDLGLAC--DFSKKKPHASVGTHG------YMAPEVLQKGVAYDSSADWFSLGC 194

Query: 383 ILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           +L++++ G  PF     ++  ++               S+ P+L+ L+E         R 
Sbjct: 195 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRL 252

Query: 443 NFNEIIAR 450
                 A+
Sbjct: 253 GCLGRGAQ 260

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-40
 Identities = 70/307 (22%), Positives = 131/307 (42%), Gaps = 41/307 (13%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY----------QVAKWNGTKVWVKILDKESHKDP 226
           P +  ++E     L++ K   + +G++                   V VK+L + +    
Sbjct: 2   PYDASKWEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQKKGR---- 281
            R    +    ++    H NVV  +GA T+   P+M+++E+   G+L++YL+ K      
Sbjct: 60  HR-ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 282 ------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
                       L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKI 175

Query: 330 SGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE 389
             FGL R  Y  P+  +       +     ++APE   +  +    D +SFG++L+E+  
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231

Query: 390 GVQ-PFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEII 448
               P+     +E       EG R           P++ + + +CW  +P  RP F+E++
Sbjct: 232 LGASPYPGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELV 288

Query: 449 ARLDRIV 455
             L  ++
Sbjct: 289 EHLGNLL 295

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (359), Expect = 3e-39
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 17/236 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           + NG    +K+L KE     +++     E  ++    HP +++  G       + ++++Y
Sbjct: 26  RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L S L+K  R        +A ++   + YLH      II+ DLKP+NILLD  G 
Sbjct: 86  IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGH 142

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FG  +  Y+      +            Y+APE+   + +++S+D +SFG+++YE
Sbjct: 143 IKITDFGFAK--YVPDVTYTLCGTPD-------YIAPEVVSTKPYNKSIDWWSFGILIYE 193

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRP 442
           M+ G  PF+     +  + +     R P       +  D+K+L+          R 
Sbjct: 194 MLAGYTPFYDSNTMKTYEKILNAELRFP-----PFFNEDVKDLLSRLITRDLSQRL 244

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-39
 Identities = 59/244 (24%), Positives = 110/244 (45%), Gaps = 14/244 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGH 143

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           +KI+ FGL +         K             Y+APE+ ++ ++ R+VD +  G+++YE
Sbjct: 144 IKITDFGLCKEGISDGATMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYE 197

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNE 446
           M+ G  PF+ +  E + +L+  E  R P     R+  P+ K L+       P  R     
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGP 252

Query: 447 IIAR 450
             A+
Sbjct: 253 SDAK 256

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-39
 Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 18/250 (7%)

Query: 207 KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K  G +   K + K    S +          E++I+++ +HPNV+           ++++
Sbjct: 32  KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           LE  A G+L  +L +K  L+  +   F   +  G+ YLH      I H DLKP+NI+L +
Sbjct: 92  LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLD 148

Query: 324 GG----QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYS 379
                 ++KI  FGL        E   I            +VAPEI   E      D +S
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE-------FVAPEIVNYEPLGLEADMWS 201

Query: 380 FGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPV 439
            G+I Y ++ G  PF     +E +  +         +  + +     K+ I       P 
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS-NTSALAKDFIRRLLVKDPK 260

Query: 440 IRPNFNEIIA 449
            R    + + 
Sbjct: 261 KRMTIQDSLQ 270

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 1e-38
 Identities = 59/237 (24%), Positives = 110/237 (46%), Gaps = 17/237 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 179

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           ++++ FG  +                 +      +APEI  ++ ++++VD ++ G+++YE
Sbjct: 180 IQVTDFGFAKRVK---------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPN 443
           M  G  PF    P ++ + +     R P       +  DLK+L+          R  
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFG 282

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 6e-38
 Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 31/255 (12%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGA----VTQNIPMM 261
           K    K  +K+L                E+ +  +A + P++V+ V            ++
Sbjct: 34  KRTQEKFALKMLQDCPK--------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85

Query: 262 IVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           IV+E    G+L S +Q +G    +  +       +   + YLH      I H D+KP+N+
Sbjct: 86  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENL 142

Query: 320 LLD---NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVD 376
           L         LK++ FG  +    +   +      +       YVAPE+   E++D+S D
Sbjct: 143 LYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTP-----YYVAPEVLGPEKYDKSCD 195

Query: 377 AYSFGLILYEMIEGVQPFHPKPPEEVVKLM---CCEGKRPPLKIKARSYPPDLKELIEEC 433
            +S G+I+Y ++ G  PF+      +   M      G+      +      ++K LI   
Sbjct: 196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 255

Query: 434 WDPKPVIRPNFNEII 448
              +P  R    E +
Sbjct: 256 LKTEPTQRMTITEFM 270

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  137 bits (346), Expect = 8e-38
 Identities = 31/258 (12%), Positives = 83/258 (32%), Gaps = 18/258 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIVLE 265
             N  +V +K   + S            E    +       +        + +  ++V++
Sbjct: 27  LLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-- 323
                          + S   V   A  +   +  +HE     +++ D+KP N L+    
Sbjct: 82  LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPN 138

Query: 324 ---GGQLKISGFGLLRLQYISPEKAKIVFPVSH-IDPANLYVAPEIYKNEEFDRSVDAYS 379
                 + +  FG+++       K  I +     +     Y++   +   E  R  D  +
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 198

Query: 380 FGLILYEMIEGVQPF---HPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDP 436
            G +    + G  P+        ++  + +  + +  PL+     +P +  + +    + 
Sbjct: 199 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL 258

Query: 437 KPVIRPNFNEIIARLDRI 454
                P+++ +     ++
Sbjct: 259 AFDATPDYDYLQGLFSKV 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 2e-36
 Identities = 39/256 (15%), Positives = 84/256 (32%), Gaps = 16/256 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPMMIVLE 265
              G +V +K+   ++            E  I +  +    +  +     +    ++V+E
Sbjct: 29  IAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL---LD 322
                    +     + S   VL  A  +   + Y+H       IH D+KP N L     
Sbjct: 84  LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 140

Query: 323 NGGQLKISGFGLLR-LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFG 381
            G  + I  FGL +  +     +        ++     Y +   +   E  R  D  S G
Sbjct: 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 200

Query: 382 LILYEMIEGVQPFHPKPPEEV---VKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKP 438
            +L     G  P+            + +  +    P+++  + YP +    +  C   + 
Sbjct: 201 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF 260

Query: 439 VIRPNFNEIIARLDRI 454
             +P+++ +      +
Sbjct: 261 DDKPDYSYLRQLFRNL 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 9e-36
 Identities = 63/276 (22%), Positives = 113/276 (40%), Gaps = 35/276 (12%)

Query: 187 PLELQVRKADGITKGSY-QVAKW----NGTKVWVKILDKESHKDPERI---NAFTHELTI 238
           PLE Q +    +  G +  V       +   V +K ++K+   D   +        E+ +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 239 VEKAR--HPNVVQFVGAVTQNIPMMIVLEY-HAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           ++K       V++ +    +    +++LE      DL  ++ ++G L       F   + 
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             + + H C    ++H D+K +NIL+D N G+LK+  FG   L   +         V   
Sbjct: 121 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV--- 174

Query: 355 DPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP 413
                Y  PE  +   +  RS   +S G++LY+M+ G  PF  +  EE++        R 
Sbjct: 175 -----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEII--------RG 219

Query: 414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
            +  + R    + + LI  C   +P  RP F EI  
Sbjct: 220 QVFFRQR-VSSECQHLIRWCLALRPSDRPTFEEIQN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  126 bits (317), Expect = 9e-34
 Identities = 52/272 (19%), Positives = 102/272 (37%), Gaps = 35/272 (12%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
           Y+     G    +K +  E  +D    +    E++I+++ +H N+V+    +     +++
Sbjct: 19  YKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           V E+  +         +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++
Sbjct: 78  VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLIN 134

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFG 381
             G+LKI+ FGL R   I   K               Y AP++    + +  ++D +S G
Sbjct: 135 REGELKIADFGLARAFGIPVRKYTHEIVTLW------YRAPDVLMGSKKYSTTIDIWSVG 188

Query: 382 LILYEMIEGVQPFHPKPPEEVVKLMC------------------------CEGKRPPLKI 417
            I  EM+ G   F      + +  +                            +  P + 
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248

Query: 418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
             +       +L+ +     P  R    + + 
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 9e-34
 Identities = 58/269 (21%), Positives = 101/269 (37%), Gaps = 35/269 (13%)

Query: 207 KWNGTKVWVKILDKE--SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           K     V +K +     S            E+ ++++  HPN++  + A      + +V 
Sbjct: 20  KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79

Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           ++               L+PS +  + L   +G+ YLH+     I+H DLKP N+LLD  
Sbjct: 80  DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 136

Query: 325 GQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLI 383
           G LK++ FGL +  + SP +A     V+       Y APE+      +   VD ++ G I
Sbjct: 137 GVLKLADFGLAK-SFGSPNRAYTHQVVTRW-----YRAPELLFGARMYGVGVDMWAVGCI 190

Query: 384 LYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-----------------------PLKIKAR 420
           L E++  V         + +  +      P                       PL     
Sbjct: 191 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 250

Query: 421 SYPPDLKELIEECWDPKPVIRPNFNEIIA 449
           +   DL +LI+  +   P  R    + + 
Sbjct: 251 AAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 57/274 (20%), Positives = 101/274 (36%), Gaps = 40/274 (14%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV----TQNIPMMI 262
             N  +V +K +     +          E+ I+ + RH N++     +     + +  + 
Sbjct: 30  NVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           ++ +    DL   L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+
Sbjct: 88  LVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 143

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFD-RSVDAYSFG 381
               LKI  FGL R+    P+     F   ++     Y APEI  N +   +S+D +S G
Sbjct: 144 TTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRW-YRAPEIMLNSKGYTKSIDIWSVG 200

Query: 382 LILYEMIEGVQPFHPKPPEEVVKLM--------------------------CCEGKRPPL 415
            IL EM+     F  K   + +  +                               + P 
Sbjct: 201 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 260

Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
                +      +L+++     P  R    + +A
Sbjct: 261 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 6e-32
 Identities = 50/252 (19%), Positives = 100/252 (39%), Gaps = 9/252 (3%)

Query: 200 KGSYQVAKWNGTKVWVKILDKES-HKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQN 257
                     G    +K+L K +  +  +       E  ++E  R  P +V    A    
Sbjct: 42  LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101

Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             + ++L+Y   G+L ++L ++ R +  +V  +  ++   + +LH+     II+ D+K +
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158

Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDA 377
           NILLD+ G + ++ FGL +       +    F  +    A          +   D++VD 
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP---DIVRGGDSGHDKAVDW 215

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPK 437
           +S G+++YE++ G  PF     +     +     +       +      K+LI+      
Sbjct: 216 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-QEMSALAKDLIQRLLMKD 274

Query: 438 PVIRPNFNEIIA 449
           P  R       A
Sbjct: 275 PKKRLGCGPRDA 286

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-31
 Identities = 53/279 (18%), Positives = 102/279 (36%), Gaps = 42/279 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP------- 259
           +  G KV +K +  E+ K+   I     E+ I++  +H NVV  +               
Sbjct: 32  RKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90

Query: 260 -MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
            + +V ++              + + S++ R    L  G+ Y+H  K   I+H D+K  N
Sbjct: 91  SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAAN 147

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDA 377
           +L+   G LK++ FGL R    S  K       ++      Y  PE+   E ++   +D 
Sbjct: 148 VLITRDGVLKLADFGLARA--FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 205

Query: 378 YSFGLILYEMIEGVQPFHPKPPEEVVKLMC---------------------------CEG 410
           +  G I+ EM            +  + L+                             + 
Sbjct: 206 WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 265

Query: 411 KRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
           ++   ++KA    P   +LI++     P  R + ++ + 
Sbjct: 266 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 4e-31
 Identities = 54/273 (19%), Positives = 102/273 (37%), Gaps = 40/273 (14%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPNVVQFVGAVT-----QNIP 259
           K  G  V +K +  ++ ++   ++       L  +E   HPNVV+     T     +   
Sbjct: 30  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89

Query: 260 MMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           + +V E+  +       +  +  +    +      L RG+++LH  +   ++H DLKP+N
Sbjct: 90  LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 146

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAY 378
           IL+ + GQ+K++ FGL R+         +V  +        Y APE+     +   VD +
Sbjct: 147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW-------YRAPEVLLQSSYATPVDLW 199

Query: 379 SFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP----------------------PLK 416
           S G I  EM      F      + +  +      P                      P++
Sbjct: 200 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 259

Query: 417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
                     K+L+ +C    P  R +    ++
Sbjct: 260 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 46/269 (17%), Positives = 96/269 (35%), Gaps = 36/269 (13%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G  V +K +  ++  +    +    E++++++  HPN+V+ +  +     + +V E+
Sbjct: 24  KLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82

Query: 267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
             +             +    +  +   L +G+ + H      ++H DLKP+N+L++  G
Sbjct: 83  LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEG 139

Query: 326 QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLIL 384
            +K++ FGL R   +                   Y APEI    + +  +VD +S G I 
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLW------YRAPEILLGCKYYSTAVDIWSLGCIF 193

Query: 385 YEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY---------------------- 422
            EM+     F      + +  +      P   +                           
Sbjct: 194 AEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253

Query: 423 --PPDLKELIEECWDPKPVIRPNFNEIIA 449
               D + L+ +     P  R +    +A
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 47/268 (17%), Positives = 96/268 (35%), Gaps = 34/268 (12%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +     V +K +  +   D    ++   E+ ++++ +H N+V+    +  +  + +V E+
Sbjct: 24  RETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             +     +    G L P  V  F   L +G+ + H      ++H DLKP+N+L++  G+
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGE 139

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYE 386
           LK++ FGL R   I             +          ++  + +  S+D +S G I  E
Sbjct: 140 LKLANFGLARAFGIPVRCYSA-----EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194

Query: 387 MIEGVQPFHPKPPEEVVKLMCCEGKRPP-------------------------LKIKARS 421
           +    +P  P    +            P                         L      
Sbjct: 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254

Query: 422 YPPDLKELIEECWDPKPVIRPNFNEIIA 449
                ++L++      PV R +  E + 
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-29
 Identities = 63/315 (20%), Positives = 106/315 (33%), Gaps = 58/315 (18%)

Query: 174 VANPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPER 228
           VA P + P+    P E+       I  GS+ V        +G  V +K + ++       
Sbjct: 7   VATPGQGPD---RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---- 59

Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQ------NIPMMIVLEYHAKG---DLASYLQKK 279
                 EL I+ K  H N+V+              + + +VL+Y  +        Y + K
Sbjct: 60  ---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116

Query: 280 GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQ 338
             L    V  +   L R + Y+H      I H D+KP+N+LLD +   LK+  FG  +  
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

Query: 339 YISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP 398
                    +    +  P        I+   ++  S+D +S G +L E++ G   F    
Sbjct: 174 VRGEPNVSYICSRYYRAP------ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227

Query: 399 PEEVVKLMC------------------------CEGKRPPLKIKARSYPPDLKELIEECW 434
             + +  +                              P  K+     PP+   L     
Sbjct: 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287

Query: 435 DPKPVIRPNFNEIIA 449
           +  P  R    E  A
Sbjct: 288 EYTPTARLTPLEACA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-28
 Identities = 62/276 (22%), Positives = 100/276 (36%), Gaps = 48/276 (17%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IPM 260
              G KV +K L +    +         EL +++  RH NV+  +   T +         
Sbjct: 40  GRTGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            +V+ +   G     L K  +L   ++      + +G+ Y+H       IH DLKP N+ 
Sbjct: 99  YLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLA 153

Query: 321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYS 379
           ++   +LKI  FGL R Q  S     +V           Y APE+  N   + ++VD +S
Sbjct: 154 VNEDCELKILDFGLAR-QADSEMTGYVVTR--------WYRAPEVILNWMRYTQTVDIWS 204

Query: 380 FGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR------------------- 420
            G I+ EMI G   F      + +K +      PP +   R                   
Sbjct: 205 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 264

Query: 421 -------SYPPDLKELIEECWDPKPVIRPNFNEIIA 449
                  +  P    L+E+        R    E +A
Sbjct: 265 DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 58/334 (17%), Positives = 108/334 (32%), Gaps = 66/334 (19%)

Query: 164 VPKTKRTPMTVANPREVPEYELNPLELQVRKADG------ITKGSYQVA-----KWNGTK 212
           VP   R    V   R    ++     ++    D       + +G Y          N  K
Sbjct: 3   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 62

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQ--NIPMMIVLEYHAK 269
           V VKIL     K          E+ I+E  R  PN++     V    +    +V E+   
Sbjct: 63  VVVKILKPVKKKK------IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLK 328
            D     Q    L+   +  +  ++ + ++Y H      I+H D+KP N+++D+   +L+
Sbjct: 117 TDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR 170

Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMI 388
           +  +GL    +   E    V       P        +   + +D S+D +S G +L  MI
Sbjct: 171 LIDWGLAEFYHPGQEYNVRVASRYFKGP------ELLVDYQMYDYSLDMWSLGCMLASMI 224

Query: 389 EGVQPF---------------------------------HPKPPEEVVKLMCCEGKRPPL 415
              +PF                                  P+  + + +      +R   
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284

Query: 416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA 449
                   P+  + +++        R    E + 
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 1e-23
 Identities = 58/274 (21%), Positives = 101/274 (36%), Gaps = 44/274 (16%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM----I 262
              G +V VK L +   +          EL +++  +H NV+  +   T    +     +
Sbjct: 40  TKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
            L  H  G   + + K  +L+   V      + RG+ Y+H      IIH DLKP N+ ++
Sbjct: 99  YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 155

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFG 381
              +LKI  FGL R              ++       Y APEI  N   ++++VD +S G
Sbjct: 156 EDCELKILDFGLAR---------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206

Query: 382 LILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR--------------------- 420
            I+ E++ G   F      + +KL+      P  ++  +                     
Sbjct: 207 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 266

Query: 421 -----SYPPDLKELIEECWDPKPVIRPNFNEIIA 449
                   P   +L+E+        R    + +A
Sbjct: 267 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.9 bits (240), Expect = 1e-22
 Identities = 48/243 (19%), Positives = 85/243 (34%), Gaps = 21/243 (8%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM----- 261
                 V +K L +   ++         EL +++   H N++  +   T    +      
Sbjct: 39  AVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97

Query: 262 -IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            +V+E             +  L   ++      +  G+ +LH      IIH DLKP NI+
Sbjct: 98  YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 151

Query: 321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSF 380
           + +   LKI  FGL R    S      V    +        APE+     +  +VD +S 
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY-------RAPEVILGMGYKENVDIWSV 204

Query: 381 GLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVI 440
           G I+ EM+     F  +   +    +  E    P     +   P ++  +E       + 
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT 263

Query: 441 RPN 443
            P 
Sbjct: 264 FPK 266

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.9 bits (232), Expect = 2e-21
 Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 6/180 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   G +  V++LL  G+  N  ++   T LH+AA  GH EV K LL  KA ++A+ 
Sbjct: 4   LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPREVPEYELNPLEL-- 190
           +   T    A   G+  +  +L    A          TP+ +A      E  L  LE   
Sbjct: 64  KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123

Query: 191 QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF 250
                         VA   G     ++L +               L +     + ++V+ 
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKL 183

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (190), Expect = 4e-16
 Identities = 30/84 (35%), Positives = 46/84 (54%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   +  G++K V+ LL   +DVN+    G + LH AA +GH ++V LLL   A+ +   
Sbjct: 301 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360

Query: 136 RWGSTAAADAKYYGNVEVYNILKA 159
             G+T  A AK  G + V ++LK 
Sbjct: 361 SDGTTPLAIAKRLGYISVTDVLKV 384

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.5 bits (174), Expect = 5e-14
 Identities = 33/149 (22%), Positives = 49/149 (32%), Gaps = 5/149 (3%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV-- 164
           T LH+A+  GH+ +VK LL + A+ +  +    T    A   G+ EV   L    AKV  
Sbjct: 2   TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61

Query: 165 -PKTKRTPMTVA--NPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKE 221
             K  +TP+  A           L         A         +A   G    V  L ++
Sbjct: 62  KAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEK 121

Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQF 250
                         L +  K     V + 
Sbjct: 122 EASQACMTKKGFTPLHVAAKYGKVRVAEL 150

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.9 bits (162), Expect = 1e-12
 Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 11/200 (5%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A +  V+    LL  G   N+  + G T LH+AA EGH E+V LLLSK+AN +  +
Sbjct: 202 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 261

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV-------ANPREVPEYELNPL 188
           + G T        G+V V ++L   G  V  T R   T         N + V     +  
Sbjct: 262 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQA 321

Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH-ELTIVEKARHPNV 247
           ++  +   G +      A   G    V +L  ++   P  +++     L I ++  + +V
Sbjct: 322 DVNAKTKLGYS--PLHQAAQQGHTDIVTLL-LKNGASPNEVSSDGTTPLAIAKRLGYISV 378

Query: 248 VQFVGAVTQNIPMMIVLEYH 267
              +  VT     ++V + H
Sbjct: 379 TDVLKVVTDETSFVLVSDKH 398

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.2 bits (160), Expect = 2e-12
 Identities = 25/84 (29%), Positives = 37/84 (44%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
             L   A  G V+  E LL   +  N+   +G T LH+A    ++++VKLLL +  +  +
Sbjct: 134 TPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHS 193

Query: 134 RDRWGSTAAADAKYYGNVEVYNIL 157
               G T    A     VEV   L
Sbjct: 194 PAWNGYTPLHIAAKQNQVEVARSL 217

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.4 bits (145), Expect = 2e-10
 Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 3/98 (3%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
            +    +   G T LH+AA  G V V +LLL + A+ +A  + G T    A ++ N+++ 
Sbjct: 122 EASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIV 181

Query: 155 NILKARGAKV---PKTKRTPMTVANPREVPEYELNPLE 189
            +L  RG           TP+ +A  +   E   + L+
Sbjct: 182 KLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQ 219

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 86.2 bits (212), Expect = 5e-19
 Identities = 38/279 (13%), Positives = 92/279 (32%), Gaps = 32/279 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-------- 258
             N T V +KI+      D     A   E+ ++++    +  +       +I        
Sbjct: 35  MVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90

Query: 259 --------PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
                    +M+               +   +    V + +  L  G++Y+H      II
Sbjct: 91  HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--II 148

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE 370
           H D+KP+N+L++     +      +     +          ++      Y +PE+     
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTREYRSPEVLLGAP 205

Query: 371 FDRSVDAYSFGLILYEMIEGVQPFHP-------KPPEEVVKLMCCEGKRPPLKIKARSYP 423
           +    D +S   +++E+I G   F P       K  + + +++   G+ P   ++   Y 
Sbjct: 206 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT 265

Query: 424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQG 462
                      +   +      +++    +   + +K+ 
Sbjct: 266 RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.5 bits (192), Expect = 8e-17
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 1/77 (1%)

Query: 89  EDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKY 147
             LL+ G+DVN     G+T L +A  + H+ +V+ LL ++   I+  D  G TA   A  
Sbjct: 203 HLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVE 262

Query: 148 YGNVEVYNILKARGAKV 164
               ++  +L  RGA  
Sbjct: 263 LKLKKIAELLCKRGAST 279

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.3 bits (176), Expect = 1e-14
 Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 76  LLFMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L+    +  +  V+ LL  E  ++N  D DG+TAL +A      ++ +LL  + A+ D  
Sbjct: 223 LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 282

Query: 135 D 135
           D
Sbjct: 283 D 283

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.4 bits (140), Expect = 4e-10
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 2/101 (1%)

Query: 75  QLLFMACR-GDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANID 132
            LL  A +  DV  V+ LL  G++VN  + + G T LH A      ++V+LLL   A+  
Sbjct: 7   HLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPV 66

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
            R + G+T    A   G+V++  +  ++GA V +      T
Sbjct: 67  LRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFT 107

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (132), Expect = 4e-09
 Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 15/134 (11%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNV----E 152
              +   G TAL  AA +GHVEV+K+LL +  A+++A D  G  A   A    +      
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200

Query: 153 VYNILKARGAKV---PKTKRTPMTVANPREVPEY-----ELNPLELQVRKADGITKGSYQ 204
           + ++L   GA V    +  +TP+ +A  ++         E   +E+    +DG T  +  
Sbjct: 201 ITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKT--ALL 258

Query: 205 VAKWNGTKVWVKIL 218
           +A     K   ++L
Sbjct: 259 LAVELKLKKIAELL 272

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (130), Expect = 7e-09
 Identities = 11/52 (21%), Positives = 23/52 (44%), Gaps = 1/52 (1%)

Query: 103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARD-RWGSTAAADAKYYGNVEV 153
           ++    L  A     V++V+ LL   AN++ ++   G T   +A      ++
Sbjct: 3   VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDI 54

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 72.1 bits (175), Expect = 1e-14
 Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 1/67 (1%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           GS+ +  D DG+T + +AA EG +EVV  L+ + A+++A D    TA   A+   +  + 
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270

Query: 155 NIL-KAR 160
           +I  + R
Sbjct: 271 DIFDRCR 277

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 60.5 bits (145), Expect = 7e-11
 Identities = 12/50 (24%), Positives = 24/50 (48%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           ++  A  G ++ V  L+ +G+ V ++D    TA  +A    H  +V +  
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFD 274

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 59.4 bits (142), Expect = 2e-10
 Identities = 15/84 (17%), Positives = 26/84 (30%), Gaps = 9/84 (10%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK--------ANI 131
              G     E +  E  ++       RT LH  A     E  + L+  +        A++
Sbjct: 9   EAAGSYAITEPITRESVNIID-PRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADV 67

Query: 132 DARDRWGSTAAADAKYYGNVEVYN 155
           +A D   +T    A       +  
Sbjct: 68  NAMDCDENTPLMLAVLARRRRLVA 91

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 40.5 bits (93), Expect = 2e-04
 Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 4/102 (3%)

Query: 78  FMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDR 136
             A     KG +   +  +  +S    GRTALH AA   ++ +VK L+ +K +N D +D 
Sbjct: 160 ASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDE 219

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
            G T    A   G +EV   L  +GA V     T  T   +A
Sbjct: 220 DGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA 261

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 39.7 bits (91), Expect = 4e-04
 Identities = 12/60 (20%), Positives = 18/60 (30%), Gaps = 2/60 (3%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +    LH  A  G   + + +  +  NI    R   T         + E    L    AK
Sbjct: 1   ESPIKLHTEAA-GSYAITEPITRESVNI-IDPRHNRTVLHWIASNSSAEKSEDLIVHEAK 58

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 72.2 bits (176), Expect = 1e-14
 Identities = 19/96 (19%), Positives = 29/96 (30%), Gaps = 6/96 (6%)

Query: 76  LLFMACR----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           + F+A        +  +  LL     V  I  +   A  +AA  GH+ V+  L       
Sbjct: 93  ICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTE 152

Query: 132 DARDR--WGSTAAADAKYYGNVEVYNILKARGAKVP 165
                      A   A   G++ V N L        
Sbjct: 153 IMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEA 188

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 66.8 bits (162), Expect = 1e-12
 Identities = 19/108 (17%), Positives = 33/108 (30%), Gaps = 6/108 (5%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVVKLL 124
           +N++   QLL   C        +     SD +   +       +AA  G    ++ + LL
Sbjct: 56  KNMEQVRQLL---CLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLL 112

Query: 125 LSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPM 172
           L+    +         A   A   G++ V N L               
Sbjct: 113 LTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAE 160

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 51.4 bits (122), Expect = 1e-07
 Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)

Query: 76  LLFMACRGDVKGVEDLLNEGSD-----VNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           L+       +  +  LL+           +I  D    L +A   G+     LLLS
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 48.3 bits (114), Expect = 1e-06
 Identities = 15/97 (15%), Positives = 25/97 (25%), Gaps = 6/97 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLD--GRTALHIAACEGHVEVVKLLLSKKANID- 132
             +A   G +  +  L           +      A  +AA  GH+ V+  L         
Sbjct: 130 FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEAT 189

Query: 133 --ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT 167
              +          A   G+  V N L      +   
Sbjct: 190 AMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYA 226

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 46.4 bits (109), Expect = 4e-06
 Identities = 10/87 (11%), Positives = 19/87 (21%), Gaps = 10/87 (11%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-----N 130
              ++    V  +                    L     E  ++ ++ LLS         
Sbjct: 255 AFKLSNPDGVFDLVT-----KSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAP 309

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNIL 157
                   +     A   GN     +L
Sbjct: 310 TATIPGDANELLRLALRLGNQGACALL 336

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 39.5 bits (91), Expect = 7e-04
 Identities = 10/138 (7%), Positives = 31/138 (22%), Gaps = 36/138 (26%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVN----------------------SIDLDG 105
           +  +          RG    +  LL+    +                       +   + 
Sbjct: 193 QAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFEYGEKYVNPFIARHVNRLKEM 252

Query: 106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA--- 162
             A  ++  +G  ++V        +   +  +             ++    L +      
Sbjct: 253 HDAFKLSNPDGVFDLV------TKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKA 306

Query: 163 -----KVPKTKRTPMTVA 175
                 +P      + +A
Sbjct: 307 LAPTATIPGDANELLRLA 324

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 37.6 bits (86), Expect = 0.003
 Identities = 16/110 (14%), Positives = 29/110 (26%), Gaps = 11/110 (10%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSI---DLDGRTALHIAACEGHVEVVKLLLSKKANID 132
               A  G +  +  L        +      +       A   GH  V+  LL     + 
Sbjct: 165 FRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLA 224

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPE 182
             +            YG   V   +     ++ K       ++NP  V +
Sbjct: 225 YAEIHEFE-------YGEKYVNPFIARHVNRL-KEMHDAFKLSNPDGVFD 266

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 68.2 bits (165), Expect = 2e-13
 Identities = 22/66 (33%), Positives = 35/66 (53%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A +G  + ++ L+    DVN  D DG T LH AA  G  E  ++L+    +++A +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262

Query: 136 RWGSTA 141
           + G TA
Sbjct: 263 KVGQTA 268

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 59.0 bits (141), Expect = 2e-10
 Identities = 15/55 (27%), Positives = 22/55 (40%)

Query: 101 IDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYN 155
           +  D       A   G  E V  LL + A+I+  +  G TA   A    NV++  
Sbjct: 36  VKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVK 90

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 53.6 bits (127), Expect = 1e-08
 Identities = 33/114 (28%), Positives = 50/114 (43%)

Query: 48  RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRT 107
           R    +     PV          D     L     GD + V  LL  G+D+N  ++DG T
Sbjct: 16  RWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLT 75

Query: 108 ALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
           ALH A  + +V++VK L+   ANI+  D  G      A   G +++   L ++G
Sbjct: 76  ALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQG 129

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 53.2 bits (126), Expect = 2e-08
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN 150
           L +   +       G TALH+AA +G+ EV+KLL+  + +++ +D  G T    A ++G 
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244

Query: 151 VEVYNILKARGAKV---PKTKRTPMTVAN 176
            E   IL      +    K  +T   VA+
Sbjct: 245 EEACRILVENLCDMEAVNKVGQTAFDVAD 273

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 45.5 bits (106), Expect = 6e-06
 Identities = 14/58 (24%), Positives = 27/58 (46%), Gaps = 6/58 (10%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA--CEGHVEVVKLLLSKKANI 131
           L   A  G  +    L+    D+ +++  G+TA  +A     G++E ++    KK N+
Sbjct: 236 LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILGYLEELQ----KKQNL 289

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 68.2 bits (165), Expect = 3e-13
 Identities = 14/57 (24%), Positives = 29/57 (50%)

Query: 85  VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           ++ ++      + +N+ D +G T L+IAA  G++ +V  LL   A+    ++ G   
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 295

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 66.6 bits (161), Expect = 8e-13
 Identities = 23/120 (19%), Positives = 39/120 (32%), Gaps = 9/120 (7%)

Query: 65  TVPENLDSTMQLLFMACRGDVKGVEDLLNEGS-DVN-SIDLDGRTALHIAACEGHVEVVK 122
              E   S  Q   ++    ++ V D       ++N  +D  G T LH      ++E+VK
Sbjct: 65  RNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVK 124

Query: 123 LLLSKKANIDARDRWGSTAAADAKYYGN-------VEVYNILKARGAKVPKTKRTPMTVA 175
            L+   +N    D  G +    A    N         + + L           RT +   
Sbjct: 125 HLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHI 184

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 51.2 bits (121), Expect = 9e-08
 Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 6/91 (6%)

Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK---KANIDARDRWGSTAAADAKY 147
           +  +   + S   +  +  +    E    +++ L  K      ++A+D  G T    A  
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268

Query: 148 YGNVEVYNILKARGAKV---PKTKRTPMTVA 175
            GN+ + + L   GA      K+   P+   
Sbjct: 269 LGNISIVDALLDYGADPFIANKSGLRPVDFG 299

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 11/38 (28%), Positives = 19/38 (50%), Gaps = 1/38 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAA 113
           L +A R G++  V+ LL+ G+D    +  G   +   A
Sbjct: 263 LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.8 bits (154), Expect = 3e-12
 Identities = 32/100 (32%), Positives = 50/100 (50%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
             L   A  G  + V+ LL +G+ VN+++ +G T LH AA +   E+  +LL   AN DA
Sbjct: 72  SPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDA 131

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           +D + +TA   A   GN+++ +IL    A          T
Sbjct: 132 KDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNT 171

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.7 bits (151), Expect = 7e-12
 Identities = 31/110 (28%), Positives = 58/110 (52%), Gaps = 3/110 (2%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK 128
           N +    L + A +   +    LL  G++ ++ D    TA+H AA +G+++++ +LL  K
Sbjct: 100 NQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYK 159

Query: 129 ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           A+ + +D  G+T    A     VE   +L ++GA +    K ++TP+ VA
Sbjct: 160 ASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVA 209

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.4 bits (145), Expect = 4e-11
 Identities = 36/186 (19%), Positives = 57/186 (30%), Gaps = 39/186 (20%)

Query: 72  STMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEG-------------- 116
           S + +  +A  G ++ +++ +    S     D D RTALH A   G              
Sbjct: 3   SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVP 62

Query: 117 -------------------HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
                                E+VK LL K A ++A ++ G T    A      E+  +L
Sbjct: 63  VNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVML 122

Query: 158 KARGAKV---PKTKRTPM--TVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTK 212
              GA        + T M    A       + L   +      D        +A      
Sbjct: 123 LEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERV 182

Query: 213 VWVKIL 218
              K+L
Sbjct: 183 EEAKLL 188

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 2e-09
 Identities = 9/57 (15%), Positives = 26/57 (45%), Gaps = 1/57 (1%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           + +    L        V+  + L+++G+ +   + + +T L +A   G   ++K ++
Sbjct: 166 DTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMV 221

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (131), Expect = 3e-09
 Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 1/82 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +   A +G++K +  LL   +  N  D +G T LH+A  E  VE  KLL+S+ A+I   +
Sbjct: 140 MHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIEN 199

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
           +   T    AK  G   +   +
Sbjct: 200 KEEKTPLQVAK-GGLGLILKRM 220

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 64.0 bits (154), Expect = 4e-12
 Identities = 14/58 (24%), Positives = 22/58 (37%), Gaps = 1/58 (1%)

Query: 78  FMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
                     +E LL  G+D  +    GRT L  A    +  + +LL +  A  +  D
Sbjct: 198 LAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.0 bits (149), Expect = 2e-11
 Identities = 17/60 (28%), Positives = 23/60 (38%), Gaps = 3/60 (5%)

Query: 99  NSIDLDGRTALHIAACEGHVEVVKLLLSKKAN---IDARDRWGSTAAADAKYYGNVEVYN 155
             +  DG TALH+A    H   +  LL   A    +D ++  G TA   A   G      
Sbjct: 3   GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 61.3 bits (147), Expect = 4e-11
 Identities = 21/61 (34%), Positives = 29/61 (47%)

Query: 106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP 165
           RT LH+A       V++LLL   A+  AR   G T    A    N  +  +L+A GA  P
Sbjct: 193 RTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEP 252

Query: 166 K 166
           +
Sbjct: 253 E 253

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 53.6 bits (127), Expect = 1e-08
 Identities = 26/118 (22%), Positives = 42/118 (35%), Gaps = 4/118 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDL---DGRTALHIAACEGHVEVVKLLLSKKANID 132
           L +A        ++ LL   +    +DL    G+TALH+AA  G    V+ L +  A + 
Sbjct: 13  LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVL 72

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLEL 190
             +R G TA   A          +L       P+         +    P+    P  +
Sbjct: 73  VAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAV 130

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.4 bits (147), Expect = 2e-11
 Identities = 18/81 (22%), Positives = 37/81 (45%), Gaps = 1/81 (1%)

Query: 74  MQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
              L  A   +   +  LL + G++VN+    G +ALH A+  G + +V+ L+   A+  
Sbjct: 145 RSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSS 204

Query: 133 ARDRWGSTAAADAKYYGNVEV 153
            ++    T    A+    +++
Sbjct: 205 LKNCHNDTPLMVARSRRVIDI 225

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.9 bits (138), Expect = 3e-10
 Identities = 10/52 (19%), Positives = 23/52 (44%)

Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK 122
             +  L   + RG +  V  L+  G+D +  +    T L +A     +++++
Sbjct: 176 SGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILR 227

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (134), Expect = 1e-09
 Identities = 13/49 (26%), Positives = 20/49 (40%), Gaps = 4/49 (8%)

Query: 104 DGRTALHIAACEGHVEVVKLLLS----KKANIDARDRWGSTAAADAKYY 148
           DG T LHIA  +G++  V  L++        +D  +    T    A   
Sbjct: 2   DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVIT 50

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (99), Expect = 4e-05
 Identities = 38/189 (20%), Positives = 67/189 (35%), Gaps = 15/189 (7%)

Query: 77  LFMACR-GDVKGVEDLLNE----GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           L +A   G++  V  L+N     G +++  +   +T LH+A       VV+LL++  A+ 
Sbjct: 7   LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTP----MTVANPREVPEYELNP 187
            A DR G TAA  A  + +      L    A             +T  +     E +   
Sbjct: 67  MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETV 126

Query: 188 LELQVRKADGITKGSY------QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
             L  R AD               A  N +   V++L +       ++ + +  L     
Sbjct: 127 QLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASG 186

Query: 242 ARHPNVVQF 250
                +V+ 
Sbjct: 187 RGLLPLVRT 195

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 56.3 bits (134), Expect = 1e-09
 Identities = 12/50 (24%), Positives = 22/50 (44%)

Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL 124
            L   A  G  +  + LL+  ++    D   R    +A+   H ++V+LL
Sbjct: 159 PLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 55.2 bits (131), Expect = 2e-09
 Identities = 21/82 (25%), Positives = 34/82 (41%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L + A   + + V  LL   ++ ++ D    T L +AA EG  E  K LL   AN +  D
Sbjct: 127 LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITD 186

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
                    A    + ++  +L
Sbjct: 187 HMDRLPRDVASERLHHDIVRLL 208

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 52.1 bits (123), Expect = 2e-08
 Identities = 14/38 (36%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 88  VEDLLNEGSDVNS-IDLDGRTALHIAACEGHVEVVKLL 124
           + DLL +G+++N+ +D  G T+LH+AA     +  K L
Sbjct: 5   ISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 10/40 (25%), Positives = 20/40 (50%), Gaps = 1/40 (2%)

Query: 119 EVVKLLLSKKANIDAR-DRWGSTAAADAKYYGNVEVYNIL 157
           +V+  LL++ A ++A  D+ G T+   A  +   +    L
Sbjct: 3   QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.5 bits (129), Expect = 4e-09
 Identities = 10/49 (20%), Positives = 19/49 (38%), Gaps = 4/49 (8%)

Query: 104 DGRTALHIAACEGHV----EVVKLLLSKKANIDARDRWGSTAAADAKYY 148
           DG + LH+A          EV++ +    A ++ ++    T    A   
Sbjct: 1   DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVIT 49

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (124), Expect = 2e-08
 Identities = 10/55 (18%), Positives = 17/55 (30%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L       +   V  LL  G+DVN +   G +   +        + + L      
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.5 bits (116), Expect = 2e-07
 Identities = 14/60 (23%), Positives = 26/60 (43%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +GRTALH+A    + ++V LLL   A+++     G +         +  +   L     +
Sbjct: 144 NGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.7 bits (125), Expect = 6e-09
 Identities = 19/135 (14%), Positives = 37/135 (27%), Gaps = 43/135 (31%)

Query: 72  STMQLLFMACR-GDVKGVEDLLNEGSDVN------SIDLDGRTALHIAA---CEGHVEVV 121
           + +  L  A +  D+ G+     +G D+       +      TALH+A        + +V
Sbjct: 5   AKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIV 64

Query: 122 KLLLSKKANI---------------------------------DARDRWGSTAAADAKYY 148
             L+    N+                                 +  +  G T    AK  
Sbjct: 65  DFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRL 124

Query: 149 GNVEVYNILKARGAK 163
            +     +L    + 
Sbjct: 125 KHEHCEELLTQALSG 139

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.2 bits (123), Expect = 8e-09
 Identities = 10/32 (31%), Positives = 17/32 (53%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
             L  AA  G +E +  LL    N++A++ +G
Sbjct: 3   NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.8 bits (109), Expect = 6e-07
 Identities = 10/30 (33%), Positives = 14/30 (46%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           V   +  G TA  +A   G  EVV L+ + 
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQAN 155

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 52.5 bits (125), Expect = 1e-08
 Identities = 18/149 (12%), Positives = 39/149 (26%), Gaps = 30/149 (20%)

Query: 203 YQVAKWNGTKVWVKILDK---------------ESHKDPERINAFTHELTIVEKARHPNV 247
           +        +  VK                   + H     I +  +E   ++K +   V
Sbjct: 17  FNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPD 307
            +            +++E     +L     +               +   +   +     
Sbjct: 77  PKVYAWEG----NAVLMELIDAKELYRVRVENPD-------EVLDMILEEVAKFYHR--- 122

Query: 308 PIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            I+H DL   N+L+   G + I  F    
Sbjct: 123 GIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 52.9 bits (125), Expect = 2e-08
 Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 1/56 (1%)

Query: 107 TALHIAACEGHVEVVKLLL-SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
             LH A  E     V+ LL SK + +  +D+ G      +  +   E+ + L ++ 
Sbjct: 2   YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM 57

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 49.0 bits (115), Expect = 3e-07
 Identities = 10/54 (18%), Positives = 20/54 (37%), Gaps = 4/54 (7%)

Query: 78  FMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
                G       L+   G++ + +D  G  A  +A    + +V K  L+   +
Sbjct: 178 HALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLNNVVD 228

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 47.9 bits (112), Expect = 7e-07
 Identities = 13/44 (29%), Positives = 19/44 (43%), Gaps = 2/44 (4%)

Query: 77  LFMACR-GDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHV 118
           L  AC   +   V++LL+   S +   D DGR  LH +      
Sbjct: 4   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAH 47

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 46.0 bits (107), Expect = 3e-06
 Identities = 21/66 (31%), Positives = 25/66 (37%), Gaps = 4/66 (6%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNI 156
           VN  D  G T L  A  EGH +   LL+ K  A  D  D  G+ A   A    N +V   
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221

Query: 157 LKARGA 162
                 
Sbjct: 222 FLNNVV 227

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.5 bits (114), Expect = 1e-07
 Identities = 9/46 (19%), Positives = 20/46 (43%), Gaps = 3/46 (6%)

Query: 89  EDLLNEGSDVNSIDL-DGRTA--LHIAACEGHVEVVKLLLSKKANI 131
           + L+  G+ V ++   D +TA        EG+ +  + L   +  +
Sbjct: 84  KFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 2e-04
 Identities = 4/31 (12%), Positives = 14/31 (45%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRW 137
             L  ++ EG  ++V+ ++ +  +    +  
Sbjct: 3   ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDE 33

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.0 bits (115), Expect = 1e-07
 Identities = 13/53 (24%), Positives = 22/53 (41%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
              + +A +     V   L   SD++  D  G T L +A   G  ++V +L  
Sbjct: 102 ALPIHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 1e-05
 Identities = 13/37 (35%), Positives = 20/37 (54%), Gaps = 1/37 (2%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGST 140
               L  AA  G V+ V+ LL ++  + DA +R+G T
Sbjct: 2   AGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKT 38

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.001
 Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 1/63 (1%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G+DVN  D  G   +H+A  EGH  VV  L   ++++  RD  G T    A   G  ++ 
Sbjct: 91  GADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTPLELALQRGAQDLV 149

Query: 155 NIL 157
           +IL
Sbjct: 150 DIL 152

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 48.3 bits (113), Expect = 2e-07
 Identities = 12/51 (23%), Positives = 25/51 (49%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL 124
             L +       + VE L+  G+DV++     +TA  I+   G+ ++ ++L
Sbjct: 102 TALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 44.1 bits (102), Expect = 5e-06
 Identities = 23/64 (35%), Positives = 37/64 (57%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G+DVN+ D+   TALH A    H EVV+LL+   A++  + ++  TA   +   GN ++ 
Sbjct: 90  GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149

Query: 155 NILK 158
            IL+
Sbjct: 150 EILQ 153

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 42.9 bits (99), Expect = 1e-05
 Identities = 10/37 (27%), Positives = 17/37 (45%), Gaps = 1/37 (2%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGST 140
           D    L  AA  G  + V++L++  A     D  G++
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTS 36

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-05
 Identities = 7/22 (31%), Positives = 12/22 (54%)

Query: 105 GRTALHIAACEGHVEVVKLLLS 126
           GR  + +A   GH +V + L +
Sbjct: 102 GRLPVDLAEELGHRDVARYLRA 123

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-05
 Identities = 12/31 (38%), Positives = 16/31 (51%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRW 137
             L  AA  G VE V+ LL   AN +A + +
Sbjct: 5   DWLATAAARGRVEEVRALLEAGANPNAPNSY 35

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	473
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.9
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.89
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.89
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.89
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.89
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.88
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.85
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.84
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.84
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.83
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.82
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.82
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.82
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.81
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.8
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.79
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.78
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.77
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.77
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.77
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.77
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.77
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.77
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.76
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.76
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.75
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.73
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.73
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.73
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.72
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.71
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.7
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.7
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.68
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.68
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.64
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.64
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.56
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.23
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.96
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.27
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.62
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.03

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=405.09  Aligned_cols=244  Identities=25%  Similarity=0.408  Sum_probs=213.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.|     ..+++.||+|++.+.........+.+.+|+++++.++||||+++++++.+++.+|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            5788899999999866     24688999999975322222334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||++|+|.+++...+.+++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+|+......   
T Consensus        87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---  160 (263)
T d2j4za1          87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---  160 (263)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred             ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999997553321   


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....  .   .|..+|++
T Consensus       161 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~---~p~~~s~~  230 (263)
T d2j4za1         161 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--T---FPDFVTEG  230 (263)
T ss_dssp             -----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--C---CCTTSCHH
T ss_pred             -----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--C---CCccCCHH
Confidence                 2235689999999999999999999999999999999999999999998888887744322  2   24578999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||.+||+.||++|||++|+++|
T Consensus       231 ~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         231 ARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHcC
Confidence            9999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=399.41  Aligned_cols=260  Identities=28%  Similarity=0.477  Sum_probs=213.2

Q ss_pred             HhhccCceeeeEEEEEE--ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          191 QVRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      +|.+.+.||+|+||.|.  ..+..||||++..... +....+.|.+|++++++++|||||++++++.. +.+++|||||+
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            46778899999998662  2345799999976543 34556889999999999999999999998754 56899999999


Q ss_pred             CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccccc
Q 011991          269 KGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI  347 (473)
Q Consensus       269 ~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~  347 (473)
                      +|+|.+++... +.+++..+..++.||++||+|||+++   ||||||||+|||++.++.+||+|||+|+........   
T Consensus        87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~---  160 (276)
T d1uwha_          87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---  160 (276)
T ss_dssp             EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc---
Confidence            99999999764 56999999999999999999999999   999999999999999999999999999765432211   


Q ss_pred             cccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCC-CCCCcccCCCCC
Q 011991          348 VFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGK-RPPLKIKARSYP  423 (473)
Q Consensus       348 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~  423 (473)
                       .......||+.|+|||++.+   ..|+.++|||||||++|||++|+.||.+.+...........+. .|.....+..+|
T Consensus       161 -~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         161 -HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             -ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence             12345678999999999864   3589999999999999999999999998776655554444443 344444567889


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      +.+.+||.+||+.||++|||++||+++|+.+.+.++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            999999999999999999999999999999987654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=403.18  Aligned_cols=248  Identities=26%  Similarity=0.356  Sum_probs=205.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++.....  ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            5788899999999866     24689999999976532  2334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||++|+|.+++...+.+++..++.++.||++||+|||++|   |+||||||+|||++.++.+||+|||+|+........ 
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~-  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-  159 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE-
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc-
Confidence            9999999999988888999999999999999999999999   999999999999999999999999999876433211 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                         .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..................  ....+..+|+
T Consensus       160 ---~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~  234 (271)
T d1nvra_         160 ---RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  234 (271)
T ss_dssp             ---CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             ---ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCH
Confidence               12345679999999999988776 57899999999999999999999876544333222222221  2222456899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ++.+||++||+.||++|||++|+++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         235 APLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            9999999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=399.43  Aligned_cols=245  Identities=20%  Similarity=0.418  Sum_probs=212.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.|     ..+|+.||||++.......   .+.+.+|+++++.++|||||+++++|.+++.+|+|||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            5778889999999865     3568999999998654333   3578999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|.+++..+ .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+|+.......  
T Consensus        98 y~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1          98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             ecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            99999999988765 6999999999999999999999999   99999999999999999999999999986543211  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+.......+...... .. ..+..+|++
T Consensus       172 ----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~-~~~~~~s~~  245 (293)
T d1yhwa1         172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-EL-QNPEKLSAI  245 (293)
T ss_dssp             ----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CC-SSGGGSCHH
T ss_pred             ----cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CC-CCcccCCHH
Confidence                223456999999999999999999999999999999999999999998887777766555432 22 225678999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||.+||+.||.+|||++|+++|
T Consensus       246 ~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         246 FRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-52  Score=402.92  Aligned_cols=246  Identities=21%  Similarity=0.362  Sum_probs=215.8

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      +..|...+.||+|+||.|     ..+|+.||||++...........+.+.+|+++++.++|||||++++++.+++.+|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            346888899999999866     246889999999877666667778899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      ||||.+|+|..++..++.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+|+....   
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            999999999888888888999999999999999999999999   99999999999999999999999999975432   


Q ss_pred             cccccccccCCCCCCcccCCCCcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKN---EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                             .....||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.+.+..+....+......+.   .+.
T Consensus       168 -------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~  237 (309)
T d1u5ra_         168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSG  237 (309)
T ss_dssp             -------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---SCT
T ss_pred             -------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---CCC
Confidence                   123569999999999864   4689999999999999999999999999888887777755443222   245


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+|+.+.+||.+||+.||.+|||++|+++|
T Consensus       238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            789999999999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=395.18  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=202.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--CCceEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv  263 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++..... +....+.+.+|++++++++|||||++++++.+  ++.+|+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5778889999999865     34688999999987654 45567889999999999999999999999864  5668999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--CCeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          264 LEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKP--DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~--~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      ||||++|+|.+++..    ++.+++..++.++.|++.||.|||++++  .+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864    3569999999999999999999998652  2499999999999999999999999999987


Q ss_pred             cccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          338 QYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      ......      ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+... ..+.   
T Consensus       164 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~---  233 (269)
T d2java1         164 LNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRR---  233 (269)
T ss_dssp             C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCC---
T ss_pred             cccCCC------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCC---
Confidence            543211      123456899999999999999999999999999999999999999999988888777443 3222   


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+..+|+++.+||++||+.||.+|||++|+++|
T Consensus       234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            356789999999999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=404.77  Aligned_cols=248  Identities=21%  Similarity=0.367  Sum_probs=212.3

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++...........+.+.+|++++++++||||+++++++.+++.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            5888899999999865     24688999999975322222334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|.+++...+.+++..++.++.|++.||+|||++|   |+||||||+|||++.++.+||+|||+|+........ 
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-  164 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-  164 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc-
Confidence            9999999999998889999999999999999999999999   999999999999999999999999999876432211 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                         .......||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+..+....+....  +.   .+..++++
T Consensus       165 ---~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~---~p~~~s~~  236 (288)
T d1uu3a_         165 ---ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YD---FPEKFFPK  236 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CC---CCTTCCHH
T ss_pred             ---cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CC---CCccCCHH
Confidence               12234569999999999999999999999999999999999999999999888888775433  22   24678999


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.+||++||+.||.+|||++|++.+
T Consensus       237 ~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         237 ARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHcCC
Confidence            9999999999999999999998664

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-52  Score=398.41  Aligned_cols=258  Identities=26%  Similarity=0.489  Sum_probs=207.8

Q ss_pred             HhhccCceeeeEEEEEE---e--cC---cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVAK---W--NG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~--~~---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      .|++.+.||+|+||.|.   .  ++   ..||||.+....  .....+.|.+|++++++++|||||++++++..++.+++
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56777899999998652   1  23   258899886543  45666889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      |||||++|+|.+++... +.+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999988774 56999999999999999999999999   999999999999999999999999999876443


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ..... ........||+.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+.. +.+++.   +.
T Consensus       182 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~---~~  256 (299)
T d1jpaa_         182 TSDPT-YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPP---PM  256 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCC---CT
T ss_pred             CCcce-eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCC---Cc
Confidence            22111 111223457889999999999999999999999999999998 8999999999888877744 333332   56


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      .+|+.+.+||.+||+.||++|||+.||++.|+++.+..
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            78999999999999999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=395.42  Aligned_cols=250  Identities=26%  Similarity=0.452  Sum_probs=210.2

Q ss_pred             CceeeeEEEEEEe-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          196 DGITKGSYQVAKW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       196 ~~ig~G~~~~~~~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      +.||+|+||.|..       .++.||||++.... .+....+.|.+|++++++++|||||++++++.. +..++|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            4699999986621       24689999997554 344556789999999999999999999999865 46799999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      +|+|.+++.....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+........   .
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~---~  164 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---Y  164 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE---E
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc---c
Confidence            9999999999888999999999999999999999999   999999999999999999999999999865433221   1


Q ss_pred             ccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHH
Q 011991          349 FPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLK  427 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  427 (473)
                      .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. .+.+++.   |..+|+++.
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~---p~~~~~~~~  240 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGC---PAGCPREMY  240 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCC---CTTCCHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCC---CcccCHHHH
Confidence            12234568899999999999999999999999999999997 899999999888777764 4444443   567899999


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          428 ELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       428 ~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +||.+||+.||++|||+++|++.|+..+.+
T Consensus       241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         241 DLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            999999999999999999999999887654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-52  Score=390.73  Aligned_cols=251  Identities=25%  Similarity=0.513  Sum_probs=205.3

Q ss_pred             HhhccCceeeeEEEEE---E-ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~-~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|...+.||+|+||.|   . .+++.||||++......    .++|.+|++++++++|||||++++++..++..++||||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3567788999999755   2 35778999999764432    25689999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++|+|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            9999999998764 45889999999999999999999999   999999999999999999999999999765433211 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..+....+.. +.++..   |..+++
T Consensus       158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~---p~~~~~  229 (263)
T d1sm2a_         158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYK---PRLAST  229 (263)
T ss_dssp             -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCC---CTTSCH
T ss_pred             ----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCC---ccccCH
Confidence                1223468899999999999999999999999999999998 5777877787777777644 433332   567889


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ++.+|+.+||+.||++|||++||+++|+++.+.
T Consensus       230 ~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            999999999999999999999999999998753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=397.89  Aligned_cols=246  Identities=23%  Similarity=0.404  Sum_probs=210.5

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      .|++.+.||+|+||.|     ..+|+.||||++....   ....+.+.+|+++++.++|||||++++++.+++.+|+|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4788889999999866     2468899999997643   2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      ||++|+|.+++.+ .+.+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+|+......  
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            9999999999765 456999999999999999999999999   9999999999999999999999999997543221  


Q ss_pred             ccccccccCCCCCCcccCCCCcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYK-----NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                          .......||+.|+|||++.     +..|+.++|||||||++|+|++|..||.+.+..+....+.... .+.. ..+
T Consensus       165 ----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~  238 (288)
T d2jfla1         165 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE-PPTL-AQP  238 (288)
T ss_dssp             ----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC-CCCC-SSG
T ss_pred             ----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCC-Ccc
Confidence                1123456999999999884     4568999999999999999999999999998888887775433 2222 235


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+|+++.+||++||+.||++|||++|+++|
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            6789999999999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-52  Score=400.86  Aligned_cols=249  Identities=21%  Similarity=0.358  Sum_probs=200.6

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      ...|++.+.||+|+||.|     ..+|+.||||++......  .....+.+|+++++.++||||+++++++.+++.+|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            345888899999999744     246899999999865432  2335688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc---CCCcEEEEeecccccccc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD---NGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~---~~~~vkl~DfG~a~~~~~  340 (473)
                      ||||+||+|.+++...+.+++..+..++.||+.||+|||+++   |+||||||+|||+.   .++.+||+|||+|+....
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999999998888999999999999999999999999   99999999999995   468899999999976533


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ..       ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.......+ ...+.
T Consensus       163 ~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~  234 (307)
T d1a06a_         163 GS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD-SPYWD  234 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-TTTTT
T ss_pred             CC-------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-Ccccc
Confidence            21       12345699999999999999999999999999999999999999999988888887755443332 23356


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      .+|+++.+||.+||+.||++|||++|+++|
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            789999999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=391.40  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=216.3

Q ss_pred             hhccC-ceeeeEEEEEE-------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEE
Q 011991          192 VRKAD-GITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (473)
Q Consensus       192 ~~~~~-~ig~G~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  263 (473)
                      +.+.. .||+|+||.|.       .++..||||++...  ......++|.+|++++++++|||||++++++.. +.+|+|
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34444 49999998662       23457999999754  346667889999999999999999999999865 468999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||++|+|.+++... +.+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998654 56999999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ..   ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+ ..+.++..   |..
T Consensus       164 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~~~~~~~~---p~~  236 (285)
T d1u59a_         164 SY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMEC---PPE  236 (285)
T ss_dssp             CE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-HTTCCCCC---CTT
T ss_pred             cc---cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCC---CCc
Confidence            21   122334568899999999998899999999999999999998 99999998888777766 44544443   567


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      +|+++.+||.+||+.||++|||+.+|++.|+.++..+..+
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence            8999999999999999999999999999999888765443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=387.61  Aligned_cols=245  Identities=24%  Similarity=0.422  Sum_probs=203.5

Q ss_pred             hccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee----CCceEEE
Q 011991          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMMIV  263 (473)
Q Consensus       193 ~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv  263 (473)
                      +....||+|+||.|     ..++..||+|.+..... .....+.+.+|++++++++|||||++++++..    +..+|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            45567999999866     23578999999986543 35566789999999999999999999999875    3458999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc-CCCcEEEEeeccccccccCc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~-~~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||||++|+|.+++.+.+.+++..++.++.||++||+|||+++ .+|+||||||+|||++ .++.+||+|||+|+..... 
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            999999999999998888999999999999999999999986 2499999999999997 4789999999999754322 


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                             ......||+.|+|||++.+ +++.++|||||||++|+|++|+.||...............+..+.  ..+..+
T Consensus       169 -------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~  238 (270)
T d1t4ha_         169 -------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVA  238 (270)
T ss_dssp             -------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCC
T ss_pred             -------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--ccCccC
Confidence                   1234569999999999865 599999999999999999999999987655444433334443322  234567


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++++.+||.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         239 IPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            8999999999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=403.04  Aligned_cols=248  Identities=26%  Similarity=0.466  Sum_probs=204.9

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      .+|.+.+.||+|+||.|     ..+|+.||+|+++...  .....+.+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46888899999999865     2468999999998653  2344578899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |||+||+|.+++.+.+.+++..++.++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            9999999999999888899999999999999999999974 7   999999999999999999999999999865332  


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--h------------
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCC--E------------  409 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~--~------------  409 (473)
                            ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+.......  .            
T Consensus       159 ------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         159 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             ------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             ------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence                  12345799999999999999999999999999999999999999987554322110000  0            


Q ss_pred             -------------------------CCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          410 -------------------------GKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       410 -------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                               ...++.......+|+++.+||.+||..||.+|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                     00011111123467899999999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=392.08  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=216.3

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCC---HHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD---PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      ...|++.+.||+|+||.|     ..+|+.||||++.+.....   ....+.+.+|+.++++++|||||+++++|.+++.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            346889999999999866     2468999999997643322   22357799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC----cEEEEeecccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLR  336 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~----~vkl~DfG~a~  336 (473)
                      |+|||||+||+|.+++...+.+++..++.++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||+|+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence            999999999999999998888999999999999999999999999   99999999999998776    59999999997


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK  416 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  416 (473)
                      ......       ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+....... ..
T Consensus       166 ~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~  237 (293)
T d1jksa_         166 KIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF-ED  237 (293)
T ss_dssp             ECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-CH
T ss_pred             hcCCCc-------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-Cc
Confidence            654321       1234568999999999999999999999999999999999999999999888888775443322 22


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..+..+|+.+.+||++||+.||++|||++|+++|
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            3356789999999999999999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-51  Score=393.87  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=214.3

Q ss_pred             ccccChhHHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee
Q 011991          182 EYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ  256 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  256 (473)
                      .|+++..  +|++.+.||+|+||.|     ..+|+.||||+++.+..    ..++|.+|++++++++|||||++++++.+
T Consensus        11 ~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_          11 KWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             TTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            4566543  5777889999999744     23588999999975432    23578999999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecc
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~  334 (473)
                      ++..++|||||++|+|.+++...  ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccc
Confidence            99999999999999999999764  45899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhhCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQP-FHPKPPEEVVKLMCCEGKRP  413 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~p-f~~~~~~~~~~~i~~~~~~~  413 (473)
                      |+.........     .....||+.|+|||++.+..|+.++|||||||++|||++|..| |...+...+...+ ..+.++
T Consensus       162 a~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~  235 (287)
T d1opja_         162 SRLMTGDTYTA-----HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRM  235 (287)
T ss_dssp             TTTCCSSSSEE-----ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCC
T ss_pred             eeecCCCCcee-----eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCC
Confidence            98764432211     1233478889999999999999999999999999999996555 5555555555544 444444


Q ss_pred             CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          414 PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       414 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..   +..+|+.+.+||.+||+.||++|||++||++.|+.+..+
T Consensus       236 ~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         236 ER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            33   567899999999999999999999999999999887553

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=386.01  Aligned_cols=259  Identities=28%  Similarity=0.453  Sum_probs=215.2

Q ss_pred             CCccccChhHHHhhccCceeeeEEEEE---Ee-cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEe
Q 011991          180 VPEYELNPLELQVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT  255 (473)
Q Consensus       180 ~~~~~i~~~~~~~~~~~~ig~G~~~~~---~~-~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  255 (473)
                      ..+|++...  +|++.+.||+|+||.|   .. ++..||||++......    .+.|.+|++++++++|||||++++++.
T Consensus         5 ~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           5 EDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             TCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            345666543  6788889999999865   33 4678999999754322    356899999999999999999999875


Q ss_pred             eCCceEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          256 QNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      + +..++||||+++|+|.+++...  ..+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence            4 5679999999999999987543  35999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG-VQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +|+........     ......||+.|+|||++.+..++.++|||||||++|||++| .+||...+..+....+. .+.+
T Consensus       155 la~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~  228 (272)
T d1qpca_         155 LARLIEDNEYT-----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYR  228 (272)
T ss_dssp             TCEECSSSCEE-----CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred             ceEEccCCccc-----cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCC
Confidence            99876443211     12345688999999999988999999999999999999995 56667777777776663 4444


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +..   +..+|+++.+|+.+||+.||++|||++||++.|++++..
T Consensus       229 ~~~---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 MVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            433   567899999999999999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.6e-50  Score=385.45  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=217.7

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc----e
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----M  260 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~  260 (473)
                      .+|++.+.||+|+||.|     ..+|+.||||++..+...+......+.+|+++++.++||||+++++++...+.    .
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            35888899999999865     24689999999988777777788899999999999999999999999886543    8


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      |+||||++|++|.+++...+.+++..++.++.||+.||+|||++|   |+||||||+|||++.++.++|+|||.+.....
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcc
Confidence            999999999999999998888999999999999999999999999   99999999999999999999999999865533


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ....   ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+......+ ......
T Consensus       164 ~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~  239 (277)
T d1o6ya_         164 SGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-PSARHE  239 (277)
T ss_dssp             ------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-GGGTSS
T ss_pred             cccc---ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-Cchhcc
Confidence            3221   122345679999999999999999999999999999999999999999999888877775554433 333466


Q ss_pred             CCCHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRP-NFNEIIARLDRIV  455 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~  455 (473)
                      .+|+++.+||.+||+.||.+|| |++++++.|.++.
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            7899999999999999999999 8999999888764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=398.92  Aligned_cols=246  Identities=24%  Similarity=0.417  Sum_probs=215.1

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.|     ..+|+.||||++.+.........+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            5788899999999866     35789999999975432222235678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|.+++...+.+++..++.++.||+.||+|||++|   ||||||||+|||++.+|.+||+|||+|+.......  
T Consensus        86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--  160 (337)
T d1o6la_          86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  160 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--
T ss_pred             ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc--
Confidence            9999999999999889999999999999999999999999   99999999999999999999999999986543221  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                          ......||+.|+|||++.+..|+.++||||+||++|||++|..||.+.+..++...+.....  .   .|..+|++
T Consensus       161 ----~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~--~---~p~~~s~~  231 (337)
T d1o6la_         161 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--R---FPRTLSPE  231 (337)
T ss_dssp             ----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C---CCTTSCHH
T ss_pred             ----ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC--C---CCccCCHH
Confidence                12345689999999999999999999999999999999999999999999888887754332  2   25678999


Q ss_pred             HHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          426 LKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      +.+||++||+.||.+||+     ++|+++|
T Consensus       232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            999999999999999995     8888875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=381.82  Aligned_cols=247  Identities=23%  Similarity=0.448  Sum_probs=213.4

Q ss_pred             HhhccCceeeeEEEEEE----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|+..+.||+|+||.|.    .+++.||||+++.....    .+.|.+|++++++++||||+++++++.+++.+++||||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            45677889999998762    25678999999865433    25689999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      +++|+|.+++.. ...+++..++.++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            999999999755 456899999999999999999999999   999999999999999999999999999765433211 


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+. .+.++..   |..+++
T Consensus       157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~---p~~~~~  228 (258)
T d1k2pa_         157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYR---PHLASE  228 (258)
T ss_dssp             ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCC---CTTCCH
T ss_pred             ----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCC---cccccH
Confidence                1233568899999999999999999999999999999998 899999999988888774 3444433   567899


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFNEIIARLDR  453 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  453 (473)
                      .+.+||++||+.||++|||++||+++|.+
T Consensus       229 ~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         229 KVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            99999999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-50  Score=397.80  Aligned_cols=246  Identities=19%  Similarity=0.354  Sum_probs=214.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.|     ..+|+.||||++...   .....+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            6888999999999866     246899999999754   34556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC--CCcEEEEeeccccccccCc
Q 011991          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~--~~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+||+|.+++.. .+.+++..++.++.||+.||.|||++|   ||||||||+|||++.  ++.+||+|||+|+......
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999999854 457999999999999999999999999   999999999999964  5789999999998654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+ ...+..+
T Consensus       181 ~-------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~  252 (350)
T d1koaa2         181 S-------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-DSAFSGI  252 (350)
T ss_dssp             C-------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-CGGGGGC
T ss_pred             c-------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-cccccCC
Confidence            1       2335689999999999999999999999999999999999999999998888888755443332 2334578


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |+++.+||++||+.||++|||++|+++|
T Consensus       253 s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         253 SEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999999999985

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=394.60  Aligned_cols=250  Identities=25%  Similarity=0.442  Sum_probs=209.0

Q ss_pred             HhhccCceeeeEEEEEE---e--cC-----cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCc
Q 011991          191 QVRKADGITKGSYQVAK---W--NG-----TKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~--~~-----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  259 (473)
                      +|.+.+.||+|+||.|.   .  .+     ..||+|.+....  .......+.+|+.++.++ +|||||++++++.+++.
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            57788899999999762   1  11     369999997543  234456789999999998 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCC
Q 011991          260 MMIVLEYHAKGDLASYLQKK-----------------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP  316 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp  316 (473)
                      +++|||||++|+|.+++...                       +.+++..++.++.|+++||+|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            99999999999999999754                       23789999999999999999999999   99999999


Q ss_pred             CCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 011991          317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFH  395 (473)
Q Consensus       317 ~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~  395 (473)
                      +|||++.++.+||+|||+|+.........    ......||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSE----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hccccccCCeEEEeeccccccccCCCcee----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999998654432211    1223457899999999999999999999999999999997 899999


Q ss_pred             CCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 011991          396 PKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLD  452 (473)
Q Consensus       396 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  452 (473)
                      +.+..+....+...+.+++.   |..+|+++.+||.+||+.||++|||++||+++|.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            87776666666566655543   5678999999999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.1e-50  Score=396.19  Aligned_cols=247  Identities=21%  Similarity=0.372  Sum_probs=214.1

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      ..|++.+.||+|+||.|     ..+|+.||||++....   ....+.+.+|++++++++|||||+++++|.+++.+|+||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35889999999999866     2468999999997643   344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc--CCCcEEEEeeccccccccC
Q 011991          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~--~~~~vkl~DfG~a~~~~~~  341 (473)
                      |||+||+|.+++...+ .+++..++.++.||+.||.|||++|   |+||||||+|||++  .++.+||+|||+|+.....
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999999999876543 5999999999999999999999999   99999999999998  5789999999999876432


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                      ..       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... .....+..
T Consensus       183 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~  254 (352)
T d1koba_         183 EI-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSS  254 (352)
T ss_dssp             SC-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-CCSSTTTT
T ss_pred             Cc-------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCcccccC
Confidence            11       22345889999999999999999999999999999999999999999988888877554433 22334567


Q ss_pred             CCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +|+++.+||.+||+.||.+|||++|+++|
T Consensus       255 ~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         255 VSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            89999999999999999999999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-50  Score=392.35  Aligned_cols=243  Identities=24%  Similarity=0.426  Sum_probs=213.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++..+........+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            5788899999999865     25689999999975332222335778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ||+||+|..++.....+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+|+.....    
T Consensus        85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----  157 (316)
T d1fota_          85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  157 (316)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence            9999999999999888999999999999999999999999   999999999999999999999999999765332    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......     .+..+|++
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~  227 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-----FPPFFNED  227 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-----CCTTSCHH
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-----CCCCCCHH
Confidence                 23456999999999999999999999999999999999999999999998888887544321     24568999


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +.+++.+||..||.+||     |++++++|
T Consensus       228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            99999999999999996     89999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=381.64  Aligned_cols=260  Identities=26%  Similarity=0.497  Sum_probs=209.6

Q ss_pred             cccChhHHHhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeE
Q 011991          183 YELNPLELQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV  254 (473)
Q Consensus       183 ~~i~~~~~~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  254 (473)
                      |++...  +|++.+.||+|+||.|.   .     .+..||||.+...  ......+.+.+|++++++++||||+++++++
T Consensus         2 ~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           2 YEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             CBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            444433  68888999999998652   2     2346888888643  3466678899999999999999999999998


Q ss_pred             eeCCceEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          255 TQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       255 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      . ++.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence            6 46789999999999999987664 56999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +|+.......     .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.. +..
T Consensus       154 ~a~~~~~~~~-----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~  227 (273)
T d1mp8a_         154 LSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GER  227 (273)
T ss_dssp             ----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCC
T ss_pred             hheeccCCcc-----eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC
Confidence            9986543211     11233457889999999999999999999999999999997 8999999998888887743 444


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      ++.   ++++|+.+.+||.+||+.||++|||++||+++|+++..+-+
T Consensus       228 ~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         228 LPM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            332   66889999999999999999999999999999999987643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=379.94  Aligned_cols=255  Identities=27%  Similarity=0.502  Sum_probs=206.6

Q ss_pred             HhhccCceeeeEEEEEE---ec--C----cEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          191 QVRKADGITKGSYQVAK---WN--G----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~~--~----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      .|...+.||+|+||.|.   +.  +    ..||||++....  .......|.+|++++++++|||||+++|++......+
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35677889999998652   22  1    369999997543  4555678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +|||||.+++|.+++... +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999988765 56999999999999999999999999   99999999999999999999999999987644


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG-VQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||++| .+||...+..++...+ ..+.+++.   +
T Consensus       163 ~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~---~  235 (283)
T d1mqba_         163 DPEAT---YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPT---P  235 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCC---C
T ss_pred             CCccc---eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccCCCCC---c
Confidence            32111   122344588999999999999999999999999999999985 5556666666666665 44444443   5


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+|+.+.+||.+||+.||++|||+.||++.|+++...
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            67899999999999999999999999999999998875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-49  Score=378.32  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=214.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCC------HHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCC
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD------PERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI  258 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~------~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  258 (473)
                      +|.+.+.||+|+||.+     ..+|+.||||++.......      ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            5788899999999866     2478999999998654332      223467899999999997 999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccc
Q 011991          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~  338 (473)
                      .+|+|||||++|+|.+++...+.+++..++.++.||++||+|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999999999998889999999999999999999999999   999999999999999999999999999875


Q ss_pred             ccCcccccccccccCCCCCCcccCCCCcC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          339 YISPEKAKIVFPVSHIDPANLYVAPEIYK------NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       339 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      ....       ......||+.|+|||.+.      ...++.++||||+||++|+|++|..||.+.+.......+......
T Consensus       161 ~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~  233 (277)
T d1phka_         161 DPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  233 (277)
T ss_dssp             CTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             cCCC-------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence            4321       123456899999999875      335788999999999999999999999999988888777555433


Q ss_pred             CCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ++ .....++|+++.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         234 FG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             CC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            32 22345789999999999999999999999999774

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-50  Score=394.33  Aligned_cols=243  Identities=26%  Similarity=0.432  Sum_probs=213.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++...........+.+.+|+++++.++||||+++++++......++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            6888899999999865     24689999999975332222334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+.....    
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999865322    


Q ss_pred             cccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHH
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPD  425 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  425 (473)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......     .+..+|++
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~  264 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSD  264 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----CCTTCCHH
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC-----CCccCCHH
Confidence                 12356899999999999999999999999999999999999999999988888887554322     24578999


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 011991          426 LKELIEECWDPKPVIRP-----NFNEIIAR  450 (473)
Q Consensus       426 l~~li~~cl~~dP~~RP-----s~~ell~~  450 (473)
                      +.+||++||..||.+|+     |++++++|
T Consensus       265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            99999999999999994     89999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-50  Score=379.69  Aligned_cols=254  Identities=29%  Similarity=0.524  Sum_probs=206.6

Q ss_pred             HhhccCceeeeEEEEE---Eec-----CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVA---KWN-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~-----~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|++.+.||+|+||.|   ...     ...||||++...........+.|.+|++++++++||||++++|++.+ ...++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            5788889999999854   221     23789999987665566777899999999999999999999999976 46799


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ||||+++|+|.+++... +.+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            99999999999887654 56999999999999999999999999   999999999999999999999999999876443


Q ss_pred             cccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCC
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKAR  420 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  420 (473)
                      ....   .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+...+.+++.   +.
T Consensus       165 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~---~~  238 (273)
T d1u46a_         165 DDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR---PE  238 (273)
T ss_dssp             CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC---CT
T ss_pred             CCcc---eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC---cc
Confidence            2221   12233456788999999999999999999999999999998 89999999999998888777665543   56


Q ss_pred             CCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 011991          421 SYPPDLKELIEECWDPKPVIRPNFNEIIARLDRI  454 (473)
Q Consensus       421 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  454 (473)
                      .+|+.+.+||.+||+.||++|||++||++.|++.
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            7899999999999999999999999999998875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=373.43  Aligned_cols=246  Identities=29%  Similarity=0.571  Sum_probs=205.7

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-CCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~  266 (473)
                      +|+..+.||.|+||.+   ...|..||||+++.+.     ..+.+.+|++++++++||||+++++++.+ ++.+++||||
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            4667788999999855   6789999999997542     23678999999999999999999999854 5668999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      +++|+|.+++...+  .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999996643  4899999999999999999999999   999999999999999999999999999764332   


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCC
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYP  423 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  423 (473)
                            .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+ ..+.+++.   +..++
T Consensus       157 ------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~---~~~~~  226 (262)
T d1byga_         157 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDA---PDGCP  226 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCC---CTTCC
T ss_pred             ------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCC---CccCC
Confidence                  122346788999999998899999999999999999998 79999988888888777 44445543   56789


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          424 PDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       424 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +.+.+||++||+.||.+|||+.+++++|+++..+
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999998654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=382.94  Aligned_cols=245  Identities=16%  Similarity=0.323  Sum_probs=211.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|.+.+.||+|+||.|     ..+|+.||||++....    .....+.+|+++++.++|||||+++++|.+++.+|+|||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            5788899999999866     2468899999997542    233568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCC--CcEEEEeeccccccccCc
Q 011991          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG--GQLKISGFGLLRLQYISP  342 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~--~~vkl~DfG~a~~~~~~~  342 (473)
                      ||+||+|.+++...+ .+++..++.++.||+.||.|||++|   |+||||||+|||++.+  ..+||+|||+++......
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            999999999997764 6999999999999999999999999   9999999999999854  479999999997654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSY  422 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  422 (473)
                      .       .....+|+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+....... ....+..+
T Consensus       159 ~-------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~  230 (321)
T d1tkia_         159 N-------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-DEEAFKEI  230 (321)
T ss_dssp             E-------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-CHHHHTTS
T ss_pred             c-------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-ChhhccCC
Confidence            1       122357889999999999999999999999999999999999999999998888885544332 22334578


Q ss_pred             CHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          423 PPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       423 ~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      |+++.+||++||..||.+|||++|+++|
T Consensus       231 s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         231 SIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=378.79  Aligned_cols=255  Identities=27%  Similarity=0.485  Sum_probs=205.0

Q ss_pred             HhhccCceeeeEEEEEEe----------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee-CC
Q 011991          191 QVRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ-NI  258 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~~----------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~~  258 (473)
                      +|.+.+.||+|+||.|..          +++.||||++....  .....+.+..|..++.++ .||||+.+++++.. +.
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            678889999999986621          34689999987543  345567788888888887 58899999998765 45


Q ss_pred             ceEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEc
Q 011991          259 PMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD  322 (473)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~  322 (473)
                      .+++|||||++|+|.+++...                ..+++..++.++.||+.||+|||+++   |+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            689999999999999999753                23889999999999999999999999   99999999999999


Q ss_pred             CCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHH
Q 011991          323 NGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG-VQPFHPKPPEE  401 (473)
Q Consensus       323 ~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~  401 (473)
                      .++.+||+|||+|+........    .......||+.|+|||++.+..++.++|||||||++|||++| ..||.+....+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             GGGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             CCCcEEEccCcchhhccccccc----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999865433221    123345689999999999999999999999999999999986 56888777666


Q ss_pred             HHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          402 VVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       402 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ........+.++..   +..+++++.+||.+||+.||++|||++|++++|+++++.
T Consensus       245 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         245 EFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            55555566655543   567899999999999999999999999999999998754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=374.65  Aligned_cols=262  Identities=30%  Similarity=0.542  Sum_probs=217.4

Q ss_pred             CccccChhHHHhhccCceeeeEEEEEE---e---------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCee
Q 011991          181 PEYELNPLELQVRKADGITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNV  247 (473)
Q Consensus       181 ~~~~i~~~~~~~~~~~~ig~G~~~~~~---~---------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  247 (473)
                      |.|+++..  +|.+.+.||.|+||.|.   .         ++..||||+++.+.  .......+.+|...+.++ +||||
T Consensus         6 ~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnI   81 (299)
T d1fgka_           6 PRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNI   81 (299)
T ss_dssp             TTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeE
Confidence            45665544  67788899999998552   1         22479999997653  455668899999999888 79999


Q ss_pred             eeEEeeEeeCCceEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 011991          248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (473)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  311 (473)
                      |+++++|.+++..++|||||++|+|.+++...                ..+++..++.++.||+.||+|||+++   |||
T Consensus        82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivH  158 (299)
T d1fgka_          82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH  158 (299)
T ss_dssp             CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEe
Confidence            99999999999999999999999999999754                24899999999999999999999999   999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-C
Q 011991          312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-G  390 (473)
Q Consensus       312 ~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g  390 (473)
                      |||||+|||++.++.+||+|||+++........    .......+|+.|+|||.+.+..|+.++|||||||++|||++ |
T Consensus       159 rDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g  234 (299)
T d1fgka_         159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG  234 (299)
T ss_dssp             SCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             eeecccceeecCCCCeEeccchhhccccccccc----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence            999999999999999999999999866543221    12344568889999999999999999999999999999998 7


Q ss_pred             CCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          391 VQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       391 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..||.+.+..++...+. .+..+..   +..+|+++.+||.+||+.||.+|||+.||++.|+++.+.
T Consensus       235 ~~p~~~~~~~~~~~~i~-~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         235 GSPYPGVPVEELFKLLK-EGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             CCSSTTCCHHHHHHHHH-TTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHH-cCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            99999988888777664 4544443   567899999999999999999999999999999999764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=375.27  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=209.0

Q ss_pred             ccccChhHHHhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC
Q 011991          182 EYELNPLELQVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  257 (473)
                      +|+++.  .+|++.+.||+|+||.|    ..+++.||||++......    .+.|.+|+.++++++|||||++++++.+ 
T Consensus        11 ~~~i~~--~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3          11 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             CSBCCG--GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ceEcCH--HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            345543  36889999999999855    234568999999755432    2568999999999999999999999854 


Q ss_pred             CceEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          258 IPMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      +..++||||+++|+|..++..  .+.+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence            568999999999999999854  356999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhCCCCC
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG-VQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      +........     ......||+.|+|||++....++.++|||||||++|||++| .+|+......+....+. .+.+++
T Consensus       161 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~  234 (285)
T d1fmka3         161 RLIEDNEYT-----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMP  234 (285)
T ss_dssp             C-------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred             hhccCCCce-----eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCC
Confidence            865433221     12334589999999999999999999999999999999995 55566677777776664 344433


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                      .   +..+|+++.+||.+||+.||++|||+++|++.|++++....
T Consensus       235 ~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         235 C---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             C---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            3   56789999999999999999999999999999998776543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.2e-49  Score=389.76  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCC---CHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK---DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++.+....   ..........|+.+++.++|||||+++++|.+++.+|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            4778889999999866     246899999999643221   12222233344666777789999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCc
Q 011991          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP  342 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~  342 (473)
                      |||||+||+|.+++...+.+++..++.++.||+.||.|||++|   ||||||||+|||++.++.+||+|||+|+......
T Consensus        85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            9999999999999998888999999999999999999999999   9999999999999999999999999998654321


Q ss_pred             ccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCC
Q 011991          343 EKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARS  421 (473)
Q Consensus       343 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  421 (473)
                              .....||+.|+|||++.. ..|+.++|||||||++|+|++|..||...+......... ...... ...+..
T Consensus       162 --------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-~~~~~~-~~~~~~  231 (364)
T d1omwa3         162 --------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMA-VELPDS  231 (364)
T ss_dssp             --------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-HSSSCC-CCCCSS
T ss_pred             --------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcccCC-CCCCCC
Confidence                    234569999999999864 578999999999999999999999998765443332221 111111 123567


Q ss_pred             CCHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          422 YPPDLKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       422 ~~~~l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      +|+++.+||.+||+.||.+|||     ++|+++|
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            8999999999999999999999     7888875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=385.53  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=209.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHH-hcCCCeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVE-KARHPNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|.+.+.||+|+||.|     ..+|+.||||++.+.........+.+..|..++. .++||||+++++++.+++.+|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            4777889999999765     3478999999997532111222355677777665 689999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccc
Q 011991          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK  344 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~  344 (473)
                      |||++|+|.+++...+.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--  157 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--  157 (320)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred             eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc--
Confidence            99999999999999888999999999999999999999999   9999999999999999999999999997543321  


Q ss_pred             ccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcccCCCCCH
Q 011991          345 AKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPP  424 (473)
Q Consensus       345 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  424 (473)
                          .......||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..++...+....  +.   .|..+|+
T Consensus       158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~---~p~~~s~  228 (320)
T d1xjda_         158 ----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PF---YPRWLEK  228 (320)
T ss_dssp             ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC---CCTTSCH
T ss_pred             ----ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC---CCccCCH
Confidence                12234568999999999999999999999999999999999999999999988888775432  22   2567899


Q ss_pred             HHHHHHHHccCCCCCCCCCHH-HHHHH
Q 011991          425 DLKELIEECWDPKPVIRPNFN-EIIAR  450 (473)
Q Consensus       425 ~l~~li~~cl~~dP~~RPs~~-ell~~  450 (473)
                      ++.+||++||..||.+||++. ++++|
T Consensus       229 ~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         229 EAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence            999999999999999999995 77653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-48  Score=375.81  Aligned_cols=252  Identities=28%  Similarity=0.448  Sum_probs=214.2

Q ss_pred             HhhccCceeeeEEEEEE---e-------cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCce
Q 011991          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-------~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  260 (473)
                      +|.+.+.||+|+||.|.   +       +++.||||++....  .....++|.+|+++++.++||||+++++++......
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            57788899999998662   2       34689999987543  456678899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCC
Q 011991          261 MIVLEYHAKGDLASYLQKKG------------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP  316 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp  316 (473)
                      ++||||+++|+|.+++....                        .+++..++.++.|++.||+|||+++   ||||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999996532                        3788999999999999999999999   99999999


Q ss_pred             CCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCC-CCCC
Q 011991          317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGV-QPFH  395 (473)
Q Consensus       317 ~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~-~pf~  395 (473)
                      +|||++.++.+||+|||+|+.......    ........+|+.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cceEECCCCcEEEccchhheeccCCcc----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999976533211    11233456788999999999999999999999999999999985 6899


Q ss_pred             CCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          396 PKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       396 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      +.+..+....+. .+..+.   .+..+|+++.+||.+||+.||++|||+.||++.|+++.
T Consensus       245 ~~~~~e~~~~v~-~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVIYYVR-DGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHHHHHH-TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHH-cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            998888888774 344433   25678999999999999999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=378.03  Aligned_cols=253  Identities=21%  Similarity=0.449  Sum_probs=208.4

Q ss_pred             HhhccCceeeeEEEEEE-----ecCc----EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceE
Q 011991          191 QVRKADGITKGSYQVAK-----WNGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~-----~~~~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  261 (473)
                      +|++.+.||+|+||.|.     .+|+    .||+|.+....  .....+.|.+|++++++++|||||++++++.++ ..+
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            57888999999999762     2343    58999886532  233457899999999999999999999999764 568


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      ++||++.+|+|.+++... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            889999999999988764 56999999999999999999999999   99999999999999999999999999987644


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GVQPFHPKPPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      .....    ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+ ..+.+++.   +
T Consensus       164 ~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~---p  235 (317)
T d1xkka_         164 EEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQ---P  235 (317)
T ss_dssp             TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCC---C
T ss_pred             ccccc----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCC---C
Confidence            32211    1233458999999999999999999999999999999998 89999988888777666 44544433   5


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ..+|+.+.+|+.+||+.||.+|||+.||+++|+.+...
T Consensus       236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            67899999999999999999999999999999988753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=372.95  Aligned_cols=266  Identities=25%  Similarity=0.460  Sum_probs=216.1

Q ss_pred             HhhccCceeeeEEEEEE---e-----cCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee-CCceE
Q 011991          191 QVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~~---~-----~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~  261 (473)
                      .+...+.||+|+||.|.   .     +...||||.++..  ......++|.+|++++++++||||++++|++.. ++..+
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            33335679999998762   2     1236899999643  356777899999999999999999999999875 56799


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +|||||++|+|.+++... ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            999999999999998754 34778899999999999999999999   99999999999999999999999999987644


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhhCCCCCCcccC
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPK-PPEEVVKLMCCEGKRPPLKIKA  419 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  419 (473)
                      .....  ........||+.|+|||.+....++.++|||||||++|||++|..||... +..+....+ ..+.++..   +
T Consensus       183 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~---p  256 (311)
T d1r0pa_         183 KEFDS--VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQ---P  256 (311)
T ss_dssp             TTCCC--TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCC---C
T ss_pred             ccccc--ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCC---c
Confidence            32221  12233456899999999999999999999999999999999977776544 333444444 44554443   5


Q ss_pred             CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCCcccccc
Q 011991          420 RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQGWWKDT  467 (473)
Q Consensus       420 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~~~~~  467 (473)
                      ..+++.+.+||.+||+.||++|||+.||+++|+++...+..+.+++.+
T Consensus       257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~~~~  304 (311)
T d1r0pa_         257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN  304 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCCC
T ss_pred             ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhchhcc
Confidence            678999999999999999999999999999999999998888776554

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-48  Score=373.05  Aligned_cols=262  Identities=27%  Similarity=0.474  Sum_probs=222.1

Q ss_pred             ccccChhHHHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeE
Q 011991          182 EYELNPLELQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQF  250 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  250 (473)
                      .|++...  +|.+.+.||+|+||.|.          .+++.||||+++...  .......+.+|+.+++.+ +|||||++
T Consensus        17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            3555543  67778899999999762          234689999997653  455667899999999999 69999999


Q ss_pred             EeeEeeCCceEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeC
Q 011991          251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKG------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHC  312 (473)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~  312 (473)
                      ++++..+...++|||||++|+|.+++....                  .+++..++.++.||+.||+|||+++   ++||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr  169 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR  169 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            999999999999999999999999997643                  4889999999999999999999999   9999


Q ss_pred             CCCCCCEEEcCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHh-CC
Q 011991          313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIE-GV  391 (473)
Q Consensus       313 Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~-g~  391 (473)
                      ||||+||+++.++.+||+|||+++........    .......||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus       170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~  245 (311)
T d1t46a_         170 DLAARNILLTHGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS  245 (311)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSCTTSCTTS----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccccccccccccCcccccccchheeccCCCcc----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence            99999999999999999999999866433221    12234568899999999999999999999999999999998 67


Q ss_pred             CCCCCCChHHHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          392 QPFHPKPPEEVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       392 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      +||...+..+.+..+...+.++..   +..+|+++.+||.+||+.||++|||++||++.|+++++.
T Consensus       246 p~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         246 SPYPGMPVDSKFYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             CSSTTCCSSHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHhcCCCCCC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            777777776776666666665543   567899999999999999999999999999999988765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=375.56  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=199.7

Q ss_pred             CceeeeEEEEE-----EecCcEEEEEEEcCCCCCC--HHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEeccC
Q 011991          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKD--PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (473)
Q Consensus       196 ~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  268 (473)
                      +.||+|+||.|     ..+|+.||||++.......  ....+.+.+|+++++.++|||||++++++..++..|+||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            57999999876     3468999999997543221  1223578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccccc
Q 011991          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIV  348 (473)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~~~  348 (473)
                      ++++..+...++.+++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+|+.......     
T Consensus        84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-----  155 (299)
T d1ua2a_          84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-----  155 (299)
T ss_dssp             EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-----
T ss_pred             chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-----
Confidence            8877777666677999999999999999999999999   99999999999999999999999999976543211     


Q ss_pred             ccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc-----------
Q 011991          349 FPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK-----------  416 (473)
Q Consensus       349 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----------  416 (473)
                       ......||+.|+|||++.+. .|+.++||||+||++|+|++|..||.+.+..+....+......+...           
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence             12345689999999988654 67999999999999999999999999998888777664432221110           


Q ss_pred             ------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 ------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                  ...+.+++++.+||++||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence                        0123567899999999999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=374.92  Aligned_cols=252  Identities=27%  Similarity=0.491  Sum_probs=209.4

Q ss_pred             HhhccCceeeeEEEEE-----EecCc--EEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEeeCCceEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGT--KVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  262 (473)
                      +|++.+.||+|+||.|     ..+|.  .||||.+....  .....+.|.+|+++++++ +|||||++++++.+++.+++
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            5666788999999866     23444  47788875432  234457799999999999 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCc
Q 011991          263 VLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (473)
Q Consensus       263 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~  326 (473)
                      ||||+++|+|.+++...                ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            99999999999999653                45899999999999999999999999   999999999999999999


Q ss_pred             EEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Q 011991          327 LKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG-VQPFHPKPPEEVVKL  405 (473)
Q Consensus       327 vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~  405 (473)
                      +||+|||+++.......       .....||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...
T Consensus       166 ~kl~DfG~a~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~  238 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK-------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  238 (309)
T ss_dssp             EEECCTTCEESSCEECC-------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             eEEcccccccccccccc-------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999975433211       1234578899999999999999999999999999999996 467888888888777


Q ss_pred             HHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhc
Q 011991          406 MCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNC  458 (473)
Q Consensus       406 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  458 (473)
                      + ..+.++..   +..+++++.+||.+||+.||++|||++||+++|+++..+.
T Consensus       239 i-~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         239 L-PQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             G-GGTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             H-HhcCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            6 44444443   5678999999999999999999999999999999998753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=376.17  Aligned_cols=242  Identities=22%  Similarity=0.353  Sum_probs=194.7

Q ss_pred             HhhccC-ceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc-CCCeeeeEEeeEee----CCc
Q 011991          191 QVRKAD-GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ----NIP  259 (473)
Q Consensus       191 ~~~~~~-~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~  259 (473)
                      +|.+.. .||+|+||.|     ..+++.||||++...        ..+.+|++++.++ +|||||+++++|.+    +..
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            576654 5999999866     256899999999642        3567899987655 89999999999875    466


Q ss_pred             eEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeecc
Q 011991          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGL  334 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG~  334 (473)
                      +|+|||||+||+|.+++...  ..+++..++.++.||+.||+|||++|   |+||||||+|||++.   .+.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            89999999999999999874  35999999999999999999999999   999999999999985   45799999999


Q ss_pred             ccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCC
Q 011991          335 LRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPP  414 (473)
Q Consensus       335 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  414 (473)
                      |+.......       .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+........
T Consensus       161 a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~  233 (335)
T d2ozaa1         161 AKETTSHNS-------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  233 (335)
T ss_dssp             CEECCCCCC-------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred             eeeccCCCc-------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence            976543321       2345699999999999999999999999999999999999999987765554443322222111


Q ss_pred             Cc---ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 LK---IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      ..   ..+..+|+++.+||++||+.||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11   1223578999999999999999999999999885

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=364.18  Aligned_cols=259  Identities=27%  Similarity=0.459  Sum_probs=218.5

Q ss_pred             ccccChhHHHhhccCceeeeEEEEEE----------ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEE
Q 011991          182 EYELNPLELQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV  251 (473)
Q Consensus       182 ~~~i~~~~~~~~~~~~ig~G~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  251 (473)
                      +|+++.  .+|.+.+.||+|+||.|.          ..++.||||+++..  ........|.+|++++++++||||++++
T Consensus        14 ~~ei~~--~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCG--GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ceeecH--HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            456664  367788999999998652          23578999999754  3455667899999999999999999999


Q ss_pred             eeEeeCCceEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEE
Q 011991          252 GAVTQNIPMMIVLEYHAKGDLASYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (473)
Q Consensus       252 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili  321 (473)
                      +++..++..++||||+++|+|.+++...          ..+++..+..++.|+++||.|||+++   |+||||||+|||+
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl  166 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  166 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence            9999999999999999999999998642          23688999999999999999999999   9999999999999


Q ss_pred             cCCCcEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChH
Q 011991          322 DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEG-VQPFHPKPPE  400 (473)
Q Consensus       322 ~~~~~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~  400 (473)
                      +.++++||+|||+|+........    .......+|+.|+|||.+.+..++.++|||||||++|||++| ..||.+.+..
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~  242 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  242 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             cCCceEEEeecccceeccCCcce----eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999865443221    122334578999999999999999999999999999999997 5889999998


Q ss_pred             HHHHHHHhhCCCCCCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHH
Q 011991          401 EVVKLMCCEGKRPPLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIV  455 (473)
Q Consensus       401 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  455 (473)
                      +....+.. +..+.   .+..+|+.+.++|.+||+.||++|||+++|+++|++..
T Consensus       243 ~~~~~i~~-~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         243 QVLRFVME-GGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHHHHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHHh-CCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            88887754 33333   25678999999999999999999999999999987653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=364.75  Aligned_cols=249  Identities=22%  Similarity=0.387  Sum_probs=200.6

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++..... .....+.+.+|++++++++|||||++++++.+++.+|+|||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5778889999999865     34689999999975432 22334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcc
Q 011991          266 YHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (473)
Q Consensus       266 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~  343 (473)
                      |+.+ ++.+++..  .+.+++..++.++.|++.||.|||++|   ||||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9976 55555533  356999999999999999999999999   99999999999999999999999999976543221


Q ss_pred             cccccccccCCCCCCcccCCCCcCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc-----
Q 011991          344 KAKIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI-----  417 (473)
Q Consensus       344 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----  417 (473)
                            ......||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..+....+......+....     
T Consensus       158 ------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         158 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             ------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccc
Confidence                  223456899999999877665 57899999999999999999999999887776665543222111100     


Q ss_pred             -------------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          418 -------------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       418 -------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         ....+++++.+|+++||..||++|||++|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                               112567889999999999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=365.84  Aligned_cols=240  Identities=23%  Similarity=0.395  Sum_probs=198.6

Q ss_pred             HHHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCH---HHHHHHHHHHHHHHhcC--CCeeeeEEeeEeeCC
Q 011991          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKAR--HPNVVQFVGAVTQNI  258 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~  258 (473)
                      +.+|++.+.||+|+||.|     ..+|+.||||++........   ....++.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            446888999999999866     24689999999975433221   11234678999999996  899999999999999


Q ss_pred             ceEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-CCcEEEEeecccc
Q 011991          259 PMMIVLEYHAK-GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR  336 (473)
Q Consensus       259 ~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-~~~vkl~DfG~a~  336 (473)
                      ..++||||+.+ +++.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++. .+.+||+|||+|+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence            99999999976 688899988888999999999999999999999999   999999999999985 4799999999997


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEF-DRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      .....        ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+  .    +.....    
T Consensus       160 ~~~~~--------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~~~~~----  221 (273)
T d1xwsa_         160 LLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRGQV----  221 (273)
T ss_dssp             ECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHCCC----
T ss_pred             ecccc--------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----Hhhccc----
Confidence            64322        1234569999999999987665 578999999999999999999997532  1    212211    


Q ss_pred             cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                       ..+..+|+++.+||++||+.||++|||++|+++|
T Consensus       222 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 -FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             1245789999999999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=362.76  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=200.8

Q ss_pred             hHHHhhccCceeeeEEEEEE-----ec-CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhc---CCCeeeeEEeeEee--
Q 011991          188 LELQVRKADGITKGSYQVAK-----WN-GTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQ--  256 (473)
Q Consensus       188 ~~~~~~~~~~ig~G~~~~~~-----~~-~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~--  256 (473)
                      ...+|++.+.||+|+||.|.     .+ ++.||||++....... .....+.+|+.+++.|   +||||++++++|..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            34578999999999998662     23 5679999997543221 1123456778877776   79999999999853  


Q ss_pred             ---CCceEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEee
Q 011991          257 ---NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (473)
Q Consensus       257 ---~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~Df  332 (473)
                         ....+++|||++++++...... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence               3468999999988666544433 355999999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          333 GLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       333 G~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      |+++.....       .......||+.|+|||++.+.+|+.++||||+||++|||++|..||.+.+..+....+......
T Consensus       161 g~~~~~~~~-------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         161 GLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             CSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hhhhhhccc-------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            998754322       1234567999999999999999999999999999999999999999999888777666432211


Q ss_pred             CC----------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PP----------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.                      ....+..+++.+.+||++||..||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11                      111234578899999999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-46  Score=359.19  Aligned_cols=250  Identities=22%  Similarity=0.344  Sum_probs=204.1

Q ss_pred             HhhccCceeeeEEEEE----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEec
Q 011991          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  266 (473)
                      +|.+.+.||+|+||.|    ..+|+.||||++..... .....+.+.+|+.++++++||||+++++++..++..+++||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5778889999999865    34689999999976532 233346799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCccccc
Q 011991          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK  346 (473)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~~  346 (473)
                      +.++.+..+....+.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|........   
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---  155 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc---
Confidence            988777777776778999999999999999999999999   99999999999999999999999999976543321   


Q ss_pred             ccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC----------
Q 011991          347 IVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL----------  415 (473)
Q Consensus       347 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------  415 (473)
                         ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+..+....+......+..          
T Consensus       156 ---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         156 ---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             ---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence               12334578899999998754 5689999999999999999999999988877766655332211110          


Q ss_pred             --------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          416 --------------KIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       416 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                    ......+++++.+||++||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                          11234568899999999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-46  Score=356.86  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=197.9

Q ss_pred             HhhccCceeeeEEEEE---EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC----ceEEE
Q 011991          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----PMMIV  263 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv  263 (473)
                      +|...+.||+|+||.|   ..+|+.||||++....    ........|+..+..++||||+++++++.+++    .+|+|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4556678999998754   6889999999996432    22222334555556789999999999998654    58999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh--------cCCCCeEeCCCCCCCEEEcCCCcEEEEeeccc
Q 011991          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE--------CKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (473)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a  335 (473)
                      ||||++|+|.+++.+. .+++..++.++.|++.||+|||+        ++   |+||||||+||||+.++.+||+|||++
T Consensus        80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999875 59999999999999999999997        46   999999999999999999999999999


Q ss_pred             cccccCcccccccccccCCCCCCcccCCCCcCCCC------CCCchhHHHHHHHHHHHHhCCCCCCC-------------
Q 011991          336 RLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEE------FDRSVDAYSFGLILYEMIEGVQPFHP-------------  396 (473)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~~l~ell~g~~pf~~-------------  396 (473)
                      +.........  ........||+.|+|||++.+..      ++.++|||||||++|||++|..||..             
T Consensus       156 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         156 VRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             EEEETTTTEE--CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccCCCcce--eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            8765432211  12234567999999999987653      56789999999999999999887632             


Q ss_pred             --CChHHHHHHHHhhCCCCCCcccC--CCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 011991          397 --KPPEEVVKLMCCEGKRPPLKIKA--RSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCS  459 (473)
Q Consensus       397 --~~~~~~~~~i~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  459 (473)
                        .........+...+.+|..+...  ...+..+.+|+.+||+.||.+|||+.||++.|+++..+-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence              12233344443344444432221  1223568999999999999999999999999999987643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=357.96  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=198.8

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCC------c
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~  259 (473)
                      .|++.+.||+|+||.|     ..+|+.||||++.... ......+.+.+|+++|+.++|||||+++++|...+      .
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            6888899999999865     2468999999997654 35566788999999999999999999999997654      4


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      +|+||||+ +.+|.++++. +.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+|+...
T Consensus        98 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccC
Confidence            79999999 5688887755 46999999999999999999999999   9999999999999999999999999997643


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-----
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-----  413 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  413 (473)
                      ..         .....||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+......+     
T Consensus       173 ~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         173 SE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             SS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             Cc---------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            22         234568999999999865 467899999999999999999999999887766555443222111     


Q ss_pred             ---------------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 ---------------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 ---------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                           .......++++++.+||++||..||++|||++|+|+|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                 1112235678999999999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-45  Score=356.06  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=198.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCc----eE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----MM  261 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~  261 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++....  .....+.+.+|+++|+.++||||+++++++.....    .+
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            5888999999999855     3468999999997543  45667789999999999999999999999876432    23


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccC
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS  341 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~  341 (473)
                      ++++++.+|+|.+++..+ .+++..++.++.|++.||+|||++|   ||||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            444556688999999765 6999999999999999999999999   999999999999999999999999999765433


Q ss_pred             cccccccccccCCCCCCcccCCCCcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCC-------
Q 011991          342 PEKAKIVFPVSHIDPANLYVAPEIYK-NEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRP-------  413 (473)
Q Consensus       342 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------  413 (473)
                      ...   ........||+.|+|||++. +..++.++||||+||++|+|++|..||.+.+..............+       
T Consensus       163 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         163 HDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             Ccc---ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            221   12234566899999999984 4567899999999999999999999999877655544432211111       


Q ss_pred             -------------------CCcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          414 -------------------PLKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       414 -------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                         +.......+++++.+|+.+||..||.+|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                               0111234577899999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.1e-44  Score=345.43  Aligned_cols=262  Identities=14%  Similarity=0.223  Sum_probs=214.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCC-CeeeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~  264 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++......     ..+.+|++.++.+.| +||+.+++++..+...++||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            6888899999999865     246889999998754322     246789999999975 89999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC-----CCcEEEEeecccccc
Q 011991          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-----GGQLKISGFGLLRLQ  338 (473)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~-----~~~vkl~DfG~a~~~  338 (473)
                      ||+ +++|.+++...+ .++...+..++.|++.||.|||++|   |+||||||+|||++.     ++.+||+|||+|+..
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 679999987754 6999999999999999999999999   999999999999974     568999999999876


Q ss_pred             ccCccccc-ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhCCCCC
Q 011991          339 YISPEKAK-IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKP---PEEVVKLMCCEGKRPP  414 (473)
Q Consensus       339 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~  414 (473)
                      ........ .........||+.|+|||++.+..++.++|||||||++|||++|..||.+..   .......+......++
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            54322211 1122345679999999999999999999999999999999999999997543   3333334433332233


Q ss_pred             CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHhccCC
Q 011991          415 LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCNCSKQ  461 (473)
Q Consensus       415 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  461 (473)
                      ....+.++|+++.+++..|+..+|++||+++.+.+.|++++.+.+..
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~  283 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  283 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence            33345678999999999999999999999999999999998876544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-45  Score=352.78  Aligned_cols=254  Identities=20%  Similarity=0.275  Sum_probs=199.5

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEee--------
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--------  256 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------  256 (473)
                      .+|++.+.||+|+||.|     ..+|+.||||++...... ......+.+|++++++++||||+++++++..        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47889999999999865     246899999998755432 2334668899999999999999999998854        


Q ss_pred             CCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ++.+|+||||+.++++..+......+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence            3468999999988766666555677999999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCC
Q 011991          337 LQYISPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPL  415 (473)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  415 (473)
                      ........  .........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+......+..
T Consensus       166 ~~~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         166 AFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             ECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eccccccc--ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            65433221  11223345689999999998765 7899999999999999999999999988887776655433322221


Q ss_pred             cccC---------------------------CCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          416 KIKA---------------------------RSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       416 ~~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                      ....                           ...++++.+||.+||..||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1100                           012567889999999999999999999997

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=355.68  Aligned_cols=245  Identities=24%  Similarity=0.304  Sum_probs=195.2

Q ss_pred             HHHhhccCceeeeEEEEEE-----ecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------
Q 011991          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------  257 (473)
Q Consensus       189 ~~~~~~~~~ig~G~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------  257 (473)
                      +.+|...+.||+|+||.|.     .+|+.||||++..+...       +.+|++++++++||||++++++|...      
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            3468888899999998762     46899999999765422       34799999999999999999998543      


Q ss_pred             CceEEEEeccCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeec
Q 011991          258 IPMMIVLEYHAKGDLASYL---QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFG  333 (473)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG  333 (473)
                      .++|+|||||+++.+..+.   .....+++..++.++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence            3479999999865333332   23456999999999999999999999999   99999999999999775 89999999


Q ss_pred             cccccccCcccccccccccCCCCCCcccCCCCcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCC
Q 011991          334 LLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKN-EEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKR  412 (473)
Q Consensus       334 ~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~  412 (473)
                      +++......       ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+......
T Consensus       169 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         169 SAKQLVRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             TCEECCTTS-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             chhhccCCc-------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            997654321       1234568999999998765 57899999999999999999999999988877666555322111


Q ss_pred             CC------------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          413 PP------------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       413 ~~------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                      +.                        ........++++.+||++||..||++|||+.|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            10                        011234578999999999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-44  Score=347.95  Aligned_cols=258  Identities=17%  Similarity=0.219  Sum_probs=202.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCe-eeeEEeeEeeCCceEEEE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN-VVQFVGAVTQNIPMMIVL  264 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~  264 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++..+...     .++..|+++++.++|+| |+.+.+++..++..++||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            5888999999999866     245889999998765322     34788999999998766 555566677888899999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcC---CCcEEEEeecccccccc
Q 011991          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRLQYI  340 (473)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~---~~~vkl~DfG~a~~~~~  340 (473)
                      ||+. ++|.+.+.. .+.+++..+..++.|++.||+|||++|   |+||||||+|||++.   +..+||+|||+|+....
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9995 577766654 457999999999999999999999999   999999999999864   45799999999987654


Q ss_pred             Cccccc-ccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhhCCCCCCc
Q 011991          341 SPEKAK-IVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLM---CCEGKRPPLK  416 (473)
Q Consensus       341 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~  416 (473)
                      ...... .........||+.|+|||++.+..++.++|||||||++|||++|..||...........+   ......++.+
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            322111 112234567999999999999999999999999999999999999999876654433322   1111122233


Q ss_pred             ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHHHHHHHHh
Q 011991          417 IKARSYPPDLKELIEECWDPKPVIRPNFNEIIARLDRIVCN  457 (473)
Q Consensus       417 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  457 (473)
                      ....++|+++.+||.+||+.||++||+++++.+.|+.++..
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            34567899999999999999999999999999999988764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=359.07  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=203.6

Q ss_pred             HHhhccCceeeeEEEEEE--------ecCcEEEEEEEcCCCCC-CHHHHHHHHHHHHHHHhcCC-CeeeeEEeeEeeCCc
Q 011991          190 LQVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIP  259 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~~--------~~~~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~  259 (473)
                      .+|++.+.||+|+||.|.        .+|+.||||++...... +....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            358899999999999762        25789999998653211 11223567899999999977 899999999999999


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      .+++|||+.+|+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999999999999888999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCcc
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNE--EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLKI  417 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  417 (473)
                      .....     ......|++.|+|||.+.+.  .++.++|||||||++|+|++|..||.+.+.......+......... .
T Consensus       181 ~~~~~-----~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-~  254 (322)
T d1vzoa_         181 ADETE-----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-P  254 (322)
T ss_dssp             GGGGG-----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-C
T ss_pred             ccccc-----cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-C
Confidence            33221     12334588999999998754  4688999999999999999999999876544433333222111111 1


Q ss_pred             cCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 011991          418 KARSYPPDLKELIEECWDPKPVIRPN-----FNEIIAR  450 (473)
Q Consensus       418 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~  450 (473)
                      .+..+|+++.+||++||..||++|||     ++|+++|
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            25578999999999999999999995     7888763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-44  Score=342.59  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=205.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeCCceEEEEe
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  265 (473)
                      +|++.+.||+|+||.|     ..+|+.||||+++.... .......+.+|+.+++.++||||+++++++......++|+|
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5788899999999866     34788999999976543 34566889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccccCcccc
Q 011991          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA  345 (473)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~~~~~~  345 (473)
                      ++.+++|..++...+.+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++.......  
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence            9999999999888888999999999999999999999999   99999999999999999999999999976543321  


Q ss_pred             cccccccCCCCCCcccCCCCcCCCC-CCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhhCCCCC---------
Q 011991          346 KIVFPVSHIDPANLYVAPEIYKNEE-FDRSVDAYSFGLILYEMIEGVQPFH-PKPPEEVVKLMCCEGKRPP---------  414 (473)
Q Consensus       346 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~---------  414 (473)
                          ......+++.|+|||++.+.. ++.++||||+||++|+|++|..||. +.+..+....+......+.         
T Consensus       157 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         157 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             ----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             ----cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence                122344677899999887664 6899999999999999999998864 4444444444432222111         


Q ss_pred             ---------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          415 ---------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       415 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                     .......+++.+.+|+++||..||.+|||++|+|+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                           111234567899999999999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.4e-43  Score=342.03  Aligned_cols=241  Identities=20%  Similarity=0.313  Sum_probs=192.3

Q ss_pred             HHhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEee--CCceE
Q 011991          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQ--NIPMM  261 (473)
Q Consensus       190 ~~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~  261 (473)
                      .+|++.+.||+|+||.|     ..+|+.||||+++...      .+++.+|+++|+.+. ||||++++++|..  ...++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            36899999999999866     2468999999997532      356889999999995 9999999999974  45699


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCC-cEEEEeecccccccc
Q 011991          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRLQYI  340 (473)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~-~vkl~DfG~a~~~~~  340 (473)
                      +|||||++++|.++.   +.+++..++.++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||+|+....
T Consensus       109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999999998763   46999999999999999999999999   99999999999998765 599999999976543


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHh----------
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPE-EVVKLMCC----------  408 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~i~~----------  408 (473)
                      ..       ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||...... .....+..          
T Consensus       183 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         183 GQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             TC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             CC-------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            21       12345688999999998765 5799999999999999999999999765432 22111110          


Q ss_pred             ---hCCCCC-------------------CcccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHH
Q 011991          409 ---EGKRPP-------------------LKIKARSYPPDLKELIEECWDPKPVIRPNFNEIIA  449 (473)
Q Consensus       409 ---~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~  449 (473)
                         ......                   .......+++++.+||++||..||.+|||++|+|+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000000                   00012346789999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=348.31  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=192.0

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC------Cc
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~  259 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++..... ......++.+|+.+++.++||||++++++|...      ..
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6889999999999866     24689999999986653 456667899999999999999999999999643      57


Q ss_pred             eEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeeccccccc
Q 011991          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (473)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~  339 (473)
                      +|+|||||.+ ++.+.+.  ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+|++|||+++...
T Consensus        97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence            8999999976 5555553  45999999999999999999999999   9999999999999999999999999987554


Q ss_pred             cCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc---
Q 011991          340 ISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK---  416 (473)
Q Consensus       340 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  416 (473)
                      ...       ......+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+.......+......+...   
T Consensus       171 ~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         171 TSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccc-------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            321       2234568999999999999999999999999999999999999999887666555443222111000   


Q ss_pred             ------------------c----------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 ------------------I----------------KARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 ------------------~----------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                        .                .....++++.+||++||..||++|||++|+|+|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                              0                001134678999999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=348.89  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=198.7

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCeeeeEEeeEeeC-----Cce
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~  260 (473)
                      +|++.+.||+|+||.|     ..+|+.||||++.... .+....+.+.+|+++++.++||||+++++++...     ...
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            5888899999999754     3568999999998654 3455667899999999999999999999998643     234


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeecccccccc
Q 011991          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (473)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~~~~  340 (473)
                      +++|+++.+|+|.+++.. +.+++..++.++.||+.||+|||++|   |+||||||+|||++.++.+|++|||++.....
T Consensus        98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence            666777789999999865 46999999999999999999999999   99999999999999999999999999865422


Q ss_pred             CcccccccccccCCCCCCcccCCCCcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhCCCCCCc---
Q 011991          341 SPEKAKIVFPVSHIDPANLYVAPEIYKNE-EFDRSVDAYSFGLILYEMIEGVQPFHPKPPEEVVKLMCCEGKRPPLK---  416 (473)
Q Consensus       341 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  416 (473)
                      .         .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+......+...   
T Consensus       174 ~---------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         174 E---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             G---------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             c---------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            1         2345678899999987665 56899999999999999999999999888776666554332222110   


Q ss_pred             -----------------------ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 011991          417 -----------------------IKARSYPPDLKELIEECWDPKPVIRPNFNEIIAR  450 (473)
Q Consensus       417 -----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  450 (473)
                                             ....++++++.+||++||..||.+|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                                   1124578999999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-36  Score=299.51  Aligned_cols=244  Identities=18%  Similarity=0.342  Sum_probs=180.2

Q ss_pred             HhhccCceeeeEEEEE-----EecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-----------CCeeeeEEeeE
Q 011991          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----------HPNVVQFVGAV  254 (473)
Q Consensus       191 ~~~~~~~ig~G~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~  254 (473)
                      +|++.+.||.|+||.|     ..+|+.||||+++..    ....+.+.+|+++++.+.           ||||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            4899999999999866     256899999999743    344567888999988875           57899999988


Q ss_pred             ee--CCceEEEEeccCCCCH-HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCCEEEcCCC---
Q 011991          255 TQ--NIPMMIVLEYHAKGDL-ASYLQK--KGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGG---  325 (473)
Q Consensus       255 ~~--~~~~~lv~e~~~~gsL-~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~Nili~~~~---  325 (473)
                      ..  ....+++|+++..+.. ......  ...+++..++.++.|++.||.|||+ .|   |+||||||+|||++.++   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence            65  3456666666554433 332222  3568999999999999999999998 77   99999999999998654   


Q ss_pred             ---cEEEEeeccccccccCcccccccccccCCCCCCcccCCCCcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--
Q 011991          326 ---QLKISGFGLLRLQYISPEKAKIVFPVSHIDPANLYVAPEIYKNEEFDRSVDAYSFGLILYEMIEGVQPFHPKPPE--  400 (473)
Q Consensus       326 ---~vkl~DfG~a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--  400 (473)
                         .++++|||.|......         .....||+.|+|||++.+..++.++||||+||++++|++|+.||......  
T Consensus       167 ~~~~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             ccceeeEeecccccccccc---------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence               3999999998754322         23456899999999999999999999999999999999999999754321  


Q ss_pred             ----HHHH-HHHhhCCCC------------------------CCc------------ccCCCCCHHHHHHHHHccCCCCC
Q 011991          401 ----EVVK-LMCCEGKRP------------------------PLK------------IKARSYPPDLKELIEECWDPKPV  439 (473)
Q Consensus       401 ----~~~~-~i~~~~~~~------------------------~~~------------~~~~~~~~~l~~li~~cl~~dP~  439 (473)
                          .... .+...+..+                        ...            ......++++.+||.+||..||.
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence                1111 111111100                        000            00112356799999999999999


Q ss_pred             CCCCHHHHHHH
Q 011991          440 IRPNFNEIIAR  450 (473)
Q Consensus       440 ~RPs~~ell~~  450 (473)
                      +|||++|+|+|
T Consensus       318 ~Rpta~e~L~H  328 (362)
T d1q8ya_         318 KRADAGGLVNH  328 (362)
T ss_dssp             TCBCHHHHHTC
T ss_pred             HCcCHHHHhcC
Confidence            99999999874

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.90  E-value=1.6e-24  Score=185.54  Aligned_cols=121  Identities=17%  Similarity=0.135  Sum_probs=107.0

Q ss_pred             ceeeccCCCCccccCCCCCccC------CCCCCCCCChHHHHHHHc---CCHHHHHHHHHcCCCCcccCCCCCcHHHHHH
Q 011991           43 RFSFGRQSSLDPIRRSPVQDEL------TVPENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (473)
Q Consensus        43 ~~~~~~~g~~~~~~~~l~~~~~------~~~~~~~g~t~L~~aa~~---g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~  113 (473)
                      ++.|++.+++..+.+++..+..      ....+..|+||||+|+..   |+.++|++|+++|+|+|.+|.+|+||||+||
T Consensus        10 L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~   89 (154)
T d1dcqa1          10 LCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCC   89 (154)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHH
T ss_pred             HHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhcccccccc
Confidence            5677788888888877766532      112366799999999974   7899999999999999999999999999999


Q ss_pred             HcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          114 CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       114 ~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      ..|+.+++++|+++|+|++.+|..|+||||+|++.|+.+++++|++.+..
T Consensus        90 ~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~i~~~L~~~~~~  139 (154)
T d1dcqa1          90 LTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSG  139 (154)
T ss_dssp             HTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTT
T ss_pred             ccccccccccccccCccccccCCCCCCHHHHHHHcCCHHHHHHHHHhCCC
Confidence            99999999999999999999999999999999999999999999987654

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.89  E-value=7.5e-24  Score=173.26  Aligned_cols=104  Identities=31%  Similarity=0.458  Sum_probs=97.0

Q ss_pred             ChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChh
Q 011991           73 TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVE  152 (473)
Q Consensus        73 ~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~  152 (473)
                      .|||++||..|+.++|++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|+|++.+|..|+||||+|+..|+.+
T Consensus         3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~   82 (118)
T d1myoa_           3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS   82 (118)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred             ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence            48999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          153 VYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       153 ~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      ++++|+++|++++.++   .|+++.|.
T Consensus        83 ~v~~Ll~~Gad~~~~d~~G~t~l~~a~  109 (118)
T d1myoa_          83 CVKLLLSKGADKTVKGPDGLTALEATD  109 (118)
T ss_dssp             HHHHHHTTCCCSSSSSSSTCCCCCTCS
T ss_pred             hhhhhhcccccceeeCCCCCCHHHHHh
Confidence            9999999999997765   45665553

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.3e-24  Score=181.17  Aligned_cols=119  Identities=25%  Similarity=0.218  Sum_probs=86.6

Q ss_pred             ceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHH
Q 011991           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (473)
Q Consensus        43 ~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~  122 (473)
                      ++.||..|+++.|+.+++.+......|.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.+|+.++|+
T Consensus         5 L~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~   84 (130)
T d1ycsb1           5 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCK   84 (130)
T ss_dssp             HHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHH
Confidence            45677777777777777766443334777778888887777777777777777777777777778888887778888888


Q ss_pred             HHHhCCCCCCccCC-CCCcHHHHH--HHcCChhhhhhhhhcC
Q 011991          123 LLLSKKANIDARDR-WGSTAAADA--KYYGNVEVYNILKARG  161 (473)
Q Consensus       123 ~Ll~~ga~~~~~~~-~g~t~l~~A--~~~~~~~~~~~L~~~g  161 (473)
                      +|+++|||++.++. .|.||+++|  ...|+.+++++|+..+
T Consensus        85 ~Ll~~ga~v~~~~~~~~~~~~~~~~a~~~g~~eiv~~L~~~~  126 (130)
T d1ycsb1          85 FLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ  126 (130)
T ss_dssp             HHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHH
T ss_pred             HHHHcCCCcccccCCCCCCHHHHHHHHHcChHHHHHHHHhHH
Confidence            88777777776654 477776654  4567777777776543

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.89  E-value=5.8e-25  Score=179.97  Aligned_cols=113  Identities=28%  Similarity=0.244  Sum_probs=102.3

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv  121 (473)
                      +++.|++.|+++.|+.+++.|......+.+|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.++|
T Consensus         5 pL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v   84 (118)
T d1myoa_           5 EFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCV   84 (118)
T ss_dssp             HHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHH
T ss_pred             HHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhh
Confidence            46779999999999999998754444588999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhh
Q 011991          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILK  158 (473)
Q Consensus       122 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~  158 (473)
                      ++|+++|+|++.+|..|.||||+|.    .+.++.|+
T Consensus        85 ~~Ll~~Gad~~~~d~~G~t~l~~a~----~~~i~~LL  117 (118)
T d1myoa_          85 KLLLSKGADKTVKGPDGLTALEATD----NQAIKALL  117 (118)
T ss_dssp             HHHHTTCCCSSSSSSSTCCCCCTCS----STTTGGGG
T ss_pred             hhhhcccccceeeCCCCCCHHHHHh----HHHHHHhc
Confidence            9999999999999999999999883    34555554

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.1e-24  Score=178.51  Aligned_cols=119  Identities=23%  Similarity=0.271  Sum_probs=108.2

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCC-cHHHHHHHcCCHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR-TALHIAACEGHVE  119 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~-T~lh~A~~~g~~~  119 (473)
                      +.++.|+..|+++.++.+++.|......+.+|.||||.| ..|+.+++++|+++|+++|.+|..|. ||||+|+..|+.+
T Consensus         5 ~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a-~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~   83 (125)
T d1bi7b_           5 DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVM-MMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLD   83 (125)
T ss_dssp             THHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSS-CTTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHH
T ss_pred             hHHHHHHHCCCHHHHHHHHHcCCcccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence            567889999999999999998744334488999999866 57999999999999999999998876 6999999999999


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhc
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~  160 (473)
                      ++++|+++|+|++.+|..|+||||+|+..|+.+++++|+..
T Consensus        84 ~v~~Ll~~ga~~~~~d~~G~T~l~~A~~~g~~~~v~~Llsa  124 (125)
T d1bi7b_          84 TLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAA  124 (125)
T ss_dssp             HHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSSC
T ss_pred             ccccccccccccccccCCCCCHHHHHHHcCCHHHHHHHHhc
Confidence            99999999999999999999999999999999999999753

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=7.5e-23  Score=170.25  Aligned_cols=96  Identities=33%  Similarity=0.374  Sum_probs=92.7

Q ss_pred             hHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhh
Q 011991           74 MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEV  153 (473)
Q Consensus        74 t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~  153 (473)
                      ++||.||..|+.++|+.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|.+|+||||+|+..|+.++
T Consensus         3 ~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~   82 (130)
T d1ycsb1           3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV   82 (130)
T ss_dssp             HHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcCccCcC
Q 011991          154 YNILKARGAKVPKTKR  169 (473)
Q Consensus       154 ~~~L~~~g~~i~~~~~  169 (473)
                      +++|+++|++++..+.
T Consensus        83 v~~Ll~~ga~v~~~~~   98 (130)
T d1ycsb1          83 CKFLVESGAAVFAMTY   98 (130)
T ss_dssp             HHHHHHTTCCTTCCCS
T ss_pred             HHHHHHcCCCcccccC
Confidence            9999999999986543

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.5e-21  Score=167.59  Aligned_cols=120  Identities=23%  Similarity=0.239  Sum_probs=80.2

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHH
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~  119 (473)
                      +...+.+|..|+.+.++.+++.+......+.+|.+||+.|+..++.++++.++++|+++|.+|..|+||||+||..|+.+
T Consensus        36 g~t~L~~A~~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~  115 (156)
T d1bd8a_          36 GKTALQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTA  115 (156)
T ss_dssp             SCCHHHHSCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHH
T ss_pred             CCcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCeeecccccccccc
Confidence            33444555566666666666655433333556677777777777777777777777777777777777777777777777


Q ss_pred             HHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhc
Q 011991          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (473)
Q Consensus       120 iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~  160 (473)
                      ++++|+ .|+|++.+|..|+||||+|+..|+.+++++|++|
T Consensus       116 i~~~L~-~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~h  155 (156)
T d1bd8a_         116 VVSFLA-AESDLHRRDARGLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             HHHHHH-TTSCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             cccccc-ccccccccCCCCCCHHHHHHHcCCHHHHHHHHhh
Confidence            777665 5667777777777777777777777777777654

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=3.9e-22  Score=171.26  Aligned_cols=134  Identities=21%  Similarity=0.273  Sum_probs=120.1

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ++.++.||..|+++.|+++|..++.+++. |..|+||||+|+ .|+.+++++|+++|+++|.++..|.+||++|+..++.
T Consensus         3 g~~L~~Aa~~g~~~~vk~lL~~~~~~~n~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~   81 (156)
T d1bd8a_           3 GDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFL   81 (156)
T ss_dssp             HHHHHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             cHHHHHHHHcCCHHHHHHHHHhCCCCCCccCCCCCccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence            45678999999999999999987766665 899999999876 5899999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      +++++++++|++++.+|..|.||||+|+..|+.+++++|+ .|++++.++.   ||++.|
T Consensus        82 ~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~TpL~~A  140 (156)
T d1bd8a_          82 DTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTPLELA  140 (156)
T ss_dssp             HHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCCHHHHH
T ss_pred             cccccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCCCCCHHHHH
Confidence            9999999999999999999999999999999999999988 6788776543   444444

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=2.2e-21  Score=176.86  Aligned_cols=137  Identities=22%  Similarity=0.213  Sum_probs=118.7

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ....+..++..|+.+.++.+++.+......|.+|.||||+|+..|+.+++++|+++|+|+|.+|..|.||||+|+..|+.
T Consensus        70 ~~~~~~~~~~~~~~~i~~~Ll~~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~  149 (223)
T d1uoha_          70 GWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNL  149 (223)
T ss_dssp             CCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred             ccccccccccccccchhHHHhccCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCc
Confidence            33445556666777777777776643334488999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      +++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++..+   +||++.|
T Consensus       150 ~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tpl~~A  209 (223)
T d1uoha_         150 KMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVA  209 (223)
T ss_dssp             HHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHC
T ss_pred             chhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            99999999999999999999999999999999999999999999998765   4666666

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=7.6e-22  Score=175.49  Aligned_cols=131  Identities=13%  Similarity=0.044  Sum_probs=101.1

Q ss_pred             hccCceeeeEEEEE----EecCcEEEEEEEcCCCCC---------------CHHHHHHHHHHHHHHHhcCCCeeeeEEee
Q 011991          193 RKADGITKGSYQVA----KWNGTKVWVKILDKESHK---------------DPERINAFTHELTIVEKARHPNVVQFVGA  253 (473)
Q Consensus       193 ~~~~~ig~G~~~~~----~~~~~~vavK~l~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  253 (473)
                      .+++.||+|+||.+    ..+|+.||||++......               .......+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45678999999855    357899999997642211               01123445678899999999999988766


Q ss_pred             EeeCCceEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCCEEEcCCCcEEEEeec
Q 011991          254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (473)
Q Consensus       254 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~Nili~~~~~vkl~DfG  333 (473)
                      ..    .+++|||+++..+.+       ++...+..++.|++.+|.|||++|   |+||||||+|||++++ .++|+|||
T Consensus        83 ~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCT
T ss_pred             cC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECC
Confidence            32    379999998865532       455667789999999999999999   9999999999999964 58999999


Q ss_pred             ccccc
Q 011991          334 LLRLQ  338 (473)
Q Consensus       334 ~a~~~  338 (473)
                      +|...
T Consensus       148 ~a~~~  152 (191)
T d1zara2         148 QSVEV  152 (191)
T ss_dssp             TCEET
T ss_pred             CcccC
Confidence            98654

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.83  E-value=3.5e-21  Score=175.58  Aligned_cols=104  Identities=21%  Similarity=0.195  Sum_probs=81.9

Q ss_pred             CChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCC-CCCCccCCCCCcHHHHHHHcCC
Q 011991           72 STMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGN  150 (473)
Q Consensus        72 g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~g-a~~~~~~~~g~t~l~~A~~~~~  150 (473)
                      +.|+|+.++..++.+++++|++.|.+.+.+|..|+||||+|+..|+.+++++|++.| .+++.+|.+|+||||+|+..|+
T Consensus       105 ~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~  184 (229)
T d1ixva_         105 GVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGH  184 (229)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTC
T ss_pred             cccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhccccc
Confidence            344455555555555555555555555557888999999999999999999999987 7899999999999999999999


Q ss_pred             hhhhhhhhh-cCCcCccCcC---CCCcCC
Q 011991          151 VEVYNILKA-RGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       151 ~~~~~~L~~-~g~~i~~~~~---t~l~~a  175 (473)
                      .+++++|++ .|++++.++.   |+++.|
T Consensus       185 ~~~v~~Ll~~~gad~~~~d~~g~t~l~~A  213 (229)
T d1ixva_         185 GDAAVLLVEKYGAEYDLVDNKGAKAEDVA  213 (229)
T ss_dssp             HHHHHHHHHHHCCCSCCCCTTSCCTGGGC
T ss_pred             HHHHHHHHHhcCCCCCCcCCCCCCHHHHH
Confidence            999999996 5999887754   555555

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=5.5e-21  Score=157.66  Aligned_cols=100  Identities=26%  Similarity=0.300  Sum_probs=92.2

Q ss_pred             CCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCC-cHHHHHHHcC
Q 011991           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS-TAAADAKYYG  149 (473)
Q Consensus        71 ~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~-t~l~~A~~~~  149 (473)
                      .+.++||+||..|++++|++|+++|+|+|.+|.+|.||||+|+ .|+.+++++|+++|++++.+|..|. ||||+|++.|
T Consensus         2 p~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g   80 (125)
T d1bi7b_           2 PSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREG   80 (125)
T ss_dssp             CSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHT
T ss_pred             CChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence            3578999999999999999999999999999999999999775 7999999999999999999999876 6999999999


Q ss_pred             ChhhhhhhhhcCCcCccCcCCC
Q 011991          150 NVEVYNILKARGAKVPKTKRTP  171 (473)
Q Consensus       150 ~~~~~~~L~~~g~~i~~~~~t~  171 (473)
                      +.+++++|+++|++++..+..+
T Consensus        81 ~~~~v~~Ll~~ga~~~~~d~~G  102 (125)
T d1bi7b_          81 FLDTLVVLHRAGARLDVRDAWG  102 (125)
T ss_dssp             CHHHHHHHHHHTCCSSCCCTTC
T ss_pred             cccccccccccccccccccCCC
Confidence            9999999999999998765433

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.82  E-value=3.4e-21  Score=182.34  Aligned_cols=140  Identities=24%  Similarity=0.277  Sum_probs=120.1

Q ss_pred             cCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcc----------------
Q 011991           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNS----------------  100 (473)
Q Consensus        37 ~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~----------------  100 (473)
                      ...+.+++.||..|+++.|+.||+.|......|.+|+||||+|+..|+.++|++|+++|++++.                
T Consensus        38 ~~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~  117 (291)
T d1s70b_          38 FDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCG  117 (291)
T ss_dssp             ECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred             CCCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeeccccccccccccccccccccccccc
Confidence            3344567889999999999999988744334499999999999999999999999999877443                


Q ss_pred             -----------------------------------------------------------------------------cCC
Q 011991          101 -----------------------------------------------------------------------------IDL  103 (473)
Q Consensus       101 -----------------------------------------------------------------------------~d~  103 (473)
                                                                                                   .+.
T Consensus       118 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (291)
T d1s70b_         118 YLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAK  197 (291)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTT
T ss_pred             ccchhhcccccCcccccccccCccccccccccccchhccccccccccccccccccccccccccchhhhcccccccccccC
Confidence                                                                                         234


Q ss_pred             CCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       104 ~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      .|.||||+|+..|+.+++++|+++|+|++.+|..|+||||+|+..|+.++|++|+++|++++..+   .|+++.|.
T Consensus       198 ~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~A~  273 (291)
T d1s70b_         198 SGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVAD  273 (291)
T ss_dssp             TCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSCC
T ss_pred             CCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            56788888899999999999999999999999999999999999999999999999999998775   46777774

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=7.7e-21  Score=173.12  Aligned_cols=127  Identities=30%  Similarity=0.345  Sum_probs=112.3

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .++.+|..|+++.|++++..++..++. |.+|+||||+||..|+.+++++|+..+.+....+..+.|+++.|+..|+.++
T Consensus         6 ~~~~~a~~G~~~~v~~~l~~~~~~~~~~D~~G~TpLh~Aa~~g~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i   85 (223)
T d1uoha_           6 MVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEI   85 (223)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTCCCHHHHHHHHTCHHH
T ss_pred             HHHHHHHhCCHHHHHHHHHhCCCcCcCcCCCCCCHHHHHHHhhhhcccccccccccccccccccccccccccccccccch
Confidence            456688999999999988877655555 8899999999999999999999999999988888889999999999999999


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      +++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus        86 ~~~Ll~~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~  133 (223)
T d1uoha_          86 VKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD  133 (223)
T ss_dssp             HHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             hHHHhccCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence            999999999999999999999999999999999999999998886554

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.81  E-value=3.3e-20  Score=173.75  Aligned_cols=137  Identities=25%  Similarity=0.249  Sum_probs=109.6

Q ss_pred             CCCcceeeccCCCCccccCCCCC-------ccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQ-------DELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH  110 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~-------~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh  110 (473)
                      ...+++-||..|+.+.++.|+..       .+.+++. |.+|+||||+||..|+.++|++|+++|||+|.+|..|.||||
T Consensus        33 g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~l~  112 (277)
T d2fo1e1          33 NRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALH  112 (277)
T ss_dssp             CCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHH
T ss_pred             CccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccccccccccccccccccccccccccc
Confidence            44666678889999988887533       2345554 899999999999999999999999999999998888777777


Q ss_pred             HHHHcCC-------------------------------------------------------------------------
Q 011991          111 IAACEGH-------------------------------------------------------------------------  117 (473)
Q Consensus       111 ~A~~~g~-------------------------------------------------------------------------  117 (473)
                      +|+..|+                                                                         
T Consensus       113 ~a~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~  192 (277)
T d2fo1e1         113 QAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALH  192 (277)
T ss_dssp             HHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHH
T ss_pred             chhhhcchhhhhhhhhcccccccccccccccchhHHHHHhcccccccccccccccccccccccccccccccccCCCCccc
Confidence            7665544                                                                         


Q ss_pred             -------HHHHHH-HHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          118 -------VEVVKL-LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       118 -------~~iv~~-Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                             .+++++ +...|.+++.+|..|+||||+|+..|+.+++++|+++|++++.++.   |+++.|
T Consensus       193 ~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L~~A  261 (277)
T d2fo1e1         193 YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA  261 (277)
T ss_dssp             HHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHH
T ss_pred             cccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCHHHHH
Confidence                   345554 4467889999999999999999999999999999999999977654   455544

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.80  E-value=1.7e-19  Score=167.06  Aligned_cols=97  Identities=32%  Similarity=0.326  Sum_probs=92.6

Q ss_pred             CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCccc-CCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHH
Q 011991           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSI-DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK  146 (473)
Q Consensus        68 ~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~-d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~  146 (473)
                      .+.+|.||||+||..|+.++|++|++.|++.+.. +..|.||||+|+..|+.+++++|+++|+|++.+|..|.||||+|+
T Consensus       154 ~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~L~~A~  233 (255)
T d1oy3d_         154 ENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSAL  233 (255)
T ss_dssp             CCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             ccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            4889999999999999999999999999998864 678999999999999999999999999999999999999999999


Q ss_pred             HcCChhhhhhhhhcCCcC
Q 011991          147 YYGNVEVYNILKARGAKV  164 (473)
Q Consensus       147 ~~~~~~~~~~L~~~g~~i  164 (473)
                      ..|+.+++++|+++|++-
T Consensus       234 ~~~~~~i~~~Ll~~Ga~~  251 (255)
T d1oy3d_         234 LRPNPILARLLRAHGAPE  251 (255)
T ss_dssp             TSSCHHHHHHHHHTTCCC
T ss_pred             HCCCHHHHHHHHHcCCCC
Confidence            999999999999999963

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.79  E-value=2.4e-20  Score=174.67  Aligned_cols=112  Identities=18%  Similarity=0.234  Sum_probs=100.7

Q ss_pred             CCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHH--------HHcCCCCcccCCCCCcHHHHHHHcCCHHHH
Q 011991           50 SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDL--------LNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (473)
Q Consensus        50 g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~L--------l~~ga~~n~~d~~g~T~lh~A~~~g~~~iv  121 (473)
                      +..+.+++.|.+.+.+...+.+|+||||+||..|+.++|++|        +++|||||.+|.+|+||||+|+..|+.++|
T Consensus        11 ~~~~~~~~~l~~~~~n~~~~~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv   90 (277)
T d2fo1e1          11 AGSYAITEPITRESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLV   90 (277)
T ss_dssp             HSSSCCCSCCSTTTTTTCCCSSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHH
T ss_pred             CCCHHHHHHHHhcCCCcCCCCCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccccc
Confidence            445677788877777766666799999999999999998777        567999999999999999999999999999


Q ss_pred             HHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       122 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      ++|+++|||++.+|.+|.|||++|...++.++++++...+
T Consensus        91 ~~Ll~~Gad~n~~~~~g~t~l~~a~~~~~~~~~~~l~~~~  130 (277)
T d2fo1e1          91 AYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNST  130 (277)
T ss_dssp             HHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSH
T ss_pred             ccccccccccccccccccccccchhhhcchhhhhhhhhcc
Confidence            9999999999999999999999999999999999887654

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=1.8e-19  Score=161.68  Aligned_cols=116  Identities=18%  Similarity=0.206  Sum_probs=100.4

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .....+.......+.+.+...+.+++. +..|.|||++|+..|..++++.|++.++++|.+|..|.||||+||..|+.++
T Consensus        92 ~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~  171 (209)
T d1ot8a_          92 TPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEA  171 (209)
T ss_dssp             CHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             ccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHH
Confidence            333444444555555544444444444 8899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhh
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL  157 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L  157 (473)
                      |++|+++|||++.+|..|+||||+|++.|+.++|++|
T Consensus       172 v~~Ll~~gad~n~~d~~g~Tpl~~A~~~~~~~iv~lL  208 (209)
T d1ot8a_         172 SKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL  208 (209)
T ss_dssp             HHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHCCCCCCCcCCCCCCHHHHHHHcCCHHHHhhc
Confidence            9999999999999999999999999999999999987

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.4e-19  Score=179.15  Aligned_cols=121  Identities=25%  Similarity=0.231  Sum_probs=99.4

Q ss_pred             CCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCC
Q 011991           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (473)
Q Consensus        38 ~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~  117 (473)
                      ....++..++..++.+.++.+++.+......+..+.||||.|+..|+.++++++++.|+|+|.+|.+|.||||+|+..|+
T Consensus       263 ~g~~~l~~a~~~~~~~i~~~Ll~~g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~  342 (408)
T d1n11a_         263 SGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH  342 (408)
T ss_dssp             TCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCChhhhhhhcCcHHHHHHHHHCCCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCC
Confidence            34445677778888887777777664444447778888888888888888888888889998888889999999999999


Q ss_pred             HHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhh
Q 011991          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILK  158 (473)
Q Consensus       118 ~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~  158 (473)
                      .++|++|+++|||++.+|.+|+||||+|++.|+.++|++|.
T Consensus       343 ~~iv~~Ll~~GAd~n~~d~~G~t~L~~A~~~~~~~iv~~L~  383 (408)
T d1n11a_         343 TDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLK  383 (408)
T ss_dssp             HHHHHHHHHTTCCSCCCCSSSCCHHHHHHHTTCHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHH
Confidence            99999999999999988989999999999988888888663

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.77  E-value=2.3e-19  Score=152.84  Aligned_cols=116  Identities=26%  Similarity=0.236  Sum_probs=65.9

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv  121 (473)
                      +++.++..++.+.+..++.........+..+.++++.++...+.+++++++.+|++++.+|.+|+||||+|+..|+.++|
T Consensus        37 ~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv  116 (153)
T d1awcb_          37 PLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVV  116 (153)
T ss_dssp             HHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccceeeecccccCCccccccccCchHHHhhhhcchhhee
Confidence            33333344444433333333333333333444444444444444555555555566666666667777777777777777


Q ss_pred             HHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhh
Q 011991          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL  157 (473)
Q Consensus       122 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L  157 (473)
                      ++|+++|+|++.+|.+|.||||+|+..|+.+++++|
T Consensus       117 ~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL  152 (153)
T d1awcb_         117 ELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             HHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             eeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence            776666777766666677777777766776666665

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.4e-19  Score=154.71  Aligned_cols=125  Identities=21%  Similarity=0.196  Sum_probs=89.5

Q ss_pred             cceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHH
Q 011991           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (473)
Q Consensus        42 ~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv  121 (473)
                      +++.||..|+++.|+.|+++|......|.+|.||||+|+ .|+.+++++|+++|+|++.++..|.|+|+.++..++.+++
T Consensus         4 ~Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~   82 (156)
T d1ihba_           4 ELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTL   82 (156)
T ss_dssp             HHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHH
T ss_pred             HHHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCcccccccccccccccc
Confidence            455677777777777777766443334777777777664 6777777777777777777777777777777777777777


Q ss_pred             HHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCC-cCccC
Q 011991          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA-KVPKT  167 (473)
Q Consensus       122 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~-~i~~~  167 (473)
                      ++|++.+.+++..|..|.+|+++|+..++.+++++|++++. +++.+
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~  129 (156)
T d1ihba_          83 QTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHR  129 (156)
T ss_dssp             HHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            77777777777777777777777777777777777776664 44444

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=2.4e-19  Score=168.58  Aligned_cols=128  Identities=20%  Similarity=0.163  Sum_probs=114.2

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCC-CCCCChHHHHHHHc----CCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACR----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~-~~~g~t~L~~aa~~----g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~  115 (473)
                      .+++.|++.|+.+.++.|+++.+.+++. +..|.++++.+...    +..+++++|+++|+++|.+|..|.||||+|+..
T Consensus       150 t~L~~A~~~~~~~~~~~Ll~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~  229 (285)
T d1wdya_         150 TALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEK  229 (285)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHT
T ss_pred             hHHHHHHHcCCHHHHHHHHhccCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhc
Confidence            3466789999999999999887776665 78888888776553    345799999999999999999999999999999


Q ss_pred             CCHHHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc
Q 011991          116 GHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       116 g~~~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~  168 (473)
                      |+.++|++|++ .|+|++.+|.+|.||||+|+..|+.+++++|+++|++++..+
T Consensus       230 ~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d  283 (285)
T d1wdya_         230 KHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD  283 (285)
T ss_dssp             TCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred             CcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence            99999999997 499999999999999999999999999999999999998865

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.77  E-value=1.2e-19  Score=165.29  Aligned_cols=121  Identities=23%  Similarity=0.123  Sum_probs=108.9

Q ss_pred             CCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcC-CCCcccCCCCCcHHHHHHHcCCH
Q 011991           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~g-a~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ...+..++..++.+.+..++..+......+.+|+||||+|+..|+.+++++|++.| .++|.+|.+|+||||+|+..|+.
T Consensus       106 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~  185 (229)
T d1ixva_         106 VTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHG  185 (229)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCH
T ss_pred             ccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccH
Confidence            34455667788888888888888776667999999999999999999999999987 68999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCc
Q 011991          119 EVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (473)
Q Consensus       119 ~iv~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~  163 (473)
                      ++|++|++ .|+|++.+|..|+||||+|+   +.+++++|+++|+|
T Consensus       186 ~~v~~Ll~~~gad~~~~d~~g~t~l~~A~---~~~~~~~Ll~~g~d  228 (229)
T d1ixva_         186 DAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLNNVVD  228 (229)
T ss_dssp             HHHHHHHHHHCCCSCCCCTTSCCTGGGCS---CHHHHHHHHHHCCC
T ss_pred             HHHHHHHHhcCCCCCCcCCCCCCHHHHHh---hHHHHHHHHHcCCC
Confidence            99999997 59999999999999999997   45899999999987

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.77  E-value=4.4e-19  Score=164.20  Aligned_cols=96  Identities=22%  Similarity=0.133  Sum_probs=91.2

Q ss_pred             CCCCChHHHHHHHcCCHHHHHHHHHcCCC---CcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHH
Q 011991           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSD---VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (473)
Q Consensus        69 ~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~---~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A  145 (473)
                      +.+|.||||+||..|+.+++++||++|++   +|.+|..|.||||+||..|+.+++++|+++||+++.+|.+|.||||+|
T Consensus         6 ~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~A   85 (255)
T d1oy3d_           6 TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLA   85 (255)
T ss_dssp             CTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHH
T ss_pred             CcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhhh
Confidence            78999999999999999999999999998   678889999999999999999999999999999999999999999999


Q ss_pred             HHcCChhhhhhhhhcCCcC
Q 011991          146 KYYGNVEVYNILKARGAKV  164 (473)
Q Consensus       146 ~~~~~~~~~~~L~~~g~~i  164 (473)
                      +..++.+++++|++.+...
T Consensus        86 ~~~~~~~~~~~Ll~~~~~~  104 (255)
T d1oy3d_          86 CRVRAHTCACVLLQPRPSH  104 (255)
T ss_dssp             TTTTCHHHHHHHSSSCCSS
T ss_pred             hccCchHHHHHHHhhccch
Confidence            9999999999998876544

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=8.6e-19  Score=149.69  Aligned_cols=133  Identities=26%  Similarity=0.337  Sum_probs=116.9

Q ss_pred             cccCCCCCc--CCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCC
Q 011991           29 MSRQSSFDP--RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR  106 (473)
Q Consensus        29 ~~~~~~~~~--~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~  106 (473)
                      +.+..+++.  ..+..++.+|..|+.+.++.+++.+......+..|.|+|+.++..|+.+.++.|++.+.+++..|..|.
T Consensus        21 l~~g~d~n~~d~~g~TpL~~A~~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  100 (156)
T d1ihba_          21 LQNNVNVNAQNGFGRTALQVMKLGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGN  100 (156)
T ss_dssp             TTSCCCTTCCCTTSCCHHHHCCSSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HHCCCCcCccCCcccccccccccccccccccccccccccccccccCcccccccccccccccccccccccccccccccccc
Confidence            334444442  244556678889999999888888755545588999999999999999999999999999999999999


Q ss_pred             cHHHHHHHcCCHHHHHHHHhCCC-CCCccCCCCCcHHHHHHHcCChhhhhhhhhcC
Q 011991          107 TALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (473)
Q Consensus       107 T~lh~A~~~g~~~iv~~Ll~~ga-~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g  161 (473)
                      ||||+|+..|+.+++++|+++|+ +++.+|..|+||||+|+..|+.+++++|+++|
T Consensus       101 ~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g~TpL~~A~~~~~~~iv~~Ll~~G  156 (156)
T d1ihba_         101 LPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG  156 (156)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred             cccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHhcC
Confidence            99999999999999999999986 89999999999999999999999999999987

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.76  E-value=3.5e-19  Score=151.63  Aligned_cols=134  Identities=27%  Similarity=0.306  Sum_probs=122.1

Q ss_pred             CcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHH
Q 011991           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~i  120 (473)
                      .+++.||+.|+.+.|+.||+.+. +++.+..|+||||+|+..++.++++.++......+..+..+.++++.++...+.++
T Consensus         4 t~L~~Aa~~g~~~~v~~LL~~ga-~~~~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (153)
T d1awcb_           4 KKLLEAARAGQDDEVRILMANGA-PFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANI   82 (153)
T ss_dssp             HHHHHHHHHTCHHHHHHHHHHTC-CCCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred             HHHHHHHHCCCHHHHHHHHHcCC-CcccccCCCcccccccccccccccccccccccccccccccccccccccccccccee
Confidence            45778999999999999999875 55679999999999999999999999999999888888999999999999999999


Q ss_pred             HHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       121 v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      +++|+.+|++++.+|..|+||||+|+..|+.+++++|+++|++++..+.   ||++.|
T Consensus        83 ~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A  140 (153)
T d1awcb_          83 VEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDIS  140 (153)
T ss_dssp             HHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             eecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHH
Confidence            9999999999999999999999999999999999999999999977654   444444

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.75  E-value=1.5e-18  Score=165.13  Aligned_cols=104  Identities=20%  Similarity=0.251  Sum_probs=88.3

Q ss_pred             CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH-------HHHHHH-----------------
Q 011991           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV-------EVVKLL-----------------  124 (473)
Q Consensus        69 ~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~-------~iv~~L-----------------  124 (473)
                      |.+|+||||+||..|+.++|++||++|||++.+|..|+||||+||..++.       +++++|                 
T Consensus       104 D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~~g~t~lh~  183 (301)
T d1sw6a_         104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHH  183 (301)
T ss_dssp             STTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcccccCCHHHH
Confidence            88999999999999999999999999999999999999999999986642       333332                 


Q ss_pred             -------------------------HhCCCC-------------------------------------CCccCCCCCcHH
Q 011991          125 -------------------------LSKKAN-------------------------------------IDARDRWGSTAA  142 (473)
Q Consensus       125 -------------------------l~~ga~-------------------------------------~~~~~~~g~t~l  142 (473)
                                               ++.+..                                     +|.+|..|+|||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~TpL  263 (301)
T d1sw6a_         184 IIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL  263 (301)
T ss_dssp             HHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHH
T ss_pred             HHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCCCCCCCCHH
Confidence                                     222221                                     688999999999


Q ss_pred             HHHHHcCChhhhhhhhhcCCcCccCcCCCC
Q 011991          143 ADAKYYGNVEVYNILKARGAKVPKTKRTPM  172 (473)
Q Consensus       143 ~~A~~~~~~~~~~~L~~~g~~i~~~~~t~l  172 (473)
                      |+|++.|+.++|++|+++|++++..+..+.
T Consensus       264 h~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~  293 (301)
T d1sw6a_         264 NIAARLGNISIVDALLDYGADPFIANKSGL  293 (301)
T ss_dssp             HHHHHHCCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence            999999999999999999999987765443

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.73  E-value=1.8e-20  Score=182.36  Aligned_cols=126  Identities=13%  Similarity=0.043  Sum_probs=97.3

Q ss_pred             CcceeeccCCCCcccc--CCCCCccCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC--CCCCcHHHHHHHc
Q 011991           41 NMRFSFGRQSSLDPIR--RSPVQDELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID--LDGRTALHIAACE  115 (473)
Q Consensus        41 ~~~~~~~~~g~~~~~~--~~l~~~~~~~~-~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d--~~g~T~lh~A~~~  115 (473)
                      ..++-||..|+.+.+.  ++|...+.+++ .+.+|+||||+||.+|+.++|++|+++|+++|..|  .+|+||||+||..
T Consensus        92 t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~  171 (346)
T d2ajaa1          92 VICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAEN  171 (346)
T ss_dssp             HHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHT
T ss_pred             cHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHH
Confidence            3456688888876543  23444445555 48888999999999999999999999999988775  4588999999999


Q ss_pred             CCHHHHHHHHhCCCCCC---ccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCcc
Q 011991          116 GHVEVVKLLLSKKANID---ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK  166 (473)
Q Consensus       116 g~~~iv~~Ll~~ga~~~---~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~  166 (473)
                      ||.+||++|++.|++..   ..+.+|.||++.|+..|+.+++++|+++|++++.
T Consensus       172 g~~~iv~~Ll~~~~~~~~~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~~~  225 (346)
T d2ajaa1         172 GHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAY  225 (346)
T ss_dssp             TCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHHHH
T ss_pred             hhHHHHHHHHHcCCcccccccccCCCcchhhHHhhcCHHHHHHHHHhCCCCcch
Confidence            99999999999987653   4445677888888889999999999988887643

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=5.1e-18  Score=152.18  Aligned_cols=137  Identities=24%  Similarity=0.204  Sum_probs=115.7

Q ss_pred             CCcceeeccCCCCccccCCCC---CccCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-------------
Q 011991           40 NNMRFSFGRQSSLDPIRRSPV---QDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-------------  102 (473)
Q Consensus        40 ~~~~~~~~~~g~~~~~~~~l~---~~~~~~~~-~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-------------  102 (473)
                      ..+++.||..|+++.++.++.   ..+.+++. |.+|+||||+||..|+.+++++|+++|+++|..+             
T Consensus         4 ~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~~~   83 (228)
T d1k1aa_           4 DTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEH   83 (228)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             ccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccccc
Confidence            345678889999998888764   23444554 8899999999999999999999999999887633             


Q ss_pred             ----------------------------------------------------------CCCCcHHHHHHHcCCHHHHHHH
Q 011991          103 ----------------------------------------------------------LDGRTALHIAACEGHVEVVKLL  124 (473)
Q Consensus       103 ----------------------------------------------------------~~g~T~lh~A~~~g~~~iv~~L  124 (473)
                                                                                ..|.+|||.|+..++.++++.+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~~  163 (228)
T d1k1aa_          84 RSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLL  163 (228)
T ss_dssp             TCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHH
T ss_pred             ccccchhhhhhccccccccccccccccccccccccccccchhhhhhhccccccccccccchhhHHHHHHHhhhhhhhhhh
Confidence                                                                      2356778888888999999999


Q ss_pred             HhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          125 LSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       125 l~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      +++|.+++.+|..|.||||+|+..|+.+++++|+++|++++.++   .||++.|.
T Consensus       164 ~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~  218 (228)
T d1k1aa_         164 LQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVAR  218 (228)
T ss_dssp             HHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCS
T ss_pred             hhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            99999999999999999999999999999999999999998764   56666653

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=9.6e-19  Score=156.76  Aligned_cols=80  Identities=35%  Similarity=0.363  Sum_probs=69.6

Q ss_pred             HHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCcC
Q 011991           90 DLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR  169 (473)
Q Consensus        90 ~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~~  169 (473)
                      .|+.+|++++.+|..|+||||+|+..|..++++.|++++++++.+|..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus       108 ~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~  187 (209)
T d1ot8a_         108 DLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDH  187 (209)
T ss_dssp             HHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             hhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCC
Confidence            33334444444677788999999999999999999999999999999999999999999999999999999999977654

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=6.4e-18  Score=166.94  Aligned_cols=137  Identities=21%  Similarity=0.298  Sum_probs=122.0

Q ss_pred             CCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~  118 (473)
                      ...++..++..++.+.++.++..+......+..|.|||+.|+..++.+++++|+++|++++..+..+.||||.|+..++.
T Consensus       231 ~~t~l~~a~~~~~~~~~~~~~~~~~~~~~~~~~g~~~l~~a~~~~~~~i~~~Ll~~g~~~~~~~~~~~t~L~~~~~~~~~  310 (408)
T d1n11a_         231 GVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNI  310 (408)
T ss_dssp             CCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCS
T ss_pred             CCCHHHHHHHhCcHhHhhhhhccccccccccCCCCChhhhhhhcCcHHHHHHHHHCCCccccccccccccchhhcccCcc
Confidence            34455667788888888887777655555688999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCC
Q 011991          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA  175 (473)
Q Consensus       119 ~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a  175 (473)
                      +++++|+++|++++.+|.+|.||||+|++.|+.++|++|+++|++++.++   +|+++.|
T Consensus       311 ~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t~L~~A  370 (408)
T d1n11a_         311 KLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIA  370 (408)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCCHHHHH
T ss_pred             eeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            99999999999999999999999999999999999999999999998775   4555555

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.71  E-value=5.7e-19  Score=171.54  Aligned_cols=96  Identities=21%  Similarity=0.162  Sum_probs=85.6

Q ss_pred             CCCCChHHHHHHHcCCHHHHHH---HHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccC--CCCCcHHH
Q 011991           69 NLDSTMQLLFMACRGDVKGVED---LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD--RWGSTAAA  143 (473)
Q Consensus        69 ~~~g~t~L~~aa~~g~~~~v~~---Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~--~~g~t~l~  143 (473)
                      +..|.||||+||.+|+.+++++   |++.|+++|.+|.+|+||||+||..||.++|++|+++|++++..+  .+|+||||
T Consensus        87 ~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~  166 (346)
T d2ajaa1          87 GIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFR  166 (346)
T ss_dssp             TCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHH
T ss_pred             cCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhH
Confidence            6689999999999999887765   789999999999999999999999999999999999999999876  46999999


Q ss_pred             HHHHcCChhhhhhhhhcCCcC
Q 011991          144 DAKYYGNVEVYNILKARGAKV  164 (473)
Q Consensus       144 ~A~~~~~~~~~~~L~~~g~~i  164 (473)
                      +|+..|+.++|++|++.|.+.
T Consensus       167 ~Aa~~g~~~iv~~Ll~~~~~~  187 (346)
T d2ajaa1         167 LAAENGHLHVLNRLCELAPTE  187 (346)
T ss_dssp             HHHHTTCHHHHHHHHHSCGGG
T ss_pred             HHHHHhhHHHHHHHHHcCCcc
Confidence            999999999999999998765

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.70  E-value=3.6e-17  Score=139.20  Aligned_cols=101  Identities=25%  Similarity=0.319  Sum_probs=89.5

Q ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCccc------CCCCCcHHHHHHHc---CCHHHHHHHHhCCCCCCccCCCCCcHHHHH
Q 011991           75 QLLFMACRGDVKGVEDLLNEGSDVNSI------DLDGRTALHIAACE---GHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (473)
Q Consensus        75 ~L~~aa~~g~~~~v~~Ll~~ga~~n~~------d~~g~T~lh~A~~~---g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A  145 (473)
                      .|+.|+..+++..+..++..|+|++.+      +..|+||||+|+..   |+.++|++|+++|+|++.+|..|+||||+|
T Consensus         9 ~L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A   88 (154)
T d1dcqa1           9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYC   88 (154)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHH
T ss_pred             HHHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccc
Confidence            456778899999999999999998765      77899999999974   789999999999999999999999999999


Q ss_pred             HHcCChhhhhhhhhcCCcCccCcC---CCCcCC
Q 011991          146 KYYGNVEVYNILKARGAKVPKTKR---TPMTVA  175 (473)
Q Consensus       146 ~~~~~~~~~~~L~~~g~~i~~~~~---t~l~~a  175 (473)
                      +..|+.+++++|+++|++++..+.   ||++.|
T Consensus        89 ~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A  121 (154)
T d1dcqa1          89 CLTDNAECLKLLLRGKASIEIANESGETPLDIA  121 (154)
T ss_dssp             HHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             cccccccccccccccCccccccCCCCCCHHHHH
Confidence            999999999999999999977654   455544

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=4e-18  Score=154.47  Aligned_cols=149  Identities=18%  Similarity=0.166  Sum_probs=119.6

Q ss_pred             ccCCCCCc---CCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCC------cc
Q 011991           30 SRQSSFDP---RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDV------NS  100 (473)
Q Consensus        30 ~~~~~~~~---~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~------n~  100 (473)
                      .....++.   ....+++-|+..|+.+.++.+++.+......|..|.||||+|+..|+.++++.|++.+.+.      +.
T Consensus        27 ~~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  106 (221)
T d1iknd_          27 GDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKA  106 (221)
T ss_dssp             --CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGC
T ss_pred             hCCCCcccCCCCCCccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccc
Confidence            34444443   3455677788899989888888887655556899999999999999999999999887653      34


Q ss_pred             cCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccC-CCCCcHHHHHHHcCChhhhhhhhhcCCcCccCc---CCCCcCCC
Q 011991          101 IDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVAN  176 (473)
Q Consensus       101 ~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~~g~~i~~~~---~t~l~~a~  176 (473)
                      ....|.||||.|+..|+.+++++|+..|++++.++ .+|.||||+|+..|+.+++++|+++|++++.++   .||++.|.
T Consensus       107 ~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~  186 (221)
T d1iknd_         107 TNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTW  186 (221)
T ss_dssp             CCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCT
T ss_pred             cccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHH
Confidence            45678999999999999999999999999988765 579999999999999999999999999987664   57777765


Q ss_pred             CC
Q 011991          177 PR  178 (473)
Q Consensus       177 ~~  178 (473)
                      ..
T Consensus       187 ~~  188 (221)
T d1iknd_         187 GR  188 (221)
T ss_dssp             TS
T ss_pred             HC
Confidence            43

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=8.3e-17  Score=145.63  Aligned_cols=126  Identities=21%  Similarity=0.153  Sum_probs=101.9

Q ss_pred             CCCcceeeccCCCCccccCCCCCccC------CCCCCCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccC-CCCCcHHHH
Q 011991           39 RNNMRFSFGRQSSLDPIRRSPVQDEL------TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHI  111 (473)
Q Consensus        39 ~~~~~~~~~~~g~~~~~~~~l~~~~~------~~~~~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d-~~g~T~lh~  111 (473)
                      ...++..++..|+.+.++.++..+..      ......+|.||||.|+..|+.+++++|+..|+++|.++ .+|+||||+
T Consensus        72 g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~  151 (221)
T d1iknd_          72 GNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHL  151 (221)
T ss_dssp             CCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHH
T ss_pred             cccccccccccccccccchhhhhcccccccccccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCcccc
Confidence            33456677778888777766654422      22235568899999999999999999999999988765 578999999


Q ss_pred             HHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHcCChhhhhhhhhcCCcC
Q 011991          112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (473)
Q Consensus       112 A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g~~i  164 (473)
                      |+..|+.+++++|+++|+|++.+|..|+||||+|+..++.+++++|.+...+.
T Consensus       152 A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~~~~~~~~~~l~~~~~~~  204 (221)
T d1iknd_         152 AVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLEN  204 (221)
T ss_dssp             HHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTTSSCHHHHHHHHTTSCGG
T ss_pred             ccccccHHHHHHHHhcCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCcc
Confidence            99999999999999999999999999999999999999999999998887653

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.68  E-value=6e-17  Score=152.59  Aligned_cols=100  Identities=32%  Similarity=0.465  Sum_probs=94.6

Q ss_pred             CCCCChHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHHHc
Q 011991           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYY  148 (473)
Q Consensus        69 ~~~g~t~L~~aa~~g~~~~v~~Ll~~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~~~  148 (473)
                      +.++.|+||.||..|+.++|++||++|+|||.+|.+|+||||+|+..|+.++|++|+++|++.+..+..+.|||+.|+..
T Consensus        37 ~~~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~  116 (291)
T d1s70b_          37 KFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC  116 (291)
T ss_dssp             EECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHH
T ss_pred             CCCCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccc
Confidence            34678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhhhhhhhhcCCcCccCc
Q 011991          149 GNVEVYNILKARGAKVPKTK  168 (473)
Q Consensus       149 ~~~~~~~~L~~~g~~i~~~~  168 (473)
                      ++.++++.|+++|...+..+
T Consensus       117 ~~~~~~~~l~~~~~~~~~~~  136 (291)
T d1s70b_         117 GYLDIAEYLISQGAHVGAVN  136 (291)
T ss_dssp             TCHHHHHHHHHTTCCTTCCC
T ss_pred             cccchhhcccccCccccccc
Confidence            99999999999998775543

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=3.9e-16  Score=139.62  Aligned_cols=93  Identities=28%  Similarity=0.283  Sum_probs=87.2

Q ss_pred             CCCChHHHHHHHcCCHHHHHHHHH----cCCCCcccCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHH
Q 011991           70 LDSTMQLLFMACRGDVKGVEDLLN----EGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (473)
Q Consensus        70 ~~g~t~L~~aa~~g~~~~v~~Ll~----~ga~~n~~d~~g~T~lh~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A  145 (473)
                      .+|+||||+||..|+.++|+.|++    .|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..|.++++.|
T Consensus         1 ~dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a   80 (228)
T d1k1aa_           1 EDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLA   80 (228)
T ss_dssp             CTTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             CCCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhcccccccccccccccccccccccccccccccc
Confidence            479999999999999999999884    8999999999999999999999999999999999999999999999999999


Q ss_pred             HHcCChhhhhhhhhcCC
Q 011991          146 KYYGNVEVYNILKARGA  162 (473)
Q Consensus       146 ~~~~~~~~~~~L~~~g~  162 (473)
                      ...++.++++.+.....
T Consensus        81 ~~~~~~~~~~~~~~~~~   97 (228)
T d1k1aa_          81 CEHRSPTCLRALLDSAA   97 (228)
T ss_dssp             HHTTCHHHHHHHHHHSC
T ss_pred             cccccccchhhhhhccc
Confidence            99999999988766544

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.64  E-value=3.7e-17  Score=155.41  Aligned_cols=111  Identities=16%  Similarity=0.119  Sum_probs=88.6

Q ss_pred             CcCCCCcceeeccCCCCccccCCCCCccCCCCCCCCCChHHHHHHHcCCH-------HHHHH------------------
Q 011991           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDV-------KGVED------------------   90 (473)
Q Consensus        36 ~~~~~~~~~~~~~~g~~~~~~~~l~~~~~~~~~~~~g~t~L~~aa~~g~~-------~~v~~------------------   90 (473)
                      |.....+++.||..|+++.|+.|++.|......|..|+||||.||..++.       +++++                  
T Consensus       104 D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~~g~t~lh~  183 (301)
T d1sw6a_         104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHH  183 (301)
T ss_dssp             STTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcccccCCHHHH
Confidence            44444567778899999999999988754444588999999999986541       23322                  


Q ss_pred             ------------------------HHHcCC-------------------------------------CCcccCCCCCcHH
Q 011991           91 ------------------------LLNEGS-------------------------------------DVNSIDLDGRTAL  109 (473)
Q Consensus        91 ------------------------Ll~~ga-------------------------------------~~n~~d~~g~T~l  109 (473)
                                              +++.+.                                     .+|.+|.+|+|||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~TpL  263 (301)
T d1sw6a_         184 IIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL  263 (301)
T ss_dssp             HHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHH
T ss_pred             HHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCCCCCCCCHH
Confidence                                    222221                                     1688999999999


Q ss_pred             HHHHHcCCHHHHHHHHhCCCCCCccCCCCCcHHHHHH
Q 011991          110 HIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK  146 (473)
Q Consensus       110 h~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~l~~A~  146 (473)
                      |+||..|+.++|++|+++|||++++|..|+|||++|+
T Consensus       264 h~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~  300 (301)
T d1sw6a_         264 NIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA  300 (301)
T ss_dssp             HHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred             HHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence            9999999999999999999999999999999999984

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=1.4e-15  Score=142.30  Aligned_cols=90  Identities=23%  Similarity=0.259  Sum_probs=76.9

Q ss_pred             eccCCCCccc-cCCCCCccCCCC-CCCCCChHHHHHHHcCCHHHHHHHHH-cCCCCcccCCCCCcHHHHHHHcCCHHHHH
Q 011991           46 FGRQSSLDPI-RRSPVQDELTVP-ENLDSTMQLLFMACRGDVKGVEDLLN-EGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (473)
Q Consensus        46 ~~~~g~~~~~-~~~l~~~~~~~~-~~~~g~t~L~~aa~~g~~~~v~~Ll~-~ga~~n~~d~~g~T~lh~A~~~g~~~iv~  122 (473)
                      ++..++...+ +.|++.+ .+++ .+..|.||||+||..|+.++|++||+ .|+|+|.+|.+|.||||+|+..|+.|+|+
T Consensus       192 ~~~~~~~~~i~~~Li~~g-a~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~  270 (285)
T d1wdya_         192 SSDDSDVEAITHLLLDHG-ADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAE  270 (285)
T ss_dssp             CSCTTTHHHHHHHHHHTT-CCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHH
T ss_pred             cccchHHHHHHHHHHHCC-CCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHH
Confidence            3555555544 4556555 4444 48899999999999999999999998 59999999999999999999999999999


Q ss_pred             HHHhCCCCCCccCC
Q 011991          123 LLLSKKANIDARDR  136 (473)
Q Consensus       123 ~Ll~~ga~~~~~~~  136 (473)
                      +||++|||+|++|.
T Consensus       271 ~Ll~~GAd~n~~d~  284 (285)
T d1wdya_         271 LLCKRGASTDCGDL  284 (285)
T ss_dssp             HHHHHSSCSCCSSC
T ss_pred             HHHHCCCCCCcccC
Confidence            99999999999884

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.23  E-value=2.6e-06  Score=77.23  Aligned_cols=125  Identities=10%  Similarity=0.031  Sum_probs=86.1

Q ss_pred             EEEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcCCC
Q 011991          204 QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL  282 (473)
Q Consensus       204 ~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l  282 (473)
                      ..+..++..+++|+........   ...+.+|...++.+. +--+++++.+...++..++||++++|.++.+.....   
T Consensus        31 ~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---  104 (263)
T d1j7la_          31 YKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---  104 (263)
T ss_dssp             EEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---
T ss_pred             EEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---
Confidence            3456677888999986543221   124677888888774 434677888888888899999999998886543211   


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------------------C
Q 011991          283 SPSKVLRFALDLARGMNYLHECK--------------------------------------------------------P  306 (473)
Q Consensus       283 ~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------------------------~  306 (473)
                        .....++.+++..+..||+..                                                        +
T Consensus       105 --~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  182 (263)
T d1j7la_         105 --QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEE  182 (263)
T ss_dssp             --SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCC
T ss_pred             --ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCC
Confidence              122334555666666666421                                                        1


Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      ..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       183 ~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cEEEEeeccCcceeecCCceEEEeechhcc
Confidence            137999999999999976666799999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.96  E-value=1.2e-05  Score=72.11  Aligned_cols=120  Identities=19%  Similarity=0.152  Sum_probs=77.4

Q ss_pred             EEEEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC--CCeeeeEEeeEeeCCceEEEEeccCCCCHHHHHHHcC
Q 011991          203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG  280 (473)
Q Consensus       203 ~~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  280 (473)
                      |-+....+..+++|.-......      .+..|+..++.+.  .-.+++++.+..+++..++||++++|.++.+.     
T Consensus        28 ~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~-----   96 (255)
T d1nd4a_          28 FRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS-----   96 (255)
T ss_dssp             EEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS-----
T ss_pred             EEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc-----
Confidence            4444455667899987654332      3677888888774  23367788888888889999999988665321     


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhh---------------------------------------------------cC----
Q 011991          281 RLSPSKVLRFALDLARGMNYLHE---------------------------------------------------CK----  305 (473)
Q Consensus       281 ~l~~~~~~~i~~qi~~~L~~LH~---------------------------------------------------~~----  305 (473)
                      ..+..   ..+.++...|..||+                                                   ..    
T Consensus        97 ~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          97 HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            01111   112233333333332                                                   11    


Q ss_pred             CCCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       306 ~~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      +..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            1237999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.27  E-value=0.00039  Score=66.44  Aligned_cols=29  Identities=21%  Similarity=0.265  Sum_probs=25.1

Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       308 ~iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      .++|+|+.|.|||++.+ .++|+||..+.+
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            49999999999999875 489999988754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.62  E-value=0.0029  Score=58.42  Aligned_cols=130  Identities=15%  Similarity=0.125  Sum_probs=72.4

Q ss_pred             EEEEEEecCcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcCCCe--eeeEEe-----eEeeCCceEEEEeccCCCCH--
Q 011991          202 SYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFVG-----AVTQNIPMMIVLEYHAKGDL--  272 (473)
Q Consensus       202 ~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~-----~~~~~~~~~lv~e~~~~gsL--  272 (473)
                      +|-+...+|..+++|+..+...+.    +.+..|...+..|...+  ++..+.     .+...+..+.++++++|..+  
T Consensus        38 vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          38 VYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             EEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             eEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            455556688899999997664432    44667888887774211  111111     23456678899999876332  


Q ss_pred             ---HHH------H---HH----c-----CC-------------------CCHH---HHHHHHHHHHHHHHHH-hhcCCCC
Q 011991          273 ---ASY------L---QK----K-----GR-------------------LSPS---KVLRFALDLARGMNYL-HECKPDP  308 (473)
Q Consensus       273 ---~~~------l---~~----~-----~~-------------------l~~~---~~~~i~~qi~~~L~~L-H~~~~~~  308 (473)
                         ..+      +   +.    .     ..                   ++..   .....+.++...+.-. .+..+..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               111      1   00    0     00                   1111   1222233333333222 1222345


Q ss_pred             eEeCCCCCCCEEEcCCCcEEEEeeccccc
Q 011991          309 IIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (473)
Q Consensus       309 iiH~Dlkp~Nili~~~~~vkl~DfG~a~~  337 (473)
                      +||+|+.+.|||++. + ..++||+-++.
T Consensus       194 liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeC-C-ceEEechhccc
Confidence            899999999999974 3 45899998753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.08  E-value=0.066  Score=48.41  Aligned_cols=30  Identities=20%  Similarity=0.245  Sum_probs=26.6

Q ss_pred             CCeEeCCCCCCCEEEcCCCcEEEEeecccc
Q 011991          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (473)
Q Consensus       307 ~~iiH~Dlkp~Nili~~~~~vkl~DfG~a~  336 (473)
                      .++||+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            359999999999999988777899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.03  E-value=0.023  Score=53.60  Aligned_cols=54  Identities=15%  Similarity=0.115  Sum_probs=34.6

Q ss_pred             CcEEEEEEEcCCCCCCHHHHHHHHHHHHHHHhcC-CCeeeeEEeeEeeCCceEEEEeccCCCCH
Q 011991          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (473)
Q Consensus       210 ~~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (473)
                      .+.|.+++... . ...   ....+|..+++.+. +.-.+++++++.+    ++|+||++|.+|
T Consensus        74 ~~~vllRi~g~-~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          74 PNKVLLRVYFN-P-ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             CSEEEEEEECS-C-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             CCcEEEEecCC-c-chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            35677777642 1 222   23457999999885 4334577887753    689999987544